<SEC-DOCUMENT>0001613103-22-000063.txt : 20221201
<SEC-HEADER>0001613103-22-000063.hdr.sgml : 20221201
<ACCEPTANCE-DATETIME>20221201161757
ACCESSION NUMBER:		0001613103-22-000063
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		109
CONFORMED PERIOD OF REPORT:	20221028
FILED AS OF DATE:		20221201
DATE AS OF CHANGE:		20221201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medtronic plc
		CENTRAL INDEX KEY:			0001613103
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0428

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36820
		FILM NUMBER:		221439034

	BUSINESS ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		01135314381700

	MAIL ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Ltd
		DATE OF NAME CHANGE:	20150112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Holdings Ltd
		DATE OF NAME CHANGE:	20140711

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kalani I Ltd
		DATE OF NAME CHANGE:	20140709
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mdt-20221028.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a,d:3900fafdc57a4da3bf71572260ed33b5--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:mdt="http://www.medtronic.com/20221028" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdt-20221028</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF80LTEtMS0xLTExOTg2OA_f142d26a-a4d2-412b-8fdc-97edf48194f1">0001613103</ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF81LTEtMS0xLTExOTg2OA_9bcc01f8-125c-4668-bc5e-8cfeffd4e8ca">4/28</ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF82LTEtMS0xLTExOTg2OA_1ca55924-bf88-4dff-98f2-a66d37c8575d">false</ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF83LTEtMS0xLTExOTg2OA_1c0a7377-db98-4fc2-b807-fca93ba76631">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF84LTEtMS0xLTExOTg2OA_8e075691-32ba-4ed7-b256-3abe65107dec">2023</ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF85LTEtMS0xLTExOTg2OA_0a4dbd16-093c-4a2e-ba41-bec6b0717e17">D02 XH02</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdt-20221028.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due20230000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if582051bf4124134a62ad07d19497784_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb33528b47724a289550d115188aeb99_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20394500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b27bafc1ca94489ba6518e9a3ef1483_I20221128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia0b6116555c34c9f83363705bad2dc7b_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c24ef1adeed4623bdd58565d19980a7_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf939ef7ba9b40d9b919eaff4d3aaf20_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f7d0c01899c445db04cd9b2d85f6968_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a2b3356080044499be1ee38fa01063b_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic96f676fdbed43a1af73c94a459a0027_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if81b699157ef400babbd49b79ce01d51_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04258c79de92422585b957b7ea074863_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf8710ac3ce4ccdac40ee3b1b558b39_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba553ebece994593a02b2325d2eaf828_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabee6461cac44d1b9e9883c0e2236533_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7b953379f84fdaa442b1f9a50a4444_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830c7cc13ba0450aa6d50f69c10d139a_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9edbc694c8954441b58c7dfcf548932d_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3715049e1f9a4a64bc2f20c1b2d751b1_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0140ab23f7415d9e84fba89d2ce274_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb31e75e6e81437d992d025c15bdbab7_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c26438766584fc093b6da547164787e_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479bc235eb204cc6bd9b5d428f9c482d_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id957c1291b754cb3989f2c5e3ac8dbf8_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90b6c031e74f4b8192cfe7653b448f7a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12e89df7a7284768b084b028fb30c0b3_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7de7fa9e2bd14d9cb49275324f2d4fff_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3889946f4cd466eb0c8de4cb9692332_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac68bc9471644ffc8005764e8ae89b46_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5462aaf0c094c7db4f015d2fc1cccfe_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7303ffa9282c44ada71fcf27f9caf878_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b4eb2cd7eb34e68bc0bfff863e48a7f_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i576eb2cb85264ebe977159af31544200_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id815d10cd7364e4c8224095110455793_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805e77a5795b43879236735b12530491_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3812240d458431e8ef07e8d1e16b569_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad2d789542f4a2382dd3a428fefa32f_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93039fe1caf846e29eab3a6ecfe114fd_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cfefe3cebb942b897dafda418007e00_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i674c328ca4cf4cacacc5730fead09f35_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie98b1d14c436463b872fdeceb9f130aa_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i758fd510e93e480db9ffe7c253a337a3_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4c020bc4494a4998a6177261e6225b_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9e3f477203428683ae92a742041fd6_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3190fe1c894e4a2b85407bc0557e735c_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a75125a2ce45cbb0110cffa8149de1_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b27da620ade4165842447d930ad60a5_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8245ba0bf94b40b7b27dc0842b8cc6b9_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26383b4523e74135acd4c7e7659b4845_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000ae0a85877429aaf119fe579aa99b6_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a3dd382c6945438731d0f15056527b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i104380acc80d4b33bdb75a56ac2c6c3a_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c7b3868ea6348b284ebcfa636598a64_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6cb2b2a61d40dd88447e04bbb15481_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd3cbd04fd67492bafbb8147b08ca285_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4016f75f0a6c48efba5e59908d817ef1_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96aaaa79ddc3450fa9639b6e04b840d5_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i739110963f73456da89189576a2091f4_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f70332fc7824fcabcb5d642eb7a2f6a_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie324a3122889429ebaf0032db23c5238_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d18929121a14b85ba7ae8f5ef22c1a9_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6e04e462ae4a2492cf55f9a81f3d29_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd255fc2b256464d83f0adcaf79f0ddd_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd10fb8d585649da82b0209da784c586_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298f3e560bc74437ab29be651d20c23c_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9689fd91f59346fcacc698cec3a68895_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f231991285846759c45d083b2999740_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6173309cb7a641cbaf71ef41eb3b7527_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9d5b9a26751433ea892c9f8b363dbe2_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3918c5f3d0af4735a961ab1815e1cf3d_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf9de08f7ea344bab23f761eeec19428_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1692b6fd84064547866e4a84aab6e13a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i369bfcdc666b4698958b63d22fedcb62_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9adc4ac26074f52a4fc617426b96edb_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17c53a8b4d840bf9f1f5c07e4dd2a76_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa1c2c8fbbd4ef994753457a37c388e_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i094e4d8aeb954d2cbf3b8cb59a49db5f_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i057120522c584c6fae651608298e537a_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a9931ef8274f7284b66ad7e01a834b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3febdd347f7f477d9298fd0419ce511b_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91330ecb8454e3c87bbd07559e10c3b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64bce33fbd78408f8084a88248f2eca1_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d8dc2aa18b4777873305f761bbf8b0_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd0dc280b5c24b7b82ea150e787a2baa_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea5fa54c40f4e3a8bc238188a9f7811_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92b937fd099a4e338e041ac1dcd2d695_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c0d78811777448cace0976925773be8_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie251fa17aa3949fe9f0839d52f9cd5c9_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6632c3723b974d80bbfd7795c6cef933_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d71e3989c6f4d4f9aba2569ad2a5bf3_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eeef53bad4b48bfb1c302257f4c2bf3_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed3671c909f416cab9afaf75dfcf9fb_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f1c372ed204eaa8382d90ad65d4902_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie028302d82c14ab399e272eb03720bb6_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c3b2e62cc94239b99a9e996b5678f1_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i610eea5eb3484fd6bf51b42709374d0b_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44d79d0fb65746aaa6359715a89e2ee7_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de1c8c6c0d445a083e6c55af3d03c6e_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298ed1e39d63426681947aac7c92c6fc_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfaba2c830554de58c19cb60762cabe6_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e4167c253b04797beb9ec205174739b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33446d8e0ee24892b0c64f6aaebbf045_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a344f488304d06b2d1c07cd4cc008b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab66a53e9d4144e895fc21c33e195eab_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32deed4df6594deba88fcc157d9318b9_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb7d8d91058f46969b341026534b0f8b_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3fb4f39283f4f57af883c4294c05e2f_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d72e4f26a74e2a9e315d0f49903406_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d368c56378c40fb904cbc84bf222cf2_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04fb1213c4b84a8a8f8565296c9cbb98_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie746f4753ebd49d4806edf24d4bc054f_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5214f11f980d4654b157bce110db9b3f_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7055abe559314041bd8f3e48e5c1b5ac_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1864b5e68da47c18ee80fc6916d798c_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01b3e03620d64556acc1932365baea4c_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9383983150046f9bf39c566f31fdcd5_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974d74af34f64bba98080397f378b049_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9145fb48548b429fa67e81114c3a7f77_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4886727899c748af9b7ca6ecc006d607_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4119f66ab242497fbd1a7129a09ef938_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1394b8d1d604848b1afc29f179024b5_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia54914f294dd447a8c3201ee0160b967_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6034dedd81034ca58a3efaa8aaf912b2_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47330c898c084aa5838659f2f34d4c10_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c1ab6b402e94618aaf6a6d53b19afaa_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644a9f4b3e1f4b2cbd1ddb0e7ec2d231_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac1e8c6edbf463894ff0a4a97c65b0c_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id75288cda0d146909d982333f28bd033_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i886d34bbec8640b6b611a39dd7f55630_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dbab7c4dd864773bfc6e76adab58533_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i582ee1774f514ca68b795b9717b436f9_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f59093bb7f543e795d5e21aa6b22695_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i878fa8e82bf64ae7aab3cb9e7cb532ff_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f850d1105104e52a1834603e5aa1069_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f9d4e944db0457eb58a4abb5fb0ac50_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d359386ad44272b635669807e608f6_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59834bcd47a841d88758402a4ea93e11_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b47df2f3bfd4e52b3825a46ddd428e5_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32be93843e34926a15aeb2dcc3dbcc2_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i993a3f339e894c8dafef5e5049915240_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31a13d28f0194f8eb5115201dbe86f3c_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9b22d428114c4ab5ee78a571295915_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00b55f38c464a969df5efc27c1c7d80_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a714d7dd59b4092861465d25ffd24ab_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7acac8017744c558ae12f06f24486c7_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce3653f29834ec387f827999d02f9fc_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fefedf1e5ea47b4a531ab78ce1ff37a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd8b96342484a81b5fa2dc86cd010e4_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202e893b22f240a5b7c9fd460ba69357_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4725c44b1daf418f8388bf7dc0380194_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8d8356269248db86adef62aabe056a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49cdfed15a07485aa1fe2b7e67209ebf_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2a4321a5aba4098afc2e72f4addc84d_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e81b5be3ebd42d6b0a7d11e27c5a66c_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib091f63ce1ed47fa86badb21ce620a7e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3f93df1ec946d38393e3dd053885a1_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d5f411538846809c17df42d6baca81_I20220513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-13</xbrli:startDate><xbrli:endDate>2022-05-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib15e9005fdf54bb388c5a1ebc77ec0c1_I20220513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e8fea31e19645bf890da6ac5660baec_I20220513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac13f4d55474a59bd8fd8d73215242f_I20220513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19cd5686ee1b41f4a0781c0d70df295d_D20220830-20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AfferaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-30</xbrli:startDate><xbrli:endDate>2022-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26636377353846a2a7e4ae845aeb7572_I20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AfferaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3a8e5da34e4451a2cc414372ccc1f7_I20220830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2aacc1c206e4a01aec2ccb24a371680_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c69bc171625454788f2c35a7111a3cf_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b9df38c023342f9ba4c348f76154832_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6da65d65d594808b778a60b752c29d5_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5499b0d188aa457384102e9d56fa1649_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f469be1b25343c2afe5256eef30c662_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc6a84fee82c404bac6319d748601679_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mdt:InProcessResearchDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51339e6172a4fa89793c01ac5372310_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c8100ac3fc3472cb1b2257195df4d15_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ieaec69ca2a9d420196afba03c715564d_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8536fb1f3cc8405c85d5955abab804d9_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7770b13078c4633b39a58a920db477c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2589490d854b4bbc9e1da49cf061a2e8_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc3efebb4dd43008c52a5f4f54db6ab_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4458127713949c4a58c258ac31d5b0f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eab4cc7e4a74091a2af9b1421a69dca_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf0cf08134fb482896645f610dcd043e_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5870d0d38b43288e41b0362ecae37f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:HeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic303609806184f2a8805b32d1c783a34_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16be2ec2863d4cd48ac8e0eb7c5810ca_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf42b4b6d0454f69954bbee47e517f83_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifccb4ab61ed34b10bc32266e11c04021_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76aa15f0495a412bb5fc7e8ff902a5d1_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb118eb3cf3495fa67564bb77d2993e_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10b9bf7f4c04b34a8e912ac100537a7_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23fad8dce9c14b88b09f562c0af053eb_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bd78bbe8f143f88fc76d50131fcd9c_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e280053272b4dd5b8c64cde259c885a_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc87cf841c074114a5ac8137bc707c99_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a4dc8016694646972d6448816d5640_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4182f25b264fa0a677c170f7aa55f9_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b041edd8d56490d893ff0c11caa0d8a_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d6cdd73391542f3b7994da4e26578af_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546d50a1a554496194d00f2caddaf5ca_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87940cb6cac741d6b1f3cc6fb389a371_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff0490f25be4b77b9b8f6dce7ac4704_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a7d73ef1c947bfac5459b19b344d12_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8cf02e126cb40ff876492202959b05e_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04964d69fc284d70b8188fb55131e440_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a172149369e4566a362a7034cff8552_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67cae084ba3e474287026bb8a735a3da_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750e8435c8c8420982689bdc80379523_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e3f285c5dfb4c6c8e9ef6bff8bbad66_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba560acd2e9b4ac59cc8a3b89523e6cd_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd39c4b6e9034559b7adc2252123cce6_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i388aa93f36a249c1a5b546222a59df60_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if90275cb55b4415a836c84bf7e67ed62_D20210501-20210730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-07-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a082f3a04564610933344f50f0c3196_D20220129-20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-29</xbrli:startDate><xbrli:endDate>2022-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb47a5513b8248b38d166e23c6e226cb_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0e9a2126f3451a9364ecb102f47619_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17c51259199438d92935700e9a84f38_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5183de769d9943e0bbf4bf305875caee_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaedf855a588542ea8b681a551750a94c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46181f8111394859b9590a8fcf87dea4_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6630e92f38ab4432b631dd6c08be1b5b_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0acdf85d52b44d0aab8be69ef0dfca9a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d3b04d42694befb06b33d5afa3ac4f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ea21efa0974fd89079e5ff7597d05c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2adc065c1c31426ca784f2f3aac4c338_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087fd6abf6244d26810b363ad7f12b34_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3cf62ad6eb249199fc96aa7235ad10e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc5013382474ea0bac44885f9583479_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9134674ac1064b3b88dfa58578f7b28f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14fac49e993e425480a39ef2da97c7e1_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16dab65d5fee4b13a1b5536b9061af57_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62f58f99517d475280eae05a72bba5a7_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5cf66c9d744fa6b08216cffcee6ea1_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e4261fc6da42f78a32a5697fd40ebc_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7679e68037ad488cad0ab87fcf105814_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e89ca409848475c9dd855df62f568ba_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f79d5bae0a4e73a42a93007576b58c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e31c2e0429a4641939c2538318931cc_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672142582fb643789a7c2276926b53c2_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692de9ddca214b599e9a03ae112ad3e2_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13212ed214a64a10aa002be4cdfbe506_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8558d9858fd3413fb08153977c7c737f_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76bbc05331214b40b0fd449dedfe22ea_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b399a04cb7646b5b07096251d2007a8_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e218fa6cf914c4388b263f46820286a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf32105f8fc437ab7b7ecaa4fba22e3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96538ee63df541aba2adf1f7c5ee69c7_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f21aaefede4ee3aa44f247594563e3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da397896f3b426988512b961eafff1c_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f45d131dfd44f8b06d2d1fbb1101b1_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefba2a09bdf2400fa659329962a625be_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18fb875e6a54bd698fc23cdb9435208_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4146b3ff2414dff8bec3c9d91d6df09_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e886b3a97c44676b6e52bc92376095e_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50675223fb9c4d24bac91bf5a8b500c5_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5341030da8404ab23eb314af6659f0_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b0751698534580a06d7e591c567510_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9959424fd6a4e18a014b452439974f3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4f16ecd76844a249feacc0c1f4a7db9_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af62c64c70e496180646fa5003616d9_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibabaf9d9de764e76a341637628038690_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i181e138f85db48af8965b7d878b7e8b9_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273769593a42414b9854eed6b2e7d297_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a9d94e94f1a4706a534771364ec005b_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac252a414964d53a7d3be0ec2452d75_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b9515044e8742dc9dfce5361f230a6e_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0b7ef8524844b0804a1928fb54d9b4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9259b16d9d1a47a3a029f28c0f8a81bd_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if29182b593044b31bebc366410e41692_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4027240c2d7f4b0697e1af8767791e37_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39738394791c43f39b81aa42666e1649_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia51c0979773246909434b1ce27622157_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad8f6d897f54b9abcdbb3985c505800_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965da10df5234587b1d528532b979fa4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3942d4373f44f7497691c840fa95db3_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc14bfe25a24c169750f3b677e3850f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a435f6230ca46b3a412340e46d67d2b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b73054f5384db484d17a799d1f1a64_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74804d544e17446ca08e983c8f7fa76f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie52a26d33fd64110b616f85161449591_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b14f05a2554bdbaf9b274cdfd744d4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i261e682721ee4018a0e687ae0df46295_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751c32721c1046dcb276c399e66b615a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f1d04b0787461cbd677984bf68ea36_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4ceaa34c16b4e969c2d70f8a46b0700_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16fd5558ce984801a4ce4154ad7e4bf0_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48a1296b3e44c84bf9342a1671330da_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bce3bdd02d842a78def75f12929df2e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01af7fce485a44f38019814091a50b8f_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72a79cc7e714e3f98098deb1aec4fd1_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2353fa72d44d49ceb3efd49225a21e23_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7012e804387641a7813faf2625661ec8_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9f92a697414dfd8bfd28a672323199_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4a0cb342f9428fb9e71a786d8f86df_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cda2d6fee9d41349edb516fb0368284_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84656a75b0454be4a3e0b59a5bf56733_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7489de2611c44626bfd326f30908b1a5_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7813502cc324fdfb9cad82fca2aef6f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7f465b4b499407f84b13e2f34e98cda_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a8b596b4464a54ad3624a0e04bd604_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4d3e7efdd64bbe98b4ba1443d485e3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaecd0e4856b431fa395153da8bc83d0_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i074c3d2b9e5943a78a8bc0e775eaae2a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d2f2ee743674b16a4e766f4653881b6_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74d22bb72025442cac41507454e9f728_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600fd760a9284c3ba2ce36a2e1c4adb7_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd3d2cc9e4b461bb1e2c4f66d747810_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec69cbbc5484f558ee3b3e485197f4b_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52f4d1f6b37466eb1f1c57c273f68fe_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45066488b7f44235877f7d05b88cecbf_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88da43b7ee240e08c8140ee86cda15b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854fe8577e324d2fb0c40211182aaae5_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c69d5ca1d547218da8e846cc583837_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e7c703e42e54e418769101e3009a751_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4da084f549423ba1edd47c97745dea_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i492e3b74b21647618e19d98fc5af4be6_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3c6736ad474abe80247b6c428621e8_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3d7e100f644b319c3dc758d8c3e5ff_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60f67805a834aeb81d478d6048c30b7_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604c687d118d48988cea0c15344b587f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440aa4baa5804f8ba1255729affe7a07_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ade45514b07472abf3a976bad5075e2_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d581765eaf46a1b425828d5e6cdf3e_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id024eb4c94014ec49c6e27a68351c003_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9eca626aa454e1aa7d4f2ef86f83b88_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9404b5c0aa234b1e930f980973644052_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74e2615fe889465fa885b1b6dcef97e6_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78cb708996bc40d3a6481f7074ed4455_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia56942c6785c408da58413bcc56847ee_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0371e11afaea42b6b38732fc042d143e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be8c589cbef433e9f5cce07fc5b8204_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic826d07adf4e44dea0e204d5cc54354e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b1f37320f264fe39b6118d6996cf34f_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209002c36bbe4ea7b59430177cf18c4c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008bf53905884d179baf55ce1247fc76_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee9e5b36677f4eba9b71eb4a0b2714b5_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i079968c0f4134d4dac2b4878e02b237a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02d94fcae21461da3cf9a8c555a40bd_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3eacc8baafb46ddac0e1a5fbabe3485_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad63036539624fd9bc73ae5d7fb42005_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4897e04ca5f64263850346fe30de0a81_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c245862ed0462798a29da9f9f74ce0_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a20fcb76734c22a3eade9a14f5ce50_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b459c8ec71b4a15896e2da7ac25a1b6_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c925d8d64c94da082cd3422a727785b_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705ac2374d1743abb58218fe5ad12b01_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d94e3d1a39247e387019fed8a18ad46_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc5cbdea31c4c78aeabffef218a50f3_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efa321d8ec04cb1a95bed2a3f6976d4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da25349c4044b8c9d6bde3df1b958aa_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909fae803c5149209129a0a704330f2b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3f00def7b8347c4a557ae6a1cfd1374_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c769314b80147a5b1c216eb5b25c8b3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7955403a09be4b6da70bed7e2f69d629_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f01a54621494ecbbc0f453611f0bc4e_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf2d68341064175b8f864b73593f1d7_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i089c1b9b426a4c1da92f3dc5e97a7581_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2c9edb05074480991cd9fb871378cd4_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76269c4f7bb649cf8290db9a195e6624_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e51a2b394114d97a8e5c9f7166fab23_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8511290ec62844a4aae4405642d778c3_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c49bd14a1743a0821f157639e97f08_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e59ec9a7e4d4ce783bed9fa0bda5c61_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d55dae7970a4dd2b220ed120119dd5f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936640005c7a4c09bb3f8a284850c7bc_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506a7161216440d0bbcb96f17c77d8cd_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87db6e6fdecd4f628af3c73a2715dbee_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i754149b1402a4ff58be77407ecd96c4c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a0a9687dcdb42e79003c2c3005eb8c4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9103f0f331f14c2d925ee30459c3419c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415c753918f5402cbae9f769aa6af00d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e9b3944f1f4b6fb772acd25b65ac7e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4da5fa079404f4887bbcc27e401662a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0741f7081c8944bb9005b5622a22f293_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f63498f65d45aeba257d88d0f27555_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852117f888144b7abbee72f3bbb5e8a4_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ee8e50af9441eb87ebc10bce2dee83_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d8ed26dc30942128f011855ed0d3857_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c06bcfbe30049bb8d35ab3bd0de7891_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78c924a87c844f9495ea3277ad27c097_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aefe516de204b16be7ddf84dca1f0df_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018f8199d0a84888910a13567f64f9e5_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91156a4cd65b45e78be0eb72d39dfeb8_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21748abe44f4b12903d6c9dcfd1a0ee_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2cf68665dfc4e2b9d53778d119549ba_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2453d698b504decb33b115bb6f57fab_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="if9d010c11bbf46a3a80141df5fc433c4_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if23f6f1cf4f1419886209a1983b1efe1_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95bf75a4681040b69ec7a41ec26fca98_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mdt:TokyoInterBankOfferedRateTIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd0dc4372b54d09b9d6fcf86a905998_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8501e4357d94654a4b7f096cf014e1e_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac7ff8ab22ab491e8c00fb7695d6bd7c_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13d9c16cf83847d8b9dc071854e7249e_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ebd3167ead94b20bb0cf7ca721fde30_I20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i161f2ac0c7ae4093a36c525826d423bc_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i678b39b151df49b2ba21b6aea15b2c79_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17154ded948b43b795f47e739a934d01_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic328877cbe2640fabe36e10bcb5a5194_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36cbb82fcc7646f6bff301a9323152ad_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01e16de38004386abf16c41bcca590a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide9ac26ecdb447a5b065fa1afca7c2af_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac80a3fc9174c3fbd499cdda5660e8f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb15af4122d40f094823a9045c8305c_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a6af32d4b8247b4b5b8e8370744ce94_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f985b4d85524a5e894505c6ba972295_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32e75265ade74bd1b82d3b46447ba700_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a7ac115f1d4e669668238c726ec554_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id475727b6150430e9d00cf9d847ab244_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib77747096918490f971ab8604b359744_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90500a074bb3400493c7a435521e7259_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56e46722aac483a8619dd533deb3322_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72954acc9e57495896b675167421b561_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb4c499d238442789c803ba3b479b911_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd16066db5b741dfa7eb70f35224624f_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic070ac672e7e4600bb8f39e2dfd14cb2_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i030ec29f92aa49e58cf998d20561e1bb_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe75196bd192408f9bb4a29e186401b4_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id51ce1803c5c4ba6810ae2c023e74833_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3c626f296fc49089588a3e25c3e2b23_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia500e65b15db40148004c1bc60ce317d_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9451fb3d1f04f6187e22f627a237e7d_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6126e03c431748d39e312714f45be287_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74e6b87b21534ddcb6def602654c92e5_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ea2486c0a94abfb5ca1108224bba7c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21219af6460740dc8a8f2b42aa062bc0_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4b74a32e9248a69778cfd5232923a2_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83392e630d054b0bb17f041fb38ee1b6_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2bed4f3dfd4f3b860e60ba24d59a28_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40052aaebd204ac8bdb5ce6801703b30_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8c7fb5b46d345b1b31c77de8ad93269_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19424ad839704570b79f42bfb5ddc820_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bcc9eef7a754a0ea0e93d2b1b2324b5_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec60c574487f47fd970e5240db2d6a74_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09f696edac744dd7a1aa89ee92b1b57f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34fbedc968094ed2a24602471bb9832e_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b003f2db6844f2a18ece5fe1fec528_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f54a6d38f86409f9d004826da691d0a_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47c72990d6894f6999fbd71fa806b6ec_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705cf34bc80b41febb1dd15cddb734cb_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60d4bffbfd284a6a905e87223d86432d_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd53369c48e4ef5b68f6051807d5349_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec5f74b25924bd0bc17044be8b8cc7f_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08338469c554b8e9fa1ed1bf628cde1_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i617c5f38a82c413fa4b606a553f802cf_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d8dc10f7f74a269ac42c7af38e438d_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50dc8a72d1e845f0bc5eeb780b4167ce_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4bd5b464cf4754bc657a4694f52b1a_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f3035beec5446b898886392399c009_I20220525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaaa9f5a211e46648d43a13986dd518a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae88943d08a644079847bc841e0fe18f_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78ca089b4a214117984874b09ca1d0e6_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16fb407d39c49d580ac035048e8ce43_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfa7eec43314902906140d18188a9c2_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i351d6e481f7f40618e1994166ab8abe7_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0837b81f7bc4637bc63f5b62fb85a48_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb5fa643d9584c9bb178f09a350973e3_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2e63efa08c4ca7914dcaaece2d58c2_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3affa50db84b49f895fa4532797c87be_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80b3537de0145e8b97523443127c857_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1398815934fb4c929000688ee41577ab_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b6674cdea049859601401c887d0ed0_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74db199c9a774fdb9da00363fa038371_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eff972d77b347488f63d31d746a15a0_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d98793895484125aa0679ce08f1dcd6_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c07e51d429d4cbbad584cb5fe45515d_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de56b7be4e5417d8cc74ecf01292422_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dedf22af6864313999d497de5e5d6ee_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7ca207cf164dcc8a0c586bf2859962_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce28f9819d44f1cb7eec69a55f52fc9_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d75dfd093f41b79b84cc712dd4bdeb_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b29f486c461430ea0700ecce5ccc168_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8a11e621df491c8e9bcf6998fa2316_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c12dca8003843c9b905c9a3220a9dd3_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida185280d375499c84936e4a6364ca45_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b788a6030cc4d249b9f10c42c12d4b3_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fe0629813fc4a7f9ee052e38f52a06d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0871f5c80684792904d5a9b080d8746_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9f32e60ed34e03b1eee7e4dd64092d_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93bc1e6379124613960fd7675b514cd8_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedf7ecfabdfa4fd796a4fc91dfd1466b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b972ff441f4b5f9da1923ccd6b5eba_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b964c634650403f81e221664044f7b8_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac4974ad9d20428ba8fa1009b1d7e83d_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ab310b699e340a0b46bb1aa55af0ce5_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3378e12209024d9d8052dcc6dc3f0a2c_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0b5ac28482240b38b40b82a5691ce06_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188641c285b14b8895fd2296677da61c_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef8f476015148708517a60a5d58f505_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8775a870674f4665a7af461c974860c6_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ba042775474bc28935c1b5764479ca_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80f7f42761a242f0ace890eaa6dc8247_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8142fb31d264e0699b5a2404ecd7e2e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d55bb9abcdd40f88c78b3fb670e6a98_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69d21fb1bb9c4c179514a671cbf4e411_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2b7c40e2d14604869e3828bebf8f6c_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763fe5a14b6f4a0abca07febc595186a_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dbf04decd1248789e7cf49bc6bfc8f3_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a1f4a27446424fa83923dcf918a2a5_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40837b287fac4cbe8238278e9bd46ede_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7edfc27e40204f9580fd94d3ad2410e5_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic869d6f490e64df1aaefa8121f2d93a3_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dbdac6c2f7b45c588961b7bd1c42e81_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c544a31d4554d418bd424cc41e57b32_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eee748d81154109a2314b15b0389e0c_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f70b5cc5d64bf3933f7dc026250876_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>mdt:subsidiary</xbrli:measure></xbrli:unit><xbrli:unit id="manufacturer"><xbrli:measure>mdt:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-04-25</xbrli:startDate><xbrli:endDate>2016-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mdt:claim</xbrli:measure></xbrli:unit><xbrli:context id="id7f39f4a31bc4c9a9b552b6baf0224b9_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3323d48e49714e21a2aa0924d7d7fd8e_I20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claimant"><xbrli:measure>mdt:claimant</xbrli:measure></xbrli:unit><xbrli:context id="ie8ade720172b41b4909dc7e2c1b1d88e_D20221102-20221102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if898f1e4a80d473cabc86d838cccee2e_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plantiff"><xbrli:measure>mdt:plantiff</xbrli:measure></xbrli:unit><xbrli:context id="i8380ebe92e864b56ae1b2c2197ab9fa3_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02d1ebdd9f994625a9014f70c6861e5c_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a6362b35d847688440a2d5375ea168_I20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">mdt:OrringtonMaineChemicalManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="landfill"><xbrli:measure>mdt:landfill</xbrli:measure></xbrli:unit><xbrli:unit id="portfolio"><xbrli:measure>mdt:portfolio</xbrli:measure></xbrli:unit><xbrli:context id="i168eaf54a32a4b10ae055d1fd309420b_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c68c9b8053c4e069d0d10d554ee743e_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a634b3ac7e4a93bcc654038f139554_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19bc2cc12e847f686364b13145bcfa2_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149726acb078405a812214d92610bf74_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94ae48a92e344d458bdf1af7ef9dfb83_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70e9b68daa7e476b86394d75a37314c8_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4db2d7938ece4d1188f55fb0d90ed8ca_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if684219172ea489d828654ce6bda19c7_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88ac8796d2b4f16995fb97c31c6448e_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dbc31eff45b4bfa9d8c0fbeda13eb34_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f69ab25f0944c209d12b73a3e7b2556_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb28ceec1a245729e4603a23ff55bf9_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ff869d0a4a41f786d7d359f94cb14c_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3857837c700c47ee90158dd782777f47_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5b877f4e5a4a5f80879a1c21a2d977_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47ff2bf6f8a94d3e97118363d9a224a2_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6af4191c704ad28f09d2139ee771bb_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50c477f464714ac1be4ba61e84a7fe9a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da000fddfa54c00b738a9d7fa43607b_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if121f0c93f2542b787d18dc65313b4ec_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20fd350e6d74274a06ac9c4f5a4d7f1_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03ff4fbd770e476a93fac4538e7a739a_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7e46384f064832b227315992afe5e9_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec30626328141edab3ec5e1fd7fad30_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied00ece93e9e4688918b205b9ade91fc_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i827544a4779342aca7ddd0cc9e3e3373_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b62391f8b8740d7bb9d8216c3714f9e_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4de15689258429f96c8aede9acd4189_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1297ee8d0604a979f5928e67af71318_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0d54845eef646a0b6664bce4c66a85d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de2e2a292af422b8f366ef645be1066_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52660540190940b693d1bd02d12d492a_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic46769724c574bac915cd348f37fcf2d_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i214e01a959c846e88851e34cc42dc32b_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaeb28a3e4b44b1fa4ad70e8b96300c1_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aa56bae6c344578b698d10d544eafe8_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5224032c63584bec8b1b1523947f71dd_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8120e40de324a48a75b99dadc77ac4d_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eaeba13607d4490a06e297131324140_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88c0c1ed9ab49caa522738259c03475_D20220730-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52482a063c8a45dfaeab8842374cd025_D20210731-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-31</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia092a03ef5384e598bb50ffc1990cce7_D20220430-20221028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-30</xbrli:startDate><xbrli:endDate>2022-10-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3d02155da748508b967c01e3e9fc3f_D20210501-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001613103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3900fafdc57a4da3bf71572260ed33b5_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xODEw_e62f00ca-33d3-4950-b0b9-7897a7307283">10-Q</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.200%"><tr><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8wLTAtMS0xLTExOTg2OA_2e15efac-2e84-4265-9508-74b71ce89063">&#9746;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the quarterly period ended </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8xLTItMS0xLTExOTg2OC90ZXh0cmVnaW9uOjI5ZTg4MDhiZjI3ZDQ5NGE5OTlmMmMzOWUxMWZkMDczXzQ_375c979b-cf20-4643-bb5c-818e20a6a2d2">October&#160;28, 2022</ix:nonNumeric></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8zLTAtMS0xLTExOTg2OA_033c62ec-67d0-41bb-be83-ce31fab60b99">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.<br/>For the transition period from __________ to __________</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMTM_ad821d82-d8a6-46e6-bdcb-595bf3db0e08">001-36820</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20221028_g1.jpg" alt="mdt-20221028_g1.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:448px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#174;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.800%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8wLTAtMS0xLTExOTg2OA_506e52ff-8a67-4757-9dee-58c760c9824c">Medtronic plc</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8zLTAtMS0xLTExOTg2OA_b0018fe8-2106-4aa9-9521-6cf3bc2a140a">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8zLTEtMS0xLTExOTg2OA_1b02ecbc-543e-4daa-945a-f38ebf84fe77">98-1183488</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjE_c0ceaba7-7d32-4de1-8086-3980d2c79cf7">20 On Hatch, Lower Hatch Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjU_c15bf27b-e96e-4e70-a874-6980c2905e27">Dublin 2</ix:nonNumeric>, <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjk_527c0778-4604-493e-909e-487edd6b2c63">Ireland</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xODc_d7916ae9-351c-4e21-8124-e1bf66211877">353</ix:nonNumeric> <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xOTA_bf93683b-f50c-4edb-9bdb-e56369d50cc0">1</ix:nonNumeric> <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xOTM_52ba3ed5-f252-491f-880d-9eca10f3d7c5">438-1700</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.933%"><tr><td style="width:1.0%"></td><td style="width:38.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTAtMS0xLTExOTg2OA_07da57f5-b4d9-4718-ac83-adaeb9d3fe2d">Ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTEtMS0xLTExOTg2OA_69ca9ae5-c1f1-474e-9bc4-7aaf16a07ef3">MDT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTItMS0xLTExOTg2OA_ac6fa33a-23a4-4b3b-a1e4-4e9c8c0ee8fb">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTAtMS0xLTExOTg2OA_6509f76e-12b3-48dc-ad64-054161d817ca">0.00% Senior Notes due 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTEtMS0xLTExOTg2OA_476af46a-94bc-4487-9078-d8be6e2ff100">MDT/22B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTItMS0xLTExOTg2OA_f08b49aa-2742-4ca0-9858-92dd6e647e5f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTAtMS0xLTExOTg2OA_0c3a16e9-7d12-4cd9-8ec7-00789ed17e44">0.375% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTEtMS0xLTExOTg2OA_1313a233-a01f-4bc8-a347-70e1bf24a355">MDT/23B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTItMS0xLTExOTg2OA_88cc0937-4513-4e16-aea4-6dc5091cfdb7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTAtMS0xLTExOTg2OA_51cf0b9d-0266-419e-b192-4a83259264d6">0.000% Senior Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTEtMS0xLTExOTg2OA_4f9934ad-e168-45f0-8fd8-6b654519973e">MDT/23C</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTItMS0xLTExOTg2OA_163cc40d-edbc-46dd-9bac-164eca7ef5c9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTAtMS0xLTExOTg2OA_1c7f76e3-ba48-44da-ac62-f65bedaf14c0">0.25% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTEtMS0xLTExOTg2OA_36f1c065-c6a8-428d-84a7-a309c99fa121">MDT/25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTItMS0xLTExOTg2OA_6f17852a-0d04-40d4-856c-5aa27146bb1d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTAtMS0xLTExOTg2OA_d5f1ac97-503e-4235-97f7-69a99537f624">0.000% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTEtMS0xLTExOTg2OA_dedb4540-67cd-4dbd-b070-d6f540e43557">MDT/25A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTItMS0xLTExOTg2OA_8ade32f9-de47-421f-8626-4b4fe448158d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTAtMS0xLTEzODc0OQ_5c5fa4a0-d2d5-447f-8a80-606e5832fba3">2.625% Senior Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTEtMS0xLTEzODc0OQ_f6c2d02a-33c5-472f-bb18-f2ed9dc88945">MDT/25B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTItMS0xLTEzODc0OQ_a8dcdd8b-c9fd-4aaf-84ed-60b1f37f2364">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTAtMS0xLTExOTg2OA_15e498bd-9489-49fa-8ac0-a9a39ae9e4e5">1.125% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTEtMS0xLTExOTg2OA_5c2c19d6-3e42-4ccd-870c-1367f0f6e7b2">MDT/27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTItMS0xLTExOTg2OA_fbc132fb-d73b-4b84-9459-67cafba23aa2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTAtMS0xLTExOTg2OA_768967d3-51b8-4e66-a750-7c62dd018760">0.375% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTEtMS0xLTExOTg2OA_02d17093-c6ae-40af-9484-53bc1a61e4a5">MDT/28</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTItMS0xLTExOTg2OA_59294218-9373-4d6a-8df7-6c2b1f260166">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0wLTEtMS0xMzg3NzA_ebc1ba7e-4f33-42fb-984a-a64e1c4c5381">3.000% Senior Notes due 2028</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0xLTEtMS0xMzg3NzA_95221de4-336d-455a-bfed-f8bf43d1d9ac">MDT/28A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0yLTEtMS0xMzg3NzA_d595b68d-20f0-4724-a72a-9e16bddf4d64">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0wLTEtMS0xMTk4Njg_17a06a53-3045-41f9-b5a5-6ef4a7ec3a32">1.625% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0xLTEtMS0xMTk4Njg_70b6611b-2957-41e6-9d34-a73587e3fb3b">MDT/31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0yLTEtMS0xMTk4Njg_1568a98e-f84d-43e2-8d11-2cd84bc0521b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0wLTEtMS0xMTk4Njg_b539c500-da62-41d2-9392-379e3e70b5db">1.00% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0xLTEtMS0xMTk4Njg_e61e9488-e033-4c48-ad51-55f0a07fb061">MDT/31A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0yLTEtMS0xMTk4Njg_e9053218-14f4-4fe0-a1c0-a62867b988c0">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0wLTEtMS0xMzg3NzI_b32bacdc-1e4e-41d0-a7d0-09b88149bed0">3.125% Senior Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0xLTEtMS0xMzg3NzI_ee84a124-1a35-4016-bf64-8210d3fffd75">MDT/31B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0yLTEtMS0xMzg3NzI_d082a4c5-cf20-4bd3-a777-ebdfae279888">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0wLTEtMS0xMTk4Njg_a6f900c4-293a-45f5-ae6c-e305b364ad1e">0.750% Senior Notes due 2032</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0xLTEtMS0xMTk4Njg_36b649a9-4478-4841-a2a5-9dbff81af5cc">MDT/32</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0yLTEtMS0xMTk4Njg_0a1af27d-d512-4a63-8f99-041080901652">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0wLTEtMS0xMzg3NzQ_a22fed5e-0227-459f-9245-c12de455d8a5">3.375% Senior Notes due 2034</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0xLTEtMS0xMzg3NzQ_12ee7df9-5169-4d88-a8e8-b951796272aa">MDT/34</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0yLTEtMS0xMzg3NzQ_1ebf6dea-5768-44f2-91b8-3f7914b4eb83">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0wLTEtMS0xMTk4Njg_4559fd84-e0fe-4d54-8df2-e4c623ae5b02">2.250% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0xLTEtMS0xMTk4Njg_008042ec-ea9a-47d4-9283-6532264778eb">MDT/39A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0yLTEtMS0xMTk4Njg_0e876de6-9656-4aff-a470-eb4c3314ed7e">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0wLTEtMS0xMTk4Njg_806d6793-7bf1-452f-bf40-0c9a8fe6b5f3">1.50% Senior Notes due 2039</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0xLTEtMS0xMTk4Njg_633398c3-0e0f-4dd4-873b-8dc2ae07d581">MDT/39B</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0yLTEtMS0xMTk4Njg_0e802238-4182-4954-8e14-272be69bebbf">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0wLTEtMS0xMTk4Njg_10b9c965-77a5-4627-a521-3b40c1ad3730">1.375% Senior Notes due 2040</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0xLTEtMS0xMTk4Njg_35a8b880-17ca-41d6-b114-283e5f5719bf">MDT/40A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0yLTEtMS0xMTk4Njg_086d79b7-ef36-4cb7-83b1-f3078088d1f5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0wLTEtMS0xMTk4Njg_dd9c6fe7-1e4d-40bc-9c9f-6730d7a9e260">1.75% Senior Notes due 2049</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0xLTEtMS0xMTk4Njg_db250bad-bd00-4939-97e0-b125057966f3">MDT/49</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0yLTEtMS0xMTk4Njg_922db4d9-a736-4a2a-a4cc-08ac5c3d3391">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0wLTEtMS0xMTk4Njg_94c9b84f-f960-4e4b-94f7-0c0c90aa70e3">1.625% Senior Notes due 2050</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0xLTEtMS0xMTk4Njg_ca077fba-3523-465d-a620-175ef11bcc23">MDT/50</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0yLTEtMS0xMTk4Njg_2174608f-108b-46fb-b3a3-1d41f6dc64bd">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF82NTc_e4b4668e-80d1-494d-88ff-7ad445519b3d">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF85ODU_6c7d2e48-4681-4220-9f23-ff122eea8811">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.200%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8wLTAtMS0xLTExOTg2OA_65199d4b-b918-4849-a0d5-14ca30a15fc1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8wLTUtMS0xLTExOTg2OA_51ea2937-1819-411b-a03e-f2f498401f12">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8xLTMtMS0xLTExOTg2OA_78eb2f57-8412-4312-9d54-5fc505def8cb">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If&#160;an&#160;emerging&#160;growth&#160;company,&#160;indicate&#160;by&#160;check&#160;mark&#160;if&#160;the&#160;registrant&#160;has&#160;elected&#160;not&#160;to&#160;use&#160;the&#160;extended&#160;transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;1(a)&#160;of&#160;the&#160;Exchange&#160;Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xNzE1_c4842017-f2da-4c51-a132-39141e76a4a0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;28, 2022, <ix:nonFraction unitRef="shares" contextRef="i9b27bafc1ca94489ba6518e9a3ef1483_I20221128" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xNzMz_89caa065-4a5a-4745-a631-72c4148e97b2">1,330,179,978</ix:nonFraction> ordinary shares, par value $0.0001, of the registrant were outstanding. </span></div><div style="margin-bottom:3pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:8pt"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_97">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_175">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_175">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_178">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_178">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_181">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_184">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_184">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_187">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_187">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_190">Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_190">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_193">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_193">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_196">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3900fafdc57a4da3bf71572260ed33b5_196">54</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8212; FINANCIAL INFORMATION</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_16"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.600%"><tr><td style="width:1.0%"></td><td style="width:49.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.680%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi0xLTEtMS0xMTk4Njg_8ce41178-976b-4c82-b9be-d472d3e7ede8">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi0zLTEtMS0xMTk4Njg_d31738c6-b3c2-40f9-81dd-4cc334b7e0ca">7,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi01LTEtMS0xMTk4Njg_4007a6a0-bd7b-48c7-b3a9-9f8efedf92b1">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi03LTEtMS0xMTk4Njg_029299bd-a123-41e2-ab82-f98f68036164">15,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold, excluding amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC0xLTEtMS0xMTk4Njg_6de48451-a342-41d8-af64-59ef2a1c6577">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC0zLTEtMS0xMTk4Njg_4b3197aa-7909-459f-bc69-932489d08595">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC01LTEtMS0xMTk4Njg_4e26efa3-8970-4810-b49f-21407e8cee5e">5,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC03LTEtMS0xMTk4Njg_cddc86c6-bcbf-41be-bf47-df1101e7723a">5,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS0xLTEtMS0xMTk4Njg_957c6b3b-a799-4f74-a7ac-83974a9aaca2">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS0zLTEtMS0xMTk4Njg_490f6871-4e4d-45d8-a129-92f7d6b43599">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS01LTEtMS0xMTk4Njg_62dda990-7f7a-4419-9542-ced0e3c58148">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS03LTEtMS0xMTk4Njg_1c380c03-d33d-4b96-8d9a-4f349d8b2688">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi0xLTEtMS0xMTk4Njg_d7946f60-b163-439c-8b8f-8ffeb8a6821c">2,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi0zLTEtMS0xMTk4Njg_e3f0eb3c-3511-47e1-a436-598f72929881">2,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi01LTEtMS0xMTk4Njg_f100da21-78c6-43a0-ae3e-e7897c9f6f7f">5,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi03LTEtMS0xMTk4Njg_d4d8e049-1fb9-4b62-813e-d55d574dbc54">5,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy0xLTEtMS0xMTk4Njg_0728e3fd-a8ce-434c-a368-59f461b5019f">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy0zLTEtMS0xMTk4Njg_42206212-2af6-4578-8cc1-f3a88e6a4059">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy01LTEtMS0xMTk4Njg_a479059a-a587-42d8-8e30-f0d375f9a7c2">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy03LTEtMS0xMTk4Njg_8f9bab11-5886-4664-8a57-38ac5b36f520">866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC0xLTEtMS0xMTk4Njg_1d9297a6-a9d7-4fea-b851-4f1e9a17f697">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC0zLTEtMS0xMTk4Njg_cc6515eb-191d-45a7-865e-97158008a370">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC01LTEtMS0xMTk4Njg_7ad1e876-6738-48a0-913b-343c73f2035d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC03LTEtMS0xMTk4Njg_8c9362f3-7904-4c04-82c6-9794822d1f51">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS0xLTEtMS0xMTk4Njg_6b0a4770-45c6-4738-87f5-99f889644479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS0zLTEtMS0xMTk4Njg_fff144e4-3c26-48af-a60d-ce89d7a4c681">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS01LTEtMS0xMTk4Njg_6316cc64-4512-45be-8d3a-9509b497d9be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS03LTEtMS0xMTk4Njg_977f430d-db53-427e-8035-8be3d0e2243b">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtMS0xLTEtMTE5ODY4_2ca5bbb0-182c-4987-bd5e-1b7ad919d3bf">97</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtMy0xLTEtMTE5ODY4_6f30f373-662b-421c-9bea-f599dd99d46f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNS0xLTEtMTE5ODY4_bf858656-8927-4757-9b4f-98c847f686bb"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNS0xLTEtMTE5ODY4_fe9ae95b-dfb9-450f-b9dd-fda46f038881">62</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNy0xLTEtMTE5ODY4_231d6c0a-1b40-494c-a186-5c3ff7baf908"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNy0xLTEtMTE5ODY4_cfb501b2-9e41-46f6-a98b-74ef6a1be520">781</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtMS0xLTEtMTE5ODY4_4a72509b-9b4c-4c46-a5cf-789a3f507a2a">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtMy0xLTEtMTE5ODY4_daedc2e2-1637-4ce2-848c-5572252daa42">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtNS0xLTEtMTE5ODY4_4bc42dd2-827a-49b5-afe2-741e03fc2016">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtNy0xLTEtMTE5ODY4_a27749cb-5252-468d-a3e0-0f40c969932f">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItMS0xLTEtMTE5ODY4_d9dd657a-4197-4688-a529-0540f386c3b7">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItMy0xLTEtMTE5ODY4_c85d126c-33b2-4e90-b576-19a2714fedb9">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItNS0xLTEtMTE5ODY4_60ff9198-9d68-4943-a898-afcb8ffd3a90">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItNy0xLTEtMTE5ODY4_d6120614-13b1-48cb-bc52-bd736fbc2b7e">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtMS0xLTEtMTE5ODY4_fb0c40c7-7719-4ad0-9c78-b9b9f16048eb">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtMy0xLTEtMTE5ODY4_47fa9b10-2ab3-4ed1-9cde-6a54157f2a25">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtNS0xLTEtMTE5ODY4_3c11bb04-0749-4c85-b5db-a801c17dd8a5">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtNy0xLTEtMTE5ODY4_6f013d12-78e2-42f7-8eaa-0bab9fe0126f">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtMS0xLTEtMTE5ODY4_d657fbd7-67d2-4e11-b95b-eeb55536a7bb">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtMy0xLTEtMTE5ODY4_b68a183e-d285-4c46-a902-ec9c629e9aee">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtNS0xLTEtMTE5ODY4_8b485cc8-8095-4062-8a56-1f6766acf05e">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtNy0xLTEtMTE5ODY4_3139c509-d77c-4451-9a98-374987f85c72">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtMS0xLTEtMTE5ODY4_cda077f8-2af7-48e4-8780-fc802d086ee7">959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtMy0xLTEtMTE5ODY4_552c3b3d-fcd6-4f23-ab27-8e104a5110a2">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtNS0xLTEtMTE5ODY4_5c215cff-9957-415c-8150-ab04308142c8">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtNy0xLTEtMTE5ODY4_070068d2-1c69-4c8a-9f0f-9cafc375175c">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtMS0xLTEtMTE5ODY4_b8a0709a-c94a-4f68-8f18-dc53bdf32085">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtMy0xLTEtMTE5ODY4_d2c75291-b83a-4c5a-83c2-5b48c50f155c">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtNS0xLTEtMTE5ODY4_235f94d4-f8ad-424a-b863-28fd97d4cf18">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtNy0xLTEtMTE5ODY4_050b00d5-4b9a-4787-be3f-8e60a1ef7644">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctMS0xLTEtMTE5ODY4_53850764-c38d-41d5-a1fa-6dd4461ed580">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctMy0xLTEtMTE5ODY4_e0683e69-de9e-4883-82cd-430d65f89c0e">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctNS0xLTEtMTE5ODY4_9fd67de1-29d8-4bfa-97bb-4edc1d61e17e">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctNy0xLTEtMTE5ODY4_df3b56c2-7628-4db8-a358-91ee5ee93e0e">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Medtronic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtMS0xLTEtMTE5ODY4_b9541d8b-3192-432d-942b-dbad5c588071">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtMy0xLTEtMTE5ODY4_de31728d-e85e-413e-bf80-fc8cedecc505">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtNS0xLTEtMTE5ODY4_f36ad4c2-08e2-487b-a825-41b347f4f4bc">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtNy0xLTEtMTE5ODY4_6e05057b-55e3-4de5-b832-81c93af153cf">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktMS0xLTEtMTE5ODY4_40f5bab9-f183-4fad-bbea-9ea5cd9ddc48">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktMy0xLTEtMTE5ODY4_1a008d80-4e1b-488b-8cbd-daf8e639df51">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktNS0xLTEtMTE5ODY4_fb53645f-1281-47ce-aac1-3586106ce408">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktNy0xLTEtMTE5ODY4_a6a509c1-54e0-4f35-9801-0b0eed15a4df">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtMS0xLTEtMTE5ODY4_03490ece-4bfe-4353-94ff-3f2f09f8c220">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtMy0xLTEtMTE5ODY4_b9cfc900-2836-4188-a804-76bc4d27dc53">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtNS0xLTEtMTE5ODY4_82ff5b7e-ae7f-411e-b5ad-34a6d68aeb64">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtNy0xLTEtMTE5ODY4_c3610492-8980-4e13-a4ed-b13da18af11b">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtMS0xLTEtMTE5ODY4_0df8ff80-31de-49c7-acfa-433aaa84f2af">1,329.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtMy0xLTEtMTE5ODY4_03a59c87-023b-43ba-ae36-3882bda215c4">1,345.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtNS0xLTEtMTE5ODY4_8a44d5c3-6dc2-47a0-bc54-8feeb189b228">1,329.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtNy0xLTEtMTE5ODY4_1dc98efd-896e-47b5-b759-d7130175279b">1,344.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItMS0xLTEtMTE5ODY4_ec18b13c-1f21-4171-824a-324aa2c3b15b">1,332.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItMy0xLTEtMTE5ODY4_1122ae2d-c4b6-42e1-813a-4898a6956e77">1,355.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItNS0xLTEtMTE5ODY4_cb56d6d4-f65c-4f7f-84f9-4b55ae3609dc">1,333.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItNy0xLTEtMTE5ODY4_fdcaf0a3-841a-4035-8461-1187d4317c29">1,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi0xLTEtMS0xMTk4Njg_b8a0709a-c94a-4f68-8f18-dc53bdf32085">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi0zLTEtMS0xMTk4Njg_f3148d45-207f-4811-b91f-d9968bc73cb0">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi01LTEtMS0xMTk4Njg_235f94d4-f8ad-424a-b863-28fd97d4cf18">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi03LTEtMS0xMTk4Njg_050b00d5-4b9a-4787-be3f-8e60a1ef7644">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investment securities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS0xLTEtMS0xMTk4Njg_2206f75a-3efd-4797-b4f8-d684f017e415">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS0zLTEtMS0xMTk4Njg_6b9743a3-4247-420a-9296-54e0dffa017a">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS01LTEtMS0xMTk4Njg_f47c0c71-1553-4409-82bb-6243f01667d8">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS03LTEtMS0xMTk4Njg_61779360-cf11-4f00-9cd0-f964f1dcf2d6">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi0xLTEtMS0xMTk4Njg_d82bdefe-75a8-496f-aa44-76e1e12da6a6">826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi0zLTEtMS0xMTk4Njg_1150de7d-3545-44fb-8edd-9ed10fbb02de">247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi01LTEtMS0xMTk4Njg_1eef7b9f-351f-474c-aea9-830321da79e9">1,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi03LTEtMS0xMTk4Njg_71f46c93-1b50-4c42-8361-96eb45232e99">602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy0xLTEtMS0xMTk4Njg_d4963042-cfa1-4599-b6b8-f8efa05517f0">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy0zLTEtMS0xMTk4Njg_03ffb804-4387-4f89-9d62-860f0b2dc6f7">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy01LTEtMS0xMTk4Njg_d7a7289b-69c9-4ef5-a3fe-802ad52b8984">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy03LTEtMS0xMTk4Njg_51bf9480-4637-4323-94b0-bb97f92a8704">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in retirement obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC0xLTEtMS0xMTk4Njg_f909421d-d995-4fd6-a903-9efc2d7014b4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC0zLTEtMS0xMTk4Njg_f4b45189-bf0a-4bdd-86d6-197832b06413">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC01LTEtMS0xMTk4Njg_524be701-035b-45a7-9b64-1a83329ae3e7">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC03LTEtMS0xMTk4Njg_472e4915-26fa-461f-9fa0-59b358cab5a3">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain on cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS0xLTEtMS0xMTk4Njg_4712bed7-16ef-4c36-8f6b-aed08a6f7679">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS0zLTEtMS0xMTk4Njg_e3d55575-b0de-4b3f-8bf4-1ce0c77030c2">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS01LTEtMS0xMTk4Njg_956d09ac-31d9-4ab4-93d0-f4a7710a436d">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS03LTEtMS0xMTk4Njg_f38ac800-b821-4bd4-9fb1-07005ac2a589">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtMS0xLTEtMTE5ODY4_75547828-f3c0-469c-92b1-a7e370d679c2">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtMy0xLTEtMTE5ODY4_f232e159-6d64-4c79-a75d-4b2c343154de">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtNS0xLTEtMTE5ODY4_e8db7d42-c4bc-4323-b0b7-a23fc95a5a86">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtNy0xLTEtMTE5ODY4_294f8b86-2897-4b02-8c7f-ce495be8c027">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income including noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtMS0xLTEtMTE5ODY4_978febc2-ce77-4c8e-a635-411317e29441">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtMy0xLTEtMTE5ODY4_7c54aef8-5bbb-40da-a1a7-79f966e71b72">1,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtNS0xLTEtMTE5ODY4_8924772a-61f3-4205-be66-63b8476ff8a4">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtNy0xLTEtMTE5ODY4_c207df82-4de2-4f16-925f-a8372a0d2321">2,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItMS0xLTEtMTE5ODY4_158fc0d0-ca31-41a6-ba69-7343ab57b69d">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItMy0xLTEtMTE5ODY4_f11a7561-f138-49a0-91b4-93dc46b9f7e6">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItNS0xLTEtMTE5ODY4_62716816-eb49-4d4b-a609-56878512ea46">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItNy0xLTEtMTE5ODY4_b9a6bee9-5829-4e0a-b797-69d7fe172a53">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Medtronic</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtMS0xLTEtMTE5ODY4_1774774b-d9f9-4e85-9150-6fba83cc581c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtMy0xLTEtMTE5ODY4_55d5907b-cc53-496e-b33e-07e377944e02">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtNS0xLTEtMTE5ODY4_9278fd33-4e32-4815-86f7-b6e284bf24e7">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtNy0xLTEtMTE5ODY4_da3ae810-717a-4b0c-ac40-fec23376ad2e">2,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMy0xLTEtMS0xMTk4Njg_38d05c20-fc71-4570-a5e4-926faead4a45">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMy0zLTEtMS0xMTk4Njg_15aff5e4-73c1-4349-b210-b8ede26d7e09">3,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNC0xLTEtMS0xMTk4Njg_c90a61de-5599-4e76-901f-f8a0e3b3ad73">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNC0zLTEtMS0xMTk4Njg_f7481166-94f0-41b9-abcf-e6ffd190a936">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less allowances and credit losses of $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0ODlhMzgzOTliYWM0ZWE2OTkxOTlmOTU3MjljMzlhOV82Mg_028e7fe2-3170-4515-8fd7-cafa0239ba28">203</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0ODlhMzgzOTliYWM0ZWE2OTkxOTlmOTU3MjljMzlhOV82OQ_eb189325-5d87-4054-af45-9651de6c136b">230</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0xLTEtMS0xMTk4Njg_ef810b30-9120-4f8d-8e46-d91bb45dcb42">5,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0zLTEtMS0xMTk4Njg_70ff78bf-bed3-47d6-bd2a-562f9ad22e20">5,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNi0xLTEtMS0xMTk4Njg_7d9a7037-8919-40c7-b66f-a4070b9c82a8">5,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNi0zLTEtMS0xMTk4Njg_2ae084be-5dfc-4f85-8f9f-fed880094a7e">4,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNy0xLTEtMS0xMTk4Njg_6938f44d-92e0-4824-bcc4-dffde78b4b9b">3,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNy0zLTEtMS0xMTk4Njg_d90d8c29-df01-45ff-b876-b72d4075a292">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOC0xLTEtMS0xMTk4Njg_573c404f-0f33-476e-80c4-e3cd90971894">25,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOC0zLTEtMS0xMTk4Njg_a1600593-b4ea-42c0-affc-beb260831d27">23,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOS0xLTEtMS0xMTk4Njg_e63328b8-a53d-4291-b75a-0c948d77fce7">13,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOS0zLTEtMS0xMTk4Njg_0972f46a-1088-45d4-9462-5292ccfb361c">13,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTAtMS0xLTEtMTE5ODY4_d460be19-aab2-4479-9e05-63a78d56c62a">8,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTAtMy0xLTEtMTE5ODY4_1f32b0c0-e22c-4aff-b008-febcf45c8689">7,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTEtMS0xLTEtMTE5ODY4_f13f5466-4b8e-4703-9cc5-96d40d7207a4">5,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTEtMy0xLTEtMTE5ODY4_24297948-32c4-4306-8ba1-ab2f3e2b07e4">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTItMS0xLTEtMTE5ODY4_5f31eb5b-c2d4-486a-aaea-4d7dc9d1ff04">40,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTItMy0xLTEtMTE5ODY4_310618e7-32fd-414c-b968-a1db56b51215">40,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTMtMS0xLTEtMTE5ODY4_68fd6af9-3d58-452f-8183-d8f9e8a10d95">15,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTMtMy0xLTEtMTE5ODY4_a72f4d15-7d6b-4c96-8850-ae8732c93b25">15,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTQtMS0xLTEtMTE5ODY4_7903baaf-9ed5-429a-a975-d212f99f5607">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTQtMy0xLTEtMTE5ODY4_ba89a973-237b-49b8-8614-3a98b8a72fb4">3,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTUtMS0xLTEtMTE5ODY4_4d4de7bf-09cf-486c-b972-aaea4926625b">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTUtMy0xLTEtMTE5ODY4_987c7704-5eff-417b-b67c-a055da9b3480">3,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTYtMS0xLTEtMTE5ODY4_e69ab1d9-39f2-466a-b46a-c6e86c7b04c4">93,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTYtMy0xLTEtMTE5ODY4_f80e7c49-308e-4e00-99d4-9112eeaee465">90,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTktMS0xLTEtMTE5ODY4_8f503127-3f65-49d9-9449-ef23f3f06564">5,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTktMy0xLTEtMTE5ODY4_24bbc2a8-509d-407d-8280-394324e91fa0">3,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjAtMS0xLTEtMTE5ODY4_13bd63fa-10fd-49ef-8cf4-a0224d7d3023">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjAtMy0xLTEtMTE5ODY4_d4e992d6-ea46-463e-af66-eb6557e29e60">2,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjEtMS0xLTEtMTE5ODY4_5fe5de32-35d7-46e1-88e6-5f984929ee0e">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DeferredCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjEtMy0xLTEtMTE5ODY4_e78db928-410f-4c97-8ee9-5d5662263376">2,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjItMS0xLTEtMTE5ODY4_380d71c7-cb9f-4660-9c08-2dbc3165a363">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjItMy0xLTEtMTE5ODY4_da8955aa-34e3-4ea3-8186-a254a225ad16">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjMtMS0xLTEtMTE5ODY4_8e841a93-b6ef-44e1-8161-251c32b237a3">4,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjMtMy0xLTEtMTE5ODY4_a88a9256-347a-42fa-842f-973896dc5b89">3,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjQtMS0xLTEtMTE5ODY4_5f5ecfd7-e05d-4568-bed5-a6b1d0a6e19c">14,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjQtMy0xLTEtMTE5ODY4_ba4d06d7-6366-4f0e-969b-078a464099e3">12,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjUtMS0xLTEtMTE5ODY4_34c52d0f-5df4-4482-9c87-02e782bd855c">20,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjUtMy0xLTEtMTE5ODY4_2e4dfe8b-1da6-4288-92f3-6f13fc96b0e5">20,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued compensation and retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjYtMS0xLTEtMTE5ODY4_7ec31257-294a-4357-9e98-15ec8e84e572">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjYtMy0xLTEtMTE5ODY4_cf9ecb5a-d452-4b54-b216-b329d90e1368">1,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjctMS0xLTEtMTE5ODY4_78f5a66e-b838-4c61-8f8e-dd193666fdba">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjctMy0xLTEtMTE5ODY4_af65486e-d7c7-4489-b8d8-a18bf3ddbe78">2,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjgtMS0xLTEtMTE5ODY4_1bbc3968-7754-48d7-bf2a-9fcb50797412">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjgtMy0xLTEtMTE5ODY4_4f24dfe0-8200-4e62-b190-d020830e8d24">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjktMS0xLTEtMTE5ODY4_505052c2-61cc-4912-9257-a917c09ab1e8">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjktMy0xLTEtMTE5ODY4_37edb0f8-a8a5-402c-aad0-56372e652173">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzAtMS0xLTEtMTE5ODY4_9ffa3efe-a89e-45a1-9a6a-789966ad4892">41,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzAtMy0xLTEtMTE5ODY4_0d6d1201-fef3-4fc9-a2ff-5389af0f0f5d">38,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzEtMS0xLTEtMTE5ODY4_69138778-e0c7-49d1-bac8-6dae88d7c6b5"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzEtMy0xLTEtMTE5ODY4_34dfff7b-4363-4b2d-9077-4f1c6eb1706a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares&#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzE_a6ea1c4d-e363-4f68-b1a2-c00bae99d132"><ix:nonFraction unitRef="usdPerShare" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzE_dade26df-d7b8-4c8a-b4f0-529ca2aec846">0.0001</ix:nonFraction></ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-8" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzU_1ff3d250-c785-4733-b15d-271846f9b6f8"><ix:nonFraction unitRef="shares" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzU_d4b82930-7eae-47e1-9975-1117308b8357">2.6</ix:nonFraction></ix:nonFraction> billion shares authorized, <ix:nonFraction unitRef="shares" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNTc_770c65e2-369c-435c-a521-7154dd6e95b3"><ix:nonFraction unitRef="shares" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNTc_de8ed660-036b-4676-b902-4f37231e3d8d">1,330,148,578</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNjQ_46ffdba3-2ad8-41c9-b21b-4b76f17f9191"><ix:nonFraction unitRef="shares" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNjQ_879dde7a-656b-4011-add2-914463c69e50">1,330,743,395</ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMS0xLTEtMTE5ODY4_d9b4817d-873c-4eeb-bf4f-7317efe9ec75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMy0xLTEtMTE5ODY4_4b73806c-682f-4284-83f2-44341c15ce7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzQtMS0xLTEtMTE5ODY4_26760c0a-9a7d-4431-938a-3c508c048c50">24,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzQtMy0xLTEtMTE5ODY4_431758e7-7f52-4d22-a53d-b5f06b138854">24,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzUtMS0xLTEtMTE5ODY4_8cb8d798-ad76-4e7f-b814-ec91d8d82949">29,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzUtMy0xLTEtMTE5ODY4_a7c29326-8c7a-4ca6-8fa6-1e80683beb30">30,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzYtMS0xLTEtMTE5ODY4_6e6a0135-85d7-4395-8acb-7b487ec1818a">2,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzYtMy0xLTEtMTE5ODY4_475a3372-f34a-4f72-8eea-21d37d9100bf">2,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzctMS0xLTEtMTE5ODY4_baa111c2-105e-4852-b2fc-7c2176c142e4">51,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzctMy0xLTEtMTE5ODY4_7417f298-255e-40ad-aad7-6a6f93c68727">52,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzgtMS0xLTEtMTE5ODY4_e64c0700-2310-4029-871e-2e7e22dfffd5">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzgtMy0xLTEtMTE5ODY4_b0345184-e6bd-4ed5-a46a-2d4cd2f4fc87">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzktMS0xLTEtMTE5ODY4_dbf29085-7c5b-48c2-b083-7c168fa09d45">52,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzktMy0xLTEtMTE5ODY4_080f450e-d089-42cc-bb4a-437bf7fa0d42">52,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNDAtMS0xLTEtMTE5ODY4_3c725027-0e48-4fc2-93d8-294b55f76f86">93,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNDAtMy0xLTEtMTE5ODY4_1318592c-a62e-4371-af6a-c980ffa75b4c">90,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.866%"><tr><td style="width:1.0%"></td><td style="width:25.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.442%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.316%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>&#160;Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0yLTEtMS0xMTk4Njg_66399716-183c-4ef0-a95d-c69fecb36bae">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi00LTEtMS0xMTk4Njg_f2c5a110-270e-4e28-85d9-6f2eb6e69508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c24ef1adeed4623bdd58565d19980a7_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi02LTEtMS0xMTk4Njg_ddfbe387-7205-4176-b7da-38f320df53ff">24,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf939ef7ba9b40d9b919eaff4d3aaf20_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi04LTEtMS0xMTk4Njg_2f4291c0-a2b8-408a-a831-1c8efd46f5c1">30,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f7d0c01899c445db04cd9b2d85f6968_I20220429" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xMC0xLTEtMTE5ODY4_c1544935-8d99-457f-8d08-01ae0a84ad96">2,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a2b3356080044499be1ee38fa01063b_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xMi0xLTEtMTE5ODY4_186ca13b-82e0-4a30-9f91-55de4a6d7689">52,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96f676fdbed43a1af73c94a459a0027_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xNC0xLTEtMTE5ODY4_85a701b6-066b-4928-be23-8e2c0edb323f">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xNi0xLTEtMTE5ODY4_1e213546-7b0d-4c5c-93e3-749da2049e7c">52,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81b699157ef400babbd49b79ce01d51_D20220430-20220729" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy04LTEtMS0xMTk4Njg_dc538329-8058-4b03-8023-a57e5739c711">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xMi0xLTEtMTE5ODY4_ab882d18-13d1-4705-beeb-8932ae64a726">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xNC0xLTEtMTE5ODY4_3ab84010-3d43-443f-a0de-f32ee90bbf5b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xNi0xLTEtMTE5ODY4_288dd7d2-087a-4070-9946-5daeba120912">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf8710ac3ce4ccdac40ee3b1b558b39_D20220430-20220729" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xMC0xLTEtMTE5ODY4_d90f41ee-f4fe-4e57-9b11-3381b316ce94">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xMi0xLTEtMTE5ODY4_ebb7d9a2-918d-49ed-8fa8-426a7092346d">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xNC0xLTEtMTE5ODY4_3369833d-6123-49c7-b515-52a7141fce55">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xNi0xLTEtMTE5ODY4_13800407-b177-4bc8-89da-0b0d1b9ce0a9">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjowYzhlMzU0ZmI2OTQ0ZTNhYTI4MzRhMjA5OTM1YmU1MV8zMQ_874bc3cf-5391-480a-9d97-cdf7c502ca77">0.68</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if81b699157ef400babbd49b79ce01d51_D20220430-20220729" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS04LTEtMS0xMTk4Njg_b5616df3-60a2-4ddb-b86e-73edeaf872be">903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0xMi0xLTEtMTE5ODY4_3dce3400-2abe-41db-afe0-366f00fa7fc9">903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0xNi0xLTEtMTE5ODY4_473fa17d-2f6a-42e7-809e-62a77fdf5526">903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0yLTEtMS0xMTk4Njg_aea1fa5e-4cc5-4734-8449-3f5b6fbf6079">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi02LTEtMS0xMTk4Njg_65559a54-4e6a-4590-9fe8-16afd73b2cb7">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0xMi0xLTEtMTE5ODY4_a44cafca-5db6-470c-850c-a4c9f9b6eeda">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0xNi0xLTEtMTE5ODY4_e145dcbc-1d08-44c5-bdbc-fa2fc1c5e506">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0yLTEtMS0xMTk4Njg_9e52639d-6cc0-446d-826a-6ec199ed5edf">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy02LTEtMS0xMTk4Njg_d07c3bc8-a7b0-49f9-b152-01227ccfd4fe">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0xMi0xLTEtMTE5ODY4_3de0833e-604b-4f74-afd6-4c78da00aac1">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0xNi0xLTEtMTE5ODY4_9517fe19-98d8-4497-8d99-b5561d4bf5c9">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC02LTEtMS0xMTk4Njg_6660897b-501e-4b1e-a63e-dc3197f9ee01">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC0xMi0xLTEtMTE5ODY4_59847b82-2510-419c-a0b7-4e3d5e60f7e6">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC0xNi0xLTEtMTE5ODY4_f49cf901-326a-4ce1-be5b-bf235b1e67c2">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 29, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba553ebece994593a02b2325d2eaf828_I20220729" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMi0xLTEtMTE5ODY4_18215ecb-30e4-4f55-9a78-2003ab54a3e6">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba553ebece994593a02b2325d2eaf828_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtNC0xLTEtMTE5ODY4_50ea1540-b33b-43c3-ab62-2ed327376fad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabee6461cac44d1b9e9883c0e2236533_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtNi0xLTEtMTE5ODY4_cff18b19-06b6-4881-ba0a-fc9b95d4afc7">24,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7b953379f84fdaa442b1f9a50a4444_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtOC0xLTEtMTE5ODY4_05094781-d5d6-4c3b-a3dd-d83c89b6be40">30,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830c7cc13ba0450aa6d50f69c10d139a_I20220729" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTAtMS0xLTExOTg2OA_bb6afaa1-6f3e-4355-b47a-37793c884689">1,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9edbc694c8954441b58c7dfcf548932d_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTItMS0xLTExOTg2OA_58b4d05f-3805-44f3-a068-cf22ab1005ff">52,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3715049e1f9a4a64bc2f20c1b2d751b1_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTQtMS0xLTExOTg2OA_e665a65b-df23-451a-99ec-d72e7d8cfae2">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0140ab23f7415d9e84fba89d2ce274_I20220729" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTYtMS0xLTExOTg2OA_505c1c06-153c-447a-841d-25430e783df6">52,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItOC0xLTEtMTE5ODY4_4d7cbfe0-bce8-4a19-8df8-9d91dac14331">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTItMS0xLTExOTg2OA_146b889c-5133-4bcb-a01d-7435ec3484bf">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTQtMS0xLTExOTg2OA_ba52fec3-8f29-4e5a-9456-9e95b3bedd16">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTYtMS0xLTExOTg2OA_27ff8f11-8f6f-4cb3-aaa1-4fc137410e95">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb31e75e6e81437d992d025c15bdbab7_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTAtMS0xLTExOTg2OA_9d044ddb-c57e-4f79-8063-70cc24bf972a">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTItMS0xLTExOTg2OA_6c4e5d29-8bfa-449d-bfb9-5d65c638ff17">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTQtMS0xLTExOTg2OA_05407e69-9617-4f6a-b351-bf1b57e5f782">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTYtMS0xLTExOTg2OA_b72da522-6a70-446c-a1af-c71024c48f67">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246YWY4ZmYyMTBmNzM1NDFmODgxZTE4YmM0MTg5YmZkZDlfNTQ5NzU1ODEzOTQ5_f58fdf08-8a30-480d-bf47-cec670da067b">0.68</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtOC0xLTEtMTE5ODY4_05f10188-1f3c-40a6-bd5a-344cbab5a037">904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMTItMS0xLTExOTg2OA_6ce4cedb-49f6-40bc-81cd-dc4009ba6935">904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMTYtMS0xLTExOTg2OA_e1e1c20d-e93f-4bef-a749-186e71719f26">904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMi0xLTEtMTE5ODY4_47a01839-3aaf-49cf-ae5f-4544ca300d1d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtNi0xLTEtMTE5ODY4_afc8ab1f-7e96-4243-a7f6-313c51143628">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMTItMS0xLTExOTg2OA_f4bf2ed4-f093-4576-b4ea-a012b166461b">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMTYtMS0xLTExOTg2OA_55782320-00a0-432c-81fe-75fff174bce3">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMi0xLTEtMTE5ODY4_eca26e01-e305-4f8e-b598-e1d55bea90c8">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtNi0xLTEtMTE5ODY4_92561583-0cad-490d-b987-e4df3054487b">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMTItMS0xLTExOTg2OA_fb09b108-cefe-4dd7-af85-3b59a9cdfd6d">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMTYtMS0xLTExOTg2OA_e2675fb2-dae6-4871-be2f-b89063f08b52">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctNi0xLTEtMTE5ODY4_0c41514e-daf3-4c54-926d-75e2606eacb4">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctMTItMS0xLTExOTg2OA_8930582c-c40f-42fb-8125-a6d92be8d6f5">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctMTYtMS0xLTExOTg2OA_3c512585-8e3f-4e96-a8a6-defe3106a7b1">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i479bc235eb204cc6bd9b5d428f9c482d_I20221028" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMi0xLTEtMTE5ODY4_c319b7e5-a66f-4ba7-828b-74282217f23e">1,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479bc235eb204cc6bd9b5d428f9c482d_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtNC0xLTEtMTE5ODY4_b5f38069-63ff-4f8c-a1e3-76e2c7ba5777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id957c1291b754cb3989f2c5e3ac8dbf8_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtNi0xLTEtMTE5ODY4_ef50333c-d607-4266-b2a7-62a53d073ea9">24,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b6c031e74f4b8192cfe7653b448f7a_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtOC0xLTEtMTE5ODY4_2b9ee427-7271-4fc1-87ee-f8d58900651f">29,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12e89df7a7284768b084b028fb30c0b3_I20221028" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTAtMS0xLTExOTg2OA_c705f9c1-ebeb-49e9-af6c-915d06668af8">2,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de7fa9e2bd14d9cb49275324f2d4fff_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTItMS0xLTExOTg2OA_e8ec7b4d-64f8-4390-a55a-d1178b37bf7f">51,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3889946f4cd466eb0c8de4cb9692332_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTQtMS0xLTExOTg2OA_e44d0212-8c7d-47a6-8bcc-b1b0a8b85f15">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTYtMS0xLTExOTg2OA_705548e7-f891-4da5-8e6e-42b070b35135">52,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>&#160;Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iac68bc9471644ffc8005764e8ae89b46_I20210430" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0yLTEtMS0xMTk4Njg_e15ab75f-89a6-43c9-9c3c-a223a3bb00e3">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac68bc9471644ffc8005764e8ae89b46_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi00LTEtMS0xMTk4Njg_1d4640ba-ece3-46b9-962e-817378d1d142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5462aaf0c094c7db4f015d2fc1cccfe_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi02LTEtMS0xMTk4Njg_0fc50df8-4e8b-4178-a0aa-991d5fc76494">26,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7303ffa9282c44ada71fcf27f9caf878_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi04LTEtMS0xMTk4Njg_2065d596-93ab-4a11-8609-41085385e734">28,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xMC0xLTEtMTE5ODY4_6925e0cf-ca9c-475b-9713-bfa59ff60cb9">3,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b4eb2cd7eb34e68bc0bfff863e48a7f_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xMi0xLTEtMTE5ODY4_6de45549-b8ab-45d2-92fa-ea3c5d20c842">51,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576eb2cb85264ebe977159af31544200_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xNC0xLTEtMTE5ODY4_e0f8fb0b-2bdf-43da-93d0-6d06b1360118">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id815d10cd7364e4c8224095110455793_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xNi0xLTEtMTE5ODY4_ea01b0e6-54b0-4b65-ae3c-dff8b7eccaac">51,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy04LTEtMS0xMTk4Njg_8f45e2b7-db6c-481c-924b-ff631cc80c87">763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xMi0xLTEtMTE5ODY4_ae2834e7-541d-4e7d-b6a0-dce78c21c1c7">763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xNC0xLTEtMTE5ODY4_94f68f88-668e-4d11-8b33-0d9df19babdd">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xNi0xLTEtMTE5ODY4_6b7e7b8e-aa53-4979-bcee-f4ac898be83f">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3812240d458431e8ef07e8d1e16b569_D20210501-20210730" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xMC0xLTEtMTE5ODY4_53eb6582-4e45-4aa9-88b4-e8ffe161d2c2">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xMi0xLTEtMTE5ODY4_bab5f8a7-b64a-4a5c-bc8d-0bca6530f2e1">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xNC0xLTEtMTE5ODY4_eb3e417d-b954-472a-a2fd-83f399f5a335">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xNi0xLTEtMTE5ODY4_d8c1ef93-dd67-4d9d-b6a8-728ddb71d213">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1MGM2YThkZjc2YzE0MDIwODhhOGQzMzQzZWE2MTFjYl8zMQ_221c2aa8-8192-4e56-a1a9-ccfdde9fd57b">0.63</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS04LTEtMS0xMTk4Njg_d33a5ed1-fac8-44db-9c0f-af68f7a777b1">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0xMi0xLTEtMTE5ODY4_39c1728d-3023-45f9-9670-83c9e8b165b6">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0xNi0xLTEtMTE5ODY4_0258d65a-d486-4962-9bf8-3e3354e0dd55">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0yLTEtMS0xMTk4Njg_7bcd0c75-8829-4839-9340-77f8df14da76">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi02LTEtMS0xMTk4Njg_5a3facc5-e1f3-4629-bafb-aadee0389863">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0xMi0xLTEtMTE5ODY4_c66ebb4b-4a6e-4557-8b1d-66c68ae97f01">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0xNi0xLTEtMTE5ODY4_acf31b75-18a5-4d1c-bc9d-5bd08bdf1925">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0yLTEtMS0xMTk4Njg_707db50c-9d09-4eb7-9d32-061b57b6bd6e">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy02LTEtMS0xMTk4Njg_61e6e855-e947-4c67-bb25-da49777791a4">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0xMi0xLTEtMTE5ODY4_534ac67b-33d0-44f1-a84a-37808041d092">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0xNi0xLTEtMTE5ODY4_f8ff0f45-a7a8-4f82-8c61-08054f6300f9">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC02LTEtMS0xMTk4Njg_6215bf49-2941-4821-943b-d353fbd792d6">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC0xMi0xLTEtMTE5ODY4_b75b627b-21cd-45ed-a8ac-5ba0fb08dcbb">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC0xNi0xLTEtMTE5ODY4_39b7683c-e2b9-48fe-a4d5-7458713e1d3f">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibad2d789542f4a2382dd3a428fefa32f_I20210730" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMi0xLTEtMTE5ODY4_40830f53-7af2-4cbf-bd07-ca58977721f1">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad2d789542f4a2382dd3a428fefa32f_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtNC0xLTEtMTE5ODY4_776c3781-4ef6-4bd2-b60a-60e495b22335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93039fe1caf846e29eab3a6ecfe114fd_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtNi0xLTEtMTE5ODY4_19799fe6-e0da-424f-a175-3cd5ad11b655">26,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfefe3cebb942b897dafda418007e00_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtOC0xLTEtMTE5ODY4_8b194539-0516-4c15-89de-a0db61514d4b">28,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i674c328ca4cf4cacacc5730fead09f35_I20210730" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTAtMS0xLTExOTg2OA_d94785fb-4121-4d6b-8061-7be820839909">3,209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b1d14c436463b872fdeceb9f130aa_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTItMS0xLTExOTg2OA_e29b5ac0-8275-4e93-ae52-5ee1d580f134">51,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i758fd510e93e480db9ffe7c253a337a3_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTQtMS0xLTExOTg2OA_ec11275a-f0b4-4f87-ad97-109e7152cdbe">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTYtMS0xLTExOTg2OA_396fedfe-bd98-4337-9bd7-09889c942794">51,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItOC0xLTEtMTE5ODY4_f0614ee4-f5be-4ea9-bd21-e1017d1d863b">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTItMS0xLTExOTg2OA_76269e74-d5a1-41d7-93b0-7259c19708ed">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTQtMS0xLTExOTg2OA_46892620-c936-4a4c-834f-2f80a3324e55">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTYtMS0xLTExOTg2OA_0bc34899-677a-4d2e-be5b-9bf91bb62a49">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4c020bc4494a4998a6177261e6225b_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTAtMS0xLTExOTg2OA_273bddd4-ffa3-4189-9c6c-5bd2c21c84d8">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTItMS0xLTExOTg2OA_4c8ebd9c-04e9-4ba4-ac80-3d455364cea0">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTQtMS0xLTExOTg2OA_66c9a98c-9e5b-42af-983a-090d98899a56">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTYtMS0xLTExOTg2OA_d6cfa102-36ba-43d4-9f3f-0745b8dace1c">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends to shareholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzkwNTJmN2QyOGFmNDA5ZmJhOWJlOGIyYjFiMzk0NTdfNTQ5NzU1ODEzOTQ5_68d4591f-81c4-4764-a0d6-fabcb9d12695">0.63</ix:nonFraction> per ordinary share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtOC0xLTEtMTE5ODY4_b84b39b9-8d5e-4993-b053-e5d9d594bd9d">847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMTItMS0xLTExOTg2OA_32c2676e-3b14-499c-958d-cf8954315160">847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMTYtMS0xLTExOTg2OA_43546047-08db-4d06-b674-671a3384c3dc">847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under stock purchase and award plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMi0xLTEtMTE5ODY4_aa1e484b-67a4-4a2a-86ad-8ea7191d1e43">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtNi0xLTEtMTE5ODY4_b941a093-911f-416f-a8f1-e4d209c4f4af">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMTItMS0xLTExOTg2OA_91c88042-3ae7-4851-af87-675855711b8a">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMTYtMS0xLTExOTg2OA_9fa01280-f13b-440b-9f9f-c9d79420ac50">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMi0xLTEtMTE5ODY4_06d0065c-1771-4297-8da4-3aed3f1c7a67">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtNi0xLTEtMTE5ODY4_9ba4f11d-ed0d-4399-b0ba-60193dab0495">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMTItMS0xLTExOTg2OA_8432e2e2-85d8-4f1f-9c7c-140c3571292b">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMTYtMS0xLTExOTg2OA_eda21cc4-e440-45aa-9846-b2a05491c5e3">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctNi0xLTEtMTE5ODY4_eb6d506a-d6c0-4a53-ac9b-1640cc5ec9f8">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctMTItMS0xLTExOTg2OA_8da74d28-1d37-4d39-95ea-6e2516892649">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctMTYtMS0xLTExOTg2OA_1cb64a11-a2c3-44d6-b696-f11a7243ef60">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes to noncontrolling ownership interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtNi0xLTEtMTE5ODY4_ba9f6685-9931-4d01-8a68-d2883d78a153">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029" decimals="-6" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTItMS0xLTExOTg2OA_31aa553e-d966-48bb-a75c-cebb205086bd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTQtMS0xLTExOTg2OA_99479ef2-f38e-450a-812b-51b3c604e064">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTYtMS0xLTExOTg2OA_e6e7545a-3371-449f-a8b6-aac9e5d67a7a">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b9e3f477203428683ae92a742041fd6_I20211029" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMi0xLTEtMTE5ODY4_8575e3d5-248e-4051-8e72-087eb71c6a49">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9e3f477203428683ae92a742041fd6_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtNC0xLTEtMTE5ODY4_aa461a60-3564-4f8f-b860-62e251b4bfa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3190fe1c894e4a2b85407bc0557e735c_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtNi0xLTEtMTE5ODY4_e2db6196-6db5-416d-b499-b554aab383e3">26,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a75125a2ce45cbb0110cffa8149de1_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtOC0xLTEtMTE5ODY4_a9a035c8-404b-44d9-99eb-e9df14450373">28,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b27da620ade4165842447d930ad60a5_I20211029" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTAtMS0xLTExOTg2OA_80081f89-e6e6-4fdd-8ea2-e323c71de6b0">3,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8245ba0bf94b40b7b27dc0842b8cc6b9_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTItMS0xLTExOTg2OA_38211a4c-b6ce-4e8e-9857-ef41fb948b65">51,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26383b4523e74135acd4c7e7659b4845_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTQtMS0xLTExOTg2OA_9679991c-0a33-483f-a61c-247a1f3fb920">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTYtMS0xLTExOTg2OA_6c54addb-e8a9-4d4f-82b8-c5ab52a747a3">52,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMy0xLTEtMS0xMTk4Njg_4bac8ee6-63c3-480e-916d-7e257beca638">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMy0zLTEtMS0xMTk4Njg_1e5ecb1a-d963-4949-b299-301c4a06f266">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNS0xLTEtMS0xMTk4Njg_1d312267-6b8d-4af2-b983-070a0a33d288">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNS0zLTEtMS0xMTk4Njg_31f8df81-9953-4be4-a02b-60c3395f2509">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNi0xLTEtMS0xMTk4Njg_fb2b6569-ae67-4651-807c-71f60058eacc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNi0zLTEtMS0xMTk4Njg_6800502a-d06e-41f1-9dea-761dc79ec445">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNy0xLTEtMS0xMTk4Njg_f12324ca-4d79-420a-911a-ece2754ccc1a">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNy0zLTEtMS0xMTk4Njg_f16d57d4-e7f5-4f3c-9659-9d798b215b8b">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOC0xLTEtMS0xMTk4Njg_6e54ba49-b0f6-4a99-8e08-a2579c2f5263">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOC0zLTEtMS0xMTk4Njg_fa05a457-06e8-4ad0-8337-fd80ce297577">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOS0xLTEtMS0xMTk4Njg_ba55e9c1-0a2d-4a56-9343-bdf132260121">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOS0zLTEtMS0xMTk4Njg_b908859d-eb84-413a-94d1-f17c97ff9954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS asset impairment and inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:AssetImpairmentChargesAndInventoryWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTItMS0xLTEtMTE5ODY4_3bfabdd5-3776-434a-8a17-2e8da0b0a182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:AssetImpairmentChargesAndInventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTItMy0xLTEtMTE5ODY4_33a80ba0-5a93-4662-a62b-719a255969f3">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTMtMS0xLTEtMTE5ODY4_2bda618e-bf30-457a-bf6b-b0947dcf91da">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTMtMy0xLTEtMTE5ODY4_07d5ff06-bbbd-48c8-8762-d2f41d6e4987">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTUtMS0xLTEtMTE5ODY4_6eae2ab9-2f42-42ed-a56c-4d509aa87126">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTUtMy0xLTEtMTE5ODY4_f1e25625-027d-4de1-b099-eb30149d5fb5">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTYtMS0xLTEtMTE5ODY4_b1530b04-aa1b-49ea-9405-1306eb39f869">784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTYtMy0xLTEtMTE5ODY4_819da989-f246-4ba9-a652-16a7b7ca61ef">156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTctMS0xLTEtMTE5ODY4_824670e7-9487-4385-998b-5d89c3b6d070">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTctMy0xLTEtMTE5ODY4_d66da57e-e889-4d4c-88b1-070431404d7e">446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTgtMS0xLTEtMTE5ODY4_e3fadbae-e20f-4431-a7ef-4e05773a4312">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTgtMy0xLTEtMTE5ODY4_d24b7dc1-f5ee-4985-a8c4-6bae014781a0">409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjEtMS0xLTEtMTE5ODY4_e8e4018a-48f9-485f-8e17-bec10a27af84">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjEtMy0xLTEtMTE5ODY4_934e9f38-8c86-4309-8040-cfa105605140">3,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjMtMS0xLTEtMTE5ODY4_5058047b-c524-4922-9006-87f3dbc03d72">1,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjMtMy0xLTEtMTE5ODY4_1790e3c9-11b4-4787-a893-fda3a6b00653">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjUtMS0xLTEtMTE5ODY4_917f01c5-17a3-4e86-a0ff-b44a17f2723a">749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjUtMy0xLTEtMTE5ODY4_8a8eefe9-167d-428a-b3db-c201fc1d31fa">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjYtMS0xLTEtMTE5ODY4_70b64dac-707b-465a-b4ab-49bd82f6e61b">3,743</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjYtMy0xLTEtMTE5ODY4_3d4f1309-ce6d-4784-b4dd-1db9baef8797">5,311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjctMS0xLTEtMTE5ODY4_49606f23-0b8c-4ab6-a85b-7c7c2533f22d">3,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjctMy0xLTEtMTE5ODY4_c5469018-0ba0-4147-b6b3-98e9b9abfb7d">4,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjgtMS0xLTEtMTE5ODY4_b0d065e1-461f-40b9-a36a-77c04f497bf7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjgtMy0xLTEtMTE5ODY4_b4ebbf9e-f734-42a4-b30e-f94e8c7950b9">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjktMS0xLTEtMTE5ODY4_8a0bac8e-a6ed-499e-9a57-ce17e2849c00">2,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjktMy0xLTEtMTE5ODY4_31229f09-8a45-4535-bef4-2125b4c85fb7">1,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in current debt obligations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzEtMS0xLTEtMTE5ODY4_e3fef99a-d0cd-4a4c-b3f7-b93a0fb4fa7d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzEtMy0xLTEtMTE5ODY4_7a84f8e1-0ebb-4eaf-af8b-2f1ec7121ee9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings (maturities greater than 90 days)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzMtMS0xLTEtMTE5ODY4_ee1b2fa9-0c02-4ac7-a719-8142f7a08058">2,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzMtMy0xLTEtMTE5ODY4_529ac5ce-aba4-48b0-97d5-0beca7ff2532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzQtMS0xLTEtMTE5ODY4_28347a30-bf83-40e9-b04e-ac569bfe55a9">3,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzQtMy0xLTEtMTE5ODY4_7dea4a08-0e76-4c9b-8069-e4332eeb8117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzUtMS0xLTEtMTE5ODY4_3bcd3b9d-87dd-42ef-9abd-449983f8c817">2,311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzUtMy0xLTEtMTE5ODY4_7b90235c-e569-48d9-b404-9a98137c2245">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends to shareholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzYtMS0xLTEtMTE5ODY4_60c82fcc-03d6-432f-9544-f461367bea52">1,807</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzYtMy0xLTEtMTE5ODY4_98e95374-1ac7-4c39-bcbb-d804be5009b0">1,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzctMS0xLTEtMTE5ODY4_3f68d6e0-f96a-4d85-865e-656d75d11a92">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzctMy0xLTEtMTE5ODY4_3127d54b-503b-4fb7-8dad-3a5236f8eeef">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzgtMS0xLTEtMTE5ODY4_90cabe45-c982-425b-b339-eb94c5e8376f">477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzgtMy0xLTEtMTE5ODY4_dde91d26-6cb2-4880-8e88-16362e85d6c2">744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzktMS0xLTEtMTE5ODY4_fc8bd772-2b66-4fbc-8c4c-57674c2a87bc">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzktMy0xLTEtMTE5ODY4_844e4cb1-a68d-470c-9242-f290b3d79918">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDAtMS0xLTEtMTE5ODY4_6130eaa8-9e93-4bea-aca0-94bb8d637bbe">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDAtMy0xLTEtMTE5ODY4_5f0b9c55-6970-4f6c-85dd-f8afba39813d">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDEtMS0xLTEtMTE5ODY4_c7756326-24f9-44f1-b0e2-bdbcd9a780e4">223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDEtMy0xLTEtMTE5ODY4_f0c55e29-9276-4ca5-9e1a-b82f3046fc9d">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDItMS0xLTEtMTE5ODY4_eaed04b2-afc4-4c65-8eef-a4be29139a82">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDItMy0xLTEtMTE5ODY4_0acb348d-c78a-499e-b991-cc5287441ac1">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDMtMS0xLTEtMTE5ODY4_e70b14a3-b6f3-4218-90ae-33691b92b27a">3,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id815d10cd7364e4c8224095110455793_I20210430" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDMtMy0xLTEtMTE5ODY4_b96245df-569f-4f75-8d92-250c655db041">3,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDQtMS0xLTEtMTE5ODY4_a312c4eb-15bb-4803-8970-9932d8bb3d7f">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDQtMy0xLTEtMTE5ODY4_53f67c98-da20-42a2-9843-02413d72afd0">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDgtMS0xLTEtMTE5ODY4_722ab482-431d-4258-9100-8d87dfee360b">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDgtMy0xLTEtMTE5ODY4_a1ae05fe-9669-4d2b-acd6-aed03b600911">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDktMS0xLTEtMTE5ODY4_226834f3-9967-4219-9bf2-3781f84605ec">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDktMy0xLTEtMTE5ODY4_d1bf2c23-5f65-4104-8480-b0b14df5783a">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_37"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc5OQ_a2bd96e9-b99c-4aaa-a08b-2c5422a90e14" continuedAt="i057e658953fd48d595480579ce3229e8" escape="true">Basis of Presentation </ix:nonNumeric></span></div><ix:continuation id="i057e658953fd48d595480579ce3229e8"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc4Ng_392e58de-511a-40cc-a452-d7b614725846" continuedAt="i323778a56668491991e600c6cc042acd" escape="true">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year.</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i323778a56668491991e600c6cc042acd">Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.</ix:continuation> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain uncertain and unpredictable. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended October&#160;28, 2022, changes in the Company&#8217;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc3Mg_60e9c30a-890e-474b-96e6-998375424f4d" escape="true">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding.</ix:nonNumeric> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended April&#160;29, 2022. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc3NA_b1e93223-a37a-48bd-aa91-222b35aac60d" escape="true">The Company&#8217;s fiscal years 2023, 2022, and 2021 will end or ended on April&#160;28, 2023, April&#160;29, 2022, and April&#160;30, 2021, respectively. Fiscal year 2021 was a 53-week year.</ix:nonNumeric></span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_40"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80MC9mcmFnOjQ4NWU4MWUwOGI3NTRlMzliMWQyZTE2YzJjZTA4MTU0L3RleHRyZWdpb246NDg1ZTgxZTA4Yjc1NGUzOWIxZDJlMTZjMmNlMDgxNTRfMzM5_b15fc739-989a-47e2-876b-1a0c6c4d59fb" continuedAt="ia69461606bd94c609724428c6a47d1ea" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><ix:continuation id="ia69461606bd94c609724428c6a47d1ea"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80MC9mcmFnOjQ4NWU4MWUwOGI3NTRlMzliMWQyZTE2YzJjZTA4MTU0L3RleHRyZWdpb246NDg1ZTgxZTA4Yjc1NGUzOWIxZDJlMTZjMmNlMDgxNTRfMzMw_159d8790-1829-4514-9b26-fff1cb3a0650" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, there were no newly adopted accounting pronouncements that had a material impact to our consolidated financial statements. As of October&#160;28, 2022, there are no recently issued but not yet adopted accounting pronouncements that are expected to materially impact our consolidated financial statements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_43"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3OQ_45c42a92-5b12-458a-a4a7-4ac0f5c951bd" continuedAt="i734270bd5f9e4ce59c665c33362fcdab" escape="true">Revenue </ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i734270bd5f9e4ce59c665c33362fcdab" continuedAt="i669e8f6634b84dd98f8cfb1282409072">The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include healthcare systems, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i669e8f6634b84dd98f8cfb1282409072" continuedAt="i128b71540ba347f3b73c85831956791a"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3Nw_7b69a02f-5852-4552-94d2-d5874947c4e4" escape="true"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a3dd382c6945438731d0f15056527b_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi0xLTEtMS0xMTk4Njg_9f8c8aac-aee1-4117-a47d-a216bdc598a4">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i104380acc80d4b33bdb75a56ac2c6c3a_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi0zLTEtMS0xMTk4Njg_448f33cc-b636-43e3-9fe9-4d6cf0a39211">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7b3868ea6348b284ebcfa636598a64_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi01LTEtMS0xMTk4Njg_db9543e2-668c-4b21-90e5-95bfdbd94a93">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6cb2b2a61d40dd88447e04bbb15481_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi03LTEtMS0xMTk4Njg_149f84ac-0066-47e2-9428-03a199e05a1e">2,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Heart &amp; Aortic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd3cbd04fd67492bafbb8147b08ca285_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy0xLTEtMS0xMTk4Njg_cd8ef300-722c-465d-9421-e4c9fc6cd05f">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4016f75f0a6c48efba5e59908d817ef1_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy0zLTEtMS0xMTk4Njg_4ba2706b-e9b8-4bc9-af66-0c28d37ff92e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96aaaa79ddc3450fa9639b6e04b840d5_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy01LTEtMS0xMTk4Njg_d3780c0a-9433-4165-a4bf-020da1cf3c31">1,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739110963f73456da89189576a2091f4_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy03LTEtMS0xMTk4Njg_6c7c5fca-c085-4988-8215-26cba18a7abd">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Peripheral Vascular </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f70332fc7824fcabcb5d642eb7a2f6a_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC0xLTEtMS0xMTk4Njg_db044d51-ae1a-463d-9af3-319226be785c">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie324a3122889429ebaf0032db23c5238_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC0zLTEtMS0xMTk4Njg_6405f67c-30c0-4481-ac83-28484ccd4677">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d18929121a14b85ba7ae8f5ef22c1a9_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC01LTEtMS0xMTk4Njg_484340ce-817b-4e65-ac16-c0fab19c8ef3">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6e04e462ae4a2492cf55f9a81f3d29_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC03LTEtMS0xMTk4Njg_5ab2c389-bb82-4ba7-aba5-e77d0eb16edb">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd255fc2b256464d83f0adcaf79f0ddd_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS0xLTEtMS0xMTk4Njg_ca5a4869-a857-430a-80df-f929c02dcca1">2,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10fb8d585649da82b0209da784c586_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS0zLTEtMS0xMTk4Njg_693fcd5d-9ba0-41b9-ad31-ff7397d9ab80">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS01LTEtMS0xMTk4Njg_e14e7ad3-8c86-4b7f-8243-c22b4a59bd26">5,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298f3e560bc74437ab29be651d20c23c_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS03LTEtMS0xMTk4Njg_6e85f236-11e2-4557-85cb-cc4da65e9ab4">5,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9689fd91f59346fcacc698cec3a68895_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi0xLTEtMS0xMTk4Njg_ddff9431-1b89-4d69-85a2-8a043aca17d1">1,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f231991285846759c45d083b2999740_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi0zLTEtMS0xMTk4Njg_1cd2b37f-2246-4b04-8bd3-4f88783f862d">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6173309cb7a641cbaf71ef41eb3b7527_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi01LTEtMS0xMTk4Njg_ecb77ae2-20f7-4b18-baad-5fda9566af0e">2,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d5b9a26751433ea892c9f8b363dbe2_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi03LTEtMS0xMTk4Njg_0efe3cbb-c09b-4688-b32e-ca4ffe40b61e">3,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3918c5f3d0af4735a961ab1815e1cf3d_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy0xLTEtMS0xMTk4Njg_42ae11c7-efa1-4349-81ca-be5d5d8de3e9">671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9de08f7ea344bab23f761eeec19428_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy0zLTEtMS0xMTk4Njg_ae8821d3-dc0e-440d-83cb-4c99b461d5d4">802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1692b6fd84064547866e4a84aab6e13a_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy01LTEtMS0xMTk4Njg_b5b5ec0b-615d-4ef2-87f8-3bcee0090551">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369bfcdc666b4698958b63d22fedcb62_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy03LTEtMS0xMTk4Njg_6c9ad224-d69d-41a0-90e3-ad69aee5d9da">1,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9adc4ac26074f52a4fc617426b96edb_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC0xLTEtMS0xMTk4Njg_f6b6eb1c-88f8-492e-ad3b-8b17e9b4fc65">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17c53a8b4d840bf9f1f5c07e4dd2a76_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC0zLTEtMS0xMTk4Njg_860f78b4-b2ae-449a-a7f5-082bafb466ab">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC01LTEtMS0xMTk4Njg_f4775ad2-a48d-4f59-ba4c-5438bc0dd40b">4,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa1c2c8fbbd4ef994753457a37c388e_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC03LTEtMS0xMTk4Njg_a8c84c17-0f9e-4947-b2e0-678c8ddf48ce">4,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094e4d8aeb954d2cbf3b8cb59a49db5f_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS0xLTEtMS0xMTk4Njg_b23114a7-ef9f-40cb-9f21-3b5abdb29aca">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057120522c584c6fae651608298e537a_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS0zLTEtMS0xMTk4Njg_71b13f8b-1c63-4bf2-a4a0-7e2ad0dea3b7">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3a9931ef8274f7284b66ad7e01a834b_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS01LTEtMS0xMTk4Njg_7981ce7a-82a3-4fd7-adad-80f5ec75ad18">2,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3febdd347f7f477d9298fd0419ce511b_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS03LTEtMS0xMTk4Njg_e54c1302-ba37-4e92-847f-2408f54ad44b">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91330ecb8454e3c87bbd07559e10c3b_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtMS0xLTEtMTE5ODY4_ec034fac-c176-473c-9373-b194595edc99">686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64bce33fbd78408f8084a88248f2eca1_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtMy0xLTEtMTE5ODY4_acdb5fdf-f9a0-4620-8425-ca0672cacd1b">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55d8dc2aa18b4777873305f761bbf8b0_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtNS0xLTEtMTE5ODY4_86791820-8778-41b0-8386-8a6ddb434674">1,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0dc280b5c24b7b82ea150e787a2baa_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtNy0xLTEtMTE5ODY4_64bbcba2-a957-41ec-b129-6a0b8155049d">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea5fa54c40f4e3a8bc238188a9f7811_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtMS0xLTEtMTE5ODY4_0e79c184-a1f0-468b-9264-b7127f065b46">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b937fd099a4e338e041ac1dcd2d695_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtMy0xLTEtMTE5ODY4_1b131680-fe1c-43e7-a8ba-c901cb98ff62">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0d78811777448cace0976925773be8_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtNS0xLTEtMTE5ODY4_f9bfedc1-b9d5-4540-92f3-a07394d18937">824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie251fa17aa3949fe9f0839d52f9cd5c9_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtNy0xLTEtMTE5ODY4_5925cf10-fdc4-43db-8ba9-acb9bf88344a">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6632c3723b974d80bbfd7795c6cef933_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItMS0xLTEtMTE5ODY4_127966f7-4c8a-4583-9227-8cd728f97400">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d71e3989c6f4d4f9aba2569ad2a5bf3_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItMy0xLTEtMTE5ODY4_8a6fc012-ee2b-4a12-9e91-2ab073bdf1eb">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItNS0xLTEtMTE5ODY4_15e9bca6-25b4-4045-9351-ecf7fb9ebe35">4,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eeef53bad4b48bfb1c302257f4c2bf3_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItNy0xLTEtMTE5ODY4_d66d2d1a-2841-4b83-b33b-83041fd6b877">4,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed3671c909f416cab9afaf75dfcf9fb_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtMS0xLTEtMTE5ODY4_69876bbd-a773-4b46-8696-9022b6e3b895">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f1c372ed204eaa8382d90ad65d4902_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtMy0xLTEtMTE5ODY4_8bfd9e20-1c05-45a0-a4f3-faf0a4f430da">585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtNS0xLTEtMTE5ODY4_f2ada53a-2035-4d15-a130-a20554ac080a">1,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie028302d82c14ab399e272eb03720bb6_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtNy0xLTEtMTE5ODY4_e0059064-3462-440e-ac21-bbc379e98dde">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtMS0xLTEtMTE5ODY4_e6d4ed67-ef2a-4b15-a25b-66e1d69afdda">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtMy0xLTEtMTE5ODY4_e5151d24-9e43-493b-b0ea-bff2fa380b47">7,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtNS0xLTEtMTE5ODY4_9fa8fc15-8397-48d8-8864-66fb76e960ce">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtNy0xLTEtMTE5ODY4_68ae2d4b-d1f7-45b8-97dd-6a47478caa1c">15,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c3b2e62cc94239b99a9e996b5678f1_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0xLTEtMS0xMTk4Njg_43201b7b-ab28-4b78-9571-7896bc5d03fb">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i610eea5eb3484fd6bf51b42709374d0b_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0zLTEtMS0xMTk4Njg_cd903405-8bd6-41cb-b113-2a77ab29b8af">1,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d79d0fb65746aaa6359715a89e2ee7_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy01LTEtMS0xMTk4Njg_bb148827-69d8-4df8-954a-babceac7b7de">802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de1c8c6c0d445a083e6c55af3d03c6e_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy03LTEtMS0xMTk4Njg_a154ca48-939a-40b9-ac2c-613904fcb1d1">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298ed1e39d63426681947aac7c92c6fc_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy05LTEtMS0xMTk4Njg_2e7f92b9-c980-4fc7-b239-b4e60293bf9f">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfaba2c830554de58c19cb60762cabe6_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0xMS0xLTEtMTE5ODY4_baf86aa8-d3bf-40b1-8db8-ee8d73d5ea61">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4167c253b04797beb9ec205174739b_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0xLTEtMS0xMTk4Njg_757ad81e-f9e0-49fe-b250-945258f45076">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33446d8e0ee24892b0c64f6aaebbf045_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0zLTEtMS0xMTk4Njg_1a19bf36-e5e0-425c-b64a-4fbba26e84ad">970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a344f488304d06b2d1c07cd4cc008b_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC01LTEtMS0xMTk4Njg_4ec5ea7a-b5f1-4bf6-9387-78b8896e1cd8">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab66a53e9d4144e895fc21c33e195eab_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC03LTEtMS0xMTk4Njg_6356ccdf-f00e-437c-af75-1fbab3d00664">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32deed4df6594deba88fcc157d9318b9_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC05LTEtMS0xMTk4Njg_6b600b46-d615-4762-b8a1-133c781e53b0">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb7d8d91058f46969b341026534b0f8b_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0xMS0xLTEtMTE5ODY4_cea342c2-d166-4c5c-b68d-cac2c771f9ce">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fb4f39283f4f57af883c4294c05e2f_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0xLTEtMS0xMTk4Njg_ed825b96-beed-4031-84d6-9cae959e58ad">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d72e4f26a74e2a9e315d0f49903406_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0zLTEtMS0xMTk4Njg_21e0bfc0-46d2-4410-900a-3c074a7154d5">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d368c56378c40fb904cbc84bf222cf2_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS01LTEtMS0xMTk4Njg_3f530d5c-f230-48b9-994f-5f977ab22e87">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04fb1213c4b84a8a8f8565296c9cbb98_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS03LTEtMS0xMTk4Njg_f2c45f2a-3ab8-4d52-824b-95fff77dffdb">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie746f4753ebd49d4806edf24d4bc054f_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS05LTEtMS0xMTk4Njg_dfb7f4ba-8c07-49f5-9471-353579a58ee9">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5214f11f980d4654b157bce110db9b3f_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0xMS0xLTEtMTE5ODY4_417bae65-79c2-4a68-9404-733897ba4b97">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7055abe559314041bd8f3e48e5c1b5ac_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0xLTEtMS0xMTk4Njg_5ecef0da-5e39-4a0b-a217-4d8e000c82b9">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1864b5e68da47c18ee80fc6916d798c_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0zLTEtMS0xMTk4Njg_1002f694-a346-4a4c-a945-c447b84033ec">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01b3e03620d64556acc1932365baea4c_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi01LTEtMS0xMTk4Njg_535f64b0-17dd-4c51-9e8f-0f83142ff47c">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9383983150046f9bf39c566f31fdcd5_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi03LTEtMS0xMTk4Njg_a6899cd4-ed83-4cdc-8ad0-1a8edebcb554">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974d74af34f64bba98080397f378b049_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi05LTEtMS0xMTk4Njg_2a457eb1-524f-4404-bc53-8c581bc36fee">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9145fb48548b429fa67e81114c3a7f77_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0xMS0xLTEtMTE5ODY4_e4e1d9e9-3f1d-4742-97fc-98432b0a4e4b">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0xLTEtMS0xMTk4Njg_11aa1949-0a1f-4eac-8d54-3cffa1cbef23">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0zLTEtMS0xMTk4Njg_b387211a-74a9-4699-85e2-74cc42b086a5">3,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4886727899c748af9b7ca6ecc006d607_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy01LTEtMS0xMTk4Njg_e9ce6f1f-8439-47f0-a973-6027ed4bd2da">2,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4119f66ab242497fbd1a7129a09ef938_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy03LTEtMS0xMTk4Njg_5b7a6896-58bf-4504-9d2b-7a9e2e5fa994">2,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1394b8d1d604848b1afc29f179024b5_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy05LTEtMS0xMTk4Njg_b67e1eeb-4475-4ddf-8de4-1e756f867db7">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia54914f294dd447a8c3201ee0160b967_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0xMS0xLTEtMTE5ODY4_f9f82c9b-c3b5-432c-aff8-7e86af2066e9">1,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6034dedd81034ca58a3efaa8aaf912b2_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMS0xLTEtMTE5ODY4_83b710e9-d51b-46f4-b526-0d7e99162910">2,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47330c898c084aa5838659f2f34d4c10_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMy0xLTEtMTE5ODY4_f7cd6bf3-1ca9-44ed-87fc-bc088d154ecb">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c1ab6b402e94618aaf6a6d53b19afaa_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItNS0xLTEtMTE5ODY4_583cb5be-e87e-449f-b0ef-aca737845d38">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644a9f4b3e1f4b2cbd1ddb0e7ec2d231_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItNy0xLTEtMTE5ODY4_b596a705-47b1-42ed-b906-2f5d567c667e">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ac1e8c6edbf463894ff0a4a97c65b0c_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItOS0xLTEtMTE5ODY4_b1faa8f1-ee98-4967-9a88-a460710f1a02">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75288cda0d146909d982333f28bd033_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMTEtMS0xLTExOTg2OA_de549728-d7a5-4865-8777-03f5abdf6120">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886d34bbec8640b6b611a39dd7f55630_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMS0xLTEtMTE5ODY4_b1c088fd-097a-434f-9e5b-5e66bae9d393">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dbab7c4dd864773bfc6e76adab58533_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMy0xLTEtMTE5ODY4_abbc14db-f494-4816-afd5-6a4c36ee94b5">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582ee1774f514ca68b795b9717b436f9_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtNS0xLTEtMTE5ODY4_75687dc0-ba01-4c3d-bbfd-db35e890470d">1,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f59093bb7f543e795d5e21aa6b22695_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtNy0xLTEtMTE5ODY4_a4b2d782-19c3-463c-a1d8-7279a4d683a5">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i878fa8e82bf64ae7aab3cb9e7cb532ff_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtOS0xLTEtMTE5ODY4_4f3db8bd-6d42-4ba1-a881-9923f7f05d4d">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f850d1105104e52a1834603e5aa1069_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMTEtMS0xLTExOTg2OA_e0768938-abd3-4216-855d-d82b0d32db0d">951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f9d4e944db0457eb58a4abb5fb0ac50_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMS0xLTEtMTE5ODY4_8734cdca-0952-41f1-be7d-b6b6f18c2be6">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d359386ad44272b635669807e608f6_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMy0xLTEtMTE5ODY4_a8302089-7a36-4001-8b8a-b30586a528cc">2,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59834bcd47a841d88758402a4ea93e11_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtNS0xLTEtMTE5ODY4_57ff0658-fdb2-4425-8485-bf5cb41f55bb">788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b47df2f3bfd4e52b3825a46ddd428e5_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtNy0xLTEtMTE5ODY4_494982aa-541e-4525-9382-fbd123cc7e43">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32be93843e34926a15aeb2dcc3dbcc2_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtOS0xLTEtMTE5ODY4_33f98e7a-fe2c-4c79-b7a5-0ec4abae6f5c">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i993a3f339e894c8dafef5e5049915240_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMTEtMS0xLTExOTg2OA_5be74d2d-feed-4c96-a0a5-0e8727f91609">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31a13d28f0194f8eb5115201dbe86f3c_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMS0xLTEtMTE5ODY4_a734de80-7bb6-4cda-9205-64616fca05a3">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9b22d428114c4ab5ee78a571295915_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMy0xLTEtMTE5ODY4_da834f80-d793-4d2c-bf64-0c20172115df">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00b55f38c464a969df5efc27c1c7d80_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtNS0xLTEtMTE5ODY4_cf700345-3315-4187-b831-ec2a7d1efe94">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a714d7dd59b4092861465d25ffd24ab_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtNy0xLTEtMTE5ODY4_dde3d5e0-20ce-40c6-9e44-7e09b016f531">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7acac8017744c558ae12f06f24486c7_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtOS0xLTEtMTE5ODY4_2bfe9dbc-c2be-4adc-8475-8678c67a1e79">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce3653f29834ec387f827999d02f9fc_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMTEtMS0xLTExOTg2OA_eafbedde-03b5-4db7-a7e9-ece85bfbe50b">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMS0xLTEtMTE5ODY4_d6ec0ffa-f53d-49c9-8f87-fc06663e9ea2">7,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMy0xLTEtMTE5ODY4_57394bf0-d7fd-4a44-adfd-da47de58ae30">8,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fefedf1e5ea47b4a531ab78ce1ff37a_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtNS0xLTEtMTE5ODY4_b0e3cd78-2c7c-4155-ac26-65f0ec2f293b">4,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd8b96342484a81b5fa2dc86cd010e4_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtNy0xLTEtMTE5ODY4_08a2531a-acf2-4460-9837-0159703c929a">5,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202e893b22f240a5b7c9fd460ba69357_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtOS0xLTEtMTE5ODY4_ac432511-e106-4df3-9618-fa1fa1f0e151">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4725c44b1daf418f8388bf7dc0380194_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMTEtMS0xLTExOTg2OA_24752326-aa3d-4a4d-ae82-fe7d3b47a9aa">2,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;28, 2022, $<ix:nonFraction unitRef="usd" contextRef="ied8d8356269248db86adef62aabe056a_I20221028" decimals="-7" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTQ2OA_6776d171-9732-4101-8521-8b3f5df3469f">1.0</ix:nonFraction> billion of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i49cdfed15a07485aa1fe2b7e67209ebf_I20221028" decimals="-6" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTUyOQ_77ec90e4-f138-4f6d-a760-e8cc5446db2e">536</ix:nonFraction> million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. At April&#160;29, 2022, $<ix:nonFraction unitRef="usd" contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429" decimals="-6" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTYzOQ_2f2d8940-d762-4788-a763-a4867c9bcd1e">981</ix:nonFraction> million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i7e81b5be3ebd42d6b0a7d11e27c5a66c_I20220429" decimals="-6" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTcwMA_22c175c6-48d1-4f29-9e06-ef75d06a0699">548</ix:nonFraction> million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i128b71540ba347f3b73c85831956791a"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue and Remaining Performance Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;28, 2022 and April&#160;29, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjA4MA_2c24de1b-bd1f-4cf5-8d08-5b5ae2f23128">380</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjA4Nw_7bc82a4d-f5c7-4594-ba3e-f14127a61a57">399</ix:nonFraction> million, respectively. At October&#160;28, 2022 and April&#160;29, 2022, $<ix:nonFraction unitRef="usd" contextRef="ied8d8356269248db86adef62aabe056a_I20221028" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjExOQ_992cdaec-1e46-4c0b-9654-b512d5dd7b53">293</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjEyNg_4309de5a-272e-41ad-ac3f-375a47c15320">305</ix:nonFraction> million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively, and $<ix:nonFraction unitRef="usd" contextRef="ib091f63ce1ed47fa86badb21ce620a7e_I20221028" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjE4Nw_13b40f5a-d175-41dc-b4bc-8c975154b772">87</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b3f93df1ec946d38393e3dd053885a1_I20220429" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjE5NA_87e1e97a-4764-4e30-9790-6362d0ccc7eb">94</ix:nonFraction> million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. During the six months ended October&#160;28, 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjMwMw_b5397cbe-cc0e-4c3c-85cf-ffdd130f71c7">160</ix:nonFraction>&#160;million of revenue that was included in deferred revenue as of April&#160;29, 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;28, 2022, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjc1NQ_3c0441c0-7053-44e2-b7bb-f98939bc901e">719</ix:nonFraction> million. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3Mw_021546e1-8d6b-4769-9a6b-46719ecc9b7b">three years</ix:nonNumeric>.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_46"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODA5Ng_75041bbb-a980-44d9-8340-9b6557e75342" continuedAt="i7b506498a76d42e3bf6d3082953686f2" escape="true">Acquisitions and Assets and Liabilities Held for Sale</ix:nonNumeric></span></div><ix:continuation id="i7b506498a76d42e3bf6d3082953686f2" continuedAt="i9e527c662cd443dc85e0bd1ced257715"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended October&#160;28, 2022 and October&#160;29, 2021, the Company had acquisitions that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future, yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired. For the three and six months ended October&#160;28, 2022, purchase price allocation adjustments were not significant. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2023</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intersect ENT</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2022, the Company acquired Intersect ENT, a global ear, nose, and throat (ENT) medical technology leader. The acquisition expands the Neuroscience segment portfolio of products used during ENT procedures, and combined with the Company's navigation, powered instruments, and existing tissue health products, will offer a broader suite of solutions to assist surgeons treating patients who suffer from chronic rhinosinusitis (CRS). Total consideration, net of cash acquired, for the transaction, in which the Company acquired all outstanding shares of Intersect ENT for $<ix:nonFraction unitRef="usdPerShare" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTU5MA_304bd878-93ab-4a88-86bd-6db316c3a138">28.25</ix:nonFraction> per share, was $<ix:nonFraction unitRef="usd" contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTYwOA_a484e03b-de1b-40bb-9e90-37b695fdfc3f">1.2</ix:nonFraction>&#160;billion consisting of $<ix:nonFraction unitRef="usd" contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513" decimals="-8" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTYyNQ_fbc3b389-b068-4458-ab02-88a8874916dd">1.1</ix:nonFraction>&#160;billion of cash and $<ix:nonFraction unitRef="usd" contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTY0MA_ff08bb7e-8c50-4cf0-9664-6b166af18982">98</ix:nonFraction>&#160;million previously held investments in Intersect ENT. Based upon a preliminary acquisition valuation, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTc1OA_4ccde1a7-d42a-4cae-a7f1-44a84d1682cf">615</ix:nonFraction>&#160;million of goodwill, $<ix:nonFraction unitRef="usd" contextRef="ib15e9005fdf54bb388c5a1ebc77ec0c1_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTc3NA_46c1c099-b3bd-49e9-8265-bab6656b2158">635</ix:nonFraction> million of technology-based intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i6e8fea31e19645bf890da6ac5660baec_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTgxNg_0ca7a6c5-6b88-4ebc-b697-23baf32f2eb2">35</ix:nonFraction> million of customer-related intangible assets, and $<ix:nonFraction unitRef="usd" contextRef="idac13f4d55474a59bd8fd8d73215242f_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTg2Mg_567d3e33-dc11-49b5-a09f-ed75bfc1cc4c">13</ix:nonFraction> million of tradenames with estimated useful lives of <ix:nonNumeric contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTkxMA_75c27270-436f-4cfa-a55a-bf184255a489">20</ix:nonNumeric> years. The goodwill is not deductible for tax purposes. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and net loss attributable to Intersect ENT since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three and six months ended October&#160;28, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Affera, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2022, the Company acquired Affera, Inc. (Affera) a privately-held company focused on the development of cardiac mapping and navigation systems and catheter-based cardiac ablation technologies. The acquisition expands the Cardiovascular segment portfolio of advanced cardiac ablation products and accessories to include its first cardiac mapping and navigation platform to meet physician needs within a growing patient population. Total consideration, net of cash acquired for the transaction, was $<ix:nonFraction unitRef="usd" contextRef="i19cd5686ee1b41f4a0781c0d70df295d_D20220830-20220830" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM1OTgw_ef0f64a0-a9c7-47fc-8142-cc0a97399084">904</ix:nonFraction>&#160;million. Based upon a preliminary acquisition valuation, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM3NjU2_79b6978a-3916-419f-805e-c5a20169e21b">660</ix:nonFraction> million of goodwill and $<ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM4MzUx_b07ed189-fa67-45a5-a497-e761b3902562">300</ix:nonFraction>&#160;million of in-process research and development. The goodwill is not deductible for tax purposes. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i6d3a8e5da34e4451a2cc414372ccc1f7_I20220830" decimals="-6" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM2Mjky_704d47ab-57cc-4a97-9c90-4d04306ddb1c">201</ix:nonFraction>&#160;million of contingent consideration liabilities in connection with the acquisition, which are comprised of product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and net loss attributable to Affera since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three months ended October&#160;28, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9e527c662cd443dc85e0bd1ced257715" continuedAt="i1a1729a58e91417db77c0894f6a488db"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODEwNA_acfd1364-5fe8-466d-a87a-30ee962ea193" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values of the assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intersect ENT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affera</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMS0xLTEtMS0xMTk4Njg_5ef12b22-65cd-495f-b957-b9cd2aec207b">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMS0yLTEtMS0xMjcwNjk_db9397ca-f389-4a05-ab8d-2001d4ac73c9">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMi0xLTEtMS0xMTk4Njg_4b0da6c6-dbe0-45f6-912d-8385747ffcf1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMi0yLTEtMS0xMjcwNjk_2eacc865-2178-4e35-a126-01dd5e745152">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMy0xLTEtMS0xMTk4Njg_4ccde1a7-d42a-4cae-a7f1-44a84d1682cf">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMy0yLTEtMS0xMjcwNjk_79b6978a-3916-419f-805e-c5a20169e21b">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNC0xLTEtMS0xMTk4Njg_bdac86c9-02e4-4101-8bff-0ce1edc8849d">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNC0yLTEtMS0xMjcwNjk_f82f16a7-91e7-4055-b3ea-c161c96d0b00">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNS0xLTEtMS0xMTk4Njg_28f53376-24dd-4063-852e-c7bcfce9c78a">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNS0yLTEtMS0xMjcwNjk_2b353179-cedf-4f38-8aee-9491401c9ce7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNi0xLTEtMS0xMTk4Njg_c01c717d-8590-40ea-a883-8daefacba2ed">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNi0yLTEtMS0xMjcwNjk_96d14bb9-7af6-4fc0-862a-2db8753ddc21">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOC0xLTEtMS0xMTk4Njg_b4a6b82f-b44b-4cd2-9197-cfd2371e326b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOC0yLTEtMS0xMjcwNjk_54be0662-e56e-46d4-aaec-811b72223cdd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOS0xLTEtMS0xMTk4Njg_a2992ec7-7517-4364-b3b6-2c20ea896759">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOS0yLTEtMS0xMjcwNjk_701f00a3-27df-4a24-ab7d-cee775894317">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTAtMS0xLTEtMTE5ODY4_b859e45b-f399-4c23-84c9-007ed44a4ffa">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTEtMi0xLTEtMTI3MDY5_0a37c504-c8d8-46d5-b140-002f0d21dd8a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTEtMS0xLTEtMTE5ODY4_bb492a6f-a69d-4175-b3bf-f71fb16d8a4e">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTItMi0xLTEtMTI3MDY5_53c21d9e-0c7c-4f65-8ab3-a68d2062c9f3">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d5f411538846809c17df42d6baca81_I20220513" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTItMS0xLTEtMTE5ODY4_b6abb3a7-69d1-48ff-ae76-851def7cd775">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTMtMi0xLTEtMTI3MDY5_0c38bf0d-d9fd-48bc-895d-20f49eb43391">970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For acquisitions other than Intersect ENT and Affera, the acquisition date fair value of net assets acquired during the six months ended October&#160;28, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ib2aacc1c206e4a01aec2ccb24a371680_I20221028" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjQ2Mg_6cf6e934-4de6-489c-b42e-4e4f550d546b">123</ix:nonFraction> million. Based upon preliminary valuations, assets acquired were primarily comprised of $<ix:nonFraction unitRef="usd" contextRef="ib2aacc1c206e4a01aec2ccb24a371680_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjU0NQ_d53b7ee0-ba27-42b3-afc6-6416f84e8cc6">66</ix:nonFraction> million of goodwill and $<ix:nonFraction unitRef="usd" contextRef="i7c69bc171625454788f2c35a7111a3cf_I20221028" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjU2NA_c36db2da-57fa-474a-9bd4-396dd27734df">57</ix:nonFraction> million of technology-based intangible assets with estimated useful lives of <ix:nonNumeric contextRef="i4b9df38c023342f9ba4c348f76154832_D20220430-20221028" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjYzNg_995fb10b-94c0-4d43-81ea-d1da4761bc5b">16</ix:nonNumeric> years. The goodwill is deductible for tax purposes. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="ic6da65d65d594808b778a60b752c29d5_D20220430-20221028" decimals="-6" name="mdt:BusinessAcquisitionPriceContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjcwOA_01ed3b75-4b09-4f58-9d29-04def2b95a44">73</ix:nonFraction>&#160;million of contingent consideration liabilities in connection with these acquisitions during the six months ended October&#160;28, 2022, which are comprised of revenue and product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal year 2022</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;29, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMTM2_fcde333f-b861-4104-8437-107b626356e8">125</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTI1_062e7c8f-c623-462a-bb9d-1fe8540e181e">154</ix:nonFraction> million of assets acquired and $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMTIx_abace7a5-770b-4a69-88a5-f47eba420324">29</ix:nonFraction> million of liabilities assumed. Assets acquired were primarily comprised of $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTcx_367b1c9a-b117-44b8-93ee-7b44fe321290">80</ix:nonFraction> million of goodwill and $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="mdt:TechnologyBasedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTQy_4b5e31f9-d2fa-4cff-a6ed-61e4affde657">50</ix:nonFraction> million of technology-based intangible assets with estimated useful lives ranging from <ix:nonNumeric contextRef="i5499b0d188aa457384102e9d56fa1649_D20210501-20211029" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTUw_07727271-08b7-44cb-a6c7-077cb01aedec">15</ix:nonNumeric> years to <ix:nonNumeric contextRef="i0f469be1b25343c2afe5256eef30c662_D20210501-20211029" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTY0_ef204081-048c-4b2a-9f9e-02791cdd5867">16</ix:nonNumeric> years. The goodwill is not deductible for tax purposes. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMjk0_bbc0780f-cf02-415e-917d-197b491469eb">31</ix:nonFraction>&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;29, 2021, which are comprised of revenue and product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-Process Research &amp; Development (IPR&amp;D)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D with no alternative future use acquired outside of a business combination is expensed immediately. The Company did not acquire any IPR&amp;D in connection with asset acquisitions of technology not yet approved during the three months ended October&#160;28, 2022 and October&#160;29, 2021. During the six months ended October&#160;28, 2022, IPR&amp;D acquired in connection with asset acquisitions of technology not yet approved by regulators was not significant. During the six months ended October&#160;29, 2021, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="ifc6a84fee82c404bac6319d748601679_D20210501-20211029" decimals="-6" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNDczMA_41d9c7cd-5e70-4a37-964b-1b5b210d11e0">90</ix:nonFraction> million of IPR&amp;D in connection with asset acquisitions of technology not yet approved by regulators, which was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">research and development expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration at October&#160;28, 2022 and April&#160;29, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTU5MQ_7d29e52e-2189-4da8-bfd8-7da45f4d5b67">349</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTU5OA_26ffbc24-27ba-4737-ba9c-6f826d0c62b9">119</ix:nonFraction> million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. At October&#160;28, 2022, $<ix:nonFraction unitRef="usd" contextRef="ied8d8356269248db86adef62aabe056a_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTYyMw_0fe1f495-f3d8-4759-9203-f93ca6ec88b5">149</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $<ix:nonFraction unitRef="usd" contextRef="ib091f63ce1ed47fa86badb21ce620a7e_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTY3MA_ef2a222b-dc21-445e-8018-909a168ad0f1">200</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheet. At April&#160;29, 2022, $<ix:nonFraction unitRef="usd" contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTc0OQ_3e9f9f04-397d-438d-8219-447d9bda6b85">35</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $<ix:nonFraction unitRef="usd" contextRef="i4b3f93df1ec946d38393e3dd053885a1_I20220429" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTc5Ng_9a0dc0c6-d30a-4fd7-a430-2cf82c52cb1b">84</ix:nonFraction> million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheet. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1a1729a58e91417db77c0894f6a488db" continuedAt="i761210efa61041c8b3f2e064ab6f1aa4"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODEwNQ_c1ad8add-922b-4c08-bfb9-1e60ece96d61" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0140ab23f7415d9e84fba89d2ce274_I20220729" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi0xLTEtMS0xMTk4Njg_3a395c29-a6cf-4978-a11a-cd6958f5d5cc">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi0zLTEtMS0xMTk4Njg_53453a7e-79e4-45a0-b388-341af0c44c3c">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi01LTEtMS0xMTk4Njg_86dab03b-2199-4e2a-9da3-0ee34a37a34e">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id815d10cd7364e4c8224095110455793_I20210430" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi03LTEtMS0xMTk4Njg_5de45d7b-3443-48ab-b925-e0f5186e7e0c">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:BusinessAcquisitionPriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy0xLTEtMS0xMTk4Njg_e91d56f6-52e3-4ac6-9c11-551f9c1fecd8">201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:BusinessAcquisitionPriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy0zLTEtMS0xMTk4Njg_efea0c16-8fed-490a-b04c-91315d819335">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:BusinessAcquisitionPriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy01LTEtMS0xMTk4Njg_a7e299e6-d7cf-4562-9d03-2c0fc0863c02">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:BusinessAcquisitionPriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy03LTEtMS0xMTk4Njg_91088fe1-88a6-42f2-908e-483771e1bb2a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC0xLTEtMS0xMTk4Njg_6579c7c6-8679-4317-99e0-dd38699d1c59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC0zLTEtMS0xMTk4Njg_6b633606-87b3-4f69-92a4-e9a7fa063120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC01LTEtMS0xMTk4Njg_93a22b61-9078-4c65-9ec3-6713d915b600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:BusinessAcquisitionPurchasePriceContingentConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC03LTEtMS0xMTk4Njg_ef430c81-3c59-4338-a9a6-3fb5e87738ca">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS0xLTEtMS0xMTk4Njg_3fac2cac-8cae-48fd-8c4d-27f0ac1a2d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS0zLTEtMS0xMTk4Njg_fe135fb8-3664-4dff-86c1-82d0a790c9c5">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS01LTEtMS0xMTk4Njg_e3f85e66-83a4-4891-9c42-745772a8d383">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:BusinessAcquisitionContingentConsiderationMilestonePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS03LTEtMS0xMTk4Njg_09709882-6ee1-47d0-b032-1ccd262cb002">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi0xLTEtMS0xMTk4Njg_fa9e28e7-e4cf-406a-ba7d-d22538549633">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi0zLTEtMS0xMTk4Njg_b35a39a1-8857-4ecd-bb35-0d88a39be27d">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi01LTEtMS0xMTk4Njg_5d8509d0-1358-46cd-9b95-e87e17db5c01">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi03LTEtMS0xMTk4Njg_aaa7434a-3a52-49db-9dfc-e99a45c773c6">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy0xLTEtMS0xMTk4Njg_3964daa5-81be-4a83-af3c-4d528282f483">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy0zLTEtMS0xMTk4Njg_325de144-c9fe-40cd-89ed-6d61b49428af">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy01LTEtMS0xMTk4Njg_f52091bf-eeef-4948-8acf-1c7e4a38063c">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy03LTEtMS0xMTk4Njg_4ae33e3e-31df-4854-8997-613e500ac3d1">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODA5MQ_a8428270-7d17-4968-af3e-e2a1efff1637" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id51339e6172a4fa89793c01ac5372310_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi0yLTEtMS0xMTk4Njg_3522eec4-1c6c-4510-810a-7968bfbbb469">95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c8100ac3fc3472cb1b2257195df4d15_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo3MDFiMzlkMzg1ZGQ0NGFkYWY3MGQzN2QzNGQ3NmQzN180_ded90aac-8233-45ef-b6e5-d163b55225c6">11.2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ieaec69ca2a9d420196afba03c715564d_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo3MDFiMzlkMzg1ZGQ0NGFkYWY3MGQzN2QzNGQ3NmQzN185_395261db-39d2-4e8b-8c00-b8d48a3e5f2b">27.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8536fb1f3cc8405c85d5955abab804d9_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi0xMC0xLTEtMTE5ODY4_2db1daee-748e-41b2-905c-acb480b54bb5">17.1</ix:nonFraction>%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib7770b13078c4633b39a58a920db477c_I20221028" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC0yLTEtMS0xMTk4Njg_b047ee91-349b-439d-819f-24de06bdfb2d">254</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2589490d854b4bbc9e1da49cf061a2e8_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjoyYjFhMTg5OGMxOTA0MDExODllMTY2YWIyNzc0ZDgyZF80_a67c31fa-8425-4813-a84a-559b2f8afcbd">3.9</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i3fc3efebb4dd43008c52a5f4f54db6ab_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjoyYjFhMTg5OGMxOTA0MDExODllMTY2YWIyNzc0ZDgyZF8yNzQ4Nzc5MDY5NDQ5_bd3db806-0feb-438c-8b45-085596035478">5.5</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4458127713949c4a58c258ac31d5b0f_I20221028" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC0xMC0xLTEtMTE5ODY4_3753dffa-b2da-431a-8273-db06c9c33d5a">4.3</ix:nonFraction>%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets and Liabilities Held for Sale</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 25, 2022, the Company and DaVita Inc. (&#8220;DaVita&#8221;) entered into a definitive agreement for the Company to sell half of its Renal Care Solutions (RCS) business. This sale is part of an agreement between Medtronic and DaVita to form a new, independent kidney care-focused medical device company (&#8220;NewCo&#8221;) with equal equity ownership. As a result of entering into the definitive agreement and as of that date, the RCS business met the criteria to be classified as held for sale. The transaction is expected to close in calendar year 2023, subject to customary regulatory approvals and closing conditions. RCS is part of the Company&#8217;s Medical Surgical portfolio. The Company recorded non-cash pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i0eab4cc7e4a74091a2af9b1421a69dca_D20220730-20221028" decimals="-6" name="us-gaap:ImpairmentChargeOnReclassifiedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM3OTEy_3704c4ea-2675-405a-b17a-2b1795f99fc5">14</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaf0cf08134fb482896645f610dcd043e_D20220430-20221028" decimals="-6" name="us-gaap:ImpairmentChargeOnReclassifiedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNzE1Mg_66068fae-5c5e-4b5b-8306-326867b42280">81</ix:nonFraction>&#160;million, primarily related to impairment of goodwill and changes in the carrying amount of the disposal group, in the three and six months ended October&#160;28, 2022, respectively, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. Refer to Note 10 to the consolidated financial statements for additional information on the goodwill impairment.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i761210efa61041c8b3f2e064ab6f1aa4"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODExMg_807a4674-05dd-4b9f-9bbb-805b6b5f922a" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale in our consolidated balance sheet:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.800%"><tr><td style="width:1.0%"></td><td style="width:87.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMS0xLTEtMS0xMTk4Njg_a044e5e9-aeb7-467b-883d-7a9ebcf9b434">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMi0xLTEtMS0xMTk4Njg_96ee06e3-81c1-47e8-a856-f60e20506444">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMy0xLTEtMS0xMTk4Njg_8e21ed40-e6f5-42a1-b26f-531e5092a526">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNC0xLTEtMS0xMTk4Njg_4f48fcf4-9521-46c7-bf1b-e5497392183c">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNS0xLTEtMS0xMTk4Njg_d252eba9-536b-4f65-a3e1-52cf7e9c556f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNi0xLTEtMS0xMTk4Njg_18c072e7-496c-41a3-81e2-c954e766ae4c">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfOC0xLTEtMS0xMTk4Njg_45f988b4-2548-430e-be3a-95e11b1b1e96">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Total assets held for sale and total liabilities held for sale are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, respectively in the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)  No separate class of liability classified as held for sale was individually significant enough for separate disclosure.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no assets or liabilities classified as held for sale at April&#160;29, 2022. The Company determined that the agreement to sell half of the RCS business does not meet the criteria to be classified as discontinued operations.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDczMA_fb56a94a-b7fa-4a5c-b249-59f84c67adcc" continuedAt="i896c0c9f03344743bcdc2f233eb81b03" escape="true">Restructuring and Other Costs</ix:nonNumeric></span></div><ix:continuation id="i896c0c9f03344743bcdc2f233eb81b03" continuedAt="ica1f23ba036f4d5cb4d481307bd83de1"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $<ix:nonFraction unitRef="usd" contextRef="ic303609806184f2a8805b32d1c783a34_I20221028" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzMx_1268b14c-2598-4f15-9f5b-cf81a0dc5a3d">1.7</ix:nonFraction> billion in connection with the Enterprise Excellence program. In total, the Company estimates it will recognize approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ic303609806184f2a8805b32d1c783a34_I20221028" decimals="-8" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDUy_277942e6-99e8-445a-90cc-d8cd0dbc82ce">1.8</ix:nonFraction> billion of exit and disposal costs and other costs related to the program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries and benefits for employees supporting the program, including program management and transition teams, and strategic and operational consulting services related to the three objectives of the program. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">restructuring charges, net, cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the consolidated statements of income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $<ix:nonFraction unitRef="usd" contextRef="i16be2ec2863d4cd48ac8e0eb7c5810ca_D20220730-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTA5NA_5bd1f002-f492-49e4-b6b6-df7408185bb0">53</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf42b4b6d0454f69954bbee47e517f83_D20220430-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTk0NQ_e86cfa55-0a29-4565-99e3-0b0a9ae84961">93</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="ifccb4ab61ed34b10bc32266e11c04021_D20220730-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTEwNw_9aa752a6-6218-4f2b-aec2-d7405291500c">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i76aa15f0495a412bb5fc7e8ff902a5d1_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTgxMw_db79ac6d-c4d4-47b3-8a00-be9f2376aed5">38</ix:nonFraction> million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i2fb118eb3cf3495fa67564bb77d2993e_D20220730-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTE1OA_125d5c9e-e51f-4753-909f-d755a63b7b4a">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia10b9bf7f4c04b34a8e912ac100537a7_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTgyMQ_5f9e2953-866d-491c-8260-8bf62b6f1f74">55</ix:nonFraction> million, respectively, were recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. For the three months and six months ended October&#160;29, 2021, the Company recognized net charges of $<ix:nonFraction unitRef="usd" contextRef="i23fad8dce9c14b88b09f562c0af053eb_D20210731-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTMzOQ_8e88a7ab-49c2-4d81-a508-d5449a405bfb">62</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i73bd78bbe8f143f88fc76d50131fcd9c_D20210501-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTg4MA_6ce2a003-9367-4eab-846f-baebc2e14a77">136</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i1e280053272b4dd5b8c64cde259c885a_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTM1Mg_d7989662-19fb-40ad-9b43-e6004968b789">31</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibc87cf841c074114a5ac8137bc707c99_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTkyOQ_7673786d-f546-4f7d-ab67-b221f477d4a6">64</ix:nonFraction> million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="ic7a4dc8016694646972d6448816d5640_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTQwNA_12314a04-1171-48d1-a546-1c60eca9078d">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2d4182f25b264fa0a677c170f7aa55f9_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTkzNA_cff4b8ad-eccf-4243-afae-5932633c8f34">57</ix:nonFraction> million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $<ix:nonFraction unitRef="usd" contextRef="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTgwMQ_5710cf08-1cdc-41c2-89ea-13e107ae597a">427</ix:nonFraction>&#160;million in connection with the Simplification program. In total, the Company estimates it will recognize approximately $<ix:nonFraction unitRef="usd" contextRef="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTkxNQ_8d2513ce-6a05-45f4-a414-fe6e21316a4e">450</ix:nonFraction>&#160;million of exit and disposal costs and other costs related to the Simplification program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $<ix:nonFraction unitRef="usd" contextRef="i0b041edd8d56490d893ff0c11caa0d8a_D20220730-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjQzMg_4bcc3488-9008-45af-8fa5-de73d8202dbd">43</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1d6cdd73391542f3b7994da4e26578af_D20220430-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA0MA_5cab6d75-def6-4665-ae99-d685e3284e3f">78</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i546d50a1a554496194d00f2caddaf5ca_D20220730-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjQ0NA_5f98d295-bbbb-4b22-9b01-389afdc54e72">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i87940cb6cac741d6b1f3cc6fb389a371_D20220430-20221028" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA0Nw_5e4ece4a-1596-456d-9152-06e49d35abed">31</ix:nonFraction> million, respectively, were recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. For the three and six months ended October&#160;29, 2021, the Company recognized net charges of $<ix:nonFraction unitRef="usd" contextRef="i8ff0490f25be4b77b9b8f6dce7ac4704_D20210731-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjYyNg_3167f95e-20d3-42ab-b456-bb7d47497682">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie6a7d73ef1c947bfac5459b19b344d12_D20210501-20211029" decimals="-6" name="mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA1NA_3450a7c5-9d3e-4caa-b7c8-c382b00e28bc">25</ix:nonFraction> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ica1f23ba036f4d5cb4d481307bd83de1"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="ic8cf02e126cb40ff876492202959b05e_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA2Mw_ecbc1319-c529-4d2d-89b4-25d04c873b78">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04964d69fc284d70b8188fb55131e440_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA3MQ_19d0b4a1-a603-405a-bfbb-2fa3bd4af220">16</ix:nonFraction> million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDcyNg_01adaa25-b243-4aa6-8866-da13ec5b22db" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the restructuring programs above for the six months ended October&#160;28, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other <br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a172149369e4566a362a7034cff8552_I20220429" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS0xLTEtMS0xMTk4Njg_42001a54-c5a5-4768-aff9-51fab54c5e27">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67cae084ba3e474287026bb8a735a3da_I20220429" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS0zLTEtMS0xMTk4Njg_e93383c8-0b77-4039-b282-173933b2abe1">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750e8435c8c8420982689bdc80379523_I20220429" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS03LTEtMS0xMTk4Njg_3d788254-8f4c-496d-b5a6-a2a5734a97d4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS05LTEtMS0xMTk4Njg_7bb2da56-16ad-4bdd-ab34-7cff2ec2721c">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi0xLTEtMS0xMTk4Njg_33b50e8b-e4e5-470c-a3ed-214839c66b82">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi0zLTEtMS0xMTk4Njg_29ab072d-d6e2-4947-ab2f-6e6075905dfc">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi03LTEtMS0xMTk4Njg_a0d758b4-6613-4c57-9967-cbc7a78b4e49">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi05LTEtMS0xMTk4Njg_422745df-4591-4d41-b44d-05e3e59b0128">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy0xLTEtMS0xMTk4Njg_531a475d-7869-4974-a136-6966c3da4527">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy0zLTEtMS0xMTk4Njg_fff9011c-037a-4d6b-957c-93d88515123f">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy03LTEtMS0xMTk4Njg_2781d501-441f-4149-9d6b-2020731bb87e">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy05LTEtMS0xMTk4Njg_658cf7cb-30a9-4bea-9436-980936130a98">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC0xLTEtMS0xMTk4Njg_73fb9154-1901-4575-a413-a20d33c20f9a">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC0zLTEtMS0xMTk4Njg_83da1c87-6fa2-4d44-adee-d881b4c1dec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC03LTEtMS0xMTk4Njg_77cba62f-b937-49c0-a5cd-0a65c0780c3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC05LTEtMS0xMTk4Njg_c6890dc7-bdb6-464c-bc4d-df73d7497e35">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3f285c5dfb4c6c8e9ef6bff8bbad66_I20221028" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS0xLTEtMS0xMTk4Njg_f3481f32-0f05-4e33-9082-08904a5dc0f3">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba560acd2e9b4ac59cc8a3b89523e6cd_I20221028" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS0zLTEtMS0xMTk4Njg_a75b2f64-2843-4a40-b740-c47b2ec9a6ef">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd39c4b6e9034559b7adc2252123cce6_I20221028" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS03LTEtMS0xMTk4Njg_6b4b75ff-f141-42f0-8d10-4f63d7d71d00">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS05LTEtMS0xMTk4Njg_3e805211-a136-4bc8-952c-7d1ef50c0b16">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)   Accrual adjustments relate to certain employees identified for termination finding other positions within the Company.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mechanical Circulatory Support (MCS)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company announced the decision to stop the distribution and sale of the Medtronic HVAD System in light of a growing body of observational clinical comparisons indicating a lower frequency of neurological adverse events and mortality with another circulatory support device available to patients compared to the HVAD system. In connection with this decision, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730" decimals="-6" name="mdt:RestructuringWriteDownAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzYxNA_ae598216-773f-4173-9bdd-68ac9a3f86e1">726</ix:nonFraction>&#160;million (MCS charges) within the Cardiovascular segment during the three months ended July 30, 2021, including $<ix:nonFraction unitRef="usd" contextRef="i388aa93f36a249c1a5b546222a59df60_D20210501-20210730" decimals="-6" name="mdt:RestructuringWriteDownAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzcwOQ_8944fc56-68bd-4fb9-9ae7-e417aca35b9a">58</ix:nonFraction>&#160;million recognized in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="if90275cb55b4415a836c84bf7e67ed62_D20210501-20210730" decimals="-6" name="mdt:RestructuringWriteDownAndImpairmentProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzc1Mw_f0d881b6-9234-4417-b77a-974c485f1f44">668</ix:nonFraction>&#160;million recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statement of income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges included $<ix:nonFraction unitRef="usd" contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730" decimals="-6" name="mdt:AssetImpairmentChargesAndInventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzg2NQ_58d7dda8-6be2-4c44-9922-30bc67aabf41">515</ix:nonFraction>&#160;million of non-cash impairments and write-downs primarily related to $<ix:nonFraction unitRef="usd" contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzkyOQ_9c4d5f62-9740-4245-880e-b1068e4726cb">409</ix:nonFraction>&#160;million of intangible asset impairments and $<ix:nonFraction unitRef="usd" contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzk2OA_c08c3c06-059d-44ba-988e-05a674c96827">58</ix:nonFraction>&#160;million of inventory write-downs. The Company also recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730" decimals="-6" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDAzNA_e9a5fb80-11e7-4b57-980b-962b11f20ac4">211</ix:nonFraction>&#160;million for commitments and obligations associated with the decision, which included charges for patient support obligations, restructuring, and other associated costs. During the fourth quarter of fiscal year 2022, the Company recorded additional charges of $<ix:nonFraction unitRef="usd" contextRef="i3a082f3a04564610933344f50f0c3196_D20220129-20220429" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDI4OA_be9a6a8d-a76e-4029-99d3-df4483bf4417">155</ix:nonFraction>&#160;million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily related to incremental commitments and obligations associated with the exit of the business. As of October&#160;28, 2022, accruals were recorded in the consolidated balance sheet for these obligations, with $<ix:nonFraction unitRef="usd" contextRef="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028" decimals="-6" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDUyNg_ed41381f-5b7d-46a4-b6f8-4bd2ff5043fe">83</ix:nonFraction>&#160;million reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028" decimals="-6" name="us-gaap:RestructuringReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDU2OQ_16e794e3-48e8-43b6-a8b0-02318541720e">120</ix:nonFraction>&#160;million recorded in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Medtronic remains committed to serving the needs of the patients currently implanted with the HVAD system.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_52"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUyNg_cefdffa5-e4d4-4cc5-8dc9-ab8f078c61c0" continuedAt="id583048a0016430daf77c3086ad9ae04" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="id583048a0016430daf77c3086ad9ae04" continuedAt="ib331787a534c41d68b789d251440a05c"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and are remeasured on a recurring basis. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ3Nw_1e28b44a-d012-46fe-b9bb-17402b3b6741" continuedAt="ie4d4dcfcf4f7462bbcbc12921d30d8b7" escape="true">The following tables summarize the Company's investments in available-for-sale debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;28, 2022 and April&#160;29, 2022:</ix:nonNumeric></span></div><ix:continuation id="ie4d4dcfcf4f7462bbcbc12921d30d8b7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0xLTEtMS0xMTk4Njg_a8e412a0-d997-402b-8993-2dd78d8a2ca5">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0zLTEtMS0xMTk4Njg_54187feb-3453-4dcf-a5e0-bc96150ce428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC01LTEtMS0xMTk4Njg_1fa5cd93-1851-4636-9427-a821ce48833a">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC03LTEtMS0xMTk4Njg_baba3601-f72d-4a36-922f-7a4f5bb48752">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0e9a2126f3451a9364ecb102f47619_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC05LTEtMS0xMTk4Njg_7d8c3909-7ecf-4e2f-a8f2-00ca6b409bcc">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17c51259199438d92935700e9a84f38_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0xMS0xLTEtMTE5ODY4_03f8b237-262e-4d13-8500-481da77a2950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0xLTEtMS0xMTk4Njg_bfe16d3f-3cfa-4277-acc1-d004f3e4f300">4,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0zLTEtMS0xMTk4Njg_f26610a8-2d20-4f01-b995-16d00ca34437">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi01LTEtMS0xMTk4Njg_0d3eb0c8-8c68-4474-bae0-cf9651e94d9e">273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi03LTEtMS0xMTk4Njg_2fb9bb32-e071-43b6-9c2e-f3799e34d077">4,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5183de769d9943e0bbf4bf305875caee_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi05LTEtMS0xMTk4Njg_36e66dd7-408e-4d98-8094-6ea017d22f7d">4,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaedf855a588542ea8b681a551750a94c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0xMS0xLTEtMTE5ODY4_16b7a939-d686-483d-bf49-682989c3b16c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0xLTEtMS0xMTk4Njg_5049b368-b0b5-408c-8c8f-4ca1e1872ecb">946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0zLTEtMS0xMTk4Njg_4e5aa560-f6c2-4cc4-b035-4cc7dd1a2f37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy01LTEtMS0xMTk4Njg_a9252b6f-2d0a-4686-b97b-031a1a3b576c">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy03LTEtMS0xMTk4Njg_4d08c8c5-7354-4f5f-b0ed-d55e3b0288ae">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6630e92f38ab4432b631dd6c08be1b5b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy05LTEtMS0xMTk4Njg_d19edaee-b3be-4bf6-a3ab-314149a6f584">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acdf85d52b44d0aab8be69ef0dfca9a_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0xMS0xLTEtMTE5ODY4_986d644d-bdf6-4293-969d-7263259ba23e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0xLTEtMS0xMTk4Njg_af4b73b6-b065-4fca-9f1f-ee9d438ec7ed">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0zLTEtMS0xMTk4Njg_c5f4aaeb-6d95-4f08-b691-7675ecfae891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC01LTEtMS0xMTk4Njg_fbe29499-f184-42e4-99b3-4bc0ec224fba">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC03LTEtMS0xMTk4Njg_2748c829-44c7-4d4c-8c1b-4a0409e6f7b8">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ea21efa0974fd89079e5ff7597d05c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC05LTEtMS0xMTk4Njg_2d33eee1-a8b9-417a-aab0-12479487720f">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2adc065c1c31426ca784f2f3aac4c338_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0xMS0xLTEtMTE5ODY4_995c234a-26d3-4664-93f7-d1f7439e3760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0xLTEtMS0xMTk4Njg_062ac347-ebc2-44b7-8db2-71a875fd374e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0zLTEtMS0xMTk4Njg_1659f90a-7c2f-4d30-8807-f6183c086f6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS01LTEtMS0xMTk4Njg_c487da1b-4b93-4c4c-9c6d-a7f14ef7ecd3">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS03LTEtMS0xMTk4Njg_9e1104dd-fecb-467f-8027-26569ec4e6c9">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3cf62ad6eb249199fc96aa7235ad10e_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS05LTEtMS0xMTk4Njg_6904c691-81b8-4a3b-9c4e-faf5e5a755a1">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc5013382474ea0bac44885f9583479_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0xMS0xLTEtMTE5ODY4_0b6778e5-97fb-42ad-9d16-85448b5b9b8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMS0xLTEtMTE5ODY4_13166b39-ae9e-49ec-94c4-72a012d94cbc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMy0xLTEtMTE5ODY4_5e960ff1-4da5-42aa-a8d5-45b794fc57ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtNS0xLTEtMTE5ODY4_afed5a91-3b87-47e3-8332-c92af903b3f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtNy0xLTEtMTE5ODY4_7b543073-f003-4fd9-a208-4d80b10ae9f2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fac49e993e425480a39ef2da97c7e1_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtOS0xLTEtMTE5ODY4_8ea9b9ff-6205-412d-9284-392a1b90deef">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16dab65d5fee4b13a1b5536b9061af57_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMTEtMS0xLTExOTg2OA_b75c5b7d-b330-48c4-a491-a24c982ec17d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMS0xLTEtMTE5ODY4_b5f4ade2-c17a-4bbf-a6cc-ef39af404fb0">587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMy0xLTEtMTE5ODY4_902a8328-c200-4f68-b8ba-82691c178578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtNS0xLTEtMTE5ODY4_a6354240-5ac2-4d34-ad85-48ad818fa576">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtNy0xLTEtMTE5ODY4_154d43c3-8a27-4e17-84b9-dfc2f078c632">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5cf66c9d744fa6b08216cffcee6ea1_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtOS0xLTEtMTE5ODY4_1a694796-0d2d-4bcc-835a-4a1ebb21d148">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e4261fc6da42f78a32a5697fd40ebc_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMTEtMS0xLTExOTg2OA_4c7f94f0-00f9-4ecf-b79a-18c8c7569b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMS0xLTEtMTE5ODY4_d5bac640-8909-4534-9da9-076e738fd6c3">6,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMy0xLTEtMTE5ODY4_2004d351-c359-4703-bf3c-f19349c739c4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItNS0xLTEtMTE5ODY4_0ab9d803-9ec2-4b53-9cb3-b456a175511c">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItNy0xLTEtMTE5ODY4_092b8ee2-cf30-4eb8-a3de-5b14ddfad34a">6,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7679e68037ad488cad0ab87fcf105814_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItOS0xLTEtMTE5ODY4_b0e9d247-e405-4273-a929-94200bf96ed4">6,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e89ca409848475c9dd855df62f568ba_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMTEtMS0xLTExOTg2OA_e9097cb3-798c-41c0-942d-a4b6f64e905c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMS0xLTEtMTE5ODY4_76192f93-f8cc-4cc5-b758-5aa9abec8556">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMy0xLTEtMTE5ODY4_a81c18a7-64f7-473b-9e95-ace49e9f10e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtNS0xLTEtMTE5ODY4_a5d93d41-68b6-4df6-be50-2079fa7ab980">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtNy0xLTEtMTE5ODY4_7455170e-a53f-41ac-a689-a20e2c97d9f5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e31c2e0429a4641939c2538318931cc_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtOS0xLTEtMTE5ODY4_22303075-1aee-4e96-8173-8b617cb2e664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672142582fb643789a7c2276926b53c2_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMTEtMS0xLTExOTg2OA_e15d52e6-39d5-45ce-84a3-e4a9faa92b46">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMS0xLTEtMTE5ODY4_04f81ffd-9b86-466f-92cb-aa972bbdf275">7,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMy0xLTEtMTE5ODY4_40ace7d2-c6fb-4860-a6c3-7221533f1318">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtNS0xLTEtMTE5ODY4_e87a64a3-a24d-4208-bfad-56843c1779bb">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtNy0xLTEtMTE5ODY4_b8a6253a-c7f8-4276-9ff6-93c6f9bbe42e">6,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i692de9ddca214b599e9a03ae112ad3e2_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtOS0xLTEtMTE5ODY4_cebde24d-ea02-420f-8561-293f181ed531">6,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMTEtMS0xLTExOTg2OA_e6c1b3a5-0a6d-4d56-bbb7-fa2166c7e460">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0xLTEtMS0xMTk4Njg_280e9726-5209-45e2-8e8e-087a2e26d76d">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0zLTEtMS0xMTk4Njg_10b78ea0-03c9-4e47-b1cb-07021111ea6a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC01LTEtMS0xMTk4Njg_bcd87d1c-8c93-49f0-bac3-46fbe52253fc">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC03LTEtMS0xMTk4Njg_72386ac9-2c49-494c-accc-d557b16996bb">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76bbc05331214b40b0fd449dedfe22ea_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC05LTEtMS0xMTk4Njg_e5090ac9-183a-4a6e-baaf-a424d40565b0">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b399a04cb7646b5b07096251d2007a8_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0xMS0xLTEtMTE5ODY4_94d3109f-e0fe-4220-9fbb-025cc946b352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0xLTEtMS0xMTk4Njg_648f7676-96dd-4bf5-aa6d-125ff92b7208">4,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0zLTEtMS0xMTk4Njg_402aace7-a59e-429d-904a-cf02d310b430">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi01LTEtMS0xMTk4Njg_3c5ff306-d352-4f69-87b7-9899078cae83">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi03LTEtMS0xMTk4Njg_a9907cef-40f2-4e9e-ab62-9cb77450f524">4,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf32105f8fc437ab7b7ecaa4fba22e3_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi05LTEtMS0xMTk4Njg_b8010635-a3ef-496d-acf5-b28c2fe57b81">4,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96538ee63df541aba2adf1f7c5ee69c7_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0xMS0xLTEtMTE5ODY4_f32704a2-094a-4183-a7f9-acf9d0d27af4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0xLTEtMS0xMTk4Njg_88e46baf-b083-4d34-bd81-dc2adcdb7f15">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0zLTEtMS0xMTk4Njg_2f9d6cce-65db-468e-a35d-07da8d877b10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy01LTEtMS0xMTk4Njg_28bb6aa5-814f-49e0-8572-e98e1fef2656">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy03LTEtMS0xMTk4Njg_63ee59e7-5416-4c2d-9376-dfe5b3d26c26">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da397896f3b426988512b961eafff1c_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy05LTEtMS0xMTk4Njg_d29fcc48-81f8-4093-933f-eb3c678a0de2">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f45d131dfd44f8b06d2d1fbb1101b1_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0xMS0xLTEtMTE5ODY4_a1bf29d6-368f-4745-8bc1-db41de7347a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefba2a09bdf2400fa659329962a625be_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0xLTEtMS0xMTk4Njg_2648b4cc-0c21-4157-8d62-7444e29c7bbd">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefba2a09bdf2400fa659329962a625be_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0zLTEtMS0xMTk4Njg_e0577a01-6d93-4016-b000-e857dd415211">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefba2a09bdf2400fa659329962a625be_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC01LTEtMS0xMTk4Njg_caab03bb-fb88-440a-b0fa-f2b662018fcd">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefba2a09bdf2400fa659329962a625be_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC03LTEtMS0xMTk4Njg_09c07a77-8fef-4375-9f33-50d2ddb0dbdd">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia18fb875e6a54bd698fc23cdb9435208_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC05LTEtMS0xMTk4Njg_7db18105-7a39-4e0f-ae58-2af50d1ac5f6">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4146b3ff2414dff8bec3c9d91d6df09_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0xMS0xLTEtMTE5ODY4_10768633-6a39-4d5c-97ec-34b4c27b4311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0xLTEtMS0xMTk4Njg_95794262-4ff2-4adf-b3fe-3e89fbbcf4f2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0zLTEtMS0xMTk4Njg_dcca623b-b6b2-4bb0-8cf5-ecfa476cedb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS01LTEtMS0xMTk4Njg_9a647897-b355-4113-9763-7f594fe51896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS03LTEtMS0xMTk4Njg_39817396-d0e9-4d36-b2e1-61d675e5b73c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50675223fb9c4d24bac91bf5a8b500c5_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS05LTEtMS0xMTk4Njg_d52bdcba-8f08-4aaa-8bed-0db4a01aeff3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5341030da8404ab23eb314af6659f0_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0xMS0xLTEtMTE5ODY4_f37abc54-d981-44a7-93aa-44c3a269ab97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0751698534580a06d7e591c567510_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMS0xLTEtMTE5ODY4_0cad699d-b1cc-4c3f-9715-e50236388049">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0751698534580a06d7e591c567510_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMy0xLTEtMTE5ODY4_2ecc2662-8568-4869-af24-5d1fc8629d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0751698534580a06d7e591c567510_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtNS0xLTEtMTE5ODY4_04b411f1-8655-4925-ac00-6a212014dc86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0751698534580a06d7e591c567510_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtNy0xLTEtMTE5ODY4_9d414f4a-e05f-4aaf-b7b0-7aae660bba80">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9959424fd6a4e18a014b452439974f3_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtOS0xLTEtMTE5ODY4_bb77df86-55c2-458c-9a0a-54d2de22f4b7">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4f16ecd76844a249feacc0c1f4a7db9_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMTEtMS0xLTExOTg2OA_b4270668-1520-428a-816a-0e1d6fd341c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af62c64c70e496180646fa5003616d9_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMS0xLTEtMTE5ODY4_df158831-9028-476f-a68e-b7557b14b500">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af62c64c70e496180646fa5003616d9_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMy0xLTEtMTE5ODY4_0887564a-cd45-4824-87ad-18ca3a9b386e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0af62c64c70e496180646fa5003616d9_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtNS0xLTEtMTE5ODY4_ffca444a-157f-4192-9b35-543d1f3ddbfe">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0af62c64c70e496180646fa5003616d9_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtNy0xLTEtMTE5ODY4_a6fa5f2d-19b4-4627-b511-e6676360ffdb">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibabaf9d9de764e76a341637628038690_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtOS0xLTEtMTE5ODY4_39a58213-e5e5-4010-97f2-a6c3305393f6">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181e138f85db48af8965b7d878b7e8b9_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMTEtMS0xLTExOTg2OA_341e4c8d-3cea-4e05-b1b5-68294180e694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMS0xLTEtMTE5ODY4_cd5c5437-fcf3-480b-97a4-40f3a4c9fa7a">6,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMy0xLTEtMTE5ODY4_f91c5d75-0028-4199-9e35-2fba660f8a09">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItNS0xLTEtMTE5ODY4_41aaa7df-d2f0-4069-814a-0bda999d7caa">227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItNy0xLTEtMTE5ODY4_ff926e3a-15ff-4181-b5f9-ae44aad3b6af">6,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a9d94e94f1a4706a534771364ec005b_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItOS0xLTEtMTE5ODY4_ed6c090c-92bf-4a63-9aa9-7c0ba45b29a7">6,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac252a414964d53a7d3be0ec2452d75_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMTEtMS0xLTExOTg2OA_ed0d1715-a8ca-49d6-ba86-f46d4d1a60e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMS0xLTEtMTE5ODY4_15a8e8e6-7a6e-42f1-b65d-71b15fbf9087">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMy0xLTEtMTE5ODY4_8e5e23c5-2050-462d-bc2f-43b06e04f2ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtNS0xLTEtMTE5ODY4_f54c1023-277c-4f32-9f35-c90af65a4ed5">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtNy0xLTEtMTE5ODY4_12a869e6-fab2-44d7-b267-ddae6eb5524b">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0b7ef8524844b0804a1928fb54d9b4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtOS0xLTEtMTE5ODY4_7fb93a3d-0e0a-4e5b-a7ea-60e1ce19d9d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9259b16d9d1a47a3a029f28c0f8a81bd_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMTEtMS0xLTExOTg2OA_ec96c443-917a-4679-9e23-c5179523818c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMS0xLTEtMTE5ODY4_51ee0f8f-7fa1-4094-ab79-1615308a744f">7,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMy0xLTEtMTE5ODY4_fc46583c-464e-4773-95c3-65fb4346827e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtNS0xLTEtMTE5ODY4_4c436ad0-a608-4e41-bbae-c4d8b19fc916">245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtNy0xLTEtMTE5ODY4_38b89947-8e87-4741-8748-74170d40c5d4">6,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if29182b593044b31bebc366410e41692_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtOS0xLTEtMTE5ODY4_251f3c4b-7007-4320-a6ee-371a40d06aba">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMTEtMS0xLTExOTg2OA_40ad7898-07f9-4536-b83e-36da36555b6e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of debt securities excludes accrued interest, which is reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib331787a534c41d68b789d251440a05c" continuedAt="iee3a2bc4b08c4326a3123f20b201dc29"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ4OQ_069a6c9d-bd23-45a5-ace6-a80dd59d25f6" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;28, 2022 and April&#160;29, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy0xLTEtMS0xMTk4Njg_79cbd353-ad94-4fc1-ab32-951ca4628ffb">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy0zLTEtMS0xMTk4Njg_63b19a60-bf83-460a-a4bd-433a2cc067f5">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy01LTEtMS0xMTk4Njg_c02e8d1e-dbe3-4771-a092-a995818e36d6">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy03LTEtMS0xMTk4Njg_92730b9a-c6d1-428b-8a4c-7451ccdac2a9">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39738394791c43f39b81aa42666e1649_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC0xLTEtMS0xMTk4Njg_57165944-a69d-4725-94ca-e327c0f00862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39738394791c43f39b81aa42666e1649_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC0zLTEtMS0xMTk4Njg_8e67a165-c4b3-43b0-a411-2253b8eac948">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39738394791c43f39b81aa42666e1649_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC01LTEtMS0xMTk4Njg_4801f5c5-fbb2-487f-94db-f0ee49e4dfbf">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39738394791c43f39b81aa42666e1649_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC03LTEtMS0xMTk4Njg_e8f26283-959d-44d5-ac8c-b979ee9ed5c6">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS0xLTEtMS0xMTk4Njg_e6642a94-a8e3-4969-9b33-ff07cc7ddaa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS0zLTEtMS0xMTk4Njg_48a67958-3f87-49f1-a539-8e9831dd9b8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS01LTEtMS0xMTk4Njg_4ce5aed9-22d8-408e-bad6-dc5664008b90">491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS03LTEtMS0xMTk4Njg_9885d0b5-6959-4d8b-b207-82d41463b321">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi0xLTEtMS0xMTk4Njg_45acf808-fd97-4c27-86ec-959181f0cd23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi0zLTEtMS0xMTk4Njg_d75f1714-d131-43f6-808b-773c8eeb4b66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi01LTEtMS0xMTk4Njg_7db3682d-f4bd-4d7e-a7f9-fc2be0554e9a">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi03LTEtMS0xMTk4Njg_cd170686-8572-4562-8469-6e0a0dd80716">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy0xLTEtMS0xMTk4Njg_8243c948-e39f-4fdb-8e21-39e6286a0eab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy0zLTEtMS0xMTk4Njg_484c02c4-e0ce-42ed-98f6-efe2874f47cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy01LTEtMS0xMTk4Njg_76d13bed-1db0-4615-8f4f-7aea9b51d36e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy03LTEtMS0xMTk4Njg_e6f8a8c1-ba26-4dfa-8dd2-2ff3369ca587">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC0xLTEtMS0xMTk4Njg_782e0c3b-9283-401a-a53c-5f0acd83c1ba">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC0zLTEtMS0xMTk4Njg_d8b413ef-a4f1-485f-9495-e5a6e4bcab01">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC01LTEtMS0xMTk4Njg_88eadea2-001c-4848-9e5c-2ec64effd27b">5,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC03LTEtMS0xMTk4Njg_27b10632-78a7-4c2c-b1eb-7002b84a0486">456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy0xLTEtMS0xMTk4Njg_fcb1f029-9576-4dcc-9003-9e614802fc52">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy0zLTEtMS0xMTk4Njg_af826771-6a3c-4a1c-8e34-51a1f83b4986">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy01LTEtMS0xMTk4Njg_2e109b07-51f6-411c-ad6d-613ddbd6f398">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy03LTEtMS0xMTk4Njg_9c58ab3f-a701-4f79-ab28-2401420cf1a3">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51c0979773246909434b1ce27622157_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC0xLTEtMS0xMTk4Njg_f8838f8f-7337-4747-9fbf-2f1319a17ad9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51c0979773246909434b1ce27622157_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC0zLTEtMS0xMTk4Njg_7e56d1c5-ad41-4770-8ca2-a73a1c4f18d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia51c0979773246909434b1ce27622157_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC01LTEtMS0xMTk4Njg_1b9dbabb-3523-4813-acc2-bf1892c48956">945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51c0979773246909434b1ce27622157_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC03LTEtMS0xMTk4Njg_99107795-0559-4374-a7c0-73dec15f21c4">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS0xLTEtMS0xMTk4Njg_85159a72-3952-47a6-978d-6b12e0013b91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS0zLTEtMS0xMTk4Njg_32f8f6b2-4981-43ed-92a5-5c0ce4edd122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS01LTEtMS0xMTk4Njg_93cc2e0f-a413-4add-909c-8e018fbe028e">507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS03LTEtMS0xMTk4Njg_83bed58f-3165-4022-88ef-2ab261ce14a2">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi0xLTEtMS0xMTk4Njg_36b108fa-6979-44d4-add3-fd70a45e42ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi0zLTEtMS0xMTk4Njg_b8b154be-f628-44f7-8750-6463f4b424cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi01LTEtMS0xMTk4Njg_9ad3c7c7-f940-4830-afc9-f3d80dfc4d57">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi03LTEtMS0xMTk4Njg_6da0b42d-d9b8-46b0-a8eb-4de0f1bbaabe">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965da10df5234587b1d528532b979fa4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy0xLTEtMS0xMTk4Njg_3491ab61-a248-4ce9-b3d8-b43199bbce91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965da10df5234587b1d528532b979fa4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy0zLTEtMS0xMTk4Njg_140a1b0c-3665-48dd-8ca5-979301dbe9e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965da10df5234587b1d528532b979fa4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy01LTEtMS0xMTk4Njg_494cedb4-c22d-4870-b023-d9eaeb230f01">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i965da10df5234587b1d528532b979fa4_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy03LTEtMS0xMTk4Njg_5d1fbae7-48a8-4546-938e-fb86750680be">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC0xLTEtMS0xMTk4Njg_ba286aba-4103-404a-8f0f-5d7519150de6">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC0zLTEtMS0xMTk4Njg_a5c7ad81-1ad2-4aa4-9b90-38c01fb91835">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC01LTEtMS0xMTk4Njg_d7ecf539-4645-44ea-b5b7-2f3558cc690e">5,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC03LTEtMS0xMTk4Njg_94354c96-aea9-4cdd-84c5-e34b088ab834">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUxMA_66018f26-be39-4a3f-b06b-f93655b6110f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi0xLTEtMS0xMTk4Njg_cea6b770-0cdd-4c68-a183-65e4a5079f2b">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi0zLTEtMS0xMTk4Njg_1bd5e3d9-ac9b-443c-aa32-d36c1a08f187">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi01LTEtMS0xMTk4Njg_5f2170bd-cf35-49dd-86f2-2757b63b54ee">3,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi03LTEtMS0xMTk4Njg_b52e087b-1805-4b7f-8ca0-6ed29dac1bcf">4,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy0xLTEtMS0xMTk4Njg_5c76d179-a490-4b09-b4c3-54f8c848f956">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy0zLTEtMS0xMTk4Njg_d2304d10-ee18-406b-bfac-cbdcc4359ef6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy01LTEtMS0xMTk4Njg_ffa04d4e-61f8-4e77-88b8-d3a53ea59e15">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy03LTEtMS0xMTk4Njg_150a7fe1-e617-4beb-9533-24a81da2222d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC0xLTEtMS0xMTk4Njg_555b18d2-cae6-43a9-bdae-b633d6346168">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC0zLTEtMS0xMTk4Njg_faae5b5d-9f0b-4f19-bbd7-5a745f39df84">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC01LTEtMS0xMTk4Njg_ac8f4c4d-d97a-4055-876a-3604e464ccc7">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC03LTEtMS0xMTk4Njg_c8721089-a09e-4e19-872a-b5ae2115b9ff">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ5NA_9c725319-d0cc-4dd8-a746-4e3335b72722" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;28, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMS0xLTEtMS0xMTk4Njg_dc28a433-cd96-41d0-9906-6c49d8af8727">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMi0xLTEtMS0xMTk4Njg_429ef9ee-057f-4b69-8161-1280412e2219">3,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMy0xLTEtMS0xMTk4Njg_5b3e9f51-08c5-493b-b0a7-81646103f1b7">899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfNC0xLTEtMS0xMTk4Njg_429507d4-2034-42e5-9085-67e094270830">669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfNS0xLTEtMS0xMTk4Njg_e148f7e7-d1ae-43c0-b64d-efce54d8f3b1">6,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iee3a2bc4b08c4326a3123f20b201dc29" continuedAt="i9a87f23ce58946bb9d8867dffeb3b1dc"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Securities, Equity Method Investments, and Other Investments </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. </span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUwNQ_ef09e4b2-b28a-4689-8bc8-685f04b43837" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;28, 2022 and April&#160;29, 2022, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMS0yLTEtMS0xMTk4Njg_51b9e368-333c-47dd-835f-26f42d78ee49">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMS00LTEtMS0xMTk4Njg_40113735-3e9a-4668-9e27-08b39e00912e">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMi0yLTEtMS0xMTk4Njg_c447682d-578d-4542-b5e2-bda731e9c062">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMi00LTEtMS0xMTk4Njg_5bc63561-2047-42f6-9bfc-4ed8b1d4edb6">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMy0yLTEtMS0xMTk4Njg_0ebb3786-c4fa-4d31-987c-387c8852fd74">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMy00LTEtMS0xMTk4Njg_e5a51d15-63cd-4b7a-9b17-d809f286fa1b">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028" decimals="-6" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfNC0yLTEtMS0xMTk4Njg_feb1d94f-e1cd-451e-9edf-7c5c1b5c8c56">912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429" decimals="-6" name="mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfNC00LTEtMS0xMTk4Njg_2acbb0a6-2417-45b3-8f4e-e7b20964d69e">881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="mdt:ScheduleofInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUwNg_4c4f52f7-b6b1-4dae-8b1d-eb2fee08acbc" escape="true"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi0yLTEtMS0xMTk4Njg_7523d14f-8678-486e-b960-a5a4e7c28d25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi00LTEtMS0xMTk4Njg_d322bd28-ad49-40c9-899a-84682af1e412">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi02LTEtMS0xMTk4Njg_7ecf7b6d-2883-4bd7-88de-0f2aa4b59648">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029" decimals="-6" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi04LTEtMS0xMTk4Njg_d5895d5b-2e67-4ce8-ab98-f97580552de3">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy0yLTEtMS0xMTk4Njg_d4e407a8-4b80-4f71-96d3-4938868bad82">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy00LTEtMS0xMTk4Njg_cb347b4c-5451-49af-be15-fd0612505e63">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy02LTEtMS0xMTk4Njg_22d52a49-adb7-4513-89df-d513982ff9fb">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029" decimals="-6" name="mdt:GainonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy04LTEtMS0xMTk4Njg_6157e11f-5302-48d2-b644-a705893799c5">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC0yLTEtMS0xMTk4Njg_c8557a4c-b124-4cd0-b4b6-5b92b922394d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC00LTEtMS0xMTk4Njg_a9148450-c5a1-49cc-a767-d826a787493e">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC02LTEtMS0xMTk4Njg_86a66781-067d-4386-98a4-697f1b1a6b6b">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029" decimals="-6" name="mdt:LossonInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC04LTEtMS0xMTk4Njg_71ffee9e-fdb8-4e9b-b82c-8e8b72cc9109">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS0yLTEtMS0xMTk4Njg_0ac97e67-daae-454b-8a35-3f8e662fe9e7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029" decimals="-6" name="us-gaap:ImpairmentOfInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS00LTEtMS0xMTk4Njg_acd537c9-d718-45be-b0f3-31d2c3db931b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS02LTEtMS0xMTk4Njg_79f7fcd7-d545-41ec-914a-855f3a0c8ca6">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029" decimals="-6" name="us-gaap:ImpairmentOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS04LTEtMS0xMTk4Njg_c566642e-e8dd-4279-870c-9ea5338d8df1">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a87f23ce58946bb9d8867dffeb3b1dc">During the three and six months ended October&#160;28, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzI1Nw_196e3f29-c2da-4225-adfb-c351f2c5c4f8">7</ix:nonFraction>&#160;million of net unrealized losses and $<ix:nonFraction unitRef="usd" contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfNzE0NjgyNTU4NDE3NQ_6b465753-12ab-4944-899a-d1e67511c0ff">1</ix:nonFraction>&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;28, 2022. During the three and six months ended October&#160;29, 2021, there were $<ix:nonFraction unitRef="usd" contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfNDM5ODA0NjUxNDk1OA_ff5a932d-8330-41bc-b246-d2d994cfbd6a">8</ix:nonFraction>&#160;million of net unrealized losses and $<ix:nonFraction unitRef="usd" contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029" decimals="-6" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzM5MA_8d1e15bc-89a8-452d-9e4b-4b742b82523f">7</ix:nonFraction>&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;29, 2021.</ix:continuation> </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_55"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUzMw_721d497e-b0c4-499f-b20a-fff7dbe55b48" continuedAt="i670d82d177b14a33abf79d5c373e9619" escape="true">Financing Arrangements </ix:nonNumeric></span></div><ix:continuation id="i670d82d177b14a33abf79d5c373e9619" continuedAt="i890e9bb6883d49fab86a0f1d29a1e194"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $<ix:nonFraction unitRef="usd" contextRef="ia3942d4373f44f7497691c840fa95db3_I20221028" decimals="-8" name="mdt:CommercialPaperMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjkw_49958ca9-83f2-4bc8-8ac5-010d2d6e38eb">3.5</ix:nonFraction> billion. Commercial paper outstanding at October&#160;28, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i8cc14bfe25a24c169750f3b677e3850f_I20221028" decimals="INF" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIwNjAx_10391554-416c-41a4-a294-069ac120b115">349</ix:nonFraction> million. During the three months ended October&#160;28, 2022, the commercial paper outstanding had a weighted average original maturity of <ix:nonNumeric contextRef="i5a435f6230ca46b3a412340e46d67d2b_D20220730-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIyMDMx_85795272-0a9f-44ca-9ee5-7c755214f947">26</ix:nonNumeric> days and a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="i8cc14bfe25a24c169750f3b677e3850f_I20221028" decimals="5" name="us-gaap:DebtWeightedAverageInterestRate" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIyMDMw_64e99b04-9a15-4e58-b457-6f2619cc1f92">3.057</ix:nonFraction> percent. <ix:nonFraction unitRef="usd" contextRef="i50b73054f5384db484d17a799d1f1a64_I20220429" decimals="INF" name="us-gaap:DebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIwNjUz_9c2c4f41-199b-4672-85ad-5d334c6fd2cd">No</ix:nonFraction> commercial paper was outstanding at April&#160;29, 2022. The issuance of commercial paper reduces the amount of credit available under the Company&#8217;s existing Credit Facility, as defined below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Line of Credit</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $<ix:nonFraction unitRef="usd" contextRef="i74804d544e17446ca08e983c8f7fa76f_I20221028" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTEz_6e106bac-6bcf-4f3f-b443-f54ad09a5baa">3.5</ix:nonFraction> billion <ix:nonNumeric contextRef="ie52a26d33fd64110b616f85161449591_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUxOQ_a2ccbce6-3c17-49ff-ad27-5c5ab5b2351e">five-year</ix:nonNumeric> unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;28, 2022 and April&#160;29, 2022, <ix:nonFraction unitRef="usd" contextRef="i74804d544e17446ca08e983c8f7fa76f_I20221028" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNzgx_81093de7-4088-410c-8780-8d4cd5691489"><ix:nonFraction unitRef="usd" contextRef="ic1b14f05a2554bdbaf9b274cdfd744d4_I20220429" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNzgx_a1353dd9-4bbc-48d2-a6e3-118ad97c330b">no</ix:nonFraction></ix:nonFraction> amounts were outstanding under the Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard &amp; Poor&#8217;s Ratings Services and Moody&#8217;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The Company is in compliance with the covenants under the Credit Facility. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i890e9bb6883d49fab86a0f1d29a1e194" continuedAt="i78c5d1a12a534671ae18b610f887a1a7"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="margin-top:8pt"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUyMw_1f2a40e4-c605-4a51-bdce-d43cb05785d4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMS00LTEtMS0xMTk4Njg_c2c9d870-fa92-4ec5-9235-5655aa5dc176">5,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMS02LTEtMS0xMTk4Njg_6435a7d4-9c59-40e9-8c67-d8544f8c2ac8">3,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i261e682721ee4018a0e687ae0df46295_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0MmJkZWZhNWQ4Njg0ZDU2OTFlNWJmN2ZmYTM0NmUzN180_43818ea0-52dd-4ece-8f30-24bad59056de">3.500</ix:nonFraction> percent <ix:nonNumeric contextRef="i751c32721c1046dcb276c399e66b615a_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0MmJkZWZhNWQ4Njg0ZDU2OTFlNWJmN2ZmYTM0NmUzN18xNQ_02626c33-d6d5-4c3f-a2c6-228aa1391bda">ten-year</ix:nonNumeric> 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f1d04b0787461cbd677984bf68ea36_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC00LTEtMS0xMTk4Njg_254ada8e-7be8-4fa0-810d-60a3d33ec264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ceaa34c16b4e969c2d70f8a46b0700_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC02LTEtMS0xMTk4Njg_527314b8-fbc7-467d-9460-0c1c4979278e">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16fd5558ce984801a4ce4154ad7e4bf0_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1OTFmYmZlZDUwMzM0MDI2OTNjZTFhZTY1N2M2NWNiMV80_a4d8ba3a-5ea9-446e-89e4-5d72249a198f">0.250</ix:nonFraction> percent <ix:nonNumeric contextRef="ic48a1296b3e44c84bf9342a1671330da_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1OTFmYmZlZDUwMzM0MDI2OTNjZTFhZTY1N2M2NWNiMV8xNQ_0e1f8465-a0fb-482a-aabc-dd86e6140f83">six-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bce3bdd02d842a78def75f12929df2e_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS00LTEtMS0xMTk4Njg_2c671453-fd54-414e-bd4e-42a485f8f701">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01af7fce485a44f38019814091a50b8f_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS02LTEtMS0xMTk4Njg_1db11413-e881-4437-9849-97585b529283">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie72a79cc7e714e3f98098deb1aec4fd1_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMzIwNjUvdGV4dHJlZ2lvbjozZjAwMjY1YWZmMzM0YWQ0OTViZjk1ODQ2MjdlNmZlN180_0a1856ef-2ff4-477e-959d-e5387dfcbb2b">2.625</ix:nonFraction> percent <ix:nonNumeric contextRef="i2353fa72d44d49ceb3efd49225a21e23_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMzIwNjUvdGV4dHJlZ2lvbjozZjAwMjY1YWZmMzM0YWQ0OTViZjk1ODQ2MjdlNmZlN18xNQ_dddaed69-9e1a-4e4b-91d7-451ea9cb5ae5">three-year</ix:nonNumeric> 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7012e804387641a7813faf2625661ec8_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy00LTEtMS0xMzIwNjU_813ec09f-e3b0-478d-a683-9282548447b2">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9f92a697414dfd8bfd28a672323199_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy02LTEtMS0xMzIwNjU_57c4785e-2c86-4790-8579-9d5fdd86474e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f4a0cb342f9428fb9e71a786d8f86df_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjplNGNhY2FmY2ZkYjA0Zjg4YjAyNTE3NTEzNjM5OTJjN180_fa375839-4e8c-494b-bf08-713197f14102">0.000</ix:nonFraction> percent <ix:nonNumeric contextRef="i4cda2d6fee9d41349edb516fb0368284_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjplNGNhY2FmY2ZkYjA0Zjg4YjAyNTE3NTEzNjM5OTJjN18xNQ_3198b564-ef22-4e4a-b06d-8ec294c4986f">five-year</ix:nonNumeric> 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84656a75b0454be4a3e0b59a5bf56733_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi00LTEtMS0xMTk4Njg_89b60512-c0da-4fa1-9b43-7d5e39d9f441">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7489de2611c44626bfd326f30908b1a5_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi02LTEtMS0xMTk4Njg_9e54723a-78a5-47fa-8fbf-d5834c91a07f">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7813502cc324fdfb9cad82fca2aef6f_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo4YjM1YmE0NWFiZmQ0MjM1YjY1OGE1ZDlmNTg5YjJkZF80_6d7cba0e-3725-4584-bdec-17ec58d0cda8">1.125</ix:nonFraction> percent <ix:nonNumeric contextRef="ie7f465b4b499407f84b13e2f34e98cda_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo4YjM1YmE0NWFiZmQ0MjM1YjY1OGE1ZDlmNTg5YjJkZF8xNQ_4363048c-cfe5-4ab2-8643-b54c6e19329f">eight-year</ix:nonNumeric> 2019 senior notes </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a8b596b4464a54ad3624a0e04bd604_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy00LTEtMS0xMTk4Njg_59993439-de91-47d7-a20c-53a7d29f7952">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4d3e7efdd64bbe98b4ba1443d485e3_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy02LTEtMS0xMTk4Njg_857bf8b3-6615-4f53-a881-a250b1613778">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaecd0e4856b431fa395153da8bc83d0_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0NGY2MjQ3NzFjZWQ0NDdlYjI2Y2E1OGZkMjE5NmU3ZV80_3b52deee-fd5c-40fa-8524-6427153107e3">3.350</ix:nonFraction> percent <ix:nonNumeric contextRef="i074c3d2b9e5943a78a8bc0e775eaae2a_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0NGY2MjQ3NzFjZWQ0NDdlYjI2Y2E1OGZkMjE5NmU3ZV8xNQ_2f2fd1cd-3f20-4162-a2cf-f0c05c6f018b">ten-year</ix:nonNumeric> 2017 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2f2ee743674b16a4e766f4653881b6_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC00LTEtMS0xMTk4Njg_4e7477a0-c996-497e-aabf-a33d4058eb91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d22bb72025442cac41507454e9f728_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC02LTEtMS0xMTk4Njg_36dda5d4-e41f-4017-9fad-c21f947500f9">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i600fd760a9284c3ba2ce36a2e1c4adb7_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTIxNTU2L3RleHRyZWdpb246OGIxZGUyZDIwYzY3NDIwYzg5NDNjNWEyMWNiMjUyNThfMjc0ODc3OTA2OTQ4OQ_5e43d132-73c6-4fd9-8491-94a60c4ae687">3.000</ix:nonFraction> percent <ix:nonNumeric contextRef="iddd3d2cc9e4b461bb1e2c4f66d747810_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTIxNTU2L3RleHRyZWdpb246OGIxZGUyZDIwYzY3NDIwYzg5NDNjNWEyMWNiMjUyNThfMjc0ODc3OTA2OTUwMA_32760e58-ad5a-4ffc-bd6c-1ad20985b7d9">six-year</ix:nonNumeric> 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec69cbbc5484f558ee3b3e485197f4b_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNC0xLTEtMTIxNTIw_393de2cf-d037-40f8-8d82-8fd1a952c8b9">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if52f4d1f6b37466eb1f1c57c273f68fe_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNi0xLTEtMTIxNTIw_8f153ae2-375e-4175-b9da-84048cb3a332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45066488b7f44235877f7d05b88cecbf_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjpmNzc0ODk2MmQ4YWM0YWI0Yjg1MjBiZjlmMDNkOGE2ZV80_120751de-1cca-4594-90b5-e076ba8d4465">0.375</ix:nonFraction> percent <ix:nonNumeric contextRef="ia88da43b7ee240e08c8140ee86cda15b_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjpmNzc0ODk2MmQ4YWM0YWI0Yjg1MjBiZjlmMDNkOGE2ZV8xNQ_89c8f418-8731-4d20-9957-1607c287c315">eight-year</ix:nonNumeric> 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854fe8577e324d2fb0c40211182aaae5_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS00LTEtMS0xMTk4Njg_47af4589-a89b-46df-84ee-b2252d6d9e20">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c69d5ca1d547218da8e846cc583837_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS02LTEtMS0xMTk4Njg_3de5c41b-12d9-4c0c-acd2-f7e7e7708691">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e7c703e42e54e418769101e3009a751_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzBjZWY3OWE5ZmNlNGVhNDkzZGExNDQ1MTEyMzZkMDhfNA_b86b77ed-8055-461e-ac9b-6e66a9afeb66">1.625</ix:nonFraction> percent <ix:nonNumeric contextRef="i4c4da084f549423ba1edd47c97745dea_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzBjZWY3OWE5ZmNlNGVhNDkzZGExNDQ1MTEyMzZkMDhfMTU_ce799e26-0bf3-4cce-8b29-c208992df253">twelve-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492e3b74b21647618e19d98fc5af4be6_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNC0xLTEtMTE5ODY4_3548e8b5-2847-4db1-aaa0-cc1dd8319033">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3c6736ad474abe80247b6c428621e8_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNi0xLTEtMTE5ODY4_90b54e0d-5e0e-45a9-83f3-42dd87f4d8e9">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3d7e100f644b319c3dc758d8c3e5ff_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTMyMTAyL3RleHRyZWdpb246NDQ4NjljZmM2NjNlNDU1YmI0ODYyMjRjZWIxOGEyODNfNA_07e02fc1-71af-4bf6-aa2f-81e2c8e86894">1.000</ix:nonFraction> percent <ix:nonNumeric contextRef="if60f67805a834aeb81d478d6048c30b7_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTMyMTAyL3RleHRyZWdpb246NDQ4NjljZmM2NjNlNDU1YmI0ODYyMjRjZWIxOGEyODNfMTU_ffccee38-c25e-4832-aaeb-33b33027026a">twelve-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604c687d118d48988cea0c15344b587f_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTMyMTAy_ad39412e-7c91-4886-bc41-f5cdb6bbfe4a">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440aa4baa5804f8ba1255729affe7a07_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTMyMTAy_6bc9c2c6-b4d8-4884-a0a6-40f396d1cc5f">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ade45514b07472abf3a976bad5075e2_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTIxNTY5L3RleHRyZWdpb246ZGQ2NmRmMDEwMDFhNDFmYWEzMjgzMGMyN2EyNGM2Y2NfMjc0ODc3OTA2OTQ5MA_b9a7bdbf-cce1-42ae-9751-f1c048db092e">3.125</ix:nonFraction> percent <ix:nonNumeric contextRef="ie6d581765eaf46a1b425828d5e6cdf3e_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTIxNTY5L3RleHRyZWdpb246ZGQ2NmRmMDEwMDFhNDFmYWEzMjgzMGMyN2EyNGM2Y2NfMjc0ODc3OTA2OTUwMg_43090bb2-24d1-4545-bd34-fafb485f053b">nine-year</ix:nonNumeric> 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id024eb4c94014ec49c6e27a68351c003_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTIxNTI3_01abe872-8b56-4087-8273-b0c16d28d3de">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9eca626aa454e1aa7d4f2ef86f83b88_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTIxNTI3_3cd90bf3-b804-44f5-8ac6-b95f8abe4feb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9404b5c0aa234b1e930f980973644052_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246Zjc3MjQ4YWI3ZTg2NDU2NGI2NDYzYWEzYzQxOTI4OTdfNA_ace407fb-2484-4f67-84d6-937eabf29a1f">0.750</ix:nonFraction> percent <ix:nonNumeric contextRef="i74e2615fe889465fa885b1b6dcef97e6_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246Zjc3MjQ4YWI3ZTg2NDU2NGI2NDYzYWEzYzQxOTI4OTdfMTU_949f4b67-c31f-4a49-a54a-ad7629f25f6d">twelve-year</ix:nonNumeric> 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cb708996bc40d3a6481f7074ed4455_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItNC0xLTEtMTE5ODY4_1795a043-fe8b-426f-b7c6-c4e022196a0f">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia56942c6785c408da58413bcc56847ee_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItNi0xLTEtMTE5ODY4_2dc4d087-0c3f-47d3-92b5-6f6d81f1798f">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0371e11afaea42b6b38732fc042d143e_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTIxNTgyL3RleHRyZWdpb246YTYyYjA5ZDYzZWQzNGFiODgyYzQzODEzZGM3N2FmODBfMjc0ODc3OTA2OTQ5Mg_9c0da6bf-a2db-4aa6-b33d-f43b2d4f59f8">3.375</ix:nonFraction> percent <ix:nonNumeric contextRef="i3be8c589cbef433e9f5cce07fc5b8204_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTIxNTgyL3RleHRyZWdpb246YTYyYjA5ZDYzZWQzNGFiODgyYzQzODEzZGM3N2FmODBfMjc0ODc3OTA2OTQ5OQ_fe6fb493-b788-480a-a6dc-ce8ebcd924fd">twelve-year</ix:nonNumeric> 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic826d07adf4e44dea0e204d5cc54354e_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNC0xLTEtMTIxNTM0_935027e9-2517-4cc0-9dbf-2fdbeb0e96be">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b1f37320f264fe39b6118d6996cf34f_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNi0xLTEtMTIxNTM0_c736e91c-c42c-408e-9d12-67d546e5edad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i209002c36bbe4ea7b59430177cf18c4c_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzcxMTg5OTAyNTgzNDY4OTlhN2FkMjgyMTVjNTljMGJfNA_631ffe3c-a6cc-45dc-a30e-3b08afd17558">4.375</ix:nonFraction> percent <ix:nonNumeric contextRef="i008bf53905884d179baf55ce1247fc76_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzcxMTg5OTAyNTgzNDY4OTlhN2FkMjgyMTVjNTljMGJfMTU_d21e7ed5-5152-4c11-b5d6-b4a722b7798b">twenty-year</ix:nonNumeric> 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9e5b36677f4eba9b71eb4a0b2714b5_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTE5ODY4_f85025d3-ec62-45d4-b085-cda3bfffa1a2">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079968c0f4134d4dac2b4878e02b237a_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTE5ODY4_eecfe6fe-f164-43a2-a64e-4813ee5a093b">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib02d94fcae21461da3cf9a8c555a40bd_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NTM3YmE5ODRkY2E4NDkzMGI2OTgzZmY5ZGIyOGNhMTVfNA_d872e4b7-aa8b-45d8-8e55-ec2ffb9fb2df">6.550</ix:nonFraction> percent <ix:nonNumeric contextRef="ia3eacc8baafb46ddac0e1a5fbabe3485_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NTM3YmE5ODRkY2E4NDkzMGI2OTgzZmY5ZGIyOGNhMTVfMTU_6b6a3c75-43ed-4b0b-b276-13ade4abbac7">thirty-year</ix:nonNumeric> 2007 CIFSA senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad63036539624fd9bc73ae5d7fb42005_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtNC0xLTEtMTE5ODY4_a4571497-9996-45d1-a7a7-93c2caabec17">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4897e04ca5f64263850346fe30de0a81_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtNi0xLTEtMTE5ODY4_2c864b57-2580-4ccb-a801-9c85899821e5">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9c245862ed0462798a29da9f9f74ce0_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NmQ0ZTBlZGVkNzNmNDgzYmJiNTNjYmEwYzgwNzNlMjdfNA_487673f7-83e5-484c-a4df-06ea7744afa5">2.250</ix:nonFraction> percent <ix:nonNumeric contextRef="i24a20fcb76734c22a3eade9a14f5ce50_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NmQ0ZTBlZGVkNzNmNDgzYmJiNTNjYmEwYzgwNzNlMjdfMTU_9828f9bb-bc47-45f9-8c68-bed91dd9cac4">twenty-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b459c8ec71b4a15896e2da7ac25a1b6_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtNC0xLTEtMTE5ODY4_96accbb2-99c0-45f0-ab9d-780c46f2c028">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c925d8d64c94da082cd3422a727785b_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtNi0xLTEtMTE5ODY4_b4f733c6-ec42-4cdc-9e8e-96dd9c0c4c1f">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i705ac2374d1743abb58218fe5ad12b01_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246N2Q2MGJjNmI5OGRiNDJlN2I5NjUwODc0ZDBiNzBlN2NfNA_7a8493a0-a781-40ed-97e6-6c88807fdb9d">6.500</ix:nonFraction> percent <ix:nonNumeric contextRef="i7d94e3d1a39247e387019fed8a18ad46_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246N2Q2MGJjNmI5OGRiNDJlN2I5NjUwODc0ZDBiNzBlN2NfMTU_57f1f544-b43f-44d6-8a4a-dab45985759e">thirty-year</ix:nonNumeric> 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc5cbdea31c4c78aeabffef218a50f3_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNC0xLTEtMTE5ODY4_b868abf1-96e0-422b-a839-20fca734ee10">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efa321d8ec04cb1a95bed2a3f6976d4_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNi0xLTEtMTE5ODY4_890ad051-8a43-4f50-a460-1edd8424eecf">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1da25349c4044b8c9d6bde3df1b958aa_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzY4Y2MyOTk1ZmMwNDY2NzkwNTc5Njg0ODg3NjAzMGRfNA_8e4c4062-5c7b-4c54-aaca-11dcc4948104">1.500</ix:nonFraction> percent <ix:nonNumeric contextRef="i909fae803c5149209129a0a704330f2b_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzY4Y2MyOTk1ZmMwNDY2NzkwNTc5Njg0ODg3NjAzMGRfMTU_4e435065-0256-4ec9-bb92-1d83d5e9cabc">twenty-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f00def7b8347c4a557ae6a1cfd1374_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctNC0xLTEtMTE5ODY4_f199f31f-e3bb-4b5d-a828-0ab0eeaa45b8">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c769314b80147a5b1c216eb5b25c8b3_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctNi0xLTEtMTE5ODY4_9f4ddcfd-9638-4f27-abcf-807bb70f62a5">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7955403a09be4b6da70bed7e2f69d629_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZmU3NmE1ZmViZmI1NDg4ZWJkY2EzMTdmMjA4YWM5ZDZfNA_dd6a0947-1462-4b07-8af3-e631a5967baa">5.550</ix:nonFraction> percent <ix:nonNumeric contextRef="i2f01a54621494ecbbc0f453611f0bc4e_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZmU3NmE1ZmViZmI1NDg4ZWJkY2EzMTdmMjA4YWM5ZDZfMTU_808add74-4c94-4283-9064-62bc4bf3556e">thirty-year</ix:nonNumeric> 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf2d68341064175b8f864b73593f1d7_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtNC0xLTEtMTE5ODY4_c6a38e98-1a71-40dd-a1a0-8dcd77c3e6bf">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i089c1b9b426a4c1da92f3dc5e97a7581_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtNi0xLTEtMTE5ODY4_54724a73-58cf-4d75-bbb8-08f66925789d">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2c9edb05074480991cd9fb871378cd4_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MWE0NDFkYmM0MzI3NDU1NGFkMDA5NDA1YzhmYTgzM2ZfNA_72065ab6-2267-4838-8acc-d242b755e20e">1.375</ix:nonFraction> percent <ix:nonNumeric contextRef="i76269c4f7bb649cf8290db9a195e6624_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MWE0NDFkYmM0MzI3NDU1NGFkMDA5NDA1YzhmYTgzM2ZfMTU_228af91a-28e4-4a7b-adf9-0fa6bc2282bc">twenty-year</ix:nonNumeric> 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e51a2b394114d97a8e5c9f7166fab23_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktNC0xLTEtMTE5ODY4_e55ccec5-1652-465a-94c5-e12097478331">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8511290ec62844a4aae4405642d778c3_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktNi0xLTEtMTE5ODY4_48229d8a-be09-4ec3-9f12-e61d5eda9601">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3c49bd14a1743a0821f157639e97f08_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGU0ZWJiYTFmZTQ4NGNjMzg5Y2UwYjQ3MDc0ZTUxMzhfNA_badca06d-d0fc-41ad-893d-6512c0be8e69">4.500</ix:nonFraction> percent <ix:nonNumeric contextRef="i5e59ec9a7e4d4ce783bed9fa0bda5c61_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGU0ZWJiYTFmZTQ4NGNjMzg5Y2UwYjQ3MDc0ZTUxMzhfMTU_99cca807-68e3-440c-ab44-e7381b7f019a">thirty-year</ix:nonNumeric> 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d55dae7970a4dd2b220ed120119dd5f_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtNC0xLTEtMTE5ODY4_691869de-d308-46d5-8c30-c4b06b55abc9">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936640005c7a4c09bb3f8a284850c7bc_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtNi0xLTEtMTE5ODY4_dffdbcf9-0d55-4e0f-91df-77bf452f82b2">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i506a7161216440d0bbcb96f17c77d8cd_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZDE5MmM0MjY4NDVkNDg0Mjg4YmVlZjkzNzRiYmI5ZTFfNA_0250587c-0ae3-43b7-8b31-76d68f5d3b0f">4.000</ix:nonFraction> percent <ix:nonNumeric contextRef="i87db6e6fdecd4f628af3c73a2715dbee_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZDE5MmM0MjY4NDVkNDg0Mjg4YmVlZjkzNzRiYmI5ZTFfMTU_ec03cca7-cdc1-4af3-8743-9cc466675714">thirty-year</ix:nonNumeric> 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i754149b1402a4ff58be77407ecd96c4c_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtNC0xLTEtMTE5ODY4_b155a831-8bef-4d06-88db-1716dfd0357f">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0a9687dcdb42e79003c2c3005eb8c4_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtNi0xLTEtMTE5ODY4_8fee885d-0508-4dca-a795-c64e3b42964e">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9103f0f331f14c2d925ee30459c3419c_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWUzZWM1ZTQwODExNGRkMzg5Mzk5YWIwY2UwNTI2MGRfNA_e87ae3a6-3b76-488b-a637-e2c277c39765">4.625</ix:nonFraction> percent <ix:nonNumeric contextRef="i415c753918f5402cbae9f769aa6af00d_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWUzZWM1ZTQwODExNGRkMzg5Mzk5YWIwY2UwNTI2MGRfMTU_49c8d3b6-8b7c-440f-88a6-0dec65fa55d9">thirty-year</ix:nonNumeric> 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e9b3944f1f4b6fb772acd25b65ac7e_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItNC0xLTEtMTE5ODY4_705109a6-5505-4294-9019-fd67706853ac">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4da5fa079404f4887bbcc27e401662a_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItNi0xLTEtMTE5ODY4_2f599f47-75d8-4250-9cc0-13cc8dbe795f">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0741f7081c8944bb9005b5622a22f293_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGFjZGRhMTg4MTdiNDViZDk4ZmU2YWE3OTBlNjVlZWZfNA_97c10ee8-70d4-4b43-b042-7795ab7f02ce">4.625</ix:nonFraction> percent <ix:nonNumeric contextRef="ib0f63498f65d45aeba257d88d0f27555_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGFjZGRhMTg4MTdiNDViZDk4ZmU2YWE3OTBlNjVlZWZfMTU_d543254a-1fa3-4c00-8b70-179acb7c9010">thirty-year</ix:nonNumeric> 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852117f888144b7abbee72f3bbb5e8a4_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtNC0xLTEtMTE5ODY4_b4bb2aba-c6ff-45e3-b376-949a22836da8">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74ee8e50af9441eb87ebc10bce2dee83_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtNi0xLTEtMTE5ODY4_038a1f74-3b27-4bc6-aa76-ab054282eec9">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d8ed26dc30942128f011855ed0d3857_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NDQzYTY4M2RlNzVkNGYwMGFlMWE1NGNkZjVkY2U1NTBfNA_31f373fd-f0d9-49bf-9174-f3a7c6ab5068">1.750</ix:nonFraction> percent <ix:nonNumeric contextRef="i4c06bcfbe30049bb8d35ab3bd0de7891_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NDQzYTY4M2RlNzVkNGYwMGFlMWE1NGNkZjVkY2U1NTBfMTU_fdc7eef6-2253-4476-9b9c-cbcdbd22a360">thirty-year</ix:nonNumeric> 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c924a87c844f9495ea3277ad27c097_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtNC0xLTEtMTE5ODY4_790b2436-afe9-4c41-819a-a4ac2b597b45">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aefe516de204b16be7ddf84dca1f0df_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtNi0xLTEtMTE5ODY4_0f459e41-a192-4f41-a826-7bc5a47a319e">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i018f8199d0a84888910a13567f64f9e5_I20221028" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWMzYTkzOTE2ZTkwNDJkYmE5YWY4OGE4ZjhkZTY0OWVfNA_4d1ffb88-087c-4fc1-8a1a-1477e7266ecf">1.625</ix:nonFraction> percent <ix:nonNumeric contextRef="i91156a4cd65b45e78be0eb72d39dfeb8_D20220430-20221028" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWMzYTkzOTE2ZTkwNDJkYmE5YWY4OGE4ZjhkZTY0OWVfMTU_6d7c2c3b-77ff-4cbf-98bd-22a38b334566">thirty-year</ix:nonNumeric> 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21748abe44f4b12903d6c9dcfd1a0ee_I20221028" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtNC0xLTEtMTE5ODY4_b5b3ce8c-d30d-47fa-86e3-6bfa4e68f2e6">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cf68665dfc4e2b9d53778d119549ba_I20220429" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtNi0xLTEtMTE5ODY4_48b2f964-8726-4926-b6e2-ee9fde909fdc">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzItNC0xLTEtMTE5ODY4_f7390f73-8185-481b-999d-dc948693cac6">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzItNi0xLTEtMTE5ODY4_1cb65120-6d6d-4fff-8828-951635802952">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzMtNC0xLTEtMTE5ODY4_15323d7a-1350-4fad-9610-41f82db6ee4e">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzMtNi0xLTEtMTE5ODY4_31996c4b-8fe1-4209-835c-813e72c7a6df">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzQtNC0xLTEtMTE5ODY4_9d0bc2fc-9887-41a5-997a-9c9f7fff3e8f">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzQtNi0xLTEtMTE5ODY4_2c0efcd1-722f-4812-b3c4-d5722a1e51ae">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzUtNC0xLTEtMTE5ODY4_41d66139-bec8-48a9-b3d1-ba1367c05cff">20,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzUtNi0xLTEtMTE5ODY4_64366744-a9d6-4828-91c9-c86706ba3926">20,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The Company is in compliance with all covenants related to the Senior Notes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, Medtronic Luxco issued four tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;<ix:nonFraction unitRef="eur" contextRef="id2453d698b504decb33b115bb6f57fab_I20220930" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODE5MDYx_516bf23d-1b9b-4459-9fd9-7781d027a3e7">3.5</ix:nonFraction> billion, with maturities ranging from fiscal year 2026 to 2035, resulting in cash proceeds of approximately &#8364;<ix:nonFraction unitRef="eur" contextRef="if9d010c11bbf46a3a80141df5fc433c4_D20220901-20220930" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODE4NzU4_bf393f76-3a57-4e3b-a65f-402aa4ac66a0">3.5</ix:nonFraction> billion, net of discounts and issuance costs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i78c5d1a12a534671ae18b610f887a1a7"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Agreements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, Medtronic Luxco entered into a term loan agreement (Fiscal 2023 Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Fiscal 2023 Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#165;<ix:nonFraction unitRef="jpy" contextRef="if23f6f1cf4f1419886209a1983b1efe1_I20220531" decimals="-9" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMTk4Nw_78ff6819-3fa0-4589-8c34-a416deeff2df">300</ix:nonFraction>&#160;billion with a term of <ix:nonNumeric contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjAwNQ_b0cb1485-4259-443b-a20c-7cd2b62380c8">364</ix:nonNumeric> days. Borrowings under the Fiscal 2023 Loan Agreement bear interest at the TIBOR Rate (as defined in the Fiscal 2023 Loan Agreement) plus a margin of <ix:nonFraction unitRef="number" contextRef="i95bf75a4681040b69ec7a41ec26fca98_D20220501-20220531" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjE1Mw_918d5d57-e1ff-46fd-aa0b-4221b59fc5ad">0.40</ix:nonFraction>% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Fiscal 2023 Loan Agreement. In May and June 2022, Medtronic Luxco borrowed an aggregate of &#165;<ix:nonFraction unitRef="jpy" contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531" decimals="-9" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjM1Mw_e79cdec8-cdf3-481a-8c74-2692ed0b1878">297</ix:nonFraction>&#160;billion, or approximately $<ix:nonFraction unitRef="usd" contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531" decimals="-8" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjM3NA_22d489ac-6490-4fdc-a81e-cc7d094c4ad5">2.3</ix:nonFraction>&#160;billion, of the term loan, under the Fiscal 2023 Loan Agreement. The Company used the net proceeds of the borrowings to fund the early redemption of $<ix:nonFraction unitRef="usd" contextRef="i6dd0dc4372b54d09b9d6fcf86a905998_I20220531" decimals="-8" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjUxOA_79209db5-2680-4605-81bf-483de7f67e68">1.9</ix:nonFraction>&#160;billion of Medtronic Inc.'s <ix:nonFraction unitRef="number" contextRef="ic8501e4357d94654a4b7f096cf014e1e_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjU0MQ_1200b743-b8b7-415c-aab3-64367b4330f0">3.500</ix:nonFraction>% Senior Notes due 2025 for $<ix:nonFraction unitRef="usd" contextRef="iac7ff8ab22ab491e8c00fb7695d6bd7c_D20220501-20220531" decimals="-8" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjU2OQ_01ca8eee-a073-4ca9-bf4b-6c54736ed1dc">1.9</ix:nonFraction>&#160;billion of total consideration, and $<ix:nonFraction unitRef="usd" contextRef="i13d9c16cf83847d8b9dc071854e7249e_I20220531" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjYwMA_d1a5cd8b-4ab4-44a7-a404-aaa5f87bbb5e">368</ix:nonFraction>&#160;million of Medtronic Luxco's <ix:nonFraction unitRef="number" contextRef="i9ebd3167ead94b20bb0cf7ca721fde30_I20220531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjYyNA_a37ef70e-eb2a-4e2c-80da-b09846804b77">3.350</ix:nonFraction>% Senior Notes due 2027 for $<ix:nonFraction unitRef="usd" contextRef="i161f2ac0c7ae4093a36c525826d423bc_D20220501-20220531" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjY1Mw_b15e4697-fa8c-48a8-ba2b-cf8c301275e2">376</ix:nonFraction>&#160;million of total consideration. The Company recognized a total loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i678b39b151df49b2ba21b6aea15b2c79_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjc0Mg_bcd777ff-99e1-4daf-896c-124dc9e79c80">53</ix:nonFraction>&#160;million in the three months ended July 29, 2022, which primarily includes cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income during the six months ended October&#160;28, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022, the estimated fair value of the Company&#8217;s Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzEwMA_bd93fe14-2830-46af-b75f-c13dcd1f17ae">21.1</ix:nonFraction> billion compared to a principal value of $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzEzNg_ff8da349-76e1-413f-b7d3-8c195de88bd9">24.4</ix:nonFraction> billion. At April&#160;29, 2022, the estimated fair value was $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-8" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzE3Ng_a07ab2e5-ba82-46f6-9004-62ea23d81c58">22.9</ix:nonFraction> billion compared to a principal value of $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzIxMg_f72ca3df-c423-4e3d-b6cf-93bb3de2c4ae">24.2</ix:nonFraction> billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUyMw_06f6bb14-d671-46bc-bb7a-34f5d4f32492" continuedAt="i1a807434db424b18831346f0bbc5e772" escape="true">Derivatives and Currency Exchange Risk Management </ix:nonNumeric></span></div><ix:continuation id="i1a807434db424b18831346f0bbc5e772" continuedAt="id221b33185fe48ceb3262468c1f5871d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $<ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMTEyNw_8edffb30-5961-415e-9a2f-d8c50f948668">17.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMTEzNA_dc1d5e1b-6d2e-4ae0-8e26-bd64c78c4738">13.8</ix:nonFraction> billion at October&#160;28, 2022 and April&#160;29, 2022, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#8217;s consolidated balance sheets and statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Freestanding Derivative Contracts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freestanding derivative contracts are primarily used to offset the Company&#8217;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ic328877cbe2640fabe36e10bcb5a5194_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjA1OA_e5e87d1d-3d21-43ac-a117-4749981fdff1">5.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i36cbb82fcc7646f6bff301a9323152ad_I20220429" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjA2NQ_529e6577-67ad-42fe-b50b-01af7174ea8c">4.9</ix:nonFraction> billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses total return swaps to hedge the liability of a non-qualified deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ib01e16de38004386abf16c41bcca590a_I20221028" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjYwNg_b8921336-bba4-4f49-91bc-53a2c1d907ae">208</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ide9ac26ecdb447a5b065fa1afca7c2af_I20220429" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjYxMw_f7e238dc-515e-43b3-8ffe-49c95297d55f">226</ix:nonFraction> million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating or financing activities, depending on the nature of the underlying hedged item, in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ieac80a3fc9174c3fbd499cdda5660e8f_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMzM0MA_5ef0a260-f49d-485d-aa7a-a031a1cf4dbb">8.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6fb15af4122d40f094823a9045c8305c_I20220429" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMzM0Nw_ba80fba7-1532-4308-b147-37487d69a5db">8.8</ix:nonFraction> billion, respectively, and will mature within the subsequent <ix:nonNumeric contextRef="i2a6af32d4b8247b4b5b8e8370744ce94_D20220430-20221028" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxMw_160a8dde-336f-497d-980f-583200402110">three-year</ix:nonNumeric> period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="id221b33185fe48ceb3262468c1f5871d" continuedAt="i7e87213711f341f8a51b2ea4f885a6f1"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative instrument is reported as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gain or loss on the derivative instrument is reclassified into earnings and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings on a straight-line basis over the term of the hedge. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022 and April&#160;29, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDIxMw_7efed22b-4f72-4bec-90a9-bf57b402f055">852</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDIyMA_51c01b1a-7ede-44ba-87f5-0d2c16986dd1">474</ix:nonFraction> million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects that $<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDM5Mw_a6c65b63-35d6-4fb6-8be0-ca51fa988e30">617</ix:nonFraction> million of after-tax net unrealized gains at October&#160;28, 2022 will be recognized in the consolidated statements of income over the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated Euro-denominated and Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;28, 2022, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i0f985b4d85524a5e894505c6ba972295_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDg0Ng_1884df5f-1929-41ab-85a7-5c2e7a02fab3">16.0</ix:nonFraction> billion, or $<ix:nonFraction unitRef="usd" contextRef="i32e75265ade74bd1b82d3b46447ba700_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDg1Mw_fdba2911-ec88-4b6d-986c-8de363f573b6">15.9</ix:nonFraction> billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#165;<ix:nonFraction unitRef="jpy" contextRef="i0f985b4d85524a5e894505c6ba972295_I20221028" decimals="-9" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDk4MQ_05c3a4e4-b7cc-4455-a63d-c000a9ddbc72">297</ix:nonFraction> billion, or $<ix:nonFraction unitRef="usd" contextRef="i95a7ac115f1d4e669668238c726ec554_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDk4OA_2aff4717-fe0f-43e4-b479-b19906d7374e">2.0</ix:nonFraction> billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s 2023 through 2051, and the Yen-denominated debt will mature in fiscal year 2024. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may also use derivative instruments to hedge the currency risk associated with its net investment in foreign operations. Foreign currency forward contracts may be used on a standalone basis or in combination with option collars. At October&#160;28, 2022, the Company had foreign currency contracts with a notional value of &#8364;<ix:nonFraction unitRef="eur" contextRef="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTU2Mw_e777d149-8720-4efa-89de-34666ff9fe40">4.5</ix:nonFraction> billion, or $<ix:nonFraction unitRef="usd" contextRef="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTU3MA_9c659624-3750-43ab-9b39-400443da1b8c">4.5</ix:nonFraction> billion, hedging a portion of its net investment in certain of its European operations. The foreign exchange contracts mature in fiscal years 2024 and 2025. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a straight-line basis over the term of the hedge. During the three and six months ended October&#160;28, 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTQ5NzU1ODIyNTAy_71118995-83ff-45d9-ac16-e1592698eaf0">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTQ5NzU1ODIyNTEy_f39546c4-e93b-46b5-99a5-ec7a5170777b">47</ix:nonFraction> million in after-tax unrealized gains representing excluded components in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gains and Losses on Hedging Instruments and Derivatives not Designated as Hedging Instruments</span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxOQ_46fe7d86-9e56-4e0d-9c46-9b702c6dae3a" continuedAt="i8c3e68fbf2a945b7b1c46201caaa34f3" escape="true"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-top:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.706%"></td><td style="width:0.1%"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Reclassified into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:27pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xLTEtMS0xMTk4Njg_e141e705-1d15-417a-a23b-5dac20cbe03c">266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0zLTEtMS0xMTk4Njg_4d4fc02a-a1e5-464e-895a-5d88b9f7c531">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS01LTEtMS0xMTk4Njg_0aed9808-49b4-48aa-9447-53e2aa039b2b">608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS03LTEtMS0xMTk4Njg_7b28498f-c6fa-4890-b993-1f72005ae82d">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS05LTEtMS0xMTk4Njg_bca62cdf-1035-4f0e-a07d-0b2bd0c8ec82">205</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xMS0xLTEtMTE5ODY4_eb5f6225-4ce7-4f73-8171-1b062896e31d">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xMy0xLTEtMTE5ODY4_c97bdf50-3298-498f-83d7-c0173f52fc23">343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xNS0xLTEtMTE5ODY4_4e7d019b-9dfe-4656-a86b-95cf76e77e79">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xLTEtMS0xMTk4Njg_54f6a7e9-9e5f-4596-9083-da3f838e4af5">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0zLTEtMS0xMTk4Njg_779c122e-3bff-46bb-b4a2-f84f18a6e4d4">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id475727b6150430e9d00cf9d847ab244_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi01LTEtMS0xMTk4Njg_ba7cad2f-0fb7-4f39-81d2-4989ebbdade8">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi03LTEtMS0xMTk4Njg_df0d9003-ea4d-40e2-895a-d758b1e6faf5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi05LTEtMS0xMTk4Njg_0cd99de3-f4db-41b1-81bd-0d7ac6876b57">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xMS0xLTEtMTE5ODY4_82e83518-a7ae-4291-9c7f-61f4810d9af2">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id475727b6150430e9d00cf9d847ab244_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xMy0xLTEtMTE5ODY4_f813070b-babc-4571-bceb-d99ab12303fe">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xNS0xLTEtMTE5ODY4_266994bd-1377-4a94-87bb-8cbeffb093e4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xLTEtMS0xMTk4Njg_1a9324d3-5ea3-421c-8835-7ebc7ebe6e20">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77747096918490f971ab8604b359744_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0zLTEtMS0xMTk4Njg_a26c2d67-cc1f-4598-aa06-19de84b5906b">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC01LTEtMS0xMTk4Njg_21725a2a-2a79-4f60-aea8-a2b5ec0ddbf3">1,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC03LTEtMS0xMTk4Njg_8ebd1683-db02-4c26-b9ca-c31d7b8eff32">780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC05LTEtMS0xMTk4Njg_ee52bfde-50b6-48fd-b9c1-d773fd288a3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77747096918490f971ab8604b359744_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xMS0xLTEtMTE5ODY4_e6b89a02-8d61-4759-a9d4-23679ae0fe1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xMy0xLTEtMTE5ODY4_7db23a4e-f9a6-4942-ad85-b345e09090cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xNS0xLTEtMTE5ODY4_42f7ab0a-f109-45f3-a91d-e3ee4e82f012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90500a074bb3400493c7a435521e7259_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xLTEtMS0xMTk4Njg_6bbafa24-85bc-4809-8f85-6dcbea625546">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0zLTEtMS0xMTk4Njg_8243a613-a88c-4d9f-b035-f089ace77474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS01LTEtMS0xMTk4Njg_613f5f90-2ab9-493b-a897-a3e804625f00">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56e46722aac483a8619dd533deb3322_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS03LTEtMS0xMTk4Njg_e8eb1b06-b479-47ae-9d18-080c9082ccb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90500a074bb3400493c7a435521e7259_D20220730-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS05LTEtMS0xMTk4Njg_0af60948-a6cd-41b1-9b24-fdaf826ec7d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xMS0xLTEtMTE5ODY4_32877376-0aa4-4eaf-8d1a-7f3b0c047af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xMy0xLTEtMTE5ODY4_2928b5c4-ddee-4f5b-a57f-9cfa64863c12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56e46722aac483a8619dd533deb3322_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xNS0xLTEtMTE5ODY4_b28f831b-ef40-403d-91be-09e46b15d3da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMS0xLTEtMTE5ODY4_e5125a32-ee54-4d02-9a08-6250f116c910">806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMy0xLTEtMTE5ODY4_8e7082c3-5256-4332-8ba8-b32450af1946">475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtNS0xLTEtMTE5ODY4_c97404e8-7750-4fc9-bd80-1a9e93acc17d">2,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtNy0xLTEtMTE5ODY4_e155a75a-fef1-4fe1-8955-fb9c31c54ba3">1,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtOS0xLTEtMTE5ODY4_878b148d-5ef9-4047-8577-84b45e80b4ae">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTEtMS0xLTExOTg2OA_97fcd6b3-d92a-4f3d-9502-7439e63b887d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTMtMS0xLTExOTg2OA_2041650d-08d1-456e-9c0a-c3b20fb2a556">322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" sign="-" name="mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTUtMS0xLTExOTg2OA_3504142f-eb7b-44d5-8ecd-e93fef1ab075">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7e87213711f341f8a51b2ea4f885a6f1" continuedAt="i3f584078e0414fb697b429af37210642"><ix:continuation id="i8c3e68fbf2a945b7b1c46201caaa34f3"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC0xLTEtMS0xMTk4Njg_8ddba0d1-3dcc-41ed-b3ab-3546cf7943fe">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC0zLTEtMS0xMTk4Njg_2e09f564-b1ef-40b6-8599-5327cc3778fe">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC01LTEtMS0xMTk4Njg_4085ec79-8e8a-4b5d-8544-05cee32f606f">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC03LTEtMS0xMTk4Njg_55fc2152-24ad-497f-ade6-382de1eae877">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72954acc9e57495896b675167421b561_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS0xLTEtMS0xMTk4Njg_2591c33f-b4ee-4210-ad7f-b5c70fb4164e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb4c499d238442789c803ba3b479b911_D20210731-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS0zLTEtMS0xMTk4Njg_5bdacbd5-7aa3-4a38-b2ed-300d89b54192">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd16066db5b741dfa7eb70f35224624f_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS01LTEtMS0xMTk4Njg_cd72148b-00ac-4af4-99d0-79f3723d2830">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic070ac672e7e4600bb8f39e2dfd14cb2_D20210501-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS03LTEtMS0xMTk4Njg_b8aa2874-fd01-4289-a551-10e66927221d">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi0xLTEtMS0xMTk4Njg_9a2d2b32-ec75-41e9-9e89-99fd0ef0fed3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi0zLTEtMS0xMTk4Njg_dedc2718-c7b0-4292-a241-8968eb2fb50d">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi01LTEtMS0xMTk4Njg_54192dd8-68f2-4475-9a13-2f954b0eb197">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi03LTEtMS0xMTk4Njg_616bec46-b24a-4d70-8bcd-82e970adccb9">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet Presentation</span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUzNw_e2ee3021-74ca-4064-b320-86d07eb530d6" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;28, 2022 and April&#160;29, 2022. The fair value amounts are presented on a gross basis, and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments, and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i030ec29f92aa49e58cf998d20561e1bb_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy0xLTEtMS0xMTk4Njg_3fc58942-f0f5-48fa-a032-0058b211e4e7">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe75196bd192408f9bb4a29e186401b4_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy0zLTEtMS0xMTk4Njg_acf8461a-7881-4464-8a26-e13e8ac094ff">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51ce1803c5c4ba6810ae2c023e74833_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy03LTEtMS0xMTk4Njg_a3a18882-572a-4c3d-849d-6a852ce8e275">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c626f296fc49089588a3e25c3e2b23_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy05LTEtMS0xMTk4Njg_a355ed23-5dd0-4d9c-b154-c493d2abd9a8">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia500e65b15db40148004c1bc60ce317d_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS0xLTEtMS0xMTk4Njg_c7e00c61-c9db-4c8f-a559-a7db40944246">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9451fb3d1f04f6187e22f627a237e7d_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS0zLTEtMS0xMTk4Njg_555fd8ba-6d27-4ae4-9da8-88cde4ae65a8">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6126e03c431748d39e312714f45be287_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS03LTEtMS0xMTk4Njg_3f83bfc3-dfa0-44ea-9a83-3fad74755561">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74e6b87b21534ddcb6def602654c92e5_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS05LTEtMS0xMTk4Njg_330db7ee-4071-483f-892b-6afd6c65cb85">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ea2486c0a94abfb5ca1108224bba7c_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi0xLTEtMS0xMTk4Njg_39d6b11d-3abf-4613-9d8b-718f0754b3f3">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21219af6460740dc8a8f2b42aa062bc0_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi0zLTEtMS0xMTk4Njg_e4ad7045-44a4-4d3d-bfba-08f6028e0e1d">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ea2486c0a94abfb5ca1108224bba7c_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi03LTEtMS0xMTk4Njg_edd08dea-47f4-4e3d-9dd4-fe2b5c06b9da">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21219af6460740dc8a8f2b42aa062bc0_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi05LTEtMS0xMTk4Njg_431b1055-90a6-48a7-888e-eb50583ce849">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4b74a32e9248a69778cfd5232923a2_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC0xLTEtMS0xMTk4Njg_e6024ca3-6404-44db-b937-7ab6d525d337">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83392e630d054b0bb17f041fb38ee1b6_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC0zLTEtMS0xMTk4Njg_066e26aa-41a4-4e68-83fe-d5db08279c89">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2bed4f3dfd4f3b860e60ba24d59a28_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC03LTEtMS0xMTk4Njg_860d7fc8-7bf0-405e-84d6-5a5f5abe06c5">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40052aaebd204ac8bdb5ce6801703b30_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC05LTEtMS0xMTk4Njg_6661cf8b-383a-478e-906f-3d9b0a149925">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8c7fb5b46d345b1b31c77de8ad93269_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS0xLTEtMS0xMTk4Njg_76cfa0c5-5823-40f9-9f0b-322e02499d41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19424ad839704570b79f42bfb5ddc820_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS0zLTEtMS0xMTk4Njg_15c16b6d-e669-42b5-bb87-3bdbe81ffa9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcc9eef7a754a0ea0e93d2b1b2324b5_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS03LTEtMS0xMTk4Njg_24465bf2-1141-402e-ab70-ee65ef1ec95f">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec60c574487f47fd970e5240db2d6a74_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS05LTEtMS0xMTk4Njg_aed1e007-400e-4979-92b7-4e10b6353623">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f696edac744dd7a1aa89ee92b1b57f_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtMS0xLTEtMTE5ODY4_7198e347-ceca-4c08-ab58-1d3473561c14">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34fbedc968094ed2a24602471bb9832e_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtMy0xLTEtMTE5ODY4_baddaa3f-5a86-477f-828f-5d11376bc193">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f696edac744dd7a1aa89ee92b1b57f_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtNy0xLTEtMTE5ODY4_c4b0c549-951b-43ef-8823-cd35c8724e84">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34fbedc968094ed2a24602471bb9832e_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtOS0xLTEtMTE5ODY4_a8d6f637-38dc-490d-8277-f69ae340a981">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtMS0xLTEtMTE5ODY4_4e7c7431-1e52-4482-859a-3198b9fc0eb5">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtMy0xLTEtMTE5ODY4_6937ddfb-4a83-49cd-b2b5-25c1dc21450f">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtNy0xLTEtMTE5ODY4_2f0059f0-d5d4-426d-b194-5a0465dccbc0">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtOS0xLTEtMTE5ODY4_c824fb8c-5e52-4df9-bc0e-b9399b2f4806">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxNw_26f68df4-ac1c-4804-a28c-1e2d300fa178" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b003f2db6844f2a18ece5fe1fec528_I20221028" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi0xLTEtMS0xMTk4Njg_5ac2ecba-baf0-4cc6-a8b1-e3a5b9e07272">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b003f2db6844f2a18ece5fe1fec528_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi0zLTEtMS0xMTk4Njg_173568ab-69ec-4b33-af69-4c9b9d19d7c1">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f54a6d38f86409f9d004826da691d0a_I20220429" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi03LTEtMS0xMTk4Njg_8660a713-c740-4840-b02a-e6592b9c83fc">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f54a6d38f86409f9d004826da691d0a_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi05LTEtMS0xMTk4Njg_e8e980c9-bc88-4696-8716-6db799533c77">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy0xLTEtMS0xMTk4Njg_a87f99a2-9b8d-4f91-954f-0dd374e23e3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy0zLTEtMS0xMTk4Njg_0f2c238f-9640-4031-8bf9-3057f60bfd2a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy03LTEtMS0xMTk4Njg_ce104910-1df8-48e2-82fa-9a460571f1df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273769593a42414b9854eed6b2e7d297_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy05LTEtMS0xMTk4Njg_4a427e03-f47c-4ddd-8110-f1ae0e69437b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC0xLTEtMS0xMTk4Njg_b57a4088-47bf-4f6d-93bd-890e8cf5f01a">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC0zLTEtMS0xMTk4Njg_5619c69b-78c1-4740-a89c-152309e71c5d">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC03LTEtMS0xMTk4Njg_b1850629-ac8e-4fd8-9504-8bf402297052">695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC05LTEtMS0xMTk4Njg_fca980ed-7134-4168-8ce6-383790db5dd7">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i3f584078e0414fb697b429af37210642"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:OffsettingAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUwNA_9ee6bd0c-b666-4ceb-8543-2112226065f1" escape="true"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:OffsettingLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODU0MA_b192dacb-a775-4212-905f-38a1e6f0c2c7" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC0yLTEtMS0xMTk4Njg_df63da44-c1b0-465c-a798-5da0bb0a84e2">1,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC00LTEtMS0xMTk4Njg_8cf032e4-a6a8-4320-9feb-a54b1af0c724">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC02LTEtMS0xMTk4Njg_e727dd6d-1fa5-4889-8e19-13c4916e32fc">704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC0xMC0xLTEtMTE5ODY4_fd0f7e6b-83fa-4414-962e-7745aaa2206c">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtMi0xLTEtMTE5ODY4_475a9fbf-e02f-4abb-a8cb-285f544cb695">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtNC0xLTEtMTE5ODY4_6ac83ef3-6c7f-477d-8d6c-77e7ea30d1a9">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtNi0xLTEtMTE5ODY4_4d118849-d46b-4934-be4d-41ba06d51414">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtMTAtMS0xLTExOTg2OA_b3e6e068-d618-4439-9b76-86e78339ea0d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMi0xLTEtMTMzNzA5_d99368b8-df23-4f31-94d5-e58831a799f1">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNC0xLTEtMTMzNzA5_ea266caa-4e5b-4383-bdcf-199433a5ad30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNi0xLTEtMTMzNzA5_f1530483-9b5b-4b6b-9b79-796a9ce60404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMTAtMS0xLTEzMzcwOQ_7d774da4-44c8-4837-80ea-e0c6a5d2f740">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMi0xLTEtMTE5ODY4_0d011161-481d-4fb9-890e-bb5d1395314b">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNC0xLTEtMTE5ODY4_cc9f5304-627f-4fe5-beab-1bcc3e64c027">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNi0xLTEtMTE5ODY4_37c60beb-36ae-4c1b-9ae2-c9230a7c6495">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMTAtMS0xLTExOTg2OA_d9df2b17-41c8-459a-a254-85c8107f215e">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtMi0xLTEtMTE5ODY4_e7259b76-5cb8-43a7-80cc-cfede7724578">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtNC0xLTEtMTE5ODY4_d265f6ce-ee45-47cf-be37-44040d596baf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtNi0xLTEtMTE5ODY4_d885a231-0aab-4585-9084-a51f71ccb514">703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtMTAtMS0xLTExOTg2OA_9258a088-3548-4ae0-bbd7-e259703895a9">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC0yLTEtMS0xMTk4Njg_a5c6eee9-74f8-4888-ba82-d140ade6037e">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC00LTEtMS0xMTk4Njg_e456c610-bca9-41c6-80aa-d3045cc388ba">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeCollateralObligationToReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC02LTEtMS0xMTk4Njg_39ab9365-08b7-4891-a97c-40b620bc10af">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC0xMC0xLTEtMTE5ODY4_e9851686-456b-4af6-8ef3-74ad14ad183e">332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtMi0xLTEtMTE5ODY4_dae24d2a-3eec-43bc-9bc8-bc17a7be5b19">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtNC0xLTEtMTE5ODY4_0426dbb4-7df4-46e0-a39e-6f336a26cb55">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtNi0xLTEtMTE5ODY4_c439ca94-14d4-4d4b-8079-97bc63fc9b99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17154ded948b43b795f47e739a934d01_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtMTAtMS0xLTExOTg2OA_abaf7876-0b4d-4823-bec9-882768074791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtMi0xLTEtMTE5ODY4_fed6387a-4f7e-4e95-a5b2-8fef0e39860a">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtNC0xLTEtMTE5ODY4_b8622bb4-21e4-4b8b-ba0b-fdcfa4a9f3c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtNi0xLTEtMTE5ODY4_ff474fab-38ef-4e2b-af01-4f327c6bdcf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtMTAtMS0xLTExOTg2OA_85ca109f-7e90-43a5-ba2c-6cd7c28fb1a3">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtMi0xLTEtMTE5ODY4_a1304582-e187-4c86-83b8-52b93659235b">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtNC0xLTEtMTE5ODY4_204af104-ece7-4d0d-9328-18ef7711cc60">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeCollateralRightToReclaimCash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtNi0xLTEtMTE5ODY4_3c56323b-7657-470c-989b-9638cf232086">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtMTAtMS0xLTExOTg2OA_6fd007a3-29f0-46db-8517-d573b0450e3a">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtMi0xLTEtMTE5ODY4_948e345d-5eb6-49d2-9355-518e280e5221">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtNC0xLTEtMTE5ODY4_532cf99f-5c8c-42bf-9000-792d820ee0a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtNi0xLTEtMTE5ODY4_36deb9af-364a-48ee-89f9-5e09093a6697">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtMTAtMS0xLTExOTg2OA_9cf80ba6-c22e-435c-8e32-db33a42b3f55">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_64"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RleHRyZWdpb246NmQ4N2M4NzBmMGVkNGUxNDllY2E2MGExZmM4YWRjNTVfNzM_b820f871-bf9e-4e3f-b5ca-178c7c077bef" continuedAt="i1c9d6a4924884246a00ae1cd4ccdad92" escape="true">Inventories </ix:nonNumeric></span></div><ix:continuation id="i1c9d6a4924884246a00ae1cd4ccdad92"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RleHRyZWdpb246NmQ4N2M4NzBmMGVkNGUxNDllY2E2MGExZmM4YWRjNTVfNzU_7dcc6004-f167-4e02-a5ed-3b7f2b5e38a4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMS0xLTEtMS0xMTk4Njg_2004dc06-f93c-4b5a-b781-f922d4bc31d5">3,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMS0zLTEtMS0xMTk4Njg_0c680c49-f264-4f32-89a4-a49a92eddcb7">3,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMi0xLTEtMS0xMTk4Njg_2be8d543-5609-47a7-8f8a-d7690731b6c8">769</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMi0zLTEtMS0xMTk4Njg_6fe8548a-dbdc-4c2b-bb08-805c371ebc3b">682</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMy0xLTEtMS0xMTk4Njg_748f7df0-c3d0-494e-b4b6-07be9da4b4f6">969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMy0zLTEtMS0xMTk4Njg_2d701674-8483-4e71-989d-58c53606c665">864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfNC0xLTEtMS0xMTk4Njg_3a4bf07b-a4b4-4faa-8527-75648b90835c">5,055</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfNC0zLTEtMS0xMTk4Njg_c35a4c89-0b8c-4d60-b3e3-10219bd23697">4,616</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_67"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI5OQ_4070330f-a33f-4318-b6ab-4fccf29a0866" continuedAt="i24a35547cbac4cdf9d85b105a0419549" escape="true">Goodwill and Other Intangible Assets </ix:nonNumeric></span></div><ix:continuation id="i24a35547cbac4cdf9d85b105a0419549" continuedAt="i87037a669cdb4125a6ea1c280b4c0efc"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI4Mw_b4e111f9-692a-477b-9e4a-888b4fc44de6" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d4bffbfd284a6a905e87223d86432d_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS0xLTEtMS0xMTk4Njg_5ac4a59b-e008-47f9-b807-2c80631f4578">7,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd53369c48e4ef5b68f6051807d5349_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS0zLTEtMS0xMTk4Njg_3e18b775-9eb2-426f-89df-e095207ad475">19,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec5f74b25924bd0bc17044be8b8cc7f_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS01LTEtMS0xMTk4Njg_528548a2-f43b-4ff6-805a-7c1d8bbf96f9">11,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08338469c554b8e9fa1ed1bf628cde1_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS03LTEtMS0xMTk4Njg_00a38788-a465-4b64-bd7b-c8818bab3c84">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS05LTEtMS0xMTk4Njg_a95ee66e-7c3d-4820-8dc6-de65890c7ad3">40,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi0xLTEtMS0xMTk4Njg_468a08ca-03bb-49e4-a911-466d68d220ae">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi0zLTEtMS0xMTk4Njg_79eb1fda-a2c7-4170-a7fc-7cc46abbab3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi01LTEtMS0xMTk4Njg_c37076e0-3ead-43d7-a5a1-f62380337c82">615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi03LTEtMS0xMTk4Njg_69c27db9-642e-49ec-8802-ce8c50cc1746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi05LTEtMS0xMTk4Njg_e039cf24-5b42-44db-97ff-8c6b03ffbaaf">1,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy0xLTEtMS0xMTk4Njg_68d36e20-e77c-4d1f-9ec1-120b8baa098a">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy0zLTEtMS0xMTk4Njg_4a9945c2-27ae-4a8a-9a06-d89078ef306a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy01LTEtMS0xMTk4Njg_65c2c2d1-aaec-49a1-a457-a95ba0395927">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy03LTEtMS0xMTk4Njg_b52419af-a0a8-4596-90fd-5832bb62a19f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy05LTEtMS0xMTk4Njg_72558c5c-cf45-474a-8d55-d0b330972b8b">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC0xLTEtMS0xMTk4Njg_ba6bf663-ba04-416d-9b4a-c1be2d093748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC0zLTEtMS0xMTk4Njg_346ffb91-3da9-4f86-80ae-47ac101d122a">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC01LTEtMS0xMTk4Njg_8f05bdf2-825c-425a-914e-c237e37b4f91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillTransfers" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC03LTEtMS0xMTk4Njg_a71202bf-fdf5-4b02-ad41-e913987ffbf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC05LTEtMS0xMTk4Njg_1b5b6061-c8d7-453f-898a-95fcb7ebc3d0">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS0xLTEtMS0xMTk4Njg_abd08873-8940-4b23-8045-1d49468cd4ed">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS0zLTEtMS0xMTk4Njg_9681d89a-165e-4518-8862-b649c588ae90">951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS01LTEtMS0xMTk4Njg_499e9010-c7ba-40f9-a56d-c2bb33b4ead2">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS03LTEtMS0xMTk4Njg_a8db8ae4-b0ce-4461-8645-4e0b5b27bafe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS05LTEtMS0xMTk4Njg_4fbe813b-fa24-4e23-adff-c5804bec93c9">1,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i617c5f38a82c413fa4b606a553f802cf_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi0xLTEtMS0xMTk4Njg_3bfaf686-a4a9-4b71-b3af-f80f4f471d13">7,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50d8dc10f7f74a269ac42c7af38e438d_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi0zLTEtMS0xMTk4Njg_cf8dad91-e7ee-466a-bd3b-f704e0e91cda">18,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50dc8a72d1e845f0bc5eeb780b4167ce_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi01LTEtMS0xMTk4Njg_abcf1697-4aba-4cb9-80d5-5509a2d8c84c">11,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4bd5b464cf4754bc657a4694f52b1a_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi03LTEtMS0xMTk4Njg_87eb3443-d31c-4067-9f59-2d8f371dff1d">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi05LTEtMS0xMTk4Njg_086acddf-a4bc-4638-9cdb-1e1cb9ae399e">40,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the agreement with DaVita, as disclosed in Note 4 to the consolidated financial statements, the Company allocated $<ix:nonFraction unitRef="usd" contextRef="i64f3035beec5446b898886392399c009_I20220525" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjQz_26e16e51-7cb2-404b-afde-d363f6a2c5c6">208</ix:nonFraction>&#160;million of goodwill to the RCS business that met the criteria to be classified as held for sale during the first quarter of fiscal year 2023. Upon allocation, a goodwill impairment test was performed for the RCS business, and the Company recognized $<ix:nonFraction unitRef="usd" contextRef="iaaaa9f5a211e46648d43a13986dd518a_D20220430-20221028" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNDQy_064dbd2f-be9c-4842-80d5-eab68f5d4108">61</ix:nonFraction> million of goodwill impairment during the six months ended October&#160;28, 2022. The goodwill impairment charges are recognized in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. The Company did <ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNjM5_4a8b19c4-96ee-4dcf-9e22-445d42e48bbb">no</ix:nonFraction>t recognize any goodwill impairments during the three months ended October&#160;28, 2022 and the three and six months ended October&#160;29, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets </span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI3Nw_ffa8a8ac-745a-40c1-82bd-23f5e72169cb" escape="true"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI5Ng_4e0dd992-f373-413f-83f7-f7724545d867" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae88943d08a644079847bc841e0fe18f_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy0xLTEtMS0xMTk4Njg_df9993ed-b52d-43b9-a5f0-307f9ac34c34">16,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae88943d08a644079847bc841e0fe18f_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy0zLTEtMS0xMTk4Njg_fb2d795f-f5e6-4738-9319-b5d0d5c30ede">7,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ca089b4a214117984874b09ca1d0e6_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy01LTEtMS0xMTk4Njg_7f7ef8f0-f012-4e0e-91b0-70a574d73d17">16,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78ca089b4a214117984874b09ca1d0e6_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy03LTEtMS0xMTk4Njg_b18d185e-5e01-4bf5-aba2-785b8f84a7b3">7,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic16fb407d39c49d580ac035048e8ce43_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC0xLTEtMS0xMTk4Njg_64c606c5-a34c-4aa9-990f-1d6c47b9c1ea">11,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic16fb407d39c49d580ac035048e8ce43_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC0zLTEtMS0xMTk4Njg_c7c6d649-61ea-4cff-90e2-d1a094765f47">5,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfa7eec43314902906140d18188a9c2_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC01LTEtMS0xMTk4Njg_81d97d49-8bbd-467d-91f9-249353a99c03">10,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bfa7eec43314902906140d18188a9c2_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC03LTEtMS0xMTk4Njg_a63941a6-bbdc-4c7c-9b66-e49458ae0511">5,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351d6e481f7f40618e1994166ab8abe7_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS0xLTEtMS0xMTk4Njg_7e4f5e24-f7b1-434b-b3c3-01a39441ed83">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i351d6e481f7f40618e1994166ab8abe7_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS0zLTEtMS0xMTk4Njg_57dcc334-d57e-4b72-8b0a-16ab5c4f9d9f">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0837b81f7bc4637bc63f5b62fb85a48_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS01LTEtMS0xMTk4Njg_b78af00f-21b5-4185-8409-eb73df065c98">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0837b81f7bc4637bc63f5b62fb85a48_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS03LTEtMS0xMTk4Njg_83a311e8-afea-4ed5-82b0-056708775adc">266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi0xLTEtMS0xMTk4Njg_1bd6f74b-11d7-47ba-ad83-35f854cbcc4f">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi0zLTEtMS0xMTk4Njg_3b4cb3ee-9b69-4e6a-8067-0de57899e3b4">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi01LTEtMS0xMTk4Njg_e5df35e6-2480-4b75-82c9-66b16670bf51">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi03LTEtMS0xMTk4Njg_e440d9e4-4d84-49ee-8b46-6d21f869950f">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy0xLTEtMS0xMTk4Njg_63412b2e-62bb-4877-8a42-8179415bff5b">28,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy0zLTEtMS0xMTk4Njg_d3b42110-a1bb-4765-a0af-47c22fc8272e">13,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy01LTEtMS0xMTk4Njg_d005833f-a368-4e77-aeaa-dfe6df268472">28,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy03LTEtMS0xMTk4Njg_013fcdcf-5f86-41fd-a943-238283bbd0d3">13,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5fa643d9584c9bb178f09a350973e3_I20221028" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfOS0xLTEtMS0xMTk4Njg_cdcbd711-2e90-47a3-8b01-1130a369b54b">583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2e63efa08c4ca7914dcaaece2d58c2_I20220429" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfOS01LTEtMS0xMTk4Njg_296cf63e-c08b-4edd-af4b-cb2f9dbf7b2b">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfODU2_7577c196-ed25-4c14-ae21-6e4ef845222f">no</ix:nonFraction>t recognize any definite-lived intangible asset charges during the three and six months ended October&#160;28, 2022 and the three months ended October&#160;29, 2021. During the six months ended October&#160;29, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTAwNA_deb63398-4b96-473f-92f7-6a8cb567e2d7">409</ix:nonFraction>&#160;million of definite-lived intangible asset charges in connection with MCS within the Cardiovascular Portfolio. Refer to Note 5 to the consolidated financial statements for additional information on what led to the impairment. Intangible asset impairment charges are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTM2OA_11b68e9d-e9a0-4e36-8bd9-b4d16a847477"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTM2OA_aacb2ed3-ba05-45e9-829e-621674ed0357">no</ix:nonFraction></ix:nonFraction>t recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. Due to the nature of IPR&amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i87037a669cdb4125a6ea1c280b4c0efc"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTk3Mw_af008768-540b-47fa-9bad-4a8769111bac">421</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTk4MA_c834538d-562c-42b8-8310-3d44f5236c7f">431</ix:nonFraction>&#160;million, respectively. Intangible asset amortization expense for the six months ended October&#160;28, 2022 and October&#160;29, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNTQ5NzU1ODE2MzQ4_3d5ddf6f-41d9-440d-8fe3-0a9a53fe2fa8">844</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNTQ5NzU1ODE2MzUy_755630ef-08a4-46c9-8056-e89f79be7ba2">866</ix:nonFraction>&#160;million, respectively. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI4OA_7edd6a32-614c-4247-a976-3b86166af5b1" continuedAt="i66c8ea0db80a4cc19d4e9c9d1c390eb2" escape="true">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;28, 2022, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><ix:continuation id="i66c8ea0db80a4cc19d4e9c9d1c390eb2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMS0xLTEtMS0xMTk4Njg_00c8c06b-6b42-40c9-920b-e22e00ea8b4d">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMi0xLTEtMS0xMTk4Njg_f7ec9911-da6f-4e98-9cf8-1498fcd14be0">1,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMy0xLTEtMS0xMTk4Njg_76bec348-f828-4672-8a54-22e0e9b2bba0">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNC0xLTEtMS0xMTk4Njg_af414d35-a4a6-48e2-adeb-d2c1a04697e6">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNS0xLTEtMS0xMTk4Njg_09248f3c-c2d5-4851-932d-4991edeaf5dc">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNi0xLTEtMS0xMTk4Njg_067f9b1d-1fc2-49b7-9f5d-117fc9f84067">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_70"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMzA1OQ_986562bc-2a5f-49a9-bcde-01ad4449a3b1" continuedAt="i3cc4b569fa3a4ee88dc9ebcb559f3aac" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="i3cc4b569fa3a4ee88dc9ebcb559f3aac"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the U.S. Tax Court (Tax Court) issued its opinion on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for fiscal years 2005 and 2006 (Opinion). While the Opinion rejected the IRS&#8217;s position and the Tax Court determined the methodology advanced by Medtronic was appropriate for purposes of determining the intercompany royalty rate between Puerto Rico and the U.S., it determined that the royalty rate should be higher, thereby increasing income allocated to the U.S. and consequently subject to U.S. tax. This case relates only to fiscal years 2005 and 2006. The Opinion remains subject to finalization by the Tax Court and to appeal by either or both parties. The Company has assumed the Tax Court findings will be applied for all years following fiscal year 2006. As a result, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMjc0ODc3OTA4MDI1MA_03335912-58ed-4e0b-9938-ac60a77491bb"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMjc0ODc3OTA4MDI1MA_a102ddd4-b6e6-4951-a2ab-b4a8f220b0fd">764</ix:nonFraction></ix:nonFraction>&#160;million net tax charge during the three months ended October&#160;28, 2022 to recognize the estimated tax impact of the Tax Court Opinion. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for the three and six months ended October&#160;28, 2022 was <ix:nonFraction unitRef="number" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfODA_632870d5-ea00-4168-aecc-8ff139e2cb78">68.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE5MTQ3_cf897072-c9f0-40a1-887d-536c47c0e70e">44.0</ix:nonFraction>%, respectively, as compared to <ix:nonFraction unitRef="number" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfOTk_53e92fff-d363-4514-bf50-84b96d88a995">11.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE5MTY5_b264b071-fef9-48d3-9726-fb5cfdd23901">10.3</ix:nonFraction>% for the three and six months ended October&#160;29, 2021, respectively. The increase in our effective tax rate for the three and six months ended October&#160;28, 2022, as compared to the corresponding periods in the prior fiscal year, was primarily due to the $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTM3NDM4OTUzNTU3NzQ_03335912-58ed-4e0b-9938-ac60a77491bb"><ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTM3NDM4OTUzNTU3NzQ_a102ddd4-b6e6-4951-a2ab-b4a8f220b0fd">764</ix:nonFraction></ix:nonFraction>&#160;million net tax charge referenced above.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022 and April&#160;29, 2022, the Company's gross unrecognized tax benefits were $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE3NzMz_b6053c4c-3a8e-4e76-b47b-cd99edbf2dd8">2.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNzkz_512b2784-4aa0-4173-9749-316771ce8a42">1.7</ix:nonFraction>&#160;billion, respectively. In addition, the Company had accrued gross interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfODY2_64711d4c-ea92-4f50-a015-d82325936cff">196</ix:nonFraction>&#160;million at October&#160;28, 2022. If all of the Company&#8217;s unrecognized tax benefits were recognized, approximately $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfOTU3_65f4fc1e-f0b6-4fd9-a740-08320d2b4e4a">2.4</ix:nonFraction>&#160;billion would impact the Company&#8217;s effective tax rate. At October&#160;28, 2022 and April&#160;29, 2022, the amount of the Company's gross unrecognized tax benefits, net of cash advance, recorded as a noncurrent liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated balance sheets was $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTIwNQ_12605922-a676-47d0-8b4b-33fe211933bd">1.8</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-6" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTIxMg_e6b57660-eaa5-4eca-837f-2232a5f9d83b">802</ix:nonFraction>&#160;million, respectively. The increase in the Company's gross unrecognized tax benefits, net of cash advance, was primarily due to an increase in unrecognized tax benefits relating to the Tax Court Opinion. The Company recognizes interest and penalties related to income tax matters within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income and records the liability within either current or noncurrent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accrued income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfMTA1MQ_08da7395-69d3-463b-aacc-ab0d55d4c9f7" continuedAt="i44be4d93a85b435aa8d9f9f64c269add" escape="true">Earnings Per Share </ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i44be4d93a85b435aa8d9f9f64c269add" continuedAt="i701bb8bc53f44f77927c5277eb0f0e52">Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i701bb8bc53f44f77927c5277eb0f0e52" continuedAt="i605d97749d064a9ab8ec6cd110f813ef"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfMTA1NQ_7dbbeaa1-acdb-4992-8a9b-89d06dd3c090" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy0xLTEtMS0xMTk4Njg_d2c04f46-7d0a-40f1-a084-38ab61cef2d7">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy0zLTEtMS0xMTk4Njg_c40950b2-8c76-4d36-ab8b-6786d7bb4228">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy01LTEtMS0xMTk4Njg_0fd8cd4f-6252-4036-85ea-6473ba9f8f83">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy03LTEtMS0xMTk4Njg_9fd5444b-356d-422f-b56e-d1e007fbc748">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS0xLTEtMS0xMTk4Njg_85dd336d-652f-4b69-8125-b7d9eeb2607e">1,329.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS0zLTEtMS0xMTk4Njg_9c9c062b-7c7a-4782-93fb-c9a89f6a8a5d">1,345.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS01LTEtMS0xMTk4Njg_8a44d5c3-6dc2-47a0-bc54-8feeb189b228">1,329.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS03LTEtMS0xMTk4Njg_4dbfbe97-cadd-491d-a1fb-f7e2f5a261db">1,344.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy0xLTEtMS0xMTk4Njg_cd655acc-1c77-43eb-9bd5-f0df96f30773">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3affa50db84b49f895fa4532797c87be_D20210731-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy0zLTEtMS0xMTk4Njg_0c6e99c5-2c30-4940-bff4-0dabd6e49bbf">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy01LTEtMS0xMTk4Njg_dfcb41ca-1bbb-43f7-b58e-8493f18385d2">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy03LTEtMS0xMTk4Njg_10e7881b-03ea-422b-9483-5933d40dee70">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC0xLTEtMS0xMTk4Njg_e9fdfcc1-c0d6-420f-b328-aa6db1c831f2">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia80b3537de0145e8b97523443127c857_D20210731-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC0zLTEtMS0xMTk4Njg_8a6f8e28-4ca5-4532-8a91-633fe511b188">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC01LTEtMS0xMTk4Njg_ad3205f3-75c0-4e50-b427-3762b8493e89">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC03LTEtMS0xMTk4Njg_59029991-86ed-40bd-b055-d70ff4f41c31">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1398815934fb4c929000688ee41577ab_D20220730-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS0xLTEtMS0xMTk4Njg_b47c69c5-105d-4142-af23-8abdd29a3c24">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS0zLTEtMS0xMTk4Njg_e3d9c12d-9563-4d92-8550-9961ee093f67">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4b6674cdea049859601401c887d0ed0_D20220430-20221028" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS01LTEtMS0xMTk4Njg_90531219-2df1-42c5-8102-f1df2ec041f6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS03LTEtMS0xMTk4Njg_06663622-5507-4bc2-9c49-b77103fd56c6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtMS0xLTEtMTE5ODY4_88c3220e-b645-4359-986c-9a395fce9c78">1,332.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtMy0xLTEtMTE5ODY4_8179a366-951d-4f2e-b660-e8343a95e637">1,355.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtNS0xLTEtMTE5ODY4_cb56d6d4-f65c-4f7f-84f9-4b55ae3609dc">1,333.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtNy0xLTEtMTE5ODY4_fecdaa6e-c321-400f-9923-91cd16c4e5f2">1,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtMS0xLTEtMTE5ODY4_40f5bab9-f183-4fad-bbea-9ea5cd9ddc48">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtMy0xLTEtMTE5ODY4_1a008d80-4e1b-488b-8cbd-daf8e639df51">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtNS0xLTEtMTE5ODY4_fb53645f-1281-47ce-aac1-3586106ce408">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtNy0xLTEtMTE5ODY4_a6a509c1-54e0-4f35-9801-0b0eed15a4df">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItMS0xLTEtMTE5ODY4_03490ece-4bfe-4353-94ff-3f2f09f8c220">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItMy0xLTEtMTE5ODY4_b9cfc900-2836-4188-a804-76bc4d27dc53">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItNS0xLTEtMTE5ODY4_82ff5b7e-ae7f-411e-b5ad-34a6d68aeb64">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItNy0xLTEtMTE5ODY4_c3610492-8980-4e13-a4ed-b13da18af11b">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i605d97749d064a9ab8ec6cd110f813ef">The calculation of weighted average diluted shares outstanding excludes options to purchase approximately <ix:nonFraction unitRef="shares" contextRef="i74db199c9a774fdb9da00363fa038371_D20220730-20221028" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfODcz_0ab8c88e-41f3-40c1-84fc-bf1f357ff7e6">25</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i0eff972d77b347488f63d31d746a15a0_D20220430-20221028" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfNTQ5NzU1ODE0OTQ5_3491f410-b6c8-4697-b9e2-f6802a1d4356">20</ix:nonFraction> million ordinary shares for the three and six months ended October&#160;28, 2022, respectively, and <ix:nonFraction unitRef="shares" contextRef="i8d98793895484125aa0679ce08f1dcd6_D20210731-20211029" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfODgw_16008d67-ca92-46b4-8b79-1b12e85b7985">4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i3c07e51d429d4cbbad584cb5fe45515d_D20210501-20211029" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfNTQ5NzU1ODE1MDIx_442550db-07e5-4046-8208-99fe306621c4">2</ix:nonFraction> million ordinary shares for the three and six months ended October&#160;29, 2021, respectively, because their effect would have been anti-dilutive on the Company&#8217;s earnings per share.</ix:continuation> </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RleHRyZWdpb246ODRiYzUwZTZlMjIyNGZjYWI1ZDI0OGQxZGRlYzc1YzdfMjcy_eed0884d-a6dd-40fd-aeac-cc2f50bf3789" continuedAt="id944ee9452644086bdb9be17d0ce53b9" escape="true">Stock-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="id944ee9452644086bdb9be17d0ce53b9"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RleHRyZWdpb246ODRiYzUwZTZlMjIyNGZjYWI1ZDI0OGQxZGRlYzc1YzdfMjc0_367a6cd0-2194-4bcf-84d7-299005e821ba" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, performance share units, and employee stock purchase plan shares recognized for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi0xLTEtMS0xMTk4Njg_8d0a0a50-a62b-4b74-a701-d0c405e96bbb">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3affa50db84b49f895fa4532797c87be_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi0zLTEtMS0xMTk4Njg_a5cda662-fa37-4153-b362-c612ddb6bf5f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi01LTEtMS0xMTk4Njg_e3564314-0b33-4071-a1cc-7e59c9371332">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi03LTEtMS0xMTk4Njg_60a281af-4971-4a0b-bf23-9ff1543e7a1a">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy0xLTEtMS0xMTk4Njg_8c99c7e0-8f78-4f01-8fb1-c093d7bfc90a">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia80b3537de0145e8b97523443127c857_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy0zLTEtMS0xMTk4Njg_9de0ef61-a3dd-4f27-be30-19286858c51e">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy01LTEtMS0xMTk4Njg_e220ed37-6a8a-4e65-8a1e-bed0deae5331">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy03LTEtMS0xMTk4Njg_e9d5c699-71ac-42c1-9472-d0581a9c52f2">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1398815934fb4c929000688ee41577ab_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC0xLTEtMS0xMTk4Njg_88a3b06c-d974-4b08-a8e7-19205a0ae096">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC0zLTEtMS0xMTk4Njg_2902b432-e494-49ad-b7d0-2a4f164f14fe">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b6674cdea049859601401c887d0ed0_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC01LTEtMS0xMTk4Njg_af92c8a2-770b-41df-8c77-2aac7cde6fe7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC03LTEtMS0xMTk4Njg_8be68b3a-b0c1-4f67-aa0e-3695c11fc889">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de56b7be4e5417d8cc74ecf01292422_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS0xLTEtMS0xMTk4Njg_30bbc07a-001f-41e4-87c7-44bc7e178ed3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dedf22af6864313999d497de5e5d6ee_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS0zLTEtMS0xMTk4Njg_174c3da3-31e4-4bef-a607-7e484fffcfd7">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7ca207cf164dcc8a0c586bf2859962_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS01LTEtMS0xMTk4Njg_cbc56c67-5c61-450a-87d4-b172c9a995c9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce28f9819d44f1cb7eec69a55f52fc9_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS03LTEtMS0xMTk4Njg_e3bbec72-b841-42cf-b8f2-e82eae3ba867">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi0xLTEtMS0xMTk4Njg_070d7f83-7fe3-4fbe-9b40-e8e1646982b7">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi0zLTEtMS0xMTk4Njg_1da04f70-a7af-49f9-9fa8-a9d198d1fa71">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi01LTEtMS0xMTk4Njg_8ae3e2c1-608c-43ec-b6ed-1b2e13dfe2cb">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi03LTEtMS0xMTk4Njg_d6629962-5551-4a7b-ad06-9096829d5427">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d75dfd093f41b79b84cc712dd4bdeb_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC0xLTEtMS0xMTk4Njg_457380b6-835e-44ed-985f-d9d917756b8c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b29f486c461430ea0700ecce5ccc168_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC0zLTEtMS0xMTk4Njg_256feb5f-f591-430b-a082-866f842fb1bc">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8a11e621df491c8e9bcf6998fa2316_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC01LTEtMS0xMTk4Njg_86ee7ef8-01c0-40c1-81fb-c3cc463b6a17">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c12dca8003843c9b905c9a3220a9dd3_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC03LTEtMS0xMTk4Njg_cb7572d7-5717-46bc-bc87-8dce3ee15009">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida185280d375499c84936e4a6364ca45_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS0xLTEtMS0xMTk4Njg_118b9ea3-ce08-415a-a193-92a3d36da70e">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b788a6030cc4d249b9f10c42c12d4b3_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS0zLTEtMS0xMTk4Njg_ea2d47f7-8a90-4b64-ae1a-8f9f1835762c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe0629813fc4a7f9ee052e38f52a06d_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS01LTEtMS0xMTk4Njg_86beac84-df08-4768-9388-647107d7b099">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0871f5c80684792904d5a9b080d8746_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS03LTEtMS0xMTk4Njg_59f0805f-deae-4d1a-9e21-dd62ae60c6d8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9f32e60ed34e03b1eee7e4dd64092d_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtMS0xLTEtMTE5ODY4_a7914fc8-ad30-42b8-a359-cc1f03f968f0">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93bc1e6379124613960fd7675b514cd8_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtMy0xLTEtMTE5ODY4_8f8bcfdf-04ab-457a-b7ef-be67f7e8a384">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedf7ecfabdfa4fd796a4fc91dfd1466b_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtNS0xLTEtMTE5ODY4_546e89c0-80be-4e04-a7a2-012c86ccda13">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b972ff441f4b5f9da1923ccd6b5eba_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtNy0xLTEtMTE5ODY4_c0ad589c-37a8-436f-abea-3ff2f3ce6000">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtMS0xLTEtMTE5ODY4_c23f79f2-7c2c-442a-a67e-08c99712e468">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtMy0xLTEtMTE5ODY4_5cf61cf9-c12b-4651-a91b-330a76bf7be3">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtNS0xLTEtMTE5ODY4_cca5dba8-9350-4b32-9b0c-7428de70d629">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtNy0xLTEtMTE5ODY4_c1011d48-6998-4179-9e05-7c7b756c7f02">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItMS0xLTEtMTE5ODY4_c9cdd5b7-629e-420a-9b60-b116ac40d821">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItMy0xLTEtMTE5ODY4_c9d55af4-976d-4538-8241-94d32e6fe95a">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItNS0xLTEtMTE5ODY4_9b4ea10d-0f01-44e7-831e-56e598e0d2de">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItNy0xLTEtMTE5ODY4_897c703d-b0f3-419c-89d3-88e8eb1dcfc1">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtMS0xLTEtMTE5ODY4_c28da299-4637-42ec-a056-d3571b081bf6">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtMy0xLTEtMTE5ODY4_187f5efe-24f0-4168-a8bc-44f439fbfa08">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtNS0xLTEtMTE5ODY4_828d5efb-c107-4d17-816f-90867b364bb0">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtNy0xLTEtMTE5ODY4_f55e0ebf-4058-44ff-96c5-31783a232c73">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_79"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RleHRyZWdpb246NzJhNmEwZWFiYmRhNGU0YjgyNjY5MmI4Y2E0NDljYTRfNTky_4443fe7b-da08-4a01-81c1-b6fde6d8e110" continuedAt="i01aa72f11b734a58984e6f7d5d376d98" escape="true">Retirement Benefit Plans </ix:nonNumeric></span></div><ix:continuation id="i01aa72f11b734a58984e6f7d5d376d98" continuedAt="i23818ed79d664511bb9587f65ccd3e2e"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RleHRyZWdpb246NzJhNmEwZWFiYmRhNGU0YjgyNjY5MmI4Y2E0NDljYTRfNjA4_acde77ed-608f-46d7-827f-2f5b4cc4525b" continuedAt="i70aeed6bbdc14310aab4598f45f34801" escape="true">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><ix:continuation id="i70aeed6bbdc14310aab4598f45f34801"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC0xLTEtMS0xMTk4Njg_9632fb8d-419a-4635-a445-bc28c975c7d4">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC0zLTEtMS0xMTk4Njg_261f5d9e-ee74-4a76-aaf6-799bdb2e8751">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC01LTEtMS0xMTk4Njg_1aaf45b0-47f2-48e9-a82d-5d79648db554">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC03LTEtMS0xMTk4Njg_37c2aeff-0031-4ace-ab6b-ec8e98c4e895">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS0xLTEtMS0xMTk4Njg_efcfea5d-aab4-4d24-85f0-7ded1f01bbd9">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS0zLTEtMS0xMTk4Njg_aa9fc209-320c-4442-83d4-09cff7f4c7ea">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS01LTEtMS0xMTk4Njg_80398e81-b57e-4f97-a376-7a5ee5427ad7">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS03LTEtMS0xMTk4Njg_d54d97d2-c719-48c3-8894-943258da63ab">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi0xLTEtMS0xMTk4Njg_792a88ee-db61-4935-b37a-4da2ca6d1157">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi0zLTEtMS0xMTk4Njg_52cea887-eca1-48b9-9565-012d172e8620">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi01LTEtMS0xMTk4Njg_cdd868a0-d1b6-43d5-aae1-6bb7173b5538">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi03LTEtMS0xMTk4Njg_4b295968-9a8e-4372-b038-66e4e14f9530">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC0xLTEtMS0xMTk4Njg_c3df6a4b-f3c4-452e-843b-24c3e6b4c9e8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC0zLTEtMS0xMTk4Njg_c54006de-968b-4faf-9487-4621539c2766">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC01LTEtMS0xMTk4Njg_70dc1016-ef4f-4754-ada3-3b11195c8e51">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC03LTEtMS0xMTk4Njg_a9bb41df-d1a0-4405-8344-8f9e73fec486">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS0xLTEtMS0xMTk4Njg_8c26b0c9-e3cf-48dc-b77b-91316862d605">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS0zLTEtMS0xMTk4Njg_cca50c27-8100-4cb1-9a81-54a49a99c12b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS01LTEtMS0xMTk4Njg_054fdab1-f724-42db-be95-1cedb6c29b53">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS03LTEtMS0xMTk4Njg_86b8ea08-bf0a-4736-9c75-c0f82c47d5c4">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtMS0xLTEtMTE5ODY4_14bf5f3d-b8c4-4ada-9ac4-02e360f89d83">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtMy0xLTEtMTE5ODY4_f8c6f3f0-9fd9-4b57-beb5-f64c4860fcee">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtNS0xLTEtMTE5ODY4_54319bf8-660d-43d8-87b5-0cdc192f3dae">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtNy0xLTEtMTE5ODY4_18727469-5ef8-4687-acfa-788c8e780196">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtMS0xLTEtMTE5ODY4_47a732bd-2a36-401c-835a-c41d543838fe">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtMy0xLTEtMTE5ODY4_f86656d2-65fc-4667-9718-83e4dcfd275a">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtNS0xLTEtMTE5ODY4_aa56ad00-f852-4b25-94ec-1dab2adb2286">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtNy0xLTEtMTE5ODY4_20982729-0abd-460d-8b30-3fde9b48eef7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctMS0xLTEtMTE5ODY4_c672abc0-482c-4269-aaf3-aa0c1a631904">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctMy0xLTEtMTE5ODY4_5c9af817-f3d5-4b3b-86e4-73aefa87004e">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctNS0xLTEtMTE5ODY4_09136c9e-99d2-4c1b-a680-d51235d3dd89">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctNy0xLTEtMTE5ODY4_3c82321e-b302-4b55-9f0e-95557c62412b">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktMS0xLTEtMTE5ODY4_8faf03cb-7b5a-4ab7-a545-133e2ead8edf">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktMy0xLTEtMTE5ODY4_d0e2dd5d-0e07-4eef-93ba-81532a4852ad">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktNS0xLTEtMTE5ODY4_4b3822b2-afa7-4262-88a7-c59da1eba6eb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktNy0xLTEtMTE5ODY4_ae8ebf56-5dc5-4982-86cb-fc8bb23c7851">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtMS0xLTEtMTE5ODY4_6a5afc7d-b3b4-484a-8193-46050919bb6f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtMy0xLTEtMTE5ODY4_3a44c4df-ca08-40c7-8a1e-fa4ef45e6827">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtNS0xLTEtMTE5ODY4_1accffdb-df14-404f-b224-098c117d74d6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtNy0xLTEtMTE5ODY4_ab74ab3b-4674-42fa-b7f5-7b37c95eeddd">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><ix:continuation id="i23818ed79d664511bb9587f65ccd3e2e" continuedAt="ifbf0792ba11844b8a28c25a229536685"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost other than the service component are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifbf0792ba11844b8a28c25a229536685"> in the consolidated statements of income.</ix:continuation> </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjU3Mg_5eb2998b-526e-49bd-96d9-25c0e788e2d5" continuedAt="ibcd3bf21faee49bfbe4945366a9428ed" escape="true">Accumulated Other Comprehensive Loss </ix:nonNumeric></span></div><ix:continuation id="ibcd3bf21faee49bfbe4945366a9428ed" continuedAt="i037fd37c7b044b0c9fe6b7e0027c354e"><div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjU4Nw_471c2bf0-1bd0-4029-bbb5-7d5ffe76889f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in accumulated other comprehensive loss (AOCI), net of tax, and by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac4974ad9d20428ba8fa1009b1d7e83d_I20220429" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0xLTEtMS0xMTk4Njg_ae0b935c-0d76-4465-b9c3-f7f6d7b317c6">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ab310b699e340a0b46bb1aa55af0ce5_I20220429" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0zLTEtMS0xMTk4Njg_6bab5a4b-296d-4988-9e7f-0e8ef1c067e2">2,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3378e12209024d9d8052dcc6dc3f0a2c_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS01LTEtMS0xMTk4Njg_6bb67ffe-3d35-4629-918b-9ea063223cc5">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0b5ac28482240b38b40b82a5691ce06_I20220429" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS03LTEtMS0xMTk4Njg_7ab8cac9-76dd-4b3e-920a-2ddf2a564f7d">773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188641c285b14b8895fd2296677da61c_I20220429" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS05LTEtMS0xMTk4Njg_ad8c9c49-a5a3-419a-825e-ceaedfa65564">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f7d0c01899c445db04cd9b2d85f6968_I20220429" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0xMS0xLTEtMTE5ODY4_11cbd966-dac6-4cf5-a224-78258ab6f22b">2,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0xLTEtMS0xMTk4Njg_e934cbeb-acb2-466b-8f78-8be1227562b9">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0zLTEtMS0xMTk4Njg_3117269f-053c-4549-b795-eabcefbe07f6">1,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi01LTEtMS0xMTk4Njg_aef9f004-3ec3-4fd5-a92b-d2009311f4ce">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi03LTEtMS0xMTk4Njg_5296489a-ef11-49cf-9bd0-59ee20200093">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi05LTEtMS0xMTk4Njg_0a3b132d-01ec-4aca-92d8-2a090378795e">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0xMS0xLTEtMTE5ODY4_daca0c25-d65c-4ebd-9f78-c61286ec7a5e">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0xLTEtMS0xMTk4Njg_f789d757-7cdd-460d-8398-651a602ebb0f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0zLTEtMS0xMTk4Njg_1aae3f20-9c04-4660-849a-ae21307c1392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy01LTEtMS0xMTk4Njg_dcda3fd3-5f3b-4666-8dbb-c576af1412d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy03LTEtMS0xMTk4Njg_42edff25-5651-4364-b3c7-b1144c7446ee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy05LTEtMS0xMTk4Njg_75e1f7c2-d9c4-4b00-b574-e032484ef5c2">256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0xMS0xLTEtMTE5ODY4_5e5a3a80-31ad-46d2-98b2-8faaa93e2c45">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0xLTEtMS0xMTk4Njg_6e8283a1-df5b-4312-8b36-adf07f6092a3">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0zLTEtMS0xMTk4Njg_b9ef89df-97af-42ae-8e3c-4e82e68f750a">1,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC01LTEtMS0xMTk4Njg_d9fb03e9-b523-4db5-955c-d6dcdbb8d3e0">1,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC03LTEtMS0xMTk4Njg_1a09f79d-44bd-4100-9b83-67dc947e4434">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC05LTEtMS0xMTk4Njg_68eba18b-88c9-4400-b9e5-c1678b81ad3e">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0xMS0xLTEtMTE5ODY4_93afcb20-26d6-4ead-bd58-77ab3ccd2811">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80f7f42761a242f0ace890eaa6dc8247_I20221028" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0xLTEtMS0xMTk4Njg_91f7302d-9241-495e-af0d-0e08c24c7009">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8142fb31d264e0699b5a2404ecd7e2e_I20221028" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0zLTEtMS0xMTk4Njg_c21e954a-d3e2-47a9-8d9e-bbaad39e3065">4,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d55bb9abcdd40f88c78b3fb670e6a98_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS01LTEtMS0xMTk4Njg_b9e62b0a-5cbe-4ae6-8c52-b9119d4c8b5c">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69d21fb1bb9c4c179514a671cbf4e411_I20221028" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS03LTEtMS0xMTk4Njg_25f660a6-86c8-4846-85d5-7b77b1ca25c4">769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2b7c40e2d14604869e3828bebf8f6c_I20221028" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS05LTEtMS0xMTk4Njg_2f2a8bad-7b03-4eea-9665-f0983ab2f62f">852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12e89df7a7284768b084b028fb30c0b3_I20221028" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0xMS0xLTEtMTE5ODY4_17f7f2af-a2de-45b3-aabe-cef1d1106414">2,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763fe5a14b6f4a0abca07febc595186a_I20210430" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0xLTEtMS0xMTk4Njg_c91fe69e-1b62-4dc7-8c2d-fd0060bce9e7">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbf04decd1248789e7cf49bc6bfc8f3_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0zLTEtMS0xMTk4Njg_26f8779e-4ddd-4b99-9cfc-eb7e572976cd">519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51a1f4a27446424fa83923dcf918a2a5_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS01LTEtMS0xMTk4Njg_32311dd4-6550-4797-9548-2a3a82039502">1,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40837b287fac4cbe8238278e9bd46ede_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS03LTEtMS0xMTk4Njg_b209d11a-8a1e-47dd-b677-5400376e9aaa">1,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7edfc27e40204f9580fd94d3ad2410e5_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS05LTEtMS0xMTk4Njg_1ed7e93e-e0be-453c-8ce5-344f12184e78">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0xMS0xLTEtMTE5ODY4_ba368826-a05f-4a75-b92f-16479a68907a">3,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMS0xLTEtMTE5ODY4_32e09357-7b1d-44d4-85d0-034f885ad968">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMy0xLTEtMTE5ODY4_65c01ed4-6013-4546-998c-17ae71a0169c">599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtNS0xLTEtMTE5ODY4_7e5b28ca-b49c-43b0-a99a-6db6e8766975">780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtNy0xLTEtMTE5ODY4_40f8fd0c-ea49-4491-9aab-ecb96c11ed3f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtOS0xLTEtMTE5ODY4_df245265-9f1a-43eb-9856-bec5b1a5b788">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMTEtMS0xLTExOTg2OA_4e9e9beb-3b65-49ca-805c-cd37ab1e5917">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMS0xLTEtMTE5ODY4_cd96eae0-89ea-4802-93bb-a13427361f1d">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMy0xLTEtMTE5ODY4_67effdfe-b689-44a8-8886-db3c6af115ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtNS0xLTEtMTE5ODY4_c95f239a-db9b-48ff-b8dd-d51b22e1acff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtNy0xLTEtMTE5ODY4_ae31fc9b-0e1f-4480-897e-cb3abf06999f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtOS0xLTEtMTE5ODY4_57f789d6-a36d-472e-a03d-50bab66a1120">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMTEtMS0xLTExOTg2OA_9370300e-2810-4685-bfa8-5ff90c5c175c">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMS0xLTEtMTE5ODY4_68d7176c-3bb7-4a23-949b-9cbaa0f2a9d8">44</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMy0xLTEtMTE5ODY4_0e0304aa-ce5f-4910-8490-6896603dc7de">599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItNS0xLTEtMTE5ODY4_79296a8a-7f04-46aa-8ba0-7b7b8d2e6b1b">780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItNy0xLTEtMTE5ODY4_dc8810b2-bdb5-47a5-af4e-0798032dd92a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItOS0xLTEtMTE5ODY4_17bb0ca6-b58c-4d28-af34-41b0aac32b31">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMTEtMS0xLTExOTg2OA_40e6fff2-9722-420b-be17-210c563385df">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic869d6f490e64df1aaefa8121f2d93a3_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMS0xLTEtMTE5ODY4_394b5cb4-5801-4e9b-a184-ca0dd2cd7a76">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dbdac6c2f7b45c588961b7bd1c42e81_I20211029" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMy0xLTEtMTE5ODY4_1658ec5c-2ca1-4fe7-98f8-6937d9c8fec7">1,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c544a31d4554d418bd424cc41e57b32_I20211029" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtNS0xLTEtMTE5ODY4_8b2529e5-cfa8-4731-84db-0f2b34e88022">678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8eee748d81154109a2314b15b0389e0c_I20211029" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtNy0xLTEtMTE5ODY4_d6ef70a7-49f6-4573-97a6-b679038db448">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f70b5cc5d64bf3933f7dc026250876_I20211029" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtOS0xLTEtMTE5ODY4_c2f5f4b7-f5f3-452b-8fbe-9369ff5118cf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b27da620ade4165842447d930ad60a5_I20211029" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMTEtMS0xLTExOTg2OA_212f0f2b-458c-454a-81f2-5990c35f54b6">3,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021 was a benefit of $<ix:nonFraction unitRef="usd" contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjQ2_f2b51b82-d07d-4735-9832-8ead9d05c305">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjY3_85f37e2a-f8c9-4651-8aed-5816971d61c7">6</ix:nonFraction> million, respectively. During the six months ended </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i037fd37c7b044b0c9fe6b7e0027c354e"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;28, 2022, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $<ix:nonFraction unitRef="usd" contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfNDI1_3a1bc277-abdd-4297-9fe2-d99a7ab55110">4</ix:nonFraction>&#160;million. During the six months ended October&#160;29, 2021, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $<ix:nonFraction unitRef="usd" contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTY0OTI2NzQ0NDUyNg_8a46eddb-257f-47ee-9300-2c0ac3905535">1</ix:nonFraction>&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended October&#160;28, 2022, the income tax on cumulative translation adjustment was a benefit of $<ix:nonFraction unitRef="usd" contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfODU0_34162625-4666-4fc0-b4c0-0f5b66f9cc1f">3</ix:nonFraction> million. During the six months ended October&#160;29, 2021, there was <ix:nonFraction unitRef="usd" contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTAy_08a9efe1-2847-4352-9ddb-e4b4257a95dd">no</ix:nonFraction> income tax on cumulative translation adjustment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;28, 2022 and October&#160;29, 2021, there were <ix:nonFraction unitRef="usd" contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTkw_89bc4692-04d8-41a7-8316-adde5c890a90"><ix:nonFraction unitRef="usd" contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029" decimals="INF" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTkw_c700cc54-97c5-454f-a2eb-192980b08f32">no</ix:nonFraction></ix:nonFraction> tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, the net change in retirement obligations in other comprehensive income before reclassifications resulted in income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTQyOQ_8459df30-ddfc-4a27-b118-549fdbe1191f">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTY0OTI2NzQ0NDYyMg_5b3295fc-4b2f-480a-9f63-1480c7179a10">2</ix:nonFraction>&#160;million, respectively. During both the six months ended October&#160;28, 2022 and October&#160;29, 2021, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTU3MQ_6b806201-d7e6-4c58-b4b7-e036e5af8ed1"><ix:nonFraction unitRef="usd" contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTU3MQ_9b17eab1-9cc8-4d64-8b03-eae3fe3057f5">7</ix:nonFraction></ix:nonFraction> million. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021&#160;was&#160;an expense of&#160;$<ix:nonFraction unitRef="usd" contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTk5Ng_11ccf151-58db-4517-ad3c-cdc30cbdc812">141</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjAwMw_d27cbf8f-669d-446b-ba3d-0519201758c6">42</ix:nonFraction> million, respectively. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$<ix:nonFraction unitRef="usd" contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjEzMQ_80d68f87-e8dd-4703-a85e-91151ddc2c91">59</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjE3MA_6f9cc167-31d7-42d8-ab4b-011ca144de03">1</ix:nonFraction> million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_88"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMTI5Mzk_4f6b4e90-d314-406f-a128-d3775a587785" continuedAt="ifc511e4094f54ece9e89a3f292f22bd1" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="ifc511e4094f54ece9e89a3f292f22bd1" continuedAt="i4eecc4a985fd43df85d239c04d46c329"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are involved in a number of legal actions from time to time involving product liability, employment, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state, and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#8217;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies certain specified litigation charges and gains related to significant legal matters as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">certain litigation charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. The Company recognized <ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjU5NA_9cb01b81-15e4-462d-9426-0a4f8d326ece">no</ix:nonFraction> certain litigation charges during the three and six months ended October&#160;28, 2022, respectively, whereas the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjY4OQ_fff144e4-3c26-48af-a60d-ce89d7a4c681">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDM5ODA0NjUyNDIxOA_977f430d-db53-427e-8035-8be3d0e2243b">60</ix:nonFraction> million of certain litigation charges during the three and six months ended October&#160;29, 2021, respectively. At October&#160;28, 2022 and April&#160;29, 2022, accrued litigation was approximately $<ix:nonFraction unitRef="usd" contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjc5MQ_83aff16d-2087-41ba-9ba8-004e888d388e"><ix:nonFraction unitRef="usd" contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429" decimals="-8" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjc5MQ_ca4101f7-b2b0-4bd4-a82e-03c9709eae59">0.3</ix:nonFraction></ix:nonFraction>&#160;billion. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4eecc4a985fd43df85d239c04d46c329" continuedAt="i7d5c478b6c1f4f1c9108d838e76dee08"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any given time, the Company is involved in litigation relating to patents, trademarks, copyrights, trade secrets, and other intellectual property (IP) rights, and licenses, acquisitions or other agreements relating to such rights. This litigation includes, but is not limited to, alleged infringement or misappropriation of IP rights, or breach of obligations related to IP rights, or other claims asserted by competitors, individuals, or, consistent with a growing trend across technology-intensive industries, other entities created specifically to fund IP litigation. While the outcome of these litigation matters is inherently uncertain, it is possible that the results of such litigation could require the Company to pay significant monetary damages and/or royalty payments, and negatively impact the Company's ability to sell current or future products, which could have a material adverse impact on the Company's business, results of operations, financial condition, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pelvic Mesh Litigation</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. <ix:nonFraction unitRef="subsidiary" contextRef="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028" decimals="INF" name="mdt:LossContingencyNumberofSubsidiaries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMzc0MA_4f072377-5072-4dac-8777-bbc0aaf834dd">Two</ix:nonFraction> subsidiaries of Covidien supplied pelvic mesh products to <ix:nonFraction unitRef="manufacturer" contextRef="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028" decimals="INF" name="mdt:LossContingencyNumberofManufacturers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMzgwMQ_109607db-bccd-469d-a797-f0bf109f11f7">one</ix:nonFraction> of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $<ix:nonFraction unitRef="usd" contextRef="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDI5Mw_674f11d3-0697-426c-88b9-5cfd67f7fc5e">121</ix:nonFraction>&#160;million towards the settlement of <ix:nonFraction unitRef="claim" contextRef="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429" decimals="-3" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDMyMg_281d69a6-48c2-43dc-b39d-59b39c4dc257">11,000</ix:nonFraction> of these claims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional <ix:nonFraction unitRef="claim" contextRef="id7f39f4a31bc4c9a9b552b6baf0224b9_D20170501-20170531" decimals="-3" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDQ0Mw_92b1dfb5-04eb-4313-ab25-0991e6ca6b32">5,000</ix:nonFraction> claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#8217;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately <ix:nonFraction unitRef="claimant" contextRef="i3323d48e49714e21a2aa0924d7d7fd8e_I20221028" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDgxNg_5c051a9a-2ce0-4eea-8e08-b497bba3ec49">16,200</ix:nonFraction> claimants have asserted or may assert claims involving products manufactured by Covidien&#8217;s subsidiaries. As of November 2, 2022, the Company had reached agreements to settle approximately <ix:nonFraction unitRef="claim" contextRef="ie8ade720172b41b4909dc7e2c1b1d88e_D20221102-20221102" decimals="-2" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTAwNQ_7774b63d-3e93-4e93-ba75-83e222929a42">15,900</ix:nonFraction> of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hernia Mesh Litigation</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting in fiscal year 2020, plaintiffs began filing lawsuits against certain subsidiaries of the Company in U.S. state and federal courts that allege personal injury from hernia mesh products sold by those subsidiaries. As of November 10, 2022, subsidiaries of the Company have been named as defendants in lawsuits filed on behalf of approximately <ix:nonFraction unitRef="plantiff" contextRef="if898f1e4a80d473cabc86d838cccee2e_D20221110-20221110" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTUwMw_f1244075-0c1e-4497-80a5-26c8d4037ded">6,050</ix:nonFraction> individual plaintiffs, and certain plaintiffs&#8217; law firms have advised the Company that they may file additional cases in the future. Approximately <ix:nonFraction unitRef="plantiff" contextRef="i8380ebe92e864b56ae1b2c2197ab9fa3_D20221110-20221110" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTY1Mw_238170d2-c4e5-453c-b423-46d17b00515d">5,600</ix:nonFraction> plaintiffs have filed lawsuits in a coordinated proceeding in Massachusetts state court, where they have been consolidated before a single judge. Approximately <ix:nonFraction unitRef="plantiff" contextRef="i02d1ebdd9f994625a9014f70c6861e5c_D20221110-20221110" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTgxNg_0f47de5a-db4a-4120-be47-12257f6df83f">350</ix:nonFraction> plaintiffs have filed lawsuits in a coordinated action in Minnesota state court, and there are approximately <ix:nonFraction unitRef="claim" contextRef="i30a6362b35d847688440a2d5375ea168_I20221110" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTkyOA_7340110e-630d-432a-8964-80bc64e26a3f">90</ix:nonFraction> actions coordinated in a federal Multidistrict Litigation in the U.S. District Court for the District of Massachusetts. The pending lawsuits relate almost entirely to hernia mesh products that have not been subject to recalls, withdrawals, or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable and reasonably estimable. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Proceedings</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a successor to a company which owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of <ix:nonFraction unitRef="landfill" contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028" decimals="INF" name="mdt:SiteContingencyNumberofLandfillsRequiringRemoval" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzc5NQ_4752ab07-7612-473b-8f84-666f386ac3e2">two</ix:nonFraction> landfills, capping of the remaining <ix:nonFraction unitRef="landfill" contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028" decimals="INF" name="mdt:SiteContingencyNumberOfLandfillsRequiringCapping" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzgzNA_e1c87673-ad58-483c-b926-923e35bebe95">three</ix:nonFraction> landfills, installation of a groundwater extraction system and long-term monitoring of the site and the <ix:nonFraction unitRef="landfill" contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028" decimals="INF" name="mdt:SiteContingencyNumberOfLandfillsRequiringCapping" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzk0MQ_497b00a1-bba1-40f8-b4b0-1bfa009a017d">three</ix:nonFraction> remaining landfills. The Company has proceeded with remediation in accordance with the MDEP order as modified by the Maine Board order. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#8217;s Alliance. Plaintiffs sought an injunction requiring the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7d5c478b6c1f4f1c9108d838e76dee08"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a trial in March 2002, the court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#8217;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. In March 2021, the parties notified the court that they had agreed on a settlement in principle of all issues in this matter. Following conditional approval of the settlement by the court in August 2022, in September 2022 the parties filed a joint motion for final approval by the court. The conditional court approval did not result in a change to the Company's previous accrual for this matter. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court (Tax Court) reviewed this dispute, and in June 2016, issued an opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006 whereby it generally rejected the IRS&#8217;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. In April 2017, the IRS filed a Notice of Appeal to the U.S. Court of Appeals for the Eighth Circuit regarding the Tax Court opinion. Oral argument for the Appeal occurred in March 2018. The U.S. Court of Appeals issued its opinion in August 2018 and remanded the case back to the Tax Court for additional factual findings, which it concluded in June 2021. The Tax Court issued its opinion on August 18, 2022, and it remains subject to appeal by either or both parties. At this time, the Company is evaluating whether to file an appeal.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IRS has issued its audit reports on Medtronic, Inc. for fiscal years 2007 through 2016. Medtronic, Inc. and the IRS have reached agreement on all significant issues except for the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court matter for fiscal years 2005 and 2006.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic, Inc.&#8217;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covidien LP (a wholly owned subsidiary of Medtronic plc) has either reached agreement with the IRS or the statute of limitations has lapsed on its U.S. federal income tax returns through fiscal year 2018.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional discussion of income taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#8217; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#8217;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div></ix:continuation><div id="i3900fafdc57a4da3bf71572260ed33b5_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg1Mg_d21a989d-0876-4f38-876c-f38b908884e4" continuedAt="ic3daebdcdd97477ead6038d33678a398" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3daebdcdd97477ead6038d33678a398" continuedAt="i5c72bc7e223241558397f588537af4ce">Segment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. The Company&#8217;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medtronic plc</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i5c72bc7e223241558397f588537af4ce"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the reportable segments during the quarter ended October&#160;28, 2022. The Company's <ix:nonFraction unitRef="portfolio" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="0" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTEzNg_558b603c-21d6-4708-8c68-dc8b6c3abac6"><ix:nonFraction unitRef="portfolio" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="0" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTEzNg_ea3dea4f-135b-439b-ac8b-35cf451b8cc3">four</ix:nonFraction></ix:nonFraction> principal operating and reportable segments are as follows: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. </span></div><ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg3MQ_21e71863-7092-430f-aadf-221e1a4c794c" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i168eaf54a32a4b10ae055d1fd309420b_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi0xLTEtMS0xMTk4Njg_84f8873c-0139-4fb2-b30c-32ae6e646d8e">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c68c9b8053c4e069d0d10d554ee743e_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi0zLTEtMS0xMTk4Njg_d94c8a7e-e8b8-4eb4-9881-f13374049dbb">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69a634b3ac7e4a93bcc654038f139554_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi01LTEtMS0xMTk4Njg_8eb8b64a-b379-41fd-8351-2d83cc38b618">2,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19bc2cc12e847f686364b13145bcfa2_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi03LTEtMS0xMTk4Njg_0f7e6101-50e5-4717-add4-657c01a51b7b">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i149726acb078405a812214d92610bf74_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy0xLTEtMS0xMTk4Njg_9136fb5c-0a1e-4b3b-a004-c86dbd9ce1df">714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ae48a92e344d458bdf1af7ef9dfb83_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy0zLTEtMS0xMTk4Njg_cbae718c-694f-4226-bae9-6c08f14de9a2">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70e9b68daa7e476b86394d75a37314c8_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy01LTEtMS0xMTk4Njg_593217a6-cc82-4c3c-b3b1-ee8ee0ea2ad4">1,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4db2d7938ece4d1188f55fb0d90ed8ca_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy03LTEtMS0xMTk4Njg_d06172bd-8d0f-4136-bdd9-999177aff39c">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if684219172ea489d828654ce6bda19c7_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC0xLTEtMS0xMTk4Njg_da2195b9-30c1-464a-80bd-8ff288681837">876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88ac8796d2b4f16995fb97c31c6448e_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC0zLTEtMS0xMTk4Njg_2945e010-b348-4f94-92be-91f5affd17b4">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dbc31eff45b4bfa9d8c0fbeda13eb34_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC01LTEtMS0xMTk4Njg_9b764f08-dece-458c-84f9-10489abd13c1">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f69ab25f0944c209d12b73a3e7b2556_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC03LTEtMS0xMTk4Njg_fd2aa4c4-b1fe-4060-8ba9-9be763a4d71c">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb28ceec1a245729e4603a23ff55bf9_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS0xLTEtMS0xMTk4Njg_23218a6c-fab8-4dd1-9ae6-9e5f78918461">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ff869d0a4a41f786d7d359f94cb14c_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS0zLTEtMS0xMTk4Njg_05480084-11b1-4935-a3ed-ed38fee54634">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3857837c700c47ee90158dd782777f47_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS01LTEtMS0xMTk4Njg_0fc81a31-7833-43c0-9296-1fd9c763a175">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b877f4e5a4a5f80879a1c21a2d977_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS03LTEtMS0xMTk4Njg_9613da80-3136-4474-bc7b-ef28d187d0bd">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ff2bf6f8a94d3e97118363d9a224a2_D20220730-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi0xLTEtMS0xMTk4Njg_34e308e7-71bf-42ba-8099-7e4f036f83c6">2,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a6af4191c704ad28f09d2139ee771bb_D20210731-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi0zLTEtMS0xMTk4Njg_6bab31aa-bbab-4121-ab47-8da04d6c57aa">3,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c477f464714ac1be4ba61e84a7fe9a_D20220430-20221028" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi01LTEtMS0xMTk4Njg_e9f4f209-5867-48ce-b5b6-400a5a41c91f">5,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5da000fddfa54c00b738a9d7fa43607b_D20210501-20211029" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi03LTEtMS0xMTk4Njg_57a3ab13-f4ca-4e79-81c0-884d41542001">6,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy0xLTEtMS0xMTk4Njg_3dd523cb-d818-4760-9f11-677232cf0bdf">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy0zLTEtMS0xMTk4Njg_b6fc18db-00e8-4fe3-a4a1-b82bb3164b3f">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy01LTEtMS0xMTk4Njg_6c9097ee-0a35-4688-800c-7cd4719afef3">282</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy03LTEtMS0xMTk4Njg_a966a41f-bc5a-4a2e-bd65-a144b54f504f">273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC0xLTEtMS0xMTk4Njg_586b3ad1-5b0c-4c0d-a730-4d375f292ec2">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC0zLTEtMS0xMTk4Njg_d9e8d2bf-940e-4891-b2b4-ffe41c3e4cbc">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC01LTEtMS0xMTk4Njg_345d69d0-fcd8-454e-a131-abebfea94de8">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC03LTEtMS0xMTk4Njg_b403a678-cb2e-4855-bf00-71fe1a8c098a">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS0xLTEtMS0xMTk4Njg_3c7371df-4e7a-4a2b-8428-85c6e88884e5">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS0zLTEtMS0xMTk4Njg_0b978fa7-bf0e-4d8d-b52a-530bb2ba80ed">431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS01LTEtMS0xMTk4Njg_05816836-68bf-4250-aaee-1191a81e6c0e">844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS03LTEtMS0xMTk4Njg_0a24bf9b-008a-492a-b35a-ba7ca2fd06d4">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtMS0xLTEtMTE5ODY4_cd546c46-cda0-4941-8793-9ccc3841153c">402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtMy0xLTEtMTE5ODY4_53940a05-958b-4721-865e-7230cbd1e9f1">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtNS0xLTEtMTE5ODY4_4300e103-9aa9-4fd1-86e3-4d4309781383">816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="mdt:CorporateOverhead" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtNy0xLTEtMTE5ODY4_c11cfc04-3e9b-43ab-b924-8f9feaec9b99">864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtMS0xLTEtMTE5ODY4_4f79d9f6-6d0e-4a47-9e90-33e5fb6cc0c5">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtMy0xLTEtMTE5ODY4_0f6542a9-d863-4b1c-8bfd-acaa09b8fb71">516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtNS0xLTEtMTE5ODY4_75f090c7-6903-455d-9c85-767304d10ffb">622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="mdt:CentralizedDistributionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtNy0xLTEtMTE5ODY4_32490803-8722-42c7-a4cb-8ee65812fc99">981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if121f0c93f2542b787d18dc65313b4ec_D20220730-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItMS0xLTEtMTE5ODY4_4d0453c0-14be-4805-aa7e-c391cf584506">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie20fd350e6d74274a06ac9c4f5a4d7f1_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItMy0xLTEtMTE5ODY4_4cc38b25-0ca6-4b88-8e94-500ff1e77ce2">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03ff4fbd770e476a93fac4538e7a739a_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItNS0xLTEtMTE5ODY4_2774e65f-6aa5-42ca-bfe1-21e61740450c">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida7e46384f064832b227315992afe5e9_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItNy0xLTEtMTE5ODY4_4aa146e6-5286-42a9-8add-a99f27c789c3">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtMS0xLTEtMTE5ODY4_72b85c73-3586-4558-a40b-60b65b03974d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" sign="-" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtMy0xLTEtMTE5ODY4_7cfb179f-1f81-4aa8-bb5f-95fd7e82f6c5">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtNS0xLTEtMTE5ODY4_ca7f0253-46d6-43f0-a75e-e0fe2b061046">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtNy0xLTEtMTE5ODY4_9a627c67-b4b5-40eb-b37c-657821477cc5">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtMS0xLTEtMTE5ODY4_7baecc29-5f4e-4a76-a4ac-0d70e4d9b6a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtMy0xLTEtMTE5ODY4_75dde7f5-95f9-4302-9384-3b0aac24bff3">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtNS0xLTEtMTE5ODY4_6ad0b124-265f-49c2-8b8b-eed354e04070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtNy0xLTEtMTE5ODY4_bc66ea80-de40-4a29-87b6-7cccda6c0b86">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCS impairments / costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifec30626328141edab3ec5e1fd7fad30_D20220730-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtMS0xLTEtMTE5ODY4_cb7ff636-c109-41d5-a4e1-3f6edce9e8c9">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied00ece93e9e4688918b205b9ade91fc_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtMy0xLTEtMTE5ODY4_14883cd9-099b-4d89-a985-e7c3d21f402e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i827544a4779342aca7ddd0cc9e3e3373_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtNS0xLTEtMTM1MTc4_57aeb622-75a8-49e5-adb5-b4a6c569fad8">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b62391f8b8740d7bb9d8216c3714f9e_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtNy0xLTEtMTM1MTc4_bab4754c-64ca-406c-827a-86fbfaafa2b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS impairments / costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4de15689258429f96c8aede9acd4189_D20220730-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtMS0xLTEtMTE5ODY4_8bc41500-1e71-4170-bd11-24d2aad34838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1297ee8d0604a979f5928e67af71318_D20210731-20211029" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtMy0xLTEtMTE5ODY4_cf9a3814-61ea-4b32-ad28-5be0d22a4e9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0d54845eef646a0b6664bce4c66a85d_D20220430-20221028" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtNS0xLTEtMTE5ODY4_0d8c45e8-1428-4cd5-94ad-d3fefa548cdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0de2e2a292af422b8f366ef645be1066_D20210501-20211029" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtNy0xLTEtMTE5ODY4_acf7ff46-1bfe-40df-8633-8365863df1a8">726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctMS0xLTEtMTE5ODY4_6f4dfdc7-c0d8-498b-98a4-1231d8df55c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctMy0xLTEtMTE5ODY4_c7c9e41c-4d02-4114-b553-7fdf5fd5cb36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctNS0xLTEtMTM1OTgy_c3d2e83f-08ef-461f-8f0d-b362c3297a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctNy0xLTEtMTM1OTgy_79829eb7-f43a-49d6-b0d6-03bf8851df0f">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtMS0xLTEtMTE5ODY4_2f5a7c7b-e558-4e46-8651-d92b6fc4dfbe">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtMy0xLTEtMTE5ODY4_ef473a9e-a018-4d75-878c-7e101450f995">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtNS0xLTEtMTE5ODY4_10561799-cfab-47dd-a77c-ab7c4c534cbe">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="mdt:MedicalDeviceRegulations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtNy0xLTEtMTE5ODY4_9d31ece6-7089-4c75-8d20-c84d221e62a4">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMS0xLTEtMTM1MjAx_8913af93-8ef5-4420-8d85-04baafad062e">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMy0xLTEtMTM1MjAx_ac8b50aa-0a0e-43df-add9-dd277b8e1056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNS0xLTEtMTM1MjAx_a354bf38-2741-4067-b163-97c3d1353fd7">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNy0xLTEtMTM1MjAx_25ff1980-2c46-45a3-9f08-d0355924f8d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMS0xLTEtMTE5ODY4_4184cc75-a7ca-4744-adf9-875b6309532c">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMy0xLTEtMTE5ODY4_037e76a1-d88a-459d-a0ac-dccc5abbe4c3">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNS0xLTEtMTE5ODY4_657b9804-fd15-4361-9050-a142e487d046">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNy0xLTEtMTE5ODY4_76f98ea4-2faa-4553-94fe-33895dd59a43">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. <ix:nonNumeric contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg1Nw_17b28aa1-b921-46f8-a38c-35daa3ca7372" continuedAt="ie35c53b360f4426d823797cbb1092473" escape="true">The following table presents net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 for the Company's country of domicile, countries with significant concentrations, and all other countries:</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><ix:continuation id="ie35c53b360f4426d823797cbb1092473"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52660540190940b693d1bd02d12d492a_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi0xLTEtMS0xMTk4Njg_41a25ac1-da59-409d-8e55-efb33d13e1e5">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46769724c574bac915cd348f37fcf2d_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi0zLTEtMS0xMTk4Njg_a7b671f8-e95e-4282-9b1c-60ebf37cba61">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214e01a959c846e88851e34cc42dc32b_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi01LTEtMS0xMTk4Njg_a30eee93-1e24-4aa9-8f72-e1d04466ed64">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaeb28a3e4b44b1fa4ad70e8b96300c1_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi03LTEtMS0xMTk4Njg_ae132ad0-a550-4f02-b192-369d1616f879">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC0xLTEtMS0xMTk4Njg_029f8403-4e87-4784-853b-3136c05ddd04">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC0zLTEtMS0xMTk4Njg_f47136d1-3acd-4948-8544-1c64568f68af">3,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC01LTEtMS0xMTk4Njg_d3385d6a-cc40-4056-9786-a2e87470022f">7,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC03LTEtMS0xMTk4Njg_e3f30091-d527-45a5-b2ec-6e95af0b1eb0">8,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa56bae6c344578b698d10d544eafe8_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS0xLTEtMS0xMTk4Njg_0e16affb-895a-475e-b99f-77d3c4053c18">3,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5224032c63584bec8b1b1523947f71dd_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS0zLTEtMS0xMTk4Njg_e047702f-a676-4605-8b2f-acc866d95e34">3,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8120e40de324a48a75b99dadc77ac4d_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS01LTEtMS0xMTk4Njg_57beb005-77ec-4f68-9b31-75384a6d6a15">7,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eaeba13607d4490a06e297131324140_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS03LTEtMS0xMTk4Njg_4eace995-847a-4030-adc4-70fb499e93ee">7,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib88c0c1ed9ab49caa522738259c03475_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi0xLTEtMS0xMTk4Njg_d4cc4a89-4274-456c-8cb9-cf7f52572e76">7,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52482a063c8a45dfaeab8842374cd025_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi0zLTEtMS0xMTk4Njg_74367cc8-ae64-4556-9c8b-e606a857abbf">7,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia092a03ef5384e598bb50ffc1990cce7_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi01LTEtMS0xMTk4Njg_de995aed-b913-48f6-95fa-239246b5d44a">14,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba3d02155da748508b967c01e3e9fc3f_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi03LTEtMS0xMTk4Njg_6a2b71e7-5a2a-4feb-9f45-17a89a352fc2">15,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy0xLTEtMS0xMTk4Njg_bf4a8b75-b885-4a87-b23b-ec35733aaee5">7,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy0zLTEtMS0xMTk4Njg_ceb94694-89cb-462b-83f5-234b564090b2">7,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy01LTEtMS0xMTk4Njg_b2e12a8d-02cc-4a4d-a9e2-0c9f978389e9">14,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy03LTEtMS0xMTk4Njg_7b207544-a6b7-4fda-8f0f-66cdd831a6ab">15,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_100"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDERSTANDING OUR FINANCIAL INFORMATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company, or we, us, or our). For a full understanding of financial condition and results of operations, you should read this discussion along with Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended April&#160;29, 2022. In addition, you should read this discussion along with our consolidated financial statements and related notes thereto at and for the three and six months ended October&#160;28, 2022. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Trends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this Management&#8217;s Discussion and Analysis, we present certain financial measures that facilitate management's review of the operational performance of the Company and as a basis for strategic planning; however, such financial measures are not presented in our financial statements prepared in accordance with accounting principles generally accepted in the United States (U.S.) (U.S. GAAP). These financial measures are considered "non-GAAP financial measures" and are intended to supplement, and should not be considered as superior to, financial measures presented in accordance with U.S. GAAP. We believe that non-GAAP financial measures provide information useful to investors in understanding the Company's underlying operational performance and trends and may facilitate comparisons with the performance of other companies in the medical technologies industry. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As presented in the GAAP to Non-GAAP Reconciliations section below, our non-GAAP financial measures exclude the impact of certain charges or benefits that contribute to or reduce earnings and that may affect financial trends and include certain charges or benefits that result from transactions or events that we believe may or may not recur with similar materiality or impact to our operations in future periods (Non-GAAP Adjustments). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event there is a Non-GAAP Adjustment recognized in our operating results, the tax cost or benefit attributable to that item is separately calculated and reported. Because the effective rate can be significantly impacted by the Non-GAAP Adjustments that take place during the period, we often refer to our tax rate using both the effective rate and the non-GAAP nominal tax rate (Non-GAAP Nominal Tax Rate). The Non-GAAP Nominal Tax Rate is calculated as the income tax provision, adjusted for the impact of Non-GAAP Adjustments, as a percentage of income before income taxes, excluding Non-GAAP Adjustments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a non-GAAP financial measure calculated by subtracting property, plant, and equipment additions from operating cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the &#8220;GAAP to Non-GAAP Reconciliations," "Income Taxes," and "Free Cash Flow" sections for reconciliations of the non-GAAP financial measures to their most directly comparable financial measures prepared in accordance with U.S. GAAP.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_103"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE LEVEL OVERVIEW</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic is the leading global healthcare technology company &#8212; alleviating pain, restoring health, and extending life for millions of people around the world. Our primary products include those for cardiac rhythm disorders, cardiovascular disease, advanced and general surgical care, respiratory and monitoring solutions, renal care, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat, and diabetes conditions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global healthcare system is continuing to respond to the challenges posed by the COVID-19 pandemic ("COVID-19" or the "pandemic"). Several of our businesses continued to be affected by the pandemic, including the impacts of healthcare system staffing shortages on procedural volumes, and, in the first quarter of fiscal year 2023, the COVID-19 lockdowns in China, which continued through the end of May. In addition to the impacts of the pandemic, certain businesses continue to be impacted by supply chain disruptions that began during the fourth quarter of fiscal year 2022. We cannot predict with confidence the duration and severity of the pandemic and its impact on global procedure volumes. We expect medical procedure rates may continue to vary by therapy and country and to be impacted by regional COVID-19 case volumes, vaccine and booster immunization rates, and new COVID-19 variants. Additionally, we cannot predict the impact further healthcare system staffing shortages will have on procedural volumes, and the continued impact certain supply chain disruptions will have on the business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of revenue and diluted earnings per share for the three months ended October&#160;28, 2022 and October&#160;29, 2021, and operating cash flow for the six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><img src="mdt-20221028_g2.jpg" alt="mdt-20221028_g2.jpg" style="height:421px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GAAP to Non-GAAP Reconciliations </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting with the quarter ended April 29, 2022, the Company no longer adjusts non-GAAP financial measures for certain license payments for, or acquisitions of, technology not approved by regulators due to recent industry guidance from the U.S. Securities and Exchange Commission. Historical non-GAAP financial measures presented in this quarterly report have been recast for comparability. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present our GAAP to Non-GAAP reconciliations for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision<br/>(Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCS impairments / costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 29, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include business combination costs and changes in fair value of contingent consideration.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and/or one-time costs, which are limited to a specific time period.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges predominantly relate to changes in the carrying amount of the disposal group and other associated costs, as a result of the anticipated sale of half of the Company's Renal Care Solutions (RCS) business related to the May 25, 2022 agreement with DaVita Inc.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the exit of a business and are primarily comprised of inventory write-downs.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charge primarily relates to a $764 million reserve adjustment that was a direct result of the U.S. Tax Court opinion, issued on August 18, 2022, on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly owned subsidiary operating in Puerto Rico.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charge includes the amortization on previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present our GAAP to Non-GAAP reconciliations for the six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision<br/>(Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCS impairments / costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt redemption premium and other charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended October 29, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Before Income Taxes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income <br/>Tax Provision (Benefit)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Attributable to Medtronic</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diluted EPS</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective <br/>Tax Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain)/loss on minority investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS impairment / costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain tax adjustments, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges primarily include business combination costs and changes in fair value of contingent consideration.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing or future business operations.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges represent incremental costs of complying with the new European Union (E.U.) medical device regulations for previously registered products and primarily include charges for contractors supporting the project and other direct third-party expenses. We consider these costs to be duplicative of previously incurred costs and/or one-time costs, which are limited to a specific time period. </span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges predominantly include non-cash pre-tax impairments, primarily related to goodwill, and other associated costs, as a result of the anticipated sale of half of the Company's Renal Care Solutions (RCS) business related to the May 25, 2022 agreement with DaVita Inc.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the early redemption of approximately $2.3 billion of debt and were recorded within interest expense within the consolidated statements of income.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the exit of a business and are primarily comprised of inventory write-downs.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charge primarily relates to a $764 million reserve adjustment that was a direct result of the U.S. Tax Court opinion, issued on August 18, 2022, on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly owned subsidiary operating in Puerto Rico.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The charges relate to the Company&#8217;s June 2021 decision to stop the distribution and sale of the Medtronic HVAD System within the Mechanical Circulatory Support Operating Unit (MCS). The charges included $515 million of non-cash impairments, primarily related to $409&#160;million of intangible asset impairments, as well as $211 million for commitments and obligations in connection with the decision, including customer support </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">obligations, restructuring, and other associated costs. Medtronic is committed to serving the needs of the patients currently implanted with the HVAD System.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">The charge is associated with a change in the company&#8217;s permanently reinvestment assertion on certain historical earnings and the amortization on previously established deferred tax assets from intercompany intellectual property transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow, a non-GAAP financial measure, is calculated by subtracting additions to property, plant, and equipment from net cash provided by operating activities. Management uses this non-GAAP financial measure, in addition to U.S. GAAP financial measures, to evaluate our operating results. Free cash flow should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with U.S. GAAP. Reconciliations between net cash provided by operating activities (the most comparable U.S. GAAP measure) and free cash flow are as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to property, plant, and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the Summary of Cash Flows section for drivers of the change in cash provided by operating activities.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET SALES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment and Division</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below illustrate the percent of net sales by segment for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20221028_g3.jpg" alt="mdt-20221028_g3.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/><img src="mdt-20221028_g4.jpg" alt="mdt-20221028_g4.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Heart &amp; Aortic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Peripheral Vascular </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Segment and Market Geography </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below illustrate the percent of net sales by market geography for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20221028_g5.jpg" alt="mdt-20221028_g5.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/><img src="mdt-20221028_g6.jpg" alt="mdt-20221028_g6.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes net sales by market geography for each of our segments for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.866%"><tr><td style="width:1.0%"></td><td style="width:16.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decline in net sales for three and six months ended October&#160;28, 2022, as compared to the corresponding period in the prior fiscal year, was driven primarily by unfavorable currency impact and supply chain challenges in certain businesses, particularly in the first quarter of fiscal year 2023. For the three months ended October&#160;28, 2022, currency had an unfavorable impact on emerging markets and non-U.S. developed markets of $66&#160;million and $390&#160;million, respectively. For the six months ended October&#160;28, 2022, currency had an unfavorable impact on emerging markets and non-U.S. developed markets of $101&#160;million and $705&#160;million, respectively. The decline in net sales for the three and six months ended October 28, 2022 was partially offset by growth in certain product lines, including Transcatheter Aortic Valve replacements (TAVR), Core Spine in the U.S., and Diabetes in international markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking ahead, a number of macro-economic and geopolitical factors could negatively impact our business, including without limitation: </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Competitive product launches and pricing pressure, geographic macro-economic risks including fluctuations in currency exchange rates, general price inflation, rising interest rates, reimbursement challenges, impacts from changes in the mix of our product offerings, delays in product registration approvals, and replacement cycle challenges; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">National and provincial tender pricing for certain products, particularly in China;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The uncertain and uneven impact of COVID-19 on future procedural volumes, supply constraints including certain electronic components and semiconductors, healthcare staffing, and resulting impacts on demand for our products and therapies; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The potential impact that sanctions and other measures being imposed in response to the Russia-Ukraine conflict could have on revenue and supply chain. The financial impact of the conflict in the second quarter of fiscal year 2023, including on accounts receivable and inventory reserves, was not material, and for the three and six months ended October&#160;28, 2022, the business of the Company in these countries represented less than 1% of the Company's consolidated revenues and assets. Although the implications of this conflict are difficult to predict at this time, the ongoing conflict may increase pressure on the global economy and supply chains, resulting in increased future volatility risk for our business operations and performance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cardiovascular</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiovascular products include pacemakers, insertable cardiac monitors, cardiac resynchronization therapy devices, implantable cardioverter defibrillators (ICD), leads and delivery systems, electrophysiology catheters, products for the treatment of atrial fibrillation, information systems for the management of patients with Cardiac Rhythm &amp; Heart Failure devices, products designed to reduce surgical site infections, coronary and peripheral stents and related delivery systems, balloons and related delivery systems, endovascular stent graft systems, heart valve replacement technologies, cardiac tissue ablation systems, and open heart and coronary bypass grafting surgical products. Cardiovascular also includes Care Management Services and Cath Lab Managed Services (CLMS) within the Cardiac Rhythm &amp; Heart Failure division. Cardiovascular's net sales for the three and six months ended October&#160;28, 2022 were $2.8 billion and $5.5 billion, respectively, a decrease of 2 percent and 4 percent, respectively, compared to the corresponding periods in the prior fiscal year. Currency had an unfavorable impact of $177 million and $315 million on net sales for the three and six months ended October&#160;28, 2022. The net sales decrease for both periods was primarily driven by unfavorable currency impact and supply chain challenges in certain businesses. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Cardiovascular net sales by division for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div><span><br/></span></div><div style="margin-top:8pt;text-align:center"><img src="mdt-20221028_g7.jpg" alt="mdt-20221028_g7.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/><img src="mdt-20221028_g8.jpg" alt="mdt-20221028_g8.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiac Rhythm &amp; Heart Failure (CRHF) net sales for the three and six months ended October&#160;28, 2022 decreased 3 percent and 4 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The net sales declines were driven by unfavorable currency partially offset by increases from continued adoption of Micra AV, TYRX antibacterial envelopes, and LINQ II implants. Additionally, Cardiac Ablation Solutions net sales for the six months ended October&#160;28, 2022 were negatively impacted by competitive pressures in Western Europe and Japan, as well as the pending volume-based procurement (VBP) in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Structural Heart &amp; Aortic (SHA) net sales for the three and six months ended October&#160;28, 2022 increased 1 percent and decreased 3 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The net sales for both periods were impacted by unfavorable currency. The net sales for both periods were also impacted by growth in transcatheter aortic valve replacement (TAVR), surgical valves therapies, and perfusion systems. For the three months ended October&#160;28, 2022, Aortic experienced growth due to lessening impacts from previous supply chain challenges. Net sales for the six months ended October&#160;28, 2022 were also impacted by a field corrective action with the Harmony Transcatheter Pulmonary Valve and Delivery Catheter System, staffing shortages, and supply shortages of contrast. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Coronary &amp; Peripheral Vascular (CPV) net sales for the three and six months ended October&#160;28, 2022 decreased 4 percent and 5 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The net sales declines were driven by unfavorable currency, partially offset by strong demand combined with improved product availability of the SpiderFX embolic protection device (EPD) and strong performance of our superficial venous product portfolio, including the VenaSeal system. Coronary &amp; Renal Denervation also experienced growth driven by Coronary Balloons and the launch of the Onyx Frontier DES platform in the U.S. Net sales for the six months ended October&#160;28, 2022 were also impacted by market procedural volumes in Coronary remaining below pre-COVID levels in several major </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">markets, headwinds related to U.S. hospital contrast shortages early in the first quarter of fiscal year 2023, and declines in Peripheral Vascular Health due to competitors re-entering the market and supply chain challenges.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the macro-economic and geopolitical factors described in the Executive Level Overview, looking ahead, we expect Cardiovascular could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth of our Micra transcatheter pacing system. The Micra AV launched in Japan in November 2021 and China in August 2022. Micra AV expands the Micra target population from 15 percent to 45 percent of pacemaker patients.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from the Azure XT and S SureScan pacing systems and the 3830 lead. Azure pacemakers feature Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless remote monitoring with increased device longevity. The 3830 lead, previously labeled for His bundle pacing, has now been expanded to include left bundle branch area pacing. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Growth of the Cobalt and Crome portfolio of ICDs and CRT-Ds. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and expansion of the Claria MRI CRT-D system with AdaptivCRT and compatibility with TriageHF technology.</span></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and expansion of the LINQ II cardiac monitor. During the third quarter of fiscal year 2022, we launched two AccuRhythm AI algorithms on the LINQ II platform to significantly reduce false positive alerts for Atrial Fibrillation and Pause while retaining sensitivity for true positive detection and reduce clinic workload and burden. AccuRhythm AI launched in Europe during the first quarter of fiscal year 2023.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Growth of the CRT-P quadripolar pacing system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth, adoption, and utilization of the TYRX Envelope for implantable devices.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth of Arctic Front cryoablation for treatment of atrial fibrillation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the self-expanding CoreValve Evolut transcatheter aortic valve replacement platform. This includes Evolut PRO which provides enhanced hemodynamics, reliable delivery, enhanced durability, advanced sealing, and Evolut FX, a system designed to improve the overall procedural experience through enhancements in deliverability, implant visibility, and deployment stability.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued expansion and training of field support to increase coverage in the U.S. centers performing TAVR procedures.</span></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Onyx Frontier DES platform. The platform launched in the U.S. in the first quarter of fiscal year 2023 and in select international countries in the second quarter of fiscal year 2023. Onyx Frontier is a drug-eluding stent (DES) that introduces an enhanced delivery system and is used for complex percutaneous coronary intervention (PCI).</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth from the VenaSeal Closure System in the U.S. The VenaSeal Closure System is a unique non-thermal solution to address superficial venous disease that provides improved patient comfort, reduces the recovery time, and eliminates the risk of thermal nerve injury.</span></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Acceptance and growth of IN.PACT 018 drug-coated balloons (DCB). The product was launched under limited market release in the first quarter of fiscal year 2023 with full market release expected in the third quarter of fiscal year 2023. IN.PACT 018 is used in endovascular therapies to treat femoropopliteal disease.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Pressure from competitors re-entering the market contributing to the decline in sales of the Abre venous self-expanding stent system. Abre is designed for the unique challenges of venous disease. It offers easy deployment and delivers demonstrated endurance, to give patients freedom of movement. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Strengthening our position in the cardiac ablation technologies market as a result of the August 2022 acquisition of Affera, Inc. The acquisition expands the Cardiovascular segment portfolio of advanced cardiac ablation products and accessories to include its first cardiac mapping and navigation platform to meet physician needs within a growing patient population. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to successfully develop, obtain regulatory approval of and commercialize the products within our pipeline, which include, but not limited to, the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, a novel energy source that is non-thermal and Aurora Extravascular ICD.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical Surgical </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Surgical&#8217;s products span the entire continuum of patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. The products include those for advanced and general surgical products, surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, advanced ablation, interventional lung, ventilators, airway products, renal care products, and sensors and monitors for pulse oximetry, capnography, level of consciousness and cerebral oximetry. Medical Surgical's net sales for the three and six months ended October&#160;28, 2022 were $2.1 billion and $4.1 billion, respectively, a decrease of 10 percent and 12 percent, respectively, compared to the corresponding periods in the prior fiscal year. Currency had an unfavorable impact of $149&#160;million and $264 million on net sales for the three and six months ended October&#160;28, 2022, respectively. The net sales decrease for both periods was primarily driven by unfavorable currency impact, supply chain disruptions particularly in Surgical Innovations, provincial volume-based procurement (VBP) stapling tenders in China, and a decline in ventilator sales due to the high COVID-19 demand in the corresponding period in the prior fiscal year.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Medical Surgical net sales by division for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-top:8pt;text-align:center"><img src="mdt-20221028_g9.jpg" alt="mdt-20221028_g9.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/><img src="mdt-20221028_g10.jpg" alt="mdt-20221028_g10.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Innovations (SI) net sales for the three and six months ended October&#160;28, 2022 decreased 7 percent and 10 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The decrease for the three months ended October&#160;28, 2022 was attributable to slower than expected procedure volumes, and declines in Advanced Stapling primarily driven by provincial VBP stapling tenders in China, partially offset by growth in Hernia and Wound Management due to supply chain recoveries. The decrease for the six months ended October&#160;28, 2022 was led by Advanced Surgical Instruments, driven by global supply chain challenges, including resins, semiconductors, and packaging trays, which impacted energy and stapling products, and provincial VBP stapling tenders and COVID-19 lockdowns in China.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respiratory, Gastrointestinal, &amp; Renal (RGR) net sales for the three and six months ended October&#160;28, 2022 decreased 16 percent and 15 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The decrease for three and six months ended October&#160;28, 2022 was largely due to declines in ventilator demand when compared to the corresponding period in the prior fiscal year as demand dropped below pre-pandemic levels. Pulse oximetry products also contributed to the decrease, driven by lower COVID-19 related utilization compared to the prior period.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the macro-economic and geopolitical factors described in the Executive Level Overview, looking ahead we expect Medical Surgical could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The pending separation of the combined Patient Monitoring and Respiratory Interventions businesses from the Medical Surgical Portfolio. The Company announced its intention to pursue a separation in October 2022 and expects to complete the separation 12 to 18 months from the announcement date.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The pending contribution of our Renal Care Solutions business as a result of the May 25, 2022 definitive agreement with DaVita Inc.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Acceptance and continued growth of Open-to-MIS (minimally invasive surgery) techniques and tools through our efforts to transition open surgery to MIS. Open-to-MIS initiative focuses on capturing the market opportunity that exists in transitioning open procedures to MIS, whether through traditional MIS, advanced instrumentation, or robotics. Through our approach, in parallel, we also expand our presence and optimize open surgery in current open surgery markets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued global acceptance and future growth of powered stapling and energy platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to execute ongoing strategies addressing the competitive pressure of reprocessing vessel sealing disposables and growth of our surgical soft tissue robotics procedures in the U.S.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to create markets and drive products and procedures into emerging markets with our high quality and cost-effective surgical products designed for customers in emerging markets. An example is our ValleyLab LS10 single channel vessel sealing generator, which is compatible with our line of LigaSure instruments and designed for simplified use and affordability.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Acceptance of less invasive standards of care in gastrointestinal and hepatology products, including products that span the care continuum from diagnostics to therapeutics. Recently launched products include GI Genius and PillCam capsule endoscopy.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Expanding the use of less invasive treatments and furthering our commitment to improving options for women with abnormal uterine bleeding. Our expanded and strengthened surgical offerings complement our global gynecology business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Global adoption of robotic-assisted surgery and installations of Hugo robotic assisted surgery (RAS) system for urologic, bariatric, gynecologic, and general surgery procedures. This includes continued integration and adoption of Touch Surgery Enterprise with the first artificial intelligence powered surgical videos and analytics platform to make it easier to train and discover new techniques within the robotics platform. The Hugo RAS system, which received CE Mark in October 2021, as well as secured additional regulatory approvals outside the U.S., is designed to help reduce unwanted variability, improve patient outcomes, and, by extension, lower per procedure cost.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to successfully develop, obtain regulatory approval of and commercialize the products within our pipeline, which include, but are not limited to, our Hugo RAS system in the U.S., Signia power stapling devices, and our Ligasure and Sonicision vessel sealing devices.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_118"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neuroscience</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neuroscience's products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems, robotic guidance systems used in robot-assisted spine procedures, and systems that incorporate advanced energy surgical instruments. Neuroscience's products also focus on the treatment of overactive bladder, urinary retention, fecal incontinence, as well as products to treat ear, nose, and throat (ENT), and therapies to treat the diseases of the vasculature in and around the brain, including coils, neurovascular stents and flow diversion products. Neuroscience also manufactures products related to implantable neurostimulation therapies and drug delivery systems for the treatment of chronic pain, movement disorders, and epilepsy. Neuroscience&#8217;s net sales for the three and six months ended October&#160;28, 2022 were&#160;$2.2 billion and $4.3&#160;billion, respectively, an increase of 2 percent and a decrease of 1 percent, respectively, compared to the corresponding periods in the prior fiscal year. Currency had an unfavorable impact of $85&#160;million and $149 million on net sales for the three and six months ended October&#160;28, 2022, respectively. The net sales increase for the three months ended October&#160;28, 2022, was primarily due to growth in U.S. Core Spine, ENT, and continued supply risk mitigation, partially offset by unfavorable currency impact. The net sales decrease for the six months ended October&#160;28, 2022, was driven by unfavorable currency impact, supply chain challenges in certain businesses, and prolonged purchasing timelines for large capital. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphs below illustrate the percent of Neuroscience net sales by division for the three months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><img src="mdt-20221028_g11.jpg" alt="mdt-20221028_g11.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/><img src="mdt-20221028_g12.jpg" alt="mdt-20221028_g12.jpg" style="height:360px;margin-bottom:5pt;vertical-align:text-bottom;width:320px"/></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cranial and Spinal Technologies (CST) net sales for the three and six months ended October&#160;28, 2022 increased 1 percent and decreased 3 percent, respectively, as compared to the corresponding periods in the prior fiscal year. For the three months ended October&#160;28, 2022, the growth was driven by increased sales in Core Spine products and strong sales of the Infuse Bone Graft in the U.S. The net sales increase was also attributable to strong sales of StealthStation Navigation and Midas Rex powered surgical instruments. For the six months ended October&#160;28, 2022, the net sales decrease was driven by prolonged customer capital purchasing timelines and Biologics, which experienced decreases in customer ordering patterns, when compared to the corresponding period in the prior fiscal year. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty Therapies (Specialty) net sales for the three and six months ended October&#160;28, 2022 increased 8 percent and 6 percent, respectively, as compared to the corresponding periods in the prior fiscal year. The increase for both periods was driven by growth in hemorrhagic and ischemic stroke, flow diversion and access delivery products. The net sales increase was also driven by benefits from the recent May 2022 acquisition of Intersect ENT. For the six months ended October 28, 2022, the growth in ENT growth was partially offset by supply chain disruption in disposables. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neuromodulation (NM) net sales for the three and six months ended October&#160;28, 2022 decreased 4 percent and 6 percent, respectively, as compared to the corresponding periods in the prior fiscal year. For both periods, declines were largely due to unfavorable currency impacts, healthcare staffing challenges impacting spinal cord stimulation implant volumes and continued supply chain challenges in Interventional. For the three months ended October&#160;28, 2022, there was growth driven by Pain Stim and Targeted Drug Delivery.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the macro-economic and geopolitical factors described in the Executive Level Overview, looking ahead we expect Neuroscience could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth from enabling technologies, including StealthStation and O-arm Imaging Systems, Midas, and ENT Navigation and Power Systems, as well as acceptance of the Stealth Autoguide cranial robotic guidance platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued sales of Mazor robotic units and associated market adoption of robot-assisted spine procedures, including the Mazor X Stealth, our integrated robotics and navigation platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued growth from spine titanium interbody implants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued adoption of our integrated solutions through the Aible offering (formerly Surgical Synergy strategy) which integrates our spinal implants with enabling technologies such as imaging, navigation, power instruments, nerve monitoring, and Mazor robotics, as well as AI-driven surgical planning, personalized spinal implants, and robot-assisted surgery due to the acquired Medicrea technologies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and continued global adoption of innovative new spine products and procedural solutions within our CST division, such as our Infinity OCT System and Prestige LP cervical disc system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Growth in the broader vertebral compression fracture (VCF) and adjacent markets as we continue to pursue the development of other therapies to treat more patients with VCF, including continued success of both the Kyphon V vertebroplasty system and the Osteocool RF Spinal Tumor ablation system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of our ENT and Pelvic Health therapies, including our InterStim therapy with InterStim II, InterStim Micro and InterStim X neurostimulators for the treatment of the symptoms of overactive bladder, urinary retention, and bowel incontinence, and capital equipment sales of the Stealth Station ENT surgical navigation system and intraoperative NIM nerve monitoring system. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Solitaire FR revascularization device for treatment of acute ischemic stroke and the Pipeline Embolization Devices, endovascular treatments for large or giant wide-necked brain aneurysms.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance of our React Catheter and Riptide aspiration system, along with our next-generation Solitaire revascularization device.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and continued global adoption of our Intellis spinal cord stimulator, DTM proprietary waveform, Evolve workflow algorithm, and Snapshot reporting to treat chronic pain in major markets around the world.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of our Percept PC DBS device with BrainSense technology, including its treatment of Parkinson's Disease, epilepsy, and other movement disorders.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and growth from SCS therapy for treating Diabetic Peripheral Neuropathy (DPN) on Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator which received U.S. FDA approval in January 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Ongoing obligations under the U.S. FDA consent decree entered in April 2015 relating to the SynchroMed drug infusion system and the Neuromodulation quality system. The U.S. FDA lifted its distribution requirements on our implantable drug pump in October 2017 and its warning letter in November 2017.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Strengthening our position in the ear, nose and throat market as a result of the May 2022 acquisition of Intersect ENT, a global ear, nose and throat medical technology leader. The acquisition expands Neuroscience's portfolio of products used during ENT procedures and, combined with the Company's navigation, powered instruments, and existing tissue health products, will offer a broader suite of solutions to assist surgeons treating patients who suffer from chronic rhinosinusitis (CRS).</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to successfully develop, obtain regulatory approval of and commercialize the products within our pipeline, which include our closed-loop Percept PC and RC devices with adaptive DBS (aDBS) and Inceptiv Neurostimulator, as well as our hemorrhagic stroke intravascular device, and our next-generation spine enabling technologies.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_121"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diabetes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diabetes' products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. Diabetes' net sales for the three and six months ended October&#160;28, 2022 were $556 million and $1.1 billion, a decrease of 5 percent as compared to the corresponding periods in the prior fiscal year. Currency had an unfavorable impact of $47&#160;million and $80&#160;million on net sales for the three and six months ended October&#160;28, 2022, respectively. The decrease in net sales for both periods was primarily driven by unfavorable currency impacts and declines in the U.S. across most product lines. The net sales declines were partially offset by strong international growth primarily driven by the continued international expansion of the MiniMed 780G insulin pump system and integrated CGM. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the macro-economic and geopolitical factors described in the Executive Level Overview, looking ahead we expect Diabetes could be affected by the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued patient demand for the MiniMed 770G insulin pump system, which is powered by SmartGuard technology and features the added benefits of smartphone connectivity and an expanded age indication to children as young as age two.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth internationally for the MiniMed 780G insulin pump system. The global adoption of sensor-augmented insulin pump systems has resulted in strong sensor attachment rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued acceptance and growth of the Guardian Connect CGM system, which displays glucose information directly to a smartphone to help ensure patients have access to their glucose levels seamlessly and discretely. The Guardian Connect CGM system is available on both Apple iOS and Android devices. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Market acceptance and growth of our InPen smart pen system, which allows users to have their Medtronic CGM readings in real-time alongside insulin dose information, all in one view. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Continued pump, CGM, and consumable competition in an expanding global market. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in medical reimbursement policies and programs, along with additional payor coverage on insulin pumps.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Resolution of findings contained in a December 2021 U.S. FDA warning letter relating to the MiniMed 600 series insulin pump and a remote controller device for MiniMed 508 and Paradigm pumps. We are currently working with the U.S. FDA to resolve the findings. The existence of the warning letter may limit our ability to launch certain new Diabetes products in the U.S. prior to resolution of the findings.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:76.5pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our ability to successfully develop, obtain regulatory approval of and commercialize the products within our pipeline, which include, but are not limited to, our MiniMed 780G insulin pump and the Guardian 4 sensor, which have been submitted to the U.S. FDA, and our next-generation sensor Simplera. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_124"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COSTS AND EXPENSES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cost of products sold, research and development, and selling, general, and administrative expenses as a percent of net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-top:8pt;text-align:center"><img src="mdt-20221028_g13.jpg" alt="mdt-20221028_g13.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="margin-bottom:8pt;margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Products Sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   We continue to focus on reducing our costs of production through supplier management, manufacturing improvements, and optimizing our manufacturing network. Cost of products sold for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $2.5 billion and for the six months ended October&#160;28, 2022 and October 29, 2021 was $5.1 billion. The increase in cost of products sold as a percentage of net sales was primarily attributable to increased labor and direct material manufacturing costs, predominantly due to inflationary pressures and supply chain challenges as well as increased freight due to higher fuel costs and expedited shipments for backorders resulting from supply chain challenges. The six months ended October 29, 2021 included $58 million of inventory write-downs associated with our June 2021 decision to stop the distribution and sale of Medtronic's HVAD System (MCS charges). Looking forward, our cost of products sold likely will be further negatively impacted by inflation, supply chain challenges, and higher labor and direct material costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain committed to deliver the best possible experiences for patients, physicians, and caregivers we serve; to create technologies that expand what&#8217;s possible across the entire human body to transform lives; to turn data and insights into real action to serve patient needs to improve care; and to expand healthcare access and deliver positive outcomes. Research and development expense for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $676 million and for the six months ended October&#160;28, 2022 and October&#160;29, 2021 was $1.4 billion. The six months ended October&#160;29, 2021 included $90&#160;million of acquisitions of, and license payments for, technology not yet approved by regulators, primarily in our Diabetes segment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General, and Administrative Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to continue to leverage selling, general, and administrative expense initiatives. Selling, general, and administrative expense primarily consists of salaries and wages, other administrative costs, such as professional fees and marketing expenses, and certain acquisition and restructuring expenses. Selling, general, and administrative expense for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $2.6 billion and for the six months ended October&#160;28, 2022 and October&#160;29, 2021 was $5.2 billion. The increase in selling, general, and administrative expense as a percentage of net sales was primarily driven by net sales declines and increased employee travel as compared to the corresponding period in the prior fiscal year when travel was limited, partially offset by reduced incentive accruals.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_127"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of other costs and expenses (income):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i3900fafdc57a4da3bf71572260ed33b5_130"></div><div style="margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization of Intangible Assets   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets includes the amortization expense of our definite-lived intangible assets, consisting of purchased patents, trademarks, tradenames, customer relationships, purchased technology, and other intangible assets. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_133"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring Charges, Net </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of fiscal year 2018, we announced a multi-year global Enterprise Excellence Program designed to drive long-term business growth and sustainable efficiency. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $1.7 billion in connection with the Enterprise Excellence program. In total, the Company estimates it will recognize approximately&#160;$1.8 billion of exit and disposal costs and other costs related to the Enterprise Excellence program, the majority of which are expected to be incurred by the end of this fiscal year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, we recognized net charges of $53 million and $93 million, respectively, associated with our Enterprise Excellence Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charges for the three and six months ended October&#160;28, 2022 included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $19 million and $38 million, respectively, recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $27 million and $55 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income. Charges recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the period were not significant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;29, 2021, we recognized net charges of $62 million and $136 million, respectively, associated with our Enterprise Excellence Program, including $4 million and $15 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income primarily comprised of employee termination benefits. Net charges for the three and six months ended October&#160;29, 2021 also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $31 million and $64 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $27 million and $57 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2021, we initiated our Simplification restructuring program, designed to make the Company a more nimble and competitive organization. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $427&#160;million in connection with the Simplification program. In total, the Company estimates it will recognize approximately $450&#160;million of exit and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disposal costs and other costs related to the Simplification program, the majority of which are expected to be incurred by the end of this fiscal year.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, we recognized net charges of $43 million and $78 million, respectively, including $23 million and $44 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income primarily comprised of employee termination benefits. Net charges for the three and six months ended October&#160;28, 2022 also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $18 million and $31 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;29, 2021, we recognized net charges of $18 million and $25 million, respectively, including $9 million recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income for both periods primarily comprised of employee termination benefits. Net charges for the three and six months ended October&#160;29, 2021 also included costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses, including $9 million and $16 million, respectively, recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about our restructuring programs, refer to Note 5 to the current period's consolidated financial statements.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_136"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Litigation Charges, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify specified certain litigation charges and gains related to significant legal matters as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">certain litigation charges, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income. For additional information, refer to Note 16 in the current period's consolidated financial statements. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_139"></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Operating (Income) Expense, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating (income) expense, net primarily includes royalty income and expense, currency remeasurement and derivative gains and losses, Puerto Rico excise taxes, changes in the fair value of contingent consideration, MCS charges, RCS charges, impairment charges, and income from funded research and development arrangements. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended October&#160;28, 2022, the change in other operating (income) expense, net was primarily driven by the net currency impact of remeasurement expense and our hedging programs, which resulted in a net gain of $138&#160;million as compared to a net loss of $3&#160;million for the corresponding period in the prior year.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended October&#160;28, 2022, the change in other operating (income) expense, net was primarily driven by MCS charges recorded during three months ended July 30, 2021. The charges of $668&#160;million primarily included $409&#160;million of intangible asset impairments and $211&#160;million for commitments and obligations, including customer support obligations, restructuring, and other associated costs. Additionally, the change is driven by the net currency impact of remeasurement expense and our hedging programs, which resulted in a net gain of $219&#160;million combined for the six months ended October&#160;28, 2022 as compared to a net loss of $36&#160;million for the corresponding period in the prior year. During the six months ended October&#160;28, 2022, the Company also recorded non-cash pre-tax charges of $81&#160;million, primarily related to impairment of goodwill, as a result of the anticipated sale of half of the Company's RCS business, related to the May 25, 2022 agreement with DaVita Inc.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_142"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Non-Operating Income, Net   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net includes the non-service component of net periodic pension and postretirement benefit cost, investment gains and losses, and interest income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, the increase in other non-operating income, net is primarily attributable to an increase in interest income, partially offset by reduced gains on our equity method and minority investment portfolios for the six months ended. Interest income was $73&#160;million and $128&#160;million for the three and six months ended October&#160;28, 2022, respectively, and $46&#160;million and $89&#160;million for the three and six months ended October&#160;29, 2021, respectively. Gains on equity method and minority investments were $12 million and $15&#160;million for the three and six months ended October&#160;28, 2022, respectively, compared to a loss of $5&#160;million and gain of $38&#160;million for the three and six months ended October&#160;29, 2021, respectively. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_145"></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes interest incurred on our outstanding borrowings, amortization of debt issuance costs and debt premiums or discounts, amortization of amounts excluded from the effectiveness assessment of certain net investment hedges, and charges recognized in connection with the early redemption of senior notes.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended October&#160;28, 2022, the decrease in interest expense was primarily due to $27 million in after-tax unrealized gains representing amounts excluded from the effectiveness assessment of certain net investment hedges. For the six months ended October&#160;28, 2022, the increase in interest expense was primarily due to the $53&#160;million charge incurred as a result of the early redemption of approximately $2.3 billion of senior notes, during the three months ended July 29, 2022, partially offset by $47 million in after-tax unrealized gains representing amounts excluded from the effectiveness assessment of certain net investment hedges during the six months ended October&#160;28, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME TAXES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP income tax provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Nominal Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Difference between the effective tax rate and Non-GAAP Nominal Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the U.S. Tax Court (Tax Court) issued its opinion on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for fiscal years 2005 and 2006 (Opinion). While the Opinion rejected the IRS&#8217;s position and the Tax Court determined the methodology advanced by Medtronic was appropriate for purposes of determining the intercompany royalty rate between Puerto Rico and the U.S., it determined that the royalty rate should be higher, thereby increasing income allocated to the U.S. and consequently subject to U.S. tax. This case relates only to fiscal years 2005 and 2006. The Opinion remains subject to finalization by the Tax Court and to appeal by either or both parties. We have assumed the Tax Court findings will be applied for all years following fiscal year 2006. As a result, we have recorded a $764&#160;million net tax charge during the current quarter to recognize the estimated tax impact of the Tax Court Opinion.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three and six months ended October&#160;28, 2022 was 68.7% and 44.0%, respectively, as compared to 11.8% and 10.3% for the three and six months ended October&#160;29, 2021, respectively. The increase in our effective tax rate for the three and six months ended October&#160;28, 2022, as compared to the corresponding periods in the prior fiscal year, was primarily due to the $764 million net tax charge referenced above. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Non-GAAP Nominal Tax Rate for both the three and six months ended October&#160;28, 2022 was 13.3%, as compared to 12.4% and 12.6% for the three and six months ended October&#160;29, 2021, respectively. The change in our Non-GAAP Nominal Tax Rate was primarily due to the decrease in the stock-based compensation benefit and the impact of year-over-year changes in operational results by jurisdiction. An increase in our Non-GAAP Nominal Tax Rate of 1 percent would result in an additional income tax provision for the three and six months ended October 28, 2022 of approximately $20&#160;million and $37&#160;million, respectively.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_151"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently in a strong financial position, and we believe our balance sheet and liquidity as of October&#160;28, 2022 provide us with flexibility, and our cash, cash equivalents, and current investments, along with our credit facility and related commercial paper programs will satisfy our foreseeable operating needs.</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity and capital structure are evaluated regularly within the context of our annual operating and strategic planning processes. We consider the liquidity necessary to fund our operations, which includes working capital needs, investments in research and development, property, plant, and equipment, and other operating costs. We also consider capital allocation alternatives that balance returning value to shareholders through dividends and share repurchases, satisfying maturing debt, and acquiring businesses and technology.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Cash Flows</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of cash provided by (used in) operating, investing, and financing activities, the effect of exchange rate changes on cash and cash equivalents, and the net change in cash and cash equivalents:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The $1.1 billion decrease in net cash provided was primarily driven by a decrease in cash collected from customers, an increase in cash paid for income taxes and an increase in spend on inventory. The decrease in net cash was partially offset by a decrease in cash paid to employees. The decrease in cash collected from customers was primarily related to timing of sales, slower collections and supply chain challenges, as compared to the corresponding period in the prior fiscal year. The increase in cash paid for income taxes in the six months ended October&#160;28, 2022, is due to estimated income tax payments, and the increase in spend for inventory is due to inflationary impacts to direct labor and material costs. Cash paid to employees decreased due to lower annual incentive plan payouts for prior year performance compared to the corresponding period in the prior fiscal year. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing Activities   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.2 billion increase in cash used was primarily attributable to cash paid for acquisitions of $1.8 billion, partially offset by a decrease in net purchases of investments of $540 million, as compared to the corresponding period in the prior fiscal year. For more information on the aforementioned acquisitions, refer to Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the current's period's consolidated financial statements. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  There was a $4.3 billion increase in net cash provided during the six months ended October&#160;28, 2022, as compared to the corresponding period in the prior fiscal year. In the current period, the Company issued four tranches of Euro-denominated Senior Notes of approximately $3.4&#160;billion, as well as had $349 million of commercial paper that was issued and outstanding at quarter end. In the first quarter of fiscal year 2023, the Company issued short-term borrowings of approximately $2.3 billion under the Fiscal 2023 Loan Agreement and used the proceeds to fund the early redemption of senior notes for total consideration of $2.3 billion. For more information on the issuance of the senior notes, commercial paper, and Term Loan and redemption of senior notes, refer to the Debt and Capital section.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_154"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt and Capital </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital structure consists of equity and interest-bearing debt. We primarily utilize unsecured senior debt obligations to meet our financing needs and, to a lesser extent, bank borrowings. From time to time, we may repurchase our outstanding debt obligations in the open market or through privately negotiated transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt at October&#160;28, 2022 was $26.6 billion as compared to $24.1 billion at April&#160;29, 2022. The increase in total debt was driven by issuance of Euro-denominated Senior Notes of $3.4&#160;billion, offset by fluctuations in exchange rates.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, we entered into a term loan agreement (Fiscal 2023 Loan Agreement) with Mizuho Bank, Ltd. for an aggregate principal amount of up to &#165;300&#160;billion with a term of 364 days. In May and June 2022, Medtronic Luxco borrowed an aggregate of &#165;297&#160;billion, or approximately $2.3&#160;billion, of the term loan, under the Fiscal 2023 Loan Agreement. The Company used the net proceeds of the borrowings to fund the early redemption of $1.9&#160;billion of Medtronic Inc. Senior Notes for $1.9&#160;billion of total consideration, and $368&#160;million of Medtronic Luxco Senior Notes for $376&#160;million of total consideration. The Company recognized a total loss on debt extinguishment of $53&#160;million in the quarter ended July 29, 2022, which primarily included cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we issued four tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;3.5 billion, with maturities ranging from fiscal year 2026 to 2035, resulting in cash proceeds of approximately &#8364;3.5 billion, net of discounts and issuance costs. The Company intends to use the proceeds to repay at maturity &#8364;750&#160;million of 0.000% Medtronic Luxco Senior Notes in December 2022 and &#8364;1.5 billion of 0.375% Medtronic Luxco Senior Notes and &#8364;1.25 billion of 0.000% Medtronic Luxco Senior Notes in March 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We repurchase our ordinary shares on occasion as part of our focus on returning value to our shareholders. In March 2019, the Company's Board of Directors authorized the repurchase of $6.0&#160;billion of the Company's ordinary shares. There is no specific time period associated with these repurchase authorizations. During the six months ended October&#160;28, 2022, the Company repurchased a total of 4 million shares under this program at an average price of $95.69. At October&#160;28, 2022, we had approximately $2.5 billion remaining under the share repurchase program authorized by our Board of Directors. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on credit arrangements, refer to Note 7 to the current period's consolidated financial statements and Note 6 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our liquidity sources at October&#160;28, 2022 included $4.8 billion of cash and cash equivalents and $6.6&#160;billion of current investments. Additionally, we maintain commercial paper programs and a Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments primarily include available-for-sale debt securities, including U.S. and non-U.S. government and agency securities, corporate debt securities, mortgage-backed securities, certificates of deposits, and other asset-backed securities. Refer to Note 6 to the current period's consolidated financial statements for additional information regarding fair value measurements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain multicurrency commercial paper programs for short-term financing, which allow us to issue unsecured commercial paper notes on a private placement basis up to a maximum aggregate amount outstanding at any time of $3.5 billion. At October&#160;28, 2022 and April&#160;29, 2022, we had $349&#160;million and no commercial paper outstanding, respectively. The issuance of commercial paper reduces the amount of credit available under our existing line of credit, as explained below.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a $3.5 billion five-year syndicated credit facility (Credit Facility), which expires in December 2026. At each anniversary date of the Credit Facility we can request a one-year extension of the maturity date. The Credit Facility provides backup funding for the commercial paper programs and may also be used for general corporate purposes. The Credit Facility provides us with the ability to increase our borrowing capacity by an additional $1.0 billion at any time during the term of the agreement. At October&#160;28, 2022 and April&#160;29, 2022, no amounts were outstanding under the Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances of our Credit Facility are determined by a pricing matrix based on our long-term debt ratings assigned by Standard &amp; Poor's Ratings Services (S&amp;P) and Moody's Investors Service (Moody&#8217;s). Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. We are in compliance with all covenants related to the Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our S&amp;P and Moody's long-term debt ratings and short-term debt ratings:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agency Rating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's Ratings Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-1</span></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's Investors Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P-2</span></td></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Agency ratings are subject to change, and there may be no assurance that an agency will continue to provide ratings and/or maintain its current ratings. A security rating is not a recommendation to buy, sell or hold securities, and may be subject to revision or withdrawal at any time by the rating agency, and each rating should be evaluated independently of any other rating.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S&amp;P and Moody's long-term debt ratings and short-term debt ratings at October&#160;28, 2022 were unchanged as compared to the ratings at April&#160;29, 2022. We do not expect the S&amp;P and Moody's ratings to have a significant impact on our liquidity or future flexibility to access additional liquidity given our balance sheet, Credit Facility, and related commercial paper programs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have future contractual obligations and other minimum commercial commitments that are entered into in the normal course of business. We believe our off-balance sheet arrangements do not have a material current or anticipated future effect on our consolidated earnings, financial position, and/or cash flows. Refer to the Debt and Capital section above for changes in debt obligations during the second quarter of fiscal year 2023; there have been no other material changes to our long-term contractual obligations as reported in our most recent Annual Report filed on Form 10-K for the fiscal year ended April&#160;29, 2022.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_160"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding acquisitions is included in Note 4 to the current period's consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_1929"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOODWILL</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess goodwill and indefinite-lived intangible assets for impairment annually in the third quarter of the fiscal year and whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. Definite-lived intangible assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount of an intangible asset (asset group) may not be recoverable. Refer to our Other Operating (Income) Expense, Net section for further details on impairment charges in the current fiscal year. Further adverse changes to macroeconomic conditions or significant changes to our current and future expected financial performance could lead to goodwill or intangible asset impairment charges in future periods, and such charges could be material to our results of operations.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_163"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have used various accounting policies to prepare the consolidated financial statements in accordance with U.S. GAAP. Our significant accounting policies are disclosed in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires us to use judgment in making estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates reflect our best judgment about economic and market conditions and the potential effects on the valuation and/or carrying value of assets and liabilities based upon relevant information available. We base our estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;28, 2022, there were no material changes to our critical accounting estimates. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_166"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding new accounting pronouncements is included in Note 2 to the current period's consolidated financial statements.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_169"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTAL GUARANTOR FINANCIAL INFORMATION</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic plc and Medtronic Global Holdings S.C.A. (Medtronic Luxco), a wholly-owned subsidiary guarantor, each have provided full and unconditional guarantees of the obligations of Medtronic, Inc., a wholly-owned subsidiary issuer, under the Senior Notes (Medtronic Senior Notes) and full and unconditional guarantees of the obligations of Covidien International Finance S.A. (CIFSA), a wholly-owned subsidiary issuer, under the Senior Notes (CIFSA Senior Notes). The guarantees of the CIFSA Senior Notes are in addition to the guarantees of the CIFSA Senior Notes by Covidien Ltd. and Covidien Group Holdings Ltd., both of which are wholly-owned subsidiary guarantors of the CIFSA Senior Notes. Medtronic plc and Medtronic, Inc. each have provided a full and unconditional guarantee of the obligations of Medtronic Luxco under the Senior Notes (Medtronic Luxco Senior Notes). The following is a summary of these guarantees:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of Medtronic Senior Notes</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">Parent Company Guarantor &#8211; Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Issuer &#8211; Medtronic, Inc.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Guarantor &#8211; Medtronic Luxco</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of Medtronic Luxco Senior Notes</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Parent Company Guarantor &#8211; Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Issuer &#8211; Medtronic Luxco</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Guarantor &#8211; Medtronic, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees of CIFSA Senior Notes</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Parent Company Guarantor &#8211; Medtronic plc</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Issuer &#8211; CIFSA</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Subsidiary Guarantors &#8211; Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. (CIFSA Subsidiary Guarantors)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present summarized results of operations for the six months ended October&#160;28, 2022 and summarized balance sheet information at October&#160;28, 2022 and April&#160;29, 2022 for the obligor groups of Medtronic and Medtronic Luxco Senior Notes, and CIFSA Senior Notes. The obligor group consists of the parent company guarantor, subsidiary issuer, and subsidiary guarantors for the applicable senior notes. The summarized financial information is presented after elimination of (i) intercompany transactions and balances among the guarantors and issuers and (ii) equity in earnings from and investments in any subsidiary that is a non-guarantor or issuer. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized results of operations information for the six months ended October&#160;28, 2022 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Medtronic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet information at October&#160;28, 2022 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,442&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Medtronic Senior Notes and Medtronic Luxco Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, and Medtronic, Inc. Refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The CIFSA Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, CIFSA, and CIFSA Subsidiary Guarantors. Refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes receivables due from non-guarantor subsidiaries of $17.2&#160;billion and $6.9&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans receivable due from non-guarantor subsidiaries of $6.5&#160;billion and $8.4&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes payables due to non-guarantor subsidiaries of $28.8&#160;billion and $20.1&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans payable due to non-guarantor subsidiaries of $27.8&#160;billion and $46.6&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet information at April&#160;29, 2022 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medtronic &amp; Medtronic Luxco Senior Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CIFSA Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total noncurrent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Medtronic Senior Notes and Medtronic Luxco Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, and Medtronic, Inc. Refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The CIFSA Senior Notes obligor group consists of the following entities: Medtronic plc, Medtronic Luxco, CIFSA, and CIFSA Subsidiary Guarantors. Refer to the guarantee summary above for further details.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes receivables due from non-guarantor subsidiaries of $20.2&#160;billion and $6.9&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans receivable due from non-guarantor subsidiaries of $6.5&#160;billion and $8.3&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes payables due to non-guarantor subsidiaries of $26.4&#160;billion and $20.2&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes loans payable due to non-guarantor subsidiaries of $29.0&#160;billion and $46.4&#160;billion for Medtronic &amp; Medtronic Luxco Senior Notes, and CIFSA Senior Notes, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, and other written reports and oral statements made by or with the approval of one of the Company&#8217;s executive officers from time to time, may include &#8220;forward-looking&#8221; statements. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations and financial position, business strategy and plans, objectives of management for future operations and current expectations or forecasts of future results, are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Our forward-looking statements may include statements related to our growth and growth strategies, developments in the markets for our products, therapies and services, financial results, product development launches and effectiveness, research and development strategy, regulatory approvals, competitive strengths, the potential or anticipated direct or indirect impact of COVID-19 on our business, results of operations, and/or financial condition, restructuring and cost-saving initiatives, intellectual property rights, litigation and tax matters, governmental proceedings and investigations, mergers and acquisitions, divestitures, market acceptance of our products, therapies and services, accounting estimates, financing activities, ongoing contractual obligations, working capital adequacy, value of our investments, our effective tax rate, our expected returns to shareholders, and sales efforts. In some cases, such statements may be identified by the use of terminology such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;looking ahead,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and similar words or expressions. Forward-looking statements in this Quarterly Report include, but are not limited to, statements regarding our ability to drive long-term shareholder value, development and future launches of products and continued or future acceptance of products, therapies and services in our segments; expected timing for completion of research studies relating to our products; market positioning and performance of our products, including stabilization of certain product markets; divestitures and the potential benefits thereof; the costs and benefits of integrating previous acquisitions; anticipated timing for United States (U.S.) Food and Drug Administration (U.S. FDA) and non-U.S. regulatory approval of new products; increased presence in new markets, including markets outside the U.S.; changes in the market and our market share; acquisitions and investment initiatives, including the timing of regulatory approvals as well as integration of acquired companies into our operations; the resolution of tax matters; the effectiveness of our development activities in reducing patient care costs and hospital stay lengths; our approach towards cost containment; our expectations regarding healthcare costs, including potential changes to reimbursement policies and pricing pressures; our expectations regarding changes to patient standards of care; our ability to identify and maintain successful business partnerships; the elimination of certain positions or costs related to restructuring initiatives; outcomes in our litigation matters and governmental proceedings and investigations; general economic conditions; the adequacy of available working capital and our working capital needs; our payment of dividends and redemption of shares; the continued strength of our balance sheet and liquidity; our accounts receivable exposure; and the potential impact of our compliance with governmental regulations and accounting guidance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, results of operations, financial condition, and/or cash flows. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of risks, uncertainties and assumptions described in the &#8220;Risk Factors&#8221; section and elsewhere in our Annual Report on Form 10-K. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. One must carefully consider forward-looking statements and understand that such forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and involve a variety of risks and uncertainties, known and unknown, including, among others, those discussed in the sections entitled &#8220;Government Regulation&#8221; within &#8220;Item 1. Business&#8221; and &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K, as well as those related to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition in the medical device industry;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in regulatory approvals;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the global COVID-19 pandemic, including new COVID-19 variants that may emerge, as well as impacts of the pandemic on healthcare staffing levels; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">reduction or interruption in our supply;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">failure to complete or achieve the intended benefits of acquisitions or divestitures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">adverse regulatory action;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">laws and governmental regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">litigation results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">quality problems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">healthcare policy changes;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">cybersecurity incidents;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">international operations, including the impact of armed conflicts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">self-insurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">commercial insurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">changes in applicable tax rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">positions taken by taxing authorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">decreasing selling prices and pricing pressure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">liquidity shortfalls;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">fluctuations in currency exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">inflation; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.5pt">disruption of our current plans and operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, no forward-looking statement may be guaranteed, and actual results may vary materially from those projected in the forward-looking statements. We intend to take advantage of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding our forward-looking statements and are including this sentence for the express purpose of enabling us to use the protections of the safe harbor with respect to all forward-looking statements. While we may elect to update these forward-looking statements at some point in the future, whether as a result of any new information, future events, or otherwise, we have no current intention of doing so except to the extent required by applicable law.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_175"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENCY EXCHANGE RATE RISK</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the global nature of our operations, we are exposed to currency exchange rate changes, which may cause fluctuations in earnings and cash flows. Fluctuations in the currency exchange rates of currency exposures that are unhedged, such as in certain emerging markets, may result in future earnings and cash flow volatility. The gross notional amount of all currency exchange rate derivative instruments outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $17.9 billion and $13.8 billion, respectively. At October&#160;28, 2022, these contracts were in a net unrealized gain position of $1.0&#160;billion. Additional information regarding our currency exchange rate derivative instruments is included in Note 8 to the current period's consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of changes in the fair value of all currency exchange rate derivative contracts at October&#160;28, 2022 indicates that, if the U.S. dollar uniformly strengthened/weakened by 10 percent against all currencies, it would have the following impact on the fair value of these contracts:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% appreciation in the U.S. dollar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10% depreciation in the U.S. dollar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any gains and losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying transactions. These offsetting gains and losses are not reflected in the above analysis. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEREST RATE RISK</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to interest rate risk on our short-term investments and our borrowings. We manage interest rate risk in the aggregate, while focusing on our immediate and intermediate liquidity needs. Our debt portfolio at October&#160;28, 2022 was comprised of debt predominantly denominated in U.S. dollars, Euros, and Yen, of which substantially all is fixed rate debt. We are also exposed to interest rate changes affecting our investments in interest rate sensitive instruments, which include our marketable debt securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of the impact on our interest rate-sensitive financial instruments of a hypothetical 10 basis point change in interest rates, as compared to interest rates at October&#160;28, 2022, would have the following impact on the fair value of these instruments:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 basis point increase in interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 basis point decrease in interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of current market conditions and the impact on our financial condition and results of operations, please see the &#8220;Liquidity&#8221; section of the current period's Management's Discussion and Analysis. For additional discussion of market risk, refer to Notes 6 and 8 to the current period's consolidated financial statements.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_178"></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) and changes in the Company&#8217;s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) are effective.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act) during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting. </span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_181"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_184"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Item 103 of Regulation S-K, we have adopted a $1 million disclosure threshold for proceedings under environmental laws to which a governmental authority is a party, as we believe matters under this threshold are not material to the Company. A discussion of the Company&#8217;s legal proceedings and other loss contingencies are described in Note 16 to the current period's consolidated financial statements.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_187"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table provides information about the shares repurchased by the Company during the second quarter of fiscal year 2023: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares<br/>Purchased as a Part of<br/>Publicly Announced<br/>Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Approximate Dollar Value of Shares that may yet be Purchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/30/2022-8/26/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545,462,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/27/2022-9/30/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535,587,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022-10/28/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531,435,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921,101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531,435,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company's Board of Directors authorized the repurchase of $6.0&#160;billion of the Company's ordinary shares. There is no specific time period associated with these repurchase authorizations.</span></div><div id="i3900fafdc57a4da3bf71572260ed33b5_190"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic has engaged in certain activities that it is required to disclose pursuant to Section 13(r)(1)(D)(ii) of the Securities Exchange Act of 1934, as amended. In particular, during the second quarter of fiscal year 2023, Medtronic engaged in certain regulatory activities involving Russia&#8217;s Federal Security Service (&#8220;FSB&#8221;) related to its medical devices that were expressly authorized by the U.S. Government under applicable economic sanctions regulations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal year 2023 ending October 28, 2022, in the normal course of business and consistent with Office of Foreign Assets Control authorizations as in effect at the time, Medtronic Russia filed three notifications with the FSB, as required under local Russian law for the import of medical devices that make use of encryption functionality. These activities did not directly result in any revenues or profits for Medtronic. To the extent that notifications with the FSB remain permissible under U.S. law, Medtronic may decide to continue engaging in such activities for the limited purposes of complying with local law requirements in Russia.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.766%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mdt-2023q210qxex322.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i3900fafdc57a4da3bf71572260ed33b5_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned authorized officer.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medtronic plc</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jennifer M. Kirk</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer M. Kirk</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Global Controller and Chief Accounting Officer (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mdt-2023q210qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i44ed898f316a41eab3066264d7e46102_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Geoffrey S. Martha, certify that&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Medtronic plc&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;1, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Geoffrey S. Martha</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Martha</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mdt-2023q210qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3b9d4a8918a84febac9dd621afdc6ff0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen L. Parkhill, certify that&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Medtronic plc&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;1, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karen L. Parkhill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>mdt-2023q210qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iac847cb854de45aaa06094d9aa523376_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this quarterly report on Form 10-Q of Medtronic plc for the quarter ended October&#160;28, 2022, the undersigned hereby certifies, in his capacity as Chief Executive Officer of Medtronic plc, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Medtronic plc. </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;1, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Geoffrey S. Martha </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey S. Martha </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>mdt-2023q210qxex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i21fce34f93b24908817c6af8d7ec3650_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this quarterly report on Form 10-Q of Medtronic plc for the quarter ended October&#160;28, 2022, the undersigned hereby certifies, in her capacity as Chief Financial Officer of Medtronic plc, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Medtronic plc. </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December&#160;1, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Karen L. Parkhill</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen L. Parkhill </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mdt-20221028.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdt="http://www.medtronic.com/20221028" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medtronic.com/20221028">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20221028_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20221028_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20221028_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdt-20221028_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medtronic.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncomeUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited">
        <link:definition>0000002 - Statement - Consolidated Statements of Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited">
        <link:definition>0000006 - Statement - Consolidated Statements of Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityUnauditedParenthetical" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical">
        <link:definition>0000007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.medtronic.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.medtronic.com/role/NewAccountingPronouncements">
        <link:definition>0000010 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.medtronic.com/role/Revenue">
        <link:definition>0000011 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSale" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale">
        <link:definition>0000012 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCosts" roleURI="http://www.medtronic.com/role/RestructuringandOtherCosts">
        <link:definition>0000013 - Disclosure - Restructuring and Other Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.medtronic.com/role/FinancialInstruments">
        <link:definition>0000014 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangements" roleURI="http://www.medtronic.com/role/FinancingArrangements">
        <link:definition>0000015 - Disclosure - Financing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagement" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement">
        <link:definition>0000016 - Disclosure - Derivatives and Currency Exchange Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.medtronic.com/role/Inventories">
        <link:definition>0000017 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000018 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.medtronic.com/role/IncomeTaxes">
        <link:definition>0000019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.medtronic.com/role/EarningsPerShare">
        <link:definition>0000020 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.medtronic.com/role/StockBasedCompensation">
        <link:definition>0000021 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlans" roleURI="http://www.medtronic.com/role/RetirementBenefitPlans">
        <link:definition>0000022 - Disclosure - Retirement Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000023 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.medtronic.com/role/CommitmentsandContingencies">
        <link:definition>0000024 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation">
        <link:definition>0000025 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies">
        <link:definition>0000026 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.medtronic.com/role/RevenueTables">
        <link:definition>0000027 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleTables" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables">
        <link:definition>0000028 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCostsTables" roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsTables">
        <link:definition>0000029 - Disclosure - Restructuring and Other Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables">
        <link:definition>0000030 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsTables" roleURI="http://www.medtronic.com/role/FinancingArrangementsTables">
        <link:definition>0000031 - Disclosure - Financing Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementTables" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables">
        <link:definition>0000032 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.medtronic.com/role/InventoriesTables">
        <link:definition>0000033 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>0000034 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.medtronic.com/role/EarningsPerShareTables">
        <link:definition>0000035 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.medtronic.com/role/StockBasedCompensationTables">
        <link:definition>0000036 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlansTables" roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables">
        <link:definition>0000037 - Disclosure - Retirement Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>0000038 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables">
        <link:definition>0000039 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails">
        <link:definition>0000040 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails">
        <link:definition>0000041 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails">
        <link:definition>0000042 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails">
        <link:definition>0000043 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails">
        <link:definition>0000044 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails">
        <link:definition>0000045 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails">
        <link:definition>0000046 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails">
        <link:definition>0000047 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails">
        <link:definition>0000048 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCostsNarrativeDetails" roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails">
        <link:definition>0000049 - Disclosure - Restructuring and Other Costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails" roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails">
        <link:definition>0000050 - Disclosure - Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails">
        <link:definition>0000051 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails">
        <link:definition>0000052 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails">
        <link:definition>0000053 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails">
        <link:definition>0000054 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails">
        <link:definition>0000055 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>0000056 - Disclosure - Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsNarrativeDetails" roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails">
        <link:definition>0000057 - Disclosure - Financing Arrangements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancingArrangementsLongTermDebtDetails" roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails">
        <link:definition>0000058 - Disclosure - Financing Arrangements - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails">
        <link:definition>0000059 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000060 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>0000061 - Disclosure - Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails">
        <link:definition>0000062 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000063 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails">
        <link:definition>0000064 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1">
        <link:definition>0000064 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.medtronic.com/role/InventoriesDetails">
        <link:definition>0000065 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>0000066 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>0000067 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails">
        <link:definition>0000068 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails">
        <link:definition>0000069 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.medtronic.com/role/IncomeTaxesDetails">
        <link:definition>0000070 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails">
        <link:definition>0000071 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareNarrativeDetails" roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails">
        <link:definition>0000072 - Disclosure - Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails">
        <link:definition>0000073 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>0000074 - Disclosure - Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossChangesinAOCIDetails" roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails">
        <link:definition>0000075 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000076 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationNarrativeDetails" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails">
        <link:definition>0000077 - Disclosure - Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails">
        <link:definition>0000078 - Disclosure - Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails" roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails">
        <link:definition>0000079 - Disclosure - Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mdt_CommercialPaperMaximumBorrowingCapacity" abstract="false" name="CommercialPaperMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2022Due2034Member" abstract="true" name="SeniorNotes2022Due2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2009Due20396500PercentMember" abstract="true" name="SeniorNotes2009Due20396500PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_A2007CIFSASeniorNotesDue20386550PercentMember" abstract="true" name="A2007CIFSASeniorNotesDue20386550PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20230000PercentMember" abstract="true" name="SeniorNotes2020Due20230000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_TotalOtherCountriesExcludingIrelandMember" abstract="true" name="TotalOtherCountriesExcludingIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_InProcessResearchDevelopmentMember" abstract="true" name="InProcessResearchDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2022Due2028Member" abstract="true" name="SeniorNotes2022Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due20253500PercentMember" abstract="true" name="SeniorNotes2015Due20253500PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311625PercentMember" abstract="true" name="SeniorNotes2019Due20311625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2049Member" abstract="true" name="SeniorNotes2019Due2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CardiacRhythmandHeartFailureDivisionMember" abstract="true" name="CardiacRhythmandHeartFailureDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_NeuromodulationDivisionMember" abstract="true" name="NeuromodulationDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20260000PercentMember" abstract="true" name="SeniorNotes2020Due20260000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_BusinessAcquisitionPurchasePriceContingentConsideration" abstract="false" name="BusinessAcquisitionPurchasePriceContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_EnterpriseExcellenceMember" abstract="true" name="EnterpriseExcellenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_HeldForSaleMember" abstract="true" name="HeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_MedicalSurgicalMember" abstract="true" name="MedicalSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2025Member" abstract="true" name="SeniorNotes2019Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2040Member" abstract="true" name="SeniorNotes2020Due2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" abstract="false" name="RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_TechnologyBasedIntangibleAssets" abstract="false" name="TechnologyBasedIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_OrringtonMaineChemicalManufacturingFacilityMember" abstract="true" name="OrringtonMaineChemicalManufacturingFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_RespiratoryGastrointestinalandRenalDivisionMember" abstract="true" name="RespiratoryGastrointestinalandRenalDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_PelvicMeshLitigationMember" abstract="true" name="PelvicMeshLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_MedicalDeviceRegulations" abstract="false" name="MedicalDeviceRegulations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_MedtronicLuxcoMember" abstract="true" name="MedtronicLuxcoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_AssociatedCostsMember" abstract="true" name="AssociatedCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2032Member" abstract="true" name="SeniorNotes2020Due2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_TokyoInterBankOfferedRateTIBORMember" abstract="true" name="TokyoInterBankOfferedRateTIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2017Due20273350PercentMember" abstract="true" name="SeniorNotes2017Due20273350PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" abstract="false" name="DerivativeAssetLiabilityFairValueGrossAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_IncomeTaxesandInterestPaidAbstract" abstract="true" name="IncomeTaxesandInterestPaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2050Member" abstract="true" name="SeniorNotes2020Due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_OtherAccruedExpensesMember" abstract="true" name="OtherAccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_A2265PercentThreeYear2022SeniorNotesMember" abstract="true" name="A2265PercentThreeYear2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" abstract="false" name="UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SurgicalInnovationsDivisionMember" abstract="true" name="SurgicalInnovationsDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_A3000PercentSixYear2022SeniorNotesMember" abstract="true" name="A3000PercentSixYear2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2013Due20434000PercentMember" abstract="true" name="SeniorNotes2013Due20434000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20501750PercentMember" abstract="true" name="SeniorNotes2019Due20501750PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_NeuroscienceGroupMember" abstract="true" name="NeuroscienceGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2022Due2031Member" abstract="true" name="SeniorNotes2022Due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_PurchasedTechnologyAndPatentsMember" abstract="true" name="PurchasedTechnologyAndPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" abstract="true" name="BusinessAcquisitionContingentConsiderationAtFairValueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_NonDerivativeInstrumentsMember" abstract="true" name="NonDerivativeInstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_AfferaIncMember" abstract="true" name="AfferaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20354375PercentMember" abstract="true" name="SeniorNotes2020Due20354375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2014Due20444625PercentMember" abstract="true" name="SeniorNotes2014Due20444625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetLiabilityAbstract" abstract="true" name="DerivativeAssetLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SpecialtyTherapiesDivisionMember" abstract="true" name="SpecialtyTherapiesDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_ScheduleOfDebtTable" abstract="true" name="ScheduleOfDebtTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" abstract="true" name="MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20411375PercentMember" abstract="true" name="SeniorNotes2020Due20411375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_EarningsPerShareReconciliationNumeratorAbstract" abstract="true" name="EarningsPerShareReconciliationNumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_BusinessAcquisitionPriceContingentConsideration" abstract="false" name="BusinessAcquisitionPriceContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_EquityInvestmentsMember" abstract="true" name="EquityInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" abstract="false" name="DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SiteContingencyNumberOfLandfillsRequiringCapping" abstract="false" name="SiteContingencyNumberOfLandfillsRequiringCapping" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_A2015CommercialPaperProgramMember" abstract="true" name="A2015CommercialPaperProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_OffsettingAssetsandLiabilitiesTable" abstract="true" name="OffsettingAssetsandLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20401500PercentMember" abstract="true" name="SeniorNotes2019Due20401500PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_EmployeesStockPurchasePlanMember" abstract="true" name="EmployeesStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CranialAndSpinalTechnologiesDivisionMember" abstract="true" name="CranialAndSpinalTechnologiesDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_GainonInvestments" abstract="false" name="GainonInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SiteContingencyNumberofLandfillsRequiringRemoval" abstract="false" name="SiteContingencyNumberofLandfillsRequiringRemoval" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_A3125PercentNineYear2022SeniorNotesMember" abstract="true" name="A3125PercentNineYear2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_OutsideOfTheUnitedStatesMember" abstract="true" name="OutsideOfTheUnitedStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_LossContingencyNumberofSubsidiaries" abstract="false" name="LossContingencyNumberofSubsidiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20230375PercentMember" abstract="true" name="SeniorNotes2019Due20230375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2012Due20424500PercentMember" abstract="true" name="SeniorNotes2012Due20424500PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20511625PercentMember" abstract="true" name="SeniorNotes2020Due20511625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_ScheduleofInvestmentsTableTextBlock" abstract="false" name="ScheduleofInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdt_OtherAcquisitionsMember" abstract="true" name="OtherAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_A3375PercentTwelveYear2022SeniorNotesMember" abstract="true" name="A3375PercentTwelveYear2022SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" abstract="false" name="EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due2022Member" abstract="true" name="SeniorNotes2019Due2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_StructuralHeartAndAorticDivisionMember" abstract="true" name="StructuralHeartAndAorticDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_AmendedandRestatedRevolvingCreditAgreementMember" abstract="true" name="AmendedandRestatedRevolvingCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20290375PercentMember" abstract="true" name="SeniorNotes2020Due20290375PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" abstract="true" name="MechanicalCirculatorySupportOperatingUnitMCSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2010Due20405550PercentMember" abstract="true" name="SeniorNotes2010Due20405550PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_AssetImpairmentChargesAndInventoryWriteDown" abstract="false" name="AssetImpairmentChargesAndInventoryWriteDown" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_MechanicalCirculatorySupportMember" abstract="true" name="MechanicalCirculatorySupportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdt_RestructuringWriteDownAndImpairmentProvisions" abstract="false" name="RestructuringWriteDownAndImpairmentProvisions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20391.50PercentMember" abstract="true" name="SeniorNotes2019Due20391.50PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_MedtronicLuxcoSeniorNotesMember" abstract="true" name="MedtronicLuxcoSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_RenalCareBusinessRCSMember" abstract="true" name="RenalCareBusinessRCSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" abstract="true" name="JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2028Member" abstract="true" name="SeniorNotes2020Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CentralizedDistributionCosts" abstract="false" name="CentralizedDistributionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" abstract="false" name="DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20260250PercentMember" abstract="true" name="SeniorNotes2019Due20260250PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2015Due20454625PercentMember" abstract="true" name="SeniorNotes2015Due20454625PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_RestructuringsExcludingRCSAndMCSMember" abstract="true" name="RestructuringsExcludingRCSAndMCSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2022Due2025Member" abstract="true" name="SeniorNotes2022Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_ProductDevelopmentMilestoneMember" abstract="true" name="ProductDevelopmentMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20394500PercentMember" abstract="true" name="SeniorNotes2019Due20394500PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_PreTaxExitandDisposalCostsMember" abstract="true" name="PreTaxExitandDisposalCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due2025Member" abstract="true" name="SeniorNotes2020Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CardiovascularMember" abstract="true" name="CardiovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2020Due20330750PercentMember" abstract="true" name="SeniorNotes2020Due20330750PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20321000PercentMember" abstract="true" name="SeniorNotes2019Due20321000PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CoronaryAndPeripheralVascularDivisionMember" abstract="true" name="CoronaryAndPeripheralVascularDivisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_RevenueMilestoneMember" abstract="true" name="RevenueMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_HerniaMeshLitigationMember" abstract="true" name="HerniaMeshLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20311.00PercentMember" abstract="true" name="SeniorNotes2019Due20311.00PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" abstract="true" name="TotalOtherCountriesExcludingUnitedStatesandIrelandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_SimplificationRestructuringProgramMember" abstract="true" name="SimplificationRestructuringProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" abstract="false" name="BusinessAcquisitionContingentConsiderationMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_OffsettingAssetsandLiabilitiesLineItems" abstract="true" name="OffsettingAssetsandLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20271125PercentMember" abstract="true" name="SeniorNotes2019Due20271125PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_CorporateOverhead" abstract="false" name="CorporateOverhead" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_LossonInvestments" abstract="false" name="LossonInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdt_SeniorNotes2019Due20392250PercentMember" abstract="true" name="SeniorNotes2019Due20392250PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_IntersectENTMember" abstract="true" name="IntersectENTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_EarningsPerShareReconciliationDenominatorAbstract" abstract="true" name="EarningsPerShareReconciliationDenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdt_DiabetesGroupMember" abstract="true" name="DiabetesGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" abstract="false" name="EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mdt-20221028_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78655e43-4b6f-4410-8046-dda5b4dbfd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_78655e43-4b6f-4410-8046-dda5b4dbfd99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fd6b444e-4cf8-473c-9870-255a19ebc327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fd6b444e-4cf8-473c-9870-255a19ebc327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d60ffcaa-3fb9-4617-b8ec-7078e856b6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d60ffcaa-3fb9-4617-b8ec-7078e856b6f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_155702ef-2042-4fbb-a23b-3297552f9c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_155702ef-2042-4fbb-a23b-3297552f9c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_942d855b-e472-4bdc-82cd-0310d9e9105d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_942d855b-e472-4bdc-82cd-0310d9e9105d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_009a7996-36b8-4645-8964-926b7870a98f" xlink:href="mdt-20221028.xsd#mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_009a7996-36b8-4645-8964-926b7870a98f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_01d6ccc5-825d-4602-8fdd-dd10e0245277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_01d6ccc5-825d-4602-8fdd-dd10e0245277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_42e68684-239f-4c19-85b2-83a393dcf038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f8636c6f-abe6-4e20-a003-b4ade77af4bc" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_42e68684-239f-4c19-85b2-83a393dcf038" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a8807de0-35e7-4a07-9fac-5d0594345d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fbf354e6-92d7-4250-aef1-0a2e7fac0838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8807de0-35e7-4a07-9fac-5d0594345d53" xlink:to="loc_us-gaap_ProfitLoss_fbf354e6-92d7-4250-aef1-0a2e7fac0838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8b77b1e1-007c-484d-a34c-88d43df6b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a8807de0-35e7-4a07-9fac-5d0594345d53" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8b77b1e1-007c-484d-a34c-88d43df6b76e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505af4d6-3180-4ae4-9372-1fc36699c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_60a8172a-4ee8-4478-9bd7-0b04e75e08be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505af4d6-3180-4ae4-9372-1fc36699c73d" xlink:to="loc_us-gaap_OperatingIncomeLoss_60a8172a-4ee8-4478-9bd7-0b04e75e08be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a1ea1800-2cdb-4035-8bd5-7ad7f03f38dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505af4d6-3180-4ae4-9372-1fc36699c73d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a1ea1800-2cdb-4035-8bd5-7ad7f03f38dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_fd54318c-2d23-4c41-a9c4-4972aeb23370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505af4d6-3180-4ae4-9372-1fc36699c73d" xlink:to="loc_us-gaap_InterestExpense_fd54318c-2d23-4c41-a9c4-4972aeb23370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_07071649-7405-4d16-bf73-9b5686191f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b7ece550-9ada-44d0-bcd5-881667a8bcc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_07071649-7405-4d16-bf73-9b5686191f6c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b7ece550-9ada-44d0-bcd5-881667a8bcc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_68ab4bab-7cd2-45a3-b742-49611deadd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_07071649-7405-4d16-bf73-9b5686191f6c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_68ab4bab-7cd2-45a3-b742-49611deadd80" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b4bea74b-5848-4f71-aa47-b77e6cef28c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e63e2115-1f9f-4588-b086-61dc3cc1e049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b4bea74b-5848-4f71-aa47-b77e6cef28c0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e63e2115-1f9f-4588-b086-61dc3cc1e049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3e8bc040-0d84-4632-96a0-36794c09cddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b4bea74b-5848-4f71-aa47-b77e6cef28c0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3e8bc040-0d84-4632-96a0-36794c09cddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57769eb7-2ea6-407b-a31d-c6ac0ed04397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9776878-77ce-441f-b35b-914ae58b1ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57769eb7-2ea6-407b-a31d-c6ac0ed04397" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9776878-77ce-441f-b35b-914ae58b1ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9177dc1b-70c2-4cd3-83ac-c0e9ed394743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_57769eb7-2ea6-407b-a31d-c6ac0ed04397" xlink:to="loc_us-gaap_ProfitLoss_9177dc1b-70c2-4cd3-83ac-c0e9ed394743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9146e04d-212f-49bf-bb54-52adace99960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9146e04d-212f-49bf-bb54-52adace99960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9a80b278-8b07-45ae-a59c-b769288f625e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_9a80b278-8b07-45ae-a59c-b769288f625e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_a3bc99c3-c83f-4489-b631-bcfb41023989" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:to="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_a3bc99c3-c83f-4489-b631-bcfb41023989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_aeda5d48-ac68-424d-b757-16d6ea53543f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_aeda5d48-ac68-424d-b757-16d6ea53543f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5ab3d30b-4f52-453a-b3f4-2c4df80b33da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_501d68ca-0af8-434d-8c13-04b8b8dbf8b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5ab3d30b-4f52-453a-b3f4-2c4df80b33da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80ab36b8-d420-4eb1-9544-14ff35714d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_80ab36b8-d420-4eb1-9544-14ff35714d98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a28e9f3e-adfe-4407-8c92-23d33abef414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:to="loc_us-gaap_ShortTermInvestments_a28e9f3e-adfe-4407-8c92-23d33abef414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cb33aef0-8393-4ac2-a963-c4ab321bf2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cb33aef0-8393-4ac2-a963-c4ab321bf2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5a3d87f8-3e0d-407e-80b9-2d9ccae3e5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:to="loc_us-gaap_InventoryNet_5a3d87f8-3e0d-407e-80b9-2d9ccae3e5a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7a75de35-1f98-419c-bbcc-a80453c49ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e9b5fe84-85b3-43c3-a60e-c8a724868b06" xlink:to="loc_us-gaap_OtherAssetsCurrent_7a75de35-1f98-419c-bbcc-a80453c49ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf97a55c-fbc1-470a-9451-a0bcb47a0fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d50f7364-ef67-495d-8ef6-b061715d05c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf97a55c-fbc1-470a-9451-a0bcb47a0fd7" xlink:to="loc_us-gaap_StockholdersEquity_d50f7364-ef67-495d-8ef6-b061715d05c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_95e3b07a-f821-4f87-ae80-d29210f2177c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf97a55c-fbc1-470a-9451-a0bcb47a0fd7" xlink:to="loc_us-gaap_MinorityInterest_95e3b07a-f821-4f87-ae80-d29210f2177c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_45b6bd98-46e2-40f1-badb-6cc6b3b84240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_44077a39-7629-446c-a183-fe236d8f0c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_45b6bd98-46e2-40f1-badb-6cc6b3b84240" xlink:to="loc_us-gaap_CommonStockValue_44077a39-7629-446c-a183-fe236d8f0c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_339c7058-288b-484c-8c90-580290766b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_45b6bd98-46e2-40f1-badb-6cc6b3b84240" xlink:to="loc_us-gaap_AdditionalPaidInCapital_339c7058-288b-484c-8c90-580290766b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa68320d-faa4-4f32-a822-2d5401a83565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_45b6bd98-46e2-40f1-badb-6cc6b3b84240" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa68320d-faa4-4f32-a822-2d5401a83565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82c5d59f-ad69-43ea-8051-cd4c6b0f5a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_45b6bd98-46e2-40f1-badb-6cc6b3b84240" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_82c5d59f-ad69-43ea-8051-cd4c6b0f5a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d261cde-8f87-44fb-95bf-2b8aff38ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_358ec86d-852a-4b02-b142-3ebd4f430690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d261cde-8f87-44fb-95bf-2b8aff38ae68" xlink:to="loc_us-gaap_Liabilities_358ec86d-852a-4b02-b142-3ebd4f430690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f8d5ec23-65c5-4a97-b2c1-0a6d540ce1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d261cde-8f87-44fb-95bf-2b8aff38ae68" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f8d5ec23-65c5-4a97-b2c1-0a6d540ce1ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_496c58a6-778c-44ca-9244-9c87f2e3d81a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d261cde-8f87-44fb-95bf-2b8aff38ae68" xlink:to="loc_us-gaap_StockholdersEquity_496c58a6-778c-44ca-9244-9c87f2e3d81a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e6a3e1d3-f0df-4609-8387-c7989dcef7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d261cde-8f87-44fb-95bf-2b8aff38ae68" xlink:to="loc_us-gaap_MinorityInterest_e6a3e1d3-f0df-4609-8387-c7989dcef7d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5474defd-a92d-4724-8585-3239b162cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:to="loc_us-gaap_DebtCurrent_5474defd-a92d-4724-8585-3239b162cae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_83bf01da-0309-4948-a33e-c8cf8b7387dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:to="loc_us-gaap_AccountsPayableCurrent_83bf01da-0309-4948-a33e-c8cf8b7387dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_30773fa7-0c23-4427-929d-4105c131001d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_30773fa7-0c23-4427-929d-4105c131001d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c55cc10b-5995-46e9-b55e-f58f5c67b237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c55cc10b-5995-46e9-b55e-f58f5c67b237" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bfe52b2e-4840-4693-a8db-80ee6381d3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_be3321cd-c043-47ed-a865-72058091100d" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bfe52b2e-4840-4693-a8db-80ee6381d3b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e45f93b5-1c45-4aed-810e-14cefc0cf840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4c477727-4682-4e40-8303-ab701837b625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e45f93b5-1c45-4aed-810e-14cefc0cf840" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4c477727-4682-4e40-8303-ab701837b625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_40f93435-56a7-4a62-ad1f-460a0d12404e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e45f93b5-1c45-4aed-810e-14cefc0cf840" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_40f93435-56a7-4a62-ad1f-460a0d12404e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6adb8404-9751-4dfc-bbf0-5ce789c72a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_LiabilitiesCurrent_6adb8404-9751-4dfc-bbf0-5ce789c72a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b3f15387-91ad-48ae-888c-ee7e46148dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b3f15387-91ad-48ae-888c-ee7e46148dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d2f49c3b-2067-4bff-9a8b-f601b965224b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d2f49c3b-2067-4bff-9a8b-f601b965224b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_e0b39a2e-3fe1-4ba8-9728-58315e3f181d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_e0b39a2e-3fe1-4ba8-9728-58315e3f181d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fec2e58b-8a00-4802-87b8-19272c6b3488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fec2e58b-8a00-4802-87b8-19272c6b3488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_31330199-3e5b-4a18-9509-4205d0ea5127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_15695ab9-f4e7-46ba-b997-d85c2dbed82a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_31330199-3e5b-4a18-9509-4205d0ea5127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0ba7f10a-95b4-418b-9545-2347a9f7b766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_AssetsCurrent_0ba7f10a-95b4-418b-9545-2347a9f7b766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6555fea6-9bf4-4ee4-a5c6-1df3d6855f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6555fea6-9bf4-4ee4-a5c6-1df3d6855f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8bef436a-5df3-4b8d-b36b-04fc2a723a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_Goodwill_8bef436a-5df3-4b8d-b36b-04fc2a723a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9e658d3c-9f93-4f24-8e83-20887dde1424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9e658d3c-9f93-4f24-8e83-20887dde1424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_1167217e-1999-41fc-b602-bdc814bced25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_1167217e-1999-41fc-b602-bdc814bced25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c8b27f8b-ff01-45fa-b155-7b38e593a2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4e7d40c4-859f-4229-b9aa-9bc23614afee" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c8b27f8b-ff01-45fa-b155-7b38e593a2f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1754976d-f83e-4027-bee7-33e66c2496c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_ProfitLoss_1754976d-f83e-4027-bee7-33e66c2496c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2f9273d6-08b6-42ea-b165-c05e050a3a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2f9273d6-08b6-42ea-b165-c05e050a3a5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_dae237bf-5006-4fe1-bde7-64eb1b1804c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_dae237bf-5006-4fe1-bde7-64eb1b1804c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1a019a49-d2da-4071-9766-8a44a2bca9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_1a019a49-d2da-4071-9766-8a44a2bca9d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_acf48187-8ae4-4248-9a98-c7c99a57cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_ShareBasedCompensation_acf48187-8ae4-4248-9a98-c7c99a57cb94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_04b9f934-bca2-47de-8201-4270e4a81d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_04b9f934-bca2-47de-8201-4270e4a81d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_b0c097c1-a95f-40ea-8990-9c44aaa727ec" xlink:href="mdt-20221028.xsd#mdt_AssetImpairmentChargesAndInventoryWriteDown"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_b0c097c1-a95f-40ea-8990-9c44aaa727ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_6124a468-a629-4a34-b5e7-326acacf5b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_6124a468-a629-4a34-b5e7-326acacf5b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2876987b-41ce-4efc-b568-4760d6cdf90f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2876987b-41ce-4efc-b568-4760d6cdf90f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d670be6a-7292-4478-9522-6c4131a34a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d670be6a-7292-4478-9522-6c4131a34a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f4576d9-1750-41df-8cf8-ae7a47322ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f4576d9-1750-41df-8cf8-ae7a47322ca2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_99be266a-bf26-4947-9bd0-43f23ea96abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4bef6ec0-bf11-4ea1-a5e7-37a29cee06bc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_99be266a-bf26-4947-9bd0-43f23ea96abd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0686002c-6c6c-4d5d-b611-6a4ad54bbc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ca9699-11b9-41a0-9af7-fe2067776315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0686002c-6c6c-4d5d-b611-6a4ad54bbc5b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ca9699-11b9-41a0-9af7-fe2067776315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e8a10a06-49d1-4697-82ff-515765a583d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0686002c-6c6c-4d5d-b611-6a4ad54bbc5b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e8a10a06-49d1-4697-82ff-515765a583d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f38b556-18d3-42b4-93ac-09986e14daaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0686002c-6c6c-4d5d-b611-6a4ad54bbc5b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f38b556-18d3-42b4-93ac-09986e14daaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0519c63-2377-41f3-9b95-91d78be08ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0686002c-6c6c-4d5d-b611-6a4ad54bbc5b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0519c63-2377-41f3-9b95-91d78be08ab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_511a71b1-3a6f-418a-81e1-35165935b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_511a71b1-3a6f-418a-81e1-35165935b6af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_7e94976d-1a80-4f79-beec-eda71715a868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_7e94976d-1a80-4f79-beec-eda71715a868" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_64fea0e5-e9e1-4907-8f8f-92ab764a7b04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_64fea0e5-e9e1-4907-8f8f-92ab764a7b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_07df2663-a133-4429-a308-b2841a3a3324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_07df2663-a133-4429-a308-b2841a3a3324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_27ea3cf9-4b78-4c18-a707-df1f064b28cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_27ea3cf9-4b78-4c18-a707-df1f064b28cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_a7dc3382-98d8-4715-81f9-7475619fceff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_a7dc3382-98d8-4715-81f9-7475619fceff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6d5cf015-1357-4fce-adb8-3b9e14670933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6d5cf015-1357-4fce-adb8-3b9e14670933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f23f4c8b-8135-4bab-b5f8-a2b515ad4695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7e9c41c-a58f-4df7-b079-8a7af848bfd4" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_f23f4c8b-8135-4bab-b5f8-a2b515ad4695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fcc135ea-ff10-4e5b-b259-1b6c9a1e9ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fcc135ea-ff10-4e5b-b259-1b6c9a1e9ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e911ea1-d43f-4244-8c5c-6762d3ff7ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e911ea1-d43f-4244-8c5c-6762d3ff7ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_44288d14-c6bb-47ae-acf6-0b1b4d3fc27a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_44288d14-c6bb-47ae-acf6-0b1b4d3fc27a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_4d832d3a-33ae-4431-9b90-d35fe329e134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_4d832d3a-33ae-4431-9b90-d35fe329e134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2744174e-9b7b-42e4-980e-5b7fb9cc3036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe5fc22d-6924-43ea-ab3c-085e3e61de9f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2744174e-9b7b-42e4-980e-5b7fb9cc3036" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_60376543-8eeb-4aff-bb2f-f3a6b5eb682c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_60376543-8eeb-4aff-bb2f-f3a6b5eb682c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_6dbc9a78-e2ff-4cfa-bbc4-1cd521168aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_6dbc9a78-e2ff-4cfa-bbc4-1cd521168aed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_09809555-ca1e-4eb2-918d-1a8c844f5ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:to="loc_us-gaap_Goodwill_09809555-ca1e-4eb2-918d-1a8c844f5ca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_52526ce3-ff88-4f49-b8c0-50157a5fd941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_52526ce3-ff88-4f49-b8c0-50157a5fd941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9a986f31-2d15-4647-a4eb-922c9f5875bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c1aa0a9d-1d2e-4175-8a09-56eeaec45c43" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9a986f31-2d15-4647-a4eb-922c9f5875bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a5908f8e-eb3b-4682-be49-83d6c419b294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8abe45d5-55c8-4e49-a3d1-3646929db89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a5908f8e-eb3b-4682-be49-83d6c419b294" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8abe45d5-55c8-4e49-a3d1-3646929db89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55994648-fdfe-42e3-b93c-fda42c33462f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a5908f8e-eb3b-4682-be49-83d6c419b294" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_55994648-fdfe-42e3-b93c-fda42c33462f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f0b09b8-bf30-471c-bc82-05b67e599c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a5908f8e-eb3b-4682-be49-83d6c419b294" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1f0b09b8-bf30-471c-bc82-05b67e599c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1d667324-879f-40bb-b829-80a35d510cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e95d94d2-c990-4e7c-80e4-afc50395dd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1d667324-879f-40bb-b829-80a35d510cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e95d94d2-c990-4e7c-80e4-afc50395dd6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee9e7159-bfb5-4cc3-9f8a-5f2139ed6136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1d667324-879f-40bb-b829-80a35d510cc1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee9e7159-bfb5-4cc3-9f8a-5f2139ed6136" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_06176b61-001c-4a7f-9f18-c343d3487ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_06176b61-001c-4a7f-9f18-c343d3487ebf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_312cfb18-4b40-4cce-8058-00584357be37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_312cfb18-4b40-4cce-8058-00584357be37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5f78cede-4e04-48f2-9e05-7916890b8f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_5f78cede-4e04-48f2-9e05-7916890b8f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_fc0df1a5-933c-4836-be18-13a99f5078bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_fc0df1a5-933c-4836-be18-13a99f5078bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_165afe1d-c558-4e30-a3c1-5949262652d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_795958ea-f8e6-49cf-8c99-81baeb8f0ae0" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_165afe1d-c558-4e30-a3c1-5949262652d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_91632bd4-1e9c-4ca2-9477-f27f84fdd704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_24e8f314-2d5d-4977-9d08-014e9c116855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_91632bd4-1e9c-4ca2-9477-f27f84fdd704" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_24e8f314-2d5d-4977-9d08-014e9c116855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_d7feff7b-5980-483d-ad0f-cf02a4797bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_91632bd4-1e9c-4ca2-9477-f27f84fdd704" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_d7feff7b-5980-483d-ad0f-cf02a4797bbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6a0dbde5-aa69-4230-a8e1-b7d5a4a8fe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_91632bd4-1e9c-4ca2-9477-f27f84fdd704" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6a0dbde5-aa69-4230-a8e1-b7d5a4a8fe5c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_111c5c60-c77d-4e4d-a137-1831fa811627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_3aa48d39-bb13-47af-a43b-856c7dd2f686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_111c5c60-c77d-4e4d-a137-1831fa811627" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_3aa48d39-bb13-47af-a43b-856c7dd2f686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8c15ef61-1ab4-49df-b9b1-5b6f7e0688c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_111c5c60-c77d-4e4d-a137-1831fa811627" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8c15ef61-1ab4-49df-b9b1-5b6f7e0688c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3041e918-6402-44d9-9c0d-a6f6e70ce9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_111c5c60-c77d-4e4d-a137-1831fa811627" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_3041e918-6402-44d9-9c0d-a6f6e70ce9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_92c79228-f765-4920-9499-ee1c5f510dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_111c5c60-c77d-4e4d-a137-1831fa811627" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_92c79228-f765-4920-9499-ee1c5f510dac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_d84ee8db-1dc2-4868-bc34-c37509a5e89e" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_91d685ab-6894-4891-9258-d0349d2a4f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_d84ee8db-1dc2-4868-bc34-c37509a5e89e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_91d685ab-6894-4891-9258-d0349d2a4f1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_57f82f60-2ed5-4298-adc1-02df016e53a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_d84ee8db-1dc2-4868-bc34-c37509a5e89e" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_57f82f60-2ed5-4298-adc1-02df016e53a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_47059274-1fe6-4846-842a-d286ae1f2b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_d84ee8db-1dc2-4868-bc34-c37509a5e89e" xlink:to="loc_us-gaap_EquityMethodInvestments_47059274-1fe6-4846-842a-d286ae1f2b63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d3b0209-6e54-44f5-a94e-5a5418551561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7fb54fae-c382-481a-9f32-ed1d05d87de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d3b0209-6e54-44f5-a94e-5a5418551561" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7fb54fae-c382-481a-9f32-ed1d05d87de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8c5a594e-b336-49dc-9672-ba8717b00f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d3b0209-6e54-44f5-a94e-5a5418551561" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8c5a594e-b336-49dc-9672-ba8717b00f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f4e0ca7d-8689-4ea0-923c-18e9f2ec1dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d3b0209-6e54-44f5-a94e-5a5418551561" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f4e0ca7d-8689-4ea0-923c-18e9f2ec1dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f8773109-788f-4c9d-a2fb-df640025380f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8d3b0209-6e54-44f5-a94e-5a5418551561" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f8773109-788f-4c9d-a2fb-df640025380f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_f4e7c08e-d015-4ce4-bd4e-405c6155c461" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b54d8793-03c0-40dc-93c3-c1fbae2902c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_f4e7c08e-d015-4ce4-bd4e-405c6155c461" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_b54d8793-03c0-40dc-93c3-c1fbae2902c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_7df428a1-ef9b-4ddf-bc0e-07b674172bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_f4e7c08e-d015-4ce4-bd4e-405c6155c461" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_7df428a1-ef9b-4ddf-bc0e-07b674172bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_87c510e4-7a02-4fab-ab7f-dc40f1fee1f8" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a4831752-5d58-49bf-9964-4bf9fdc0db0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_87c510e4-7a02-4fab-ab7f-dc40f1fee1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a4831752-5d58-49bf-9964-4bf9fdc0db0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ee0cdc0a-0f30-4d87-94b8-5f11c74d22db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_87c510e4-7a02-4fab-ab7f-dc40f1fee1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ee0cdc0a-0f30-4d87-94b8-5f11c74d22db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_50364d2c-5e99-4b6d-94a4-83de1a596b1a" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_3b49a3c3-2643-46bd-960c-25048a3d1369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_50364d2c-5e99-4b6d-94a4-83de1a596b1a" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_3b49a3c3-2643-46bd-960c-25048a3d1369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_d9037d1a-9542-410a-8114-b83e3fbb8111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_50364d2c-5e99-4b6d-94a4-83de1a596b1a" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_d9037d1a-9542-410a-8114-b83e3fbb8111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_86b710d0-e534-4276-a5b7-d865e7e8d2b0" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_20af3eee-de43-4881-8275-22081bed1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_86b710d0-e534-4276-a5b7-d865e7e8d2b0" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_20af3eee-de43-4881-8275-22081bed1d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_b558cbc9-a5dd-44ad-97ed-e119158615a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_86b710d0-e534-4276-a5b7-d865e7e8d2b0" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_b558cbc9-a5dd-44ad-97ed-e119158615a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_99d0d1e7-967e-4e3d-a556-acab395f4301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_af925314-39d5-4893-bbd1-45408a33dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_99d0d1e7-967e-4e3d-a556-acab395f4301" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_af925314-39d5-4893-bbd1-45408a33dc4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_7cef6624-e5b7-44d5-a543-434748c01ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_99d0d1e7-967e-4e3d-a556-acab395f4301" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_7cef6624-e5b7-44d5-a543-434748c01ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_f928f7c7-319b-487b-9413-eb7a3619d4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_99d0d1e7-967e-4e3d-a556-acab395f4301" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_f928f7c7-319b-487b-9413-eb7a3619d4f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_723a2c83-2980-461c-9de6-fd6837eac2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4e2f23fb-8bdc-423e-9374-c563c8881c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_723a2c83-2980-461c-9de6-fd6837eac2df" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4e2f23fb-8bdc-423e-9374-c563c8881c57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_091f8ed4-3038-4add-bacf-06d54cff3e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_723a2c83-2980-461c-9de6-fd6837eac2df" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_091f8ed4-3038-4add-bacf-06d54cff3e4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_a5ec54d4-1d10-4fb9-8d3a-35e09a404085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_723a2c83-2980-461c-9de6-fd6837eac2df" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_a5ec54d4-1d10-4fb9-8d3a-35e09a404085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_91eb5945-10fe-4270-97b9-7305bad5fd16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_f351f90f-1ae3-4983-87fd-1613936cc0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_91eb5945-10fe-4270-97b9-7305bad5fd16" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_f351f90f-1ae3-4983-87fd-1613936cc0aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_57a13908-c8d8-436d-be2f-ee971cc8a3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_91eb5945-10fe-4270-97b9-7305bad5fd16" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_57a13908-c8d8-436d-be2f-ee971cc8a3af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_635d6bad-cf6e-4023-b283-1810d21c628d" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7565b9ef-4511-45d6-a0f1-037a3400a757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_635d6bad-cf6e-4023-b283-1810d21c628d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7565b9ef-4511-45d6-a0f1-037a3400a757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_71215daf-530a-4c45-949e-d27f50db139d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_635d6bad-cf6e-4023-b283-1810d21c628d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_71215daf-530a-4c45-949e-d27f50db139d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_26e37f00-d9e1-41dd-9b93-79c49f2dc332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_ef199fa8-19ab-47ec-8276-2b6b4e68e8e7" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_26e37f00-d9e1-41dd-9b93-79c49f2dc332" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_ef199fa8-19ab-47ec-8276-2b6b4e68e8e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_74e413fd-faa1-4320-9fbb-0ee565432002" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_26e37f00-d9e1-41dd-9b93-79c49f2dc332" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_74e413fd-faa1-4320-9fbb-0ee565432002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_1e319d2c-8a9f-4de0-9947-f79bc0b7bf04" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_26e37f00-d9e1-41dd-9b93-79c49f2dc332" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_1e319d2c-8a9f-4de0-9947-f79bc0b7bf04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3fd59a91-5925-4d79-a159-e7dd9321833d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4e3a214b-8087-46b3-a807-843c0dda3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3fd59a91-5925-4d79-a159-e7dd9321833d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4e3a214b-8087-46b3-a807-843c0dda3a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ada41ece-f7b1-40e5-a905-f32ae4d17094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3fd59a91-5925-4d79-a159-e7dd9321833d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ada41ece-f7b1-40e5-a905-f32ae4d17094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66e78291-4250-430c-829c-60dd64bbea76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3fd59a91-5925-4d79-a159-e7dd9321833d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66e78291-4250-430c-829c-60dd64bbea76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c5b7d26-cad9-42a8-bc2e-0796fef8b9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98da6402-1f36-4c31-bfac-1f0ca32f36b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c5b7d26-cad9-42a8-bc2e-0796fef8b9a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_98da6402-1f36-4c31-bfac-1f0ca32f36b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_55f5f6f1-6db3-48a6-b23e-bd1526cfef47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c5b7d26-cad9-42a8-bc2e-0796fef8b9a6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_55f5f6f1-6db3-48a6-b23e-bd1526cfef47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_d3bbdf7a-76ef-4ab0-934b-925543ec4279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c5b7d26-cad9-42a8-bc2e-0796fef8b9a6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_d3bbdf7a-76ef-4ab0-934b-925543ec4279" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#StockBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2148dd07-c4c6-4118-9a16-89695ea8232b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d24ab414-f57f-4ad8-99e2-12eb66a38556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2148dd07-c4c6-4118-9a16-89695ea8232b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d24ab414-f57f-4ad8-99e2-12eb66a38556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_659d310a-769e-4b42-9bc6-b5e48b8e4cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2148dd07-c4c6-4118-9a16-89695ea8232b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_659d310a-769e-4b42-9bc6-b5e48b8e4cd8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a041df8a-b994-4cd3-99c8-a72caabdc32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_1687deb7-9a03-4250-9ff6-2bb7058bed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a041df8a-b994-4cd3-99c8-a72caabdc32b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_1687deb7-9a03-4250-9ff6-2bb7058bed9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_26257575-36c9-4569-8da7-517007299b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a041df8a-b994-4cd3-99c8-a72caabdc32b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_26257575-36c9-4569-8da7-517007299b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_317c8a4c-625a-4789-b905-ac0c271005a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a041df8a-b994-4cd3-99c8-a72caabdc32b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_317c8a4c-625a-4789-b905-ac0c271005a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8f0258ad-e357-4858-8b47-25f2af2ea720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a041df8a-b994-4cd3-99c8-a72caabdc32b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8f0258ad-e357-4858-8b47-25f2af2ea720" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c08436d6-8b4c-4566-a63b-012f6786d507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78e75cc5-c312-42fe-82d1-f1aad8def509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c08436d6-8b4c-4566-a63b-012f6786d507" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78e75cc5-c312-42fe-82d1-f1aad8def509" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8abb8ab2-a44e-4f34-a81d-90a6a0e2e547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c08436d6-8b4c-4566-a63b-012f6786d507" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8abb8ab2-a44e-4f34-a81d-90a6a0e2e547" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"/>
  <link:calculationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8b0a75d1-9aa1-4e94-86c5-e559c9879f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_OperatingIncomeLoss_8b0a75d1-9aa1-4e94-86c5-e559c9879f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_9e5c3355-4949-4c47-bf0d-3e113c82bc0c" xlink:href="mdt-20221028.xsd#mdt_MedicalDeviceRegulations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_mdt_MedicalDeviceRegulations_9e5c3355-4949-4c47-bf0d-3e113c82bc0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_008089a3-5395-4ad5-92e7-f4895fa12c61" xlink:href="mdt-20221028.xsd#mdt_CentralizedDistributionCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_mdt_CentralizedDistributionCosts_008089a3-5395-4ad5-92e7-f4895fa12c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_f9997ab3-8cab-4ae4-b962-d49556563bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_f9997ab3-8cab-4ae4-b962-d49556563bcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bea77a12-d666-42c8-9af2-d6b7608aa804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bea77a12-d666-42c8-9af2-d6b7608aa804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_dbfcf64d-5c43-4a1e-a95f-93af27810134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_dbfcf64d-5c43-4a1e-a95f-93af27810134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6f69023a-dfab-4835-bf4e-6736fac02dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6f69023a-dfab-4835-bf4e-6736fac02dee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_f79849d9-795f-4bcc-8038-478018156da7" xlink:href="mdt-20221028.xsd#mdt_CorporateOverhead"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_mdt_CorporateOverhead_f79849d9-795f-4bcc-8038-478018156da7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e4b3a377-417e-4bee-915d-92ff1d2f552b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_RestructuringCharges_e4b3a377-417e-4bee-915d-92ff1d2f552b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9307e469-f057-4acf-b02b-8fffc7a262c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9307e469-f057-4acf-b02b-8fffc7a262c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_ddf7f704-0e91-47d6-9a5c-b78ca545ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_BusinessExitCosts1_ddf7f704-0e91-47d6-9a5c-b78ca545ef8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_41dae86f-85af-4142-81ea-e20b0e252691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f25a0dfb-5415-49e8-a245-01ec86c63fc9" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_41dae86f-85af-4142-81ea-e20b0e252691" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mdt-20221028_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/Cover" xlink:type="simple" xlink:href="mdt-20221028.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/Cover" xlink:type="extended" id="i8aedd7d08143418b876255812a76f647_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_01f1557e-bc7f-4771-8883-ab85377f5dd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentType_01f1557e-bc7f-4771-8883-ab85377f5dd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_909e2686-a879-4dbc-a414-c506e774a580" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentQuarterlyReport_909e2686-a879-4dbc-a414-c506e774a580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_846ee3f6-287e-4512-b076-16c89ec20703" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentPeriodEndDate_846ee3f6-287e-4512-b076-16c89ec20703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5d845398-5824-448b-91a9-6b202beac5f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentTransitionReport_5d845398-5824-448b-91a9-6b202beac5f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_dbd8b62d-5729-4308-b7a7-d8cb0df5999f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityFileNumber_dbd8b62d-5729-4308-b7a7-d8cb0df5999f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_eb0ae9ac-8b2c-4e48-898a-e06e93a81d0d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityRegistrantName_eb0ae9ac-8b2c-4e48-898a-e06e93a81d0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e4af0431-7520-47cc-bec4-1690baa97996" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e4af0431-7520-47cc-bec4-1690baa97996" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f72b009b-c2b9-40b5-899a-e3d39ccd4b98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityTaxIdentificationNumber_f72b009b-c2b9-40b5-899a-e3d39ccd4b98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2221863b-8299-4b8c-9e65-611659719e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressAddressLine1_2221863b-8299-4b8c-9e65-611659719e61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9eeb4209-691f-4614-a950-1beb231ae636" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressCityOrTown_9eeb4209-691f-4614-a950-1beb231ae636" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_20b6ba8b-533a-4bc2-b383-71057c3f75ac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressCountry_20b6ba8b-533a-4bc2-b383-71057c3f75ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_13ba5704-5dc8-4d32-8151-562e169adfde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CountryRegion_13ba5704-5dc8-4d32-8151-562e169adfde" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_18c78ecd-436e-4a43-8d5e-fcc77e90360d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CityAreaCode_18c78ecd-436e-4a43-8d5e-fcc77e90360d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3dc39d4d-93bd-4cea-bb42-e0c2eb335df3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_LocalPhoneNumber_3dc39d4d-93bd-4cea-bb42-e0c2eb335df3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_33cf2dba-83bd-4d36-906c-25030be4ac4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_Security12bTitle_33cf2dba-83bd-4d36-906c-25030be4ac4c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_573010f3-559b-46e9-a383-b221d6036e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_TradingSymbol_573010f3-559b-46e9-a383-b221d6036e22" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3bbb2209-7e02-467c-a5b4-ee8493074978" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_SecurityExchangeName_3bbb2209-7e02-467c-a5b4-ee8493074978" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_eb397bb4-a595-4c6d-849b-b89acbe8927f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCurrentReportingStatus_eb397bb4-a595-4c6d-849b-b89acbe8927f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad60131e-61eb-4688-87a7-bcd7a2e40b6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad60131e-61eb-4688-87a7-bcd7a2e40b6b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_4814e43c-6401-4e3c-ac56-139a62892a2f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityFilerCategory_4814e43c-6401-4e3c-ac56-139a62892a2f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8c54f0d4-ceb7-43ab-8cec-791fb112e372" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityEmergingGrowthCompany_8c54f0d4-ceb7-43ab-8cec-791fb112e372" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_13d03c99-2db7-4417-80d7-8fa285b3259b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntitySmallBusiness_13d03c99-2db7-4417-80d7-8fa285b3259b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2630002a-9277-4bf3-a89d-188a88704587" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityShellCompany_2630002a-9277-4bf3-a89d-188a88704587" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0d046a8b-81f8-4e28-9e2d-c17d87a6dbe0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0d046a8b-81f8-4e28-9e2d-c17d87a6dbe0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8ca40b31-7430-47f9-ae0f-a63292c1b896" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCentralIndexKey_8ca40b31-7430-47f9-ae0f-a63292c1b896" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6bd3f732-57d1-41c0-b27d-8238ab09d62f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CurrentFiscalYearEndDate_6bd3f732-57d1-41c0-b27d-8238ab09d62f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8363955b-c4ee-4f32-878a-8442fb156042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_AmendmentFlag_8363955b-c4ee-4f32-878a-8442fb156042" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fcb96cec-1ee8-48c3-9071-130752e1c4bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fcb96cec-1ee8-48c3-9071-130752e1c4bc" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e481ba4-a600-41fa-8a7c-ee88ae7b6076" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentFiscalYearFocus_2e481ba4-a600-41fa-8a7c-ee88ae7b6076" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3e348412-5ad2-4745-ad22-3e242fbe1909" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressPostalZipCode_3e348412-5ad2-4745-ad22-3e242fbe1909" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:to="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_132d14c5-9f93-47da-970e-c7756ac248c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:to="loc_us-gaap_ClassOfStockDomain_132d14c5-9f93-47da-970e-c7756ac248c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:to="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c029067-8f47-4f63-a18b-54a81d3ef2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_us-gaap_CommonStockMember_2c029067-8f47-4f63-a18b-54a81d3ef2d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_19420b02-f220-4393-9933-5ac078fa8fee" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_19420b02-f220-4393-9933-5ac078fa8fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230375PercentMember_c842d789-b8cc-4a52-bf60-af688ed4d4a0" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20230375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20230375PercentMember_c842d789-b8cc-4a52-bf60-af688ed4d4a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20230000PercentMember_e6ba0fd6-d36f-449c-b402-f9cd3d189373" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20230000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due20230000PercentMember_e6ba0fd6-d36f-449c-b402-f9cd3d189373" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_22ab4a65-f627-46c8-bfcc-b3a09080fdba" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_22ab4a65-f627-46c8-bfcc-b3a09080fdba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_85dd305f-bba6-4ccb-ac78-c482cf6914b7" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_85dd305f-bba6-4ccb-ac78-c482cf6914b7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2025Member_4b4cfbc6-333a-4954-8c72-b4691273267d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2025Member_4b4cfbc6-333a-4954-8c72-b4691273267d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20271125PercentMember_1815b289-8375-4511-9988-3cb6e0d175c1" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20271125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20271125PercentMember_1815b289-8375-4511-9988-3cb6e0d175c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_028269f4-70e5-4011-92de-6f1d7852e259" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_028269f4-70e5-4011-92de-6f1d7852e259" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2028Member_ec685783-ddf8-44e6-82bf-4ffe1a87fc24" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2028Member_ec685783-ddf8-44e6-82bf-4ffe1a87fc24" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311625PercentMember_30752932-9fe7-47b4-8540-610529c4f592" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20311625PercentMember_30752932-9fe7-47b4-8540-610529c4f592" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ad2c1c16-cc03-485f-825b-553f7ee49e1c" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ad2c1c16-cc03-485f-825b-553f7ee49e1c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2031Member_d0cd45eb-8502-4ed8-ba4e-fa96ad14b1e3" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2031Member_d0cd45eb-8502-4ed8-ba4e-fa96ad14b1e3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_77c2634d-49eb-45f5-b42c-c0fd9567b313" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_77c2634d-49eb-45f5-b42c-c0fd9567b313" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2034Member_0b984fed-632c-4c9d-b479-028c7be0895a" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2034Member_0b984fed-632c-4c9d-b479-028c7be0895a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20394500PercentMember_31f02b3b-cd4d-4b55-9665-edf422a78d20" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20394500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20394500PercentMember_31f02b3b-cd4d-4b55-9665-edf422a78d20" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_0175120c-402f-4ffa-be98-4e62e4091b3a" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_0175120c-402f-4ffa-be98-4e62e4091b3a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_91792788-a1a0-4016-87d7-f8d071f6085b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_91792788-a1a0-4016-87d7-f8d071f6085b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_02519bb4-d773-43c0-a6db-2176cea48d82" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_02519bb4-d773-43c0-a6db-2176cea48d82" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_3fc3bdfd-6f53-4e0a-832e-c1e57ed5df64" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_3fc3bdfd-6f53-4e0a-832e-c1e57ed5df64" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="extended" id="i9a6a65e69a1f460583d6417386d28e7d_ConsolidatedStatementsofEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a5901d1c-4115-451a-af34-e7bca30c6690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a5901d1c-4115-451a-af34-e7bca30c6690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_335c38a4-20af-48d2-9711-7f5cd83d43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_335c38a4-20af-48d2-9711-7f5cd83d43f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_16265c75-551a-4535-9897-4941e41d7ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_ProfitLoss_16265c75-551a-4535-9897-4941e41d7ef0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b94ed86b-9adc-4678-b750-97001efef1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b94ed86b-9adc-4678-b750-97001efef1e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_6ad67d1b-6887-475c-b68c-0bd6b5d46809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_DividendsCommonStockCash_6ad67d1b-6887-475c-b68c-0bd6b5d46809" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a04f5fd-4d1e-4a3b-ab17-dd3c8e395d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a04f5fd-4d1e-4a3b-ab17-dd3c8e395d89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3afae37f-b2e4-41e7-9021-98e2b5fccac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3afae37f-b2e4-41e7-9021-98e2b5fccac3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d66d1cf8-7848-48e4-a830-25fd9fe1f80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d66d1cf8-7848-48e4-a830-25fd9fe1f80e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_409a0c50-b3b0-458b-ba09-f820d6808059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_409a0c50-b3b0-458b-ba09-f820d6808059" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_59b34f3d-8655-4afb-b6e2-96815cc28da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_59b34f3d-8655-4afb-b6e2-96815cc28da7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_324b2223-85a8-47cb-8aa4-25a4b6af07ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_324b2223-85a8-47cb-8aa4-25a4b6af07ae" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2d3961cc-89fe-46a1-863e-14dc2215692f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e404b7f-1749-46c7-91cc-2f5088f1500a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:to="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9af0831-e3b4-47d3-8373-a4182caecbca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:to="loc_us-gaap_EquityComponentDomain_c9af0831-e3b4-47d3-8373-a4182caecbca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:to="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:to="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ca8aa728-3d20-434c-bac7-a655747343b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_CommonStockMember_ca8aa728-3d20-434c-bac7-a655747343b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b1172586-ec02-4124-9bbb-018fb2afc847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b1172586-ec02-4124-9bbb-018fb2afc847" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96b30e46-0baf-494f-8dbd-660f954bd907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_RetainedEarningsMember_96b30e46-0baf-494f-8dbd-660f954bd907" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f9022403-9ddd-4840-8986-60a9137cc556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f9022403-9ddd-4840-8986-60a9137cc556" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8b2ef87f-a87a-4d00-b57a-bde757e57d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8b2ef87f-a87a-4d00-b57a-bde757e57d75" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="extended" id="i6560f82c90654b1abf090577b26bb1d9_RevenueDisaggregationofNetSalesbySegmentandDivisionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa52071c-1356-4cb7-80b7-d6eb1321e036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa52071c-1356-4cb7-80b7-d6eb1321e036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a828dc09-5507-4822-b786-b0f70f58da54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:to="loc_us-gaap_SegmentDomain_a828dc09-5507-4822-b786-b0f70f58da54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:to="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_b1077158-2ae9-480e-8ba5-5e6ca1b30872" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_CardiovascularMember_b1077158-2ae9-480e-8ba5-5e6ca1b30872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_07b660d5-4213-4997-8520-0c57283f4631" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_MedicalSurgicalMember_07b660d5-4213-4997-8520-0c57283f4631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_aa22425a-67aa-445c-b841-393f07b6c363" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_NeuroscienceGroupMember_aa22425a-67aa-445c-b841-393f07b6c363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_aa2e400a-acce-437c-bc2b-eb6629182565" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_DiabetesGroupMember_aa2e400a-acce-437c-bc2b-eb6629182565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:to="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_f84c0bb5-228c-4a52-93c6-3cb20f1671ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:to="loc_us-gaap_SubsegmentsDomain_f84c0bb5-228c-4a52-93c6-3cb20f1671ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:to="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_7fe24410-50f4-41b6-9171-a6b085e6b470" xlink:href="mdt-20221028.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_7fe24410-50f4-41b6-9171-a6b085e6b470" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_StructuralHeartAndAorticDivisionMember_1780c073-0496-4e13-8396-f451f2487a57" xlink:href="mdt-20221028.xsd#mdt_StructuralHeartAndAorticDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_StructuralHeartAndAorticDivisionMember_1780c073-0496-4e13-8396-f451f2487a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryAndPeripheralVascularDivisionMember_6ecc15da-b49f-472d-9939-6bebd146ecde" xlink:href="mdt-20221028.xsd#mdt_CoronaryAndPeripheralVascularDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CoronaryAndPeripheralVascularDivisionMember_6ecc15da-b49f-472d-9939-6bebd146ecde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember_e274c95f-3d8b-4a8e-a343-28806585d792" xlink:href="mdt-20221028.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_SurgicalInnovationsDivisionMember_e274c95f-3d8b-4a8e-a343-28806585d792" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_7b0f37e3-f5d2-4121-8d21-89df5e64d555" xlink:href="mdt-20221028.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_7b0f37e3-f5d2-4121-8d21-89df5e64d555" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_48bdb408-c0dd-465e-9143-33a08ab19126" xlink:href="mdt-20221028.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_48bdb408-c0dd-465e-9143-33a08ab19126" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember_077739d9-2f0e-4a1b-a01a-c554f4d23f7a" xlink:href="mdt-20221028.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_SpecialtyTherapiesDivisionMember_077739d9-2f0e-4a1b-a01a-c554f4d23f7a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember_3f8299f8-7d40-45ac-a09f-eaaa9b97e0d0" xlink:href="mdt-20221028.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_NeuromodulationDivisionMember_3f8299f8-7d40-45ac-a09f-eaaa9b97e0d0" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="extended" id="i480c7dcfd25940a49af46a783d82729c_RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_817f0f4e-1149-45ac-a1be-d9ecd958ba9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_817f0f4e-1149-45ac-a1be-d9ecd958ba9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_57ff65d2-097c-44c5-a2b1-5e98516d71b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:to="loc_us-gaap_SegmentDomain_57ff65d2-097c-44c5-a2b1-5e98516d71b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:to="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_f05694c3-ba40-47f0-8f19-87ddc2d76682" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_CardiovascularMember_f05694c3-ba40-47f0-8f19-87ddc2d76682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_1f52561d-adc6-4145-9b64-e53a88ee127e" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_MedicalSurgicalMember_1f52561d-adc6-4145-9b64-e53a88ee127e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_ad71717c-875b-4421-a152-0eae1db69d57" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_NeuroscienceGroupMember_ad71717c-875b-4421-a152-0eae1db69d57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_432446f6-d62b-464e-9571-e78b0a2c427c" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_DiabetesGroupMember_432446f6-d62b-464e-9571-e78b0a2c427c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:to="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_250b65cb-524d-4563-9fd3-ed2d336b1640_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:to="loc_srt_SegmentGeographicalDomain_250b65cb-524d-4563-9fd3-ed2d336b1640_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:to="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_36854490-4e60-4005-90b0-07fbdaf4ba0f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_country_US_36854490-4e60-4005-90b0-07fbdaf4ba0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_d1ce5310-92d8-49b6-a701-96d66b658081" xlink:href="mdt-20221028.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_d1ce5310-92d8-49b6-a701-96d66b658081" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_5dedd47e-b4b1-4c6c-b2b6-0d7fcb69b7a8" xlink:href="mdt-20221028.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_5dedd47e-b4b1-4c6c-b2b6-0d7fcb69b7a8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="extended" id="id6eb9e40ba034d4b9e9db12b3f391003_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_f419519b-ddf7-4acf-b361-e415f3aa1cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_f419519b-ddf7-4acf-b361-e415f3aa1cb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_6c5699e6-3b80-4f1b-a101-4736452b0bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerLiability_6c5699e6-3b80-4f1b-a101-4736452b0bdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_552d19b3-28a4-4565-8134-c0f90540b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_552d19b3-28a4-4565-8134-c0f90540b7f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_947e8a20-721c-4233-87e4-834c4662b5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_947e8a20-721c-4233-87e4-834c4662b5bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_0d3fb7f6-57d4-4317-b80c-72db795864ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_0d3fb7f6-57d4-4317-b80c-72db795864ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a520a5f-9ec6-475a-9251-82496d282c2a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a520a5f-9ec6-475a-9251-82496d282c2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_6dbebb7e-0fd7-4bed-b579-a5e2fe91ee7c" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_mdt_OtherAccruedExpensesMember_6dbebb7e-0fd7-4bed-b579-a5e2fe91ee7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_b0669b7e-b129-42f2-ad74-41bcc9a874b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_us-gaap_AccountsReceivableMember_b0669b7e-b129-42f2-ad74-41bcc9a874b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ce31fab6-0d51-4af1-a2fa-080c351e3162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ce31fab6-0d51-4af1-a2fa-080c351e3162" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails" xlink:type="extended" id="i88a478e86c954c428ba17e70878fc32b_AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_a380cfc0-9246-4a60-8d8e-778c682f5d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_a380cfc0-9246-4a60-8d8e-778c682f5d9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_56b9c0d6-d826-4bd4-8a62-3043c201afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_56b9c0d6-d826-4bd4-8a62-3043c201afcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_71a07f12-014f-4ccd-8e5a-ca6ed553cc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_71a07f12-014f-4ccd-8e5a-ca6ed553cc17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f812fd24-0e79-43a2-8a55-a761aeefe274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f812fd24-0e79-43a2-8a55-a761aeefe274" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16dd3318-07fb-4813-b3da-6744b0cfd6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_Goodwill_16dd3318-07fb-4813-b3da-6744b0cfd6fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_bc2488d4-f67d-45f3-9bae-3cb61488ff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_bc2488d4-f67d-45f3-9bae-3cb61488ff4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2539c7a4-4a63-4f37-ad62-6aeca690d426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2539c7a4-4a63-4f37-ad62-6aeca690d426" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de98a8e9-c0bd-4a2f-a118-955f017e941d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de98a8e9-c0bd-4a2f-a118-955f017e941d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_430a823b-c050-449e-b9a4-57e564100108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_430a823b-c050-449e-b9a4-57e564100108" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_9515a791-7016-4248-bed9-66904db784bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_9515a791-7016-4248-bed9-66904db784bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9d9c6562-995a-4c04-b2d4-738fe3636489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9d9c6562-995a-4c04-b2d4-738fe3636489" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPriceContingentConsideration_17b862cf-b7d5-45f7-a260-4e7e50cfa8b5" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPriceContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_mdt_BusinessAcquisitionPriceContingentConsideration_17b862cf-b7d5-45f7-a260-4e7e50cfa8b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_5686ec6e-9230-40ab-8a41-9265c2d1a1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_5686ec6e-9230-40ab-8a41-9265c2d1a1f4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_664827ef-ce1a-4696-b24a-2b3424ce0033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_664827ef-ce1a-4696-b24a-2b3424ce0033" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee7c054c-35a3-44ba-b4c7-9644de8b802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee7c054c-35a3-44ba-b4c7-9644de8b802c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TechnologyBasedIntangibleAssets_2f716577-e145-4054-9ec2-589a05ea5988" xlink:href="mdt-20221028.xsd#mdt_TechnologyBasedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_mdt_TechnologyBasedIntangibleAssets_2f716577-e145-4054-9ec2-589a05ea5988" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_47bb17e7-df55-4a62-a7e1-f0e9f3c6e92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_47bb17e7-df55-4a62-a7e1-f0e9f3c6e92e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c460dbaf-7984-49be-bb58-f1800b93e5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c460dbaf-7984-49be-bb58-f1800b93e5b6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_f601f045-7ff2-4758-9c4d-b53b0daad6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_f601f045-7ff2-4758-9c4d-b53b0daad6d4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IntersectENTMember_11b18985-82a5-4033-a380-6957161aa925" xlink:href="mdt-20221028.xsd#mdt_IntersectENTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_IntersectENTMember_11b18985-82a5-4033-a380-6957161aa925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAcquisitionsMember_c7cc954f-6fb9-45ca-a8cf-2c6817dceebb" xlink:href="mdt-20221028.xsd#mdt_OtherAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_OtherAcquisitionsMember_c7cc954f-6fb9-45ca-a8cf-2c6817dceebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_71f5f5c9-ac9c-47d6-a0a3-62bf621b6f37" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_AfferaIncMember_71f5f5c9-ac9c-47d6-a0a3-62bf621b6f37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_219b9ea0-b7d3-4222-ba2a-448ebf61e292_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_219b9ea0-b7d3-4222-ba2a-448ebf61e292_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_24a18275-90a4-4a1e-bfd8-12849cdad984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_24a18275-90a4-4a1e-bfd8-12849cdad984" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_f75b0ab5-d713-4476-a40d-dd3f07e928fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_f75b0ab5-d713-4476-a40d-dd3f07e928fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_22bb34ab-a525-4864-bf64-211410189107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_TradeNamesMember_22bb34ab-a525-4864-bf64-211410189107" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9224406d-0ad2-4423-afff-38e585c00f23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9224406d-0ad2-4423-afff-38e585c00f23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_54d297e1-def4-4734-a889-175281ed11e4" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:to="loc_mdt_OtherAccruedExpensesMember_54d297e1-def4-4734-a889-175281ed11e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_658ca23e-52ca-4dfb-bdd8-7e500a4ad76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:to="loc_us-gaap_OtherLiabilitiesMember_658ca23e-52ca-4dfb-bdd8-7e500a4ad76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_a23d391a-0db8-45b0-8e6b-0c3119fb1d47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:to="loc_us-gaap_AssetAcquisitionDomain_a23d391a-0db8-45b0-8e6b-0c3119fb1d47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:to="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_InProcessResearchDevelopmentMember_02d7acf6-594c-4313-b730-18ee63851128" xlink:href="mdt-20221028.xsd#mdt_InProcessResearchDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:to="loc_mdt_InProcessResearchDevelopmentMember_02d7acf6-594c-4313-b730-18ee63851128" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_36c97e49-2570-4bea-b804-ee89f6ad6f52_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:to="loc_srt_RangeMember_36c97e49-2570-4bea-b804-ee89f6ad6f52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:to="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8cad5b21-a01f-427a-a854-0399e3a0cae9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:to="loc_srt_MinimumMember_8cad5b21-a01f-427a-a854-0399e3a0cae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15f8bcc7-c04d-4a3e-92da-2d75cdf1f682" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:to="loc_srt_MaximumMember_15f8bcc7-c04d-4a3e-92da-2d75cdf1f682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2293ba03-ac04-4142-9da2-5bdc699e26c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2293ba03-ac04-4142-9da2-5bdc699e26c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_99dc32a2-03bd-4ed4-ba82-eae965e4664f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_99dc32a2-03bd-4ed4-ba82-eae965e4664f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b19330e9-80db-4796-8fa1-6a8b5788e6af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b19330e9-80db-4796-8fa1-6a8b5788e6af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b432edc4-cf08-42de-acd5-c6509eb164a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:to="loc_us-gaap_SubsequentEventMember_b432edc4-cf08-42de-acd5-c6509eb164a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="extended" id="ia1dbca7213d54e62a9d40631549d9b52_AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4edf8d5-2211-4615-93b9-564aa7fdffed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4edf8d5-2211-4615-93b9-564aa7fdffed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c765cff3-763e-407e-997a-7a4323228e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c765cff3-763e-407e-997a-7a4323228e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bf044100-6db2-4862-8447-358b1d02445d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_Goodwill_bf044100-6db2-4862-8447-358b1d02445d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6b6045a4-9eeb-4fcd-892a-931270cde63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6b6045a4-9eeb-4fcd-892a-931270cde63c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0ed70c0c-c499-4b4c-8440-c289a105915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0ed70c0c-c499-4b4c-8440-c289a105915e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da15edc6-c8e2-4432-ae86-5243ce946106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da15edc6-c8e2-4432-ae86-5243ce946106" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8a238168-af4c-44e7-a55a-f216910d781b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8a238168-af4c-44e7-a55a-f216910d781b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ba1183d8-36b1-42c5-8db0-c51aff9bc033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ba1183d8-36b1-42c5-8db0-c51aff9bc033" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3624c981-bb27-4e87-971a-6140c86d8778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3624c981-bb27-4e87-971a-6140c86d8778" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4298bcfd-56e9-4db9-b588-c51615b18869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4298bcfd-56e9-4db9-b588-c51615b18869" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7ef9e055-7ba4-4aec-bf6b-88434ef6c51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7ef9e055-7ba4-4aec-bf6b-88434ef6c51a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4255bf5d-58bc-48bb-aca6-a1c79a6e9289_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4255bf5d-58bc-48bb-aca6-a1c79a6e9289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IntersectENTMember_11988728-4ce7-4ae4-b185-8fad71c82964" xlink:href="mdt-20221028.xsd#mdt_IntersectENTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:to="loc_mdt_IntersectENTMember_11988728-4ce7-4ae4-b185-8fad71c82964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_74ea608b-fd6e-48af-aaf0-d7ce304778bc" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:to="loc_mdt_AfferaIncMember_74ea608b-fd6e-48af-aaf0-d7ce304778bc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails" xlink:type="extended" id="i8e2fd4df587c4506a663d5e72c136fb7_AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_93b27367-ea41-4b49-ae46-bb4b7da57c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_93b27367-ea41-4b49-ae46-bb4b7da57c0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b64c73e5-f092-4c90-abcb-dc7a305f5c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b64c73e5-f092-4c90-abcb-dc7a305f5c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_928594bc-6f6d-460d-bf73-665e2c6fc3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_Goodwill_928594bc-6f6d-460d-bf73-665e2c6fc3da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_73c27426-af33-40fd-9ff1-95d9f86b6ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_73c27426-af33-40fd-9ff1-95d9f86b6ced" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_84685767-59c0-45c7-9829-653ec9193218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_84685767-59c0-45c7-9829-653ec9193218" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2135a679-72f6-49a6-a4a8-b07ce88b4030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2135a679-72f6-49a6-a4a8-b07ce88b4030" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_28d1470c-2697-4202-9855-9023751b2fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_28d1470c-2697-4202-9855-9023751b2fb7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_023a13a7-f82d-4fb9-accf-5752b04743a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_023a13a7-f82d-4fb9-accf-5752b04743a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_31c0945b-afbd-40d2-89f5-69a344e70be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_31c0945b-afbd-40d2-89f5-69a344e70be2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a4613501-f8a3-4872-9aef-7b76312bb712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a4613501-f8a3-4872-9aef-7b76312bb712" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a947de2d-8fed-46ee-b93b-6be10331cc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a947de2d-8fed-46ee-b93b-6be10331cc63" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_6f01d1e1-9c50-4356-979d-f67784a2ffd0" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:to="loc_mdt_AfferaIncMember_6f01d1e1-9c50-4356-979d-f67784a2ffd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="extended" id="i74a303f3d01741c295a315ca584a34e9_AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4779f3e5-91ce-4fdc-bb45-9de773dbcd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4779f3e5-91ce-4fdc-bb45-9de773dbcd74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:to="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9363e5de-af49-4488-92fc-ec0a0b7181de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9363e5de-af49-4488-92fc-ec0a0b7181de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_751f80ab-0b8a-4cac-98fa-e9230ee7c88a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_751f80ab-0b8a-4cac-98fa-e9230ee7c88a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember_35f66913-edc2-4186-a5c3-e8f313a6e0c6" xlink:href="mdt-20221028.xsd#mdt_RevenueMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:to="loc_mdt_RevenueMilestoneMember_35f66913-edc2-4186-a5c3-e8f313a6e0c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember_a2bdcc83-3861-4a55-9d7c-de28cb08248a" xlink:href="mdt-20221028.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:to="loc_mdt_ProductDevelopmentMilestoneMember_a2bdcc83-3861-4a55-9d7c-de28cb08248a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_124e6d45-5704-42a6-8b5a-26a93ba27f83_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:to="loc_srt_RangeMember_124e6d45-5704-42a6-8b5a-26a93ba27f83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:to="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3fa08178-08f0-4aca-9dd8-05b22ae5cb2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_MinimumMember_3fa08178-08f0-4aca-9dd8-05b22ae5cb2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9ae1610-2449-4439-af50-561736c87eb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_MaximumMember_a9ae1610-2449-4439-af50-561736c87eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e944fb62-9206-44c8-b4b7-025092cc8b54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_WeightedAverageMember_e944fb62-9206-44c8-b4b7-025092cc8b54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_544636b8-073c-4d5e-884d-7d520c5a72db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_544636b8-073c-4d5e-884d-7d520c5a72db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_46196991-15f1-464e-81bc-ba1f63ce40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_46196991-15f1-464e-81bc-ba1f63ce40f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28403f9b-0377-40c0-86b5-060f5593bb42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28403f9b-0377-40c0-86b5-060f5593bb42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_be24acd8-28b4-4d20-9dfb-32fed835e446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_be24acd8-28b4-4d20-9dfb-32fed835e446" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_14ea36d1-2148-45ed-8386-d0f98324af61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_14ea36d1-2148-45ed-8386-d0f98324af61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7e43f0e4-561f-46b6-bf1d-8503006a7007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7e43f0e4-561f-46b6-bf1d-8503006a7007" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="extended" id="ia09f3709abe9441da2d9dc22abeba049_AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c00c0174-c5c9-4ca3-8c4a-c17a7aef4ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c00c0174-c5c9-4ca3-8c4a-c17a7aef4ace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f2d41f7-2a0f-4d00-a447-241beb727456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f2d41f7-2a0f-4d00-a447-241beb727456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_33407405-e762-4651-9f18-5387e321e1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_33407405-e762-4651-9f18-5387e321e1aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_27b698ff-ba93-446a-a3d7-4212fc01975a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_27b698ff-ba93-446a-a3d7-4212fc01975a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_87569407-7b2a-4c00-87f8-2f89e8c27029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_87569407-7b2a-4c00-87f8-2f89e8c27029" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_98d5d23d-f9fe-4855-9d5c-283af8b435f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_98d5d23d-f9fe-4855-9d5c-283af8b435f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d91bbee7-9fe1-4659-a372-d0688d143869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d91bbee7-9fe1-4659-a372-d0688d143869" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8eff480-68ad-4599-ad35-8bceed67bb1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c8eff480-68ad-4599-ad35-8bceed67bb1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HeldForSaleMember_618508a8-27c0-4d6e-be86-6ceea95aeefe" xlink:href="mdt-20221028.xsd#mdt_HeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:to="loc_mdt_HeldForSaleMember_618508a8-27c0-4d6e-be86-6ceea95aeefe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_90fc5559-9bf8-4275-b4e2-228ee7c5efff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_90fc5559-9bf8-4275-b4e2-228ee7c5efff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails" xlink:type="extended" id="i490f7806f2df42caae59cbec98bd9d04_RestructuringandOtherCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_4cfc8636-b7f3-4dc8-a07b-01ea4a9f076a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_4cfc8636-b7f3-4dc8-a07b-01ea4a9f076a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_4f7db5dd-a998-4f20-8b9a-0ed910b62ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_4f7db5dd-a998-4f20-8b9a-0ed910b62ccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_73f02e64-9668-4cde-a665-ceb453565df5" xlink:href="mdt-20221028.xsd#mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_73f02e64-9668-4cde-a665-ceb453565df5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_14e04969-9070-462f-bf53-aed5c72d5ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringCharges_14e04969-9070-462f-bf53-aed5c72d5ce2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringWriteDownAndImpairmentProvisions_12d2d7ac-4585-4e58-b797-bee39dbed0ba" xlink:href="mdt-20221028.xsd#mdt_RestructuringWriteDownAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_RestructuringWriteDownAndImpairmentProvisions_12d2d7ac-4585-4e58-b797-bee39dbed0ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_470de002-f2fd-46af-9a26-46849d93442a" xlink:href="mdt-20221028.xsd#mdt_AssetImpairmentChargesAndInventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_470de002-f2fd-46af-9a26-46849d93442a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6c3adf14-adf2-4b7d-a280-5c3d9f8917f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6c3adf14-adf2-4b7d-a280-5c3d9f8917f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_405ff2cf-cec6-4f9e-a539-424f56ed9226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_InventoryWriteDown_405ff2cf-cec6-4f9e-a539-424f56ed9226" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_4d5c6720-2487-4d71-a490-1753b00cc25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_OtherRestructuringCosts_4d5c6720-2487-4d71-a490-1753b00cc25c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_637ff324-4cad-4540-9cd5-ac5e5d0182fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringReserveCurrent_637ff324-4cad-4540-9cd5-ac5e5d0182fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_41ce5821-ef40-43ab-a343-1fe764acd487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_41ce5821-ef40-43ab-a343-1fe764acd487" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1a45f232-0d62-4aae-a632-46129d12d16a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:to="loc_us-gaap_RestructuringPlanDomain_1a45f232-0d62-4aae-a632-46129d12d16a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:to="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_5aaed9b4-df65-40fd-84e6-5efeb3a718ff" xlink:href="mdt-20221028.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_EnterpriseExcellenceMember_5aaed9b4-df65-40fd-84e6-5efeb3a718ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_8e9f4953-67a6-4cd7-abcf-cc6e6c99c35d" xlink:href="mdt-20221028.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_8e9f4953-67a6-4cd7-abcf-cc6e6c99c35d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportMember_87e48c6c-1a7a-48bf-b10e-2f0205259814" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_MechanicalCirculatorySupportMember_87e48c6c-1a7a-48bf-b10e-2f0205259814" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4e429447-f835-4038-891b-79808eafadf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4e429447-f835-4038-891b-79808eafadf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember_c39d83cd-094e-411d-902a-61a6ac15dfd3" xlink:href="mdt-20221028.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:to="loc_mdt_PreTaxExitandDisposalCostsMember_c39d83cd-094e-411d-902a-61a6ac15dfd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bbbfa0e7-2ff0-440d-b062-9077d3806653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_CostOfSalesMember_bbbfa0e7-2ff0-440d-b062-9077d3806653" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5c0a57ad-3b77-4078-a6d9-6471851745a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5c0a57ad-3b77-4078-a6d9-6471851745a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_5dc42244-03c7-4ea7-b1dc-581ed1cff958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_5dc42244-03c7-4ea7-b1dc-581ed1cff958" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_00f43d66-4fdd-4a95-9cd4-b67b190f7efc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:to="loc_us-gaap_SegmentDomain_00f43d66-4fdd-4a95-9cd4-b67b190f7efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:to="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_9e673b0d-4d57-4420-b0ba-041cc45ddae3" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:to="loc_mdt_CardiovascularMember_9e673b0d-4d57-4420-b0ba-041cc45ddae3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails" xlink:type="extended" id="ib881d52debb2409b8dd532819e5cf941_RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:to="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_406eeb14-0f9a-45fc-842a-c1d8c20eb005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringReserve_406eeb14-0f9a-45fc-842a-c1d8c20eb005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_56922436-2805-46b3-931e-32c453b9666f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringCharges_56922436-2805-46b3-931e-32c453b9666f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4687e589-cc8e-4a05-bb8c-0f8cac494d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_PaymentsForRestructuring_4687e589-cc8e-4a05-bb8c-0f8cac494d8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_52590e8d-a74f-467e-861e-39d479fc08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_52590e8d-a74f-467e-861e-39d479fc08d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_443eb051-0d11-4592-9d0b-9f2a292d1bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c832e97a-19a8-4266-abd0-e34200529e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c832e97a-19a8-4266-abd0-e34200529e12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember_28687a13-fcb7-459c-9d99-84dde5a7bb85" xlink:href="mdt-20221028.xsd#mdt_AssociatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_mdt_AssociatedCostsMember_28687a13-fcb7-459c-9d99-84dde5a7bb85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_ae8b16f4-e936-4596-8ed0-876701243828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_us-gaap_OtherRestructuringMember_ae8b16f4-e936-4596-8ed0-876701243828" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended" id="i53059a7450ac4b1896a668b26fa40cc6_FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_79c24e23-ea43-4e71-a7e6-1097f3b96cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_79c24e23-ea43-4e71-a7e6-1097f3b96cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_793a88fc-5b4f-4344-97ef-01b1044b05e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_793a88fc-5b4f-4344-97ef-01b1044b05e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a812f468-5040-4eca-9fc7-4aa1843627cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a812f468-5040-4eca-9fc7-4aa1843627cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f1b0775e-0973-4d98-9efc-8db83e73dc14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f1b0775e-0973-4d98-9efc-8db83e73dc14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_abcacfb9-e897-479a-9ae8-d5e4b5cfe719_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_abcacfb9-e897-479a-9ae8-d5e4b5cfe719_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_52706170-29c6-4b24-a6ef-ad556edfb248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_52706170-29c6-4b24-a6ef-ad556edfb248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ee748cce-64d2-4b5a-a9dd-8cbc5d79c56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ee748cce-64d2-4b5a-a9dd-8cbc5d79c56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_0db5cf38-e9ae-4606-9c44-f63a50fc47cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_0db5cf38-e9ae-4606-9c44-f63a50fc47cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b212d2a5-63c0-4814-b127-7d8a7f4b9017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b212d2a5-63c0-4814-b127-7d8a7f4b9017" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1e08747c-96b0-4cac-85b7-8a446f0edb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1e08747c-96b0-4cac-85b7-8a446f0edb54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_d9d72fe6-07eb-487e-940b-567d2157b063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_d9d72fe6-07eb-487e-940b-567d2157b063" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_1e3f548d-6269-4932-a778-0c9cced4825e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_1e3f548d-6269-4932-a778-0c9cced4825e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67f6da1d-dee9-4296-8c9d-b48902fad142_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67f6da1d-dee9-4296-8c9d-b48902fad142_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_540317eb-260a-43f3-b532-744fd1fbc55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_540317eb-260a-43f3-b532-744fd1fbc55f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_38470711-9b59-4619-8cb6-0758b46cb1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_38470711-9b59-4619-8cb6-0758b46cb1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_79ae35be-e510-48af-b157-a21793bfa6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_79ae35be-e510-48af-b157-a21793bfa6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_34d31814-d4af-4c51-a389-0b7c6ed004b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_34d31814-d4af-4c51-a389-0b7c6ed004b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_44228ca8-6d9d-43b2-9b76-627a42948679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:to="loc_us-gaap_InvestmentsMember_44228ca8-6d9d-43b2-9b76-627a42948679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_0358f0b7-af80-4201-8b89-95a5cf4b0e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:to="loc_us-gaap_OtherAssetsMember_0358f0b7-af80-4201-8b89-95a5cf4b0e42" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="extended" id="i74997d50ee0c400aac5519df1ba5fa1d_FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:href="mdt-20221028.xsd#mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0a8ea642-fc2a-4a72-804b-739e953e635f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0a8ea642-fc2a-4a72-804b-739e953e635f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fc1566db-7b61-41e7-bfa2-7252391a74bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fc1566db-7b61-41e7-bfa2-7252391a74bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_fa5b25dc-bb9b-4e82-a243-f6ef77ea0553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_fa5b25dc-bb9b-4e82-a243-f6ef77ea0553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_3fd69e45-8d2c-4cd0-886b-1f837972f712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_3fd69e45-8d2c-4cd0-886b-1f837972f712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_63f7a202-ce81-4f95-95f7-fe2dd999fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_63f7a202-ce81-4f95-95f7-fe2dd999fa9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b05de690-51f8-4f53-8590-39bb6d2eefa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b05de690-51f8-4f53-8590-39bb6d2eefa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_38a17de7-727b-44b4-b0ee-58ba7fada814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_38a17de7-727b-44b4-b0ee-58ba7fada814" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_3525f0f1-26e0-4c70-a12f-1fa2efb7ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_3525f0f1-26e0-4c70-a12f-1fa2efb7ce75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_da261ce9-e6e8-48fb-a48c-612ccce58028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_da261ce9-e6e8-48fb-a48c-612ccce58028" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended" id="iaf85b395074a4bfa8f514850ee992d5b_FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1377d311-625a-4e19-806a-b6a298f55e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1377d311-625a-4e19-806a-b6a298f55e7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_52126131-09f0-4611-a1af-20622f377437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_52126131-09f0-4611-a1af-20622f377437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_892120d1-e8fc-4777-bfe6-d3475746f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquityMethodInvestments_892120d1-e8fc-4777-bfe6-d3475746f16c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_1d1d3948-a6d9-43a6-9ee2-70d1e380f30b" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_1d1d3948-a6d9-43a6-9ee2-70d1e380f30b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d01f4884-9975-4ec7-9916-9bf1e7b6c624_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d01f4884-9975-4ec7-9916-9bf1e7b6c624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_ea49fcbf-c24e-432e-a6a8-2d00bafafa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:to="loc_us-gaap_OtherAssetsMember_ea49fcbf-c24e-432e-a6a8-2d00bafafa4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="extended" id="i41e00cdd769f463eb6f0a9ec226eb123_FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_f60d0a6d-c87e-4dde-8a8e-1cf65cb2a924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_f60d0a6d-c87e-4dde-8a8e-1cf65cb2a924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments_6378e7db-3427-4b19-a1fb-cbd7e5c6823f" xlink:href="mdt-20221028.xsd#mdt_GainonInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_mdt_GainonInvestments_6378e7db-3427-4b19-a1fb-cbd7e5c6823f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments_d23f6523-d8d1-42d2-b72d-8a0640fd9398" xlink:href="mdt-20221028.xsd#mdt_LossonInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_mdt_LossonInvestments_d23f6523-d8d1-42d2-b72d-8a0640fd9398" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_972f3a9d-7d87-4e78-9168-cb25ecf2a588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_us-gaap_ImpairmentOfInvestments_972f3a9d-7d87-4e78-9168-cb25ecf2a588" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d81b47a3-e344-4560-827a-131923193dde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d81b47a3-e344-4560-827a-131923193dde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_6dfd9245-a469-4249-8b17-2d2886a67516" xlink:href="mdt-20221028.xsd#mdt_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:to="loc_mdt_EquityInvestmentsMember_6dfd9245-a469-4249-8b17-2d2886a67516" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="i7d218836c1204e68839c5bd4cfaf0303_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_de9ba53e-54ee-42c6-9940-bc1b1150742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_de9ba53e-54ee-42c6-9940-bc1b1150742a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7a99b62-d481-451a-ad52-6055b329097d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7a99b62-d481-451a-ad52-6055b329097d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_6368130b-1de2-478a-8898-dbabd6d4dc61" xlink:href="mdt-20221028.xsd#mdt_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:to="loc_mdt_EquityInvestmentsMember_6368130b-1de2-478a-8898-dbabd6d4dc61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended" id="ib1624ad6122d4baab3e9a53606cf979c_FinancingArrangementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity_bfa66fc3-bf37-4d0c-90ee-4cf6cf15b86a" xlink:href="mdt-20221028.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_mdt_CommercialPaperMaximumBorrowingCapacity_bfa66fc3-bf37-4d0c-90ee-4cf6cf15b86a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_cb21fe49-0c47-4021-b987-44c849b04cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtCurrent_cb21fe49-0c47-4021-b987-44c849b04cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a7184c7e-c307-46b2-882f-3d681f8acde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentTerm_a7184c7e-c307-46b2-882f-3d681f8acde2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a52add73-5778-40db-8a52-70c214f6e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a52add73-5778-40db-8a52-70c214f6e7f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a3b610c0-4b64-4604-a1c7-021c446ca1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a3b610c0-4b64-4604-a1c7-021c446ca1a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fb330649-0462-4f68-932b-1b3bebbace59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LineOfCredit_fb330649-0462-4f68-932b-1b3bebbace59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_57c7bd75-2f0b-4329-87e1-491b2931827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_57c7bd75-2f0b-4329-87e1-491b2931827e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfDebt_666f164d-3a83-44ab-a4d4-b900ec50698b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfDebt_666f164d-3a83-44ab-a4d4-b900ec50698b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5fe5de2-b76b-4524-8f19-d99a98af378b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5fe5de2-b76b-4524-8f19-d99a98af378b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_e903342a-3b85-4d46-b733-9e070b43ea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_e903342a-3b85-4d46-b733-9e070b43ea99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_cfc8f556-a586-4cd0-82de-d1af36287bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_cfc8f556-a586-4cd0-82de-d1af36287bef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0a6c66b-87a1-425b-92d2-0edc9bba1007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0a6c66b-87a1-425b-92d2-0edc9bba1007" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_125ab0ab-e8f8-4887-8af7-522a2cb09ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_RepaymentsOfDebt_125ab0ab-e8f8-4887-8af7-522a2cb09ca5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_586052dc-eb23-4ba1-a0eb-6fd61c3ed8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_586052dc-eb23-4ba1-a0eb-6fd61c3ed8bb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_dd6dc960-b9d1-444a-a5b5-3b303f892b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LongTermDebtFairValue_dd6dc960-b9d1-444a-a5b5-3b303f892b22" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:href="mdt-20221028.xsd#mdt_ScheduleOfDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_06e4a32d-7c02-4bd5-914b-feaa067de6ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_06e4a32d-7c02-4bd5-914b-feaa067de6ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember_4c10d460-5486-4b5f-8739-0481356f4d06" xlink:href="mdt-20221028.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_A2015CommercialPaperProgramMember_4c10d460-5486-4b5f-8739-0481356f4d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_4aba3f1c-c970-4e0a-b3dd-ed6f56c30e1b" xlink:href="mdt-20221028.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_4aba3f1c-c970-4e0a-b3dd-ed6f56c30e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember_0eb8b0a3-1101-48ee-a097-b2b38fc00983" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_MedtronicLuxcoSeniorNotesMember_0eb8b0a3-1101-48ee-a097-b2b38fc00983" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20253500PercentMember_fb7a4df4-3c2b-4a26-b3a0-1b376ba9207b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20253500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_SeniorNotes2015Due20253500PercentMember_fb7a4df4-3c2b-4a26-b3a0-1b376ba9207b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due20273350PercentMember_a8f2e437-7f80-4d96-a4a2-435aa4f29b2c" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2017Due20273350PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_SeniorNotes2017Due20273350PercentMember_a8f2e437-7f80-4d96-a4a2-435aa4f29b2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_f04d1a65-f039-4550-b894-da45172c8f8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_f04d1a65-f039-4550-b894-da45172c8f8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ddba0cbe-07b8-471a-bf67-0e5dfb6d3c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:to="loc_us-gaap_CommercialPaperMember_ddba0cbe-07b8-471a-bf67-0e5dfb6d3c62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_bb57fadd-2900-43ad-9b6a-8d0b0403a519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:to="loc_us-gaap_LoansPayableMember_bb57fadd-2900-43ad-9b6a-8d0b0403a519" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cfb2add0-6d48-40e3-a949-16cca6915bf2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:to="loc_us-gaap_CreditFacilityDomain_cfb2add0-6d48-40e3-a949-16cca6915bf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:to="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7dbf2a7d-1f3d-459b-911d-8227d0513970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:to="loc_us-gaap_LineOfCreditMember_7dbf2a7d-1f3d-459b-911d-8227d0513970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_582ecb15-d476-4ecd-97fa-6ddde785fe16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_582ecb15-d476-4ecd-97fa-6ddde785fe16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9b62e28e-9364-4464-8ed1-5564fd16e953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:to="loc_us-gaap_SeniorNotesMember_9b62e28e-9364-4464-8ed1-5564fd16e953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_07f9766c-d905-4501-b221-c11eee7b1cf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:to="loc_us-gaap_VariableRateDomain_07f9766c-d905-4501-b221-c11eee7b1cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:to="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06b16119-39d0-47c5-a352-bd65cf2d15ea" xlink:href="mdt-20221028.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:to="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06b16119-39d0-47c5-a352-bd65cf2d15ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_818ec4a7-6718-4ba5-b42b-1d68f514525f_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:to="loc_dei_EntityDomain_818ec4a7-6718-4ba5-b42b-1d68f514525f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:to="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember_718c67fc-073f-4bd8-aa22-63767d5c09a7" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:to="loc_mdt_MedtronicLuxcoMember_718c67fc-073f-4bd8-aa22-63767d5c09a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended" id="i9b7225f1ca914775904e37fa40c77228_FinancingArrangementsLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_debce659-040b-4bb2-ae81-b20b4e605694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:to="loc_us-gaap_DebtCurrent_debce659-040b-4bb2-ae81-b20b4e605694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e2d47c5-2e0b-40ba-a816-7868896d4efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e2d47c5-2e0b-40ba-a816-7868896d4efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_77ffeac0-6033-49a9-8ac5-fd354d224a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentTerm_77ffeac0-6033-49a9-8ac5-fd354d224a5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5827abcf-10bc-4c4b-975b-2ca5bd022de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5827abcf-10bc-4c4b-975b-2ca5bd022de2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ccdcfb11-12d7-4c53-a8c0-8251ff975a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ccdcfb11-12d7-4c53-a8c0-8251ff975a11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9c6cbcaa-b35e-4030-ab0b-bff1320162c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9c6cbcaa-b35e-4030-ab0b-bff1320162c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_933f87ea-af13-4054-8423-613252dbf210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_933f87ea-af13-4054-8423-613252dbf210" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c2563afa-d680-4a97-96ad-84fb4e626fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c2563afa-d680-4a97-96ad-84fb4e626fe8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:to="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_800773f5-9cc8-46a8-83e0-42a79e1ca0ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_800773f5-9cc8-46a8-83e0-42a79e1ca0ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d91884d7-cc9f-4c7f-abe6-4b417bc54100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:to="loc_us-gaap_SeniorNotesMember_d91884d7-cc9f-4c7f-abe6-4b417bc54100" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c6a83693-09ed-4904-ada1-bdcb9be47712_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c6a83693-09ed-4904-ada1-bdcb9be47712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20253500PercentMember_57b16b84-ac80-4268-b675-8b4048dc9d43" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20253500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2015Due20253500PercentMember_57b16b84-ac80-4268-b675-8b4048dc9d43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20260250PercentMember_7095c46d-92cf-4295-b8c6-d3537b067fbb" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20260250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20260250PercentMember_7095c46d-92cf-4295-b8c6-d3537b067fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember_5d848a87-03ff-44d3-893f-6ebaab027023" xlink:href="mdt-20221028.xsd#mdt_A2265PercentThreeYear2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember_5d848a87-03ff-44d3-893f-6ebaab027023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20260000PercentMember_28546e3d-a416-446f-a03f-f07bc19cc342" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20260000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20260000PercentMember_28546e3d-a416-446f-a03f-f07bc19cc342" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20271125PercentMember_290efbd3-ce46-4aee-9d37-c8f1474d9d28" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20271125PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20271125PercentMember_290efbd3-ce46-4aee-9d37-c8f1474d9d28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due20273350PercentMember_d58cede4-18b0-4f5f-844b-cfca6740030d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2017Due20273350PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2017Due20273350PercentMember_d58cede4-18b0-4f5f-844b-cfca6740030d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3000PercentSixYear2022SeniorNotesMember_ea7563fa-7fa5-4912-89ba-8250896d74c5" xlink:href="mdt-20221028.xsd#mdt_A3000PercentSixYear2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3000PercentSixYear2022SeniorNotesMember_ea7563fa-7fa5-4912-89ba-8250896d74c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20290375PercentMember_cc513e55-278f-4494-8fea-82d3afa80493" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20290375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20290375PercentMember_cc513e55-278f-4494-8fea-82d3afa80493" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311625PercentMember_46707d9e-4ff6-41ad-9e62-ab31087b19cb" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20311625PercentMember_46707d9e-4ff6-41ad-9e62-ab31087b19cb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20321000PercentMember_a57c31e5-97c9-4de2-af52-72a13d2f1681" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20321000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20321000PercentMember_a57c31e5-97c9-4de2-af52-72a13d2f1681" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3125PercentNineYear2022SeniorNotesMember_c06c3d28-ec92-48f8-8475-dee7cf819be5" xlink:href="mdt-20221028.xsd#mdt_A3125PercentNineYear2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3125PercentNineYear2022SeniorNotesMember_c06c3d28-ec92-48f8-8475-dee7cf819be5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20330750PercentMember_006ee99c-abc0-42f8-98ce-cb12b8ebb284" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20330750PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20330750PercentMember_006ee99c-abc0-42f8-98ce-cb12b8ebb284" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember_ae3f137e-b11a-4e6a-bcf3-bccf0bc1a761" xlink:href="mdt-20221028.xsd#mdt_A3375PercentTwelveYear2022SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember_ae3f137e-b11a-4e6a-bcf3-bccf0bc1a761" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20354375PercentMember_060c13b1-3fb9-497b-9dee-4f3d5872280b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20354375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20354375PercentMember_060c13b1-3fb9-497b-9dee-4f3d5872280b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_47324f24-0380-4e5a-96e9-65c45ce1c94b" xlink:href="mdt-20221028.xsd#mdt_A2007CIFSASeniorNotesDue20386550PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_47324f24-0380-4e5a-96e9-65c45ce1c94b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392250PercentMember_ece257b1-ea1a-42f2-96a3-cb04a5b7daa8" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20392250PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20392250PercentMember_ece257b1-ea1a-42f2-96a3-cb04a5b7daa8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due20396500PercentMember_b0b2ed2d-cfb1-45a2-a089-16214624359e" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2009Due20396500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2009Due20396500PercentMember_b0b2ed2d-cfb1-45a2-a089-16214624359e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20401500PercentMember_ba2ac0e1-371a-4bf9-bfcf-df7556d32c95" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20401500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20401500PercentMember_ba2ac0e1-371a-4bf9-bfcf-df7556d32c95" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due20405550PercentMember_40db53c6-c13f-46ab-9867-1c7c8cb1a703" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2010Due20405550PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2010Due20405550PercentMember_40db53c6-c13f-46ab-9867-1c7c8cb1a703" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20411375PercentMember_ddf53b1c-f30b-4a0f-8bfc-a3cceabf7f02" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20411375PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20411375PercentMember_ddf53b1c-f30b-4a0f-8bfc-a3cceabf7f02" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due20424500PercentMember_d6180eb3-bb6d-45f4-80a0-bb7168d6742d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2012Due20424500PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2012Due20424500PercentMember_d6180eb3-bb6d-45f4-80a0-bb7168d6742d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due20434000PercentMember_8d0698bd-8c38-409a-9494-216beadbff05" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2013Due20434000PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2013Due20434000PercentMember_8d0698bd-8c38-409a-9494-216beadbff05" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due20444625PercentMember_7f9db12c-81f0-4f55-9bb7-977bf6ff04a2" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2014Due20444625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2014Due20444625PercentMember_7f9db12c-81f0-4f55-9bb7-977bf6ff04a2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20454625PercentMember_5110a103-2ea5-4b8f-96cd-267b9c63efbd" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20454625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2015Due20454625PercentMember_5110a103-2ea5-4b8f-96cd-267b9c63efbd" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20501750PercentMember_9aceeadd-18a4-4399-94b6-fc0e14d6f486" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20501750PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20501750PercentMember_9aceeadd-18a4-4399-94b6-fc0e14d6f486" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20511625PercentMember_242a07d3-9322-4231-abb1-9e5bc07a1267" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20511625PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20511625PercentMember_242a07d3-9322-4231-abb1-9e5bc07a1267" xlink:type="arc" order="25"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="extended" id="i1c892f47418649e0a4d3d27fd2e0839a_DerivativesandCurrencyExchangeRiskManagementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2ffdf57e-d832-4956-a6e7-e580cec423cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2ffdf57e-d832-4956-a6e7-e580cec423cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_88bcfce3-ebfe-4696-9fc7-52c6e67d0472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_88bcfce3-ebfe-4696-9fc7-52c6e67d0472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_0cd062bb-a053-46be-9ca8-010aa18462d8" xlink:href="mdt-20221028.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_0cd062bb-a053-46be-9ca8-010aa18462d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_39c35102-7dfc-4325-abfd-369f24f841a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_39c35102-7dfc-4325-abfd-369f24f841a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_92995b06-fcdc-4b83-a668-51d097a53c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_92995b06-fcdc-4b83-a668-51d097a53c3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_23bc4db7-b86b-43a4-b03d-1539db9edf45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_23bc4db7-b86b-43a4-b03d-1539db9edf45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9c14661f-9a02-42bc-bbff-98c8f0082327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9c14661f-9a02-42bc-bbff-98c8f0082327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_aa500dac-1130-447b-b25e-3a4536da2ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:to="loc_us-gaap_TotalReturnSwapMember_aa500dac-1130-447b-b25e-3a4536da2ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3e978d1f-6d42-4c34-9265-33a271a0b18b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:to="loc_us-gaap_HedgingDesignationDomain_3e978d1f-6d42-4c34-9265-33a271a0b18b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:to="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_69296336-f73d-4d59-ba3d-8a679b84ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:to="loc_us-gaap_NondesignatedMember_69296336-f73d-4d59-ba3d-8a679b84ed37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_72644963-9fc5-40c3-a2ca-dd4c46a91b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_72644963-9fc5-40c3-a2ca-dd4c46a91b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b9b00119-d196-4de4-9c6b-518195d06c16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b9b00119-d196-4de4-9c6b-518195d06c16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_098ca7ef-d192-48a4-912c-4f6f191ee4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:to="loc_us-gaap_CashFlowHedgingMember_098ca7ef-d192-48a4-912c-4f6f191ee4a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d7bb7cb3-1e93-456e-b23d-5db0728db1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d7bb7cb3-1e93-456e-b23d-5db0728db1cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_d50383fb-a671-414c-b8d1-d656f83c814b_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:to="loc_currency_AllCurrenciesDomain_d50383fb-a671-414c-b8d1-d656f83c814b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:to="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_864906d5-53d7-4317-ab43-209bbd6ebe1c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:to="loc_currency_EUR_864906d5-53d7-4317-ab43-209bbd6ebe1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1fc68339-85f0-4b0f-9b20-7ec6b658cd38" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:to="loc_currency_JPY_1fc68339-85f0-4b0f-9b20-7ec6b658cd38" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i6820ca60273f45979a438132bce5acc7_DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_77b83a31-cf06-4484-89b6-138db0a7776d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_77b83a31-cf06-4484-89b6-138db0a7776d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_679c2298-1b85-45bc-8f86-75cbca8c790c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_679c2298-1b85-45bc-8f86-75cbca8c790c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bff0690a-4010-45a7-a9ce-b9655d6ee2b8" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bff0690a-4010-45a7-a9ce-b9655d6ee2b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6dda7961-6f90-4aea-a541-71352bb1e7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6dda7961-6f90-4aea-a541-71352bb1e7fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cdf2cec7-d2ab-4bef-b7cf-c03edbf19c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cdf2cec7-d2ab-4bef-b7cf-c03edbf19c67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_3eb0c5ed-4d0f-410e-8fd7-866d09ada0e5" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_3eb0c5ed-4d0f-410e-8fd7-866d09ada0e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f4cc62ce-b484-49c3-b3c9-611c02441082_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f4cc62ce-b484-49c3-b3c9-611c02441082_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3d5f8284-c743-4e27-8e16-29520f3f78ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3d5f8284-c743-4e27-8e16-29520f3f78ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NonDerivativeInstrumentsMember_668b66c1-fc76-4fdd-b8f2-3eb8d56eb60b" xlink:href="mdt-20221028.xsd#mdt_NonDerivativeInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:to="loc_mdt_NonDerivativeInstrumentsMember_668b66c1-fc76-4fdd-b8f2-3eb8d56eb60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b17669a4-0132-46d5-bf3b-ce3f470b5696_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b17669a4-0132-46d5-bf3b-ce3f470b5696_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_924fb15d-b948-4442-a91c-fc8267ed3ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_924fb15d-b948-4442-a91c-fc8267ed3ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7a779805-968e-49c0-b522-6b3e97632981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:to="loc_us-gaap_CostOfSalesMember_7a779805-968e-49c0-b522-6b3e97632981" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i6dd0d0ffa3614730838997ecaf3b4881_DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_f7f78184-c8b1-42dd-af2f-4739a23ffeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_f7f78184-c8b1-42dd-af2f-4739a23ffeae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_22f9a730-4daa-45c1-99fb-29510d08d0e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_22f9a730-4daa-45c1-99fb-29510d08d0e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_b1f90b7a-45ce-49a8-84a2-e8c9b72b7331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_b1f90b7a-45ce-49a8-84a2-e8c9b72b7331" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8de609a4-94d1-4a3d-af50-500a37c98f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8de609a4-94d1-4a3d-af50-500a37c98f65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_fb8f59d8-893b-4f45-8f6b-5af978f72e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:to="loc_us-gaap_TotalReturnSwapMember_fb8f59d8-893b-4f45-8f6b-5af978f72e34" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="extended" id="i3259b6fa04084805885382ac1d2f0687_DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1fc3580e-c73e-426e-907d-dab7fb3e19fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1fc3580e-c73e-426e-907d-dab7fb3e19fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd51c3e-298b-4ebc-aa5c-febf1dceccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd51c3e-298b-4ebc-aa5c-febf1dceccd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e374c74-7c0b-4e69-a4a5-cf63202d4d08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e374c74-7c0b-4e69-a4a5-cf63202d4d08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:to="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a2f06bc8-ef47-406d-a513-1090f754a39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a2f06bc8-ef47-406d-a513-1090f754a39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_81278a5b-cd9f-4300-bfa2-5f959522f6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:to="loc_us-gaap_NondesignatedMember_81278a5b-cd9f-4300-bfa2-5f959522f6e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d6e55077-df7e-4d6b-b514-0cee9c249549_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d6e55077-df7e-4d6b-b514-0cee9c249549_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9e748365-5e7d-4e2d-9c20-21b0c460264c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9e748365-5e7d-4e2d-9c20-21b0c460264c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_ad694fa0-d6da-4c8f-8c81-f1b264e10516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:to="loc_us-gaap_TotalReturnSwapMember_ad694fa0-d6da-4c8f-8c81-f1b264e10516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6be199bb-d36c-49a6-b460-cd19d65472e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6be199bb-d36c-49a6-b460-cd19d65472e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fdb7425e-9872-40c0-8340-0026d7db9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fdb7425e-9872-40c0-8340-0026d7db9f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_7e2e5a98-655e-4444-a7fa-9fc2a38cce2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_OtherAssetsMember_7e2e5a98-655e-4444-a7fa-9fc2a38cce2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_dd7b87db-7670-4e8b-9e09-075ddd63402e" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_mdt_OtherAccruedExpensesMember_dd7b87db-7670-4e8b-9e09-075ddd63402e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_3b56a627-b152-4a62-b83e-d45e7862be38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_OtherLiabilitiesMember_3b56a627-b152-4a62-b83e-d45e7862be38" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i2cf0fe25bed6466a90c3d547daabf667_DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_19cd0765-906c-4cd8-93f2-8f9aa9c5740d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:to="loc_us-gaap_DerivativeAssets_19cd0765-906c-4cd8-93f2-8f9aa9c5740d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0a91fcd1-7939-487b-82e5-6f40e40f2d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:to="loc_us-gaap_DerivativeLiabilities_0a91fcd1-7939-487b-82e5-6f40e40f2d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e41ebb87-95f0-41b6-8b0a-b3fbfada5518_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e41ebb87-95f0-41b6-8b0a-b3fbfada5518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c06657c4-ef14-477e-8cc1-20e73c958733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c06657c4-ef14-477e-8cc1-20e73c958733" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_124b9744-4c9e-4403-9560-c789c669f425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_124b9744-4c9e-4403-9560-c789c669f425" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended" id="i35458a05b4034d2f9f618db82cec1d85_DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_629489b8-7493-47c3-8b5d-5925a97fe253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_629489b8-7493-47c3-8b5d-5925a97fe253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_23e97f3f-e8ef-4fc9-89be-e317cb545421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_23e97f3f-e8ef-4fc9-89be-e317cb545421" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_02e2a11d-332c-4256-8545-4767509b4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_02e2a11d-332c-4256-8545-4767509b4a86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_02a1282e-e982-4b6d-b325-a822a2e53dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_02a1282e-e982-4b6d-b325-a822a2e53dfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5d0ae346-22ac-4451-b39c-a81fe5e7ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5d0ae346-22ac-4451-b39c-a81fe5e7ec6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_fd1befe6-c94e-4fca-9b2f-aaba0015b499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_fd1befe6-c94e-4fca-9b2f-aaba0015b499" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_90c2d8d8-a859-4a1d-86b1-46ee6c55db28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_90c2d8d8-a859-4a1d-86b1-46ee6c55db28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f4fb3b72-1851-457f-a8c4-af5c504c1ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f4fb3b72-1851-457f-a8c4-af5c504c1ce3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_8990144d-046e-4c38-ad87-3cf00d1777db" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_8990144d-046e-4c38-ad87-3cf00d1777db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_488e45e3-ec3a-49e6-b2a2-60f7ca64c950" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_488e45e3-ec3a-49e6-b2a2-60f7ca64c950" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_4cd66c37-be2c-4422-85f5-4f10f7dfc5df" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_4cd66c37-be2c-4422-85f5-4f10f7dfc5df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_0dc8b1cd-aaa7-461a-8210-2e37cdfc20cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_0dc8b1cd-aaa7-461a-8210-2e37cdfc20cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7bd25360-a49a-433f-82ec-c1c4f9344e0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7bd25360-a49a-433f-82ec-c1c4f9344e0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_35d8adf7-dc13-469f-a54f-c826d70b0bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_35d8adf7-dc13-469f-a54f-c826d70b0bcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_37767fd0-6210-4e69-b915-5e9fb0633b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:to="loc_us-gaap_TotalReturnSwapMember_37767fd0-6210-4e69-b915-5e9fb0633b10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="i8f512a264d8c453e8b824bbf3b912e63_GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:to="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f901e65c-d835-4f8d-a68e-2bb06b5162ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_Goodwill_f901e65c-d835-4f8d-a68e-2bb06b5162ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b5d20dd9-8b52-4cb2-8a9f-ef3af73ef69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b5d20dd9-8b52-4cb2-8a9f-ef3af73ef69b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9f55cba5-c5d6-4422-b81f-fb7eae086c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9f55cba5-c5d6-4422-b81f-fb7eae086c48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_60ffb392-b909-4633-bc6d-3af336a46fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillTransfers_60ffb392-b909-4633-bc6d-3af336a46fbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_21439f21-acad-45d1-8e50-9b515fff4510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_21439f21-acad-45d1-8e50-9b515fff4510" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5aad9077-877d-4ada-bfe8-04b8572de8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_91e38c50-d331-4357-b92f-e2e769c0c0ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:to="loc_us-gaap_SegmentDomain_91e38c50-d331-4357-b92f-e2e769c0c0ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:to="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_5d5d3909-7798-4345-a4d4-41c8af8aabe9" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_CardiovascularMember_5d5d3909-7798-4345-a4d4-41c8af8aabe9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_7513bf9f-8703-41d3-88ec-0cfade5b33b5" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_MedicalSurgicalMember_7513bf9f-8703-41d3-88ec-0cfade5b33b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_fe56ef55-62b9-4635-85e5-b2f1d22f5b26" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_NeuroscienceGroupMember_fe56ef55-62b9-4635-85e5-b2f1d22f5b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_142f5c84-665d-4714-9b33-32fcfbbf39e2" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_DiabetesGroupMember_142f5c84-665d-4714-9b33-32fcfbbf39e2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="ib224aa497f8543cfb883b2b38833afe7_GoodwillandOtherIntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_950485be-e0fc-4142-bef7-69dda4060e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_950485be-e0fc-4142-bef7-69dda4060e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2dd8bdfe-5f07-4e0e-a627-4aa16867d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2dd8bdfe-5f07-4e0e-a627-4aa16867d77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b7421472-4c39-49fb-8952-ac959c8c92c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b7421472-4c39-49fb-8952-ac959c8c92c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4baccd5b-c533-4a89-8a09-bcf7e77980d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4baccd5b-c533-4a89-8a09-bcf7e77980d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_00f7590e-b785-4b68-9724-d02a03d386ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_00f7590e-b785-4b68-9724-d02a03d386ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ab810776-4930-4cbb-9234-6d4e38b8192e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:to="loc_us-gaap_SegmentDomain_ab810776-4930-4cbb-9234-6d4e38b8192e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:to="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_5e9b9414-c056-460a-a54b-ef0503a5b792" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:to="loc_mdt_MedicalSurgicalMember_5e9b9414-c056-460a-a54b-ef0503a5b792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RenalCareBusinessRCSMember_df445c88-e052-40d3-9f06-9a096cbb6882" xlink:href="mdt-20221028.xsd#mdt_RenalCareBusinessRCSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:to="loc_mdt_RenalCareBusinessRCSMember_df445c88-e052-40d3-9f06-9a096cbb6882" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="extended" id="id554634227734aa3936d5ab4552f28af_GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32225121-b53c-4b5f-ac89-4336c8214b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32225121-b53c-4b5f-ac89-4336c8214b49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_376c69d6-442a-483f-8858-17e5d2f53011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_376c69d6-442a-483f-8858-17e5d2f53011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c677188c-3049-45a5-a80f-c299e70375b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c677188c-3049-45a5-a80f-c299e70375b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_bf68aa78-fa2c-4444-83a4-ade7a80d9ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_bf68aa78-fa2c-4444-83a4-ade7a80d9ed2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember_d4349887-e55a-4876-b7de-b57d65995bc4" xlink:href="mdt-20221028.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_mdt_PurchasedTechnologyAndPatentsMember_d4349887-e55a-4876-b7de-b57d65995bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7402fd6-354f-4df9-9582-b07768006ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7402fd6-354f-4df9-9582-b07768006ff3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_e175dce3-a7ae-42d0-b467-f4480a8bf5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_e175dce3-a7ae-42d0-b467-f4480a8bf5a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ffa85569-f445-429d-ab24-718a4bc3d966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ffa85569-f445-429d-ab24-718a4bc3d966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61baf7c-6206-4438-9188-9893614025f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61baf7c-6206-4438-9188-9893614025f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended" id="i7a94d2edc28a428d9a20164c8547a1eb_EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationNumeratorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:to="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a6bc649b-277e-4f4e-acf1-9a570770dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:to="loc_us-gaap_NetIncomeLoss_a6bc649b-277e-4f4e-acf1-9a570770dcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationDenominatorAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:to="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31fce39a-9667-422f-a4b9-79b43fb449d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31fce39a-9667-422f-a4b9-79b43fb449d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05e83023-c868-4832-9106-c062c9017985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05e83023-c868-4832-9106-c062c9017985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_dc1cf35b-8a8e-4ebd-aa44-b61fbca864ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_dc1cf35b-8a8e-4ebd-aa44-b61fbca864ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f45c497-f661-46be-8e81-852dbf750e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f45c497-f661-46be-8e81-852dbf750e0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_253ba39e-b23c-4170-93f8-fc8b5950fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_EarningsPerShareBasic_253ba39e-b23c-4170-93f8-fc8b5950fb27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_21319e20-51aa-4d36-b36f-765fb29e4289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_21319e20-51aa-4d36-b36f-765fb29e4289" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:to="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2b72a143-9333-45db-b74d-171f44ed33c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2b72a143-9333-45db-b74d-171f44ed33c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fee4766d-7f8e-442d-80d3-1d753753bce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fee4766d-7f8e-442d-80d3-1d753753bce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_94fdf60d-ecfb-4b97-a09f-e7a1d8b6c2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_PerformanceSharesMember_94fdf60d-ecfb-4b97-a09f-e7a1d8b6c2a8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended" id="if450bdd1ec5a483ea4af204cb5f5e42d_EarningsPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_80ed0d36-7e14-4a97-8f31-c4f9e76c87de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_80ed0d36-7e14-4a97-8f31-c4f9e76c87de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_51a23946-07f2-4ce7-ace3-05e12b27af5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_51a23946-07f2-4ce7-ace3-05e12b27af5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended" id="i58dec6697bdc453bbdb8c4beca491dc1_StockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7cc5fb6-7542-45db-a4ef-c0b420a08a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7cc5fb6-7542-45db-a4ef-c0b420a08a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f2a82da3-71ad-418a-9ffa-0840fb086d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f2a82da3-71ad-418a-9ffa-0840fb086d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3b514046-8ead-4887-9915-dc93499fd6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3b514046-8ead-4887-9915-dc93499fd6ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:to="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932756ea-535e-4db2-b22b-dd27b5d36654_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_932756ea-535e-4db2-b22b-dd27b5d36654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0434cc64-d306-4590-81e7-f99bb1cd81d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0434cc64-d306-4590-81e7-f99bb1cd81d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_920b1bde-2141-4302-81dc-16a8cef169c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_920b1bde-2141-4302-81dc-16a8cef169c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_76dbea58-7ecd-484e-ac2f-2dd41e4ba5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_PerformanceSharesMember_76dbea58-7ecd-484e-ac2f-2dd41e4ba5f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember_6398999f-5aa3-4e9e-9b37-3cb1eb40c7e3" xlink:href="mdt-20221028.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_mdt_EmployeesStockPurchasePlanMember_6398999f-5aa3-4e9e-9b37-3cb1eb40c7e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0ce663cd-efd1-4813-980b-f0645eecbd7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0ce663cd-efd1-4813-980b-f0645eecbd7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_991d1cda-2f11-4478-a108-120e596e33f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_CostOfSalesMember_991d1cda-2f11-4478-a108-120e596e33f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd8683f8-2df9-401b-b585-fcce8cfa3231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd8683f8-2df9-401b-b585-fcce8cfa3231" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_21023252-5622-49a3-a689-bcd9957a081d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_21023252-5622-49a3-a689-bcd9957a081d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="i758ade8148a44854b20347e2665dc922_RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_40b2949b-b663-4689-878e-f7000843622c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_40b2949b-b663-4689-878e-f7000843622c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d08db1dc-d627-4e23-8f00-b4d2fdfdecac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d08db1dc-d627-4e23-8f00-b4d2fdfdecac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0a242bb2-1ae3-4f73-aa14-ca631f5d11d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0a242bb2-1ae3-4f73-aa14-ca631f5d11d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3fad4171-8abb-4c1a-86b6-5a969f0db5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3fad4171-8abb-4c1a-86b6-5a969f0db5e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b907632-908c-4170-a123-dc4f8aaf55cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b907632-908c-4170-a123-dc4f8aaf55cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_90d56096-f4c0-46c8-8f49-5da93392322c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_90d56096-f4c0-46c8-8f49-5da93392322c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:to="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3ee4de36-b7fa-4d49-834f-4c8f6a339e7d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:to="loc_country_US_3ee4de36-b7fa-4d49-834f-4c8f6a339e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:href="mdt-20221028.xsd#mdt_OutsideOfTheUnitedStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:to="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_d1adc657-b995-40fd-84d3-fe8fc2929245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:to="loc_us-gaap_ForeignPlanMember_d1adc657-b995-40fd-84d3-fe8fc2929245" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f1488e3d-1a75-44ab-93fa-a2474b61c479_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f1488e3d-1a75-44ab-93fa-a2474b61c479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f866c74b-b005-47d3-b1af-a37dd78f6d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f866c74b-b005-47d3-b1af-a37dd78f6d76" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended" id="i6032f5ab272a415e9d13393bce565395_AccumulatedOtherComprehensiveLossChangesinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124701da-583a-4d36-8feb-9a17c40518eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124701da-583a-4d36-8feb-9a17c40518eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dbb27cf7-8313-4bf2-8267-155b8edd51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dbb27cf7-8313-4bf2-8267-155b8edd51c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b85c54dd-7329-4e97-8733-3ecba5e337a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b85c54dd-7329-4e97-8733-3ecba5e337a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f33fefa-708c-44ef-8290-312edf95f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f33fefa-708c-44ef-8290-312edf95f32b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7124f959-d64c-4096-a967-4509204ad5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ebc442b-cb6c-4d78-bc8a-7cc6fffe3047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ebc442b-cb6c-4d78-bc8a-7cc6fffe3047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77e375ee-07a2-4733-8ce6-a5035e1ae62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77e375ee-07a2-4733-8ce6-a5035e1ae62f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2e20693-8400-4e5b-af94-8a1bba85426e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:to="loc_us-gaap_EquityComponentDomain_a2e20693-8400-4e5b-af94-8a1bba85426e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:to="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3dd34cdc-6869-46ec-83b7-b5f2ce1dc269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3dd34cdc-6869-46ec-83b7-b5f2ce1dc269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_923cec9d-4cc7-4d2c-9be8-6bfb1e798083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_923cec9d-4cc7-4d2c-9be8-6bfb1e798083" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_f0081f9a-0b69-4270-bd73-b8f3cf9bb7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_f0081f9a-0b69-4270-bd73-b8f3cf9bb7a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3bc42144-2033-4cb6-b1f1-1f1714f421c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3bc42144-2033-4cb6-b1f1-1f1714f421c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ea75dc98-8162-4320-a6be-90197af6ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ea75dc98-8162-4320-a6be-90197af6ca89" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i65c5934615f14a318c738870c525210e_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1531b8a0-f104-4cf9-9c1d-77449d51fb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1531b8a0-f104-4cf9-9c1d-77449d51fb76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_03c81c36-6893-4977-85c7-1e81e8e9dea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_03c81c36-6893-4977-85c7-1e81e8e9dea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries_ce9deb80-899c-47fe-88ca-e4b09421b07f" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_LossContingencyNumberofSubsidiaries_ce9deb80-899c-47fe-88ca-e4b09421b07f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers_21dd6dab-22c2-4586-b728-16ce57c5ca42" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_LossContingencyNumberofManufacturers_21dd6dab-22c2-4586-b728-16ce57c5ca42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_2a41ca05-4e6a-4bfa-9e90-f9972002d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_2a41ca05-4e6a-4bfa-9e90-f9972002d4b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_94441f3f-9c25-4e2c-a03c-2b9e323ba054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_94441f3f-9c25-4e2c-a03c-2b9e323ba054" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_59e0c804-8a14-498b-9f65-969a94ff5ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_59e0c804-8a14-498b-9f65-969a94ff5ab8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3faff196-0c89-439d-affa-11bc6286ddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3faff196-0c89-439d-affa-11bc6286ddfc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_9558ac00-8ce0-40ce-90e6-1d4641a66e92" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_9558ac00-8ce0-40ce-90e6-1d4641a66e92" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_7d72f925-a8b9-482b-9ab6-eb0714c79767" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_7d72f925-a8b9-482b-9ab6-eb0714c79767" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_67eab3e8-eda8-436a-8c61-478e7f9ff43b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:to="loc_srt_LitigationCaseTypeDomain_67eab3e8-eda8-436a-8c61-478e7f9ff43b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:to="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember_002b4c47-7d25-46fe-9430-beaafb4d9b9f" xlink:href="mdt-20221028.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:to="loc_mdt_PelvicMeshLitigationMember_002b4c47-7d25-46fe-9430-beaafb4d9b9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HerniaMeshLitigationMember_5548a28f-8d30-4656-97ea-61a5d0c49a5a" xlink:href="mdt-20221028.xsd#mdt_HerniaMeshLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:to="loc_mdt_HerniaMeshLitigationMember_5548a28f-8d30-4656-97ea-61a5d0c49a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_df272f07-db21-4b00-b8d2-d4cca4326b85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_df272f07-db21-4b00-b8d2-d4cca4326b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_6789d485-5cbf-4791-a59b-cd500be23d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_6789d485-5cbf-4791-a59b-cd500be23d84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d31cc7df-6c77-43bb-bac7-f94c78e8c81f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:to="loc_us-gaap_LitigationStatusDomain_d31cc7df-6c77-43bb-bac7-f94c78e8c81f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:to="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_19d6205e-16f2-4460-8c76-ba6e8b8f36e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:to="loc_us-gaap_PendingLitigationMember_19d6205e-16f2-4460-8c76-ba6e8b8f36e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_2f59516c-45a4-43cb-b130-c4b8a47293fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_2f59516c-45a4-43cb-b130-c4b8a47293fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_cb5f7fbf-a5a5-4ea9-96f8-9e2c8815fa0b" xlink:href="mdt-20221028.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:to="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_cb5f7fbf-a5a5-4ea9-96f8-9e2c8815fa0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_15a215fd-6b72-4c72-b500-68a9fbdd3400_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:to="loc_srt_SegmentGeographicalDomain_15a215fd-6b72-4c72-b500-68a9fbdd3400_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:to="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_500fc6ba-f76a-4aae-b540-14c68f8478d3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:to="loc_stpr_MA_500fc6ba-f76a-4aae-b540-14c68f8478d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_e6243b9c-36c3-4b99-bca0-a6415979af4b" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:to="loc_stpr_MN_e6243b9c-36c3-4b99-bca0-a6415979af4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9baec4e8-c689-4665-8c76-c5ce30eddddb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9baec4e8-c689-4665-8c76-c5ce30eddddb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ff84641b-3439-421d-8164-3aa12cb482c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:to="loc_us-gaap_SubsequentEventMember_ff84641b-3439-421d-8164-3aa12cb482c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="extended" id="i9d17f4e36ecb410c8255f7a343e76fd8_SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e7281df-cd31-4056-88ab-412cc62ff8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e7281df-cd31-4056-88ab-412cc62ff8f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_91728575-7984-4636-b4c0-06042da1b678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_91728575-7984-4636-b4c0-06042da1b678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9ea44a25-d7ec-4bbf-a4ea-8eb7d20119bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9ea44a25-d7ec-4bbf-a4ea-8eb7d20119bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ea1052b2-cc8a-487a-8c8c-522b025b427a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ea1052b2-cc8a-487a-8c8c-522b025b427a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_125a9cce-be5a-4bf9-95aa-05c2e326bf20" xlink:href="mdt-20221028.xsd#mdt_CorporateOverhead"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_CorporateOverhead_125a9cce-be5a-4bf9-95aa-05c2e326bf20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_6bb91c02-19fe-4376-9b99-14d4b2739eed" xlink:href="mdt-20221028.xsd#mdt_CentralizedDistributionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_CentralizedDistributionCosts_6bb91c02-19fe-4376-9b99-14d4b2739eed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_38a05d18-28e8-41eb-af31-ac58b44021b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_RestructuringCharges_38a05d18-28e8-41eb-af31-ac58b44021b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c6740a9e-863d-4b72-bdc3-b9953488cf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c6740a9e-863d-4b72-bdc3-b9953488cf65" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_66d0a9b6-627d-4eda-bf19-d791a3c49d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_66d0a9b6-627d-4eda-bf19-d791a3c49d46" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_0980493f-d2cc-4a03-a7a1-2fb39ff9a567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_0980493f-d2cc-4a03-a7a1-2fb39ff9a567" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_4e31d8fe-a558-4487-9839-68dc66e2804f" xlink:href="mdt-20221028.xsd#mdt_MedicalDeviceRegulations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_MedicalDeviceRegulations_4e31d8fe-a558-4487-9839-68dc66e2804f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_8e881600-01b8-4e16-9449-0fea9b7c850b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_BusinessExitCosts1_8e881600-01b8-4e16-9449-0fea9b7c850b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_168636e2-6297-4052-97d3-d2888fa4c19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_168636e2-6297-4052-97d3-d2888fa4c19a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_60a67481-f461-4321-b79f-158be990c8b7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:to="loc_srt_ConsolidationItemsDomain_60a67481-f461-4321-b79f-158be990c8b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:to="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_287be94d-cc38-434e-8df0-d2a76f7ae417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:to="loc_us-gaap_OperatingSegmentsMember_287be94d-cc38-434e-8df0-d2a76f7ae417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_23707221-d083-42f6-a90c-a064dd70a141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_23707221-d083-42f6-a90c-a064dd70a141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d743add3-65a2-4402-aee1-41214cc33d0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:to="loc_us-gaap_SegmentDomain_d743add3-65a2-4402-aee1-41214cc33d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:to="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_11e3a437-428d-4152-ac33-9907ccbaad56" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_CardiovascularMember_11e3a437-428d-4152-ac33-9907ccbaad56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_ad22ca1d-44c5-4353-8fb0-edef52620609" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_MedicalSurgicalMember_ad22ca1d-44c5-4353-8fb0-edef52620609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_321d93ef-e12b-428e-98bc-8795c1dd8129" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_NeuroscienceGroupMember_321d93ef-e12b-428e-98bc-8795c1dd8129" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_e3584c84-04df-4a6e-800e-4ea0bf464787" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_DiabetesGroupMember_e3584c84-04df-4a6e-800e-4ea0bf464787" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6e4d6165-940c-45a5-8faa-8c36477d8b37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:to="loc_us-gaap_RestructuringPlanDomain_6e4d6165-940c-45a5-8faa-8c36477d8b37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:to="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringsExcludingRCSAndMCSMember_17963a89-63f6-40fe-bbea-10b49a7f4479" xlink:href="mdt-20221028.xsd#mdt_RestructuringsExcludingRCSAndMCSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_RestructuringsExcludingRCSAndMCSMember_17963a89-63f6-40fe-bbea-10b49a7f4479" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RenalCareBusinessRCSMember_5d320541-c0ed-467b-97fa-c33a02a3a262" xlink:href="mdt-20221028.xsd#mdt_RenalCareBusinessRCSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_RenalCareBusinessRCSMember_5d320541-c0ed-467b-97fa-c33a02a3a262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_1b1f0ce9-1fca-4a86-a2e4-38604a0b7acc" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportOperatingUnitMCSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_1b1f0ce9-1fca-4a86-a2e4-38604a0b7acc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"/>
  <link:definitionLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails" xlink:type="extended" id="ib7a759da48e04a36aac23bba4c481033_SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1fd1c7ba-eb8c-4397-965b-446981d53cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1fd1c7ba-eb8c-4397-965b-446981d53cdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:to="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ee32f724-9d04-41b2-9a50-112e580cb8b0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:to="loc_srt_SegmentGeographicalDomain_ee32f724-9d04-41b2-9a50-112e580cb8b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:to="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_63b5c6c9-dbbf-438c-9910-30abe50c7f5d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:to="loc_country_IE_63b5c6c9-dbbf-438c-9910-30abe50c7f5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:to="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cbd95f66-7957-4c52-bc28-5060101e79e6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:to="loc_country_US_cbd95f66-7957-4c52-bc28-5060101e79e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_963e79bb-8048-4583-a4f0-ae5cd725ff5a" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:to="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_963e79bb-8048-4583-a4f0-ae5cd725ff5a" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mdt-20221028_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_c69ab03c-0b40-4fef-83e9-177ea9ee21fd_terseLabel_en-US" xlink:label="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.550 percent thirty-year 2007 CIFSA senior notes</link:label>
    <link:label id="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_label_en-US" xlink:label="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 CIFSA Senior Notes Due 2038, 6.550 Percent [Member]</link:label>
    <link:label id="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_documentation_en-US" xlink:label="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 CIFSA Senior Notes Due 2038, 6.550 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:href="mdt-20221028.xsd#mdt_A2007CIFSASeniorNotesDue20386550PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:to="lab_mdt_A2007CIFSASeniorNotesDue20386550PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5d139cdb-4977-4e08-ace4-b9a642b9c337_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d59468cb-a810-40de-9696-7fd440a2aed2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1cfa62ef-ff1b-49d7-8829-b4f307e703c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_83b9529e-88c5-49b2-bc5b-21b98ace7b0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_83f7f352-5bc3-4b7a-8361-c328e4868023_terseLabel_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased technology and patents</link:label>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_label_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Technology and Patents [Member]</link:label>
    <link:label id="lab_mdt_PurchasedTechnologyAndPatentsMember_documentation_en-US" xlink:label="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased technology and patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember" xlink:href="mdt-20221028.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PurchasedTechnologyAndPatentsMember" xlink:to="lab_mdt_PurchasedTechnologyAndPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_3a365b6e-0763-4b27-b4a4-d17a6fabb8ba_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_088a9fc1-8517-44f9-b5ec-1099fb3f0e97_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9d0396ae-ac45-4b50-851f-c3d8e53bbd1c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_a5d6c0a2-76e8-4c49-aeb6-33de1fba7131_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20391.50PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 1.50 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20391.50PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_793658e1-5741-4265-8432-fdb989c0c549_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claimants (in claimants)</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_9548a649-99d7-4f7a-98b6-9820fc161658_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_339a8a28-5537-4d72-88c9-4f5c3bf22a5b_negatedTotalLabel_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss Reclassified into Income</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_documentation_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c557dd2d-775f-4621-807c-de6cabe34522_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_a02917b6-9c63-485e-9fe3-3096951ac2bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses and Fair Values of Available-for-sale Securities that Have Been in a Continuous Unrealized Loss Position Deemed to be Temporary, Aggregated by Investment Category</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_38ce989e-6261-4582-b307-1677d1fad924_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_f1159101-530e-4b85-bd32-595a8d669691_terseLabel_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers (in manufacturers)</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mdt_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossContingencyNumberofManufacturers" xlink:to="lab_mdt_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_9b84ddfb-aa1a-4cb9-993a-7b17db58d37b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_5328129d-04d8-45ed-8c95-b0d8305a4640_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit of business</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7d81f029-fe09-42fa-bcc8-438a180f9562_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3246f03f-501d-49c9-b70e-3955f0668552_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_e64a86de-3f4e-4528-9165-7e4dedffe4da_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_63dcf35f-440d-46ce-9edc-965f651c5d1e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7f77f574-b60c-4593-8d0b-fa65ee250756_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, maximum capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_844606e0-799d-4fef-8aa2-8e3c1e50efa9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_IntersectENTMember_06dd3036-1398-479c-9a2e-27eab12679de_terseLabel_en-US" xlink:label="lab_mdt_IntersectENTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersect ENT</link:label>
    <link:label id="lab_mdt_IntersectENTMember_label_en-US" xlink:label="lab_mdt_IntersectENTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersect ENT [Member]</link:label>
    <link:label id="lab_mdt_IntersectENTMember_documentation_en-US" xlink:label="lab_mdt_IntersectENTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersect ENT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IntersectENTMember" xlink:href="mdt-20221028.xsd#mdt_IntersectENTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_IntersectENTMember" xlink:to="lab_mdt_IntersectENTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_66514ca4-68a2-4e0f-8bec-6440069ef219_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_ec27f0ee-60fa-48d7-99cf-cfcd3129645f_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_ff2e2ae7-a2da-4d53-af86-77de93456a13_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency exchange rate contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_42cd0cba-d820-472f-b375-cfd18d52f898_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RevenueMilestoneMember_8cefa837-5894-4f24-8128-61695e73c114_terseLabel_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and other performance-based payments</link:label>
    <link:label id="lab_mdt_RevenueMilestoneMember_label_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Milestone [Member]</link:label>
    <link:label id="lab_mdt_RevenueMilestoneMember_documentation_en-US" xlink:label="lab_mdt_RevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A milestone in achieving certain revenue target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember" xlink:href="mdt-20221028.xsd#mdt_RevenueMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RevenueMilestoneMember" xlink:to="lab_mdt_RevenueMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_20a3cd15-cd13-4cd8-a1f5-4a333d93445e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_9e1e6918-35d7-435d-bec7-0477c9f69748_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of ordinary shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_cfbb6149-ba4c-4b69-baf2-e348acaa59bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_ce64fc27-fe69-4886-82c3-09dd70404fed_terseLabel_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco senior notes</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_label_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoSeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicLuxcoSeniorNotesMember" xlink:to="lab_mdt_MedtronicLuxcoSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cbe75492-738c-4581-b499-ed2e6d4405d3_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_69b6e5ef-f79a-48a5-84ba-6973d19da4ba_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs (in plaintiffs)</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_74fdb229-f8be-4fa2-9154-309970e69c5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin added to variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_cfcce92b-5296-41ae-93fe-bf28c29e67fb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6b5d39a5-1521-45c3-8209-c90415b458dc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6f6ed677-f8d8-4425-bb89-f47b046a5673_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_4db8899f-085f-47a7-8e8f-f21bc44fc64b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestructuringWriteDownAndImpairmentProvisions_d5d66af6-bc6b-49d8-9e4d-941a8b288493_terseLabel_en-US" xlink:label="lab_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring write down and impairment provisions</link:label>
    <link:label id="lab_mdt_RestructuringWriteDownAndImpairmentProvisions_label_en-US" xlink:label="lab_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Write Down And Impairment Provisions</link:label>
    <link:label id="lab_mdt_RestructuringWriteDownAndImpairmentProvisions_documentation_en-US" xlink:label="lab_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Write Down And Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:href="mdt-20221028.xsd#mdt_RestructuringWriteDownAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:to="lab_mdt_RestructuringWriteDownAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_c318d8bc-af7e-4ae1-b641-feaee684bb8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_bb1247d2-4946-4830-a336-568b5d9ac362_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_6f0b5dde-0344-40d2-81d9-68032645fe90_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activities Related to Debt Securities Portfolio</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_2a787bab-0ee0-44cc-a61e-8fc5e6223ec1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales to External Customers by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_abc084d8-7363-46d5-931f-170cf924dd58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Balances of Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_237574aa-a581-4473-92fc-643d91744885_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains and Losses on Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fd466174-6328-466f-8420-6c17e3da7c7a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2014Due20444625PercentMember_7bc0a838-d77e-4df4-88da-8fb44dac8028_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2014Due20444625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 percent thirty-year 2014 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due20444625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2014Due20444625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2014 Due 2044, 4.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2014Due20444625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2014Due20444625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2014 Due 2044, 4.625 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due20444625PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2014Due20444625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2014Due20444625PercentMember" xlink:to="lab_mdt_SeniorNotes2014Due20444625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20321000PercentMember_76a0dd3f-4aa1-4ea7-bbec-00eafee6dec5_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20321000PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000 percent twelve-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20321000PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20321000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2032, 1.000 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20321000PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20321000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2032, 1.000 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20321000PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20321000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20321000PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20321000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_bc433926-86c7-44fd-942b-ae3ac840cbe6_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_62021f1c-1eeb-4f08-b74c-7d383a6222e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee restricted stock units (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_0cf084a5-6271-46c6-ac4c-33ffba21abfc_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_320035e6-3225-4f31-9cb3-e159f5af6489_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_7d5801dd-0dc5-49df-9f51-2fd8696ef058_negatedLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, Milestone Payment</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent milestone payments in business acquisition transactions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionContingentConsiderationMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:to="lab_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_af30dae3-8997-480f-8931-b5e2652607b8_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Medtronic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3aaee781-9dae-4dcc-882c-f429331af46b_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to ordinary shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_48016a55-66c8-40ce-8a7f-68ba7daad561_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0b42e43a-5af1-4b61-92e5-afed6dfe20f1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca2add43-1cbb-42ad-9ebe-6fe27cddc835_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_1797a9ef-4a27-45ed-8dd1-6e04d0f79573_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_ac2d9bb5-ce46-4528-a9bf-6d544d89c901_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_a6494b3d-f0ef-4ef6-ab4b-ce81af84cb76_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_91298d6a-2297-4ae0-9107-03e2d01a6777_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedicalDeviceRegulations_86a25168-44c1-4e39-9d58-62d43f4d1639_negatedTerseLabel_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical device regulations</link:label>
    <link:label id="lab_mdt_MedicalDeviceRegulations_label_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations</link:label>
    <link:label id="lab_mdt_MedicalDeviceRegulations_documentation_en-US" xlink:label="lab_mdt_MedicalDeviceRegulations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations" xlink:href="mdt-20221028.xsd#mdt_MedicalDeviceRegulations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedicalDeviceRegulations" xlink:to="lab_mdt_MedicalDeviceRegulations" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember_6b2b81d2-7f40-4890-8485-5b6373d6cd82_terseLabel_en-US" xlink:label="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 percent three-year 2022 senior notes</link:label>
    <link:label id="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember_label_en-US" xlink:label="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.265 Percent Three-Year 2022 Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.265 Percent Three-Year 2022 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:href="mdt-20221028.xsd#mdt_A2265PercentThreeYear2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:to="lab_mdt_A2265PercentThreeYear2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4e107395-0461-4a3a-87ec-d3920510250b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_253c4b47-6919-4c7f-931a-9dcc9892f3f2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_6acc7963-d43b-4a13-8418-301a5143fcfb_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_55b5c59d-69c1-4f6a-9d5d-bf476b931f1c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_31672e34-8225-4298-bd72-6a7b03c007f5_terseLabel_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_label_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation, Denominator [Abstract]</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract_documentation_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationDenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:to="lab_mdt_EarningsPerShareReconciliationDenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_9dfa1d73-604d-44c9-9582-2aac091dcc38_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20394500PercentMember_1aba2df0-3c2e-4389-a215-90f9411bf168_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20394500PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Senior Notes due 2039</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20394500PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20394500PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 4.500 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20394500PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20394500PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20394500PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20394500PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20394500PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20394500PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_138a41c5-f870-4a95-b073-4ccd3bc242bf_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_a458308b-7b06-4a03-87b4-e7d6257f84d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_10219b6b-8570-4d04-a6e8-1fdf3dea3689_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f30045c3-d10a-432a-ac3b-6625b505e161_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_306879fe-740b-4dab-9026-05aba6ae69c6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_f6300a5d-6b41-492e-a4a6-6eecaf278b02_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments (in segments)</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_f8d03a1b-587f-4b5c-bead-6c7696818248_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AssociatedCostsMember_b12c86ce-8f0c-40dc-8fa2-dff4c05ac5bc_terseLabel_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs</link:label>
    <link:label id="lab_mdt_AssociatedCostsMember_label_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs [Member]</link:label>
    <link:label id="lab_mdt_AssociatedCostsMember_documentation_en-US" xlink:label="lab_mdt_AssociatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember" xlink:href="mdt-20221028.xsd#mdt_AssociatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AssociatedCostsMember" xlink:to="lab_mdt_AssociatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_85f6b536-48f7-4683-af17-ff4b5a06c7de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RenalCareBusinessRCSMember_89fd93a9-fb66-4ff7-aa5b-85985cad8acd_terseLabel_en-US" xlink:label="lab_mdt_RenalCareBusinessRCSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care Business (RCS)</link:label>
    <link:label id="lab_mdt_RenalCareBusinessRCSMember_label_en-US" xlink:label="lab_mdt_RenalCareBusinessRCSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care Business (RCS) [Member]</link:label>
    <link:label id="lab_mdt_RenalCareBusinessRCSMember_documentation_en-US" xlink:label="lab_mdt_RenalCareBusinessRCSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care Business (RCS)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RenalCareBusinessRCSMember" xlink:href="mdt-20221028.xsd#mdt_RenalCareBusinessRCSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RenalCareBusinessRCSMember" xlink:to="lab_mdt_RenalCareBusinessRCSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_c2c8ee84-8ef2-4f7e-8e88-5cfe9eac32ba_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9a698111-e8f5-4d77-a1f3-934e0ebe423b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d1ade312-d711-484f-9a90-f84681fe7860_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2013Due20434000PercentMember_e81a6520-6a9d-4e76-b154-135cd32519a1_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2013Due20434000PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000 percent thirty-year 2013 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due20434000PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2013Due20434000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2043, 4.000 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2013Due20434000PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2013Due20434000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 Due 2043, 4.000 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due20434000PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2013Due20434000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2013Due20434000PercentMember" xlink:to="lab_mdt_SeniorNotes2013Due20434000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2bd2d34e-8c94-489f-b190-3ae1be42496f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_885566ab-7f00-4231-af4b-6a13e9958949_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_eae70ad1-0b7e-4ca7-9953-7f2b088d484c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_34df11f3-ed3e-4c02-a9e5-8d2e47a43510_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f78248aa-479a-4dad-8e34-9c9e3b07e03a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments by Category and Related Balance Sheet Presentation</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_88a9af36-a2f8-424e-9a4e-6d10a62a23fe_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_HerniaMeshLitigationMember_ae4cdb89-ba74-4392-ab92-16370328d101_terseLabel_en-US" xlink:label="lab_mdt_HerniaMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hernia Mesh Litigation</link:label>
    <link:label id="lab_mdt_HerniaMeshLitigationMember_label_en-US" xlink:label="lab_mdt_HerniaMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hernia Mesh Litigation [Member]</link:label>
    <link:label id="lab_mdt_HerniaMeshLitigationMember_documentation_en-US" xlink:label="lab_mdt_HerniaMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hernia Mesh Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HerniaMeshLitigationMember" xlink:href="mdt-20221028.xsd#mdt_HerniaMeshLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_HerniaMeshLitigationMember" xlink:to="lab_mdt_HerniaMeshLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_9ae5c606-4679-4044-ab22-ff84c35f6f07_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d12997d4-2aa5-48ca-931e-d8edcc4a5751_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_cfbc4949-71b4-4529-a192-b888251577f5_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_40d213b6-b2a7-4a81-9b2e-0a4fa9cacd89_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3b147c62-d520-4e90-9c3c-f733ef265550_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_89e7790f-13ad-48a2-97e7-dcbb591e3625_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_b4085a81-e6a6-4e19-901e-2f11219aacac_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_94fb6539-3ab4-43a5-9286-6308dbb5d3df_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_78287f2b-fdd8-4796-83e4-9ea2aae82e44_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown_04454156-bb01-4954-bbce-97cb90583035_terseLabel_en-US" xlink:label="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MCS asset impairment and inventory write-down</link:label>
    <link:label id="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown_label_en-US" xlink:label="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges And Inventory Write-Down</link:label>
    <link:label id="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown_documentation_en-US" xlink:label="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges And Inventory Write-Down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:href="mdt-20221028.xsd#mdt_AssetImpairmentChargesAndInventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:to="lab_mdt_AssetImpairmentChargesAndInventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9b163b18-812c-47c0-93ca-326be0e061e1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6225697f-49d4-4d93-a3d5-1af18cec1e3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8a26e4e3-4cb0-430c-a728-34c4e1b40d58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in income, cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_5df99b51-fd92-443f-b9e9-49b725c81255_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_b24c17fa-4a35-4d25-8711-5a73fc356b81_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f274810a-aa1a-454b-8e16-6390f431cdd9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2012Due20424500PercentMember_cd45a86d-0358-43e4-a5c8-d49d7ab4c8e7_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2012Due20424500PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.500 percent thirty-year 2012 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due20424500PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2012Due20424500PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 Due 2042, 4.500 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2012Due20424500PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2012Due20424500PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 Due 2042, 4.500 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due20424500PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2012Due20424500PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2012Due20424500PercentMember" xlink:to="lab_mdt_SeniorNotes2012Due20424500PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_bd7a3598-12d9-456d-91de-4e457bf1689e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and retirement benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_72d3d51a-ac10-43d9-b276-24cf2acc9652_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_9ebf3216-8442-486a-82d2-37a50d0aaf12_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1080b32c-d895-43b3-ba12-e61afa3ec138_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3db5fc6b-13ee-444e-9758-268ebc688199_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DiabetesGroupMember_a32d6845-d0d0-4432-901b-191384d43556_terseLabel_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes</link:label>
    <link:label id="lab_mdt_DiabetesGroupMember_label_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Group [Member]</link:label>
    <link:label id="lab_mdt_DiabetesGroupMember_documentation_en-US" xlink:label="lab_mdt_DiabetesGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DiabetesGroupMember" xlink:to="lab_mdt_DiabetesGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_458c291a-ac25-4a2a-a006-6ad3e23ecaa6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investment Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_cf7ca421-c3c8-44e6-b75b-bbf5ec2758c4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_73743000-bb96-42d2-a36c-dc166d8b9248_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_082b4f1b-4f54-44c0-9e92-7a8ef43a0691_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_b3945fc0-f791-4b43-97c6-a65e28009c48_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_364b2805-257d-4479-9367-d6805d7cf732_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate obligations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_5b4e6142-0619-49ab-a9d1-d8a01f1206d9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7582af0c-25ee-415f-8aa6-a0d1b3fb8d86_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_2dbb0d26-fa97-4858-84a7-40fab505d875_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_09520ac4-f788-43d0-a46b-641bd5a09449_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_285a9856-d214-49c4-b795-23a2560bf426_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ce868f2e-d442-4328-830c-7a38eb45e97d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_c6a83305-affc-499f-9d02-285c8dbe69ca_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_a0b07950-422b-4860-b4aa-f7ca425ed560_terseLabel_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic mesh</link:label>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_label_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Mesh Litigation [Member]</link:label>
    <link:label id="lab_mdt_PelvicMeshLitigationMember_documentation_en-US" xlink:label="lab_mdt_PelvicMeshLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Mesh Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember" xlink:href="mdt-20221028.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PelvicMeshLitigationMember" xlink:to="lab_mdt_PelvicMeshLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_38f9d596-a295-4167-a12f-c4b5fe0247f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_466dd986-5729-40e2-afb1-d5d28f4f8ea8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other restructuring costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A3000PercentSixYear2022SeniorNotesMember_6f747968-6f32-42a0-addf-f45b31682ed2_terseLabel_en-US" xlink:label="lab_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.000 percent six-year 2022 senior notes</link:label>
    <link:label id="lab_mdt_A3000PercentSixYear2022SeniorNotesMember_label_en-US" xlink:label="lab_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.000 Percent Six-Year 2022 Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_A3000PercentSixYear2022SeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.000 Percent Six-Year 2022 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:href="mdt-20221028.xsd#mdt_A3000PercentSixYear2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:to="lab_mdt_A3000PercentSixYear2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_a6fd043f-fecf-4355-a545-a94f569d30f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_2035e313-5162-4a25-a0ac-275e89c63f31_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Liabilities</link:label>
    <link:label id="lab_us-gaap_OffsettingLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OffsettingLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_2074b22e-d0c7-4ea5-bfb1-335fc275cf37_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a95597ad-26fd-4379-82eb-7d2e407dfb2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in AOCI, Cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_e08548d0-321a-4a1e-ab5e-bbe6301d3a4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_29ac6146-2683-456f-9a0b-f9a288421f9a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_2dd0b07e-3cfb-480a-9014-e8935a3ab840_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b4e126ca-4230-4dce-87fa-1762c6379859_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c2863f95-6efa-4f9c-b53f-d1e44e4b6965_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_abbf5e59-1fce-464a-819f-b00b00778c4a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f4d2d8f2-90cc-4cd6-b419-a03ad5a984a5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3bc184e3-8a3c-4c64-89a3-a4687e6ca753_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (AOCI) by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9a69f777-cb48-4ef2-9328-b4a46f2831ef_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_58090638-5b6b-46eb-b744-e8f29311f225_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a1c2086a-748d-467f-aa1a-094d11214dbf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f0079ac7-142b-4074-b0e8-b48502570995_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of settlement received</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a35b5d3c-95e5-4f1c-98f9-515154efea90_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_209a8219-7c75-48b4-bf6b-024ae66d10b6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_a301d1d6-591f-4203-a2e0-39b344d47698_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_4a1a56d0-1776-44eb-abc7-e3575f359c97_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments with readily determinable fair value (marketable equity securities)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_e1c34fab-d090-4497-88e1-a6a08b3e53dd_terseLabel_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for:</link:label>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_label_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes and Interest Paid [Abstract]</link:label>
    <link:label id="lab_mdt_IncomeTaxesandInterestPaidAbstract_documentation_en-US" xlink:label="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes and Interest Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncomeTaxesandInterestPaidAbstract" xlink:href="mdt-20221028.xsd#mdt_IncomeTaxesandInterestPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract" xlink:to="lab_mdt_IncomeTaxesandInterestPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_e5ef5848-44de-4d55-b805-a8c74e20182f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_b01d71a1-d5a8-4093-9b7a-9543c760407b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1589b98b-c8f8-4be7-99dd-bd87f0c35e59_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ScheduleOfDebtTable_dc1c8dcb-14dc-4027-a59e-db6ad6f91926_terseLabel_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table]</link:label>
    <link:label id="lab_mdt_ScheduleOfDebtTable_label_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table]</link:label>
    <link:label id="lab_mdt_ScheduleOfDebtTable_documentation_en-US" xlink:label="lab_mdt_ScheduleOfDebtTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A table or schedule providing information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable" xlink:href="mdt-20221028.xsd#mdt_ScheduleOfDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ScheduleOfDebtTable" xlink:to="lab_mdt_ScheduleOfDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_8a441a45-811d-4776-90dc-d538ef993e41_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_1803d4b1-220e-49d5-90c3-21fb708def7e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_0374be2e-4263-4dbc-91de-a2f3804542cb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_StructuralHeartAndAorticDivisionMember_9e14b7f7-5179-43d0-abd8-f03c14d70a33_terseLabel_en-US" xlink:label="lab_mdt_StructuralHeartAndAorticDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Structural Heart &amp; Aortic</link:label>
    <link:label id="lab_mdt_StructuralHeartAndAorticDivisionMember_label_en-US" xlink:label="lab_mdt_StructuralHeartAndAorticDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Structural Heart and Aortic Division [Member]</link:label>
    <link:label id="lab_mdt_StructuralHeartAndAorticDivisionMember_documentation_en-US" xlink:label="lab_mdt_StructuralHeartAndAorticDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary and Structural Heart Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_StructuralHeartAndAorticDivisionMember" xlink:href="mdt-20221028.xsd#mdt_StructuralHeartAndAorticDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_StructuralHeartAndAorticDivisionMember" xlink:to="lab_mdt_StructuralHeartAndAorticDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_89016abe-2492-4393-ad8e-6ac73931b866_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a626465-4c0f-4cdc-a468-451856340b4d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_433b73f9-3978-49e2-9507-36ad5cc48a80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_5cb75f21-4cf6-4332-9267-9cb8976c86f8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_2efbaa38-68cf-40cd-a947-dad98c54de0a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_029a3ce3-19de-4ab9-9cc0-b4590a84fe88_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_412b08ee-b96a-4c34-85aa-ca1199331027_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_93c8b259-f576-4435-9447-ff1bd686eca5_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japanese Yen-denominated Debt</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_2c99e486-ef0f-48b7-a1de-7f4d0e21e44d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2dc59267-1a70-40b2-8e32-8896c2e0bd71_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_227f2e91-972f-49d1-81c7-b91d948bf45d_terseLabel_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subsidiaries (in subsidiaries)</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_label_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Subsidiaries</link:label>
    <link:label id="lab_mdt_LossContingencyNumberofSubsidiaries_documentation_en-US" xlink:label="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossContingencyNumberofSubsidiaries" xlink:to="lab_mdt_LossContingencyNumberofSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_f7cf96b6-8d6f-4a67-9eb8-948c6cb9d01b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a52c8c6e-1300-4689-937d-bdec6989d83c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income including noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_d5988444-0dd0-4067-9028-24a16cd58888_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims settled (in claims)</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_40bd5da7-6d78-481d-940f-a560cf74a0cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized in AOCI, net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_63483e23-8c57-4a05-bb63-6ad039600b35_terseLabel_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification</link:label>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_label_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification Restructuring Program [Member]</link:label>
    <link:label id="lab_mdt_SimplificationRestructuringProgramMember_documentation_en-US" xlink:label="lab_mdt_SimplificationRestructuringProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simplification Restructuring Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember" xlink:href="mdt-20221028.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SimplificationRestructuringProgramMember" xlink:to="lab_mdt_SimplificationRestructuringProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_d36a609c-d7be-4282-866e-6505170193a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d89663b4-44bb-4c44-b50d-86feb90c9f8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_97e6ddba-9472-4777-bce0-2ae7e5cb690b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_f761f84c-db6a-41c5-b0b6-1756599d2e6b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_8bda0496-7882-4f27-9718-5028c293698d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b1d3e872-90fc-43c5-9060-6ed7d31297bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_37eafbbf-810b-478a-a822-972b9f2efec9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_fb0c6cfe-f373-45f8-bbe4-ee7b2ed80e77_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_8c427e36-1fff-49bf-906e-35c42a30839c_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_59d160e1-9d08-4821-babc-6bc5835cc5d2_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_44565010-53c6-4abc-b3bf-0c32e16f8988_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_10a5f263-00a3-45c3-82e3-bd65ba78c9e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_0ba84a36-d57d-4570-a021-7d23b954629a_terseLabel_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations</link:label>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_label_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations Division [Member]</link:label>
    <link:label id="lab_mdt_SurgicalInnovationsDivisionMember_documentation_en-US" xlink:label="lab_mdt_SurgicalInnovationsDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Innovations Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember" xlink:href="mdt-20221028.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SurgicalInnovationsDivisionMember" xlink:to="lab_mdt_SurgicalInnovationsDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_1b996dbb-f19d-41ea-9bac-7e56f888fac2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax adjustments</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:to="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d5ffc9bd-5f97-4704-8324-b28fe221090f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a5eb8558-c75b-4a8d-ac8b-0e62f629f04a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_027d1b78-97c5-4c29-a955-60fef3d30913_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_adbe6ab4-52f8-41b8-b10b-e092d6ec3c52_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_88798387-5f99-41ae-8c7a-350a37a23d3a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b4f00698-3a1b-42da-9f47-f70870e4fff8_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_d0b7a7cf-aa20-4bd6-b9db-e1848e999ccc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_523b0f16-d855-4bcc-94fc-5acaaa2ceafb_terseLabel_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm &amp; Heart Failure</link:label>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_label_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm and Heart Failure Division [Member]</link:label>
    <link:label id="lab_mdt_CardiacRhythmandHeartFailureDivisionMember_documentation_en-US" xlink:label="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiac Rhythm and Heart Failure Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:href="mdt-20221028.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:to="lab_mdt_CardiacRhythmandHeartFailureDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_dacbd0c8-81b1-49df-986d-6c317f64d097_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4520bf41-bd17-47d1-a4dd-b28931dad918_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e0be929-106a-4fcb-a807-1e62de09d7eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ef959c7b-0b5d-4d37-925b-a9bd4af2e8dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_fc62ce38-aa7c-4ac7-be32-a74da32b888d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_4686672b-dbf5-42fe-ad74-43d38595fdc3_terseLabel_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_label_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) [Abstract]</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityAbstract_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract" xlink:to="lab_mdt_DerivativeAssetLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_56e865d3-d86b-437a-8a5b-2fe9633c76a8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_0da4a0a3-2b30-4960-a3cf-951eab0abfa9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_41c5ed01-565f-4ca6-8d09-12b17aaa941a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_28b9d03b-1c29-435b-9acd-6767723e7778_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20354375PercentMember_c13cc59e-b3c2-405b-84d9-2271433fd0d3_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20354375PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375 percent twenty-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20354375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20354375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2035, 4.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20354375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20354375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2035, 4.375 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20354375PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20354375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20354375PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20354375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d18d8d93-babb-4580-a495-9caf92e6bdfe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_5697c00a-8f20-433e-b45a-c5d599b5551e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_7baaa4b5-612f-4d09-b571-24707757788e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_25976b88-15da-4c4b-8553-ecc5d5689316_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9e9440ba-00cf-46a9-b107-1d89dfe29398_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_26f3a71f-6475-4c6e-8a97-7f8c18d6ef00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fc86a9f9-d9d6-4524-b95e-3856e68bac35_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fb5f78cc-b6ca-4f74-8fe7-9677f48ccda1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_8655cfe8-350d-46ae-9905-8ccd632412e8_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_e09ffc8d-6f90-4744-991c-a2863a74256d_terseLabel_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Line Items]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_label_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Line Items]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesLineItems_documentation_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Offsetting Assets and Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:to="lab_mdt_OffsettingAssetsandLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_fffb3d61-ea42-4ffb-89ce-f94a2df6dd83_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_d0d7d8ad-6074-4517-be26-2fbf95aa2182_terseLabel_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, maximum borrowing amount</link:label>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_label_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_mdt_CommercialPaperMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:href="mdt-20221028.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:to="lab_mdt_CommercialPaperMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_888152c1-5bc6-4bed-8a04-1b09d78499bc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_89625aaa-1c7e-4105-9938-6c0ec340815f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f00b581f-d5e4-4b47-b122-5985b52f4f0e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20271125PercentMember_84734efa-2b09-45c1-8562-c52aa6a93c08_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20271125PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Senior Notes due 2027</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20271125PercentMember_1b6a45be-449a-4bdb-b96a-e7a21576c7cb_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20271125PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125 percent eight-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20271125PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20271125PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027, 1.125 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20271125PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20271125PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2027, 1.125 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20271125PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20271125PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20271125PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20271125PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_1f67b123-ed12-42e1-9eff-ed8616a2241e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_99d97b97-00fe-457b-a332-f760ff06a0f9_terseLabel_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_label_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_mdt_EmployeesStockPurchasePlanMember_documentation_en-US" xlink:label="lab_mdt_EmployeesStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember" xlink:href="mdt-20221028.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EmployeesStockPurchasePlanMember" xlink:to="lab_mdt_EmployeesStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_1897dd39-0b63-4199-a124-bf0b43a5e14d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications, tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_a2be83f7-f3a1-4c61-b077-64d746ebe3fb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_56079211-2081-4883-b1f4-6e56687bfec7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_7be66e4b-0e7b-4e3b-bafd-861760af8ebb_terseLabel_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence</link:label>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_label_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence [Member]</link:label>
    <link:label id="lab_mdt_EnterpriseExcellenceMember_documentation_en-US" xlink:label="lab_mdt_EnterpriseExcellenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Excellence [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember" xlink:href="mdt-20221028.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EnterpriseExcellenceMember" xlink:to="lab_mdt_EnterpriseExcellenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_cbfa671d-aeaf-4a73-892b-6c5257dabe4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_c23bdd51-8223-49cd-a3c5-6a20be832c9f_terseLabel_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine chemical manufacturing facility</link:label>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_label_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine Chemical Manufacturing Facility [Member]</link:label>
    <link:label id="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember_documentation_en-US" xlink:label="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orrington, Maine Chemical Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:href="mdt-20221028.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:to="lab_mdt_OrringtonMaineChemicalManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_5edff9b9-de3e-4ad6-b959-74c9903c89a6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_bf9f47ab-1878-4e5d-a7d8-8123a426abbb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_b5aab0da-1cfd-4f59-8b0b-74426a46220a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_24beac2c-68f1-4732-9bc6-1fba1120070e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6b845377-2f34-4658-9198-71522a40635f_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_bb77840e-4bf2-4e9e-a899-3b4c795e0206_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7201715f-67ff-48b9-8dd4-711e2ce486a9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_215989d2-f7d2-4654-9af1-70e8d119342e_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_fa9d0dc3-74e8-4bde-b0a7-6442d16f647d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_7909565a-b0e7-48d0-a9d8-f9a3f491d6a4_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Amount Offset Against Collateral, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:to="lab_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_111ddd98-2838-4e55-a997-05062380dab1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_467df77c-685e-474c-9a8f-dc50e50cd43d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability_a2c44112-5cf9-420e-8b45-4441303b6c75_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_85362890-a43e-4f32-878d-30ecf1ada28f_terseLabel_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support Operating Unit (MCS)</link:label>
    <link:label id="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_label_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support Operating Unit (MCS) [Member]</link:label>
    <link:label id="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_documentation_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support Operating Unit (MCS)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportOperatingUnitMCSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:to="lab_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a2bc12c9-6798-4250-9db9-bb4e0a344948_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_474555ff-a292-4dbd-aac4-2a9b485d315c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost incurred to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cf9fd2a1-f985-4e64-8624-adac5070e079_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_320bd2aa-9c5d-4dc2-814a-d01388a24a04_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities:</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_2db12637-eec6-420f-ab9f-030f8790a7a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_1df70e1c-76a4-473a-b0dd-91e1aab3135b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_bc3731f3-fac9-462f-9fbe-b875c856493b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a1843dfa-861f-4c0c-9665-b9f56653fbe9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_3bbc89da-5268-4c5a-8337-5d985f98c747_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_a61d4031-3c85-4844-98b7-76cb264243ef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_17c1f263-0286-43d5-910b-50d06e998abd_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_e760db26-2d7e-4377-ad4d-6187ed14096c_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_5a2c6014-ca39-406d-bb3f-fefcba9de5fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_363d0e46-10a4-485c-a707-b16d73abffb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c20b52fe-2040-4383-a79a-913b482191fc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3ef10e93-7c8c-43e9-b826-066227f6cd64_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20260250PercentMember_0b4db8ca-e2b1-46b2-bec7-7056bf1f7b98_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20260250PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250 percent six-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20260250PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20260250PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2026, 0.250 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20260250PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20260250PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2026, 0.250 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20260250PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20260250PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20260250PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20260250PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_5019c70e-2bb4-46a8-98c6-d403bd642555_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b3d344be-a951-4d07-b282-840cb546801b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_b76c068d-e9d7-48fb-931e-0d7e38e49aa8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_e852186e-3c84-4ccf-89ae-648c50d251bb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_f70d4ec2-4cb0-4b59-b953-a3ece5d52ab5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_2565b32c-67cb-4c82-9f48-3549b741f5bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Retirement Obligations</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_NonDerivativeInstrumentsMember_37a4ae47-945b-4d2f-9fea-9f5a6537dd1d_terseLabel_en-US" xlink:label="lab_mdt_NonDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-derivative instruments</link:label>
    <link:label id="lab_mdt_NonDerivativeInstrumentsMember_label_en-US" xlink:label="lab_mdt_NonDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivative Instruments [Member]</link:label>
    <link:label id="lab_mdt_NonDerivativeInstrumentsMember_documentation_en-US" xlink:label="lab_mdt_NonDerivativeInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NonDerivativeInstrumentsMember" xlink:href="mdt-20221028.xsd#mdt_NonDerivativeInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_NonDerivativeInstrumentsMember" xlink:to="lab_mdt_NonDerivativeInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_6c16023a-3fb9-49a4-b0c1-2b4726dcfc21_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_123f634e-44ee-4f1a-8258-b467fa8e9bbd_terseLabel_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_documentation_en-US" xlink:label="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="mdt-20221028.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c20b3490-c086-48d7-8bc5-7e17f6f74cf6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0e0b5c73-236e-4eb6-948d-9df134c7cb22_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d836ff23-ad87-4e3a-a016-ddf447470310_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Currency Exchange Risk Management</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_47d6e689-634f-45e2-906e-52b3f57b4e3a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_b1041126-1d63-4eb2-8f57-b5ba65c18e41_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20290375PercentMember_888ebbb9-c0e8-4b29-9488-12e731d1fa6c_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20290375PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375 percent eight-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20290375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20290375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2029, 0.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20290375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20290375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2029, 0.375 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20290375PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20290375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20290375PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20290375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a2da9eb5-652d-4912-89e6-1fd0be6d8c0e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, (Gain) Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ef687e3d-8297-4b75-9bc3-c3542809758c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d684f158-2445-474a-864c-38756397f90e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_2ed3de60-20ed-478f-bd14-6a6471a37afb_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_52bc9dd6-c706-4665-85a0-aeaaefcedd25_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_604cba6d-7264-4307-ba62-ef787b57143f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TotalReturnSwapMember_6053964c-0530-4510-9a76-289785f82ae7_verboseLabel_en-US" xlink:label="lab_us-gaap_TotalReturnSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total return swaps</link:label>
    <link:label id="lab_us-gaap_TotalReturnSwapMember_label_en-US" xlink:label="lab_us-gaap_TotalReturnSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Return Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TotalReturnSwapMember" xlink:to="lab_us-gaap_TotalReturnSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_0a76ff95-d141-45f3-b23c-918a2835aa33_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_aeaf8053-b6a3-4a80-a57f-b0f08fe8a5dd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2c02ae5b-ac9d-4903-9d90-298da467a788_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_2d25022b-b388-4175-bb47-ffcf4e9f1c50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CardiovascularMember_4cb0a16a-7323-4659-8ba8-fc0e01869f30_terseLabel_en-US" xlink:label="lab_mdt_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:label id="lab_mdt_CardiovascularMember_label_en-US" xlink:label="lab_mdt_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular [Member]</link:label>
    <link:label id="lab_mdt_CardiovascularMember_documentation_en-US" xlink:label="lab_mdt_CardiovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CardiovascularMember" xlink:to="lab_mdt_CardiovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_f858b302-0a65-4f72-9d2b-3cdf2cce3752_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_099a42e5-8a32-4ca0-a3d2-2a2865adaca4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, par value $0.0001 per share</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_e617213f-5ef2-445c-b92b-d9126d220e25_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_917d5523-3fae-49c7-9e94-ac06851d2455_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under stock purchase and award plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4a4cfa8c-9d07-435f-ac52-7c8dc65c883d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments (in segments)</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e35d7cc0-09af-4a66-8152-38870cc3bcc3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b1c9a9a2-9a3a-4a73-87eb-779d7690f6b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_893e7109-d4a1-4b46-8675-2b15420418f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_99d0c0c9-317d-48dd-bbf0-fa0ad1cef602_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_3d9fd539-3ad6-48c4-84f9-139d75fb1785_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CoronaryAndPeripheralVascularDivisionMember_daa07898-78d1-4170-a7ab-0d1437f44601_terseLabel_en-US" xlink:label="lab_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary &amp; Peripheral Vascular</link:label>
    <link:label id="lab_mdt_CoronaryAndPeripheralVascularDivisionMember_label_en-US" xlink:label="lab_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronary and Peripheral Vascular Division [Member]</link:label>
    <link:label id="lab_mdt_CoronaryAndPeripheralVascularDivisionMember_documentation_en-US" xlink:label="lab_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic, Peripheral and Venous Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:href="mdt-20221028.xsd#mdt_CoronaryAndPeripheralVascularDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:to="lab_mdt_CoronaryAndPeripheralVascularDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_22e20fd3-3eaa-40bf-8583-3524f6a06430_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_01ca0e5b-3bc9-43e8-9b60-496f98c20eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Classified as Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_f9bb7f9e-c5fa-4100-a046-278e790403ff_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_685b4313-6144-4cb4-9dbf-2e2271efdb63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to held for sale</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e7547d0f-0006-450a-9300-fb46425c0998_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_4d182f6c-b0c2-40df-a0fa-3e468c550d83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e236bde4-4024-4d45-a219-5702a62f4ce4_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_179cd247-93c1-41f8-b8f3-8c42b5e2f479_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_217c9924-7b3d-41db-a034-4e6b2a7e06c3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, held-for-sale, not discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_NeuroscienceGroupMember_c6b308fa-8dc4-44a4-aed6-967ec125097f_terseLabel_en-US" xlink:label="lab_mdt_NeuroscienceGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience</link:label>
    <link:label id="lab_mdt_NeuroscienceGroupMember_label_en-US" xlink:label="lab_mdt_NeuroscienceGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience Group [Member]</link:label>
    <link:label id="lab_mdt_NeuroscienceGroupMember_documentation_en-US" xlink:label="lab_mdt_NeuroscienceGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_NeuroscienceGroupMember" xlink:to="lab_mdt_NeuroscienceGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2017Due20273350PercentMember_192e7ae6-ba9a-4fbf-a6e8-48d87a83b161_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2017Due20273350PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.350 percent ten-year 2017 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2017Due20273350PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2017Due20273350PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2017 Due 2027, 3.350 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2017Due20273350PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2017Due20273350PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2017 Due 2027, 3.350 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due20273350PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2017Due20273350PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2017Due20273350PercentMember" xlink:to="lab_mdt_SeniorNotes2017Due20273350PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_2dd2ce96-c741-46b9-837c-3dbab92cc6bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_677a07fb-9c60-4c07-ac6b-a91b2419adb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D charges</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Asset Acquired Other than Through Business Combination, Written-off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9238f0b3-855a-41f1-8781-75f8487c828f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_a2e93b70-3bdf-4df2-a18b-d2c32026f0c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_941debfa-d6dc-422c-bf80-91e0f7a055ee_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount, Indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_591f4818-e73a-4f3c-8c60-e52dde173112_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_82f5465e-8275-4d9c-95b1-69f4600351a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CorporateOverhead_0ad047c9-e4cf-4010-9639-c94044730ffc_negatedTerseLabel_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_mdt_CorporateOverhead_label_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Overhead</link:label>
    <link:label id="lab_mdt_CorporateOverhead_documentation_en-US" xlink:label="lab_mdt_CorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate overhead expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead" xlink:href="mdt-20221028.xsd#mdt_CorporateOverhead"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CorporateOverhead" xlink:to="lab_mdt_CorporateOverhead" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2c21d0a1-41a8-4b31-8f56-d3c6aaa442f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowances and credit losses of $203 and $230, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6a4b931c-fadf-420f-9add-b0f56e3684a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d54ae3c5-193d-4d1f-9509-3c57794711e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AfferaIncMember_c468b724-7f4d-4b0f-ac3f-1209de53225e_terseLabel_en-US" xlink:label="lab_mdt_AfferaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affera Inc</link:label>
    <link:label id="lab_mdt_AfferaIncMember_label_en-US" xlink:label="lab_mdt_AfferaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affera Inc [Member]</link:label>
    <link:label id="lab_mdt_AfferaIncMember_documentation_en-US" xlink:label="lab_mdt_AfferaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affera Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AfferaIncMember" xlink:to="lab_mdt_AfferaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_23dd9d9a-0071-4680-93c9-bfcf978d2016_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_11a3d9ff-3803-4db4-b375-d0960d5b68c9_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_42b26e07-816a-483a-8587-9f1955f2db9d_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9c938d74-1f62-4927-bce0-32f77e1e4250_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_eaebd1a5-dca6-4e0c-aab5-e22fa78d75eb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_279ef077-e39e-4fd4-a50d-56a5923223dc_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_aa15d0e7-fcbf-4d53-8980-d60cfc4cb542_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% Senior Notes due 2049</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2049Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2049Member" xlink:to="lab_mdt_SeniorNotes2019Due2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_87820553-fcd4-4070-853a-51a177d43cbe_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f6919325-440d-4c75-a21a-5dd027c2efd9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8a2e8f69-e56a-4079-8104-754b8b911950_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20411375PercentMember_06d46f65-74dc-409f-9e37-edacedfeefb2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20411375PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.375 percent twenty-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20411375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20411375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2041, 1.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20411375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20411375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2041, 1.375 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20411375PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20411375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20411375PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20411375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_6ea19ac6-12ff-41ce-8c2c-be5cf80a1be1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_6c6ca1dd-dd8b-4b5b-a214-5be9bf7ae4c9_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2050</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2050Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2050Member" xlink:to="lab_mdt_SeniorNotes2020Due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_1662f8b6-5982-4dc9-9cd9-82011a34f10d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_e9af8178-e5b5-4b1b-be42-507f8a55211c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_626f2a2f-f527-4e9b-bda7-243699002f49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5e307529-a72d-4e56-b91e-4f294782ca02_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_5909df72-5cad-41e0-aa5e-832e32d1ffc1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_df871aa0-4db2-4462-9e9c-71c70f8b536e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2010Due20405550PercentMember_7c7f1b2a-d5d9-4425-be38-dfb4d638a445_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2010Due20405550PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.550 percent thirty-year 2010 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2010Due20405550PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2010Due20405550PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2010 Due 2040, 5.550 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2010Due20405550PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2010Due20405550PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2010 Due 2040, 5.550 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due20405550PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2010Due20405550PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2010Due20405550PercentMember" xlink:to="lab_mdt_SeniorNotes2010Due20405550PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_96c93f72-646b-402c-ac8e-8bef3a58a351_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_04a40abd-ed91-4b74-ab34-a120f046e3dd_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_334c7308-4113-44c6-aa9c-2772f20d0525_terseLabel_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity Related to the Company's Equity and Other Investments Portfolio</link:label>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_label_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table Text Block]</link:label>
    <link:label id="lab_mdt_ScheduleofInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleofInvestmentsTableTextBlock" xlink:href="mdt-20221028.xsd#mdt_ScheduleofInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ScheduleofInvestmentsTableTextBlock" xlink:to="lab_mdt_ScheduleofInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9176e670-95a8-4581-87e8-82fdfebb07c2_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e05b352f-7291-4833-bd04-553330775e87_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_6e1273bd-dc69-484f-a2f0-d0c071b84141_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_bbb82d0e-1044-4824-a8a3-30fa0c871ba3_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2e3f1a7b-dd60-441a-b090-e3328f38f99b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fbc11d87-55fb-43a6-923f-d9d13f068ced_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1f737826-e098-4f7f-bb1f-b75fe9420d40_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8110c320-4da9-4270-8fef-1c8a41c1dbd2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311625PercentMember_96991659-ee33-4c06-937b-e5f6f648ab20_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311625PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311625PercentMember_568878f2-6ff0-4854-bea1-f725c19efb78_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625 percent twelve-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311625PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311625PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_33e05abf-2351-4982-ae6e-e93f42c9f21a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d09e0961-898b-4dcc-a526-fbf801ad6a89_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_3f407f8b-e47a-4182-ba73-f2d3f90df03d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_2b42918a-5cf9-4ad0-9a63-9a4d996b1170_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_cfdb9d90-50c7-46a7-a72b-330ca9a222bc_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_e5533e88-72aa-4a83-b033-53566cc86a9c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_bd513175-3997-4a60-89ae-abaa340439cb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1f7389cb-3c45-441f-bb86-caa275b4e502_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ac64c192-d6c7-49fb-8456-3295b2c96215_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_70a0e176-c520-4c98-a61b-c65aaca5b90c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_8f263ac5-967f-4870-a8b7-7cb7be27bc6f_terseLabel_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_label_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:label id="lab_mdt_OffsettingAssetsandLiabilitiesTable_documentation_en-US" xlink:label="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets and Liabilities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable" xlink:to="lab_mdt_OffsettingAssetsandLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1d09a34c-f253-4970-ba59-2a09beb67328_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6dae4ebf-06fc-4880-8579-19c0363516ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_41cb7fbe-3adb-42ea-8a48-e1a54d57142d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e03487ef-f502-4c17-a3be-200959cc1772_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_InProcessResearchDevelopmentMember_28149867-d1f5-4d87-9c33-ef6f68d7731d_terseLabel_en-US" xlink:label="lab_mdt_InProcessResearchDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D</link:label>
    <link:label id="lab_mdt_InProcessResearchDevelopmentMember_label_en-US" xlink:label="lab_mdt_InProcessResearchDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process Research &amp; Development [Member]</link:label>
    <link:label id="lab_mdt_InProcessResearchDevelopmentMember_documentation_en-US" xlink:label="lab_mdt_InProcessResearchDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process Research &amp; Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_InProcessResearchDevelopmentMember" xlink:href="mdt-20221028.xsd#mdt_InProcessResearchDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_InProcessResearchDevelopmentMember" xlink:to="lab_mdt_InProcessResearchDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_503c449b-43ee-456c-abf5-aaefe75c80d0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_86b09b6f-5b75-4bbb-a454-218436c4ae91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d55d38f6-b27b-4ed8-8fab-f20d42cdeb7a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f70d2a69-5f51-4312-ae59-a700f28957f1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20330750PercentMember_7575ba20-a8ec-43fe-8038-583fb2bfe16c_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20330750PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750 percent twelve-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20330750PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20330750PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2033, 0.750 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20330750PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20330750PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2033, 0.750 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20330750PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20330750PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20330750PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20330750PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_92d84e8c-efa3-4828-b683-e73ca47b7c55_negatedTotalLabel_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_documentation_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_6a167ad7-6b4f-4d21-97d8-87645f0004fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (repayments of) short-term borrowings (maturities greater than 90 days)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_2b144c7d-0d24-4e3c-9757-bcb2397c3bde_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d0705e9e-534a-46c0-9abd-8c0773caf0f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_501bae72-ae3d-43de-9019-9ffce9b7f143_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_98367a40-c033-42de-8e12-7cc5cf601617_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which remaining performance obligations are expected to be recognized as revenue</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7647cc6e-f781-4b36-aa16-be9066e8ebcb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_289b992c-b06f-4541-bd02-a4d17184e6d9_terseLabel_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_label_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) On Derivatives Arising During Period, Net Investment Hedge, Net Of Tax</link:label>
    <link:label id="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_documentation_en-US" xlink:label="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) On Derivatives Arising During Period, Net Investment Hedge, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:to="lab_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3cc6c63b-6518-4652-bebb-1d283e74faf2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8cf716b9-7b71-47cf-9301-9dc668a0ea95_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_c5a73df2-6823-42fb-b1e1-834f5f9abddd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold, excluding amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5ca8c39a-9a1e-4d3b-b50e-0d6cb97f3f8a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_060044e8-9e1c-41d9-bb1c-81d31b9417ab_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted - weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_29e55a83-e530-400a-9697-a0358f2d9927_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral (Received) Posted</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralRightToReclaimCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:to="lab_us-gaap_DerivativeCollateralRightToReclaimCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_0b9e39a1-ff81-4679-8021-ae3101daa037_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_229bb990-e7b0-4434-90d5-1af9ef5eba38_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_5c7c602f-a706-4177-b2ff-7c7b8eb5fcf4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_bee77fb0-d9ee-4bc1-957d-ba945a29fe7b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2022Due2028Member_e3b721f6-324a-4b5c-9635-94317eaf2d42_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.000% Senior Notes due 2028</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2028Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2028 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2028Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2028Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2022Due2028Member" xlink:to="lab_mdt_SeniorNotes2022Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_c4a2f5a2-c53a-43c5-952e-db242624888e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_31c4b772-db07-445f-88ae-721e94a31435_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recognized Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_39796718-8636-4f6a-b9b9-6813153bbdce_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_79f0abbb-c39f-43bc-a8cf-0a2981b986fa_terseLabel_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TIBOR Rate</link:label>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_label_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tokyo Inter-bank Offered Rate (TIBOR) [Member]</link:label>
    <link:label id="lab_mdt_TokyoInterBankOfferedRateTIBORMember_documentation_en-US" xlink:label="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tokyo Inter-bank Offered Rate (TIBOR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:href="mdt-20221028.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:to="lab_mdt_TokyoInterBankOfferedRateTIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05e81aa3-9355-4ed7-80a7-f1da8eabb109_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_ced9130a-6e8d-4b63-8eec-89ed1e50247c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_f6dafddd-3a66-4454-a763-e71d6aa992cc_terseLabel_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax exit and disposal costs and other</link:label>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_label_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Tax Exit and Disposal Costs [Member]</link:label>
    <link:label id="lab_mdt_PreTaxExitandDisposalCostsMember_documentation_en-US" xlink:label="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Tax Exit and Disposal Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember" xlink:href="mdt-20221028.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_PreTaxExitandDisposalCostsMember" xlink:to="lab_mdt_PreTaxExitandDisposalCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9c5cb349-9719-4d0b-adba-2410169c9d0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares&#8212; par value $0.0001, 2.6 billion shares authorized, 1,330,148,578 and 1,330,743,395 shares issued and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_4467d699-f283-491d-bde4-173fe92783ae_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b1eb8d10-7a93-4602-bf53-3ccfaf3d84be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_d4e55465-9e69-4f3a-a825-3e87d2b18f81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_09a0d244-ff3a-4891-807f-1f3c0fb1f45a_terseLabel_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_label_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding United States and Ireland [Member]</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_documentation_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding United States and Ireland [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:to="lab_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_393ccfb4-38cc-4d10-abbf-5808037fdb2c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedicalSurgicalMember_cb42af52-90e2-4cd4-846e-baa2cf2fb393_terseLabel_en-US" xlink:label="lab_mdt_MedicalSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Surgical</link:label>
    <link:label id="lab_mdt_MedicalSurgicalMember_label_en-US" xlink:label="lab_mdt_MedicalSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Surgical [Member]</link:label>
    <link:label id="lab_mdt_MedicalSurgicalMember_documentation_en-US" xlink:label="lab_mdt_MedicalSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Surgical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedicalSurgicalMember" xlink:to="lab_mdt_MedicalSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_dd14f865-9631-46f5-9b6b-6722e8b079b6_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_0da5e2be-3c64-4c32-a835-5ee08e251e28_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.00% Senior Notes due 2022</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2022Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2022Member" xlink:to="lab_mdt_SeniorNotes2019Due2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_c0b81f23-6bd6-48d8-8c2a-f68feedb8692_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, net of cash advance, recorded as noncurrent liability</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8d9eaf69-413d-4966-ad03-666db2afb09e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_bb52f0a1-3e8f-4c69-8bd0-537d53637cff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_8534df3e-08fa-4b28-af02-d99e4c1dc3ab_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge unrealized gains to be reclassified over the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20230000PercentMember_259e090e-ed65-467e-9538-762c284994f6_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20230000PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20230000PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20230000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023, 0.000 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20230000PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20230000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2023, 0.000 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20230000PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20230000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20230000PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20230000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_4dde0b06-6ac5-4b67-a868-f518a942c541_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b841e195-4e73-496e-8623-0aa4b0fcba46_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible asset charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fa2dbd1-e250-4f92-b3a3-9a535585d17a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e81bb87-d049-411d-ae47-44508a6e2af1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_fd68b98e-e1ae-4a94-b028-c7aec5036363_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan agreement</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_863be6ac-1c19-4ca6-86c0-b78be10c52c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_709e8857-9bb5-4b69-81f1-49e9b13203ed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_88d1122c-f6f3-4221-a393-88062885ae10_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_037e582b-1cc7-4a20-b502-d00dc3156f9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_e4140c5a-a77f-4c64-be2c-88f8779be751_negatedTotalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral (Received) Posted</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_label_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:to="lab_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_39c021cc-027c-49d1-8eca-1345161ab319_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_fb408090-7a7f-4b5f-873e-530250466b5f_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_63d8f971-6408-4f60-82a2-ece4ec70cb1b_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b0040e32-5825-4e9e-9c0d-ad424288f067_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related items</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_abd2a9ef-ca6b-43a1-80c8-410a41b02c2d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets:</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e00703e1-3a11-4f58-9532-0a3b072edfd1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_0917ae07-4e06-4af5-93af-1add0150c09a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5e27b393-d038-4c43-952c-f71040fe5f7a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_65b7967a-cb45-47bb-b35f-ba1033c4911a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0cf8bd62-f6ca-47b1-aa4a-3d773b264f1d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ab4da1b-fdd3-4b42-9343-3bed1b2b4c7e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20401500PercentMember_fadee448-aaa7-4be4-a446-a3d7f46e617a_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20401500PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500 percent twenty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20401500PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20401500PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2040, 1.500 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20401500PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20401500PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2040, 1.500 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20401500PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20401500PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20401500PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20401500PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b3ccfbfb-d702-4cd8-9779-e14537523c2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_38806fd8-1295-41ac-9425-e4c61df75d4e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5d3c4f8c-9655-4d22-a1ab-d924ddf9fc72_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f7bca0d9-8665-40aa-92dd-943893214995_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Medtronic</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_c146aa3d-f4c1-43cd-9595-b5de2e72850d_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_98da50a3-f4d4-4282-b1db-57de2e241081_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill as a result of acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_6b3f9a62-3e42-44e9-a20a-4375b50d272c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve, current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_8c5e49e0-4bc2-4549-8b79-46019f0d930f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3b57a27c-b610-4a4e-bddf-3978730f213e_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d73dc9ce-00fe-454b-aa12-7bf832e06cc0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_615cf22c-28bc-4a22-9b27-b457692ce4c5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a5afae50-3ac2-40ae-bcc5-068d1d0d6468_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b2c9ebdc-4751-4755-8e78-7e3ec67b9ba5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b43d36c6-3422-4e44-b6c2-50fa6197a8f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ca6599c1-9959-4a72-8770-f7cd35eb660c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_97536f35-22a6-4c55-928e-ecd6799049ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CentralizedDistributionCosts_f9d9dcb2-02c9-47e4-b89a-79262be7e7af_negatedTerseLabel_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized distribution costs</link:label>
    <link:label id="lab_mdt_CentralizedDistributionCosts_label_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized Distribution Costs</link:label>
    <link:label id="lab_mdt_CentralizedDistributionCosts_documentation_en-US" xlink:label="lab_mdt_CentralizedDistributionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centralized Distribution Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts" xlink:href="mdt-20221028.xsd#mdt_CentralizedDistributionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CentralizedDistributionCosts" xlink:to="lab_mdt_CentralizedDistributionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_d15c9e30-ae7a-4768-b784-c60da60de8dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_d347202d-7d6d-4ef1-8408-c8035d311b84_terseLabel_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_label_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]</link:label>
    <link:label id="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_documentation_en-US" xlink:label="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:href="mdt-20221028.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:to="lab_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20230375PercentMember_d90b3a05-912d-4238-b5c6-e327ec64f37a_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230375PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2023</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230375PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230375PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20230375PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20230375PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2023, 0.375 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230375PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20230375PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20230375PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20230375PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_320440a3-64af-4369-9688-431bc504cfce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in current debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_3fa65079-2f73-4df1-babc-bf4f5a398ae5_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MedtronicLuxcoMember_09debeab-1e9a-409e-8b40-814f8e893176_terseLabel_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoMember_label_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco [Member]</link:label>
    <link:label id="lab_mdt_MedtronicLuxcoMember_documentation_en-US" xlink:label="lab_mdt_MedtronicLuxcoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medtronic Luxco [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MedtronicLuxcoMember" xlink:to="lab_mdt_MedtronicLuxcoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d838b738-ae9e-4d68-8ae2-5c744e11b577_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8d4f2706-dbf4-4921-92d4-8d0d268a0323_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_93b3772a-4052-4077-94e9-4329a3ddf093_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_3415a9bf-8ccf-4c2f-a712-ca44e51236c7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination Benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_07b5c430-6118-475a-a02e-dc1e37b7f4cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of the Assets Acquired and Liabilities Assumed (Intersect ENT)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_15373b72-06aa-40fe-8558-0767b245e420_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Affera)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9ef13c42-416d-4593-ab69-de072e5d7691_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2009Due20396500PercentMember_e719dbaf-4ad8-4174-a3de-64a253a07686_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2009Due20396500PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.500 percent thirty-year 2009 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2009Due20396500PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2009Due20396500PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2009 Due 2039, 6.500 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2009Due20396500PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2009Due20396500PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2009 Due 2039, 6.500 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due20396500PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2009Due20396500PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2009Due20396500PercentMember" xlink:to="lab_mdt_SeniorNotes2009Due20396500PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20392250PercentMember_15a65873-47d3-4d60-bfdf-325f3ee97739_verboseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392250PercentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250 percent twenty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392250PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392250PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2039, 2.250 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20392250PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20392250PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.625 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392250PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20392250PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20392250PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20392250PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_071a529c-4414-4614-8e2a-94978d73c240_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_66972283-a109-438b-9dff-e6052d7567f9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20260000PercentMember_e4739c6a-10d0-483f-ae57-3d1608ab450a_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20260000PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000 percent five-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20260000PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20260000PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2026, 0.000 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20260000PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20260000PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2026, 0.000 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20260000PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20260000PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20260000PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20260000PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_7ed71bc1-b5e9-4f0e-afc4-235eda54c525_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_65f90e07-7ce8-46a8-96f5-c49e61157a3a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_7f5288c0-4397-47e1-b446-a16528f1a49f_terseLabel_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product development and other milestone-based payments</link:label>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_label_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Development Milestone [Member]</link:label>
    <link:label id="lab_mdt_ProductDevelopmentMilestoneMember_documentation_en-US" xlink:label="lab_mdt_ProductDevelopmentMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A milestone in achieving certain product development target.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember" xlink:href="mdt-20221028.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_ProductDevelopmentMilestoneMember" xlink:to="lab_mdt_ProductDevelopmentMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5af7be3b-964f-451e-9f84-66a9918cf5b7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8144245-779d-4738-8ddc-21ea80f06619_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c6099f40-d1e1-4131-b639-c77a0703c006_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_73d2ebdd-a481-42b6-bd3e-60fbfcdd49d8_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_75b9a1f8-6c6a-4fa2-a364-e8065ab83ddb_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_1278ed01-e59c-4005-8dc9-84b309f2bb0b_terseLabel_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_label_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Revolving Credit Agreement [Member]</link:label>
    <link:label id="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember_documentation_en-US" xlink:label="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Revolving Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:href="mdt-20221028.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:to="lab_mdt_AmendedandRestatedRevolvingCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_f0508e3c-59f9-440e-87e8-829c8ad157de_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_556d0df4-af8f-49ba-b11c-0c9905b0e745_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0d005848-c2f2-4f12-b6f7-80674fab6aff_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_ddaf38b9-7cbe-4f9f-bcb4-97b9305b0897_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_596bcec5-e457-45b9-9592-15092e7e16d0_terseLabel_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of landfills requiring removal (in landfills)</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_label_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Removal</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_documentation_en-US" xlink:label="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Removal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:to="lab_mdt_SiteContingencyNumberofLandfillsRequiringRemoval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d57625cd-4e80-4df9-a6f0-c6aedd8a0122_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in retirement obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MN_e8a42dea-c350-47e7-a9ea-8aba2317ca60_terseLabel_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minnesota</link:label>
    <link:label id="lab_stpr_MN_label_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MINNESOTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MN" xlink:to="lab_stpr_MN" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_ff9ff3c3-345d-45b4-92fc-16b0dc1d2e2a_terseLabel_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper Program</link:label>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_label_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Commercial Paper Program [Member]</link:label>
    <link:label id="lab_mdt_A2015CommercialPaperProgramMember_documentation_en-US" xlink:label="lab_mdt_A2015CommercialPaperProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Commercial Paper Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember" xlink:href="mdt-20221028.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A2015CommercialPaperProgramMember" xlink:to="lab_mdt_A2015CommercialPaperProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_942f6eac-07f3-4636-b562-806ad97d12d2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.375% Senior Notes due 2028</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2028Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2028Member" xlink:to="lab_mdt_SeniorNotes2020Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_fa9f4c05-5261-4306-b5a8-45b09eee051b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_7f2ae7ec-668f-4899-a647-62ed9527db1f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9b1e2b36-3582-47b4-8988-bfda8e1db149_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_02a4c4d0-f541-4124-9ca9-e65437c812d0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_cc48db17-170b-4d46-9e52-ac9c15dbfc88_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Other Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b8f2dc6e-7d29-47d4-ae04-bb450fe2bcc0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3332643f-2d72-454c-a438-338ec71e07cb_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_740f7e56-ae67-4022-baa9-d2afc5d311d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11d492c5-f25b-4b7d-b55b-84e5ef0e533c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7ccf1b05-c7a4-41a5-b0a6-804273f06c82_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_90b94a71-64f6-42e9-8e95-b8255394567f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b0e73c2b-1805-4e33-ac61-1704aa169028_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_31687617-fd59-49f3-972b-2a83e671f360_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.00% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20311.00PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2031, 1.00 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20311.00PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_0fdb4bd6-8fff-4fe7-bc80-0271f3d7438f_terseLabel_en-US" xlink:label="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges, net</link:label>
    <link:label id="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_label_en-US" xlink:label="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Net of Restructuring Reversals Including Cost of Product Sold Impact</link:label>
    <link:label id="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_documentation_en-US" xlink:label="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:href="mdt-20221028.xsd#mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:to="lab_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_836a2aab-a4a9-461d-bb22-8d76f1964a26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_f508f79b-b6d2-471a-8e8a-bfef21e7390d_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750% Senior Notes due 2032</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2032Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2032Member" xlink:to="lab_mdt_SeniorNotes2020Due2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_465416b1-26ec-48a6-8c47-13b89d07d8a7_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_52c62b5a-b4fb-4b37-9e7e-d29dd0dd4a7e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_45d644e6-bc3e-4373-8e4e-7b0ac0dc6611_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_53c41684-95e5-4b01-b294-138b3f6d5fde_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_669e1167-b2bd-4c23-aa25-8c18b44bb142_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_8281a186-9812-4ca9-94c8-eb2c646ab9a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_4b9b2596-ce03-41b3-a31e-f0aa7149a0d7_totalLabel_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity and other investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_label_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_documentation_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:to="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_64897ecc-dfa0-4a67-b7e1-034363a4fe26_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously included in deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_de326961-dbad-4301-89fe-2a9849376800_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_649f9101-f0b4-4340-a87c-d097d849ba27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_020ee402-a610-491a-9d46-e2e1cca7a924_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes to noncontrolling ownership interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_9c2a3ce0-9fc2-4022-ab92-8f84680a9b30_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_1f20b780-74f9-47b3-a8b2-92cb3946c4f0_terseLabel_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_label_en-US" xlink:label="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:to="lab_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_da504506-5642-4da1-954f-37965d6554f4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b179de61-419e-40af-a8dc-d7ee90f0a5f3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2f9628b6-ff9e-4bcd-9540-034a048cf13f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_de379292-f4f7-4142-9cb8-6fcc4864910f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_9e9bb2bd-5e39-4606-8870-f6a6d4c74819_terseLabel_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_label_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation, Numerator [Abstract]</link:label>
    <link:label id="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract_documentation_en-US" xlink:label="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationNumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:to="lab_mdt_EarningsPerShareReconciliationNumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_b5732562-78ab-48d1-9a13-17dfa1e1a869_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_624c2666-1db6-4e60-9c04-e2520fe130dc_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.375% Senior Notes due 2040</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2040Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2040Member" xlink:to="lab_mdt_SeniorNotes2020Due2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OutsideOfTheUnitedStatesMember_836ae163-2f48-44ff-a920-162e24ad5df3_terseLabel_en-US" xlink:label="lab_mdt_OutsideOfTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign plan</link:label>
    <link:label id="lab_mdt_OutsideOfTheUnitedStatesMember_label_en-US" xlink:label="lab_mdt_OutsideOfTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside Of The United States [Member]</link:label>
    <link:label id="lab_mdt_OutsideOfTheUnitedStatesMember_documentation_en-US" xlink:label="lab_mdt_OutsideOfTheUnitedStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside Of The United States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OutsideOfTheUnitedStatesMember" xlink:href="mdt-20221028.xsd#mdt_OutsideOfTheUnitedStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OutsideOfTheUnitedStatesMember" xlink:to="lab_mdt_OutsideOfTheUnitedStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due20253500PercentMember_7b0b22d6-2e5a-4d5d-b48e-5efbfd6f2fb9_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20253500PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500 percent ten-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due20253500PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20253500PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2025, 3.500 percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due20253500PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20253500PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2025, 3.500 percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20253500PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20253500PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due20253500PercentMember" xlink:to="lab_mdt_SeniorNotes2015Due20253500PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4a164cfb-ce20-4581-a88a-f5fa1c8b6a77_negatedLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_211c5f25-5148-4c30-a373-8f5371350c41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of ordinary shares (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due20511625PercentMember_e5a96ac2-f0d4-42cd-bfb6-b1f81c6fa94e_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20511625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625 percent thirty-year 2020 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20511625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20511625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2051, 1.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due20511625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due20511625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2051, 1.625 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20511625PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20511625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due20511625PercentMember" xlink:to="lab_mdt_SeniorNotes2020Due20511625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0ac2d982-fd10-479f-82f6-28bec415f19a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3684c230-b656-4f78-862f-78998b17a401_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_b6ccc307-92a9-4d02-a21a-86ccf8c308d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_0265ce31-5932-4dc7-af34-c923ee69e8ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_f1312b23-b6e2-4dcf-8d5a-2d1c0d877abb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_aa41d763-e42f-433b-83d4-bdabaa54fe5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4d64cfc1-6fcd-4a3c-a3ca-934d7e757d1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2b8732dc-ba91-4fb7-b10d-360b1b1f6c55_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_e34fbcdb-2f46-40e5-8e6e-113658a581bd_terseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_7c6ccfc3-79ac-47d0-a685-3a2d482e6004_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ae4a4a29-f873-47c8-8fbf-8e05ec8433ef_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under stock purchase and award plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_749d6630-1103-4d32-96bb-bef78b2b9a4c_terseLabel_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of landfills requiring capping (in landfills)</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_label_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Capping</link:label>
    <link:label id="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_documentation_en-US" xlink:label="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency, Number of Landfills Requiring Capping</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:to="lab_mdt_SiteContingencyNumberOfLandfillsRequiringCapping" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4eac3910-086e-4335-86c7-74d3755b7079_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a824ae5b-e42f-4a66-8751-bfe12a717d23_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_14fded60-a5ec-4457-a945-d1ca3fdf5042_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d8cea688-e78a-4db3-95d1-bad9eae75a3e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_3dbaf1ad-c9c8-40fb-b61a-202f6f5fd0dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_151fe27d-310c-4538-b7e2-c5928c352791_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4bec0243-a686-4730-a293-e75d94a7af77_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">More than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets_8c5ed525-bbff-4233-a31d-b27712e275fe_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash pre-tax charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets_label_en-US" xlink:label="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Reclassified Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:to="lab_us-gaap_ImpairmentChargeOnReclassifiedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_93b6ae64-d910-439c-8500-b56a1ffff930_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_6341a1b2-d6e5-4680-a93d-08c6d1edb4dc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e2937d99-319f-4ee7-90c1-0e9c73f95433_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_0903909f-767a-47df-9c7d-4644984740f5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_757cf584-bf0a-4c29-acc6-59a16f7ca205_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_020f9308-44e8-4cd4-b385-95598c5cf6a2_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_50aff6b6-d8a0-4745-9857-28a284de8065_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_ae2acecf-8cb3-4bec-a9c0-0c9bcce3dc98_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_8fe59318-de4f-431f-b182-c2768232b1c1_negatedLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and associated costs and RCS/MCS impairment / costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2022Due2025Member_f1011a39-3295-403c-b7e7-32b19289c737_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2025Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2022Due2025Member" xlink:to="lab_mdt_SeniorNotes2022Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_eb855bd0-60fc-4b2e-9625-fac9a75a8499_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses recognized</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_60768717-09a2-41ef-b98e-e1382c2d4de2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_aaba71e6-343e-45aa-8f51-c1078676e2c0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-For-Sale Debt Securities, Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_e3444ad8-bb17-40b1-8a21-55f1013cda75_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_57717466-904c-4cd7-ab19-d07c55198c5e_terseLabel_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Equity and Other Investments</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_label_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</link:label>
    <link:label id="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:to="lab_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_9ae5740d-cf55-47a8-a755-1ea470a16e58_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a426216b-2d49-4986-b017-7897dd46a182_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1b1040c4-c777-481d-a5f7-fd88a1a2b5d1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic - weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_abb67509-e6b0-48f0-a43a-7bce71710a3a_terseLabel_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, &amp; Renal</link:label>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_label_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, and Renal Division [Member]</link:label>
    <link:label id="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember_documentation_en-US" xlink:label="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Respiratory, Gastrointestinal, and Renal Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:href="mdt-20221028.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:to="lab_mdt_RespiratoryGastrointestinalandRenalDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_fca42cdd-7737-4b97-851c-8027ee926119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfGainLossOnInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9fe62b23-14aa-4677-9dbb-97f4f7941088_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_a9966c13-c522-4996-8f2f-8650fdd4a565_netLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2816b2ca-0466-4c32-981c-edc0d34a1353_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued litigation charges</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_086435c0-516f-4f2c-b516-9d6357883883_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c32474ef-faa8-4f0f-a6b0-f2ab431bf46f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_662e4af4-5d31-4c83-832d-e5caa82bf021_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_22eac2fe-36d7-45a7-b7f3-1fa3cc716b79_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_155d5aed-c00b-4a4c-8a98-53a7dc55008b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfDebt_90d9ba3c-5785-4a3e-a216-1b6f55ea964f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (repayments of) debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_882e07df-0039-4fc2-85cd-4d98f3c2a28e_terseLabel_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation</link:label>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_label_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Division [Member]</link:label>
    <link:label id="lab_mdt_NeuromodulationDivisionMember_documentation_en-US" xlink:label="lab_mdt_NeuromodulationDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuromodulation Division</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember" xlink:href="mdt-20221028.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_NeuromodulationDivisionMember" xlink:to="lab_mdt_NeuromodulationDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_3e99c2b8-60c5-4777-8d4d-30aad8a2a40a_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_60b67c90-954b-4a4b-b28a-a7dc1c3d49b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, fair value of net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_77442b9e-18ce-47a0-bd0c-0a360153da2e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_47f1c5b6-e0ee-43d9-891c-9b9568fa5476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_45e807e1-5f30-439a-9a04-e91c679675f2_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.25% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due2025Member" xlink:to="lab_mdt_SeniorNotes2019Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_0e478a32-c617-420a-8fa5-9dca2645d2d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_5de43366-a667-4b63-9e00-a70a06d06c98_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b35594e-eb71-45b9-b2b5-4601b8e5e4f2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_58a5731d-9c02-4a73-beed-451bf113e247_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously held investments in Intersect ENT</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_1f0428b4-5f7f-4dd5-8083-e924ca347f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_LossonInvestments_610a7f6a-856e-403c-bbc4-33517fc28806_negatedTerseLabel_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses</link:label>
    <link:label id="lab_mdt_LossonInvestments_label_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Investments</link:label>
    <link:label id="lab_mdt_LossonInvestments_documentation_en-US" xlink:label="lab_mdt_LossonInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments" xlink:href="mdt-20221028.xsd#mdt_LossonInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_LossonInvestments" xlink:to="lab_mdt_LossonInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_ec1aa63a-fd55-49c0-8d79-13a0fe04e859_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_bfc0bd79-9bde-42a7-ad94-5e58840065aa_netLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of current debt obligations outstanding</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_789f3704-5a48-4965-8e6c-2ad02f3e7c91_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_45f8d2dc-3e42-4c59-b82b-a85fa906cd86_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_5a7a385b-139b-408d-8874-279ed816f9fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3e71abf7-4b41-46ae-9b1e-75145eac9ec3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_85e04a34-9251-4ce4-93fa-110421605c53_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_8d6d1508-2ef5-4627-a30e-fb36b1835c2e_terseLabel_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_label_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Expenses [Member]</link:label>
    <link:label id="lab_mdt_OtherAccruedExpensesMember_documentation_en-US" xlink:label="lab_mdt_OtherAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherAccruedExpensesMember" xlink:to="lab_mdt_OtherAccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d154956d-235c-4c73-852c-4fa4f10b7a25_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_3f5a1ecf-29a9-4db8-8af4-34609e05bf44_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_7f78176a-7b53-459a-bde4-7b6dbb1112dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components and Classification of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_66b16038-c53c-415a-8cfb-ea14830bc11a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_79f2979c-8e57-40f1-b6cc-b6ed4514195d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_12a9f12d-4fb7-4bf2-b192-723614199917_terseLabel_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial &amp; Spinal Technologies</link:label>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_label_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial And Spinal Technologies Division [Member]</link:label>
    <link:label id="lab_mdt_CranialAndSpinalTechnologiesDivisionMember_documentation_en-US" xlink:label="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cranial And Spinal Technologies Division</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:href="mdt-20221028.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:to="lab_mdt_CranialAndSpinalTechnologiesDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_2df3a6ce-f6ad-4fc2-b61b-8ca15b18198f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_d7f8af27-fa81-448b-ba95-bf653b1bd87f_terseLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price allocation adjustments</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Purchase Price Contingent Consideration</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of contingent consideration arrangement resulting from business combinations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:to="lab_mdt_BusinessAcquisitionPurchasePriceContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_f6be058d-b08a-454f-814e-17fda282adc3_totalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recognized Assets (Liabilities)</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_label_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</link:label>
    <link:label id="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:to="lab_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_0a16714f-4c2e-43b8-afe5-fc4f489a812e_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_150795e5-d111-4f68-bf21-1010d462d8df_terseLabel_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Developed Markets</link:label>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_label_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]</link:label>
    <link:label id="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_documentation_en-US" xlink:label="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:href="mdt-20221028.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:to="lab_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_f3ae06b4-067d-45c6-a525-ee9539d14c43_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_45e57857-1506-4976-bcaa-339114b67ee2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain litigation charges, net</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3c45e5e2-cb75-4176-a9cb-43e216465bed_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_84ce7e99-2481-4de1-9ea5-352c2b60a830_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_0e91a897-f876-46e5-956a-98fd023431f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_bc97313e-6cdc-4787-bfc1-3b8c492d87d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_a692c0e7-578e-49aa-9f40-00c00c32a206_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_447282da-5beb-4e0c-8f53-503d676b8387_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4aa0ca88-f129-4fe5-8b04-28ba72c9eaca_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_5be7524c-83b7-4ba9-a923-aaababe719e2_terseLabel_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability litigation</link:label>
    <link:label id="lab_us-gaap_DamagesFromProductDefectsMember_label_en-US" xlink:label="lab_us-gaap_DamagesFromProductDefectsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages from Product Defects [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DamagesFromProductDefectsMember" xlink:to="lab_us-gaap_DamagesFromProductDefectsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9b11f971-200e-4847-b84b-ece848a891a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based payments</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e9ff6b6-5cfa-4d4e-b9db-5cd66f6da850_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_88a22f6f-c69b-443d-9607-688006a34934_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9b8e8d36-f3a2-432d-83c7-279a956309a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_37749c66-1d0f-4f10-b7c4-e6523d133250_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f223ac7f-36f5-46cd-998e-3bd5d2865490_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1868430b-dbc2-4972-80cd-285bb5529d84_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_32469a33-a3a5-423f-9b00-bdd1b8f1edc4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_28bbdaca-211f-4609-933b-f8a70cac3892_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_90c87d95-2a33-4602-a488-cd90ddd47691_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued gross interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_5aa8f0b9-e757-4d05-ad45-98273b7fd5b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6a059a68-9378-45a9-8155-1a736827bc08_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_c94b418e-831b-44a4-af45-7368bab73a6a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9a3c48f2-f018-484d-805b-e3b42e0e4f96_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_32a34001-0204-48bb-8de0-43fc11225de9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2015Due20454625PercentMember_31bc3d73-4ef4-447b-bc82-feb1a7b63c85_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20454625PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 percent thirty-year 2015 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due20454625PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20454625PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2045, 4.625 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2015Due20454625PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2015Due20454625PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2015 Due 2045, 4.625 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20454625PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20454625PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2015Due20454625PercentMember" xlink:to="lab_mdt_SeniorNotes2015Due20454625PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionPriceContingentConsideration_6c3405ad-44b3-4172-90c1-47dfb9cae02a_terseLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price contingent consideration</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPriceContingentConsideration_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Price Contingent Consideration</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionPriceContingentConsideration_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Price Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPriceContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:to="lab_mdt_BusinessAcquisitionPriceContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_bfa2ca23-ae7d-41f3-b052-3ed21d658d76_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and tradenames</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_b2006909-44da-45f3-ba56-0c71f1f8e00d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:to="lab_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d41792d9-2b28-44cb-b170-f8a7dafd7c5a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_a2a7d1d9-8789-48d8-bddb-dd6fd63c4f1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_97313fe0-3589-459c-9ddf-fa4a5ba1cf63_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2022Due2031Member_bad2f04f-44ab-4e23-aaea-a40eab7b73be_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Senior Notes due 2031</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2031Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2031 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2031Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2031Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2022Due2031Member" xlink:to="lab_mdt_SeniorNotes2022Due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_847a36ad-9258-4911-bb66-bed150d3349b_terseLabel_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies</link:label>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_label_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies Division [Member]</link:label>
    <link:label id="lab_mdt_SpecialtyTherapiesDivisionMember_documentation_en-US" xlink:label="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Therapies Division [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember" xlink:href="mdt-20221028.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SpecialtyTherapiesDivisionMember" xlink:to="lab_mdt_SpecialtyTherapiesDivisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6f062afe-edde-444a-8c17-996fb1d4deeb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_5c586195-e167-4be1-ae28-076e85d3b4c8_terseLabel_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other countries, excluding Ireland</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_label_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding Ireland [Member]</link:label>
    <link:label id="lab_mdt_TotalOtherCountriesExcludingIrelandMember_documentation_en-US" xlink:label="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Countries, Excluding Ireland [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:to="lab_mdt_TotalOtherCountriesExcludingIrelandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_e983fc32-6705-4b2f-b646-8513229e4a95_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_MechanicalCirculatorySupportMember_c7ab64e8-32d4-4350-be33-0543d2839d89_terseLabel_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support</link:label>
    <link:label id="lab_mdt_MechanicalCirculatorySupportMember_label_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support [Member]</link:label>
    <link:label id="lab_mdt_MechanicalCirculatorySupportMember_documentation_en-US" xlink:label="lab_mdt_MechanicalCirculatorySupportMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mechanical Circulatory Support</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportMember" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_MechanicalCirculatorySupportMember" xlink:to="lab_mdt_MechanicalCirculatorySupportMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_d1633b65-ed44-499d-aed1-2ffa484a295f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c921d939-1107-423b-ae02-5bf55501128f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_24adbbfb-bd6d-49ca-9204-3535e92b6c12_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3aea106f-6046-44d4-a13f-0ff754f04b25_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_EquityInvestmentsMember_ed0a874f-af70-4088-9230-c5380c7109d4_terseLabel_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Other Investments</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_84fe63d6-aaa5-4224-9dff-94dafe36838a_verboseLabel_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities and Other Investments</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_label_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments [Member]</link:label>
    <link:label id="lab_mdt_EquityInvestmentsMember_documentation_en-US" xlink:label="lab_mdt_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember" xlink:href="mdt-20221028.xsd#mdt_EquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_EquityInvestmentsMember" xlink:to="lab_mdt_EquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_3141d9c0-16e0-4f34-b2f7-2e8edae176e8_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_16013f31-25b9-48a8-a2ef-824e72928b72_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2019Due20501750PercentMember_f542aa5d-750e-4ff1-9aab-5ca779800543_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20501750PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750 percent thirty-year 2019 senior notes</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20501750PercentMember_label_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20501750PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2050, 1.750 Percent [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2019Due20501750PercentMember_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2019Due20501750PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 Due 2050, 1.750 Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20501750PercentMember" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20501750PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2019Due20501750PercentMember" xlink:to="lab_mdt_SeniorNotes2019Due20501750PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bda01723-dedd-495c-b41a-322ab479ee5d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_4ba71a6f-6770-4c12-95b6-63419960ecee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0f4360a6-61d2-4fbe-bd13-75ccbac7aa4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7900f5e0-571d-4ffe-91ca-a59bdfae6212_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_91dd03cd-932b-44b4-a7d0-356a2e9189c7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_ea7c9b27-eadc-431f-a47d-7cf18c2acd25_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount of Recognized Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_70f3bcf1-8fc3-409c-a78f-1e221a35b0b6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_fe0f1f6e-e12c-46b2-a358-d060fa753f13_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.000% Senior Notes due 2025</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2020Due2025Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2020Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2020 Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2020Due2025Member" xlink:to="lab_mdt_SeniorNotes2020Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_OtherAcquisitionsMember_2025d819-91ed-40df-bf1d-fadaaecdb993_terseLabel_en-US" xlink:label="lab_mdt_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquisitions</link:label>
    <link:label id="lab_mdt_OtherAcquisitionsMember_label_en-US" xlink:label="lab_mdt_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquisitions [Member]</link:label>
    <link:label id="lab_mdt_OtherAcquisitionsMember_documentation_en-US" xlink:label="lab_mdt_OtherAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAcquisitionsMember" xlink:href="mdt-20221028.xsd#mdt_OtherAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_OtherAcquisitionsMember" xlink:to="lab_mdt_OtherAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b58c4e1c-0263-475e-b9e5-f2f6d00b6d2d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract_74b95ca1-3497-41ba-9c57-bc655bbed769_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_8ca33e6a-b528-4088-a404-15e15cd37a70_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fa886e99-7709-4cc5-ac6e-7344c5f4d49e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_2f3cf693-98b4-4dae-95e3-7022c1cdd1a0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_3550fe97-9a17-4e8d-8117-28d3d40060b4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_01474e38-2ada-41f9-a4e1-dfc80c340741_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains (losses) on equity and other investments still held</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_f381d638-a8fe-48a8-972d-6d7a64015159_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems_13986b54-f19f-4b00-b2f2-b8522463ba78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Segment Allocation [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Segment Allocation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_48938388-0ac7-439f-a0a8-32782ba106fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified into Income, net investment hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_6a5b4177-4c5e-431c-8052-fc7f89efa73e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, excluded component, gain (loss), recognized in earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_c566ced0-e362-4313-88fe-cdfc395dcce8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6990e68e-c3ea-43d0-88bd-ec71d08395f7_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_7577ad51-466a-4a1d-a17a-d3d54eb6f8bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Collateral (Received) Posted</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnCash_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dbb58644-b806-4bba-b38f-6f07406a3838_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b02cd14b-a546-4826-a400-e7f9aeaac74c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0cb49763-6629-4f38-8a71-01edf63f28e6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_31beb95a-abf3-4da8-a47b-1ab4edf50f55_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5de487d8-672b-44ec-ac43-ecdd36061d73_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_330224c0-3694-4dae-87b3-e9532d663bc9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_68de82ec-3460-494f-b30c-6b0314a871fa_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_d2dc14ef-e61f-4d03-8ff9-e2dee36ab578_terseLabel_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_label_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration, at Fair Value [Roll Forward]</link:label>
    <link:label id="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_documentation_en-US" xlink:label="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:to="lab_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_bbd46b3e-83c3-4b68-8fd6-e903292d22e2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_e926ec6e-6cce-4a81-91a1-262ddcb53f86_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_eda98e44-c4da-4b7c-b5c5-e4078dc34e43_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_721b824b-bf4f-4cb9-a0fd-e7f18fe5aa42_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_453a353a-ad30-474c-8b61-90cb5792012e_negatedTotalLabel_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_label_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</link:label>
    <link:label id="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_documentation_en-US" xlink:label="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:to="lab_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_b0cc7f2a-864c-4643-b7ad-d0ca9db3b003_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_392a8359-14ef-40e8-80ee-2b8d76c265c1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_caad4505-7b78-448a-8811-ec5b709a3906_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_47c9e379-b95a-4c5e-a948-46c629521caa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_c8f6f9db-47dd-4008-a97a-435b7130b795_terseLabel_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="mdt-20221028.xsd#mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_efe9c96e-b38c-4d82-a49b-0cdab9c6a142_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum remaining maturity of foreign currency derivatives</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_92ed716d-2999-4859-bd9d-fa6412dca70f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_33ebd287-d950-40fd-9bbd-fdb5075faade_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_40d9e9e0-3106-467c-bce0-49d20fd5cb04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_deca5a2d-a338-4001-9b35-342acac3296e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_0481ac8f-e372-491d-8500-558b0232030e_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0935c66f-faaa-4f99-9941-bc4a59a210f4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_HeldForSaleMember_c400e61c-2332-4b4a-98a8-3698b0d40dca_terseLabel_en-US" xlink:label="lab_mdt_HeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held For Sale</link:label>
    <link:label id="lab_mdt_HeldForSaleMember_label_en-US" xlink:label="lab_mdt_HeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held For Sale [Member]</link:label>
    <link:label id="lab_mdt_HeldForSaleMember_documentation_en-US" xlink:label="lab_mdt_HeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HeldForSaleMember" xlink:href="mdt-20221028.xsd#mdt_HeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_HeldForSaleMember" xlink:to="lab_mdt_HeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2b3cb406-8d2b-48b3-b58f-faf246030492_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_70a073c3-7c52-4729-b10f-296032b8a5ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, significant unobservable inputs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_2ed2a6db-b795-435b-871b-2f220f1a20f0_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b51b6cfa-d8ac-4b53-b87e-d5466c45858a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7664ad7b-21cc-4f83-85ca-dab82827f5c4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_cf4e6b28-5855-4069-988f-33980e779e44_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_7c40381b-1f8c-4230-87ed-aaadf97b086d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5e89998b-75bd-4e0b-a453-c8257fa90966_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8a731a9-3f2d-47cc-b6a9-a326ec9cc0e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_ccce8507-4ace-4366-a4d5-04e98f5508ba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration for the transaction, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_974b61f3-f7c4-47e1-83bc-0e03bf1d00fe_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_c4fc9288-b8fe-42b1-b342-817719a14d2a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_167f8999-ebfa-4b0b-a26d-7b7166dff0d8_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_66033e26-995d-4c42-87ee-4d2c85856172_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_55c5f5d1-026b-4ea1-b3d1-72553c352729_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5ccdcfce-b0b1-45a3-a127-842155ea5b89_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5f831a5e-a417-4c3e-9935-ce90c38cff10_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_f14df052-bf3f-47bc-9bae-026e747d3c20_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_TechnologyBasedIntangibleAssets_6cc3b965-4356-4271-b6d3-8c07d3eb6e48_terseLabel_en-US" xlink:label="lab_mdt_TechnologyBasedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-based intangible assets</link:label>
    <link:label id="lab_mdt_TechnologyBasedIntangibleAssets_label_en-US" xlink:label="lab_mdt_TechnologyBasedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_mdt_TechnologyBasedIntangibleAssets_documentation_en-US" xlink:label="lab_mdt_TechnologyBasedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TechnologyBasedIntangibleAssets" xlink:href="mdt-20221028.xsd#mdt_TechnologyBasedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_TechnologyBasedIntangibleAssets" xlink:to="lab_mdt_TechnologyBasedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_8e8fb20b-35a4-478b-8eaf-d37c4f0341ec_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro-denominated Debt</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_GainonInvestments_56e3417c-fe62-426a-b361-e24d784c3eaf_terseLabel_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains</link:label>
    <link:label id="lab_mdt_GainonInvestments_label_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Investments</link:label>
    <link:label id="lab_mdt_GainonInvestments_documentation_en-US" xlink:label="lab_mdt_GainonInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments" xlink:href="mdt-20221028.xsd#mdt_GainonInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_GainonInvestments" xlink:to="lab_mdt_GainonInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_5feaa914-013f-421c-a52f-a4e2cb6ef775_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A3125PercentNineYear2022SeniorNotesMember_dcd934ed-23fb-4667-80cd-6c193fcb8abb_terseLabel_en-US" xlink:label="lab_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125 percent nine-year 2022 senior notes</link:label>
    <link:label id="lab_mdt_A3125PercentNineYear2022SeniorNotesMember_label_en-US" xlink:label="lab_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125 Percent Nine-Year 2022 Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_A3125PercentNineYear2022SeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125 Percent Nine-Year 2022 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:href="mdt-20221028.xsd#mdt_A3125PercentNineYear2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:to="lab_mdt_A3125PercentNineYear2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember_730d6d73-c62d-4197-aa01-d91649b2cbc5_terseLabel_en-US" xlink:label="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375 percent twelve-year 2022 senior notes</link:label>
    <link:label id="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember_label_en-US" xlink:label="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375 Percent Twelve-Year 2022 Senior Notes [Member]</link:label>
    <link:label id="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember_documentation_en-US" xlink:label="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375 Percent Twelve-Year 2022 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:href="mdt-20221028.xsd#mdt_A3375PercentTwelveYear2022SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:to="lab_mdt_A3375PercentTwelveYear2022SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AuctionRateSecuritiesMember_75266f95-1f09-49b8-8a28-abe553b06e04_terseLabel_en-US" xlink:label="lab_us-gaap_AuctionRateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction rate securities</link:label>
    <link:label id="lab_us-gaap_AuctionRateSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AuctionRateSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auction Rate Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AuctionRateSecuritiesMember" xlink:to="lab_us-gaap_AuctionRateSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f3ccdb40-0f76-496a-abf8-7a3b53351c91_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_09553ca6-2fe6-4a17-859d-b5efcf578773_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity Related to the Company's Available-for-Sale Securities Portfolio</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_cd029870-6f7b-415d-9a2d-256ba16e4fec_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_11276ba3-80a9-4aba-bd0d-518c0dff83c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_RestructuringsExcludingRCSAndMCSMember_4f2f59b5-4511-490e-8ef8-9165208f697d_terseLabel_en-US" xlink:label="lab_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructurings Excluding RCS and MCS</link:label>
    <link:label id="lab_mdt_RestructuringsExcludingRCSAndMCSMember_label_en-US" xlink:label="lab_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructurings Excluding RCS and MCS [Member]</link:label>
    <link:label id="lab_mdt_RestructuringsExcludingRCSAndMCSMember_documentation_en-US" xlink:label="lab_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructurings Excluding RCS and MCS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:href="mdt-20221028.xsd#mdt_RestructuringsExcludingRCSAndMCSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:to="lab_mdt_RestructuringsExcludingRCSAndMCSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_4554c278-abda-4851-a84a-94febde98bd6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fe266c86-cf1d-43f1-ae89-33e9d9a363a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_6259e447-eb1d-423f-baef-1b171f614e07_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1c6b6af-bcb4-4099-bf46-be96130ca2eb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b30cf22-9e32-4b86-a4d9-537ebe37e772_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_eeb20630-35c2-4cad-99fe-c22de7a0947b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_f3bef0b8-0ee3-4462-880e-b8f01975463d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_5464bfde-c909-4264-8dda-a4462cfd23e2_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5247c993-a449-4408-9d57-191397d93a76_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cde97447-9d40-4542-a74f-ad43cda99f01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_dea72dce-4e65-4bf2-b4a8-9d8206a4ba76_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_336ed286-4249-4f36-8c6a-ad50ed67a564_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdt_SeniorNotes2022Due2034Member_95862b6e-8fae-45b4-8b9f-75ffd13fb3ca_terseLabel_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Senior Notes due 2034</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2034Member_label_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2034 [Member]</link:label>
    <link:label id="lab_mdt_SeniorNotes2022Due2034Member_documentation_en-US" xlink:label="lab_mdt_SeniorNotes2022Due2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2022 Due 2034</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2034Member" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdt_SeniorNotes2022Due2034Member" xlink:to="lab_mdt_SeniorNotes2022Due2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_d11b9ca5-f5d5-4dea-8046-e991961c8f0b_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTableTextBlock" xlink:to="lab_us-gaap_OffsettingAssetsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mdt-20221028_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:d0d27130-afb5-4dfb-94b6-1cc9696bfce8,g:110bc92f-cdeb-48e8-86a3-a51374aab93a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medtronic.com/role/Cover" xlink:type="simple" xlink:href="mdt-20221028.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1dc25047-54fa-46f0-8c09-6e50f94626f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1dc25047-54fa-46f0-8c09-6e50f94626f7" xlink:to="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:to="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_132d14c5-9f93-47da-970e-c7756ac248c8" xlink:to="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c029067-8f47-4f63-a18b-54a81d3ef2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_us-gaap_CommonStockMember_2c029067-8f47-4f63-a18b-54a81d3ef2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2022Member_19420b02-f220-4393-9933-5ac078fa8fee" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2022Member_19420b02-f220-4393-9933-5ac078fa8fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20230375PercentMember_c842d789-b8cc-4a52-bf60-af688ed4d4a0" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20230375PercentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20230375PercentMember_c842d789-b8cc-4a52-bf60-af688ed4d4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20230000PercentMember_e6ba0fd6-d36f-449c-b402-f9cd3d189373" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20230000PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due20230000PercentMember_e6ba0fd6-d36f-449c-b402-f9cd3d189373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2025Member_22ab4a65-f627-46c8-bfcc-b3a09080fdba" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2025Member_22ab4a65-f627-46c8-bfcc-b3a09080fdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2025Member_85dd305f-bba6-4ccb-ac78-c482cf6914b7" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2025Member_85dd305f-bba6-4ccb-ac78-c482cf6914b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2025Member_4b4cfbc6-333a-4954-8c72-b4691273267d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2025Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2025Member_4b4cfbc6-333a-4954-8c72-b4691273267d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20271125PercentMember_1815b289-8375-4511-9988-3cb6e0d175c1" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20271125PercentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20271125PercentMember_1815b289-8375-4511-9988-3cb6e0d175c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2028Member_028269f4-70e5-4011-92de-6f1d7852e259" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2028Member_028269f4-70e5-4011-92de-6f1d7852e259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2028Member_ec685783-ddf8-44e6-82bf-4ffe1a87fc24" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2028Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2028Member_ec685783-ddf8-44e6-82bf-4ffe1a87fc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311625PercentMember_30752932-9fe7-47b4-8540-610529c4f592" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311625PercentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20311625PercentMember_30752932-9fe7-47b4-8540-610529c4f592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ad2c1c16-cc03-485f-825b-553f7ee49e1c" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311.00PercentMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20311.00PercentMember_ad2c1c16-cc03-485f-825b-553f7ee49e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2031Member_d0cd45eb-8502-4ed8-ba4e-fa96ad14b1e3" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2031Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2031Member_d0cd45eb-8502-4ed8-ba4e-fa96ad14b1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2032Member_77c2634d-49eb-45f5-b42c-c0fd9567b313" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2032Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2032Member_77c2634d-49eb-45f5-b42c-c0fd9567b313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2022Due2034Member_0b984fed-632c-4c9d-b479-028c7be0895a" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2022Due2034Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2022Due2034Member_0b984fed-632c-4c9d-b479-028c7be0895a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20394500PercentMember_31f02b3b-cd4d-4b55-9665-edf422a78d20" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20394500PercentMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20394500PercentMember_31f02b3b-cd4d-4b55-9665-edf422a78d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20391.50PercentMember_0175120c-402f-4ffa-be98-4e62e4091b3a" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20391.50PercentMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due20391.50PercentMember_0175120c-402f-4ffa-be98-4e62e4091b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2040Member_91792788-a1a0-4016-87d7-f8d071f6085b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2040Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2040Member_91792788-a1a0-4016-87d7-f8d071f6085b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due2049Member_02519bb4-d773-43c0-a6db-2176cea48d82" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due2049Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2019Due2049Member_02519bb4-d773-43c0-a6db-2176cea48d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due2050Member_3fc3bdfd-6f53-4e0a-832e-c1e57ed5df64" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due2050Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_447e772b-4cd8-44d0-84a8-e776a2ca241d" xlink:to="loc_mdt_SeniorNotes2020Due2050Member_3fc3bdfd-6f53-4e0a-832e-c1e57ed5df64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_4cab32df-cd6a-46b6-b797-cdaf48d98eff" xlink:to="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_01f1557e-bc7f-4771-8883-ab85377f5dd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentType_01f1557e-bc7f-4771-8883-ab85377f5dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_909e2686-a879-4dbc-a414-c506e774a580" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentQuarterlyReport_909e2686-a879-4dbc-a414-c506e774a580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_846ee3f6-287e-4512-b076-16c89ec20703" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentPeriodEndDate_846ee3f6-287e-4512-b076-16c89ec20703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5d845398-5824-448b-91a9-6b202beac5f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentTransitionReport_5d845398-5824-448b-91a9-6b202beac5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_dbd8b62d-5729-4308-b7a7-d8cb0df5999f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityFileNumber_dbd8b62d-5729-4308-b7a7-d8cb0df5999f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_eb0ae9ac-8b2c-4e48-898a-e06e93a81d0d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityRegistrantName_eb0ae9ac-8b2c-4e48-898a-e06e93a81d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e4af0431-7520-47cc-bec4-1690baa97996" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e4af0431-7520-47cc-bec4-1690baa97996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f72b009b-c2b9-40b5-899a-e3d39ccd4b98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityTaxIdentificationNumber_f72b009b-c2b9-40b5-899a-e3d39ccd4b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2221863b-8299-4b8c-9e65-611659719e61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressAddressLine1_2221863b-8299-4b8c-9e65-611659719e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9eeb4209-691f-4614-a950-1beb231ae636" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressCityOrTown_9eeb4209-691f-4614-a950-1beb231ae636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_20b6ba8b-533a-4bc2-b383-71057c3f75ac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressCountry_20b6ba8b-533a-4bc2-b383-71057c3f75ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_13ba5704-5dc8-4d32-8151-562e169adfde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CountryRegion_13ba5704-5dc8-4d32-8151-562e169adfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_18c78ecd-436e-4a43-8d5e-fcc77e90360d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CityAreaCode_18c78ecd-436e-4a43-8d5e-fcc77e90360d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3dc39d4d-93bd-4cea-bb42-e0c2eb335df3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_LocalPhoneNumber_3dc39d4d-93bd-4cea-bb42-e0c2eb335df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_33cf2dba-83bd-4d36-906c-25030be4ac4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_Security12bTitle_33cf2dba-83bd-4d36-906c-25030be4ac4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_573010f3-559b-46e9-a383-b221d6036e22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_TradingSymbol_573010f3-559b-46e9-a383-b221d6036e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3bbb2209-7e02-467c-a5b4-ee8493074978" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_SecurityExchangeName_3bbb2209-7e02-467c-a5b4-ee8493074978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_eb397bb4-a595-4c6d-849b-b89acbe8927f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCurrentReportingStatus_eb397bb4-a595-4c6d-849b-b89acbe8927f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad60131e-61eb-4688-87a7-bcd7a2e40b6b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad60131e-61eb-4688-87a7-bcd7a2e40b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_4814e43c-6401-4e3c-ac56-139a62892a2f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityFilerCategory_4814e43c-6401-4e3c-ac56-139a62892a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8c54f0d4-ceb7-43ab-8cec-791fb112e372" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityEmergingGrowthCompany_8c54f0d4-ceb7-43ab-8cec-791fb112e372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_13d03c99-2db7-4417-80d7-8fa285b3259b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntitySmallBusiness_13d03c99-2db7-4417-80d7-8fa285b3259b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2630002a-9277-4bf3-a89d-188a88704587" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityShellCompany_2630002a-9277-4bf3-a89d-188a88704587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0d046a8b-81f8-4e28-9e2d-c17d87a6dbe0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0d046a8b-81f8-4e28-9e2d-c17d87a6dbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8ca40b31-7430-47f9-ae0f-a63292c1b896" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityCentralIndexKey_8ca40b31-7430-47f9-ae0f-a63292c1b896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6bd3f732-57d1-41c0-b27d-8238ab09d62f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_CurrentFiscalYearEndDate_6bd3f732-57d1-41c0-b27d-8238ab09d62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8363955b-c4ee-4f32-878a-8442fb156042" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_AmendmentFlag_8363955b-c4ee-4f32-878a-8442fb156042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fcb96cec-1ee8-48c3-9071-130752e1c4bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fcb96cec-1ee8-48c3-9071-130752e1c4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e481ba4-a600-41fa-8a7c-ee88ae7b6076" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_DocumentFiscalYearFocus_2e481ba4-a600-41fa-8a7c-ee88ae7b6076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3e348412-5ad2-4745-ad22-3e242fbe1909" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_f38e85de-b3ab-4223-a570-8c9bf458bb7c" xlink:to="loc_dei_EntityAddressPostalZipCode_3e348412-5ad2-4745-ad22-3e242fbe1909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a04c13cd-709e-4f3f-9824-80fd468879d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a04c13cd-709e-4f3f-9824-80fd468879d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_99c9aca5-b95c-42df-a037-78fafccf8dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_99c9aca5-b95c-42df-a037-78fafccf8dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9388d6f2-76dd-47e7-84b6-e928e4649e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_9388d6f2-76dd-47e7-84b6-e928e4649e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_778f3266-1204-4938-8e35-f4018e4e3489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_778f3266-1204-4938-8e35-f4018e4e3489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5c0d1894-c1c6-42e3-9c4b-4df4f0a20c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5c0d1894-c1c6-42e3-9c4b-4df4f0a20c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_1222f726-3b92-4b50-b32a-3e723ec93ba8" xlink:href="mdt-20221028.xsd#mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_1222f726-3b92-4b50-b32a-3e723ec93ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_9b99eca1-d7b5-474a-b09b-d3e5fb0c6354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_9b99eca1-d7b5-474a-b09b-d3e5fb0c6354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_0cfdc9e1-bd9a-44d3-81ca-bbc8fb6910e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_92c8373d-276d-423f-935c-bfd860476c64" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_0cfdc9e1-bd9a-44d3-81ca-bbc8fb6910e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6046cd5a-7797-4b1d-bb9a-404402e3a128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_OperatingIncomeLoss_6046cd5a-7797-4b1d-bb9a-404402e3a128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9e160ba3-5b6d-45df-9972-f85e19327d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9e160ba3-5b6d-45df-9972-f85e19327d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ebbe77ae-2846-4eed-8666-d08aea410b77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_InterestExpense_ebbe77ae-2846-4eed-8666-d08aea410b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8fd3e2a9-92c9-4fe5-bb27-c6427cebcffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8fd3e2a9-92c9-4fe5-bb27-c6427cebcffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_95e7eece-f167-469c-8942-f7c45d4331fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_95e7eece-f167-469c-8942-f7c45d4331fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89a3b4a9-2c37-4806-b8fd-495dc99159d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_ProfitLoss_89a3b4a9-2c37-4806-b8fd-495dc99159d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0122a602-62bc-4c78-ac48-86d70ac647be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0122a602-62bc-4c78-ac48-86d70ac647be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b325156c-d067-4c07-92e8-91d6fe252df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_NetIncomeLoss_b325156c-d067-4c07-92e8-91d6fe252df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_05334066-4826-47d3-ab1b-03b3fde21f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_EarningsPerShareBasic_05334066-4826-47d3-ab1b-03b3fde21f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be2e9b89-d25a-41d2-b501-607fd3f49379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be2e9b89-d25a-41d2-b501-607fd3f49379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7243e01-57f2-47b9-8a7a-9deb2767770c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7243e01-57f2-47b9-8a7a-9deb2767770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_592a7c1d-4544-439c-ac42-c322d714c5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_2712ba6c-c16d-4913-b550-1e1d4daf8006" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_592a7c1d-4544-439c-ac42-c322d714c5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_646f7411-e502-4871-b26e-0e38fc5bd626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:to="loc_us-gaap_ProfitLoss_646f7411-e502-4871-b26e-0e38fc5bd626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f6e47c26-b047-48f3-b013-dd90285ce126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f6e47c26-b047-48f3-b013-dd90285ce126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_30c9e896-9b28-4038-8f69-e80e7c01e2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_30c9e896-9b28-4038-8f69-e80e7c01e2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_4bf17889-d2ec-40df-b9f0-c64e6d4cbdaf" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax_4bf17889-d2ec-40df-b9f0-c64e6d4cbdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f0e354f4-2b1e-4b8e-915a-637b5697f1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f0e354f4-2b1e-4b8e-915a-637b5697f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_40e52e87-539b-4060-b903-260ad025d1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_40e52e87-539b-4060-b903-260ad025d1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf47e462-3b88-4af9-859b-0c2a0a48180a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c2604131-ee7a-4303-a3da-776518b41a72" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf47e462-3b88-4af9-859b-0c2a0a48180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_875f0730-6866-403a-8769-19529df4260f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_875f0730-6866-403a-8769-19529df4260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_66d02c4d-d832-4ea7-ad4d-53452f9ece19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_66d02c4d-d832-4ea7-ad4d-53452f9ece19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e91403a-ad5a-4cfe-a95e-ab0dc61ab9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0df842a0-eea8-4da7-ac28-8f9631b002d8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5e91403a-ad5a-4cfe-a95e-ab0dc61ab9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_572238ab-8b26-41a8-aee9-d6c60ebc6520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_572238ab-8b26-41a8-aee9-d6c60ebc6520" xlink:to="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2635ae43-9e80-4254-9ea6-f576cd43c566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2635ae43-9e80-4254-9ea6-f576cd43c566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3c9e69d5-f89f-4bde-a568-074369b1d71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_ShortTermInvestments_3c9e69d5-f89f-4bde-a568-074369b1d71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dab7ce65-90dc-4cff-86a6-327afceb55d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dab7ce65-90dc-4cff-86a6-327afceb55d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0f2e99ea-192b-496d-b2f0-b9d60e4698d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_InventoryNet_0f2e99ea-192b-496d-b2f0-b9d60e4698d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_fb32a53b-9228-4db4-99c0-081c414ebfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_OtherAssetsCurrent_fb32a53b-9228-4db4-99c0-081c414ebfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5e8119d1-51a2-46a3-903c-be11c10e56ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fccaeb48-7ae7-4fdb-b3d2-c8b614463286" xlink:to="loc_us-gaap_AssetsCurrent_5e8119d1-51a2-46a3-903c-be11c10e56ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_af10f5ca-3794-44c2-a316-f02558c63c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_af10f5ca-3794-44c2-a316-f02558c63c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_84333e1e-9424-4981-9fe0-b3bffb877e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_84333e1e-9424-4981-9fe0-b3bffb877e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ebe69387-1aad-475a-9d07-620f1d231584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ebe69387-1aad-475a-9d07-620f1d231584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_30d0cc30-90f2-4996-a105-93547dfdc4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_Goodwill_30d0cc30-90f2-4996-a105-93547dfdc4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ec00b71-97b2-4f41-82fe-ffb07dc9dbff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ec00b71-97b2-4f41-82fe-ffb07dc9dbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_1dc48616-1fe8-437c-b01f-f2184d48968c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_1dc48616-1fe8-437c-b01f-f2184d48968c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9d3f163f-1a1d-4f89-be92-51a07d0f1cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9d3f163f-1a1d-4f89-be92-51a07d0f1cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5f950ddb-dd0c-43b9-881d-a55203f2dff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a1a6bacf-a0a5-4e33-990e-50ebdfa30c32" xlink:to="loc_us-gaap_Assets_5f950ddb-dd0c-43b9-881d-a55203f2dff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_572238ab-8b26-41a8-aee9-d6c60ebc6520" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_7725ad92-005d-49c1-9f27-431aaecb4820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_DebtCurrent_7725ad92-005d-49c1-9f27-431aaecb4820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_106cde51-9a79-484c-81ba-cfe29341fe96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_AccountsPayableCurrent_106cde51-9a79-484c-81ba-cfe29341fe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_c6a6fdc6-059e-4267-a267-730d85f32dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_c6a6fdc6-059e-4267-a267-730d85f32dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_94e29f71-23f1-45ff-911d-a8829ddedc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_94e29f71-23f1-45ff-911d-a8829ddedc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3ac4e4ca-277d-4736-b07c-14906514ee7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3ac4e4ca-277d-4736-b07c-14906514ee7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dd5a78eb-ec05-427c-8e57-3504e3465948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b400e675-03ce-4c6c-a38e-966287d4b1f4" xlink:to="loc_us-gaap_LiabilitiesCurrent_dd5a78eb-ec05-427c-8e57-3504e3465948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dd9ffb61-e62b-4053-a0cd-a48d94b39345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_dd9ffb61-e62b-4053-a0cd-a48d94b39345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ce8ecb60-5a56-4a77-abf1-48da6d48d174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ce8ecb60-5a56-4a77-abf1-48da6d48d174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_03e6cd22-388f-47c1-b145-80c9fe088b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_03e6cd22-388f-47c1-b145-80c9fe088b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c12ed564-2e84-4bd5-88f0-cb2a19390151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c12ed564-2e84-4bd5-88f0-cb2a19390151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3f954458-11d0-4d1c-8559-b651de7036b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3f954458-11d0-4d1c-8559-b651de7036b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a59b04a3-9a78-45c4-9601-ed09d79e3cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_Liabilities_a59b04a3-9a78-45c4-9601-ed09d79e3cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2fadbb98-b9fa-4cde-8449-6dd73778e7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2fadbb98-b9fa-4cde-8449-6dd73778e7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_acd26386-00b6-4ff8-9ecd-3567daea0a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_CommonStockValue_acd26386-00b6-4ff8-9ecd-3567daea0a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b632a3bd-a8f7-4ee4-8761-8832eabec0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b632a3bd-a8f7-4ee4-8761-8832eabec0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_606c7adc-0571-49b6-bdf0-242eba09d9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_606c7adc-0571-49b6-bdf0-242eba09d9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b34e1ef-c6a1-437e-a9c7-6402a663e108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b34e1ef-c6a1-437e-a9c7-6402a663e108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e40483ac-1667-4f39-89ca-c0896815e380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_StockholdersEquity_e40483ac-1667-4f39-89ca-c0896815e380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7aba576d-d8ea-4286-8942-b18f8d2a5167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_MinorityInterest_7aba576d-d8ea-4286-8942-b18f8d2a5167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10a234d6-b248-4f4c-bbc2-4134c576defa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a492fec3-f6a3-4f43-884f-0b2c61d27063" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10a234d6-b248-4f4c-bbc2-4134c576defa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d570c93-ad8b-4f3a-b7a9-0d83969c2db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0aaee7b1-2ac8-4d0c-b54a-961f94e15b58" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d570c93-ad8b-4f3a-b7a9-0d83969c2db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9569fd39-d2bd-4e7d-ac03-48a8ad1e570a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9569fd39-d2bd-4e7d-ac03-48a8ad1e570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_7e35b90c-8dfb-4d72-aeae-ba30e0adbb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_7e35b90c-8dfb-4d72-aeae-ba30e0adbb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9184a468-6c55-40ef-bc30-57414929e109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9184a468-6c55-40ef-bc30-57414929e109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_765948fa-e075-4a9d-80c7-cc15a7d8679f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:to="loc_us-gaap_CommonStockSharesIssued_765948fa-e075-4a9d-80c7-cc15a7d8679f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_26d7cc00-5efa-4000-9bed-36bedb91d692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3dd74eb2-d2fb-4c7c-9abb-d3e27dc52406" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_26d7cc00-5efa-4000-9bed-36bedb91d692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_787959bd-9850-4678-b241-08e70ddef825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_787959bd-9850-4678-b241-08e70ddef825" xlink:to="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9af0831-e3b4-47d3-8373-a4182caecbca" xlink:to="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:to="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ca8aa728-3d20-434c-bac7-a655747343b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_CommonStockMember_ca8aa728-3d20-434c-bac7-a655747343b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b1172586-ec02-4124-9bbb-018fb2afc847" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b1172586-ec02-4124-9bbb-018fb2afc847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_96b30e46-0baf-494f-8dbd-660f954bd907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_RetainedEarningsMember_96b30e46-0baf-494f-8dbd-660f954bd907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f9022403-9ddd-4840-8986-60a9137cc556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_0da0183c-6bc1-43a1-b4af-3e22b99ea8ee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f9022403-9ddd-4840-8986-60a9137cc556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8b2ef87f-a87a-4d00-b57a-bde757e57d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_72860c66-0ace-4b73-bbb5-9930faa2ad04" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8b2ef87f-a87a-4d00-b57a-bde757e57d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5de66ee7-ceb6-4a2c-8b97-2de3027a2f8e" xlink:to="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a34d800-1c51-49b3-899a-cdff95aa1d8f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a5901d1c-4115-451a-af34-e7bca30c6690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a5901d1c-4115-451a-af34-e7bca30c6690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_335c38a4-20af-48d2-9711-7f5cd83d43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_335c38a4-20af-48d2-9711-7f5cd83d43f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_16265c75-551a-4535-9897-4941e41d7ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_ProfitLoss_16265c75-551a-4535-9897-4941e41d7ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b94ed86b-9adc-4678-b750-97001efef1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b94ed86b-9adc-4678-b750-97001efef1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_6ad67d1b-6887-475c-b68c-0bd6b5d46809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_DividendsCommonStockCash_6ad67d1b-6887-475c-b68c-0bd6b5d46809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a04f5fd-4d1e-4a3b-ab17-dd3c8e395d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a04f5fd-4d1e-4a3b-ab17-dd3c8e395d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3afae37f-b2e4-41e7-9021-98e2b5fccac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3afae37f-b2e4-41e7-9021-98e2b5fccac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d66d1cf8-7848-48e4-a830-25fd9fe1f80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d66d1cf8-7848-48e4-a830-25fd9fe1f80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_409a0c50-b3b0-458b-ba09-f820d6808059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_409a0c50-b3b0-458b-ba09-f820d6808059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_59b34f3d-8655-4afb-b6e2-96815cc28da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_59b34f3d-8655-4afb-b6e2-96815cc28da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_324b2223-85a8-47cb-8aa4-25a4b6af07ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_324b2223-85a8-47cb-8aa4-25a4b6af07ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2d3961cc-89fe-46a1-863e-14dc2215692f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2d3961cc-89fe-46a1-863e-14dc2215692f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e404b7f-1749-46c7-91cc-2f5088f1500a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43a39ccb-317b-4c1f-9646-a216624c9eeb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9e404b7f-1749-46c7-91cc-2f5088f1500a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8bd5236-befd-49dd-93bb-13549a6f6607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_53a93e71-0d85-4eed-8802-66f3116c5b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8bd5236-befd-49dd-93bb-13549a6f6607" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_53a93e71-0d85-4eed-8802-66f3116c5b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="mdt-20221028.xsd#ConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fb74aec9-a91c-4142-91ad-f2956262487c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fb74aec9-a91c-4142-91ad-f2956262487c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8d2c6d2e-dcfa-4e3d-a793-0e58f2fb3138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fb74aec9-a91c-4142-91ad-f2956262487c" xlink:to="loc_us-gaap_ProfitLoss_8d2c6d2e-dcfa-4e3d-a793-0e58f2fb3138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fb74aec9-a91c-4142-91ad-f2956262487c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b32c9dec-9c24-4763-982c-9c1733d112ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b32c9dec-9c24-4763-982c-9c1733d112ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_94d5b6a6-ae1c-486e-be56-e466bfc97dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_94d5b6a6-ae1c-486e-be56-e466bfc97dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_dd3fccc6-3e13-4ec9-b43c-b33691333ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_dd3fccc6-3e13-4ec9-b43c-b33691333ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_23544e01-c146-459d-a4cf-54036b7dc00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_ShareBasedCompensation_23544e01-c146-459d-a4cf-54036b7dc00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2026dd6e-f28a-44af-ad50-6eb22d99a047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2026dd6e-f28a-44af-ad50-6eb22d99a047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_c98687c2-7d71-452c-8fc6-fadd2b0cd0b6" xlink:href="mdt-20221028.xsd#mdt_AssetImpairmentChargesAndInventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_c98687c2-7d71-452c-8fc6-fadd2b0cd0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_6a617109-0359-4cf4-8dc2-49deee443dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_6a617109-0359-4cf4-8dc2-49deee443dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_faa4b75d-2849-4330-b377-ce69a3376ac0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_ce7fe68c-905b-4ade-be35-cabb7f650d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_ce7fe68c-905b-4ade-be35-cabb7f650d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7ebbc52a-72d8-4234-9230-12395739631c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7ebbc52a-72d8-4234-9230-12395739631c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_67ea09a0-7657-4dad-9c46-9b0f1a7e1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_67ea09a0-7657-4dad-9c46-9b0f1a7e1cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d653a8c6-0c6c-4036-bcc1-351a577ed968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_928b9747-8131-4633-abd5-3b1b6d48086e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d653a8c6-0c6c-4036-bcc1-351a577ed968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b7c8b3cb-13c2-4be6-8058-24bd8ee3d183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fb74aec9-a91c-4142-91ad-f2956262487c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b7c8b3cb-13c2-4be6-8058-24bd8ee3d183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2654ce83-83a4-4275-ba90-954df2299e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2654ce83-83a4-4275-ba90-954df2299e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60a2ceb1-135e-4353-88d0-3945f2486849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60a2ceb1-135e-4353-88d0-3945f2486849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b6f1a3c1-7894-43a6-be69-7c00c8715bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b6f1a3c1-7894-43a6-be69-7c00c8715bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bb81d91c-6609-4cb5-97da-ddbd69416c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bb81d91c-6609-4cb5-97da-ddbd69416c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ef3ea7b9-0205-42f7-bb6d-1c7966189278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ef3ea7b9-0205-42f7-bb6d-1c7966189278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4acc3a6-9deb-4656-9d94-a7f22e8d9081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2919dcfa-d084-49c0-95d0-bb22df320174" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4acc3a6-9deb-4656-9d94-a7f22e8d9081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_e581766e-bd8c-44dd-97ff-a1fd28e84c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_e581766e-bd8c-44dd-97ff-a1fd28e84c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_b959297c-7e6f-4e63-9e52-4c65d5988d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_b959297c-7e6f-4e63-9e52-4c65d5988d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9108391f-c2df-465e-b974-1508787e4b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9108391f-c2df-465e-b974-1508787e4b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_546994b1-fef9-4437-974f-6afa7dfaf15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_546994b1-fef9-4437-974f-6afa7dfaf15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_781859a0-94cb-458d-817f-c0dd16d8bb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_781859a0-94cb-458d-817f-c0dd16d8bb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_aa8d72f2-6b09-4d39-86c6-c1b467ba7135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_aa8d72f2-6b09-4d39-86c6-c1b467ba7135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2e16b4f0-d1e2-4aca-9dee-2dd098af4514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2e16b4f0-d1e2-4aca-9dee-2dd098af4514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f8dbcc69-3d49-456b-981e-a74206f1f534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f8dbcc69-3d49-456b-981e-a74206f1f534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63870568-7141-48f1-9fdf-9b89f7ce7460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_39e1beab-9234-46d0-b1a4-161e97732745" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_63870568-7141-48f1-9fdf-9b89f7ce7460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5d3ccd4-c56c-4521-8ec7-b3ac4ca3a586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5d3ccd4-c56c-4521-8ec7-b3ac4ca3a586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a8e3332-ed1c-45e8-b3e2-200e385c1100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a8e3332-ed1c-45e8-b3e2-200e385c1100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7432eee6-edbb-42bd-857e-877797e60583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7432eee6-edbb-42bd-857e-877797e60583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_85ae00d3-91e9-470e-b88a-5c3450d481cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_85ae00d3-91e9-470e-b88a-5c3450d481cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b6e55ef7-6c16-4821-91fe-0344122d280e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_53d662a8-8116-447d-bde2-7e37df7adf3d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b6e55ef7-6c16-4821-91fe-0344122d280e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IncomeTaxesandInterestPaidAbstract_989a758f-5d54-4276-842a-02590e658397" xlink:href="mdt-20221028.xsd#mdt_IncomeTaxesandInterestPaidAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b6e55ef7-6c16-4821-91fe-0344122d280e" xlink:to="loc_mdt_IncomeTaxesandInterestPaidAbstract_989a758f-5d54-4276-842a-02590e658397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6f46a602-db0f-4212-a384-b01dbed6e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract_989a758f-5d54-4276-842a-02590e658397" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6f46a602-db0f-4212-a384-b01dbed6e8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_1b0a8535-ae6a-44b7-915c-6219fd0287e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_IncomeTaxesandInterestPaidAbstract_989a758f-5d54-4276-842a-02590e658397" xlink:to="loc_us-gaap_InterestPaidNet_1b0a8535-ae6a-44b7-915c-6219fd0287e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="mdt-20221028.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66fcade8-92a5-48a9-8b7e-1390fe8e41c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_2e2c0e09-0ae2-45d4-94a2-18a710817c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_66fcade8-92a5-48a9-8b7e-1390fe8e41c0" xlink:to="loc_us-gaap_BasisOfAccounting_2e2c0e09-0ae2-45d4-94a2-18a710817c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="mdt-20221028.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_f6149c3d-a05e-46fd-8889-aeab23083d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_da71fbc0-d527-4d6f-aa70-24341274c608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_f6149c3d-a05e-46fd-8889-aeab23083d03" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_da71fbc0-d527-4d6f-aa70-24341274c608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Revenue" xlink:type="simple" xlink:href="mdt-20221028.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f51ae9f-b612-4aa0-8400-099f26fe33f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_27a3b4d6-b1b2-4456-945d-4e857b9591e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f51ae9f-b612-4aa0-8400-099f26fe33f7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_27a3b4d6-b1b2-4456-945d-4e857b9591e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSale"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_191a11a3-fcb5-4599-9396-ed979b6b7e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_355fbccb-57fc-4b01-a8a9-48f1445fbe57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_191a11a3-fcb5-4599-9396-ed979b6b7e42" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_355fbccb-57fc-4b01-a8a9-48f1445fbe57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCosts" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCosts"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee07b6e7-00d0-42a7-aa43-508716fb98ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2aa0b7e4-2cd7-40fd-a96f-79136112461b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ee07b6e7-00d0-42a7-aa43-508716fb98ed" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2aa0b7e4-2cd7-40fd-a96f-79136112461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_06ac1142-0901-4829-a5e8-39a86e63d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_22069186-a135-48be-8960-5722068fb908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_06ac1142-0901-4829-a5e8-39a86e63d399" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_22069186-a135-48be-8960-5722068fb908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangements" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangements"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cca5cf2b-32f7-4c59-be54-ba6213981866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_46c3e24d-9048-4349-a134-3b246eebfa9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cca5cf2b-32f7-4c59-be54-ba6213981866" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_46c3e24d-9048-4349-a134-3b246eebfa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagement"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da96f3bb-7f94-40fa-8f75-adfb83c412de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7c5f666c-aea0-4a1e-96d8-1194f319c47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da96f3bb-7f94-40fa-8f75-adfb83c412de" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7c5f666c-aea0-4a1e-96d8-1194f319c47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/Inventories" xlink:type="simple" xlink:href="mdt-20221028.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2679a8e8-9066-49ec-a402-d110c7ee2e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_1ce81d80-8821-42a3-97f4-8aa9d7b75f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2679a8e8-9066-49ec-a402-d110c7ee2e1c" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_1ce81d80-8821-42a3-97f4-8aa9d7b75f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c01b246d-0efb-4c94-ae6c-a1882ed5103f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9162f571-bd35-46c4-98c8-779266679728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c01b246d-0efb-4c94-ae6c-a1882ed5103f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9162f571-bd35-46c4-98c8-779266679728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mdt-20221028.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33e36437-c67a-4aea-8597-5d1c791ddb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_653cc195-4a80-43c5-a3ea-a25785f2c9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33e36437-c67a-4aea-8597-5d1c791ddb53" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_653cc195-4a80-43c5-a3ea-a25785f2c9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShare" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_88110bb3-a16c-4b91-b5ca-02246882b467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fd1e6670-b6f7-45b4-b70b-abcdf4df8d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_88110bb3-a16c-4b91-b5ca-02246882b467" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fd1e6670-b6f7-45b4-b70b-abcdf4df8d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mdt-20221028.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e728e8d5-3952-4a18-b693-2a6e4f0c0068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_76d5f944-af4d-4462-a96a-72c04da59c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e728e8d5-3952-4a18-b693-2a6e4f0c0068" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_76d5f944-af4d-4462-a96a-72c04da59c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="simple" xlink:href="mdt-20221028.xsd#RetirementBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6dbed53c-0533-4100-b6e5-d27a45cbb886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bdfaea5f-6669-49ba-977b-c337208838de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6dbed53c-0533-4100-b6e5-d27a45cbb886" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_bdfaea5f-6669-49ba-977b-c337208838de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="mdt-20221028.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b5bfbf62-af9d-4209-bfa5-f48627749703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7c078de0-53f8-46ee-825e-5e883c17abd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b5bfbf62-af9d-4209-bfa5-f48627749703" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7c078de0-53f8-46ee-825e-5e883c17abd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mdt-20221028.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29013c67-dc67-412d-b1d9-1f6b560f657d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_f36c69d1-bcbc-441d-a4cc-6776b50aa6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29013c67-dc67-412d-b1d9-1f6b560f657d" xlink:to="loc_us-gaap_LossContingencyDisclosures_f36c69d1-bcbc-441d-a4cc-6776b50aa6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a18ae175-9ac0-420f-8586-97092e2bcc41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0225ffca-75ed-4494-8d27-e0e56e2ec89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a18ae175-9ac0-420f-8586-97092e2bcc41" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0225ffca-75ed-4494-8d27-e0e56e2ec89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="mdt-20221028.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a4e17780-615b-4875-a4b1-0abe8ce9b8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_558b6fcd-9890-4fa4-9f47-49f79449b0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a4e17780-615b-4875-a4b1-0abe8ce9b8ac" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_558b6fcd-9890-4fa4-9f47-49f79449b0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_783347de-df96-45b0-974e-37b475911fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a4e17780-615b-4875-a4b1-0abe8ce9b8ac" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_783347de-df96-45b0-974e-37b475911fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_f459f3a0-4fb2-47eb-8cb3-8988a49ec3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a4e17780-615b-4875-a4b1-0abe8ce9b8ac" xlink:to="loc_us-gaap_FiscalPeriod_f459f3a0-4fb2-47eb-8cb3-8988a49ec3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ce84dcce-7b2c-4f89-961a-1c10408122af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a4e17780-615b-4875-a4b1-0abe8ce9b8ac" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ce84dcce-7b2c-4f89-961a-1c10408122af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3956b6b8-4f04-4ea6-af39-b997453aca14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3bf8504e-3313-4d4a-a762-8bbef20bcf9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3956b6b8-4f04-4ea6-af39-b997453aca14" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3bf8504e-3313-4d4a-a762-8bbef20bcf9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_415781a5-08d0-4b1f-9f9a-2160435f4126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_415781a5-08d0-4b1f-9f9a-2160435f4126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_04fb90d0-6eee-4e87-a06a-bca8d5013ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_04fb90d0-6eee-4e87-a06a-bca8d5013ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_03c79891-30a4-4370-9bad-b55a70fda481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_03c79891-30a4-4370-9bad-b55a70fda481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_d62b42c5-eaf8-4724-b2b0-c2f789ca7fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_d62b42c5-eaf8-4724-b2b0-c2f789ca7fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e6eebb74-667e-4229-b892-119f3fccc339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_98053e57-4219-41ef-987a-a9e899997d7b" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_e6eebb74-667e-4229-b892-119f3fccc339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCostsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3fd51a17-a687-4eb3-baec-69fd1ad3bdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_84ebf27f-c188-4aed-acbf-b38cc3656a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_3fd51a17-a687-4eb3-baec-69fd1ad3bdec" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_84ebf27f-c188-4aed-acbf-b38cc3656a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_5dab0516-5c10-49a1-96b3-e8e63bd88adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_5dab0516-5c10-49a1-96b3-e8e63bd88adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_2441f2e9-fbe8-41e0-8cd8-e5112d1f9a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_2441f2e9-fbe8-41e0-8cd8-e5112d1f9a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_ef57ad4e-96d8-44cc-85c6-760f8b076c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_ef57ad4e-96d8-44cc-85c6-760f8b076c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_58c6cbd1-3508-465c-8d7f-a450162e7e04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_58c6cbd1-3508-465c-8d7f-a450162e7e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_752cc89e-83e4-49b9-aff0-4204181f3239" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock_752cc89e-83e4-49b9-aff0-4204181f3239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleofInvestmentsTableTextBlock_7d71abfd-7fe8-4a93-906e-f6356ea25332" xlink:href="mdt-20221028.xsd#mdt_ScheduleofInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_282842c7-c40e-4bb5-a095-32f2e6b6be5e" xlink:to="loc_mdt_ScheduleofInvestmentsTableTextBlock_7d71abfd-7fe8-4a93-906e-f6356ea25332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8ab9bf07-2e6e-4f88-b9f7-6fdf7a12ace0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_d0f7f9ec-7c34-4bed-a117-2d9dd7117ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8ab9bf07-2e6e-4f88-b9f7-6fdf7a12ace0" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_d0f7f9ec-7c34-4bed-a117-2d9dd7117ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_10a8498b-fde8-4e18-a8d4-761a46d9037c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_10a8498b-fde8-4e18-a8d4-761a46d9037c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_0f49eb40-574f-49d9-bfe4-3be670921fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_0f49eb40-574f-49d9-bfe4-3be670921fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6417ec95-a3aa-4124-9adf-c0112af454a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6417ec95-a3aa-4124-9adf-c0112af454a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_09310502-642e-4148-b991-c2f875dee545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_09310502-642e-4148-b991-c2f875dee545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_d184bb91-75ae-4aac-837f-589541abcc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_63c1a2ee-1acf-4e3e-86c6-9fbbaca91ff6" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_d184bb91-75ae-4aac-837f-589541abcc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3f136ccb-d454-4b92-aa43-37f7c0cc2e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b3231725-8001-44de-9f5c-0c3b0e1b52cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3f136ccb-d454-4b92-aa43-37f7c0cc2e9c" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b3231725-8001-44de-9f5c-0c3b0e1b52cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86b27a5a-4a38-4e1d-8f05-adf50afb6a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_075847bf-a541-42d8-b911-3ab33dd32bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86b27a5a-4a38-4e1d-8f05-adf50afb6a69" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_075847bf-a541-42d8-b911-3ab33dd32bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_57276650-8804-488b-b253-b90080e56ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86b27a5a-4a38-4e1d-8f05-adf50afb6a69" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_57276650-8804-488b-b253-b90080e56ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3bbea5e4-b51d-476b-bbcb-7c81fa6815ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86b27a5a-4a38-4e1d-8f05-adf50afb6a69" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_3bbea5e4-b51d-476b-bbcb-7c81fa6815ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83ee1d66-870c-4e79-9f67-8f76e0995876" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_86b27a5a-4a38-4e1d-8f05-adf50afb6a69" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83ee1d66-870c-4e79-9f67-8f76e0995876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_52592e60-1707-4579-bca3-a4616aa3dafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9d9ed3c7-a683-42a7-b4c1-19de7a754277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_52592e60-1707-4579-bca3-a4616aa3dafe" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9d9ed3c7-a683-42a7-b4c1-19de7a754277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_27104aa1-d697-44a0-8008-9dbae24f928b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_995e31ac-2cd0-4d6f-8418-a01c9dc99c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_27104aa1-d697-44a0-8008-9dbae24f928b" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_995e31ac-2cd0-4d6f-8418-a01c9dc99c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#RetirementBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9c9255af-8bfe-468c-a024-aa748fcf52d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_76304c2d-70ad-4040-97b5-07fa70dd6713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9c9255af-8bfe-468c-a024-aa748fcf52d5" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_76304c2d-70ad-4040-97b5-07fa70dd6713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2470ac9d-a510-4ec6-99fc-50ae180d65fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1edc897d-94f7-4300-8129-7a333137f731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2470ac9d-a510-4ec6-99fc-50ae180d65fc" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1edc897d-94f7-4300-8129-7a333137f731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_953962b5-a902-421f-a7e4-6f16df485269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_d3eb3079-8fae-4a0f-8faa-101428870997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_953962b5-a902-421f-a7e4-6f16df485269" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_d3eb3079-8fae-4a0f-8faa-101428870997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_2630eb66-d605-4072-a65c-110dac64f022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_953962b5-a902-421f-a7e4-6f16df485269" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_2630eb66-d605-4072-a65c-110dac64f022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd9c9f5e-ac5b-4f14-9e14-700ebb7bcd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dd9c9f5e-ac5b-4f14-9e14-700ebb7bcd4c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a828dc09-5507-4822-b786-b0f70f58da54" xlink:to="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_b1077158-2ae9-480e-8ba5-5e6ca1b30872" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_CardiovascularMember_b1077158-2ae9-480e-8ba5-5e6ca1b30872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_07b660d5-4213-4997-8520-0c57283f4631" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_MedicalSurgicalMember_07b660d5-4213-4997-8520-0c57283f4631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_aa22425a-67aa-445c-b841-393f07b6c363" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_NeuroscienceGroupMember_aa22425a-67aa-445c-b841-393f07b6c363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_aa2e400a-acce-437c-bc2b-eb6629182565" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29b01973-b327-40d9-8065-5443c115fd3c" xlink:to="loc_mdt_DiabetesGroupMember_aa2e400a-acce-437c-bc2b-eb6629182565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:to="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_f84c0bb5-228c-4a52-93c6-3cb20f1671ec" xlink:to="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_7fe24410-50f4-41b6-9171-a6b085e6b470" xlink:href="mdt-20221028.xsd#mdt_CardiacRhythmandHeartFailureDivisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CardiacRhythmandHeartFailureDivisionMember_7fe24410-50f4-41b6-9171-a6b085e6b470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_StructuralHeartAndAorticDivisionMember_1780c073-0496-4e13-8396-f451f2487a57" xlink:href="mdt-20221028.xsd#mdt_StructuralHeartAndAorticDivisionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_StructuralHeartAndAorticDivisionMember_1780c073-0496-4e13-8396-f451f2487a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CoronaryAndPeripheralVascularDivisionMember_6ecc15da-b49f-472d-9939-6bebd146ecde" xlink:href="mdt-20221028.xsd#mdt_CoronaryAndPeripheralVascularDivisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CoronaryAndPeripheralVascularDivisionMember_6ecc15da-b49f-472d-9939-6bebd146ecde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SurgicalInnovationsDivisionMember_e274c95f-3d8b-4a8e-a343-28806585d792" xlink:href="mdt-20221028.xsd#mdt_SurgicalInnovationsDivisionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_SurgicalInnovationsDivisionMember_e274c95f-3d8b-4a8e-a343-28806585d792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_7b0f37e3-f5d2-4121-8d21-89df5e64d555" xlink:href="mdt-20221028.xsd#mdt_RespiratoryGastrointestinalandRenalDivisionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_RespiratoryGastrointestinalandRenalDivisionMember_7b0f37e3-f5d2-4121-8d21-89df5e64d555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_48bdb408-c0dd-465e-9143-33a08ab19126" xlink:href="mdt-20221028.xsd#mdt_CranialAndSpinalTechnologiesDivisionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_CranialAndSpinalTechnologiesDivisionMember_48bdb408-c0dd-465e-9143-33a08ab19126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SpecialtyTherapiesDivisionMember_077739d9-2f0e-4a1b-a01a-c554f4d23f7a" xlink:href="mdt-20221028.xsd#mdt_SpecialtyTherapiesDivisionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_SpecialtyTherapiesDivisionMember_077739d9-2f0e-4a1b-a01a-c554f4d23f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuromodulationDivisionMember_3f8299f8-7d40-45ac-a09f-eaaa9b97e0d0" xlink:href="mdt-20221028.xsd#mdt_NeuromodulationDivisionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_706b4f5e-667f-424f-8e0c-5cb24dfb8dad" xlink:to="loc_mdt_NeuromodulationDivisionMember_3f8299f8-7d40-45ac-a09f-eaaa9b97e0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_23b46396-0d07-414d-a1b0-92b5e7634d27" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa52071c-1356-4cb7-80b7-d6eb1321e036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_649227db-6062-4fb4-adaa-2f34e7cfe2e2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa52071c-1356-4cb7-80b7-d6eb1321e036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_706be3bf-51ac-4401-8594-d77e7babcef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_706be3bf-51ac-4401-8594-d77e7babcef1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_57ff65d2-097c-44c5-a2b1-5e98516d71b8" xlink:to="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_f05694c3-ba40-47f0-8f19-87ddc2d76682" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_CardiovascularMember_f05694c3-ba40-47f0-8f19-87ddc2d76682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_1f52561d-adc6-4145-9b64-e53a88ee127e" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_MedicalSurgicalMember_1f52561d-adc6-4145-9b64-e53a88ee127e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_ad71717c-875b-4421-a152-0eae1db69d57" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_NeuroscienceGroupMember_ad71717c-875b-4421-a152-0eae1db69d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_432446f6-d62b-464e-9571-e78b0a2c427c" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1e259b8b-4955-4016-af18-262e044c8314" xlink:to="loc_mdt_DiabetesGroupMember_432446f6-d62b-464e-9571-e78b0a2c427c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:to="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_250b65cb-524d-4563-9fd3-ed2d336b1640" xlink:to="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_36854490-4e60-4005-90b0-07fbdaf4ba0f" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_country_US_36854490-4e60-4005-90b0-07fbdaf4ba0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_d1ce5310-92d8-49b6-a701-96d66b658081" xlink:href="mdt-20221028.xsd#mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember_d1ce5310-92d8-49b6-a701-96d66b658081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_5dedd47e-b4b1-4c6c-b2b6-0d7fcb69b7a8" xlink:href="mdt-20221028.xsd#mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_84e75316-a371-44fe-80d8-935e7d733a04" xlink:to="loc_mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember_5dedd47e-b4b1-4c6c-b2b6-0d7fcb69b7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b1097d2-5545-43da-9245-a21eaf85f349" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_817f0f4e-1149-45ac-a1be-d9ecd958ba9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dc0c2792-e5cf-488d-844e-dcf3889bd611" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_817f0f4e-1149-45ac-a1be-d9ecd958ba9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_46aabaa2-aa8f-470f-8e9c-e41ee2f153ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_46aabaa2-aa8f-470f-8e9c-e41ee2f153ad" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a520a5f-9ec6-475a-9251-82496d282c2a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_6dbebb7e-0fd7-4bed-b579-a5e2fe91ee7c" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_mdt_OtherAccruedExpensesMember_6dbebb7e-0fd7-4bed-b579-a5e2fe91ee7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_b0669b7e-b129-42f2-ad74-41bcc9a874b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_us-gaap_AccountsReceivableMember_b0669b7e-b129-42f2-ad74-41bcc9a874b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_ce31fab6-0d51-4af1-a2fa-080c351e3162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4acb0b0f-a48c-4911-bc2b-d034f2c6356c" xlink:to="loc_us-gaap_OtherLiabilitiesMember_ce31fab6-0d51-4af1-a2fa-080c351e3162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_06c07bee-9d10-4050-8cd8-15f48794677f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_f419519b-ddf7-4acf-b361-e415f3aa1cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_f419519b-ddf7-4acf-b361-e415f3aa1cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_6c5699e6-3b80-4f1b-a101-4736452b0bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerLiability_6c5699e6-3b80-4f1b-a101-4736452b0bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_552d19b3-28a4-4565-8134-c0f90540b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_552d19b3-28a4-4565-8134-c0f90540b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_947e8a20-721c-4233-87e4-834c4662b5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_947e8a20-721c-4233-87e4-834c4662b5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_0d3fb7f6-57d4-4317-b80c-72db795864ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_d3346ec6-928a-4153-8408-5db926925d16" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_0d3fb7f6-57d4-4317-b80c-72db795864ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6425fc1c-dfe6-48ca-87b7-464d2fdada46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6425fc1c-dfe6-48ca-87b7-464d2fdada46" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9c0a7db3-a98b-4163-a5ea-a1abc714a5e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IntersectENTMember_11b18985-82a5-4033-a380-6957161aa925" xlink:href="mdt-20221028.xsd#mdt_IntersectENTMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_IntersectENTMember_11b18985-82a5-4033-a380-6957161aa925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAcquisitionsMember_c7cc954f-6fb9-45ca-a8cf-2c6817dceebb" xlink:href="mdt-20221028.xsd#mdt_OtherAcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_OtherAcquisitionsMember_c7cc954f-6fb9-45ca-a8cf-2c6817dceebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_71f5f5c9-ac9c-47d6-a0a3-62bf621b6f37" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3504d916-594c-4a19-895e-21687e2a052b" xlink:to="loc_mdt_AfferaIncMember_71f5f5c9-ac9c-47d6-a0a3-62bf621b6f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_219b9ea0-b7d3-4222-ba2a-448ebf61e292" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_24a18275-90a4-4a1e-bfd8-12849cdad984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_24a18275-90a4-4a1e-bfd8-12849cdad984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_f75b0ab5-d713-4476-a40d-dd3f07e928fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_f75b0ab5-d713-4476-a40d-dd3f07e928fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_22bb34ab-a525-4864-bf64-211410189107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3b494b8-4638-4c0e-82ac-c1850751e463" xlink:to="loc_us-gaap_TradeNamesMember_22bb34ab-a525-4864-bf64-211410189107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9224406d-0ad2-4423-afff-38e585c00f23" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_54d297e1-def4-4734-a889-175281ed11e4" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:to="loc_mdt_OtherAccruedExpensesMember_54d297e1-def4-4734-a889-175281ed11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_658ca23e-52ca-4dfb-bdd8-7e500a4ad76b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_04cb54a3-ceef-4373-8e05-86210f7466cb" xlink:to="loc_us-gaap_OtherLiabilitiesMember_658ca23e-52ca-4dfb-bdd8-7e500a4ad76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_a23d391a-0db8-45b0-8e6b-0c3119fb1d47" xlink:to="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_InProcessResearchDevelopmentMember_02d7acf6-594c-4313-b730-18ee63851128" xlink:href="mdt-20221028.xsd#mdt_InProcessResearchDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_9d0ca0ef-764e-472d-a312-68db690c68f6" xlink:to="loc_mdt_InProcessResearchDevelopmentMember_02d7acf6-594c-4313-b730-18ee63851128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_36c97e49-2570-4bea-b804-ee89f6ad6f52" xlink:to="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8cad5b21-a01f-427a-a854-0399e3a0cae9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:to="loc_srt_MinimumMember_8cad5b21-a01f-427a-a854-0399e3a0cae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_15f8bcc7-c04d-4a3e-92da-2d75cdf1f682" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad6b6bb4-7edd-4170-a250-42ef48fba677" xlink:to="loc_srt_MaximumMember_15f8bcc7-c04d-4a3e-92da-2d75cdf1f682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2293ba03-ac04-4142-9da2-5bdc699e26c1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_99dc32a2-03bd-4ed4-ba82-eae965e4664f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_825af423-c53e-468d-9503-13e87648a693" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_99dc32a2-03bd-4ed4-ba82-eae965e4664f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b19330e9-80db-4796-8fa1-6a8b5788e6af" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b432edc4-cf08-42de-acd5-c6509eb164a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_53b98595-207f-4fde-9b46-b2f83323da9f" xlink:to="loc_us-gaap_SubsequentEventMember_b432edc4-cf08-42de-acd5-c6509eb164a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9c34a095-a4dd-4170-ae68-cafe6dbed316" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_a380cfc0-9246-4a60-8d8e-778c682f5d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_a380cfc0-9246-4a60-8d8e-778c682f5d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_56b9c0d6-d826-4bd4-8a62-3043c201afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_56b9c0d6-d826-4bd4-8a62-3043c201afcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_71a07f12-014f-4ccd-8e5a-ca6ed553cc17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_71a07f12-014f-4ccd-8e5a-ca6ed553cc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f812fd24-0e79-43a2-8a55-a761aeefe274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f812fd24-0e79-43a2-8a55-a761aeefe274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_16dd3318-07fb-4813-b3da-6744b0cfd6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_Goodwill_16dd3318-07fb-4813-b3da-6744b0cfd6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_bc2488d4-f67d-45f3-9bae-3cb61488ff4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_bc2488d4-f67d-45f3-9bae-3cb61488ff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2539c7a4-4a63-4f37-ad62-6aeca690d426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2539c7a4-4a63-4f37-ad62-6aeca690d426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de98a8e9-c0bd-4a2f-a118-955f017e941d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de98a8e9-c0bd-4a2f-a118-955f017e941d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_430a823b-c050-449e-b9a4-57e564100108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_430a823b-c050-449e-b9a4-57e564100108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_9515a791-7016-4248-bed9-66904db784bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_9515a791-7016-4248-bed9-66904db784bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9d9c6562-995a-4c04-b2d4-738fe3636489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9d9c6562-995a-4c04-b2d4-738fe3636489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPriceContingentConsideration_17b862cf-b7d5-45f7-a260-4e7e50cfa8b5" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPriceContingentConsideration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_mdt_BusinessAcquisitionPriceContingentConsideration_17b862cf-b7d5-45f7-a260-4e7e50cfa8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_5686ec6e-9230-40ab-8a41-9265c2d1a1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_5686ec6e-9230-40ab-8a41-9265c2d1a1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_664827ef-ce1a-4696-b24a-2b3424ce0033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_664827ef-ce1a-4696-b24a-2b3424ce0033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee7c054c-35a3-44ba-b4c7-9644de8b802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ee7c054c-35a3-44ba-b4c7-9644de8b802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TechnologyBasedIntangibleAssets_2f716577-e145-4054-9ec2-589a05ea5988" xlink:href="mdt-20221028.xsd#mdt_TechnologyBasedIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_mdt_TechnologyBasedIntangibleAssets_2f716577-e145-4054-9ec2-589a05ea5988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_47bb17e7-df55-4a62-a7e1-f0e9f3c6e92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_47bb17e7-df55-4a62-a7e1-f0e9f3c6e92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c460dbaf-7984-49be-bb58-f1800b93e5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c460dbaf-7984-49be-bb58-f1800b93e5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_f601f045-7ff2-4758-9c4d-b53b0daad6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentChargeOnReclassifiedAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a112702f-05a3-4396-8b4f-3b0f718be188" xlink:to="loc_us-gaap_ImpairmentChargeOnReclassifiedAssets_f601f045-7ff2-4758-9c4d-b53b0daad6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b9a13f5c-2797-4e9f-bd90-a8f9f4a91577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b9a13f5c-2797-4e9f-bd90-a8f9f4a91577" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4255bf5d-58bc-48bb-aca6-a1c79a6e9289" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_IntersectENTMember_11988728-4ce7-4ae4-b185-8fad71c82964" xlink:href="mdt-20221028.xsd#mdt_IntersectENTMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:to="loc_mdt_IntersectENTMember_11988728-4ce7-4ae4-b185-8fad71c82964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_74ea608b-fd6e-48af-aaf0-d7ce304778bc" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dbbfb62-0152-43a6-90c1-b658e5bcfe97" xlink:to="loc_mdt_AfferaIncMember_74ea608b-fd6e-48af-aaf0-d7ce304778bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_efd1ddc6-15bc-4617-a423-3d6e4c9cfa35" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4edf8d5-2211-4615-93b9-564aa7fdffed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f4edf8d5-2211-4615-93b9-564aa7fdffed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c765cff3-763e-407e-997a-7a4323228e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c765cff3-763e-407e-997a-7a4323228e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bf044100-6db2-4862-8447-358b1d02445d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_Goodwill_bf044100-6db2-4862-8447-358b1d02445d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6b6045a4-9eeb-4fcd-892a-931270cde63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6b6045a4-9eeb-4fcd-892a-931270cde63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0ed70c0c-c499-4b4c-8440-c289a105915e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0ed70c0c-c499-4b4c-8440-c289a105915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da15edc6-c8e2-4432-ae86-5243ce946106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da15edc6-c8e2-4432-ae86-5243ce946106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8a238168-af4c-44e7-a55a-f216910d781b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_8a238168-af4c-44e7-a55a-f216910d781b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ba1183d8-36b1-42c5-8db0-c51aff9bc033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ba1183d8-36b1-42c5-8db0-c51aff9bc033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3624c981-bb27-4e87-971a-6140c86d8778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3624c981-bb27-4e87-971a-6140c86d8778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4298bcfd-56e9-4db9-b588-c51615b18869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4298bcfd-56e9-4db9-b588-c51615b18869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7ef9e055-7ba4-4aec-bf6b-88434ef6c51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_eea06743-8bd3-4474-a71b-27b848fd55bf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7ef9e055-7ba4-4aec-bf6b-88434ef6c51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0fc87a0a-1047-4598-8c1f-078a05fc7f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0fc87a0a-1047-4598-8c1f-078a05fc7f13" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08fac7fd-2c35-479d-bd24-ee88aaf6e7a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AfferaIncMember_6f01d1e1-9c50-4356-979d-f67784a2ffd0" xlink:href="mdt-20221028.xsd#mdt_AfferaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_816bc9af-edc7-4e8d-9e17-535e7096c0f8" xlink:to="loc_mdt_AfferaIncMember_6f01d1e1-9c50-4356-979d-f67784a2ffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0524da89-70db-43ef-bf76-cf937c047d8c" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_93b27367-ea41-4b49-ae46-bb4b7da57c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_93b27367-ea41-4b49-ae46-bb4b7da57c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b64c73e5-f092-4c90-abcb-dc7a305f5c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b64c73e5-f092-4c90-abcb-dc7a305f5c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_928594bc-6f6d-460d-bf73-665e2c6fc3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_Goodwill_928594bc-6f6d-460d-bf73-665e2c6fc3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_73c27426-af33-40fd-9ff1-95d9f86b6ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_73c27426-af33-40fd-9ff1-95d9f86b6ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_84685767-59c0-45c7-9829-653ec9193218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_84685767-59c0-45c7-9829-653ec9193218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2135a679-72f6-49a6-a4a8-b07ce88b4030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2135a679-72f6-49a6-a4a8-b07ce88b4030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_28d1470c-2697-4202-9855-9023751b2fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_28d1470c-2697-4202-9855-9023751b2fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_023a13a7-f82d-4fb9-accf-5752b04743a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_023a13a7-f82d-4fb9-accf-5752b04743a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_31c0945b-afbd-40d2-89f5-69a344e70be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_31c0945b-afbd-40d2-89f5-69a344e70be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a4613501-f8a3-4872-9aef-7b76312bb712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a4613501-f8a3-4872-9aef-7b76312bb712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a947de2d-8fed-46ee-b93b-6be10331cc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_90bfc096-b4ea-4f10-b3df-1e422e7ea619" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a947de2d-8fed-46ee-b93b-6be10331cc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4e3ec443-015a-444c-a173-5c1376128d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4e3ec443-015a-444c-a173-5c1376128d8c" xlink:to="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e61a1c29-0ac5-409a-9cb5-1eed3d55721b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e61a1c29-0ac5-409a-9cb5-1eed3d55721b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPriceContingentConsideration_e89916d4-0040-485e-8322-62ee5e5db747" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPriceContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_mdt_BusinessAcquisitionPriceContingentConsideration_e89916d4-0040-485e-8322-62ee5e5db747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_96ab901d-3136-4078-922b-72f8f81f6586" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionPurchasePriceContingentConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_mdt_BusinessAcquisitionPurchasePriceContingentConsideration_96ab901d-3136-4078-922b-72f8f81f6586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_924d4ce6-c556-47fc-b503-f1067a8e358d" xlink:href="mdt-20221028.xsd#mdt_BusinessAcquisitionContingentConsiderationMilestonePayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment_924d4ce6-c556-47fc-b503-f1067a8e358d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f6d2f63-b973-46ed-99b5-dfefef1cfd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f6d2f63-b973-46ed-99b5-dfefef1cfd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_336dfcd6-4dcf-46e1-9726-8a97d6bccdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward_770cee65-c45f-4f81-a78b-f0180d9ab95c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_336dfcd6-4dcf-46e1-9726-8a97d6bccdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d7a6e5a-3103-432a-b6c3-78939b4b073c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9d7a6e5a-3103-432a-b6c3-78939b4b073c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_751f80ab-0b8a-4cac-98fa-e9230ee7c88a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RevenueMilestoneMember_35f66913-edc2-4186-a5c3-e8f313a6e0c6" xlink:href="mdt-20221028.xsd#mdt_RevenueMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:to="loc_mdt_RevenueMilestoneMember_35f66913-edc2-4186-a5c3-e8f313a6e0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ProductDevelopmentMilestoneMember_a2bdcc83-3861-4a55-9d7c-de28cb08248a" xlink:href="mdt-20221028.xsd#mdt_ProductDevelopmentMilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_691a66a5-121f-4004-ac7e-064d29c07c62" xlink:to="loc_mdt_ProductDevelopmentMilestoneMember_a2bdcc83-3861-4a55-9d7c-de28cb08248a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_124e6d45-5704-42a6-8b5a-26a93ba27f83" xlink:to="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3fa08178-08f0-4aca-9dd8-05b22ae5cb2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_MinimumMember_3fa08178-08f0-4aca-9dd8-05b22ae5cb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a9ae1610-2449-4439-af50-561736c87eb2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_MaximumMember_a9ae1610-2449-4439-af50-561736c87eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_e944fb62-9206-44c8-b4b7-025092cc8b54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb41b4a9-7cf1-4a67-bf9b-568d57d69300" xlink:to="loc_srt_WeightedAverageMember_e944fb62-9206-44c8-b4b7-025092cc8b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_544636b8-073c-4d5e-884d-7d520c5a72db" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_46196991-15f1-464e-81bc-ba1f63ce40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_33dc0bff-336c-4854-abfd-e14ed979f988" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_46196991-15f1-464e-81bc-ba1f63ce40f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_28403f9b-0377-40c0-86b5-060f5593bb42" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_be24acd8-28b4-4d20-9dfb-32fed835e446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4f57efc-3b23-4993-af58-c262b95a0bc4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_be24acd8-28b4-4d20-9dfb-32fed835e446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_14ea36d1-2148-45ed-8386-d0f98324af61" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7e43f0e4-561f-46b6-bf1d-8503006a7007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_af9ca312-70fe-442e-978e-5d5a41146363" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7e43f0e4-561f-46b6-bf1d-8503006a7007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_8740df94-4a15-4307-a165-7e15983de2b0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4779f3e5-91ce-4fdc-bb45-9de773dbcd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4779f3e5-91ce-4fdc-bb45-9de773dbcd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_21f70afa-a35c-4d6b-a992-9c49f1acf6f3" xlink:to="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9363e5de-af49-4488-92fc-ec0a0b7181de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_cb0c7b00-88c6-4552-97b8-bb81079f57ea" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9363e5de-af49-4488-92fc-ec0a0b7181de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8f97e8a3-ae1c-48a6-9864-58ae75677f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8f97e8a3-ae1c-48a6-9864-58ae75677f87" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c8eff480-68ad-4599-ad35-8bceed67bb1a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HeldForSaleMember_618508a8-27c0-4d6e-be86-6ceea95aeefe" xlink:href="mdt-20221028.xsd#mdt_HeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f38ecd25-caf1-43a3-85e5-4d69581cbd54" xlink:to="loc_mdt_HeldForSaleMember_618508a8-27c0-4d6e-be86-6ceea95aeefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e0e25672-3a2c-45d4-8dde-8e3ded7b4cd7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_90fc5559-9bf8-4275-b4e2-228ee7c5efff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2760040d-c9cf-4ec0-ae44-bd25619ed9ed" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_90fc5559-9bf8-4275-b4e2-228ee7c5efff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_77cae511-43aa-4510-a666-9cbb6dee5c99" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c00c0174-c5c9-4ca3-8c4a-c17a7aef4ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_c00c0174-c5c9-4ca3-8c4a-c17a7aef4ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f2d41f7-2a0f-4d00-a447-241beb727456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_6f2d41f7-2a0f-4d00-a447-241beb727456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_33407405-e762-4651-9f18-5387e321e1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_33407405-e762-4651-9f18-5387e321e1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_27b698ff-ba93-446a-a3d7-4212fc01975a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_27b698ff-ba93-446a-a3d7-4212fc01975a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_87569407-7b2a-4c00-87f8-2f89e8c27029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_87569407-7b2a-4c00-87f8-2f89e8c27029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_98d5d23d-f9fe-4855-9d5c-283af8b435f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_98d5d23d-f9fe-4855-9d5c-283af8b435f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d91bbee7-9fe1-4659-a372-d0688d143869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a8f1dc76-d90a-4621-82b8-b8c6b440c33a" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d91bbee7-9fe1-4659-a372-d0688d143869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_2fd4d90d-e9aa-4de5-9cbd-23ebf864e826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_2fd4d90d-e9aa-4de5-9cbd-23ebf864e826" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_1a45f232-0d62-4aae-a632-46129d12d16a" xlink:to="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EnterpriseExcellenceMember_5aaed9b4-df65-40fd-84e6-5efeb3a718ff" xlink:href="mdt-20221028.xsd#mdt_EnterpriseExcellenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_EnterpriseExcellenceMember_5aaed9b4-df65-40fd-84e6-5efeb3a718ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SimplificationRestructuringProgramMember_8e9f4953-67a6-4cd7-abcf-cc6e6c99c35d" xlink:href="mdt-20221028.xsd#mdt_SimplificationRestructuringProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_SimplificationRestructuringProgramMember_8e9f4953-67a6-4cd7-abcf-cc6e6c99c35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportMember_87e48c6c-1a7a-48bf-b10e-2f0205259814" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bc3abf2c-bf97-41ff-85fa-b472f1f03dcb" xlink:to="loc_mdt_MechanicalCirculatorySupportMember_87e48c6c-1a7a-48bf-b10e-2f0205259814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4e429447-f835-4038-891b-79808eafadf3" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PreTaxExitandDisposalCostsMember_c39d83cd-094e-411d-902a-61a6ac15dfd3" xlink:href="mdt-20221028.xsd#mdt_PreTaxExitandDisposalCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_66922380-668f-4d7c-aa52-c87971ddec44" xlink:to="loc_mdt_PreTaxExitandDisposalCostsMember_c39d83cd-094e-411d-902a-61a6ac15dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_69aff5f9-da78-4f27-b7d2-3f1ba3a786fc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bbbfa0e7-2ff0-440d-b062-9077d3806653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_CostOfSalesMember_bbbfa0e7-2ff0-440d-b062-9077d3806653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5c0a57ad-3b77-4078-a6d9-6471851745a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5c0a57ad-3b77-4078-a6d9-6471851745a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_5dc42244-03c7-4ea7-b1dc-581ed1cff958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ea024db7-9c4f-490b-80f4-47f513970f57" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_5dc42244-03c7-4ea7-b1dc-581ed1cff958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_00f43d66-4fdd-4a95-9cd4-b67b190f7efc" xlink:to="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_9e673b0d-4d57-4420-b0ba-041cc45ddae3" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_623b5c04-00fc-41a3-857f-6b97e3a20192" xlink:to="loc_mdt_CardiovascularMember_9e673b0d-4d57-4420-b0ba-041cc45ddae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_4c173eef-f926-48ea-9b18-5f1b5561e723" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_4cfc8636-b7f3-4dc8-a07b-01ea4a9f076a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_4cfc8636-b7f3-4dc8-a07b-01ea4a9f076a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_4f7db5dd-a998-4f20-8b9a-0ed910b62ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_4f7db5dd-a998-4f20-8b9a-0ed910b62ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_73f02e64-9668-4cde-a665-ceb453565df5" xlink:href="mdt-20221028.xsd#mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact_73f02e64-9668-4cde-a665-ceb453565df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_14e04969-9070-462f-bf53-aed5c72d5ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringCharges_14e04969-9070-462f-bf53-aed5c72d5ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringWriteDownAndImpairmentProvisions_12d2d7ac-4585-4e58-b797-bee39dbed0ba" xlink:href="mdt-20221028.xsd#mdt_RestructuringWriteDownAndImpairmentProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_RestructuringWriteDownAndImpairmentProvisions_12d2d7ac-4585-4e58-b797-bee39dbed0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_470de002-f2fd-46af-9a26-46849d93442a" xlink:href="mdt-20221028.xsd#mdt_AssetImpairmentChargesAndInventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_mdt_AssetImpairmentChargesAndInventoryWriteDown_470de002-f2fd-46af-9a26-46849d93442a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6c3adf14-adf2-4b7d-a280-5c3d9f8917f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6c3adf14-adf2-4b7d-a280-5c3d9f8917f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_405ff2cf-cec6-4f9e-a539-424f56ed9226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_InventoryWriteDown_405ff2cf-cec6-4f9e-a539-424f56ed9226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_4d5c6720-2487-4d71-a490-1753b00cc25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_OtherRestructuringCosts_4d5c6720-2487-4d71-a490-1753b00cc25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_637ff324-4cad-4540-9cd5-ac5e5d0182fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringReserveCurrent_637ff324-4cad-4540-9cd5-ac5e5d0182fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_41ce5821-ef40-43ab-a343-1fe764acd487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e5c9b6ec-2277-486f-afd2-e7a91d642a07" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_41ce5821-ef40-43ab-a343-1fe764acd487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55e11901-94fb-42db-b170-e052bd5c6c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_55e11901-94fb-42db-b170-e052bd5c6c64" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4cbdca83-d1a7-43fb-8a29-8ba89d5bd1dd" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c832e97a-19a8-4266-abd0-e34200529e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c832e97a-19a8-4266-abd0-e34200529e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AssociatedCostsMember_28687a13-fcb7-459c-9d99-84dde5a7bb85" xlink:href="mdt-20221028.xsd#mdt_AssociatedCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_mdt_AssociatedCostsMember_28687a13-fcb7-459c-9d99-84dde5a7bb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_ae8b16f4-e936-4596-8ed0-876701243828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2c98e6c-fac0-4571-9e5d-0de8e12c7a01" xlink:to="loc_us-gaap_OtherRestructuringMember_ae8b16f4-e936-4596-8ed0-876701243828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5e4c3ed4-dc80-45a0-9697-3b4d6c4f9135" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78e6d370-bfd3-489d-bc61-ef0192066388" xlink:to="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_406eeb14-0f9a-45fc-842a-c1d8c20eb005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringReserve_406eeb14-0f9a-45fc-842a-c1d8c20eb005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_56922436-2805-46b3-931e-32c453b9666f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringCharges_56922436-2805-46b3-931e-32c453b9666f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4687e589-cc8e-4a05-bb8c-0f8cac494d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_PaymentsForRestructuring_4687e589-cc8e-4a05-bb8c-0f8cac494d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_52590e8d-a74f-467e-861e-39d479fc08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_52590e8d-a74f-467e-861e-39d479fc08d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_443eb051-0d11-4592-9d0b-9f2a292d1bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_20814930-9dbe-4c45-b01e-7e00b56f0e21" xlink:to="loc_us-gaap_RestructuringReserve_443eb051-0d11-4592-9d0b-9f2a292d1bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ecb40f05-cb13-4dc7-bfba-cdaf1092f71e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ecb40f05-cb13-4dc7-bfba-cdaf1092f71e" xlink:to="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_abcacfb9-e897-479a-9ae8-d5e4b5cfe719" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_52706170-29c6-4b24-a6ef-ad556edfb248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_52706170-29c6-4b24-a6ef-ad556edfb248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ee748cce-64d2-4b5a-a9dd-8cbc5d79c56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ee748cce-64d2-4b5a-a9dd-8cbc5d79c56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_0db5cf38-e9ae-4606-9c44-f63a50fc47cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_0db5cf38-e9ae-4606-9c44-f63a50fc47cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b212d2a5-63c0-4814-b127-7d8a7f4b9017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b212d2a5-63c0-4814-b127-7d8a7f4b9017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1e08747c-96b0-4cac-85b7-8a446f0edb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1e08747c-96b0-4cac-85b7-8a446f0edb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_d9d72fe6-07eb-487e-940b-567d2157b063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_d9d72fe6-07eb-487e-940b-567d2157b063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_1e3f548d-6269-4932-a778-0c9cced4825e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_747789df-dee6-43d5-92ab-41d97cc1fbc6" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_1e3f548d-6269-4932-a778-0c9cced4825e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67f6da1d-dee9-4296-8c9d-b48902fad142" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_540317eb-260a-43f3-b532-744fd1fbc55f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_540317eb-260a-43f3-b532-744fd1fbc55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_38470711-9b59-4619-8cb6-0758b46cb1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_38470711-9b59-4619-8cb6-0758b46cb1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_79ae35be-e510-48af-b157-a21793bfa6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1422e5d8-4051-4e02-8449-ea8a4a3878a0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_79ae35be-e510-48af-b157-a21793bfa6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_34d31814-d4af-4c51-a389-0b7c6ed004b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_44228ca8-6d9d-43b2-9b76-627a42948679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:to="loc_us-gaap_InvestmentsMember_44228ca8-6d9d-43b2-9b76-627a42948679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_0358f0b7-af80-4201-8b89-95a5cf4b0e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f3f8063b-f9ac-4a9e-abe1-2e8b4882a60b" xlink:to="loc_us-gaap_OtherAssetsMember_0358f0b7-af80-4201-8b89-95a5cf4b0e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsTable_c66da3a7-3431-4462-b036-e242886a1b27" xlink:to="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_79c24e23-ea43-4e71-a7e6-1097f3b96cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_79c24e23-ea43-4e71-a7e6-1097f3b96cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_793a88fc-5b4f-4344-97ef-01b1044b05e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_793a88fc-5b4f-4344-97ef-01b1044b05e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a812f468-5040-4eca-9fc7-4aa1843627cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a812f468-5040-4eca-9fc7-4aa1843627cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f1b0775e-0973-4d98-9efc-8db83e73dc14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentsLineItems_40425525-fc96-4d65-80ff-893479057aa1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_f1b0775e-0973-4d98-9efc-8db83e73dc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_72b69af5-f8a8-48ff-8a6c-94bc323a3a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_72b69af5-f8a8-48ff-8a6c-94bc323a3a78" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e7acd53-e0b0-4206-92cc-e65bd3a0eff8" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_63f7a202-ce81-4f95-95f7-fe2dd999fa9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_63f7a202-ce81-4f95-95f7-fe2dd999fa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b05de690-51f8-4f53-8590-39bb6d2eefa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b05de690-51f8-4f53-8590-39bb6d2eefa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesMember_38a17de7-727b-44b4-b0ee-58ba7fada814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_MortgageBackedSecuritiesMember_38a17de7-727b-44b4-b0ee-58ba7fada814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_3525f0f1-26e0-4c70-a12f-1fa2efb7ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_3525f0f1-26e0-4c70-a12f-1fa2efb7ce75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AuctionRateSecuritiesMember_da261ce9-e6e8-48fb-a48c-612ccce58028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AuctionRateSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f6df474-1abf-45d6-a3bb-c5865fd392e5" xlink:to="loc_us-gaap_AuctionRateSecuritiesMember_da261ce9-e6e8-48fb-a48c-612ccce58028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_692afacc-8bec-4381-a891-2f6b612939da" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:href="mdt-20221028.xsd#mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:to="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0a8ea642-fc2a-4a72-804b-739e953e635f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0a8ea642-fc2a-4a72-804b-739e953e635f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fc1566db-7b61-41e7-bfa2-7252391a74bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b018595c-7a4e-4d14-a9aa-f375458a857e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_fc1566db-7b61-41e7-bfa2-7252391a74bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_72bbc9f4-9429-4c67-b6fc-2330b0706d43" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_fa5b25dc-bb9b-4e82-a243-f6ef77ea0553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_fa5b25dc-bb9b-4e82-a243-f6ef77ea0553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_3fd69e45-8d2c-4cd0-886b-1f837972f712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4096428a-8ee8-4ae0-ad3a-6b81822a703a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_3fd69e45-8d2c-4cd0-886b-1f837972f712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_4eefb670-399f-4d0b-9e8a-f715e961805c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_3b683c3f-8cba-4cc7-8c8c-57e17addd4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4eefb670-399f-4d0b-9e8a-f715e961805c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_3b683c3f-8cba-4cc7-8c8c-57e17addd4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fc81ebe5-2f44-4eac-b425-780f39221abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_3b683c3f-8cba-4cc7-8c8c-57e17addd4ef" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fc81ebe5-2f44-4eac-b425-780f39221abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_5f90aa4a-5999-4a8c-8680-e6c458da6e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_3b683c3f-8cba-4cc7-8c8c-57e17addd4ef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_5f90aa4a-5999-4a8c-8680-e6c458da6e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_b96336d0-a803-4757-a223-e89db7a90f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract_3b683c3f-8cba-4cc7-8c8c-57e17addd4ef" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_b96336d0-a803-4757-a223-e89db7a90f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_4eefb670-399f-4d0b-9e8a-f715e961805c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ff680c33-a718-482d-925b-1b2abe5acd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ff680c33-a718-482d-925b-1b2abe5acd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a5a967c6-c3e7-4a2b-a0ec-db7dc2d4df2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a5a967c6-c3e7-4a2b-a0ec-db7dc2d4df2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_31cb3095-c8e9-404f-a9c9-88306911fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_31cb3095-c8e9-404f-a9c9-88306911fc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e865c34e-cfbb-49ec-8c03-b16f77855db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e865c34e-cfbb-49ec-8c03-b16f77855db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_030a6c93-a7ed-4d52-966c-278accc805ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_f1841286-2a9f-4805-b8af-3b2417f35e54" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_030a6c93-a7ed-4d52-966c-278accc805ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e73db05d-af82-4faf-ae85-5bb28474ae98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e73db05d-af82-4faf-ae85-5bb28474ae98" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d01f4884-9975-4ec7-9916-9bf1e7b6c624" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_ea49fcbf-c24e-432e-a6a8-2d00bafafa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_93df12af-2665-439f-b1de-60997fb39aa6" xlink:to="loc_us-gaap_OtherAssetsMember_ea49fcbf-c24e-432e-a6a8-2d00bafafa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_c5896114-9449-4fb6-93bf-1e26a559a8f6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1377d311-625a-4e19-806a-b6a298f55e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1377d311-625a-4e19-806a-b6a298f55e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_52126131-09f0-4611-a1af-20622f377437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_52126131-09f0-4611-a1af-20622f377437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_892120d1-e8fc-4777-bfe6-d3475746f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_us-gaap_EquityMethodInvestments_892120d1-e8fc-4777-bfe6-d3475746f16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_1d1d3948-a6d9-43a6-9ee2-70d1e380f30b" xlink:href="mdt-20221028.xsd#mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_709f20ed-af72-48eb-a571-06b4c814cfad" xlink:to="loc_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments_1d1d3948-a6d9-43a6-9ee2-70d1e380f30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_c7154c63-8ef0-4998-a252-3cf490f034cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_c7154c63-8ef0-4998-a252-3cf490f034cb" xlink:to="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d81b47a3-e344-4560-827a-131923193dde" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_6dfd9245-a469-4249-8b17-2d2886a67516" xlink:href="mdt-20221028.xsd#mdt_EquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e32ab9e3-7910-40d6-8441-d8bbc9fcc809" xlink:to="loc_mdt_EquityInvestmentsMember_6dfd9245-a469-4249-8b17-2d2886a67516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d66ef228-5a7b-4efc-815e-db64c0015aed" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_f60d0a6d-c87e-4dde-8a8e-1cf65cb2a924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_f60d0a6d-c87e-4dde-8a8e-1cf65cb2a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_GainonInvestments_6378e7db-3427-4b19-a1fb-cbd7e5c6823f" xlink:href="mdt-20221028.xsd#mdt_GainonInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_mdt_GainonInvestments_6378e7db-3427-4b19-a1fb-cbd7e5c6823f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossonInvestments_d23f6523-d8d1-42d2-b72d-8a0640fd9398" xlink:href="mdt-20221028.xsd#mdt_LossonInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_mdt_LossonInvestments_d23f6523-d8d1-42d2-b72d-8a0640fd9398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_972f3a9d-7d87-4e78-9168-cb25ecf2a588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_97997fde-32d5-4aa9-8dd7-de8482050b82" xlink:to="loc_us-gaap_ImpairmentOfInvestments_972f3a9d-7d87-4e78-9168-cb25ecf2a588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_6fa804ef-007e-4d1f-9c97-65d47bbf8d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_6fa804ef-007e-4d1f-9c97-65d47bbf8d2b" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d7a99b62-d481-451a-ad52-6055b329097d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EquityInvestmentsMember_6368130b-1de2-478a-8898-dbabd6d4dc61" xlink:href="mdt-20221028.xsd#mdt_EquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e4e9c502-3dc3-43cb-9512-19e519645772" xlink:to="loc_mdt_EquityInvestmentsMember_6368130b-1de2-478a-8898-dbabd6d4dc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsTable_04367e51-0228-4e3d-9e8f-a52766b8a445" xlink:to="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_de9ba53e-54ee-42c6-9940-bc1b1150742a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems_1f8fe911-d33d-45ee-8685-2d16a5853052" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_de9ba53e-54ee-42c6-9940-bc1b1150742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f6e31347-fca0-4c86-b304-ab2cf299dc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:href="mdt-20221028.xsd#mdt_ScheduleOfDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f6e31347-fca0-4c86-b304-ab2cf299dc3d" xlink:to="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_06e4a32d-7c02-4bd5-914b-feaa067de6ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2015CommercialPaperProgramMember_4c10d460-5486-4b5f-8739-0481356f4d06" xlink:href="mdt-20221028.xsd#mdt_A2015CommercialPaperProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_A2015CommercialPaperProgramMember_4c10d460-5486-4b5f-8739-0481356f4d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_4aba3f1c-c970-4e0a-b3dd-ed6f56c30e1b" xlink:href="mdt-20221028.xsd#mdt_AmendedandRestatedRevolvingCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_AmendedandRestatedRevolvingCreditAgreementMember_4aba3f1c-c970-4e0a-b3dd-ed6f56c30e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoSeniorNotesMember_0eb8b0a3-1101-48ee-a097-b2b38fc00983" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoSeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_MedtronicLuxcoSeniorNotesMember_0eb8b0a3-1101-48ee-a097-b2b38fc00983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20253500PercentMember_fb7a4df4-3c2b-4a26-b3a0-1b376ba9207b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20253500PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_SeniorNotes2015Due20253500PercentMember_fb7a4df4-3c2b-4a26-b3a0-1b376ba9207b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due20273350PercentMember_a8f2e437-7f80-4d96-a4a2-435aa4f29b2c" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2017Due20273350PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cfc03b7c-b318-42bd-a283-9eaae09ed5e6" xlink:to="loc_mdt_SeniorNotes2017Due20273350PercentMember_a8f2e437-7f80-4d96-a4a2-435aa4f29b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_f04d1a65-f039-4550-b894-da45172c8f8b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ddba0cbe-07b8-471a-bf67-0e5dfb6d3c62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:to="loc_us-gaap_CommercialPaperMember_ddba0cbe-07b8-471a-bf67-0e5dfb6d3c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_bb57fadd-2900-43ad-9b6a-8d0b0403a519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_c8f05225-e898-4470-872a-6703b0e25d42" xlink:to="loc_us-gaap_LoansPayableMember_bb57fadd-2900-43ad-9b6a-8d0b0403a519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_cfb2add0-6d48-40e3-a949-16cca6915bf2" xlink:to="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7dbf2a7d-1f3d-459b-911d-8227d0513970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_61b1b0a1-c0f8-45b6-900f-4a17b030cdd6" xlink:to="loc_us-gaap_LineOfCreditMember_7dbf2a7d-1f3d-459b-911d-8227d0513970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_582ecb15-d476-4ecd-97fa-6ddde785fe16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_9b62e28e-9364-4464-8ed1-5564fd16e953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3adb6f5d-ce90-4e1f-8b7d-f908d5798238" xlink:to="loc_us-gaap_SeniorNotesMember_9b62e28e-9364-4464-8ed1-5564fd16e953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_07f9766c-d905-4501-b221-c11eee7b1cf5" xlink:to="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06b16119-39d0-47c5-a352-bd65cf2d15ea" xlink:href="mdt-20221028.xsd#mdt_TokyoInterBankOfferedRateTIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9567e9c8-cc4d-449d-b83a-9e9bb17a1c85" xlink:to="loc_mdt_TokyoInterBankOfferedRateTIBORMember_06b16119-39d0-47c5-a352-bd65cf2d15ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_818ec4a7-6718-4ba5-b42b-1d68f514525f" xlink:to="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedtronicLuxcoMember_718c67fc-073f-4bd8-aa22-63767d5c09a7" xlink:href="mdt-20221028.xsd#mdt_MedtronicLuxcoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_4bbd534d-1d1c-42f6-9f4d-edd9bbae0edf" xlink:to="loc_mdt_MedtronicLuxcoMember_718c67fc-073f-4bd8-aa22-63767d5c09a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_ScheduleOfDebtTable_a196c5bb-e55c-487c-8f62-a64249c48da2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CommercialPaperMaximumBorrowingCapacity_bfa66fc3-bf37-4d0c-90ee-4cf6cf15b86a" xlink:href="mdt-20221028.xsd#mdt_CommercialPaperMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_mdt_CommercialPaperMaximumBorrowingCapacity_bfa66fc3-bf37-4d0c-90ee-4cf6cf15b86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_cb21fe49-0c47-4021-b987-44c849b04cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtCurrent_cb21fe49-0c47-4021-b987-44c849b04cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a7184c7e-c307-46b2-882f-3d681f8acde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentTerm_a7184c7e-c307-46b2-882f-3d681f8acde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_a52add73-5778-40db-8a52-70c214f6e7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_a52add73-5778-40db-8a52-70c214f6e7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a3b610c0-4b64-4604-a1c7-021c446ca1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a3b610c0-4b64-4604-a1c7-021c446ca1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fb330649-0462-4f68-932b-1b3bebbace59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LineOfCredit_fb330649-0462-4f68-932b-1b3bebbace59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_57c7bd75-2f0b-4329-87e1-491b2931827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_57c7bd75-2f0b-4329-87e1-491b2931827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfDebt_666f164d-3a83-44ab-a4d4-b900ec50698b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfDebt_666f164d-3a83-44ab-a4d4-b900ec50698b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5fe5de2-b76b-4524-8f19-d99a98af378b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a5fe5de2-b76b-4524-8f19-d99a98af378b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_e903342a-3b85-4d46-b733-9e070b43ea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_e903342a-3b85-4d46-b733-9e070b43ea99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_cfc8f556-a586-4cd0-82de-d1af36287bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_cfc8f556-a586-4cd0-82de-d1af36287bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0a6c66b-87a1-425b-92d2-0edc9bba1007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0a6c66b-87a1-425b-92d2-0edc9bba1007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_125ab0ab-e8f8-4887-8af7-522a2cb09ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_RepaymentsOfDebt_125ab0ab-e8f8-4887-8af7-522a2cb09ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_586052dc-eb23-4ba1-a0eb-6fd61c3ed8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_586052dc-eb23-4ba1-a0eb-6fd61c3ed8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_dd6dc960-b9d1-444a-a5b5-3b303f892b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5f3ce19-40e6-4766-b9cb-eff1fd3abb1b" xlink:to="loc_us-gaap_LongTermDebtFairValue_dd6dc960-b9d1-444a-a5b5-3b303f892b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#FinancingArrangementsLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_01123cbc-6fb8-4f10-86d4-46f937c3af7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_01123cbc-6fb8-4f10-86d4-46f937c3af7d" xlink:to="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_800773f5-9cc8-46a8-83e0-42a79e1ca0ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d91884d7-cc9f-4c7f-abe6-4b417bc54100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b5b9b907-d377-43ed-ba4e-e51edf22bed1" xlink:to="loc_us-gaap_SeniorNotesMember_d91884d7-cc9f-4c7f-abe6-4b417bc54100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6a83693-09ed-4904-ada1-bdcb9be47712" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20253500PercentMember_57b16b84-ac80-4268-b675-8b4048dc9d43" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20253500PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2015Due20253500PercentMember_57b16b84-ac80-4268-b675-8b4048dc9d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20260250PercentMember_7095c46d-92cf-4295-b8c6-d3537b067fbb" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20260250PercentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20260250PercentMember_7095c46d-92cf-4295-b8c6-d3537b067fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember_5d848a87-03ff-44d3-893f-6ebaab027023" xlink:href="mdt-20221028.xsd#mdt_A2265PercentThreeYear2022SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A2265PercentThreeYear2022SeniorNotesMember_5d848a87-03ff-44d3-893f-6ebaab027023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20260000PercentMember_28546e3d-a416-446f-a03f-f07bc19cc342" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20260000PercentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20260000PercentMember_28546e3d-a416-446f-a03f-f07bc19cc342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20271125PercentMember_290efbd3-ce46-4aee-9d37-c8f1474d9d28" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20271125PercentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20271125PercentMember_290efbd3-ce46-4aee-9d37-c8f1474d9d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2017Due20273350PercentMember_d58cede4-18b0-4f5f-844b-cfca6740030d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2017Due20273350PercentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2017Due20273350PercentMember_d58cede4-18b0-4f5f-844b-cfca6740030d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3000PercentSixYear2022SeniorNotesMember_ea7563fa-7fa5-4912-89ba-8250896d74c5" xlink:href="mdt-20221028.xsd#mdt_A3000PercentSixYear2022SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3000PercentSixYear2022SeniorNotesMember_ea7563fa-7fa5-4912-89ba-8250896d74c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20290375PercentMember_cc513e55-278f-4494-8fea-82d3afa80493" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20290375PercentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20290375PercentMember_cc513e55-278f-4494-8fea-82d3afa80493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20311625PercentMember_46707d9e-4ff6-41ad-9e62-ab31087b19cb" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20311625PercentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20311625PercentMember_46707d9e-4ff6-41ad-9e62-ab31087b19cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20321000PercentMember_a57c31e5-97c9-4de2-af52-72a13d2f1681" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20321000PercentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20321000PercentMember_a57c31e5-97c9-4de2-af52-72a13d2f1681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3125PercentNineYear2022SeniorNotesMember_c06c3d28-ec92-48f8-8475-dee7cf819be5" xlink:href="mdt-20221028.xsd#mdt_A3125PercentNineYear2022SeniorNotesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3125PercentNineYear2022SeniorNotesMember_c06c3d28-ec92-48f8-8475-dee7cf819be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20330750PercentMember_006ee99c-abc0-42f8-98ce-cb12b8ebb284" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20330750PercentMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20330750PercentMember_006ee99c-abc0-42f8-98ce-cb12b8ebb284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember_ae3f137e-b11a-4e6a-bcf3-bccf0bc1a761" xlink:href="mdt-20221028.xsd#mdt_A3375PercentTwelveYear2022SeniorNotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A3375PercentTwelveYear2022SeniorNotesMember_ae3f137e-b11a-4e6a-bcf3-bccf0bc1a761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20354375PercentMember_060c13b1-3fb9-497b-9dee-4f3d5872280b" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20354375PercentMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20354375PercentMember_060c13b1-3fb9-497b-9dee-4f3d5872280b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_47324f24-0380-4e5a-96e9-65c45ce1c94b" xlink:href="mdt-20221028.xsd#mdt_A2007CIFSASeniorNotesDue20386550PercentMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_A2007CIFSASeniorNotesDue20386550PercentMember_47324f24-0380-4e5a-96e9-65c45ce1c94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20392250PercentMember_ece257b1-ea1a-42f2-96a3-cb04a5b7daa8" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20392250PercentMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20392250PercentMember_ece257b1-ea1a-42f2-96a3-cb04a5b7daa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2009Due20396500PercentMember_b0b2ed2d-cfb1-45a2-a089-16214624359e" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2009Due20396500PercentMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2009Due20396500PercentMember_b0b2ed2d-cfb1-45a2-a089-16214624359e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20401500PercentMember_ba2ac0e1-371a-4bf9-bfcf-df7556d32c95" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20401500PercentMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20401500PercentMember_ba2ac0e1-371a-4bf9-bfcf-df7556d32c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2010Due20405550PercentMember_40db53c6-c13f-46ab-9867-1c7c8cb1a703" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2010Due20405550PercentMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2010Due20405550PercentMember_40db53c6-c13f-46ab-9867-1c7c8cb1a703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20411375PercentMember_ddf53b1c-f30b-4a0f-8bfc-a3cceabf7f02" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20411375PercentMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20411375PercentMember_ddf53b1c-f30b-4a0f-8bfc-a3cceabf7f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2012Due20424500PercentMember_d6180eb3-bb6d-45f4-80a0-bb7168d6742d" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2012Due20424500PercentMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2012Due20424500PercentMember_d6180eb3-bb6d-45f4-80a0-bb7168d6742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2013Due20434000PercentMember_8d0698bd-8c38-409a-9494-216beadbff05" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2013Due20434000PercentMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2013Due20434000PercentMember_8d0698bd-8c38-409a-9494-216beadbff05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2014Due20444625PercentMember_7f9db12c-81f0-4f55-9bb7-977bf6ff04a2" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2014Due20444625PercentMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2014Due20444625PercentMember_7f9db12c-81f0-4f55-9bb7-977bf6ff04a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2015Due20454625PercentMember_5110a103-2ea5-4b8f-96cd-267b9c63efbd" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2015Due20454625PercentMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2015Due20454625PercentMember_5110a103-2ea5-4b8f-96cd-267b9c63efbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2019Due20501750PercentMember_9aceeadd-18a4-4399-94b6-fc0e14d6f486" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2019Due20501750PercentMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2019Due20501750PercentMember_9aceeadd-18a4-4399-94b6-fc0e14d6f486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SeniorNotes2020Due20511625PercentMember_242a07d3-9322-4231-abb1-9e5bc07a1267" xlink:href="mdt-20221028.xsd#mdt_SeniorNotes2020Due20511625PercentMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e6f9af37-63ca-483b-bb2c-aa5e35d51da7" xlink:to="loc_mdt_SeniorNotes2020Due20511625PercentMember_242a07d3-9322-4231-abb1-9e5bc07a1267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_52be356c-c9e0-4635-84a7-5e75440b3c5f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_debce659-040b-4bb2-ae81-b20b4e605694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:to="loc_us-gaap_DebtCurrent_debce659-040b-4bb2-ae81-b20b4e605694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ba9f6cb1-f1e5-4372-93d2-01caf2f5bb14" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e2d47c5-2e0b-40ba-a816-7868896d4efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8e2d47c5-2e0b-40ba-a816-7868896d4efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_77ffeac0-6033-49a9-8ac5-fd354d224a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentTerm_77ffeac0-6033-49a9-8ac5-fd354d224a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5827abcf-10bc-4c4b-975b-2ca5bd022de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5827abcf-10bc-4c4b-975b-2ca5bd022de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ccdcfb11-12d7-4c53-a8c0-8251ff975a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ccdcfb11-12d7-4c53-a8c0-8251ff975a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9c6cbcaa-b35e-4030-ab0b-bff1320162c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9c6cbcaa-b35e-4030-ab0b-bff1320162c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_933f87ea-af13-4054-8423-613252dbf210" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_933f87ea-af13-4054-8423-613252dbf210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c2563afa-d680-4a97-96ad-84fb4e626fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_6816bc2a-4e6c-45aa-b3a5-49ffdda631f3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c2563afa-d680-4a97-96ad-84fb4e626fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_50e7b6f4-48c0-4f44-8f6c-f9a1c63e5e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_50e7b6f4-48c0-4f44-8f6c-f9a1c63e5e70" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_23bc4db7-b86b-43a4-b03d-1539db9edf45" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9c14661f-9a02-42bc-bbff-98c8f0082327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9c14661f-9a02-42bc-bbff-98c8f0082327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_aa500dac-1130-447b-b25e-3a4536da2ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_45275f67-5905-4716-b40c-6672abad68c1" xlink:to="loc_us-gaap_TotalReturnSwapMember_aa500dac-1130-447b-b25e-3a4536da2ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3e978d1f-6d42-4c34-9265-33a271a0b18b" xlink:to="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_69296336-f73d-4d59-ba3d-8a679b84ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:to="loc_us-gaap_NondesignatedMember_69296336-f73d-4d59-ba3d-8a679b84ed37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_72644963-9fc5-40c3-a2ca-dd4c46a91b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_813895bd-27b1-4f65-8990-0288e6a4c4af" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_72644963-9fc5-40c3-a2ca-dd4c46a91b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9b00119-d196-4de4-9c6b-518195d06c16" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_098ca7ef-d192-48a4-912c-4f6f191ee4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:to="loc_us-gaap_CashFlowHedgingMember_098ca7ef-d192-48a4-912c-4f6f191ee4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_d7bb7cb3-1e93-456e-b23d-5db0728db1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_e40026eb-6b3a-4df9-b674-f126e0128ac1" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_d7bb7cb3-1e93-456e-b23d-5db0728db1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_d50383fb-a671-414c-b8d1-d656f83c814b" xlink:to="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_864906d5-53d7-4317-ab43-209bbd6ebe1c" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:to="loc_currency_EUR_864906d5-53d7-4317-ab43-209bbd6ebe1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_1fc68339-85f0-4b0f-9b20-7ec6b658cd38" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_b20ec9f7-2217-4726-b7dd-3a1303bd8aef" xlink:to="loc_currency_JPY_1fc68339-85f0-4b0f-9b20-7ec6b658cd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_b98f2fa0-64d6-410e-8bbc-cf7af733dce1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2ffdf57e-d832-4956-a6e7-e580cec423cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2ffdf57e-d832-4956-a6e7-e580cec423cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_88bcfce3-ebfe-4696-9fc7-52c6e67d0472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_88bcfce3-ebfe-4696-9fc7-52c6e67d0472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_0cd062bb-a053-46be-9ca8-010aa18462d8" xlink:href="mdt-20221028.xsd#mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax_0cd062bb-a053-46be-9ca8-010aa18462d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_39c35102-7dfc-4325-abfd-369f24f841a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_39c35102-7dfc-4325-abfd-369f24f841a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_92995b06-fcdc-4b83-a668-51d097a53c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2cc101b1-2a1a-45a8-b90c-9b52613b51d5" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_92995b06-fcdc-4b83-a668-51d097a53c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e1844a53-df89-4526-9836-0af470c49caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e1844a53-df89-4526-9836-0af470c49caf" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f4cc62ce-b484-49c3-b3c9-611c02441082" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3d5f8284-c743-4e27-8e16-29520f3f78ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3d5f8284-c743-4e27-8e16-29520f3f78ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NonDerivativeInstrumentsMember_668b66c1-fc76-4fdd-b8f2-3eb8d56eb60b" xlink:href="mdt-20221028.xsd#mdt_NonDerivativeInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_95f862f0-ff38-44e6-8f3b-59435c8d41b4" xlink:to="loc_mdt_NonDerivativeInstrumentsMember_668b66c1-fc76-4fdd-b8f2-3eb8d56eb60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b17669a4-0132-46d5-bf3b-ce3f470b5696" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_924fb15d-b948-4442-a91c-fc8267ed3ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_924fb15d-b948-4442-a91c-fc8267ed3ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7a779805-968e-49c0-b522-6b3e97632981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e093f5a9-4ea3-43ff-aaec-3729575c083e" xlink:to="loc_us-gaap_CostOfSalesMember_7a779805-968e-49c0-b522-6b3e97632981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e3fddaab-02b9-4e14-9c02-e8cae69b0786" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_77b83a31-cf06-4484-89b6-138db0a7776d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_77b83a31-cf06-4484-89b6-138db0a7776d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_679c2298-1b85-45bc-8f86-75cbca8c790c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_679c2298-1b85-45bc-8f86-75cbca8c790c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bff0690a-4010-45a7-a9ce-b9655d6ee2b8" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax_bff0690a-4010-45a7-a9ce-b9655d6ee2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6dda7961-6f90-4aea-a541-71352bb1e7fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_6dda7961-6f90-4aea-a541-71352bb1e7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cdf2cec7-d2ab-4bef-b7cf-c03edbf19c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_cdf2cec7-d2ab-4bef-b7cf-c03edbf19c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_3eb0c5ed-4d0f-410e-8fd7-866d09ada0e5" xlink:href="mdt-20221028.xsd#mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_7710c414-7e4f-4a12-9597-bc568d733214" xlink:to="loc_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax_3eb0c5ed-4d0f-410e-8fd7-866d09ada0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5490b9e1-69e3-46a5-8aff-125a94a2a381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5490b9e1-69e3-46a5-8aff-125a94a2a381" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_22f9a730-4daa-45c1-99fb-29510d08d0e8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_b1f90b7a-45ce-49a8-84a2-e8c9b72b7331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d4174f96-e3f4-49c0-8fad-b55d8ea612ad" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_b1f90b7a-45ce-49a8-84a2-e8c9b72b7331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d5c41a34-6e6e-4b2e-bcc5-23cb8b976511" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8de609a4-94d1-4a3d-af50-500a37c98f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8de609a4-94d1-4a3d-af50-500a37c98f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_fb8f59d8-893b-4f45-8f6b-5af978f72e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e72df0e3-cbac-42fa-8c45-972f4b6250ba" xlink:to="loc_us-gaap_TotalReturnSwapMember_fb8f59d8-893b-4f45-8f6b-5af978f72e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4cc832ca-fa6a-492a-9ec5-3d60d8bbef05" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_f7f78184-c8b1-42dd-af2f-4739a23ffeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_013ba6aa-aa01-415d-b53a-38332cbed257" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_f7f78184-c8b1-42dd-af2f-4739a23ffeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01f964b4-dafa-4223-b92d-f1e5413e5e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01f964b4-dafa-4223-b92d-f1e5413e5e23" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e374c74-7c0b-4e69-a4a5-cf63202d4d08" xlink:to="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a2f06bc8-ef47-406d-a513-1090f754a39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a2f06bc8-ef47-406d-a513-1090f754a39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_81278a5b-cd9f-4300-bfa2-5f959522f6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f50b8e27-0eee-446b-b82e-4cea141c6adc" xlink:to="loc_us-gaap_NondesignatedMember_81278a5b-cd9f-4300-bfa2-5f959522f6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d6e55077-df7e-4d6b-b514-0cee9c249549" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9e748365-5e7d-4e2d-9c20-21b0c460264c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9e748365-5e7d-4e2d-9c20-21b0c460264c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_ad694fa0-d6da-4c8f-8c81-f1b264e10516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_33b322f3-84fd-4922-91eb-f6f541ff5ed7" xlink:to="loc_us-gaap_TotalReturnSwapMember_ad694fa0-d6da-4c8f-8c81-f1b264e10516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6be199bb-d36c-49a6-b460-cd19d65472e7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fdb7425e-9872-40c0-8340-0026d7db9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fdb7425e-9872-40c0-8340-0026d7db9f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_7e2e5a98-655e-4444-a7fa-9fc2a38cce2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_OtherAssetsMember_7e2e5a98-655e-4444-a7fa-9fc2a38cce2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OtherAccruedExpensesMember_dd7b87db-7670-4e8b-9e09-075ddd63402e" xlink:href="mdt-20221028.xsd#mdt_OtherAccruedExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_mdt_OtherAccruedExpensesMember_dd7b87db-7670-4e8b-9e09-075ddd63402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_3b56a627-b152-4a62-b83e-d45e7862be38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a49a4e4b-c780-40be-ba29-2a0eb9a5a114" xlink:to="loc_us-gaap_OtherLiabilitiesMember_3b56a627-b152-4a62-b83e-d45e7862be38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_37454438-96ce-43c2-a5e4-910532416c4c" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1fc3580e-c73e-426e-907d-dab7fb3e19fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1fc3580e-c73e-426e-907d-dab7fb3e19fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd51c3e-298b-4ebc-aa5c-febf1dceccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_c204bc98-bb38-4553-918f-696be3d47dc9" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ddd51c3e-298b-4ebc-aa5c-febf1dceccd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b67c18a4-9b53-4e28-b1ca-10f07ad9b596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b67c18a4-9b53-4e28-b1ca-10f07ad9b596" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e41ebb87-95f0-41b6-8b0a-b3fbfada5518" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_c06657c4-ef14-477e-8cc1-20e73c958733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_c06657c4-ef14-477e-8cc1-20e73c958733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_124b9744-4c9e-4403-9560-c789c669f425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c039699b-c8d9-49c2-9b45-5b1c4a7b2c9f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_124b9744-4c9e-4403-9560-c789c669f425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f47b645-3135-447f-afde-073f38096ed9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_19cd0765-906c-4cd8-93f2-8f9aa9c5740d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:to="loc_us-gaap_DerivativeAssets_19cd0765-906c-4cd8-93f2-8f9aa9c5740d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0a91fcd1-7939-487b-82e5-6f40e40f2d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_475892c5-32f7-41bf-aaed-e43ef287c4a7" xlink:to="loc_us-gaap_DerivativeLiabilities_0a91fcd1-7939-487b-82e5-6f40e40f2d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8391f5bf-91ab-4707-bb1b-e3dc87e22549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8391f5bf-91ab-4707-bb1b-e3dc87e22549" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7bd25360-a49a-433f-82ec-c1c4f9344e0a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_35d8adf7-dc13-469f-a54f-c826d70b0bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_35d8adf7-dc13-469f-a54f-c826d70b0bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TotalReturnSwapMember_37767fd0-6210-4e69-b915-5e9fb0633b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TotalReturnSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0265bbe1-cfe4-48c7-9217-484b2f3f546f" xlink:to="loc_us-gaap_TotalReturnSwapMember_37767fd0-6210-4e69-b915-5e9fb0633b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:href="mdt-20221028.xsd#mdt_OffsettingAssetsandLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesTable_9b2bd7bf-8458-49ce-977b-582268afe101" xlink:to="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_629489b8-7493-47c3-8b5d-5925a97fe253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_629489b8-7493-47c3-8b5d-5925a97fe253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_23e97f3f-e8ef-4fc9-89be-e317cb545421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction_23e97f3f-e8ef-4fc9-89be-e317cb545421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_02e2a11d-332c-4256-8545-4767509b4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_02e2a11d-332c-4256-8545-4767509b4a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_02a1282e-e982-4b6d-b325-a822a2e53dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_1723a1c8-da3d-4ef1-a2d4-d745dec556e2" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_02a1282e-e982-4b6d-b325-a822a2e53dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5d0ae346-22ac-4451-b39c-a81fe5e7ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_5d0ae346-22ac-4451-b39c-a81fe5e7ec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_fd1befe6-c94e-4fca-9b2f-aaba0015b499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction_fd1befe6-c94e-4fca-9b2f-aaba0015b499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_90c2d8d8-a859-4a1d-86b1-46ee6c55db28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_90c2d8d8-a859-4a1d-86b1-46ee6c55db28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f4fb3b72-1851-457f-a8c4-af5c504c1ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_d1d9e1ad-a55a-40c6-b5c5-1d29a7a576cb" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f4fb3b72-1851-457f-a8c4-af5c504c1ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OffsettingAssetsandLiabilitiesLineItems_38030438-37f9-48b8-8d0d-07b52cf9ad7a" xlink:to="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_8990144d-046e-4c38-ad87-3cf00d1777db" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability_8990144d-046e-4c38-ad87-3cf00d1777db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_488e45e3-ec3a-49e6-b2a2-60f7ca64c950" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction_488e45e3-ec3a-49e6-b2a2-60f7ca64c950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_4cd66c37-be2c-4422-85f5-4f10f7dfc5df" xlink:href="mdt-20221028.xsd#mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash_4cd66c37-be2c-4422-85f5-4f10f7dfc5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_0dc8b1cd-aaa7-461a-8210-2e37cdfc20cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_DerivativeAssetLiabilityAbstract_c5aed7b2-a568-41d0-9b4b-4291523b1922" xlink:to="loc_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet_0dc8b1cd-aaa7-461a-8210-2e37cdfc20cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="mdt-20221028.xsd#DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medtronic.com/role/InventoriesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c3d7feb4-f6bd-4725-829f-85ff85f1570f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_40a8b7c8-0550-494f-88f5-9ffd75a982a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c3d7feb4-f6bd-4725-829f-85ff85f1570f" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_40a8b7c8-0550-494f-88f5-9ffd75a982a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7fd6fe18-6063-400f-9969-c6dd589877f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c3d7feb4-f6bd-4725-829f-85ff85f1570f" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7fd6fe18-6063-400f-9969-c6dd589877f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_728bde26-ae42-4fda-bf53-056af5110c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c3d7feb4-f6bd-4725-829f-85ff85f1570f" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_728bde26-ae42-4fda-bf53-056af5110c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ece046ef-1548-448f-bd7b-24e751aeea08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c3d7feb4-f6bd-4725-829f-85ff85f1570f" xlink:to="loc_us-gaap_InventoryNet_ece046ef-1548-448f-bd7b-24e751aeea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d42eab1-e641-47b2-86a1-37766ac80642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6d42eab1-e641-47b2-86a1-37766ac80642" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91e38c50-d331-4357-b92f-e2e769c0c0ba" xlink:to="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_5d5d3909-7798-4345-a4d4-41c8af8aabe9" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_CardiovascularMember_5d5d3909-7798-4345-a4d4-41c8af8aabe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_7513bf9f-8703-41d3-88ec-0cfade5b33b5" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_MedicalSurgicalMember_7513bf9f-8703-41d3-88ec-0cfade5b33b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_fe56ef55-62b9-4635-85e5-b2f1d22f5b26" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_NeuroscienceGroupMember_fe56ef55-62b9-4635-85e5-b2f1d22f5b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_142f5c84-665d-4714-9b33-32fcfbbf39e2" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_78439334-211f-4ad1-9470-1b6abf745010" xlink:to="loc_mdt_DiabetesGroupMember_142f5c84-665d-4714-9b33-32fcfbbf39e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5f25497f-26be-4b14-9af8-3c80b0762ec6" xlink:to="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2525b87e-8ff6-4c36-9255-bd329d1705bb" xlink:to="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f901e65c-d835-4f8d-a68e-2bb06b5162ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_Goodwill_f901e65c-d835-4f8d-a68e-2bb06b5162ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b5d20dd9-8b52-4cb2-8a9f-ef3af73ef69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b5d20dd9-8b52-4cb2-8a9f-ef3af73ef69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9f55cba5-c5d6-4422-b81f-fb7eae086c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9f55cba5-c5d6-4422-b81f-fb7eae086c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_60ffb392-b909-4633-bc6d-3af336a46fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillTransfers_60ffb392-b909-4633-bc6d-3af336a46fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_21439f21-acad-45d1-8e50-9b515fff4510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_21439f21-acad-45d1-8e50-9b515fff4510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5aad9077-877d-4ada-bfe8-04b8572de8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ff7c99f6-9cd8-409b-bfdd-c65c671b6c0c" xlink:to="loc_us-gaap_Goodwill_5aad9077-877d-4ada-bfe8-04b8572de8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ad5da3b3-de46-4045-96f1-47952c5a7dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ad5da3b3-de46-4045-96f1-47952c5a7dde" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ab810776-4930-4cbb-9234-6d4e38b8192e" xlink:to="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_5e9b9414-c056-460a-a54b-ef0503a5b792" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_647accb2-753f-4493-a562-3cb880459ba6" xlink:to="loc_mdt_MedicalSurgicalMember_5e9b9414-c056-460a-a54b-ef0503a5b792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2bad672e-1c49-48d3-ae0d-55fc9c06cbdf" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RenalCareBusinessRCSMember_df445c88-e052-40d3-9f06-9a096cbb6882" xlink:href="mdt-20221028.xsd#mdt_RenalCareBusinessRCSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_83e152c8-2e86-42dd-b57b-cbe8191af4f2" xlink:to="loc_mdt_RenalCareBusinessRCSMember_df445c88-e052-40d3-9f06-9a096cbb6882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_147daa4c-dedb-4927-ab10-a07380039f60" xlink:to="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_950485be-e0fc-4142-bef7-69dda4060e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_950485be-e0fc-4142-bef7-69dda4060e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2dd8bdfe-5f07-4e0e-a627-4aa16867d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2dd8bdfe-5f07-4e0e-a627-4aa16867d77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b7421472-4c39-49fb-8952-ac959c8c92c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b7421472-4c39-49fb-8952-ac959c8c92c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4baccd5b-c533-4a89-8a09-bcf7e77980d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4baccd5b-c533-4a89-8a09-bcf7e77980d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_00f7590e-b785-4b68-9724-d02a03d386ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_27716fca-b7c2-4df2-a713-b7baee492802" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_00f7590e-b785-4b68-9724-d02a03d386ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f21d0e0-6bf0-4ea7-987d-330c3e67cbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f21d0e0-6bf0-4ea7-987d-330c3e67cbba" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c677188c-3049-45a5-a80f-c299e70375b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_bf68aa78-fa2c-4444-83a4-ade7a80d9ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_bf68aa78-fa2c-4444-83a4-ade7a80d9ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PurchasedTechnologyAndPatentsMember_d4349887-e55a-4876-b7de-b57d65995bc4" xlink:href="mdt-20221028.xsd#mdt_PurchasedTechnologyAndPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_mdt_PurchasedTechnologyAndPatentsMember_d4349887-e55a-4876-b7de-b57d65995bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f7402fd6-354f-4df9-9582-b07768006ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f7402fd6-354f-4df9-9582-b07768006ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_e175dce3-a7ae-42d0-b467-f4480a8bf5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d919e8d-3839-4c1c-b961-5d3dce4d2f01" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_e175dce3-a7ae-42d0-b467-f4480a8bf5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fbffb635-068a-4ae7-910f-fa4acc6051f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32225121-b53c-4b5f-ac89-4336c8214b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32225121-b53c-4b5f-ac89-4336c8214b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_376c69d6-442a-483f-8858-17e5d2f53011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_279f96a5-3c9e-4186-b247-17b481ccc483" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_376c69d6-442a-483f-8858-17e5d2f53011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f21d0e0-6bf0-4ea7-987d-330c3e67cbba" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3c7c0ef7-f49c-40b3-92f7-1a8b5bac4a9d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61baf7c-6206-4438-9188-9893614025f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d82405ed-b005-4fb6-b628-cc0d995600ea" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e61baf7c-6206-4438-9188-9893614025f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0e510f8b-e483-4056-a61e-743815f37db8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ffa85569-f445-429d-ab24-718a4bc3d966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0635a45c-ad5c-4c99-ba34-c5784bd0b94f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ffa85569-f445-429d-ab24-718a4bc3d966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6a038ab1-0484-48c1-8e81-10a73ff26159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6a038ab1-0484-48c1-8e81-10a73ff26159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_16382342-45ad-451f-9fc6-8d03040327d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_16382342-45ad-451f-9fc6-8d03040327d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1d159805-2c76-4619-a02b-e90da66571bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1d159805-2c76-4619-a02b-e90da66571bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_285cedc5-6a01-451e-80f8-5efb2a31ae39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_285cedc5-6a01-451e-80f8-5efb2a31ae39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_02d06d22-e4f7-45e3-ba18-1fee8cff6768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_02d06d22-e4f7-45e3-ba18-1fee8cff6768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aadb31fe-e68a-4204-b6b8-7d0cab820367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8a3a924c-dc50-4c31-baa8-224b054c6a38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aadb31fe-e68a-4204-b6b8-7d0cab820367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_ace34699-714e-4684-a859-ee75461330e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_ace34699-714e-4684-a859-ee75461330e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e7c0f927-1f9a-4dd6-b90c-23642cfa26d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e7c0f927-1f9a-4dd6-b90c-23642cfa26d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4adec0e9-9227-430a-85fa-1f7912e4814b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4adec0e9-9227-430a-85fa-1f7912e4814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_373953d1-93a7-4751-9fbb-b5a77d0fa0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_373953d1-93a7-4751-9fbb-b5a77d0fa0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_349bed3f-aa68-4552-9de2-acf464f9b1f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_349bed3f-aa68-4552-9de2-acf464f9b1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_6666ee4d-6f4a-4211-a6d4-7c0af69c8ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d2f84fbc-777c-4451-ae29-82c25d215f3d" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_6666ee4d-6f4a-4211-a6d4-7c0af69c8ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c5d1c917-6bab-404f-adc5-165c38de0391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_28f7228d-0a9c-41e3-a83c-5952fe6fd498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c5d1c917-6bab-404f-adc5-165c38de0391" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_28f7228d-0a9c-41e3-a83c-5952fe6fd498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_28f7228d-0a9c-41e3-a83c-5952fe6fd498" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:to="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_84cdc77a-082c-40db-bf4b-ddd3dd4aa7ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2b72a143-9333-45db-b74d-171f44ed33c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2b72a143-9333-45db-b74d-171f44ed33c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fee4766d-7f8e-442d-80d3-1d753753bce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fee4766d-7f8e-442d-80d3-1d753753bce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_94fdf60d-ecfb-4b97-a09f-e7a1d8b6c2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a7e8310-84d1-4062-8bbc-2d8885af7fda" xlink:to="loc_us-gaap_PerformanceSharesMember_94fdf60d-ecfb-4b97-a09f-e7a1d8b6c2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_2e85ca4e-7f51-4b37-8a22-bcc4379d4181" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationNumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:to="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a6bc649b-277e-4f4e-acf1-9a570770dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationNumeratorAbstract_42d1f425-152e-461a-859f-4dee7bd5c17f" xlink:to="loc_us-gaap_NetIncomeLoss_a6bc649b-277e-4f4e-acf1-9a570770dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:href="mdt-20221028.xsd#mdt_EarningsPerShareReconciliationDenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_57ef6196-5d14-4d32-89ce-1490074318a5" xlink:to="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31fce39a-9667-422f-a4b9-79b43fb449d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_31fce39a-9667-422f-a4b9-79b43fb449d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05e83023-c868-4832-9106-c062c9017985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_05e83023-c868-4832-9106-c062c9017985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_dc1cf35b-8a8e-4ebd-aa44-b61fbca864ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5034e310-b784-4135-bd12-0c455cf36b9e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends_dc1cf35b-8a8e-4ebd-aa44-b61fbca864ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f45c497-f661-46be-8e81-852dbf750e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f45c497-f661-46be-8e81-852dbf750e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_253ba39e-b23c-4170-93f8-fc8b5950fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_EarningsPerShareBasic_253ba39e-b23c-4170-93f8-fc8b5950fb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_21319e20-51aa-4d36-b36f-765fb29e4289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_EarningsPerShareReconciliationDenominatorAbstract_72c070e4-353b-4677-b98d-9df53eb31a5c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_21319e20-51aa-4d36-b36f-765fb29e4289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#EarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/EarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_424c3e75-c3c0-4f47-8b15-33fcc7eefdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_424c3e75-c3c0-4f47-8b15-33fcc7eefdb2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f81015e4-1b3e-42ab-ac7f-cb0ca6d110b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_51a23946-07f2-4ce7-ace3-05e12b27af5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_96bd18a2-cacc-4130-a4e4-c8022c2c90e8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_51a23946-07f2-4ce7-ace3-05e12b27af5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c4decc08-c4c6-4066-b0cd-3e722b71df79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_80ed0d36-7e14-4a97-8f31-c4f9e76c87de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_3ed20bcc-13e5-4ad3-a6f7-da153094071c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_80ed0d36-7e14-4a97-8f31-c4f9e76c87de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb6ca6be-a0c5-4dbf-af4a-de45a86ea703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb6ca6be-a0c5-4dbf-af4a-de45a86ea703" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:to="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_932756ea-535e-4db2-b22b-dd27b5d36654" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0434cc64-d306-4590-81e7-f99bb1cd81d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0434cc64-d306-4590-81e7-f99bb1cd81d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_920b1bde-2141-4302-81dc-16a8cef169c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_920b1bde-2141-4302-81dc-16a8cef169c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_76dbea58-7ecd-484e-ac2f-2dd41e4ba5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_us-gaap_PerformanceSharesMember_76dbea58-7ecd-484e-ac2f-2dd41e4ba5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_EmployeesStockPurchasePlanMember_6398999f-5aa3-4e9e-9b37-3cb1eb40c7e3" xlink:href="mdt-20221028.xsd#mdt_EmployeesStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e9eba1f8-fed6-4703-98fd-e8fc51d197f2" xlink:to="loc_mdt_EmployeesStockPurchasePlanMember_6398999f-5aa3-4e9e-9b37-3cb1eb40c7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0ce663cd-efd1-4813-980b-f0645eecbd7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_991d1cda-2f11-4478-a108-120e596e33f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_CostOfSalesMember_991d1cda-2f11-4478-a108-120e596e33f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd8683f8-2df9-401b-b585-fcce8cfa3231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fd8683f8-2df9-401b-b585-fcce8cfa3231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_21023252-5622-49a3-a689-bcd9957a081d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_08677eff-86df-4a82-b926-117a3e0ba9e6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_21023252-5622-49a3-a689-bcd9957a081d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dff99bfb-e34d-4d89-88ef-ab9ceb536e70" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7cc5fb6-7542-45db-a4ef-c0b420a08a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c7cc5fb6-7542-45db-a4ef-c0b420a08a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f2a82da3-71ad-418a-9ffa-0840fb086d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f2a82da3-71ad-418a-9ffa-0840fb086d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3b514046-8ead-4887-9915-dc93499fd6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6782170f-032b-4961-919a-9e9ad0c9df6b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_3b514046-8ead-4887-9915-dc93499fd6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0803ed3d-df4b-4bed-bfcb-4c2d0b914cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0803ed3d-df4b-4bed-bfcb-4c2d0b914cea" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_90d56096-f4c0-46c8-8f49-5da93392322c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:to="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3ee4de36-b7fa-4d49-834f-4c8f6a339e7d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_ead15ab8-6afc-4f31-85fa-3f157de03be0" xlink:to="loc_country_US_3ee4de36-b7fa-4d49-834f-4c8f6a339e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:href="mdt-20221028.xsd#mdt_OutsideOfTheUnitedStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_93789e85-897c-4c7b-952e-c5a63ed42bbd" xlink:to="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_d1adc657-b995-40fd-84d3-fe8fc2929245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_OutsideOfTheUnitedStatesMember_d433e59c-028e-461c-8df3-9f2ef8807b26" xlink:to="loc_us-gaap_ForeignPlanMember_d1adc657-b995-40fd-84d3-fe8fc2929245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f1488e3d-1a75-44ab-93fa-a2474b61c479" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f866c74b-b005-47d3-b1af-a37dd78f6d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_fc1d14a8-4873-4c31-aeeb-e3e96fcabf92" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f866c74b-b005-47d3-b1af-a37dd78f6d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d46eeb99-55a7-4823-bec5-9db650a1bd81" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a86d4b21-a597-46e6-b4ed-47908d8652be" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_40b2949b-b663-4689-878e-f7000843622c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_40b2949b-b663-4689-878e-f7000843622c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d08db1dc-d627-4e23-8f00-b4d2fdfdecac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d08db1dc-d627-4e23-8f00-b4d2fdfdecac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0a242bb2-1ae3-4f73-aa14-ca631f5d11d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0a242bb2-1ae3-4f73-aa14-ca631f5d11d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3fad4171-8abb-4c1a-86b6-5a969f0db5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3fad4171-8abb-4c1a-86b6-5a969f0db5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b907632-908c-4170-a123-dc4f8aaf55cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_51d43c55-81a4-4ae8-8ff7-4843823c84d9" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9b907632-908c-4170-a123-dc4f8aaf55cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#AccumulatedOtherComprehensiveLossChangesinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_667e6c7b-3b49-4761-bd51-65d41928884e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_667e6c7b-3b49-4761-bd51-65d41928884e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a2e20693-8400-4e5b-af94-8a1bba85426e" xlink:to="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cfe11fbd-796b-42c4-b756-0f6d0f1bae01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3dd34cdc-6869-46ec-83b7-b5f2ce1dc269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3dd34cdc-6869-46ec-83b7-b5f2ce1dc269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_923cec9d-4cc7-4d2c-9be8-6bfb1e798083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_923cec9d-4cc7-4d2c-9be8-6bfb1e798083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_f0081f9a-0b69-4270-bd73-b8f3cf9bb7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember_f0081f9a-0b69-4270-bd73-b8f3cf9bb7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3bc42144-2033-4cb6-b1f1-1f1714f421c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3bc42144-2033-4cb6-b1f1-1f1714f421c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ea75dc98-8162-4320-a6be-90197af6ca89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef1d9f3d-18a3-4252-98d1-87e255334683" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_ea75dc98-8162-4320-a6be-90197af6ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4bd09106-bc07-4090-af58-3bc3bd33f5f1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124701da-583a-4d36-8feb-9a17c40518eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124701da-583a-4d36-8feb-9a17c40518eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dbb27cf7-8313-4bf2-8267-155b8edd51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dbb27cf7-8313-4bf2-8267-155b8edd51c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b85c54dd-7329-4e97-8733-3ecba5e337a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b85c54dd-7329-4e97-8733-3ecba5e337a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f33fefa-708c-44ef-8290-312edf95f32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2f33fefa-708c-44ef-8290-312edf95f32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7124f959-d64c-4096-a967-4509204ad5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_645df9e8-4100-4842-980d-7e458bdb4829" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7124f959-d64c-4096-a967-4509204ad5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_89562171-71fd-4c50-b441-542d24e2790a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ebc442b-cb6c-4d78-bc8a-7cc6fffe3047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_7ebc442b-cb6c-4d78-bc8a-7cc6fffe3047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77e375ee-07a2-4733-8ce6-a5035e1ae62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_66d03cb7-30d7-42f7-8203-ceca7e9242d2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77e375ee-07a2-4733-8ce6-a5035e1ae62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4799e303-6679-4dc8-b996-2ed13be5d353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4799e303-6679-4dc8-b996-2ed13be5d353" xlink:to="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_67eab3e8-eda8-436a-8c61-478e7f9ff43b" xlink:to="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_PelvicMeshLitigationMember_002b4c47-7d25-46fe-9430-beaafb4d9b9f" xlink:href="mdt-20221028.xsd#mdt_PelvicMeshLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:to="loc_mdt_PelvicMeshLitigationMember_002b4c47-7d25-46fe-9430-beaafb4d9b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_HerniaMeshLitigationMember_5548a28f-8d30-4656-97ea-61a5d0c49a5a" xlink:href="mdt-20221028.xsd#mdt_HerniaMeshLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_83a6e03f-206e-4d9f-9929-22425d3ae53b" xlink:to="loc_mdt_HerniaMeshLitigationMember_5548a28f-8d30-4656-97ea-61a5d0c49a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_df272f07-db21-4b00-b8d2-d4cca4326b85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DamagesFromProductDefectsMember_6789d485-5cbf-4791-a59b-cd500be23d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_addbde33-713d-4aec-a104-dd08259e18c8" xlink:to="loc_us-gaap_DamagesFromProductDefectsMember_6789d485-5cbf-4791-a59b-cd500be23d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d31cc7df-6c77-43bb-bac7-f94c78e8c81f" xlink:to="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_19d6205e-16f2-4460-8c76-ba6e8b8f36e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_888b4854-6616-45e3-83bf-5f7001fc1223" xlink:to="loc_us-gaap_PendingLitigationMember_19d6205e-16f2-4460-8c76-ba6e8b8f36e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_2f59516c-45a4-43cb-b130-c4b8a47293fb" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_cb5f7fbf-a5a5-4ea9-96f8-9e2c8815fa0b" xlink:href="mdt-20221028.xsd#mdt_OrringtonMaineChemicalManufacturingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_4733e734-162e-4796-bb1e-7556fef92b24" xlink:to="loc_mdt_OrringtonMaineChemicalManufacturingFacilityMember_cb5f7fbf-a5a5-4ea9-96f8-9e2c8815fa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_15a215fd-6b72-4c72-b500-68a9fbdd3400" xlink:to="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_500fc6ba-f76a-4aae-b540-14c68f8478d3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:to="loc_stpr_MA_500fc6ba-f76a-4aae-b540-14c68f8478d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_e6243b9c-36c3-4b99-bca0-a6415979af4b" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00e3d10b-4106-4f7e-b7af-4fbe416b1616" xlink:to="loc_stpr_MN_e6243b9c-36c3-4b99-bca0-a6415979af4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9baec4e8-c689-4665-8c76-c5ce30eddddb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ff84641b-3439-421d-8164-3aa12cb482c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aaf242fd-714e-4414-a00b-b681ebfcb4c8" xlink:to="loc_us-gaap_SubsequentEventMember_ff84641b-3439-421d-8164-3aa12cb482c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3e693f84-2fcd-4eb0-b350-bb998f2c0e3c" xlink:to="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1531b8a0-f104-4cf9-9c1d-77449d51fb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1531b8a0-f104-4cf9-9c1d-77449d51fb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_03c81c36-6893-4977-85c7-1e81e8e9dea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_03c81c36-6893-4977-85c7-1e81e8e9dea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofSubsidiaries_ce9deb80-899c-47fe-88ca-e4b09421b07f" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_LossContingencyNumberofSubsidiaries_ce9deb80-899c-47fe-88ca-e4b09421b07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_LossContingencyNumberofManufacturers_21dd6dab-22c2-4586-b728-16ce57c5ca42" xlink:href="mdt-20221028.xsd#mdt_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_LossContingencyNumberofManufacturers_21dd6dab-22c2-4586-b728-16ce57c5ca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_2a41ca05-4e6a-4bfa-9e90-f9972002d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_2a41ca05-4e6a-4bfa-9e90-f9972002d4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_94441f3f-9c25-4e2c-a03c-2b9e323ba054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_94441f3f-9c25-4e2c-a03c-2b9e323ba054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_59e0c804-8a14-498b-9f65-969a94ff5ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_59e0c804-8a14-498b-9f65-969a94ff5ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3faff196-0c89-439d-affa-11bc6286ddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_3faff196-0c89-439d-affa-11bc6286ddfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_9558ac00-8ce0-40ce-90e6-1d4641a66e92" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberofLandfillsRequiringRemoval"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_SiteContingencyNumberofLandfillsRequiringRemoval_9558ac00-8ce0-40ce-90e6-1d4641a66e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_7d72f925-a8b9-482b-9ab6-eb0714c79767" xlink:href="mdt-20221028.xsd#mdt_SiteContingencyNumberOfLandfillsRequiringCapping"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9f1526d2-ec11-42af-8835-3f4775d5fb33" xlink:to="loc_mdt_SiteContingencyNumberOfLandfillsRequiringCapping_7d72f925-a8b9-482b-9ab6-eb0714c79767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fab8753f-9814-4567-ab0f-2b90e74fd03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1e691fa6-911c-436c-a78d-27fd6788a625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fab8753f-9814-4567-ab0f-2b90e74fd03f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1e691fa6-911c-436c-a78d-27fd6788a625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_253d434f-142d-4752-9672-7cd8d00bb40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fab8753f-9814-4567-ab0f-2b90e74fd03f" xlink:to="loc_us-gaap_NumberOfReportableSegments_253d434f-142d-4752-9672-7cd8d00bb40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d573f962-5093-4d90-b553-18da099db0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d573f962-5093-4d90-b553-18da099db0e2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_60a67481-f461-4321-b79f-158be990c8b7" xlink:to="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_287be94d-cc38-434e-8df0-d2a76f7ae417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:to="loc_us-gaap_OperatingSegmentsMember_287be94d-cc38-434e-8df0-d2a76f7ae417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_23707221-d083-42f6-a90c-a064dd70a141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_154fe554-9024-4674-9966-549936d5573e" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_23707221-d083-42f6-a90c-a064dd70a141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d743add3-65a2-4402-aee1-41214cc33d0a" xlink:to="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CardiovascularMember_11e3a437-428d-4152-ac33-9907ccbaad56" xlink:href="mdt-20221028.xsd#mdt_CardiovascularMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_CardiovascularMember_11e3a437-428d-4152-ac33-9907ccbaad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalSurgicalMember_ad22ca1d-44c5-4353-8fb0-edef52620609" xlink:href="mdt-20221028.xsd#mdt_MedicalSurgicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_MedicalSurgicalMember_ad22ca1d-44c5-4353-8fb0-edef52620609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_NeuroscienceGroupMember_321d93ef-e12b-428e-98bc-8795c1dd8129" xlink:href="mdt-20221028.xsd#mdt_NeuroscienceGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_NeuroscienceGroupMember_321d93ef-e12b-428e-98bc-8795c1dd8129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_DiabetesGroupMember_e3584c84-04df-4a6e-800e-4ea0bf464787" xlink:href="mdt-20221028.xsd#mdt_DiabetesGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4ec3cb51-ecfc-45dc-9f5d-46cd29fd50b2" xlink:to="loc_mdt_DiabetesGroupMember_e3584c84-04df-4a6e-800e-4ea0bf464787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_6e4d6165-940c-45a5-8faa-8c36477d8b37" xlink:to="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RestructuringsExcludingRCSAndMCSMember_17963a89-63f6-40fe-bbea-10b49a7f4479" xlink:href="mdt-20221028.xsd#mdt_RestructuringsExcludingRCSAndMCSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_RestructuringsExcludingRCSAndMCSMember_17963a89-63f6-40fe-bbea-10b49a7f4479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_RenalCareBusinessRCSMember_5d320541-c0ed-467b-97fa-c33a02a3a262" xlink:href="mdt-20221028.xsd#mdt_RenalCareBusinessRCSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_RenalCareBusinessRCSMember_5d320541-c0ed-467b-97fa-c33a02a3a262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_1b1f0ce9-1fca-4a86-a2e4-38604a0b7acc" xlink:href="mdt-20221028.xsd#mdt_MechanicalCirculatorySupportOperatingUnitMCSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bdef8bb4-a0a6-45d0-ac62-0b5492209950" xlink:to="loc_mdt_MechanicalCirculatorySupportOperatingUnitMCSMember_1b1f0ce9-1fca-4a86-a2e4-38604a0b7acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ff0f89cc-7bd2-4bb4-8d8e-d9c51044d592" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e7281df-cd31-4056-88ab-412cc62ff8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e7281df-cd31-4056-88ab-412cc62ff8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_91728575-7984-4636-b4c0-06042da1b678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_91728575-7984-4636-b4c0-06042da1b678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9ea44a25-d7ec-4bbf-a4ea-8eb7d20119bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9ea44a25-d7ec-4bbf-a4ea-8eb7d20119bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ea1052b2-cc8a-487a-8c8c-522b025b427a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ea1052b2-cc8a-487a-8c8c-522b025b427a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CorporateOverhead_125a9cce-be5a-4bf9-95aa-05c2e326bf20" xlink:href="mdt-20221028.xsd#mdt_CorporateOverhead"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_CorporateOverhead_125a9cce-be5a-4bf9-95aa-05c2e326bf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_CentralizedDistributionCosts_6bb91c02-19fe-4376-9b99-14d4b2739eed" xlink:href="mdt-20221028.xsd#mdt_CentralizedDistributionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_CentralizedDistributionCosts_6bb91c02-19fe-4376-9b99-14d4b2739eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_38a05d18-28e8-41eb-af31-ac58b44021b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_RestructuringCharges_38a05d18-28e8-41eb-af31-ac58b44021b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c6740a9e-863d-4b72-bdc3-b9953488cf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c6740a9e-863d-4b72-bdc3-b9953488cf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_66d0a9b6-627d-4eda-bf19-d791a3c49d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_66d0a9b6-627d-4eda-bf19-d791a3c49d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_0980493f-d2cc-4a03-a7a1-2fb39ff9a567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_0980493f-d2cc-4a03-a7a1-2fb39ff9a567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_MedicalDeviceRegulations_4e31d8fe-a558-4487-9839-68dc66e2804f" xlink:href="mdt-20221028.xsd#mdt_MedicalDeviceRegulations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_mdt_MedicalDeviceRegulations_4e31d8fe-a558-4487-9839-68dc66e2804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_8e881600-01b8-4e16-9449-0fea9b7c850b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_BusinessExitCosts1_8e881600-01b8-4e16-9449-0fea9b7c850b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_168636e2-6297-4052-97d3-d2888fa4c19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ccbc0c74-022a-40c7-9b4f-aa9b210667b6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_168636e2-6297-4052-97d3-d2888fa4c19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails" xlink:type="simple" xlink:href="mdt-20221028.xsd#SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"/>
  <link:presentationLink xlink:role="http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_35d6a337-763a-4ad5-873e-cdfa4d4cb442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_35d6a337-763a-4ad5-873e-cdfa4d4cb442" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:to="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ee32f724-9d04-41b2-9a50-112e580cb8b0" xlink:to="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_63b5c6c9-dbbf-438c-9910-30abe50c7f5d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:to="loc_country_IE_63b5c6c9-dbbf-438c-9910-30abe50c7f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingIrelandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b6c69d3b-5738-43b8-bf33-1eece035cfa8" xlink:to="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cbd95f66-7957-4c52-bc28-5060101e79e6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:to="loc_country_US_cbd95f66-7957-4c52-bc28-5060101e79e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_963e79bb-8048-4583-a4f0-ae5cd725ff5a" xlink:href="mdt-20221028.xsd#mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdt_TotalOtherCountriesExcludingIrelandMember_eb0cb630-7a29-4d95-bfc1-1b27df7ce350" xlink:to="loc_mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember_963e79bb-8048-4583-a4f0-ae5cd725ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b9af50e-0940-4624-a6a2-7a16e0be3612" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1fd1c7ba-eb8c-4397-965b-446981d53cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_70bc2d5a-3f6b-4cbc-b484-b09f15b0db9e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1fd1c7ba-eb8c-4397-965b-446981d53cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>mdt-20221028_g1.jpg
<DESCRIPTION>IMAGE 1
<TEXT>
begin 644 mdt-20221028_g1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>IZV5YY@\PYOJDK\MKZ-;W[^A-1117DGKA1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!L@R/QK\>?^#L$
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M+N#<QQN'CBJ/+RRVO*SWMV/E<PXQR_!XB6&K<W-'>RNMD^_F?T 45_/_ /\
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MW?%KQ"D_V>Y70)M.M9 <,D]WBTC88YR'G4\>E?R[=2>.Y)_'_P#4?PK]V_\
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MH?\ ;W_I$CY/C7_D35_^W?\ TN)^/5%%%?T$?@9[Q_P2[_Y2*_!7_L<-._\
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MJ&$I.OB)<L4?3/QH^/'@_P#9Z\$3>(_&_B?1_"VB6WW[O4+E848XSM7)R[$
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M7#F:5EJUIOT:/9RWB#'8"#IX2?*F[O1/7;JF?L'_ ,18G_5!1_X7'_WOH/\
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MR;SQE>V7A^W.?O>9,)IA^-O!,/QK\IRS"?6<72P_\TDOQU/U3-,5]7P=6O\
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M0]1]:6D/4?6OT%GY^C^JO_@G=_RC_P#@9_V3[0/_ $VV]>Q5X[_P3N_Y1_\
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M3SC_ .M_("OUSPWP"C1JXR6[?*O16_5GY'XCXYRK4\''9+F?J_\ @("<FE&
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MZII/\&?F?B/@H.C2Q:6J?*_1JZ_(^2J-N\A?[Q HI5.T],_@37[ ?D9^U/\
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M^_V6;;]G_P#8$T77;FT2/Q#\2W/B"^D9/G\ALI:QYZ[!" X'0&9R/O'/W*%
M.0 ":_ ^,L[GCL=*E%_NZ;:2[OJ_6^GH?N_!V20P6"C6DOWDTFWV71>G4"H(
MQ@8HV =A^5+17R!]@(%"] !1M /04M% ",@?&0#CU%1:?IMOI-HD%K;PVT$>
M=D<2!$7)R< <#DU-10*RW"BBB@84444 %%%% #)QE1UZU^$W_!TAJWG_ +;/
M@:QV8-KX(AG+9SS)?WHQ_P"0J_=F;E/?-?S\?\'*NL#5/^"CR0@N?[.\)Z?;
M$,20,R7$N!Z#]X3]2:^V\/H7S=/M&7Y6/B>/YVRIKO*/YW/S]HHH()4XZXXK
M]U;T/PT_0W_@V9T0ZK_P42U.?RDD&F>#+^Y+-UC!N;.+</?]YCZ$U^_:*H)(
M4_7UK\+O^#6K28[O]M#Q_?E'+VO@IX V/D DOK1L'W_=#\J_=3:,C@<=*_">
M/Y\V;R7:,3]SX!A;*4^\F?G_ /\ !R%\$A\2O^"==QXA@@\R[\ ZY9ZKN4?-
MY$K-:2#Z?Z0C'_KF/2OY]. 2.X_S_C7]8'[9GP9'[0O[*'Q$\$B)9IO$OA^\
ML;96[3M"WDM]5EV,/=:_E E0QRL"&# D,&7:<@D<CUX_2OLO#C&>TP-3#O>$
MK_*7_!1\AXBX3DQM/$):3C;YK_@,2NH^"/Q.N?@I\9O"?C"SW?:_"NL6FKQ;
M21EK>9)0/H=F/QKEZ#NV,%QN(P,]*_0JL%.#A+9IH_/J<W":FMTTS^ONUUJU
MO= BU*&>,V4\"W23 _*8B-^[/IMYK^3?]HWXI3?'#]H'QOXRG9C)XIUZ^U7!
M8G:)YWD5?H P '8 "OWP\"_M69_X(&I\1C?'[?8_#6;3TN#(=SW\,+V"\YR&
M-PB^^37\[@7864@9![=/3'Z5^:>'F7NA5Q4YK52Y/_ ;W_0_1^/\P5:GAH1>
MCCS_ 'VL%(1D9].?I2UL_#GP/>_$[XAZ!X:TT$ZCXAU&WTRU 7=F6>18DX]-
MS"OTR<E&+E+9'YO"+E)1CNS^C[_@A_\ !G_A2W_!-'X:6\D7EWOB&SD\0W!*
M[3)]LE::(D>H@,(_X"*^LISMC)K)\ ^#['X>^#M)T'3(1!IVB64-A:Q@?<BB
M140?0*H'X5KRC*>OMZU_+V.Q3Q6(J8B6\VW][/Z:P&&6'PU.A'[*2^Y:G\UW
M_!=W1AHG_!5SXKHBN(YY--N06_B+Z9:,V/;=N%?(U?<G_!Q/I)TW_@J!XFF,
MA;^T-'TRY"XQM'V98_\ VG7PW7]%\/3YLLP\O[D?R1_/.?0Y<RKK^_+\P[5^
MBO\ P;&:O_9G_!0C7H O.H>!KZV5MV/+Q>6,@.._W,8]Z_.JON;_ (-UM773
M?^"GWAJ IO.HZ/J=N/FQM(MVDS[_ .KZ5EQ-#FRK$+^Z_P -37AN?+FE!_WE
M^.A_1#(_<'O7\FW[5OB27QG^U%\2=8F(:35O%6J7K,&W;S)=ROG/XU_6,W,9
M[Y' ]:_D7^*%C+IGQ-\0VTT?ERV^I743J3G!69P:_/O#))U<1+K:/YL^]\2I
M/V="*VO+\D8=!&0<],<GC@44=C[\5^O'Y.>M_ 3]NSXO_LN^$;K0O 'C[7?"
MNDWMX^H36MBZHDDS(D9<Y4\[8U&?0#TKN/\ A\!^TS_T63QE_P!_T_\ B*^;
M.OYYI,#T%<,\LPDY.<Z46WU:3_-';3S+%TXJ$*LDET3:_)GTI_P^ _:9_P"B
MR>,O^_Z?_$4?\/@/VF?^BR>,O^_Z?_$5\UX'H*,#T%1_9."_Y\Q_\!7^1?\
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MQ]%%;55]-F2YMHI8V5TD0.K*00P/((JQ7\K2;;;EN?U'3244D%%%%(L****
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M97YMU^DO_!KE_P G_P#C#_LGU[_Z<M,K'BO_ )%%?_"='"O_ "-J'^(_>8*
M<@#-+117\YG]$A1110 C ,,$9K^>3_@XZ 7_ (*9ZI@8SX>TW/\ WPU?T.'I
M7\\?_!QW_P I,]4_[%[3?_0&K[KP\_Y&K_P2_.)\)XA?\BQ?XE^3/@^@C-%%
M?N1^)'Z2_P#!KD3_ ,-_>,.?^:?7G_IQTROWGK\&/^#7+_D__P 8?]D^O?\
MTY:97[SU^$^('_(WE_AB?N? /_(I7^*1\>?\%]/^42_Q8_[A'_IYL:_FV[GZ
MU_23_P %]/\ E$O\6/\ N$?^GFQK^;;N?K7VOAQ_R+)_]?'_ .DP/C/$7_D9
M0_Z]K_TJ84AZCZTM(>H^M?H+/S]']5?_  3N_P"4?_P,_P"R?:!_Z;;>O87R
M0.O6O'O^"=W_ "C_ /@9_P!D^T#_ --MO7L$@W+C.*_EW&_[S4_Q/\S^G<#_
M +M3_P *_)'YI_\ !T-XFETO]AOP=IJ%E75/&MNTSYX*QV5X=N/]XJ?JM?A!
MR",\;AG&<XQQ7[I?\'2MG(_[&W@"X5<PQ^,XXW;T9K&[*C\0K?E7X6A0O0 9
MK]MX 2641M_-(_%N/6WFTK]D+0#MSUZ=C@T4!0YVGHW%?:2V/C([G]<_P<\"
MP_#'X4>&/#=LBQP>'M)M=,C50 %6&%(P!CMA!72U0\-:M#K^A6=_;-OMK^".
MYB;/WD=0P/Y$5?K^5IMN3<M[G]1TDE!*.U@HHHJ30**** "BBB@ HHHH ***
M* "BBB@!EQ_JCVK^<G_@X-US^U_^"J?CZ#?*PTNSTJVP[$A<Z?;RX4=A^\)X
M[FOZ-Y,!>>G>OYF_^"UVO?\ "1_\%1OB_<"1Y1%JD%KELY7R;*WBQ]!LQ^%?
MH'AQ"^93EV@_SB?G_B-*V707>:_)GRS1UXR!D@9(SWHHS@&OVSU/Q<_6/_@U
M2TGSOC!\8;[?M-MI&GP; .#YDTK!L_\ ;/%?M37X_P#_  :A:24T_P".=^0I
M2:30X%..05%^3^>Y?R%?L!7\_P#&\^;.:OER_P#I*/WW@F-LGI/OS?\ I3&7
M"[HB,9]O6OY8_P#@H_\ !D_L_?MV?%3PHL/V>UL/$%S/91A<".UN'-S !_VR
MF3\J_J<N #'SG'?%?@I_P<V_!D^!OVXM"\6PQ!+3QQX=A:60#'FW=J[0R?7$
M1MO?D5Z7AUB_9YC*@]IQ_%:_E<\OQ$PGM,OC72UA+\'I^=C\X:/\_3WHHVEN
M@)QUP,X'>OVUL_%C[V\/_M5&V_X-Z/$7@-YD^U/\1X- BCW_ #K:2!=5#X[
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MN?>;/>OR;PWQ2IX^="7VXZ>JU_*Y^J>(F%<\#"M'[$M?1Z?G8^ Z#GL&)[
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M_P#$2,P_Y]P_\F_S/H?^(<X#_GY/_P E_P C^9W_ (<B_M4?]$AUC_P/L?\
MY(H_X<B_M4?]$AUC_P #['_Y(K^F+ ]!1@>@H_XB1F'_ #[A_P"3?YA_Q#G
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M +)]>_\ IRTRL>*_^117_P )T<*_\C:A_B/WGHHHK^<S^B0HHHH #TK^>/\
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M(55!)( R/Z6?^"7?_!/G1_\ @GI^SC:^&8_LVH>*]5VWOB75(X\"^NB/N(2
M?)B!9$!QU9L N:^1XQX@CE^$=.F_WL]%Y+J_ET/J^$,@EF&+52:_=PU?GV1]
M'VQ&XX&,C./3\.W6ICTI%14)P ,]<#K2GI7X(?O/0_G,_P"#A/\ Y2D^-O\
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M'_!+K]HL'GX*_$=?<:'/_P#$U^H_VGA/^?T/_ D?F']G8O\ Y]2_\!9^QO\
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M_$FDV&M:%K,)M[VQNXA)#<1D=&!]."",$$ @@BO$X>SZKE6*]M!7B])+NO\
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MF_#.!Q,,TH2G3DDI=8L_9RBBBOY_/WX****  ]*_GC_X.._^4F>J?]B]IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>mdt-20221028_g10.jpg
<DESCRIPTION>IMAGE 2
<TEXT>
begin 644 mdt-20221028_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT444 %%16E]8Z@CR6%Y%.L<KQ2-#(&"NK%64XZ$$$$=01BI: "BBB@ HHHH
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M6/B#\9/#N@7'B?Q?I>H:6(M%^QP(T]S8Z;ES);0V\0?R0<JXB"[(R^5^E/\
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M&Z,:YVRM!LD=$)7S6=4. I^GJ* /R,_85_X(G_MM>(?^"5&N?\$G/^"@%YX
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M?>>%W_)QLI_Z_P!/_P!*1^)'_!P?_P IC?CA_P!AVP_]-=G7QI7V7_P<'_\
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MA'^KM]6^K/\ -[B'B'-^*<WJ9EF55U*LWJWLETC%;**V26P4445WGBA1110
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MKHOQ?5MG^BW!_!F0<#Y3' 972Y8_:D]9SE_-.75_@MHI+0****\<^K"BBB@
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M$#\5K_\ :N\=> ?&'VOQM?7?P?T[PM!+8?9-"(S:V=]*\/$N<!F"S%?F/F2
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MO'#X)X*J2P\K8G$?NZ?=77OS7^&.SZ2<3Q8DL2S$DD\DTE%%?U&?YM!1110
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M444 %%%% !1110 54U_7--\,Z%>^)-8G$5II]I)<W4I_@CC4LQ_  U;KPO\
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MB;MZ;K\#=.Z"BBBN$84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?#?_  5G\=M=^,?"OPV@F^2QTZ74;E >
M"TS^6F?<"%_P>ON2OR^_;P\8-XS_ &J/%5PLNZ'3[F/3X1G[OD1JCC_OX'/X
MU^C^%N!6*XF]LUI2A*7S=HK\)/[C^?\ Z26<O+?#IX6+UQ-6$/\ MV-ZC_&$
M4_4\@HHHK^D3_/L**** "BBB@#NOV:/A@/C'\=/#?P_GA+VMYJ*OJ '_ #[1
M@RRC/;*(P!]2*_66.-(D$42!54 *JC  ]*^'/^"3GPY2_P#%WB;XJ7D.1IUG
M'IUDS#^.5M\A'N%C0?20U]R5_.?BGF;QG$"PL7[M&*7_ &]+WG^'*OD?WW]&
MKAR.5<"RS*<;3Q<V[]>2%X17_@7._1A1117YF?T2%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4?Q6GY6-8;!1117R984444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@X(N;6.8$8[?/7\1E?U[_P#!$#Q[+\2/^"2_P%\0S3^8UOX MM+#9S@6+O9
M?@+<#\*^,XSI7PU*IV;7WJ_Z%T]SZIHHHK\^-0HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \L_;9U3^R/V5O
M&MWNQOTH0?\ ?V5(_P#V>ORRK],_^"B5T;;]D7Q1&#_KI;!/_)V!O_9:_,RO
MZ%\)*:CP_6GWJO\ ",/\S^$/I1UW/CG"TND</%_-U*O^2"BBBOU,_FH****
M"M'PAI/]O^+-+T(+N^VZC!!M]=\BK_6LZNS_ &<[1+_]H+P-9RIN23Q?IH=?
M5?M4>?TKFQE5T,)4J+[,6_N5ST,IPRQF:T,.]ISA'[Y)?J?K:  , 8 Z 444
M5_&!_KH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEBJ?PU(QDO2237YA1116)U!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117G?[7GQ:C^ O[*7
MQ+^-TET(#X1\!:OJ\<A.,/;V<LJ >Y90 .Y(%5"#J345N] /XY?VM_'J_%7]
MJSXF_%!)0X\2?$+6M4#@_>%Q?339_P#'Z\]H)).2<D]2:*_<(14(**Z'.%%%
M%4 4444 %?U2?\&Q_A8^'?\ @C9\--0>+8VLZIK]\P(Y/_$WNX ?Q6$?ABOY
M6Z_L#_X(N^ /^%:_\$I?@'X;,'EF?X;:?J;)C'-\GVTGZDW&?QKY+C&=LOA#
MO+\D_P#,N&Y].T445^<&H4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 1W5M!>VLEG<QAXYHRDBGNI&"/RK\<?
M%&AS^&/$NH^&[K/FZ??36TF1SNC<H?U%?LE7Y:?MM^$#X+_:D\8:<L.R.[U+
M[?$<<,+A%F)'_ G8?4&OV#PAQ:AF&)PS^U&,O_ 7;_VX_E/Z5.5NKD679BE_
M#J3IO_N)%27_ *;/*J***_>#^)PHHHH **** /TD_P"";/CA?%W[,%AI#R[I
MO#^HW.GRY/.-WG)^&V8*/]VO?*^&?^"3OQ$CT[QIXF^%]Y/@:G8Q7]DK'CS(
M6*2 >Y613](Z^YJ_E7CK+WEW%.)A;23YU_V_J_Q;7R/],?!;/%GWAKE]5N\J
M</92\G2?(K^L5%_,****^1/U,**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/_P#X.:_CW#\$
M/^"2'C;1(;WR-0\?ZMIOAC3B&P6\V<7-PN.X-K:W"_\  J_0"OP+_P"#QO\
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M@RJLYM1<"U:4;S"23GZ>HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ =Y)(<&VG;_ &46W'/6OB<=PCC*+<L.U-=MG_D_O^1HIKJ?T+45\4?LM?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLH CEX(VL3&OZ5D7$,,?%4*[M4_"7_!\ON[+*4;;'PC1117U! 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '"?M%_LQ_ ']K;X9W?P>_:0^%&C^+_#M[R^GZM;;C$^"!+#(,/!* 3B
M2-E=<\$5^%W_  4I_P"#3CXN_#6?4/BI_P $ZO$DGC30!NFD^'^O721:Q9KU
M*VT[;8KQ0,X5_+EP !YS'-?T&45Z67YMC<MG>C+3JGJG\OU6HG%,_AU\<^ _
M''PP\6W_ (!^)/@_5/#^N:7.8-2T?6K"2UNK60=4DBD 9#[$"LFO[+?VT?\
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MZTM.B6B7R_5ZFBBD%%%%>:,**** "BBB@ HHHH **** "BBB@ HHHH ****
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MI6LW=AX9U*6^TM=&UAK-EFDC\MBQ4'<-O:OES_B%1_X)(_\ 0G^.O_"VE_\
MB*_2*BNVCF./P]-0I59179,5DS\W?^(5'_@DC_T)_CK_ ,+:7_XBOL?]BG]B
MGX&_L!? VW_9X_9XL-2MO#=MJ5Q?11:KJ+74WG3L&D)D8 XR!@=J];HI5\PQ
MV*AR5:CDNS=P22*^I:/I.LQ10ZQI=M=I!<1W$*7,"R".6-@T<BA@<,K ,&'(
M(!%<)I7[(G[)^A?$@?&31/V8?AY9^+UE,J^*K7P581ZD'_O?:5B$N??=FO0Z
M*XQG-^-_@Y\(OB;=P7_Q(^%?AOQ#/:QF.VFUS0[>[>)"<E5,J,5!/.!5SP5\
M// 'PUTN31/ASX&T?0+*:X,\UGHFF16D3RE54R%(E4%BJJ,D9PH'85L44 %%
M%% !1110!C_$#P+H'Q,\&:CX"\4QROI^J6YANUAEV.4)!X8=.E>*_P##LS]E
MO_H$ZU_X.&_PKZ"HKU,#G>;Y93=/"5Y4XMW:BVDWW/F\ZX/X6XCKQKYI@J=>
M<5RIS@I-*][)OI=MGS[_ ,.S/V6_^@3K7_@X;_"NY^!W[*7PC_9YU6^UGX;V
M=_%/J-NL-R;N^,H**VX8!''->DT5MBN(\^QM"5"OB9RA+=.3:?75')EWA_P1
ME&-AC,%EU&G5AK&4814E=6T:6FC:*?B#P[X?\6:-<>'/%6A6>IZ==Q[+NPU"
MU2:&9<YVNC@JPX'!%<WX7_9Z^ 7@?78/%/@KX'^#]'U.UW?9M1TOPS:V\\.Y
M2C;9(XPRY5F4X/(8CH:["BO%/KSF/&WP4^#7Q+U*+6?B-\)/#'B"\@@$,-WK
M>@V]W)'&"6"*TJ,0N68X'&23WK:\1>&_#OB_0[GPSXLT"RU33;V(QWFGZC:I
M/!.AZJ\;@JP]B"*NT4 >9?#W]BG]C;X2>*%\;_"G]DKX9>&-:1]ZZOX>\!:=
M970;^\)885?/)YSWKJ?&_P &_A#\3;N"_P#B1\*O#?B">VC,=M-KFAV]V\2$
MY*J948J,\X%=)10!C^"OAYX ^&NER:'\.? VCZ!937!GEL]$TR*UB>4JJF0I
M$J@L551NQG"@=A5#P;\$_@U\.M8E\1?#[X2>&-"U">!H9K[1M!M[6:2-F5F1
MGC16*EE4D$X)4'L*Z>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>mdt-20221028_g11.jpg
<DESCRIPTION>IMAGE 3
<TEXT>
begin 644 mdt-20221028_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&C]H?XI:+X.\+:4J_;M;UV]6"%&8X5 3R\C'A8U!9CPH)XKQ_P#8]_X*]_\
M!-O]OCQG=?#G]D[]J_0?%/B&TB>5]!>TN]/O98T^_)#!>PPO.BCEFC# #!)
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M/XUYK\#=8\>:M_P9._$2/QG).]G9ZK-;^&GG).; >*;)L*3U47#7*CTP1VH
MZC_@@M_P51T?]@G_ ((I_P!O0?LB?%SXF6/A/Q;K6I>-M9\#^'8SIOA^T:5&
MW3W5S)&LCA/WC)")/+C(>4Q*5)_7S_@G]_P4*_9H_P""E_[/=K^TA^S!XGN;
MO1Y+M[+5--U2W$%_I%ZBJSVMU$&8)(%=&!5F1E=65F!S7YU?\&YUGH^H_P#!
MMOXWT_Q!%')83P^.8[Z.4 JT+6SAPV>VTG-?#/\ P;;ZM\<?!O\ P2Y_X*&>
M._A[+?PV]E\)5DT"> L#'JD>E:T\DD&/^6J1-"QQSGRNO% '[">)_P#@N_\
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M_!/[3WPXT[4;/0_'?ANUUG3+35X%BNH(ID#B.559E#KD@[693C*D@@G\G/\
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M!N+MT7?-<R$A8K:!,@RSRR,D4<8Y9W4<=:_//]@[0/V<OA!\3_BA_P %NO\
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MZ;='2KV>.\TO5M-D5+W1]0B#"*\MV9642*'=2&!5DD=",,:^)/V"_P#@V_\
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MK5ZVQ3<:E)-J5_+,&5 #%"8$ 9P,!CG[PHH _(G_ (.;/^".WP=_:T\,:?\
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MIE?KY)M<_I7C7C#_ (.>/^"J7B;?_8OBWP5X>W_=_L?P;$^SZ?:FF_7-?HN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDD;J2&4@]17Y?FF58G*ZW+4UB]GT?^3\C923-:BBBO+&%%%% !1110 4444
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M:TZWB/\ P%;$L/\ ONOH']BK_@A]^Q!^P5\:8/CY\"H?%S>(K?3)[&.76_$
MN(A%,H60[%B0;B .>WI7V#17PF:^*_B/G>$J87&YI5G3J)QE'FM&2>Z:22L^
MQU0P.#IR4HP2:/A#]K/_ (-T_P#@G?\ MG?'[Q/^TI\8%\=)XG\63Q3:I)H_
MB9((%>.".!3'&T+;?DB7@DC.?I7A/BS_ (,]O^">&IH\GA#X]?&#2I6!V+<Z
MMIEU$A[?+]@1B/J]?K+17R-+.<THQ4856DM$CJY4?AA\2?\ @S(3RI;KX/\
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M=*LKQ?\ 5UYC3:9_<)\-?B5X!^,?@'2/BG\+?%MCKWAW7[".]T?6--G$D%W
MXRKJP_4=0000""*W*_E[_P"""?\ P6\\3_\ !.7XF0? CX[:W>:A\$_$M_\
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MTQCRSC+K#E5/YSU]_A<7A\;156C*Z_K?L9--!11172 4444 %%%% !7[&_\
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M ()<'9G]05%%%?EYJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJOD_P:-H.Z"BBBO!*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;_:WT3X'Z:+BU\.6F-2\<:U"O_'AI<;+YFTD8$LA*Q1CGYY Q&U6Q_5E\/O
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M)X!:+[5#CJS2QCL!7S_$N"^N99*27O0]Y>G7\-?D5!V9_2Q1117Y6;!1110
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M _O5\(ZYH.N>&-8N?#WB71KO3K^SE,5W8WUNT,T#CJKHX#*1Z$9K^ASX2?\
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M\W[J_P#2G]Q^ _21SAY;X<RPT79XBK"'R5ZC^7N)/U/&J***_I(_SY"BBB@
MHHHH ]+_ &27^)-_\=_#OA/X;^+]3TB75-4B6_DTZZ9 ULA,DI=1\L@6-7.U
M@17ZJU\'?\$HOA[_ &O\3?$'Q)NH,Q:+I:6ELS#@37#9)'N$B8'_ *Z5]XU_
M.?BICJ>(XB5""7[N*3=M6Y:ZOK9<MNVI_?GT:<FQ& X"EC:LF_K%23BFW90A
M[NBV3<U.[6^G8****_,S^B HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=^!H?AA^UA\3_AK;V_E1^'OB'K6F)$!C8(+^:(+^&S%>>5](_P#!8;1$\/\
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M 3QAIO[,5UH-O\0[KP]=0>#;OQ/<RPZ?:Z@\96&>=HHI7*1L0^T(VXJ%X!+
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M  30^ OA&2#RI8?A-H4US&1C;--8Q3R#ZAY&KY#C*=L#3AWE?[D_\RX;GO\
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M:_)N(L3]9S>HUM'W5\M_QN;15HA1117B%!1110 4444 %%%% !1110 4444
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M_#NQ;#,VHRH<W14]8[=-TS9&TLL:$@R"ML/0J8FO&E35Y2=D#T/Q1_X.C_\
M@H$G[5/[<2_LW> ]=%QX.^#:2Z8Y@DS'=:Y(5-])QU\K9'; '[K03$'#U^8U
M3:CJ.H:QJ$^K:M?375U=3--<W-Q(7DED8EF=F/+,2223R2:AK]DP6%IX'"PH
M0VBOO[OYLP;NPHHHKJ$%%%% !6U\-_A_XJ^+/Q#T'X6>!=,:]UOQ+K-KI6CV
M:=9[JXE6*)!]7=1^-8M?IA_P:O\ ['3?M%?\%&D^.'B'23/X>^#^COK,CO'F
M-M5GW6]C&?1AF>X4_P!ZT%<N.Q4<%A)UY?95_GT7S8TKL_H\_9Q^"?AK]FWX
M >"OV?O!RC^S/!?A>QT6S<)M,JV\"1>8?]IRI8GJ2Q)KM***_%Y2E.3E+=FX
M4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 >/\ [<OP9;XS_L^:K8:=:^9JFC?\3/2@JY9GB4[X
MQW.Z,NH'][;Z5^7]?M!7Y>?MM? T_ SX[ZEI>FV?E:-JY.H:*57"K%(QW1#T
MV/N4#KMVGO7[;X39XK5<JJ/^_#\I+\FE_B9_'GTG^#97PW$V'CI_"JV^;IR?
M_DT6_P# CR*BBBOVL_CX**** "BBB@#TK]E7]H/5?V<_BQ:>,(C)+I5SBVUV
MR0_ZZV8C+ ?WT/S+[@C(#&OU,T/6])\2Z-:>(=!OX[JROK=)[2YA;*2QNH96
M!]""#7XTU]=?\$X?VM/^$;U&']GSXAZGC3[R8_\ "-7DS\6\[')MB3T5R25]
M')'.\8_*?$KA1YEAO[3PL;U*:]]+[45U]8_BO1(_IOZ/7B=#A_,/]7<RG;#U
MY?NI/:%1Z<OE&I]RG;^:3/N:BBBOY]/[I"BBB@ HHHH **** "BBB@ HHHH
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MC7]_XOHFBBBOR0_J,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K\R/^#@K_@N#I'[ ?P]N?V7_ -G+Q##<_&?Q-IQ$UY;N
M&'A"RE7BZD_Z>G4YAC/W1^];Y1&LO0?\%Q_^"[7P]_X)O>"[OX'_  .U*PU_
MXVZO9?Z)8_+-;^&(I%^6\O!T,N"&BMSRW#N F!)_,=\0?B#XW^*_CC5?B5\2
MO%5]KFOZY?27NKZOJ=PTL]W<2,6>1W;DDDU]?P]D#Q4EB<0O<6R_F\_3\_0B
M4K:(S+^_OM5OIM3U.]EN;FYE:6XN)Y"[RNQ)9V8\LQ)))/))J*BBOT4R"BBB
M@ HHHH ***^]_P#@WO\ ^"83_P#!1+]LRV\0?$70#<?#'X;/!J_C(S1YBU&;
M<3::;[^<Z,SC_GC%(,@LM<^*Q-+!X>5:H](J_P#7J-*[/V0_X-JO^"<'_#$G
M[#]O\7_B%H/V?X@?%R.WUG5A/'B6PTO:3869SRI\MVG<<$/<;&_U8K]&:155
M%"(H"@8  X I:_',7BJF-Q,J]3>3O_P/EL;)604445S#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKS_]I7]I_P""_P"R1\-'
M^*OQQ\3S:?IK7D=E86MAIL]]?:G>2!C':6EI;(\US.P1V$<:,0J.QPJ,P /0
M**^=OV'/^"IG['?_  4(UGQ/X,_9_P#&>JP^*O!CJ/%/@OQ9X>N=)U?3E8[5
MD>VN45BA;Y2R[MI*AMI90=[]MK_@HA^Q]_P3Q^'+_$S]K'XR6/ART8#[%IZ1
M275_?,<A5AMH5:1\E2N_ 0'[S*.: /:Z*** "BO(_B[^W#^SE\$OVE_AI^R%
MXZ\:,GQ ^+#WO_"(Z#:6YF=HK6!YI9YRO$$6(W56;[[JP7.UMM7]HC]N_P"
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MIMY%J.G7<MO<02+)!/#(4>-U.0RL.001D$=*BHI-)JS'&4HR33LT?=W['O\
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M_;$\<:O8W (GT>TU8Z?829_O6EF(H#^*5\_445ZU*C2HQY:<5%>2L2%%%%:
M%%%% !1110 4444 %%%% !7VQ_P1K_X(R_&#_@J9\6EU+4([[P[\)M O%'B_
MQF(<&9AAC866X%9+EE(RV"L*L'<$E(Y.Z_X(L?\ ! _XO_\ !2+Q'8_&CXRV
MVH>$?@K9W6;C62GEWGB,HV&MK ,/N9!5[D@HIRJ[W#!?Z:/@W\&?A;^SW\,=
M&^#/P5\#V'ASPQX?LUM=(T?38=D4$8Y^K,Q)9G8EG9F9B223\IGW$,,$G0P[
MO4ZOI'_@_EU[%QC?5E?X#_ ?X2?LR?"30_@7\#/!%GX=\+>';);;2M+L4PJ*
M.6=F.6DD=B7>1B6=F9F)))KKJ**_-Y2E.3E)W;-0HHHI %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4V2..:-H9HU='4AE89!!Z@BG44!N
M?'7[7'_!.*'5&NOB-^SQ8)#<$M+?>%U(5)#U+6Q/"GOY1X_ND<*?BK4-.O\
M2;Z;2]5L9K:YMY#'<6]Q$4DB<'!5E/((/4&OV:KR']I;]C3X7?M'6;ZE?P?V
M3XB2/;;:]9Q#>V!PLR<"9?J0P[,!D'];X2\2JV 4<)FK<Z>RGO*/^+^9>?Q+
MS/Y<\4?H]83.I3S3AE1I5WK*CM3F^\'M"3[? _[NK?Y>T5W_ ,=OV:/BQ^SS
MK7]G>/=!/V.60K9:Q:9>UN?]U\?*V/X& ;VQS7 5^ZX7%X;'4(U\/-3A+9IW
M1_%N9Y7F.38Z>#QU*5*K!V<9)IKY/IV>S6JT"BBBN@X HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** /E'_@N5_RB1^/'_8BR_\ HV*OY#:_KR_X+E?\HD?CQ_V(LO\
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M\3Z!:6$NG >)<WL-M"ELPN6C@MV#S2O<W<EOY0MF4QEV16T?^">/_!77P?\
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M>$/'W@;QQ\)+6XUG5K^R M5>*(VCR7\\_EH6C4--YS.K+]UF[;]H[XZ^'/\
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MKFF6^M:+J,%Y9W<"S6MW:S+)%-&P!5T920RD$$$<$&@">BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#B?VC_V?OAU^U3\#?$W[/'Q:MKN;PWXMTUK'6(K&Z,$S0E@Q"2#
ME3E1S7PG_P 0J/\ P21_Z$_QU_X6TO\ \17Z145UX?'8S"Q<:-1Q3[.PFDS\
MW?\ B%1_X)(_]"?XZ_\ "VE_^(KW_P#8"_X(^_L8_P#!-3Q?X@\<?LOZ)XAM
M;_Q-IL5CJC:SKSWBM#')YBA0P&T[N]?4=%75S/,*]-PJ59-/=-L+)!7)?%KX
M!? GX^Z7!H?QU^"OA+QK96SE[:S\6^'+74HHF.,E4N(W"DX'(':NMHKA&8'P
MV^%/PN^#7AB/P3\(/AMH'A3187+Q:1X;T>"QM48XR1% JH"<#G':LSXB?LZ?
ML^?%[0V\,?%GX$^#?%&F-=R73:=XB\,6E[ 9Y#F24QS1LN]CR6QDGJ:[*B@#
M%^'_ ,-_AW\)O"UOX&^%?@+1?#.B6>?LFC^']+ALK6#)R=D4*JBY/H*H^-?@
MC\%_B5JL>N_$;X1>%]?OHK<017FMZ!;74J1!F81AY48A0S,=N<98GN:ZBB@#
M+\(>"/!?P^T9?#G@+PAI>AZ>LC2+8:1I\=M"';[S!(U"Y/<XYK4HHH ****
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MAIX?T[PLELUNOAJPT:"'3Q"V=T8MT01A#DY7;@Y-5O"OP-^"G@5;Q?!/P?\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>mdt-20221028_g12.jpg
<DESCRIPTION>IMAGE 4
<TEXT>
begin 644 mdt-20221028_g12.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
MT *  P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT444 %%16E]8Z@CR6%Y%.L<KQ2-#(&"NK%64XZ$$$$=01BI: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@/
M_@X<_P""N>L?\$G_ -CVSUKX406DWQ/^(=_-I/@7[=$)8M/$4:O=:B\;<2B!
M9(E5#E3+/$6#(&4^(?\ !OG_ ,$V_A;^T?\ L>:;_P %&O\ @HGX6M?C=\5O
MB[<7E_%J_P 5;=-<&D:4ES)!!!;178DBA\P1-,6100DR1C:J;:^:_P#@^)^'
M7C"9_P!GGXM0VTTN@6X\0Z1<3 $QVUY)]AFC4GH&ECBE(]1;MZ5^HG_!!'7]
M&\2?\$<?V>=1T*9'@C^'=M:NR'($T$DD$P^HEC<'W!H _,+_ (+B)\3/^#>;
M]LGX7_ME?\$S]4;P;X"^)+7L/C3X06DKKX8N[ZS:%Y/]!!\J!;B"XP#"JM$T
M+LA7>17[3?LG?M<?"O\ :X_9(\'?MC^"]1CT_P +^+/"T>M.VHW**-- 0_:(
M9Y#A08)$EC=ON@Q,<XYK\A_^#W_7=(M_V=_@-X9FF07]WXTU>ZMHR?F,,-I"
MDA'L&GBS]17S;^V#\3_CO^R1_P &D_[-OP'M;V^TAOB[XJU"37&1F1GT*:^U
M+5(+<'@A)Q):2GLR;EY5C0!^X_A#_@L1_P $R?'?Q,T7X1^&/VQ_"<VL^);E
M[?PRTSSP66M2K+Y12RO98UM;L^9^[ AE?<_RC)XJ[_P4J_X*:_LR_P#!+C]G
MV[^./[0OBB/[7/%+'X2\(VDZ_P!H^(KQ5!$%NAY"@LGF3$;(E8%CDJK?&?CG
M_@B[^SQ_P6/_ ."2W['NE6'Q;O\ P&G@#X9Z)=Z'JV@:7%=%X+K2[(7MNR,R
M;96EMXV\S<2LB,65R2*ZS_@ZA\+Z1IW_  0Y\?QRP_;+C2K[PW;VFH7X$MR!
M_;%DC,9",[F &XC&X]: -?\ X(-?\%A_AI^WG^SCH.C?&[]HOPQ<_'+Q-KWB
M34[SP#!? 7>GV*ZE=2V\$<1Y$,-IY00DD^6JDDDDGWF[_P""Q_\ P3"LO%<_
MA*Y_;/\ !P-KK0TB[UI9Y6T>"_(R+635!&;))<9^1I@>#Z5^-/A#XT>)?V;/
M^#-K2?''PJM(M-\1^+_%.I^%;KQ'9VZI=VUC=Z]>BY E W 201/;GG[LQQ@X
MKU'X%_#3P<?^#);7'O=%MG?4?#VMZS=.T0R]Y#XLF$,O^^JV\"@]<(!0!^Y>
MNZ!X0^(?A6Y\/>)M%TW7-#U>S,5W8WUO'<VM[;NO*NC@I(C*>A!!!K^;3_@V
M0_:0^!W[(_\ P4%_:4^('[0WQCTGP7X)T'P?>VL5_P"(M5\JWAQKD"10QASE
MY"JX6- 7;& #7Z.?\&B_[1'Q)^/7_!)&#0?B/JUS?_\ "N?B%J/A30KN[D+N
M=.CM;*\ACW'DK$;UXE'14C11PH ^ O\ @TZ\">"O%7_!87X_>(?$_A+3=1OM
M!\.ZM<:)=WUDDLEA,^MPQM+"6!,;E&9-RX.UF&<,00#]W_V2/V^OV-OV\/#V
MH>)_V1?VAO#OCFVTF58]5ATJX9;FR+9V&:WE5)HE;:VUF0!MK;2<'&K^T'^V
M#^S3^RNVC6OQY^+FFZ%?^([EK?PYHFR6ZU+5Y%&76ULK9)+BYVC!;RXVVY&<
M9%?@5^SK=WO[(_\ P>2^(/A;\ ;0:5X>\5>-=0L-<T+3$\NVFM+_ $7^T9HS
M&F $CN2LX4 !3"O88KJ?V6_VL?CQ\9_^#KSXV>.;?X21_$CQ#X(M?%'A+P%X
M;U+Q5%I4>E6FG7<5CYEO+/&ZJ3"ET[(J@N;N9\\MD _=S]GC]IOX ?M9?#Q/
MBM^SA\6=&\8: UU):RW^CW6_[/<)C?!,AP\$RY&8I%5P&!(Y%<E^TG_P41_8
MB_8[\26/A#]J3]I?POX$U'4[4W.G6WB2]-M]JB!VLT;,-KX. <$D9&<9%?$7
M_!(__@G[_P %$?V6?^"J?[0O[4/QA^'F@>$?A)\;VOM9'A;2_&,6H26FLMJ$
M<]N[)&BJ2(YKY2X SY@KYP_X/A8T/P._9_E*#</%>N@-CD VUID?H/RH _5_
MQI_P4T_8$^'GQ3\#?!'QC^U?X/LO%GQ)ALIO!6A-J6^?4H[S;]D?" B)9]RB
M)I2@D)PN3Q7H?[0+_&D?!;Q)!^SG!IC>.KC2WM_"LVMOBSM+R7$<=U..2\4)
M;SFC'S.L11>6%?!W["__  0L_P""?GC_ . /[-7[5WQE^$]QK_Q8\.^%/#OB
MF\\92ZY=+-J>J&TMKF,72K)LG@@=8D@B(VQQ01Q@;,J?TBH _FR_X+L?\&ZG
MCO\ 8X_9DUG_ (*8VW[<WB[XG>,=%UNPN/B+J/B^U6&YNGN[N*VCO+25)&>,
MI<S0@0L6PC95U\L*WZQ_\&YG[47QS_:I_P""1/P\^+O[2.MWFJZ[:2ZGI0\1
MZB[/<:O9V5W+!%<RN>9) J&)I#EG:$LQ+,2?/O\ @MUHWQ"_X*<^,_#_ /P1
M3_9DOS'+JNI:=XF_:!\9+'YEIX.\.PR^=:V\N.&O;J9$EAM\ABMN&8+&YD7[
ML_9J^#/P4_9C^#OA_P#96^!=O:66A^ -"M=-L](CNEDGMX=IV23@?,9)2'D9
MV ,C%VYR: /Q$_X(1_%7PY_P71_X*2_M(?'/]O?P9IOQ TR+P>MIX#\&^++5
M+W3_  UI-W>NAALX),I!(L,42-/&%D9GD8MND8FY_P &RW[;7QE^ '_!1SXM
M_P#!&+XG>/M3\0^#?#NK^(+;X?+JUVT\FC7>D7SPRV\+,<I!- DDAC'RK) "
MJJ9)">]_9B_X(N?\%'/^",7_  4H\8?M+_L":!\._B+\'/&.G7ME=:#XP\:-
MH4ND:=+.ERBW$I@E"FU>-0LT:R[X@^8T9\+\Y?\ !K[\,O'G[8W_  6Q^-7_
M  47U/2((=#TBY\0ZM=WVG&1[-M6UR^E,5O"\BJSIY#WC@E0P5$W*"XH _H^
MHHHH ^5O^"GO[&7[1G_!03PMHG[+?@+]H;4OA7\--3BNKKXG>)?#1#:QJR+Y
M:6VD6^6 B@DWS2SR'.1#%'M=9) /Y[/VIOV/OVC_ /@W"_X*]?#+3?V5OCEJ
MOB2#Q(VFZEX=D2,VTNLV4U\;:?1[^"-BDP9HRN1\K"2-U".,)_5KJ>IZ;HNF
MW&LZSJ$%I9VD#S75U<RB..&-069W9B J@ DD\ #-?E;^SA^RHW_!8+_@J^/^
M"Q_Q9T&:#X)_"NWAT/\ 9RTW4(#&_BJ6SFED/B%D8 K:"ZEFEMR0&E*P,<+$
M0X!]<?\ !9O]MW6O^">7_!-GXG?M0>#9(1XETO2HK#PEY\8=5U.\GCM8)2C<
M.(FE,Y4\,(2#UK\=_"7P.\(>,/\ @U2\4?\ !1_Q%9M=?'ZX\;2^+XOC-.Y;
MQ-%J$/BF+3PZ:D?])1?LT;H$#A079@,G-?<W_!VC9R_$+_@BAJWC;P-J,.HZ
M/:>,O#NJS7^GSK+!/92S&&.574E7C9[F A@2#N4CK7RA\,Y8T_X,>-7((XL[
M]6^I\=M_B* /T7_X(@_\%!/BC_P4!_X)-^&OVBM?L8O$/Q*T6QU#0]?MO/2V
M75M8L<B)F?A(FN(C;2.V JM.V % K\W/^"QW_!MU\=/$G[,'Q$_X*2_&G]O+
M6/B#\9/#N@7'B?Q?I>H:6(M%^QP(T]S8Z;ES);0V\0?R0<JXB"[(R^5^E/\
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M&Z,:YVRM!LD=$)7S6=4. I^GJ* /R,_85_X(G_MM>(?^"5&N?\$G/^"@%YX
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M > O!OPL\#:/\-/AWX<M='T#P_ID&GZ-I5E'LAM+6%!'%$@[*JJ /I7Y[_\
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MO_I+.O ?[[3]4?.__!P?_P IC?CA_P!AVP_]-=G7QI7V7_P<'_\ *8WXX?\
M8=L/_379U\:5_GMEO_(NH_X(_DC[5[A1117: 4444 %%%% !1110 5Z'^S5^
MUE^TC^QW\0HOBE^S+\9-<\':W'M$MQI%WMCND!R(YX6S%<1YY\N567VKSRBI
MG"%2+C)73Z,#^@O_ ()G_P#!V'\*OB=_9_PG_P""BWAVW\%ZZ^V&'XA:';N^
MD7;= ;J ;I+-B<9=/,BR23Y*BOV%\*>+?"OCSPU8^,_ _B6PUG1]3MDN--U7
M2KQ+BVNX6&5DCDC)5U(Y#*2#7\-]?5__  38_P""R/[97_!,CQ+'%\(O%_\
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MKHGCQ@EMI?B&3A52X'"6=TW&#Q#(Q('EL51OYVJ*\W,LJPN:4N2JM5LUNO\
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MI#I=S;ZA\3_^":_CA[><;IC\,O%U_NC?OY=E?ORAZ!8[G<"3DSJ.*_%#XU_
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M^6'58T'&),;90O"2@G"K)&#]]5^18K#5L'B)4:JM)?U^)LG=!1117.,****
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M ?A;]H_X,:V+_P .>+=)COM/E./,B)RLD$H!.V6*17C=<_*Z,.U?Q-5^O/\
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M8^("BBB@ HHHH *GTS3-2UO4K?1M&T^>[O+N=(;2UMHC))-([!51%4$LQ)
M'))Q4%?M?_P;5_\ !(R 6]C_ ,%&_P!HSPMN=F+?"G1;^'A0,AM7=#WSE;?/
M3#2@<Q./A_$/CO*?#OAFKF^.U:]V$+V=2H_ABOSD_LQ3=G:QTX3"U,765./S
M?9'TK_P0G_X(RZ+^P5\.X/V@OCWH%O=?&+Q)8Y:.4+(/"UG(O_'G$>1]H8']
M]*/^N:G:&:3]%***_P IN+.*LZXTSZMFV:5.>K4?RC'I"*Z1BM$OF[MMO[FA
M0IX:DJ<%H@HHHKYPV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *_%#_@Y*_P""%T'C?3-9_P""B?['?@M4URTC>\^*7A'3
M(,?VE" 6?5K>-?\ ENHR9T _>*#*/G5_,_:^D95=2CJ"",$$=:[LOQ]?+<2J
MU)^JZ-=F)I-'\,%%?J3_ ,'(O_!&Z#]B+XL_\-=?L[^&?)^%7CK5&74M+LX<
M1>&-7?+F$ <);389XNR,'C^4>4&_+:OUS!8RCC\-&M2>C_!]GZ&+33"BBBNH
M04444 %6M"UW6?"^N6?B7PYJMQ8ZCIUW'=6%[:2F.6WFC8.DB,.596 ((Y!
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MX=T\=5C:MC7[5]^3:DO3EO-?XV?&YSB/;8MQ6T=/GU_R^04445_0IY(4444
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MG\P/[F[&^LM4L8=3TV[CGM[B)9;>>%PR2(PRK*1P0000?>I:^1/^"$O[2_\
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M-= /X7Z*W/B=H<'ACXE>(?#5LFV/3]<N[:-?18YG0#\A6'7[DFFKG.%%%%,
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MBB@D 9)H _B3_:1,+?M$^/6MAB,^--5\L?[/VN7%<76U\2->B\5?$37_ !1
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M?$6^\,#P[XEUC1].M+RUU_34D\R!;NUN8V1Y[=RQAN%*NH=D?S(R$ !\@?\
M!+/0M5\7_P#!>']O_P"-FF1M_8%OJ/A/PX+@#]W-?P:=MF13T+1^1\P[>:OK
M2_\ !UEX:U2\_P"">/@7XDI;R-HW@#]H+POX@\4R*"5BT\"[M"[_ .SYMW /
MJ17VE\!_V)?A9^S=\ O$?P+^%7B#Q%9W'C"[U34_%7CJ345.O:KK6H!OM6L2
MW"HJ_;"Q#*RHJ1^7&J(J(JC'^#'[ 7P^\$_L&0_L ?'?X@>)?C'X;GT.]TKQ
M!K7Q$U!KG4-7M[F:64K)*#N7R_-"1%6W1+%'M;*!J /F#_@ZCO'U#_@C/XS\
M$Z/;->:GXN\6^&=*T&SMQNDN[I]7MIDCC ^\S+"V .M?2/C'_@G)\'?BIIVC
M^(?&.J^(=#\7+\+4\!>*/$/@_6?L=QK>A,J&;3[AMK QF0.R2H$GB,DGE2Q[
MVSE^%/\ @F?H4NK_  VB^/?[0GC#XG>'O@U?P7_PS\->*+>QCAM+ZWB:&TU"
M^DMX$?4;NWB9EBED*JI8R,CRXD'M'[0?PO\ $WQI^$FJ_"OPQ\3+WP@VNK':
M:EKFEP;KR.P:11=Q6SAU^SSR0>9$EP-QA:02*K,@% 'R[X//PD;0;W]H;PYX
M,BT_]G3]ECPWJ,?PH\-:6G^CZWJ.EV<T5YK$88GS(;6..:QLV8G?*UY<9<&V
MD'G'P$_X*=_M16MO^R-\:OCW?:!J/AC]K:_NK"?PUI6C^0?!]U/;M=Z0+6?>
M7N4,:^3<>?DL["2,Q*IB/WU;?"'X967PD7X#V/@C3X/!T?A[^PH_#D$ 2U33
M?(^S_951<;8_*^3 [5\L? __ ()!:%\,/%7P5L_''QYOO%G@;]G%]1D^#GA6
M?0$MKBUFN5:*&74[P3.+]K6!C%!Y<-L!P\@D89H ^RJ*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH \W_;!TK^V?V8?'%GMSL\/S3X_ZY 2_
M^R5^4]?K_P#%O0Y/$_PJ\3>&HDW-J'AZ]ME7'4R0.H'ZU^0%?O7A#6YLMQ-+
MM-/[U;_VT_B7Z5.$<.(,NQ-OBI3C_P" 3O\ ^WA1117Z\?RJ%%%% !6GX)UE
M?#GC/2/$+/M%AJ=O<%O39(K9_2LRBIG"-2#@]GH:T:LZ%:-6&\6FO5:G[0 A
M@&4@@C@BBN6^!WBA?&OP9\*^*Q+O:_\ #UI-*<])#"N\?4-D?A74U_%V(HSP
M]>=*6\6T_5.Q_KK@<73Q^"I8FG\-2,9+TDDU^84445D=04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5QG[1_CR/X5_L\^/?B?+($7PWX,U35&<G&T6]I+*3_XY79U\E_\%UOB
MTOP7_P""2/QS\5?:!&^H>#'T*+GECJ<T6GD#U^6Y8_0$]JWPM)UL5"GW:7WL
M3V/Y$Z***_;3 **** "BBB@ K^T+_@GWX8_X0G]@OX)>#O+V'2OA'X;M&7'>
M/2[=#^.17\97AO0-0\5>(K#POI,>^ZU*]BM;9/[TDCA%'YD5_<'X3\-Z?X.\
M*Z9X1TE-MKI6GPV=LN,8CB0(H_)17Q'&D[4Z,/.3^ZW^9I3-"BBBO@C0****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****  @$8(K\>?B1X<_X0_XAZ]X2V;?[+UJZM-OIY<K)_P"RU^PU?F)^WYX.
M_P"$._:I\2I%%MAU-X=0@./O>;$I<_\ ?P25^N>$6+5/-<1AG]N"E_X"[?\
MMQ_+7TI\KE7X:P&8)?PJLH/R52-_NO37X'C5%%%?OA_$ 4444 %%%% 'Z1?\
M$UO&R^*_V8+'1WGWS:!J5S82 GD*7\Y/PVS #_=]J]^KX3_X)/\ Q$72_B!X
MC^&-Y<X35].2]LT8\>; Q5E7W*29/M'[5]V5_*W'>7O+N*<1&VDWSK_M_5_C
M=?(_TP\%<]CG_AK@*C=Y4H^REY.F^57]8*+^84445\@?J@4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5^2O\ P=^?'@>!OV$O!'P'L;SR[OQ[X_6XN(]W^ML=/@:208]IY[,Y
M]O>OUJK^:C_@[1_:67XM_P#!1G3/@5I.HB73OA;X.MK2XA5\JFI7W^F3L.V3
M UDI'8QG/H/>X:PWUC-X=HWD_EM^+1,W:)^6U%%%?JQB%%%% !1110![[_P2
MN^$\GQO_ ."D7P/^&@@,L-[\3=(FOHP,YM;>Y2XN/_(,4E?V1U_,%_P:J_!6
M?XH?\%8=)\=M9[[;X>^#-7UN61E^57EB&G(/3=F^+ ?[!/:OZ?:_..,*W/F$
M*:^S'\6W^EC6&P4445\D6%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7P_\ \%:/ CVWBGPI\2X(LI=V$NFW
M+@?=:)_-CS[D2R?]\5]P5X;_ ,%$OA\WCO\ 9@U>[MK?S+G0+B'5( !R%0E)
M3]!%)(W_  &OK.!\P_LWBC#5&])2Y'Z3]W\&T_D?F'C)D3X@\-\PH15YPA[6
M/>])J;MYN*:^9^:-%%%?U8?YE!1110 4444 =A\ ?B7+\'_C+X=^(R2,L6FZ
MDC7@3JUNWR3*/<QLXK];;:YM[RWCN[299(I4#QR(V592,@@]P17XQ5^E7_!/
M'XR)\4_V?++0[^\\S5/"S#3;Q6;YC"!FW?Z&/Y,]S$U?COBUD[JX6CF4%K#W
M)>CUB_1.Z]9(_K'Z+W%<<-F.+X>K2TJKVM/_ !15II>;C9^D&>[4445^$G]I
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &-\1O'_A3X3_  ^UWXI>.]52QT/PWH]SJFL7LGW;
M>UMXFEED/LJ(Q_"OXL_VH?CQXE_:B_:-\<?M%>,"PU'QKXIO=8GB9]WD">9G
M2%3_ '8T*HH[*@%?T1_\'5G[;L'[/'[!$'[-'AC5_*\3?&+4?L,B1/AX=&M6
M2:\DXZ!W-O!@\,LTN/NFOYH:_0^$,$Z>&GB9+63LO1?YO\C*;UL%%%%?8D!1
M110 4444 ?OE_P &;/P#DTOX5?&3]I[4; _\3G7=/\-:5<.N-JVD+7-R%/<,
M;NVS[Q>QK]KJ^2/^"%G[-?\ PRS_ ,$KOA%X#OM/^SZIK'AX>)-;#+B0W.I,
M;P*X[-'%+%$?3R@.U?6]?CV<XGZWFE6HMKV7HM/T-XJR"BBBO,&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!577=%T[Q)HEYX>U>W$MI?VLEM=1'H\;J59?Q!(JU13C*4)*479HF<(58.$U
M=/1KNF?CS\1O!6H_#CQ]K/@+5@?M&CZE-:2,1C?L<J''LP (]B*Q:^HO^"I/
MPB/A7XM6'Q6TZVQ:>)K3R[ME'"W< 523Z;H_+QZE&-?+M?U_P_FD,YR:AC%O
M.*O_ (EI)?)IG^5/'/#=7A'B[&93-:4IOE\X/WH/YP:?J%%%%>P?)A1110 5
M[3^P?\=4^"/QUL_[9O?)T37U&GZJ7;"1[C^ZF/8;'QD]E=Z\6HKAS++\/FN
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M)5CMT;^)(%;&6-?3]%%?CE>M4Q%:56H[N3NS=:!11160!1110 4444 %%%%
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M;5OSPHH((."**_HT_@(**** "BBB@ I4=XW$D;%64Y5@<$&DHH#8^S?V._\
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MC4IS5XRBU*+7DUHPHHHK$ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***\7_;:_P""@?[*7_!/;X8/\4?VH/BA:Z-#*KC2=&@Q-J6KRJ/]5:VP.Z4Y
M(!;B--P+N@YJZ=.I6FH03;>R0'L6I:EIVC:=<:QK%_!:6EI \UU=7,HCCAC4
M%F=V8@*H ))/  S7X3_\%N?^#F-=?M=8_9-_X)L^+I8[5]]GXH^+5C(4:9>5
M>#2F'*J>0;O@GGR<#;*?CG_@K9_P7]_:9_X*47MY\+_!ANOA_P#",2XA\(V%
MYFYU=5/RR:C,N/-Y&X0+B)3C(D91)7P'7WV2\,1H-5\8KRZ1Z+U[ORV]3*4[
MZ(=++)/(TTTC.[L6=V.2Q/4D]Z;117V9 4444 %%%% !115G1]'U;Q#JUKH&
M@Z9<7M]?7*6]E96D+22W$KL%2-$4$LS,0 H&22 *-@/6/V#?V+/BQ_P4"_:A
M\,_LP_""S(O=;NM^IZH\1:'2-/0@W%[-CHD:'@9&]RB#YG4'^P7]F;]G7X7_
M +)7P$\*_LX_!K118>'/"6DQV.G1'&^7&3)/(0!NEED+R.V/F=V/>OD'_@@3
M_P $D[/_ ()H_LS'Q1\3](MV^+?CZ"*Z\87 VN=)MQ\T.E1N.,1YW2E>'E)Y
M98XR/OBOR_B/-_[1Q/LZ;_=PV\WU?Z+_ ()K&-D%%%%?-EA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<W\8O%/C/P3\+-
M?\4_#CP0_B7Q%9Z7*V@: LWE#4+XKM@A>3!\J-I"@>0@A$W.00M=)10!^3__
M  4%O_\ @N;_ ,$S?@O=?\%)+W_@H=X8^+&D>%;ZTNOB1\%I?A;9Z3I"Z=/<
MQPO'IUTC276(FE50\C"5D!D8L5,3?3'[9G[?WB[3_&7[,_[,/[/FK'PSXO\
MVG]3EELO$=_817$WAO0K/3TU"_N(X90T3WICDBAA$JO$'=G9)!'L;7_;@\!6
MW_!1;Q G_!/S1#Y_P_T_7-.U+X_ZW&?W7V2VEBO;;PW$XZW=W(EO).%.8+,$
MOAKJ -@?\%7/^"='QJ_:D\8?!/\ :L_8Y\:^'M ^+O[/OBJ;5?"5EXI$L>D:
MU8W"PK>:;</ C20B1($5753@&1?EW[T ,7XE_M.?'7_@G;_P40^"W[/WQ?\
MC=K/Q'^$W[0\U[H6BZGXLL;!-5\*>)[=8W@03V-M;I<6EWYRQB.2-GCD!99
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M&#Q7X'\17>EZC;',5U9RE6 [J>S*>ZG(/0@U]A_L_?\ !4BRNO(\-_M"Z/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7/UV&7%<;JG_  3'_:AT_/V2QT*^QT^RZN!G_OXJ5]%0XVX4Q*O#%P7K>/\
MZ4D?!8WP>\3<!*U7*ZK_ ,"53_TAR/GJO3OV,?\ DZ3P3_V&E_\ 06K5O_V
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M\97,>/,@MKNTTNSD]<HD,DH_"85]>_ /_@B/_P $K/V;C#<_#O\ 8K\'W5Y
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ME&/JX+&9A&%6G)QE%QJ.TEHUI!K3R9];45\D_P##VOX=_P#1(]:_\#H:^J]
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M1O\ A:GBF&XET?P3:M)<7C1P6LEW(TPB5EM1Y$3N#,T>\ !=Q900#U:BBB@
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M6IZ=<"6"=#T9'7A@>Q'!H UZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E'_ (+E?\HD
M?CQ_V(LO_HV*OY#:_KR_X+E?\HD?CQ_V(LO_ *-BK^0VOT7@W_<:G^+]$95-
MPK]EO^#-;_DYCXS?]B+8?^EIK\::_9;_ (,UO^3F/C-_V(MA_P"EIKUN(?\
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M_P 1O ^N_P#!P/\ L ZQI_B6V\G4?!GCVZM1<,89&BN]$86Q:.0*Z&0@JJL
MQ8%<9&* -7PI^WA^W+XO_P""YOCG]F$?LX1S^$_ WPEMY=)T&'QQ;0LT%[J5
MN7UJY)!1Y"L2(ENNYHT!^;,CBO;/V1/^"EOB3]IC]M'XJ_L1>,_V9+WX?^)O
MA%:V=SX@DUCQ3!<C48+O<;:XL$BBS<0,H5C(Q38)8PPWDH/G'3_C=\)/V>/^
M#F/XK7GQO^(&F>&%\5_LV>'X/"J:M<"*36[@:DD8MK-/O75PSJRI!$&D<JP5
M6(-:G_!:BR\:_L%_M*_"3_@ME\%/ NH:Z?!TH\!?&KPWHJ?Z1KOA?4I@MJP'
M1I+>^>/8#]Z2: $A4- 'V)\"?VH_%?QK_:(^*WP7'P<_L[1?A9K5OH]QXSC\
M0)<6^JW\UG;7RV\,0B5E>.VNH3-N.(Y) BF3YF7V.O'OV$/@=XJ^ G[,NA>'
M?B9)%-XXUV:Z\2_$6[A.5G\0:E.][?[6[QQS3-#%_=AAB48"@#V&@ HHHH *
M*** /XW/VE?^3C/'_P#V.VJ_^EDM<57:_M*_\G&>/_\ L=M5_P#2R6N*K_:?
M+/\ D6T?\$?R1^<S^-GU!_P18_Y2I?!#_L=HO_14E?U<5_*/_P $6/\ E*E\
M$/\ L=HO_14E?U<5_!/TNO\ DML!_P!@_P#[DJ'U.0?[M+U_1'Y#_P#!7S]B
M?]I7XL_\%0-1_;#_ ."?'B,Z+\<O@C\#?#/B?P]IEM;H(_%L4FKZ_!>:=<8P
M9GDMX(XT#':ZJ83@.KQ_0?@G_@I%\'O^"I/_  1:^,_QL\$68TO7;/X0^)]+
M^(7@>];-UX>U9-(N1-;2JP!:-N6CD(&]#R%=71?4/!WC;P?<?\%H_B!X+M_%
M%A)J\?[-7A1Y--2[0SH$U[7V;* Y&%FA8C' E0]&&?A/_@NG^PM\=/V&==^)
M/_!53_@G3HGF:1\0/!&J>'OVFOAI;(WV75;"[M983KT<2=)H6E\V5U&58&8@
MH]UN_DX]T^L?^"E7PU\(?%/_ ((LVWPG\8:8)M$UVR^'NF7]M$=A^SRZ[HL3
M!2/N$*QP1T."*\N_X-W?BOXY^"%K\6O^",_[0&MO<>-?V:O%4L/ABZNOE?5_
M"=Y(9K*Y0'DJID!]$CNK9.,5Z[_P4.\8^%/ _P#P2.\/:SXQ\1V6EVGVWX;@
M7%_=+$A(U_1G(!8C.%5F/HJL>@)KY]_X+=>!?CK^Q;^W#\#?^"QW[%OPX;Q5
MXBN+I/AC\0/"EHY5/$5KJ9,>E&0IV%TX3>>L@LQG"T ?/O\ P=2:KJ?[3WPJ
M\3>.+6_F;P)\!_'VA^$--BCD/D:IXJU$"ZU25L<2"SLQ8VR]0);V\4X:.OW7
M5550JJ  ,  =*_&3_@XH^#&A_L?_ /!!#P;\$/%'C.VU#Q))\4M(O_$NM32!
M9O$&NW,MW?ZK?A3AF,MS+<38YVJRKT45^RNEZIIFN:9;ZUHNHP7EG=P+-:W=
MK,LD4T; %71E)#*0001P0: )Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .)_:/\ V?OA
MU^U3\#?$W[/'Q:MKN;PWXMTUK'6(K&Z,$S0E@Q"2#E3E1S7PG_Q"H_\ !)'_
M *$_QU_X6TO_ ,17Z145UX?'8S"Q<:-1Q3[.PFDS\W?^(5'_ ()(_P#0G^.O
M_"VE_P#B*]__ & O^"/O[&/_  34\7^(/''[+^B>(;6_\3:;%8ZHVLZ\]XK0
MQR>8H4,!M.[O7U'15U<SS"O3<*E633W3;"R05R7Q:^ 7P)^/NEP:'\=?@KX2
M\:V5LY>VL_%OARUU**)CC)5+B-PI.!R!VKK:*X1F!\-OA3\+O@UX8C\$_"#X
M;:!X4T6%R\6D>&]'@L;5&.,D10*J G YQVK,^(G[.G[/GQ>T-O#'Q9^!/@WQ
M1IC7<ETVG>(O#%I>P&>0YDE,<T;+O8\EL9)ZFNRHH Q?A_\ #?X=_";PM;^!
MOA7X"T7PSHEGG[)H_A_2X;*U@R<G9%"JHN3Z"J/C7X(_!?XE:K'KOQ&^$7A?
M7[Z*W$$5YK>@6UU*D09F$8>5&(4,S';G&6)[FNHHH R_"'@CP7\/M&7PYX"\
M(:7H>GK(TBV&D:?';0AV^\P2-0N3W..:U*** "BBB@ HHHH \F^,'[%GP.^.
M7C-_'OCVPU*34)+>.%FM=1:--B#"_*![URW_  [,_9;_ .@3K7_@X;_"OH*B
MO=H<3<0X6C&E2Q4XQBK)*3LDNB/C,;X=<"9CBYXK%9;1G4FW*4I4XMMO=MVU
M;/GW_AV9^RW_ - G6O\ P<-_A7O6DZ9:Z)I5KHUBK""TMTAA#-DA$4*,GOP*
ML45R8_.,US116,K2J*.W,V[7WM<]/).%.&N&Y3EE6$IT'.RER14;VO:]M[7=
MO4RO$7@;P3XPCFA\6^#M*U1+BR>SG74=/CG$EL[*SPL'4YC9D0E#P2JDC@5S
MOPD_9F_9O^ -S>WOP)_9]\$>"IM2_P"0C+X2\*6>FM=<Y_>&WC0OSS\V:[>B
MO-/H#\Y_$'[*GQ3^*7_!>KQ#^T?\8?V']0\1_!/6OV=X?AZ^J^(X-%OK&;4T
MUN&_$\EE+=-*;8(C .8BP8#Y,<U^@7@?P%X%^&/ABU\$?#;P7I/A[1;%2MEI
M&AZ=%:6MNI))"11*J(,DG@#DUK44 <?J'[/7P"U;XGP?&[5/@=X/N?&EJH6V
M\7W'AFU?5(0!M 6Z,?FJ  !PW3BMCQY\/? /Q3\+77@;XG>!]'\1Z)>@"\T?
M7M,BO+6< Y >*561\$ \@\BMBB@#G]!^$WPK\+> %^$_ACX:>'].\+);-;KX
M:L-&@AT\0MG=&+=$$80Y.5VX.35;PK\#?@IX%6\7P3\'_"VC#4;8VVH#2O#]
MM;_:H3UCD\M!O0Y^ZV174T4 <=IG[/'P T7PA:?#[1_@;X.M- L-374K#0[;
MPS:1V=M>J<K<QPK&$28'D2 !@>]/\2_L_? ;QIXAF\6^,?@EX1U;5;@H;C4]
M3\-6L]Q*44(I:1XRS85549/ 4 =*ZZB@#(U7X?> M=\5:=XZUOP1I%YKFCI(
MFDZS=:;%)=V2N,.(9F4O&&'!"D9[U\>>'E_X*/\ [;GQX?X3?M:_L<:!\*/@
M[X!^)B:ZFNP_$"#5[KQ]#IUP9](MX[6%!]FA%S':WLTDS MY"0B,;I"OVU10
M 4444 %%%% !1110!\">+_\ @VN_X)A^-_%FJ>--=\*^,FOM7U&>]O&B\7RJ
MIEED:1R!MX&YCQ6?_P 0PW_!*W_H4_&W_A92_P#Q-?H717Z%#Q9\3*<%".;X
MA):+][+_ #.1X#!-_P -?<?$W[/?_!O[_P $[?V8_C5X<^/OPL\-^*XO$/A;
M45O=)DO?%$DT2RA2H+(5PPPQXK[9HHKYG/>)>(.)\1'$9MBIUYQ7*G4DY-*[
M=DWTNVS:E1I4%:G%)>1QUE^SQ^S_ *;XD3QCIWP,\'0:O'=_:H]5A\,VBW*S
M[MWFB41[@^[G=G.><UUE]8V6IV4VFZE9Q7%O<1-%<6\\8=)488964\,""00>
M"#4M%>&:G,>+/@I\&O'L5C;^.?A)X8UJ/3(/)TU-6T&WN1:1<#9$)$/EK\J\
M+@<#TK3T7P1X+\-^'K;PCX=\(:78:39R+)9Z79:?'%;P.LGFJR1JH52)/G!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>mdt-20221028_g13.jpg
<DESCRIPTION>IMAGE 5
<TEXT>
begin 644 mdt-20221028_g13.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*[22OIK9)>1^B9?B)XO TJT]Y13=MM4%%%%?.'8%%%% !1110 4444 %%%%
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M /R/1_P\+_; _P"BO?\ E T__P"1Z_2_^(2\1_\ /VE_X%/_ .5G\\?\31<
M?] V*_\  *7_ ,N/TXHK\Q_^'A?[8'_17O\ R@:?_P#(]'_#PO\ ; _Z*]_Y
M0-/_ /D>C_B$O$?_ #]I?^!3_P#E8?\ $T7 '_0-BO\ P"E_\N/TXHK\Q_\
MAX7^V!_T5[_R@:?_ /(]'_#PO]L#_HKW_E T_P#^1Z/^(2\1_P#/VE_X%/\
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M110 4444 ?T.?\&<'_)G7Q8_[*9%_P"F^"OV$K\>_P#@S@_Y,Z^+'_93(O\
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MV0?Y+A1110 4444 %%%% !1110!^AG_!*[_DV^__ .QMNO\ T1;5]*5\U_\
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M]R3_ -&-70USWPH_Y)_IW^Y)_P"C&KH: "BBB@ HHHH **** "BBB@ HHHH
M**** "O-/VTO^3.OBS_V3/7O_3?/7I=>:?MI?\F=?%G_ +)GKW_IOGK6A_'C
MZK\Q/8_BJHHHK]O, HHHH **** "BBB@ HHHH _H<_X,X/\ DSKXL?\ 93(O
M_3?!7["5^/?_  9P?\F=?%C_ +*9%_Z;X*_82OR3B#_D<5O5?DC:/PG!_M1_
M\FW>._\ L4[_ /\ 1#U^3=?K)^U'_P FW>._^Q3O_P#T0]?DW7['X0_\BO$_
MXU_Z2?Q']*C_ )*7+_\ KS+_ -+84445^N'\LA1110 4444 %%%% !7Z&?\
M!*[_ )-OO_\ L;;K_P!$6U?GG7Z&?\$KO^3;[_\ [&VZ_P#1%M7YUXH_\DJ_
M\<?U/WWZ-O\ R<N/_7FI_P"VGTI7R]_P6E_Y1=?&+_L7(?\ TLMZ^H:^7O\
M@M+_ ,HNOC%_V+D/_I9;U^)\$_\ )9Y;_P!A%'_TY$_OK,O^1=6_P2_)G\R%
M%%%?ZHGX8%%%% !1110 4444 %%%% ']%7_!NE_RBZ\+_P#8QZS_ .ECU]S5
M\,_\&Z7_ "BZ\+_]C'K/_I8]?<U?Y?\ B7_R<+-?^PBK_P"EL_;<F_Y%-#_!
M'\D<S\8/^2?WO^_%_P"C%KQ6O:OC!_R3^]_WXO\ T8M>*U\.>F%%%% !1110
M 4444 %%%% !7M_PH_Y)_IW^Y)_Z,:O$*]O^%'_)/]._W)/_ $8U '0T444
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M --\%?L)7X]_\&<'_)G7Q8_[*9%_Z;X*_82OR3B#_D<5O5?DC:/PG!_M1_\
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M\D_T[_<D_P#1C5T-<]\*/^2?Z=_N2?\ HQJZ&@ HHHH **** "BBB@ HHHH
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M?\&<'_)G7Q8_[*9%_P"F^"OGN*?^1//UC^94/B/V$K@_VH_^3;O'?_8IW_\
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M<S\8/^2?WO\ OQ?^C%K^"S]3/%:*** "BBB@ HHHH **** "BBB@#V_X4?\
M)/\ 3O\ <D_]&-70USWPH_Y)_IW^Y)_Z,:NAH **** "BBB@ HHHH **** "
MBBB@ HHHH *\T_;2_P"3.OBS_P!DSU[_ --\]>EUYI^VE_R9U\6?^R9Z]_Z;
MYZUH?QX^J_,3V/XJJ***_;S **** "BBB@ HHHH **** /Z'/^#.#_DSKXL?
M]E,B_P#3?!7["5^/?_!G!_R9U\6/^RF1?^F^"OV$K\DX@_Y'%;U7Y(VC\)P?
M[4?_ ";=X[_[%.__ /1#U^3=?K)^U'_R;=X[_P"Q3O\ _P!$/7Y-U^Q^$/\
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M_P"%'_)/]._W)/\ T8U=#7/?"C_DG^G?[DG_ *,:NAH **** "BBB@ HHHH
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M84444 %%%% !1110 4444 %>W_"C_DG^G?[DG_HQJ\0KV_X4?\D_T[_<D_\
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MVZ_]$6U?2E?-?_!*[_DV^_\ ^QMNO_1%M7TI7\G<9_\ )58O_&S_ $_\)/\
MDVF5?]>8_J?+W_!:7_E%U\8O^Q<A_P#2RWK^9"OZ;_\ @M+_ ,HNOC%_V+D/
M_I9;U_,A7]>?1?\ ^2,QG_80_P#TW3.?C;_D8T_\'ZL****_I4^,"BBB@ HH
MHH **** "OZ*O^#=+_E%UX7_ .QCUG_TL>OYU:_HJ_X-TO\ E%UX7_[&/6?_
M $L>OY[^DO\ \F]I_P#813_](J'UO!?_ "-I?X'^<3[FKF?C!_R3^]_WXO\
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MNO\ T1;5]*5\U_\ !*[_ )-OO_\ L;;K_P!$6U?2E?R=QG_R56+_ ,;/]/\
MPD_Y-IE7_7F/ZGR]_P %I?\ E%U\8O\ L7(?_2RWK^9"OZ;_ /@M+_RBZ^,7
M_8N0_P#I9;U_,A7]>?1?_P"2,QG_ &$/_P!-TSGXV_Y&-/\ P?JPHHHK^E3X
MP**** "BBB@ HHHH *_HJ_X-TO\ E%UX7_[&/6?_ $L>OYU:_HJ_X-TO^477
MA?\ [&/6?_2QZ_GOZ2__ ";VG_V$4_\ TBH?6\%_\C:7^!_G$^YJYGXP?\D_
MO?\ ?B_]&+735S/Q@_Y)_>_[\7_HQ:_@L_4SQ6BBB@ HHHH **** "BBB@ H
MHHH ]O\ A1_R3_3O]R3_ -&-70USWPH_Y)_IW^Y)_P"C&KH: "BBB@ HHHH
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M_P#Z(>OS[*?^1I0_QQ_]*1Y'$_\ R36-_P"O-3_TB1^3=%%%?V0?Y+A1110
M4444 %%%% !1110!^AG_  2N_P"3;[__ +&VZ_\ 1%M7TI7S7_P2N_Y-OO\
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MU\SR*BOI.R_X)-_MHW^@0W%MX%L3XBN? S>,K;P"=24:[+H(E$1O1;8QC>P
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M]!^)4/B7RY_B9XP\26D]\+FYDBMY+>RB5) EG!*)+A4>-1(?+3Y]WW_S5O\
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M!&,EI95.TA6Q]*?L-_M[?"?XP?\ !<GX3?M(?M'Z=I7A3X9>']5&B^"] N9
M--\'Z9#8W%MHL 9OE1(+A[>5YC@>9YDS8R::P-+!1J1I7DE'WEW4;N,/65]?
M+IJ@O<^0_C/^RA^U;\#]*7QO\>O@)XT\-6=[J)MGU3Q'H5Q AO6C$Q@E>11L
MN#&ZR&)R)-K!L8.:_=3_ (,X/^3.OBQ_V4R+_P!-\%<3^UUJGA/X&?L+_P#!
M0J/]J6%;2V^)_P =[M_A+8ZNN'UZY>.SFM;RP5^9XHT,$IFCR@6%AGC%=M_P
M9P?\F=?%C_LID7_IO@KS\VQL\;D524HVM**NMGL]/2]OD5%6D?L)7!_M1_\
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MOK*-/][6LFX7BGR\DK_7'_!*[_DV^_\ ^QMNO_1%M7TI7S7_ ,$KO^3;[_\
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MH,_B?X0_$71O$EA:WTME>7.C:A'.+:ZC.)+>4(28I4/#1N R]P* /I3X4?\
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MM)./+&235J;@I:)-KJ[M_2E?+W_!:7_E%U\8O^Q<A_\ 2RWKZAKY>_X+2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"5^2<0?\CBMZK\D;1^$X/]J/_DV[QW_V*=__ .B'K\FZ_63]J/\ Y-N\=_\
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M110![?\ "C_DG^G?[DG_ *,:NAKGOA1_R3_3O]R3_P!&-70T %%%% !1110
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M][_OQ?\ HQ:Z:N9^,'_)/[W_ 'XO_1BU_!9^IGBM%%% !1110 4444 %%%%
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M_D&C_B'W'O\ T*<3_P""*O\ \@']K95_T$0_\#C_ )GV)17QW_P_V_X)*_\
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MMMQLDEJV]$BHYIEDY*,:\&WLN:/^9].4445\J=P4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!YI^VE_P F=?%G_LF>O?\ IOGK^*JO[5?V
MTO\ DSKXL_\ 9,]>_P#3?/7\55??\&?P*WJOR9E4W"BBBOM2 HHHH **** "
MBBB@ K^AS_@S@_Y,Z^+'_93(O_3?!7\\=?T.?\&<'_)G7Q8_[*9%_P"F^"OG
MN*?^1//UC^94/B/V$K@_VH_^3;O'?_8IW_\ Z(>N\K@_VH_^3;O'?_8IW_\
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M_P!DSU[_ --\]>EUYI^VE_R9U\6?^R9Z]_Z;YZUH?QX^J_,3V/XJJ***_;S
M**** "BBB@ HHHH **** /Z'/^#.#_DSKXL?]E,B_P#3?!7["5^/?_!G!_R9
MU\6/^RF1?^F^"OV$K\DX@_Y'%;U7Y(VC\)P?[4?_ ";=X[_[%.__ /1#U^3=
M?K)^U'_R;=X[_P"Q3O\ _P!$/7Y-U^Q^$/\ R*\3_C7_ *2?Q']*C_DI<O\
M^O,O_2V%%%%?KA_+(4444 %%%% !1110 5^AG_!*[_DV^_\ ^QMNO_1%M7YY
MU^AG_!*[_DV^_P#^QMNO_1%M7YUXH_\ )*O_ !Q_4_??HV_\G+C_ ->:G_MI
M]*5\O?\ !:7_ )1=?&+_ +%R'_TLMZ^H:^7O^"TO_*+KXQ?]BY#_ .EEO7XG
MP3_R6>6_]A%'_P!.1/[ZS+_D75O\$OR9_,A1117^J)^&!1110 4444 %%%%
M!1110!_15_P;I?\ *+KPO_V,>L_^ECU]S5\,_P#!NE_RBZ\+_P#8QZS_ .EC
MU]S5_E_XE_\ )PLU_P"PBK_Z6S]MR;_D4T/\$?R1S/Q@_P"2?WO^_%_Z,6O%
M:]J^,'_)/[W_ 'XO_1BUXK7PYZ84444 %%%% !1110 4444 %>W_  H_Y)_I
MW^Y)_P"C&KQ"O;_A1_R3_3O]R3_T8U '0T444 %%%% !1110 5_/'_P>/_\
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M&W_(QI_X/U84445_2I\8%%%% !1110 4444 %?T5?\&Z7_*+KPO_ -C'K/\
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MY&&(P:I5])&49J\7<_/:E.I2E:<6GYJP4459M-%UG4+2:_L-)N9X+9=UQ-#
MS)$/5B!A1]:;E&*NV*$)U':*N_(K459TC1=9U^]73=!TFYO;A@2MO:0-(Y Z
MD*H)J*ZM;FRN'L[RWDAFB<K)%*A5D8=00>0:7-%RY;ZC=.HJ:FT^5Z7Z7[7(
MZ*G32]3DTY]7CTZ=K2*41RW2PL8T<@D*6Q@$@' Z\5!333V%*,HVNK7.\_9=
M_P"3D/ G_8VV'_H]*_62OR;_ &7?^3D/ G_8VV'_ */2OUDK\%\7O^1IAO\
M _\ TH_MSZ*__)-9A_U^C_Z0@K^=7_@XM_Y2B^*/^Q<T;_TC2OZ*J_G5_P"#
MBW_E*+XH_P"Q<T;_ -(TKZCZ-'_)PJO_ &#U/_2Z9^\\9_\ (H7^-?DSX9HK
M?^%OPL^(GQM^(.E?"KX3^$+W7O$6MW0M]+TG3XMTL\A!)QV4!069B0JJI9B
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M'K-%>2_M$?MJ?!#]FOQQX/\ A-XPO=0U3QK\0+R2V\&^"_#UH+C4=3,:[I9
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MK\Q/8_BJHHHK]O, HHHH **** "BBB@ HHHH _H<_P"#.#_DSKXL?]E,B_\
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M44 %?SQ_\'C_ /R>+\)_^R9R_P#IPGK^AROYX_\ @\?_ .3Q?A/_ -DSE_\
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M[:4;-IZ??^#W7D*UF?VJT445^-FY^>?_  50_P"3D;'_ +%.U_\ 1]Q7*?L
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MK>-2E/G2DGTNK2B[.S>J=FO0S/%3PF>5YQ5U+F7JI*VGZ,_2[_@HCXS^$/\
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M **** "BBB@ HHHH *]O^%'_ "3_ $[_ ')/_1C5XA7M_P */^2?Z=_N2?\
MHQJ .AHHHH **** "BBB@ K^>/\ X/'_ /D\7X3_ /9,Y?\ TX3U_0Y7\\?_
M  >/_P#)XOPG_P"R9R_^G">OHN%O^1Q'T?Y$3^$_'NBBBOU(R"BBB@ HHHH
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M,A7]>?1?_P"2,QG_ &$/_P!-TSGXV_Y&-/\ P?JPHHHK^E3XP**** "BBB@
MHHHH *_HJ_X-TO\ E%UX7_[&/6?_ $L>OYU:_HJ_X-TO^477A?\ [&/6?_2Q
MZ_GOZ2__ ";VG_V$4_\ TBH?6\%_\C:7^!_G$^YJYGXP?\D_O?\ ?B_]&+73
M5S/Q@_Y)_>_[\7_HQ:_@L_4SQ6BBB@ HHHH **** "BBB@ HHHH ]O\ A1_R
M3_3O]R3_ -&-70USWPH_Y)_IW^Y)_P"C&KH: "BBB@ HHHH **** "BBB@ H
MHK)\=>(=4\*>$;_Q'HGA6[UR[M(#)!I-BRB:Z;(^1"W&?KZ4 :U%>%_\-8?&
MS_HQ_P =_P#@5;?_ !5'_#6'QL_Z,?\ '?\ X%6W_P 50![I7FG[:7_)G7Q9
M_P"R9Z]_Z;YZY;_AK#XV?]&/^.__  *MO_BJYGXT_&SXV?%_X.>+/A-_PQOX
M[T[_ (2CPS?Z1_:&ZVF^S?:;=X?-\OS%W[=^[;N7.,9&<UI2DHU8M[)H&?Q\
MT5^K?_$+-\;/^BC^._\ PTUM_P#+JC_B%F^-G_11_'?_ (::V_\ EU7ZG_K+
MDG_/W_R67^1CR2/RDHK]6_\ B%F^-G_11_'?_AIK;_Y=4?\ $+-\;/\ HH_C
MO_PTUM_\NJ/]9<D_Y^_^2R_R#DD?E)17ZM_\0LWQL_Z*/X[_ /#36W_RZH_X
MA9OC9_T4?QW_ .&FMO\ Y=4?ZRY)_P _?_)9?Y!R2/RDHK]6_P#B%F^-G_11
M_'?_ (::V_\ EU1_Q"S?&S_HH_CO_P --;?_ "ZH_P!9<D_Y^_\ DLO\@Y)'
MY245^K?_ !"S?&S_ **/X[_\--;?_+JC_B%F^-G_ $4?QW_X::V_^75'^LN2
M?\_?_)9?Y!R2/L'_ (,X/^3.OBQ_V4R+_P!-\%?L)7YD?\$;_P!D_P"-G_!)
M7X.>+/A-_P *;\=_$#_A*/$RZO\ VA_8%MI7V;;;QP^5Y?VRXW_<W;MR]<8X
MS7V'_P -8?&S_HQ_QW_X%6W_ ,57YUG&(HXK,JE6D[Q;T?R7<UBK([C]J/\
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M?_)E'_#&WQL_Z)'X[_\ "=MO_DRC_B(O!O\ T%?^25/_ ) /^(!^+7_0N_\
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MW_WZMO\ X[1_PEWQL_Z--\=_]^K;_P".T =917)_\)=\;/\ HTWQW_WZMO\
MX[1_PEWQL_Z--\=_]^K;_P".T =97M_PH_Y)_IW^Y)_Z,:OF3_A+OC9_T:;X
M[_[]6W_QVNW\*?M)?&SPQX?M]"_X8J\=S_9PP\WSK9=V6+=-YQU]: /H6BO"
M_P#AK#XV?]&/^.__  *MO_BJ/^&L/C9_T8_X[_\  JV_^*H ]THKPO\ X:P^
M-G_1C_CO_P "K;_XJC_AK#XV?]&/^.__  *MO_BJ /=**\+_ .&L/C9_T8_X
M[_\  JV_^*H_X:P^-G_1C_CO_P "K;_XJ@#W2OYX_P#@\?\ ^3Q?A/\ ]DSE
M_P#3A/7[4?\ #6'QL_Z,?\=_^!5M_P#%5^>/_!9#_@F-\;/^"M7QC\)_%G_A
M"_'?P_\ ^$7\,MI']G_\(A;:K]IW7$DWF^9_:%OL^_MV[6Z9SSBO:R#%X?!9
ME&K6E:*3ULWT\KDR3:/YX:*_5O\ XA9OC9_T4?QW_P"&FMO_ )=4?\0LWQL_
MZ*/X[_\ #36W_P NJ^]_UER3_G[_ .2R_P C/DD?E)17ZM_\0LWQL_Z*/X[_
M /#36W_RZH_XA9OC9_T4?QW_ .&FMO\ Y=4?ZRY)_P _?_)9?Y!R2/RDHK]6
M_P#B%F^-G_11_'?_ (::V_\ EU1_Q"S?&S_HH_CO_P --;?_ "ZH_P!9<D_Y
M^_\ DLO\@Y)'Y245^K?_ !"S?&S_ **/X[_\--;?_+JC_B%F^-G_ $4?QW_X
M::V_^75'^LN2?\_?_)9?Y!R2/RDKTO\ 8M_Y/%^$W_93-!_].$%?HA_Q"S?&
MS_HH_CO_ ,--;?\ RZKIO@M_P;5_&SX0?&/PG\6?^$O\=ZC_ ,(OXFL-7_L_
M_A5UM#]I^S7"3>5YG]L-LW;-N[:V,YP<8J*O$F2RIR2J]']F7^0*,KG]#]%>
M%_\ #6'QL_Z,?\=_^!5M_P#%4?\ #6'QL_Z,?\=_^!5M_P#%5^5FQ\S_ /!5
M#_DY&Q_[%.U_]'W%?-=?4W[5'P\^-G[3'Q(@^(7_  SIX[T3R=)BLOL?]F6U
MSNV22/OW_:4QGS,8QVZ\UYK_ ,,;?&S_ *)'X[_\)VV_^3*_H7AGCGA;+\@P
MV&Q&(Y9PBDUR3=GZJ+7W,_A#Q%\&?$K/>.,?F&!P//1JU'*,O:T5=/K:51-?
M-)GD=%>N?\,;?&S_ *)'X[_\)VV_^3*/^&-OC9_T2/QW_P"$[;?_ "97N_\
M$1>#?^@K_P DJ?\ R!\7_P 0#\6O^A=_Y6H?_+3R.BO7/^&-OC9_T2/QW_X3
MMM_\F4?\,;?&S_HD?CO_ ,)VV_\ DRC_ (B+P;_T%?\ DE3_ .0#_B ?BU_T
M+O\ RM0_^6GD=%>N?\,;?&S_ *)'X[_\)VV_^3*/^&-OC9_T2/QW_P"$[;?_
M "91_P 1%X-_Z"O_ "2I_P#(!_Q /Q:_Z%W_ )6H?_+3R.BO7/\ AC;XV?\
M1(_'?_A.VW_R91_PQM\;/^B1^.__  G;;_Y,H_XB+P;_ -!7_DE3_P"0#_B
M?BU_T+O_ "M0_P#EIS_[+O\ R<AX$_[&VP_]'I7ZR5^;'PN_9L^-GPV^)&@_
M$'_A2/CN]_L35K>]^R?V';1^=Y4@?9O^UMMSC&<''H:^L_\ AK#XV?\ 1C_C
MO_P*MO\ XJOR+Q&S[*L^Q]"I@:G/&,6GI)6=[_:2/ZF\ >"N)N"<DQF'SJA[
M*=2HI17/"=THI7O"4DM>]F>Z5_.K_P '%O\ RE%\4?\ 8N:-_P"D:5^VW_#6
M'QL_Z,?\=_\ @5;?_%5^=7_!1;_@EU\;/V_/VHM4_:3_ .$/\=^$_P"TM.L[
M7^Q?^$.MK_R_(A6+=YW]H0YW8SC8,9QD]:]_P.XKR#@_C&ICLWK>RI.C."?+
M.7O.4&E:$9/9/6UO,_6^)L#BLPRY4L/'FES)VNEI9]VC\>**_1/_ (AZ?C9_
MT&O'?_AMK;_Y;4?\0]/QL_Z#7CO_ ,-M;?\ RVK^MO\ B/'A1_T,?_*-?_Y4
M? _ZK9]_SY_\FC_\D?G917Z)_P#$/3\;/^@UX[_\-M;?_+:C_B'I^-G_ $&O
M'?\ X;:V_P#EM1_Q'CPH_P"AC_Y1K_\ RH/]5L^_Y\_^31_^2/SLHK]$_P#B
M'I^-G_0:\=_^&VMO_EM1_P 0]/QL_P"@UX[_ /#;6W_RVH_XCQX4?]#'_P H
MU_\ Y4'^JV??\^?_ ":/_P D?G917Z)_\0]/QL_Z#7CO_P -M;?_ "VH_P"(
M>GXV?]!KQW_X;:V_^6U'_$>/"C_H8_\ E&O_ /*@_P!5L^_Y\_\ DT?_ )(_
M.ROJ'_@BU_RE%^#O_8QS?^D=Q7N7_$/3\;/^@UX[_P##;6W_ ,MJ]1_8L_X(
M]_&S]D#]J+P=^TG_ &+X[\1?\(GJ+W7]B_\ "#VUI]JW0R1;?._M*39]_.=C
M=,8YS7A<4>-GACF/#..PF'Q_-4J4:L8KV597E*$DE=TTE=O=M+N=6!X:SJCC
M:52=*R4HM^]'9->9^UE%>%_\-8?&S_HQ_P =_P#@5;?_ !5'_#6'QL_Z,?\
M'?\ X%6W_P 57\!'ZL3?%?\ Y*!J/^_'_P"BUKG:P_%?Q,^-GB?Q!<:[_P ,
MA>.X/M!4^5MMFVX4+U\T9Z>E9_\ PEWQL_Z--\=_]^K;_P".T =917)_\)=\
M;/\ HTWQW_WZMO\ X[1_PEWQL_Z--\=_]^K;_P".T =917)_\)=\;/\ HTWQ
MW_WZMO\ X[1_PEWQL_Z--\=_]^K;_P".T =917)_\)=\;/\ HTWQW_WZMO\
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M)VV_^3*/^(B\&_\ 05_Y)4_^0#_B ?BU_P!"[_RM0_\ EI]8?\$KO^3;[_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH0NL>+M:DU'4;C>[2?OKB3YI-N_:N>B*J]!0!UU%?B%^VO\ &G]K^W_X.>_
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M^+ECXT_9\TWP'<?"[4]+L]NF^))-16^:Z-\'.7@BV!#9\<'._MCG[\K\&_\
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M6_8)L]8_9WU0:9X[^(7B=/#^CZ\85D;1[<02SW-U&K@J90L:1)D':9BXY04
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M=%OKU)H([IG^PFW#M JVYCCDC;]XCLJ,O[K?\$Z/^4?'P)_[(UX7_P#33;4
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MO]LOP'\,]'\7KX,EL6U70=6U>6Q,\%S>P68,4L<4GSJ]PC$,H!56YS@'\FO
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MYTR_TZX:YMT:*7R74L-DTB/%(&7)SMW(K* ?:-%?S5_M"?';_@H!H7_!O1\
M_P#@J,W_  4O^-S?$&^^)]UI,-G:^+WMK#["NH:TF+I(P'U"?S+)")+AW41,
M(1&%7)^P_P#@N#_P49_;!^$G[!'['G[4^A:;XG;X=>.!H^N?'YO >NW.B75X
MDUA8746EKJ%H5FL8;GS;Y=T;*28HUW<X(!^R-%?#O_!%;XY_!7]I[PYX]_:
M_9C_ &M_&'Q"^'>O-I":/X-^(OB6[U'7O %Y%%<"[TRX-V\DC1L6AECF:65I
M<R#S'6-&/RUKO_!1G4?VR_\ @N1\7?V,OBY\0?B]HGP;^#/@R[LM(\-?!/3_
M !*VHZOKPELX)]0O9/#D3WGEQ-/.L:N5@5HX&(+L0P!^P]%?#'_! 3XU_M]?
M%+]CW5?!W_!13X<^.-+\9>"?%UQI6B^(O'OAFYTR^\2:-Y<<EM=R+/'&TLJE
MI(FDVY81H7)<L3]ST %%%% !7SU_P4^_X**_"S_@EY^R9JG[47Q1T*YUEDU"
M#2O#?ARRN5@EUC5+C>8;82N"L*[8Y)'D(.R.)R%<@*WT+7R/_P %KO\ @G!X
M9_X*G_L37/[*]Y\1++POXF?7X-8^'NIZB^8#K-M;W)6*1!\\B/;/=JVP,R*6
ME"MY94@&7^T5^UI_P4Z_8^_9GU_]J;XF_LO?#/X@Z=H'AV?5-=\*_#GQ3?0:
MEHT:1&1I%>Z@:/4HHL$RE/L[[%9T1\;*^OO#.K_\)!X<T_7M@7[=8Q7&U3P-
MZ!L#\Z_FS^%G_!3S_@M)_P $ _$NF?LI?\%-O@?J/Q#^#,RG2;.#Q"1=QRZ?
MMV,FE:NNY)E$6,6EP7VIA-D&<C]R?V@_V_OAG\'?^"66O?\ !1?X+V,.L^&[
M'X5+XG\%V<T9BCNA+;(UC#*H.Z)3))"CJ/F0;AU% 'TC7SI_P58_;/\ B#_P
M3T_8@\7_ +8O@'X;Z1XM/@K[)/J>@ZMJ\ME]HMYKN&V)BECBDPZM.K89<$*P
MR#BOR/\ A]^V!_P4$^)G_!,?X5_\% ?V7O&7[2'Q,_:=U/XGW.L>+=&TSP;X
MKN_"&IZ$+V^MI=)CMDMO[$^S(D-MS;GSDE,NUPX8+^@W_!P]KUQXJ_X(+_&;
MQ/=Z'=Z7+J7A+1+J73;^(I/:-)JNGN89%(!5U)VL" 00: /F[XW_ /!SG\9_
M@W^R7^S1^UJ_[''AF_TS]H=M:@72AXWN(YM$GT[4ULW!;[(5F1TDC=3\I!#J
M1C!/V!HG_!03]L#4O^"QFJ_\$_[S]A'7(/A'8^$UU&V^-#1W(MI9C9QW'F>8
M8_LYC,[-9B(.9?,0N> RK^!'[</_ "A<_P"":'_8;\=_^I!;5^C'@3]H']H^
M3_@Z^\<_L$7?[3'Q)N/A%)X:GGB\%3^/-1:WMGN?"MM>N87\[S(2MQ/))&4<
M&(E0A4*N #]I:*_FY_X)F?&+]OC]N#]@+]M[QY\7/^"F/QQMQ\%O!LVM>%(]
M'\9/#=2WMM8:M<QB6\(:=+<_8U5X(6B$OF9<G8@'TA^R#_P5C_;KTW_@UJ\<
M_MG6_BR^\8?%3P'K-SX=TSQ;K,?VZ[BM6OK.(:A<;PWVF2V@O'.^0-GR4:7>
M Y(!^VU%?SM_MI?';]J7]G3_ ((2?LR?\% OA-^W#\9Y?BO\3?&L=KXWU%OB
MIJERNMPW<&HW#PI:2S26\'D-9P01^3"A0,0<ECG][?V;/".K>!?@)X2\+Z]X
MJ\6:U>V^B0-=ZCXZU%+O5Y))%\QENYHXXEDE0N4)"+]P<4 =O117Y-?\'#W[
M:?[5_P ,?VP?V5/V'/A'\2/$'P\\ _&7QW8V?CKQKX7OI+'4+N&35;.TDLX+
MV,B2U\N*<RN8V5V\V/D*I# 'ZRT5^+NI^(?V@?!7_!S9X;_X)V_#C]K#XY)\
M(9_"MOXFN?#=E\2[R_CT>>#3WNS'<S:C]JEDLII+9(GA9Q_Q_@(Z#:M=W_P4
M"_X*2>+/&/\ P75^'?\ P2_U'QOX_P##WPG\.^&9-=^(UI\+-/UF;7?$VH2:
M?/=6UF&T2-[]+2-?LSNL&W<&F\P[0I4 _6>BOSX_X(C_ !?_ &W]1^*/Q^_9
MX_:7\"?%>;X;^$O',EW\!/'WQ7\,ZK::AJGAZ>YNE2TEN-3BCN+EH8X[=E:?
M,^)G#G"J!\B?&+XP_MB^)/\ @ZD/_!/WX>_MR?%/P?\ #7Q%I+WMYHFG>)I;
MN.T$GAB6^N%M8[PRQP,\BN8VVL+=G#1*OEH% /W"HK\8_P#@WW_:B_:8TC_@
MK#^US_P3Z^+'[2WCCXC>!_AYJ^L3^%[WXC>(YM6U"R%CK1L@?M$Q+#S(95,B
MC"%XPRJI+9\D_9^_X*,_M"?\%3?@5^U5^T]I?Q*_:"M/B'I.HO:_LT^#?@[H
M?BJ73- %O"UQ:1W/]CP/8SW%TQCBF;42V5W[1'&V  ?OO17SU_P3V^(?Q_\
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MXN\*>$_#TNC:WX5\07-A*GVC7(;25)/)=1,C13R#:X8 X8 $ U\Z_MR_&/\
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M+]%T7Q;=Q6&H1V^HZ9&@-L)/*4E+F56*J-X(W9(S0!^S-%?ALWQ3_;$^(_\
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M$^$?B7X&?%OP[%JWAGQ;HESI.NZ=*2!/;3QF-P&'*MALJPP58!@00#7Y??\
M!/'_ ()L?\%-/^"%GQ1\<?#[]F'P9X?_ &A_@+XWU9=2LM&F\7P>'_$6A7:I
MY8F(ND^RS%HA'%)MD'F^3&X$.THWZT44 >"?#K5OV\/C7\1=&\1?$SP!HWP:
M\#Z-<M<WWAV+Q!!KFO>)) C+'!-+#']ET^U5F$C>4\\TI15W0IN\SY,\.?\
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MZ7X^\!VVNVVG:KIM_*+9VN[5KQH[>>*26SAD=7E1U:67:&&T5^E5% 'YY?\
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M+^.OAZ]L?#GQ-UKQ@Z,EN;34((X%T^.)I#//'>+$SR/'';,&D!N0HC?]RZ*
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MRLD<\%Q%O0. CB5]S JH/T]^PWXA_P""G7Q,M[3QI^W]\-_ ?PT_L[2S;?\
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M^" 7PC_X)4:/\/\ P?%XY\#?$F]UG6-9G\:(-.>R:ZU2ZC,;"(NTC'4PFTH
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M+'QZ_;%_X)H^.OV0?V?-*M-:\4^,K33[&+4?$.K164,*P7MM<R7$[JG+,L#
M+&G+N.%7./K"B@#\!_VB/^" _P#P5(^,'[ O[)_[)F@_#CP+;:U^S[>^)KCQ
M!J5YX\46NI_VAJD5W MOM@+C;'&5<NJX8C;N'-?1_AK_ ()H?\%"-&_X.%-=
M_P""OUU\$_#K>!]7TG[#'X9C\<P'58POAV#3%<@H(3F: .1YG"/W(P?UIHH
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MR7-K&S*(%C=ECE9)?U: "@*HP!T KP7]IW_@GS\+_P!I/XX^"/VH[/XC>,?
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MX)5_\$N/VY/V4O\ @L3\?_VZOCC\/?#-OX(^-4^O2:?#I?BM+J\TK[7JZ7\
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MAHOB1-5UGQC#;1^7!$($5X+0.%0SW#.9'"LL<432>;%]TT44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'SXL_$#]F;Q]'<W.F^"]5^)NI+#8W8A:&>R-RTVXB":6"Y0RE@8I-AWF-FH
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M_AB!O&7AO5M*DL9[34DS%.3;R@/"KNC2(AZ)(O)ZD ]>HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OR-_;I_X).?\ !1;X&?\ !8>T_P""PG_!+/3O"GBR\\06L=OX]^'G
MB?6UT\7!^RQV<ZK)(51H98HHI<[P\<Z;@KKP/URHH \O_9:'[5VJ^#KCQO\
MM>P^&M'\1ZP\;6_@CP?=M>6'AZ!%($1O)(TDO+AV9FDDVI$,1QQI\C2S?#7_
M  5>_P""<W[6'_!63X6?$[P-\5/@E::,VC:78K^SM!!XZ@>*TU'SQ)?:AJ:J
M JRRHL=NJJ)A%!YVPAYF)_36B@#\H]2^$O[>W[-W_!MQ\:_V7_V^M#T*77/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,G[>UA?VL<\$_P"UWXECFAF0,DB&XG!5@>"""00>M9O_  5J^'7PL_9!^/\
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MUXX^$%EX:\1:6OBX^*(;6]\06]O!<6UYJ&DZ>T++>6D3I* TMQ;R3>2_E1R
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M^,J_L]_&#]M/X=>'/&?G)%/H.J^)H(I;61P"B7!+;+=B""%E9#A@>A&?E/\
MX),?LOZ#\!_^"K?[;%S^R_I$7A[X+?VKX<TVQT738MNE1>*1IXN=22TC7Y(Q
M;M<!9$7:$-PL8 $85?3_ -LG_@FW_P $[/AU_P $R_BAX.^+/P4\+7&E:7X
MU?5]?\<:KH]NVM76II:RSR:Q+>E/->^><&7S-V6=M@&T[* /M:&:&XA2XMY5
MDCD4,CHV0P/(((ZBG5\O_P#!%CX<_&KX3?\ !*CX%?#_ /:%DO?^$LT_P%;?
M;H-2+?:+2"1GEM;60-RKPVSP0E3RIBVGI7U!0 4444 ?G=\;/VZ?VJ/"/QF\
M7>$_#WQ2^SZ?I?B>_M+&W_L2Q?RH8[B1$7<T!9L*H&223CDFN8_X>%_M@?\
M17O_ "@:?_\ (]<7^TA_R<1X]_['35/_ $KEKBZ_K'+^'.'IX"C*6#I-N,;O
MV<.R\C_,#/>/^.Z.=XJG3S7$J*J322KU4DE)V27/HD>T?\/"_P!L#_HKW_E
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M'>D>+8]:TD:PP!CTO4&\BW>RN) <(0LL+,&Q+A68 'U=17QW\2_^"N(\ _\
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M#\:^&--\9>&+[[3INKV$-[I]SY3)YL$J!XWVN RY5@<, 1GD U^5_P#P6_\
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M-)L)]5U6^AMK6VA:6YN;B4)'%&H)9V8\*H ))/  KXW_ .#>/_E"Y^S_ /\
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MC^%+?Q#XSL;OQ&FG:3X8M;ABMM%>7RPSO]HG99#%#%!(62-I',:%6;-_8_\
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MZ(DZ.%;@<@9KH-+TK2]#TRWT31=-M[.RM(%AM;2UA6.*&)0%5$10 J@   #
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MLT^/-)\4^*?B?\9_#VI>"+CPYJ$=VT&G0+/+=ZT#$25M;>V=B\WW5\Q%SN<
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MB7^D>'+6VF56&&4/&@8 CJ,\T =1=W=I86LM_?W,<$$$;2333.%2- ,EF)X
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MSO\ )/F;>NSYNG-'[ GB3P]>?\'$W[>&F66N6DMQ)X:^'>V"*X5F8P:,D<V
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MT?P]I4-E:PECDE8H55%R>3@<T ?"'_!R3H'C*R_8T^'?[0NA_"C_ (3KP_\
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M[3PEX,\.V&D:5I\ AL-,TRS2WM[:,=$CCC 5%'8  5?H \NUK]MG]D7P_P#
M'_AJ?5?VD/!L?P\.G?;HO%JZ]"]I-%MW 1LK$R2'H(E!D9B%"ECBORB^#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT.RU/Q-X5U@%DU*P2XFN]-TN^1^3##&]AO@;@_9!$X*%U(![S^SI_P %+?V
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M#=5TC4H;9S((Q=3+(AB +K-&RR1/'C<KHR8R,5['XF_X+>77P6_:A\%?!O\
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MX@?&CXAZ3X9T9;F*V6_U>\6%9;B5ML4$8/,LSM\J1("[GA03Q47P=^.GP?\
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MX@>*?A5\,OBYX>\0^(O YM5\8Z/HVJQ7,VBO<F801W(C)\F1_L\V$;# (20
M1GL:_-;_ ()#^ ?!'PQ_X++?\%$O!7PY\(Z;H6CVFM?#=[72M(LH[:W@,NCZ
MA+)LCC 5=TCNQP!RQ/>OTIH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _E1_X*(?\I /CG_V6+Q/_P"G6YKQVOVY_:(_X-D?
M^%]_M >.OCI_PVU_9/\ PFGC'4]>_LO_ (5MY_V/[9=RW'D^;_:2>9L\S;OV
MKNQG:,XKCO\ B$Y_ZOY_\Q9_]]*_T(R?QQ\+L+E&'H5<PM*%.$6O95]&HI-:
M4[;]C\EQ'#.>5,1.4:6C;?Q1[_XC\=Z_>K_@UO\ ^4?_ (P_[+%J'_IJTFO'
M?^(3G_J_G_S%G_WTK[U_X);_ /!/7_AVM^S_ *Q\"_\ A;W_  FG]K>,;C7O
M[4_L#^SO*\VTM+?R?*^T3[L?9=V_<,[\;1MR?SGQH\4^ ^+>!YY?E6,]I6=2
M$N7V=6.B;N[SA%?B>QPYD>:8#,U5KT^6-FKWB_R;/I.OG3]I3_@H=\&/V4_V
MQOAA^S5\??&>B^&-&^*?A;7)]&U_7)Q!;_VK97&GK'9O,[".,317<VTO@,\2
MH#N=5;Z+K*\1>!O!/C".:'Q;X.TK5$N+)[.==1T^.<26SLK/"P=3F-F1"4/!
M*J2.!7\>GZ$?C_\ \%,?V%_V;/@/_P %*OV8?VCO^"63Z9X6^._B[XQV,'BK
MP5\/[M%M-6\,,KRZGJMU:0'9;VZ1H(YI%5$E6Z8D,ZAJ]T_;/\3>'+/_ (.2
MOV.='N]<M(KO_A67C8?9Y+A0^9;*81#!.?G,<@7U*-CI7W5\)/V9OV;_ ( W
M-[>_ G]GWP1X*FU+_D(R^$O"EGIK77.?WAMXT+\\_-FK.N?L_P#P'\3>))/&
M7B3X)^$=0UB65)9=5OO#=K+<NZ@!6,KQEB0%4 YR,#TH ^$?^"O7[,^C_P#!
M91]7_8R_9YUOPS'XM^" /B'4_'5XJ7!T?7I[646'A]0&X%TH\R\+ATBA2 &.
M1Y5,/M?_  1]_P""DG@[_@HM^R];ZQ?V&G^'OB7X'N&\/?%7P);R(K:+JUL?
M*D:.,$XM92A>)AE0-T>XM$U?1_A_X0?";PGJ.HZOX5^%_AW3+O5U==6NM/T2
M"&2]5B683,B R DDG=G))J#P;\#/@E\.=7/B#X>_!WPKH-^T+0M>Z-X>MK68
MQD@E-\2*VTD D9QP/2@#Y;_X.&-3TW2O^",/Q_FU.^AMTE\&I#$TT@4/(]W;
MJB#/5F8@ =237S!_P6_\6>%C_P &W?P]U/\ X2*Q-O?V/PZ-C/\ :DVW&'LI
M#L.?FPB.QQT56/0&OU1\;_#7X<_$RRATWXD> -$\06UM+YMO;ZWI4-VD3XQN
M5958*<$C(YQ6)<_LT_LY7NF6NB7GP \$RV5BTC65I+X5LVBMS(07*(8\(6*J
M3@#.!GI0!\(?\'"_B_PII^H?L2:A>^)K"& _ML^"-06:2\0*;2,SF2X!S@QJ
M'0E_NC>N3R*R/A/XMN_V.O\ @Y1^-=K^T7J::/X>_:6^'>@77PF\2ZK*(K.]
MN](M8+6?2HY6PBW&?/D$602!&<9E3=^@VH?LT_LY:M#:6VJ_ #P3=1V%M]FL
M8[CPI9NMM#O=_+C!C.Q-[NVT8&YV/4FKWCOX'_!;XI>"(?AE\3?A!X7\1^&[
M98UM_#^N^'[:\L8A&NU L$J-&H5>!A>!P* /A/X3?#@?&;_@X^^(/[7/PLU"
M*;P3\.OV=[+P3XPU^QD#6MWXDN-0-W]A\U?DD>&T6%Y0"3$PA5@I85YC_P $
M//&/A&Y_X(H_M"ZU!XET][*U\>?$B:ZN1=IY<,;1-(K,V<*I1E8$\%2#TK]0
M])^%7POT'P$OPJT/X;Z!9>%UMVMU\-VFCP1V B)R8Q;JHCVDDDKMQS6/;?LS
M?LWV5A<Z59_L_>"(;6]""\MHO"EFL<X1MR;U$>&VGD9S@\B@#\3OC!<0ZU_P
M9:>"-3T:07D&E+HSZB]K^\^SB+Q8$DW[<XVL0#Z9KZ;_ ."^O[3G[/7QM_9,
M_9Z^(?PC^,WAWQ%X?/[8G@Q8=>TG5(YK*X\E+F6=H9U/ES)$LBB1XV98W#HQ
M#HZK^DVB_!3X->&_#>H^#/#OPD\,6&CZPA35M*LM!MXK:]4KM(FB5 L@*G&&
M!XXJKJW[.W[/VO6.GZ7KGP+\'7MMI-H+32K>[\,6DD=E #D11*T9$: DG:N!
MSTH ^#_^"O\ XE\.Z7_P5?\ ^">,.HZ[9P2M\2_$Y1);E58K)I]K$AP3T:1E
M0>K$#K7%?M??LE_#?X]?M#?'/]MW_@FU^VUJ7P"_:2^$MRUG\4;-=9B;1?$2
M6=A%<6TNK6,ORB"2W,:K<%6A!C?='(Z,P_1_4OV9OV;]9DBEU?\ 9]\$73P6
M\=O"USX4LW,<4:A4C4M&<*J@ *. !@57\8_LH_LM_$3Q##XM^('[-?@#7=5M
MYQ-;ZGK'@ZQNKB*48PZR21,RL,#D'/ H XK_ ()E_M!?%7]JO]@/X4?M$?&[
MP#'X9\5>+?!]M?:QI$%LT,2N<JLT<;9,<<R*DR(2=JRJ,G&3^?W[:7Q-_9<_
M8H_X+OZQ\1?^"FOP@\.:G\'_ (X_"G1[#P3X^\8^$8M6T[0=8TR25)+1S+%)
M]G#K*SNRCCSH&;Y-S)^NH 4!5   X K!^)'PK^&'QD\+R^!_B]\.-!\5:+-(
MKS:/XDT>"^M9&7.UFBG5D)&3@D<9H ^'D^(G_!-SQM^R?^TW\2O^"?WP4^&V
MF>%;'X/:Q:^*?BSX&\)6>E6.L7W]G7;?V>ES#;Q_;?L\8221][1QFYB12S^8
M(_FK7?$7AX_\&9,=T=;L_*/P5M[02?:%V_:/[42/RLY^_O\ EV]=W'6OUO/P
M8^#Q\!6OPJ/PG\-?\(O9!19>&_["M_L%N%)*A+?9Y:8))&%&":S?^&9OV;SI
M(T _L_>"/L N?M LO^$4L_)\[;M\S9Y>W=MXW8SCB@#\H?VI?B_9?LI?M>_\
M$W/^"A7Q7U!C\#].^%<WA;6/%<(,MEH%_J>B)#%<S.N1&D@DC)?_ )YVLO\
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MGP!\$ZIXNLBALO%.H^%;.?4K<IC9LN7C,J;<#&&&,<4 ?AIXQ_9N^)_[(?\
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MOL5\%P!^A/C#P9X/^(7AN[\&^/O"FFZYH]_'Y=]I6L6$=S;7"9!VR12 JXR
M<$'I4'AGX<_#WP7X,B^''@[P)HVD^'H;=K>'0=,TN*"RCB;.Z-8$4(%.3E0,
M')]: /SD^,7_  60_P""4?[5OQBN_A;\8_VVO FE_"3P'X@C>_T>\U!G/CW5
M[619(]X164Z1;3*K@$_Z;/$IP+:(?:_IK5_^"OG[!FC_ +'6N_M[7'QA7_A5
MNDZM<:7I7B22T:$>);R(!3%IL<VQ[DF;S8%)"@O;S-D1)YM>M_\ #)_[+/\
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MC,J;OT&U#]FG]G+5H;2VU7X >";J.PMOLUC'<>%+-UMH=[OY<8,9V)O=VVC
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M]MM)M!::5;W?ABTDCLH <B*)6C(C0$D[5P.>E 'P?_P5_P#$OAW2_P#@J_\
M\$\8=1UVS@E;XE^)RB2W*JQ633[6)#@GHTC*@]6('6N*_:^_9+^&_P >OVAO
MCG^V[_P3:_;:U+X!?M)?"6Y:S^*-FNLQ-HOB)+.PBN+:75K&7Y1!);F-5N"K
M0@QONCD=&8?H_J7[,W[-^LR12ZO^S[X(NG@MX[>%KGPI9N8XHU"I&I:,X55
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M(Z1YS3?V5X8T2"PMO,;&Y_*@15W' R<9.* /R@_X)C>(O"_C7X+?\%!_V -
M^*.EZ/\ &3Q]^TG\6(/"GA>:\":BJWFEQPV^H&(?.EL)(G_TA@(PP5=VYT#>
MQ_\ !"_]L7X#>%/^".ND^ _V@?$^F>#]<^ FDZEX9^+_ (5\2S);7>B26<\X
MQ<02$-B6#8R\89V=!EE8#]!],^'W@+1/%FH^/-&\$:1::YJ\<<>K:U:Z;%'=
MWJ(,(LTRJ'D"@  ,3C'%8/B+]FO]G/Q?\1[7XQ>+/@#X)U3Q=9%#9>*=1\*V
M<^I6Y3&S9<O&94VX&,,,8XH _#3QC^S=\3_V0_\ @V&^!VD_'/1[[0[K_AH#
M0?%NJ:=JD;(WA_3+K5IIHOM&X?N1Y+12.&V['G*MA@:^Y_\ @O!IW@_]N[X
M?"7]BW]GWQ/I7BOQI\2?BQH.K^'FT"^CO/[,T:TD:6]UYWB+".TAA8H9LX9K
MA$3<S@5^B6J:5IFN:;<:-K>FP7EG=PM%=6EU"LD4T;##(ZL"&4@D$$8(KF/A
M7^S]\!O@5'>0_!'X)>$?!J:C()-03PKX;M=.%TXR0T@MXTWGD\G/4T ?E+\0
M?BW^Q=^Q1_P7.^/OAK_@J[\)/!Y\(?'73_#GB'X0_$KQ_P"#X-1T^)K'3([&
M[L&GFAD%O\Z =55?)4N1YT>?4_VK/''[!/BG_@D%^U]\2/V#O@EX"\+> -0^
M&NHV#_$#P=X6M=%L_&.JK;7"2+%Y4$7VV.%YHXDN<NLDTT\:<Q,6_1#XH_!C
MX/?'#08_"WQJ^$_AKQAID4XGBT[Q3H5OJ$"2@8#B.=&4, 3SC/-.UGX._"/Q
M'X3L/ ?B'X6>'+_0]+V?V9HM[H=O+:6FQ"B>5"R%(]JDJ-H& 2!P: /(_P#@
ME'KNB^)/^"8/[.VJ:!JUO>V__"D?"T)FM9@ZB2/2;:.1"1T975D9>JLI!P01
M77_MA?MB_L^_L)? ?5_VC/VE?'EMH7AS24"J9'7S[^Y8'RK2VC)'FSR$$*H(
M  9F*HK,O<>"OA[X!^&NE2:%\.O ^CZ!8RW!GEL]$TR*UB>4JJF0I$J@L551
MNQG"@=A3?&_PV^'?Q,L(=+^(_@'1?$%K;S>;!;:WI4-W'')@C>JRJP5L$C(Y
MP30!^=7P/_X+#?\ !*FP\:ZI^UQ\;OVTO!OB+XM>(]+32M%\)>$S<ZG)X?TQ
MI0\&@::J0YN)Y9MC7$X"_:9]G*PPP)']3?\ !0+]FW_@GO\ &'X>Z7\;?V_O
M#.E:?8_#R0ZEH_C&[\276BZCH,I )6WO]/N(;E'9E4>5%(?,=5 5FVUZAIO[
M,'[-6CZC!J^D?L\>!K6[M9EFM;JV\)6:20R*0RNK+$"K @$$<@BM;6O@Y\(O
M$GCFQ^)_B+X5^&[_ ,2Z9&L>F^(KW0[>6^M$4L0L4[(9(P"[$!6&"Q]30!^?
M_P#P2#_8(O9OVP_B?_P5@\??!S4? =OXVTN+PS\&O!GB1IY-9L_#,1C+ZIJC
MW3O<&^O7ACEVSNTT:%D9B& 7Z_\ V1_^"@G['G[=LGB^#]E#XW:?XOE\!ZW_
M &3XKAM;2X@>QN27"_+/&ADB<Q2;)DW1OY;[6.TX]DKQ7]F7]D/PQ\#OBMX^
M^/8\(>%="\0_$%+"UO=(\%Z6EM86=E927DT*EECC-W<O/J%[-+=,B,YF1-N(
M0S &U^V%^V+^S[^PE\!]7_:,_:5\>6VA>'-)0*ID=?/O[E@?*M+:,D>;/(00
MJ@@ !F8JBLR_$'P/_P""PW_!*FP\:ZI^UQ\;OVTO!OB+XM>(]+32M%\)>$S<
MZG)X?TQI0\&@::J0YN)Y9MC7$X"_:9]G*PPP)'^BOC?X;?#OXF6$.E_$?P#H
MOB"UMYO-@MM;TJ&[CCDP1O5958*V"1D<X)K TW]F#]FK1]1@U?2/V>/ UK=V
MLRS6MU;>$K-)(9%(975EB!5@0"".010!\/\ QB^'UW^RE_P<-_#S]MSQ7"=.
M\#?'7X+W7PUOM9O'58--\1P7$5_;6\\F=D9N8K6**$$_/+&ZJ22 6Z7\/_\
MAK'_ (.+YOVK/"=Y#<^ /V;?@B?"^I^)(90UH_BJ_FNY);%)1\CM!8W>Z8*2
M87V*^"X _0GQAX,\'_$+PW=^#?'WA33=<T>_C\N^TK6+".YMKA,@[9(I 5<9
M ."#TJ#PS\.?A[X+\&1?#CP=X$T;2?#T-NUO#H.F:7%!91Q-G=&L"*$"G)RH
M&#D^M 'YR?&+_@LA_P $H_VK?C%=_"WXQ_MM>!-+^$G@/Q!&]_H]YJ#.?'NK
MVLBR1[PBLITBVF57 )_TV>)3@6T0^U_=/[*G[6_P._;6^&4WQJ_9R\2SZ]X0
M_MFXT[3/$?V&2"VU5H-JS36WF!7DA68R0[RJ@R02;<J%=KG_  R?^RS_ -&U
M?#__ ,(VQ_\ C5=;H7@SP?X7\-)X+\,^%--T[1XHWCCTFQL8X;9$<DNHB0!
M&+,2,<ECGK0!^=__  2R\5>&-3_X+C?\%%++3O$-E/-/JWPZ,$4-TC-)Y&CW
ML4^T \^7(0CX^ZQ .":_2*N.\-?L[?L_>#-<M_$W@_X%^#M)U*T8M:ZAIOAB
MT@GA)4J2DB1AER"1P>A(KL: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>mdt-20221028_g2.jpg
<DESCRIPTION>IMAGE 6
<TEXT>
begin 644 mdt-20221028_g2.jpg
M_]C_X  02D9)1@ ! @$ R #(  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
MQ@#+ -  U0#; .  Y0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%%
M 4P!4@%9 6 !9P%N 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C :=!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-
M^ X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE
M3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
M   !_]L 0P ," @;"ALB$1<D*B0<&R D*R@H("0I)24Q+R4I+BHK*SDK*BXO
M-#4U-30O.SL[.SL[.SL[.SL[.SL[.SL[.SL[_]L 0P$-"PL0#A ;%!LD,B@A
M*#([-#(R,CL[.SL[.SL[.SL[.SL[.SL[0$! 0$ [0$! 0$! 0$! 0$! 0$!
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPEEY_P _$W_?Y_\ XJNE^'?C.=+V..XF=XYLH1([N 6^Z0,G!+ #.. 3TZ@
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M*L 00<@@\@@CJ#3ZQ **\J^*NLSV5TB0RNBF%3A'91G>XS@$<\5QO_"47?\
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MU,J#BKW'<]5HK.\1RF&UG=20RPR$$'!!"$@@CH17A/\ PE%W_P _$W_?U_\
M&IITG- ?0]%?/'_"47?_ #\3?]_7_P :/^$HN_\ GXF_[^O_ (UI]6?<5SZ'
MHKPC2OB'>Z<>)#(N22LOSYR,?>/S #K@,!GZG/IW@OQVGB(>405G5-S#'RGG
M!*GGCD<'D9P-V":B=&4=1G4T45POCKXB_P!CLUG ,S;>6/1"P!& 1\QP<^@X
MZ\@1&+D[(#NJH?V];[_)\Z/S-VW;YB[MV<;<9SG/&.N:^?\ 4M8FU,[YY&<Y
M)&XD@;NN!T ]@ *IUNL-W8KGTW17SAINL3:8=\$C(<@G:2 =O3(Z$>Q!%>I>
M OB$^LN+.="9,9#H/EPHY+C/!SW'!+ 8'>)T'%7'<[VBBBL0"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BL+Q1XQ@\/+^\.92I*QCJ><<G!"C/<^AP"1BO*-:^(EYJ3'
M;(8X]V56,[2., ;QAC[Y."><#@#2%&4P/;+R_CLAOF=44G&78*,]<9)'/%1V
M>LP7IV0RH[ 9PCJQQTS@$\<U\X45M]67<5SZ;HKYUTKQ%<:2<P2,@R3@'*Y(
MP25.5)QZCT]!7J7@_P")B:N5MK@".9B0"/\ 5MZ 9)(8],'@XX.2%K.="4==
MQW.XHHHK$ HKYX_X2B[_ .?B;_OZ_P#C1_PE%W_S\3?]_7_QKH^K/N*Y]#T5
M\\?\)1=_\_$W_?U_\:N:;X\O=/.Y9F8$@D2GS <=OFR0#WVD'WX%)X:7<+GO
M=%<5X+^(ZZVPM9EVSMNQM!V-@9[DD'&>O''7) KM:RE%Q=F,**\9^(.O7%K?
M2QQS2*HV859&4#,:D\ XZUSW_"47?_/Q-_W]?_&M8X=M)W%<^AZ*^>/^$HN_
M^?B;_OZ_^-'_  E%W_S\3?\ ?U_\:?U9]PN?0]%>$>'/$=U-=0(T\I5IHP09
M'((+@$$$\@U[O652FX,845X1XC\1W4-U.BSRA5FD  D<  .0  #P!6?_ ,)1
M=_\ /Q-_W]?_ !K189M;BN?0]%?/'_"47?\ S\3?]_7_ ,:GL_&M[:'>L[DD
M8^=O,'Y/N&??&:?U9]PN?0%%>;>$_BMY[+;WH"YX$HX&< #<.@R<Y88 X^4#
M)'I-8S@X.S&%%%%2 45Y'\2?%TOVK[/;2NJPKAO+;:"YY;E3DX&!@]"",#G/
M*?\ "47?_/Q-_P!_7_QK>.';5Q7/H>BN3^&WB!M8M<2MNEA;:22"Q'56(Z].
M,G.2I.2<UUE8RBXNPPHKQGX@Z]<6M]+''-(JC9A5D90,QJ3P#CK7/?\ "47?
M_/Q-_P!_7_QK:.';2=Q7/H>BOGC_ (2B[_Y^)O\ OZ_^-'_"47?_ #\3?]_7
M_P :?U9]PN?0]%?/'_"47?\ S\3?]_7_ ,:T/#GB.ZFNH$:>4JTT8(,CD$%P
M""">0:3PS2W"Y[O17._$&Z>UL99(V*L-F&4E2,R*#R.>E>-?\)1=_P#/Q-_W
M]?\ QJ:=%S5QGT/17&?"J_DO;5WF=G83,,NQ8XV(<9)/'-:/Q!NGM;&62-BK
M#9AE)4C,B@\CGI4.%I<H'145\\?\)1=_\_$W_?U_\:T- \=W.G3++)*\D>0'
M5V+Y4GG 8\,.QR.>O!(.KPS[BN>[T4R*43 .I!5@""#D$'D$$=0:?6 PHKRK
MXJZS/972)#*Z*85.$=E&=[C. 1SQ7&_\)1=_\_$W_?U_\:VC0<E>X7/H>BBB
ML0"BN,\6_$J+1R8(<2S D$9(52!W..3G^$'L02I%>7ZUXNNM9)\Z0[6_@4[4
MQG(&T<'!Z$Y/ R>*UA0E+78+GN]YK,%D=DTJ(Q&<.ZJ<=,X)''%26=_'>C?"
MZNH.,HP89ZXR">>:^;**U^K+N*Y]-T5X)HGCJ[T<@)(60 #9)EUP 0 .<J!G
M^$CH,Y Q7K?@_P 8)XE1G52CQD!E)SC.=I#8&0<'L""#QC!.-2C*&O09T%%%
M%9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:%@Z$AE(((."".001T(KVOXR:.+NT%T,;K=P<DG[KD*0!T)+;3SV!P>Q\2H
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MW_H#4 ?-=>J_ S_EZ_[8_P#M2O*J]5^!G_+U_P!L?_:E '5?%+_D'3_]L_\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#+\4?\>EQ_UPE_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;ID>GK1XH_X^[C_KO+_Z&:T_AK_R$(?^VG_HMZ[&[0OY".F_X4M_T\?^0O\
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M[I\2O^0?-_VS_P#1B5X76^&^%^HF>P_![_CT?_KNW_H"5I_$K_D'S?\ ;/\
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MS=):J9)&"J.K,0H&3@<GCK5#_A*+3_GXA_[^I_C7,JM1ZC/'+/P%<37?]G.
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M>5)R._49 )H S:]5^!G_ "]?]L?_ &I7E5>J_ S_ )>O^V/_ +4H ZKXI?\
M(.G_ .V?_HU*\ KW_P"*7_(.G_[9_P#HU*\ H ]J^"G_ !YR?]?#?^@1UZ!7
MFGP0OM\,]MC[DBOG/7S%QC&.VSUYS[<^ET %?*M?4\TRPJ7<@*H)))P !R22
M>@%?+% '?_!3_C\D_P"O=O\ T..O:Z\4^"G_ !^2?]>[?^AQU[70!\U>+/\
MC\N?^OB;_P!#:LJM7Q9_Q^7/_7Q-_P"AM6A\.+1+N_ABE570^9E7 93B-B,@
M\=: .:HKZ4_X1.S_ .?>'_ORG_Q-'_")V?\ S[P_]^4_^)H \J^"G_'Y)_U[
MM_Z''7M=4;+0[>P;?#%&C$8)1%4XZXR ..*O4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% &7XH_X]+C_KA+_P"@&OGBOH?Q1_QZ7'_7"7_T U\\5U8;9B9Z;\%O
M^7G_ +9?^U*].KS'X+?\O/\ VR_]J5Z=6-?XV-!7F/QI_P"7;_MK_P"TZ].K
MQ3XF^)$UBX5(6W10J1D 8+$_,0>I& !GIQD<')=!-SN#./KW3X:_\@^'_MI_
MZ,>O"Z^@_!^G?V=9PPX((C!(;@AG^9AC Q@DC'4=ZVQ+]U"1YM\8?^/M/^N"
M_P#H;UPM=U\8?^/M/^N"_P#H;UPM:4O@0'TW7F/QI_Y=O^VO_M.O3J\Q^-/_
M "[?]M?_ &G7)0^-#9YE7T/X7_X]+?\ ZX1?^@"OGBOH?PO_ ,>EO_UPB_\
M0!6V)V0D:E%%%<HSPOXE?\A";_MG_P"BTK,\+_\ 'W;_ /7>+_T,5I_$K_D(
M3?\ ;/\ ]%I6%I=[]@FCN,9\J1&QG&=K XSSC.*[X_ O01](T445P#/,?C3_
M ,NW_;7_ -IUYE7I?QHE!-NF1N E)&>0#L ./0X./H?2O-*[J'P(3/H?PO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>*^CZ^9*^BM UM-:A6YC(^8#< <[6QRIX'(^@R,$<$56)3T8(R?B5_R#YO\
MMG_Z,2O"Z^D=3TR/4XVMYANC;&1DCH01R"#U%87_  K73_\ GC_Y$D_^+J:-
M905F!X77=?![_C[?_K@W_H:5PM=U\'O^/M_^N#?^AI715^!@>PT445P#"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO%/C7_Q^1_\ 7NO_ *')7M=>*?&O_C\C_P"O=?\ T.2@#@*]J_X779_W)O\
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M_P"U*].KS'X+?\O/_;+_ -J5Z=6-?XV-!11168%>^ODL$:>5@J(,DG_/)/0
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M7DSG[B$8QZ[]G7VS[UXK14_5X!<*[KX/?\?;_P#7!O\ T-*XRSL)+T[(49V
MSA%+''3. #QS7IWPQ\'W&ER&\G4(KQ%0I/S\E&!('0<$8)# ]155I)1: ]&H
MHHKA&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 0W5HEVIBE570XRK@,IP<C(/'6L__A$[/_GWA_[\I_\ $UK44 4;+0[>
MP;?#%&C$8)1%4XZXR ..*O444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!0N=!M[IC))#&S'JS1JQ.!@<D9Z5%_PB]I_S[P_]^D_PK4HI\S 9%$(0
M$4 *H   P !P  .@%/HHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9T
MOARUF)=H(BS$DDQH22>222.2:9_PB]I_S[P_]^D_PK4HI\S ****0!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 9TOARUF)=H(BS$DDQH22>222.2:9_P (
MO:?\^\/_ 'Z3_"M2BGS,"*VM4M5$<:A5'15 4#)R>!QUJ6BBD 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT ;=%>/V/Q5U+4,^1;I)MQGRXI6QG.,X<XS@UM^$/BD^H3BPO(UCD9F4,N5
M8=$97)()((ZYSA=O>@#T6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*WSLZOO8@C8H8X 7.#G-6/!]Q)!+<Z9([2_970K)(<N5F7<%/J5P><\YX
MK8T.U:UC9'&"9IVZ@\/,[J>/4$'^?-9^C:7);7MY<NN(Y_L^PY!SLC(;@'(P
M?4#VH Z"N,\%Z&]Y:Q3W3R9:*,(D<KQ(J*N$/[MQN9Q\S%CGD* ,8KLZX_PN
M+W0XH[.:%ID6,$/')'O4G!\IED< [#D!E;&T* .N "QH=Q)IEVVD.[2IY'G(
M\IS(/GV,A;^(9Y!X('R\C&-7P],TL;%B2?/N1DG/"SR #Z   >@XK-T#29YK
MA]6NQY<CQB)(0RN$0$$Y=0-Q9@2/0'!)Z+JZ':M:QLCC!,T[=0>'F=U/'J"#
M_/F@#$_Y@W_</_\ :%;'B&9HHU*D@^?;#(..&GC!'T()!]1Q5+^RY/[-^Q;?
MWOV/R]N1][RMN,YQUXSG'O6AKEJUU&J(,D30-U X29'8\^@!/\N: ,SQ1J$A
MEM]-C8Q_:S)ND7[ZK&NY@OHS9P&_AZ@$XQ7UGPU)9PF>TGN!/#&Q&9&F$A"]
M&C?<"3@@;0,$YP< 5=\2:/).\-]!AIK0N51CA7$B[77/\+8^Z>@/48.15U2X
MO-7B^QK;F+ST*R22R1LL888;:J,6<XR!G;S@GC. !FM:P^H6$=_:_P"M9K=D
M59#MW-(BF-BI4,,DJP.!ZX(XBU[P])96CW"7,WVB%6E,GF-M8IERIBW>6%/0
M*!P,9W#(.Q>:.8K>*TARPB>V R1G;%+&22>!D*I/OV':K'B&U:[MIX8QEY(9
M%49 R60@#)XZT <YXLU:6ZLK>YC,D23/"TQAR72)E+N=RJ2 O&3CV/!P;'AY
M[:^F6YL[IW7RV#0M*TF?F #E9277!]AGY<$#(:Q$EWI=I;K#&LCQ11K)$S!6
M.$"_+)DJ"IZY!!&<$'&:IT>34+^'4! (5A#[V<Q^9(70H!B,OD)@<LPX. ..
M0"[XRL?M*029QY-Y;/C&<YD$>.O'W\]^F.^:Z"N7\5A;^XL[$$[UG$YP-VU(
M0WWN<@,Q"@],Y[C!ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7=CR,[I3J0@HIO7HKE2Q_P!8G^\O\Z[NW^Z*X^UTF6-U8KP&!/(['ZUV%O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR?\ Q%9GQA_X]$_Z[K_Z ]>/5T4J,9QNQ'NG_"RM/_Y[?^0Y/_B*/^%E:?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@"SU)=IC$9'1H0$(Y&>@P>F.0<<XQ7145RJ33O<9POA#X9+I$IN9V$C(W[L
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MG/'-71IR@W<&=!\-?^0A#_VT_P#1;U[I7A?PU_Y"$/\ VT_]%O7NE9XGXEZ
M@HHHK 9POQA_X]$_Z[K_ .@/7CU>P_&'_CT3_KNO_H#UX]79A_@$SV;X?:#;
MW5C%))#&S'?EFC5B<2,!R1GI70_\(O:?\^\/_?I/\*X'PC\2;?1K6.TD60LF
M[)55(^9V8=7!Z'TK8_X7#:?W)O\ OE/_ (NL9PJ<SW&=-_PB]I_S[P_]^D_P
MK1BB$("* %4   8  X  '0"N/L/BK:WLB0*DH:1U495,98@#.'/'-=G6<E);
M@>%_$K_D(3?]L_\ T6E9GA?_ (^[?_KO%_Z&*T_B5_R$)O\ MG_Z+2LSPO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGQ*_Y!\W_;/_ -&)7A=3AOA?J#-C1_"-UK*&:WCW*&*D[D7D '&&8'H15_\
MX5KJ'_/'_P B1_\ Q==U\'O^/1_^N[?^@)7=5,Z\HR:"QX7_ ,*UU#_GC_Y$
MC_\ BZYVZMFM7:%QAD8JPX."IP1D<=:^EJ^>/%'_ !]W'_7>7_T,U=&JYMW
MT_AK_P A"'_MI_Z+>O=*\+^&O_(0A_[:?^BWKW2LL3\2] 04445@,X7XP_\
M'HG_ %W7_P! >O'J]A^,/_'HG_7=?_0'KQZNS#_ )A17NGPU_P"0?#_VT_\
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M)(51T S^9Z DDX&:H6MLUTZPH,L[!5' R6. ,GCK7?3CRQ2$>W_#7_D'P_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BD8[1FJ3ZLD9VD@'T+ 4TF]A2DHZMV+U%4/[9C_O+_ -]"C^V8
M_P"\O_?0I\DNS(]M3_F7WE^BJ']LQ_WE_P"^A1_;,?\ >7_OH4<DNS#VU/\
MF7WE^BJ']LQ_WE_[Z%']LQ_WE_[Z%')+LP]M3_F7WE^BJ']LQ_WE_P"^A1_;
M,?\ >7_OH4<DNS#VU/\ F7WE^BJ']LQ_WE_[Z%']LQ_WE_[Z%')+LP]M3_F7
MWE^BJ']LQ_WE_P"^A1_;,?\ >7_OH4<DNS#VU/\ F7WE^BJ']LQ_WE_[Z%']
MLQ_WE_[Z%')+LP]M3_F7WE^BJ']LQ_WE_P"^A1_;,?\ >7_OH4<DNS#VU/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !39.A^AIU-DZ'Z&@#B-9_UK?A_(52J[K/^M;\/Y"J5>[0_AQ]%
M^1\7C/\ >*G^)_F%%%%:'.%=FKKJ*JZ$X#*?^^3G:1_GL:XRM>RTR:V:.3!
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M+9P3+T0C'U.>OX<_YS4.C:&+H>;)]WL!WP><^W;U^G?4U%IL>5"F!@#=E1^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!LG0_0UQ&L_ZUOP_D*[>3H?H:XC6?]:WX?R%=
MN7?Q'Z?JCR<]_P!WC_B7Y,I4445ZA\R%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >@6O3\:FJ&UZ?C4U?/'W@4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39.A^
MAIU-DZ'Z&@#B-9_UK?A_(52J[K/^M;\/Y"J5>[0_AQ]%^1\7C/\ >*G^)_F%
M%%%:'.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5V^C?ZM?]U?
MY5Q%=OHW^K7_ '5_E7#F/PQ]3V\@_B3]"_1117F'T(4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% #9.A^AKB-9_UK?A_(5V\G0_0UQ&L_P"M;\/Y"NW+OXC]/U1Y.>_[O'_$
MOR92HHHKU#YD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M] M>GXU-4-KT_&IJ^>/O HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "FR=#]#3J;)T/T- '$:S_ *UO
MP_D*I5=UG_6M^'\A5*O=H?PX^B_(^+QG^\5/\3_,****T.<**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ KM]&_U:_[J_P JXBNWT;_5K_NK_*N'
M,?ACZGMY!_$GZ%^BBBO,/H0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBLWQ'J3:9 ]P@!9=N-V<<L!V(]:%J!I45YBWQ4F7@B/C_
M &7_ /BJ3_A:TWI'_P!\O_\ %5U+ 8EZ\DON9/M(GI]%>8?\+6F](_\ OE__
M (JC_A:TWI'_ -\O_P#%4?V?B?Y)?<P]I$]/HKS#_A:TWI'_ -\O_P#%4?\
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M_3O_ .1?_L*/^%P_].__ )%_^PKSBBC^Q<%_)^+_ ,P]I(]'_P"%P_\ 3O\
M^1?_ +"C_A</_3O_ .1?_L*\XHH_L7!?R?B_\P]I(]'_ .%P_P#3O_Y%_P#L
M*/\ A</_ $[_ /D7_P"PKSBBC^Q<%_)^+_S#VDCT?_A</_3O_P"1?_L*/^%P
M_P#3O_Y%_P#L*\XHH_L7!?R?B_\ ,/:2/1_^%P_]._\ Y%_^PH_X7#_T[_\
MD7_["O.**/[%P7\GXO\ S#VDCT?_ (7#_P!._P#Y%_\ L*/^%P_]._\ Y%_^
MPKSBBC^Q<%_)^+_S#VDCT?\ X7#_ -.__D7_ .PH_P"%P_\ 3O\ ^1?_ +"O
M.**/[%P7\GXO_,/:2/1_^%P_].__ )%_^PH_X7#_ -.__D7_ .PKSBBC^Q<%
M_)^+_P P]I(]]\.ZQ_;,"7>W;OW?+G=C:Q7K@>GI6E7-_#K_ (\(?^VG_HQJ
MZ2ODL5",*]2*V4FE]YO%W2"BBBL1A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 -DZ'Z&N(UG_6M^'\A7;R=#]#7$:S_
M *UOP_D*[<N_B/T_5'DY[_N\?\2_)E*BBBO4/F0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#T"UZ?C4U0VO3\:FKYX^\"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *;)T/T-.ILG0_0T <1K/\ K6_#^0JE5W6?]:WX?R%4J]VA_#CZ+\CXO&?[
MQ4_Q/\PHHHK0YPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NWT
M;_5K_NK_ "KB*[?1O]6O^ZO\JX<Q^&/J>WD'\2?H7Z***\P^A"BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)T/T-<1K/\
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MW_H:5PM=U\'O^/M_^N#?^AI45?@8'L-%%%< PHHHH **** "BBB@#Q3XB_\
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M\)CO]YJ_XG^;.J.R"BBBN<84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% #9.A^AKB-9_UK?A_(5V\G0_0UQ&L_ZUOP_D
M*[<N_B/T_5'DY[_N\?\ $OR92HHHKU#YD**** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% !1110 5A>./\ CSE_X!_Z&M;M87CC_CSE_P"
M?^AK3CNA/8\0G^\?J?YTRGS_ 'C]3_.F5]_1_AQ]$<K"BBBK **** "BBB@
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M->9G?^Z/U14/B/8:***^/.D**** "BBB@ HHHH **** "BBB@ HHHH ****
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M_0TJ*OP,#V&BBBN 84444 %%%% !1110!XI\1?\ C_F_[9_^BUKFZZ3XB_\
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M/"'_ +:?^C&KI*^$QW^\U?\ $_S9U1V04445SC"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N%^,/\ QZ)_UW7_ - >NZKA?C#_ ,>B?]=U_P#0'JZ7QH#QZBBBN\04444
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M "BBB@ HHHH *T?#?_'U!_UVB_\ 0Q6=6CX;_P"/J#_KM%_Z&*4MF!ZCK/\
MK6_#^0JE5W6?]:WX?R%4J[*'\./HOR/C,9_O%3_$_P PHHHK0YPHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "NWT;_5K_NK_*N(KM]&_P!6O^ZO
M\JX<Q^&/J>WD'\2?H7Z***\P^A"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *PO''_'G+_P#_T-:W:PO''_ !YR_P# /_0UIQW0GL>(
M3_>/U/\ .F4^?[Q^I_G3*^_H_P ./HCE844458!1110 4444 %%%% !1110
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M]O(/XD_0OT445YA]"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5A>./^/.7_@'_H:UNUA>./\ CSE_X!_Z&M..Z$]CQ"?[Q^I_G3*?
M/]X_4_SIE??T?X<?1'*PHHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "NN^&W_ !]1_5__ $6:Y&NN^&W_ !]1
M_5__ $6:\S._]T?JBH?$>PT445\>=(4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<+\8?^/1/^NZ_P#H#UW5<+\8?^/1/^NZ_P#H#U=+XT!X]111
M7>(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "NZ^#W_'V_\ UP;_ -#2N%KNO@]_Q]O_ -<&_P#0TJ*OP,#V
M&BBBN 84444 %%%% !1110!XI\1?^/\ F_[9_P#HM:YNND^(O_'_ #?]L_\
MT6M<W7W>!_W:E_A7Y(Y9;L****Z!!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110![7\.O^/"'_ +:?^C&KI*YO
MX=?\>$/_ &T_]&-725\)CO\ >:O^)_FSJCL@HHHKG&%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V3H?H:XC6?]:WX?
MR%=O)T/T-<1K/^M;\/Y"NW+OXC]/U1Y.>_[O'_$OR92HHHKU#YD**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ] M>GXU-4-KT_&IJ^>/O
MHHHH **** "BBB@ HHHH Y/XD_\ 'NO_ %U7_P!!>O$*]O\ B3_Q[K_UU7_T
M%Z\0KKPVS)ZA1116XPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"M'PW_Q]0?\ 7:+_ -#%9U:/AO\ X^H/^NT7_H8I2V8'J.L_ZUOP_D*I5=UG
M_6M^'\A5*NRA_#CZ+\CXS&?[Q4_Q/\PHHHK0YPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "NWT;_5K_NK_ "KB*[?1O]6O^ZO\JX<Q^&/J>WD'
M\2?H7Z***\P^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)T/T-<1K/^M;\/Y"NWDZ'Z
M&N(UG_6M^'\A7;EW\1^GZH\G/?\ =X_XE^3*5%%%>H?,A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'H%KT_&IJAM>GXU-7SQ]X%%%% !1
M110 4444 %%%% ')_$G_ (]U_P"NJ_\ H+UXA7M_Q)_X]U_ZZK_Z"]>(5UX;
M9D]0HHHK<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6CX;_X^
MH/\ KM%_Z&*SJT?#?_'U!_UVB_\ 0Q2ELP/4=9_UK?A_(52J[K/^M;\/Y"J5
M=E#^''T7Y'QF,_WBI_B?YA1116ASA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %=OHW^K7_ '5_E7$5V^C?ZM?]U?Y5PYC\,?4]O(/XD_0OT445
MYA]"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !117"^/?%,^C2A8GVKY:D@*IY+,/X@?04XQ<G83=CNJ*\9_
MX6A<_P#/0_\ ?$?^%'_"T+G_ )Z'_OB/_"M/83#F/9J*\9_X6A<_\]#_ -\1
M_P"%'_"T+G_GH?\ OB/_  H]A,.8]FHKQG_A:%S_ ,]#_P!\1_X4?\+0N?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N%^,/_ !Z)_P!=U_\ 0'KNJX7XP_\ 'HG_ %W7_P! >KI?&@/'J***
M[Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5W7P>_X^W_ZX-_Z&E<+7=?![_C[?_K@W_H:5%7X&![#1117
M,**** "BBB@ HHHH \4^(O\ Q_S?]L__ $6M<W72?$7_ (_YO^V?_HM:YNON
M\#_NU+_"OR1RRW84445T""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#VOX=?\>$/_;3_ -&-725S?PZ_X\(?
M^VG_ *,:NDKX3'?[S5_Q/\V=4=D%%%%<XPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** &R=#]#7$:S_K6_#^0KMY.A^A
MKB-9_P!:WX?R%=N7?Q'Z?JCR<]_W>/\ B7Y,I4445ZA\R%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 >@6O3\:FJ&UZ?C4U?/'W@4444 %
M%%% !1110 4444 <G\2?^/=?^NJ_^@O7B%>W_$G_ (]U_P"NJ_\ H+UXA77A
MMF3U"BBBMQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:/AO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *[KX/?\?;_]<&_]#2N%KNO@]_Q]O_UP;_T-*BK\# ]AHHHK@&%%%% !
M1110 4444 >*?$7_ (_YO^V?_HM:YNND^(O_ !_S?]L__1:US=?=X'_=J7^%
M?DCEENPHHHKH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'M?PZ_X\(?^VG_ *,:NDKF_AU_QX0_]M/_ $8U
M=)7PF._WFK_B?YLZH[(****YQA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 -DZ'Z&N(UG_6M^'\A7;R=#]#7$:S_K6_
M#^0KMR[^(_3]4>3GO^[Q_P 2_)E*BBBO4/F0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#T"UZ?C4U0VO3\:FKYX^\"BBB@ HHHH ****
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M\8?^/1/^NZ_^@/5TOC0'CU%%%=X@HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M-DZ'Z&N(UG_6M^'\A7;R=#]#7$:S_K6_#^0KMR[^(_3]4>3GO^[Q_P 2_)E*
MBBBO4/F0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T"UZ
M?C4U0VO3\:FKYX^\"BBB@ HHHH **** "BBB@#D_B3_Q[K_UU7_T%Z\0KV_X
MD_\ 'NO_ %U7_P!!>O$*Z\-LR>H4445N,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K1\-_P#'U!_UVB_]#%9U:/AO_CZ@_P"NT7_H8I2V8'J.
ML_ZUOP_D*I5=UG_6M^'\A5*NRA_#CZ+\CXS&?[Q4_P 3_,****T.<**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KM]&_P!6O^ZO\JXBNWT;_5K_
M +J_RKAS'X8^I[>0?Q)^A?HHHKS#Z$**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+?BW_K!_P!<D_\ 0VKU
M*O+?BW_K!_UR3_T-JTH_&A2/-J***[@"BBB@ HHHH **** "GQ('(4D $@9.
M<#W. 3@>P)]J910!ZQHW@.TG6WNK67<T+HS./F#X(;:5S\AZ8'4#[P)YKHWA
MAT.2?4)I HG*9W8 'EI@ =V8X)XY/0#CGPNQO#92).N"T;JPSTRI!&>G'%3Z
MWJ[ZQ,UU( &?&0H('RJ%'4D]!ZU@Z,F]7H!KZ-;1>(M2PX/E32ROCH<?,X!Q
MG&<8.#]#WKV:YL1+$;="8QMV@Q84J.F%R"!QQTX[8.#7SI155*/,UKL!ZGKO
MPSM[>*:Z\R5G5)'RS*<L 6Y^3)R>O.:S?AQX5M=8BDDG&]U?&W>1A< @X4@\
MDGD\<<=#7GU%'LY<MK@=5X9UF+PW?N0=T&YX]WWCLW?*PVX!Y4$D \9P,XKO
MO$W@>/Q-)'=^:0H0 [0&#+G<"ISP3D\_,.G''/B]3V]]);!DC=E5QA@K$!AS
MP0#R.3U]:)4VW=.S ],^)WB"*UA_LN+&YMFY0.$1<%1Q@ D@8&#\N>F5SY91
M150@H*P!1115@%%%% !1110 4444 %>N?";[DG^[%_)J\CKUSX3?<D_W8OY-
M6.(^$75'?T445QE!1110 4444 %87CC_ (\Y?^ ?^AK6[6%XX_X\Y?\ @'_H
M:TX[H3V/$)_O'ZG^=,I\_P!X_4_SIE??T?X<?1'*PHHHJP"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NN^&W_'U'
M]7_]%FN1KKOAM_Q]1_5__19KS,[_ -T?JBH?$>PT445\>=(4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<+\8?\ CT3_ *[K_P"@/7=5POQA_P"/
M1/\ KNO_ * ]72^- >/4445WB"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KNO@]_P ?;_\ 7!O_ $-*X6NZ
M^#W_ !]O_P!<&_\ 0TJ*OP,#V&BBBN 84444 %%%% !1110!XI\1?^/^;_MG
M_P"BUKFZZ3XB_P#'_-_VS_\ 1:US=?=X'_=J7^%?DCEENPHHHKH$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'M?PZ_X\(?^VG_HQJZ2N;^'7_'A#_VT_P#1C5TE?"8[_>:O^)_FSJCL@HHH
MKG&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 V3H?H:XC6?]:WX?R%=O)T/T-<1K/\ K6_#^0KMR[^(_3]4>3GO^[Q_
MQ+\F4J***]0^9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /0+7I^-35#:]/QJ:OGC[P**** "BBB@ HHHH **** .3^)/_'NO_75?_07K
MQ"O;_B3_ ,>Z_P#75?\ T%Z\0KKPVS)ZA1116XPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "M'PW_Q]0?]=HO_ $,5G5H^&_\ CZ@_Z[1?^ABE
M+9@>HZS_ *UOP_D*I5=UG_6M^'\A5*NRA_#CZ+\CXS&?[Q4_Q/\ ,****T.<
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KM]&_U:_[J_RKB*[?
M1O\ 5K_NK_*N',?ACZGMY!_$GZ%^BBBO,/H0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\M^+?^L'_7)/\
MT-J]2KRWXM_ZP?\ 7)/_ $-JTH_&A2/-J***[@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KUSX3?<D_P!V
M+^35Y'7KGPF^Y)_NQ?R:L<1\(NJ._HHHKC*"BBB@ HHHH *PO''_ !YR_P#
M/_0UK=K"\<?\><O_  #_ -#6G'=">QXA/]X_4_SIE/G^\?J?YTROOZ/\./HC
ME844458!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !77?#;_CZC^K_ /HLUR-==\-O^/J/ZO\ ^BS7F9W_ +H_5%0^
M(]AHHHKX\Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X7XP_\
M'HG_ %W7_P! >NZKA?C#_P >B?\ 7=?_ $!ZNE\: \>HHHKO$%%%% !1110
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M8S_>*G^)_F%%%%:'.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5V^C?ZM?]U?Y5Q%=OHW^K7_=7^5<.8_#'U/;R#^)/T+]%%%>8?0A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5Y;\6_]8/\ KDG_ *&U>I5Y;\6_]8/^N2?^AM6E'XT*1YM1117< 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %>N?";[DG^[%_)J\CKUSX3?<D_W8OY-6.(^$75'?T445QE!1110 4444 %
M87CC_CSE_P" ?^AK6[6%XX_X\Y?^ ?\ H:TX[H3V/$)_O'ZG^=,I\_WC]3_.
MF5]_1_AQ]$<K"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Z[X;?\?4?U?\ ]%FN1KKOAM_Q]1_5_P#T6:\S
M._\ ='ZHJ'Q'L-%%%?'G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7"_&'_CT3_KNO_H#UW5<+\8?^/1/^NZ_^@/5TOC0'CU%%%=X@HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *[KX/?\?;_]<&_]#2N%KNO@]_Q]O_UP;_T-*BK\# ]AHHHK@&%%%% !1110
M 4444 >*?$7_ (_YO^V?_HM:YNND^(O_ !_S?]L__1:US=?=X'_=J7^%?DCE
MENPHHHKH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'M?PZ_X\(?^VG_ *,:NDKF_AU_QX0_]M/_ $8U=)7P
MF._WFK_B?YLZH[(****YQA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 -DZ'Z&N(UG_6M^'\A7;R=#]#7$:S_K6_#^0K
MMR[^(_3]4>3GO^[Q_P 2_)E*BBBO4/F0HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#T"UZ?C4U0VO3\:FKYX^\"BBB@ HHHH **** "BBB
M@#D_B3_Q[K_UU7_T%Z\0KV_XD_\ 'NO_ %U7_P!!>O$*Z\-LR>H4445N,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K1\-_P#'U!_UVB_]#%9U
M:/AO_CZ@_P"NT7_H8I2V8'J.L_ZUOP_D*I5=UG_6M^'\A5*NRA_#CZ+\CXS&
M?[Q4_P 3_,****T.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ^I_G3*^_H_PX^B.5A1115@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %==\-O^/J/ZO_ .BS7(UUWPV_X^H_J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#VOX=?\
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M>HZS_K6_#^0KR[PW_P ?4'_7:+_T,5ZCK/\ K6_#^0JJ'\;Y?JCR<]_W>/\
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M^K7_ '5_E7#F/PQ]3V\@_B3]"_1117F'T(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>6_%O_6#_KDG_H;5
MZE7EOQ;_ -8/^N2?^AM6E'XT*1YM1117< 4444 %%%% !1110 4444 %%%%
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MYC\,?4]O(/XD_0OT445YA]"%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7EOQ;_U@_ZY)_Z&U>I5Y;\6_P#6
M#_KDG_H;5I1^-"D>;4445W %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7KGPF^Y)_NQ?R:O(Z]<^$WW)/\
M=B_DU8XCX1=4=_1117&4%%%% !1110 5A>./^/.7_@'_ *&M;M87CC_CSE_X
M!_Z&M..Z$]CQ"?[Q^I_G3*?/]X_4_P Z97W]'^''T1RL****L HHHH ****
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Z[X;?\?4?U?\
M]%FN1KKOAM_Q]1_5_P#T6:\S._\ ='ZHJ'Q'L-%%%?'G2%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7"_&'_CT3_KNO_H#UW5<+\8?^/1/^NZ_^
M@/5TOC0'CU%%%=X@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *[KX/?\?;_]<&_]#2N%KNO@]_Q]O_UP;_T-
M*BK\# ]AHHHK@&%%%% !1110 4444 >*?$7_ (_YO^V?_HM:YNND^(O_ !_S
M?]L__1:US=?=X'_=J7^%?DCEENPHHHKH$%%%% !1110 4444 %%%% !1110
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M_P JX<Q^&/J>WD'\2?H7Z***\P^A"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRWXM_ZP?]<D_]#:O4J\M^
M+?\ K!_UR3_T-JTH_&A2/-J***[@"BBB@ HHHH **** "BBB@ HHHH ****
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M![_C[?\ ZX-_Z&E15^!@>PT445P#"BBB@ HHHH **** /%/B+_Q_S?\ ;/\
M]%K7-UTGQ%_X_P";_MG_ .BUKFZ^[P/^[4O\*_)'++=A11170(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M:_AU_P >$/\ VT_]&-725S?PZ_X\(?\ MI_Z,:NDKX3'?[S5_P 3_-G5'9!1
M117.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *Y/XD_\>Z_]=5_]!>NLKD_B3_Q[K_UU7_T%ZJ.Z%+8\0HHHKT "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -'PW_ ,?4'_7:
M+_T,5ZCK/^M;\/Y"O+O#?_'U!_UVB_\ 0Q7J.L_ZUOP_D*JA_&^7ZH\G/?\
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M?ZM?]U?Y5PYC\,?4]O(/XD_0OT445YA]"%%%% !1110 4444 %%%% !1110
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MX?R%50_C?+]4>3GO^[Q_Q+\F4J***[3YH**** "BBB@ HHHH **** "BBB@
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M "%_]LH_X4M_T\?^0O\ [91[>'<+'F5%>F_\*6_Z>/\ R%_]LH_X4M_T\?\
MD+_[91[>'<+'F5%>F_\ "EO^GC_R%_\ ;*/^%+?]/'_D+_[91[>'<+'F5%>F
M_P#"EO\ IX_\A?\ VRC_ (4M_P!/'_D+_P"V4>WAW"QYE17IO_"EO^GC_P A
M?_;*/^%+?]/'_D+_ .V4>WAW"QYE17IO_"EO^GC_ ,A?_;*/^%+?]/'_ )"_
M^V4>WAW"QYE17IO_  I;_IX_\A?_ &RC_A2W_3Q_Y"_^V4>WAW"QYE17IO\
MPI;_ *>/_(7_ -LH_P"%+?\ 3Q_Y"_\ ME'MX=PL>945Z;_PI;_IX_\ (7_V
MRC_A2W_3Q_Y"_P#ME'MX=PL>95W7P>_X^W_ZX-_Z&E:?_"EO^GC_ ,A?_;*W
M?!_P]_X1R9KCS=^Z,KC9MZLISG<?2IJ5H.+5P.QHHHKD&%%%% !1110 4444
M >*?$7_C_F_[9_\ HM:YNO6?$7PV_MF=[OSMN_;\OE[L;5"]=X]/2LW_ (4]
M_P!/'_D+_P"SKZS"YMA(4*<7+512>C[>AA*G)MGG%%>C_P#"GO\ IX_\A?\
MV='_  I[_IX_\A?_ &=;_P!M8+^?\'_D+V<CSBBO1_\ A3W_ $\?^0O_ +.C
M_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/
M'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\
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M_P#/&/\ []K_ (4?V#;_ //&/_OVO^%'UE]@LSY]_LR3T_4?XT?V9)Z?J/\
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M_P#GC'_W[7_"CZR^P69\^_V9)Z?J/\:T/#VGNES 2.!-'W']\>]>Y?V#;_\
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M_?;_ /Q-'_"I)/6/_OM__B:/;P \VHKTG_A4DGK'_P!]O_\ $T?\*DD]8_\
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M8_\ OI__ (FC_6##=I?<O\P]G(\_HKT#_A5,WK'_ -]/_P#$T?\ "J9O6/\
M[Z?_ .)H_P!8,-VE]R_S#V<CS^BO0/\ A5,WK'_WT_\ \31_PJF;UC_[Z?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9+,-J4H*^:@6,'NI(8L1CH<#;SR,G&"IJC\:;> R)*9&%P(U C"94KN;#;N
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MSEW7)[G:K  >@].I)Y/F7BG0)?!%VKPNV/OQ28P<="IXP2.C#H01D -B@#Z
MHK/TK64O[=+[*JCQAV^8%5XRP+<#Y3D'IC!SBN$U/XVQ0N4@A:1!_$S^7DY/
M0;6.,8(S@^H% 'I=%>=-\8E^SBZ%N^[S A!)$>2&/$H4@D #*D*?FXR 37G7
M@KQ7_P (Q,USL\S=&4QNV]64YSAO[OI0!]%45SFH>.8-,M8KZ?(\]$98UPSG
M<H8@9VY"YY)P/Q(!X^'XY*6 >W(7(R1+D@=R 4&3[9'U% 'J=>?^%OBO_;UR
MEEY&SS-WS>;NQM4MTV#TQUKL-"UV+7(A<P'*MU!^\I[J1V(_^N,@@GY_\&:V
MFB7<=Y*&*1[\A "WS(RC&2!U/K0!](45YIIGQMBF<)/"T:'^)7\S!R.HVJ<
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MY W!!D$#L<XY![UZQK?@RTUMQ-<Q[W"A0=[KP"3C"L!U)KDOBOXF@L[<Z1&
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MWSL[$*,<GYV(''4\<9&<$UY)XUU;_A,KY5M$9OE$:>K8+,6P<;1R>O0#)QR
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M^&_C-O$D3+*/WL&T,PP%8-G#8['Y3D=.XZX !V%%>&:3\1M3OF-M&YDEE 5
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MGA]K6X%^,E)P 3Z.@ QTP 5 (Y))#=A6[:?&V'RU,L3^;QN";=G7#$$MGIR
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M^#M?;P3=R)=(X!4HZ*1D$8*M@D!O8YZ,2"1P?<[+3HK!=D**BDY(10HSTS@
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M:VB6BB*)51!G"H JC)R< <=:S[GPI:7+>:\$1;<6),:Y)(()/'S9R3SGGGJ
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M)P6)4]P ,G@\$ '>T5XOKZ#Q1K0M<AHT=4P<K\L0W2KD '.0X!]3P<8->T4
M,FF6%2[D!5!)).  .223T KQ?QGXSE\7RC3;(,8BV !PTA'.XYQA1C(!QC&Y
ML8 7T/XA^%Y?$ENMO"5#+*&)<D# 5AV#<_-7GG_"E+S^_#_WT_\ \;H ]#\#
M>!H_#,>3AIW'SO\ KM7/11^;'D]@/-/&UZMAK)N'R5BEMV('7"I&3C..>*Z/
MP9\+[G1+N.\E>(I'OR$9RWS(RC&4 ZGUK=^(/P^'B4+/$P6= %!8G8RY)P<
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MPE0RRAB7) P%8=@W/S4 >>>,_&<OB^4:;9!C$6P .&D(YW'.,*,9 .,8W-C
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M5D;N2Y9@6))SCIQSN!('MNM^#+36W$US'O<*%!WNO ).,*P'4FL__A5NG?\
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M:?\ /Q#_ -_4_P :/^$HM/\ GXA_[^I_C1RL#4HK+_X2BT_Y^(?^_J?XT?\
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M^$HM/^?B'_OZG^-'*P-2BLO_ (2BT_Y^(?\ OZG^-'_"46G_ #\0_P#?U/\
M&CE8&I167_PE%I_S\0_]_4_QH_X2BT_Y^(?^_J?XT<K U**R_P#A*+3_ )^(
M?^_J?XT?\)1:?\_$/_?U/\:.5@:E%9?_  E%I_S\0_\ ?U/\:/\ A*+3_GXA
M_P"_J?XT<K U**R_^$HM/^?B'_OZG^-'_"46G_/Q#_W]3_&CE8&I167_ ,)1
M:?\ /Q#_ -_4_P :/^$HM/\ GXA_[^I_C1RL#4HK+_X2BT_Y^(?^_J?XT?\
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M^$HM/^?B'_OZG^-'*P-2BLO_ (2BT_Y^(?\ OZG^-'_"46G_ #\0_P#?U/\
M&CE8&I167_PE%I_S\0_]_4_QH_X2BT_Y^(?^_J?XT<K U**R_P#A*+3_ )^(
M?^_J?XT?\)1:?\_$/_?U/\:.5@:E%9?_  E%I_S\0_\ ?U/\:L6>LP7IV0RH
M[ 9PCJQQTS@$\<T68%RBBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% %2WTF&V=IXXT61\[F5%#')R<L!DY/)]ZMT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*/^$A@_O\ _CK?X4>P
MJ?RO[@^N8?\ GC]Z-*BLW_A(8/[_ /XZW^%'_"0P?W__ !UO\*/85/Y7]P?7
M,/\ SQ^]&E16;_PD,']__P =;_"C_A(8/[__ (ZW^%'L*G\K^X/KF'_GC]Z-
M*BLW_A(8/[__ (ZW^%'_  D,']__ ,=;_"CV%3^5_<'US#_SQ^]&E16;_P )
M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*/^$A@_O\ _CK?X4>P
MJ?RO[@^N8?\ GC]Z-*BLW_A(8/[_ /XZW^%'_"0P?W__ !UO\*/85/Y7]P?7
M,/\ SQ^]&E16;_PD,']__P =;_"C_A(8/[__ (ZW^%'L*G\K^X/KF'_GC]Z-
M*BLW_A(8/[__ (ZW^%'_  D,']__ ,=;_"CV%3^5_<'US#_SQ^]&E16;_P )
M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*/^$A@_O\ _CK?X4>P
MJ?RO[@^N8?\ GC]Z-*BLW_A(8/[_ /XZW^%'_"0P?W__ !UO\*/85/Y7]P?7
M,/\ SQ^]&E16;_PD,']__P =;_"C_A(8/[__ (ZW^%'L*G\K^X/KF'_GC]Z-
M*BLW_A(8/[__ (ZW^%'_  D,']__ ,=;_"CV%3^5_<'US#_SQ^]&E16;_P )
M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*/^$A@_O\ _CK?X4>P
MJ?RO[@^N8?\ GC]Z-*BLW_A(8/[_ /XZW^%'_"0P?W__ !UO\*/85/Y7]P?7
M,/\ SQ^]&E16;_PD,']__P =;_"C_A(8/[__ (ZW^%'L*G\K^X/KF'_GC]Z-
M*BLW_A(8/[__ (ZW^%'_  D,']__ ,=;_"CV%3^5_<'US#_SQ^]&E16;_P )
M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*/^$A@_O\ _CK?X4>P
MJ?RO[@^N8?\ GC]Z-*BLW_A(8/[_ /XZW^%'_"0P?W__ !UO\*/85/Y7]P?7
M,/\ SQ^]&E16;_PD,']__P =;_"C_A(8/[__ (ZW^%'L*G\K^X/KF'_GC]Z-
M*BLW_A(8/[__ (ZW^%'_  D,']__ ,=;_"CV%3^5_<'US#_SQ^]&E16;_P )
M#!_?_P#'6_PH_P"$A@_O_P#CK?X4>PJ?RO[@^N8?^>/WHTJ*S?\ A(8/[_\
MXZW^%'_"0P?W_P#QUO\ "CV%3^5_<'US#_SQ^]&E16;_ ,)#!_?_ /'6_P *
M/^$A@_O_ /CK?X4>PJ?RO[@^N8?^>/WHTJ*S?^$A@_O_ /CK?X4?\)#!_?\
M_'6_PH]A4_E?W!]<P_\ /'[T:5%9O_"0P?W_ /QUO\*NV]PMRHD0Y4]#TZ<=
MZ4J<XJ[315/$4JCM&2;\FF2T445!J%%%% !1110 4444 %%%% !1110 4444
M >%_$K_D(3?]L_\ T6E<Q73_ !*_Y"$W_;/_ -%I7,5Z%/X5Z""BBBJ ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPLXK_A);K_GO+_W]?_&C_A);K_GO+_W]?_&LVBOK_84_Y5]R,+LTO^$ENO\
MGO+_ -_7_P :/^$ENO\ GO+_ -_7_P :S:*/84_Y5]R"[-+_ (26Z_Y[R_\
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MK_GO+_W]?_&LVBCV%/\ E7W(+LTO^$ENO^>\O_?U_P#&C_A);K_GO+_W]?\
MQK-HH]A3_E7W(+LTO^$ENO\ GO+_ -_7_P :/^$ENO\ GO+_ -_7_P :S:*/
M84_Y5]R"[-+_ (26Z_Y[R_\ ?U_\:/\ A);K_GO+_P!_7_QK-HH]A3_E7W(+
MLTO^$ENO^>\O_?U_\:/^$ENO^>\O_?U_\:S:*/84_P"5?<@NS2_X26Z_Y[R_
M]_7_ ,:/^$ENO^>\O_?U_P#&LVBCV%/^5?<@NS2_X26Z_P">\O\ W]?_ !H_
MX26Z_P">\O\ W]?_ !K-HH]A3_E7W(+LTO\ A);K_GO+_P!_7_QH_P"$ENO^
M>\O_ ']?_&LVBCV%/^5?<@NS2_X26Z_Y[R_]_7_QH_X26Z_Y[R_]_7_QK-HH
M]A3_ )5]R"[-+_A);K_GO+_W]?\ QH_X26Z_Y[R_]_7_ ,:S:*/84_Y5]R"[
M-+_A);K_ )[R_P#?U_\ &C_A);K_ )[R_P#?U_\ &LVBCV%/^5?<@NS2_P"$
MENO^>\O_ ']?_&C_ (26Z_Y[R_\ ?U_\:S:*/84_Y5]R"[-+_A);K_GO+_W]
M?_&C_A);K_GO+_W]?_&LVBCV%/\ E7W(+LTO^$ENO^>\O_?U_P#&C_A);K_G
MO+_W]?\ QK-HH]A3_E7W(+LTO^$ENO\ GO+_ -_7_P :/^$ENO\ GO+_ -_7
M_P :S:*/84_Y5]R"[-+_ (26Z_Y[R_\ ?U_\:/\ A);K_GO+_P!_7_QK-HH]
MA3_E7W(+LTO^$ENO^>\O_?U_\:/^$ENO^>\O_?U_\:S:*/84_P"5?<@NS2_X
M26Z_Y[R_]_7_ ,:/^$ENO^>\O_?U_P#&LVBCV%/^5?<@NS2_X26Z_P">\O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZBCV\^X6/,?^%+?]/'_D+_[91_PI;_IX_P#(7_VRO3J*/;S[A8\Q_P"%+?\
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M/,?^%+?]/'_D+_[91_PI;_IX_P#(7_VRO3J*/;S[A8\Q_P"%+?\ 3Q_Y"_\
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MKJ__ .>7_D2/_P"*H_X5U?\ _/+_ ,B1_P#Q5>UT4?ZPXGM'[G_F'LD>*?\
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M /YY?^1(_P#XJC_A75__ ,\O_(D?_P 57M=%'^L.)[1^Y_YA[)'BG_"NK_\
MYY?^1(__ (JC_A75_P#\\O\ R)'_ /%5[711_K#B>T?N?^8>R1XI_P *ZO\
M_GE_Y$C_ /BJ/^%=7_\ SR_\B1__ !5>UT4?ZPXGM'[G_F'LD>*?\*ZO_P#G
ME_Y$C_\ BJ/^%=7_ /SR_P#(D?\ \57M=%'^L.)[1^Y_YA[)'BG_  KJ_P#^
M>7_D2/\ ^*H_X5U?_P#/+_R)'_\ %5[711_K#B>T?N?^8>R1XI_PKJ__ .>7
M_D2/_P"*H_X5U?\ _/+_ ,B1_P#Q5>UT4?ZPXGM'[G_F'LD>*?\ "NK_ /YY
M?^1(_P#XJC_A75__ ,\O_(D?_P 57M=%'^L.)[1^Y_YA[)'BG_"NK_\ YY?^
M1(__ (JC_A75_P#\\O\ R)'_ /%5[711_K#B>T?N?^8>R1XI_P *ZO\ _GE_
MY$C_ /BJ/^%=7_\ SR_\B1__ !5>UT4?ZPXGM'[G_F'LD>*?\*ZO_P#GE_Y$
MC_\ BJ/^%=7_ /SR_P#(D?\ \57M=%'^L.)[1^Y_YA[)'BG_  KJ_P#^>7_D
M2/\ ^*H_X5U?_P#/+_R)'_\ %5[711_K#B>T?N?^8>R1XI_PKJ__ .>7_D2/
M_P"*H_X5U?\ _/+_ ,B1_P#Q5>UT4?ZPXGM'[G_F'LD>*?\ "NK_ /YY?^1(
M_P#XJC_A75__ ,\O_(D?_P 57M=%'^L.)[1^Y_YA[)'BG_"NK_\ YY?^1(__
M (JC_A75_P#\\O\ R)'_ /%5[711_K#B>T?N?^8>R1XI_P *ZO\ _GE_Y$C_
M /BJ/^%=7_\ SR_\B1__ !5>UT4?ZPXGM'[G_F'LD>*?\*ZO_P#GE_Y$C_\
MBJ/^%=7_ /SR_P#(D?\ \57M=%'^L.)[1^Y_YA[)'BG_  KJ_P#^>7_D2/\
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M_P#/+_R)'_\ %5[711_K#B>T?N?^8>R1XI_PKJ__ .>7_D2/_P"*H_X5U?\
M_/+_ ,B1_P#Q5>UT4?ZPXGM'[G_F'LD>*?\ "NK_ /YY?^1(_P#XJC_A75__
M ,\O_(D?_P 57M=%'^L.)[1^Y_YA[)'BG_"NK_\ YY?^1(__ (JC_A75_P#\
M\O\ R)'_ /%5[711_K#B>T?N?^8>R1XI_P *ZO\ _GE_Y$C_ /BJ/^%=7_\
MSR_\B1__ !5>UT4?ZPXGM'[G_F'LD>*?\*ZO_P#GE_Y$C_\ BJ/^%=7_ /SR
M_P#(D?\ \57M=%'^L.)[1^Y_YA[)'BG_  KJ_P#^>7_D2/\ ^*H_X5U?_P#/
M+_R)'_\ %5[711_K#B>T?N?^8>R1XI_PKJ__ .>7_D2/_P"*H_X5U?\ _/+_
M ,B1_P#Q5>UT4?ZPXGM'[G_F'LD>*?\ "NK_ /YY?^1(_P#XJC_A75__ ,\O
M_(D?_P 57M=%'^L.)[1^Y_YA[)'BG_"NK_\ YY?^1(__ (JC_A75_P#\\O\
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M !5>UT4?ZPXGM'[G_F'LD>*?\*ZO_P#GE_Y$C_\ BJ/^%=7_ /SR_P#(D?\
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MJ_S,/[.PO\B,7_A$XO5OS'_Q-'_")Q>K?F/_ (FMJBCZU5_F8?V=A?Y$8O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7:B6)E=#G#(0RG!P<$<=: )J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,SYA8?>VXQA6_NF@#S3_ (6EJ/\ SV_\AQ?_ !%'_"TM1_Y[?^0XO_B*U?\
MA2EY_?A_[Z?_ .-T?\*4O/[\/_?3_P#QN@#*_P"%I:C_ ,]O_(<7_P 11_PM
M+4?^>W_D.+_XBCQ+\.9_#L7VF=XMI8* A<L2<G R@'0$\D=/7 /*T >U?"CQ
M3<Z]Y_VE]_E^5M^55QNWY^Z!Z#K7H%>:?!+3'ABFNF&$E9 N<Y/E[LGIC&6Q
MD'J".U>ET %%%% !114-W=+:(TTAPD:EF."<!1DG YZ4 8'C[Q8/#EN77_6R
M96, C(./OX.<A?H>2 <9S7DG_"TM1_Y[?^0XO_B*S_&'B5O$5PURWW1\L8P
M0@)*@X)YYR>3R3CC &?I6F/JDJ6L0R\C #K@9ZDX!. .2<< $T >E_#OQ'J/
MB.?]Y-^XBP9/DB!.<[5'R9Y(YZ< \@XKU6LSPYH,>A0):Q@?*!N(&-S8^9CR
M>3]3@8 X K3H *\/\0_$>_M+F>&.;"1S2*H\N,X"N0!DKGI7N%?-7BS_ (_+
MG_KXF_\ 0VH U?\ A:6H_P#/;_R'%_\ $4?\+2U'_GM_Y#B_^(K*\+:%_;UR
MEENV>9N^;;NQM4MTR/3'6NZNO@<ZJ3%<*S\8#QE%Z\Y8,Q''L?ZT <_:_%C4
M(6#M(K@9^5XT"GCOL"GCKP1^5>@>#_BK%K3+;3KY4S< YS&QP. 3R"3G"G/8
M;B2!7E7B?PA/X;94G"X?.UD;*M@#..A&-P'('MD5CPS-"P="0RD$$'!!'(((
MZ$4 ?5%%9_AZZ:[MH)I#EY(8V8X R60$G XZUH4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#@9+!C@DCDYKP2:%H6*."&4D$$8((X((/0B@#Z0\*^)H_$< NHP1SM93_"P
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M $DLT>!@$=]N.J]NJ\Y#5_B9X-C\.2HT&?*F#$!CD@J>1T'RX9<9)/7)KC:
M/JJBN:^&]TUUI\#N<D*R] .$=D4<>@ '\^:Z6@ HHHH **** "BBB@ HHHH
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M:U-K$GGW#EWP!DX& .@    ^@ZY/4FJ5.>%D )! 89!(QD9(R/49!'U!%-H
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M!IT! .,C:YP?49 /U -=/X8\0IX@@6[C&-V0RY!*L.H./S'0D$' S7*_&O\
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MV/PZ#I6]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 54U:Q_M"&2VSM\V-TSC.-RD9QD9Q
MGUJW10!\M7=JUH[0R##QL589!P5.",CCK71>"_'LOA<LH421.02I8C! (RIY
M )XS\IR !Q7J'CGX<1^(S]HC(CG Y.,J^!\H;'0C@;N2!P0<#'E&L^ KW2,F
M2)B@W?/'\ZX7JQVY*C'/S <?0X #P%JD>E7L5S.VV--^3@G&8V X )ZD=J]_
MTS58M4030.KH>ZG.#@'!'4'!&0<$=Q7S!4MK=O:,)8F9'&<,A*L,C!P1STH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5:*R?"VN_P!O6R7NW9YF[Y=V[&UBO7 ],]*UJ "BBB@ HHHH **** "BBB@
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MH\?GW#A$R!DY.2>@  ))^@Z GH#5ZOF_Q9XLE\22^=+PJY"(#\JC^I/<]_8
M  %WQSXYD\328&5@0_(GZ;FQU8_DHX'<G T_3Y-1D6WA4M(YP /\\ =23P!R
M>*KUU_@SQU%X84E;??*_WI#+@XSPH&PX'KR<GD]   >A_#SX>+H*BZG -RP^
MHC![#U8_Q-^ XR6[BO*O^%Y_].W_ )&_^UT?\+S_ .G;_P C?_:Z /5:**\G
M^*?CN:WF.GVS-'Y8'F,I +%@KJ 1\P '<$9R01@<@'K%%?-^E^,[O3765)G.
MUBVUW9D)8DME2<'<223UR<@@\U]!:)JBZK!'=+C$J*V =V"1RN?53D'W'04
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5G9%V.J\MC.5(4#)Y8[N3V., FO+;+1)[Z7[+%&S2@X*A3D8.T[L_= )P2<
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M))/J22>P] !Q5ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*O@J>:X^W6Z-(LH4,$!9E91C[H&=I4#GGG.<94'UVB@#YGT'PY/KL@A@4GD
MM@[%SGEF[#@^YQ@ GBOHK1-+72H([5<8B15R!MR0.6QZL<D^YZFKU% %?4-/
MCU&-K>90T;C!!_SP1U!'(/(YKPSQA\-I]#9I(E:2W'(<#+*,$D,!R-H'+8V]
M#P3@>]T4 ?*M6M,TJ75'$,",[GLHS@9 R3T R1DG '<U]044 >>?#SX:-HKB
M]NB#,!\BJ<A=RX8D]VY(P,J.3DY&/0Z** .'^+NG2W]HB0HSL)U)"*6.-CC.
M #QS7D7_  B=Y_S[S?\ ?E__ (FOI6B@#YJ_X1.\_P"?>;_OR_\ \31_PB=Y
M_P ^\W_?E_\ XFOI6B@#P?1_A1>W[+YBB*-@"6<@G!QQL!+;L'.&V],$@UZK
MX0\#0>&5)CRTK@!G;&>V0 /NKGG')Z9)P,='10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !5'6-:AT>/S[APB9 R<G)/0  $D_0= 3T!J]7@5\6\<
M:F8U<!9'948AL"- 2"%/.2H)QQEB>F> #T+_ (7)8[_+Q+MW8W[!MQG&[&[=
MCO\ =SCMGBNKT;7X-:7S+:17 ZXX8<D#*G!&<'&0,]1Q7&:OX3T7P\J+=*07
M! ):9BVW&2=AP#R.P'/ K0^'USIMN&L]/<N^"[EE8.0"!RQ11@;L #ZXR22
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 444R:985+N0%4$DDX  Y
M))/0"@"*]U&*P7?,ZHI. 78*,]<9)'/%85K\2-/NF$:SJ"<_?5T7@9Y9U 'X
MGVZUY/ MS\0;PH7(7+-AFRL:9 X'&3]T< %C@MCDCK=3^%^FV.8Y+EHY"N5\
MV6(=<@':54D9'J,X(R* /389EF4.A!5@""#D$'D$$=0:BO=1BL%WS.J*3@%V
M"C/7&21SQ6)X&T^UTR#[+:2K+M.Z1E=6RS#&2%)V@[< >@[G)/#_ !<UEM3G
MBT>'DJRDC@9D?A%R0,8#=<X.[GE: /4[+48K]=\+JZ@X)1@PSUQD$\\U8KQ?
MX8Z@= OY-/E8 2%HSC&TR1L=IRV#@_,!ZE@,>GM% %&]URWL&V32QHQ&0'=5
M..F<$CCBK<,RS*'0@JP!!!R"#R"".H->"^)KN3QE=S3PX,<$3L"3C$40)ST!
MRQ.0",@M@\#([CX,:Z+B![%C\\+%E!P/D?GCN<-G)(XW 9[  [>]URWL&V32
MQHQ&0'=5..F<$CCBJ_\ PEEG_P _$/\ W^3_ .*KRKXU_P#'Y'_U[K_Z')3]
M6^']K9:<NI>8RRO%$P#LNPLX#%0 FXDC..>.I. 30![117FGP2U-YHIK5CE(
MF0KG.1YF[(ZX RN< =23WKTN@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **J:M??V?#)<XW>5&[XSC
M.U2<9P<9QZ5P6B_&:.^F2":(1(YP7,NX#@XR-@X)P,Y &<G@4 >D45D^*==_
ML&V>]V[_ "]OR[MN=S!>N#ZYZ55\%>*_^$GA:YV>7MD*8W;NBJ<YPO\ >]*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\_JK>"-2#,K;(I#M
MW8):)LKN&"H)*DXZ -P>A%?0%9/B'PQ!X@017"YVYVL#AE)&,@_T.02!D'%
M'->(?[+\8+')+=*HCW[<2)&WS$ Y609'W>.!Z\@BN-^#4RPW<KN0%6V<DDX
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MY8ER"<D =@O'RUL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA>)X@P=G?<7V;#C  7JV0.2.>YXH \5\5>)QK5S]OB0POA<X<L=R=&!PN#@
M<>F>IKU7Q1XY TL7\.0UR BXS\C,#OY^4Y7:P##^( XQ6[XO\,+XD@-JQVG<
MK*V"=I'?&5SD$CD]\]17%-\%F9!";KY%9F \@=7"ACGS,\A1^7UH XSP-XT7
MPLTCF$2-(% .[:5 R2,[6X/&>G0=>T7A/Q$FCWRW8!2$NP*AF.U'R,$X)8)D
M'IDE1WKWK1-+72H([5<8B15R!MR0.6QZL<D^YZFN=\<?#M?%#I,)/+=%*D[2
M^X9RHQN4#!)^N?84 <)\:_\ C\C_ .O=?_0Y*O:'\&UOXH;IYR%E1'*B/G#
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M+!W'+,OFIM?H,XSM/4Y +'+"M7X5:FFEZ;/=2G"1S.3TR<1QX R0,D\ 9Y)
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M6V69%V9WN-IRJN,J48<$_IFN)TG4[CX>7;QRINRN&7<0KC^%U.,=>A(. 67
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M_P"L,  #0HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH^87/=/^%E:?_P ]O_(<G_Q%'_"RM/\ ^>W_ )#D_P#B*\+HH^K1\PN>Z?\
M"RM/_P">W_D.3_XBC_A96G_\]O\ R')_\17A=%'U:/F%SW3_ (65I_\ SV_\
MAR?_ !%'_"RM/_Y[?^0Y/_B*\+HH^K1\PN>Z?\+*T_\ Y[?^0Y/_ (BC_A96
MG_\ /;_R')_\17A=%'U:/F%SW3_A96G_ //;_P AR?\ Q%'_  LK3_\ GM_Y
M#D_^(KPNBCZM'S"Y[I_PLK3_ /GM_P"0Y/\ XBC_ (65I_\ SV_\AR?_ !%>
M%T4?5H^87/=/^%E:?_SV_P#(<G_Q%'_"RM/_ .>W_D.3_P"(KPNBCZM'S"Y[
MI_PLK3_^>W_D.3_XBC_A96G_ //;_P AR?\ Q%>%T4?5H^87/=/^%E:?_P ]
MO_(<G_Q%'_"RM/\ ^>W_ )#D_P#B*\+HH^K1\PN>Z?\ "RM/_P">W_D.3_XB
MC_A96G_\]O\ R')_\17A=%'U:/F%SW3_ (65I_\ SV_\AR?_ !%'_"RM/_Y[
M?^0Y/_B*\+HH^K1\PN>Z?\+*T_\ Y[?^0Y/_ (BC_A96G_\ /;_R')_\17A=
M%'U:/F%SW3_A96G_ //;_P AR?\ Q%'_  LK3_\ GM_Y#D_^(KPNBCZM'S"Y
M[I_PLK3_ /GM_P"0Y/\ XBC_ (65I_\ SV_\AR?_ !%>%T4?5H^87/=/^%E:
M?_SV_P#(<G_Q%'_"RM/_ .>W_D.3_P"(KPNBCZM'S"Y[I_PLK3_^>W_D.3_X
MBC_A96G_ //;_P AR?\ Q%>%T4?5H^87/=/^%E:?_P ]O_(<G_Q%'_"RM/\
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M  LK3_\ GM_Y#D_^(KPNBCZM'S"Y[I_PLK3_ /GM_P"0Y/\ XBC_ (65I_\
MSV_\AR?_ !%>%T4?5H^87/=/^%E:?_SV_P#(<G_Q%'_"RM/_ .>W_D.3_P"(
MKPNBCZM'S"Y[I_PLK3_^>W_D.3_XBC_A96G_ //;_P AR?\ Q%>%T4?5H^87
M/=/^%E:?_P ]O_(<G_Q%'_"RM/\ ^>W_ )#D_P#B*\+HH^K1\PN>Z?\ "RM/
M_P">W_D.3_XBC_A96G_\]O\ R')_\17A=%'U:/F%SW3_ (65I_\ SV_\AR?_
M !%'_"RM/_Y[?^0Y/_B*\+HH^K1\PN>Z?\+*T_\ Y[?^0Y/_ (BC_A96G_\
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M:_\ />+_ +^I_C1_PDMK_P ]XO\ OZG^->!44?ZN4_YW^ >V9[[_ ,)+:_\
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MXO\ OZG^->!44?ZN4_YW^ >V9[[_ ,)+:_\ />+_ +^I_C1_PDMK_P ]XO\
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M:_\ />+_ +^I_C1_PDMK_P ]XO\ OZG^->!44?ZN4_YW^ >V9[[_ ,)+:_\
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MXO\ OZG^->!44?ZN4_YW^ >V9[[_ ,)+:_\ />+_ +^I_C1_PDMK_P ]XO\
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M_J?XT?\ "2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?XT?\
M"2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?XT?\ "2VO_/>+
M_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?XT?\ "2VO_/>+_OZG^->!
M44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?XT?\ "2VO_/>+_OZG^->!44?ZN4_Y
MW^ >V9[[_P )+:_\]XO^_J?XT?\ "2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[
M_P )+:_\]XO^_J?XT?\ "2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\
M]XO^_J?XT?\ "2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?X
MT?\ "2VO_/>+_OZG^->!44?ZN4_YW^ >V9[[_P )+:_\]XO^_J?XT?\ "2VO
M_/>+_OZG^->!44?ZN4_YW^ >V9]%6URETHDC8,IZ%2"#@XZCCK4M<W\.O^/"
M'_MI_P"C&KI*^>Q%-4JLX=FU]S-4[JX4C,$&3P!ZTM5M2_U4G^XW\C6<5=I"
MG+EBWV0?VE%_?7_OH?XT?VE%_?7_ +Z'^-<%17I?V='NSP/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QH_M*+^^O_?0_P :X*BC^SH]
MV']OU/Y4=[_:47]]?^^A_C1_:47]]?\ OH?XUP5%']G1[L/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QH_M*+^^O_?0_P :X*BC^SH]
MV']OU/Y4=[_:47]]?^^A_C1_:47]]?\ OH?XUP5%']G1[L/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QH_M*+^^O_?0_P :X*BC^SH]
MV']OU/Y4=[_:47]]?^^A_C1_:47]]?\ OH?XUP5%']G1[L/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QH_M*+^^O_?0_P :X*BC^SH]
MV']OU/Y4=[_:47]]?^^A_C1_:47]]?\ OH?XUP5%']G1[L/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QH_M*+^^O_?0_P :X*BC^SH]
MV']OU/Y4=[_:47]]?^^A_C1_:47]]?\ OH?XUP5%']G1[L/[?J?RH[W^THO[
MZ_\ ?0_QH_M*+^^O_?0_QK@J*/[.CW8?V_4_E1WO]I1?WU_[Z'^-']I1?WU_
M[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O\ WT/\:/[2B_OK_P!]#_&N"HH_LZ/=
MA_;]3^5'>_VE%_?7_OH?XT?VE%_?7_OH?XUP5%']G1[L/[?J?RH[W^THO[Z_
M]]#_ !H_M*+^^O\ WT/\:X*BC^SH]V']OU/Y4=[_ &E%_?7_ +Z'^-']I1?W
MU_[Z'^-<%11_9T>[#^WZG\J.]_M*+^^O_?0_QJ>.42C<I!![@Y%>=UVGA[_4
M)_P+_P!"-88G"*C!23OJ=F79G+%5'!I*RO\ D:5%%%<9ZH4444 %%%% !111
M0 4444 %%%% !1110!E^*/\ CTN/^N$O_H!KYXKZ3O[,7L;P-D+(C*<=<,"#
MC.>>:XW_ (4]:?WYO^^D_P#B*WHU(P3N)GCU%>P_\*>M/[\W_?2?_$4?\*>M
M/[\W_?2?_$5K]8@%CQZBO8?^%/6G]^;_ +Z3_P"(H_X4]:?WYO\ OI/_ (BC
MZQ +'CU%>P_\*>M/[\W_ 'TG_P 11_PIZT_OS?\ ?2?_ !%'UB 6/'J*]A_X
M4]:?WYO^^D_^(H_X4]:?WYO^^D_^(H^L0"QX]17L/_"GK3^_-_WTG_Q%'_"G
MK3^_-_WTG_Q%'UB 6/'J*]A_X4]:?WYO^^D_^(H_X4]:?WYO^^D_^(H^L0"Q
MX]17L/\ PIZT_OS?]])_\11_PIZT_OS?]])_\11]8@%CQZBO8?\ A3UI_?F_
M[Z3_ .(H_P"%/6G]^;_OI/\ XBCZQ +'CU%>P_\ "GK3^_-_WTG_ ,11_P *
M>M/[\W_?2?\ Q%'UB 6/'J*]A_X4]:?WYO\ OI/_ (BC_A3UI_?F_P"^D_\
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M4?\ "GK3^_-_WTG_ ,11]8@%CQZBO8?^%/6G]^;_ +Z3_P"(H_X4]:?WYO\
MOI/_ (BCZQ +'CU%>P_\*>M/[\W_ 'TG_P 11_PIZT_OS?\ ?2?_ !%'UB 6
M/'J*]A_X4]:?WYO^^D_^(H_X4]:?WYO^^D_^(H^L0"QX]17L/_"GK3^_-_WT
MG_Q%'_"GK3^_-_WTG_Q%'UB 6/'J*]A_X4]:?WYO^^D_^(H_X4]:?WYO^^D_
M^(H^L0"QX]17L/\ PIZT_OS?]])_\11_PIZT_OS?]])_\11]8@%CQZBO8?\
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M $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\
M[.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_
MX4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\
MD+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_M
MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_
M (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]
MG(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\
MA3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^
M0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_
M^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T
M\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^
MSH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK
M!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_
M ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO
M1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_
MT\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_
M )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X
M4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_
MY"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"S
MH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_
M/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<C
MSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\
MX4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?
M]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^
MSH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W
M_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+
M_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^
MVL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R
M#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHK
MT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_
M^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_
MY"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C
M_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/
M'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\
M[.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/
M^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(
M\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSB
MBO1_^%/?]/'_ )"_^SH_X4]_T\?^0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W
M_3Q_Y"_^SH_X4]_T\?\ D+_[.C^VL%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_
M +.C_A3W_3Q_Y"_^SH_MK!?S_@_\@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]
M_P!/'_D+_P"SH_MK!?S_ (/_ "#V<CSBBO1_^%/?]/'_ )"_^SH_X4]_T\?^
M0O\ [.C^VL%_/^#_ ,@]G(\XHKT?_A3W_3Q_Y"_^SH_X4]_T\?\ D+_[.C^V
ML%_/^#_R#V<CSBBO1_\ A3W_ $\?^0O_ +.C_A3W_3Q_Y"_^SH_MK!?S_@_\
M@]G(\XHKT?\ X4]_T\?^0O\ [.C_ (4]_P!/'_D+_P"SH_MK!?S_ (/_ "#V
M<CI/AU_QX0_]M/\ T8U=)6;X=T?^QH$M-V[9N^;&W.YBW3)]?6M*ODL5.,Z]
M22V<FU]YO%62"JVI?ZJ3_<;^1JS45S#YZ-'TW*1GZC%9P=I)DU4Y0DEV//J*
MZ/\ X1#_ *:?^.__ &5'_"(?]-/_ !W_ .RKU_KM'O\ @SY7^R,7_+^*_P S
MG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z
M/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$
M/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG
M_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_
M -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1
M_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (
MA_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT
M_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'
M?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ
M/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'
MO^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##
M^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7
M_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*
M_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P S
MG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z
M/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$
M/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG
M_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_
M -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1
M_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (
MA_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT
M_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'
M?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ
M/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'
MO^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##
M^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7
M_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*
M_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P S
MG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z
M/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$
M/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG
M_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_
M -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1
M_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (
MA_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT
M_P#'?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'
M?_LJ/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ
M/KM'O^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'
MO^##^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##
M^R,7_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7
M_+^*_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*
M_P SG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P S
MG**Z/_A$/^FG_CO_ -E1_P (A_TT_P#'?_LJ/KM'O^##^R,7_+^*_P SG*[3
MP]_J$_X%_P"A&L[_ (1#_II_X[_]E6UIUG]CC$6<[<\XQU)/OZUS8S$4ZD$H
MN^IZ.4X&O0K.4XV5K;KNNS+-%%%>>>X%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<8SSR<GO0!U=%<(_B&\\,3I#?LLUM,P59PJQE6..& (4 8)YY()8,=I4=W0
M4444 %%%% !1110 4444 %%8^M^*(M'E@MY Q:Z?:A4 @'*CG)''S#IGO5C7
MX9YH'2T94G.W:S\J/F&<_*W;(Z&@#0HID(8* Y!; R0, GN0"3@>V3]33Z "
MBBB@ HHHH **** "BBB@ HHHH ***Y3P!_R^?]A"X_\ 9: .KHHHH **YSXA
MZA)I]A--"Q5P$ 8=1N=5.#V.">>HZCFJ5WX.M?#]G<FW3#FUD5G8EF("'UX&
M3R0H )QQP, '845D^$_^/.V_Z]X?_0%K6H **** "BBB@ HHHH ***Y3P[_R
M$=0_[=?_ $4: .KHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN
M4\1?\A'3_P#MZ_\ 10KJZ "F"92Q0$;@ 2,\@'(!QZ'!Q]#Z5SOC?Q&^EK%;
MV^T7%U((XR^=JY(!<\$'!(X/KG! (.3!X3G6YD*7DPG6&%M[;60EWF# Q$8V
MC!V+GY"2030!W=%4=%2=(46Z*M,!AC'G:<$X/(')&,\ 9S@8KG?&/BBXMB]M
M9)\\4+2RRR*=B*%8C;GAF)''5<C!!PVT ["BN?\  6J2:K917,[;I'WY. ,X
MD8#@ #H!VKH* "BJFJZDNF1/<N&*QJ6(12S8'H!_,X ZD@ FN%TWQ7?S:C;V
MUR%BCGC=_* !8+B0KN8C(;Y1G! Z9 .10!Z+1110 45RG@#_ )?/^PA<?^RU
MU= !16?K\,\T#I:,J3G;M9^5'S#.?E;MD=#6%\3 PTR8.06Q%D@8!/F)D@$G
M ]LGZF@#K:*Y3XI?\@Z?_MG_ .C4KH]121XG6$A92C!">@8@[2>#P#['Z4 6
M**J:5'+%$BW#*\H4;V0;5)]A_P#JSU 7H+= !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5Y_%J-S9ZC??9K?S]WV;=^]6+;B+C[P.<Y/3ICWKT"N4\._P#(1U#_ +=?
M_11H Q9=8O?&@ET^*-+=$8I.S2^8XPPRJA-IY 8<C:XR-PK=\3ZFVB10:?9
M>=,1%$#N8(J@ N>&R$&.O^\<@$',\7Q_\(S=)KT:L4?]W<*O)*D (PR"!@J,
M\J"0HXW,:/B-IZWHM]0:/S[6#>9%C8ABD@7#J5(R%QN.".W\.2 "]-X,N(E,
MT-Y/]IP2/,8& L>O[K:0%/.!SMX(SBG:?KD_B&P>6#]U>)N4KMSB2,@E,28
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M*OS,N-H() X(Y[9&<C2\1^)C:Z>VI0@Y:)&3. 1YNT*2/F&5W9QR#C'O7/\
MBNST[1[-HX(HGEDB8Q  /(0X)\T-AFVJ,MN)QA< CBMNUU>'2M-MY;D$Q&"!
M6PA<8=%4[@ ?EYYSUZ#)(! *2^%IYT%W9W\KRG)W,RR6['!! 0 JHW=/O;>@
M!(&-?Q5K[:#;>: ))V*HBA6 :1O11N.."<9YQMW9(-<EX@LM+L8I;JSG6&?:
MQ!MKCYF)Z)M5F^4MC(4#&.H K3\6:7/K.GV[O&9)(S#++&<H[X0^8H '#'<>
M  >N!G (!;A\&7$JB::\G^TX!/EL! &'3]UM *CC(XW<DXS5KP;KLM^LEK=
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MQQ%)JMM'=6.V4V\Z3*%.X-Y>X$#:?F.>P()P0.< @#/^$+NKQ-US>S>?MP#
M1%&#CNJ@;L$GGY21@<8JQX7UF=9Y=*O"&FB =) I7S(V/WL !05) .#UXYVE
MC:T_QS97L:S">-=PSMD=4<>H*D\$?D>H)&#61X<U >(-1EU&#FWBMUA#D,-[
M,PD. 5&-O((Z]#T;@ [6N?T;5)+F]O+9VS'!]GV# &-\9+<@9.3ZD^U=!7%6
MFJ1Z/J=VMRRQBXC@=&=E52(UV$9)ZYS@>@)Z8R :OB_5)-/^S>4VWS;R&-N
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M(=20,FNXT"RCLX(XX$:./;D(^=R[_F(.23G).1G@\4 :%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <IX=_P"0CJ'_
M &Z_^BC75UQ6F:M#I^HW_GR)'N^RX\QU7.(CG&2,XR*U=3\>V.GH93,C^BQ,
M)&)P3C"DXSCJ<#.,D4 8^K6RVVLVLJ, T\4JR(O!(1&*LV#R#P!D?P#!..-C
M^U)/[2^Q;OW7V/S-N!][S=N<XSTXQG'M65X0L)]5N'UF]C\MMOEP1L,,BY.2
M05SGL#P3EN I6K7_ #&?^X?_ .UZ #Q%_P A'3_^WK_T4*MZSJDEM>V=LC8C
MG^T;Q@'.R,%>2,C!]"/>JGB+_D(Z?_V]?^BA47C.Y&GW=A>R<1))*C-D  S(
M%4G)''!)/8 ^P(!T'B&Z:TMIYHSAXX9&4X!P50D'!XZUA:H9-1TO[0TC*QLB
MSA1'ART63G*' Z_=V]3[8/&WBF!+.58G65YHG"+&P8D$,K/\N[Y4 8D]/E(R
M#4L,+3:0$0$LU@  !DDF'   ZDT 4OA;9/\ 8H)?-?;^\_=XCV?ZQQUV;^O/
MWNOMQ3I+F?Q1<S6L4C0VEL=CO%E9)).I4.5^4(1@XZCU#C:WX6ZM#]B@M?,3
MS?WGR;UW_P"L=ONYSTYZ=.:P3H%G:WDT.J1@&XEDEAF,CK&RL<E"05 9??J3
MC^[N -O46G\&-'<>=)/9LX643DR.F[@2!U7.T8QM/&>!DME=7QEKLM@L=K:@
M&YNGV1Y!(4#[TAP#PN1U]<X(!%<U/H>B+)%;QH)I)GV@02O)CU9L2<*.I[XR
M0" <;'CQ9;*2VU6-=Z6C2>:!RVR0*K,!D9P >_!P3\H. !\7@JXC'FB^G\_)
M.XX,/).?W)R,8. ,X!Y&, 54\"7,MQ>7[3J$E!MU8+G;E$9=PW ':V-RY[$<
MGK6[_P )M8[/.^T1;=N[&\;L8S]S[V?]G&<\8S6%X$U,:I>7]R 0KFWVYR,J
M$8*V" <,H##CH>_6@#N*X36[V>TU8/;0^<YL0"OF+'@><?FRW'7 Q[^U=W7&
M7NHQ6&K[YG5%-A@%V"C/G9QDD<\4 6/^$BU'_GP_\FHO\*B^(\C2Z5*\B['*
MPEER&VDR)E<C@X/&>];7_"66?_/Q#_W^3_XJL7XCW:7>ES2Q,KH?+PR$,IQ*
MH."..M $O_"1:C_SX?\ DU%_A4WA+P]):M)J%V5-U<XW!0-J*!@1@]>F-QR0
M<#KC<>EHH X_4-"NM'N)-0T\(ZS[?.A?"$E2/F1N "023N/4D_,2 +&D^/(Y
MY1972-;7). DG*MRP&UP "#C@\ DX7=5JT\:VT\[V+,8YD<KME&S=R "IZ$-
MD;1G<1SC%<Q\1;^+6);;3;=\W(N =\0W-$!D-R""""-Q (QLRV, T >BUSGC
M+79;!8[6U -S=/LCR"0H'WI#@'A<CKZYP0"*Z.N/\>++926VJQKO2T:3S0.6
MV2!59@,C. #WX."?E!P /B\%7$8\T7T_GY)W'!AY)S^Y.1C!P!G /(Q@"JG@
M2YEN+R_:=0DH-NK!<[<HC+N&X [6QN7/8CD]:W?^$VL=GG?:(MNW=C>-V,9^
MY][/^SC.>,9K"\":F-4O+^Y (5S;[<Y&5",%;! .&4!AQT/?K0!+)<S^*+F:
MUBD:&TMCL=XLK)))U*ARORA",''4>H<;8M1:?P8T=QYTD]FSA91.3(Z;N!('
M5<[1C&T\9X&2V5Q#H%G:WDT.J1@&XEDEAF,CK&RL<E"05 9??J3C^[NMSZ'H
MBR16\:":29]H$$KR8]6;$G"CJ>^,D @' !TOC+79;!8[6U -S=/LCR"0H'WI
M#@'A<CKZYP0"*JQ>"KB,>:+Z?S\D[C@P\DY_<G(Q@X S@'D8P!3/'BRV4EMJ
ML:[TM&D\T#EMD@568#(S@ ]^#@GY0<:O_";6.SSOM$6W;NQO&[&,_<^]G_9Q
MG/&,T 4O%VIW.DZ<]R647*!,M&OR M(H( ?=D8.,GKUP.@-%T2>^9-0NYI59
MCN6!'*1HIR41U"J69<_,3C)&T@@<U/B%?IJ&E2SQDE'$94E67(\U,'# '![<
M<CD<5V= '#Z<T_C-I+CSI(+-7*Q" F-WV\&0NRYVG.-HXSP<%<M+'<S^%[F&
MUED::TN3L1Y<M)')U"EPOS!R<#/0>@0[N7\/^&]/LRUAJD:QW,63O>5UCD4D
M[64[E'MCKQZ[@NWIVCZ.MW%!:Q^9+_K T4CR(FSD%FWD#)& .><9 R,@'6ZY
MITVH*L<,QA7/SE4!<J>,*Q/R'K\V"0<$8P0>:U>SF\((+^.XEEA1T\Z.X82D
MHS!<H<+M8;LXR >,GC!9XM>.XOX[2^D9+-K<D*6,<3R!^0S#&<  @$C!VX^]
MALKXDV]CI=J;2WBB\\; =B@R1J"IWLP!(SE5^8@MNSD\T =;XYUI]+A3RW$;
M33QQ^8=I$88DLY##! "D<XZYSQ5*+PI/;E+BRO96!VDBX;SXV4E3D8QCC/(Y
M/0,H)-;'B35[:Q5(KP QSN%^=-T8(^8;B1M R!C/?GH&(X3Q#;V6C1>;I,Y6
MY+H%CMYS)YC;A@,F7R -V.@).#G(% '8>,M=EL%CM;4 W-T^R/()"@?>D. >
M%R.OKG! (JK-X,N(E,T-Y/\ :<$CS&!@+'K^ZVD!3S@<[>",XJI\2])$Y@O)
M(C-;VYD\Y%8A]KA1N&,9"XR>1[X7)%+^P] V>=F+;MW8\]]V,9^YOW9_V<9S
MQC- '2^&_%8U&T-Y./+:'>)EPWR-'RW!&>F#CDC.W)(-8FDZ==^*U%_<3RP1
M/N,<-N?+8*2 I9R,MD#/((Y#*0#MK0T;2(+K3I([&-H4NHY-JRELY=2@8Y+G
M! !&,\8(ZU7\'>*XK: 6-XRP7%J!&RR,$R%&$8$G# J!D@]><;2N0#*\2P7.
MG2V=K,YFA-["R2,N'78=OEN0,,2""&X8D/D=,>D5YYXO\40ZE/:6MNPD"7L#
M.Z9**<_(NX#:2P+'@\;2,>GH= !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <IXB_Y".G_]O7_HH5G\>"KS^%;&];_:"Q2!?Q4!_P ./14YT/$7
M_(1T_P#[>O\ T4*W=:T>/6(7M)L[)!@X.",$$$'U! /IZ@CB@#"\??\ +G_V
M$+?_ -FJ[XN\2'1(U$:AYYW$<2$@99N,G)'RCC/N0"1G(X :Q)";71;K'VBT
MO[8#:/E:(#Y3D=QD=0#@KD%MV.J\=7+:9<6>I%288'D61A_")@J!B "<#D].
M2 N02* )I=+U9QYXN8A)D'R1%^YX(R/,.9,$<GC.3@$#!%_PCXD.MQL)%"3P
M.8Y4!!PR\9&"?E/./<$ G&3L?:TV>?N7R]N[=D;=N,[MW3&.<],5RO@RY&H7
M=_>Q\Q/)$BMD$$PH58C!/'((/<$>X  RY\47-U>3Z1 %5E$960C.Q"@,CD$_
M.P+ (H &3EC@')]OO/#L\27<@N8+EUC#A$B=)&)V_*.JGN<GIVP ]CP[_P A
M'4/^W7_T4:/'W_+G_P!A"W_]FH ZNL_Q#=-:6T\T9P\<,C*< X*H2#@\=:AU
MW0/[7V_OIHMF[_42;,YQUX.<8X],FFVOAI8;>2R>6619@X+2OO<!UVD D< =
M1P>2: *GP]TM=.L85&"702$@8R9/FY]2 0N>X Z=*NZ[XIMM!V_:7V>9NV_*
MS9VXS]T'U'6N:\ ZG_8@_L2\*QS1,?+SPLBNV058GYB6)&, XP,9#8[N@#)T
M+Q3;:]N^S/O\O;N^5EQNSC[P'H>E9'Q&NV>%--ASYUZX1<%AA009&)4'Y0.&
M']TD\@$5D_#*99KO470@JTX((.007E(((Z@TVWM)O%=[+J-K*L*6V((Y/*27
M=C)<C+$#EN&'56 _O4 :7CO2?L%M%>6H(DTXJ8P-S?(,*R'# [=H!8G)VJ1G
M!)KK;2Z6[19HSE)%#*<$9##(.#STKF)O#&H3*4>^!5@00;2(@@\$$$\@U4^'
MMU_8ZW&DW#@-9NS MM4>4WS!N">.2S9^[N )[  E\;G^UY[?1E!(=Q+-RP'E
M(3P=HZ,<XY&&"],@@\;C^R)[?65) 1Q%-PQ'E.3R=IZ*<XX.6*]< '*\/:7<
MZ_)-K4$PM_M#E5_<)(QCCPJG+,=I.WY@.I&>FW&KJ'@V^U&-K>:^#1N,$&UB
M_P >".H(Y!Y'- '9UYIX"\7_ -GV44'V:YDV[_FBAW(<R,>&W#.,X/OFN@^&
M^IFXM?LLI_?VC&*13MR-A(7[IZ8^7/<J>O4GPM_Y!T'_ &T_]&O0!2AM9?%E
MW%>2PM#;69)03*5E=R <[0>%4@$=0<8YR0O<444 <IXB_P"0CI__ &]?^BA7
M5URGB+_D(Z?_ -O7_HH5U$TRPJ7<@*H)))P !R22>@% '%?%BR86Z:A'@2VD
MJL&/8,0.!R"=VT\CH#]#N^)];?2OL_EA3Y]U%$VX$X5\Y(P1SQQU'M7*ZQJ"
M^.;I--A7?:V\@>:49VDJ& 0$$<-DKD')^\HVKD[7C[_ES_["%O\ ^S4 'Q2_
MY!T__;/_ -&I6AXSUM]$M)+R(*7CV8#@E?F=5.<$'H?6L_XI?\@Z?_MG_P"C
M4I_Q-A:73IPH).$. ,\+(I)^@ )/H.: .HKG]"UB;5UN0"B/#=21(2C,NU"O
M)7>I)()Z$#V['8AU".6(708>4R!PQ^4;2-VXYQ@8YYZ=ZY3X87JW\5S<)D++
M>S, >N&"$9QGGF@#%\ Q7#7>H"-XU83_ #EHF8$[Y>0!*NT=>"6[<\<]5XH\
M226,D5C:JKW5P3M#G"*J\LS $-C .,=<'&2-IPOAQ_Q^:E_U\?\ L\U,\:6J
MQZA%//)+!!) (A-"^S#[V;:S<X4CU&,\]%8@ T-0CU+08VO#.MRL8R\;Q+%\
M@Y9E93]X =\C&>"0 =W_ (2:'[)_:>?W7E[^JY_W>N-V?EQG[W%86H>$(].C
M:XFOKM8T&23<?_8\D] !R3P.:BUGP^O]CFTL=TJE%=,_?93()3QA><$X&,]L
M9H ?IRZGKZB\\]+6.10T:)&LS;2206+]\8Z'![JIR*HR:E/-J=E;7:JLT0N&
M)B),;+)&=I&[Y@05((/<9'!X[#PYKT>NP)=1D?,!N .=K8^93P.1]!D8(X(K
MFM7UB*\U:RMXV#-"+C>5((!9"-O!X8;#D'&,B@#N*X_XE7'V9+67#-LOH3M0
M98X#G '<GL/6NPKE/'W_ "Y_]A"W_P#9J #_ (3[_ISO/_ ?_P"RK;T35_[5
M0R^7+%AB-LZ;&. #D#)XYZ^H-:%% 'FG@+Q?_9]E%!]FN9-N_P":*'<AS(QX
M;<,XS@^^:TX;67Q9=Q7DL+0VUF24$RE97<@'.T'A5(!'4'&.<D+=^%O_ "#H
M/^VG_HUZZN@#E/%>@2M/!JUHJO/;Y5D9MN]&R,!B< KN8C/KDYP%)IWQ%@E8
M07*O:RE0=MPNQ3D'.&/& 01EMN>PSP-NXU^"VF6RDD5974,JMQD%MHP3P23P
M%SGVK*^(OD?89?M.W&T^7NZ^9@[-N.<Y].V<_+F@#I:*P? J2)8VXE(+>4I!
M']T\H.@Y"8!]QU/4[U !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% '&> 55Y[^8N6E-VRD%LX2,D1\=0.2!VPN!T-=G7":@&\(7LFI$9LK
MO:)=BC,;C #L "2"2<D8R6.06"[NCA\8V4JAQ<188 C,BJ>?4$@@^Q&1WH K
M^/[=)["X60[5$9(.0/F4AD'/JP QU.<#FLS5]:FL-'2\C<B806YWG#'+% Q.
MX').3UJEXEU3_A-#_9%@V4W SS8S&JJ3A1D?,21D;2 <#!*EBNA\1[5;32I8
M8QA(UA51DG 61 !D\]* 'PZ!<ZZHN;JXEAW@,D-N?*\L-_"S$;G;&,Y VMN
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M DG5\ 7322W<2323VT;QB.25M^6VGS 'P,@''3C&"/O9-CP!_P OG_80N/\
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M-=Z6C2>:!RVR0*K,!D9P >_!P3\H. !\7@JXC'FB^G\_).XX,/).?W)R,8.
M,X!Y&, 54\"7,MQ>7[3J$E!MU8+G;E$9=PW ':V-RY[$<GK6[_PFUCL\[[1%
MMV[L;QNQC/W/O9_V<9SQC-87@34QJEY?W(!"N;?;G(RH1@K8(!PR@,..A[]:
M )9+F?Q1<S6L4C0VEL=CO%E9)).I4.5^4(1@XZCU#C;%J+3^#&CN/.DGLV<+
M*)R9'3=P) ZKG:,8VGC/ R6RN(= L[6\FAU2, W$LDL,QD=8V5CDH2"H#+[]
M2<?W=UN?0]$62*WC0323/M @E>3'JS8DX4=3WQD@$ X .E\9:[+8+':VH!N;
MI]D>02% ^](< \+D=?7." 156+P5<1CS1?3^?DG<<&'DG/[DY&,' &< \C&
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MH ROA;_R#H/^VG_HUZZNN4^%O_(.@_[:?^C7K;U+7X-->*&9MKSMMC&UCDY
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M4@@B) 01R""!P16G110!F3>&+29B[P1%F)))B0DD\DDD<DUH0PK"H1  J@
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MU% %>]TZ*_79,BNH.0'4,,],X(//-0V6AV]@V^&*-&(P2B*IQUQD <<5>HH
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M10!#=6B7:F*55=#C*N RG!R,@\=:FHHH **** "BBB@ HHHH **** "BBB@
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MW=E=32/&I)BN#YRN 0=H  () (X&3G *\F@#M:*Q+;Q.MU8G5$&0(6?;DCE
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MAW_D(ZA_VZ_^BC1_S&?^X?\ ^UZ/#O\ R$=0_P"W7_T4:/\ F,_]P_\ ]KT
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M%I)UF:"R#E$$2[9) G_+02,H*@G'3L"A ()++XW'@MDN&F>>R>0+()LO)&&
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M+GYB<9(VD$#FQHVJ27-[>6SMF.#[/L& ,;XR6Y R<GU)]J *GAW_ )".H?\
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M\.:]?^,(_,B=+=4X=Q&'+29)VJK.1MV%22<'=P,C..]A0HH4DL0 "3C)QW.
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M;\.(SJ/G:U*N)+J0A<[3B-/E4 @ ]1@YQNV@X[GM:9#"L*A$ "J   ,  <
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ME-12?PM+;+'=/+'<7"(T5QMD<A^&</PP"_+P. QR>N#7\:6JQZA%//)+!!)
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MFS@]<C/'%I/A58B5F,0\HH@4>9+D,"^\_>Z$%<<]CP._80PK"H1  J@  #
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M#VR.<9'0F@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"/.V_Z]X?_ $!:T+JT2[4Q2JKH<95P&4X.1D'CK3X85A4(@ 50  !@ #@
M = * .7\ ?\ +Y_V$+C_ -EK"\&6=IK"&[OV$MY&93*MPQ_=A6.1Y;84(H.?
MNX5B>01@>A6]HEMN\M57>Q9MH RQZL<=2>YZU5NO#UM=L9988G<XRSQHS' P
M,DC/2@#C/#-Q!/JTGV5%2%;0A3&H5'Q*NYQ@ $;LKD9!V\&MC_F,_P#</_\
M:]='#IT4+!T10RH$!"@$(.0@('"CTZ4[[(F_S]J^9MV[L#=MSG;NZXSSCIF@
M#/\ %G_'G<_]>\W_ * U97_,&_[A_P#[0KJ)H5F4HX!5@001D$'@@@]0:9]D
M39Y&U?+V[=N!MVXQMV],8XQTQ0!G^$_^/.V_Z]X?_0%KB-8U"3PY-=Z="Q,E
M\4DMQZ/._ER#<-NUNZ9.T!1DYR#Z++-%IT>6*QQ( ,DA$4< #L .@'Y5R5O<
M)XJU!9D&^VL%?;)@;&F8KP"<[@H (( PP!S@KD Z?1-+72H([5<8B15R!MR0
M.6QZL<D^YZFC7+)K^WFMTP&EB=03TRRD#.,\<U>HH XSP=XKBMH!8WC+!<6H
M$;+(P3(481@2<,"H&2#UYQM*YS_%_BB'4I[2UMV$@2]@9W3)13GY%W ;26!8
M\'C:1CT[6]T.WOVWS11NP& 716..N,D'CFGKI,**L0C0)&VY%"+M5@2=P&,
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M,XSC(.,X% %2U\56MY*+6*19)"I;$>74 =RR@J/Q(ZCU&<KP!_R^?]A"X_\
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M;KQTSZ%2?4H85A4(@ 50  !@ #@  = *J7NAV]^V^:*-V P"Z*QQUQD@\<T
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M )!T'_;3_P!&O75T %%%% !1110 4444 %%%% !1110!#<6B7.WS%5MC!EW
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MBB+6)9[>,,&M7VN6  )RPXP3Q\IZX[4 ;%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%<I\4O^0=/_VS_P#1J4 =7115?44D>)UA(64H
MP0GH&(.TG@\ ^Q^E %BBJFE1RQ1(MPRO*%&]D&U2?8?_ *L]0%Z"W0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%<IX=_Y".H?]NO_HHT =71110
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MVLS7BAV2&.58XR!'N5HQ^]QE6R"<<L#P>,'.,_QQ>MX=N(]67&&@EA8MRH8
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M,YE4JP^4D!0K$@%@J%MS;<9 .33O^8S_ -P__P!KT>(O^0CI_P#V]?\ HH4
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M]:2.-MQA;:^ =H;&=N[&"1W )*]#@U;H **** "BBB@ HHHH **** "BBB@
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M $CD@<5O^+/^/.Y_Z]YO_0&K*^%O_(.@_P"VG_HUZ +'A'7)KLRV5VH%S:E
M[+C8X<$HXQT) R1@?09VK;UR"\N66.U>.*,CYI&4O(#U 5" F.,$D]"< $<Y
MGAW_ )".H?\ ;K_Z*-5;@R:_?7%@UP\,=LL158&"2,77)8MR2!G! XY7H1R
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M-9_@#_E\_P"PA<?^RUGZAJ?_  B-Y/*Y7R+J%I44_*#-$HW(,$@%QR6*_,2
M,D<@&WI?B%]1O;BU0)Y%LJ L"2YD?GMP N&4CJ&'7J!T%<_X&TQ[&U5IA^_G
M9I9>H):0YY! VD# (  !!^IZ"@#C]0UVZUBXDT_3RB+!M\Z9\.06(^5%Y!(
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M8$NHR/F W '.UL?,IX'(^@R,$<$5;MM1BNF9(W5FC.'"L&*GD8(!X/!Z^AH
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M.T!1RP)8Y %-M;N\N+N70!.VR+:YF(7SO** &/.""V77]YPP(+<Y"C:^%O\
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MZ@JS2(5GP2HB);YY>3NC89X_A"CD\=,;7@"Z:26[B2:2>VC>,1R2MORVT^8
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MH[AA*2C,%RAPNUANSC(!XR>,'8\>ZI)I5E+<P-MD39@X!QF10>"".A/:N/\
MB3;V.EVIM+>*+SQL!V*#)&H*G>S $C.57YB"V[.3S72_%+_D'3_]L_\ T:E
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MN**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZD]SUJ:B@ J&.T2)FE55#R8W,  S;1@9/4X'3/2IJ* (;BT2YV^8JML8,NX
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M _(4ZXM$N=OF*K;&#+N .&'1AGH1V/6IJ* "LG_A$[/_ )]X?^_*?_$UK44
M%0VMHEHHBB5409PJ *HR<G ''6IJ* *][IT5^NR9%=0<@.H89Z9P0>>:98Z3
M#I^?(C2/=C/EHJYQG&< 9QDU;HH *KWNG17Z[)D5U!R ZAAGIG!!YYJQ10!G
MQ^'K:)6B6&())C<HC0*VTY&1C!P>F>E6KJT2[4Q2JKH<95P&4X.1D'CK4U%
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MD+!T@B#*001$@((Y!! X(J[':)$S2JJAY,;F  9MHP,GJ<#IGI4U% !1110
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M!R<G/N068 ZBBN/UW4+C6+HZ39R>2L<>Z:8*68%Q\L8X !((;((/H05(+YM
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MD\N!M3('<D#./<C%8^G^&+G6(UNKRYGCED&?+MV\E$4\A"NW)89Y)Y[$G&2
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M/EMS;D^7)/7+ !N>>>_4Y7P^/]K27.LLN/M$@2/*8/EQ@ '.3G=P&QQN7\
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M%8.NT]>S@$\$@9:E\+8YOL4#;T\K]Y\OEMO_ -8_\?F8Z\_<Z<>] ':T444
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MNX X8=&&>A'8]: .5\>++926VJQKO2T:3S0.6V2!59@,C. #WX."?E!QJ_\
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M_MU_]%&NHAA6%0B !5   &  .  !T ID=HD3-*JJ'DQN8 !FVC R>IP.F>E
M'(75Y_PC6HO<3\6U^L8\PCY4DC&U5)SP",G)'?T5C6O>^,K>-<6[K/,YVI%"
MZLS,?7!.U1C+,> !GT!BUCQ=!83_ &&\4I'*@VR2 &)]QVLIQG &1G=@=<X&
MTMGZAXJL-!C867E-/*,(ENJMN<<(&\O'&6[D$C.W)XH L?"W_D'0?]M/_1KU
MT&FZI'J:F6%MR!F7< 0I*G!P2 &&?XAD'L>*Q=!T:?1M-%K'_P ?"PR%?N\2
M/N<+R2IPQQG.#C/2M+PUHXT>VBM!C,: -@D@L>7()YP6)/;Z#I0!IUY_\1_^
M/S3?^OC_ -GAKT"J]SIT5TRO(BLT9RA90Q4\'()'!X'3T% %'Q9_QYW/_7O-
M_P"@-1X3_P"/.V_Z]X?_ $!:TYH5F4HX!5@001D$'@@@]0:(85A4(@ 50  !
M@ #@  = * ."U""#5M1FL]1=O+"P_9XF=HXV+##,,;=S;B5'.3EASCY:GBI[
M2&YM+>TBB#K>0^8\**-A#X$;%5QEB&.TG(V<CO7H%]I,.H8\^-)-N<>8BMC.
M,XR#C.!3(=#MX5")%&%5PX 10 XX#@ <,/7K0!A>/O\ ES_["%O_ .S5U=0W
M%HESM\Q5;8P9=P!PPZ,,]".QZU-0!Q7@/4ETS2([EPQ6-96(12S8$K] /YG
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MXP,\9ZD#FL71])T2^CWR(L,@)5XYIW1U8=1AG&1Z''UP00/2H85A4(@ 50
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MYVW_ %[P_P#H"UIS0K,I1P"K @@C((/!!!Z@T0PK"H1  J@  #  '   Z 4
M>?\ B29;+6K6XE(2+R&&]SM3($N1N.!GYA^8]16G\1[M+O2YI8F5T/EX9"&4
MXE4'!''6NHO=.BOUV3(KJ#D!U##/3."#SS3/[)A\O[+Y:>5_<V+LZ[ONXQUY
MZ=>: ,+XA:?/<P1S6RAY+:=)@IS\WEAN !U//3()&0.< VM/\<V5[&LPGC7<
M,[9'5''J"I/!'Y'J"1@UO5F3>&+29B[P1%F)))B0DD\DDD<DT 2Z/K,6L1_:
M("6C)(!*LN<=<;@,CMD<9R.H-7J9#"L*A$ "J   ,  <  #H!3Z /*O$UZ^@
MW%WIL2[O[35#$-Q*AI28Y,AB "YW'(.!A<C'"^CZ)I:Z5!':KC$2*N0-N2!R
MV/5CDGW/4U-<Z=%=,KR(K-&<H64,5/!R"1P>!T]!5B@#SS2;.WUR[N(]08O/
M%<L(8I6*J(P,J5CX#!@,MP<@ D<Y:+[1:R:K:)9)&(T$VZ2%5",QB)*Y4 $H
M,$X)QOQP:[J]T.WOVWS11NP& 716..N,D'CFGPZ3#!LV1HOE;MF$4;=WWMN!
MQGOCKWH Y_Q%_P A'3_^WK_T4*?\0M/,EN+R-09K-UF3./X""X).#MVC) ()
M*CZ5T4EHDK+*RJ7CSM8@%EW#!P>HR.N.M34 </X6G7Q+>R:PH'DQ1)%%E?FW
M$!WSDG#+N*Y P0W!.#FIX^TF)+N/4+V(R6?E")RK,#&V\D.0N"5YQP?7OM#=
MW9:=%8+LA144G)"*%&>F< #GBI9H5F4HX!5@001D$'@@@]0: /.M0T;0;*-I
MCY;;1G;'<,[GT 42<D_D.I(&372M=6OAZR0M&R6Q"@HR,Y43')#@[L ;CNR3
M_=&20#H0^&+2%@Z01!E(((B0$$<@@@<$5IT >:>(++2[&*6ZLYUAGVL0;:X^
M9B>B;59OE+8R% QCJ *[6SU3[):1W=XVPB%&D+C:0Q4;LJ!USQM SG@#/%/A
M\,6D+!T@B#*001$@((Y!! X(JIXOT>36(X[5,&-IXS,"<9B7+,,]<DA0-O.>
MX&30!MPRB50XSA@",@J>?4$ @^Q&1WK$\:^&1XCMFM@0'!#(3G 8>N.Q!([X
MSG!(%;U% ')>'_'<3+]EOF$-W$,2"4A02,?.&X3#9R /? *@,=+7?&5IH@/G
M2+O7^!3NDR1N VCD9'0G Y&2,U=U31(-579<1JXP0-R@D;NN#U4^X(/3TJKH
M_A"TT<[H(55@20QRSC(P<,V6 QV!QU]30!B>+8[G5K."\AB*S0RQSF)^6^0-
M\N!U/.<<,1Q@-\M:NG^.;*]C683QKN&=LCJCCU!4G@C\CU!(P:WJS)O#%I,Q
M=X(BS$DDQ(22>222.2: .=\.:@/$&HRZC!S;Q6ZPAR&&]F82' *C&WD$=>AZ
M-Q:\._\ (1U#_MU_]%&NHAA6%0B !5   &  .  !T ID=HD3-*JJ'DQN8 !F
MVC R>IP.F>E '-?$?1GU.W38GF^3,DC1@E6=5#!E!'.2#VY],G .%I^C:#>Q
MK,/+7<,[9+AD<>H*F3@C\CU!(P:](K,F\,6DS%W@B+,223$A))Y))(Y)H RO
M =M9B.2XL(V2-WVY??\ /Y><,NYF^7YB.QSD$9%=13(85A4(@ 50  !@ #@
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M4$],L\@&<9XYKN*AM;1+11%$JH@SA4 51DY. ..M ')>#O%<5M +&\98+BU
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MR_A?13JD4=_/<S2M-&"528Q1 G' 6(K@KC:>>3DD9Z5/A_<QW-Y?O 6:/=
M6<R$[5=2=Y9B02"5.>F.G2M@_#VQ(=1$0LI!=5DE5#@Y&55PN >@Q@=L5JV.
MBPV#O+$@5I0@;&<8C7:@"YP !QP!0!A>'?\ D(ZA_P!NO_HHUSNE:*LMY<V<
MT]Q;S23R2QI%+Y:2(YR&'!RW'/? _P!EL>A6^EQVTDERBXDGV;SDG.P87@G
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MWA_] 6JMCX!L;$.(X5'F*5))9FPP*D!F)*Y#$':1FMJTM5M$6&,82-0JC).
MHP!D\]* ,_Q9_P >=S_U[S?^@-1X3_X\[;_KWA_] 6M"[M5NT:&09212K#)&
M0PP1D<]*+2U6T188QA(U"J,DX"C &3STH YKX6_\@Z#_ +:?^C7H_P"8S_W#
M_P#VO70:7I<>E1K;0+MC3.!DG&22>22>I/>C^RX_.^V[?WOE^7NR?N[MV,9Q
MUYSC/O0!RMI??V3JL\<XVI>K$8G)^5FB4*4'&,DD]2#P!@[EKK;W48K!=\SJ
MBDX!=@HSUQDD<\5#K&BPZQ'Y%P@=,@X.1@CH0000?H>F1T)K*T_X>6&GR+/'
M" Z'*DN[8/8X9B,CMQP>1S0!7\1?\A'3_P#MZ_\ 10JQ\0]/DU"PFAA4LY"$
M*.IVNK' [G /'4]!S6Q<:7'<R1W+KF2#?L.2,;QAN <'(]0?:K= '":%X>BU
MR(7,%[>%6Z@W'S*>ZD;>"/\ ZXR"";WA?1[:"ZEDBN)9YX4$3^<^_:&;<!NV
MCD%3P"<'((!JUJ'P\L-0D:>2$%W.6(=UR>YPK 9/?CD\GFM71]%AT>/R+= B
M9)P,G)/4DDDD_4] !T H Y724D\33W#2W$B+:W+1K# _E?*IQEROSL'QZC!#
M;2,X%>]\F#5[.UB9V>-9B^^5Y0-\1VCYW8J<#)&!D%3SVZB]\(VU[-]L=")@
M,;T=XVZ8ZHR\X.,]<<=*+#PC:Z>8S%&%,!<H06X,@PY.3\Q( 'S9P  ,8H I
M:YHMEXAF\AVQ=0*K!HGVRH"V0<].OJ#MW C&X$Y]O+/H5];Z?]H::*=9?DF"
MM*@5=P8N,,VY@0,C  (&<9&_K?A6UUO!N8U<C&&Y5L#/&Y2#CD\9QGG&:;H?
MA&UT-F>VC",XP3EF..N,L3@>N.N!GH* .*TK15EO+FSFGN+>:2>26-(I?+21
M'.0PX.6XY[X'^RV-#6_!]M"$M[J\NB+APBH\V_<V1CY=AX!QR> <9(XKJM<\
M-V^NJJ7*!PARO)4C/7E2#@]QG!P/054T?P-9Z/)]H@B"R $ EG;&>N-S'![9
M'.,CH30!E>.KEM,N+/4BI,,#R+(P_A$P5 Q !.!R>G) 7()%=;]K39Y^Y?+V
M[MV1MVXSNW=,8YSTQ3YH5F4HX!5@001D$'@@@]0:YJ'X9:=$P<0#*D$9>1AQ
MZ@L01[$8/>@"EX*U--3OM0GB.4+0 '@@[%="002""5R#W&*[6J-CHL-@[RQ(
M%:4(&QG&(UVH N<  << 5>H XJTOO[)U6>.<;4O5B,3D_*S1*%*#C&22>I!X
M P=RUUM[J,5@N^9U12< NP49ZXR2.>*AUC18=8C\BX0.F0<'(P1T((((/T/3
M(Z$UE:?\/+#3Y%GCA =#E27=L'L<,Q&1VXX/(YH S==OO[%U2*\F&+>:W\GS
M"<*K;RXSP<9P!S@8).<*:Z^ZNTM%,LK*B#&6<A5&3@9)XZTW4-/CU&-K>90T
M;C!!_P \$=01R#R.:Y^'X9:=$P<0#*D$9>1AQZ@L01[$8/>@#/\ !=[$MI=7
M]QA;:XN9Y!YF#E'(7!49Y)!7;R2>!G(S*G@B+3U-S87,ENA&\8<26X&T9<J_
M# J,Y+<<$< "NM^R)L\C:OE[=NW V[<8V[>F,<8Z8KG9OAEITK%S ,L23AY%
M'/H P 'L!@=J *EGK$FL:-)=38,C6UP"0,9VAUSCU.,G'&>@ XJQ\+?^0=!_
MVT_]&O740PK"H1  J@  #  '   Z 5B6'@:ST^87D,064%B"&? W @X7=M P
M3QC [4 ;U%%% !1110 4444 <IX=_P"0CJ'_ &Z_^BC1X=_Y".H?]NO_ **-
M=+':)$S2JJAY,;F  9MHP,GJ<#IGI1':)$S2JJAY,;F  9MHP,GJ<#IGI0!S
M7C[_ )<_^PA;_P#LU=!JNF)JD3VLHRDBD'ID9Z$9!&0>0<<$ U+<6B7.WS%5
MMC!EW '##HPST(['K4U 'E6EW3>(_LFC2*H:RD8W"E00!;81!]XA@^[:W7GG
M&WKU7Q'T9]3MTV)YODS)(T8)5G50P901SD@]N?3)P#T::=$DAN BB5A@N% <
MCC@MC)' _(58H \WT_1M!O8UF'EKN&=LEPR./4%3)P1^1Z@D8-=!X#MK,1R7
M%A&R1N^W+[_G\O.&7<S?+\Q'8YR",BM6;PQ:3,7>"(LQ)),2$DGDDDCDFM"&
M%85"( %4   8  X  '0"@#E_ '_+Y_V$+C_V6CQ%_P A'3_^WK_T4*Z6WM$M
MMWEJJ[V+-M &6/5CCJ3W/6B2T25EE95+QYVL0"R[A@X/49'7'6@#A?B9^ZN=
M.G;B-+CYF/"K\\9Y;H.%)Y[ ^E;?BN >)[&:&S=)&;;C:X*Y1E<KD9 ) XSZ
MC.!S6_=6B7:F*55=#C*N RG!R,@\=:;9:=%8+LA144G)"*%&>F< #GB@#"T+
MQW;WL0:>1(IE^62.5A&RNO##:QSC/3KZ'D$#,75D\1ZG ;8AXK))B\@W;=T@
M\L(#MP3QD'.&&<'CGJ+KP];7;&66&)W.,L\:,QP,#)(STJU:VB6BB*)51!G"
MH JC)R< <=: .:_YC/\ W#__ &O75U#]D3?Y^U?,V[=V!NVYSMW=<9YQTS3;
MW48K!=\SJBDX!=@HSUQDD<\4 >7DR6ZOX5B<^8UR%5L=+=U\UCD;,L.=X/4,
M57(Z>JPPK"H1  J@  #  '   Z 5Q_AEE\0WDNL;#Y4:+%;LRXW %C(^#DYR
M< C'RDJ1G=CLZ *FJZDNF1/<N&*QJ6(12S8'H!_,X ZD@ FN*NK'1I0;R*9(
M7*A@]O-Y<BC'.V,'@D<%=F3D\;C7H%9DWABTF8N\$19B228D))/)))')- '.
MZ;=2W>BM+<%C(UK/DN/F(PX4GURN#GOUR<YIW@OQG;&UB@FD6*6**-665MG&
MW","X4$,H#<9P".>F=WQ9_QYW/\ U[S?^@-570=)AU"SM?/C23;;Q8\Q%;&4
M7.,@XS@4 8FMZG_PDUW;V=F5DCMIHYII!R@V_=4."0206X /..1A\5_'VDQ)
M=QZA>Q&2S\H1.59@8VWDAR%P2O..#Z]]H;N[+3HK!=D**BDY(10HSTS@ <\5
M+-"LRE' *L""",@@\$$'J#0!YUJ&C:#91M,?+;:,[8[AG<^@"B3DG\AU) R:
MZ.]LH[/2Y8X$:./[+*0CYW+O1F(.23G).1G@\5I0^&+2%@Z01!E(((B0$$<@
M@@<$5H30K,I1P"K @@C((/!!!Z@T 9GA/_CSMO\ KWA_] 6LKP[_ ,A'4/\
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MV_Z]X?\ T!:Y+Q),MEK5K<2D)%Y##>YVID"7(W' S\P_,>HKT"&%85"( %4
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M0<GH+KP];7;&66&)W.,L\:,QP,#)(STJU:VB6BB*)51!G"H JC)R< <=: .
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M_H#4 :U%9/A/_CSMO^O>'_T!:UJ "BBB@ HHHH **** "BBB@ HHHH ****
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M/<7$T\J)!<M$D4#F)-L1_BP<DMGDC!'.#C 4 [BBBB@ HHHH **** "BBB@
MHHKFO&]V]M]D\MF7??0*VTD94[LJ<=0>XZ4 =+1110 4444 %%%9^FZ_!J3R
MPPMN>!ML@VL,')&,D 'E3TS0!H4444 %%%% !1110 445F>)YFAM+AT)#+!*
M00<$$(2"".A% &G169X8F::TMW<DLT$1))R22@)))ZDUIT %%<UKUV\5_8Q*
MS!)/M.Y02%;;&",CH<'IGI72T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1163XL_X
M\[G_ *]YO_0&H UJ*R?"?_'G;?\ 7O#_ .@+6M0 4444 %%%% !1110 4444
M %%%% !5>]TZ*_79,BNH.0'4,,],X(//-6** &0PK"H1  J@  #  '   Z 4
M^BB@ HK/U^&>:!TM&5)SMVL_*CYAG/RMVR.AJ["&"@.06P,D# )[D DX'MD_
M4T $T*S*4< JP(((R"#P00>H-$,*PJ$0 *H   P !P  .@%/HH **** "BBB
M@ HHHH ***Y3_F,_]P__ -KT =71110 5#:VB6BB*)51!G"H JC)R< <=:FH
MH **** "BBL_7X9YH'2T94G.W:S\J/F&<_*W;(Z&@#0HID(8* Y!; R0, GN
M0"3@>V3]33Z "BN4_P"8S_W#_P#VO75T %%8]SXHBM[N/2R&\V5"P( V8 8\
MG.<_(>Q[5L4 %0W5HEVIBE570XRK@,IP<C(/'6IJ* (;6T2T411*J(,X5 %4
M9.3@#CK4U%% !1110 4444 %%%% !1110 45RGPM_P"0=!_VT_\ 1KUU= !1
M110 4444 %5+'28=/SY$:1[L9\M%7.,XS@#.,FK=% !1110 4444 %%%% !1
M17*?"W_D'0?]M/\ T:] '5T444 %%%% !115?4;U;")[A\E8D9B!UPH).,XY
MXH L45GZ!K::W EY$&"2;L!P WRL5.<$CJ/6M"@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKC]0T*ZT>XDU#3PCK/M\Z%\(25(^9&X )!).X]23\Q( ["L&T\:VT\[V+,8Y
MD<KME&S=R "IZ$-D;1G<1SC% %72?'D<\HLKI&MKDG 23E6Y8#:X !!QP> 2
M<+NJ+QEKMSIUQ:06H#&<RJ58?*2 H5B0"P5"VYMN,@')K'^(M_%K$MMIMN^;
MD7 .^(;FB R&Y!!!!&X@$8V9;& :N^.]3&EWEA<D$JAN-V,G"E%#-@ G"J2Q
MXZ#MUH MR^"KB0>:;Z?S\@[A@0\$8_<C Q@8(S@GDYR15KP;KLM^LEK= "YM
M7V28! 8'[L@R!PV#T],X (%6/^$VL=GG?:(MNW=C>-V,9^Y][/\ LXSGC&:R
MO :RWLESJLB[$NVC\H'AMD8958C)QD$=^3DCY2,@&AHVJ27-[>6SMF.#[/L&
M ,;XR6Y R<GU)]JQY=1N]3O[G2XW*0J(B9 !N12@+*I"_?D+<%C\H#%02!B[
MX=_Y".H?]NO_ **-'AW_ )".H?\ ;K_Z*- %*XMY_"<\#K-)/!<RI"Z7#EW5
MG)VNK8X YR,<^^04U?&6NRV"QVMJ ;FZ?9'D$A0/O2' /"Y'7US@@$57\??\
MN?\ V$+?_P!FJE\2])$Y@O)(C-;VYD\Y%8A]KA1N&,9"XR>1[X7) !;F\&7$
M2F:&\G^TX)'F,# 6/7]UM("GG YV\$9Q6EX0\0'78!,Z[)49DD3!&UUZCYAG
MI@XYQG!)(-<K_8>@;/.S%MV[L>>^[&,_<W[L_P"SC.>,9KI_!5M;Q6RR6D;1
M12DN%DSNY^7=RS<$*",'!&#WH WJY_PAJDFH?:?-;=Y5Y-&O &%7;M' &<9Z
MGGWKH*Y3P!_R^?\ 80N/_9: ,W2KF[\2RW-H\C1P07,@\R/"R$ X2)6"X 7&
MYSRQ!5>A)JU8>?X=O([%I6G@NPY0S,6E1HDRWS8Y4\8''7M@E['@#_E\_P"P
MA<?^RT>(O^0CI_\ V]?^BA0!U=>;_&BV9;993(Q4SH A";!^[?D$*'SQW8CD
M\=,>D5P7QHA9[)2 2%G0D@9P-KC)]!D@?4@4 =E8V3VV=\KR9QCS!&,8ST\M
M$Z^^>G&.:\]^'^F3ZW9QQM))!!"7"F%BDDC%RQ8L1]Q=VT 9RP))X KT*QU:
M'4,^1(DFW&?+=6QG.,X)QG!KG_A;_P @Z#_MI_Z->@"+PU+/I=Y)I4TK31^2
M)8G<Y=5WE2K'&6))ZYQA1@#. _6-1GU>[_LJV<Q1Q(&N)5!WC>.(U)7"L0<A
MLY[CE2"[_F,_]P__ -KUS_B+1;:#4'GU*/=;W7EB.7>RJC*@4J^TKC=C()X
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M!9;2"9VCM)7D$Q4E5/RC8C..BMD@C(!&2<;<C/\ %=GIVCV;1P11/+)$QB
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M"?\ QYVW_7O#_P"@+6M0 4444 %%%% !1110 4444 %%%% '#RZK>W]_<Z;
MX2-!$PD,8?RQL!*@8 9G8_Q'A0V!GH_4?"]WHZF[LKJ:1XU),5P?.5P"#M
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MJ"2C;E8=I&9MI# <X;# CKD5P\C,T;>$U&'^U;5+ $^029O,R& +# )'&00
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MT3^V[66SS@R+\IS@;E(9<\'C(&>,XSCF@"KXYUQ]'M6DA_U\C+'$-I8EG/0
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MQMVQ-RN'.,@ DJ!DC.X$9K5^(^C/J=NFQ/-\F9)&C!*LZJ&#*".<D'MSZ9.
M0!L/@RXE4337D_VG )\M@( PZ?NMH!4<9'&[DG&:M>#==EOUDM;H 7-J^R3
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M=T^?:&8NK\?PDE>1GC(QDKG=NO&UC:J9&N(B!C[CAVY..%3)/X#WZ4 'A#Q
M==@$SKLE1F21,$;77J/F&>F#CG&<$D@UMURGPXC=H)+N1=OVNXEF5><A7QC.
M0/3(/0@@]ZZN@ HHHH **** "BBB@ HHHH **** .<\4>))+&2*QM55[JX)V
MASA%5>69@"&Q@'&.N#C)&TTKG3M6MQ]HCN(I7Y)@:()'R#\JN#N.#@+N*YZL
M>H,6NWW]BZI%>3#%O-;^3YA.%5MY<9X.,X YP,$G.%-=?=7:6BF65E1!C+.0
MJC)P,D\=: ,?1=>;Q';)=6K+&S'#"1?-VD9!7"NG/0@D\K@[1GC%\!Q7!:Z(
M>/:+^;>#$Q)/R[BI\T;0>P(;'<FK?PV<W$,]V 0ES=S2)G&=K$#D G!R",>W
MI@T[P!_R^?\ 80N/_9: .KKDM>\63V=ZNF0(KM-!N3=D8?<V2QS]Q44D@#<2
M,#KQUM</JFL1:7K"&9@JR66T,Q"J#YC/R21@';CZD"@"Q<Z=JUN/M$=Q%*_)
M,#1!(^0?E5P=QP<!=Q7/5CU!VO#'B%/$$"W<8QNR&7()5AU!Q^8Z$@@X&:O:
MAJ$>G1M<3,%C09)/^>2>@ Y)X'-<U\-1))!+=2(4^U7,DR@G/RR!<'MQP<'
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MXGD=;%TAMH9"AF(65W90<[5Y7;ROH<8(/51:^%O_ "#H/^VG_HUZJ_"^^\F
MZ5*-EQ:LP9"?F*LVX..,$9;'!(Z'.&% &E91:C;M]GD>*12,K.5*L,<D-$I
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M!![C(X/'H=</J^L17FK65O&P9H1<;RI! +(1MX/##8<@XQD5W% %'6#<"/\
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MXVA+ED95=V9PJ1JQ&5((SQDL,KCO6/\ :+635;1+)(Q&@FW20JH1F,1)7*@
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MD:8)W.W0?*,],G'&<8!!(K*MO!=U(/.GO9OM!P1Y1"P@@# \O&& (Y^[N'4
MDU8^(6GSW,$<ULH>2VG28*<_-Y8;@ =3STR"1D#G -K3_'-E>QK,)XUW#.V1
MU1QZ@J3P1^1Z@D8- &!H,LYU9HKG!DBLMN]05$@\U6#XQP3NPP&0&!P<<#O:
MX+0==36]6:>('RA9;48AAO E4E@& . Q*_53SZ=[0!YEJVGNNM6T1FD+&!B'
M(BWCB;@ 1A,<=U)Y//3'6^)=:;PY:[P6FF9@D8<#<[N3@$1JHX&> !G&,Y.:
MYSQ),MEK5K<2D)%Y##>YVID"7(W' S\P_,>HK6\<12:K;1W5CME-O.DRA3N#
M>7N! VGYCGL""<$#G ( S_A"[J\3=<WLWG[< P$11@X[JH&[!)Y^4D8'&*L>
M%]9G6>72KPAIH@'20*5\R-C][  4%20#@]>.=I8VM/\ '-E>QK,)XUW#.V1U
M1QZ@J3P1^1Z@D8-9'AS4!X@U&748.;>*W6$.0PWLS"0X!48V\@CKT/1N #M:
MY+6-1GU>[_LJV<Q1Q(&N)5!WC>.(U)7"L0<ALY[CE2#UM>:>(M%MH-0>?4H]
MUO=>6(Y=[*J,J!2K[2N-V,@G@ >FXJ :>L:?<^%(_MUO-+.D9!EBN&\S<G3*
ML%RA7.3VQR>%P=/QEK[6NGO?VK8)6)D;:#P[KSAAW![C]:YG4M(T*R4,JK*S
M,JK'!,\DC%C@ *)/YX].I .W\1[5;32I88QA(UA51DG 61 !D\]* 'PZ!<ZP
MHOI;B6"5@&2*(XCC'5%=& WL/X\XR<K@ "L?PG/=>-HO.FG>*.+"$6Y".\B\
MERVW@;6 VC(+<X7 %>BUY_\ !3_CSD_Z^&_] CH T_#=Q/IEV^D3.9D\HS12
M.29 I?;L8_Q'/0^GL0JPZ]K-V-073K8@++;9RRAA&=[9EZ9)"KM4$A2Q&?>Q
M_P QG_N'_P#M>LW7M=31-66>4'RC9;78!CL!E8AB%!."P"]N6'/J 7;GP7=1
MCSH+V;[0,D^:0T))!R/+QA02>/O;1T!(%:OA#Q ==@$SKLE1F21,$;77J/F&
M>F#CG&<$D@TS4/'-E91M,9XVVC.V-U=SZ *#R3^0ZD@9-5?A[I\]M!)-<J$D
MN9WF*C/R^8%X(/0\=,D@8!YR  ,^%O\ R#H/^VG_ *->J6G2W/C%I)UF:"R#
ME$$2[9) G_+02,H*@G'3L"A ()-WX6_\@Z#_ +:?^C7K-\#ZPOAU&T>_98I(
M"Q1F.U'1FSN#L<$[B?0XP,9#8 '7QN/!;)<-,\]D\@6039>2,, /,W@$D CI
M@#D* 6;<-;Q!JT^DW=L^<VMPWDLNU<K(V=C Y!YZ'J %/!)%8_CSQ##K40TF
MT=99KEXQ\A+*JAMQ<LH88&WD9R =V,#GI_%6B?VW:RV><&1?E.<#<I#+G@\9
M SQG&<<T 5?'.N/H]JTD/^OD98XAM+$LYZ #OC)&>,@#!Z&OXGUF?2XH+.$A
M[RY(C5RI X \R4JH( &<XZ#.<$*16%X;U9O&,]M(3F.SA#R[E',[;D&1G'&-
MZ, =O(X)P+OQ+TD3F"\DB,UO;F3SD5B'VN%&X8QD+C)Y'OA<D %N;P9<1*9H
M;R?[3@D>8P,!8]?W6T@*><#G;P1G%7?#?BL:C:&\G'EM#O$RX;Y&CY;@C/3!
MQR1G;DD&N:_L/0-GG9BV[=V//?=C&?N;]V?]G&<\8S6UHVD076G21V,;0I=1
MR;5E+9RZE QR7." ",9XP1UH I:/I]SXKC^W7$TL"2$F**W;R]J=,LQ7+EL9
M';'(X; MZ/J,^D7?]E7+F6.5"UO*P.\[!S&Q"X9@!DMG/<\L .7\/:)I3H8+
MZ-8;J#"R+-,R9./OJ=X!#=>.F?0J3N^&=,TM;LK8QEI($W&5'=XAO&W;N+D%
MB">Q'7G((  ^^N#KM]+IS7#P) L>U(75))&92Y8-C=A5."HR.C<5K^'=&N=+
M9TEN#-!CY/,7]Z"68D%\_,,8Y.<]@@&&S=9N=+UJ22WO-BR6[!29CY+$8R-K
M$J67D\9QGYL8*DU/"4RPW\EK:3/+:);@D%S)&C[_ )45L8 "= "<X.22O !W
M=<?KNH7&L71TFSD\E8X]TTP4LP+CY8QP "00V00?0@J0>PKAYKUO#6I2SW&%
MM;X1A9.H5XU"A6/&T'YNQ'0Y #8 +<V@7.A*;FUN)9M@+/#<'S?,"_PJP&Y&
MQG& =S;01@4[X6_\@Z#_ +:?^C7JWJ?CFTM$+1RI+(>$CB;>S,0=JX3<1N/&
M<8!(JI\+?^0=!_VT_P#1KT 6_ 6J2:K917,[;I'WY. ,XD8#@ #H!VH_M23^
MTOL6[]U]C\S;@?>\W;G.,].,9Q[5C_#C68;*U%C,ZQS6SS*ZNZ _*S.Q'S<J
M >3TX/89IFCZRNJZP\D?,:6917&=KA95RPX&0&)7(R#MR#0!I^*-9G:>+2K,
MA9I07>0J6\N-3][!!4EB"!D]>.-P85-0\,7.CQM=6=S/)+&,^7<-YR.HY*!=
MN0QQP1SV!&<C/\?:3$EW'J%[$9+/RA$Y5F!C;>2'(7!*\XX/KWVAHM0T;0;*
M-ICY;;1G;'<,[GT 42<D_D.I(&30!W&@:RNM01W:<"1<XYX(X9<D#."",XYQ
MD<51\:VS36D[+(R!8)B0H0AOD/!W*QQQ_"5/)YZ8O:!91V<$<<"-''MR$?.Y
M=_S$'))SDG(SP>*9XGA::TN$0$LT$H  R22A   ZDT <[\+;)_L4$OFOM_>?
MN\1[/]8XZ[-_7G[W7VXITE[<^)+F:VMY3!:VQ\MW5,O(Y^^JLP^4KR,CD'#?
M,&&&_"W5H?L4%KYB>;^\^3>N_P#UCM]W.>G/3IS4.B:G_P (S=W%G>%8X[F:
M2:&0\(=WWE+D@ @!>"!SGDY3( :MIUWX44W]O/+/$FTR0W!\QBH)#%7 RN <
M\ #@LQ(&VNUM+I;M%FC.4D4,IP1D,,@X//2N2\9^,[;[-);0R+--<(T:)$V\
MDOA/X V"-V0#C=C KI=#LFL+>&W?!:*)%)'3*J <9QQQ0!>HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "L_4_#]OJF3/$CDKMW,H+ <\!NHZG&",'D<UH44 4=+T2#2EV6\:H, ':H!
M.WID]6/N23U]:PO$7_(1T_\ [>O_ $4*ZNH9+1)665E4O'G:Q ++N&#@]1D=
M<=: *4WABTF8N\$19B228D))/)))')-:=%% $,=HD3-*JJ'DQN8 !FVC R>I
MP.F>E$=HD3-*JJ'DQN8 !FVC R>IP.F>E344 0W%HESM\Q5;8P9=P!PPZ,,]
M".QZU-110!D_\(G9_P#/O#_WY3_XFM:BB@ J&WM$MMWEJJ[V+-M &6/5CCJ3
MW/6IJ* (;>T2VW>6JKO8LVT 98]6..I/<]:)+1)665E4O'G:Q ++N&#@]1D=
M<=:FHH *9-"LRE' *L""",@@\$$'J#3Z* *ECI,.GY\B-(]V,^6BKG&<9P!G
M&34MK:):*(HE5$&<*@"J,G)P!QUJ:B@"'[(F_P _:OF;=N[ W;<YV[NN,\XZ
M9HNK1+M3%*JNAQE7 93@Y&0>.M344 9]KX>MK1A+%#$CC.&2-%89&#@@9Z5H
M444 %8^L>$+36#NGA5F)!+#*N<# RRX8C'8G'3T%;%% %>RTZ*P79"BHI.2$
M4*,],X '/%%[IT5^NR9%=0<@.H89Z9P0>>:L44 ,FA692C@%6!!!&00>""#U
M!K'_ .$)L=_G?9XMVW;C8-N,Y^Y]W/\ M8SCC.*VZ* "J]MIT5JS/&BJTARY
M50I8\G)(')Y/7U-6** ,'P7H\FF6X$^//E=Y)2#G+N<]N 0, A?ER.,]3O44
M4 9]UX>MKMC++#$[G&6>-&8X&!DD9Z58ATZ*%@Z(H94" A0"$'(0$#A1Z=*L
M44 0_9$W^?M7S-NW=@;MN<[=W7&><=,T75HEVIBE570XRK@,IP<C(/'6IJ*
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MHR.N.M%Q:)<[?,56V,&7< <,.C#/0CL>M344 %0VMHEHHBB5409PJ *HR<G
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M5#R8W,  S;1@9/4X'3/2IJ &30K,I1P"K @@C((/!!!Z@T0PK"H1  J@  #
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M23;;Q8\Q%;&47.,@XS@5NS0K,I1P"K @@C((/!!!Z@T0PK"H1  J@  #  '
M  Z 4 166G16"[(45%)R0BA1GIG  YXIUQ:)<[?,56V,&7< <,.C#/0CL>M3
M44 %0V]HEMN\M57>Q9MH RQZL<=2>YZU-10!#;VB6V[RU5=[%FV@#+'JQQU)
M[GK37TZ)Y!<%%,JC <J"X'/ ;&0.3^9JQ10!#=6B7:F*55=#C*N RG!R,@\=
M:?-"LRE' *L""",@@\$$'J#3Z* ,^U\/6UHPEBAB1QG#)&BL,C!P0,]*M6MH
MEHHBB5409PJ *HR<G ''6IJ* (;6T2T411*J(,X5 %49.3@#CK1):)*RRLJE
MX\[6(!9=PP<'J,CKCK4U% $-Q:)<[?,56V,&7< <,.C#/0CL>M9^N^*+?0U+
MSNH95W! 1YC#.!A<Y.3QGIZD $C6JI<:3#<NL\D:-(F-K,BEA@Y&&(R,'D>]
M &+X"TIK2!KF9-EQ=2/+(" ""S$JOJ !SM))!)SSD5TM%% !69-X8M)F+O!$
M68DDF)"23R221R36G10!#]D3?Y^U?,V[=V!NVYSMW=<9YQTS3;W3HK]=DR*Z
M@Y =0PSTS@@\\U8HH SX_#UM$K1+#$$DQN41H%;:<C(Q@X/3/2M"BB@#,F\,
M6DS%W@B+,223$A))Y))(Y)K0AA6%0B !5   &  .  !T I]% !52^TF'4,>?
M&DFW./,16QG&<9!QG JW10!#]D39Y&U?+V[=N!MVXQMV],8XQTQ5*'PQ:0L'
M2"(,I!!$2 @CD$$#@BM.B@ HHHH **** "BBB@ HHHH **** "BBB@"OJ&GQ
MZC&UO,H:-Q@@_P">".H(Y!Y'-<_#\,M.B8.(!E2",O(PX]06((]B,'O7444
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M=<XZ9VL,GMD\XP.@%/MO!=G:JD:1*HCD61<%MVY"2I+9RV-QP&)'.,8K;HH
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MUIT4 ,AA6%0B !5   &  .  !T JE=>'K:[8RRPQ.YQEGC1F.!@9)&>E:%%
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M!&#F@#5\??\ +G_V$+?_ -FKJZXSQ?9BRCL80S-MO[<;I&+N?O9)8]2?R'0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M45Q]SIVK6X^T1W$4K\DP-$$CY!^57!W'!P%W%<]6/4'K82Q4%P V!D Y /<
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M+YLLI8YS/(9",=AT 'T&3W)P,:= !1110 4444 %%%% !1110 4444 %%%%
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M#\A5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6()[$=><@@=5>Z';W[;YHHW8# +HK''7&2#QS4UEIT5@NR%%12<D(H49Z9P
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M$Y"136C1J[,H4,C^8<DD8&,#/<D =\4OBIXDB>S:UB99'DV$[&W;$W*X<XR
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M9N"%!&#@C![U8_X1.S_Y]X?^_*?_ !-:U '*?"W_ )!T'_;3_P!&O1_S&?\
MN'_^UZZ6UM$M%$42JB#.%0!5&3DX XZT?9$W^?M7S-NW=@;MN<[=W7&><=,T
M <+\3/W5SIT[<1I<?,QX5?GC/+=!PI//8'TKN++48K]=\+JZ@X)1@PSUQD$\
M\TZZM$NU,4JJZ'&5<!E.#D9!XZTVRTZ*P79"BHI.2$4*,],X '/% %BBBB@
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M[+C\[[;M_>^7Y>[)^[NW8QG'7G.,^] '/_%+_D'3_P#;/_T:E'Q2_P"0=/\
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M^G>"$:[6-%DVDH&8EV(&-JEBQ&=V&*C@'+<"M#P#ICZ98PP2C#A22.01O8N
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M;'0B8#&]'>-NF.J,O.#C/7''2BP\(VNGF,Q1A3 7*$%N#(,.3D_,2 !\V<
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M%E'9P1QP(T<>W(1\[EW_ #$'))SDG(SP>*A\6?\ 'G<_]>\W_H#5K5D^+/\
MCSN?^O>;_P! :@#"\%^,[8VL4$TBQ2Q11JRRMLXVX1@7"@AE ;C. 1STS7UO
M4_\ A)KNWL[,K)';31S32#E!M^ZH<$@D@MP ><<C#XV]!TF'4+.U\^-)-MO%
MCS$5L91<XR#C.!6Q9:=%8+LA144G)"*%&>F< #GB@#E/']P%EM()G:.TE>03
M%254_*-B,XZ*V2",@$9)QMR,_P 5V>G:/9M'!%$\LD3&( !Y"'!/FAL,VU1E
MMQ.,+@$<5WMU:)=J8I55T.,JX#*<'(R#QUJK;^'K:VW>7#$N]2K;8T&5/53@
M<@]QTH HZ'9+?Z=#;OD++:(I(ZX:( XSGGFN*TFYDUG[-H3$$VDK_:?E^4I;
ML!&N,J&1LA2""V0&(XR?0[[5;?1$ E=(D"G:I(7A .%7J<#'"@]@!6%X'MS?
M//K$B%&NG CW  ^2B@(<<D%L9;G!P"!C!(!?\<Z/)K%G+:PX,C!2 3C.UU;&
M?4XP,\9ZD#FH-"\=V][$&GD2*9?EDCE81LKKPPVL<XSTZ^AY! Z6L^Z\/6UV
MQEEAB=SC+/&C,<# R2,]* .775D\1ZG ;8AXK))B\@W;=T@\L(#MP3QD'.&&
M<'CF75KY=)U6*XG(2*:T:-79E"AD?S#DDC Q@9[D@#OCK;6T2T411*J(,X5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<I_S&?^X?
M_P"UZT[GQ1%;W<>ED-YLJ%@0!LP QY.<Y^0]CVH V**S-=@N9EC%HZHPE4N7
M7<"@SN&,<D\="I_VA6G0 4444 %%%% !1110 45P7P_\.PZI%'K-P#+=2.[%
MW)."K%%PHPN %XXX/3   [V@ HHHH **** "BBB@!DT*S*4< JP(((R"#P00
M>H-166G16"[(45%)R0BA1GIG  YXJQ5?4;U;")[A\E8D9B!UPH).,XYXH L4
M5GZ!K::W EY$&"2;L!P WRL5.<$CJ/6L3P!_R^?]A"X_]EH ZNBBB@ HHHH
M***Y_P !:I)JME%<SMND??DX SB1@.  .@':@#H**S_$-TUI;3S1G#QPR,IP
M#@JA(.#QUH\/737=M!-(<O)#&S' &2R DX''6@#0HJ&[NEM$::0X2-2S'!.
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M,>3@'G&0,XZDY.0#K:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M21GI5O6KF3P[%%I]J[RW-U(51YV:1@/XI#P1A!CC  ^\0<-F7P[_ ,A'4/\
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MG- '0>'KIKNV@FD.7DAC9C@#)9 2<#CK6?HVJ27-[>6SMF.#[/L& ,;XR6Y
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M@#JZP?&MLTUI.RR,@6"8D*$(;Y#P=RL<<?PE3R>>F-ZLSQ/"TUI<(@)9H)0
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M:=[!6S/&NYEVMP#MYSC!^\.A[T :%9/BS_CSN?\ KWF_] :M:LGQ9_QYW/\
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M/4W-A<R6Z$;QAQ);@;1ERK\,"HSDMQP1P *I75Q/XHT0R8WSR*,A!@MY<W)
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MW/BN/[=<32P)(28HK=O+VITRS%<N6QD=L<CAL"WH^HSZ1=_V5<N98Y4+6\K
M[SL',;$+AF &2V<]SRP Y?P]HFE.A@OHUANH,+(LTS)DX^^IW@$-UXZ9]"I.
M[X9TS2UNRMC&6D@3<94=WB&\;=NXN06()[$=><@@ #_$6K7C7ZZ;:OM66W5M
MVQ6$9$AW2'*G.578 2!EAR#5C6$;PA93W$<DLLF!AIY-Y4L0BD C;A2V[&/F
MZ$XQAW_,9_[A_P#[7K8\1:O#I4)EN03$2%;"%QASM.X 'Y>><]>@R2 0#G5\
M+3SH+NSOY7E.3N9EDMV."" @!51NZ?>V] "0,:7CC4YM)L)+B-@)D$?S!1C)
M=58A6W8!R>#G'KWKE_$%EI=C%+=6<ZPS[6(-M<?,Q/1-JLWREL9"@8QU %;'
MBV&:_P!';>"9C!$[@@*<J4>3(XP1@G'X =J .SKG_"&J2:A]I\UMWE7DT:\
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M_LRR<1"% \TICWX+#Y8P&&W)!#=>1G!&T@U]1\+W>CJ;NRNII'C4DQ7!\Y7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!#':)$S2JJAY,;F  9MHP,GJ<#IGI4U%%
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M((R"#P00>H-9\/ABTA8.D$092""(D!!'((('!%:=% !4-O:);;O+55WL6;:
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M* (;6T2T411*J(,X5 %49.3@#CK34TZ))#<!%$K#!<* Y''!;&2.!^0JQ10
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M9/W=V[&,XZ\YQGWJW10!#=VJW:-#(,I(I5ADC(88(R.>E-AT^.*(6H4>4J!
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M'6IJ* &30K,I1P"K @@C((/!!!Z@UGP^&+2%@Z01!E(((B0$$<@@@<$5IT4
M%4;W0[>_;?-%&[ 8!=%8XZXR0>.:O44 5%TF%%6(1H$C;<BA%VJP).X#& <D
M\CGFGWNG17Z[)D5U!R ZAAGIG!!YYJQ10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!R7B;Q5,LXTFP0-<NF2Y(V1 G[S#!Y YYQU7 ;.VG?\(1)/\\][
M<F0]3$XA3T&(P"!QC//)R>]5_ *J\]_,7+2F[92"V<)&2(^.H') [87 Z&NS
MH P?#\%[:R217;K-%A2DH41OD\%"BC&!C.<]QR<D)O45QDE[<^)+F:VMY3!:
MVQ\MW5,O(Y^^JLP^4KR,CD'#?,&& #LZ*X35M.N_"BF_MYY9XDVF2&X/F,5!
M(8JX&5P#G@ <%F) VUK>,M?:UT][^U;!*Q,C;0>'=><,.X/<?K0!TM%%<_X0
MU234/M/FMN\J\FC7@#"KMVC@#.,]3S[T =!6/XH\41>&XA<3!BK.% 0 G)!/
M<KQ\M<OI<UYXEFN+9IGBMX+B52\0578;@(XU8)QLVDL<DD, 1@YK/^+&DFPL
MXQYLKJ)D&V4J_.Q\MNV[R2<]6(&2     #U"BJEC9/;9WRO)G&/,$8QC/3RT
M3K[YZ<8YJ6[NEM$::0X2-2S'!. HR3@<]* )J*X?1[*[\51_;+B>2"&4EHXH
M,1N .%)D*[B",G&,'(88X4/M[BX\+7$5K/*T]K<L41Y 3)&Y)*JS '=NR "2
M.A("JI! .UHKDO&6NW.G7%I!:@,9S*I5A\I("A6) +!4+;FVXR <FB7P5<2#
MS3?3^?D'<,"'@C'[D8&,#!&<$\G.2* .MK,LX+E;B5Y'4VS!/*0+\ZD ;B6P
M."<\?-GC!7&#G^#==EOUDM;H 7-J^R3 (# _=D&0.&P>GIG ! I^C:I)<WMY
M;.V8X/L^P8 QOC);D#)R?4GVH Z"BN'EU&[U._N=+C<I"HB)D &Y%* LJD+]
M^0MP6/R@,5!(&"XMY_"<\#K-)/!<RI"Z7#EW5G)VNK8X YR,<^^04 .EUV"Y
MF6,6CJC"52Y==P*#.X8QR3QT*G_:%:=<_P"+]4DT_P"S>4VWS;R&-N <JV[<
M.0<9QU'/O4OB_P 0'0H#,B[Y794C3!.YVZ#Y1GIDXXSC ()% &W17'_\(7=7
MB;KF]F\_;@& B*,''=5 W8)//RDC XQ5CPOK,ZSRZ5>$--$ Z2!2OF1L?O8
M"@J2 <'KQSM+$ ZBBN'EU&[U._N=+C<I"HB)D &Y%* LJD+]^0MP6/R@,5!(
M&"XMY_"<\#K-)/!<RI"Z7#EW5G)VNK8X YR,<^^04 .XHHHH **** "BBB@
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M)D#RQW,#D!RR"%TX;) 0$$=.N23@849:@#8U+7X-->*&9MKSMMC&UCDY QD
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M8]B ;U%8/B[Q(=$C41J'GG<1Q(2!EFXR<D?*.,^Y )&<BA-INJP*;A;B.20
MGR#"%C)/\ DW!\#^$G&2!N(!- '6T5D^&/$*>((%NXQC=D,N02K#J#C\QT)!
M!P,UROAS7K_QA'YD3I;JG#N(PY:3).U59R-NPJ23@[N!D9P >@45S7B+Q#)I
MS0Z?;!9+J?H92 H51EI'"[3R <!0 <-CIM-'4(]2T&-KPSK<K&,O&\2Q?(.6
M964_> '?(QG@D $ [.BJFE:FFJ1)=1'*2*".F1GJ#@D9!X(SP015N@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6DS%W@B+,223$A))Y))(Y)K0AA6%0B !5   &  .  !T H Y?P[_ ,A'4/\
MMU_]%&CQ]_RY_P#80M__ &:NECM$B9I550\F-S  ,VT8&3U.!TSTHN+1+G;Y
MBJVQ@R[@#AAT89Z$=CUH JZWK\&B()KEMB%@H.UFY()QA03T!K0JO>Z=%?KL
MF174'(#J&&>F<$'GFK% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RGC[_ES_["%O\
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M(;5KNVGAC&7DAD51D#)9" ,GCK4.A>%K;0=WV9-GF;=WS,V=N<?>)]3TK6H
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MO][T'O6M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 0R6B2LLK*I>/.UB 67<,'!ZC(ZXZU-110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 5[W3HK]=DR*Z@Y =0PSTS@@\\UA6OPWT^U82+ I(S]]G=>1C
ME78@_B/?K6_=W2VB--(<)&I9C@G 49)P.>E1:7JD>JQK<P-NC?.#@C."0>"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <EXGA6;4+!' *L+
ML$$9!!B ((/4&I9OAEITK%S ,L23AY%'/H P 'L!@=JW;C2X[F2.Y=<R0;]A
MR1C>,-P#@Y'J#[5;H 9#"L*A$ "J   ,  <  #H!6)<>![.>22<QD/,"'*22
M)N#?>!", 0<<\<GDY-;U% &9I_ANWTYEEA0*R1>4,$_<W;L8S@DMR2?F)ZFK
M']EQ^=]MV_O?+\O=D_=W;L8SCKSG&?>K=% !6#8>!K/3YA>0Q!906((9\#<"
M#A=VT#!/&,#M6]10!4T_2X]/W^4NWS9&D;DG+-C<>2<9QT''M69<>![.>22<
MQD/,"'*22)N#?>!", 0<<\<GDY-;U% &9I_ANWTYEEA0*R1>4,$_<W;L8S@D
MMR2?F)ZFK']EQ^=]MV_O?+\O=D_=W;L8SCKSG&?>K=% %2XTN.YDCN77,D&_
M8<D8WC#< X.1Z@^U5/%&LQ:1;R3S[2NT@(W1R0<)T.=W0\' R3P#6M6/+X1M
M9;C^T&C!GR#N)8\J H.W.W( &..#SUYH J?#_01HMG'&00[CS'R"#N<#@@DX
M*C"]NF< DUT=%% %?4-/CU&-K>90T;C!!_SP1U!'(/(YKGX?AEIT3!Q ,J01
MEY&''J"Q!'L1@]ZZBB@!D,*PJ$0 *H   P !P  .@%5[?2X[:22Y1<23[-YR
M3G8,+P3@8'H![U;HH J?V7'YWVW;^]\OR]V3]W=NQC..O.<9]ZJ:WX5M=;P;
MF-7(QAN5; SQN4@XY/&<9YQFM:B@#'T/PC:Z&S/;1A&<8)RS''7&6)P/7'7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **YSQ1XDDL9(K&U57NK@G:'.$55Y9F (;& <8ZX.,D;3
M2N=.U:W'VB.XBE?DF!H@D?(/RJX.XX. NXKGJQZ@@'85GZ)K\&MH9K9MZ!BI
M.UEY !QA@#T(JCHNO-XCMDNK5EC9CAA(OF[2,@KA73GH02>5P=HSQR7P<CF:
MV8QN@C%P=RM&S,?D3.&$B@9'3Y3@\\]* .F^UO\ VMY&YO+^P[MN3MW>=C=M
MZ9QQGKBNEK@M>U*2SU95@4/--9;$#'" ^:S%F/7:JJ20.3C ZY#M8NM0\+!;
MV6=;FW#*)5,*1LJLRC<NUAD]N3@$C@C)4 [NBLGQ/XA3P_ UW(,[<!5R 68]
M ,_F>I !.#BLB'3=5G47#7$<<A /D"$-&"/X#)N+X/\ $1G!)VD@"@#K:*P?
M"/B0ZW&PD4)/ YCE0$'#+QD8)^4\X]P0"<9.%9^([WQ!-/8VY2'[/-(KR[-Y
M"AL1 *S8+,5;=D;0.1@X! .[HJOI\#V\:I(YD<#YG*JN3W.U0 !Z#TZDGDT?
M$_B%/#\#7<@SMP%7(!9CT S^9ZD $X.* -:BN/\ [.U:^3S6N(H)-O$4<0=<
MXR-SN6(.3@[=P &1FKOA?Q))?22V-TJI=6Y&X(<HRMRK*"2V,$9STR,X)V@
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M?&.AP>ZJ<B@#M:*R=)N[A$=KY8D\O^.-SL(QN+88 J ..2<D$\#&<#3=2O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!6)+X&LY)_MQB'G;P^X,X^8$$-M#!<Y&3QR>3G)H I?\QG_N'_\ M>CXI?\
M(.G_ .V?_HU*Z#^RX_.^V[?WOE^7NR?N[MV,9QUYSC/O1JFEQZK&UM.NZ-\9
M&2,X((Y!!Z@=Z .:^)]JTMO'*H?;!<1R2&(@2*BA@S+GN,Y![=3P":9I_A"/
M48UN(;Z[:-QD$7'_ -CP1T(/(/!YKLZY>;X9:=*Q<P#+$DX>11SZ , ![ 8'
M:@ \$Z?;1&:XMII)R[JCO*V_YHAQAMJY&&Z\@C&#3/ '_+Y_V$+C_P!EKH]/
MT^/3HUMX5"QH, #_ #R3U)/)/)YIFGZ7'I^_REV^;(TC<DY9L;CR3C..@X]J
M +=<E\2A)'!%=1H7^RW,<S ''RQALGOQR,G!P.2, UUM% %?3]0CU&-;B%@T
M;C((_P \$="#R#P>:Y32;Y=6U66X@(>*&T6-G5E*EG?S!@@G(QD9[$$'MFW-
M\,M.E8N8!EB2</(HY] &  ]@,#M6[IFE1:6@A@140=E&,G &2>I. ,DY)[F@
M#DM(UB*SU:]MY&"M,+?86( )5 -O)Y8[Q@#.<&NE\1Z]'H4#W4A'R@[03C<V
M/E4<'D_0X&2> :YVPTJ+5+[489T5T/V7AAG!\EAD'J#@G!&".QK2T_X>6&GR
M+/'" Z'*DN[8/8X9B,CMQP>1S0!SO]@3_P!A?8_+;SMN[9_%CSO,Z>NWG;US
MQC/%6M"\/1:Y$+F"]O"K=0;CYE/=2-O!'_UQD$$]W7.:A\/+#4)&GDA!=SEB
M'=<GN<*P&3WXY/)YH J^%]'MH+J62*XEGGA01/YS[]H9MP&[:.05/ )P<@@&
MG>'?^0CJ'_;K_P"BC6[H^BPZ/'Y%N@1,DX&3DGJ2222?J>@ Z 4^WTN.VDDN
M47$D^S><DYV#"\$X&!Z >] &+X\UF33(HO*=8C-<1QF1@&"*V26PW'&.<\8S
MT/(9<:'#H<$EQ/-<.L8+$O=2!NG"C:\:Y)X&>23C/2N@U#3X]1C:WF4-&XP0
M?\\$=01R#R.:R;/P/9VC1ND9_<$F,-)(ZJ3R2%9BH.>>G7!ZC- %+X6_\@Z#
M_MI_Z->LKX*?\><G_7PW_H$==KI>EQZ5&MM NV-,X&2<9))Y))ZD]ZS)? UG
M)/\ ;C$/.WA]P9Q\P((;:&"YR,GCD\G.30!2\._\A'4/^W7_ -%&CP[_ ,A'
M4/\ MU_]%&N@M]+CMI)+E%Q)/LWG).=@PO!.!@>@'O1;Z7';227*+B2?9O.2
M<[!A>"<# ] />@#G_'W_ "Y_]A"W_P#9J/B/&ZP1W<:[OLEQ%,R\Y*IG., ^
MN2>@ )[5T&H:7'J&SS5W>5(LB\D89<[3P1G&>AX]JBUS7(]$C^T3;M@902JE
ML;CC)QT [G\!EB 0"QI^H1ZC&MQ"P:-QD$?YX(Z$'D'@\UQ^E:Q'JNKM)#DH
MMD5#8^5MLPR5/\2YR,]"0<9')N_\(9I=U_IXCB*#YMROB+"=3A6\O Q\W&.N
M>]5?#DRZIJ,MW;A?LUM;K;JRYVL=P?Y?E PO3@]-I&0W !VM<I_S&?\ N'_^
MUZZNJG]EQ^=]MV_O?+\O=D_=W;L8SCKSG&?>@#G_ !%_R$=/_P"WK_T4*U?%
MG_'G<_\ 7O-_Z U6[C2X[F2.Y=<R0;]AR1C>,-P#@Y'J#[5+=VJW:-#(,I(I
M5ADC(88(R.>E '&ZOI\FH:(D,*EG-M;D*.IV[&.!W. >.IZ#FNE\.:]'KL"7
M49'S ;@#G:V/F4\#D?09&"."*NVEJMHBPQC"1J%49)P%& ,GGI6%J'P\L-0D
M:>2$%W.6(=UR>YPK 9/?CD\GF@"WK$RZK;W-K;LKR^5(A574D,RLH4\_*<\<
MX[^E4OA]K*W]HD/W9;91%(ASN4I\HR" 1D#/L<C)(-:^CZ+#H\?D6Z!$R3@9
M.2>I))))^IZ #H!6?K'@:SUB3[1/$&D( )#.N<=,[6&3VR><8'0"@#*\:7RW
M=Q9Z?&0TPNXY&4,ORK$"S;AG()5L@8Y ..V;'B+_ )".G_\ ;U_Z*%:NB>%;
M71,FVC5"<Y;EFP<<;F)..!QG&><9JW<:7'<R1W+KF2#?L.2,;QAN <'(]0?:
M@#G_ (I?\@Z?_MG_ .C4K5\)_P#'G;?]>\/_ * M6]4TN/58VMIUW1OC(R1G
M!!'((/4#O4MI:K:(L,8PD:A5&2<!1@#)YZ4 <UX _P"7S_L(7'_LM<[I6BK+
M>7-G-/<6\TD\DL:12^6DB.<AAP<MQSWP/]EL>A:?I<>G[_*7;YLC2-R3EFQN
M/).,XZ#CVJOKGANWUU52Y0.$.5Y*D9Z\J0<'N,X.!Z"@#E=;\'VT(2WNKRZ(
MN'"*CS;]S9&/EV'@'')X!QDCBNUO=1BL%WS.J*3@%V"C/7&21SQ63H_@:ST>
M3[1!$%D (!+.V,]<;F.#VR.<9'0FKVMZ!!K:"&Y7>@8,!N9>0",Y4@]": -"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"I;Z7';227*+B2?9O.2<[!A>"<# ] />K=%%
M !1110 4444 %%%% !1110 4444 %,FA692C@%6!!!&00>""#U!I]% '-77P
MWT^Z8R- H)Q]QG1>!CA48 ?@/?K6_:VB6BB*)51!G"H JC)R< <=:FHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>mdt-20221028_g3.jpg
<DESCRIPTION>IMAGE 7
<TEXT>
begin 644 mdt-20221028_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ? ?\ P<.?\%<]8_X)
M/_L>V>M?"B"TF^)_Q#OYM)\"_;HA+%IXBC5[K47C;B40+)$JH<J99XBP9 RG
MQ#_@WS_X)M_"W]H_]CS3?^"C7_!1/PM:_&[XK?%VXO+^+5_BK;IK@TC2DN9(
M((+:*[$D4/F")IBR*"$F2,;53;7S7_P?$_#KQA,_[//Q:AMII= MQXATBXF
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MWBKQKJ%AKFA:8GEVTUI?Z+_:,T9C3 "1W)6<*  IA7L,5U/[+?[6/QX^,_\
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M=:V\N.&O;J9$EAM\ABMN&8+&YD7[M_9I^#7P5_9A^#WA[]E?X%6]I9:'\/\
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MTO2HK#PEY\8=5U.\GCM8)2C<.(FE,Y4\,(2#UK\=_"7P.\(>,/\ @U2\4?\
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M31OAQX*T^)I;SQ/XAN<I9:?!&GSN7?YG*@E(DD?!VXH _%'_ (- ?C/^U/\
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MMM])UWP_):RW+VL4J7H6"=$2\GB9TEW. DFU2/+/=?\ !,?_ ((U?%+X3_\
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MCS7OV(O'>ERKX+UWP>/#ICMBHEM(4B5()HB00)86CBD0D$!XU)!'%?E[I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5X3^WW^US\4OV3/AGI&H
M_ #]EK6/C3\0/$NNIIWASX>:)K"Z?)<QA&DN;N:Z>*5+:WAC7YI779YDL,9*
MF537NU-,$+3+<M"ID12JR%1N"D@D ^AVC/T'I0!^<$O_  6'_P""HW@?XM?#
M/X<_M"?\$-9O FG_ !-^(FG^$=,UVY_:+TO4!#<7.^1Y?L]K8/(ZQ6\-Q.V
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M?.?W.45_%1X&_;*_:^^&,D<WPV_:J^)'A]HL>6VB>.+^UV^P\J9<5[O\+_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?@V4/L\OQ5X8N]/);T'GQKFO9HXS"8C^%4C+T:8K-'%4445T""BBB@ HHHH
M**** "BBB@#J/@S\:?BO^SQ\2])^,?P1\?:EX8\3Z'<B?2]9TFX,<L+="/1T
M895D8%74E6!!(K^DO_@B?_P<&_#+_@H79V'[//[1C:?X2^,T-N$MT1A%I_BH
M*O,EIN/[NXP"7MB3GEHRR[EC_F,JQI6JZIH6J6VMZ)J5Q9WMG<)/9WEI,T<L
M$J,&21'4@JRL 00<@@$5Y6:Y1ALUI<L])+:75?YKR&I-']S%%?D#_P $"_\
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M7#6C\4M%^K/EN:::XF>XN)6DD=BSN[9+$\DDGJ:;117^H.Q\4%%%% !1110
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M>_X*<S_M&_L^7?["WQ<\0^?XP^%]@DOA2>YES+J/A[<$6/GEFM'9(NW[J6
M':QK]:J_BU_8@_:U^(/[#7[5/@O]J/X;3.;_ ,*ZPD]S9"4HNH6;92YM'/\
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MG?PEI'@7P7>>)O"TNLG1QJ,4DL]Q:6PN;>-9Y9;:\W3NS?NIO+V-N#)])?\
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M'O&VJW.FP%6G34-+U5)H+:Y9BN\Q30%%S&597W*5?@?V<_V/8O@#^S)\/?\
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MZ7H_Q5^*'_"3Z;>Z/)8V=S!+=WNE1PSO>33W0@Q%%<VUNL1F8NY\I1+]YT4
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MRE\-O'G[1?A1="\?:UX%TJ]\9Z,D)B%GJ<MI&]S%Y9YC*REP4).P_+DXS7Y
M:]^P#\;OVO\ X-Z?_P '%7[#?]A>"?CCJNJ7/CC3/A4-'MY]"UK1[9Y8[>VN
ME9?WVK20QM.]WE0TTY5!"RK.OZS?L#?M66/[</[&7PW_ &L[#PT^C?\ "=>%
M[?4KC27<O]CN""D\2L0"Z+*CA7(&Y0IP,XH ^;_^"IO[7,GP:_;7_9D_9L^+
M?Q5UGX=_!WXH:EKR>,?&.BZW-I+W>IVUO#_9NER:E R36$,LTQ9GBDC>0JB[
MUC$N=WX$^+_'_P -_P#@KIXG_9(^#OCSQ/XI^$]A\%;;7_&EKXF\3WFN?\(C
MXFDU#R[.WBOKV6:>,W5EYDILGD*JL*2HL8<A\;_@K/;_  W_ &S/C5\*_P#@
MCGXX\#6%[8?%VVU+Q-XM\27UJLEQH&D:2JMOTTN"(]0GFD$"3\B&(S,4?<%K
MQ_\ X)9Z!^TA_P $F?V]IO\ @CM\7=8@\<?"WQUH.J>,O@A\1/L$<.J*;>1/
MMMAJ1C \^5$93YS9(Q$%.R18H #R71OVUOVG+C]@7P+_ ,%:)_BWXR'Q$UW]
MK0:)J?@EO$UX=';P])K=QI)\.KI7F?9%"P1HZS"+[2)E,AD))S^FO[7WQ9\>
M&[T/]E+]GW6C9?$?XBQSB+688UD/A+0XBBW^NNI!7=$)$AMD8$27<\ (,:S%
M>(^-G['7[!/[.>GZC^U/\1?!>I)HGA;QN_Q M_"-MJEU/IC^+IL0QW]KI@?R
MY=1FFD5(8E7:US.'1!-(9#X[^T_\8OCY^PK\#/#_ ,>==TW3(?V@?VI/C5X5
M\ _;KU!?67@F'4)IEL]/B4%5GBT^U6Y/4)/>SSSD;93'0!]Z^"O">G> O!VE
M>!]'N[^XM-'TZ"RMKC5=1EN[J5(D"*\T\S-)-(0N6D=BS,2S$DDUIU\G_L>_
MM8?%34?V]_CI_P $\_C%XI?Q3+\,]+T#Q#X1\9W-A;VU[J&F:E;DRV]ZEK'%
M;^=!<(P62**,/'(NY R%G^L* "OY;?\ @O?\?Y_V@O\ @J9\3;^*_P#.T_PE
M?Q>%M+3=D0K8((IT'UN_M3?\#K^G7XH>/M'^%/PT\1?%'Q"3_9_AO0KO5;[!
MQ^YMX7F?GM\J&OXV?'7C'7/B)XVUCX@>)KGSM2UW5;C4-0F_OSS2M)(WXLQ-
M?V%]$3(57S[,<XFOX5.-*/K4ES.WFE32])>9\_G]6U*%/N[_ '?\.95%%%?W
MD?+A1110 445]&?\$E?V;%_:P_X**?"OX/7VGBYTN3Q-%J>O1.F4:PL@;N='
M[ .D)B^L@'4UYN<YIALCRC$9CB':G1A*I+TA%R?X(NG"56HH+=NQ_1K_ ,$@
M_P!DN/\ 8P_X)[_#OX07^E"UUVYTA=:\5@IB0ZG>8GE1_5H@R09_NP+7TO11
M7^.&=9MB\^SC$9EBG>I6G*<O63;?RUT\C]"ITXTJ:A'9*P4445YA84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?&_\ P7G_ &+X?VV_^"9_CWP9I>FBX\2>$K0^+/"1"9?[98H[O$@[M+;&
MXA _O2J>U?9%))''+&T4J!E8$,K#((/8UMAZ\\-7C5AO%I_<#5T?PP45[W_P
M5#_98?\ 8M_;_P#BG^SC;V)M]-T+Q5-+X?C(X_LNY NK+GOBWFB!([@^E>"5
M^U4JL*U*-2.TDFOF<X4445H 4444 >U?\$X_VB6_9._;O^$_[0LMZ;>S\->-
M[&;5Y0V/^)?)((;Q<]LVTDP_&O[-@01D'(/0U_"_7]F'_!-'XXR?M)?\$_?@
MY\;+NZ\^\USX>Z8^JR[L[KZ.!8;KG_KO'+7PO&>'_A5UYQ?YK]32F^A[A111
M7PIH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'QA
M\?/^"+/@_P"/_P"T;XA_:AOO^"AW[57A'Q'XB@CM)H/AY\68]$L[2QB9FAL8
M8[:S!6"-G=@K,S%G9V9G=F/HO[%/_!-GX;?L5:WXL\66WQ]^+OQ4USQA9VMG
MJ&O?&KQRWB&\MK2 S,MK;R/$GE0LTSLZ<[R%S]T5]%44 ?,OP^_X)F>&_@S\
M,=4_9V^!G[2_Q'\'_"O4YKUH? &DS::\>CP7<CR7%GI]Y/9O=VEL[22D*)6>
M+S&\F2'"[=;]IC_@G'\)/V@?V6O"/[(?@SX@^-/A1X4\$:MI%UH!^%FNG3+F
M&WT\%(;,R%7+0E2"0<MO2-\EEY^A** /'_VF/V+OAM^TKXS\$?%VY\2Z]X2\
M?_#:_N+KP/X\\*30)?Z<MS%Y5U;,MS%-!<6T\8"R0RQN"%!78P#";X:_LD>'
M_"?QI;]I/XD_$+7/'GCZ/P\VA:7KWB"*TACT;39)5FFMK*WM(8HXA-)'&\DC
M"29_*13)L147UJB@#SSXF?L_:;\6_B_X)^(GC7Q)/<:-X$GN-2TKPD( +:XU
MEE$<&HSMG,C6T1G$,> JR3F4Y>.$QY/[9W['OPY_;9^$%O\ "SQ_JFH:5<Z/
MXDT[Q)X3\2:08_MFA:U83B>TO81(K(S(P*LCJ59'=3C=D>LT4 >'?LP?L2Z-
M\ OC-\2OVG?&7CZX\8?$OXKW&G#Q5XCDTY+*V@L["W\BSL;.U5G^SP1J69MT
MDCR2.S,Y^4+[C110!\H_\%P_BO\ \*=_X)4?&;Q''<^7-J7A<:'" <%_[1N(
MK%E'K\EPY/L#7\JM?T4?\'5GCO\ X1G_ ()O:-X4AFQ)XD^)^G6KQ@_>BBM;
MRX8_0/%%^8K^=>O]%_HH99'">'-;%->]6KS=_P"[&,(I?>I?>?(Y[/FQBCV0
M4445_3IXH4444 %?KK_P:1? O_A(/VAOBC^T7?6>Z+PQX4M=#L9'7CS[^<RN
MR_[2QV6T^@F_VJ_(JOZ*/^#5CX4?\(3_ ,$Y]6^(MU;8G\:?$.^NH9BN-]M;
MPP6J+[@2Q7'_ 'T:_"?I(9U+)_"?%Q@[2KRITE_V])2DOG",E\ST\GI^TQT?
M*[/TPHHHK_,$^U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /YVO\ @\)_9]_X0O\ ;&^'7[1N
MGV/EVOCKP1)IMY(J\27NFS_,Y/J8+RV7Z1?6OR$K^D+_ (.]_A*/%_\ P3R\
M(?%6TM=]SX.^)EL)I-O^KM+NTN8GY[9F6V%?S>U^K<-5W7RB%]XW7W/3\+&,
M_B"BBBO>)"BBB@ K^H#_ (-5OBQ+\1_^"2FC>$Y[GS&\"^-]9T, MDJKRIJ
M!_\  _CV^E?R_P!?OS_P9G?$"34?@G\<OA6UQE=(\4Z/JJ0D]#>6UQ"S#Z_8
M5'X"OF^*J7M,HE+^5I_I^I4/B/VGHHHK\O-@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\<?^
M#O?Q1-:?##X'^"UFQ'J&O:Y>M'G[S6\%G&#^'VD_G7X:U^R?_!WUK4D_Q!^!
M7ATD[;71M?N1Z9EEL5/_ *)%?C97^HWT=,.L/X/9;WE[63^=>I;\$CXG-W?,
M)_+\D%%%%?MQYH4444 %?U3?\$,? @^'?_!)WX+:&8=C77AN;5&XY;[;>W%V
M#^4X_#%?RLU_7G_P3IT >%O^"?WP.\/%-K6GPB\.1RC_ &_[,M]Q_%LFOY)^
MEYBY0X1R["WTG7<O_ *<E_[>>]D$;XB<O+]?^ >RT445_ )]4%%%% !1110
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M\?/X\V3UEY?DTRH_$?T=T445^1FP4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^%'_  =X-GXX
M?!A/3PIJA_\ )F'_  K\?J_9'_@[YT;R/B+\#/$&W_CZT37K?/KY4UDW_M:O
MQNK_ %0^C].,_!_*FOY:B^ZM41\1FW_(PG\OR04445^R'G!1110 5_8?^QI&
M(?V0/A3"IX7X;:$!CVT^"OX\*_KZ_P""?.L+X@_8*^"6N+(&^V?"/PW,2#GE
MM+MR?U-?QU],"$GD>53Z*I47WQC_ )'T'#_\6IZ(]>HHHK^$#Z@**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \=_X*(Q0S?\$_OCI#<N%C?X.^)UD8] ITJYR:_C!K^R'_ (*M
MZT/#_P#P3&_:#U+S-A/P9\20HV>C2Z;/&/QRXK^-ZOT'@Q?[-5?FOR,JFX44
M45]F0%%%% !7ZK_\&?JNW_!33QD57('P0U/<?0?VOH_]<5^5%?KC_P &=6BR
MS_M\?$GQ"$REK\()K9F]#+JNGL!_Y!/Y5Y.>M+**WH./Q']%]%%%?D)N%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'AKF> @KS=-SBNKE3:J12\VXV^9V9?5]AC(3??\ /0_JLHHHK_),^\"BBB@
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M  ZP?G%GWF Q"Q6%C/KL_5?U<****_-CL"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KXX_X+S?MDVO[%?\
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MV4MI?G_P=C]\:***_P Y#Z\**** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?GY_P '#G_!."Y_;;_9(_X6K\,M"^T_$+X7I/J6E0P1
M9FU/32H-Y9#'+/M19HQR2\111F4FOT#HKZ'A3B7,N#^(L-G& =JM&2DNTEM*
M+\I1;B_)F->C#$473ELS^*>BOT0_X.&?^"85S^Q3^TO)\?/A9X;\GX9?$J_D
MN;-;:+$6C:LV9+BQ('"(_P TT(X&TNBC$)-?G?7^N'"7%&5\9</8?.,OE>G6
MBG;K%[2A+^]%WB_-::'P=>A/#UG3GN@HHKI?@]\'/BA\?_B3I/P@^#/@B_\
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MX96&58'((]:6OQ^\)?%3XF^ F5O!/Q"UK20ISLT[4Y85/U56 (]B*](\._\
M!0/]K#PZ%C'Q.-]$O_++4=-MY<_5M@?_ ,>KXO%^$6;4W_LV(A-?WE*+_#F_
M,_7<L^E-PQ6BEF&!K4G_ ''"HOO;IO\  _3FBOSWTK_@JG^T/9874?#7A6]7
MN7L)T;\UF _2MFV_X*T?%)!_IGPL\/R<?\LIYTY_%C7BU/#'BR#TA%^DU^MC
MZZA](SPPJJ\JU2'K2E_[;S'W?17PA/\ \%:/BDQ/V7X6>'T&./,GG;!_!A6-
MJG_!53]HB]5H]/\ #7A2S!^Z\>GSNX_%IR/THI^&/%DWK"*]9K]+A7^D9X84
MHWC6J3]*4O\ V[E/T(ILTT5O$T\\JHB*2[NV H]23TK\R/$?_!0+]K#Q&C0M
M\3S8Q-_RSTW3;>$CZ.$WC_OJO-?%WQ0^)/CYL^./'^M:N,Y"ZEJ<LR@^P=B!
M^%>UA/"+-:C7UG$0@O[J<G^/+^9\AFGTIN&:,6LOP-6J_P"^X4U^#J/\#]./
MB'^V#^S?\,5=/$?Q6TR6X3/^A:7)]LFW?W2L.[8?][%?/OQ3_P""L4"B2P^#
M/PW9CR$U+Q%)@#W$$3<^Q,@]Q7Q917VN6>%_#F!:EB.:M+^\[1^Z-OQ;/R#B
M/Z2''V<1=/ \F%@_Y%S3M_CG=?.,8L[?XL_M&_&CXW7#/\1?'EY>6Y?<FG1M
MY5K'Z8B3"Y']X@M[UQ%%%?H.&PN&P=%4J$%"*V44DON1^%YAF689MBI8G&UI
M5:DMY3DY2?JVVPHHHK<X@HHHH **** "BBK.CZ/JOB'5;?0]"TZ:\O+N98K6
MUMHR\DKL<!54<DDTI2C%-MV2*A"=2:A!7;T26[8W3=-U#6=1@TC2+&6YNKJ9
M8K:V@C+O*['"JJCDDD@ "OU&_8\^%?Q(^$'P3T_PI\4/%4NH7X_>163L'73(
MB!MME?J^WOR0"=J\ $\1^Q7^Q!I7P*LH?B'\1+>&\\7W$68TR'CTI6'*(>C2
MD'#..G*KQDM]%5_/7B'QGA\[DL!@TG2@[N=OBDOY>R7?[7IO_=_@/X28[@^F
M\\S9RAB:L;1I)M*$'9_O$MYNR]UW4.OO?"4445^6G])A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^_MA_L->'?C];R^-_
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M/JV4T%"_Q3>LYM=92W?DE:*Z)!1117BGUX4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R'
MQ4^ WPC^-5A]A^)/@:RU%@FV*[9-EQ"/]B5,.H[X!P>X-?+GQ9_X)02+YNI?
M!3XA!AR4TOQ"N#]%GC7\ "GU;O7VE17T.3\59]D5EA*S4?Y7K'[GM\K/S/@^
M*_#/@GC-.69X2+J/_EY'W*G_ (%&S=NBES+R/R9^)G[,_P =OA$TC^._AGJ=
MK;1$[M0AA\^VQZ^;'N0?0D'VKA:_: @$8(KSKXA?LE_LZ?%!Y+GQ;\*-+:YE
MY>\L8S:S,?[Q>$J6/^]FOTS+/%V-E',,/\X/_P!ME_\ )'\[\1?18G=SR+'Z
M=(5E_P"Y(+_W'\S\I**^[_'/_!)WX::H[3_#WXDZMI#'D0:C;I>1CV&#&P'U
M+&O)_%__  2R_:!T0M+X7US0-;B'W$CNWMYC]5D4(/\ ONON,%X@<)XU*V(4
M'VFG'\6N7\3\:SCP,\3LG;<L ZL5UI2C._I%/G^^*/FBBO4O$?[%/[4_A?<=
M1^"VK3!>^G".\S]/(9ZXO5OA;\3= )&N_#K7K(K][[7I$T>/^^E%?2X?-,LQ
M:O0KPGZ2B_R9^?8[AOB++';&8.K2?]^G./YI&#12O&\3F.1"K \JPP125W'B
M[!113HH99Y!%!$SL>BHN2:-@2;=D-HKH-$^$_P 4_$K!?#GPU\0:@3T%EHT\
MN?\ OE37:^&_V(OVJ?%#JMA\&M3@#=6U)XK0 >I\YU/]:X,1FN5X17KUX0]9
M17YL]O \,\29HTL'@JM6_P#)3G+\DSRJBOIWPG_P2K^.^KLDOBKQ3X>T>(_?
M07$EQ,O_  %4"'_ONO6_!'_!*/X1:1LF\=^/=:UJ1?O1VB1V<+?4?._Y.*^:
MQOB#PI@E_O'.^T$Y?C\/XGZ'D_@3XG9PTU@72B^M6486_P"W;N?_ )*? ]>C
M?"W]DS]H'XP&.?P=\-[X6<F"-2U!?LUMM_O!Y,;Q_N;C[5^C_P .OV9/@)\*
M?+E\#_"W2;6XB^Y>S0>?< ^HEE+./P-=W7PV9^+LFG'+\/;^]-_^VQ_^2/V?
MASZ+$$XU,]Q]^\**_P#<DU_[C^9\=_"+_@E'H]D\>I_&WQXUZPP6TK008XL^
MC3.-S#V54/O7T_\ #;X._"_X0:9_9/PV\$6&DQ,H65[:'][+C_GI(V7D_P"!
M$UTM%?F6;\3YYGDO]LK-Q_E6D?\ P%67S=WYG]$\*^'7!G!D%_96#C"?\[]Z
MH^_ORO)7[)I>04445X)]L%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 0W6FZ=??\?MA#-_UUB#?S%9\_@'P+=-NNO!6DR$9P9-
M-B/\UK6HK2-6K#X9-?,PJ8;#5OXD$_5)F5'X%\$1((XO!VE*HZ*NG1 #_P =
MK0M+"QL(_*L+.*!/[L,84?D*EHI2JU)_%)OYCIX?#T7>G!+T204445!L%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BMK*SLA
M(+.TBB\V5I)?*C"[W/5CCJ3W/6I:* *^IZ3I6MVAL-9TRWNX"P8PW4*R(2#D
M'# C((!%6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BODW_@K%_P
M5B^'O_!)[X>^$OB%\0OA-K/BV'Q9K,^G6]OHU[# T#1P^:78R\$$<<5\-_\
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M[P[X6A\1ZSX46SN!);:9+(D:7!E,8A;+R1@HKEU$B$J P) /1Z*** "BBB@
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M0< 'I-%5M9UG2/#ND77B#Q!JMM86%C;/<7U]>3K%#;PHI9Y'=B%154$EB0
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MEMIW@F""9$9E$B, X&UL94L""0#T"BBB@ HHHH **** "BBB@ HHHH ****
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M?!+Q#XZT?P>+S_A/O TEW%INO>'7LEW7T$T,@=#-;KB1XPXW1$.A?(!^?_\
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MUW1?$W[ ?P1USP]JMO?6<_PE\.F&ZM9@Z/C38%."..""".Q!!Y%>QT %%%%
M!1110 4444 >8_MG?\FM^-O^P*W_ *$M?E;7ZI?MG?\ )K?C;_L"M_Z$M?E;
M7] ^$?\ R)*__7S_ -MB?PS]*;_DK\%_UX_]R3"OK;_@DI_R43Q=_P!@6#_T
M=7R37UM_P24_Y*)XN_[ L'_HZOJ./O\ DD<5Z+_TJ)^;>"/_ "=/+/\ %/\
M]-S/NJOP@_9@U2__ ."6'_!5+0OVQWO)+;X1?M4_&SXD_#KXB%W(MM*\0V?C
M?68M)N6Z+&IC6"-<\+&MZYK]WF944N[  #))/2OS"?\ 9#\ _P#!5+_@B_\
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MT&3XAV6I^,K+6(I-%CN[O1(88;9=05OLTDWF21*T:R%D,\08*9%! /<_'?\
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MDZ=K%B4$R13Q?)<0D.I64!<_,-HQS\T?\&K4<</_  1B\!PQ*%5/%/B8*HZ
M#6;JN#_X-W?B]\"=$^*O[97PJ\.^-5MKG_AI[Q-KNFZ-K$MRNH0Z&%A2.]N5
MN_\ 2(HSMVF6XVL7!#$OD5VO_!J=K.DZM_P1J\&1:9J4%P]KXN\21W*12AC$
M[:K<2*K ?=)1T;![,#T- 'Z.4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 > ?M^_\$T_V7_\ @I7X/\/^!_VH-*UF[L/#.I2WVEKH
MVL-9LLTD?EL6*@[AM[5\N?\ $*C_ ,$D?^A/\=?^%M+_ /$5[]_P5'_X*C^
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MCX1\.Z7X0\)_L_\ @G2])T/6O[8T72].\*6<%OI^H['C^V01I&%BGV2.OFJ
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MR6F3<+DCR8XCYDC1A'"^)?M*?%3]E/\ 8D_X+N_$/Q%_P5/^#WA6Z^&?Q_\
MAYX;D^'GC_QEX2BU;3-%U/2;=[6XL?,FA?[.)&ED=V &,V[. KAE /O+_@GY
M_P %'? W[=EU\1?AY/\ #G5? GQ(^$/BDZ!\2O 6LW<-S)IER3((IH;F$^7<
MVTODR[)0%+>4WR@;2WT=7S%_P3W\6_\ !/[XD>(_''CK_@G=\!? &F>$S]BL
M]7^)G@#PA:Z7:>)M10SM):1RP6\9OEM4:,M,&>,/=F-2724+].T %%%% !11
M10 4444 %%%% &)\1_\ D1M3_P"O8_S%>%5[K\1_^1&U/_KV/\Q7A5 !7?\
MP!_Y#&H?]>R_^A5P%=_\ ?\ D,:A_P!>R_\ H5 'J-?E[_P;P6MM:_M0?\%
MX[:W2-4_:\\0(@10,*+V]PH]AZ5^H+,JJ69@ !DDGI7Y(?\ ! /]HK]G_P +
M?M._MYW'BGXX^$-+36/VK=?U'23J7B6U@^V6;7MX5N(O,D'F1$$8=<KSUH Q
M_P#@X)^'NE_\$IOBO\*O^"U/[&NBP^$O$UM\0K;PW\6]"T",6MGXTTJYBFG(
MO(4Q'))BVDB,A&\F:)\[H49?MSX^_P#!0KX=?##]OKX _LE>(_V8M;U/4?BY
M)JLO@7XE7AT\6%HEMIOVF[-MB62Z$FQX8G5HH 1,"'< BOC#_@K9XAL_^"\O
MQB^&?_!,G]B&\;Q=\.?#7Q M_$OQW^,&A RZ#HL%O%+"NG07RYANKMX[B<^7
M$S8<0C.%F,7JW_!4W6_"OA__ (+7?\$Y=%EU>RM#;:WX_1;9YU4Q)+I%E# ,
M$\!Y!Y:?WF! R10!]&^,/^"@7BCQ!^UAX^_8R_94^ <?CSQC\+/"^GZSX\DU
MWQ8-"LK8W\;2V5C;R_9KAKBZEB4O\R1PH"NZ8'(7Y?\ ^"B/[;OPO_X*._\
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M#YNY/D9:^FJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /"OVZ?\ @G5^S7_P44\)Z%X+_:3T
MS5[JQ\.:C)>Z8ND:LUHRRO'Y;%BH.X;>U?-/_$,-_P $K?\ H4_&W_A92_\
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M9A(JJJOOFB9MP5$4'.0%4=A7=T4 ,MK:WL[>.TM($BBB0)%%&H544#   X
MXQ3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mdt-20221028_g4.jpg
<DESCRIPTION>IMAGE 8
<TEXT>
begin 644 mdt-20221028_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT444 %%16E]8Z@CR6%Y%.L<KQ2-#(&"NK%64XZ$$$$=01BI: "BBB@ HHHH
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M6/B#\9/#N@7'B?Q?I>H:6(M%^QP(T]S8Z;ES);0V\0?R0<JXB"[(R^5^E/\
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M&Z,:YVRM!LD=$)7S6=4. I^GJ* /R,_85_X(G_MM>(?^"5&N?\$G/^"@%YX
M\-> +>+4W\.:EX,NY=4U>YU*:]^W6EY*TB)%!#;7!9]D9\RX!5&:%5<3<]X=
M_P""9/\ P5N\%_\ !&_5_P#@B%I_P=\ WL=WK<]EI?QH'Q $>E0Z'/J_]J2O
M)9&#[9Y^]I8@BQE0LF=QVX;]E** /GG_ ();_P#!/7X??\$P?V,/#'[)G@/6
MGU>73#+>^(O$$L'E-JVJ3MNGN-@)V+PL:+DE8XHP2Q!8_G/_ ,$J/^".G_!2
M/_@DY^T[XL_;6M_ G@WXDK\2;76--\0?#?2?%JV&IZ/!+?Q7=G<QW5P@M;AS
MY3)+%O0()%*O(00/V>HH _,[_@F?_P $:?C#X*_X*1?$S_@L%^W<^@6WQ'\:
M:G?/X(\!^'-1:_@\*VMPOD;I[LH@GN1:J+8>6OEA&D;),@6/P?\ X*0?\$(_
M^"@_PX_X*G0?\%:?^"0WBCPU)XBU#5QJ^M>$M?U%;1H=0>$PW>#)B*XM+J,R
M&5&D20--)MX*E/VIHH ^<_V(O#'_  41\3W+?&S_ (*):]X+T+7#I)T[1/AI
M\+KBZ?2=/1WCDFO+V:XD8W=X[1(B!?W=O&'"%VGD:OD+_@Y)_P""4/[;?_!6
M;3/AC\/?V8M*\$V>E>"+O4-0U+5_%7BB6VDN)KE(8UACACMI.%$3$N6&2X '
M!-?J310!Y9^Q+X.^*WPU_9-^'OPL^-?A;3=(\2>$_"&FZ)J4&D:P;ZVE>TM(
MH#-'*8HSM<H6"E 1G!SUK<_:0U#X_P"F? WQ+=?LL^&O#^K?$(Z:T?A.T\5Z
MB]KIHNV(59;B2-'<QQY,A15R^S9N3=O7MZ* /YW-%_X(3?\ !T;X6\4>)_&7
M@S_@H%IV@ZAXS\03ZYXHE\/_ !DU:P74=0EP'N)$M[5%+;551QA4154!5 'Z
ML?\ !$;]B;]K#]B#]E7Q#H7[<?Q3;QU\5O&'CN[U_P 2^)&\27&K2W,?V6UM
M+:(W5TJR/LAM5PIPJ[B!Q7V710!\6_MP_!'_ (*1?\%#?!>I?LQ>![W0_P!G
M[X6^(HGLO&OBV^U5=7\7:KI[C$MG:6EH39V22IN1Y6NY7*N0$7D-[?\ L)_L
M(?LX_P#!.?\ 9XTO]FG]F/P@VFZ%8.T][>7<@EO=6O'"B6\NY0!YLS[5!( 5
M55415154>QT4 ?A__P %<_V:?^"PWP%_X*V>%?\ @H3\(OVIYKCX<:W\2_"7
MASP1X,M/%EU$[M=R06TVCG3 ODRQR%+J:1LD-&SR$AU('[@5P&K?LV?#?Q1\
M=-._:$\;_P!H:]KGA^)T\(6VJW>^Q\.M)%Y4\UG;J%1;B52RM<2"28+(\:2)
M&S1GOZ /@S_@O)^R_P#\%0OVX/V>X?V3?V!-6\%^'_#?B:)Q\2/$'B+Q+/9W
MEY; X738%BMY-L,GWIGW NN(\;&D#?FJO_!"C_@Z3U3PPOPTUG_@I/)'X9GL
MAIMSI47QSUPVZV)7RVA$(@"F,1Y7R^%*_+TK^AVB@#RKX_?L<_!K]HS]CS7O
MV(O'>ERKX+UWP>/#ICMBHEM(4B5()HB00)86CBD0D$!XU)!'%?E[I?\ P2*_
MX*?^$_\ @E%X@_X(9Z1X.\#7WAG5?&N^P^.\OBWRK2WT!M5BU1]^E^4US]L,
ML;)Y2EHL2_Z[Y=Y_9>B@#P_]DW]DC0_^"=_["_A_]E?]F30X==E\#>&)HM%C
MUB\%DNM:HWF3237$J))Y GNI'=F57\L2$*K!0#^,WQ#_ ."*_P#P=%^.OVB_
M'/[4&C_ML^%_"7B?X@WT<VO-X+^*^JZ9"8(=RVUHJPVH/D0(Q2-"3M!))+,S
M'^@FB@#\^O\ @A%_P3U_X* ?L96GQ1^(W_!2GX^/\1?B#XVNM)LM,UB?QE>Z
MX]MI-@ERT<(FNT5HP9KR=O+4;?XNIK0_X+W_ +&G[:7_  4?_9"U#]C?]F3X
M?>$8;?5-?TZ_OO%7BOQ@]HJQ6S><8X[>*VE9F,@1<LRC 8\Y%?>M% 'P[_P0
M=_9"_;"_X)Z?L5:'^Q?^T]X#\*!?#6HZG<Z?XG\*^+7O8[F.ZNGN1')#);1-
M&P::1<@L"%4\$X'W%110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<+\4?VHOV9_
M@?KD'AGXU?M$^!?"&I75H+JVT_Q1XNLM/GE@+,@E6.>569"R.NX#&589R#0!
MW5%</\+?VG/V;/CEJUSH'P4_:$\#^,+^SMOM%W9>%O%EGJ$T$.X+YCI!([*N
MY@-Q&,D#O7<4 %%>:>,OVT?V.OAUXIN_ WQ!_:Q^&FA:WI\HCO\ 1]9\=Z?:
MW5LY 8+)%+,KH2"#@@'!'K6[\7/C]\"O@!HMMXC^.OQF\*^#-/O9FBL[WQ3X
M@M]/BG=4+LJ-.ZAB$5G(&<*I8X )H ZZBJVCZQI'B'2;77] U2VOK"^MDN+*
M]LYUEAN(74,DB.I*NK*00P)!!!%4]*\<>#-<\4:MX)T7Q5I]WK&@I;MK>EVU
MVCSV G5GA\Y <Q[U5F7<!N R.* -6BBB@ HHHH **** "BBB@ HHHH ****
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M[.-[^U]H_P"U%X,E^&&FZ@;'4/')UJ-=.MK@7"6WE/*Q 5C+)&H!^]YB$9#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>/_AC\//BK
MIUCH_P 2?!>FZY::9K-GJ]A;:I:K-'!?6DRS6URJL"!)%*BR(W564$<@5NT4
M (Z)(I1U#*PP01D$5YUX>_8__92\)_!"^_9G\-?LV^!K+X=ZH\S:EX&@\+6J
MZ3=M-)YDADM?+\I]S@,<J>57T&/1J* /.?V??V0?V5?V3].N]+_9D_9Q\$^
M8;\J=0'A'PS;6#79'0RM"BM+CMN)Q74_$OX:>!?C%X$U+X8_$SP[#J^@:S!Y
M&K:5<LPBO(=P+12!2-\;8PR'Y74LK JQ!W:* $1$C01QH%51A5 P /2O+?#?
M[$G[*'A'XOCX\>&_@7H=IXICU"\U"UU".%MEI?7BA;N\@@+&&WN9U&);B)%E
ME!(=FR<^IT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 44C,J*7=@ !DDGI6)JWQ(\%:-
ME;G7H7<?\L[<^8<^GRY _&@#<HKS[4_C[IL1*Z1H,TWH]Q*$_0;JPM0^.'C&
MZR+..UM1V*1;C^;$C]* /7J*\*N_B/XYO<^=XFN5S_SQ81_^@@5FSZUK-T2;
MG5KF3/7S)V/\S0!]"R3PQ'$LRKGIN8"F1WMG-)Y4-W$[?W5D!-?.A)8Y8Y/J
M:ZWX*?\ (\Q_]>TG\J ._P!3^,?PBT75I] UGXJ>&[2_M9!'<V5SKEO'-"Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444RXN+>TMWNKJ=(HHD+R22,%5%
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M;OPT^&7Q"^,OCO3/AA\*?!NH^(/$.LW2V^EZ/I5JTT]Q(>RJO8 $DGA0"20
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MS^TY\%-3,VC^(K/=+9S,//TV[7Y9[.<#[LL3@J>S##+E64G^+.OT=_X-R/\
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MZ_ETX)>\M5ZK_-:#B[,_KMHHZ]**_(S<\!_:2_X)V?"K]I3X[^'OVE+[XO\
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MI/(-/N/&?@^T\76OP_NO%>FQ:]?:?/?V6B27T:WEQ:0O%'-<)"3O>)'FA5G
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M)]2S.I32TO=>CU_#8VB[H****\HH**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *YGXR_&7X6?L]?"[7/C5\;/'6G^&O"OARP>\UK6]4F\N
M&VA7N>[,20JHH+.S*J@L0#TU<=\<?V>?@/\ M->"T^''[17P<\,^.?#Z7L=X
MFB>*]%AO[47"*RI+Y4RLN]0[@-C(W'UH ^./AM^W=_P3T^(GQ03]OK]IW]M_
MX-Z3=:!HUW;?"_P/=?$[29[CPGIDZC[3=SQ17#E]6O$1%D6,,8(@MK'N9KAY
MOMO6/B/X3\.?#.Z^+OB6^DTS0K#0GUC4+G4(&A:TM$A,TCRHP#(50$LI (P0
M1D5XEI__  2'_P""5VDW\&JZ9_P3G^"<%S;3++;SQ?#/3%:-U(*L"(>"" 0?
M:O;_ (E?#CP1\8/A]K?PI^)?AV'5_#OB/2Y]-US2;DL(KVTF0QRPOM()1T9E
M(SR"1WH ^</^".G@WQ(O['B_M)?$+2I+/Q7\?/%6I?$[Q!;S#Y[=-5D#Z?;'
MN!!IB6$&T]#$:]R\#?M+_L]?$W6_&GAOX??&OPQK%_\ #G4#8^/;73]:AD?P
M_<!69H[L!OW! 23.[&#'(#RC =AI.E:9H6EVVAZ+816MG9VZ06EK @5(8D4*
MJ*!P%    Z 5YS9?L5_LD:=;_$.SM/V</!H@^+5Z;OXFV[:!"T?B>8A@7O49
M2)\[G)# @M([$9=B0#Y2O/V]?^">/[;GQ9TKQU\4_P!MSX/:5\*/ASXC&H>$
MO#FM_$O2K:?Q9KMJY$>KW<$MP'CL;5P6M(G ,TP%TRA(K8O]C?#[Q]\%/VLO
M@U;>./!\^F>+_!'B:*9;2>YLA-9:K;I,\7F*LJ[9H':,LCX*2(5=2592?)?^
M'/'_  2@_P"D;GP/_P##8Z9_\9KW;0/A]X*\(^ +/X6>#/#EMH?A[3=(32]+
MTG0E-E%86:1"*.&W$&PP*B *GE[2@ VXP* /GKP9H.A?M;_'ZUE\.:+:6GP3
M^!NN-;>&]/L+98K/Q)XNM6,<DZ1J C6>E-NBC &UK_S7P&L8F;\]/VB?C;\7
M-<_90_;[_;L\3?$/6M$^+/P-_:1D\/?";4X]3FB/AS1],N=*2P@MX=WEB"^2
MZF\]"I6Z^T'>'PN/V-^&GPV\"_!WX?Z-\*_AEX:M]'\/^'].BL='TNT!V6T$
M:A44%B2QP.68EF)))))->??$']@W]D?XI_%"7XP^/O@K8:AKEU?Z??:H6O+F
M.SU6[L?^/&YOK))5MKZ:WX\F6XBD>+:NPKM& #T?P'K.L>(_ ^C>(?$.D'3]
M0O\ 2;>XOK!@0;:9XE9XN>?E8E>?2M:BB@ K^1/_ (*0?M"O^U3^W;\5/CPE
MX9[37/&%T-(E+9SI\#?9K0?A;PPC\*_J,_X*"?&W_AG+]B#XK?&R&\\BZT#P
M)J,VF2;L?Z:T#1VPSVS.\0_&OY!Z_MCZ(.0Q<LTSJ:U]RC%_?.HOPIGS>?U?
M@I^K_1?J%%%%?VX?-A1110 4 $G %%?2_P#P1[_9H@_:Q_X*/?"WX3ZKI_VG
M2(O$"ZQK\;+E&LK%&NY(W_V9/*6'ZRBO,SO-<-D63XC,L1_#H0G4EZ0BY/YV
M6A=.G*K44%NW8_HR_P""2_[(T'[$_P"P'\/?@I=Z<+?7&TE=6\693#MJEWB>
M=6]3'N6 '^[ M?1]%%?XX9SFN,SW-L1F.*=ZE:<IR?G)MOY:Z=D?H5.$:5-0
MCLM HHHKS2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^+_ /@OU^QM:_MG?\$Q_'WA[3])^T^(_!5H?%WA
M5D3=(+FQ1WEC4=6,MJ;F(+W:13V%?:%,G@@NH'MKF%)(Y$*R1R*"K*1@@@]0
M1VK?#5YX7$1JPWBT_N!JZ/X8J*]T_P""F?[+R?L8_M\?%3]FRSMFBT_PYXLG
M_L-''(TV<+<V6?4_9IH<GUS7A=?M-*I&M2C4CLTFOF<X4445H 4444 ?67_!
M#;]HF3]F3_@JG\'/'DVH?9]/U3Q2GAW5RS8C-MJ2M9$O_LH\T<OL8@>U?UW5
M_#/I&K:EH.JVNN:/>/;WEE<)/:W$1PT4B,&5@>Q! /X5_;-^SG\6]/\ C[^S
M[X&^.>E%/LWC+P?INN0",\!;JUCG _#?C\*^!XRP]JM*LNJ:?RU7YLTIL[*B
MBBOB30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH _/C_@YO^*/_"OO^"5NM^%TN?+?QKXOT?15
M ."P29K\@?A8G/M7\UU?NC_P=Y^.7L/@]\%?AHMP0NJ^)=7U-X@>";2WMX@Q
M'M]L8?B:_"ZO]+?HOY;' ^%%*NE_'JU:GW2]E_[C/C<ZGS8YKLDOU_4****_
MH<\D**** "OV$_X-&_@3#K/QC^+'[2.HV.?[ \/V7A_3)G7(+WDS3S[?1E6S
MA!/7$V.YK\>Z_HZ_X-;_ (4Q^ _^"9?_  G<EH%F\;^/-3U(3E>7AA$5BJY]
M ]K+CW9J_!?I*9U+)_"C%4X.TL1.G27SESR7SA"2]&>ID]/VF.B^UW_7WGZ/
M4445_F*?:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '\ZG_!X%^SO'X#_ &T? '[1NFV@CMOB
M#X*>QO65?];?:9,%=R?7[/=6B_\ ;.OR*K^CO_@[\^#7_"9?L!^"OC)9VN^Y
M\%?$>**>3'^KL[VUFCD.?>:*U'XU_.)7ZMPU7=?**=]XW7W/3\+&,M)!1117
MO$A1110 5_6)_P &Z?Q:/Q=_X(_?".\N;GS+O0+._P!!NP3G9]DOIXH5_P#
M<0'\:_D[K^CS_@S]^(;^(/\ @GMXX^'ES+ND\._%:YDA&?N07-A9LHQ_UTCF
M/XU\OQ;2Y\K4OY9)_FOU+AN?K)1117YF:A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X/_P#!
MW7XHGN_VB?A!X*:3,>G^"K^]1,]&N+L1D_B+9?RK\AZ_43_@[+U>2Z_X*%>"
M]'&?+M/@]8L ?[SZIJ>?T5:_+NO]6_ O#K#>$N4P76FY?^!3E+]3X;,W?'U/
M7] HHHK]9. **** "OZNO^"+_@=?A[_P2P^!^@+ (_M'@>#4]H&,_;7>\S^/
MGY_&OY1:_L'_ &'="'AC]BKX/^&@FT:=\+O#]MMQT\O38$Q^E?R']+W%RAPO
MEN%Z2K2E_P" 0:_]O9[^01O6G+R_7_@'J-%%%?P.?4A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'Q/_P<4> /^%B?\$<_C+810;Y],T_3=5@8#)3[+JEI,Y_[]+(/H37\F]?V
M/?\ !6/1!X@_X)A?M!Z<8PY7X-^(YU4CO%IT\H_'*"OXX:_1>#IMX&I'M+\T
MO\C*>X4445]>0%%%% !7[N?\&8/BR6;0/VA/ TLOR6UYX9OX$SU,J:G'(?\
MR%'^=?A'7[2?\&9^J/#\=/CCHHDPMQX3TB<KZF.ZG4'_ ,BG\Z\/B2/-DM7Y
M?^E(J/Q'[^4445^3FP4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGFW%TV/_ "%^E>+Q$[9-6]%^:*C\1^^]%%%?DIL%%%% !1110 4444 %%%%
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M%-3DR>:[M+\;_H5#XC]4J***_+38**** "BBB@ HHHH **** "BBB@ HHHH
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M9B8<D<?M_7Y?Q5BO;YHX+:"2^>[_ #M\C6"L@HHHKYLL**** "BBB@ HHHH
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MRPC@X/5ZR].B_7Y(T@NI)1117P)H%%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7\^O$_ACQ#X+U^Z\+>*]'N-/U&RE,=U:7495XV'J/U!Z$$$<&OV1KS']H_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Q/Q;_ &=?@W\<+0P?$?P-:7DX3;%J,:^5
M=1>FV5,-@?W22OJ#7RU\6/\ @E#JUKYNH_!;X@QW2#)32]?79)CT$T8VL?8H
MH]Z^VZ*^CR?BW/\ (K1PM9\G\K]Z/W/;Y69\!Q7X7\#\9WGF6$C[5_\ +R'N
M5/G*-N;R4N9>1^2/Q)_9[^-7PBE=?B%\-]4T^&-L&]-OYEL?I,F8S_WU7&U^
MS[HDB&.10RL,,I&017F7Q#_8V_9K^)KO=>(OA7I\-T^2;S2@UG(6_O'R2H<_
M[P-?IN6>+M)I1S##M><'?_R65O\ TIG\Z\1?18Q$6YY%CTUTA65G_P"!P33_
M /!:]3\K:*^Y_'7_  29\#WV^X^&_P 4M2TYNJV^KVB72$^@=/+*CW(8_6O)
M_%G_  2\_:0T+=)X?N=!UQ!]Q+343#(?J)E10?\ @1^M?<8+CWA3')<N)47V
MFG'\6K?B?C>;^"/B=DTGSY?*I%=:3C4OZ*+<OOBCYPHKTCQ!^Q_^T[X99EU+
MX(Z_)L/S&PL_M8_. N#7&:SX&\;>'',?B'P?JM@R]5O=/DB(_P"^E%?28?,<
MOQ?\"M&?^&2?Y,_/L=D.>Y8VL9A:E+_'"4?S2,JBBBNP\D*** "3@#)/0"@
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M_M+3O[._M?[?#]D\GSOM7FCR_+QNW[LXVXYSTQS7+? GXU^$OVB/AAI_QA\
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MDGT^Z&HVL=I/#>78!ATW["Z,S&Z>(/&$,6\G:/>?$'PR\)?M_?\ !4O]G_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1VEU;WUK%>VDH>*:-7B<=&4C(/Y5)0 4444 %%%><? #]KC]G7]J35_'&A?
M7XFVWB*[^&_C"Y\+>-88+.XA.F:M;\36Q,T:"3:>/,CW1D@@,2#@ ]'HHHH
M**R?'?CWP3\+_"&H?$#XC^+=.T'0]*MS/J6KZO>);VUM&"!N>1R%49(')Y)
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M&G:;';?$?X?>(;^.PU;P_J\2!+N&:UG*RK&)5?9)MVLOHP95_,S4ZVX_9Q^
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M/@EXF\.3_P#!TA\9]$AURT:\7]E[1HFM5N%,@D74+:1EVYSN"21L1U <'H:
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M?BO5/B==ZA;Z9>^(K@WQ@7P_;:I<873H=D#W$LD3+.YC1(WB.UG /9/V:O\
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MM!%;%Y9'/14C3)8] OM7H'_!##QU\>_VMOA!;?\ !2K]MS1VT/7[#P)!\/\
MPTNKR&,Q6&F2?\3G6)?,"^3+?:C"?-!X5-+AYQ7RQ_P0\\">(?VG?^#;']HS
MX#?!'5(;[Q5XAU/QUINF6%M<KYDEQ=:=$8(&Y^03!@@)P"'STS0!]Q?M _\
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M1TH ]<_X+U_ +]HW]I;_ ():_$CX6?LLZ3)JWBJ0:??GPU"3OUZRM;Z&XN;
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MT;![,#T- 'Z.4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW_!4W6_"OA__ (+7?\$Y=%EU>RM#;:WX_1;9YU4Q)+I%E# ,$\!Y!Y:?WF!
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M[0_[1_A*STGQAKME=KJ9TZW\FVU$07L]O%J$*=%CN8XDG&WY#YNY/D9:^FJ
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MG^*_"?A7QWX<O?!WCCPSI^LZ1J,#0:AI6JV27%M=1'JDD4@*NI[A@16%X>^
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LH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>mdt-20221028_g5.jpg
<DESCRIPTION>IMAGE 9
<TEXT>
begin 644 mdt-20221028_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ? ?\ P<.?\%<]8_X)
M/_L>V>M?"B"TF^)_Q#OYM)\"_;HA+%IXBC5[K47C;B40+)$JH<J99XBP9 RG
MQ#_@WS_X)M_"W]H_]CS3?^"C7_!1/PM:_&[XK?%VXO+^+5_BK;IK@TC2DN9(
M((+:*[$D4/F")IBR*"$F2,;53;7S7_P?$_#KQA,_[//Q:AMII= MQXATBXF
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MWBKQKJ%AKFA:8GEVTUI?Z+_:,T9C3 "1W)6<*  IA7L,5U/[+?[6/QX^,_\
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M=:V\N.&O;J9$EAM\ABMN&8+&YD7[M_9I^#7P5_9A^#WA[]E?X%6]I9:'\/\
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MTO2HK#PEY\8=5U.\GCM8)2C<.(FE,Y4\,(2#UK\=_"7P.\(>,/\ @U2\4?\
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M31OAQX*T^)I;SQ/XAN<I9:?!&GSN7?YG*@E(DD?!VXH _%'_ (- ?C/^U/\
M"G]NOXP?\$YO&_B*\U'P7X:\-ZE?:AI3W;SVFBZU8ZI;63/;%N(UF\^8,J@>
M88T8CY#7]#M? G_!"_\ X)96_P#P3!^".H^.OVBO$NG7OQU^-6LC4?'VI/=1
MX2Z837*:3;-G$IC#7$LA3/F/YC#='&A'WW0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XQ^WY^PE\"?^"CW[
M,&O_ +*_[0FE32Z-K 2:QU*R*K=Z1?1Y,%[;.P(65"2.00R,Z,"KL#\5_P#!
M,?\ 92_X*O?\$:_ASJ?[($/PD\,_M$?">VUFYU#P#KWASQK!H.L:.D[EYK:X
MM-1 A,;R%I@(YV*/))\SAP$_3NB@#\E?VA/^"+/[7G_!9/\ ;D\-_M-?\%0S
MX>^'7PC\"6HM?"?P7\)^(VU;4KV+S!+-]MODCCAA-PX3S&@+MY<21KL9?//U
MI_P5V_X)3?#O_@IW^PA/^R-IM_8^$M0T&XM=1^'.I166+72+ZUB>&&)HHP,6
M[0R20,J#Y%<,JDHJGZVHH _';_@DU^QO_P ')/[%7PWA_84U[Q!\%M&^%VFW
MDZZ3\0]:N9=:U+0K665GE&EV\4D8G.YWDBCO8PB,_P Q*#RJ^Z_^"K/_  3^
MUO\ X*%_\$V_&G[$WASXB_V?K>L:9IYT3Q%KV9%DO;&Y@N8C=&-<[96@V2.B
M$KYK.J' 4_3U% 'Y&?L*_P#!$_\ ;:\0_P#!*C7/^"3G_!0"\\ >&O %O%J;
M^'-2\&7<NJ:O<ZE->_;K2\E:1$B@AMK@L^R,^9< JC-"JN)N>\._\$R?^"MW
M@O\ X(WZO_P1"T_X.^ ;V.[UN>RTOXT#X@"/2H=#GU?^U)7DLC!]L\_>TL01
M8RH63.X[<-^RE% 'SS_P2W_X)Z_#[_@F#^QAX8_9,\!ZT^KRZ89;WQ%X@E@\
MIM6U2=MT]QL!.Q>%C1<DK'%&"6(+'\Y_^"5'_!'3_@I'_P $G/VG?%G[:UOX
M$\&_$E?B3:ZQIOB#X;Z3XM6PU/1X);^*[L[F.ZN$%K<.?*9)8MZ!!(I5Y""!
M^SU% 'YG?\$S_P#@C3\8?!7_  4B^)G_  6"_;N?0+;XC^--3OG\$> _#FHM
M?P>%;6X7R-T]V403W(M5%L/+7RPC2-DF0+'X/_P4@_X(1_\ !0?X<?\ !4Z#
M_@K3_P $AO%'AJ3Q%J&KC5]:\):_J*VC0Z@\)AN\&3$5Q:749D,J-(D@::3;
MP5*?M310!\Y_L1>&/^"B/B>Y;XV?\%$M>\%Z%KATDZ=HGPT^%UQ=/I.GH[QR
M37E[-<2,;N\=HD1 O[NWC#A"[3R-7R%_P<D_\$H?VV_^"LVF?#'X>_LQ:5X)
ML]*\$7>H:AJ6K^*O%$MM)<37*0QK#'#';2<*(F)<L,EP .":_4FB@#RS]B7P
M=\5OAK^R;\/?A9\:_"VFZ1XD\)^$--T34H-(U@WUM*]I:10&:.4Q1G:Y0L%*
M C.#GK6Y^TAJ'Q_TSX&^);K]EGPUX?U;XA'36C\)VGBO47M=-%VQ"K+<21H[
MF./)D**N7V;-R;MZ]O10!_.YHO\ P0F_X.C?"WBCQ/XR\&?\% M.T'4/&?B"
M?7/%$OA_XR:M8+J.H2X#W$B6]JBEMJJHXPJ(JJ J@#]6?^"(7[$G[5W[$?[+
M'B#P_P#MR_%<^./BKXQ\>7>O>)O$TGB2YU>2>/[+:VEM$UU<JLCA(;5<*1A=
MQ XK[*HH _)[_@G-_P $J/VSO^"(G[7_ ,7]8_9H^%ND?&'X)_%<6LNG6%IX
MMM])UWP_):RW+VL4J7H6"=$2\GB9TEW. DFU2/+/=?\ !,?_ ((U?%+X3_\
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MCS7OV(O'>ERKX+UWP>/#ICMBHEM(4B5()HB00)86CBD0D$!XU)!'%?E[I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI\/_ ,]3[E_7Y'\N'@W_ (-_O^"N7C95FLOV0[VQB;K+K/B72[,K]4ENE?\
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M(P/XU^6\1Y7_ &?C.>FO<GJO)]5_EY>AM%W1LT445\Z4%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%8'Q4^(6C_  H^'6L_$;72/LVD6#W#)NP96 PD
M8/JSE5'NPK2C2J5ZL:5-7E)I)=V]$C#%8K#X+#3Q%>2C""<I-[**5VWY)*Y^
M9?\ P=1_M,_%OX=?LL>'OV=_A]X1UV/0_'&HF;QIXJM].E^PQ6MNZM#I[7 7
M8LDTV)"FX-MM\8(D-?S]5_3W\,/^"F^D^)],F\"?M0?#>RU+3+^-H+N\L;-9
M8I8FX*3VLN5D4@G.T].-AKQ']J7_ (-Z?^"=_P"W1HEW\5OV(?'EK\.M?FS(
M]OH2?:-&DE/(6:P8K)9D\ "(QJHR?*8U_;?A'XFY1X59)#A_B# SP\.>4GB8
M?O*<Y2>]1)<T6DE%64G:*]U:L_+LDXTX7\0'[;)\7&=2VM*7N5(V_NO==VKQ
M\S^?*BOI?]M[_@D=^W/^P)=W%_\ &OX13WGAF*3;#XW\,EKW29!G +RJH:W)
M/ 6=8V/8'K7S17]A91G649_@8XS+:\*U*6TH24EZ76S75/5=4>G4IU*4N6:L
MPHHHKTR KZ8_X)8?\$VOB3_P4O\ VDK;X5^'7GTWPKI'EWOCKQ.D>5TVQ+8V
M)D8:XE*LD2'/(9R-L;X\&^%?PP\<_&KXDZ%\(_AEX?FU7Q!XDU6#3M'T^ ?-
M/<2N$1<GA1DY+' 4 DD $U_5C_P3#_X)]?#_ /X)P?LL:3\#O#'D7NO7&+_Q
MKXACCPVJ:FZ@.P)&1$@ CB4XPB@D;F<G\,\=?%:'AOPW[+!R3QV(35);\B^U
M5:_N[13WE;1J,CT\LP+QE:\OA6_GY'K_ ,$_@O\ #3]G?X4:%\$O@]X5M]%\
M->&]/2STG3K8<1QKR68GEW9BSN[99V9F8DDFNIHHK_,.O7KXJO*M6DY3DVY-
MN[;;NVV]6V]6S[1)15D%%%%9#"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N+_:(_9\^$O[57P6\0_L__ !R\)0:WX7\3Z>UIJ=C,,'!P
M5DC;K'*CA71QRCHK#D5VE%5&4H24HNS0'\?'_!5?_@F=\5_^"7G[3U[\%O&S
M3:EX<U(/>^!/%?E;8]8T_=@$XX2>,D)+'_"V&&4=&;YFK^P3_@K-_P $V?A[
M_P %//V2]5^"'B#[-8>)]/W:CX"\22QY;2]35"%#$ GR)1^ZE49RK!@-Z(1_
M(U\4_AAX[^"GQ)UWX1?%#PY<:1XB\-:M/INM:9<C#VUS"Y1T..#R#@C((P02
M"#7ZID&;K,\+:?\ $COY^?SZ^?R,91LS HHHKWB0HHHH *_H,_X-)_\ @HA+
M\2_@]K__  3W^).O&75_ R/K/@0W$F7FT>64?:;9<]?(N) X'79=8&%BX_GS
MKV#]@7]KCQ9^PK^V!X#_ &IO"7FR/X5UR.74[*%\&^T^0&*[MN>/WD#RH">C
M%6["O,SC +,<!.E]K=>JV^_;YCB[,_M HK)\!^./"WQ-\#Z-\2/ VL1:AHOB
M#2K?4M'OX#E+FUGB66*1?9D92/K6M7X^TT[,W"BBBD 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7R#_P5;^+1T[PSH/P7TVZQ)J4QU+5$5N?)C)2%3ZAGWM]8
M17U]7Y5_M@_$U_BQ^T5XF\2QW/F6D%\UCIQ!RH@@_=J5]F*L_P!7-?HOAEE*
MS#B)5YKW:*YO^WGI']7\C\$^D5Q0\AX!E@J3M4Q<E3\^1>]-^C24'Y3/,ZTO
M"?C+Q9X#UN+Q)X+\1WNE7\/^KN["Y:)P.XRIY![@\'O6;17](SA"K!PFKI[I
MZIG^?5&M6P]6-6E)QE%W33LTUU36J9]:_!G_ (*AZ]:V@\*_M#>$HM>L)HS%
M/JFGP(D[(00PE@.(I00<'&SC/#5YQ^TM_P $,?\ @F#_ ,%&])O?B/\ LL>(
M;7X;^+95,LT_A&V461D/>ZTIR@C&<\P^3D\DO7B-7-!\0:]X6U:'7O#.M7>G
MWUNVZWO+*X:*6,^JLI!%?,T.'\5D6.>8<-8J>"K]>1WIR\ITW[K7E;E6_*S]
M\X0^D)Q3DT8X7.HK&T%I>3M52\JFO-_V^FWMS(_/+]NC_@B=^WI^P<UYXB\<
M_#)O%'@ZVW,/&W@T/>64<8_BN$"B6UP,9,J*F3A7;K7R17],'P/_ ."H7Q#\
M*"+0OC7HB^)-/&%;4K55AO47U(XCFX['83U+&L']H'_@D%_P2E_X*D6=WX\^
M$D4?@+QHZ^=>ZEX+@2SE+DC+7>G./*E!8G,J*C,Q_P!::_5\A^D%G&1..'XT
MP5H;?6:"<H>LZ>\?-K=[0/Z9X5XXX+XYBEE&)Y:S_P"7-2T:GRUM*W]UR2ZL
M^=/^#6S_ ()NP6>EWO\ P4<^*NB!KBY-QI/PS@N(_P#5Q@F*\U%<]V.^V0CH
M%N,@[E-?M#7._"+X5>"/@9\+?#WP;^&NC)I^@>%]'M],TBS3_EG!#&$7)_B8
M@99CRS$D\FNBK^,?$?C;&^(/%^)SBO=1D[4XO[%./P1];:RMO)R?4_8<'AHX
M3#JFOGZA1117PQU!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?AM_P=D_\$PK>:PLO^"FOPAT(+-"UMI'Q4MK:+_6(2(K+
M4VQW!V6LA[@V^!\K&OW)KF?C-\(O 7Q^^$OB3X(_%'1$U'P[XKT6XTO6;-_^
M6EO-&4;:?X6 .58<JP!'(%>AEF/J9=C8UH[+==UU7]=1-71_$+17JW[<'[*'
MC7]A[]J_QQ^RSX^9I;WPAK;VT%Z8]@OK1@);6Z4=A+ \4F.V_':O*:_8:=2%
M6"G!W35UZ,P"BBBK **** /Z8O\ @U1_;1E_:(_X)_7/[/7BG5_M'B#X.ZN-
M-C$CYD?1KK?-9,?966Y@ Z!+=/6OT^K^6O\ X-D?VM&_9H_X*B>'/!.LZH8-
M!^*FGS>%=05WP@NY")K%\=W-S$D(/87+>M?U*5^5<28/ZIFDFEI/WE\]_P ;
MFT'=!1117@%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <9^T3\06^%?P.\4>/8
M9O+GL-(E-FY/2X<>7#_Y$=*_)(DDY)R3U)K]!/\ @JAXX;0?@7IO@RWEVR:]
MK:>:N?O00*9&'_?PPFOS[K^A_"C+UA\AJ8IK6K-_^ QT7X\Q_!OTG,\>/XVH
M9=%^[AJ2NNTZCYG]\53"BBBOU$_FT**** "OT&_X)@_!Z/P9\&KGXGZC:XO_
M !3<DP,R\I9PLR(/;<_F-[C9Z"O@KPCX9U+QIXJTSP?HT>Z[U6_AM+9<=9)'
M"+^I%?K]X0\+Z5X)\*:;X.T.'R[/2K"*TM4]$C0*,^^!7Y/XL9N\-E=+ 0>M
M5WE_AC;3YR:^YG]/?1BX6CF/$N(SNM&\<-'EA_U\J75U_A@I)_XT:-%%%?S^
M?W,%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'X;?\'@7[#\,NG^ _P#@H'X.TL"6&1?"7C9HDY9&\R>PN&QZ
M$7$+.?[\"]A7X45_9A_P4D_92LOVW/V&/B9^S+-;1R7GB3PQ,-":7&(M4AQ<
M63DGH!<Q1$_[.1WK^-.ZM;FQNI+*]MWBFAD*2Q2*59&!P5(/0@\8K],X4QCQ
M&7NE)ZP=OD]5^J^1E-69'1117U! 4444 :_P_P#''B3X8^/-$^)/@Z_-KJ_A
M[5[;4]*NEZPW,$JRQ/\ @Z*?PK^UK]G[XP^'_P!H7X$>#/CSX4P--\9^%K#6
M[)-V2D=U;I,J$^JA]I]"#7\1U?U*?\&O_P ?I?C;_P $F/"WAO4+[S[[X>>(
M=2\,7+,WS>6D@NX ?98+R)![1^QKX[C'#<^$IUUO%V^3_P""OQ+@]3]#****
M_/#4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#X._X*R>+#?_%+PQX*23*Z9H<E
MVP!^Z\\I4CZX@4_B*^4*]O\ ^"B>O_VY^UAXA@5]R:=!9VL9SZ6\;L/^^G:O
M$*_K/@["K"<+X2FNL%+_ ,"][]3_ "^\6<QEFGB3FE=N]JTH?*G^[7X1"BBB
MOI3\\"BBB@#WG_@G!X#7QG^T_INI3P;X- L;C4I0PXW!1%'^(>56'^[7Z3U\
M9_\ !)'PGMM?&?CF:/[\EI86[XZ8$DD@_P#'HORK[,K^:/$W&O%\53IWTI1C
M%?=S/\96^1_HA]'7)XY9X:4:]K2Q$ZE1_?[-?A!->H4445^?'[H%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\@^'7]J_LB?"7XKB#<=#^(T^E&0#[JWMA++^1-@/R%?L17YI?\'8'A_^V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*(5CSA !]NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGHOR_$T@NH4445\4:!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSI[6_DM9>ZV>B4445^3G].A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?B%_P=E?\ !3FRTSP[8_\ !,[X1>(=U]?M;ZO\
M4I[67_46ZXEL]-;'\3MLN77@A4M^HD8#]*?^"JO_  4@^&G_  3&_90U;X[>
M+S!?>(+L-8>!?#3RX?5]39"44@<B&,?O)7_A1<#YV16_D4^+'Q4\??''XFZ_
M\8OBEXDGU?Q'XFU:?4M:U*Y.7N+B5R[MZ*,G 48"@    "OK^%LJ>(K_ %NH
MO=CMYR_X'Y^C(G*RL<]1117Z*9!1110 445Z)^R7^S;X[_;!_:4\%?LR_#6
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M_A'=2F^T^3J\/D(/.E@VMMBDS&V\[AP* /M7]LG3-:^$G_!97X ?M=_%:_\
ML/PFT_X7>*O#4WB.^;;IWAW6YS%<+)=2M\EL+F"(PI(Y =X1'G<R!N&_X);>
M,_BG^QM_P3AUWQ7K_P -M1?Q!\5_COXGO?@'\-]7BDLKJ]AU6^DETZW>)UWV
MD!6.XOIG*_N;42S%?EP?O+X2^'/$?P4^!VD^'_C/\:Y_%VH>'=&_XJ'QYKUM
M!8O?^6I:2[G2+$4(V@DXPH"YKR?]EG2-5_::^)LW[?/Q TRX@TNZTZ73/@CH
M5_"R/IWA^1E:75Y(V *76I-''( 0&BLX[6,A'>X5@#L_V5_A3X3_ &>O"K_"
M[5OB/8^(?B'K,\OB3X@ZO)-&E[K>J7&T3WQ@W%XX!M2"&/E88(((5.(Q7K%?
MA%H^J?$.Q_X)N>$/CI+:E/VIIO\ @H$UK?WPC UB37VUF:VFTYV_UA@.E 1M
M ?W?V8*-NP"OW=H **** /DS_@J+\!?^$C\(67QV\/V6;S1 MIK01>9+1V^2
M0_[DC8^DA)X6OA*OV5U[0M)\4:'>>&]?L4NK&_MGM[RVE&5EC=2K*?J":_*;
M]I+X(ZO^S]\6]3^'NH>9);1OY^DW;C_CYM')\M_J,%6_VD:OWWPLXB6*P4LK
MK/WZ>L/.#W7_ &ZW]S78_A_Z2G 4LMSB'$N$A^ZKVC5M]FJEI)^4XK_P*+;U
MDC@Z***_6S^6PHHHH *]&_9B_:)\2_LW?$B'Q?I2O<Z=< 0ZWI@? NH,YX[!
MUY*MV.1T8@^<T5S8S!X;,,+/#XB/-":LT^W];/H]3T,IS7,,CS*EC\#4<*M*
M2E&2Z-?FGLT]&KIZ,_8GP)XY\+_$KPC8>.?!FJI>Z;J, EMIT].ZD=58'(*G
MD$$'I6O7YE?L<_M>:[^S;XI_LO66GO?">I3 ZG8(<M;OT^T1 ]& QN7HX&.H
M4C])?"OBOPYXX\.VGBSPEK$%_IU_");2[MWRLBG^1!R"#R""" 17\N\6\*8O
MAC'<KO*C+X)?H^TE^.Z\O](_"[Q.ROQ&R93BU#%4TO:T[[/^>/5PD]OY7[KZ
M-Z%%%%?)'ZB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<9^T+^T#\)/V6/@SX@^/WQS\7V^A^%_#-@UWJFH7!R0!@+&BCF25V*HD:Y9W
M95 )(J_\7_B_\,_@%\,]:^,GQD\:6/A[PQX>L7O-8UC49=D5O$O?U9B2%5%!
M9F954$D _P N/_!;3_@M3\1O^"I'Q27P?X-6\T#X/>&;]G\+>')6VS:C, 4_
MM&]"D@S,I(2/)6%&*@EF=V]C)\HK9K7LM(+=_HO/_AR92Y4>8?\ !6/_ (*;
M?$__ (*C?M0WGQE\5PSZ7X7TI7L/ ?A5IMR:5I^[.7Q\K7$I >5QU.U0=D:
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M6-AAE(]"#7YF?MC?LJZQ^S9XZW:<DMSX8U21GT6_;DQ]S;R'^^HZ'^)>1SN
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#P]KOA36;CP[XFT>YL+^TD,=S9W<)CDB8=BIY%4Z_6+XY?LT_"3]H/2/L'Q
M\.J;N.,K::Q:8CN[;_=?!R/]E@R^V>:^&/V@?^"?/QF^#;SZWX8LV\4:#&2P
MO--A)N(4_P"FL RPQW9-RX&25Z5_0'#?B%D^>)4J[]C6[2?NM_W9?H[/M?<_
MAKQ!\!^*^#93Q.#B\5A5KS07OQ7]^"N].LHWCU?+L>"44$$'!&".HHK[\_#0
MHHHH *^Q/^"6&AZ7X;TCQW\:O$<Z6UEIUG';&\D.%BB16GN"3V 58C7QW7O?
M[7_CX?LD?\&^OQ4\?F K?^+O#-WI\4:/L<OJ]PFE)(IXY6"42\<X0XZ5\'XB
MXEPX>^K1?O5YP@OF^9_^DV^9^[?1TR;^U/$FGB)*\<-3G4\KV]FOG>=UZ>1_
M-C\?OBWJWQ^^._C7X[Z_:K!?>-?%NI:]>P(V1'+>74EPZ@]P&D(_"N2HHKY:
M,5"*BMD?Z#!1113 **** "BBB@ HHHH **** "BBG112SRK!!&SN[!41%R6)
MZ #N: &UO_"_X5_$KXV>.].^&'PA\":MXE\1:O.(=-T71+%[FYN']%1 20!D
MD]  22 ":_07_@F__P &SG[;7[9LNG_$+X\6$WPA^'\Y64WOB&R)UC4(NO\
MHUBQ5D##I).8UPP95D'%?OW^P5_P3#_8Y_X)O^"#X4_9H^&$5KJ-U L>M>+M
M5*W.KZKC!_?7!4$)D ^5&$B!Y" DD_.9GQ+@L#>%/WY]ELO5_HOP*4&S\W/^
M"2/_  :Q>%OAO/I?Q_\ ^"E,-CX@UR/9<:;\*[699M.LGX*G4)5.V[<'K A\
MD8^9I@Q4?L]IVG:?H^GP:3I-A#:VEK"L-K:VT02.&-0%5%5<!5    X %345
M^=X[,,7F-7VE>5^RZ+T7]/N:I)!1117$,**** "BBB@ HHHH **** "BBB@
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MSE:/9:+Y]7\V6HI!1117C%!1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBA(BK$D%0,$Y%<]\&/VI?V;_ -HR?4K?X!_'/PMXS?1[E[?5AX9UN&]%E,A
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MUN+W]G7]HGP-X\BM%!O&\'>*[/4_L^3C]X+>1_+.>,-@YXH [RBBB@ HHHH
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MBEET36HK.>!;I(YGA=@DZ)( )(W )49QD9!!(!V=%%% !1110 4444 %%%%
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MO^$<UVXCD0GYMGGVUNTB*REUCQN4A6&9_P $8/\ @H_\9/&'BGQ#_P $L_\
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M?QTUN6U6QN+J3/E2SV*L9[*W< R*9RDQB5G\G"L%^EOBQ^U9K&C?&>3]F?X
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M^'>CZO%:ZEJH.JWGGW$/FJ8Q%;H5EFEE:.*./+-(&*(_TA^SIXR\)7/_  1
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M/B?Q/I>CSW7B#XA_#_P)96C>%-.DB=(XI+Z.U5EGN)'\M;0.KF/[1(P"Q%7
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M/A]/@-XDU(:M%:V^HNTKWFBW!)DB6W19)77"M$8]T[2@/M /V5HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#R;XP?L6? [XY>,W\>^/;#4I-0DMXX6:UU%
MHTV(,+\H'O7+?\.S/V6_^@3K7_@X;_"O /\ @HK_ ,' /P?_ ."=?[2EU^S9
MXT_9]\2^([ZUTBTU!M3TO4[>*)EG4L%VR#.1CFO"O^(NK]G/_HT/QM_X/+/_
M  K]MR3P]\<,PRBAB<LP]9X><4Z;52"3BUI9.::5NC2/S_,.#/#?&XZI7QF
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M:OA__P"$;8__ !JNQ\.^&/#7@_2H]!\)>'K'2[&+/E66G6B01)GKA$  _*N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3;MVK.D0D4;>,!NG%=]110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>mdt-20221028_g6.jpg
<DESCRIPTION>IMAGE 10
<TEXT>
begin 644 mdt-20221028_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2BU&31%T]M,%S%8N;(PK<3XY!GR6!(N@=N,,P!UVN?\ !V'_ ,$W+']D"/\
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M/A6/4I4M'D\QK-;B2ZCCEA4X\OSX)6CVJ2SL-Q^S?V@?^"8FD?%C_@GUK_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2SE474LDA,L*)/DD?+,OR@@UW'[9G[1%W^S+\ ]2\?\ AK2+/5?%5_=VNA^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R_P#\
M%KO^41_[1O\ V2#7/_21Z^H*\'_X*6_ #XT_M8_L5_$']EWX(#PO!J7Q!\,7
M>A3ZMXJU>YMH-.BN(]C3*D%M.T[!2V$/EC./F[4 3?\ !,/_ )1J_L\_]D-\
M)?\ IFM*XS_@L3X]\5:/^Q3J/P-^&FIM:>,OCAX@T[X8^$YT^]#/K,WV>YN
M>J^18?;;G<.GV?/&,CTC]A#X3_%WX _LB?#S]G_XU6WAS^V? /@S2O#?V[PO
MJUQ=VVH1V-E#;+<_O[:!H6D\LL8L.%S]]JQ/B_\ LS>/_C%^WA\)/CGX@O\
M2Q\/_A-X>UV_T_3OM$C7EWXHOTBLH9VB*>6(8+!KX*^_=YEW]W"[J /7OAQ\
M/_"OPG^'F@_"SP+IBV6B>&M%M=*T:S3I;VEO"L,,8]E1%'X5Y-^WI_P3C_9.
M_P""EGPQT_X1_M<^"-2UW1M(U(ZCI,.G^);[3_LUX8FB%QMMI425U1W5?-5P
MH=L ;CG8_;B\.?MF^+/V;M;T/]@+X@^$/"_Q0EGM#H>L^.;-Y].BB%Q&;@.J
M12D,T(D528W&2.!G<O(_M5:'_P %34UCX=^(_P!BCQI\%[F+3H9H_B;X9^)=
MMJ-I;ZNS)%LFL[NSCGEMRC"7",A'SJ6+XVT ?)O[!WPM_:2_X)*?\%--%_X)
MJ7GQS\2?$K]G[XL>!M6U[X22>,;O[3J?A&_TMH3=V'G  -;^5/&<!53=+$51
M&$ID].^*/_!%G1?&7@'XF_LT6_QSMM,^!/Q<^,4?Q'\>^$9/#A;4A/\ :+6\
MO-.MK_[2L<%G/=6<,V6@9XE\V-20ZM'[[\%_V;_B5>?&U?VLOVJ?$'A_4_'M
MKX:ET#PSHWA2VF&D^%].GFBGNT@DN/WUU<7$D%N9;EUB!2VAC2&/$C2Z/[6W
MPC^)/[1&EZ'\ ](F33_ ?B&\D/Q4U:.]\NZN-'B52=(MU7Y@;UV$,LN1LMEN
M%4B22-E /G#XM?M>_#WP3X(U[_@KO\:]$O\ 4OAWX(B&B?L[>$]/11/KLU[,
MED=;C5R%$NH22+;VKGB+3P\P(%Y*@]O^ '[;NH_$']J;Q7^Q'\<?A=9^"_B;
MX9\':?XM@T_2/$K:QI^JZ)=2-!]IM[E[6UDWPW*-#*CPJ 60HT@8[<W_ (*@
M_L)77[=7[$NJ_LV_#C7=,\-:[87^EZQX(NKNW86%K?Z;=17%O%,D0)6W<1F%
MMBDHLFY58J%/-?L[_LC?''Q!_P %*O%__!2[]H;P_I'A6]N_A#I_PY\(^#=)
MUS^TI(K)+XZC>7=S.(HTW/=%4B1 3Y2;GVLVQ0#ZVHHHH **** "BBB@ HKQ
M_P#:>_;]_8U_8UL&NOVD_P!H?PWX8N!%YD>D3WGGZC,N/O1V<(>=Q[JA'(YK
M\X_VF?\ @[3^"7AIKG1/V3?V<M:\4SJ2D6N^,+Q=-M,]G2"+S995]F:%OI7W
MO"WAAQ[QG:64X"I.#^VUR4__  .?+%^B;?D<M?&X7#_Q)I/MU^X_7RJNM:[H
MGAO3)=:\1:Q:V%G NZ>[O;A8HHQZLS$ ?B:_F7_: _X.+/\ @J9\=I)K73/C
M18^ M.FS_P 2[P%HT=H5';%Q-YMRI'M*/Y5\?_$SXU?&/XU:N=?^,?Q8\2^+
M+XL6^V>)==N+Z7/KNF=C7[YD7T1N)\5%3S;'TJ"?2$959>CO[.*?HY+U/*JY
M_0C_  X-^NG^9_5=\3_^"L7_  36^#QDB\<_ML_#M9H>)K72O$46HSQGT:*S
M,K@^Q&:\)\<_\'+O_!)WPB[QZ)\6?$GB8IGG0_!=Z@)]C=I!G^5?S0T5^I9=
M]$G@/#I/&8O$57Y.G"/W<DG_ .3'%//L4_ABE]_^9_0AX@_X.S/V +"5H?#O
MP1^+>H;3Q++I&FP(WTS?,WYJ/ZUZ=_P3V_X+^_ W_@HA^TG:?LV?#SX$>+-!
MOKK2+N__ +2UJ[MFB1(%#%=L3,23G\*_FAK]"_\ @V&_Y2I:3_V).L_^BDKF
MX\^CWX:<-\"YCF.$HU/;4:,YP<JLG:48MIM:)Z]+6'A<VQE;$PA)JS:6Q^C7
M[:W_  <Y?LW?L/?M7>,?V4OB#^SAXXU;4/!VH06UUJVC7EF8;@26T,^Y%D=6
M&!*!@]UZ\URGAG_@\#_X)PZI(L/B3X)_&/2V(&91H>F3QK]2NH!OR6OR(_X.
M#_\ E,;\</\ L.V'_IKLZ^-*_D7"<-957P5.I*+O**;U>[2/IN>1_4UX!_X.
M@/\ @CSXT9(M9^.VO>&'<X"Z_P"!M1(!]VM8IE'U)Q[U]!_"C_@J_P#\$T_C
M;)%;?#C]N3X9W=S/_J+"\\5V]E=2'T6"Y:.0GV"U_'%14U>#L!+X)R7W/]%^
M8<[/[F=-U/3=9L(M4T?4(+NUG3=#<VTJR1R+ZJRD@CZ5/7\2?P@_:/\ VA/V
M?=3&L_ CXY^+_!EUOWF?PMXDNK!F/^UY#KN]P<@CBOM7]G3_ (.=_P#@K#\!
MVM['Q/\ %71?B/ID! ^P^/- CED*=Q]IM3!.S?[3N^#V/2O)Q'!V,AK1J*7K
MH_U7XE*:/ZEZ*_'3]EG_ (/!_P!F3QO);:%^UO\ L\>(_ ET^U)-<\,72ZQ8
M ]Y'C*Q3Q+_LHLQ^M?IA^R]^WG^QQ^VEHW]M?LO?M%^&/&&V+S)]/T_4 E_;
M+ZS6<H6XA'^_&M?/8O*\PP7\:FTN^Z^]:%)IGK=%%%< PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BOG']OK_ (*H_L@?\$Z/#'VWXZ>/!<^(KFW,ND>"
M-#VW&JWPYVMY>X"",D'][*40X(!9AMK\'/\ @H=_P7X_;4_;I>^\$>'-<?X;
M?#^X+1CPMX7O76>\A/\ #>7@"R3Y!(**(XB.L9(S7[%X=>"/&GB*XUZ%/V&%
M>]:HFHM=>2.]1^EHWT<DSS\7F6&PFC=Y=E^O8_9O]NW_ (+U?L%?L/2WGA"3
MQLWC_P :VNY&\*>"I8[C[/*.-EU=9\FWP>&7+RK_ ,\S7X\?MG_\'&W_  4(
M_:H>[\.?#OQ5#\*/"\Y94TSP3,ZW[QGH)=0;$Q;J,P^2I[K7P)17]P<#?1\\
M/>#(QJU*/UO$+_EY62DD_P"[3^"/DVI27\Q\UB<VQ>(T3Y5V7^98U;5]5U[4
MY]:UW4[B]O+J5I;J[NYFDEF<G)9F8DL2>I)S5>BBOW%144DE9(\P****8!11
M10 5^A?_  ;#?\I4M)_[$G6?_125^>E?H7_P;#?\I4M)_P"Q)UG_ -%)7YWX
MN?\ )L,X_P"P>K_Z2SKP'^^T_5'SO_P<'_\ *8WXX?\ 8=L/_379U\:5]E_\
M'!__ "F-^.'_ &';#_TUV=?&E?Y[9;_R+J/^"/Y(^U>X4445V@%%%% !5SP]
MXC\0^$=;M?$WA37;S3-2L9A+9:AIUT\$]O(.CI(A#(P]00:IT4-)H#](/V'_
M /@Y^_X**_LKRV?AKXRZY;?&3PK!M1[+QC,4U2.,=?*U)%,C,?[UPL_L!7[2
M?L ?\%_O^">G[?3V7A#1OB*? ?CB[*QKX+\<R1VDUQ*>-EK<;C!=9/W55A*1
MR8UK^3NBO Q_#>6XU-QCR2[Q_5;?D_,I3:/[H**_EA_X)O?\'&/[<_[!TMAX
M%\<:])\5/AW;[8SX8\5W[F[L81QBROB&DAP  (Y!+$ ,*BYW5_0-_P $\O\
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M!UW2+E;C2]8T>]>VN;25>CQR1D,C#U!K)HI-)JS _=W_ ()(?\'4=KJ\NF_
M'_@IO=0VMPVRVTOXM6-H$BD/ 4:G!&,1G/'VF)0O(WQJ TM?MQH.O:%XJT2S
M\3>&-:M-2TW4+9+BPU"PN5F@N874,DD<B$JZ,I!# D$$$5_#57WG_P $@?\
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M*EO["^TJ^FTS5+*:VN;>5H[BWN(RCQ.IPRLIY4@@@@\BHJ]DD**** "BBB@
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M(**** "BBB@ JSHNBZSXDU>V\/\ AW2;J_O[V=8;.RLH&EFGE8X5$1069B2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2KJ1R&4D&@"_16>OBWPJ_BI_ J>)M/.MQZ>M_)HPO4^UK:,[1K<&'.\1%U9
M^-I92,Y!K0H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1K#R:9I\C[O[/T^,"*TM1CC]W D:DC[S!FZL:\>K]ARC _V?E\*+WW?J]_\
M+Y&$G=A1117I""BBB@#7\ >!_$GQ-\>:)\-O!U@UUJ_B'5[;3-*M5ZS7,\JQ
M1(/J[J/QK^UK]G_X/>'?V>O@5X-^ WA(#^S/!GA:PT2Q8+@O':VZ0JY'JP3<
M?4DU_,Y_P;'?LE2_M*_\%0O#OCO5],\[0/A5I\WBG47=/D-VF(;%,]G%Q*DP
M'<6S>E?U)5^>\8XI3Q-/#K[*N_5_\!?B:06EPHHHKXTT"BBB@ HHHH ****
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M1110 5Q/[0MY^T59?"C5)/V5?#_@W4?&[0LNCQ^/M6NK/3(Y-C;9)3:P32R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:Q9D1W=O_NO@[EZ_*P9>>F:^'/V@O^">OQD^#TDVM^$;63Q5H2Y876G0'[3
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MSE:/9:+_ #?S9:BD%%%%>.4%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!B^)/AM\.O&(8>+O .BZIN^]_:.EPSY_P"^U-<+K/[$G[*F
MO,SWWP6TN,OU^Q/+;#\!"ZX_"O5**[L/FF9X-6H5YP_PRDOR9XN/X;X=S5WQ
MN#I57_?IPE_Z4F</\)_V=?A/\$-.U72OACX?ETVWUDJ;U#?2S9*JRC:968C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*YWXK_%SX8? KP!J7Q4^,GC[2?#'AS1[<SZEK6M7J6]O;H!G+.Y R>@ Y)X
M)K._9Z_:%^#O[5GP<T3]H#X >-(_$7@_Q'%++HFM16<\"W21S/"[!)T20 21
MN 2HSC(R""0#LZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M\X?^"FG_ "=)=_\ 8%L__037S[7T%_P4T_Y.DN_^P+9_^@FOGVOZWX2_Y)C!
M_P#7N/Y'^7'BE_R<;-?^O]3_ -*85^PWPW_Y)WH'_8%M?_1*U^/-?L-\-_\
MDG>@?]@6U_\ 1*U^=^,'^[8/UG^43]Y^BE_R,,U_PTOSJ'P]_P ' 7[&/A3]
MO3X1_!#]FW7-=?0;[Q-\<H['2?%5I:H]UI,W_".:[<1R(3\VSS[:W:1%92ZQ
MXW*0K#,_X(P?\%'_ (R>,/%/B'_@EG_P4: TC]I/X0Q>1+=W4O[OQSHR >3J
MUM(P'G2>64:0XRZLLV,F58O:?^"D'C;P?X3^+O[*-GXF\46%A->_M*VR6D5Y
M=I&TQ/AO7XAM#$$_O)8DR/XI4'5@#P/_  6<_P""7GBS]LCPKX>_:K_9$\0#
MPC^TM\'9?[3^&'BNU=8FU%8R9'TBY=OE>&7+A/,RBO(P;]W-,&_##^SCM/V"
MO&WP_P#@S\"_CY\4_'VM66A>'M _: ^(VK^(=6N?DBM;:'5KB6:>0@=%1"Q/
M)XK ^(O_  5G\9_"_P#9FTS]OGQ1^Q3XF'P(U"WM=0N/$=MXA@D\1:?H]RRB
M#5Y]&$>!:LLD<I5+IYTBD#/"I5U7Y.^%6@?M1?\ !1+_ (-Q_P!H:TL/AS<Z
M%\6?'GC#QEJ&I^#;6"6.9-2CUK[3>:;'')\ZO(89H%C;YLR!23R:]<T;]MW]
MG#X]_P#!N1J_BA_%FFR7<W[/5UX)U;PD9E-_'XF_LAM,_L<6W^M^TR7FV.*/
M:&<21L!A@: /:/VQO^"OWPJ_9,NO@;JEA\'/%7CCPE\>/$VD:7X6\>^%WMIM
M,"7Y5T=8HY'O;B7R&\Y(H[8B4?*L@?Y:9\+/^"J/B;5_V]-"_81_:._8M\8_
M"75/'OAV_P!9^%FLZ_X@TW4$\0P6:F2XBECL)9193K$K2>4TCD!?F*DKN^%/
MVD/A!XC_ &.OV.?^"5G[/?QTUJ"P\4>'/VC?!DFN6=]=JKV3Y>6:%B3C;;M<
M)"S#Y057G!%?1/\ P4,\2>'M._X.%_V +._URT@F32/B0)(I;A59?/T(Q09!
M.1YDBLB?WF! R>* /T@K\N_V\["QF_X.?OV')IK2-G;P#XTW,R D[-(U1D_[
MY8DCT)S7MWQ!_P""7?[8WC'XTZW\4-!_X+-_&O0-'U7Q1<ZI9>#-/TW3C9:;
M;2W+2I81,R;S#&C")23NVJ,\UXG_ ,%C99?V6O\ @KC^QA_P4H^(<#VOPN\*
M7^O>$?'/BEXR;7P])JEG):VL]TX&(H6:ZE)D;Y5\DY()7(!^H+HDB&.1 RL,
M,K#((]*^9O\ @C%:6MC_ ,$G_P!GJVLK=(HQ\)M&8)&H RULC$X'J22?<UV?
MQ]_;Z_9:^ GPAF^*VJ?&3P[J[75J?^$4T30=7AOK_P 37KK_ */9:?;P,TEW
M-,Y5$2(-G=DX4$CB/@+XL^'?_!*[_@D[\.-6_;.\;V_A32OA9\+?#]AXYU:2
MWFNDL[WR;:UD14MDDDES=2"-1&K%BPP* /$/^#AGPY^TQH7PM^#'[5GP*^#=
MQ\3=!^!_Q@L_&/C_ .&MJK.^JV,$3A+D1JK%_L[%F!"/Y9D$I0K$V+WP?_;"
M_P""9O\ P7U\"^ M;^#?CW2U^('PS^(?AWQOIOAOQ/:I;^(O#L^G:G:W5PJ1
M$DR1RP126[RP-)#^^7<P90![1^TU_P %-/@%^S#XC^!7BKQ_\0=&L/AM\:;N
MXM+/QK?2-%:6S26*7EA</*Q"Q02C*%W "F:,L44,:_/S_@O]^Q+^RKI5_P##
MC]M?_@G9?:/X9_:OU;XF:2GP]@^&]_$L_C2::;$LLMM;MM<1INFDN]H4HKI,
MS*ZX /V:HKR_X@?ME?LV?"3]H3P'^R;\3/BM9:9\1OB5:W<W@WPVUI<.VI+:
MQEYR)4C,40 5MHE="Y4A-Q!%>H4 ?E[_ ,$X+6VA_P"#D/\ ;T,-NBD:!X,(
M*J!RVF6S-^9Y/J:H_P#!R=^RYI7P/^ $7_!83]E%8O GQP^"_B'3+V;Q9H$*
MP2Z]IMS>PV<MI?*F!=H'N(F_>[LQK+&<K(16-^P/\=O@CX/_ .#C;]NK4/%_
MQA\+Z3!?Z5X3M;&;5-?M[=;B>VT^WBN(XS(X#M&ZE7 R5(P<5I?\%POVDHO^
M"FGPO3_@C_\ \$W-2L_B9XQ^('B'31\2O$_AJ87FA>!]&M;N*Z:;4+^'=#%*
MTT$6(0QD*I(NW>\22 'V%X*_X*)Z5\1_@W\$-=^&OPWE\1_$'XY_#RV\6^'/
M!-OJ26L5C8FSMKBZN[VZ<-]FM('NX(2X261Y)HU2-R6V\Y\$/^"HFN?%GXZ?
M%7]BWQ!^S-=>'/CW\+M%AUM?A]<>+K>:Q\2Z5+Y7EW>GZF(E5E/G1*1-%$4>
M6-6Q\YC^+?V_/"7[.W_!+7_@H%^RW\1_VM/A%8^+?V:=/_9[7X-3Z[XC\*1Z
MQ9^&]0M)XI[6^F@:.0)))'#$FY1O,8N"N[8RG[+_ &'?B/\ \$K_ (O_ +0=
M_P"(/^"</P+^%>IW&F>&)$\7?%;X<^"K*RCT_P V6 V^DF]AMD-Q),%DF:!)
M#Y2VJF0*9(MP!TO_  39_P""C#?\%(OV<O$'[0GA3X+2>#?[%\17^@_\(YXD
M\0HUY#J-F!YT-YY4)%H S1_\]&VL6*#"AG^"/^"C-MK/[+7@?]HKQK\#=4TK
M5/BIKL&E_"OP%I^L07FH>)'N4>6UD21A%##')!%-=EW;;':Q^8Y#'RQ\3_$W
MX9?&/]D[_@K3\4_V%?A!X?U./X??MV:-%XAT_5=-RD7AC4X)4A\53JX(\N63
M39+BX60<_:9K)!C)([K_ (.#=-T?]GNS_9A_:\\2? BW\9_!KX*?$R2'XE^$
M(]"BOK:TT6^L/L*736LBF-DMQD(& 4221#*[L@ ^B/!G_!36\T']N[1/^">?
M[6/P!D^'7C7QKX=GUGX;ZMIOBF/6M'\210*[7%NLX@MY(+F-8Y&,4D6"$)#G
M=&'\6_X)CPQ0?\%SO^"BZ0QJH-_\,F(48Y.AWA)_$DG\:ZC]E_X[_P#!$S]H
M+X^^!V_X)^? SX->-_'"B74?^$A\%?#FSM;OP9IH@D\R^N+D6:R6+.YCMDA)
M2:1[@#:$65D\H_8BAC^)G_!7[_@IY\-_ _C:SM-:U_2/ ]CI%W'= M!.OA^]
MMGE&WG]S/(@?'W6P#SQ0!](+_P %,_'7Q/\ A+XJ_:6_9"_9)U+XH?#+PCJ&
MH6K^(+;Q9!87WB46$CQ7L^B6;12"_BCDBFC5I9K8S/"XB#C:S<Q^T;_P70_9
MT^#_ /P3>T3_ (*=_";X7^*_B5\/]?\ *BAFT.6RM3I5U).+80:A]HG$D#+/
MNA8Q1S[77^ZRN?+?^#<_]I/X;_!__@E\/V6OVA_$NF> O'G[.>KZYH_Q1\/^
M)K^*SFTE/[0N;V.[D61ABW:&X $PRC-&^&-?#?QA_9]\;?L^?\&F?Q-UCQIX
M?OM&MOB#\:(/&7AK0M0MFAGT_1KO7]/2R1HF ,?F0VZSA<#Y;@9 )(H _1CX
MU?\ !=>P_9H^._@_0OVC_P!AOXE>"?@SX^\11Z)X3^.FMRVJV-Q=29\J6>Q5
MC/96[@&13.4F,2L_DX5@OTM\6/VK-8T;XSR?LS_ #X6KX\^(%GX<BU_7;"ZU
MY-+TW0]/FEDAMGO+LQ3,DMQ)#.(8HX9&86\C/Y: ,?D?_@X:'@?]M'_@F)H?
M[.OP)UK2O%OBWXY^-O#=K\(HM+N4N/MS_;8;F>_C*9(MHK)+AY9_N1HWS$9&
M?%?V@OB%^R;^P9_P7,\=W?\ P5&^%?AO5/A?\=/AKX87X<?$CQWX0AU6PTK4
M='MFM)[1I)8I/LQE,CR2%> 6MV?"N'4 ^V?V4/\ @K=\!OC]\/OC'KWQ=T*\
M^%/B/]GK4KFS^-'ACQ+>Q7(T$1+*XNH[B#*75M(L$WER( SF)@$Y0M\A_P#!
M=_\ :]^-GQP_X(<?$/XF3_L:ZGI/PV^(&D:3)HFMWOB>!]9TZVDU.RGLK[4=
M+$02VAFVQ@".YFFC::/S(D^?9#_P46\$_LN_M@?\$E/VH[/_ ((^?LX>#%LY
M='T-]5\<_"_P;;:='XRFL=42]O\ 3X'M[>-M0^S6D18NI=&>Z,*$N)57)_X*
M:_\ !2[]C+]KS_@VT\5:K\*?CKX6EU[Q!X!T&S/@B/5X?[6L;^&^L#<VCV8;
MS5,/ER$MMV;%#@E&5B ?JO\ L_?\D%\$?]BAIO\ Z2QU^9'_  <<?L<>-_VN
M?C-\/KOX)W=Y:?$KX8_ [QO\0?AY=::2)VU32-;\)2)&F.6D:":Z6(=!+(A[
M5^CO['OQ&\!?%?\ 99^'WCKX:>,=,U[1[WP?IWV;4M(ODN()"+:,,H="1N5@
M5(Z@@@X((KR'XI^-O!]E_P %EO@QX1N_%%A%JLW[/7Q $6G27:"=S)K'A-XP
M$)R=RVMRPXY$$A'W#@ V?V /^"B'PM_;'_X)S>%?V]]7UVQTC3)?"$NH>.F:
M3$6BWEDCC4D?J5CCDAE92>3'L;&&%?F/^S#X=\=Z[_P<O_!K]IKXOV5Y:>)O
MC3\!=9\<RZ+J!._0K"X?4K72M/VGB.2'2[:R64 #,[3D_>-=!\*/V.?CY\!/
M^"HGQ;_X(V>"O"4G_#-WQLU^P^+]U>*2L&D>'XY\ZKH\:@;=MY>16>G/'NR+
M4;OXS7J7[0OC3P;:_P#!VS\"M&D\3:>ES'^S3?V+6YND#)<O/K$J0$9XD:/Y
MPG4J0<8(H ^O/&/_  4!\3Z_^UEX[_8P_96^ L7CSQE\+_"UAK?CJ37?%@T*
MQM3?HTEE8V\OV:Y:XNI8U+\I'"@*[I@<J.&TW_@M/\*_$O\ P2TN/^"IG@7]
MGGQYKGA_2[:]/B/PE9M81:AHLUI.]O<BX:>YC1HDD3[\/FN4=6\KAE7R?5_V
M_?A3\6/^"I'QX_9)_:J^/L'P=\+?"W3_  _!X?\ "VFZRVBZS\2YKNV:9[AK
MV I>W*0F2**"QLG5I?M.7$NX1CY _8O^,7PDD_X-:?VE/A5I_C6Q76]!A\:#
M5M&DD*W&FBZOG%I'<*_,$DN0(XY-KOM;:#M; !^@'A[_ (*0?$;]L+X:ZIH=
MG^P1\0=!^''CC]GF_P#%&E_%?5+BVDTF6:33\R6&Q<2 ;I'2.20(TXC,B1&%
MEF/DW_!(O]K&]_9>_P""%O[,%OX&^%5S\1/&OBU+G3/#'P[T?5XK74M5!U6\
M\^XA\U3&(K="LLTLK1Q1QY9I Q1'^D/V=/&7A*Y_X(@>"_&%OXEL7TJ+]E^P
M:745ND\F,1^'D63<^<#:RLK ]"I!P17Y0_\ !,?XF?$3_@E9^RC^SO\ \%9+
MSQ+=>-/@/X[\(+X ^-.F7#"[NOA\\>M7JVFH:<<%XK0S,3/:IPTKLQ5WDA\H
M _:GXG?M6ZQ\'])\$^%/&'PK%W\3?B+J4]AX1^'F@:\EP9Y(86N)YI;N6.%(
M;>W@7S)YMI"Y5(Q-))$DGE_PU_X*@ZOJO[77BG_@GY\;/V:[OP?\9=+\$'Q9
MX-T&T\66^H:7XRTW+QA[*_>. QN)8W1DFAC*B-V&X(V/EG_@M;\7_@K\-_VH
MOV0_^"E?Q8\":-\5/V:+&/Q!H/C74X='AUW3=-BUB"T^Q:H(]LB2(7A#;U!)
M$&Q<NZ*?H?\ 8_\ BW_P2 ^-_P"TCH]__P $Y_@;\(?$_B?2]'GNO$'Q#^'_
M ($LK1O"FG21.D<4E]':JRSW$C^6MH'5S']HD8!8BK@'F?\ P1\_X*,_M0?'
M3X=?'KX__M<_"BWTKPSX<^+_ (J;7_$=EXJCN+3PQ:Z3I]G'_9L%KL\V9(H[
M<L9D"B1Y'DV@L17OO@7_ (* _&#QAX?^$GQ9F_9'*?#SXSZGIL/AOQ'IGCJ&
M\N](M;^ SVMSJEJ+=4@\Q-J@6\]RHDD1&=<@U\8_\$;?VF_V<O@[^RW^U]\&
M_C!J^EZKXDT3X]_%#6?$/PN>96U.[TB"U26=I+8Y9+9TADA\^0"(R,(]V]E4
M\WX>^$'Q _X)4^/?@)\</^"4G[8U]\3OV:?CC\4])\/I\!O$FI#5HK6WU%VE
M>\T6X),D2VZ+)*ZX5HC'NG:4!]H!^RM%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >3?&#]BSX'?'+QF_CWQ[8:E)J$EO'"S6NHM&FQ!A?E ]ZY;_AV9^RW
M_P! G6O_  <-_A7@'_!17_@X!^#_ /P3K_:4NOV;/&G[/OB7Q'?6ND6FH-J>
MEZG;Q1,LZE@NV09R,<UX5_Q%U?LY_P#1H?C;_P 'EG_A7[;DGA[XX9AE%#$Y
M9AZSP\XITVJD$G%K2R<TTK=&D?G^8<&>&^-QU2OC,!0G5DVY2E33;D]VW;5G
MWI_P[,_9;_Z!.M?^#AO\*]ZTG3+71-*M=&L5806END,(9LD(BA1D]^!7Y(_\
M1=7[.?\ T:'XV_\ !Y9_X5^K_P /O%]M\0? 6B>/;.S>WAUO2+;4(K>5@6B6
M:)9 I(X) ;'X5\OQUPKXC<.4J$N)Z52$9N7L^><97:MS6Y92MNM['K\.\/\
M"623J2R;"TZ+E;FY(*-TKVO9*]KNQE^,?@3\#_B'K'_"0^/_ (-^%-=U#REB
M^W:QX=MKJ;8N<+OD0M@9.!G S72Z=IVGZ/I\&DZ38PVMK:PK#;6UM$$CAC4!
M5157 50   . !7G7QR_;+_9,_9CO;33_ -HS]I#P5X%FU!@M@GBWQ';Z?]I8
MC.V,SNH<X[#)KD=7_P""I7_!-KP_9'4=?_;O^$UC;A@IGO/'MC$@)Z#<TH&:
M_.CZD]PTS1=&T7[0-'TFVM/M=R]S=?9H%C\Z9_O2/M W.<#+'DXYKD[7]FO]
MG.R^*$GQOL_@#X)A\:2N6E\7Q>%;-=4=B,$FZ$?FDD<'YJ[*VN;>]MH[RSG2
M6*5 \4L; JZD9!!'4$=Z?0!R_C7X(?!;XDZJFN_$7X0^%]?OHK<01WNM>'[:
MZE2(,S",/*C$*"S'&<98GN:I:A^S7^SGJ]^NJZK\ ?!-U=)'%&ES<>%;-Y%2
M)%CC4,8R0$1%51_"J@#  KM:* "JFNZ#H?BC1[GP[XFT:TU'3[V%H;RQOK=9
MH9XV&"CHX*LI'4$$&K=% 'G'PQ_8Z_9%^"?BAO&_P:_98^''A'6G5@^K^&/
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M4> OVOK;]CC]I'_@G[\2O!/B3Q9X9NM:^$]O9:KIFMS^+A 2'L]ME,T-E<@
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M;>#_  _^WK^R%X>UWQ186=]J'C_Q.;&TN;M$DG \*:FGRJ3D_/)&O'\3J.I
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MVW XKJJ* .+LOV;OV=M-TR]T33O@)X+M[+4EC74;2'PM:)%=!&WH)$$>'"L
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I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>mdt-20221028_g7.jpg
<DESCRIPTION>IMAGE 11
<TEXT>
begin 644 mdt-20221028_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ? ?\ P<.?\%<]8_X)
M/_L>V>M?"B"TF^)_Q#OYM)\"_;HA+%IXBC5[K47C;B40+)$JH<J99XBP9 RG
MQ#_@WS_X)M_"W]H_]CS3?^"C7_!1/PM:_&[XK?%VXO+^+5_BK;IK@TC2DN9(
M((+:*[$D4/F")IBR*"$F2,;53;7S7_P?$_#KQA,_[//Q:AMII= MQXATBXF
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MWBKQKJ%AKFA:8GEVTUI?Z+_:,T9C3 "1W)6<*  IA7L,5U/[+?[6/QX^,_\
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M=:V\N.&O;J9$EAM\ABMN&8+&YD7[M_9I^#7P5_9A^#WA[]E?X%6]I9:'\/\
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MTO2HK#PEY\8=5U.\GCM8)2C<.(FE,Y4\,(2#UK\=_"7P.\(>,/\ @U2\4?\
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M31OAQX*T^)I;SQ/XAN<I9:?!&GSN7?YG*@E(DD?!VXH _%'_ (- ?C/^U/\
M"G]NOXP?\$YO&_B*\U'P7X:\-ZE?:AI3W;SVFBZU8ZI;63/;%N(UF\^8,J@>
M88T8CY#7]#M? G_!"_\ X)96_P#P3!^".H^.OVBO$NG7OQU^-6LC4?'VI/=1
MX2Z837*:3;-G$IC#7$LA3/F/YC#='&A'WW0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XQ^WY^PE\"?^"CW[
M,&O_ +*_[0FE32Z-K 2:QU*R*K=Z1?1Y,%[;.P(65"2.00R,Z,"KL#\5_P#!
M,?\ 92_X*O?\$:_ASJ?[($/PD\,_M$?">VUFYU#P#KWASQK!H.L:.D[EYK:X
MM-1 A,;R%I@(YV*/))\SAP$_3NB@#\E?VA/^"+/[7G_!9/\ ;D\-_M-?\%0S
MX>^'7PC\"6HM?"?P7\)^(VU;4KV+S!+-]MODCCAA-PX3S&@+MY<21KL9?//U
MI_P5V_X)3?#O_@IW^PA/^R-IM_8^$M0T&XM=1^'.I166+72+ZUB>&&)HHP,6
M[0R20,J#Y%<,JDHJGZVHH _';_@DU^QO_P ')/[%7PWA_84U[Q!\%M&^%VFW
MDZZ3\0]:N9=:U+0K665GE&EV\4D8G.YWDBCO8PB,_P Q*#RJ^Z_^"K/_  3^
MUO\ X*%_\$V_&G[$WASXB_V?K>L:9IYT3Q%KV9%DO;&Y@N8C=&-<[96@V2.B
M$KYK.J' 4_3U% 'Y&?L*_P#!$_\ ;:\0_P#!*C7/^"3G_!0"\\ >&O %O%J;
M^'-2\&7<NJ:O<ZE->_;K2\E:1$B@AMK@L^R,^9< JC-"JN)N>\._\$R?^"MW
M@O\ X(WZO_P1"T_X.^ ;V.[UN>RTOXT#X@"/2H=#GU?^U)7DLC!]L\_>TL01
M8RH63.X[<-^RE% 'SS_P2W_X)Z_#[_@F#^QAX8_9,\!ZT^KRZ89;WQ%X@E@\
MIM6U2=MT]QL!.Q>%C1<DK'%&"6(+'\Y_^"5'_!'3_@I'_P $G/VG?%G[:UOX
M$\&_$E?B3:ZQIOB#X;Z3XM6PU/1X);^*[L[F.ZN$%K<.?*9)8MZ!!(I5Y""!
M^SU% 'YG?\$S_P#@C3\8?!7_  4B^)G_  6"_;N?0+;XC^--3OG\$> _#FHM
M?P>%;6X7R-T]V403W(M5%L/+7RPC2-DF0+'X/_P4@_X(1_\ !0?X<?\ !4Z#
M_@K3_P $AO%'AJ3Q%J&KC5]:\):_J*VC0Z@\)AN\&3$5Q:749D,J-(D@::3;
MP5*?M310!\Y_L1>&/^"B/B>Y;XV?\%$M>\%Z%KATDZ=HGPT^%UQ=/I.GH[QR
M37E[-<2,;N\=HD1 O[NWC#A"[3R-7R%_P<D_\$H?VV_^"LVF?#'X>_LQ:5X)
ML]*\$7>H:AJ6K^*O%$MM)<37*0QK#'#';2<*(F)<L,EP .":_4FB@#RS]B7P
M=\5OAK^R;\/?A9\:_"VFZ1XD\)^$--T34H-(U@WUM*]I:10&:.4Q1G:Y0L%*
M C.#GK6Y^TAJ'Q_TSX&^);K]EGPUX?U;XA'36C\)VGBO47M=-%VQ"K+<21H[
MF./)D**N7V;-R;MZ]O10!_.YHO\ P0F_X.C?"WBCQ/XR\&?\% M.T'4/&?B"
M?7/%$OA_XR:M8+J.H2X#W$B6]JBEMJJHXPJ(JJ J@#]6?^"(7[$G[5W[$?[+
M'B#P_P#MR_%<^./BKXQ\>7>O>)O$TGB2YU>2>/[+:VEM$UU<JLCA(;5<*1A=
MQ XK[*HH _)[_@G-_P $J/VSO^"(G[7_ ,7]8_9H^%ND?&'X)_%<6LNG6%IX
MMM])UWP_):RW+VL4J7H6"=$2\GB9TEW. DFU2/+/=?\ !,?_ ((U?%+X3_\
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MCS7OV(O'>ERKX+UWP>/#ICMBHEM(4B5()HB00)86CBD0D$!XU)!'%?E[I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI7Z%_P#!L-_RE2TG_L2=9_\ 125^=^+G_)L,X_[!ZO\ Z2SKP'^^T_5'SO\
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M8VMQ,KZUX6U M/I.L*.-MQ;%@"<<"5"LJ@G:ZY-?)9IPKA\0G4PON2[?9?\
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M>(D\D1E%] *^B:_FGB/Z7M.,G3R'+;KI.O*W_E.%_P#TX>Q1R![U9_=_F_\
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M2(5YM&)^_<6R 8[O ,XS"[-^OM?D6/P5;+\5*A4W7XKHS9.Z"BBBN,84444
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M3O@L*W"G;:<MIU//F:M%_P B35G)GVF58-87#\TE[TM_\@HHHK\'/4"BBB@
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M)@OKF62:7O0]Y?+?\/T*@[,_IPHHHK\J-@HHHH **** "BBB@ HHHH ****
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MM7VCJS[MHHHK_+@^V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$_MI_$']GF_OO+M/'?@5;^UC+<2WVG3@HH'KY%U=-GT2OZ*J_D)_X(@_&D_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (_G\:^4XPC?+8/M-?E(N&Y^@E%%%?FQJ%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SS_P4Y./V7YO^P]9_
M^SU^<M?I%_P4NLS<_LKZA-C_ (]]6LI/SDV?^S5^;M?T=X5-/AB7_7R7Y1/X
M ^DS%Q\1H-]:%/\ ]*J+] HHHK]*/YZ"BBB@ KKO@ N_X\>"4]?%VFC_ ,FH
MZY&NF^"MW]@^,GA*^SCR?$UA)GZ7$9_I7)CTY8&JE_++\F>IDDHPSK#2>RJ0
M_P#2D?KU1117\9'^N 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFC^+/&U]X8\!ZE?V^EZ3",23M+# R2D>9GRXR\GRM\N1@_8?[37[0FN? ?\
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M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7P+_P59\"/HWQBT3Q[##M@US1?)D;'WI[=R&/_?$D0_"OOJOG
M3_@IS\/6\7?LZ_\ "56MONN/#6JQ73,HR?(DS#(/IEXV/LE?9\ 9BLNXJH-O
M2;<'_P!O:+_R:Q^2>..1//O#3&P@KSHI5H_]PW>7_DG.?G51117]2G^:P444
M4 %%%% '>_LP?$Y?@]\>?#7CRXN/*M+;45BU%L\"VE!BE)]<(Y;ZJ*_6)65E
M#*001D$=Z_&"OU _8:^,,?QA_9XT>\NKOS-3T5!I>J!CEB\2@(Y]=T91B?4M
MZ5^,>+>4.=*AF4%\/N2]'K%_?S+YH_KKZ+G%,:6(QG#U:7Q_OJ?JK1J+U:Y&
MEVC)GL%%%%?AQ_904444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!F^,?%WAWX?\ A'5?'GC#58K'
M2=$TV>_U2]F.$M[:&-I)9&]E16)^E?Q@?MI?M*^(/VQ/VL/B!^TYXF61+CQG
MXHNM1@MI6R;6U9]MM;Y[B*!8HQ[(*_HD_P"#H[]N6#]F#_@GS/\  3PSJHB\
M5?&:Y?18(T?#PZ1%L?4)<=PRM%;$'J+IC_#7\QE?H/!^"=/#SQ,E\6B]%O\
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M:9I-JO2&V@B6*)!]$11^%:]%%?C+;;NS<****0!1110 4444 %%%% !1110
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M>73EF.7QO1>LHK[#[K^[_P"D^FW]S>"'C32S^C3R#/*EL5%6IU&_XJ6T9/\
MY^+O]O\ Q?%] T445^3G]/!1110 4444 %%%% !1110 4444 %%%% !1110
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M$8:HITY*\91:<6NZ:T:] HHHK(Z HHHH **** "BBB@ HHHH **** "BBB@
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M,W6/Q'L:3_=P_%]_1;+[^IK"-D%%%%?,EA1110 4444 %%%% !1110 4444
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MA!/(,3/B')J?^RS=ZL(K^%)_:2_Y]R?RA+3X6DO$****_5S^8@HHHH ****
M"BBB@#=^'GQ,\>?"CQ%'XK^'GBBZTJ^CX\VV?B1?[KJ<JZ_[+ CVK[(^ 7_!
M4?PWK"0^'OC]HW]EW/"C7=,A9[>3WDB&7C/NNX$]E%?#5%?/9[PMDO$-.V+I
M^]TFM)+Y]?1W7D?><%^)7%W =?FRNO\ NV[RI2]ZG+UC?1_WHN,O.Q^Q_A;Q
M=X6\<:+%XC\'>(;/5+"<?NKNQN%EC;VRI.".XZCO6C7X_P#P]^*GQ&^%&K?V
MW\.?&>H:1<$CS#9SD)+CH'0_+(/9@17TW\)?^"K7BO2DBTSXS>!8=5C7 ?5-
M&803X]6B;Y'/T,8]J_&LZ\+,YP;<\!)5H=OAE]ST?R=WV/ZUX1^DMPGFT8T<
MZIRPE7^;6=-OU2YHW[.+2ZR/N6BO*_AK^VK^S7\45CBT;XF6=C=R8_T#6S]D
ME#'^$&3".?\ <9J]2BEBGB6:"171U!1T.0P/0@]Z_.,9@,=E]3V>*I2A+M)-
M?F?O^59WDV>X?V^78B%:'>$E)?.S=GY/4=1117(>H%%%% !1110 4444 %%5
MM9UK1O#FE3Z[XAU:VL+*UC,EU>7LZQ10H.K,[$!1[DU\:?M6_P#!P7_P2N_9
M/MKBVU?]I"R\;ZU!D+X?^&RKK$SL.JF>-A:QD'@B293GMP:WH8;$8F7+2@Y/
MR5Q-I'VI7"_M!_M-_L_?LH_#^?XH_M'?%_0O!NA0 _Z=KE^L7G,!GRX4^_/)
MZ1QJSGL#7X,_MF?\'>'[4'Q-M;SPG^QC\'-)^&UA+N2+Q-KLB:MJQ7L\<;(+
M:!CW5DGQV:ORN^-GQ_\ C?\ M)>.)_B5\?OBQX@\8Z]<9$FJ>(=4ENI57.0B
M%R?+0=D7"J.  *^GP/".+K-2Q,N1=EJ_\E^/H2YKH?LO_P %%_\ @[BO[^+4
M/AC_ ,$V_A^]FC!H3\2_&%D#+Z>996#95?59+C=UP8 >:_%OXK_%WXH_';Q]
MJ/Q3^,WQ U?Q1XCU:;S=1UK7+][FXG;MEW).T#@*,!0    !7.T5]O@<LP67
M0Y:$;/J]V_G_ $C-ML****[Q!1110 4444 %%%% !7[<?\&RO_!$^;Q-J>D_
M\%)_VK/!^-,M)%N?A+X;U&#_ (^Y@>-9E1O^6:$?Z.#]YOWPP%B9_!?^#?G_
M ((8ZM^WKXVM/VJ/VF?#T]K\&O#]_FRL)T*-XPO(FYMT[_9$88FD'WR#$ASY
MC1_TN:=IVGZ/I\&D:180VMI:PK#:VMM$$CAC4!5154 *H   '  KXKB7/53B
M\'AW[S^)]O+U[]MM]M(1ZLFHHHKX T"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K,\9^#/#'Q"\+WO@SQEH\5_INH0F*ZM9APR^H(Y4@X(88((!
M!!%:=%73J3I34X.S6J:W375&5:C1Q-&5*K%2C)---733T::>C36C3/S&_:Z_
M8_\ %/[-?B(ZE8>=J/A6^F(TW5"N6A8\^1-CA7 Z-P' R,'*CQBOV0\5>%?#
MGC?P]=^$_%NC0:AIU]"8KNTN4W)(I_D0<$$<@@$$$5^>7[8?[#7B3X!W<WCC
MP,D^J>$)),F4C=-IA)X2;'5.PD_!L'!;^@^"./Z6;1C@<PDHU]E+93_REY;/
MIKH?PIXQ^!V)X7J5,YR*#G@WK."NY4>[[NGY[Q7Q:+F/GRBBBOU(_FL****
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6O\
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MNEHG8^U\"?#3C'A7CJIB\YP<J4(T9I2;C).3E!63C*2OR\S^1_*%17VOK_\
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M"_X*0_&R2UU;XZ7OA?X3:1+AIAK6H+J6I!#W2ULV:/./X9)XB.AP:_I7\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^5/$'_!53X?^']>O=!F^%.L2/97<EN\BWL0#%&*DCZXJI_P]K^'?_1(]:_\
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M4$U'P8GBFS7:NNV&GZBZ)*V45G19HYS$3T29^H88]]K%\#_#OP=\-[/4-/\
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M%E==J,W;@@'Z!T5\7?\ !!/_ (*)Z%_P46_X)R^!O'NK>+[:^\>^&--C\/\
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M,$MYHN@6UK*\196,9>)%)4E5.W.,J#V%=1110 4444 %%%% 'P)XO_X-KO\
M@F'XW\6:IXTUWPKXR:^U?49[V\:+Q?*JF661I'(&W@;F/%9__$,-_P $K?\
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MV=I<:M>"[U6>VMDC>]N!#' )I64 R.(H88PS9.R)%SA0!<HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>mdt-20221028_g8.jpg
<DESCRIPTION>IMAGE 12
<TEXT>
begin 644 mdt-20221028_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2BU&31%T]M,%S%8N;(PK<3XY!GR6!(N@=N,,P!UVN?\ !V'_ ,$W+']D"/\
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M/A6/4I4M'D\QK-;B2ZCCEA4X\OSX)6CVJ2SL-Q^S?V@?^"8FD?%C_@GUK_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_@V&_P"4J6D_]B3K/_HI*_._%S_DV&<?]@]7_P!)9UX#_?:?JCYW_P"#@_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]_JM_/JFJ7LUS=7,S2W-S<2%Y)9&)+.S'EF))))Y)-0T5_I=P-X?\,^'N4+
M912Y;VYYO6=1KK.77R2M&/V4CXW%8NMBZG-4?RZ(****^U.8**** "BBB@ H
MHHH **** "BBB@ K]"_^#8;_ )2I:3_V).L_^BDK\]*_0O\ X-AO^4J6D_\
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M&]N^T;(U[]1UYKPGQI_P9Z?\$^]5C9_ W[0'Q<T>9AP+W4=-O(E_X"+*-O\
MQ^OUIHKY"EG.:48J,*K26B1U<J/PL^)O_!F3.ML]U\&OV\4>89\NQ\3^!2BG
MZSP71(_[]&OF#XS?\&HO_!5;X9P3WO@73O 7Q BC!:.+PQXK\B=U_P!S4([9
M=WL&/L37].5%=]'BG-Z7Q24O5+]+"Y(G\7'Q^_8._;1_99DE_P"&AOV7/'/A
M*WA;#:EJWAR=+)O]RY"F%Q[JYKR:O[GIH8;B%[>XB62-U*NCKD,#P00>HKY)
M_:I_X(7_ /!+O]KS[3J/Q#_99T71-:N,D^(_ ZG1KSS#UD?[-MBG?WFCDKV\
M+QE3;MB*5O.+O^#_ ,R7#L?R+T5^SW[:7_!H!\9O!_VOQ7^PG\=;+QA9+N>+
MPEXWV6&I!>R1W<8^SSN?5UMU'K7Y1_M'_LG_ +27[(7CIOAO^TQ\%M?\&:P-
MQAM]:L6C2Z4'!D@E&8[A,\;XF9<]Z^HP>9X''K]Q--]MG]SU(:://:***[Q!
M1110 4444 %%%% !7W?_ ,$5_P#@MO\ %?\ X)>?$=/ _C%[[Q+\'->O@WB/
MPN)-TNF2,0&O[#<<)*!@O%D),HP=K!77X0HK#$X6AC*#I55>+_K[P3L?V]?!
MOXQ_##]H/X7Z)\:/@QXTL?$/ACQ%8I>:/K&GR;HYXF^O*LI!5D8!D965@&!
MZ:OY7?\ @AA_P6K\:?\ !,?XLK\.?BC?7VK_  8\47R_\)%I";I9-$N&PO\
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M92WDVS[3#86CA*?)37^;"BBBOC#H"BBB@ HHHH **** "BBB@ HHHH ****
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M_=P?^*2YFGHXPDNIY>;8OZMA;1^*6B_5GRU1117^G9\6%%%% !1110 4 $G
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M_ W3N@HHHKC&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\9T[T:-3LVOOM_D:4]SZ#HHHKX$T"BBB@ HHHH **** "BBB@ HHHH ****
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M6VW=G^NZ2BK(****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHHK\V-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPCXH:3?)>>';-YSG_EKY2AQ_WT&%=?7\78FA+#8B=&6\6T_D['^NV7XRGF&
MI8JG\-2,9+TDDU^84445B=84444 %%%% !1110 4444 %%%% !1110 4444
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M;?$GPA:>#?AO&FDZM>:=J4$6E: EO:Q2"W>8$0PK%;R0DKN C5ESBOGG4O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(/>OO7]B#]N^T^(T%K\)?C+JR0^(4 BTO5IV"IJ8Z!'/03]@>C_[W#?A7'_
MDJ$YYGET?<>LX+[/>45V[KINM-O[2\#O&JGC:5+AS/ZMJJM&C5D])K94YM_;
M6T9/XMG[UN;ZHHHHK\</ZR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[(?[3G[--_\ !SXY_"GR)O%/@JXU=-0M;NQFQY=]:7**HDC.Z,D8*[9HF5Y
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MFR3Q';ZO^RI_P36\5S063[[3Q+\6[1BDDXY5X=*/!1>H-WPQY\H ;93\4_\
M!5W_ (+S?M5?\%,]0NOA]:S2>!/A4EQFS\#:1>$M?A6RDFH3@ W+Y 81@+$A
M"D(67S#\+5]]DW#$:#5;%ZRZ1Z+U[O\ #U,I3[#IIIKB9[BXE:221BSN[9+$
M\DDGJ:;117V1 4444 %%%% !113[>WGNITM;6%Y)9'"1QQJ2S,3@  =23VH
M]%_9'_99^*_[:?[17A;]F?X+:1]JU[Q3J2V\,CJ?*LX0"TUU,1]V**-7D<]<
M(0 20#_8)^Q5^R)\*OV%/V9O"O[,'P=LMFD^&K 1RWLD86;4;MCON+R;'626
M0LY[+D*N%50/C'_@W8_X) C_ ()[_ %OCQ\</#2Q?%_XA6$;:C!<1CS/#NED
MB2+3AGE96(62?I\X2/\ Y8[F_2*OS'B3-UC\1[&D_P!W#\7W]%LOF^IK"-D%
M%%%?,EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=6TC_@I/^U3X4*Z/83"X^$_AO4(/^/ZX4_+K$J,/]4A'[@'[[CS>%2,OX/\
M\&_G_!#/6OV^?'5I^U#^TMX;N+3X+^'[[-K9SJT;>+[R)N;:/H?LB,,32C[Q
M!B0[O,:+^E_2M*TS0],MM$T33H+.RLX$@M+2UA6.*")%"HB(H 55    P  !
M7Q?$N>JE%X3#OWG\3[>7KW[>NVD(]63T445^?F@4444 %%%% !1110 4444
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M=>)N+LZXRG@\7CJM6A3HSFXSG*:OS0BOB;M;FNK'S#X0_P"#SSP_,BQ>/O\
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MYRE_X"E_FS^L_HK8'GQ^:8UKX84H+_M]S;_](1_/W1117E']DA1110 4444
M%%%% !1110 4444 %%%% !117T[_ ,$Y_P#@DA^V/_P4S\8C3O@5X&-CX7M;
MD1:YX^UY7@TK3^A91)@FXF (_<Q!F^92VQ3N&5:O1P]-U*LDHKJPM<^=?!G@
MOQA\1O%FG^ _A_X6U#6];U:[2UTO2-*LWN+F[F<X6..- 6=B>@ )K]\O^",7
M_!L9X>^$4VE_M-_\%'M!L-;\3Q[+K0?A@[)<6&E-PRR:@1E+J8'&( 6A3'S&
M4G"?;O\ P2^_X(M?LC?\$O\ PQ'J/@#1!XG^(5S:^5K7Q&URU7[9+D?/%:IR
MMG 3G]VA+,,>8\FT$?7U?G^<\3U,2G1PEXQZOJ_3LOQ]#6,+;B1QQQ1K%$@5
M5 "JHP !V%+117R!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!F^+?!_A;QYH,_A?QGH%KJ>GW*XGM+R$.C>A
MP>A'4$<@\@U\>_M#?\$NIX?/\3_L[ZF9%Y=O#>I3_,/:&9NOLLG_ 'V>E?:E
M%>]D?$N<</5N?!U+)[Q>L7ZK]59^9\3QEX>\*<=X7V6:T%*25HU(^[4C_AEV
M_NN\>Z/QQ\5^#_%7@76Y?#?C/P[>:7?P'][:7UNT;CWPPY![$<'M6;7Z^?$O
MX0_#7XPZ(?#_ ,2?!]GJMN ?*,\>)(2>ICD7#QGW4BODKXT_\$J=2MC-K/P)
M\8K<IRRZ+KC!)!_LI.HVMZ .J^[&OVW(O$_)LP2IXY>QGW>L'\^GS5EW9_'G
M&OT<>+,BE*ODS^N4=[*T:J7G%NTO^W&V_P"1'QQ170_$+X4?$CX3ZJ=%^(W@
MO4-(GR0GVN A)<=T<920>ZDBN>K])HUJ.(IJI2DI1>S3NGZ-'\^8K"8K XB5
M#$TY0G'1QDG&2?9IV:^84445H<X4444 =M^S9H'_  E'[0/@O1&3<DWB:R,J
MXZQK,KO_ ..J:^9_^#R[X@?VE^T%\$OA7Y@/]C>#=4U79GD?;;N*'/X_8/TK
M[/\ ^">.@?V[^UCX<E=-T=A%=W4@]-MM(JG_ +[9:_,3_@['\??\)A_P5;;P
MX)0W_"*_#;1]+*@_=+O<WN/K_I8/Y5^1<8U/;<98>E_S[I.7SDVOT1_<WT7L
M#['@W&8MK6I7Y?E"$7^<V?F;1116!_2P4444 %%%% !1110 4444 %%%>N_L
MH_L%?M@_MO\ B8>%_P!EOX >(?%KK*([K4+.T\NPLR?^>]W*5@AZYP[@GMFH
MJ5*=*#E-I)=7H@/(J[S]G;]F#]H3]K7XB6_PH_9N^$.N>,=>N"#]AT:S,@@0
MG'F32'$<$8/621E0=R*_:/\ 8,_X-"-$TY[/QU_P40^,G]HR K(? 7@*=HX/
M79<W[J'8=F2%$P1\LQ%?L-^SS^S%^SY^R;\/8/A7^S=\(-"\&Z#!@_8=$LEC
M\YP,>9-)R\\A'621F<]R:^6S#BS!X>\<,N>7?:/^;^7WEJ#>Y^27_!-'_@TS
M\#>!YM/^+/\ P4A\50>)M23;-#\-?#ETZZ= W4+>7:[7N2.\46R,%<&253BO
MV3\#^!?!7PS\)6'@'X<^$=,T'0]*MUM],T?1K&.VM;2(=$CBC 5%'H *U:*^
M%QV8XS,:G-7E?LNB]%_3-$D@HHHKA&%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5-;T+0
M_$NFRZ-XCT:UO[.88FM+VW66-QZ%6!!_&O!/BI_P34_9[\?/)J'A2&\\*WKY
M.=+DWVY;U,,F0![(R"OH:BO3RW.<URBISX.M*#\GH_5;/YH^=X@X2X:XIH>R
MS;"0K+HY1]Y?X9*TH_)H_/'XE_\ !,#X^^$3)=>![S3?%%LOW5MIA;7./4QR
MD+^"NQKPWQM\*?B9\-YS;^/O .KZ0=V%>_L)(T?_ '6(VL/<$U^P%,N+:WNX
M'M;N!)8I%VO'(H96'H0>M?H67>+.<X=*.,I1JKNO<E^%X_\ DJ/PC/\ Z,'"
M6.;GE6)J89OH[58+T3<9_?-GXQ45^K'C+]D+]FCQYO?Q!\&]%61^7FT^W-G(
M3ZEH"A)^M>6>*?\ @E;\ M7=Y_#7B7Q%I#M]V);J.>)?P=-Y_P"^Z^TP?BMP
M]75J\)TWZ*2^]._X'Y#FWT9./,&V\%5HUX^4G"7W2CR_^3L\=_X)1Z!]M^.&
MN^(73*6'AEXU..CRSQ8/_?*./QK\(_\ @X%\>_\ "QO^"POQOUM9MZ6GB&TT
MM #POV+3[6T('_ H6S[DU_3C^R7^Q]9?LLWOB&ZM_'#:W_;:VRQ-)IP@:W6+
MS20<2-OW&0<\?=Z5^+O[>'_!KW_P4I^.O[5GQ+_:,\$^/OA9JUGXY\>:MKME
M8MXCO8+JWANKR6:.)UDLQ&"B.J\2,/EZU\7C^(<JS#BVOC(55[/DC&+=U?1-
MZ-)JSON?U#X.\*9IP?P%0R_,:?)7YJDIQO&5FYM1UBVG>*B]'UL]3\::*_0?
MQ#_P:^?\%C-%E\O3?@'H&KC_ )Z:?X]TM1W_ .>\\9_3O7+WG_!N'_P6CL9?
M)F_8IN6.,YA\<Z!(/S2_(_"O06:Y9+:O#_P)?YGZ?9GQ!17V]:?\&XG_  6B
MO9O(A_8INE;&<R^.-!C'YM?@5T7A[_@V'_X+)ZUM_M+]G'1](SU_M#Q_I#8^
MOD7,G^30\URQ;UX?^!+_ #"S/S_HK]2?!?\ P:,?\%/O$A5_$?C?X3>'DX+K
MJ'BB\FD'T%O92*3_ ," ]Z]N^&W_  9E_$.[>*;XO_MVZ-IZ@@S6WAOP1->%
MO4++/<P[?J4/TKFJ9_D]+>LOE=_DF/ED?B117])?PA_X-$O^"<?@F2&^^*7Q
M*^)?C6=,>;;3ZQ;:?9R?\ MX!,/^_P!7UW\"?^"-/_!+G]G"6&[^%O[$O@=;
MNWP8-0U_3FUFYC8?Q)-J#3.C>ZD&O,K\7Y;3_AQE)^EE^.OX#Y&?RC?L_P#[
M%W[6O[55^MA^SE^SAXS\9YDV/=:#X?GGMH3G'[R<+Y40SW=E%?H/^RW_ ,&D
MW_!0+XN&VU?]HSQMX3^%.F28,UK/<C6-40'N(+5A!T[&Y!'IUQ_2/8V-EIEG
M%I^FV<5O;P($A@@C")&HX"JHX 'H*EKP\3Q?CJNE&*A^+_R_ I01^=7[(?\
MP;!_\$Q_V9Y+3Q!\1?!NI_%G7[<JYN_'=R&L%D'7980A(60_W)_.^M?H+X6\
M)^%O WA^U\)>"?#6GZ/I5A$(K'3-*LTM[>W0=%2.,!4'L !6A17S>)QF*QDN
M:M-R]7^2V12204445S#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HK\@OB/_P '>W[./PY^(6O?#V]_9 \;7,V@ZS=:=-<1:[9A96@F
M:(N 1D E<C/K6-_Q&4_LS_\ 1F?CK_P?V7^%>RN'\X:NJ3^]?YD\T3]EJ*_+
M7]C;_@Z1^ G[9'[4'@K]E_PU^RSXOT:_\::RNG6NJ7VLVLD-LS*S;W5!N(^7
MMZU^I5<&+P6*P,U"O'E;UZ?H--/8**YCXO?&KX/_ +/W@:Y^)GQS^*&@>#_#
MUFRK<ZUXDU:&RMD=ONIYDK*I=B,*H.YCP 37FVG?\%)_V$[ZRN-0NOVG/#.E
M1VVG3ZA_Q45P^EM/:PQF26:!;Q8VN$1 6+1!P!SW%<HSW"BO*?C;^W3^QE^S
M3?V>E_M$?M3> O MQJ$7F6$7B[Q3;:<;E-JMNC\]UWC#*3MSC</6CX._MV_L
M3_M"^+6\ ? K]KGX:^,-?6(R'0O#GC:QO+WRP-Q?R(I3)M YW;<<'F@#U:BN
M+^-W[1OP#_9I\,IXT_:%^,?AOP3HSOL75O%.L16-MNRJX,LK*@.74 $\E@!1
M\-OVC?@+\9/A[)\6OA)\7_#WB;PO%&TC^(=!U2.[LR@SEA-&2C 8.2">E ':
M45Y)\+OV^/V)?CAXFU#P7\&?VKO 'BS6-)1WU32_#?BFVO;BS5-VXRQPNS1X
MV/G<!RI':L3_ (>@?\$Y/[<O_#'_  W/\*?[2TN8PZGI_P#PG5CY]I("5*2Q
M^9NC8$$88 Y!H ]VHKS7X&_MD_LF?M.:WJOAK]G3]I3P/XYU'0HDDUJP\*>)
M[6_FL$<E4:9(78QABI + 9(->E4 %%%% !1110 45\J>(/\ @JI\/_#^O7N@
MS?"G6)'LKN2W>1;V(!BC%21]<54_X>U_#O\ Z)'K7_@=#7UT>!.+9Q4EA79^
M<?\ Y(_+:GC5X7TJCA+,HIIV?NU-U_VX?6U%?-?PE_X*3^"/BU\2-'^&^G?#
M75;2?6+L6\=S-=Q,D9()R0.3TKZ4KQ,TR;,\EK1I8VFX2DKI-IZ;=&S[#AOB
MWAWB_"SQ.3XA5H0ERMI25I63M[R3V:"BO,OCQ^V9^RY^S)K.F^&?CG\;-$T#
M5]9A>?2M#FF::_NX4.'FCM85>9HE/#2!-BG@D5-\'?VP?V6/VA8[R7X$_M!^
M$?&(T[35O]2_X1K7(;TV=NSR(&F$3,8COBE78^&!C8$94UYA]$>CT5Y)X _;
MX_8E^*_Q*F^#7PQ_:O\ A_XA\76TK1W7AC1O%5K<ZA ZL$826\;F1,,0IW 8
M) -3_&C]N7]C7]G'Q3:^!_V@/VI/ ?@G6+XC[#IGBKQ1;6$]SD*?W:3.ID^^
MGW<_>'K0!ZI1530=>T?Q/H]OX@\/ZC%>65W$)+:Z@;*2H>C ]Q6;9_$WX?7_
M ,2;_P"#MGXPL)/%.EZ+:ZOJ&@K<#[3!8W,L\,%PR=?+>2VG4'UC.>HR ;M%
M%% !1110 4444 %%?E!\0?\ @Z\_9\^'WCW7/ 5Y^R=XRN)M$U>YT^6XBUJT
M"RM#*T98 C(!*Y_&LC_B+J_9S_Z-#\;?^#RS_P *_7:?@/XMU::G#*YM-77O
MTMG_ -OG \TP"=N?\_\ (_7:BOS/_9&_X.7O@;^UQ^TIX._9L\._LS>+-(OO
M&&KKI]MJ=[J]M)%;L59MS*HR1\O:OTPKXGBG@WB;@K&0PN=X9T:DX\T4W%WC
M=J_NMK=-'30Q%'$Q<J;N@HKF/B]\:O@_^S]X&N?B9\<_BAH'@_P]9LJW.M>)
M-6ALK9';[J>9*RJ78C"J#N8\ $UYMIW_  4G_83OK*XU"Z_:<\,Z5';:=/J'
M_%17#Z6T]K#&9)9H%O%C:X1$!8M$' '/<5\P;'N%%>4_&W]NG]C']FJ_M-+_
M &B/VI_ 7@6XU"+S+"+Q=XIM=.-RFU6W1^>Z[QAE)VYQN'K5CX(?MK?L=_M+
MZU=>&OV>/VJ/AYXXU.QC,E[I?A3QE97]S;H,#>\,,K.J\CYB .: /3J*\:\2
M?\%$OV#?!_Q1?X(>*_VQ/AOIOC..Z^S/X3O?&%I'J0F[1_9FD$A8]AMR:].\
M=^/?!7PP\(7_ ,0/B+XJL-$T/2X//U+5]4N5AM[6+(!>21B%1<D<DX% &O17
M%? W]I#X ?M.>%9?'/[.GQH\,>.=%AN3;RZOX4UJ&_MEE'6/S869=P[C.17:
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!_$S^U#_ ,G,?$3_ +'K5_\ TMEK
MA:[K]J'_ ).8^(G_ &/6K_\ I;+7"U^XTOX4?1'.?5W_  0U_P"4MWP'_P"Q
MZB_]%2U_7E7\AO\ P0U_Y2W? ?\ ['J+_P!%2U_7E7Y[QE_OU/\ P_JS6&Q^
M4_[$_C)O^"HG_!>O]H7XI?&!1JW@W]D6YM_"'PK\*7P\RST[6IKBZ@N]7$1^
M5[KS-.NU64C*))$!S$C#]#?VP?V3_@[^V[^SCXJ_9D^.GAFVU/0/%&E2VKF>
MW5Y+&<J1#>0D_<GA<B1'&"&4=LU^:7P;O]'_ ."(W_!;WXY:Q^TS=?\ "/?!
M']KG4(/$'A/XGZ@"FE:?XC2>YN)=.OK@_):,TE]?%6<A2OD'."YC_2OQS^V#
M^SQX+T&SU2S^)^C^(=0UD;/"_AWPQJD%]J/B"<C*064$;YF8]2_$<:AI)'2-
M'=?D"S\[_P#@XXL;;X>?#G]B5/&>N68/A_\ :A\)Q:GK,["&)5BA?SIBSG]V
MG[O>23@ <GBN*_X.!O$WP[_;Z^)W[/\ \'?^"8_B'3/'G[27AKXIV>IVOC'X
M<W"7_P#PANBK%-YLFHW]J62TB-R;28)*X.('('.'[3_@YF\:>']/T']C2'XF
M7FD:3>2?M0>'-1U?3)]126."WB5OM3;W5/,AC,BJTA51AE) W8J]_P %"OAK
MXH_X(W?MDVW_  67_98\(S7/PC\8M::-^U1\/] @'E_92X2V\1VT*X3S8F<!
M\8RS=0+B>10#Z0_X+]0Q3_\ !&S]H1)HU8#P!*P##/(FB(/X$ _A7&_\$P_^
M"F'_  37^'?_  38_9]\!>-/^"@7P.T+6M&^"7A6RUG1=4^*VCVUU8WD>D6J
M3P30R7(>*5) ZNC ,K @@$&D_P""T7[1WP&^-W_!"+XV?&3X2?%WP_X@\+^(
M/A^%T?6M,U..2&Y>>:$1Q @Y$I9@OED!PV5*@@BO:/\ @D)KNBZ__P $I_V;
MKW0]7MKR&'X%^%+:66UG5U2:'2+:*6,D'ADD1T9>JLI!Y% 'QI_P;O\ BOP'
M\0?VW_\ @H)\0OAIXFTG7-#UOX^Q7FE:YH=[%<VE_;R2ZG(DT4T1*2QMO+!E
M)!W9!YKF/V(?VG?V<OV7?^"^?[>]]\?/C!X>\&VVK7'A(:=)KE\MNMRZ6#-+
MM)ZD;U)_WO>NJ_X-_O'/@SQ)_P %$?\ @H=;:!XJT^]DN/C_ /:K=+:\1S-
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M,@<"0>2BL 5Q6!X7_;6_9$_:J_:!^.7_  3@_:/NO!%SK7@WQ';Z<W@7Q;'
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M%&EI:>'O!7AZVTG3(UC"LZ0QA3*^.LDC;I';JSNS'))-=Q110 4444 %%%%
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M&][<"&. 32LH!D<10PQAFR=D2+G"@"Y10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>mdt-20221028_g9.jpg
<DESCRIPTION>IMAGE 13
<TEXT>
begin 644 mdt-20221028_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ? ?\ P<.?\%<]8_X)
M/_L>V>M?"B"TF^)_Q#OYM)\"_;HA+%IXBC5[K47C;B40+)$JH<J99XBP9 RG
MQ#_@WS_X)M_"W]H_]CS3?^"C7_!1/PM:_&[XK?%VXO+^+5_BK;IK@TC2DN9(
M((+:*[$D4/F")IBR*"$F2,;53;7S7_P?$_#KQA,_[//Q:AMII= MQXATBXF
M)CMKR3[#-&I/0-+'%*1ZBW;TK]1/^"".OZ-XD_X(X_L\ZCH4R/!'\.[:U=D.
M0)H))()A]1+&X/N#0!^87_!<1/B9_P &\W[9/PO_ &RO^"9^J-X-\!?$EKV'
MQI\(+25U\,7=]9M"\G^@@^5 MQ!<8!A56B:%V0KO(K]IOV3OVN/A7^UQ^R1X
M._;'\%ZC'I_A?Q9X6CUIVU&Y11IH"'[1#/(<*#!(DL;M]T&)CG'-?D/_ ,'O
M^NZ1;_L[_ ;PS-,@O[OQIJ]U;1D_,88;2%)"/8-/%GZBOFW]L'XG_'?]DC_@
MTG_9M^ ]K>WVD-\7?%6H2:XR,R,^A37VI:I!;@\$).)+24]F3<O*L: /W'\(
M?\%B/^"9/COXF:+\(_#'[8_A.;6?$MR]OX9:9YX++6I5E\HI97LL:VMV?,_=
M@0RON?Y1D\5=_P""E7_!37]F7_@EQ^S[=_'']H7Q1']KGBEC\)>$;2=?[1\1
M7BJ"(+=#R%!9/,F(V1*P+')56^,_'/\ P1=_9X_X+'_\$EOV/=*L/BW?^ T\
M ?#/1+O0]6T#2XKHO!=:79"]MV1F3;*TMO&WF;B5D1BRN2176?\ !U#X7TC3
MO^"'/C^.6'[9<:5?>&[>TU"_ EN0/[8LD9C(1G<P W$8W'K0!K_\$&O^"P_P
MT_;S_9QT'1OC=^T7X8N?CEXFU[Q)J=YX!@O@+O3[%=2NI;>".(\B&&T\H(22
M?+522223[S=_\%C_ /@F%9>*Y_"5S^V?X.!M=:&D7>M+/*VCP7Y&1:R:H(S9
M)+C/R-,#P?2OQI\(?&CQ+^S9_P &;6D^./A5:1:;XC\7^*=3\*W7B.SMU2[M
MK&[UZ]%R!*!N D@B>W//W9CC!Q7J/P+^&G@X_P#!DMKCWNBVSOJ/A[6]9NG:
M(9>\A\63"&7_ 'U6W@4'KA * /W+UW0/"'Q#\*W/A[Q-HNFZYH>KV9BN[&^M
MX[FUO;=UY5T<%)$93T(((-?S:?\ !LA^TA\#OV1_^"@O[2GQ _:&^,>D^"_!
M.@^#[VUBO_$6J^5;PXUR!(H8PYR\A5<+&@+MC !K]'/^#1?]HCXD_'K_ ()(
MP:#\1]6N;_\ X5S\0M1\*:%=W<A=SIT=K97D,>X\E8C>O$HZ*D:*.% 'P%_P
M:=>!/!7BK_@L+\?O$/B?PEINHWV@^'=6N-$N[ZR262PF?6X8VEA+ F-RC,FY
M<':S#.&((!^[_P"R1^WU^QM^WAX>U#Q/^R+^T-X=\<VVDRK'JL.E7#+<V1;.
MPS6\JI-$K;6VLR -M;:3@XU?V@_VP?V:?V5VT:U^//Q<TW0K_P 1W+6_AS1-
MDMUJ6KR*,NMK96R27%SM&"WEQMMR,XR*_ K]G6[O?V1_^#R7Q!\+?@#:#2O#
MWBKQKJ%AKFA:8GEVTUI?Z+_:,T9C3 "1W)6<*  IA7L,5U/[+?[6/QX^,_\
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M=:V\N.&O;J9$EAM\ABMN&8+&YD7[M_9I^#7P5_9A^#WA[]E?X%6]I9:'\/\
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MTO2HK#PEY\8=5U.\GCM8)2C<.(FE,Y4\,(2#UK\=_"7P.\(>,/\ @U2\4?\
M!1_Q%9M=?'ZX\;2^+XOC-.Y;Q-%J$/BF+3PZ:D?])1?LT;H$#A079@,G-?<W
M_!VC9R_$+_@BAJWC;P-J,.HZ/:>,O#NJS7^GSK+!/92S&&.574E7C9[F A@2
M#N4CK7RA\,Y8T_X,>-7((XL[]6^I\=M_B* /T7_X(@_\%!/BC_P4!_X)-^&O
MVBM?L8O$/Q*T6QU#0]?MO/2V75M8L<B)F?A(FN(C;2.V JM.V % K\W/^"QW
M_!MU\=/$G[,'Q$_X*2_&G]O+6/B#\9/#N@7'B?Q?I>H:6(M%^QP(T]S8Z;ES
M);0V\0?R0<JXB"[(R^5^E/\ @S*\,Z[H/_!)OQ#JNK1.MOK7QJUB]TLN.&@7
M3M+MR5]O-@F'U!KW7_@N=\3?B9\9/A';_P#!)_\ 9)L4U7XO?'VS-G>@L?L_
MA;PF)574M9OV4'R;=ES;)GYI7E<1AW380#Q[_@T1_:H_:%_:5_X)N:YH?QV\
M2:CK]OX \>S:#X4U[59WFG>Q^QVUP+1I'):00-,0I).U)$085%%7O^"D_P#P
M0*^.O_!7SX@^*OB?^TS^VKK?@^RTR^NK+X/?#C0[!+O1]'M(2T45_> R#S[F
M[*F=RFQXDE2+>WEA1]J?\$]/V-/@7_P3D_9C\*?L4?!S5H)SX=THW>HSW#HM
M[JUS*^;G498P2P$DQ('544)&#A!4O_!0?]L_P_\ L,_LVZG\6I-!G\0>*=0G
M31OAQX*T^)I;SQ/XAN<I9:?!&GSN7?YG*@E(DD?!VXH _%'_ (- ?C/^U/\
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MMM])UWP_):RW+VL4J7H6"=$2\GB9TEW. DFU2/+/=?\ !,?_ ((U?%+X3_\
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MCS7OV(O'>ERKX+UWP>/#ICMBHEM(4B5()HB00)86CBD0D$!XU)!'%?E[I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^#@__E,;\</^P[8?^FNSKXTK\PRW_D74?\$?R1_J ]PHHHKM **** "BBB@
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MXQ!+JJZA<2W1T<",D0RZE(SF2-68P:=$R%MUU!*0#Z<_9/\ C7X^_:1L=?\
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MS. <%;=#CS#VW<*.>21M/#F.98'*L++$8NHH075_DENWY+4]G(>'\YXGS*&
MRNC*K5ELET7=O:,5UDVDNK/*/"7@[Q3X]U^#PMX,T"ZU/4+EL06EG"7=O4X'
M0#J2> .217V%^S__ ,$MH(A!XD_:%UKS&X<>'-*FPH_V9IQR?0K'CV<U],_!
MCX!?"[X">'QH'PY\-QVQ=0+N_EP]S=D?Q22$9//.T849X KLZ_"N)/$_,,>W
M1RR]*G_-]M__ "/RU\UL?VGX??1RR+)(PQG$36)K[^S5_91?9K1U'_BM'IRO
M<RO!W@?P?\/=$C\-^!_#-EI5C%]RVL;=8US_ 'C@?,Q[L<D]S6K117Y;4J5*
MLW.;;;W;U;/Z3HT*.&HQI48J,8JR2222[)+1(****@U"BBB@ HHHH **** "
MBBB@ HHHH *YKXM?!KX3?'KP->?#/XV?#;1/%?A^_7%WH_B#3([JWDX(#;)
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MUN+%7,,^_:0SQNF,\9&UN-T/]F+XX_M#?M"_#S]IW]L_1/!N@S?"I+ZY\#^
M? ^NW.LV\6JWEO\ 9I=2N]0NK.S:9DMVDCB@2V18VEDD:24^7Y?TI10!\$?M
MD?L\_P#!;SXJ?M=V?Q=_9W\5?LQ0^ ?"&X^ /#'Q'E\07DD%XRE6U:X2T@CC
M-[L9XX\F1;='81G>\DC^P?L/>!?^"J5GXZ\0^-/^"D'Q=^$E_:KI4%EX/\-?
M!O3]0ALED:1GN;N\:_7S7E 2!(@K% K39 + U]+T4 >&_L6^!_VS;CX#2Z%_
MP4PU3X;^*O&X\37TUM-X'TR0::NG;_\ 104N44^:%+\[>$* EF#,?,_^"@__
M  36U']JWXO_ +.?C[X5V'@K1K#X1_&6T\6>+;;4K,Q/J6GQ(5:WA$,#K)(2
M>%D*)ZM7U]10!S'Q0N_'OA#X3ZO/\#? NGZOXCL]*=/#&A7=VMG9RW6W;"DL
MG_+*!6(+E06"*VQ6;"GGOV9_V=]-_9^^$G_"#:EKTGB'7M9NY]5\=^*;J(1S
M^(-8N<&ZO'4$[%) CCB!*PP10PI\D2@>D44 ?EU\.O\ @CY^TUH7[-_P+_X)
MHZY'H:?##X'_ +0)\=M\2UUH/<:[H=OJ-]J-EIR600217KRWHBF=B(HT@+H\
MK/L7]1:** "BBFS316\37%Q*J1HI9W=L!0.223T%&X-I*[/./VJ_V@=+_9S^
M$UYXQD,<NJ7&;;0K-S_KKE@<,1_<09=O88SEA7Y9:YK>K>)=9NO$.O:A)=WM
M]<//=W,S9>61B69B?4DFO4_VT?VB)OVA?C#<ZEIETS:!I&ZST&+)PT8/SSX]
M9&&?7:$!^[7D5?T]P%PRN'\I4ZJ_?5;.7=+I'Y=?-OLC_./QN\19<=<42HX6
M=\'AVXT[;2?VJG_;S5H_W4MFV%%%%?='XN%%%% !1110 4=>E* 6(5022> *
M^Y?V&?V#[;PU!9_&;XV:,'U1MLVB:%=)\MF.JS3*>LO=4/W.I^;A/!XAXAP'
M#> >(Q+NWI&*WD^R\N[V7W)_;<!\!YWX@9TL!E\;16LZC^&G'N^[?V8[R?9)
MM<Q^QS_P3OE\116GQ1^/VGR0V+ 2Z;X:D!62X'57N.ZIW$?5OXL#Y6^W;.RL
M].M(M/T^TB@@@C6.&"&,*D: 8"JHX  X %245_,?$'$>9<1XSV^*EHOABOAB
MO)?F]V?Z,<#< \/< 94L'EM/WG;GJ/XZC763[=HK2/17;;****\$^V"BBB@
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MYKA\UH<]/22W75?\#LS&2<64J***],04444 %%%% 'IG['O[5OQ7_8D_:/\
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M@ HHHH **** "BBB@ HHHH \ _X*-_&7_A6/P"G\+Z;=;-3\62'3X IPRVP
M-P_TVD1_]M17YO5[U_P48^++?$C]HJ]T"RNM^G^%HAIMNJM\IF!W3M]?,.P_
M]<A7@M?U'P!DRRCANES*TZOOR_[>^%?*-M.]S_-OQRXL?%7B!B/9RO1P_P"Y
MAV]QOG?SGS:]8\O8****^U/Q\**** "BBB@#JO@M\)/$WQP^).F_#?PM'B>^
MF_?7#+E+:$<R3-[*N3[G ')%?JU\-OA[X9^%7@;3?A]X0LQ!I^EVPBA!QN<]
M6=B.K,Q+$]R37A?_  3@_9W_ .%6_"X_$[Q'8[-;\51))$)%^:WL>L2>Q?\
MUA]04!Y6OI"OYN\1N)GG.:/!T9?N:+MY2GLW\ME\VMS_ $%\ ?#N/"?#2S7%
MPMBL4D]=X4MXQ\G+2<O/E35XA1117YP?OX4444 %%%% !1110 4444 %%%%
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MIZ_+K_G\BH.S/Z&:***_+S8**** "BBB@ HHHH **** "BBB@ HHHH ****
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MAQ5>^CG)+T3LOP2/]3_#C*5D? >6X-*SC1@W_BDN>7_DTF%%%%>"?:A1110
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MOCR["QBMDQZ(@4?RJ]117\62E*<G*6[/]>Z5.%&G&G!6222]$%%%%26%%%%
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M<M6O8L?^.5\AQE&^!IR_O?H_\BX;GV=1117YT:A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^?\%-03^RY<
MGTUNS_\ 0FK\XJ_2?_@I+:FX_91UB8+GR-1LG/M^_5?_ &:OS8K^C?"F2?#,
MEVJ2_*)_ 7TFH./B+3;ZX>F__)ZB_0****_2S^> HHHH *Z3X.)YGQ>\*Q_W
MO$EB/_)A*YNMGX<WG]G?$+0=0SCR-9M9,^FV53_2N?%Q<L+42ZQ?Y'=E<XT\
MSH2ELIQ?_DR/V'HHHK^+S_78**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^.G_@
MKLP;_@J/^T$1_P!%>UX?^3LM?.M>W?\ !3#7D\3_ /!1KX^>((I0\=W\9_$\
MD+ Y!C.JW.W_ ,=Q7B-?MF$5L+37]U?D<[W"BBBN@ HHHH *_J]_X-N!C_@B
MO\%1_P!,O$'_ *D.I5_*%7]9O_!N[I!T3_@C3\$;-@1OTK5;CG_IKK-]+_[/
M7R?&+_X38?XU^4BX;GVG1117YN:A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!Y#^WEI;:O\ LE^,;9$R8[6W
MG'MY=U#(3^2FOR]K];OVB=!;Q/\  7QGH4:;GN/#%\(1_P!-! Y7_P > K\D
M:_?_  BK*63XBCVJ7^^*7_MI_#?TI\&X<68'%6TG0Y?_  "I)_\ MX4445^L
MG\OA1110 4^">6VG2X@<J\;AD8=B#D&F44;C3:=T?LKH.JQ:[H=EK<&-EY:1
MSICT=0P_G5NO/OV4?%0\9_LW>"]>\S>Q\/P6\K?WI(5\ES_WU&:]!K^,<=AW
MA,;5H/>$I1^YM'^N.38^.:91A\;%W56G":_[>BI?J%%%%<IZ04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4RYN8+.WDN[J98XHD+R2.<!5 R23Z 4^O&/^"B_Q<B^ _[!/QD^
M+K7 CET/X:ZS/9,6QFZ-G(D"Y[;I6C7\:NE3=6I&"W;2^\#^.?XN>-&^(_Q6
M\3_$-RQ.O>(;W427ZGSYWEY]_FKGJ**_<$E%)(YPHHHI@%%%% !7]@/_  19
M\*2>#/\ @E%\ M'D0J9OAMI]\ 1VND-R#^4U?Q_5_:Y^R#X F^%'[)GPO^%M
MQ#Y<GAKX=Z)I3QXQM-O80PD?^.5\9QG.V&I0[MO[E_P2X;GHE%%%?GQJ%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYFT59!1117D%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:2^(R& @#HPROG1FOQ;_ &[_ /@K3^W5_P %&-7D;]HWXRW+>'OM'FV7@;0
MUEHEH0<KBV5CYS*<[99VEE&2-^.*_-,XXCSCB?#SPM"DJ.'GHW-7G)>4=H_G
MU4C^P_#?Z/\ EW"&/HYMF>)=;%4WS14&XTXOUTE/Y\L6KIQ:/[#NO2BOSR_X
M-Q?^"ET'[=W[%%I\,/B!KWG_ !'^%-O;Z-XA%Q+F;4; *5LK_GEBT:&*1LDF
M6%F./,7/Z&U^*XO"U<'B94:F\7_3^>Y_1Z=T%%%%<XPHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^ ?\
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MK4:\EM'^K2+X*^C?PSDG+B,]G];K+7D5XTD_3XI_]O-)]8'[1?MB_P#!QO\
M\$W_ /@GSHE[\(/V'?!EC\3O%, ,<DOAR<1:)!*,@-<:B0S7K#((\D2*PRIE
MC-?BE^WI_P %=/V[/^"C.K2K^T-\8;A/#?G^99^!/#H:RT6VP<K_ *.K$SLI
MSMDG:609(# <5\T45Y>$RG"X:HZTKSJ/><G>3?J_^'/Z*PV&PV"P\</AX1A3
MBK*,4HQ2[)*R2] HHHKTS8^@?^"8_P"WW\0?^";?[7OAS]I3P4)KK3[>3[#X
MNT*.3:-7TB5E^T6YSQO^59(R>%EBC)R 0?Z^?@U\8/AS^T#\*?#_ ,;/A'XG
MM]9\->*-*AU#1M2MF^6:&1<C(ZJPY5D.&5E92 017\0M?K5_P;._\%D;;]E/
MXBQ_L*_M(>*?(^'7C+5-WA#6+Z;$7AS5Y6P8F8_ZNUN6(!/W8Y<.0!)*X^4X
MGRAXRC]9I+WXK7S7^:_KH7"5M#^C:BBBOS8U"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G/B]\6OAY\!OA?
MKWQF^+/BBWT7PUX9TN;4-:U.Z;"001J68X'+,>BJ,LS$* 20*_D*_P""H_\
MP4$\>_\ !2G]L#Q%^T9XK^T6FD,_V#P9H4TF1I.D1,WD0\$CS&W-+(1P9)7(
MXP!]T_\ !S-_P62@_:?^($_[!/[-_B@3?#[PAJF[QIK-C-F/Q#JT+8$",IP]
MK;.#S]V28%AD11N?R.K](X8RAX2C]9JKWY+3R7^;_+YF4Y7T"BBBOK" HHHH
M ****   DX K^N7_ ((;_L/_ /#!?_!./P/\,->T?[)XK\06Y\2^-E=-LBZC
M>*C^2X[-# L%N>V8">]?@-_P;Q_L!G]NK_@H=H%QXLT0W7@?X:^7XG\6F6/,
M4[0R#['9MG@^;<!24/WHH9O2OZM*^$XPQ]W#"1>WO2_1?K]QI!=0HHHKX8T"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "O@[_ (.+_P!D'XJ?M:?\$VO$G_"FO%6NV^M>!Y/^
M$BE\/Z5J,L<'B"QA1OM5I-"C;9RL69HPRL?,@"KCS#7WC2,JLI5@"",$'O71
MA<1/"8F%:&\7<35T?PP45]]_\'#/_!,=O^">O[:-UXG^'6@&V^&?Q,DGUCPA
MY$6(=.N-P-WIHQPHB=U>,=!#-&.2C5\"5^R87$TL9AXUJ>TE?_@?(P:LPHHH
MKH **** "BBB@#^A7_@W!_X+H0?'C0-*_8"_:^\9@>.=,MUMOAYXIU*?GQ#:
MHN%L9G;K>1J,(QYG08/[Q<R_L77\,VEZIJ>AZG;:WHFHSV=[9SI/:7=K,T<L
M$J,&1T=2"K*0""#D$ BOZ./^"!__  <#Z%^V%I>E?L@?MD^)K73?BO:PK;>'
M/$MTZQ0>+T485&/"I?X'*\";[R8;*5^?\19 Z3>*PR]W>273S7EW[>FVD9=&
M?K#1117Q9H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5^._P#P<>?\%T;7X!^'M7_8#_9#\99\>:G;FV^('BK3)^?#MJZ_
M-8PNIXO)%.'8<P(V!B1@8NF_X+W?\'!&@?L?Z3JO[(7[&?BFUU+XL74;6WB/
MQ+:,LL'A!",,BGE9+_!X3D0]7^8!*_G)U;5M5U_5;G7==U.XO;Z]N'GO+R[F
M:26>5V+/([L269F))8DDDDFOM.'<@=62Q6)7N[Q3Z^;\NW?TWSE+HBO1117Z
M 9A1110 4444 %*B/(XCC0LS'"JHR2?2DK]-/^#9;_@F*_[9?[6Z_M,?%'PX
M9_AU\);R&\*W,68=5UWA[2UYX=8N+B0<XVPJPVS5RXW%TL#A95ZFT5]_9?,:
M5V?LA_P0*_X)T#_@GE^P7HVD>,M#^R_$'Q[Y?B'QV98\2VTLB#[/8-W'V>$A
M67D"5YR.&K[<HHK\<Q.(J8O$2K5'K)W-DK(****P&%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'SW_P4]_X)_P#P]_X*3_LA>(OV;_&?D6NI2I]N\'Z[+'N;2-7B5O(G
MX&=AW-'(!RT4K@8)!'\@_P 8?A'\0O@)\4_$'P6^+'AJ?1_$GAC59M.UG3;@
M?-!/$Q5@#T93C*L,AE(8$@@U_;Y7Y"_\'//_  1^;]HOX;S?\% OV>/"IE\=
M>#M-"^.]+L8,R:YH\2\7051\]Q:J#GN\ (R?)C4_6<,9NL)6^K57[DGIY/\
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M17C_ .V;^WG^RM^P%\,G^*?[47Q7L?#]HZN-,TT'S=0U651_JK6V7YYFY )
MVID%V5>:NG3J59J$%=O9(#UR\O+33K274-0NHX(((VDGGF<*D:*,EF)X  !)
M)Z5^('_!;7_@YHLM,@U;]E+_ ()J^,$N+IU>T\3?%NQ?,< Y5X-*;^)^H-YT
M7DPY)65?BW_@K=_P<)_M*?\ !1M]0^$'PSCNOAY\(I)"A\-V=U_IVN1@\-J,
MZ'YE/7[,G[H$C<92JN/STK[W)N%U1:K8Q7?2/1>O?TV]3*4^Q)>7EWJ%W+?W
M]U)///(TDTTSEGD=CDLQ/)))))/6HZ**^T("BBB@ HHHH ***559V"(I+$X
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M**_/34**** (=1T[3]7T^?2=6L8;JUNH6AN;:XB#QRQL"&1E.0RD$@@\$&O
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M-0J(BX"@<  #H*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIINA6#3-&F<&21A\L,8SS(Y5%ZDBOV>_8/\ ^#0:"/[%XY_X*&_&GS#\LC>
MO $V!Z[+C4)%R?1DAC'^S-WK]C/V;?V4OV<?V0/A]%\+?V9_@YH?@W1(]IDM
MM'LPKW+@8$D\K9DN),<>9*S,?6OE\PXKP>'O'#KGEWVC_P 'Y?>6H-[GY$?\
M$U/^#2SPWX?_ +/^*_\ P4J\5IJUX-LT7PQ\+WS+:Q'KLOKU"&F/8QVY501_
MKI 2*_9[X=_#CX?_  B\%:=\-_A9X*TOP[X?TBW$&EZ+HMC';6UK&/X4CC 5
M1U/ Y))/)K:HKX7'9EC,QGS5Y7[+HO1?TS1)(****X!A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% '/?%#X2?"SXW>#[GX>_&3X;Z%XKT&\&+K1O$6DPWMM+P1DQRJRDC)
MP<9':OS=_:Y_X-0O^">?QV>[\0?L_:UXB^$6M3EF2+2)CJ6D[SR6:TN6\P#/
M18IXU R O3'ZAT5UX7'XS!2O0FX_E]VPFDS^8G]J#_@U<_X*=? N2YU7X3:1
MX;^*NCPY:.7PKJRVU\(QW>UO/+);_8B>8^F:^!?C%^SW\>/V>?$#>%/CS\&/
M%/@S40Y46?B?0;BQD?'=1,B[AW!&01R#BO[<*S_$_A/PMXWT2?PUXS\-:?J^
MFW*[;G3]4LTN()1Z-'("K#ZBOI<-QAC*>E>"EYK1_JOP1+@NA_#?17]<'QS_
M .""7_!)3]H"6>^\5?L8^&]'O9LD7O@N2?1&1C_$([*2.)C_ +R,/:OD;XO?
M\&>'[%7B:>6[^"_[2?Q$\)O(25M]7BL]6MXCZ*HCMY,?[TC'WKW*'%N5U/C4
MH^JNOPO^1+@S^=BBOV4^)7_!FO\ M.:7*X^#_P"V3X#UU 3Y;>)=#O=*)],B
M#[7C\S7B?C7_ (-2/^"M'A61DT+P_P##_P 2@' ?1/&BQ@^X^V10']*]*GGN
M45=JR^>GYV)Y9'YKT5]P>(?^#<+_ (+.>'&/G_L97%TF?EDT[QIHDX;I_"EZ
M6'7N!7/77_! S_@L#:2M#+^PQXI)3J8KVQ<?@5N"#^%=*S++I;5H?^!+_,+,
M^0**^P;3_@@/_P %@[V;R8?V&?$ZMC.9M0L(Q^;7 %=-X;_X-L_^"SGB/;(/
MV/C81-C][J7CG0XL=.J?;2_0Y^[V/?BAYEET=ZT/_ E_F%F?#%%?IGX%_P"#
M3?\ X*M^+=A\0#X:^%]WWO[<\8O(4^OV.WG_ $KW+X8?\&:/QQU)XW^,_P"V
MWX4T90<RQ^&/"USJ9(] T\MKCZXX]#TKEJ9]E%+>LOE=_E<.61^+5%?T>?!S
M_@T$_8!\'2QWWQ@^-'Q(\:3)C?:PWEKIEI)ZY2.%YORF%?7WP(_X(F?\$J_V
M<IH;[X<?L3^#9KR#!BO_ !/:R:W.KC^-7U!YBC>Z;<=L5YE?B[+:?\-2E\K+
M\=?P*Y&?RE? ;]D3]J7]J+55T;]G;]GKQAXSE:38\GA[P_/<PPGUDE1?+B'J
MSLH'K7Z#?LN_\&E__!1'XP26NK?M!>)_"?PHTJ4@SPWU\-6U-%/.5M[1C"3C
MLUPA'3'7'])VF:9INBZ?#I.CZ?!:6MO&$M[:VB6..)1T554 *!Z"IZ\/%<7X
MZKI1@H?B_P!%^!2@NI^</[(O_!KK_P $S/V;VM=?^*/AK5_BWKT!5VN?&EUM
MT]9!W2QM]D;(?[DYG'/7T_0OP=X+\'?#SPU:>#/A_P"$],T+1["(1V.DZ/81
MVMM;)_=CBC 5![  5IT5\UB<;B\9+FK3<O5_DMD4DD%%%%<PPHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HKY-_X*Q?\ !6+X>_\ !)[X>^$OB%\0OA-K/BV'Q9K,^G6]OHU[# T#
M1P^:78R\$$<<5\-_\1E/[,__ $9GXZ_\']E_A7I8;)\RQ=)5:--N+ZW7^8G)
M(_9:BOQI_P"(RG]F?_HS/QU_X/[+_"OT7_X)I_M^^#_^"E?[+]I^U!X'^'^I
M>&;"[UF\TY=+U:YCFF5K=@I?='\N#GBEBLIS#!4O:5Z?+':]U^C!-/8]_HJO
MJVK:5H.E7.NZ[J=O965E;O/>7EW,L<4$2*6>1W8@*JJ"2Q(  )->":5_P5<_
MX)O:Q(PM_P!L_P  PPF"::TO]0UQ+6TOXXE+2-:7$VV*\"JI;]PTG )Z"O.&
M?0=%>>?&7]K7]F+]G7PS8^-/C[\??"?@K1]31&L-4\5ZY#I]O/O&5"R3LJDD
M=!G/M70_"SXN_"_XX>#K;XA_!WQ_I/B?0;P!K/6=#ODN;6X4J&#1RH2KJ592
M""00: .BHHHH **** "BN=^+7Q$LOA+\-]8^)&HZ=+=P:/:&XDMH7"O( 0,
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M_P"39_@S_P!CU?\ _I$*_GUK]4X7_P"1-#UE^;,9_$%?T_?\&J/_ "B1T?\
M['K6_P#T:E?S U_3]_P:H_\ *)'1_P#L>M;_ /1J5S\7?\BI?XE^3'#<]D_X
M+P_ #]HO]IO_ ()8?%'X0_LM6$NH^+;RUL;J/08'*R:W:6U]!<75@N""QEAB
MD7RP?WO^K_Y:5X!^SY_P4X_X)K?\%R/V5O$'_!.KXQ:!I_PR^(VK^'9M!O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139592672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Nov. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 28,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medtronic plc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1183488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20 On Hatch, Lower Hatch Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-1700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Ordinary Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,179,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001613103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 XH02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member', window );">0.00% Senior Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.00% Senior Notes due 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/22B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230375PercentMember', window );">0.375% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due20230000PercentMember', window );">0.000% Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/23C<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member', window );">0.25% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.25% Senior Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member', window );">0.000% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.000% Senior Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2025Member', window );">2.625% Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625% Senior Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/25B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20271125PercentMember', window );">1.125% Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Senior Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member', window );">0.375% Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.375% Senior Notes due 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2028Member', window );">3.000% Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.000% Senior Notes due 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/28A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311625PercentMember', window );">1.625% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember', window );">1.00% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.00% Senior Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2031Member', window );">3.125% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Senior Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/31B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member', window );">0.750% Senior Notes due 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Senior Notes due 2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2034Member', window );">3.375% Senior Notes due 2034</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.375% Senior Notes due 2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20394500PercentMember', window );">2.250% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.250% Senior Notes due 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember', window );">1.50% Senior Notes due 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.50% Senior Notes due 2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/39B<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member', window );">1.375% Senior Notes due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.375% Senior Notes due 2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/40A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member', window );">1.75% Senior Notes due 2049</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.75% Senior Notes due 2049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member', window );">1.625% Senior Notes due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Senior Notes due 2050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDT/50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20230375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due20230000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due20230000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20271125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20271125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20311.00PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2022Due2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20394500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20394500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due20391.50PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2019Due2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mdt_SeniorNotes2020Due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143180800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income (Unaudited) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,585,000,000<span></span>
</td>
<td class="nump">$ 7,847,000,000<span></span>
</td>
<td class="nump">$ 14,955,000,000<span></span>
</td>
<td class="nump">$ 15,835,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold, excluding amortization of intangible assets</a></td>
<td class="nump">2,535,000,000<span></span>
</td>
<td class="nump">2,497,000,000<span></span>
</td>
<td class="nump">5,051,000,000<span></span>
</td>
<td class="nump">5,095,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="nump">676,000,000<span></span>
</td>
<td class="nump">676,000,000<span></span>
</td>
<td class="nump">1,368,000,000<span></span>
</td>
<td class="nump">1,426,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expense</a></td>
<td class="nump">2,617,000,000<span></span>
</td>
<td class="nump">2,615,000,000<span></span>
</td>
<td class="nump">5,184,000,000<span></span>
</td>
<td class="nump">5,163,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">421,000,000<span></span>
</td>
<td class="nump">431,000,000<span></span>
</td>
<td class="nump">844,000,000<span></span>
</td>
<td class="nump">866,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact', window );">Restructuring charges, net</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating (income) expense, net</a></td>
<td class="num">(97,000,000)<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="num">(62,000,000)<span></span>
</td>
<td class="nump">781,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit</a></td>
<td class="nump">1,404,000,000<span></span>
</td>
<td class="nump">1,563,000,000<span></span>
</td>
<td class="nump">2,528,000,000<span></span>
</td>
<td class="nump">2,422,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other non-operating income, net</a></td>
<td class="num">(109,000,000)<span></span>
</td>
<td class="num">(66,000,000)<span></span>
</td>
<td class="num">(192,000,000)<span></span>
</td>
<td class="num">(177,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">118,000,000<span></span>
</td>
<td class="nump">136,000,000<span></span>
</td>
<td class="nump">282,000,000<span></span>
</td>
<td class="nump">273,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,395,000,000<span></span>
</td>
<td class="nump">1,493,000,000<span></span>
</td>
<td class="nump">2,438,000,000<span></span>
</td>
<td class="nump">2,326,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">959,000,000<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="nump">1,072,000,000<span></span>
</td>
<td class="nump">240,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">435,000,000<span></span>
</td>
<td class="nump">1,317,000,000<span></span>
</td>
<td class="nump">1,367,000,000<span></span>
</td>
<td class="nump">2,086,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="num">(12,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Medtronic</a></td>
<td class="nump">$ 427,000,000<span></span>
</td>
<td class="nump">$ 1,311,000,000<span></span>
</td>
<td class="nump">$ 1,356,000,000<span></span>
</td>
<td class="nump">$ 2,074,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (usd per share)</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (usd per share)</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (shares)</a></td>
<td class="nump">1,329.4<span></span>
</td>
<td class="nump">1,345.1<span></span>
</td>
<td class="nump">1,329.4<span></span>
</td>
<td class="nump">1,344.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (shares)</a></td>
<td class="nump">1,332.0<span></span>
</td>
<td class="nump">1,355.3<span></span>
</td>
<td class="nump">1,333.3<span></span>
</td>
<td class="nump">1,355.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696142898496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="nump">$ 1,367<span></span>
</td>
<td class="nump">$ 2,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on investment securities</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Translation adjustment</a></td>
<td class="num">(826)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(1,709)<span></span>
</td>
<td class="num">(602)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax', window );">Net investment hedge</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">356<span></span>
</td>
<td class="nump">1,409<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change in retirement obligations</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gain on cash flow hedges</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(424)<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income including noncontrolling interests</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1,483<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">2,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Medtronic</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1,478<span></span>
</td>
<td class="nump">$ 1,260<span></span>
</td>
<td class="nump">$ 2,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Unrealized Gain (Loss) On Derivatives Arising During Period, Net Investment Hedge, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143214096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,828<span></span>
</td>
<td class="nump">$ 3,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">6,602<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowances and credit losses of $203 and $230, respectively</a></td>
<td class="nump">5,626<span></span>
</td>
<td class="nump">5,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">5,055<span></span>
</td>
<td class="nump">4,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,287<span></span>
</td>
<td class="nump">2,318<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">25,398<span></span>
</td>
<td class="nump">23,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant, and equipment</a></td>
<td class="nump">13,497<span></span>
</td>
<td class="nump">13,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(8,199)<span></span>
</td>
<td class="num">(7,952)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">5,298<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">40,417<span></span>
</td>
<td class="nump">40,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">15,655<span></span>
</td>
<td class="nump">15,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Tax assets</a></td>
<td class="nump">3,350<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,124<span></span>
</td>
<td class="nump">3,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">93,241<span></span>
</td>
<td class="nump">90,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">5,864<span></span>
</td>
<td class="nump">3,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="nump">2,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,721<span></span>
</td>
<td class="nump">2,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued income taxes</a></td>
<td class="nump">651<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">4,031<span></span>
</td>
<td class="nump">3,551<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">14,465<span></span>
</td>
<td class="nump">12,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">20,753<span></span>
</td>
<td class="nump">20,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Accrued compensation and retirement benefits</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Accrued income taxes</a></td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">1,435<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">41,184<span></span>
</td>
<td class="nump">38,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares&#8212; par value $0.0001, 2.6 billion shares authorized, 1,330,148,578 and 1,330,743,395 shares issued and outstanding, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">24,442<span></span>
</td>
<td class="nump">24,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">29,799<span></span>
</td>
<td class="nump">30,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,361)<span></span>
</td>
<td class="num">(2,265)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">51,880<span></span>
</td>
<td class="nump">52,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">52,057<span></span>
</td>
<td class="nump">52,722<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 93,241<span></span>
</td>
<td class="nump">$ 90,981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696148812864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for accounts receivable</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares authorized (shares)</a></td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued (shares)</a></td>
<td class="nump">1,330,148,578<span></span>
</td>
<td class="nump">1,330,743,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares outstanding (shares)</a></td>
<td class="nump">1,330,148,578<span></span>
</td>
<td class="nump">1,330,743,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139062464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Shareholders&#8217; Equity</div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 30, 2021</a></td>
<td class="nump">$ 51,602<span></span>
</td>
<td class="nump">$ 51,428<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 26,319<span></span>
</td>
<td class="nump">$ 28,594<span></span>
</td>
<td class="num">$ (3,485)<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">769<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(846)<span></span>
</td>
<td class="num">(846)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(846)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(311)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jul. 30, 2021</a></td>
<td class="nump">51,664<span></span>
</td>
<td class="nump">51,486<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,184<span></span>
</td>
<td class="nump">28,511<span></span>
</td>
<td class="num">(3,209)<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 30, 2021</a></td>
<td class="nump">51,602<span></span>
</td>
<td class="nump">51,428<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,319<span></span>
</td>
<td class="nump">28,594<span></span>
</td>
<td class="num">(3,485)<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 29, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 29, 2021</a></td>
<td class="nump">52,159<span></span>
</td>
<td class="nump">51,991<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,059<span></span>
</td>
<td class="nump">28,974<span></span>
</td>
<td class="num">(3,042)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Jul. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jul. 30, 2021</a></td>
<td class="nump">51,664<span></span>
</td>
<td class="nump">51,486<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,184<span></span>
</td>
<td class="nump">28,511<span></span>
</td>
<td class="num">(3,209)<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(847)<span></span>
</td>
<td class="num">(847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(358)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Changes to noncontrolling ownership interests</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 29, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 29, 2021</a></td>
<td class="nump">$ 52,159<span></span>
</td>
<td class="nump">51,991<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">26,059<span></span>
</td>
<td class="nump">28,974<span></span>
</td>
<td class="num">(3,042)<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 29, 2022</a></td>
<td class="nump">1,330,743,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,331,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 29, 2022</a></td>
<td class="nump">$ 52,722<span></span>
</td>
<td class="nump">52,551<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,566<span></span>
</td>
<td class="nump">30,250<span></span>
</td>
<td class="num">(2,265)<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">931<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(903)<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(333)<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Jul. 29, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,329,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jul. 29, 2022</a></td>
<td class="nump">$ 52,843<span></span>
</td>
<td class="nump">52,672<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,335<span></span>
</td>
<td class="nump">30,276<span></span>
</td>
<td class="num">(1,939)<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Apr. 29, 2022</a></td>
<td class="nump">1,330,743,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,331,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Apr. 29, 2022</a></td>
<td class="nump">$ 52,722<span></span>
</td>
<td class="nump">52,551<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,566<span></span>
</td>
<td class="nump">30,250<span></span>
</td>
<td class="num">(2,265)<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 28, 2022</a></td>
<td class="nump">1,330,148,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 28, 2022</a></td>
<td class="nump">$ 52,057<span></span>
</td>
<td class="nump">51,880<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,442<span></span>
</td>
<td class="nump">29,799<span></span>
</td>
<td class="num">(2,361)<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Jul. 29, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,329,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jul. 29, 2022</a></td>
<td class="nump">52,843<span></span>
</td>
<td class="nump">52,672<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24,335<span></span>
</td>
<td class="nump">30,276<span></span>
</td>
<td class="num">(1,939)<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(424)<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to shareholders</a></td>
<td class="num">(904)<span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares under stock purchase and award plans</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of ordinary shares (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Oct. 28, 2022</a></td>
<td class="nump">1,330,148,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Oct. 28, 2022</a></td>
<td class="nump">$ 52,057<span></span>
</td>
<td class="nump">$ 51,880<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24,442<span></span>
</td>
<td class="nump">$ 29,799<span></span>
</td>
<td class="num">$ (2,361)<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696148706944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends to shareholders (usd per share)</a></td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696140222496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,367<span></span>
</td>
<td class="nump">$ 2,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">1,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_AssetImpairmentChargesAndInventoryWriteDown', window );">MCS asset impairment and inventory write-down</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(784)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities</a></td>
<td class="nump">94<span></span>
</td>
<td class="num">(409)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">3,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(1,867)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant, and equipment</a></td>
<td class="num">(749)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(3,743)<span></span>
</td>
<td class="num">(5,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales and maturities of investments</a></td>
<td class="nump">3,609<span></span>
</td>
<td class="nump">4,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,731)<span></span>
</td>
<td class="num">(1,493)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Change in current debt obligations, net</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from (repayments of) short-term borrowings (maturities greater than 90 days)</a></td>
<td class="nump">2,284<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Issuance of long-term debt</a></td>
<td class="nump">3,430<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(2,311)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends to shareholders</a></td>
<td class="num">(1,807)<span></span>
</td>
<td class="num">(1,693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance of ordinary shares</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="num">(477)<span></span>
</td>
<td class="num">(744)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="nump">443<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">2,064<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(223)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="num">(693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">3,714<span></span>
</td>
<td class="nump">3,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">4,828<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_IncomeTaxesandInterestPaidAbstract', window );"><strong>Cash paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">821<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_AssetImpairmentChargesAndInventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges And Inventory Write-Down</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_AssetImpairmentChargesAndInventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_IncomeTaxesandInterestPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes and Interest Paid [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_IncomeTaxesandInterestPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146158128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain uncertain and unpredictable. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended October&#160;28, 2022, changes in the Company&#8217;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended April&#160;29, 2022. The Company&#8217;s fiscal years 2023, 2022, and 2021 will end or ended on April&#160;28, 2023, April&#160;29, 2022, and April&#160;30, 2021, respectively. Fiscal year 2021 was a 53-week year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146274096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, there were no newly adopted accounting pronouncements that had a material impact to our consolidated financial statements. As of October&#160;28, 2022, there are no recently issued but not yet adopted accounting pronouncements that are expected to materially impact our consolidated financial statements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146192544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include healthcare systems, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. <div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Heart &amp; Aortic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Peripheral Vascular </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;28, 2022, $1.0 billion of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$536 million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet. At April&#160;29, 2022, $981 million of rebates were classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $548 million of rebates were classified as a reduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheet.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Revenue and Remaining Performance Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;28, 2022 and April&#160;29, 2022 was $380 million and $399 million, respectively. At October&#160;28, 2022 and April&#160;29, 2022, $293 million and $305 million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> respectively, and $87 million and $94 million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. During the six months ended October&#160;28, 2022, the Company recognized $160&#160;million of revenue that was included in deferred revenue as of April&#160;29, 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining performance obligations include goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;28, 2022, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $719 million. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next three years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146303872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Assets and Liabilities Held for Sale</a></td>
<td class="text">Acquisitions and Assets and Liabilities Held for Sale<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended October&#160;28, 2022 and October&#160;29, 2021, the Company had acquisitions that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future, yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired. For the three and six months ended October&#160;28, 2022, purchase price allocation adjustments were not significant. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2023</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intersect ENT</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 13, 2022, the Company acquired Intersect ENT, a global ear, nose, and throat (ENT) medical technology leader. The acquisition expands the Neuroscience segment portfolio of products used during ENT procedures, and combined with the Company's navigation, powered instruments, and existing tissue health products, will offer a broader suite of solutions to assist surgeons treating patients who suffer from chronic rhinosinusitis (CRS). Total consideration, net of cash acquired, for the transaction, in which the Company acquired all outstanding shares of Intersect ENT for $28.25 per share, was $1.2&#160;billion consisting of $1.1&#160;billion of cash and $98&#160;million previously held investments in Intersect ENT. Based upon a preliminary acquisition valuation, the Company acquired $615&#160;million of goodwill, $635 million of technology-based intangible assets, $35 million of customer-related intangible assets, and $13 million of tradenames with estimated useful lives of 20 years. The goodwill is not deductible for tax purposes. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and net loss attributable to Intersect ENT since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three and six months ended October&#160;28, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Affera, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2022, the Company acquired Affera, Inc. (Affera) a privately-held company focused on the development of cardiac mapping and navigation systems and catheter-based cardiac ablation technologies. The acquisition expands the Cardiovascular segment portfolio of advanced cardiac ablation products and accessories to include its first cardiac mapping and navigation platform to meet physician needs within a growing patient population. Total consideration, net of cash acquired for the transaction, was $904&#160;million. Based upon a preliminary acquisition valuation, the Company acquired $660 million of goodwill and $300&#160;million of in-process research and development. The goodwill is not deductible for tax purposes. The Company recognized $201&#160;million of contingent consideration liabilities in connection with the acquisition, which are comprised of product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and net loss attributable to Affera since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three months ended October&#160;28, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values of the assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intersect ENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affera</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For acquisitions other than Intersect ENT and Affera, the acquisition date fair value of net assets acquired during the six months ended October&#160;28, 2022 was $123 million. Based upon preliminary valuations, assets acquired were primarily comprised of $66 million of goodwill and $57 million of technology-based intangible assets with estimated useful lives of 16 years. The goodwill is deductible for tax purposes. The Company recognized $73&#160;million of contingent consideration liabilities in connection with these acquisitions during the six months ended October&#160;28, 2022, which are comprised of revenue and product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal year 2022</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of net assets acquired during the six months ended October&#160;29, 2021 was $125 million, consisting of $154 million of assets acquired and $29 million of liabilities assumed. Assets acquired were primarily comprised of $80 million of goodwill and $50 million of technology-based intangible assets with estimated useful lives ranging from 15 years to 16 years. The goodwill is not deductible for tax purposes. The Company recognized $31&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;29, 2021, which are comprised of revenue and product development milestone-based payments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquired In-Process Research &amp; Development (IPR&amp;D)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D with no alternative future use acquired outside of a business combination is expensed immediately. The Company did not acquire any IPR&amp;D in connection with asset acquisitions of technology not yet approved during the three months ended October&#160;28, 2022 and October&#160;29, 2021. During the six months ended October&#160;28, 2022, IPR&amp;D acquired in connection with asset acquisitions of technology not yet approved by regulators was not significant. During the six months ended October&#160;29, 2021, the Company acquired $90 million of IPR&amp;D in connection with asset acquisitions of technology not yet approved by regulators, which was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">research and development expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration at October&#160;28, 2022 and April&#160;29, 2022 was $349 million and $119 million,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. At October&#160;28, 2022, $149 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $200 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheet. At April&#160;29, 2022, $35 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $84 million was recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated balance sheet. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2% - 27.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$254</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9% - 5.5%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets and Liabilities Held for Sale</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 25, 2022, the Company and DaVita Inc. (&#8220;DaVita&#8221;) entered into a definitive agreement for the Company to sell half of its Renal Care Solutions (RCS) business. This sale is part of an agreement between Medtronic and DaVita to form a new, independent kidney care-focused medical device company (&#8220;NewCo&#8221;) with equal equity ownership. As a result of entering into the definitive agreement and as of that date, the RCS business met the criteria to be classified as held for sale. The transaction is expected to close in calendar year 2023, subject to customary regulatory approvals and closing conditions. RCS is part of the Company&#8217;s Medical Surgical portfolio. The Company recorded non-cash pre-tax charges of $14&#160;million and $81&#160;million, primarily related to impairment of goodwill and changes in the carrying amount of the disposal group, in the three and six months ended October&#160;28, 2022, respectively, recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. Refer to Note 10 to the consolidated financial statements for additional information on the goodwill impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale in our consolidated balance sheet:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.800%"><tr><td style="width:1.0%"/><td style="width:87.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Total assets held for sale and total liabilities held for sale are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, respectively in the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)  No separate class of liability classified as held for sale was individually significant enough for separate disclosure.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no assets or liabilities classified as held for sale at April&#160;29, 2022. The Company determined that the agreement to sell half of the RCS business does not meet the criteria to be classified as discontinued operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146311136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Other Costs</a></td>
<td class="text">Restructuring and Other Costs<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enterprise Excellence</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $1.7 billion in connection with the Enterprise Excellence program. In total, the Company estimates it will recognize approximately&#160;$1.8 billion of exit and disposal costs and other costs related to the program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries and benefits for employees supporting the program, including program management and transition teams, and strategic and operational consulting services related to the three objectives of the program. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">restructuring charges, net, cost of products sold, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the consolidated statements of income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $53 million and $93 million, respectively, of which $19 million and $38 million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $27 million and $55 million, respectively, were recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. For the three months and six months ended October&#160;29, 2021, the Company recognized net charges of $62 million and $136 million, of which $31&#160;million and $64 million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $27 million and $57 million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplification</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $427&#160;million in connection with the Simplification program. In total, the Company estimates it will recognize approximately $450&#160;million of exit and disposal costs and other costs related to the Simplification program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">restructuring charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $43 million and $78 million, respectively, of which $18 million and $31 million, respectively, were recognized within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. For the three and six months ended October&#160;29, 2021, the Company recognized net charges of $18 million and $25 </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, respectively, of which $9 million and $16 million, respectively, were recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selling, general, and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the restructuring programs above for the six months ended October&#160;28, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other <br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)   Accrual adjustments relate to certain employees identified for termination finding other positions within the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mechanical Circulatory Support (MCS)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company announced the decision to stop the distribution and sale of the Medtronic HVAD System in light of a growing body of observational clinical comparisons indicating a lower frequency of neurological adverse events and mortality with another circulatory support device available to patients compared to the HVAD system. In connection with this decision, the Company recorded charges of $726&#160;million (MCS charges) within the Cardiovascular segment during the three months ended July 30, 2021, including $58&#160;million recognized in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> costs of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $668&#160;million recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statement of income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charges included $515&#160;million of non-cash impairments and write-downs primarily related to $409&#160;million of intangible asset impairments and $58&#160;million of inventory write-downs. The Company also recorded charges of $211&#160;million for commitments and obligations associated with the decision, which included charges for patient support obligations, restructuring, and other associated costs. During the fourth quarter of fiscal year 2022, the Company recorded additional charges of $155&#160;million within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily related to incremental commitments and obligations associated with the exit of the business. As of October&#160;28, 2022, accruals were recorded in the consolidated balance sheet for these obligations, with $83&#160;million reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $120&#160;million recorded in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Medtronic remains committed to serving the needs of the patients currently implanted with the HVAD system.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and are remeasured on a recurring basis. The following tables summarize the Company's investments in available-for-sale debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;28, 2022 and April&#160;29, 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,502&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of debt securities excludes accrued interest, which is reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;28, 2022 and April&#160;29, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;28, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.167%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Securities, Equity Method Investments, and Other Investments </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;28, 2022 and April&#160;29, 2022, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>During the three and six months ended October&#160;28, 2022, there were $7&#160;million of net unrealized losses and $1&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;28, 2022. During the three and six months ended October&#160;29, 2021, there were $8&#160;million of net unrealized losses and $7&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;29, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Financing Arrangements</a></td>
<td class="text">Financing Arrangements <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $3.5 billion. Commercial paper outstanding at October&#160;28, 2022 was $349 million. During the three months ended October&#160;28, 2022, the commercial paper outstanding had a weighted average original maturity of 26 days and a weighted average interest rate of 3.057 percent. No commercial paper was outstanding at April&#160;29, 2022. The issuance of commercial paper reduces the amount of credit available under the Company&#8217;s existing Credit Facility, as defined below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Line of Credit</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a $3.5 billion five-year unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;28, 2022 and April&#160;29, 2022, no amounts were outstanding under the Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#8217;s long-term debt ratings, assigned by Standard &amp; Poor&#8217;s Ratings Services and Moody&#8217;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The Company is in compliance with the covenants under the Credit Facility. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.500 percent ten-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250 percent six-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625 percent three-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent five-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.125 percent eight-year 2019 senior notes </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.350 percent ten-year 2017 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.000 percent six-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent eight-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent twelve-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000 percent twelve-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125 percent nine-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750 percent twelve-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375 percent twelve-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375 percent twenty-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.550 percent thirty-year 2007 CIFSA senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250 percent twenty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500 percent thirty-year 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.500 percent twenty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.550 percent thirty-year 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375 percent twenty-year 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 percent thirty-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000 percent thirty-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent thirty-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent thirty-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.750 percent thirty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent thirty-year 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The Company is in compliance with all covenants related to the Senior Notes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, Medtronic Luxco issued four tranches of Euro-denominated Senior Notes with an aggregate principal of &#8364;3.5 billion, with maturities ranging from fiscal year 2026 to 2035, resulting in cash proceeds of approximately &#8364;3.5 billion, net of discounts and issuance costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term Loan Agreements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, Medtronic Luxco entered into a term loan agreement (Fiscal 2023 Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Fiscal 2023 Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#165;300&#160;billion with a term of 364 days. Borrowings under the Fiscal 2023 Loan Agreement bear interest at the TIBOR Rate (as defined in the Fiscal 2023 Loan Agreement) plus a margin of 0.40% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Fiscal 2023 Loan Agreement. In May and June 2022, Medtronic Luxco borrowed an aggregate of &#165;297&#160;billion, or approximately $2.3&#160;billion, of the term loan, under the Fiscal 2023 Loan Agreement. The Company used the net proceeds of the borrowings to fund the early redemption of $1.9&#160;billion of Medtronic Inc.'s 3.500% Senior Notes due 2025 for $1.9&#160;billion of total consideration, and $368&#160;million of Medtronic Luxco's 3.350% Senior Notes due 2027 for $376&#160;million of total consideration. The Company recognized a total loss on debt extinguishment of $53&#160;million in the three months ended July 29, 2022, which primarily includes cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income during the six months ended October&#160;28, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022, the estimated fair value of the Company&#8217;s Senior Notes was $21.1 billion compared to a principal value of $24.4 billion. At April&#160;29, 2022, the estimated fair value was $22.9 billion compared to a principal value of $24.2 billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives and Currency Exchange Risk Management</a></td>
<td class="text">Derivatives and Currency Exchange Risk Management <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $17.9 billion and $13.8 billion at October&#160;28, 2022 and April&#160;29, 2022, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#8217;s consolidated balance sheets and statements of income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Freestanding Derivative Contracts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Freestanding derivative contracts are primarily used to offset the Company&#8217;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $5.1 billion and $4.9 billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses total return swaps to hedge the liability of a non-qualified deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $208 million and $226 million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating or financing activities, depending on the nature of the underlying hedged item, in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $8.3 billion and $8.8 billion, respectively, and will mature within the subsequent three-year period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative instrument is reported as a component of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gain or loss on the derivative instrument is reclassified into earnings and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings on a straight-line basis over the term of the hedge. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022 and April&#160;29, 2022, the Company had $852 million and $474 million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company expects that $617 million of after-tax net unrealized gains at October&#160;28, 2022 will be recognized in the consolidated statements of income over the next 12 months.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated Euro-denominated and Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;28, 2022, the Company had &#8364;16.0 billion, or $15.9 billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#165;297 billion, or $2.0 billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s 2023 through 2051, and the Yen-denominated debt will mature in fiscal year 2024. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may also use derivative instruments to hedge the currency risk associated with its net investment in foreign operations. Foreign currency forward contracts may be used on a standalone basis or in combination with option collars. At October&#160;28, 2022, the Company had foreign currency contracts with a notional value of &#8364;4.5 billion, or $4.5 billion, hedging a portion of its net investment in certain of its European operations. The foreign exchange contracts mature in fiscal years 2024 and 2025. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a straight-line basis over the term of the hedge. During the three and six months ended October&#160;28, 2022, the Company recognized $27 million and $47 million in after-tax unrealized gains representing excluded components in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gains and Losses on Hedging Instruments and Derivatives not Designated as Hedging Instruments</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-top:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.706%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Reclassified into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:27pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance Sheet Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;28, 2022 and April&#160;29, 2022. The fair value amounts are presented on a gross basis, and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments, and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,055&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,616&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146208944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the agreement with DaVita, as disclosed in Note 4 to the consolidated financial statements, the Company allocated $208&#160;million of goodwill to the RCS business that met the criteria to be classified as held for sale during the first quarter of fiscal year 2023. Upon allocation, a goodwill impairment test was performed for the RCS business, and the Company recognized $61 million of goodwill impairment during the six months ended October&#160;28, 2022. The goodwill impairment charges are recognized in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. The Company did not recognize any goodwill impairments during the three months ended October&#160;28, 2022 and the three and six months ended October&#160;29, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,730)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,006)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any definite-lived intangible asset charges during the three and six months ended October&#160;28, 2022 and the three months ended October&#160;29, 2021. During the six months ended October&#160;29, 2021, the Company recognized $409&#160;million of definite-lived intangible asset charges in connection with MCS within the Cardiovascular Portfolio. Refer to Note 5 to the consolidated financial statements for additional information on what led to the impairment. Intangible asset impairment charges are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. Due to the nature of IPR&amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortization Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $421&#160;million and $431&#160;million, respectively. Intangible asset amortization expense for the six months ended October&#160;28, 2022 and October&#160;29, 2021 was $844 million and $866&#160;million, respectively. Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;28, 2022, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146222464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the U.S. Tax Court (Tax Court) issued its opinion on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for fiscal years 2005 and 2006 (Opinion). While the Opinion rejected the IRS&#8217;s position and the Tax Court determined the methodology advanced by Medtronic was appropriate for purposes of determining the intercompany royalty rate between Puerto Rico and the U.S., it determined that the royalty rate should be higher, thereby increasing income allocated to the U.S. and consequently subject to U.S. tax. This case relates only to fiscal years 2005 and 2006. The Opinion remains subject to finalization by the Tax Court and to appeal by either or both parties. The Company has assumed the Tax Court findings will be applied for all years following fiscal year 2006. As a result, the Company recorded a $764&#160;million net tax charge during the three months ended October&#160;28, 2022 to recognize the estimated tax impact of the Tax Court Opinion. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for the three and six months ended October&#160;28, 2022 was 68.7% and 44.0%, respectively, as compared to 11.8% and 10.3% for the three and six months ended October&#160;29, 2021, respectively. The increase in our effective tax rate for the three and six months ended October&#160;28, 2022, as compared to the corresponding periods in the prior fiscal year, was primarily due to the $764&#160;million net tax charge referenced above.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At October&#160;28, 2022 and April&#160;29, 2022, the Company's gross unrecognized tax benefits were $2.6&#160;billion and $1.7&#160;billion, respectively. In addition, the Company had accrued gross interest and penalties of $196&#160;million at October&#160;28, 2022. If all of the Company&#8217;s unrecognized tax benefits were recognized, approximately $2.4&#160;billion would impact the Company&#8217;s effective tax rate. At October&#160;28, 2022 and April&#160;29, 2022, the amount of the Company's gross unrecognized tax benefits, net of cash advance, recorded as a noncurrent liability within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accrued income taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the consolidated balance sheets was $1.8&#160;billion and $802&#160;million, respectively. The increase in the Company's gross unrecognized tax benefits, net of cash advance, was primarily due to an increase in unrecognized tax benefits relating to the Tax Court Opinion. The Company recognizes interest and penalties related to income tax matters within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income and records the liability within either current or noncurrent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">accrued income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146309472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The calculation of weighted average diluted shares outstanding excludes options to purchase approximately 25 million and 20 million ordinary shares for the three and six months ended October&#160;28, 2022, respectively, and 4 million and 2 million ordinary shares for the three and six months ended October&#160;29, 2021, respectively, because their effect would have been anti-dilutive on the Company&#8217;s earnings per share.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139581264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, performance share units, and employee stock purchase plan shares recognized for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146220032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Benefit Plans</a></td>
<td class="text">Retirement Benefit Plans <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net periodic benefit cost other than the service component are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span> in the consolidated statements of income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146208944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in accumulated other comprehensive loss (AOCI), net of tax, and by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(773)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,485)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(678)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,042)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021 was a benefit of $41 million and $6 million, respectively. During the six months ended </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;28, 2022, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $4&#160;million. During the six months ended October&#160;29, 2021, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $1&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended October&#160;28, 2022, the income tax on cumulative translation adjustment was a benefit of $3 million. During the six months ended October&#160;29, 2021, there was no income tax on cumulative translation adjustment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended October&#160;28, 2022 and October&#160;29, 2021, there were no tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, the net change in retirement obligations in other comprehensive income before reclassifications resulted in income tax expense of $1 million and $2&#160;million, respectively. During both the six months ended October&#160;28, 2022 and October&#160;29, 2021, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$7 million. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021&#160;was&#160;an expense of&#160;$141 million and $42 million, respectively. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$59 million and $1 million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other operating (income) expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cost of products sold,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">interest expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146308656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are involved in a number of legal actions from time to time involving product liability, employment, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state, and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#8217;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#8217;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies certain specified litigation charges and gains related to significant legal matters as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">certain litigation charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the consolidated statements of income. The Company recognized no certain litigation charges during the three and six months ended October&#160;28, 2022, respectively, whereas the Company recognized $34 million and $60 million of certain litigation charges during the three and six months ended October&#160;29, 2021, respectively. At October&#160;28, 2022 and April&#160;29, 2022, accrued litigation was approximately $0.3&#160;billion. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Matters</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any given time, the Company is involved in litigation relating to patents, trademarks, copyrights, trade secrets, and other intellectual property (IP) rights, and licenses, acquisitions or other agreements relating to such rights. This litigation includes, but is not limited to, alleged infringement or misappropriation of IP rights, or breach of obligations related to IP rights, or other claims asserted by competitors, individuals, or, consistent with a growing trend across technology-intensive industries, other entities created specifically to fund IP litigation. While the outcome of these litigation matters is inherently uncertain, it is possible that the results of such litigation could require the Company to pay significant monetary damages and/or royalty payments, and negatively impact the Company's ability to sell current or future products, which could have a material adverse impact on the Company's business, results of operations, financial condition, and cash flows. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Liability Matters</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pelvic Mesh Litigation</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. Two subsidiaries of Covidien supplied pelvic mesh products to one of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $121&#160;million towards the settlement of 11,000 of these claims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional 5,000 claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#8217;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately 16,200 claimants have asserted or may assert claims involving products manufactured by Covidien&#8217;s subsidiaries. As of November 2, 2022, the Company had reached agreements to settle approximately 15,900 of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hernia Mesh Litigation</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting in fiscal year 2020, plaintiffs began filing lawsuits against certain subsidiaries of the Company in U.S. state and federal courts that allege personal injury from hernia mesh products sold by those subsidiaries. As of November 10, 2022, subsidiaries of the Company have been named as defendants in lawsuits filed on behalf of approximately 6,050 individual plaintiffs, and certain plaintiffs&#8217; law firms have advised the Company that they may file additional cases in the future. Approximately 5,600 plaintiffs have filed lawsuits in a coordinated proceeding in Massachusetts state court, where they have been consolidated before a single judge. Approximately 350 plaintiffs have filed lawsuits in a coordinated action in Minnesota state court, and there are approximately 90 actions coordinated in a federal Multidistrict Litigation in the U.S. District Court for the District of Massachusetts. The pending lawsuits relate almost entirely to hernia mesh products that have not been subject to recalls, withdrawals, or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable and reasonably estimable. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Proceedings</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a successor to a company which owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of two landfills, capping of the remaining three landfills, installation of a groundwater extraction system and long-term monitoring of the site and the three remaining landfills. The Company has proceeded with remediation in accordance with the MDEP order as modified by the Maine Board order. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#8217;s Alliance. Plaintiffs sought an injunction requiring the </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a trial in March 2002, the court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#8217;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. In March 2021, the parties notified the court that they had agreed on a settlement in principle of all issues in this matter. Following conditional approval of the settlement by the court in August 2022, in September 2022 the parties filed a joint motion for final approval by the court. The conditional court approval did not result in a change to the Company's previous accrual for this matter. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court (Tax Court) reviewed this dispute, and in June 2016, issued an opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006 whereby it generally rejected the IRS&#8217;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. In April 2017, the IRS filed a Notice of Appeal to the U.S. Court of Appeals for the Eighth Circuit regarding the Tax Court opinion. Oral argument for the Appeal occurred in March 2018. The U.S. Court of Appeals issued its opinion in August 2018 and remanded the case back to the Tax Court for additional factual findings, which it concluded in June 2021. The Tax Court issued its opinion on August 18, 2022, and it remains subject to appeal by either or both parties. At this time, the Company is evaluating whether to file an appeal.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IRS has issued its audit reports on Medtronic, Inc. for fiscal years 2007 through 2016. Medtronic, Inc. and the IRS have reached agreement on all significant issues except for the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court matter for fiscal years 2005 and 2006.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic, Inc.&#8217;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Covidien LP (a wholly owned subsidiary of Medtronic plc) has either reached agreement with the IRS or the statute of limitations has lapsed on its U.S. federal income tax returns through fiscal year 2018.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional discussion of income taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#8217; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#8217;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#8217;s consolidated earnings, financial position, and/or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146190544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic InformationSegment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. The Company&#8217;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. <div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to the reportable segments during the quarter ended October&#160;28, 2022. The Company's four principal operating and reportable segments are as follows: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCS impairments / costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS impairments / costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. The following table presents net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 for the Company's country of domicile, countries with significant concentrations, and all other countries:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144297968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year.Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal years 2023, 2022, and 2021 will end or ended on April&#160;28, 2023, April&#160;29, 2022, and April&#160;30, 2021, respectively. Fiscal year 2021 was a 53-week year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended October&#160;28, 2022, there were no newly adopted accounting pronouncements that had a material impact to our consolidated financial statements. As of October&#160;28, 2022, there are no recently issued but not yet adopted accounting pronouncements that are expected to materially impact our consolidated financial statements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146111024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.636%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiac Rhythm &amp; Heart Failure </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Heart &amp; Aortic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coronary &amp; Peripheral Vascular </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Innovations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Respiratory, Gastrointestinal, &amp; Renal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,621&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cranial &amp; Spinal Technologies</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S. Developed Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Emerging Markets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">U.S. includes the United States and U.S. territories.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt">Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139546208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Value of the Assets Acquired and Liabilities Assumed (Intersect ENT)</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values of the assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intersect ENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affera</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Affera)</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair values of the assets acquired and liabilities assumed were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intersect ENT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affera</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Reconciliation of Beginning and Ending Balances of Contingent Consideration</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price allocation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.766%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue and other performance-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2% - 27.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product development and other milestone-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$254</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9% - 5.5%</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected fiscal year of payment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Classified as Held for Sale</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information related to the assets and liabilities that were classified as held for sale in our consolidated balance sheet:</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.800%"><tr><td style="width:1.0%"/><td style="width:87.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Total assets held for sale and total liabilities held for sale are reported in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">other current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> other accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, respectively in the consolidated balance sheets.</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)  No separate class of liability classified as held for sale was individually significant enough for separate disclosure.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the activity related to the restructuring programs above for the six months ended October&#160;28, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Termination Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Associated Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other <br/>Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)   Accrual adjustments relate to certain employees identified for termination finding other positions within the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139609856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Investments by Category and Related Balance Sheet Presentation</a></td>
<td class="text">The following tables summarize the Company's investments in available-for-sale debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;28, 2022 and April&#160;29, 2022:<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,502&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,893&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Gross Unrealized Losses and Fair Values of Available-for-sale Securities that Have Been in a Continuous Unrealized Loss Position Deemed to be Temporary, Aggregated by Investment Category</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the gross unrealized losses and fair values of the Company&#8217;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;28, 2022 and April&#160;29, 2022:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">More than 12 months</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auction rate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,004&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Activity Related to the Company's Available-for-Sale Securities Portfolio</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity related to the Company&#8217;s available-for-sale debt securities portfolio is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Available-For-Sale Debt Securities, Contractual Maturities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The October&#160;28, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.167%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock', window );">Summary of Equity and Other Investments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's equity and other investments at October&#160;28, 2022 and April&#160;29, 2022, which are classified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated balance sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments with readily determinable fair value (marketable equity securities)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity and other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_ScheduleofInvestmentsTableTextBlock', window );">Activity Related to the Company's Equity and Other Investments Portfolio</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes activity related to the Company&#8217;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other non-operating income, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the consolidated statements of income.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_ScheduleofInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Investments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_ScheduleofInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146319264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's debt obligations consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity by <br/>Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.500 percent ten-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.250 percent six-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.625 percent three-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.000 percent five-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.125 percent eight-year 2019 senior notes </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.350 percent ten-year 2017 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.000 percent six-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.375 percent eight-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent twelve-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.000 percent twelve-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.125 percent nine-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.750 percent twelve-year 2020 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.375 percent twelve-year 2022 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375 percent twenty-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.550 percent thirty-year 2007 CIFSA senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2038</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.250 percent twenty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.500 percent thirty-year 2009 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2039</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.500 percent twenty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.550 percent thirty-year 2010 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2040</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.375 percent twenty-year 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2041</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 percent thirty-year 2012 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2042</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000 percent thirty-year 2013 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent thirty-year 2014 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2044</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625 percent thirty-year 2015 senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.750 percent thirty-year 2019 senior notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.625 percent thirty-year 2020 senior notes </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 - 2051</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696138852736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Gains and Losses on Derivative Instruments</a></td>
<td class="text"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-top:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.166%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.706%"/><td style="width:0.1%"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Reclassified into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:27pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(806)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(475)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,184)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the gains and losses on our derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.633%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of (Gain) Loss in Income Statement</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;28, 2022 and April&#160;29, 2022. The fair value amounts are presented on a gross basis, and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments, and are further segregated by type of contract within those two categories.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives not designated as hedging instruments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsTableTextBlock', window );">Offsetting Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesTableTextBlock', window );">Offsetting Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.700%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.833%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.033%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount Not Offset on the Balance Sheet</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount of Recognized Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash Collateral (Received) Posted</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225877-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225877-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146192544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Balances</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory balances, net of reserves, were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,055&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,616&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143129632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in the Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill by segment: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cardiovascular</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Neuroscience</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diabetes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill as a result of acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,730)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,006)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Gross Carrying Amount of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the gross carrying amount and accumulated amortization of intangible assets: </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">April 29, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased technology and patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,916)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,730)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,006)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets</a></td>
<td class="text">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;28, 2022, excluding any possible future amortization associated with acquired IPR&amp;D which has not yet met technological feasibility, is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.300%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146228320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets forth the computation of basic and diluted earnings per share:</span></div><div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted &#8211; weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144290752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Components and Classification of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, performance share units, and employee stock purchase plan shares recognized for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146192544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost</a></td>
<td class="text">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-U.S.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696146461840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income (AOCI) by Component</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in accumulated other comprehensive loss (AOCI), net of tax, and by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.433%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 29, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(209)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(773)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,705)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investment Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Change in Retirement Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive (Loss) Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,485)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 29, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(678)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,310)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,042)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696137557456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 28, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Operating Profit</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuroscience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-operating income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(866)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centralized distribution costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and associated costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCS impairments / costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCS impairments / costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Net Sales to External Customers by Geography</a></td>
<td class="text">The following table presents net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 for the Company's country of domicile, countries with significant concentrations, and all other countries:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.633%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 28, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 29, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other countries, excluding Ireland</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144088768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Net Sales by Segment and Division (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,585<span></span>
</td>
<td class="nump">$ 7,847<span></span>
</td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="nump">$ 15,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,773<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
<td class="nump">5,486<span></span>
</td>
<td class="nump">5,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | Cardiac Rhythm &amp; Heart Failure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">2,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | Structural Heart &amp; Aortic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | Coronary &amp; Peripheral Vascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">4,071<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | Surgical Innovations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,398<span></span>
</td>
<td class="nump">1,497<span></span>
</td>
<td class="nump">2,736<span></span>
</td>
<td class="nump">3,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | Respiratory, Gastrointestinal, &amp; Renal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">1,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">4,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | Cranial &amp; Spinal Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">2,124<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | Specialty Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | Neuromodulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">419<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="nump">824<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 556<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 1,098<span></span>
</td>
<td class="nump">$ 1,157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CardiacRhythmandHeartFailureDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CardiacRhythmandHeartFailureDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_StructuralHeartAndAorticDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_StructuralHeartAndAorticDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CoronaryAndPeripheralVascularDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CoronaryAndPeripheralVascularDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_SurgicalInnovationsDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_SurgicalInnovationsDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_RespiratoryGastrointestinalandRenalDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_RespiratoryGastrointestinalandRenalDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_CranialAndSpinalTechnologiesDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_CranialAndSpinalTechnologiesDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_SpecialtyTherapiesDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_SpecialtyTherapiesDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=mdt_NeuromodulationDivisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=mdt_NeuromodulationDivisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144530992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,585<span></span>
</td>
<td class="nump">$ 7,847<span></span>
</td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="nump">$ 15,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,069<span></span>
</td>
<td class="nump">3,997<span></span>
</td>
<td class="nump">7,835<span></span>
</td>
<td class="nump">8,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember', window );">Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,157<span></span>
</td>
<td class="nump">2,478<span></span>
</td>
<td class="nump">4,485<span></span>
</td>
<td class="nump">5,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember', window );">Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,359<span></span>
</td>
<td class="nump">1,372<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,773<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
<td class="nump">5,486<span></span>
</td>
<td class="nump">5,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">2,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">802<span></span>
</td>
<td class="nump">948<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
<td class="nump">1,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">4,071<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">970<span></span>
</td>
<td class="nump">1,748<span></span>
</td>
<td class="nump">1,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">841<span></span>
</td>
<td class="nump">1,485<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">838<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">4,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">2,931<span></span>
</td>
<td class="nump">2,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes | Non-U.S. Developed Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143706752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 380<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously included in deferred revenue</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations</a></td>
<td class="nump">$ 719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Period over which remaining performance obligations are expected to be recognized as revenue</a></td>
<td class="text">three years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember', window );">Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Rebate obligations</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Reduction of accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Rebate obligations</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696137382320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>May 13, 2022</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,417<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 40,417<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionPriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized', window );">Business combination, fair value of net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business combination, assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_TechnologyBasedIntangibleAssets', window );">Technology-based intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other operating (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentChargeOnReclassifiedAssets', window );">Non-cash pre-tax charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mdt_InProcessResearchDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember', window );">Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember', window );">Intersect ENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Shares price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration for the transaction, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Previously held investments in Intersect ENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business combination, assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember', window );">Intersect ENT | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember', window );">Intersect ENT | Customer-related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember', window );">Intersect ENT | Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_OtherAcquisitionsMember', window );">Other acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionPriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_OtherAcquisitionsMember', window );">Other acquisitions | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember', window );">Affera Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration for the transaction, net of cash acquired</a></td>
<td class="nump">904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business combination, assets acquired</a></td>
<td class="nump">1,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionPriceContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Price Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionPriceContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_TechnologyBasedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Technology-Based Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_TechnologyBasedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentChargeOnReclassifiedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 44<br> -URI https://asc.fasb.org/extlink&amp;oid=29634951&amp;loc=d3e1756-110224<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2459-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentChargeOnReclassifiedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mdt_InProcessResearchDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mdt_InProcessResearchDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_OtherAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_OtherAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696137722000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>May 13, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 40,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,502<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember', window );">Intersect ENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember', window );">Affera Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_IntersectENTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139020080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 40,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,502<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember', window );">Affera Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mdt_AfferaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696148744032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward', window );"><strong>Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionPriceContingentConsideration', window );">Purchase price contingent consideration</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration', window );">Purchase price allocation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionContingentConsiderationMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent milestone payments in business acquisition transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionContingentConsiderationMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionPriceContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Price Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionPriceContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_BusinessAcquisitionPurchasePriceContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration arrangement resulting from business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_BusinessAcquisitionPurchasePriceContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144465776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Minimum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Maximum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember', window );">Revenue and other performance-based payments | Weighted Average | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Minimum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Maximum | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember', window );">Product development and other milestone-based payments | Weighted Average | Recurring | Level 3 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueInputsQuantitativeInformationAbstract', window );"><strong>Fair Value Inputs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, significant unobservable inputs</a></td>
<td class="nump">0.043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsQuantitativeInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsQuantitativeInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mdt_RevenueMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=mdt_ProductDevelopmentMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696140189584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details) - Held For Sale - Disposal group, held-for-sale, not discontinued operations<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory</a></td>
<td class="nump">$ 111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property, plant, and equipment, net</a></td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Other intangible assets</a></td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets acquired</a></td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities assumed</a></td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mdt_HeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mdt_HeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139925184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact', window );">Restructuring charges, net</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,000,000<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_AssetImpairmentChargesAndInventoryWriteDown', window );">MCS asset impairment and inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">515,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Definite-lived intangible asset charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">409,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact', window );">Restructuring charges, net</a></td>
<td class="nump">53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="nump">136,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="nump">64,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">57,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember', window );">Enterprise Excellence | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cost incurred to date</a></td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact', window );">Restructuring charges, net</a></td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact', window );">Restructuring charges, net</a></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember', window );">Simplification | Pre-tax exit and disposal costs and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cost incurred to date</a></td>
<td class="nump">427,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportMember', window );">Mechanical Circulatory Support | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringWriteDownAndImpairmentProvisions', window );">Restructuring write down and impairment provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 726,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_AssetImpairmentChargesAndInventoryWriteDown', window );">MCS asset impairment and inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Definite-lived intangible asset charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring reserve, current</a></td>
<td class="nump">83,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring reserve, noncurrent</a></td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportMember', window );">Mechanical Circulatory Support | Cost of products sold | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringWriteDownAndImpairmentProvisions', window );">Restructuring write down and impairment provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportMember', window );">Mechanical Circulatory Support | Other operating (income) expense, net | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_RestructuringWriteDownAndImpairmentProvisions', window );">Restructuring write down and impairment provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 668,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_AssetImpairmentChargesAndInventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges And Inventory Write-Down</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_AssetImpairmentChargesAndInventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_RestructuringWriteDownAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Write Down And Impairment Provisions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_RestructuringWriteDownAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_EnterpriseExcellenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mdt_PreTaxExitandDisposalCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mdt_PreTaxExitandDisposalCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_SimplificationRestructuringProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696142920688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mdt_AssociatedCostsMember', window );">Associated Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Accrual adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mdt_AssociatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mdt_AssociatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696136420480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">$ 7,094<span></span>
</td>
<td class="nump">$ 7,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(460)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">6,635<span></span>
</td>
<td class="nump">6,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">6,602<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">6,502<span></span>
</td>
<td class="nump">6,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(424)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">6,079<span></span>
</td>
<td class="nump">6,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">6,079<span></span>
</td>
<td class="nump">6,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 1 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">4,386<span></span>
</td>
<td class="nump">4,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(273)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">4,114<span></span>
</td>
<td class="nump">4,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">4,114<span></span>
</td>
<td class="nump">4,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">Non-U.S. government and agency securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities | Level 2 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities | Level 3 | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144141024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">5,128<span></span>
</td>
<td class="nump">5,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">3,133<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">(269)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">916<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">491<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember', window );">Auction rate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">More than 12 months</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">More than 12 months</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AuctionRateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696137539936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract', window );"><strong>Activities Related to Debt Securities Portfolio</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 1,723<span></span>
</td>
<td class="nump">$ 2,299<span></span>
</td>
<td class="nump">$ 3,587<span></span>
</td>
<td class="nump">$ 4,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">3,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Total</a></td>
<td class="nump">$ 6,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,893<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143215136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Summary of Equity and Other Investments (Details) - Other Assets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments with readily determinable fair value (marketable equity securities)</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Investments without readily determinable fair values</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method and other investments</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments', window );">Total equity and other investments</a></td>
<td class="nump">$ 912<span></span>
</td>
<td class="nump">$ 881<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696147731888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,609<span></span>
</td>
<td class="nump">$ 4,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember', window );">Equity and Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_GainonInvestments', window );">Gross gains</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_LossonInvestments', window );">Gross losses</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment losses recognized</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_GainonInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_GainonInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossonInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossonInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143317424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember', window );">Equity Securities and Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems', window );"><strong>Gain (Loss) on Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net unrealized gains (losses) on equity and other investments still held</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mdt_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139719408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Narrative (Details)<br> &#8364; in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Amount of current debt obligations outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,864,000,000<span></span>
</td>
<td class="nump">$ 5,864,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,742,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,400,000,000<span></span>
</td>
<td class="nump">24,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,284,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Total debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100,000,000<span></span>
</td>
<td class="nump">21,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Amount of current debt obligations outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,000,000<span></span>
</td>
<td class="nump">$ 349,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.057%<span></span>
</td>
<td class="nump">3.057%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term loan agreement | Medtronic Luxco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="nump">&#165; 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Term loan agreement | TIBOR Rate | Medtronic Luxco</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin added to variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember', window );">Commercial Paper Program | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_CommercialPaperMaximumBorrowingCapacity', window );">Commercial paper, maximum borrowing amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember', window );">Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit, maximum capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit, amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember', window );">Medtronic Luxco senior notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal value | &#8364;</a></td>
<td class="nump">&#8364; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Proceeds from (repayments of) debt | &#8364;</a></td>
<td class="nump">&#8364; 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember', window );">3.500 percent ten-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember', window );">3.500 percent ten-year 2015 senior notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember', window );">3.350 percent ten-year 2017 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember', window );">3.350 percent ten-year 2017 senior notes | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 368,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CommercialPaperMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CommercialPaperMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mdt_MedtronicLuxcoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mdt_MedtronicLuxcoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=mdt_TokyoInterBankOfferedRateTIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=mdt_TokyoInterBankOfferedRateTIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A2015CommercialPaperProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_AmendedandRestatedRevolvingCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_MedtronicLuxcoSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696138204288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Arrangements - Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">$ 5,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount, net</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 20,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember', window );">3.500 percent ten-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20260250PercentMember', window );">0.250 percent six-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A2265PercentThreeYear2022SeniorNotesMember', window );">2.625 percent three-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20260000PercentMember', window );">0.000 percent five-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20271125PercentMember', window );">1.125 percent eight-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember', window );">3.350 percent ten-year 2017 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A3000PercentSixYear2022SeniorNotesMember', window );">3.000 percent six-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20290375PercentMember', window );">0.375 percent eight-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20311625PercentMember', window );">1.625 percent twelve-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20321000PercentMember', window );">1.000 percent twelve-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A3125PercentNineYear2022SeniorNotesMember', window );">3.125 percent nine-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20330750PercentMember', window );">0.750 percent twelve-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A3375PercentTwelveYear2022SeniorNotesMember', window );">3.375 percent twelve-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20354375PercentMember', window );">4.375 percent twenty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_A2007CIFSASeniorNotesDue20386550PercentMember', window );">6.550 percent thirty-year 2007 CIFSA senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20392250PercentMember', window );">2.250 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2009Due20396500PercentMember', window );">6.500 percent thirty-year 2009 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20401500PercentMember', window );">1.500 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2010Due20405550PercentMember', window );">5.550 percent thirty-year 2010 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20411375PercentMember', window );">1.375 percent twenty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due20424500PercentMember', window );">4.500 percent thirty-year 2012 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due20434000PercentMember', window );">4.000 percent thirty-year 2013 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due20444625PercentMember', window );">4.625 percent thirty-year 2014 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20454625PercentMember', window );">4.625 percent thirty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20501750PercentMember', window );">1.750 percent thirty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20511625PercentMember', window );">1.625 percent thirty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.500 percent ten-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.250 percent six-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 2.625 percent three-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.000 percent five-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.125 percent eight-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">1,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.350 percent ten-year 2017 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.000 percent six-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.375 percent eight-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.625 percent twelve-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.000 percent twelve-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.125 percent nine-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 0.750 percent twelve-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 3.375 percent twelve-year 2022 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.375 percent twenty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">1,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 6.550 percent thirty-year 2007 CIFSA senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 2.250 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 6.500 percent thirty-year 2009 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.500 percent twenty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.550 percent thirty-year 2010 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.375 percent twenty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.500 percent thirty-year 2012 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.000 percent thirty-year 2013 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.625 percent thirty-year 2014 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 4.625 percent thirty-year 2015 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.750 percent thirty-year 2019 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 1.625 percent thirty-year 2020 senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, gross</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,064<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20253500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20260250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20260250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A2265PercentThreeYear2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A2265PercentThreeYear2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20260000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20260000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20271125PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20271125PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2017Due20273350PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A3000PercentSixYear2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A3000PercentSixYear2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20290375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20290375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20311625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20311625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20321000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20321000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A3125PercentNineYear2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A3125PercentNineYear2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20330750PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20330750PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A3375PercentTwelveYear2022SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A3375PercentTwelveYear2022SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20354375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20354375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_A2007CIFSASeniorNotesDue20386550PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_A2007CIFSASeniorNotesDue20386550PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20392250PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20392250PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2009Due20396500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2009Due20396500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20401500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20401500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2010Due20405550PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2010Due20405550PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20411375PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20411375PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due20424500PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2012Due20424500PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due20434000PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2013Due20434000PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due20444625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2014Due20444625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20454625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2015Due20454625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20501750PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2019Due20501750PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20511625PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdt_SeniorNotes2020Due20511625PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696142413600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Narrative (Details)<br> $ in Millions, &#8364; in Billions, &#165; in Billions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI</a></td>
<td class="nump">$ 852<span></span>
</td>
<td class="nump">$ 852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge unrealized gains to be reclassified over the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, excluded component, gain (loss), recognized in earnings</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">17,900<span></span>
</td>
<td class="nump">17,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">5,100<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Euro-denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">&#8364; 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Cash flow hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">8,300<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum remaining maturity of foreign currency derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16.0<span></span>
</td>
<td class="nump">&#165; 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging | Euro-denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">15,900<span></span>
</td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Derivatives designated as hedging instruments | Net investment hedging | Japanese Yen-denominated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Gross notional amount</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696140063856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="num">$ (806)<span></span>
</td>
<td class="num">$ (475)<span></span>
</td>
<td class="num">$ (2,184)<span></span>
</td>
<td class="num">$ (1,059)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">(Gain) Loss Reclassified into Income</a></td>
<td class="num">(202)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(322)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in AOCI, net investment hedges</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Reclassified into Income, net investment hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Other operating (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in AOCI, Cash flow hedges</a></td>
<td class="num">(266)<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(608)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Recognized in income, cash flow hedges</a></td>
<td class="num">(205)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in AOCI, Cash flow hedges</a></td>
<td class="num">(133)<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Recognized in income, cash flow hedges</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mdt_NonDerivativeInstrumentsMember', window );">Non-derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Recognized in AOCI, net investment hedges</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="num">(1,350)<span></span>
</td>
<td class="num">(780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Reclassified into Income, net investment hedges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), before Reclassification and Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), Reclassification, before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mdt_NonDerivativeInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mdt_NonDerivativeInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143678816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivatives not designated as hedging instruments</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other operating (income) expense, net | Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivatives not designated as hedging instruments</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other operating (income) expense, net | Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, (Gain) Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivatives not designated as hedging instruments</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143300992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">$ 1,082<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">742<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated as hedging instruments | Currency exchange rate contracts | Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Currency exchange rate contracts | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Currency exchange rate contracts | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Total return swaps | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative assets, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Total return swaps | Other accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities, fair value</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mdt_OtherAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696140187536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">$ 1,082<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liabilities</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143716416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="nump">$ 1,082<span></span>
</td>
<td class="nump">$ 695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral (Received) Posted</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DerivativeAssetLiabilityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="nump">1,031<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash', window );">Cash Collateral (Received) Posted</a></td>
<td class="num">(703)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet', window );">Net Amount</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Currency exchange rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Derivative assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnCash', window );">Cash Collateral (Received) Posted</a></td>
<td class="num">(704)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral (Received) Posted</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember', window );">Total return swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Derivative liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Gross Amount of Recognized Assets (Liabilities)</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction', window );">Financial Instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCollateralRightToReclaimCash', window );">Cash Collateral (Received) Posted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral', window );">Net Amount</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset (Liability) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset (Liability), Fair Value, Gross Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226038-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralRightToReclaimCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226038-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralRightToReclaimCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount as of the balance sheet date of the fair value of derivative assets and derivative liabilities that in accordance with the entity's accounting policy were offset against collateral under a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TotalReturnSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696148812032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 3,317<span></span>
</td>
<td class="nump">$ 3,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">769<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 5,055<span></span>
</td>
<td class="nump">$ 4,616<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143201152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 40,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">1,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to held for sale</a></td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="num">(1,204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">40,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember', window );">Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">7,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to held for sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,784<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">19,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to held for sale</a></td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="num">(951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">18,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember', window );">Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">11,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to held for sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">11,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember', window );">Diabetes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill as a result of acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Transfer to held for sale</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation and other</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 2,254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143254464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>May 25, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Definite-lived intangible asset charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 409,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 421,000,000<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="nump">844,000,000<span></span>
</td>
<td class="nump">$ 866,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember', window );">Medical Surgical | Renal Care Business (RCS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mdt_RenalCareBusinessRCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mdt_RenalCareBusinessRCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139366224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 28,802<span></span>
</td>
<td class="nump">$ 28,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(13,730)<span></span>
</td>
<td class="num">(13,006)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount, Indefinite-lived</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">16,918<span></span>
</td>
<td class="nump">16,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,476)<span></span>
</td>
<td class="num">(7,005)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember', window );">Purchased technology and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">11,295<span></span>
</td>
<td class="nump">10,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,916)<span></span>
</td>
<td class="num">(5,667)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(266)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (66)<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdt_PurchasedTechnologyAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696142884544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remaining 2023</a></td>
<td class="nump">$ 839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">1,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">1,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">1,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">$ 1,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696143681392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Income tax adjustments</a></td>
<td class="nump">$ 764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">68.70%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued gross interest and penalties</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Gross unrecognized tax benefits, net of cash advance, recorded as noncurrent liability</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 802<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696140068320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_EarningsPerShareReconciliationNumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to ordinary shareholders</a></td>
<td class="nump">$ 427<span></span>
</td>
<td class="nump">$ 1,311<span></span>
</td>
<td class="nump">$ 1,356<span></span>
</td>
<td class="nump">$ 2,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_EarningsPerShareReconciliationDenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic - weighted average shares outstanding (shares)</a></td>
<td class="nump">1,329.4<span></span>
</td>
<td class="nump">1,345.1<span></span>
</td>
<td class="nump">1,329.4<span></span>
</td>
<td class="nump">1,344.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted - weighted average shares outstanding (shares)</a></td>
<td class="nump">1,332.0<span></span>
</td>
<td class="nump">1,355.3<span></span>
</td>
<td class="nump">1,333.3<span></span>
</td>
<td class="nump">1,355.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (usd per share)</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (usd per share)</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share based payments</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends', window );">Employee restricted stock units (shares)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share based payments</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EarningsPerShareReconciliationDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EarningsPerShareReconciliationDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_EarningsPerShareReconciliationNumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_EarningsPerShareReconciliationNumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares included in diluted EPS for potentially dilutive effect of nonvested equity-based payment award containing forfeitable rights to dividends or dividend equivalents, whether paid or unpaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 68B<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5498026-109256<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696142899888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (shares)</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144208672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefits</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Total stock-based compensation expense, net of tax</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mdt_EmployeesStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696144074160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details) - Pension plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net Periodic Benefit Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139759456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Changes in AOCI (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Jul. 30, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 52,843,000,000<span></span>
</td>
<td class="nump">$ 52,722,000,000<span></span>
</td>
<td class="nump">$ 51,664,000,000<span></span>
</td>
<td class="nump">$ 51,602,000,000<span></span>
</td>
<td class="nump">$ 52,722,000,000<span></span>
</td>
<td class="nump">$ 51,602,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(424,000,000)<span></span>
</td>
<td class="nump">324,000,000<span></span>
</td>
<td class="nump">166,000,000<span></span>
</td>
<td class="nump">274,000,000<span></span>
</td>
<td class="num">(100,000,000)<span></span>
</td>
<td class="nump">440,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">52,057,000,000<span></span>
</td>
<td class="nump">52,843,000,000<span></span>
</td>
<td class="nump">52,159,000,000<span></span>
</td>
<td class="nump">51,664,000,000<span></span>
</td>
<td class="nump">52,057,000,000<span></span>
</td>
<td class="nump">52,159,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive (Loss) Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,939,000,000)<span></span>
</td>
<td class="num">(2,265,000,000)<span></span>
</td>
<td class="num">(3,209,000,000)<span></span>
</td>
<td class="num">(3,485,000,000)<span></span>
</td>
<td class="num">(2,265,000,000)<span></span>
</td>
<td class="num">(3,485,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,000,000<span></span>
</td>
<td class="nump">381,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(243,000,000)<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(422,000,000)<span></span>
</td>
<td class="nump">326,000,000<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
<td class="nump">276,000,000<span></span>
</td>
<td class="num">(97,000,000)<span></span>
</td>
<td class="nump">443,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(2,361,000,000)<span></span>
</td>
<td class="num">(1,939,000,000)<span></span>
</td>
<td class="num">(3,042,000,000)<span></span>
</td>
<td class="num">(3,209,000,000)<span></span>
</td>
<td class="num">(2,361,000,000)<span></span>
</td>
<td class="num">(3,042,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Investment Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,000,000<span></span>
</td>
<td class="num">(209,000,000)<span></span>
</td>
<td class="nump">92,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(195,000,000)<span></span>
</td>
<td class="num">(41,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183,000,000)<span></span>
</td>
<td class="num">(44,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(392,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(392,000,000)<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,599,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(519,000,000)<span></span>
</td>
<td class="num">(2,599,000,000)<span></span>
</td>
<td class="num">(519,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,705,000,000)<span></span>
</td>
<td class="num">(599,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,705,000,000)<span></span>
</td>
<td class="num">(599,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(4,304,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,118,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,304,000,000)<span></span>
</td>
<td class="num">(1,118,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember', window );">Net Investment Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,458,000,000)<span></span>
</td>
<td class="nump">841,000,000<span></span>
</td>
<td class="num">(1,458,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,409,000,000<span></span>
</td>
<td class="nump">780,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,409,000,000<span></span>
</td>
<td class="nump">780,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">2,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(678,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000,000<span></span>
</td>
<td class="num">(678,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Net Change in Retirement Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(773,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,347,000,000)<span></span>
</td>
<td class="num">(773,000,000)<span></span>
</td>
<td class="num">(1,347,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">37,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(769,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,310,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(769,000,000)<span></span>
</td>
<td class="num">(1,310,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized Gain (Loss) on Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (253,000,000)<span></span>
</td>
<td class="nump">474,000,000<span></span>
</td>
<td class="num">(253,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634,000,000<span></span>
</td>
<td class="nump">237,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256,000,000)<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,000,000<span></span>
</td>
<td class="nump">269,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 852,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852,000,000<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications, tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696136678224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 10, 2022 </div>
<div>claim </div>
<div>plantiff</div>
</th>
<th class="th">
<div>Nov. 02, 2022 </div>
<div>claim</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($) </div>
<div>claimant</div>
</th>
<th class="th">
<div>Oct. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 28, 2022 </div>
<div>USD ($) </div>
<div>landfill </div>
<div>claimant </div>
<div>subsidiary </div>
<div>manufacturer</div>
</th>
<th class="th">
<div>Oct. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 29, 2016 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Apr. 29, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued litigation charges | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember', window );">Orrington, Maine chemical manufacturing facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_SiteContingencyNumberofLandfillsRequiringRemoval', window );">Number of landfills requiring removal (in landfills) | landfill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_SiteContingencyNumberOfLandfillsRequiringCapping', window );">Number of landfills requiring capping (in landfills) | landfill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember', window );">Pelvic mesh | Product liability litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_LossContingencyNumberofSubsidiaries', window );">Number of subsidiaries (in subsidiaries) | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_LossContingencyNumberofManufacturers', window );">Number of manufacturers (in manufacturers) | manufacturer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount of settlement received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Number of claims settled (in claims) | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claimants (in claimants) | claimant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember', window );">Pelvic mesh | Product liability litigation | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Number of claims settled (in claims) | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_HerniaMeshLitigationMember', window );">Hernia Mesh Litigation | Pending Litigation | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claimants (in claimants) | claim</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs (in plaintiffs) | plantiff</a></td>
<td class="nump">6,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_HerniaMeshLitigationMember', window );">Hernia Mesh Litigation | Pending Litigation | Massachusetts | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs (in plaintiffs) | plantiff</a></td>
<td class="nump">5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mdt_HerniaMeshLitigationMember', window );">Hernia Mesh Litigation | Pending Litigation | Minnesota | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs (in plaintiffs) | plantiff</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_LossContingencyNumberofSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_LossContingencyNumberofSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_SiteContingencyNumberOfLandfillsRequiringCapping">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Site Contingency, Number of Landfills Requiring Capping</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_SiteContingencyNumberOfLandfillsRequiringCapping</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_SiteContingencyNumberofLandfillsRequiringRemoval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Site Contingency, Number of Landfills Requiring Removal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_SiteContingencyNumberofLandfillsRequiringRemoval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationSiteAxis=mdt_OrringtonMaineChemicalManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mdt_PelvicMeshLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mdt_HerniaMeshLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mdt_HerniaMeshLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696138912096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 28, 2022 </div>
<div>portfolio</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments (in segments)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments (in segments)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696138158000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">$ 1,404,000,000<span></span>
</td>
<td class="nump">$ 1,563,000,000<span></span>
</td>
<td class="nump">$ 2,528,000,000<span></span>
</td>
<td class="nump">$ 2,422,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other non-operating income, net</a></td>
<td class="nump">109,000,000<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="nump">192,000,000<span></span>
</td>
<td class="nump">177,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(421,000,000)<span></span>
</td>
<td class="num">(431,000,000)<span></span>
</td>
<td class="num">(844,000,000)<span></span>
</td>
<td class="num">(866,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and associated costs and RCS/MCS impairment / costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(180,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(34,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(60,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,395,000,000<span></span>
</td>
<td class="nump">1,493,000,000<span></span>
</td>
<td class="nump">2,438,000,000<span></span>
</td>
<td class="nump">2,326,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">2,733,000,000<span></span>
</td>
<td class="nump">3,047,000,000<span></span>
</td>
<td class="nump">5,223,000,000<span></span>
</td>
<td class="nump">6,219,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">1,047,000,000<span></span>
</td>
<td class="nump">1,095,000,000<span></span>
</td>
<td class="nump">2,003,000,000<span></span>
</td>
<td class="nump">2,256,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">714,000,000<span></span>
</td>
<td class="nump">908,000,000<span></span>
</td>
<td class="nump">1,356,000,000<span></span>
</td>
<td class="nump">1,823,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">876,000,000<span></span>
</td>
<td class="nump">887,000,000<span></span>
</td>
<td class="nump">1,691,000,000<span></span>
</td>
<td class="nump">1,850,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Diabetes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating profit</a></td>
<td class="nump">96,000,000<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="nump">174,000,000<span></span>
</td>
<td class="nump">290,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense</a></td>
<td class="num">(118,000,000)<span></span>
</td>
<td class="num">(136,000,000)<span></span>
</td>
<td class="num">(282,000,000)<span></span>
</td>
<td class="num">(273,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other non-operating income, net</a></td>
<td class="nump">109,000,000<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="nump">192,000,000<span></span>
</td>
<td class="nump">177,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(421,000,000)<span></span>
</td>
<td class="num">(431,000,000)<span></span>
</td>
<td class="num">(844,000,000)<span></span>
</td>
<td class="num">(866,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_CorporateOverhead', window );">Corporate</a></td>
<td class="num">(402,000,000)<span></span>
</td>
<td class="num">(415,000,000)<span></span>
</td>
<td class="num">(816,000,000)<span></span>
</td>
<td class="num">(864,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_CentralizedDistributionCosts', window );">Centralized distribution costs</a></td>
<td class="num">(311,000,000)<span></span>
</td>
<td class="num">(516,000,000)<span></span>
</td>
<td class="num">(622,000,000)<span></span>
</td>
<td class="num">(981,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related items</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="num">(38,000,000)<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Certain litigation charges, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(34,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(60,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">IPR&amp;D charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(90,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdt_MedicalDeviceRegulations', window );">Medical device regulations</a></td>
<td class="num">(37,000,000)<span></span>
</td>
<td class="num">(24,000,000)<span></span>
</td>
<td class="num">(70,000,000)<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit of business</a></td>
<td class="num">(37,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(37,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items | Restructurings Excluding RCS and MCS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and associated costs and RCS/MCS impairment / costs</a></td>
<td class="num">(95,000,000)<span></span>
</td>
<td class="num">(77,000,000)<span></span>
</td>
<td class="num">(171,000,000)<span></span>
</td>
<td class="num">(159,000,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items | Renal Care Business (RCS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and associated costs and RCS/MCS impairment / costs</a></td>
<td class="num">(24,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(99,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items | Mechanical Circulatory Support Operating Unit (MCS)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and associated costs and RCS/MCS impairment / costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (726,000,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CentralizedDistributionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Centralized Distribution Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CentralizedDistributionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_CorporateOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate overhead expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_CorporateOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdt_MedicalDeviceRegulations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Device Regulations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdt_MedicalDeviceRegulations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_CardiovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_MedicalSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_NeuroscienceGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mdt_DiabetesGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_RestructuringsExcludingRCSAndMCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_RestructuringsExcludingRCSAndMCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_RenalCareBusinessRCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_RenalCareBusinessRCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportOperatingUnitMCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mdt_MechanicalCirculatorySupportOperatingUnitMCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140696139878176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Oct. 28, 2022</div></th>
<th class="th"><div>Oct. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 7,585<span></span>
</td>
<td class="nump">$ 7,847<span></span>
</td>
<td class="nump">$ 14,955<span></span>
</td>
<td class="nump">$ 15,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember', window );">Total other countries, excluding Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">7,560<span></span>
</td>
<td class="nump">7,820<span></span>
</td>
<td class="nump">14,908<span></span>
</td>
<td class="nump">15,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">4,069<span></span>
</td>
<td class="nump">3,997<span></span>
</td>
<td class="nump">7,835<span></span>
</td>
<td class="nump">8,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,491<span></span>
</td>
<td class="nump">$ 3,823<span></span>
</td>
<td class="nump">$ 7,073<span></span>
</td>
<td class="nump">$ 7,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>mdt-20221028_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdt="http://www.medtronic.com/20221028"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdt-20221028.xsd" xlink:type="simple"/>
    <context id="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20230375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due20230000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="if582051bf4124134a62ad07d19497784_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20311.00PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="icb33528b47724a289550d115188aeb99_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2022Due2034Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20394500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due20391.50PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2019Due2049Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mdt:SeniorNotes2020Due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i9b27bafc1ca94489ba6518e9a3ef1483_I20221128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia0b6116555c34c9f83363705bad2dc7b_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i4c24ef1adeed4623bdd58565d19980a7_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ibf939ef7ba9b40d9b919eaff4d3aaf20_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i7f7d0c01899c445db04cd9b2d85f6968_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9a2b3356080044499be1ee38fa01063b_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ic96f676fdbed43a1af73c94a459a0027_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="if81b699157ef400babbd49b79ce01d51_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i48888061b36f42269ac398a4797a7f84_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i04258c79de92422585b957b7ea074863_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="ibaf8710ac3ce4ccdac40ee3b1b558b39_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-07-29</endDate>
        </period>
    </context>
    <context id="iba553ebece994593a02b2325d2eaf828_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="iabee6461cac44d1b9e9883c0e2236533_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="i3c7b953379f84fdaa442b1f9a50a4444_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="i830c7cc13ba0450aa6d50f69c10d139a_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="i9edbc694c8954441b58c7dfcf548932d_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="i3715049e1f9a4a64bc2f20c1b2d751b1_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="ief0140ab23f7415d9e84fba89d2ce274_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="idb31e75e6e81437d992d025c15bdbab7_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1c26438766584fc093b6da547164787e_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i479bc235eb204cc6bd9b5d428f9c482d_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="id957c1291b754cb3989f2c5e3ac8dbf8_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i90b6c031e74f4b8192cfe7653b448f7a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i12e89df7a7284768b084b028fb30c0b3_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7de7fa9e2bd14d9cb49275324f2d4fff_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="id3889946f4cd466eb0c8de4cb9692332_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iac68bc9471644ffc8005764e8ae89b46_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="id5462aaf0c094c7db4f015d2fc1cccfe_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i7303ffa9282c44ada71fcf27f9caf878_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i1b4eb2cd7eb34e68bc0bfff863e48a7f_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i576eb2cb85264ebe977159af31544200_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="id815d10cd7364e4c8224095110455793_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i805e77a5795b43879236735b12530491_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="id3812240d458431e8ef07e8d1e16b569_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="ibad2d789542f4a2382dd3a428fefa32f_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i93039fe1caf846e29eab3a6ecfe114fd_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i6cfefe3cebb942b897dafda418007e00_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i674c328ca4cf4cacacc5730fead09f35_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="ie98b1d14c436463b872fdeceb9f130aa_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i758fd510e93e480db9ffe7c253a337a3_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2021-07-30</instant>
        </period>
    </context>
    <context id="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ieb4c020bc4494a4998a6177261e6225b_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i3b9e3f477203428683ae92a742041fd6_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i3190fe1c894e4a2b85407bc0557e735c_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="ic4a75125a2ce45cbb0110cffa8149de1_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i3b27da620ade4165842447d930ad60a5_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i8245ba0bf94b40b7b27dc0842b8cc6b9_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i26383b4523e74135acd4c7e7659b4845_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i000ae0a85877429aaf119fe579aa99b6_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="ia9a3dd382c6945438731d0f15056527b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i104380acc80d4b33bdb75a56ac2c6c3a_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2c7b3868ea6348b284ebcfa636598a64_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i7b6cb2b2a61d40dd88447e04bbb15481_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CardiacRhythmandHeartFailureDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifd3cbd04fd67492bafbb8147b08ca285_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4016f75f0a6c48efba5e59908d817ef1_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i96aaaa79ddc3450fa9639b6e04b840d5_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i739110963f73456da89189576a2091f4_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:StructuralHeartAndAorticDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i6f70332fc7824fcabcb5d642eb7a2f6a_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie324a3122889429ebaf0032db23c5238_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2d18929121a14b85ba7ae8f5ef22c1a9_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5e6e04e462ae4a2492cf55f9a81f3d29_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CoronaryAndPeripheralVascularDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifd255fc2b256464d83f0adcaf79f0ddd_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ifd10fb8d585649da82b0209da784c586_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i298f3e560bc74437ab29be651d20c23c_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9689fd91f59346fcacc698cec3a68895_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0f231991285846759c45d083b2999740_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i6173309cb7a641cbaf71ef41eb3b7527_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="if9d5b9a26751433ea892c9f8b363dbe2_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SurgicalInnovationsDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i3918c5f3d0af4735a961ab1815e1cf3d_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibf9de08f7ea344bab23f761eeec19428_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1692b6fd84064547866e4a84aab6e13a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i369bfcdc666b4698958b63d22fedcb62_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:RespiratoryGastrointestinalandRenalDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia9adc4ac26074f52a4fc617426b96edb_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic17c53a8b4d840bf9f1f5c07e4dd2a76_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4fa1c2c8fbbd4ef994753457a37c388e_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i094e4d8aeb954d2cbf3b8cb59a49db5f_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i057120522c584c6fae651608298e537a_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib3a9931ef8274f7284b66ad7e01a834b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3febdd347f7f477d9298fd0419ce511b_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:CranialAndSpinalTechnologiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib91330ecb8454e3c87bbd07559e10c3b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i64bce33fbd78408f8084a88248f2eca1_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i55d8dc2aa18b4777873305f761bbf8b0_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibd0dc280b5c24b7b82ea150e787a2baa_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:SpecialtyTherapiesDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9ea5fa54c40f4e3a8bc238188a9f7811_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i92b937fd099a4e338e041ac1dcd2d695_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9c0d78811777448cace0976925773be8_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie251fa17aa3949fe9f0839d52f9cd5c9_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">mdt:NeuromodulationDivisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i6632c3723b974d80bbfd7795c6cef933_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6d71e3989c6f4d4f9aba2569ad2a5bf3_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3eeef53bad4b48bfb1c302257f4c2bf3_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifed3671c909f416cab9afaf75dfcf9fb_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="if8f1c372ed204eaa8382d90ad65d4902_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie028302d82c14ab399e272eb03720bb6_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib1c3b2e62cc94239b99a9e996b5678f1_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i610eea5eb3484fd6bf51b42709374d0b_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i44d79d0fb65746aaa6359715a89e2ee7_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4de1c8c6c0d445a083e6c55af3d03c6e_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i298ed1e39d63426681947aac7c92c6fc_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibfaba2c830554de58c19cb60762cabe6_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i8e4167c253b04797beb9ec205174739b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i33446d8e0ee24892b0c64f6aaebbf045_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie5a344f488304d06b2d1c07cd4cc008b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iab66a53e9d4144e895fc21c33e195eab_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i32deed4df6594deba88fcc157d9318b9_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibb7d8d91058f46969b341026534b0f8b_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie3fb4f39283f4f57af883c4294c05e2f_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic7d72e4f26a74e2a9e315d0f49903406_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2d368c56378c40fb904cbc84bf222cf2_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i04fb1213c4b84a8a8f8565296c9cbb98_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie746f4753ebd49d4806edf24d4bc054f_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5214f11f980d4654b157bce110db9b3f_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i7055abe559314041bd8f3e48e5c1b5ac_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="if1864b5e68da47c18ee80fc6916d798c_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i01b3e03620d64556acc1932365baea4c_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib9383983150046f9bf39c566f31fdcd5_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i974d74af34f64bba98080397f378b049_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i9145fb48548b429fa67e81114c3a7f77_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i4886727899c748af9b7ca6ecc006d607_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4119f66ab242497fbd1a7129a09ef938_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia1394b8d1d604848b1afc29f179024b5_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia54914f294dd447a8c3201ee0160b967_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i6034dedd81034ca58a3efaa8aaf912b2_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i47330c898c084aa5838659f2f34d4c10_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i5c1ab6b402e94618aaf6a6d53b19afaa_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i644a9f4b3e1f4b2cbd1ddb0e7ec2d231_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1ac1e8c6edbf463894ff0a4a97c65b0c_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="id75288cda0d146909d982333f28bd033_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i886d34bbec8640b6b611a39dd7f55630_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6dbab7c4dd864773bfc6e76adab58533_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i582ee1774f514ca68b795b9717b436f9_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1f59093bb7f543e795d5e21aa6b22695_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i878fa8e82bf64ae7aab3cb9e7cb532ff_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2f850d1105104e52a1834603e5aa1069_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1f9d4e944db0457eb58a4abb5fb0ac50_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i54d359386ad44272b635669807e608f6_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i59834bcd47a841d88758402a4ea93e11_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4b47df2f3bfd4e52b3825a46ddd428e5_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib32be93843e34926a15aeb2dcc3dbcc2_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i993a3f339e894c8dafef5e5049915240_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i31a13d28f0194f8eb5115201dbe86f3c_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4b9b22d428114c4ab5ee78a571295915_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="if00b55f38c464a969df5efc27c1c7d80_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5a714d7dd59b4092861465d25ffd24ab_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia7acac8017744c558ae12f06f24486c7_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ibce3653f29834ec387f827999d02f9fc_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i8fefedf1e5ea47b4a531ab78ce1ff37a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3bd8b96342484a81b5fa2dc86cd010e4_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i202e893b22f240a5b7c9fd460ba69357_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4725c44b1daf418f8388bf7dc0380194_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ied8d8356269248db86adef62aabe056a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i49cdfed15a07485aa1fe2b7e67209ebf_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="id2a4321a5aba4098afc2e72f4addc84d_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i7e81b5be3ebd42d6b0a7d11e27c5a66c_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ib091f63ce1ed47fa86badb21ce620a7e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4b3f93df1ec946d38393e3dd053885a1_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i09d5f411538846809c17df42d6baca81_I20220513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-13</instant>
        </period>
    </context>
    <context id="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-13</startDate>
            <endDate>2022-05-13</endDate>
        </period>
    </context>
    <context id="ib15e9005fdf54bb388c5a1ebc77ec0c1_I20220513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-13</instant>
        </period>
    </context>
    <context id="i6e8fea31e19645bf890da6ac5660baec_I20220513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-13</instant>
        </period>
    </context>
    <context id="idac13f4d55474a59bd8fd8d73215242f_I20220513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:IntersectENTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-13</instant>
        </period>
    </context>
    <context id="i19cd5686ee1b41f4a0781c0d70df295d_D20220830-20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AfferaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="i26636377353846a2a7e4ae845aeb7572_I20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:AfferaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="i6d3a8e5da34e4451a2cc414372ccc1f7_I20220830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="ib2aacc1c206e4a01aec2ccb24a371680_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7c69bc171625454788f2c35a7111a3cf_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4b9df38c023342f9ba4c348f76154832_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic6da65d65d594808b778a60b752c29d5_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mdt:OtherAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5499b0d188aa457384102e9d56fa1649_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i0f469be1b25343c2afe5256eef30c662_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifc6a84fee82c404bac6319d748601679_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mdt:InProcessResearchDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="id51339e6172a4fa89793c01ac5372310_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4c8100ac3fc3472cb1b2257195df4d15_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ieaec69ca2a9d420196afba03c715564d_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8536fb1f3cc8405c85d5955abab804d9_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:RevenueMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ib7770b13078c4633b39a58a920db477c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2589490d854b4bbc9e1da49cf061a2e8_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3fc3efebb4dd43008c52a5f4f54db6ab_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="if4458127713949c4a58c258ac31d5b0f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">mdt:ProductDevelopmentMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i0eab4cc7e4a74091a2af9b1421a69dca_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iaf0cf08134fb482896645f610dcd043e_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6f5870d0d38b43288e41b0362ecae37f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:HeldForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ic303609806184f2a8805b32d1c783a34_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i16be2ec2863d4cd48ac8e0eb7c5810ca_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iaf42b4b6d0454f69954bbee47e517f83_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ifccb4ab61ed34b10bc32266e11c04021_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i76aa15f0495a412bb5fc7e8ff902a5d1_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2fb118eb3cf3495fa67564bb77d2993e_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia10b9bf7f4c04b34a8e912ac100537a7_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i23fad8dce9c14b88b09f562c0af053eb_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i73bd78bbe8f143f88fc76d50131fcd9c_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1e280053272b4dd5b8c64cde259c885a_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ibc87cf841c074114a5ac8137bc707c99_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ic7a4dc8016694646972d6448816d5640_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i2d4182f25b264fa0a677c170f7aa55f9_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:EnterpriseExcellenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:PreTaxExitandDisposalCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i0b041edd8d56490d893ff0c11caa0d8a_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1d6cdd73391542f3b7994da4e26578af_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i546d50a1a554496194d00f2caddaf5ca_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i87940cb6cac741d6b1f3cc6fb389a371_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i8ff0490f25be4b77b9b8f6dce7ac4704_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie6a7d73ef1c947bfac5459b19b344d12_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ic8cf02e126cb40ff876492202959b05e_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i04964d69fc284d70b8188fb55131e440_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:SimplificationRestructuringProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1a172149369e4566a362a7034cff8552_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i67cae084ba3e474287026bb8a735a3da_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i750e8435c8c8420982689bdc80379523_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0e3f285c5dfb4c6c8e9ef6bff8bbad66_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iba560acd2e9b4ac59cc8a3b89523e6cd_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mdt:AssociatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="idd39c4b6e9034559b7adc2252123cce6_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i388aa93f36a249c1a5b546222a59df60_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="if90275cb55b4415a836c84bf7e67ed62_D20210501-20210730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-07-30</endDate>
        </period>
    </context>
    <context id="i3a082f3a04564610933344f50f0c3196_D20220129-20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-29</startDate>
            <endDate>2022-04-29</endDate>
        </period>
    </context>
    <context id="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="idb47a5513b8248b38d166e23c6e226cb_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7e0e9a2126f3451a9364ecb102f47619_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia17c51259199438d92935700e9a84f38_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i5183de769d9943e0bbf4bf305875caee_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iaedf855a588542ea8b681a551750a94c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i46181f8111394859b9590a8fcf87dea4_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6630e92f38ab4432b631dd6c08be1b5b_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i0acdf85d52b44d0aab8be69ef0dfca9a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i81d3b04d42694befb06b33d5afa3ac4f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i23ea21efa0974fd89079e5ff7597d05c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2adc065c1c31426ca784f2f3aac4c338_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i087fd6abf6244d26810b363ad7f12b34_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="if3cf62ad6eb249199fc96aa7235ad10e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8cc5013382474ea0bac44885f9583479_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i9134674ac1064b3b88dfa58578f7b28f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i14fac49e993e425480a39ef2da97c7e1_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i16dab65d5fee4b13a1b5536b9061af57_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i62f58f99517d475280eae05a72bba5a7_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3c5cf66c9d744fa6b08216cffcee6ea1_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i66e4261fc6da42f78a32a5697fd40ebc_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3cb065edd06b42ab95e3ea8629134f5e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7679e68037ad488cad0ab87fcf105814_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3e89ca409848475c9dd855df62f568ba_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i22f79d5bae0a4e73a42a93007576b58c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2e31c2e0429a4641939c2538318931cc_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i672142582fb643789a7c2276926b53c2_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i692de9ddca214b599e9a03ae112ad3e2_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i13212ed214a64a10aa002be4cdfbe506_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8558d9858fd3413fb08153977c7c737f_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i76bbc05331214b40b0fd449dedfe22ea_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i3b399a04cb7646b5b07096251d2007a8_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i4e218fa6cf914c4388b263f46820286a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i4cf32105f8fc437ab7b7ecaa4fba22e3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i96538ee63df541aba2adf1f7c5ee69c7_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i15f21aaefede4ee3aa44f247594563e3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2da397896f3b426988512b961eafff1c_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i51f45d131dfd44f8b06d2d1fbb1101b1_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="iefba2a09bdf2400fa659329962a625be_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia18fb875e6a54bd698fc23cdb9435208_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="if4146b3ff2414dff8bec3c9d91d6df09_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i5e886b3a97c44676b6e52bc92376095e_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i50675223fb9c4d24bac91bf5a8b500c5_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i7e5341030da8404ab23eb314af6659f0_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia1b0751698534580a06d7e591c567510_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia9959424fd6a4e18a014b452439974f3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ic4f16ecd76844a249feacc0c1f4a7db9_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i0af62c64c70e496180646fa5003616d9_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ibabaf9d9de764e76a341637628038690_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i181e138f85db48af8965b7d878b7e8b9_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i273769593a42414b9854eed6b2e7d297_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i5a9d94e94f1a4706a534771364ec005b_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i6ac252a414964d53a7d3be0ec2452d75_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i8b9515044e8742dc9dfce5361f230a6e_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ieb0b7ef8524844b0804a1928fb54d9b4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9259b16d9d1a47a3a029f28c0f8a81bd_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="if29182b593044b31bebc366410e41692_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i4027240c2d7f4b0697e1af8767791e37_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i39738394791c43f39b81aa42666e1649_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia51c0979773246909434b1ce27622157_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9ad8f6d897f54b9abcdbb3985c505800_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i965da10df5234587b1d528532b979fa4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AuctionRateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mdt:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia3942d4373f44f7497691c840fa95db3_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2015CommercialPaperProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8cc14bfe25a24c169750f3b677e3850f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i5a435f6230ca46b3a412340e46d67d2b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i50b73054f5384db484d17a799d1f1a64_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i74804d544e17446ca08e983c8f7fa76f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie52a26d33fd64110b616f85161449591_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic1b14f05a2554bdbaf9b274cdfd744d4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:AmendedandRestatedRevolvingCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i261e682721ee4018a0e687ae0df46295_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i751c32721c1046dcb276c399e66b615a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i89f1d04b0787461cbd677984bf68ea36_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie4ceaa34c16b4e969c2d70f8a46b0700_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i16fd5558ce984801a4ce4154ad7e4bf0_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ic48a1296b3e44c84bf9342a1671330da_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i9bce3bdd02d842a78def75f12929df2e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i01af7fce485a44f38019814091a50b8f_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20260250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ie72a79cc7e714e3f98098deb1aec4fd1_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2353fa72d44d49ceb3efd49225a21e23_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i7012e804387641a7813faf2625661ec8_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2e9f92a697414dfd8bfd28a672323199_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2265PercentThreeYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2f4a0cb342f9428fb9e71a786d8f86df_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4cda2d6fee9d41349edb516fb0368284_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i84656a75b0454be4a3e0b59a5bf56733_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7489de2611c44626bfd326f30908b1a5_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20260000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia7813502cc324fdfb9cad82fca2aef6f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie7f465b4b499407f84b13e2f34e98cda_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i91a8b596b4464a54ad3624a0e04bd604_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i0d4d3e7efdd64bbe98b4ba1443d485e3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20271125PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ibaecd0e4856b431fa395153da8bc83d0_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i074c3d2b9e5943a78a8bc0e775eaae2a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2d2f2ee743674b16a4e766f4653881b6_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i74d22bb72025442cac41507454e9f728_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i600fd760a9284c3ba2ce36a2e1c4adb7_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iddd3d2cc9e4b461bb1e2c4f66d747810_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i7ec69cbbc5484f558ee3b3e485197f4b_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="if52f4d1f6b37466eb1f1c57c273f68fe_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3000PercentSixYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i45066488b7f44235877f7d05b88cecbf_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia88da43b7ee240e08c8140ee86cda15b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i854fe8577e324d2fb0c40211182aaae5_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i10c69d5ca1d547218da8e846cc583837_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20290375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2e7c703e42e54e418769101e3009a751_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4c4da084f549423ba1edd47c97745dea_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i492e3b74b21647618e19d98fc5af4be6_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4f3c6736ad474abe80247b6c428621e8_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20311625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="iad3d7e100f644b319c3dc758d8c3e5ff_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="if60f67805a834aeb81d478d6048c30b7_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i604c687d118d48988cea0c15344b587f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i440aa4baa5804f8ba1255729affe7a07_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20321000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9ade45514b07472abf3a976bad5075e2_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie6d581765eaf46a1b425828d5e6cdf3e_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="id024eb4c94014ec49c6e27a68351c003_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia9eca626aa454e1aa7d4f2ef86f83b88_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3125PercentNineYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9404b5c0aa234b1e930f980973644052_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i74e2615fe889465fa885b1b6dcef97e6_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i78cb708996bc40d3a6481f7074ed4455_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia56942c6785c408da58413bcc56847ee_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20330750PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i0371e11afaea42b6b38732fc042d143e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3be8c589cbef433e9f5cce07fc5b8204_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic826d07adf4e44dea0e204d5cc54354e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8b1f37320f264fe39b6118d6996cf34f_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A3375PercentTwelveYear2022SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i209002c36bbe4ea7b59430177cf18c4c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i008bf53905884d179baf55ce1247fc76_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iee9e5b36677f4eba9b71eb4a0b2714b5_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i079968c0f4134d4dac2b4878e02b237a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20354375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ib02d94fcae21461da3cf9a8c555a40bd_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia3eacc8baafb46ddac0e1a5fbabe3485_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iad63036539624fd9bc73ae5d7fb42005_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4897e04ca5f64263850346fe30de0a81_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:A2007CIFSASeniorNotesDue20386550PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia9c245862ed0462798a29da9f9f74ce0_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i24a20fcb76734c22a3eade9a14f5ce50_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4b459c8ec71b4a15896e2da7ac25a1b6_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6c925d8d64c94da082cd3422a727785b_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20392250PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i705ac2374d1743abb58218fe5ad12b01_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i7d94e3d1a39247e387019fed8a18ad46_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2dc5cbdea31c4c78aeabffef218a50f3_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8efa321d8ec04cb1a95bed2a3f6976d4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2009Due20396500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i1da25349c4044b8c9d6bde3df1b958aa_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i909fae803c5149209129a0a704330f2b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic3f00def7b8347c4a557ae6a1cfd1374_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i5c769314b80147a5b1c216eb5b25c8b3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20401500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i7955403a09be4b6da70bed7e2f69d629_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2f01a54621494ecbbc0f453611f0bc4e_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1cf2d68341064175b8f864b73593f1d7_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i089c1b9b426a4c1da92f3dc5e97a7581_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2010Due20405550PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="id2c9edb05074480991cd9fb871378cd4_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i76269c4f7bb649cf8290db9a195e6624_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2e51a2b394114d97a8e5c9f7166fab23_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i8511290ec62844a4aae4405642d778c3_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20411375PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ib3c49bd14a1743a0821f157639e97f08_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i5e59ec9a7e4d4ce783bed9fa0bda5c61_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i9d55dae7970a4dd2b220ed120119dd5f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i936640005c7a4c09bb3f8a284850c7bc_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2012Due20424500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i506a7161216440d0bbcb96f17c77d8cd_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i87db6e6fdecd4f628af3c73a2715dbee_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i754149b1402a4ff58be77407ecd96c4c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3a0a9687dcdb42e79003c2c3005eb8c4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2013Due20434000PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9103f0f331f14c2d925ee30459c3419c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i415c753918f5402cbae9f769aa6af00d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i50e9b3944f1f4b6fb772acd25b65ac7e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ib4da5fa079404f4887bbcc27e401662a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2014Due20444625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i0741f7081c8944bb9005b5622a22f293_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ib0f63498f65d45aeba257d88d0f27555_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i852117f888144b7abbee72f3bbb5e8a4_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i74ee8e50af9441eb87ebc10bce2dee83_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20454625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2d8ed26dc30942128f011855ed0d3857_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4c06bcfbe30049bb8d35ab3bd0de7891_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i78c924a87c844f9495ea3277ad27c097_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3aefe516de204b16be7ddf84dca1f0df_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2019Due20501750PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i018f8199d0a84888910a13567f64f9e5_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i91156a4cd65b45e78be0eb72d39dfeb8_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic21748abe44f4b12903d6c9dcfd1a0ee_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie2cf68665dfc4e2b9d53778d119549ba_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2020Due20511625PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="id2453d698b504decb33b115bb6f57fab_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if9d010c11bbf46a3a80141df5fc433c4_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:MedtronicLuxcoSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if23f6f1cf4f1419886209a1983b1efe1_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i95bf75a4681040b69ec7a41ec26fca98_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mdt:TokyoInterBankOfferedRateTIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i6dd0dc4372b54d09b9d6fcf86a905998_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="ic8501e4357d94654a4b7f096cf014e1e_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="iac7ff8ab22ab491e8c00fb7695d6bd7c_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2015Due20253500PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i13d9c16cf83847d8b9dc071854e7249e_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i9ebd3167ead94b20bb0cf7ca721fde30_I20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="i161f2ac0c7ae4093a36c525826d423bc_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdt:SeniorNotes2017Due20273350PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i678b39b151df49b2ba21b6aea15b2c79_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdt:MedtronicLuxcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib5092cafc30846dd94ed5c026e97aa0b_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i17154ded948b43b795f47e739a934d01_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ic328877cbe2640fabe36e10bcb5a5194_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i36cbb82fcc7646f6bff301a9323152ad_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ib01e16de38004386abf16c41bcca590a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ide9ac26ecdb447a5b065fa1afca7c2af_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ieac80a3fc9174c3fbd499cdda5660e8f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6fb15af4122d40f094823a9045c8305c_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2a6af32d4b8247b4b5b8e8370744ce94_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0f985b4d85524a5e894505c6ba972295_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i32e75265ade74bd1b82d3b46447ba700_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i95a7ac115f1d4e669668238c726ec554_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="id475727b6150430e9d00cf9d847ab244_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ib77747096918490f971ab8604b359744_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mdt:NonDerivativeInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i90500a074bb3400493c7a435521e7259_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="id56e46722aac483a8619dd533deb3322_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i72954acc9e57495896b675167421b561_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="idb4c499d238442789c803ba3b479b911_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifd16066db5b741dfa7eb70f35224624f_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic070ac672e7e4600bb8f39e2dfd14cb2_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i030ec29f92aa49e58cf998d20561e1bb_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ibe75196bd192408f9bb4a29e186401b4_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="id51ce1803c5c4ba6810ae2c023e74833_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="id3c626f296fc49089588a3e25c3e2b23_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia500e65b15db40148004c1bc60ce317d_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ia9451fb3d1f04f6187e22f627a237e7d_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i6126e03c431748d39e312714f45be287_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i74e6b87b21534ddcb6def602654c92e5_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i68ea2486c0a94abfb5ca1108224bba7c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i21219af6460740dc8a8f2b42aa062bc0_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i2f4b74a32e9248a69778cfd5232923a2_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i83392e630d054b0bb17f041fb38ee1b6_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="iec2bed4f3dfd4f3b860e60ba24d59a28_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i40052aaebd204ac8bdb5ce6801703b30_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ie8c7fb5b46d345b1b31c77de8ad93269_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i19424ad839704570b79f42bfb5ddc820_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i6bcc9eef7a754a0ea0e93d2b1b2324b5_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="iec60c574487f47fd970e5240db2d6a74_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mdt:OtherAccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i09f696edac744dd7a1aa89ee92b1b57f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i34fbedc968094ed2a24602471bb9832e_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i08b003f2db6844f2a18ece5fe1fec528_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i0f54a6d38f86409f9d004826da691d0a_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i47c72990d6894f6999fbd71fa806b6ec_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i705cf34bc80b41febb1dd15cddb734cb_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i60d4bffbfd284a6a905e87223d86432d_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="iebd53369c48e4ef5b68f6051807d5349_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i9ec5f74b25924bd0bc17044be8b8cc7f_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ib08338469c554b8e9fa1ed1bf628cde1_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i617c5f38a82c413fa4b606a553f802cf_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i50d8dc10f7f74a269ac42c7af38e438d_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i50dc8a72d1e845f0bc5eeb780b4167ce_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i3d4bd5b464cf4754bc657a4694f52b1a_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i64f3035beec5446b898886392399c009_I20220525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-25</instant>
        </period>
    </context>
    <context id="iaaaa9f5a211e46648d43a13986dd518a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iae88943d08a644079847bc841e0fe18f_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i78ca089b4a214117984874b09ca1d0e6_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ic16fb407d39c49d580ac035048e8ce43_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i6bfa7eec43314902906140d18188a9c2_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdt:PurchasedTechnologyAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i351d6e481f7f40618e1994166ab8abe7_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="id0837b81f7bc4637bc63f5b62fb85a48_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ieb5fa643d9584c9bb178f09a350973e3_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ibf2e63efa08c4ca7914dcaaece2d58c2_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3affa50db84b49f895fa4532797c87be_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia80b3537de0145e8b97523443127c857_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1398815934fb4c929000688ee41577ab_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="id4b6674cdea049859601401c887d0ed0_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i74db199c9a774fdb9da00363fa038371_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0eff972d77b347488f63d31d746a15a0_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i8d98793895484125aa0679ce08f1dcd6_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i3c07e51d429d4cbbad584cb5fe45515d_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i4de56b7be4e5417d8cc74ecf01292422_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4dedf22af6864313999d497de5e5d6ee_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i3d7ca207cf164dcc8a0c586bf2859962_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="icce28f9819d44f1cb7eec69a55f52fc9_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mdt:EmployeesStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i89d75dfd093f41b79b84cc712dd4bdeb_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5b29f486c461430ea0700ecce5ccc168_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="icd8a11e621df491c8e9bcf6998fa2316_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2c12dca8003843c9b905c9a3220a9dd3_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ida185280d375499c84936e4a6364ca45_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3b788a6030cc4d249b9f10c42c12d4b3_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i5fe0629813fc4a7f9ee052e38f52a06d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia0871f5c80684792904d5a9b080d8746_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i7c9f32e60ed34e03b1eee7e4dd64092d_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i93bc1e6379124613960fd7675b514cd8_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="iedf7ecfabdfa4fd796a4fc91dfd1466b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia4b972ff441f4b5f9da1923ccd6b5eba_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i8b964c634650403f81e221664044f7b8_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i68bc7daea380420bab51198ec81e539a_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="iac4974ad9d20428ba8fa1009b1d7e83d_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i3ab310b699e340a0b46bb1aa55af0ce5_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i3378e12209024d9d8052dcc6dc3f0a2c_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="if0b5ac28482240b38b40b82a5691ce06_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i188641c285b14b8895fd2296677da61c_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6ef8f476015148708517a60a5d58f505_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i8775a870674f4665a7af461c974860c6_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i28ba042775474bc28935c1b5764479ca_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i80f7f42761a242f0ace890eaa6dc8247_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie8142fb31d264e0699b5a2404ecd7e2e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i4d55bb9abcdd40f88c78b3fb670e6a98_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i69d21fb1bb9c4c179514a671cbf4e411_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i2e2b7c40e2d14604869e3828bebf8f6c_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="i763fe5a14b6f4a0abca07febc595186a_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i8dbf04decd1248789e7cf49bc6bfc8f3_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i51a1f4a27446424fa83923dcf918a2a5_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i40837b287fac4cbe8238278e9bd46ede_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i7edfc27e40204f9580fd94d3ad2410e5_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ic869d6f490e64df1aaefa8121f2d93a3_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i6dbdac6c2f7b45c588961b7bd1c42e81_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i8c544a31d4554d418bd424cc41e57b32_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i8eee748d81154109a2314b15b0389e0c_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="ie1f70b5cc5d64bf3933f7dc026250876_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-04-25</startDate>
            <endDate>2016-04-29</endDate>
        </period>
    </context>
    <context id="id7f39f4a31bc4c9a9b552b6baf0224b9_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="i3323d48e49714e21a2aa0924d7d7fd8e_I20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-28</instant>
        </period>
    </context>
    <context id="ie8ade720172b41b4909dc7e2c1b1d88e_D20221102-20221102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:PelvicMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-11-02</endDate>
        </period>
    </context>
    <context id="if898f1e4a80d473cabc86d838cccee2e_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="i8380ebe92e864b56ae1b2c2197ab9fa3_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="i02d1ebdd9f994625a9014f70c6861e5c_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="i30a6362b35d847688440a2d5375ea168_I20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mdt:HerniaMeshLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-10</instant>
        </period>
    </context>
    <context id="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">mdt:OrringtonMaineChemicalManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i168eaf54a32a4b10ae055d1fd309420b_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3c68c9b8053c4e069d0d10d554ee743e_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i69a634b3ac7e4a93bcc654038f139554_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia19bc2cc12e847f686364b13145bcfa2_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:CardiovascularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i149726acb078405a812214d92610bf74_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i94ae48a92e344d458bdf1af7ef9dfb83_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i70e9b68daa7e476b86394d75a37314c8_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i4db2d7938ece4d1188f55fb0d90ed8ca_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:MedicalSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="if684219172ea489d828654ce6bda19c7_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie88ac8796d2b4f16995fb97c31c6448e_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i1dbc31eff45b4bfa9d8c0fbeda13eb34_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3f69ab25f0944c209d12b73a3e7b2556_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:NeuroscienceGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i5fb28ceec1a245729e4603a23ff55bf9_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i63ff869d0a4a41f786d7d359f94cb14c_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i3857837c700c47ee90158dd782777f47_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i1b5b877f4e5a4a5f80879a1c21a2d977_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mdt:DiabetesGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i47ff2bf6f8a94d3e97118363d9a224a2_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3a6af4191c704ad28f09d2139ee771bb_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i50c477f464714ac1be4ba61e84a7fe9a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5da000fddfa54c00b738a9d7fa43607b_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="idb395127d92d4806adad85a3df96ef16_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="if121f0c93f2542b787d18dc65313b4ec_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ie20fd350e6d74274a06ac9c4f5a4d7f1_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i03ff4fbd770e476a93fac4538e7a739a_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ida7e46384f064832b227315992afe5e9_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RestructuringsExcludingRCSAndMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ifec30626328141edab3ec5e1fd7fad30_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ied00ece93e9e4688918b205b9ade91fc_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i827544a4779342aca7ddd0cc9e3e3373_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i3b62391f8b8740d7bb9d8216c3714f9e_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:RenalCareBusinessRCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="if4de15689258429f96c8aede9acd4189_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ia1297ee8d0604a979f5928e67af71318_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ie0d54845eef646a0b6664bce4c66a85d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i0de2e2a292af422b8f366ef645be1066_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mdt:MechanicalCirculatorySupportOperatingUnitMCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i52660540190940b693d1bd02d12d492a_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ic46769724c574bac915cd348f37fcf2d_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i214e01a959c846e88851e34cc42dc32b_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="ieaeb28a3e4b44b1fa4ad70e8b96300c1_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="i4aa56bae6c344578b698d10d544eafe8_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i5224032c63584bec8b1b1523947f71dd_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="id8120e40de324a48a75b99dadc77ac4d_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i6eaeba13607d4490a06e297131324140_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingUnitedStatesandIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ib88c0c1ed9ab49caa522738259c03475_D20220730-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="i52482a063c8a45dfaeab8842374cd025_D20210731-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-31</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="ia092a03ef5384e598bb50ffc1990cce7_D20220430-20221028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-30</startDate>
            <endDate>2022-10-28</endDate>
        </period>
    </context>
    <context id="iba3d02155da748508b967c01e3e9fc3f_D20210501-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001613103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mdt:TotalOtherCountriesExcludingIrelandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="subsidiary">
        <measure>mdt:subsidiary</measure>
    </unit>
    <unit id="manufacturer">
        <measure>mdt:manufacturer</measure>
    </unit>
    <unit id="claim">
        <measure>mdt:claim</measure>
    </unit>
    <unit id="claimant">
        <measure>mdt:claimant</measure>
    </unit>
    <unit id="plantiff">
        <measure>mdt:plantiff</measure>
    </unit>
    <unit id="landfill">
        <measure>mdt:landfill</measure>
    </unit>
    <unit id="portfolio">
        <measure>mdt:portfolio</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF80LTEtMS0xLTExOTg2OA_f142d26a-a4d2-412b-8fdc-97edf48194f1">0001613103</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF81LTEtMS0xLTExOTg2OA_9bcc01f8-125c-4668-bc5e-8cfeffd4e8ca">--04-28</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF82LTEtMS0xLTExOTg2OA_1ca55924-bf88-4dff-98f2-a66d37c8575d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF83LTEtMS0xLTExOTg2OA_1c0a7377-db98-4fc2-b807-fca93ba76631">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF84LTEtMS0xLTExOTg2OA_8e075691-32ba-4ed7-b256-3abe65107dec">2023</dei:DocumentFiscalYearFocus>
    <dei:EntityAddressPostalZipCode
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80L2ZyYWc6ODcxM2E4NzQyYmE3NGE1YjlhOTgxYTFkMWZlYjY4YTMvdGFibGU6MjE3OGE2OWU3MzljNGIwNjg3ZjhjNTNkY2Q1ZjkwOTgvdGFibGVyYW5nZToyMTc4YTY5ZTczOWM0YjA2ODdmOGM1M2RjZDVmOTA5OF85LTEtMS0xLTExOTg2OA_0a4dbd16-093c-4a2e-ba41-bec6b0717e17">D02 XH02</dei:EntityAddressPostalZipCode>
    <dei:DocumentType
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xODEw_e62f00ca-33d3-4950-b0b9-7897a7307283">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8wLTAtMS0xLTExOTg2OA_2e15efac-2e84-4265-9508-74b71ce89063">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8xLTItMS0xLTExOTg2OC90ZXh0cmVnaW9uOjI5ZTg4MDhiZjI3ZDQ5NGE5OTlmMmMzOWUxMWZkMDczXzQ_375c979b-cf20-4643-bb5c-818e20a6a2d2">2022-10-28</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6NTY1OTVkMTI1ZGY1NDk1Njg3ODdlNDQ2NzkwM2RmZmUvdGFibGVyYW5nZTo1NjU5NWQxMjVkZjU0OTU2ODc4N2U0NDY3OTAzZGZmZV8zLTAtMS0xLTExOTg2OA_033c62ec-67d0-41bb-be83-ce31fab60b99">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMTM_ad821d82-d8a6-46e6-bdcb-595bf3db0e08">001-36820</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8wLTAtMS0xLTExOTg2OA_506e52ff-8a67-4757-9dee-58c760c9824c">Medtronic plc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8zLTAtMS0xLTExOTg2OA_b0018fe8-2106-4aa9-9521-6cf3bc2a140a">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YWIzMDI0NzVkZGM0NDY5MTliM2JlMTVhMmU0YTIzMmYvdGFibGVyYW5nZTphYjMwMjQ3NWRkYzQ0NjkxOWIzYmUxNWEyZTRhMjMyZl8zLTEtMS0xLTExOTg2OA_1b02ecbc-543e-4daa-945a-f38ebf84fe77">98-1183488</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjE_c0ceaba7-7d32-4de1-8086-3980d2c79cf7">20 On Hatch, Lower Hatch Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjU_c15bf27b-e96e-4e70-a874-6980c2905e27">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xMjk_527c0778-4604-493e-909e-487edd6b2c63">IE</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xODc_d7916ae9-351c-4e21-8124-e1bf66211877">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xOTA_bf93683b-f50c-4edb-9bdb-e56369d50cc0">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xOTM_52ba3ed5-f252-491f-880d-9eca10f3d7c5">438-1700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTAtMS0xLTExOTg2OA_07da57f5-b4d9-4718-ac83-adaeb9d3fe2d">Ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTEtMS0xLTExOTg2OA_69ca9ae5-c1f1-474e-9bc4-7aaf16a07ef3">MDT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1c8169cbae754599ab9df22b94737ee5_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xLTItMS0xLTExOTg2OA_ac6fa33a-23a4-4b3b-a1e4-4e9c8c0ee8fb">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTAtMS0xLTExOTg2OA_6509f76e-12b3-48dc-ad64-054161d817ca">0.00% Senior Notes due 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTEtMS0xLTExOTg2OA_476af46a-94bc-4487-9078-d8be6e2ff100">MDT/22B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib7d150ba283245ab98d1b66fc3adeefa_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8zLTItMS0xLTExOTg2OA_f08b49aa-2742-4ca0-9858-92dd6e647e5f">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTAtMS0xLTExOTg2OA_0c3a16e9-7d12-4cd9-8ec7-00789ed17e44">0.375% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTEtMS0xLTExOTg2OA_1313a233-a01f-4bc8-a347-70e1bf24a355">MDT/23B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8dcd1118d43a48cba05ec50c5b732b7a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV80LTItMS0xLTExOTg2OA_88cc0937-4513-4e16-aea4-6dc5091cfdb7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTAtMS0xLTExOTg2OA_51cf0b9d-0266-419e-b192-4a83259264d6">0.000% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTEtMS0xLTExOTg2OA_4f9934ad-e168-45f0-8fd8-6b654519973e">MDT/23C</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i40335eb507c945acabcb8ea6105a62a0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV81LTItMS0xLTExOTg2OA_163cc40d-edbc-46dd-9bac-164eca7ef5c9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTAtMS0xLTExOTg2OA_1c7f76e3-ba48-44da-ac62-f65bedaf14c0">0.25% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTEtMS0xLTExOTg2OA_36f1c065-c6a8-428d-84a7-a309c99fa121">MDT/25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if582051bf4124134a62ad07d19497784_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV82LTItMS0xLTExOTg2OA_6f17852a-0d04-40d4-856c-5aa27146bb1d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTAtMS0xLTExOTg2OA_d5f1ac97-503e-4235-97f7-69a99537f624">0.000% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTEtMS0xLTExOTg2OA_dedb4540-67cd-4dbd-b070-d6f540e43557">MDT/25A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id5bb5e3919ff441ead19a9a409c87886_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV83LTItMS0xLTExOTg2OA_8ade32f9-de47-421f-8626-4b4fe448158d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTAtMS0xLTEzODc0OQ_5c5fa4a0-d2d5-447f-8a80-606e5832fba3">2.625% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTEtMS0xLTEzODc0OQ_f6c2d02a-33c5-472f-bb18-f2ed9dc88945">MDT/25B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7af238e07ee14804b8bfeb3dee6e0f76_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTItMS0xLTEzODc0OQ_a8dcdd8b-c9fd-4aaf-84ed-60b1f37f2364">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTAtMS0xLTExOTg2OA_15e498bd-9489-49fa-8ac0-a9a39ae9e4e5">1.125% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTEtMS0xLTExOTg2OA_5c2c19d6-3e42-4ccd-870c-1367f0f6e7b2">MDT/27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0e8d8ea8f71c44e7ab369bc16a429a95_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV84LTItMS0xLTExOTg2OA_fbc132fb-d73b-4b84-9459-67cafba23aa2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTAtMS0xLTExOTg2OA_768967d3-51b8-4e66-a750-7c62dd018760">0.375% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTEtMS0xLTExOTg2OA_02d17093-c6ae-40af-9484-53bc1a61e4a5">MDT/28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifcbf7b6e1d0b46f4bd8ea4a138833335_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV85LTItMS0xLTExOTg2OA_59294218-9373-4d6a-8df7-6c2b1f260166">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0wLTEtMS0xMzg3NzA_ebc1ba7e-4f33-42fb-984a-a64e1c4c5381">3.000% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0xLTEtMS0xMzg3NzA_95221de4-336d-455a-bfed-f8bf43d1d9ac">MDT/28A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0a4eeebf5d8149c9aab95a7bc47bd1b0_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0yLTEtMS0xMzg3NzA_d595b68d-20f0-4724-a72a-9e16bddf4d64">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0wLTEtMS0xMTk4Njg_17a06a53-3045-41f9-b5a5-6ef4a7ec3a32">1.625% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0xLTEtMS0xMTk4Njg_70b6611b-2957-41e6-9d34-a73587e3fb3b">MDT/31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i42f7c1428a8942c19e835ff37043238c_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMC0yLTEtMS0xMTk4Njg_1568a98e-f84d-43e2-8d11-2cd84bc0521b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0wLTEtMS0xMTk4Njg_b539c500-da62-41d2-9392-379e3e70b5db">1.00% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0xLTEtMS0xMTk4Njg_e61e9488-e033-4c48-ad51-55f0a07fb061">MDT/31A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4d12c0b3407c43e2a258101b523e5d26_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMS0yLTEtMS0xMTk4Njg_e9053218-14f4-4fe0-a1c0-a62867b988c0">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0wLTEtMS0xMzg3NzI_b32bacdc-1e4e-41d0-a7d0-09b88149bed0">3.125% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0xLTEtMS0xMzg3NzI_ee84a124-1a35-4016-bf64-8210d3fffd75">MDT/31B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2b76068afa284734b5cc5fafaa36cc3b_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0yLTEtMS0xMzg3NzI_d082a4c5-cf20-4bd3-a777-ebdfae279888">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0wLTEtMS0xMTk4Njg_a6f900c4-293a-45f5-ae6c-e305b364ad1e">0.750% Senior Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0xLTEtMS0xMTk4Njg_36b649a9-4478-4841-a2a5-9dbff81af5cc">MDT/32</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icb33528b47724a289550d115188aeb99_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMi0yLTEtMS0xMTk4Njg_0a1af27d-d512-4a63-8f99-041080901652">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0wLTEtMS0xMzg3NzQ_a22fed5e-0227-459f-9245-c12de455d8a5">3.375% Senior Notes due 2034</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0xLTEtMS0xMzg3NzQ_12ee7df9-5169-4d88-a8e8-b951796272aa">MDT/34</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib497d2dfe13b43d2b3f378e233a7767f_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0yLTEtMS0xMzg3NzQ_1ebf6dea-5768-44f2-91b8-3f7914b4eb83">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0wLTEtMS0xMTk4Njg_4559fd84-e0fe-4d54-8df2-e4c623ae5b02">2.250% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0xLTEtMS0xMTk4Njg_008042ec-ea9a-47d4-9283-6532264778eb">MDT/39A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i31994aed3e0443968f62cc3414b70f2a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xMy0yLTEtMS0xMTk4Njg_0e876de6-9656-4aff-a470-eb4c3314ed7e">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0wLTEtMS0xMTk4Njg_806d6793-7bf1-452f-bf40-0c9a8fe6b5f3">1.50% Senior Notes due 2039</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0xLTEtMS0xMTk4Njg_633398c3-0e0f-4dd4-873b-8dc2ae07d581">MDT/39B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5c88606ab6a94839a6474b6a4384ade2_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNC0yLTEtMS0xMTk4Njg_0e802238-4182-4954-8e14-272be69bebbf">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0wLTEtMS0xMTk4Njg_10b9c965-77a5-4627-a521-3b40c1ad3730">1.375% Senior Notes due 2040</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0xLTEtMS0xMTk4Njg_35a8b880-17ca-41d6-b114-283e5f5719bf">MDT/40A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5dc110a57ddf439aae2f4ee7ebc775c8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNS0yLTEtMS0xMTk4Njg_086d79b7-ef36-4cb7-83b1-f3078088d1f5">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0wLTEtMS0xMTk4Njg_dd9c6fe7-1e4d-40bc-9c9f-6730d7a9e260">1.75% Senior Notes due 2049</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0xLTEtMS0xMTk4Njg_db250bad-bd00-4939-97e0-b125057966f3">MDT/49</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibe41a9d21ca64dcba32ac2e270df1d33_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNi0yLTEtMS0xMTk4Njg_922db4d9-a736-4a2a-a4cc-08ac5c3d3391">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0wLTEtMS0xMTk4Njg_94c9b84f-f960-4e4b-94f7-0c0c90aa70e3">1.625% Senior Notes due 2050</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0xLTEtMS0xMTk4Njg_ca077fba-3523-465d-a620-175ef11bcc23">MDT/50</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5986f4c222f54d498b125db6e6aaddd8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6ZDRlOWFhMjY0ODAwNGJkNGFjZTdlMDVjY2IxYTFjZjUvdGFibGVyYW5nZTpkNGU5YWEyNjQ4MDA0YmQ0YWNlN2UwNWNjYjFhMWNmNV8xNy0yLTEtMS0xMTk4Njg_2174608f-108b-46fb-b3a3-1d41f6dc64bd">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF82NTc_e4b4668e-80d1-494d-88ff-7ad445519b3d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF85ODU_6c7d2e48-4681-4220-9f23-ff122eea8811">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8wLTAtMS0xLTExOTg2OA_65199d4b-b918-4849-a0d5-14ca30a15fc1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8wLTUtMS0xLTExOTg2OA_51ea2937-1819-411b-a03e-f2f498401f12">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGFibGU6YjMxMzg1MTYzY2E2NDc4ZGJkZmIwMTFiZTdkMjgyMTQvdGFibGVyYW5nZTpiMzEzODUxNjNjYTY0NzhkYmRmYjAxMWJlN2QyODIxNF8xLTMtMS0xLTExOTg2OA_78eb2f57-8412-4312-9d54-5fc505def8cb">false</dei:EntitySmallBusiness>
    <dei:EntityShellCompany
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xNzE1_c4842017-f2da-4c51-a132-39141e76a4a0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i9b27bafc1ca94489ba6518e9a3ef1483_I20221128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xL2ZyYWc6MTlkMjFkMmI3YmIyNGY4Nzk3YjYzM2FmMDQ0NDAzMmQvdGV4dHJlZ2lvbjoxOWQyMWQyYjdiYjI0Zjg3OTdiNjMzYWYwNDQ0MDMyZF8xNzMz_89caa065-4a5a-4745-a631-72c4148e97b2"
      unitRef="shares">1330179978</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi0xLTEtMS0xMTk4Njg_8ce41178-976b-4c82-b9be-d472d3e7ede8"
      unitRef="usd">7585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi0zLTEtMS0xMTk4Njg_d31738c6-b3c2-40f9-81dd-4cc334b7e0ca"
      unitRef="usd">7847000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi01LTEtMS0xMTk4Njg_4007a6a0-bd7b-48c7-b3a9-9f8efedf92b1"
      unitRef="usd">14955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMi03LTEtMS0xMTk4Njg_029299bd-a123-41e2-ab82-f98f68036164"
      unitRef="usd">15835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC0xLTEtMS0xMTk4Njg_6de48451-a342-41d8-af64-59ef2a1c6577"
      unitRef="usd">2535000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC0zLTEtMS0xMTk4Njg_4b3197aa-7909-459f-bc69-932489d08595"
      unitRef="usd">2497000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC01LTEtMS0xMTk4Njg_4e26efa3-8970-4810-b49f-21407e8cee5e"
      unitRef="usd">5051000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNC03LTEtMS0xMTk4Njg_cddc86c6-bcbf-41be-bf47-df1101e7723a"
      unitRef="usd">5095000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS0xLTEtMS0xMTk4Njg_957c6b3b-a799-4f74-a7ac-83974a9aaca2"
      unitRef="usd">676000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS0zLTEtMS0xMTk4Njg_490f6871-4e4d-45d8-a129-92f7d6b43599"
      unitRef="usd">676000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS01LTEtMS0xMTk4Njg_62dda990-7f7a-4419-9542-ced0e3c58148"
      unitRef="usd">1368000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNS03LTEtMS0xMTk4Njg_1c380c03-d33d-4b96-8d9a-4f349d8b2688"
      unitRef="usd">1426000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi0xLTEtMS0xMTk4Njg_d7946f60-b163-439c-8b8f-8ffeb8a6821c"
      unitRef="usd">2617000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi0zLTEtMS0xMTk4Njg_e3f0eb3c-3511-47e1-a436-598f72929881"
      unitRef="usd">2615000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi01LTEtMS0xMTk4Njg_f100da21-78c6-43a0-ae3e-e7897c9f6f7f"
      unitRef="usd">5184000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNi03LTEtMS0xMTk4Njg_d4d8e049-1fb9-4b62-813e-d55d574dbc54"
      unitRef="usd">5163000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy0xLTEtMS0xMTk4Njg_0728e3fd-a8ce-434c-a368-59f461b5019f"
      unitRef="usd">421000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy0zLTEtMS0xMTk4Njg_42206212-2af6-4578-8cc1-f3a88e6a4059"
      unitRef="usd">431000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy01LTEtMS0xMTk4Njg_a479059a-a587-42d8-8e30-f0d375f9a7c2"
      unitRef="usd">844000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfNy03LTEtMS0xMTk4Njg_8f9bab11-5886-4664-8a57-38ac5b36f520"
      unitRef="usd">866000000</us-gaap:AmortizationOfIntangibleAssets>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC0xLTEtMS0xMTk4Njg_1d9297a6-a9d7-4fea-b851-4f1e9a17f697"
      unitRef="usd">30000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC0zLTEtMS0xMTk4Njg_cc6515eb-191d-45a7-865e-97158008a370"
      unitRef="usd">10000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC01LTEtMS0xMTk4Njg_7ad1e876-6738-48a0-913b-343c73f2035d"
      unitRef="usd">44000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOC03LTEtMS0xMTk4Njg_8c9362f3-7904-4c04-82c6-9794822d1f51"
      unitRef="usd">21000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS0xLTEtMS0xMTk4Njg_6b0a4770-45c6-4738-87f5-99f889644479"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS0zLTEtMS0xMTk4Njg_fff144e4-3c26-48af-a60d-ce89d7a4c681"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS01LTEtMS0xMTk4Njg_6316cc64-4512-45be-8d3a-9509b497d9be"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfOS03LTEtMS0xMTk4Njg_977f430d-db53-427e-8035-8be3d0e2243b"
      unitRef="usd">60000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtMS0xLTEtMTE5ODY4_2ca5bbb0-182c-4987-bd5e-1b7ad919d3bf"
      unitRef="usd">97000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtMy0xLTEtMTE5ODY4_6f30f373-662b-421c-9bea-f599dd99d46f"
      unitRef="usd">-21000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNS0xLTEtMTE5ODY4_bf858656-8927-4757-9b4f-98c847f686bb"
      unitRef="usd">62000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNS0xLTEtMTE5ODY4_fe9ae95b-dfb9-450f-b9dd-fda46f038881"
      unitRef="usd">62000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNy0xLTEtMTE5ODY4_231d6c0a-1b40-494c-a186-5c3ff7baf908"
      unitRef="usd">-781000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTAtNy0xLTEtMTE5ODY4_cfb501b2-9e41-46f6-a98b-74ef6a1be520"
      unitRef="usd">-781000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtMS0xLTEtMTE5ODY4_4a72509b-9b4c-4c46-a5cf-789a3f507a2a"
      unitRef="usd">1404000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtMy0xLTEtMTE5ODY4_daedc2e2-1637-4ce2-848c-5572252daa42"
      unitRef="usd">1563000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtNS0xLTEtMTE5ODY4_4bc42dd2-827a-49b5-afe2-741e03fc2016"
      unitRef="usd">2528000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTEtNy0xLTEtMTE5ODY4_a27749cb-5252-468d-a3e0-0f40c969932f"
      unitRef="usd">2422000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItMS0xLTEtMTE5ODY4_d9dd657a-4197-4688-a529-0540f386c3b7"
      unitRef="usd">109000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItMy0xLTEtMTE5ODY4_c85d126c-33b2-4e90-b576-19a2714fedb9"
      unitRef="usd">66000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItNS0xLTEtMTE5ODY4_60ff9198-9d68-4943-a898-afcb8ffd3a90"
      unitRef="usd">192000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTItNy0xLTEtMTE5ODY4_d6120614-13b1-48cb-bc52-bd736fbc2b7e"
      unitRef="usd">177000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtMS0xLTEtMTE5ODY4_fb0c40c7-7719-4ad0-9c78-b9b9f16048eb"
      unitRef="usd">118000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtMy0xLTEtMTE5ODY4_47fa9b10-2ab3-4ed1-9cde-6a54157f2a25"
      unitRef="usd">136000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtNS0xLTEtMTE5ODY4_3c11bb04-0749-4c85-b5db-a801c17dd8a5"
      unitRef="usd">282000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTMtNy0xLTEtMTE5ODY4_6f013d12-78e2-42f7-8eaa-0bab9fe0126f"
      unitRef="usd">273000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtMS0xLTEtMTE5ODY4_d657fbd7-67d2-4e11-b95b-eeb55536a7bb"
      unitRef="usd">1395000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtMy0xLTEtMTE5ODY4_b68a183e-d285-4c46-a902-ec9c629e9aee"
      unitRef="usd">1493000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtNS0xLTEtMTE5ODY4_8b485cc8-8095-4062-8a56-1f6766acf05e"
      unitRef="usd">2438000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTQtNy0xLTEtMTE5ODY4_3139c509-d77c-4451-9a98-374987f85c72"
      unitRef="usd">2326000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtMS0xLTEtMTE5ODY4_cda077f8-2af7-48e4-8780-fc802d086ee7"
      unitRef="usd">959000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtMy0xLTEtMTE5ODY4_552c3b3d-fcd6-4f23-ab27-8e104a5110a2"
      unitRef="usd">176000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtNS0xLTEtMTE5ODY4_5c215cff-9957-415c-8150-ab04308142c8"
      unitRef="usd">1072000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTUtNy0xLTEtMTE5ODY4_070068d2-1c69-4c8a-9f0f-9cafc375175c"
      unitRef="usd">240000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtMS0xLTEtMTE5ODY4_b8a0709a-c94a-4f68-8f18-dc53bdf32085"
      unitRef="usd">435000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtMy0xLTEtMTE5ODY4_d2c75291-b83a-4c5a-83c2-5b48c50f155c"
      unitRef="usd">1317000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtNS0xLTEtMTE5ODY4_235f94d4-f8ad-424a-b863-28fd97d4cf18"
      unitRef="usd">1367000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTYtNy0xLTEtMTE5ODY4_050b00d5-4b9a-4787-be3f-8e60a1ef7644"
      unitRef="usd">2086000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctMS0xLTEtMTE5ODY4_53850764-c38d-41d5-a1fa-6dd4461ed580"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctMy0xLTEtMTE5ODY4_e0683e69-de9e-4883-82cd-430d65f89c0e"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctNS0xLTEtMTE5ODY4_9fd67de1-29d8-4bfa-97bb-4edc1d61e17e"
      unitRef="usd">10000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTctNy0xLTEtMTE5ODY4_df3b56c2-7628-4db8-a358-91ee5ee93e0e"
      unitRef="usd">12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtMS0xLTEtMTE5ODY4_b9541d8b-3192-432d-942b-dbad5c588071"
      unitRef="usd">427000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtMy0xLTEtMTE5ODY4_de31728d-e85e-413e-bf80-fc8cedecc505"
      unitRef="usd">1311000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtNS0xLTEtMTE5ODY4_f36ad4c2-08e2-487b-a825-41b347f4f4bc"
      unitRef="usd">1356000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTgtNy0xLTEtMTE5ODY4_6e05057b-55e3-4de5-b832-81c93af153cf"
      unitRef="usd">2074000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktMS0xLTEtMTE5ODY4_40f5bab9-f183-4fad-bbea-9ea5cd9ddc48"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktMy0xLTEtMTE5ODY4_1a008d80-4e1b-488b-8cbd-daf8e639df51"
      unitRef="usdPerShare">0.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktNS0xLTEtMTE5ODY4_fb53645f-1281-47ce-aac1-3586106ce408"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMTktNy0xLTEtMTE5ODY4_a6a509c1-54e0-4f35-9801-0b0eed15a4df"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtMS0xLTEtMTE5ODY4_03490ece-4bfe-4353-94ff-3f2f09f8c220"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtMy0xLTEtMTE5ODY4_b9cfc900-2836-4188-a804-76bc4d27dc53"
      unitRef="usdPerShare">0.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtNS0xLTEtMTE5ODY4_82ff5b7e-ae7f-411e-b5ad-34a6d68aeb64"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjAtNy0xLTEtMTE5ODY4_c3610492-8980-4e13-a4ed-b13da18af11b"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtMS0xLTEtMTE5ODY4_0df8ff80-31de-49c7-acfa-433aaa84f2af"
      unitRef="shares">1329400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtMy0xLTEtMTE5ODY4_03a59c87-023b-43ba-ae36-3882bda215c4"
      unitRef="shares">1345100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtNS0xLTEtMTE5ODY4_8a44d5c3-6dc2-47a0-bc54-8feeb189b228"
      unitRef="shares">1329400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjEtNy0xLTEtMTE5ODY4_1dc98efd-896e-47b5-b759-d7130175279b"
      unitRef="shares">1344800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItMS0xLTEtMTE5ODY4_ec18b13c-1f21-4171-824a-324aa2c3b15b"
      unitRef="shares">1332000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItMy0xLTEtMTE5ODY4_1122ae2d-c4b6-42e1-813a-4898a6956e77"
      unitRef="shares">1355300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItNS0xLTEtMTE5ODY4_cb56d6d4-f65c-4f7f-84f9-4b55ae3609dc"
      unitRef="shares">1333300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8xOS9mcmFnOmM5M2Y4NGJhYmQwYjRiZWE5NDZjNDk4ZTkyZTI0YTI1L3RhYmxlOmI5NWFhYzY4NDgwYTRlYzJiOGVlNTExMjZiN2E4ZGNjL3RhYmxlcmFuZ2U6Yjk1YWFjNjg0ODBhNGVjMmI4ZWU1MTEyNmI3YThkY2NfMjItNy0xLTEtMTE5ODY4_fdcaf0a3-841a-4035-8461-1187d4317c29"
      unitRef="shares">1355900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi0xLTEtMS0xMTk4Njg_b8a0709a-c94a-4f68-8f18-dc53bdf32085"
      unitRef="usd">435000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi0zLTEtMS0xMTk4Njg_f3148d45-207f-4811-b91f-d9968bc73cb0"
      unitRef="usd">1317000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi01LTEtMS0xMTk4Njg_235f94d4-f8ad-424a-b863-28fd97d4cf18"
      unitRef="usd">1367000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMi03LTEtMS0xMTk4Njg_050b00d5-4b9a-4787-be3f-8e60a1ef7644"
      unitRef="usd">2086000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS0xLTEtMS0xMTk4Njg_2206f75a-3efd-4797-b4f8-d684f017e415"
      unitRef="usd">-167000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS0zLTEtMS0xMTk4Njg_6b9743a3-4247-420a-9296-54e0dffa017a"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS01LTEtMS0xMTk4Njg_f47c0c71-1553-4409-82bb-6243f01667d8"
      unitRef="usd">-183000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNS03LTEtMS0xMTk4Njg_61779360-cf11-4f00-9cd0-f964f1dcf2d6"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi0xLTEtMS0xMTk4Njg_d82bdefe-75a8-496f-aa44-76e1e12da6a6"
      unitRef="usd">-826000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi0zLTEtMS0xMTk4Njg_1150de7d-3545-44fb-8edd-9ed10fbb02de"
      unitRef="usd">-247000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi01LTEtMS0xMTk4Njg_1eef7b9f-351f-474c-aea9-830321da79e9"
      unitRef="usd">-1709000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNi03LTEtMS0xMTk4Njg_71f46c93-1b50-4c42-8361-96eb45232e99"
      unitRef="usd">-602000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy0xLTEtMS0xMTk4Njg_d4963042-cfa1-4599-b6b8-f8efa05517f0"
      unitRef="usd">407000000</mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax>
    <mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy0zLTEtMS0xMTk4Njg_03ffb804-4387-4f89-9d62-860f0b2dc6f7"
      unitRef="usd">356000000</mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax>
    <mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy01LTEtMS0xMTk4Njg_d7a7289b-69c9-4ef5-a3fe-802ad52b8984"
      unitRef="usd">1409000000</mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax>
    <mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfNy03LTEtMS0xMTk4Njg_51bf9480-4637-4323-94b0-bb97f92a8704"
      unitRef="usd">780000000</mdt:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC0xLTEtMS0xMTk4Njg_f909421d-d995-4fd6-a903-9efc2d7014b4"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC0zLTEtMS0xMTk4Njg_f4b45189-bf0a-4bdd-86d6-197832b06413"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC01LTEtMS0xMTk4Njg_524be701-035b-45a7-9b64-1a83329ae3e7"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOC03LTEtMS0xMTk4Njg_472e4915-26fa-461f-9fa0-59b358cab5a3"
      unitRef="usd">-37000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS0xLTEtMS0xMTk4Njg_4712bed7-16ef-4c36-8f6b-aed08a6f7679"
      unitRef="usd">158000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS0zLTEtMS0xMTk4Njg_e3d55575-b0de-4b3f-8bf4-1ce0c77030c2"
      unitRef="usd">95000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS01LTEtMS0xMTk4Njg_956d09ac-31d9-4ab4-93d0-f4a7710a436d"
      unitRef="usd">378000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfOS03LTEtMS0xMTk4Njg_f38ac800-b821-4bd4-9fb1-07005ac2a589"
      unitRef="usd">269000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtMS0xLTEtMTE5ODY4_75547828-f3c0-469c-92b1-a7e370d679c2"
      unitRef="usd">-424000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtMy0xLTEtMTE5ODY4_f232e159-6d64-4c79-a75d-4b2c343154de"
      unitRef="usd">166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtNS0xLTEtMTE5ODY4_e8db7d42-c4bc-4323-b0b7-a23fc95a5a86"
      unitRef="usd">-100000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTAtNy0xLTEtMTE5ODY4_294f8b86-2897-4b02-8c7f-ce495be8c027"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtMS0xLTEtMTE5ODY4_978febc2-ce77-4c8e-a635-411317e29441"
      unitRef="usd">11000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtMy0xLTEtMTE5ODY4_7c54aef8-5bbb-40da-a1a7-79f966e71b72"
      unitRef="usd">1483000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtNS0xLTEtMTE5ODY4_8924772a-61f3-4205-be66-63b8476ff8a4"
      unitRef="usd">1266000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTEtNy0xLTEtMTE5ODY4_c207df82-4de2-4f16-925f-a8372a0d2321"
      unitRef="usd">2526000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItMS0xLTEtMTE5ODY4_158fc0d0-ca31-41a6-ba69-7343ab57b69d"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItMy0xLTEtMTE5ODY4_f11a7561-f138-49a0-91b4-93dc46b9f7e6"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItNS0xLTEtMTE5ODY4_62716816-eb49-4d4b-a609-56878512ea46"
      unitRef="usd">6000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTItNy0xLTEtMTE5ODY4_b9a6bee9-5829-4e0a-b797-69d7fe172a53"
      unitRef="usd">9000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtMS0xLTEtMTE5ODY4_1774774b-d9f9-4e85-9150-6fba83cc581c"
      unitRef="usd">5000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtMy0xLTEtMTE5ODY4_55d5907b-cc53-496e-b33e-07e377944e02"
      unitRef="usd">1478000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtNS0xLTEtMTE5ODY4_9278fd33-4e32-4815-86f7-b6e284bf24e7"
      unitRef="usd">1260000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yMi9mcmFnOmQwMjZkZTM1NTg3NjRjMGY5NzdmZjQ3MDdiMzliOWRiL3RhYmxlOmY5YWJkMDg4OGNkYjRmOTVhNTI4MmE2NmRjZWVmZGYzL3RhYmxlcmFuZ2U6ZjlhYmQwODg4Y2RiNGY5NWE1MjgyYTY2ZGNlZWZkZjNfMTMtNy0xLTEtMTE5ODY4_da3ae810-717a-4b0c-ac40-fec23376ad2e"
      unitRef="usd">2517000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMy0xLTEtMS0xMTk4Njg_38d05c20-fc71-4570-a5e4-926faead4a45"
      unitRef="usd">4828000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMy0zLTEtMS0xMTk4Njg_15aff5e4-73c1-4349-b210-b8ede26d7e09"
      unitRef="usd">3714000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNC0xLTEtMS0xMTk4Njg_c90a61de-5599-4e76-901f-f8a0e3b3ad73"
      unitRef="usd">6602000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNC0zLTEtMS0xMTk4Njg_f7481166-94f0-41b9-abcf-e6ffd190a936"
      unitRef="usd">6859000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0ODlhMzgzOTliYWM0ZWE2OTkxOTlmOTU3MjljMzlhOV82Mg_028e7fe2-3170-4515-8fd7-cafa0239ba28"
      unitRef="usd">203000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0ODlhMzgzOTliYWM0ZWE2OTkxOTlmOTU3MjljMzlhOV82OQ_eb189325-5d87-4054-af45-9651de6c136b"
      unitRef="usd">230000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0xLTEtMS0xMTk4Njg_ef810b30-9120-4f8d-8e46-d91bb45dcb42"
      unitRef="usd">5626000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNS0zLTEtMS0xMTk4Njg_70ff78bf-bed3-47d6-bd2a-562f9ad22e20"
      unitRef="usd">5551000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNi0xLTEtMS0xMTk4Njg_7d9a7037-8919-40c7-b66f-a4070b9c82a8"
      unitRef="usd">5055000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNi0zLTEtMS0xMTk4Njg_2ae084be-5dfc-4f85-8f9f-fed880094a7e"
      unitRef="usd">4616000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNy0xLTEtMS0xMTk4Njg_6938f44d-92e0-4824-bcc4-dffde78b4b9b"
      unitRef="usd">3287000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNy0zLTEtMS0xMTk4Njg_d90d8c29-df01-45ff-b876-b72d4075a292"
      unitRef="usd">2318000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOC0xLTEtMS0xMTk4Njg_573c404f-0f33-476e-80c4-e3cd90971894"
      unitRef="usd">25398000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOC0zLTEtMS0xMTk4Njg_a1600593-b4ea-42c0-affc-beb260831d27"
      unitRef="usd">23059000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOS0xLTEtMS0xMTk4Njg_e63328b8-a53d-4291-b75a-0c948d77fce7"
      unitRef="usd">13497000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfOS0zLTEtMS0xMTk4Njg_0972f46a-1088-45d4-9462-5292ccfb361c"
      unitRef="usd">13365000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTAtMS0xLTEtMTE5ODY4_d460be19-aab2-4479-9e05-63a78d56c62a"
      unitRef="usd">8199000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTAtMy0xLTEtMTE5ODY4_1f32b0c0-e22c-4aff-b008-febcf45c8689"
      unitRef="usd">7952000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTEtMS0xLTEtMTE5ODY4_f13f5466-4b8e-4703-9cc5-96d40d7207a4"
      unitRef="usd">5298000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTEtMy0xLTEtMTE5ODY4_24297948-32c4-4306-8ba1-ab2f3e2b07e4"
      unitRef="usd">5413000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTItMS0xLTEtMTE5ODY4_5f31eb5b-c2d4-486a-aaea-4d7dc9d1ff04"
      unitRef="usd">40417000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTItMy0xLTEtMTE5ODY4_310618e7-32fd-414c-b968-a1db56b51215"
      unitRef="usd">40502000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTMtMS0xLTEtMTE5ODY4_68fd6af9-3d58-452f-8183-d8f9e8a10d95"
      unitRef="usd">15655000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTMtMy0xLTEtMTE5ODY4_a72f4d15-7d6b-4c96-8850-ae8732c93b25"
      unitRef="usd">15595000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTQtMS0xLTEtMTE5ODY4_7903baaf-9ed5-429a-a975-d212f99f5607"
      unitRef="usd">3350000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTQtMy0xLTEtMTE5ODY4_ba89a973-237b-49b8-8614-3a98b8a72fb4"
      unitRef="usd">3403000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTUtMS0xLTEtMTE5ODY4_4d4de7bf-09cf-486c-b972-aaea4926625b"
      unitRef="usd">3124000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTUtMy0xLTEtMTE5ODY4_987c7704-5eff-417b-b67c-a055da9b3480"
      unitRef="usd">3008000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTYtMS0xLTEtMTE5ODY4_e69ab1d9-39f2-466a-b46a-c6e86c7b04c4"
      unitRef="usd">93241000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTYtMy0xLTEtMTE5ODY4_f80e7c49-308e-4e00-99d4-9112eeaee465"
      unitRef="usd">90981000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTktMS0xLTEtMTE5ODY4_8f503127-3f65-49d9-9449-ef23f3f06564"
      unitRef="usd">5864000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMTktMy0xLTEtMTE5ODY4_24bbc2a8-509d-407d-8280-394324e91fa0"
      unitRef="usd">3742000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjAtMS0xLTEtMTE5ODY4_13bd63fa-10fd-49ef-8cf4-a0224d7d3023"
      unitRef="usd">2198000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjAtMy0xLTEtMTE5ODY4_d4e992d6-ea46-463e-af66-eb6557e29e60"
      unitRef="usd">2276000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjEtMS0xLTEtMTE5ODY4_5fe5de32-35d7-46e1-88e6-5f984929ee0e"
      unitRef="usd">1721000000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjEtMy0xLTEtMTE5ODY4_e78db928-410f-4c97-8ee9-5d5662263376"
      unitRef="usd">2121000000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjItMS0xLTEtMTE5ODY4_380d71c7-cb9f-4660-9c08-2dbc3165a363"
      unitRef="usd">651000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjItMy0xLTEtMTE5ODY4_da8955aa-34e3-4ea3-8186-a254a225ad16"
      unitRef="usd">704000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjMtMS0xLTEtMTE5ODY4_8e841a93-b6ef-44e1-8161-251c32b237a3"
      unitRef="usd">4031000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjMtMy0xLTEtMTE5ODY4_a88a9256-347a-42fa-842f-973896dc5b89"
      unitRef="usd">3551000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjQtMS0xLTEtMTE5ODY4_5f5ecfd7-e05d-4568-bed5-a6b1d0a6e19c"
      unitRef="usd">14465000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjQtMy0xLTEtMTE5ODY4_ba4d06d7-6366-4f0e-969b-078a464099e3"
      unitRef="usd">12394000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjUtMS0xLTEtMTE5ODY4_34c52d0f-5df4-4482-9c87-02e782bd855c"
      unitRef="usd">20753000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjUtMy0xLTEtMTE5ODY4_2e4dfe8b-1da6-4288-92f3-6f13fc96b0e5"
      unitRef="usd">20372000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjYtMS0xLTEtMTE5ODY4_7ec31257-294a-4357-9e98-15ec8e84e572"
      unitRef="usd">1048000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjYtMy0xLTEtMTE5ODY4_cf9ecb5a-d452-4b54-b216-b329d90e1368"
      unitRef="usd">1113000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjctMS0xLTEtMTE5ODY4_78f5a66e-b838-4c61-8f8e-dd193666fdba"
      unitRef="usd">2614000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjctMy0xLTEtMTE5ODY4_af65486e-d7c7-4489-b8d8-a18bf3ddbe78"
      unitRef="usd">2087000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjgtMS0xLTEtMTE5ODY4_1bbc3968-7754-48d7-bf2a-9fcb50797412"
      unitRef="usd">871000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjgtMy0xLTEtMTE5ODY4_4f24dfe0-8200-4e62-b190-d020830e8d24"
      unitRef="usd">884000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjktMS0xLTEtMTE5ODY4_505052c2-61cc-4912-9257-a917c09ab1e8"
      unitRef="usd">1435000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMjktMy0xLTEtMTE5ODY4_37edb0f8-a8a5-402c-aad0-56372e652173"
      unitRef="usd">1410000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzAtMS0xLTEtMTE5ODY4_9ffa3efe-a89e-45a1-9a6a-789966ad4892"
      unitRef="usd">41184000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzAtMy0xLTEtMTE5ODY4_0d6d1201-fef3-4fc9-a2ff-5389af0f0f5d"
      unitRef="usd">38260000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzEtMS0xLTEtMTE5ODY4_69138778-e0c7-49d1-bac8-6dae88d7c6b5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzEtMy0xLTEtMTE5ODY4_34dfff7b-4363-4b2d-9077-4f1c6eb1706a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzE_a6ea1c4d-e363-4f68-b1a2-c00bae99d132"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzE_dade26df-d7b8-4c8a-b4f0-529ca2aec846"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzU_1ff3d250-c785-4733-b15d-271846f9b6f8"
      unitRef="shares">2600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfMzU_d4b82930-7eae-47e1-9975-1117308b8357"
      unitRef="shares">2600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNTc_770c65e2-369c-435c-a521-7154dd6e95b3"
      unitRef="shares">1330148578</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNTc_de8ed660-036b-4676-b902-4f37231e3d8d"
      unitRef="shares">1330148578</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNjQ_46ffdba3-2ad8-41c9-b21b-4b76f17f9191"
      unitRef="shares">1330743395</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MDJjNDliZjJiN2ZjNGRjYjhlODkzZTczMjExZjM1NmJfNjQ_879dde7a-656b-4011-add2-914463c69e50"
      unitRef="shares">1330743395</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMS0xLTEtMTE5ODY4_d9b4817d-873c-4eeb-bf4f-7317efe9ec75"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzMtMy0xLTEtMTE5ODY4_4b73806c-682f-4284-83f2-44341c15ce7c"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzQtMS0xLTEtMTE5ODY4_26760c0a-9a7d-4431-938a-3c508c048c50"
      unitRef="usd">24442000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzQtMy0xLTEtMTE5ODY4_431758e7-7f52-4d22-a53d-b5f06b138854"
      unitRef="usd">24566000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzUtMS0xLTEtMTE5ODY4_8cb8d798-ad76-4e7f-b814-ec91d8d82949"
      unitRef="usd">29799000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzUtMy0xLTEtMTE5ODY4_a7c29326-8c7a-4ca6-8fa6-1e80683beb30"
      unitRef="usd">30250000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzYtMS0xLTEtMTE5ODY4_6e6a0135-85d7-4395-8acb-7b487ec1818a"
      unitRef="usd">-2361000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzYtMy0xLTEtMTE5ODY4_475a3372-f34a-4f72-8eea-21d37d9100bf"
      unitRef="usd">-2265000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzctMS0xLTEtMTE5ODY4_baa111c2-105e-4852-b2fc-7c2176c142e4"
      unitRef="usd">51880000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzctMy0xLTEtMTE5ODY4_7417f298-255e-40ad-aad7-6a6f93c68727"
      unitRef="usd">52551000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzgtMS0xLTEtMTE5ODY4_e64c0700-2310-4029-871e-2e7e22dfffd5"
      unitRef="usd">177000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzgtMy0xLTEtMTE5ODY4_b0345184-e6bd-4ed5-a46a-2d4cd2f4fc87"
      unitRef="usd">171000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzktMS0xLTEtMTE5ODY4_dbf29085-7c5b-48c2-b083-7c168fa09d45"
      unitRef="usd">52057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfMzktMy0xLTEtMTE5ODY4_080f450e-d089-42cc-bb4a-437bf7fa0d42"
      unitRef="usd">52722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNDAtMS0xLTEtMTE5ODY4_3c725027-0e48-4fc2-93d8-294b55f76f86"
      unitRef="usd">93241000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yNS9mcmFnOjBjMmYzMTk2ZDQ2MDQ0NDZiZTliMWQyZjE3YTg2M2UxL3RhYmxlOjI2ZDg4NDdiZGU1OTQxNzlhYzRlOWQwOWNiNzQyMTlhL3RhYmxlcmFuZ2U6MjZkODg0N2JkZTU5NDE3OWFjNGU5ZDA5Y2I3NDIxOWFfNDAtMy0xLTEtMTE5ODY4_1318592c-a62e-4371-af6a-c980ffa75b4c"
      unitRef="usd">90981000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0yLTEtMS0xMTk4Njg_66399716-183c-4ef0-a95d-c69fecb36bae"
      unitRef="shares">1331000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83da20f2f1a84dcc9eaf3e42395bb5ae_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi00LTEtMS0xMTk4Njg_f2c5a110-270e-4e28-85d9-6f2eb6e69508"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c24ef1adeed4623bdd58565d19980a7_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi02LTEtMS0xMTk4Njg_ddfbe387-7205-4176-b7da-38f320df53ff"
      unitRef="usd">24566000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf939ef7ba9b40d9b919eaff4d3aaf20_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi04LTEtMS0xMTk4Njg_2f4291c0-a2b8-408a-a831-1c8efd46f5c1"
      unitRef="usd">30250000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f7d0c01899c445db04cd9b2d85f6968_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xMC0xLTEtMTE5ODY4_c1544935-8d99-457f-8d08-01ae0a84ad96"
      unitRef="usd">-2265000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a2b3356080044499be1ee38fa01063b_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xMi0xLTEtMTE5ODY4_186ca13b-82e0-4a30-9f91-55de4a6d7689"
      unitRef="usd">52551000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic96f676fdbed43a1af73c94a459a0027_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xNC0xLTEtMTE5ODY4_85a701b6-066b-4928-be23-8e2c0edb323f"
      unitRef="usd">171000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMi0xNi0xLTEtMTE5ODY4_1e213546-7b0d-4c5c-93e3-749da2049e7c"
      unitRef="usd">52722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if81b699157ef400babbd49b79ce01d51_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy04LTEtMS0xMTk4Njg_dc538329-8058-4b03-8023-a57e5739c711"
      unitRef="usd">929000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xMi0xLTEtMTE5ODY4_ab882d18-13d1-4705-beeb-8932ae64a726"
      unitRef="usd">929000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xNC0xLTEtMTE5ODY4_3ab84010-3d43-443f-a0de-f32ee90bbf5b"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMy0xNi0xLTEtMTE5ODY4_288dd7d2-087a-4070-9946-5daeba120912"
      unitRef="usd">931000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibaf8710ac3ce4ccdac40ee3b1b558b39_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xMC0xLTEtMTE5ODY4_d90f41ee-f4fe-4e57-9b11-3381b316ce94"
      unitRef="usd">326000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xMi0xLTEtMTE5ODY4_ebb7d9a2-918d-49ed-8fa8-426a7092346d"
      unitRef="usd">326000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12a400a2453b4f739db3f7243a9827b5_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xNC0xLTEtMTE5ODY4_3369833d-6123-49c7-b515-52a7141fce55"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNC0xNi0xLTEtMTE5ODY4_13800407-b177-4bc8-89da-0b0d1b9ce0a9"
      unitRef="usd">324000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjowYzhlMzU0ZmI2OTQ0ZTNhYTI4MzRhMjA5OTM1YmU1MV8zMQ_874bc3cf-5391-480a-9d97-cdf7c502ca77"
      unitRef="usdPerShare">0.68</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="if81b699157ef400babbd49b79ce01d51_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS04LTEtMS0xMTk4Njg_b5616df3-60a2-4ddb-b86e-73edeaf872be"
      unitRef="usd">903000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0xMi0xLTEtMTE5ODY4_3dce3400-2abe-41db-afe0-366f00fa7fc9"
      unitRef="usd">903000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNS0xNi0xLTEtMTE5ODY4_473fa17d-2f6a-42e7-809e-62a77fdf5526"
      unitRef="usd">903000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0yLTEtMS0xMTk4Njg_aea1fa5e-4cc5-4734-8449-3f5b6fbf6079"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi02LTEtMS0xMTk4Njg_65559a54-4e6a-4590-9fe8-16afd73b2cb7"
      unitRef="usd">41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0xMi0xLTEtMTE5ODY4_a44cafca-5db6-470c-850c-a4c9f9b6eeda"
      unitRef="usd">41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNi0xNi0xLTEtMTE5ODY4_e145dcbc-1d08-44c5-bdbc-fa2fc1c5e506"
      unitRef="usd">41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5dd29d0a7c3f426486455fddf2828b4c_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0yLTEtMS0xMTk4Njg_9e52639d-6cc0-446d-826a-6ec199ed5edf"
      unitRef="shares">3000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy02LTEtMS0xMTk4Njg_d07c3bc8-a7b0-49f9-b152-01227ccfd4fe"
      unitRef="usd">333000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0xMi0xLTEtMTE5ODY4_3de0833e-604b-4f74-afd6-4c78da00aac1"
      unitRef="usd">333000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfNy0xNi0xLTEtMTE5ODY4_9517fe19-98d8-4497-8d99-b5561d4bf5c9"
      unitRef="usd">333000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0c2693c122cc4b06893029c5b08d0eed_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC02LTEtMS0xMTk4Njg_6660897b-501e-4b1e-a63e-dc3197f9ee01"
      unitRef="usd">62000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i48888061b36f42269ac398a4797a7f84_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC0xMi0xLTEtMTE5ODY4_59847b82-2510-419c-a0b7-4e3d5e60f7e6"
      unitRef="usd">62000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i04258c79de92422585b957b7ea074863_D20220430-20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfOC0xNi0xLTEtMTE5ODY4_f49cf901-326a-4ce1-be5b-bf235b1e67c2"
      unitRef="usd">62000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iba553ebece994593a02b2325d2eaf828_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMi0xLTEtMTE5ODY4_18215ecb-30e4-4f55-9a78-2003ab54a3e6"
      unitRef="shares">1329000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba553ebece994593a02b2325d2eaf828_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtNC0xLTEtMTE5ODY4_50ea1540-b33b-43c3-ab62-2ed327376fad"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iabee6461cac44d1b9e9883c0e2236533_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtNi0xLTEtMTE5ODY4_cff18b19-06b6-4881-ba0a-fc9b95d4afc7"
      unitRef="usd">24335000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c7b953379f84fdaa442b1f9a50a4444_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtOC0xLTEtMTE5ODY4_05094781-d5d6-4c3b-a3dd-d83c89b6be40"
      unitRef="usd">30276000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i830c7cc13ba0450aa6d50f69c10d139a_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTAtMS0xLTExOTg2OA_bb6afaa1-6f3e-4355-b47a-37793c884689"
      unitRef="usd">-1939000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9edbc694c8954441b58c7dfcf548932d_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTItMS0xLTExOTg2OA_58b4d05f-3805-44f3-a068-cf22ab1005ff"
      unitRef="usd">52672000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3715049e1f9a4a64bc2f20c1b2d751b1_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTQtMS0xLTExOTg2OA_e665a65b-df23-451a-99ec-d72e7d8cfae2"
      unitRef="usd">170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief0140ab23f7415d9e84fba89d2ce274_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTEtMTYtMS0xLTExOTg2OA_505c1c06-153c-447a-841d-25430e783df6"
      unitRef="usd">52843000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItOC0xLTEtMTE5ODY4_4d7cbfe0-bce8-4a19-8df8-9d91dac14331"
      unitRef="usd">427000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTItMS0xLTExOTg2OA_146b889c-5133-4bcb-a01d-7435ec3484bf"
      unitRef="usd">427000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTQtMS0xLTExOTg2OA_ba52fec3-8f29-4e5a-9456-9e95b3bedd16"
      unitRef="usd">8000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTItMTYtMS0xLTExOTg2OA_27ff8f11-8f6f-4cb3-aaa1-4fc137410e95"
      unitRef="usd">435000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb31e75e6e81437d992d025c15bdbab7_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTAtMS0xLTExOTg2OA_9d044ddb-c57e-4f79-8063-70cc24bf972a"
      unitRef="usd">-422000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTItMS0xLTExOTg2OA_6c4e5d29-8bfa-449d-bfb9-5d65c638ff17"
      unitRef="usd">-422000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iacc5cfd161724d6d882b7b9b2dcbfc78_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTQtMS0xLTExOTg2OA_05407e69-9617-4f6a-b351-bf1b57e5f782"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTMtMTYtMS0xLTExOTg2OA_b72da522-6a70-446c-a1af-c71024c48f67"
      unitRef="usd">-424000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246YWY4ZmYyMTBmNzM1NDFmODgxZTE4YmM0MTg5YmZkZDlfNTQ5NzU1ODEzOTQ5_f58fdf08-8a30-480d-bf47-cec670da067b"
      unitRef="usdPerShare">0.68</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ieef0eab1290646c2aa41df3d6fa0ae62_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtOC0xLTEtMTE5ODY4_05f10188-1f3c-40a6-bd5a-344cbab5a037"
      unitRef="usd">904000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMTItMS0xLTExOTg2OA_6ce4cedb-49f6-40bc-81cd-dc4009ba6935"
      unitRef="usd">904000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTQtMTYtMS0xLTExOTg2OA_e1e1c20d-e93f-4bef-a749-186e71719f26"
      unitRef="usd">904000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMi0xLTEtMTE5ODY4_47a01839-3aaf-49cf-ae5f-4544ca300d1d"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtNi0xLTEtMTE5ODY4_afc8ab1f-7e96-4243-a7f6-313c51143628"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMTItMS0xLTExOTg2OA_f4bf2ed4-f093-4576-b4ea-a012b166461b"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTUtMTYtMS0xLTExOTg2OA_55782320-00a0-432c-81fe-75fff174bce3"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ib1431c15a0ac4dbfb5db0e2235522afa_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMi0xLTEtMTE5ODY4_eca26e01-e305-4f8e-b598-e1d55bea90c8"
      unitRef="shares">1000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtNi0xLTEtMTE5ODY4_92561583-0cad-490d-b987-e4df3054487b"
      unitRef="usd">85000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMTItMS0xLTExOTg2OA_fb09b108-cefe-4dd7-af85-3b59a9cdfd6d"
      unitRef="usd">85000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTYtMTYtMS0xLTExOTg2OA_e2675fb2-dae6-4871-be2f-b89063f08b52"
      unitRef="usd">85000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1c26438766584fc093b6da547164787e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctNi0xLTEtMTE5ODY4_0c41514e-daf3-4c54-926d-75e2606eacb4"
      unitRef="usd">137000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i24119f5257cd49cdafeaec7671403ea9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctMTItMS0xLTExOTg2OA_8930582c-c40f-42fb-8125-a6d92be8d6f5"
      unitRef="usd">137000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMTctMTYtMS0xLTExOTg2OA_3c512585-8e3f-4e96-a8a6-defe3106a7b1"
      unitRef="usd">137000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i479bc235eb204cc6bd9b5d428f9c482d_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMi0xLTEtMTE5ODY4_c319b7e5-a66f-4ba7-828b-74282217f23e"
      unitRef="shares">1330000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i479bc235eb204cc6bd9b5d428f9c482d_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtNC0xLTEtMTE5ODY4_b5f38069-63ff-4f8c-a1e3-76e2c7ba5777"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id957c1291b754cb3989f2c5e3ac8dbf8_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtNi0xLTEtMTE5ODY4_ef50333c-d607-4266-b2a7-62a53d073ea9"
      unitRef="usd">24442000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90b6c031e74f4b8192cfe7653b448f7a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtOC0xLTEtMTE5ODY4_2b9ee427-7271-4fc1-87ee-f8d58900651f"
      unitRef="usd">29799000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12e89df7a7284768b084b028fb30c0b3_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTAtMS0xLTExOTg2OA_c705f9c1-ebeb-49e9-af6c-915d06668af8"
      unitRef="usd">-2361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7de7fa9e2bd14d9cb49275324f2d4fff_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTItMS0xLTExOTg2OA_e8ec7b4d-64f8-4390-a55a-d1178b37bf7f"
      unitRef="usd">51880000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3889946f4cd466eb0c8de4cb9692332_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTQtMS0xLTExOTg2OA_e44d0212-8c7d-47a6-8bcc-b1b0a8b85f15"
      unitRef="usd">177000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOjRjYTI0NWUxM2FjNDQxNmQ4MzE0OTg3Mzc1ZGEyOTI2L3RhYmxlcmFuZ2U6NGNhMjQ1ZTEzYWM0NDE2ZDgzMTQ5ODczNzVkYTI5MjZfMjAtMTYtMS0xLTExOTg2OA_705548e7-f891-4da5-8e6e-42b070b35135"
      unitRef="usd">52057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iac68bc9471644ffc8005764e8ae89b46_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0yLTEtMS0xMTk4Njg_e15ab75f-89a6-43c9-9c3c-a223a3bb00e3"
      unitRef="shares">1345000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac68bc9471644ffc8005764e8ae89b46_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi00LTEtMS0xMTk4Njg_1d4640ba-ece3-46b9-962e-817378d1d142"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5462aaf0c094c7db4f015d2fc1cccfe_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi02LTEtMS0xMTk4Njg_0fc50df8-4e8b-4178-a0aa-991d5fc76494"
      unitRef="usd">26319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7303ffa9282c44ada71fcf27f9caf878_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi04LTEtMS0xMTk4Njg_2065d596-93ab-4a11-8609-41085385e734"
      unitRef="usd">28594000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xMC0xLTEtMTE5ODY4_6925e0cf-ca9c-475b-9713-bfa59ff60cb9"
      unitRef="usd">-3485000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b4eb2cd7eb34e68bc0bfff863e48a7f_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xMi0xLTEtMTE5ODY4_6de45549-b8ab-45d2-92fa-ea3c5d20c842"
      unitRef="usd">51428000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i576eb2cb85264ebe977159af31544200_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xNC0xLTEtMTE5ODY4_e0f8fb0b-2bdf-43da-93d0-6d06b1360118"
      unitRef="usd">174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id815d10cd7364e4c8224095110455793_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMi0xNi0xLTEtMTE5ODY4_ea01b0e6-54b0-4b65-ae3c-dff8b7eccaac"
      unitRef="usd">51602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy04LTEtMS0xMTk4Njg_8f45e2b7-db6c-481c-924b-ff631cc80c87"
      unitRef="usd">763000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xMi0xLTEtMTE5ODY4_ae2834e7-541d-4e7d-b6a0-dce78c21c1c7"
      unitRef="usd">763000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xNC0xLTEtMTE5ODY4_94f68f88-668e-4d11-8b33-0d9df19babdd"
      unitRef="usd">6000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMy0xNi0xLTEtMTE5ODY4_6b7e7b8e-aa53-4979-bcee-f4ac898be83f"
      unitRef="usd">769000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id3812240d458431e8ef07e8d1e16b569_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xMC0xLTEtMTE5ODY4_53eb6582-4e45-4aa9-88b4-e8ffe161d2c2"
      unitRef="usd">276000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xMi0xLTEtMTE5ODY4_bab5f8a7-b64a-4a5c-bc8d-0bca6530f2e1"
      unitRef="usd">276000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if3677e64316b47e79ffc7fdef8e7e74f_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xNC0xLTEtMTE5ODY4_eb3e417d-b954-472a-a2fd-83f399f5a335"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNC0xNi0xLTEtMTE5ODY4_d8c1ef93-dd67-4d9d-b6a8-728ddb71d213"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1MGM2YThkZjc2YzE0MDIwODhhOGQzMzQzZWE2MTFjYl8zMQ_221c2aa8-8192-4e56-a1a9-ccfdde9fd57b"
      unitRef="usdPerShare">0.63</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i32d65bb831054d558682bc9b3c3cbc43_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS04LTEtMS0xMTk4Njg_d33a5ed1-fac8-44db-9c0f-af68f7a777b1"
      unitRef="usd">846000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0xMi0xLTEtMTE5ODY4_39c1728d-3023-45f9-9670-83c9e8b165b6"
      unitRef="usd">846000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNS0xNi0xLTEtMTE5ODY4_0258d65a-d486-4962-9bf8-3e3354e0dd55"
      unitRef="usd">846000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0yLTEtMS0xMTk4Njg_7bcd0c75-8829-4839-9340-77f8df14da76"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi02LTEtMS0xMTk4Njg_5a3facc5-e1f3-4629-bafb-aadee0389863"
      unitRef="usd">107000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0xMi0xLTEtMTE5ODY4_c66ebb4b-4a6e-4557-8b1d-66c68ae97f01"
      unitRef="usd">107000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNi0xNi0xLTEtMTE5ODY4_acf31b75-18a5-4d1c-bc9d-5bd08bdf1925"
      unitRef="usd">107000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i6daea6cd4dfb4837ad3fe01292396a66_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0yLTEtMS0xMTk4Njg_707db50c-9d09-4eb7-9d32-061b57b6bd6e"
      unitRef="shares">2000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy02LTEtMS0xMTk4Njg_61e6e855-e947-4c67-bb25-da49777791a4"
      unitRef="usd">311000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0xMi0xLTEtMTE5ODY4_534ac67b-33d0-44f1-a84a-37808041d092"
      unitRef="usd">311000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfNy0xNi0xLTEtMTE5ODY4_f8ff0f45-a7a8-4f82-8c61-08054f6300f9"
      unitRef="usd">311000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i00401fb6c87a48c5ad66c45f22e9042b_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC02LTEtMS0xMTk4Njg_6215bf49-2941-4821-943b-d353fbd792d6"
      unitRef="usd">69000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC0xMi0xLTEtMTE5ODY4_b75b627b-21cd-45ed-a8ac-5ba0fb08dcbb"
      unitRef="usd">69000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i805e77a5795b43879236735b12530491_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfOC0xNi0xLTEtMTE5ODY4_39b7683c-e2b9-48fe-a4d5-7458713e1d3f"
      unitRef="usd">69000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibad2d789542f4a2382dd3a428fefa32f_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMi0xLTEtMTE5ODY4_40830f53-7af2-4cbf-bd07-ca58977721f1"
      unitRef="shares">1345000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibad2d789542f4a2382dd3a428fefa32f_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtNC0xLTEtMTE5ODY4_776c3781-4ef6-4bd2-b60a-60e495b22335"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93039fe1caf846e29eab3a6ecfe114fd_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtNi0xLTEtMTE5ODY4_19799fe6-e0da-424f-a175-3cd5ad11b655"
      unitRef="usd">26184000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cfefe3cebb942b897dafda418007e00_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtOC0xLTEtMTE5ODY4_8b194539-0516-4c15-89de-a0db61514d4b"
      unitRef="usd">28511000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i674c328ca4cf4cacacc5730fead09f35_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTAtMS0xLTExOTg2OA_d94785fb-4121-4d6b-8061-7be820839909"
      unitRef="usd">-3209000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie98b1d14c436463b872fdeceb9f130aa_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTItMS0xLTExOTg2OA_e29b5ac0-8275-4e93-ae52-5ee1d580f134"
      unitRef="usd">51486000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i758fd510e93e480db9ffe7c253a337a3_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTQtMS0xLTExOTg2OA_ec11275a-f0b4-4f87-ad97-109e7152cdbe"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTEtMTYtMS0xLTExOTg2OA_396fedfe-bd98-4337-9bd7-09889c942794"
      unitRef="usd">51664000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItOC0xLTEtMTE5ODY4_f0614ee4-f5be-4ea9-bd21-e1017d1d863b"
      unitRef="usd">1311000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTItMS0xLTExOTg2OA_76269e74-d5a1-41d7-93b0-7259c19708ed"
      unitRef="usd">1311000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTQtMS0xLTExOTg2OA_46892620-c936-4a4c-834f-2f80a3324e55"
      unitRef="usd">6000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTItMTYtMS0xLTExOTg2OA_0bc34899-677a-4d2e-be5b-9bf91bb62a49"
      unitRef="usd">1317000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieb4c020bc4494a4998a6177261e6225b_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTAtMS0xLTExOTg2OA_273bddd4-ffa3-4189-9c6c-5bd2c21c84d8"
      unitRef="usd">167000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTItMS0xLTExOTg2OA_4c8ebd9c-04e9-4ba4-ac80-3d455364cea0"
      unitRef="usd">167000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTQtMS0xLTExOTg2OA_66c9a98c-9e5b-42af-983a-090d98899a56"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTMtMTYtMS0xLTExOTg2OA_d6cfa102-36ba-43d4-9f3f-0745b8dace1c"
      unitRef="usd">166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzkwNTJmN2QyOGFmNDA5ZmJhOWJlOGIyYjFiMzk0NTdfNTQ5NzU1ODEzOTQ5_68d4591f-81c4-4764-a0d6-fabcb9d12695"
      unitRef="usdPerShare">0.63</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="iaf28ef37468d4e7fb0225a639252882c_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtOC0xLTEtMTE5ODY4_b84b39b9-8d5e-4993-b053-e5d9d594bd9d"
      unitRef="usd">847000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMTItMS0xLTExOTg2OA_32c2676e-3b14-499c-958d-cf8954315160"
      unitRef="usd">847000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTQtMTYtMS0xLTExOTg2OA_43546047-08db-4d06-b674-671a3384c3dc"
      unitRef="usd">847000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMi0xLTEtMTE5ODY4_aa1e484b-67a4-4a2a-86ad-8ea7191d1e43"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtNi0xLTEtMTE5ODY4_b941a093-911f-416f-a8f1-e4d209c4f4af"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMTItMS0xLTExOTg2OA_91c88042-3ae7-4851-af87-675855711b8a"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTUtMTYtMS0xLTExOTg2OA_9fa01280-f13b-440b-9f9f-c9d79420ac50"
      unitRef="usd">92000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i27a1a879000d4e7ebe7588d7431a9698_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMi0xLTEtMTE5ODY4_06d0065c-1771-4297-8da4-3aed3f1c7a67"
      unitRef="shares">3000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtNi0xLTEtMTE5ODY4_9ba4f11d-ed0d-4399-b0ba-60193dab0495"
      unitRef="usd">358000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMTItMS0xLTExOTg2OA_8432e2e2-85d8-4f1f-9c7c-140c3571292b"
      unitRef="usd">358000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTYtMTYtMS0xLTExOTg2OA_eda21cc4-e440-45aa-9846-b2a05491c5e3"
      unitRef="usd">358000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctNi0xLTEtMTE5ODY4_eb6d506a-d6c0-4a53-ac9b-1640cc5ec9f8"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctMTItMS0xLTExOTg2OA_8da74d28-1d37-4d39-95ea-6e2516892649"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTctMTYtMS0xLTExOTg2OA_1cb64a11-a2c3-44d6-b696-f11a7243ef60"
      unitRef="usd">140000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i35e9327a79034a79bc451057f5e4f158_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtNi0xLTEtMTE5ODY4_ba9f6685-9931-4d01-8a68-d2883d78a153"
      unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ie9cab8a2c5e5438f9deeaa39605d7b23_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTItMS0xLTExOTg2OA_31aa553e-d966-48bb-a75c-cebb205086bd"
      unitRef="usd">1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i7b4f45a9f1b14bd9a0538873bf59c989_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTQtMS0xLTExOTg2OA_99479ef2-f38e-450a-812b-51b3c604e064"
      unitRef="usd">-16000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMTgtMTYtMS0xLTExOTg2OA_e6e7545a-3371-449f-a8b6-aac9e5d67a7a"
      unitRef="usd">-15000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3b9e3f477203428683ae92a742041fd6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMi0xLTEtMTE5ODY4_8575e3d5-248e-4051-8e72-087eb71c6a49"
      unitRef="shares">1345000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b9e3f477203428683ae92a742041fd6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtNC0xLTEtMTE5ODY4_aa461a60-3564-4f8f-b860-62e251b4bfa0"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3190fe1c894e4a2b85407bc0557e735c_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtNi0xLTEtMTE5ODY4_e2db6196-6db5-416d-b499-b554aab383e3"
      unitRef="usd">26059000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4a75125a2ce45cbb0110cffa8149de1_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtOC0xLTEtMTE5ODY4_a9a035c8-404b-44d9-99eb-e9df14450373"
      unitRef="usd">28974000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b27da620ade4165842447d930ad60a5_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTAtMS0xLTExOTg2OA_80081f89-e6e6-4fdd-8ea2-e323c71de6b0"
      unitRef="usd">-3042000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8245ba0bf94b40b7b27dc0842b8cc6b9_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTItMS0xLTExOTg2OA_38211a4c-b6ce-4e8e-9857-ef41fb948b65"
      unitRef="usd">51991000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26383b4523e74135acd4c7e7659b4845_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTQtMS0xLTExOTg2OA_9679991c-0a33-483f-a61c-247a1f3fb920"
      unitRef="usd">168000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8yOC9mcmFnOmYzNDhmMjkzOTcwNzQ1NTY4YzJiZjZjOWRmYzlhNDU2L3RhYmxlOmIzMWU4ZTFlNDcxNTQwZTc5M2QzM2E4NjZkMzFhNmE4L3RhYmxlcmFuZ2U6YjMxZThlMWU0NzE1NDBlNzkzZDMzYTg2NmQzMWE2YThfMjAtMTYtMS0xLTExOTg2OA_6c54addb-e8a9-4d4f-82b8-c5ab52a747a3"
      unitRef="usd">52159000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMy0xLTEtMS0xMTk4Njg_4bac8ee6-63c3-480e-916d-7e257beca638"
      unitRef="usd">1367000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMy0zLTEtMS0xMTk4Njg_1e5ecb1a-d963-4949-b299-301c4a06f266"
      unitRef="usd">2086000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNS0xLTEtMS0xMTk4Njg_1d312267-6b8d-4af2-b983-070a0a33d288"
      unitRef="usd">1339000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNS0zLTEtMS0xMTk4Njg_31f8df81-9953-4be4-a02b-60c3395f2509"
      unitRef="usd">1347000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNi0xLTEtMS0xMTk4Njg_fb2b6569-ae67-4651-807c-71f60058eacc"
      unitRef="usd">41000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNi0zLTEtMS0xMTk4Njg_6800502a-d06e-41f1-9dea-761dc79ec445"
      unitRef="usd">34000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNy0xLTEtMS0xMTk4Njg_f12324ca-4d79-420a-911a-ece2754ccc1a"
      unitRef="usd">-92000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNy0zLTEtMS0xMTk4Njg_f16d57d4-e7f5-4f3c-9659-9d798b215b8b"
      unitRef="usd">-78000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOC0xLTEtMS0xMTk4Njg_6e54ba49-b0f6-4a99-8e08-a2579c2f5263"
      unitRef="usd">199000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOC0zLTEtMS0xMTk4Njg_fa05a457-06e8-4ad0-8337-fd80ce297577"
      unitRef="usd">209000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOS0xLTEtMS0xMTk4Njg_ba55e9c1-0a2d-4a56-9343-bdf132260121"
      unitRef="usd">-53000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfOS0zLTEtMS0xMTk4Njg_b908859d-eb84-413a-94d1-f17c97ff9954"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <mdt:AssetImpairmentChargesAndInventoryWriteDown
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTItMS0xLTEtMTE5ODY4_3bfabdd5-3776-434a-8a17-2e8da0b0a182"
      unitRef="usd">0</mdt:AssetImpairmentChargesAndInventoryWriteDown>
    <mdt:AssetImpairmentChargesAndInventoryWriteDown
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTItMy0xLTEtMTE5ODY4_33a80ba0-5a93-4662-a62b-719a255969f3"
      unitRef="usd">515000000</mdt:AssetImpairmentChargesAndInventoryWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTMtMS0xLTEtMTE5ODY4_2bda618e-bf30-457a-bf6b-b0947dcf91da"
      unitRef="usd">-148000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTMtMy0xLTEtMTE5ODY4_07d5ff06-bbbd-48c8-8762-d2f41d6e4987"
      unitRef="usd">-130000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTUtMS0xLTEtMTE5ODY4_6eae2ab9-2f42-42ed-a56c-4d509aa87126"
      unitRef="usd">346000000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTUtMy0xLTEtMTE5ODY4_f1e25625-027d-4de1-b099-eb30149d5fb5"
      unitRef="usd">171000000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTYtMS0xLTEtMTE5ODY4_b1530b04-aa1b-49ea-9405-1306eb39f869"
      unitRef="usd">784000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTYtMy0xLTEtMTE5ODY4_819da989-f246-4ba9-a652-16a7b7ca61ef"
      unitRef="usd">156000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTctMS0xLTEtMTE5ODY4_824670e7-9487-4385-998b-5d89c3b6d070"
      unitRef="usd">-14000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTctMy0xLTEtMTE5ODY4_d66da57e-e889-4d4c-88b1-070431404d7e"
      unitRef="usd">-446000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTgtMS0xLTEtMTE5ODY4_e3fadbae-e20f-4431-a7ef-4e05773a4312"
      unitRef="usd">-94000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMTgtMy0xLTEtMTE5ODY4_d24b7dc1-f5ee-4985-a8c4-6bae014781a0"
      unitRef="usd">409000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjEtMS0xLTEtMTE5ODY4_e8e4018a-48f9-485f-8e17-bec10a27af84"
      unitRef="usd">2005000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjEtMy0xLTEtMTE5ODY4_934e9f38-8c86-4309-8040-cfa105605140"
      unitRef="usd">3061000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjMtMS0xLTEtMTE5ODY4_5058047b-c524-4922-9006-87f3dbc03d72"
      unitRef="usd">1867000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjMtMy0xLTEtMTE5ODY4_1790e3c9-11b4-4787-a893-fda3a6b00653"
      unitRef="usd">91000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjUtMS0xLTEtMTE5ODY4_917f01c5-17a3-4e86-a0ff-b44a17f2723a"
      unitRef="usd">749000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjUtMy0xLTEtMTE5ODY4_8a8eefe9-167d-428a-b3db-c201fc1d31fa"
      unitRef="usd">649000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjYtMS0xLTEtMTE5ODY4_70b64dac-707b-465a-b4ab-49bd82f6e61b"
      unitRef="usd">3743000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjYtMy0xLTEtMTE5ODY4_3d4f1309-ce6d-4784-b4dd-1db9baef8797"
      unitRef="usd">5311000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjctMS0xLTEtMTE5ODY4_49606f23-0b8c-4ab6-a85b-7c7c2533f22d"
      unitRef="usd">3609000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjctMy0xLTEtMTE5ODY4_c5469018-0ba0-4147-b6b3-98e9b9abfb7d"
      unitRef="usd">4637000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjgtMS0xLTEtMTE5ODY4_b0d065e1-461f-40b9-a36a-77c04f497bf7"
      unitRef="usd">-19000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjgtMy0xLTEtMTE5ODY4_b4ebbf9e-f734-42a4-b30e-f94e8c7950b9"
      unitRef="usd">79000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjktMS0xLTEtMTE5ODY4_8a0bac8e-a6ed-499e-9a57-ce17e2849c00"
      unitRef="usd">-2731000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMjktMy0xLTEtMTE5ODY4_31229f09-8a45-4535-bef4-2125b4c85fb7"
      unitRef="usd">-1493000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzEtMS0xLTEtMTE5ODY4_e3fef99a-d0cd-4a4c-b3f7-b93a0fb4fa7d"
      unitRef="usd">349000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzEtMy0xLTEtMTE5ODY4_7a84f8e1-0ebb-4eaf-af8b-2f1ec7121ee9"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzMtMS0xLTEtMTE5ODY4_ee1b2fa9-0c02-4ac7-a719-8142f7a08058"
      unitRef="usd">2284000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzMtMy0xLTEtMTE5ODY4_529ac5ce-aba4-48b0-97d5-0beca7ff2532"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzQtMS0xLTEtMTE5ODY4_28347a30-bf83-40e9-b04e-ac569bfe55a9"
      unitRef="usd">3430000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzQtMy0xLTEtMTE5ODY4_7dea4a08-0e76-4c9b-8069-e4332eeb8117"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzUtMS0xLTEtMTE5ODY4_3bcd3b9d-87dd-42ef-9abd-449983f8c817"
      unitRef="usd">2311000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzUtMy0xLTEtMTE5ODY4_7b90235c-e569-48d9-b404-9a98137c2245"
      unitRef="usd">1000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzYtMS0xLTEtMTE5ODY4_60c82fcc-03d6-432f-9544-f461367bea52"
      unitRef="usd">1807000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzYtMy0xLTEtMTE5ODY4_98e95374-1ac7-4c39-bcbb-d804be5009b0"
      unitRef="usd">1693000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzctMS0xLTEtMTE5ODY4_3f68d6e0-f96a-4d85-865e-656d75d11a92"
      unitRef="usd">153000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzctMy0xLTEtMTE5ODY4_3127d54b-503b-4fb7-8dad-3a5236f8eeef"
      unitRef="usd">274000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzgtMS0xLTEtMTE5ODY4_90cabe45-c982-425b-b339-eb94c5e8376f"
      unitRef="usd">477000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzgtMy0xLTEtMTE5ODY4_dde91d26-6cb2-4880-8e88-16362e85d6c2"
      unitRef="usd">744000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzktMS0xLTEtMTE5ODY4_fc8bd772-2b66-4fbc-8c4c-57674c2a87bc"
      unitRef="usd">443000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfMzktMy0xLTEtMTE5ODY4_844e4cb1-a68d-470c-9242-f290b3d79918"
      unitRef="usd">-46000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDAtMS0xLTEtMTE5ODY4_6130eaa8-9e93-4bea-aca0-94bb8d637bbe"
      unitRef="usd">2064000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDAtMy0xLTEtMTE5ODY4_5f0b9c55-6970-4f6c-85dd-f8afba39813d"
      unitRef="usd">-2210000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDEtMS0xLTEtMTE5ODY4_c7756326-24f9-44f1-b0e2-bdbcd9a780e4"
      unitRef="usd">-223000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDEtMy0xLTEtMTE5ODY4_f0c55e29-9276-4ca5-9e1a-b82f3046fc9d"
      unitRef="usd">-51000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDItMS0xLTEtMTE5ODY4_eaed04b2-afc4-4c65-8eef-a4be29139a82"
      unitRef="usd">1114000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDItMy0xLTEtMTE5ODY4_0acb348d-c78a-499e-b991-cc5287441ac1"
      unitRef="usd">-693000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDMtMS0xLTEtMTE5ODY4_e70b14a3-b6f3-4218-90ae-33691b92b27a"
      unitRef="usd">3714000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id815d10cd7364e4c8224095110455793_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDMtMy0xLTEtMTE5ODY4_b96245df-569f-4f75-8d92-250c655db041"
      unitRef="usd">3593000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDQtMS0xLTEtMTE5ODY4_a312c4eb-15bb-4803-8970-9932d8bb3d7f"
      unitRef="usd">4828000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDQtMy0xLTEtMTE5ODY4_53f67c98-da20-42a2-9843-02413d72afd0"
      unitRef="usd">2900000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDgtMS0xLTEtMTE5ODY4_722ab482-431d-4258-9100-8d87dfee360b"
      unitRef="usd">821000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDgtMy0xLTEtMTE5ODY4_a1ae05fe-9669-4d2b-acd6-aed03b600911"
      unitRef="usd">615000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDktMS0xLTEtMTE5ODY4_226834f3-9967-4219-9bf2-3781f84605ec"
      unitRef="usd">234000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zMS9mcmFnOmYwM2I0NWNmODE5MDQxNDE4Njg0OGI0ZDg0YmVmNGYxL3RhYmxlOjdmNjFhYWY1ZDE2NzRmMGY4ZjM4YmFkNGYwMmE2N2YyL3RhYmxlcmFuZ2U6N2Y2MWFhZjVkMTY3NGYwZjhmMzhiYWQ0ZjAyYTY3ZjJfNDktMy0xLTEtMTE5ODY4_d1bf2c23-5f65-4104-8480-b0b14df5783a"
      unitRef="usd">280000000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfAccounting
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc5OQ_a2bd96e9-b99c-4aaa-a08b-2c5422a90e14">Basis of Presentation &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic ("COVID-19" or the "pandemic") has had, and may continue to have, an adverse effect on our business, results of operations, financial condition, and cash flows, and its future impacts remain uncertain and unpredictable. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the three and six months ended October&#160;28, 2022, changes in the Company&#x2019;s assessment about the length and severity of the pandemic, as well as other factors, could result in actual results differing from estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited consolidated financial statements of the Company and related notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended April&#160;29, 2022. The Company&#x2019;s fiscal years 2023, 2022, and 2021 will end or ended on April&#160;28, 2023, April&#160;29, 2022, and April&#160;30, 2021, respectively. Fiscal year 2021 was a 53-week year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc4Ng_392e58de-511a-40cc-a452-d7b614725846">The accompanying unaudited consolidated financial statements of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S.) (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the consolidated financial statements include all the adjustments necessary for a fair statement in conformity with U.S. GAAP. Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year.Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole. The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc3Mg_60e9c30a-890e-474b-96e6-998375424f4d">The accompanying unaudited consolidated financial statements include the accounts of Medtronic plc, its wholly-owned subsidiaries, entities for which the Company has a controlling financial interest, and variable interest entities for which the Company is the primary beneficiary. Intercompany transactions and balances have been eliminated in consolidation. Amounts reported in millions within this quarterly report are computed based on the amounts in thousands, and therefore, the sum of the components may not equal the total amount reported in millions due to rounding. Additionally, certain columns and rows within tables may not sum due to rounding.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV8zNy9mcmFnOjFiZTYzN2ZmMmUwYzRlNDg4M2E0NGQwOGUyNzc4ZDZlL3RleHRyZWdpb246MWJlNjM3ZmYyZTBjNGU0ODgzYTQ0ZDA4ZTI3NzhkNmVfMjc3NA_b1e93223-a37a-48bd-aa91-222b35aac60d">The Company&#x2019;s fiscal years 2023, 2022, and 2021 will end or ended on April&#160;28, 2023, April&#160;29, 2022, and April&#160;30, 2021, respectively. Fiscal year 2021 was a 53-week year.</us-gaap:FiscalPeriod>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80MC9mcmFnOjQ4NWU4MWUwOGI3NTRlMzliMWQyZTE2YzJjZTA4MTU0L3RleHRyZWdpb246NDg1ZTgxZTA4Yjc1NGUzOWIxZDJlMTZjMmNlMDgxNTRfMzM5_b15fc739-989a-47e2-876b-1a0c6c4d59fb">New Accounting Pronouncements&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;28, 2022, there were no newly adopted accounting pronouncements that had a material impact to our consolidated financial statements. As of October&#160;28, 2022, there are no recently issued but not yet adopted accounting pronouncements that are expected to materially impact our consolidated financial statements&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80MC9mcmFnOjQ4NWU4MWUwOGI3NTRlMzliMWQyZTE2YzJjZTA4MTU0L3RleHRyZWdpb246NDg1ZTgxZTA4Yjc1NGUzOWIxZDJlMTZjMmNlMDgxNTRfMzMw_159d8790-1829-4514-9b26-fff1cb3a0650">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;28, 2022, there were no newly adopted accounting pronouncements that had a material impact to our consolidated financial statements. As of October&#160;28, 2022, there are no recently issued but not yet adopted accounting pronouncements that are expected to materially impact our consolidated financial statements&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3OQ_45c42a92-5b12-458a-a4a7-4ac0f5c951bd">Revenue The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders, cardiovascular disease, renal disease, neurological disorders and diseases, spinal conditions and musculoskeletal trauma, chronic pain, urological and digestive disorders, ear, nose, and throat conditions, and diabetes conditions as well as advanced and general surgical care products, respiratory and monitoring solutions, and neurological surgery technologies. The Company's primary customers include healthcare systems, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. &lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm &amp;amp; Heart Failure &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Structural Heart &amp;amp; Aortic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coronary &amp;amp; Peripheral Vascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Innovations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respiratory, Gastrointestinal, &amp;amp; Renal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cranial &amp;amp; Spinal Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;U.S. includes the United States and U.S. territories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of revenue recognized is reduced by sales rebates and returns. Adjustments to rebates and returns reserves are recorded as increases or decreases to revenue. At October&#160;28, 2022, $1.0 billion of rebates were classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$536 million of rebates were classified as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheet. At April&#160;29, 2022, $981 million of rebates were classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $548 million of rebates were classified as a reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accounts receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Revenue and Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a deferred revenue liability if a customer pays consideration, or the Company has the right to invoice, before the Company transfers a good or service to the customer. Deferred revenue at October&#160;28, 2022 and April&#160;29, 2022 was $380 million and $399 million, respectively. At October&#160;28, 2022 and April&#160;29, 2022, $293 million and $305 million was included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; respectively, and $87 million and $94 million was included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively. During the six months ended October&#160;28, 2022, the Company recognized $160&#160;million of revenue that was included in deferred revenue as of April&#160;29, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining performance obligations include goods and services that have not yet been delivered or provided under existing, noncancellable contracts with minimum purchase commitments. At October&#160;28, 2022, the estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations for executed contracts with an original duration of one year or more was approximately $719 million. The Company expects to recognize revenue on the majority of these remaining performance obligations over the next three years.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3Nw_7b69a02f-5852-4552-94d2-d5874947c4e4">&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by segment and division for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiac Rhythm &amp;amp; Heart Failure &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Structural Heart &amp;amp; Aortic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coronary &amp;amp; Peripheral Vascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Surgical Innovations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Respiratory, Gastrointestinal, &amp;amp; Renal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cranial &amp;amp; Spinal Technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty Therapies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuromodulation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below illustrates net sales by market geography for each segment for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S. Developed Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;U.S. includes the United States and U.S. territories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:12.02pt"&gt;Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9a3dd382c6945438731d0f15056527b_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi0xLTEtMS0xMTk4Njg_9f8c8aac-aee1-4117-a47d-a216bdc598a4"
      unitRef="usd">1431000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i104380acc80d4b33bdb75a56ac2c6c3a_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi0zLTEtMS0xMTk4Njg_448f33cc-b636-43e3-9fe9-4d6cf0a39211"
      unitRef="usd">1471000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c7b3868ea6348b284ebcfa636598a64_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi01LTEtMS0xMTk4Njg_db9543e2-668c-4b21-90e5-95bfdbd94a93"
      unitRef="usd">2824000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b6cb2b2a61d40dd88447e04bbb15481_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMi03LTEtMS0xMTk4Njg_149f84ac-0066-47e2-9428-03a199e05a1e"
      unitRef="usd">2954000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd3cbd04fd67492bafbb8147b08ca285_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy0xLTEtMS0xMTk4Njg_cd8ef300-722c-465d-9421-e4c9fc6cd05f"
      unitRef="usd">757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4016f75f0a6c48efba5e59908d817ef1_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy0zLTEtMS0xMTk4Njg_4ba2706b-e9b8-4bc9-af66-0c28d37ff92e"
      unitRef="usd">750000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96aaaa79ddc3450fa9639b6e04b840d5_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy01LTEtMS0xMTk4Njg_d3780c0a-9433-4165-a4bf-020da1cf3c31"
      unitRef="usd">1499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i739110963f73456da89189576a2091f4_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMy03LTEtMS0xMTk4Njg_6c7c5fca-c085-4988-8215-26cba18a7abd"
      unitRef="usd">1537000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f70332fc7824fcabcb5d642eb7a2f6a_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC0xLTEtMS0xMTk4Njg_db044d51-ae1a-463d-9af3-319226be785c"
      unitRef="usd">584000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie324a3122889429ebaf0032db23c5238_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC0zLTEtMS0xMTk4Njg_6405f67c-30c0-4481-ac83-28484ccd4677"
      unitRef="usd">606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d18929121a14b85ba7ae8f5ef22c1a9_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC01LTEtMS0xMTk4Njg_484340ce-817b-4e65-ac16-c0fab19c8ef3"
      unitRef="usd">1163000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e6e04e462ae4a2492cf55f9a81f3d29_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNC03LTEtMS0xMTk4Njg_5ab2c389-bb82-4ba7-aba5-e77d0eb16edb"
      unitRef="usd">1226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd255fc2b256464d83f0adcaf79f0ddd_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS0xLTEtMS0xMTk4Njg_ca5a4869-a857-430a-80df-f929c02dcca1"
      unitRef="usd">2773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd10fb8d585649da82b0209da784c586_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS0zLTEtMS0xMTk4Njg_693fcd5d-9ba0-41b9-ad31-ff7397d9ab80"
      unitRef="usd">2827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS01LTEtMS0xMTk4Njg_e14e7ad3-8c86-4b7f-8243-c22b4a59bd26"
      unitRef="usd">5486000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i298f3e560bc74437ab29be651d20c23c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNS03LTEtMS0xMTk4Njg_6e85f236-11e2-4557-85cb-cc4da65e9ab4"
      unitRef="usd">5717000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9689fd91f59346fcacc698cec3a68895_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi0xLTEtMS0xMTk4Njg_ddff9431-1b89-4d69-85a2-8a043aca17d1"
      unitRef="usd">1398000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f231991285846759c45d083b2999740_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi0zLTEtMS0xMTk4Njg_1cd2b37f-2246-4b04-8bd3-4f88783f862d"
      unitRef="usd">1497000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6173309cb7a641cbaf71ef41eb3b7527_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi01LTEtMS0xMTk4Njg_ecb77ae2-20f7-4b18-baad-5fda9566af0e"
      unitRef="usd">2736000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9d5b9a26751433ea892c9f8b363dbe2_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNi03LTEtMS0xMTk4Njg_0efe3cbb-c09b-4688-b32e-ca4ffe40b61e"
      unitRef="usd">3051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3918c5f3d0af4735a961ab1815e1cf3d_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy0xLTEtMS0xMTk4Njg_42ae11c7-efa1-4349-81ca-be5d5d8de3e9"
      unitRef="usd">671000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf9de08f7ea344bab23f761eeec19428_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy0zLTEtMS0xMTk4Njg_ae8821d3-dc0e-440d-83cb-4c99b461d5d4"
      unitRef="usd">802000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1692b6fd84064547866e4a84aab6e13a_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy01LTEtMS0xMTk4Njg_b5b5ec0b-615d-4ef2-87f8-3bcee0090551"
      unitRef="usd">1335000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i369bfcdc666b4698958b63d22fedcb62_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfNy03LTEtMS0xMTk4Njg_6c9ad224-d69d-41a0-90e3-ad69aee5d9da"
      unitRef="usd">1570000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9adc4ac26074f52a4fc617426b96edb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC0xLTEtMS0xMTk4Njg_f6b6eb1c-88f8-492e-ad3b-8b17e9b4fc65"
      unitRef="usd">2070000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic17c53a8b4d840bf9f1f5c07e4dd2a76_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC0zLTEtMS0xMTk4Njg_860f78b4-b2ae-449a-a7f5-082bafb466ab"
      unitRef="usd">2299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC01LTEtMS0xMTk4Njg_f4775ad2-a48d-4f59-ba4c-5438bc0dd40b"
      unitRef="usd">4071000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fa1c2c8fbbd4ef994753457a37c388e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOC03LTEtMS0xMTk4Njg_a8c84c17-0f9e-4947-b2e0-678c8ddf48ce"
      unitRef="usd">4621000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i094e4d8aeb954d2cbf3b8cb59a49db5f_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS0xLTEtMS0xMTk4Njg_b23114a7-ef9f-40cb-9f21-3b5abdb29aca"
      unitRef="usd">1081000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i057120522c584c6fae651608298e537a_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS0zLTEtMS0xMTk4Njg_71b13f8b-1c63-4bf2-a4a0-7e2ad0dea3b7"
      unitRef="usd">1067000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3a9931ef8274f7284b66ad7e01a834b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS01LTEtMS0xMTk4Njg_7981ce7a-82a3-4fd7-adad-80f5ec75ad18"
      unitRef="usd">2124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3febdd347f7f477d9298fd0419ce511b_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfOS03LTEtMS0xMTk4Njg_e54c1302-ba37-4e92-847f-2408f54ad44b"
      unitRef="usd">2189000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib91330ecb8454e3c87bbd07559e10c3b_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtMS0xLTEtMTE5ODY4_ec034fac-c176-473c-9373-b194595edc99"
      unitRef="usd">686000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64bce33fbd78408f8084a88248f2eca1_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtMy0xLTEtMTE5ODY4_acdb5fdf-f9a0-4620-8425-ca0672cacd1b"
      unitRef="usd">634000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55d8dc2aa18b4777873305f761bbf8b0_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtNS0xLTEtMTE5ODY4_86791820-8778-41b0-8386-8a6ddb434674"
      unitRef="usd">1353000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd0dc280b5c24b7b82ea150e787a2baa_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTAtNy0xLTEtMTE5ODY4_64bbcba2-a957-41ec-b129-6a0b8155049d"
      unitRef="usd">1275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ea5fa54c40f4e3a8bc238188a9f7811_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtMS0xLTEtMTE5ODY4_0e79c184-a1f0-468b-9264-b7127f065b46"
      unitRef="usd">419000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92b937fd099a4e338e041ac1dcd2d695_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtMy0xLTEtMTE5ODY4_1b131680-fe1c-43e7-a8ba-c901cb98ff62"
      unitRef="usd">435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c0d78811777448cace0976925773be8_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtNS0xLTEtMTE5ODY4_f9bfedc1-b9d5-4540-92f3-a07394d18937"
      unitRef="usd">824000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie251fa17aa3949fe9f0839d52f9cd5c9_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTEtNy0xLTEtMTE5ODY4_5925cf10-fdc4-43db-8ba9-acb9bf88344a"
      unitRef="usd">875000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6632c3723b974d80bbfd7795c6cef933_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItMS0xLTEtMTE5ODY4_127966f7-4c8a-4583-9227-8cd728f97400"
      unitRef="usd">2186000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d71e3989c6f4d4f9aba2569ad2a5bf3_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItMy0xLTEtMTE5ODY4_8a6fc012-ee2b-4a12-9e91-2ab073bdf1eb"
      unitRef="usd">2136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItNS0xLTEtMTE5ODY4_15e9bca6-25b4-4045-9351-ecf7fb9ebe35"
      unitRef="usd">4301000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3eeef53bad4b48bfb1c302257f4c2bf3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTItNy0xLTEtMTE5ODY4_d66d2d1a-2841-4b83-b33b-83041fd6b877"
      unitRef="usd">4340000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifed3671c909f416cab9afaf75dfcf9fb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtMS0xLTEtMTE5ODY4_69876bbd-a773-4b46-8696-9022b6e3b895"
      unitRef="usd">556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8f1c372ed204eaa8382d90ad65d4902_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtMy0xLTEtMTE5ODY4_8bfd9e20-1c05-45a0-a4f3-faf0a4f430da"
      unitRef="usd">585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtNS0xLTEtMTE5ODY4_f2ada53a-2035-4d15-a130-a20554ac080a"
      unitRef="usd">1098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie028302d82c14ab399e272eb03720bb6_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTMtNy0xLTEtMTE5ODY4_e0059064-3462-440e-ac21-bbc379e98dde"
      unitRef="usd">1157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtMS0xLTEtMTE5ODY4_e6d4ed67-ef2a-4b15-a25b-66e1d69afdda"
      unitRef="usd">7585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtMy0xLTEtMTE5ODY4_e5151d24-9e43-493b-b0ea-bff2fa380b47"
      unitRef="usd">7847000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtNS0xLTEtMTE5ODY4_9fa8fc15-8397-48d8-8864-66fb76e960ce"
      unitRef="usd">14955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjcyZDg5ZDhhODZjOTQwZTFiYTRjZmVmYjEwODViMWZkL3RhYmxlcmFuZ2U6NzJkODlkOGE4NmM5NDBlMWJhNGNmZWZiMTA4NWIxZmRfMTQtNy0xLTEtMTE5ODY4_68ae2d4b-d1f7-45b8-97dd-6a47478caa1c"
      unitRef="usd">15835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1c3b2e62cc94239b99a9e996b5678f1_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0xLTEtMS0xMTk4Njg_43201b7b-ab28-4b78-9571-7896bc5d03fb"
      unitRef="usd">1424000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i610eea5eb3484fd6bf51b42709374d0b_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0zLTEtMS0xMTk4Njg_cd903405-8bd6-41cb-b113-2a77ab29b8af"
      unitRef="usd">1373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44d79d0fb65746aaa6359715a89e2ee7_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy01LTEtMS0xMTk4Njg_bb148827-69d8-4df8-954a-babceac7b7de"
      unitRef="usd">802000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4de1c8c6c0d445a083e6c55af3d03c6e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy03LTEtMS0xMTk4Njg_a154ca48-939a-40b9-ac2c-613904fcb1d1"
      unitRef="usd">948000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i298ed1e39d63426681947aac7c92c6fc_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy05LTEtMS0xMTk4Njg_2e7f92b9-c980-4fc7-b239-b4e60293bf9f"
      unitRef="usd">546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfaba2c830554de58c19cb60762cabe6_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMy0xMS0xLTEtMTE5ODY4_baf86aa8-d3bf-40b1-8db8-ee8d73d5ea61"
      unitRef="usd">506000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e4167c253b04797beb9ec205174739b_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0xLTEtMS0xMTk4Njg_757ad81e-f9e0-49fe-b250-945258f45076"
      unitRef="usd">905000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33446d8e0ee24892b0c64f6aaebbf045_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0zLTEtMS0xMTk4Njg_1a19bf36-e5e0-425c-b64a-4fbba26e84ad"
      unitRef="usd">970000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5a344f488304d06b2d1c07cd4cc008b_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC01LTEtMS0xMTk4Njg_4ec5ea7a-b5f1-4bf6-9387-78b8896e1cd8"
      unitRef="usd">719000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab66a53e9d4144e895fc21c33e195eab_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC03LTEtMS0xMTk4Njg_6356ccdf-f00e-437c-af75-1fbab3d00664"
      unitRef="usd">841000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32deed4df6594deba88fcc157d9318b9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC05LTEtMS0xMTk4Njg_6b600b46-d615-4762-b8a1-133c781e53b0"
      unitRef="usd">446000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb7d8d91058f46969b341026534b0f8b_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNC0xMS0xLTEtMTE5ODY4_cea342c2-d166-4c5c-b68d-cac2c771f9ce"
      unitRef="usd">488000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3fb4f39283f4f57af883c4294c05e2f_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0xLTEtMS0xMTk4Njg_ed825b96-beed-4031-84d6-9cae959e58ad"
      unitRef="usd">1512000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7d72e4f26a74e2a9e315d0f49903406_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0zLTEtMS0xMTk4Njg_21e0bfc0-46d2-4410-900a-3c074a7154d5"
      unitRef="usd">1394000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d368c56378c40fb904cbc84bf222cf2_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS01LTEtMS0xMTk4Njg_3f530d5c-f230-48b9-994f-5f977ab22e87"
      unitRef="usd">382000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04fb1213c4b84a8a8f8565296c9cbb98_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS03LTEtMS0xMTk4Njg_f2c45f2a-3ab8-4d52-824b-95fff77dffdb"
      unitRef="usd">433000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie746f4753ebd49d4806edf24d4bc054f_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS05LTEtMS0xMTk4Njg_dfb7f4ba-8c07-49f5-9471-353579a58ee9"
      unitRef="usd">292000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5214f11f980d4654b157bce110db9b3f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNS0xMS0xLTEtMTE5ODY4_417bae65-79c2-4a68-9404-733897ba4b97"
      unitRef="usd">309000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7055abe559314041bd8f3e48e5c1b5ac_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0xLTEtMS0xMTk4Njg_5ecef0da-5e39-4a0b-a217-4d8e000c82b9"
      unitRef="usd">228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1864b5e68da47c18ee80fc6916d798c_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0zLTEtMS0xMTk4Njg_1002f694-a346-4a4c-a945-c447b84033ec"
      unitRef="usd">261000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01b3e03620d64556acc1932365baea4c_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi01LTEtMS0xMTk4Njg_535f64b0-17dd-4c51-9e8f-0f83142ff47c"
      unitRef="usd">254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9383983150046f9bf39c566f31fdcd5_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi03LTEtMS0xMTk4Njg_a6899cd4-ed83-4cdc-8ad0-1a8edebcb554"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i974d74af34f64bba98080397f378b049_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi05LTEtMS0xMTk4Njg_2a457eb1-524f-4404-bc53-8c581bc36fee"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9145fb48548b429fa67e81114c3a7f77_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNi0xMS0xLTEtMTE5ODY4_e4e1d9e9-3f1d-4742-97fc-98432b0a4e4b"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0xLTEtMS0xMTk4Njg_11aa1949-0a1f-4eac-8d54-3cffa1cbef23"
      unitRef="usd">4069000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0zLTEtMS0xMTk4Njg_b387211a-74a9-4699-85e2-74cc42b086a5"
      unitRef="usd">3997000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4886727899c748af9b7ca6ecc006d607_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy01LTEtMS0xMTk4Njg_e9ce6f1f-8439-47f0-a973-6027ed4bd2da"
      unitRef="usd">2157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4119f66ab242497fbd1a7129a09ef938_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy03LTEtMS0xMTk4Njg_5b7a6896-58bf-4504-9d2b-7a9e2e5fa994"
      unitRef="usd">2478000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1394b8d1d604848b1afc29f179024b5_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy05LTEtMS0xMTk4Njg_b67e1eeb-4475-4ddf-8de4-1e756f867db7"
      unitRef="usd">1359000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia54914f294dd447a8c3201ee0160b967_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfNy0xMS0xLTEtMTE5ODY4_f9f82c9b-c3b5-432c-aff8-7e86af2066e9"
      unitRef="usd">1372000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6034dedd81034ca58a3efaa8aaf912b2_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMS0xLTEtMTE5ODY4_83b710e9-d51b-46f4-b526-0d7e99162910"
      unitRef="usd">2722000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47330c898c084aa5838659f2f34d4c10_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMy0xLTEtMTE5ODY4_f7cd6bf3-1ca9-44ed-87fc-bc088d154ecb"
      unitRef="usd">2793000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c1ab6b402e94618aaf6a6d53b19afaa_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItNS0xLTEtMTE5ODY4_583cb5be-e87e-449f-b0ef-aca737845d38"
      unitRef="usd">1694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i644a9f4b3e1f4b2cbd1ddb0e7ec2d231_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItNy0xLTEtMTE5ODY4_b596a705-47b1-42ed-b906-2f5d567c667e"
      unitRef="usd">1952000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac1e8c6edbf463894ff0a4a97c65b0c_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItOS0xLTEtMTE5ODY4_b1faa8f1-ee98-4967-9a88-a460710f1a02"
      unitRef="usd">1070000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id75288cda0d146909d982333f28bd033_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTItMTEtMS0xLTExOTg2OA_de549728-d7a5-4865-8777-03f5abdf6120"
      unitRef="usd">972000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i886d34bbec8640b6b611a39dd7f55630_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMS0xLTEtMTE5ODY4_b1c088fd-097a-434f-9e5b-5e66bae9d393"
      unitRef="usd">1748000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dbab7c4dd864773bfc6e76adab58533_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMy0xLTEtMTE5ODY4_abbc14db-f494-4816-afd5-6a4c36ee94b5"
      unitRef="usd">1959000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i582ee1774f514ca68b795b9717b436f9_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtNS0xLTEtMTE5ODY4_75687dc0-ba01-4c3d-bbfd-db35e890470d"
      unitRef="usd">1485000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f59093bb7f543e795d5e21aa6b22695_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtNy0xLTEtMTE5ODY4_a4b2d782-19c3-463c-a1d8-7279a4d683a5"
      unitRef="usd">1710000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i878fa8e82bf64ae7aab3cb9e7cb532ff_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtOS0xLTEtMTE5ODY4_4f3db8bd-6d42-4ba1-a881-9923f7f05d4d"
      unitRef="usd">838000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f850d1105104e52a1834603e5aa1069_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTMtMTEtMS0xLTExOTg2OA_e0768938-abd3-4216-855d-d82b0d32db0d"
      unitRef="usd">951000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f9d4e944db0457eb58a4abb5fb0ac50_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMS0xLTEtMTE5ODY4_8734cdca-0952-41f1-be7d-b6b6f18c2be6"
      unitRef="usd">2931000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54d359386ad44272b635669807e608f6_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMy0xLTEtMTE5ODY4_a8302089-7a36-4001-8b8a-b30586a528cc"
      unitRef="usd">2840000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59834bcd47a841d88758402a4ea93e11_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtNS0xLTEtMTE5ODY4_57ff0658-fdb2-4425-8485-bf5cb41f55bb"
      unitRef="usd">788000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b47df2f3bfd4e52b3825a46ddd428e5_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtNy0xLTEtMTE5ODY4_494982aa-541e-4525-9382-fbd123cc7e43"
      unitRef="usd">898000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib32be93843e34926a15aeb2dcc3dbcc2_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtOS0xLTEtMTE5ODY4_33f98e7a-fe2c-4c79-b7a5-0ec4abae6f5c"
      unitRef="usd">582000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i993a3f339e894c8dafef5e5049915240_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTQtMTEtMS0xLTExOTg2OA_5be74d2d-feed-4c96-a0a5-0e8727f91609"
      unitRef="usd">602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31a13d28f0194f8eb5115201dbe86f3c_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMS0xLTEtMTE5ODY4_a734de80-7bb6-4cda-9205-64616fca05a3"
      unitRef="usd">434000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b9b22d428114c4ab5ee78a571295915_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMy0xLTEtMTE5ODY4_da834f80-d793-4d2c-bf64-0c20172115df"
      unitRef="usd">506000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if00b55f38c464a969df5efc27c1c7d80_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtNS0xLTEtMTE5ODY4_cf700345-3315-4187-b831-ec2a7d1efe94"
      unitRef="usd">518000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a714d7dd59b4092861465d25ffd24ab_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtNy0xLTEtMTE5ODY4_dde3d5e0-20ce-40c6-9e44-7e09b016f531"
      unitRef="usd">519000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7acac8017744c558ae12f06f24486c7_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtOS0xLTEtMTE5ODY4_2bfe9dbc-c2be-4adc-8475-8678c67a1e79"
      unitRef="usd">145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibce3653f29834ec387f827999d02f9fc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTUtMTEtMS0xLTExOTg2OA_eafbedde-03b5-4db7-a7e9-ece85bfbe50b"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMS0xLTEtMTE5ODY4_d6ec0ffa-f53d-49c9-8f87-fc06663e9ea2"
      unitRef="usd">7835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMy0xLTEtMTE5ODY4_57394bf0-d7fd-4a44-adfd-da47de58ae30"
      unitRef="usd">8098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fefedf1e5ea47b4a531ab78ce1ff37a_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtNS0xLTEtMTE5ODY4_b0e3cd78-2c7c-4155-ac26-65f0ec2f293b"
      unitRef="usd">4485000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bd8b96342484a81b5fa2dc86cd010e4_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtNy0xLTEtMTE5ODY4_08a2531a-acf2-4460-9837-0159703c929a"
      unitRef="usd">5079000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i202e893b22f240a5b7c9fd460ba69357_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtOS0xLTEtMTE5ODY4_ac432511-e106-4df3-9618-fa1fa1f0e151"
      unitRef="usd">2635000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4725c44b1daf418f8388bf7dc0380194_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RhYmxlOjdhNTY5MDIxZDVlNTQwMWI4MjEwNTMyYmUxMWJiYTRiL3RhYmxlcmFuZ2U6N2E1NjkwMjFkNWU1NDAxYjgyMTA1MzJiZTExYmJhNGJfMTYtMTEtMS0xLTExOTg2OA_24752326-aa3d-4a4d-ae82-fe7d3b47a9aa"
      unitRef="usd">2658000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="ied8d8356269248db86adef62aabe056a_I20221028"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTQ2OA_6776d171-9732-4101-8521-8b3f5df3469f"
      unitRef="usd">1000000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i49cdfed15a07485aa1fe2b7e67209ebf_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTUyOQ_77ec90e4-f138-4f6d-a760-e8cc5446db2e"
      unitRef="usd">536000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTYzOQ_2f2d8940-d762-4788-a763-a4867c9bcd1e"
      unitRef="usd">981000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i7e81b5be3ebd42d6b0a7d11e27c5a66c_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMTcwMA_22c175c6-48d1-4f29-9e06-ef75d06a0699"
      unitRef="usd">548000000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjA4MA_2c24de1b-bd1f-4cf5-8d08-5b5ae2f23128"
      unitRef="usd">380000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjA4Nw_7bc82a4d-f5c7-4594-ba3e-f14127a61a57"
      unitRef="usd">399000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ied8d8356269248db86adef62aabe056a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjExOQ_992cdaec-1e46-4c0b-9654-b512d5dd7b53"
      unitRef="usd">293000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjEyNg_4309de5a-272e-41ad-ac3f-375a47c15320"
      unitRef="usd">305000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib091f63ce1ed47fa86badb21ce620a7e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjE4Nw_13b40f5a-d175-41dc-b4bc-8c975154b772"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4b3f93df1ec946d38393e3dd053885a1_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjE5NA_87e1e97a-4764-4e30-9790-6362d0ccc7eb"
      unitRef="usd">94000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjMwMw_b5397cbe-cc0e-4c3c-85cf-ffdd130f71c7"
      unitRef="usd">160000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjc1NQ_3c0441c0-7053-44e2-b7bb-f98939bc901e"
      unitRef="usd">719000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80My9mcmFnOjMzZmI5NTk3NmQ3YzRhZWRhZmUyOTczOGY2MmQzMGE4L3RleHRyZWdpb246MzNmYjk1OTc2ZDdjNGFlZGFmZTI5NzM4ZjYyZDMwYThfMjg3Mw_021546e1-8d6b-4769-9a6b-46719ecc9b7b">three years</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODA5Ng_75041bbb-a980-44d9-8340-9b6557e75342">Acquisitions and Assets and Liabilities Held for Sale&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended October&#160;28, 2022 and October&#160;29, 2021, the Company had acquisitions that were accounted for as business combinations. The assets and liabilities of the businesses acquired were recorded and consolidated on the acquisition date at their respective fair values. Goodwill resulting from business combinations is largely attributable to future, yet to be defined technologies, new customer relationships, existing workforce of the acquired businesses, and synergies expected to arise after the Company's acquisition of these businesses. The pro forma impact of these acquisitions was not significant, either individually or in the aggregate, to the consolidated results of the Company for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. The results of operations of acquired businesses have been included in the Company's consolidated statements of income since the date each business was acquired. For the three and six months ended October&#160;28, 2022, purchase price allocation adjustments were not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intersect ENT&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 13, 2022, the Company acquired Intersect ENT, a global ear, nose, and throat (ENT) medical technology leader. The acquisition expands the Neuroscience segment portfolio of products used during ENT procedures, and combined with the Company's navigation, powered instruments, and existing tissue health products, will offer a broader suite of solutions to assist surgeons treating patients who suffer from chronic rhinosinusitis (CRS). Total consideration, net of cash acquired, for the transaction, in which the Company acquired all outstanding shares of Intersect ENT for $28.25 per share, was $1.2&#160;billion consisting of $1.1&#160;billion of cash and $98&#160;million previously held investments in Intersect ENT. Based upon a preliminary acquisition valuation, the Company acquired $615&#160;million of goodwill, $635 million of technology-based intangible assets, $35 million of customer-related intangible assets, and $13 million of tradenames with estimated useful lives of 20 years. The goodwill is not deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue and net loss attributable to Intersect ENT since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three and six months ended October&#160;28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Affera, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 30, 2022, the Company acquired Affera, Inc. (Affera) a privately-held company focused on the development of cardiac mapping and navigation systems and catheter-based cardiac ablation technologies. The acquisition expands the Cardiovascular segment portfolio of advanced cardiac ablation products and accessories to include its first cardiac mapping and navigation platform to meet physician needs within a growing patient population. Total consideration, net of cash acquired for the transaction, was $904&#160;million. Based upon a preliminary acquisition valuation, the Company acquired $660 million of goodwill and $300&#160;million of in-process research and development. The goodwill is not deductible for tax purposes. The Company recognized $201&#160;million of contingent consideration liabilities in connection with the acquisition, which are comprised of product development milestone-based payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue and net loss attributable to Affera since the date of acquisition as well as costs incurred in connection with the acquisition included in the consolidated statements of income were not significant for the three months ended October&#160;28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values of the assets acquired and liabilities assumed were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intersect ENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affera&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other acquisitions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For acquisitions other than Intersect ENT and Affera, the acquisition date fair value of net assets acquired during the six months ended October&#160;28, 2022 was $123 million. Based upon preliminary valuations, assets acquired were primarily comprised of $66 million of goodwill and $57 million of technology-based intangible assets with estimated useful lives of 16 years. The goodwill is deductible for tax purposes. The Company recognized $73&#160;million of contingent consideration liabilities in connection with these acquisitions during the six months ended October&#160;28, 2022, which are comprised of revenue and product development milestone-based payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fiscal year 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair value of net assets acquired during the six months ended October&#160;29, 2021 was $125 million, consisting of $154 million of assets acquired and $29 million of liabilities assumed. Assets acquired were primarily comprised of $80 million of goodwill and $50 million of technology-based intangible assets with estimated useful lives ranging from 15 years to 16 years. The goodwill is not deductible for tax purposes. The Company recognized $31&#160;million of contingent consideration liabilities in connection with business combinations during the six months ended October&#160;29, 2021, which are comprised of revenue and product development milestone-based payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquired In-Process Research &amp;amp; Development (IPR&amp;amp;D)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D with no alternative future use acquired outside of a business combination is expensed immediately. The Company did not acquire any IPR&amp;amp;D in connection with asset acquisitions of technology not yet approved during the three months ended October&#160;28, 2022 and October&#160;29, 2021. During the six months ended October&#160;28, 2022, IPR&amp;amp;D acquired in connection with asset acquisitions of technology not yet approved by regulators was not significant. During the six months ended October&#160;29, 2021, the Company acquired $90 million of IPR&amp;amp;D in connection with asset acquisitions of technology not yet approved by regulators, which was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;research and development expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain product development milestones and/or contingent on the acquired business reaching certain performance milestones. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of contingent consideration at October&#160;28, 2022 and April&#160;29, 2022 was $349 million and $119 million,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively. At October&#160;28, 2022, $149 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and $200 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheet. At April&#160;29, 2022, $35 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and $84 million was recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue and other performance-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2% - 27.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product development and other milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$254&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9% - 5.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets and Liabilities Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 25, 2022, the Company and DaVita Inc. (&#x201c;DaVita&#x201d;) entered into a definitive agreement for the Company to sell half of its Renal Care Solutions (RCS) business. This sale is part of an agreement between Medtronic and DaVita to form a new, independent kidney care-focused medical device company (&#x201c;NewCo&#x201d;) with equal equity ownership. As a result of entering into the definitive agreement and as of that date, the RCS business met the criteria to be classified as held for sale. The transaction is expected to close in calendar year 2023, subject to customary regulatory approvals and closing conditions. RCS is part of the Company&#x2019;s Medical Surgical portfolio. The Company recorded non-cash pre-tax charges of $14&#160;million and $81&#160;million, primarily related to impairment of goodwill and changes in the carrying amount of the disposal group, in the three and six months ended October&#160;28, 2022, respectively, recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. Refer to Note 10 to the consolidated financial statements for additional information on the goodwill impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information related to the assets and liabilities that were classified as held for sale in our consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.800%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Total assets held for sale and total liabilities held for sale are reported in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, respectively in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)  No separate class of liability classified as held for sale was individually significant enough for separate disclosure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no assets or liabilities classified as held for sale at April&#160;29, 2022. The Company determined that the agreement to sell half of the RCS business does not meet the criteria to be classified as discontinued operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTU5MA_304bd878-93ab-4a88-86bd-6db316c3a138"
      unitRef="usdPerShare">28.25</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTYwOA_a484e03b-de1b-40bb-9e90-37b695fdfc3f"
      unitRef="usd">1200000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTYyNQ_fbc3b389-b068-4458-ab02-88a8874916dd"
      unitRef="usd">1100000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTY0MA_ff08bb7e-8c50-4cf0-9664-6b166af18982"
      unitRef="usd">98000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:Goodwill
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTc1OA_4ccde1a7-d42a-4cae-a7f1-44a84d1682cf"
      unitRef="usd">615000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib15e9005fdf54bb388c5a1ebc77ec0c1_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTc3NA_46c1c099-b3bd-49e9-8265-bab6656b2158"
      unitRef="usd">635000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6e8fea31e19645bf890da6ac5660baec_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTgxNg_0ca7a6c5-6b88-4ebc-b697-23baf32f2eb2"
      unitRef="usd">35000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="idac13f4d55474a59bd8fd8d73215242f_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTg2Mg_567d3e33-dc11-49b5-a09f-ed75bfc1cc4c"
      unitRef="usd">13000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id3277e16d0bb483883f64fccc93f417f_D20220513-20220513"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMTkxMA_75c27270-436f-4cfa-a55a-bf184255a489">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i19cd5686ee1b41f4a0781c0d70df295d_D20220830-20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM1OTgw_ef0f64a0-a9c7-47fc-8142-cc0a97399084"
      unitRef="usd">904000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:Goodwill
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM3NjU2_79b6978a-3916-419f-805e-c5a20169e21b"
      unitRef="usd">660000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM4MzUx_b07ed189-fa67-45a5-a497-e761b3902562"
      unitRef="usd">300000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability
      contextRef="i6d3a8e5da34e4451a2cc414372ccc1f7_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM2Mjky_704d47ab-57cc-4a97-9c90-4d04306ddb1c"
      unitRef="usd">201000000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODEwNA_acfd1364-5fe8-466d-a87a-30ee962ea193">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair values of the assets acquired and liabilities assumed were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intersect ENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affera&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMS0xLTEtMS0xMTk4Njg_5ef12b22-65cd-495f-b957-b9cd2aec207b"
      unitRef="usd">39000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMS0yLTEtMS0xMjcwNjk_db9397ca-f389-4a05-ab8d-2001d4ac73c9"
      unitRef="usd">66000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMi0xLTEtMS0xMTk4Njg_4b0da6c6-dbe0-45f6-912d-8385747ffcf1"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMi0yLTEtMS0xMjcwNjk_2eacc865-2178-4e35-a126-01dd5e745152"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:Goodwill
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMy0xLTEtMS0xMTk4Njg_4ccde1a7-d42a-4cae-a7f1-44a84d1682cf"
      unitRef="usd">615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMy0yLTEtMS0xMjcwNjk_79b6978a-3916-419f-805e-c5a20169e21b"
      unitRef="usd">660000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNC0xLTEtMS0xMTk4Njg_bdac86c9-02e4-4101-8bff-0ce1edc8849d"
      unitRef="usd">683000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNC0yLTEtMS0xMjcwNjk_f82f16a7-91e7-4055-b3ea-c161c96d0b00"
      unitRef="usd">300000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNS0xLTEtMS0xMTk4Njg_28f53376-24dd-4063-852e-c7bcfce9c78a"
      unitRef="usd">40000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNS0yLTEtMS0xMjcwNjk_2b353179-cedf-4f38-8aee-9491401c9ce7"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNi0xLTEtMS0xMTk4Njg_c01c717d-8590-40ea-a883-8daefacba2ed"
      unitRef="usd">1408000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfNi0yLTEtMS0xMjcwNjk_96d14bb9-7af6-4fc0-862a-2db8753ddc21"
      unitRef="usd">1027000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOC0xLTEtMS0xMTk4Njg_b4a6b82f-b44b-4cd2-9197-cfd2371e326b"
      unitRef="usd">63000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOC0yLTEtMS0xMjcwNjk_54be0662-e56e-46d4-aaec-811b72223cdd"
      unitRef="usd">2000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOS0xLTEtMS0xMTk4Njg_a2992ec7-7517-4364-b3b6-2c20ea896759"
      unitRef="usd">51000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfOS0yLTEtMS0xMjcwNjk_701f00a3-27df-4a24-ab7d-cee775894317"
      unitRef="usd">53000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTAtMS0xLTEtMTE5ODY4_b859e45b-f399-4c23-84c9-007ed44a4ffa"
      unitRef="usd">18000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTEtMi0xLTEtMTI3MDY5_0a37c504-c8d8-46d5-b140-002f0d21dd8a"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTEtMS0xLTEtMTE5ODY4_bb492a6f-a69d-4175-b3bf-f71fb16d8a4e"
      unitRef="usd">131000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTItMi0xLTEtMTI3MDY5_53c21d9e-0c7c-4f65-8ab3-a68d2062c9f3"
      unitRef="usd">56000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i09d5f411538846809c17df42d6baca81_I20220513"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTItMS0xLTEtMTE5ODY4_b6abb3a7-69d1-48ff-ae76-851def7cd775"
      unitRef="usd">1277000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i26636377353846a2a7e4ae845aeb7572_I20220830"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjMzODQ1ZWI0NDBiNDRmODc5ODQxN2M4OGIwMzMwZTM3L3RhYmxlcmFuZ2U6MzM4NDVlYjQ0MGI0NGY4Nzk4NDE3Yzg4YjAzMzBlMzdfMTMtMi0xLTEtMTI3MDY5_0c38bf0d-d9fd-48bc-895d-20f49eb43391"
      unitRef="usd">970000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib2aacc1c206e4a01aec2ccb24a371680_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjQ2Mg_6cf6e934-4de6-489c-b42e-4e4f550d546b"
      unitRef="usd">123000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="ib2aacc1c206e4a01aec2ccb24a371680_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjU0NQ_d53b7ee0-ba27-42b3-afc6-6416f84e8cc6"
      unitRef="usd">66000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7c69bc171625454788f2c35a7111a3cf_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjU2NA_c36db2da-57fa-474a-9bd4-396dd27734df"
      unitRef="usd">57000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4b9df38c023342f9ba4c348f76154832_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjYzNg_995fb10b-94c0-4d43-81ea-d1da4761bc5b">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <mdt:BusinessAcquisitionPriceContingentConsideration
      contextRef="ic6da65d65d594808b778a60b752c29d5_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfMjcwOA_01ed3b75-4b09-4f58-9d29-04def2b95a44"
      unitRef="usd">73000000</mdt:BusinessAcquisitionPriceContingentConsideration>
    <us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMTM2_fcde333f-b861-4104-8437-107b626356e8"
      unitRef="usd">125000000</us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTI1_062e7c8f-c623-462a-bb9d-1fe8540e181e"
      unitRef="usd">154000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMTIx_abace7a5-770b-4a69-88a5-f47eba420324"
      unitRef="usd">29000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:Goodwill
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTcx_367b1c9a-b117-44b8-93ee-7b44fe321290"
      unitRef="usd">80000000</us-gaap:Goodwill>
    <mdt:TechnologyBasedIntangibleAssets
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTQy_4b5e31f9-d2fa-4cff-a6ed-61e4affde657"
      unitRef="usd">50000000</mdt:TechnologyBasedIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5499b0d188aa457384102e9d56fa1649_D20210501-20211029"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTUw_07727271-08b7-44cb-a6c7-077cb01aedec">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0f469be1b25343c2afe5256eef30c662_D20210501-20211029"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMyNTY0_ef204081-048c-4b2a-9f9e-02791cdd5867">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODMzMjk0_bbc0780f-cf02-415e-917d-197b491469eb"
      unitRef="usd">31000000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="ifc6a84fee82c404bac6319d748601679_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNDczMA_41d9c7cd-5e70-4a37-964b-1b5b210d11e0"
      unitRef="usd">90000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTU5MQ_7d29e52e-2189-4da8-bfd8-7da45f4d5b67"
      unitRef="usd">349000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTU5OA_26ffbc24-27ba-4737-ba9c-6f826d0c62b9"
      unitRef="usd">119000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ied8d8356269248db86adef62aabe056a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTYyMw_0fe1f495-f3d8-4759-9203-f93ca6ec88b5"
      unitRef="usd">149000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib091f63ce1ed47fa86badb21ce620a7e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTY3MA_ef2a222b-dc21-445e-8018-909a168ad0f1"
      unitRef="usd">200000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id2a4321a5aba4098afc2e72f4addc84d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTc0OQ_3e9f9f04-397d-438d-8219-447d9bda6b85"
      unitRef="usd">35000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4b3f93df1ec946d38393e3dd053885a1_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTc5Ng_9a0dc0c6-d30a-4fd7-a430-2cf82c52cb1b"
      unitRef="usd">84000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODEwNQ_c1ad8add-922b-4c08-bfb9-1e60ece96d61">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price allocation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ief0140ab23f7415d9e84fba89d2ce274_I20220729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi0xLTEtMS0xMTk4Njg_3a395c29-a6cf-4978-a11a-cd6958f5d5cc"
      unitRef="usd">193000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0ca95d0b25794a92b5df28767cb3f1c0_I20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi0zLTEtMS0xMTk4Njg_53453a7e-79e4-45a0-b388-341af0c44c3c"
      unitRef="usd">294000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi01LTEtMS0xMTk4Njg_86dab03b-2199-4e2a-9da3-0ee34a37a34e"
      unitRef="usd">119000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id815d10cd7364e4c8224095110455793_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMi03LTEtMS0xMTk4Njg_5de45d7b-3443-48ab-b925-e0f5186e7e0c"
      unitRef="usd">270000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <mdt:BusinessAcquisitionPriceContingentConsideration
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy0xLTEtMS0xMTk4Njg_e91d56f6-52e3-4ac6-9c11-551f9c1fecd8"
      unitRef="usd">201000000</mdt:BusinessAcquisitionPriceContingentConsideration>
    <mdt:BusinessAcquisitionPriceContingentConsideration
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy0zLTEtMS0xMTk4Njg_efea0c16-8fed-490a-b04c-91315d819335"
      unitRef="usd">31000000</mdt:BusinessAcquisitionPriceContingentConsideration>
    <mdt:BusinessAcquisitionPriceContingentConsideration
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy01LTEtMS0xMTk4Njg_a7e299e6-d7cf-4562-9d03-2c0fc0863c02"
      unitRef="usd">274000000</mdt:BusinessAcquisitionPriceContingentConsideration>
    <mdt:BusinessAcquisitionPriceContingentConsideration
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfMy03LTEtMS0xMTk4Njg_91088fe1-88a6-42f2-908e-483771e1bb2a"
      unitRef="usd">31000000</mdt:BusinessAcquisitionPriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC0xLTEtMS0xMTk4Njg_6579c7c6-8679-4317-99e0-dd38699d1c59"
      unitRef="usd">0</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC0zLTEtMS0xMTk4Njg_6b633606-87b3-4f69-92a4-e9a7fa063120"
      unitRef="usd">0</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC01LTEtMS0xMTk4Njg_93a22b61-9078-4c65-9ec3-6713d915b600"
      unitRef="usd">0</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionPurchasePriceContingentConsideration
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNC03LTEtMS0xMTk4Njg_ef430c81-3c59-4338-a9a6-3fb5e87738ca"
      unitRef="usd">25000000</mdt:BusinessAcquisitionPurchasePriceContingentConsideration>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS0xLTEtMS0xMTk4Njg_3fac2cac-8cae-48fd-8c4d-27f0ac1a2d04"
      unitRef="usd">0</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS0zLTEtMS0xMTk4Njg_fe135fb8-3664-4dff-86c1-82d0a790c9c5"
      unitRef="usd">30000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS01LTEtMS0xMTk4Njg_e3f85e66-83a4-4891-9c42-745772a8d383"
      unitRef="usd">1000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <mdt:BusinessAcquisitionContingentConsiderationMilestonePayment
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNS03LTEtMS0xMTk4Njg_09709882-6ee1-47d0-b032-1ccd262cb002"
      unitRef="usd">41000000</mdt:BusinessAcquisitionContingentConsiderationMilestonePayment>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi0xLTEtMS0xMTk4Njg_fa9e28e7-e4cf-406a-ba7d-d22538549633"
      unitRef="usd">-45000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi0zLTEtMS0xMTk4Njg_b35a39a1-8857-4ecd-bb35-0d88a39be27d"
      unitRef="usd">-26000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi01LTEtMS0xMTk4Njg_5d8509d0-1358-46cd-9b95-e87e17db5c01"
      unitRef="usd">-43000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNi03LTEtMS0xMTk4Njg_aaa7434a-3a52-49db-9dfc-e99a45c773c6"
      unitRef="usd">-16000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy0xLTEtMS0xMTk4Njg_3964daa5-81be-4a83-af3c-4d528282f483"
      unitRef="usd">349000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy0zLTEtMS0xMTk4Njg_325de144-c9fe-40cd-89ed-6d61b49428af"
      unitRef="usd">269000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy01LTEtMS0xMTk4Njg_f52091bf-eeef-4948-8acf-1c7e4a38063c"
      unitRef="usd">349000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i000ae0a85877429aaf119fe579aa99b6_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjUzMGI4MjZlZDU1YjQ1NGU5MTk4NGE3MTNkNWY2YmYzL3RhYmxlcmFuZ2U6NTMwYjgyNmVkNTViNDU0ZTkxOTg0YTcxM2Q1ZjZiZjNfNy03LTEtMS0xMTk4Njg_4ae33e3e-31df-4854-8997-613e500ac3d1"
      unitRef="usd">269000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODA5MQ_a8428270-7d17-4968-af3e-e2a1efff1637">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The recurring Level 3 fair value measurements of contingent consideration for which a liability is recorded include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue and other performance-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2% - 27.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product development and other milestone-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$254&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9% - 5.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected fiscal year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)   Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. For projected fiscal year of payment, the amount represents the median of the inputs and is not a weighted average.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id51339e6172a4fa89793c01ac5372310_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi0yLTEtMS0xMTk4Njg_3522eec4-1c6c-4510-810a-7968bfbbb469"
      unitRef="usd">95000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i4c8100ac3fc3472cb1b2257195df4d15_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo3MDFiMzlkMzg1ZGQ0NGFkYWY3MGQzN2QzNGQ3NmQzN180_ded90aac-8233-45ef-b6e5-d163b55225c6"
      unitRef="number">0.112</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ieaec69ca2a9d420196afba03c715564d_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo3MDFiMzlkMzg1ZGQ0NGFkYWY3MGQzN2QzNGQ3NmQzN185_395261db-39d2-4e8b-8c00-b8d48a3e5f2b"
      unitRef="number">0.272</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8536fb1f3cc8405c85d5955abab804d9_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfMi0xMC0xLTEtMTE5ODY4_2db1daee-748e-41b2-905c-acb480b54bb5"
      unitRef="number">0.171</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib7770b13078c4633b39a58a920db477c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC0yLTEtMS0xMTk4Njg_b047ee91-349b-439d-819f-24de06bdfb2d"
      unitRef="usd">254000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i2589490d854b4bbc9e1da49cf061a2e8_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjoyYjFhMTg5OGMxOTA0MDExODllMTY2YWIyNzc0ZDgyZF80_a67c31fa-8425-4813-a84a-559b2f8afcbd"
      unitRef="number">0.039</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i3fc3efebb4dd43008c52a5f4f54db6ab_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC04LTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjoyYjFhMTg5OGMxOTA0MDExODllMTY2YWIyNzc0ZDgyZF8yNzQ4Nzc5MDY5NDQ5_bd3db806-0feb-438c-8b45-085596035478"
      unitRef="number">0.055</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="if4458127713949c4a58c258ac31d5b0f_I20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjliNWE1NjlmN2YxNDRlNjRhYzg1ZWJlMDM1ZTNlZmIzL3RhYmxlcmFuZ2U6OWI1YTU2OWY3ZjE0NGU2NGFjODVlYmUwMzVlM2VmYjNfNC0xMC0xLTEtMTE5ODY4_3753dffa-b2da-431a-8273-db06c9c33d5a"
      unitRef="number">0.043</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="i0eab4cc7e4a74091a2af9b1421a69dca_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNTQ5NzU1ODM3OTEy_3704c4ea-2675-405a-b17a-2b1795f99fc5"
      unitRef="usd">14000000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:ImpairmentChargeOnReclassifiedAssets
      contextRef="iaf0cf08134fb482896645f610dcd043e_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfNzE1Mg_66068fae-5c5e-4b5b-8306-326867b42280"
      unitRef="usd">81000000</us-gaap:ImpairmentChargeOnReclassifiedAssets>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RleHRyZWdpb246ZWYxNzBmMWM4YTkwNGE4OTgwMDNkZTY0NTZiNzhmNjJfODExMg_807a4674-05dd-4b9f-9bbb-805b6b5f922a">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information related to the assets and liabilities that were classified as held for sale in our consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.800%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) Total assets held for sale and total liabilities held for sale are reported in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, respectively in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)  No separate class of liability classified as held for sale was individually significant enough for separate disclosure.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMS0xLTEtMS0xMTk4Njg_a044e5e9-aeb7-467b-883d-7a9ebcf9b434"
      unitRef="usd">111000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMi0xLTEtMS0xMTk4Njg_96ee06e3-81c1-47e8-a856-f60e20506444"
      unitRef="usd">143000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfMy0xLTEtMS0xMTk4Njg_8e21ed40-e6f5-42a1-b26f-531e5092a526"
      unitRef="usd">145000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNC0xLTEtMS0xMTk4Njg_4f48fcf4-9521-46c7-bf1b-e5497392183c"
      unitRef="usd">114000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNS0xLTEtMS0xMTk4Njg_d252eba9-536b-4f65-a3e1-52cf7e9c556f"
      unitRef="usd">32000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfNi0xLTEtMS0xMTk4Njg_18c072e7-496c-41a3-81e2-c954e766ae4c"
      unitRef="usd">545000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i6f5870d0d38b43288e41b0362ecae37f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80Ni9mcmFnOmVmMTcwZjFjOGE5MDRhODk4MDAzZGU2NDU2Yjc4ZjYyL3RhYmxlOjBhYzIyMDliZjk5ODRjMjJiNDEwY2Q5MjFmZGIxOTM2L3RhYmxlcmFuZ2U6MGFjMjIwOWJmOTk4NGMyMmI0MTBjZDkyMWZkYjE5MzZfOC0xLTEtMS0xMTk4Njg_45f988b4-2548-430e-be3a-95e11b1b1e96"
      unitRef="usd">30000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDczMA_fb56a94a-b7fa-4a5c-b249-59f84c67adcc">Restructuring and Other Costs&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Enterprise Excellence&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the third quarter of fiscal year 2018, the Company announced its Enterprise Excellence restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $1.7 billion in connection with the Enterprise Excellence program. In total, the Company estimates it will recognize approximately&#160;$1.8 billion of exit and disposal costs and other costs related to the program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries and benefits for employees supporting the program, including program management and transition teams, and strategic and operational consulting services related to the three objectives of the program. These charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;restructuring charges, net, cost of products sold, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $53 million and $93 million, respectively, of which $19 million and $38 million, respectively, were recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $27 million and $55 million, respectively, were recognized within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. For the three months and six months ended October&#160;29, 2021, the Company recognized net charges of $62 million and $136 million, of which $31&#160;million and $64 million, respectively, were recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $27 million and $57 million, respectively, were recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal year 2021, the Company initiated the Simplification restructuring program. Further program details are described in Note 4 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since inception, the Company has incurred pre-tax exit and disposal costs and other costs, across all segments, of $427&#160;million in connection with the Simplification program. In total, the Company estimates it will recognize approximately $450&#160;million of exit and disposal costs and other costs related to the Simplification program by the end of fiscal year 2023. The remaining charges are costs associated with the restructuring program, such as salaries for employees supporting the program and consulting expenses. These charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;restructuring charges, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended October&#160;28, 2022, the Company recognized net charges of $43 million and $78 million, respectively, of which $18 million and $31 million, respectively, were recognized within&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. For the three and six months ended October&#160;29, 2021, the Company recognized net charges of $18 million and $25 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;million, respectively, of which $9 million and $16 million, respectively, were recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;selling, general, and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the activity related to the restructuring programs above for the six months ended October&#160;28, 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other &lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)   Accrual adjustments relate to certain employees identified for termination finding other positions within the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Mechanical Circulatory Support (MCS)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company announced the decision to stop the distribution and sale of the Medtronic HVAD System in light of a growing body of observational clinical comparisons indicating a lower frequency of neurological adverse events and mortality with another circulatory support device available to patients compared to the HVAD system. In connection with this decision, the Company recorded charges of $726&#160;million (MCS charges) within the Cardiovascular segment during the three months ended July 30, 2021, including $58&#160;million recognized in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; costs of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $668&#160;million recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statement of income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charges included $515&#160;million of non-cash impairments and write-downs primarily related to $409&#160;million of intangible asset impairments and $58&#160;million of inventory write-downs. The Company also recorded charges of $211&#160;million for commitments and obligations associated with the decision, which included charges for patient support obligations, restructuring, and other associated costs. During the fourth quarter of fiscal year 2022, the Company recorded additional charges of $155&#160;million within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;primarily related to incremental commitments and obligations associated with the exit of the business. As of October&#160;28, 2022, accruals were recorded in the consolidated balance sheet for these obligations, with $83&#160;million reflected in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $120&#160;million recorded in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Medtronic remains committed to serving the needs of the patients currently implanted with the HVAD system.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ic303609806184f2a8805b32d1c783a34_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzMx_1268b14c-2598-4f15-9f5b-cf81a0dc5a3d"
      unitRef="usd">1700000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ic303609806184f2a8805b32d1c783a34_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDUy_277942e6-99e8-445a-90cc-d8cd0dbc82ce"
      unitRef="usd">1800000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i16be2ec2863d4cd48ac8e0eb7c5810ca_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTA5NA_5bd1f002-f492-49e4-b6b6-df7408185bb0"
      unitRef="usd">53000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="iaf42b4b6d0454f69954bbee47e517f83_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTk0NQ_e86cfa55-0a29-4565-99e3-0b0a9ae84961"
      unitRef="usd">93000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <us-gaap:RestructuringCharges
      contextRef="ifccb4ab61ed34b10bc32266e11c04021_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTEwNw_9aa752a6-6218-4f2b-aec2-d7405291500c"
      unitRef="usd">19000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i76aa15f0495a412bb5fc7e8ff902a5d1_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTgxMw_db79ac6d-c4d4-47b3-8a00-be9f2376aed5"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fb118eb3cf3495fa67564bb77d2993e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTE1OA_125d5c9e-e51f-4753-909f-d755a63b7b4a"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia10b9bf7f4c04b34a8e912ac100537a7_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTgyMQ_5f9e2953-866d-491c-8260-8bf62b6f1f74"
      unitRef="usd">55000000</us-gaap:RestructuringCharges>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i23fad8dce9c14b88b09f562c0af053eb_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTMzOQ_8e88a7ab-49c2-4d81-a508-d5449a405bfb"
      unitRef="usd">62000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i73bd78bbe8f143f88fc76d50131fcd9c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTg4MA_6ce2a003-9367-4eab-846f-baebc2e14a77"
      unitRef="usd">136000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <us-gaap:RestructuringCharges
      contextRef="i1e280053272b4dd5b8c64cde259c885a_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTM1Mg_d7989662-19fb-40ad-9b43-e6004968b789"
      unitRef="usd">31000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibc87cf841c074114a5ac8137bc707c99_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTkyOQ_7673786d-f546-4f7d-ab67-b221f477d4a6"
      unitRef="usd">64000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7a4dc8016694646972d6448816d5640_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTQwNA_12314a04-1171-48d1-a546-1c60eca9078d"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2d4182f25b264fa0a677c170f7aa55f9_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMyOTkzNA_cff4b8ad-eccf-4243-afae-5932633c8f34"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTgwMQ_5710cf08-1cdc-41c2-89ea-13e107ae597a"
      unitRef="usd">427000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i9d6c716be07f4b1087039ec5e9f5aba4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMTkxNQ_8d2513ce-6a05-45f4-a414-fe6e21316a4e"
      unitRef="usd">450000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i0b041edd8d56490d893ff0c11caa0d8a_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjQzMg_4bcc3488-9008-45af-8fa5-de73d8202dbd"
      unitRef="usd">43000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i1d6cdd73391542f3b7994da4e26578af_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA0MA_5cab6d75-def6-4665-ae99-d685e3284e3f"
      unitRef="usd">78000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i546d50a1a554496194d00f2caddaf5ca_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjQ0NA_5f98d295-bbbb-4b22-9b01-389afdc54e72"
      unitRef="usd">18000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i87940cb6cac741d6b1f3cc6fb389a371_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA0Nw_5e4ece4a-1596-456d-9152-06e49d35abed"
      unitRef="usd">31000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="i8ff0490f25be4b77b9b8f6dce7ac4704_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMjYyNg_3167f95e-20d3-42ab-b456-bb7d47497682"
      unitRef="usd">18000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact
      contextRef="ie6a7d73ef1c947bfac5459b19b344d12_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA1NA_3450a7c5-9d3e-4caa-b7c8-c382b00e28bc"
      unitRef="usd">25000000</mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact>
    <us-gaap:RestructuringCharges
      contextRef="ic8cf02e126cb40ff876492202959b05e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA2Mw_ecbc1319-c529-4d2d-89b4-25d04c873b78"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i04964d69fc284d70b8188fb55131e440_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDk0NzgwMjMzMDA3MQ_19d0b4a1-a603-405a-bfbb-2fa3bd4af220"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDcyNg_01adaa25-b243-4aa6-8866-da13ec5b22db">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the activity related to the restructuring programs above for the six months ended October&#160;28, 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Termination Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Associated Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other &lt;br/&gt;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)  Associated costs include costs incurred as a direct result of the restructuring program, such as salaries for employees supporting the program and consulting expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)   Accrual adjustments relate to certain employees identified for termination finding other positions within the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i1a172149369e4566a362a7034cff8552_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS0xLTEtMS0xMTk4Njg_42001a54-c5a5-4768-aff9-51fab54c5e27"
      unitRef="usd">81000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i67cae084ba3e474287026bb8a735a3da_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS0zLTEtMS0xMTk4Njg_e93383c8-0b77-4039-b282-173933b2abe1"
      unitRef="usd">27000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i750e8435c8c8420982689bdc80379523_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS03LTEtMS0xMTk4Njg_3d788254-8f4c-496d-b5a6-a2a5734a97d4"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMS05LTEtMS0xMTk4Njg_7bb2da56-16ad-4bdd-ab34-7cff2ec2721c"
      unitRef="usd">110000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi0xLTEtMS0xMTk4Njg_33b50e8b-e4e5-470c-a3ed-214839c66b82"
      unitRef="usd">50000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi0zLTEtMS0xMTk4Njg_29ab072d-d6e2-4947-ab2f-6e6075905dfc"
      unitRef="usd">126000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi03LTEtMS0xMTk4Njg_a0d758b4-6613-4c57-9967-cbc7a78b4e49"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMi05LTEtMS0xMTk4Njg_422745df-4591-4d41-b44d-05e3e59b0128"
      unitRef="usd">180000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy0xLTEtMS0xMTk4Njg_531a475d-7869-4974-a136-6966c3da4527"
      unitRef="usd">76000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy0zLTEtMS0xMTk4Njg_fff9011c-037a-4d6b-957c-93d88515123f"
      unitRef="usd">138000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy03LTEtMS0xMTk4Njg_2781d501-441f-4149-9d6b-2020731bb87e"
      unitRef="usd">4000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfMy05LTEtMS0xMTk4Njg_658cf7cb-30a9-4bea-9436-980936130a98"
      unitRef="usd">220000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8c905881c3684c5b9910595cc14d570d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC0xLTEtMS0xMTk4Njg_73fb9154-1901-4575-a413-a20d33c20f9a"
      unitRef="usd">-9000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i5cb02e5ab5b14c8494b7b7ec61802cf5_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC0zLTEtMS0xMTk4Njg_83da1c87-6fa2-4d44-adee-d881b4c1dec5"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i562c788bd66543b48a9ccdafa4f594db_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC03LTEtMS0xMTk4Njg_77cba62f-b937-49c0-a5cd-0a65c0780c3b"
      unitRef="usd">0</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNC05LTEtMS0xMTk4Njg_c6890dc7-bdb6-464c-bc4d-df73d7497e35"
      unitRef="usd">-9000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserve
      contextRef="i0e3f285c5dfb4c6c8e9ef6bff8bbad66_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS0xLTEtMS0xMTk4Njg_f3481f32-0f05-4e33-9082-08904a5dc0f3"
      unitRef="usd">45000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iba560acd2e9b4ac59cc8a3b89523e6cd_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS0zLTEtMS0xMTk4Njg_a75b2f64-2843-4a40-b740-c47b2ec9a6ef"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idd39c4b6e9034559b7adc2252123cce6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS03LTEtMS0xMTk4Njg_6b4b75ff-f141-42f0-8d10-4f63d7d71d00"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RhYmxlOmIyMDE2ZGQyOWZmYTRkNjhiNzA0YzgwMTUwY2NhYjdhL3RhYmxlcmFuZ2U6YjIwMTZkZDI5ZmZhNGQ2OGI3MDRjODAxNTBjY2FiN2FfNS05LTEtMS0xMTk4Njg_3e805211-a136-4bc8-952c-7d1ef50c0b16"
      unitRef="usd">61000000</us-gaap:RestructuringReserve>
    <mdt:RestructuringWriteDownAndImpairmentProvisions
      contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzYxNA_ae598216-773f-4173-9bdd-68ac9a3f86e1"
      unitRef="usd">726000000</mdt:RestructuringWriteDownAndImpairmentProvisions>
    <mdt:RestructuringWriteDownAndImpairmentProvisions
      contextRef="i388aa93f36a249c1a5b546222a59df60_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzcwOQ_8944fc56-68bd-4fb9-9ae7-e417aca35b9a"
      unitRef="usd">58000000</mdt:RestructuringWriteDownAndImpairmentProvisions>
    <mdt:RestructuringWriteDownAndImpairmentProvisions
      contextRef="if90275cb55b4415a836c84bf7e67ed62_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzc1Mw_f0d881b6-9234-4417-b77a-974c485f1f44"
      unitRef="usd">668000000</mdt:RestructuringWriteDownAndImpairmentProvisions>
    <mdt:AssetImpairmentChargesAndInventoryWriteDown
      contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzg2NQ_58d7dda8-6be2-4c44-9922-30bc67aabf41"
      unitRef="usd">515000000</mdt:AssetImpairmentChargesAndInventoryWriteDown>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzkyOQ_9c4d5f62-9740-4245-880e-b1068e4726cb"
      unitRef="usd">409000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:InventoryWriteDown
      contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfMzk2OA_c08c3c06-059d-44ba-988e-05a674c96827"
      unitRef="usd">58000000</us-gaap:InventoryWriteDown>
    <us-gaap:OtherRestructuringCosts
      contextRef="i6b65ea23909f45b3810fed32ff16309a_D20210501-20210730"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDAzNA_e9a5fb80-11e7-4b57-980b-962b11f20ac4"
      unitRef="usd">211000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="i3a082f3a04564610933344f50f0c3196_D20220129-20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDI4OA_be9a6a8d-a76e-4029-99d3-df4483bf4417"
      unitRef="usd">155000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDUyNg_ed41381f-5b7d-46a4-b6f8-4bd2ff5043fe"
      unitRef="usd">83000000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="i1a952f7cfc5643e8b4131294dc10bbc7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV80OS9mcmFnOjkzMjQxMWVhYTA4ODQxNDViYTdmMTljYmE4OTUxZGJlL3RleHRyZWdpb246OTMyNDExZWFhMDg4NDE0NWJhN2YxOWNiYTg5NTFkYmVfNDU2OQ_16e794e3-48e8-43b6-a8b0-02318541720e"
      unitRef="usd">120000000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUyNg_cefdffa5-e4d4-4cc5-8dc9-ab8f078c61c0">Financial Instruments&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in marketable debt securities that are classified and accounted for as available-for-sale and are remeasured on a recurring basis. The following tables summarize the Company's investments in available-for-sale debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;28, 2022 and April&#160;29, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of debt securities excludes accrued interest, which is reported in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the gross unrealized losses and fair values of the Company&#x2019;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;28, 2022 and April&#160;29, 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There were no transfers into or out of Level 3 during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity related to the Company&#x2019;s available-for-sale debt securities portfolio is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The October&#160;28, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Securities, Equity Method Investments, and Other Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and other investments. Equity securities with readily determinable fair values are included in Level 1 of the fair value hierarchy, as they are measured using quoted market prices. Equity method investments and investments without readily determinable fair values are included within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value. To determine the fair value of these investments, the Company uses all pertinent financial information available related to the investees, including financial statements, market participant valuations from recent and proposed equity offerings, and other third-party data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's equity and other investments at October&#160;28, 2022 and April&#160;29, 2022, which are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments with readily determinable fair value (marketable equity securities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes activity related to the Company&#x2019;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;During the three and six months ended October&#160;28, 2022, there were $7&#160;million of net unrealized losses and $1&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;28, 2022. During the three and six months ended October&#160;29, 2021, there were $8&#160;million of net unrealized losses and $7&#160;million of net unrealized gains, respectively, on equity securities and other investments still held at October&#160;29, 2021.</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ3Nw_1e28b44a-d012-46fe-b9bb-17402b3b6741">The following tables summarize the Company's investments in available-for-sale debt securities by significant investment category and the related consolidated balance sheet classification at October&#160;28, 2022 and April&#160;29, 2022:&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0xLTEtMS0xMTk4Njg_a8e412a0-d997-402b-8993-2dd78d8a2ca5"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0zLTEtMS0xMTk4Njg_54187feb-3453-4dcf-a5e0-bc96150ce428"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC01LTEtMS0xMTk4Njg_1fa5cd93-1851-4636-9427-a821ce48833a"
      unitRef="usd">34000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="idb47a5513b8248b38d166e23c6e226cb_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC03LTEtMS0xMTk4Njg_baba3601-f72d-4a36-922f-7a4f5bb48752"
      unitRef="usd">522000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7e0e9a2126f3451a9364ecb102f47619_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC05LTEtMS0xMTk4Njg_7d8c3909-7ecf-4e2f-a8f2-00ca6b409bcc"
      unitRef="usd">522000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia17c51259199438d92935700e9a84f38_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNC0xMS0xLTEtMTE5ODY4_03f8b237-262e-4d13-8500-481da77a2950"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0xLTEtMS0xMTk4Njg_bfe16d3f-3cfa-4277-acc1-d004f3e4f300"
      unitRef="usd">4386000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0zLTEtMS0xMTk4Njg_f26610a8-2d20-4f01-b995-16d00ca34437"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi01LTEtMS0xMTk4Njg_0d3eb0c8-8c68-4474-bae0-cf9651e94d9e"
      unitRef="usd">273000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iccfd84d3f2a94ca2b112e0ab4eefca3e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi03LTEtMS0xMTk4Njg_2fb9bb32-e071-43b6-9c2e-f3799e34d077"
      unitRef="usd">4114000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5183de769d9943e0bbf4bf305875caee_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi05LTEtMS0xMTk4Njg_36e66dd7-408e-4d98-8094-6ea017d22f7d"
      unitRef="usd">4114000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iaedf855a588542ea8b681a551750a94c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNi0xMS0xLTEtMTE5ODY4_16b7a939-d686-483d-bf49-682989c3b16c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0xLTEtMS0xMTk4Njg_5049b368-b0b5-408c-8c8f-4ca1e1872ecb"
      unitRef="usd">946000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0zLTEtMS0xMTk4Njg_4e5aa560-f6c2-4cc4-b035-4cc7dd1a2f37"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy01LTEtMS0xMTk4Njg_a9252b6f-2d0a-4686-b97b-031a1a3b576c"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i46181f8111394859b9590a8fcf87dea4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy03LTEtMS0xMTk4Njg_4d08c8c5-7354-4f5f-b0ed-d55e3b0288ae"
      unitRef="usd">887000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6630e92f38ab4432b631dd6c08be1b5b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy05LTEtMS0xMTk4Njg_d19edaee-b3be-4bf6-a3ab-314149a6f584"
      unitRef="usd">887000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0acdf85d52b44d0aab8be69ef0dfca9a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfNy0xMS0xLTEtMTE5ODY4_986d644d-bdf6-4293-969d-7263259ba23e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0xLTEtMS0xMTk4Njg_af4b73b6-b065-4fca-9f1f-ee9d438ec7ed"
      unitRef="usd">558000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0zLTEtMS0xMTk4Njg_c5f4aaeb-6d95-4f08-b691-7675ecfae891"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC01LTEtMS0xMTk4Njg_fbe29499-f184-42e4-99b3-4bc0ec224fba"
      unitRef="usd">61000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i81d3b04d42694befb06b33d5afa3ac4f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC03LTEtMS0xMTk4Njg_2748c829-44c7-4d4c-8c1b-4a0409e6f7b8"
      unitRef="usd">497000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i23ea21efa0974fd89079e5ff7597d05c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC05LTEtMS0xMTk4Njg_2d33eee1-a8b9-417a-aab0-12479487720f"
      unitRef="usd">497000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2adc065c1c31426ca784f2f3aac4c338_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOC0xMS0xLTEtMTE5ODY4_995c234a-26d3-4664-93f7-d1f7439e3760"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0xLTEtMS0xMTk4Njg_062ac347-ebc2-44b7-8db2-71a875fd374e"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0zLTEtMS0xMTk4Njg_1659f90a-7c2f-4d30-8807-f6183c086f6b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS01LTEtMS0xMTk4Njg_c487da1b-4b93-4c4c-9c6d-a7f14ef7ecd3"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i087fd6abf6244d26810b363ad7f12b34_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS03LTEtMS0xMTk4Njg_9e1104dd-fecb-467f-8027-26569ec4e6c9"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if3cf62ad6eb249199fc96aa7235ad10e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS05LTEtMS0xMTk4Njg_6904c691-81b8-4a3b-9c4e-faf5e5a755a1"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8cc5013382474ea0bac44885f9583479_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfOS0xMS0xLTEtMTE5ODY4_0b6778e5-97fb-42ad-9d16-85448b5b9b8d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMS0xLTEtMTE5ODY4_13166b39-ae9e-49ec-94c4-72a012d94cbc"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMy0xLTEtMTE5ODY4_5e960ff1-4da5-42aa-a8d5-45b794fc57ad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtNS0xLTEtMTE5ODY4_afed5a91-3b87-47e3-8332-c92af903b3f2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9134674ac1064b3b88dfa58578f7b28f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtNy0xLTEtMTE5ODY4_7b543073-f003-4fd9-a208-4d80b10ae9f2"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i14fac49e993e425480a39ef2da97c7e1_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtOS0xLTEtMTE5ODY4_8ea9b9ff-6205-412d-9284-392a1b90deef"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i16dab65d5fee4b13a1b5536b9061af57_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTAtMTEtMS0xLTExOTg2OA_b75c5b7d-b330-48c4-a491-a24c982ec17d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMS0xLTEtMTE5ODY4_b5f4ade2-c17a-4bbf-a6cc-ef39af404fb0"
      unitRef="usd">587000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMy0xLTEtMTE5ODY4_902a8328-c200-4f68-b8ba-82691c178578"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtNS0xLTEtMTE5ODY4_a6354240-5ac2-4d34-ad85-48ad818fa576"
      unitRef="usd">31000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i62f58f99517d475280eae05a72bba5a7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtNy0xLTEtMTE5ODY4_154d43c3-8a27-4e17-84b9-dfc2f078c632"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3c5cf66c9d744fa6b08216cffcee6ea1_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtOS0xLTEtMTE5ODY4_1a694796-0d2d-4bcc-835a-4a1ebb21d148"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i66e4261fc6da42f78a32a5697fd40ebc_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTEtMTEtMS0xLTExOTg2OA_4c7f94f0-00f9-4ecf-b79a-18c8c7569b2f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMS0xLTEtMTE5ODY4_d5bac640-8909-4534-9da9-076e738fd6c3"
      unitRef="usd">6502000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMy0xLTEtMTE5ODY4_2004d351-c359-4703-bf3c-f19349c739c4"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItNS0xLTEtMTE5ODY4_0ab9d803-9ec2-4b53-9cb3-b456a175511c"
      unitRef="usd">424000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItNy0xLTEtMTE5ODY4_092b8ee2-cf30-4eb8-a3de-5b14ddfad34a"
      unitRef="usd">6079000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7679e68037ad488cad0ab87fcf105814_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItOS0xLTEtMTE5ODY4_b0e9d247-e405-4273-a929-94200bf96ed4"
      unitRef="usd">6079000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3e89ca409848475c9dd855df62f568ba_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTItMTEtMS0xLTExOTg2OA_e9097cb3-798c-41c0-942d-a4b6f64e905c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMS0xLTEtMTE5ODY4_76192f93-f8cc-4cc5-b758-5aa9abec8556"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMy0xLTEtMTE5ODY4_a81c18a7-64f7-473b-9e95-ace49e9f10e9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtNS0xLTEtMTE5ODY4_a5d93d41-68b6-4df6-be50-2079fa7ab980"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i22f79d5bae0a4e73a42a93007576b58c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtNy0xLTEtMTE5ODY4_7455170e-a53f-41ac-a689-a20e2c97d9f5"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2e31c2e0429a4641939c2538318931cc_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtOS0xLTEtMTE5ODY4_22303075-1aee-4e96-8173-8b617cb2e664"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i672142582fb643789a7c2276926b53c2_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTQtMTEtMS0xLTExOTg2OA_e15d52e6-39d5-45ce-84a3-e4a9faa92b46"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMS0xLTEtMTE5ODY4_04f81ffd-9b86-466f-92cb-aa972bbdf275"
      unitRef="usd">7094000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMy0xLTEtMTE5ODY4_40ace7d2-c6fb-4860-a6c3-7221533f1318"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtNS0xLTEtMTE5ODY4_e87a64a3-a24d-4208-bfad-56843c1779bb"
      unitRef="usd">460000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtNy0xLTEtMTE5ODY4_b8a6253a-c7f8-4276-9ff6-93c6f9bbe42e"
      unitRef="usd">6635000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i692de9ddca214b599e9a03ae112ad3e2_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtOS0xLTEtMTE5ODY4_cebde24d-ea02-420f-8561-293f181ed531"
      unitRef="usd">6602000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhZmIzN2NjZTc1MTQzZTlhYTAyMzRmNDNjZjdjZTU4L3RhYmxlcmFuZ2U6MGFmYjM3Y2NlNzUxNDNlOWFhMDIzNGY0M2NmN2NlNThfMTUtMTEtMS0xLTExOTg2OA_e6c1b3a5-0a6d-4d56-bbb7-fa2166c7e460"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0xLTEtMS0xMTk4Njg_280e9726-5209-45e2-8e8e-087a2e26d76d"
      unitRef="usd">533000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0zLTEtMS0xMTk4Njg_10b78ea0-03c9-4e47-b1cb-07021111ea6a"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC01LTEtMS0xMTk4Njg_bcd87d1c-8c93-49f0-bac3-46fbe52253fc"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8558d9858fd3413fb08153977c7c737f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC03LTEtMS0xMTk4Njg_72386ac9-2c49-494c-accc-d557b16996bb"
      unitRef="usd">518000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i76bbc05331214b40b0fd449dedfe22ea_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC05LTEtMS0xMTk4Njg_e5090ac9-183a-4a6e-baaf-a424d40565b0"
      unitRef="usd">518000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3b399a04cb7646b5b07096251d2007a8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNC0xMS0xLTEtMTE5ODY4_94d3109f-e0fe-4220-9fbb-025cc946b352"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0xLTEtMS0xMTk4Njg_648f7676-96dd-4bf5-aa6d-125ff92b7208"
      unitRef="usd">4457000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0zLTEtMS0xMTk4Njg_402aace7-a59e-429d-904a-cf02d310b430"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi01LTEtMS0xMTk4Njg_3c5ff306-d352-4f69-87b7-9899078cae83"
      unitRef="usd">140000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4e218fa6cf914c4388b263f46820286a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi03LTEtMS0xMTk4Njg_a9907cef-40f2-4e9e-ab62-9cb77450f524"
      unitRef="usd">4321000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4cf32105f8fc437ab7b7ecaa4fba22e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi05LTEtMS0xMTk4Njg_b8010635-a3ef-496d-acf5-b28c2fe57b81"
      unitRef="usd">4321000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i96538ee63df541aba2adf1f7c5ee69c7_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNi0xMS0xLTEtMTE5ODY4_f32704a2-094a-4183-a7f9-acf9d0d27af4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0xLTEtMS0xMTk4Njg_88e46baf-b083-4d34-bd81-dc2adcdb7f15"
      unitRef="usd">910000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0zLTEtMS0xMTk4Njg_2f9d6cce-65db-468e-a35d-07da8d877b10"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy01LTEtMS0xMTk4Njg_28bb6aa5-814f-49e0-8572-e98e1fef2656"
      unitRef="usd">41000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i15f21aaefede4ee3aa44f247594563e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy03LTEtMS0xMTk4Njg_63ee59e7-5416-4c2d-9376-dfe5b3d26c26"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2da397896f3b426988512b961eafff1c_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy05LTEtMS0xMTk4Njg_d29fcc48-81f8-4093-933f-eb3c678a0de2"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i51f45d131dfd44f8b06d2d1fbb1101b1_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfNy0xMS0xLTEtMTE5ODY4_a1bf29d6-368f-4745-8bc1-db41de7347a5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iefba2a09bdf2400fa659329962a625be_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0xLTEtMS0xMTk4Njg_2648b4cc-0c21-4157-8d62-7444e29c7bbd"
      unitRef="usd">592000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iefba2a09bdf2400fa659329962a625be_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0zLTEtMS0xMTk4Njg_e0577a01-6d93-4016-b000-e857dd415211"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iefba2a09bdf2400fa659329962a625be_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC01LTEtMS0xMTk4Njg_caab03bb-fb88-440a-b0fa-f2b662018fcd"
      unitRef="usd">35000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iefba2a09bdf2400fa659329962a625be_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC03LTEtMS0xMTk4Njg_09c07a77-8fef-4375-9f33-50d2ddb0dbdd"
      unitRef="usd">558000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia18fb875e6a54bd698fc23cdb9435208_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC05LTEtMS0xMTk4Njg_7db18105-7a39-4e0f-ae58-2af50d1ac5f6"
      unitRef="usd">558000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if4146b3ff2414dff8bec3c9d91d6df09_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOC0xMS0xLTEtMTE5ODY4_10768633-6a39-4d5c-97ec-34b4c27b4311"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0xLTEtMS0xMTk4Njg_95794262-4ff2-4adf-b3fe-3e89fbbcf4f2"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0zLTEtMS0xMTk4Njg_dcca623b-b6b2-4bb0-8cf5-ecfa476cedb8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS01LTEtMS0xMTk4Njg_9a647897-b355-4113-9763-7f594fe51896"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5e886b3a97c44676b6e52bc92376095e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS03LTEtMS0xMTk4Njg_39817396-d0e9-4d36-b2e1-61d675e5b73c"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i50675223fb9c4d24bac91bf5a8b500c5_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS05LTEtMS0xMTk4Njg_d52bdcba-8f08-4aaa-8bed-0db4a01aeff3"
      unitRef="usd">17000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i7e5341030da8404ab23eb314af6659f0_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfOS0xMS0xLTEtMTE5ODY4_f37abc54-d981-44a7-93aa-44c3a269ab97"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ia1b0751698534580a06d7e591c567510_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMS0xLTEtMTE5ODY4_0cad699d-b1cc-4c3f-9715-e50236388049"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia1b0751698534580a06d7e591c567510_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMy0xLTEtMTE5ODY4_2ecc2662-8568-4869-af24-5d1fc8629d53"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia1b0751698534580a06d7e591c567510_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtNS0xLTEtMTE5ODY4_04b411f1-8655-4925-ac00-6a212014dc86"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia1b0751698534580a06d7e591c567510_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtNy0xLTEtMTE5ODY4_9d414f4a-e05f-4aaf-b7b0-7aae660bba80"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia9959424fd6a4e18a014b452439974f3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtOS0xLTEtMTE5ODY4_bb77df86-55c2-458c-9a0a-54d2de22f4b7"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ic4f16ecd76844a249feacc0c1f4a7db9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTAtMTEtMS0xLTExOTg2OA_b4270668-1520-428a-816a-0e1d6fd341c8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0af62c64c70e496180646fa5003616d9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMS0xLTEtMTE5ODY4_df158831-9028-476f-a68e-b7557b14b500"
      unitRef="usd">567000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0af62c64c70e496180646fa5003616d9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMy0xLTEtMTE5ODY4_0887564a-cd45-4824-87ad-18ca3a9b386e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0af62c64c70e496180646fa5003616d9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtNS0xLTEtMTE5ODY4_ffca444a-157f-4192-9b35-543d1f3ddbfe"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0af62c64c70e496180646fa5003616d9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtNy0xLTEtMTE5ODY4_a6fa5f2d-19b4-4627-b511-e6676360ffdb"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibabaf9d9de764e76a341637628038690_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtOS0xLTEtMTE5ODY4_39a58213-e5e5-4010-97f2-a6c3305393f6"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i181e138f85db48af8965b7d878b7e8b9_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTEtMTEtMS0xLTExOTg2OA_341e4c8d-3cea-4e05-b1b5-68294180e694"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMS0xLTEtMTE5ODY4_cd5c5437-fcf3-480b-97a4-40f3a4c9fa7a"
      unitRef="usd">6563000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMy0xLTEtMTE5ODY4_f91c5d75-0028-4199-9e35-2fba660f8a09"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItNS0xLTEtMTE5ODY4_41aaa7df-d2f0-4069-814a-0bda999d7caa"
      unitRef="usd">227000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItNy0xLTEtMTE5ODY4_ff926e3a-15ff-4181-b5f9-ae44aad3b6af"
      unitRef="usd">6341000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5a9d94e94f1a4706a534771364ec005b_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItOS0xLTEtMTE5ODY4_ed6c090c-92bf-4a63-9aa9-7c0ba45b29a7"
      unitRef="usd">6341000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6ac252a414964d53a7d3be0ec2452d75_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTItMTEtMS0xLTExOTg2OA_ed0d1715-a8ca-49d6-ba86-f46d4d1a60e9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMS0xLTEtMTE5ODY4_15a8e8e6-7a6e-42f1-b65d-71b15fbf9087"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMy0xLTEtMTE5ODY4_8e5e23c5-2050-462d-bc2f-43b06e04f2ca"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtNS0xLTEtMTE5ODY4_f54c1023-277c-4f32-9f35-c90af65a4ed5"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8b9515044e8742dc9dfce5361f230a6e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtNy0xLTEtMTE5ODY4_12a869e6-fab2-44d7-b267-ddae6eb5524b"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ieb0b7ef8524844b0804a1928fb54d9b4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtOS0xLTEtMTE5ODY4_7fb93a3d-0e0a-4e5b-a7ea-60e1ce19d9d8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9259b16d9d1a47a3a029f28c0f8a81bd_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTQtMTEtMS0xLTExOTg2OA_ec96c443-917a-4679-9e23-c5179523818c"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMS0xLTEtMTE5ODY4_51ee0f8f-7fa1-4094-ab79-1615308a744f"
      unitRef="usd">7131000000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMy0xLTEtMTE5ODY4_fc46583c-464e-4773-95c3-65fb4346827e"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtNS0xLTEtMTE5ODY4_4c436ad0-a608-4e41-bbae-c4d8b19fc916"
      unitRef="usd">245000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtNy0xLTEtMTE5ODY4_38b89947-8e87-4741-8748-74170d40c5d4"
      unitRef="usd">6893000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if29182b593044b31bebc366410e41692_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtOS0xLTEtMTE5ODY4_251f3c4b-7007-4320-a6ee-371a40d06aba"
      unitRef="usd">6859000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjBhNzA1ZjQyODhkMzQ3NTRhYTY1YTI1ZDZmZGU4NTM4L3RhYmxlcmFuZ2U6MGE3MDVmNDI4OGQzNDc1NGFhNjVhMjVkNmZkZTg1MzhfMTUtMTEtMS0xLTExOTg2OA_40ad7898-07f9-4536-b83e-36da36555b6e"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ4OQ_069a6c9d-bd23-45a5-ace6-a80dd59d25f6">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the gross unrealized losses and fair values of the Company&#x2019;s available-for-sale debt securities that have been in a continuous unrealized loss position deemed to be temporary, aggregated by investment category at October&#160;28, 2022 and April&#160;29, 2022:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;More than 12 months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Auction rate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy0xLTEtMS0xMTk4Njg_79cbd353-ad94-4fc1-ab32-951ca4628ffb"
      unitRef="usd">207000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy0zLTEtMS0xMTk4Njg_63b19a60-bf83-460a-a4bd-433a2cc067f5"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy01LTEtMS0xMTk4Njg_c02e8d1e-dbe3-4771-a092-a995818e36d6"
      unitRef="usd">3133000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4027240c2d7f4b0697e1af8767791e37_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfMy03LTEtMS0xMTk4Njg_92730b9a-c6d1-428b-8a4c-7451ccdac2a9"
      unitRef="usd">269000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i39738394791c43f39b81aa42666e1649_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC0xLTEtMS0xMTk4Njg_57165944-a69d-4725-94ca-e327c0f00862"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i39738394791c43f39b81aa42666e1649_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC0zLTEtMS0xMTk4Njg_8e67a165-c4b3-43b0-a411-2253b8eac948"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i39738394791c43f39b81aa42666e1649_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC01LTEtMS0xMTk4Njg_4801f5c5-fbb2-487f-94db-f0ee49e4dfbf"
      unitRef="usd">916000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i39738394791c43f39b81aa42666e1649_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNC03LTEtMS0xMTk4Njg_e8f26283-959d-44d5-ac8c-b979ee9ed5c6"
      unitRef="usd">93000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS0xLTEtMS0xMTk4Njg_e6642a94-a8e3-4969-9b33-ff07cc7ddaa5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS0zLTEtMS0xMTk4Njg_48a67958-3f87-49f1-a539-8e9831dd9b8f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS01LTEtMS0xMTk4Njg_4ce5aed9-22d8-408e-bad6-dc5664008b90"
      unitRef="usd">491000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2947d8ecf8614d209472fb0a92dfe5a0_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNS03LTEtMS0xMTk4Njg_9885d0b5-6959-4d8b-b207-82d41463b321"
      unitRef="usd">61000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi0xLTEtMS0xMTk4Njg_45acf808-fd97-4c27-86ec-959181f0cd23"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi0zLTEtMS0xMTk4Njg_d75f1714-d131-43f6-808b-773c8eeb4b66"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi01LTEtMS0xMTk4Njg_7db3682d-f4bd-4d7e-a7f9-fc2be0554e9a"
      unitRef="usd">554000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2852261aa1cc48c6ad18f19ae32b48a9_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNi03LTEtMS0xMTk4Njg_cd170686-8572-4562-8469-6e0a0dd80716"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy0xLTEtMS0xMTk4Njg_8243c948-e39f-4fdb-8e21-39e6286a0eab"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy0zLTEtMS0xMTk4Njg_484c02c4-e0ce-42ed-98f6-efe2874f47cc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy01LTEtMS0xMTk4Njg_76d13bed-1db0-4615-8f4f-7aea9b51d36e"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6e5315d1988a4cd191a23aeea7be9e0c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfNy03LTEtMS0xMTk4Njg_e6f8a8c1-ba26-4dfa-8dd2-2ff3369ca587"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC0xLTEtMS0xMTk4Njg_782e0c3b-9283-401a-a53c-5f0acd83c1ba"
      unitRef="usd">207000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC0zLTEtMS0xMTk4Njg_d8b413ef-a4f1-485f-9495-e5a6e4bcab01"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC01LTEtMS0xMTk4Njg_88eadea2-001c-4848-9e5c-2ec64effd27b"
      unitRef="usd">5128000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjA5NWFkNjM4YzBhODQ4Y2FiNjBmMmMwMjU5NTFmZDU0L3RhYmxlcmFuZ2U6MDk1YWQ2MzhjMGE4NDhjYWI2MGYyYzAyNTk1MWZkNTRfOC03LTEtMS0xMTk4Njg_27b10632-78a7-4c2c-b1eb-7002b84a0486"
      unitRef="usd">456000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy0xLTEtMS0xMTk4Njg_fcb1f029-9576-4dcc-9003-9e614802fc52"
      unitRef="usd">222000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy0zLTEtMS0xMTk4Njg_af826771-6a3c-4a1c-8e34-51a1f83b4986"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy01LTEtMS0xMTk4Njg_2e109b07-51f6-411c-ad6d-613ddbd6f398"
      unitRef="usd">2993000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i06f0fe6133fa4a9780a19e0828fa17f8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfMy03LTEtMS0xMTk4Njg_9c58ab3f-a701-4f79-ab28-2401420cf1a3"
      unitRef="usd">139000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia51c0979773246909434b1ce27622157_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC0xLTEtMS0xMTk4Njg_f8838f8f-7337-4747-9fbf-2f1319a17ad9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia51c0979773246909434b1ce27622157_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC0zLTEtMS0xMTk4Njg_7e56d1c5-ad41-4770-8ca2-a73a1c4f18d9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia51c0979773246909434b1ce27622157_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC01LTEtMS0xMTk4Njg_1b9dbabb-3523-4813-acc2-bf1892c48956"
      unitRef="usd">945000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia51c0979773246909434b1ce27622157_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNC03LTEtMS0xMTk4Njg_99107795-0559-4374-a7c0-73dec15f21c4"
      unitRef="usd">56000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS0xLTEtMS0xMTk4Njg_85159a72-3952-47a6-978d-6b12e0013b91"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS0zLTEtMS0xMTk4Njg_32f8f6b2-4981-43ed-92a5-5c0ce4edd122"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS01LTEtMS0xMTk4Njg_93cc2e0f-a413-4add-909c-8e018fbe028e"
      unitRef="usd">507000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9ad8f6d897f54b9abcdbb3985c505800_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNS03LTEtMS0xMTk4Njg_83bed58f-3165-4022-88ef-2ab261ce14a2"
      unitRef="usd">35000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi0xLTEtMS0xMTk4Njg_36b108fa-6979-44d4-add3-fd70a45e42ee"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi0zLTEtMS0xMTk4Njg_b8b154be-f628-44f7-8750-6463f4b424cf"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi01LTEtMS0xMTk4Njg_9ad3c7c7-f940-4830-afc9-f3d80dfc4d57"
      unitRef="usd">526000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9cc120ff1df040c5a80aa8cd45216ef4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNi03LTEtMS0xMTk4Njg_6da0b42d-d9b8-46b0-a8eb-4de0f1bbaabe"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i965da10df5234587b1d528532b979fa4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy0xLTEtMS0xMTk4Njg_3491ab61-a248-4ce9-b3d8-b43199bbce91"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i965da10df5234587b1d528532b979fa4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy0zLTEtMS0xMTk4Njg_140a1b0c-3665-48dd-8ca5-979301dbe9e3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i965da10df5234587b1d528532b979fa4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy01LTEtMS0xMTk4Njg_494cedb4-c22d-4870-b023-d9eaeb230f01"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i965da10df5234587b1d528532b979fa4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfNy03LTEtMS0xMTk4Njg_5d1fbae7-48a8-4546-938e-fb86750680be"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC0xLTEtMS0xMTk4Njg_ba286aba-4103-404a-8f0f-5d7519150de6"
      unitRef="usd">222000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC0zLTEtMS0xMTk4Njg_a5c7ad81-1ad2-4aa4-9b90-38c01fb91835"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC01LTEtMS0xMTk4Njg_d7ecf539-4645-44ea-b5b7-2f3558cc690e"
      unitRef="usd">5004000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjU0OTlkMjZhNGUwNDQ3NmVhODg4YTgwZTc4MWM1NjNjL3RhYmxlcmFuZ2U6NTQ5OWQyNmE0ZTA0NDc2ZWE4ODhhODBlNzgxYzU2M2NfOC03LTEtMS0xMTk4Njg_94354c96-aea9-4cdd-84c5-e34b088ab834"
      unitRef="usd">244000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUxMA_66018f26-be39-4a3f-b06b-f93655b6110f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity related to the Company&#x2019;s available-for-sale debt securities portfolio is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi0xLTEtMS0xMTk4Njg_cea6b770-0cdd-4c68-a183-65e4a5079f2b"
      unitRef="usd">1723000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi0zLTEtMS0xMTk4Njg_1bd5e3d9-ac9b-443c-aa32-d36c1a08f187"
      unitRef="usd">2299000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi01LTEtMS0xMTk4Njg_5f2170bd-cf35-49dd-86f2-2757b63b54ee"
      unitRef="usd">3587000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMi03LTEtMS0xMTk4Njg_b52e087b-1805-4b7f-8ca0-6ed29dac1bcf"
      unitRef="usd">4571000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy0xLTEtMS0xMTk4Njg_5c76d179-a490-4b09-b4c3-54f8c848f956"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy0zLTEtMS0xMTk4Njg_d2304d10-ee18-406b-bfac-cbdcc4359ef6"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy01LTEtMS0xMTk4Njg_ffa04d4e-61f8-4e77-88b8-d3a53ea59e15"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfMy03LTEtMS0xMTk4Njg_150a7fe1-e617-4beb-9533-24a81da2222d"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC0xLTEtMS0xMTk4Njg_555b18d2-cae6-43a9-bdae-b633d6346168"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC0zLTEtMS0xMTk4Njg_faae5b5d-9f0b-4f19-bbd7-5a745f39df84"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC01LTEtMS0xMTk4Njg_ac8f4c4d-d97a-4055-876a-3604e464ccc7"
      unitRef="usd">19000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmE0ZDYwN2VjMWRjZDQ2Yjk5YWMxYzMyODIwMWRlMDQ0L3RhYmxlcmFuZ2U6YTRkNjA3ZWMxZGNkNDZiOTlhYzFjMzI4MjAxZGUwNDRfNC03LTEtMS0xMTk4Njg_c8721089-a09e-4e19-872a-b5ae2115b9ff"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzQ5NA_9c725319-d0cc-4dd8-a746-4e3335b72722">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The October&#160;28, 2022 balance of available-for-sale debt securities by contractual maturity is shown in the following table. Within the table, maturities of mortgage-backed securities have been allocated based upon timing of estimated cash flows assuming no change in the current interest rate environment. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMS0xLTEtMS0xMTk4Njg_dc28a433-cd96-41d0-9906-6c49d8af8727"
      unitRef="usd">1419000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMi0xLTEtMS0xMTk4Njg_429ef9ee-057f-4b69-8161-1280412e2219"
      unitRef="usd">3649000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfMy0xLTEtMS0xMTk4Njg_5b3e9f51-08c5-493b-b0a7-81646103f1b7"
      unitRef="usd">899000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfNC0xLTEtMS0xMTk4Njg_429507d4-2034-42e5-9085-67e094270830"
      unitRef="usd">669000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjZjYTlmNDBhMDk0ZDQ0OTViZjYyODUyMjE0NTYyMGU4L3RhYmxlcmFuZ2U6NmNhOWY0MGEwOTRkNDQ5NWJmNjI4NTIyMTQ1NjIwZThfNS0xLTEtMS0xMTk4Njg_e148f7e7-d1ae-43c0-b64d-efce54d8f3b1"
      unitRef="usd">6635000000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUwNQ_ef09e4b2-b28a-4689-8bc8-685f04b43837">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's equity and other investments at October&#160;28, 2022 and April&#160;29, 2022, which are classified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments with readily determinable fair value (marketable equity securities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity and other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMS0yLTEtMS0xMTk4Njg_51b9e368-333c-47dd-835f-26f42d78ee49"
      unitRef="usd">19000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMS00LTEtMS0xMTk4Njg_40113735-3e9a-4668-9e27-08b39e00912e"
      unitRef="usd">64000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMi0yLTEtMS0xMTk4Njg_c447682d-578d-4542-b5e2-bda731e9c062"
      unitRef="usd">808000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMi00LTEtMS0xMTk4Njg_5bc63561-2047-42f6-9bfc-4ed8b1d4edb6"
      unitRef="usd">732000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMy0yLTEtMS0xMTk4Njg_0ebb3786-c4fa-4d31-987c-387c8852fd74"
      unitRef="usd">85000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfMy00LTEtMS0xMTk4Njg_e5a51d15-63cd-4b7a-9b17-d809f286fa1b"
      unitRef="usd">85000000</us-gaap:EquityMethodInvestments>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments
      contextRef="i13212ed214a64a10aa002be4cdfbe506_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfNC0yLTEtMS0xMTk4Njg_feb1d94f-e1cd-451e-9edf-7c5c1b5c8c56"
      unitRef="usd">912000000</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments>
    <mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments
      contextRef="i123f0204b3444f8ca9d4b24fa538bc9a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOjg0NzNhMTA3YzZiMjQ2ZjdiNTZiZTk2ZTdlNGU5ZmQxL3RhYmxlcmFuZ2U6ODQ3M2ExMDdjNmIyNDZmN2I1NmJlOTZlN2U0ZTlmZDFfNC00LTEtMS0xMTk4Njg_2acbb0a6-2417-45b3-8f4e-e7b20964d69e"
      unitRef="usd">881000000</mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments>
    <mdt:ScheduleofInvestmentsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzUwNg_4c4f52f7-b6b1-4dae-8b1d-eb2fee08acbc">&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below includes activity related to the Company&#x2019;s portfolio of equity and other investments. Gains and losses on equity and other investments are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdt:ScheduleofInvestmentsTableTextBlock>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi0yLTEtMS0xMTk4Njg_7523d14f-8678-486e-b960-a5a4e7c28d25"
      unitRef="usd">0</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi00LTEtMS0xMTk4Njg_d322bd28-ad49-40c9-899a-84682af1e412"
      unitRef="usd">14000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi02LTEtMS0xMTk4Njg_7ecf7b6d-2883-4bd7-88de-0f2aa4b59648"
      unitRef="usd">21000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMi04LTEtMS0xMTk4Njg_d5895d5b-2e67-4ce8-ab98-f97580552de3"
      unitRef="usd">66000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <mdt:GainonInvestments
      contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy0yLTEtMS0xMTk4Njg_d4e407a8-4b80-4f71-96d3-4938868bad82"
      unitRef="usd">23000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy00LTEtMS0xMTk4Njg_cb347b4c-5451-49af-be15-fd0612505e63"
      unitRef="usd">12000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy02LTEtMS0xMTk4Njg_22d52a49-adb7-4513-89df-d513982ff9fb"
      unitRef="usd">37000000</mdt:GainonInvestments>
    <mdt:GainonInvestments
      contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfMy04LTEtMS0xMTk4Njg_6157e11f-5302-48d2-b644-a705893799c5"
      unitRef="usd">70000000</mdt:GainonInvestments>
    <mdt:LossonInvestments
      contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC0yLTEtMS0xMTk4Njg_c8557a4c-b124-4cd0-b4b6-5b92b922394d"
      unitRef="usd">7000000</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC00LTEtMS0xMTk4Njg_a9148450-c5a1-49cc-a767-d826a787493e"
      unitRef="usd">15000000</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC02LTEtMS0xMTk4Njg_86a66781-067d-4386-98a4-697f1b1a6b6b"
      unitRef="usd">11000000</mdt:LossonInvestments>
    <mdt:LossonInvestments
      contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNC04LTEtMS0xMTk4Njg_71ffee9e-fdb8-4e9b-b82c-8e8b72cc9109"
      unitRef="usd">20000000</mdt:LossonInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS0yLTEtMS0xMTk4Njg_0ac97e67-daae-454b-8a35-3f8e662fe9e7"
      unitRef="usd">4000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS00LTEtMS0xMTk4Njg_acd537c9-d718-45be-b0f3-31d2c3db931b"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS02LTEtMS0xMTk4Njg_79f7fcd7-d545-41ec-914a-855f3a0c8ca6"
      unitRef="usd">12000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RhYmxlOmIwMTEyNDE2YTc0NjQwMDI5ODhkZjM0OWVkOTA0YThlL3RhYmxlcmFuZ2U6YjAxMTI0MTZhNzQ2NDAwMjk4OGRmMzQ5ZWQ5MDRhOGVfNS04LTEtMS0xMTk4Njg_c566642e-e8dd-4279-870c-9ea5338d8df1"
      unitRef="usd">10000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzI1Nw_196e3f29-c2da-4225-adfb-c351f2c5c4f8"
      unitRef="usd">-7000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i0b773088b62d4dfabb6b33345e16d142_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfNzE0NjgyNTU4NDE3NQ_6b465753-12ab-4944-899a-d1e67511c0ff"
      unitRef="usd">1000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i72967db0d1ef423699c8ee60d0f8e98f_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfNDM5ODA0NjUxNDk1OA_ff5a932d-8330-41bc-b246-d2d994cfbd6a"
      unitRef="usd">-8000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ie268d9eeaae34f61b454381830ec3c1c_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81Mi9mcmFnOmI4MmRkZjUxZmJhNzRiNzNiNWQ3ZGJiODE3NDU2MTkwL3RleHRyZWdpb246YjgyZGRmNTFmYmE3NGI3M2I1ZDdkYmI4MTc0NTYxOTBfMzM5MA_8d1e15bc-89a8-452d-9e4b-4b742b82523f"
      unitRef="usd">7000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUzMw_721d497e-b0c4-499f-b20a-fff7dbe55b48">Financing Arrangements &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains commercial paper programs that allow the Company to issue U.S. dollar or Euro-denominated unsecured commercial paper notes. The aggregate amount outstanding at any time under the commercial paper programs may not exceed the equivalent of $3.5 billion. Commercial paper outstanding at October&#160;28, 2022 was $349 million. During the three months ended October&#160;28, 2022, the commercial paper outstanding had a weighted average original maturity of 26 days and a weighted average interest rate of 3.057 percent. No commercial paper was outstanding at April&#160;29, 2022. The issuance of commercial paper reduces the amount of credit available under the Company&#x2019;s existing Credit Facility, as defined below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Line of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a $3.5 billion five-year unsecured revolving credit facility (Credit Facility), which provides back-up funding for the commercial paper programs described above. The Credit Facility includes a multi-currency borrowing feature for certain specified foreign currencies. At October&#160;28, 2022 and April&#160;29, 2022, no amounts were outstanding under the Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rates on advances on the Credit Facility are determined by a pricing matrix, based on the Company&#x2019;s long-term debt ratings, assigned by Standard &amp;amp; Poor&#x2019;s Ratings Services and Moody&#x2019;s Investors Service. Facility fees are payable on the Credit Facility and are determined in the same manner as the interest rates. The Company is in compliance with the covenants under the Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's debt obligations consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity by &lt;br/&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.500 percent ten-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.250 percent six-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625 percent three-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent five-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.125 percent eight-year 2019 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.350 percent ten-year 2017 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.000 percent six-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent eight-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent twelve-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000 percent twelve-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125 percent nine-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750 percent twelve-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375 percent twelve-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375 percent twenty-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.550 percent thirty-year 2007 CIFSA senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250 percent twenty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.500 percent thirty-year 2009 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.500 percent twenty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.550 percent thirty-year 2010 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375 percent twenty-year 2020 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.500 percent thirty-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000 percent thirty-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent thirty-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent thirty-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.750 percent thirty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent thirty-year 2020 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has outstanding unsecured senior obligations, described as senior notes in the tables above (collectively, the Senior Notes). The Senior Notes rank equally with all other unsecured and unsubordinated indebtedness of the Company. The Company is in compliance with all covenants related to the Senior Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, Medtronic Luxco issued four tranches of Euro-denominated Senior Notes with an aggregate principal of &#x20ac;3.5 billion, with maturities ranging from fiscal year 2026 to 2035, resulting in cash proceeds of approximately &#x20ac;3.5 billion, net of discounts and issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Term Loan Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, Medtronic Luxco entered into a term loan agreement (Fiscal 2023 Loan Agreement) by and among Medtronic Luxco, Medtronic plc, Medtronic, Inc., and Mizuho Bank, Ltd. as administrative agent and as lender. The Fiscal 2023 Loan Agreement provides an unsecured term loan in an aggregate principal amount of up to &#xa5;300&#160;billion with a term of 364 days. Borrowings under the Fiscal 2023 Loan Agreement bear interest at the TIBOR Rate (as defined in the Fiscal 2023 Loan Agreement) plus a margin of 0.40% per annum. Medtronic plc and Medtronic, Inc. have guaranteed the obligations of Medtronic Luxco under the Fiscal 2023 Loan Agreement. In May and June 2022, Medtronic Luxco borrowed an aggregate of &#xa5;297&#160;billion, or approximately $2.3&#160;billion, of the term loan, under the Fiscal 2023 Loan Agreement. The Company used the net proceeds of the borrowings to fund the early redemption of $1.9&#160;billion of Medtronic Inc.'s 3.500% Senior Notes due 2025 for $1.9&#160;billion of total consideration, and $368&#160;million of Medtronic Luxco's 3.350% Senior Notes due 2027 for $376&#160;million of total consideration. The Company recognized a total loss on debt extinguishment of $53&#160;million in the three months ended July 29, 2022, which primarily includes cash premiums and accelerated amortization of deferred financing costs and debt discounts and premiums. The loss was recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income during the six months ended October&#160;28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments Not Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;28, 2022, the estimated fair value of the Company&#x2019;s Senior Notes was $21.1 billion compared to a principal value of $24.4 billion. At April&#160;29, 2022, the estimated fair value was $22.9 billion compared to a principal value of $24.2 billion. The fair value was estimated using quoted market prices for the publicly registered Senior Notes, which are classified as Level 2 within the fair value hierarchy. The fair values and principal values consider the terms of the related debt and exclude the impacts of debt discounts and hedging activity.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <mdt:CommercialPaperMaximumBorrowingCapacity
      contextRef="ia3942d4373f44f7497691c840fa95db3_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjkw_49958ca9-83f2-4bc8-8ac5-010d2d6e38eb"
      unitRef="usd">3500000000</mdt:CommercialPaperMaximumBorrowingCapacity>
    <us-gaap:DebtCurrent
      contextRef="i8cc14bfe25a24c169750f3b677e3850f_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIwNjAx_10391554-416c-41a4-a294-069ac120b115"
      unitRef="usd">349000000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5a435f6230ca46b3a412340e46d67d2b_D20220730-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIyMDMx_85795272-0a9f-44ca-9ee5-7c755214f947">P26D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i8cc14bfe25a24c169750f3b677e3850f_I20221028"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIyMDMw_64e99b04-9a15-4e58-b457-6f2619cc1f92"
      unitRef="number">0.03057</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtCurrent
      contextRef="i50b73054f5384db484d17a799d1f1a64_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODIwNjUz_9c2c4f41-199b-4672-85ad-5d334c6fd2cd"
      unitRef="usd">0</us-gaap:DebtCurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i74804d544e17446ca08e983c8f7fa76f_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTEz_6e106bac-6bcf-4f3f-b443-f54ad09a5baa"
      unitRef="usd">3500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie52a26d33fd64110b616f85161449591_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUxOQ_a2ccbce6-3c17-49ff-ad27-5c5ab5b2351e">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCredit
      contextRef="i74804d544e17446ca08e983c8f7fa76f_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNzgx_81093de7-4088-410c-8780-8d4cd5691489"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ic1b14f05a2554bdbaf9b274cdfd744d4_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNzgx_a1353dd9-4bbc-48d2-a6e3-118ad97c330b"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzUyMw_1f2a40e4-c605-4a51-bdce-d43cb05785d4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's debt obligations consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity by &lt;br/&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.500 percent ten-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.250 percent six-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.625 percent three-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.000 percent five-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.125 percent eight-year 2019 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.350 percent ten-year 2017 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.000 percent six-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.375 percent eight-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent twelve-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.000 percent twelve-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.125 percent nine-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.750 percent twelve-year 2020 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.375 percent twelve-year 2022 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375 percent twenty-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.550 percent thirty-year 2007 CIFSA senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.250 percent twenty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.500 percent thirty-year 2009 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.500 percent twenty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.550 percent thirty-year 2010 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.375 percent twenty-year 2020 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.500 percent thirty-year 2012 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2042&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000 percent thirty-year 2013 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent thirty-year 2014 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625 percent thirty-year 2015 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.750 percent thirty-year 2019 senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.625 percent thirty-year 2020 senior notes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 - 2051&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtCurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMS00LTEtMS0xMTk4Njg_c2c9d870-fa92-4ec5-9235-5655aa5dc176"
      unitRef="usd">5864000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMS02LTEtMS0xMTk4Njg_6435a7d4-9c59-40e9-8c67-d8544f8c2ac8"
      unitRef="usd">3742000000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i261e682721ee4018a0e687ae0df46295_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0MmJkZWZhNWQ4Njg0ZDU2OTFlNWJmN2ZmYTM0NmUzN180_43818ea0-52dd-4ece-8f30-24bad59056de"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i751c32721c1046dcb276c399e66b615a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0MmJkZWZhNWQ4Njg0ZDU2OTFlNWJmN2ZmYTM0NmUzN18xNQ_02626c33-d6d5-4c3f-a2c6-228aa1391bda">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i89f1d04b0787461cbd677984bf68ea36_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC00LTEtMS0xMTk4Njg_254ada8e-7be8-4fa0-810d-60a3d33ec264"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie4ceaa34c16b4e969c2d70f8a46b0700_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNC02LTEtMS0xMTk4Njg_527314b8-fbc7-467d-9460-0c1c4979278e"
      unitRef="usd">1890000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i16fd5558ce984801a4ce4154ad7e4bf0_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1OTFmYmZlZDUwMzM0MDI2OTNjZTFhZTY1N2M2NWNiMV80_a4d8ba3a-5ea9-446e-89e4-5d72249a198f"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic48a1296b3e44c84bf9342a1671330da_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo1OTFmYmZlZDUwMzM0MDI2OTNjZTFhZTY1N2M2NWNiMV8xNQ_0e1f8465-a0fb-482a-aabc-dd86e6140f83">P6Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9bce3bdd02d842a78def75f12929df2e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS00LTEtMS0xMTk4Njg_2c671453-fd54-414e-bd4e-42a485f8f701"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01af7fce485a44f38019814091a50b8f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNS02LTEtMS0xMTk4Njg_1db11413-e881-4437-9849-97585b529283"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie72a79cc7e714e3f98098deb1aec4fd1_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMzIwNjUvdGV4dHJlZ2lvbjozZjAwMjY1YWZmMzM0YWQ0OTViZjk1ODQ2MjdlNmZlN180_0a1856ef-2ff4-477e-959d-e5387dfcbb2b"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i2353fa72d44d49ceb3efd49225a21e23_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMzIwNjUvdGV4dHJlZ2lvbjozZjAwMjY1YWZmMzM0YWQ0OTViZjk1ODQ2MjdlNmZlN18xNQ_dddaed69-9e1a-4e4b-91d7-451ea9cb5ae5">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7012e804387641a7813faf2625661ec8_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy00LTEtMS0xMzIwNjU_813ec09f-e3b0-478d-a683-9282548447b2"
      unitRef="usd">498000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2e9f92a697414dfd8bfd28a672323199_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy02LTEtMS0xMzIwNjU_57c4785e-2c86-4790-8579-9d5fdd86474e"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f4a0cb342f9428fb9e71a786d8f86df_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjplNGNhY2FmY2ZkYjA0Zjg4YjAyNTE3NTEzNjM5OTJjN180_fa375839-4e8c-494b-bf08-713197f14102"
      unitRef="number">0.00000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4cda2d6fee9d41349edb516fb0368284_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjplNGNhY2FmY2ZkYjA0Zjg4YjAyNTE3NTEzNjM5OTJjN18xNQ_3198b564-ef22-4e4a-b06d-8ec294c4986f">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i84656a75b0454be4a3e0b59a5bf56733_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi00LTEtMS0xMTk4Njg_89b60512-c0da-4fa1-9b43-7d5e39d9f441"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7489de2611c44626bfd326f30908b1a5_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNi02LTEtMS0xMTk4Njg_9e54723a-78a5-47fa-8fbf-d5834c91a07f"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia7813502cc324fdfb9cad82fca2aef6f_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo4YjM1YmE0NWFiZmQ0MjM1YjY1OGE1ZDlmNTg5YjJkZF80_6d7cba0e-3725-4584-bdec-17ec58d0cda8"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie7f465b4b499407f84b13e2f34e98cda_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo4YjM1YmE0NWFiZmQ0MjM1YjY1OGE1ZDlmNTg5YjJkZF8xNQ_4363048c-cfe5-4ab2-8643-b54c6e19329f">P8Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i91a8b596b4464a54ad3624a0e04bd604_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy00LTEtMS0xMTk4Njg_59993439-de91-47d7-a20c-53a7d29f7952"
      unitRef="usd">1495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0d4d3e7efdd64bbe98b4ba1443d485e3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfNy02LTEtMS0xMTk4Njg_857bf8b3-6615-4f53-a881-a250b1613778"
      unitRef="usd">1596000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibaecd0e4856b431fa395153da8bc83d0_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0NGY2MjQ3NzFjZWQ0NDdlYjI2Y2E1OGZkMjE5NmU3ZV80_3b52deee-fd5c-40fa-8524-6427153107e3"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i074c3d2b9e5943a78a8bc0e775eaae2a_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjo0NGY2MjQ3NzFjZWQ0NDdlYjI2Y2E1OGZkMjE5NmU3ZV8xNQ_2f2fd1cd-3f20-4162-a2cf-f0c05c6f018b">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2d2f2ee743674b16a4e766f4653881b6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC00LTEtMS0xMTk4Njg_4e7477a0-c996-497e-aabf-a33d4058eb91"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i74d22bb72025442cac41507454e9f728_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOC02LTEtMS0xMTk4Njg_36dda5d4-e41f-4017-9fad-c21f947500f9"
      unitRef="usd">368000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i600fd760a9284c3ba2ce36a2e1c4adb7_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTIxNTU2L3RleHRyZWdpb246OGIxZGUyZDIwYzY3NDIwYzg5NDNjNWEyMWNiMjUyNThfMjc0ODc3OTA2OTQ4OQ_5e43d132-73c6-4fd9-8491-94a60c4ae687"
      unitRef="number">0.03000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="iddd3d2cc9e4b461bb1e2c4f66d747810_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTIxNTU2L3RleHRyZWdpb246OGIxZGUyZDIwYzY3NDIwYzg5NDNjNWEyMWNiMjUyNThfMjc0ODc3OTA2OTUwMA_32760e58-ad5a-4ffc-bd6c-1ad20985b7d9">P6Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7ec69cbbc5484f558ee3b3e485197f4b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNC0xLTEtMTIxNTIw_393de2cf-d037-40f8-8d82-8fd1a952c8b9"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if52f4d1f6b37466eb1f1c57c273f68fe_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNi0xLTEtMTIxNTIw_8f153ae2-375e-4175-b9da-84048cb3a332"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45066488b7f44235877f7d05b88cecbf_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjpmNzc0ODk2MmQ4YWM0YWI0Yjg1MjBiZjlmMDNkOGE2ZV80_120751de-1cca-4594-90b5-e076ba8d4465"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia88da43b7ee240e08c8140ee86cda15b_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS0wLTEtMS0xMTk4NjgvdGV4dHJlZ2lvbjpmNzc0ODk2MmQ4YWM0YWI0Yjg1MjBiZjlmMDNkOGE2ZV8xNQ_89c8f418-8731-4d20-9957-1607c287c315">P8Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i854fe8577e324d2fb0c40211182aaae5_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS00LTEtMS0xMTk4Njg_47af4589-a89b-46df-84ee-b2252d6d9e20"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i10c69d5ca1d547218da8e846cc583837_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfOS02LTEtMS0xMTk4Njg_3de5c41b-12d9-4c0c-acd2-f7e7e7708691"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e7c703e42e54e418769101e3009a751_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzBjZWY3OWE5ZmNlNGVhNDkzZGExNDQ1MTEyMzZkMDhfNA_b86b77ed-8055-461e-ac9b-6e66a9afeb66"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4c4da084f549423ba1edd47c97745dea_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NzBjZWY3OWE5ZmNlNGVhNDkzZGExNDQ1MTEyMzZkMDhfMTU_ce799e26-0bf3-4cce-8b29-c208992df253">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i492e3b74b21647618e19d98fc5af4be6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNC0xLTEtMTE5ODY4_3548e8b5-2847-4db1-aaa0-cc1dd8319033"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4f3c6736ad474abe80247b6c428621e8_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTAtNi0xLTEtMTE5ODY4_90b54e0d-5e0e-45a9-83f3-42dd87f4d8e9"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad3d7e100f644b319c3dc758d8c3e5ff_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTMyMTAyL3RleHRyZWdpb246NDQ4NjljZmM2NjNlNDU1YmI0ODYyMjRjZWIxOGEyODNfNA_07e02fc1-71af-4bf6-aa2f-81e2c8e86894"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="if60f67805a834aeb81d478d6048c30b7_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTMyMTAyL3RleHRyZWdpb246NDQ4NjljZmM2NjNlNDU1YmI0ODYyMjRjZWIxOGEyODNfMTU_ffccee38-c25e-4832-aaeb-33b33027026a">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i604c687d118d48988cea0c15344b587f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTMyMTAy_ad39412e-7c91-4886-bc41-f5cdb6bbfe4a"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i440aa4baa5804f8ba1255729affe7a07_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTMyMTAy_6bc9c2c6-b4d8-4884-a0a6-40f396d1cc5f"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9ade45514b07472abf3a976bad5075e2_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTIxNTY5L3RleHRyZWdpb246ZGQ2NmRmMDEwMDFhNDFmYWEzMjgzMGMyN2EyNGM2Y2NfMjc0ODc3OTA2OTQ5MA_b9a7bdbf-cce1-42ae-9751-f1c048db092e"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie6d581765eaf46a1b425828d5e6cdf3e_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTIxNTY5L3RleHRyZWdpb246ZGQ2NmRmMDEwMDFhNDFmYWEzMjgzMGMyN2EyNGM2Y2NfMjc0ODc3OTA2OTUwMg_43090bb2-24d1-4545-bd34-fafb485f053b">P9Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id024eb4c94014ec49c6e27a68351c003_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTIxNTI3_01abe872-8b56-4087-8273-b0c16d28d3de"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia9eca626aa454e1aa7d4f2ef86f83b88_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTIxNTI3_3cd90bf3-b804-44f5-8ac6-b95f8abe4feb"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9404b5c0aa234b1e930f980973644052_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246Zjc3MjQ4YWI3ZTg2NDU2NGI2NDYzYWEzYzQxOTI4OTdfNA_ace407fb-2484-4f67-84d6-937eabf29a1f"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i74e2615fe889465fa885b1b6dcef97e6_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246Zjc3MjQ4YWI3ZTg2NDU2NGI2NDYzYWEzYzQxOTI4OTdfMTU_949f4b67-c31f-4a49-a54a-ad7629f25f6d">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i78cb708996bc40d3a6481f7074ed4455_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItNC0xLTEtMTE5ODY4_1795a043-fe8b-426f-b7c6-c4e022196a0f"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia56942c6785c408da58413bcc56847ee_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTItNi0xLTEtMTE5ODY4_2dc4d087-0c3f-47d3-92b5-6f6d81f1798f"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0371e11afaea42b6b38732fc042d143e_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTIxNTgyL3RleHRyZWdpb246YTYyYjA5ZDYzZWQzNGFiODgyYzQzODEzZGM3N2FmODBfMjc0ODc3OTA2OTQ5Mg_9c0da6bf-a2db-4aa6-b33d-f43b2d4f59f8"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3be8c589cbef433e9f5cce07fc5b8204_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTIxNTgyL3RleHRyZWdpb246YTYyYjA5ZDYzZWQzNGFiODgyYzQzODEzZGM3N2FmODBfMjc0ODc3OTA2OTQ5OQ_fe6fb493-b788-480a-a6dc-ce8ebcd924fd">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic826d07adf4e44dea0e204d5cc54354e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNC0xLTEtMTIxNTM0_935027e9-2517-4cc0-9dbf-2fdbeb0e96be"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8b1f37320f264fe39b6118d6996cf34f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNi0xLTEtMTIxNTM0_c736e91c-c42c-408e-9d12-67d546e5edad"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i209002c36bbe4ea7b59430177cf18c4c_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzcxMTg5OTAyNTgzNDY4OTlhN2FkMjgyMTVjNTljMGJfNA_631ffe3c-a6cc-45dc-a30e-3b08afd17558"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i008bf53905884d179baf55ce1247fc76_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzcxMTg5OTAyNTgzNDY4OTlhN2FkMjgyMTVjNTljMGJfMTU_d21e7ed5-5152-4c11-b5d6-b4a722b7798b">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iee9e5b36677f4eba9b71eb4a0b2714b5_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNC0xLTEtMTE5ODY4_f85025d3-ec62-45d4-b085-cda3bfffa1a2"
      unitRef="usd">1932000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i079968c0f4134d4dac2b4878e02b237a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTMtNi0xLTEtMTE5ODY4_eecfe6fe-f164-43a2-a64e-4813ee5a093b"
      unitRef="usd">1932000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib02d94fcae21461da3cf9a8c555a40bd_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NTM3YmE5ODRkY2E4NDkzMGI2OTgzZmY5ZGIyOGNhMTVfNA_d872e4b7-aa8b-45d8-8e55-ec2ffb9fb2df"
      unitRef="number">0.06550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia3eacc8baafb46ddac0e1a5fbabe3485_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NTM3YmE5ODRkY2E4NDkzMGI2OTgzZmY5ZGIyOGNhMTVfMTU_6b6a3c75-43ed-4b0b-b276-13ade4abbac7">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iad63036539624fd9bc73ae5d7fb42005_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtNC0xLTEtMTE5ODY4_a4571497-9996-45d1-a7a7-93c2caabec17"
      unitRef="usd">253000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4897e04ca5f64263850346fe30de0a81_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTQtNi0xLTEtMTE5ODY4_2c864b57-2580-4ccb-a801-9c85899821e5"
      unitRef="usd">253000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia9c245862ed0462798a29da9f9f74ce0_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NmQ0ZTBlZGVkNzNmNDgzYmJiNTNjYmEwYzgwNzNlMjdfNA_487673f7-83e5-484c-a4df-06ea7744afa5"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i24a20fcb76734c22a3eade9a14f5ce50_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NmQ0ZTBlZGVkNzNmNDgzYmJiNTNjYmEwYzgwNzNlMjdfMTU_9828f9bb-bc47-45f9-8c68-bed91dd9cac4">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4b459c8ec71b4a15896e2da7ac25a1b6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtNC0xLTEtMTE5ODY4_96accbb2-99c0-45f0-ab9d-780c46f2c028"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6c925d8d64c94da082cd3422a727785b_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTUtNi0xLTEtMTE5ODY4_b4f733c6-ec42-4cdc-9e8e-96dd9c0c4c1f"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i705ac2374d1743abb58218fe5ad12b01_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246N2Q2MGJjNmI5OGRiNDJlN2I5NjUwODc0ZDBiNzBlN2NfNA_7a8493a0-a781-40ed-97e6-6c88807fdb9d"
      unitRef="number">0.06500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i7d94e3d1a39247e387019fed8a18ad46_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246N2Q2MGJjNmI5OGRiNDJlN2I5NjUwODc0ZDBiNzBlN2NfMTU_57f1f544-b43f-44d6-8a4a-dab45985759e">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2dc5cbdea31c4c78aeabffef218a50f3_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNC0xLTEtMTE5ODY4_b868abf1-96e0-422b-a839-20fca734ee10"
      unitRef="usd">158000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8efa321d8ec04cb1a95bed2a3f6976d4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTYtNi0xLTEtMTE5ODY4_890ad051-8a43-4f50-a460-1edd8424eecf"
      unitRef="usd">158000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1da25349c4044b8c9d6bde3df1b958aa_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzY4Y2MyOTk1ZmMwNDY2NzkwNTc5Njg0ODg3NjAzMGRfNA_8e4c4062-5c7b-4c54-aaca-11dcc4948104"
      unitRef="number">0.01500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i909fae803c5149209129a0a704330f2b_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MzY4Y2MyOTk1ZmMwNDY2NzkwNTc5Njg0ODg3NjAzMGRfMTU_4e435065-0256-4ec9-bb92-1d83d5e9cabc">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic3f00def7b8347c4a557ae6a1cfd1374_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctNC0xLTEtMTE5ODY4_f199f31f-e3bb-4b5d-a828-0ab0eeaa45b8"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5c769314b80147a5b1c216eb5b25c8b3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTctNi0xLTEtMTE5ODY4_9f4ddcfd-9638-4f27-abcf-807bb70f62a5"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7955403a09be4b6da70bed7e2f69d629_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZmU3NmE1ZmViZmI1NDg4ZWJkY2EzMTdmMjA4YWM5ZDZfNA_dd6a0947-1462-4b07-8af3-e631a5967baa"
      unitRef="number">0.05550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i2f01a54621494ecbbc0f453611f0bc4e_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZmU3NmE1ZmViZmI1NDg4ZWJkY2EzMTdmMjA4YWM5ZDZfMTU_808add74-4c94-4283-9064-62bc4bf3556e">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1cf2d68341064175b8f864b73593f1d7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtNC0xLTEtMTE5ODY4_c6a38e98-1a71-40dd-a1a0-8dcd77c3e6bf"
      unitRef="usd">224000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i089c1b9b426a4c1da92f3dc5e97a7581_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTgtNi0xLTEtMTE5ODY4_54724a73-58cf-4d75-bbb8-08f66925789d"
      unitRef="usd">224000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id2c9edb05074480991cd9fb871378cd4_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MWE0NDFkYmM0MzI3NDU1NGFkMDA5NDA1YzhmYTgzM2ZfNA_72065ab6-2267-4838-8acc-d242b755e20e"
      unitRef="number">0.01375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i76269c4f7bb649cf8290db9a195e6624_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktMC0xLTEtMTE5ODY4L3RleHRyZWdpb246MWE0NDFkYmM0MzI3NDU1NGFkMDA5NDA1YzhmYTgzM2ZfMTU_228af91a-28e4-4a7b-adf9-0fa6bc2282bc">P20Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2e51a2b394114d97a8e5c9f7166fab23_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktNC0xLTEtMTE5ODY4_e55ccec5-1652-465a-94c5-e12097478331"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8511290ec62844a4aae4405642d778c3_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMTktNi0xLTEtMTE5ODY4_48229d8a-be09-4ec3-9f12-e61d5eda9601"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib3c49bd14a1743a0821f157639e97f08_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGU0ZWJiYTFmZTQ4NGNjMzg5Y2UwYjQ3MDc0ZTUxMzhfNA_badca06d-d0fc-41ad-893d-6512c0be8e69"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5e59ec9a7e4d4ce783bed9fa0bda5c61_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGU0ZWJiYTFmZTQ4NGNjMzg5Y2UwYjQ3MDc0ZTUxMzhfMTU_99cca807-68e3-440c-ab44-e7381b7f019a">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9d55dae7970a4dd2b220ed120119dd5f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtNC0xLTEtMTE5ODY4_691869de-d308-46d5-8c30-c4b06b55abc9"
      unitRef="usd">105000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i936640005c7a4c09bb3f8a284850c7bc_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjAtNi0xLTEtMTE5ODY4_dffdbcf9-0d55-4e0f-91df-77bf452f82b2"
      unitRef="usd">105000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i506a7161216440d0bbcb96f17c77d8cd_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZDE5MmM0MjY4NDVkNDg0Mjg4YmVlZjkzNzRiYmI5ZTFfNA_0250587c-0ae3-43b7-8b31-76d68f5d3b0f"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i87db6e6fdecd4f628af3c73a2715dbee_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246ZDE5MmM0MjY4NDVkNDg0Mjg4YmVlZjkzNzRiYmI5ZTFfMTU_ec03cca7-cdc1-4af3-8743-9cc466675714">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i754149b1402a4ff58be77407ecd96c4c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtNC0xLTEtMTE5ODY4_b155a831-8bef-4d06-88db-1716dfd0357f"
      unitRef="usd">305000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3a0a9687dcdb42e79003c2c3005eb8c4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjEtNi0xLTEtMTE5ODY4_8fee885d-0508-4dca-a795-c64e3b42964e"
      unitRef="usd">305000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9103f0f331f14c2d925ee30459c3419c_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWUzZWM1ZTQwODExNGRkMzg5Mzk5YWIwY2UwNTI2MGRfNA_e87ae3a6-3b76-488b-a637-e2c277c39765"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i415c753918f5402cbae9f769aa6af00d_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWUzZWM1ZTQwODExNGRkMzg5Mzk5YWIwY2UwNTI2MGRfMTU_49c8d3b6-8b7c-440f-88a6-0dec65fa55d9">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i50e9b3944f1f4b6fb772acd25b65ac7e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItNC0xLTEtMTE5ODY4_705109a6-5505-4294-9019-fd67706853ac"
      unitRef="usd">127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib4da5fa079404f4887bbcc27e401662a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjItNi0xLTEtMTE5ODY4_2f599f47-75d8-4250-9cc0-13cc8dbe795f"
      unitRef="usd">127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0741f7081c8944bb9005b5622a22f293_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGFjZGRhMTg4MTdiNDViZDk4ZmU2YWE3OTBlNjVlZWZfNA_97c10ee8-70d4-4b43-b042-7795ab7f02ce"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib0f63498f65d45aeba257d88d0f27555_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NGFjZGRhMTg4MTdiNDViZDk4ZmU2YWE3OTBlNjVlZWZfMTU_d543254a-1fa3-4c00-8b70-179acb7c9010">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i852117f888144b7abbee72f3bbb5e8a4_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtNC0xLTEtMTE5ODY4_b4bb2aba-c6ff-45e3-b376-949a22836da8"
      unitRef="usd">1813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i74ee8e50af9441eb87ebc10bce2dee83_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjMtNi0xLTEtMTE5ODY4_038a1f74-3b27-4bc6-aa76-ab054282eec9"
      unitRef="usd">1813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2d8ed26dc30942128f011855ed0d3857_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NDQzYTY4M2RlNzVkNGYwMGFlMWE1NGNkZjVkY2U1NTBfNA_31f373fd-f0d9-49bf-9174-f3a7c6ab5068"
      unitRef="number">0.01750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4c06bcfbe30049bb8d35ab3bd0de7891_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NDQzYTY4M2RlNzVkNGYwMGFlMWE1NGNkZjVkY2U1NTBfMTU_fdc7eef6-2253-4476-9b9c-cbcdbd22a360">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i78c924a87c844f9495ea3277ad27c097_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtNC0xLTEtMTE5ODY4_790b2436-afe9-4c41-819a-a4ac2b597b45"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3aefe516de204b16be7ddf84dca1f0df_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjQtNi0xLTEtMTE5ODY4_0f459e41-a192-4f41-a826-7bc5a47a319e"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i018f8199d0a84888910a13567f64f9e5_I20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWMzYTkzOTE2ZTkwNDJkYmE5YWY4OGE4ZjhkZTY0OWVfNA_4d1ffb88-087c-4fc1-8a1a-1477e7266ecf"
      unitRef="number">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i91156a4cd65b45e78be0eb72d39dfeb8_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtMC0xLTEtMTE5ODY4L3RleHRyZWdpb246NWMzYTkzOTE2ZTkwNDJkYmE5YWY4OGE4ZjhkZTY0OWVfMTU_6d7c2c3b-77ff-4cbf-98bd-22a38b334566">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic21748abe44f4b12903d6c9dcfd1a0ee_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtNC0xLTEtMTE5ODY4_b5b3ce8c-d30d-47fa-86e3-6bfa4e68f2e6"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie2cf68665dfc4e2b9d53778d119549ba_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMjUtNi0xLTEtMTE5ODY4_48b2f964-8726-4926-b6e2-ee9fde909fdc"
      unitRef="usd">1064000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzItNC0xLTEtMTE5ODY4_f7390f73-8185-481b-999d-dc948693cac6"
      unitRef="usd">55000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzItNi0xLTEtMTE5ODY4_1cb65120-6d6d-4fff-8828-951635802952"
      unitRef="usd">56000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzMtNC0xLTEtMTE5ODY4_15323d7a-1350-4fad-9610-41f82db6ee4e"
      unitRef="usd">116000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzMtNi0xLTEtMTE5ODY4_31996c4b-8fe1-4209-835c-813e72c7a6df"
      unitRef="usd">109000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzQtNC0xLTEtMTE5ODY4_9d0bc2fc-9887-41a5-997a-9c9f7fff3e8f"
      unitRef="usd">49000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzQtNi0xLTEtMTE5ODY4_2c0efcd1-722f-4812-b3c4-d5722a1e51ae"
      unitRef="usd">52000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzUtNC0xLTEtMTE5ODY4_41d66139-bec8-48a9-b3d1-ba1367c05cff"
      unitRef="usd">20753000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RhYmxlOmY5NTdjYTYzOTVmYzQzZjc4MmU3ZTYwZGM4NTZiNGIxL3RhYmxlcmFuZ2U6Zjk1N2NhNjM5NWZjNDNmNzgyZTdlNjBkYzg1NmI0YjFfMzUtNi0xLTEtMTE5ODY4_64366744-a9d6-4828-91c9-c86706ba3926"
      unitRef="usd">20372000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id2453d698b504decb33b115bb6f57fab_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODE5MDYx_516bf23d-1b9b-4459-9fd9-7781d027a3e7"
      unitRef="eur">3500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="if9d010c11bbf46a3a80141df5fc433c4_D20220901-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfNTQ5NzU1ODE4NzU4_bf393f76-3a57-4e3b-a65f-402aa4ac66a0"
      unitRef="eur">3500000000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if23f6f1cf4f1419886209a1983b1efe1_I20220531"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMTk4Nw_78ff6819-3fa0-4589-8c34-a416deeff2df"
      unitRef="jpy">300000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjAwNQ_b0cb1485-4259-443b-a20c-7cd2b62380c8">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i95bf75a4681040b69ec7a41ec26fca98_D20220501-20220531"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjE1Mw_918d5d57-e1ff-46fd-aa0b-4221b59fc5ad"
      unitRef="number">0.0040</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjM1Mw_e79cdec8-cdf3-481a-8c74-2692ed0b1878"
      unitRef="jpy">297000000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i5986438a301044cd88205d3dfff3bcd7_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjM3NA_22d489ac-6490-4fdc-a81e-cc7d094c4ad5"
      unitRef="usd">2300000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i6dd0dc4372b54d09b9d6fcf86a905998_I20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjUxOA_79209db5-2680-4605-81bf-483de7f67e68"
      unitRef="usd">1900000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8501e4357d94654a4b7f096cf014e1e_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjU0MQ_1200b743-b8b7-415c-aab3-64367b4330f0"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="iac7ff8ab22ab491e8c00fb7695d6bd7c_D20220501-20220531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjU2OQ_01ca8eee-a073-4ca9-bf4b-6c54736ed1dc"
      unitRef="usd">1900000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i13d9c16cf83847d8b9dc071854e7249e_I20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjYwMA_d1a5cd8b-4ab4-44a7-a404-aaa5f87bbb5e"
      unitRef="usd">368000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9ebd3167ead94b20bb0cf7ca721fde30_I20220531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjYyNA_a37ef70e-eb2a-4e2c-80da-b09846804b77"
      unitRef="number">0.03350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i161f2ac0c7ae4093a36c525826d423bc_D20220501-20220531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjY1Mw_b15e4697-fa8c-48a8-ba2b-cf8c301275e2"
      unitRef="usd">376000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i678b39b151df49b2ba21b6aea15b2c79_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMjc0Mg_bcd777ff-99e1-4daf-896c-124dc9e79c80"
      unitRef="usd">-53000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzEwMA_bd93fe14-2830-46af-b75f-c13dcd1f17ae"
      unitRef="usd">21100000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzEzNg_ff8da349-76e1-413f-b7d3-8c195de88bd9"
      unitRef="usd">24400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzE3Ng_a07ab2e5-ba82-46f6-9004-62ea23d81c58"
      unitRef="usd">22900000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81NS9mcmFnOmZkZDgwNmY1ZDY0ZDQ2MDlhOGQ2ZGY0YWI0M2MxNDVlL3RleHRyZWdpb246ZmRkODA2ZjVkNjRkNDYwOWE4ZDZkZjRhYjQzYzE0NWVfMzIxMg_f72ca3df-c423-4e3d-b6cf-93bb3de2c4ae"
      unitRef="usd">24200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUyMw_06f6bb14-d671-46bc-bb7a-34f5d4f32492">Derivatives and Currency Exchange Risk Management &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses operational and economic hedges, including currency exchange rate derivative contracts and interest rate derivative instruments, to manage the impact of currency exchange and interest rate changes on earnings and cash flows. In addition, the Company uses cross currency interest rate swaps to manage currency risk related to certain debt. In order to minimize earnings and cash flow volatility resulting from currency exchange rate changes, the Company enters into derivative instruments, principally forward currency exchange rate contracts. These contracts are designed to hedge anticipated foreign currency transactions and changes in the value of specific assets and liabilities. At inception of the contract, the derivative is designated as either a freestanding derivative or a cash flow hedge. Currencies of our derivative instruments include the Euro, Japanese Yen, Chinese Yuan, and others. The Company does not enter into currency exchange rate derivative contracts for speculative purposes. The gross notional amount of all currency exchange rate derivative instruments outstanding was $17.9 billion and $13.8 billion at October&#160;28, 2022 and April&#160;29, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses derivative and non-derivative instruments to manage the impact of currency exchange rate changes on net investments in foreign currency-denominated operations. The information that follows explains the various types of derivatives and financial instruments used by the Company, reasons the Company uses such instruments, and the impact such instruments have on the Company&#x2019;s consolidated balance sheets and statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Freestanding Derivative Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Freestanding derivative contracts are primarily used to offset the Company&#x2019;s exposure to the change in value of specific foreign-currency-denominated assets and liabilities, and to offset variability of cash flows associated with forecasted transactions denominated in foreign currencies. The gross notional amount of the Company's freestanding currency exchange rate contracts outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $5.1 billion and $4.9 billion, respectively. The Company's freestanding currency exchange rate contracts are not designated as hedges, and therefore, changes in the value of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related change in value of foreign-currency-denominated assets, liabilities, and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses total return swaps to hedge the liability of a non-qualified deferred compensation plan. The gross notional amount of the Company's total return swaps outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $208 million and $226 million, respectively. The Company's total return swaps are not designated as hedges, and therefore, changes in the value of these instruments are recognized in earnings. The cash flows related to the Company's freestanding derivative contracts are reported as operating or financing activities, depending on the nature of the underlying hedged item, in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forward contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. The gross notional amount of these contracts, designated as cash flow hedges, outstanding at October&#160;28, 2022 and April&#160;29, 2022 was $8.3 billion and $8.8 billion, respectively, and will mature within the subsequent three-year period. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;derivative instrument is reported as a component of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The gain or loss on the derivative instrument is reclassified into earnings and is included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income in the same period or periods during which the hedged transaction affects earnings. Amounts excluded from the measurement of hedge effectiveness are recognized in earnings on a straight-line basis over the term of the hedge. The cash flows related to all of the Company's derivative instruments designated as cash flow hedges are reported as operating activities in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;28, 2022 and April&#160;29, 2022, the Company had $852 million and $474 million in after-tax net unrealized gains, respectively, associated with cash flow hedging instruments recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company expects that $617 million of after-tax net unrealized gains at October&#160;28, 2022 will be recognized in the consolidated statements of income over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has designated Euro-denominated and Yen-denominated debt as net investment hedges of certain of its European and Japanese operations to manage the exposure to currency and exchange rate movements for foreign currency-denominated net investments in foreign operations. At October&#160;28, 2022, the Company had &#x20ac;16.0 billion, or $15.9 billion, of outstanding Euro-denominated debt designated as a hedge of its net investment in certain of its European operations, and &#xa5;297 billion, or $2.0 billion, of outstanding Yen-denominated debt designated as a hedge of its net investment in certain of its Japanese operations. The Euro-denominated debt will mature in fiscal year&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s 2023 through 2051, and the Yen-denominated debt will mature in fiscal year 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company may also use derivative instruments to hedge the currency risk associated with its net investment in foreign operations. Foreign currency forward contracts may be used on a standalone basis or in combination with option collars. At October&#160;28, 2022, the Company had foreign currency contracts with a notional value of &#x20ac;4.5 billion, or $4.5 billion, hedging a portion of its net investment in certain of its European operations. The foreign exchange contracts mature in fiscal years 2024 and 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For instruments that are designated and qualify as net investment hedges, the gains or losses are reported as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The gains or losses are reclassified into earnings upon a liquidation event or deconsolidation of the foreign subsidiary. Amounts excluded from the assessment of effectiveness are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on a straight-line basis over the term of the hedge. During the three and six months ended October&#160;28, 2022, the Company recognized $27 million and $47 million in after-tax unrealized gains representing excluded components in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The cash flows related to the Company's derivative instruments designated as net investment hedges are reported as investing activities in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gains and Losses on Hedging Instruments and Derivatives not Designated as Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the gains and losses on our hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Reclassified into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss in Income Statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the gains and losses on our derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss in Income Statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance Sheet Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;28, 2022 and April&#160;29, 2022. The fair value amounts are presented on a gross basis, and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments, and are further segregated by type of contract within those two categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value - Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to present the fair value of derivative assets and liabilities within the consolidated balance sheets on a gross basis, even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. The cash flows related to collateral posted and received are reported gross as investing and financing activities, respectively, in the consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMTEyNw_8edffb30-5961-415e-9a2f-d8c50f948668"
      unitRef="usd">17900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMTEzNA_dc1d5e1b-6d2e-4ae0-8e26-bd64c78c4738"
      unitRef="usd">13800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic328877cbe2640fabe36e10bcb5a5194_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjA1OA_e5e87d1d-3d21-43ac-a117-4749981fdff1"
      unitRef="usd">5100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i36cbb82fcc7646f6bff301a9323152ad_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjA2NQ_529e6577-67ad-42fe-b50b-01af7174ea8c"
      unitRef="usd">4900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib01e16de38004386abf16c41bcca590a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjYwNg_b8921336-bba4-4f49-91bc-53a2c1d907ae"
      unitRef="usd">208000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ide9ac26ecdb447a5b065fa1afca7c2af_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMjYxMw_f7e238dc-515e-43b3-8ffe-49c95297d55f"
      unitRef="usd">226000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieac80a3fc9174c3fbd499cdda5660e8f_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMzM0MA_5ef0a260-f49d-485d-aa7a-a031a1cf4dbb"
      unitRef="usd">8300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6fb15af4122d40f094823a9045c8305c_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfMzM0Nw_ba80fba7-1532-4308-b147-37487d69a5db"
      unitRef="usd">8800000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i2a6af32d4b8247b4b5b8e8370744ce94_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxMw_160a8dde-336f-497d-980f-583200402110">P3Y</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDIxMw_7efed22b-4f72-4bec-90a9-bf57b402f055"
      unitRef="usd">852000000</mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDIyMA_51c01b1a-7ede-44ba-87f5-0d2c16986dd1"
      unitRef="usd">474000000</mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDM5Mw_a6c65b63-35d6-4fb6-8be0-ca51fa988e30"
      unitRef="usd">617000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f985b4d85524a5e894505c6ba972295_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDg0Ng_1884df5f-1929-41ab-85a7-5c2e7a02fab3"
      unitRef="eur">16000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i32e75265ade74bd1b82d3b46447ba700_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDg1Mw_fdba2911-ec88-4b6d-986c-8de363f573b6"
      unitRef="usd">15900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f985b4d85524a5e894505c6ba972295_I20221028"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDk4MQ_05c3a4e4-b7cc-4455-a63d-c000a9ddbc72"
      unitRef="jpy">297000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i95a7ac115f1d4e669668238c726ec554_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNDk4OA_2aff4717-fe0f-43e4-b479-b19906d7374e"
      unitRef="usd">2000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTU2Mw_e777d149-8720-4efa-89de-34666ff9fe40"
      unitRef="eur">4500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iba7e1f38a3dc4ba98b5c4d0d327c426a_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTU3MA_9c659624-3750-43ab-9b39-400443da1b8c"
      unitRef="usd">4500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTQ5NzU1ODIyNTAy_71118995-83ff-45d9-ac16-e1592698eaf0"
      unitRef="usd">27000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfNTQ5NzU1ODIyNTEy_f39546c4-e93b-46b5-99a5-ec7a5170777b"
      unitRef="usd">47000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxOQ_46fe7d86-9e56-4e0d-9c46-9b702c6dae3a">&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the gains and losses on our hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.166%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain)&#160;Loss&#160;Recognized in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" rowspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Reclassified into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss in Income Statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of the gains and losses on our derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of (Gain) Loss in Income Statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xLTEtMS0xMTk4Njg_e141e705-1d15-417a-a23b-5dac20cbe03c"
      unitRef="usd">266000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0zLTEtMS0xMTk4Njg_4d4fc02a-a1e5-464e-895a-5d88b9f7c531"
      unitRef="usd">158000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS01LTEtMS0xMTk4Njg_0aed9808-49b4-48aa-9447-53e2aa039b2b"
      unitRef="usd">608000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS03LTEtMS0xMTk4Njg_7b28498f-c6fa-4890-b993-1f72005ae82d"
      unitRef="usd">322000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS05LTEtMS0xMTk4Njg_bca62cdf-1035-4f0e-a07d-0b2bd0c8ec82"
      unitRef="usd">205000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xMS0xLTEtMTE5ODY4_eb5f6225-4ce7-4f73-8171-1b062896e31d"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xMy0xLTEtMTE5ODY4_c97bdf50-3298-498f-83d7-c0173f52fc23"
      unitRef="usd">343000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNS0xNS0xLTEtMTE5ODY4_4e7d019b-9dfe-4656-a86b-95cf76e77e79"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xLTEtMS0xMTk4Njg_54f6a7e9-9e5f-4596-9083-da3f838e4af5"
      unitRef="usd">133000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0zLTEtMS0xMTk4Njg_779c122e-3bff-46bb-b4a2-f84f18a6e4d4"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id475727b6150430e9d00cf9d847ab244_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi01LTEtMS0xMTk4Njg_ba7cad2f-0fb7-4f39-81d2-4989ebbdade8"
      unitRef="usd">167000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi03LTEtMS0xMTk4Njg_df0d9003-ea4d-40e2-895a-d758b1e6faf5"
      unitRef="usd">-43000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i94618a18231d4e4b8ce75c85d2418c75_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi05LTEtMS0xMTk4Njg_0cd99de3-f4db-41b1-81bd-0d7ac6876b57"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaf686fbb0e75485882bb1d535adc5474_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xMS0xLTEtMTE5ODY4_82e83518-a7ae-4291-9c7f-61f4810d9af2"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id475727b6150430e9d00cf9d847ab244_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xMy0xLTEtMTE5ODY4_f813070b-babc-4571-bceb-d99ab12303fe"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="if2eb4f16585e4d2b8f332830c0b37eb5_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfNi0xNS0xLTEtMTE5ODY4_266994bd-1377-4a94-87bb-8cbeffb093e4"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xLTEtMS0xMTk4Njg_1a9324d3-5ea3-421c-8835-7ebc7ebe6e20"
      unitRef="usd">405000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib77747096918490f971ab8604b359744_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0zLTEtMS0xMTk4Njg_a26c2d67-cc1f-4598-aa06-19de84b5906b"
      unitRef="usd">356000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC01LTEtMS0xMTk4Njg_21725a2a-2a79-4f60-aea8-a2b5ec0ddbf3"
      unitRef="usd">1350000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC03LTEtMS0xMTk4Njg_8ebd1683-db02-4c26-b9ca-c31d7b8eff32"
      unitRef="usd">780000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i1e129c2b25f84523a19b93e45301da98_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC05LTEtMS0xMTk4Njg_ee52bfde-50b6-48fd-b9c1-d773fd288a3c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ib77747096918490f971ab8604b359744_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xMS0xLTEtMTE5ODY4_e6b89a02-8d61-4759-a9d4-23679ae0fe1d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9d236a2af4c04cf18c9d81c7d1b16866_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xMy0xLTEtMTE5ODY4_7db23a4e-f9a6-4942-ad85-b345e09090cd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5fbe55e114a54bb59a7418e5595f88dc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOC0xNS0xLTEtMTE5ODY4_42f7ab0a-f109-45f3-a91d-e3ee4e82f012"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i90500a074bb3400493c7a435521e7259_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xLTEtMS0xMTk4Njg_6bbafa24-85bc-4809-8f85-6dcbea625546"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0zLTEtMS0xMTk4Njg_8243a613-a88c-4d9f-b035-f089ace77474"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS01LTEtMS0xMTk4Njg_613f5f90-2ab9-493b-a897-a3e804625f00"
      unitRef="usd">59000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id56e46722aac483a8619dd533deb3322_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS03LTEtMS0xMTk4Njg_e8eb1b06-b479-47ae-9d18-080c9082ccb6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i90500a074bb3400493c7a435521e7259_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS05LTEtMS0xMTk4Njg_0af60948-a6cd-41b1-9b24-fdaf826ec7d2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i046d981e0a75416cb2429f322aeb6b91_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xMS0xLTEtMTE5ODY4_32877376-0aa4-4eaf-8d1a-7f3b0c047af9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i155c8df2f842439d903942f73fabe9ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xMy0xLTEtMTE5ODY4_2928b5c4-ddee-4f5b-a57f-9cfa64863c12"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="id56e46722aac483a8619dd533deb3322_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfOS0xNS0xLTEtMTE5ODY4_b28f831b-ef40-403d-91be-09e46b15d3da"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMS0xLTEtMTE5ODY4_e5125a32-ee54-4d02-9a08-6250f116c910"
      unitRef="usd">806000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMy0xLTEtMTE5ODY4_8e7082c3-5256-4332-8ba8-b32450af1946"
      unitRef="usd">475000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtNS0xLTEtMTE5ODY4_c97404e8-7750-4fc9-bd80-1a9e93acc17d"
      unitRef="usd">2184000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtNy0xLTEtMTE5ODY4_e155a75a-fef1-4fe1-8955-fb9c31c54ba3"
      unitRef="usd">1059000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtOS0xLTEtMTE5ODY4_878b148d-5ef9-4047-8577-84b45e80b4ae"
      unitRef="usd">202000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTEtMS0xLTExOTg2OA_97fcd6b3-d92a-4f3d-9502-7439e63b887d"
      unitRef="usd">0</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTMtMS0xLTExOTg2OA_2041650d-08d1-456e-9c0a-c3b20fb2a556"
      unitRef="usd">322000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjE2NTYzMDM2YmZkMTQ3N2RhNGE3YWZiOTlmZDQ5Mjk3L3RhYmxlcmFuZ2U6MTY1NjMwMzZiZmQxNDc3ZGE0YTdhZmI5OWZkNDkyOTdfMTAtMTUtMS0xLTExOTg2OA_3504142f-eb7b-44d5-8ecd-e93fef1ab075"
      unitRef="usd">-31000000</mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ib146ec7e56404bd58c0776242a13b38e_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC0xLTEtMS0xMTk4Njg_8ddba0d1-3dcc-41ed-b3ab-3546cf7943fe"
      unitRef="usd">-21000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i1f0494f764e24dd493f2c9240002e8ef_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC0zLTEtMS0xMTk4Njg_2e09f564-b1ef-40b6-8599-5327cc3778fe"
      unitRef="usd">16000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i70aca66f4c204311916fcabcc68cc5c1_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC01LTEtMS0xMTk4Njg_4085ec79-8e8a-4b5d-8544-05cee32f606f"
      unitRef="usd">-47000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i54e5cacf89ff433683b1d05d8c294adc_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNC03LTEtMS0xMTk4Njg_55fc2152-24ad-497f-ade6-382de1eae877"
      unitRef="usd">34000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i72954acc9e57495896b675167421b561_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS0xLTEtMS0xMTk4Njg_2591c33f-b4ee-4210-ad7f-b5c70fb4164e"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="idb4c499d238442789c803ba3b479b911_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS0zLTEtMS0xMTk4Njg_5bdacbd5-7aa3-4a38-b2ed-300d89b54192"
      unitRef="usd">12000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ifd16066db5b741dfa7eb70f35224624f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS01LTEtMS0xMTk4Njg_cd72148b-00ac-4af4-99d0-79f3723d2830"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic070ac672e7e4600bb8f39e2dfd14cb2_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNS03LTEtMS0xMTk4Njg_b8aa2874-fd01-4289-a551-10e66927221d"
      unitRef="usd">25000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi0xLTEtMS0xMTk4Njg_9a2d2b32-ec75-41e9-9e89-99fd0ef0fed3"
      unitRef="usd">-34000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi0zLTEtMS0xMTk4Njg_dedc2718-c7b0-4292-a241-8968eb2fb50d"
      unitRef="usd">28000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi01LTEtMS0xMTk4Njg_54192dd8-68f2-4475-9a13-2f954b0eb197"
      unitRef="usd">-60000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjdjMDBlOTEwMmIyOTRhZWI5YWIwMDNjOTdlNDU5NzlhL3RhYmxlcmFuZ2U6N2MwMGU5MTAyYjI5NGFlYjlhYjAwM2M5N2U0NTk3OWFfNi03LTEtMS0xMTk4Njg_616bec46-b24a-4d70-8bcd-82e970adccb9"
      unitRef="usd">59000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUzNw_e2ee3021-74ca-4064-b320-86d07eb530d6">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the balance sheet classification and fair value of derivative instruments included in the consolidated balance sheets at October&#160;28, 2022 and April&#160;29, 2022. The fair value amounts are presented on a gross basis, and are segregated between derivatives that are designated and qualify as hedging instruments and those that are not designated and do not qualify as hedging instruments, and are further segregated by type of contract within those two categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value - Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i030ec29f92aa49e58cf998d20561e1bb_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy0xLTEtMS0xMTk4Njg_3fc58942-f0f5-48fa-a032-0058b211e4e7"
      unitRef="usd">742000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibe75196bd192408f9bb4a29e186401b4_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy0zLTEtMS0xMTk4Njg_acf8461a-7881-4464-8a26-e13e8ac094ff"
      unitRef="usd">481000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id51ce1803c5c4ba6810ae2c023e74833_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy03LTEtMS0xMTk4Njg_a3a18882-572a-4c3d-849d-6a852ce8e275"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id3c626f296fc49089588a3e25c3e2b23_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMy05LTEtMS0xMTk4Njg_a355ed23-5dd0-4d9c-b154-c493d2abd9a8"
      unitRef="usd">43000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia500e65b15db40148004c1bc60ce317d_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS0xLTEtMS0xMTk4Njg_c7e00c61-c9db-4c8f-a559-a7db40944246"
      unitRef="usd">318000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia9451fb3d1f04f6187e22f627a237e7d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS0zLTEtMS0xMTk4Njg_555fd8ba-6d27-4ae4-9da8-88cde4ae65a8"
      unitRef="usd">168000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6126e03c431748d39e312714f45be287_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS03LTEtMS0xMTk4Njg_3f83bfc3-dfa0-44ea-9a83-3fad74755561"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i74e6b87b21534ddcb6def602654c92e5_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNS05LTEtMS0xMTk4Njg_330db7ee-4071-483f-892b-6afd6c65cb85"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i68ea2486c0a94abfb5ca1108224bba7c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi0xLTEtMS0xMTk4Njg_39d6b11d-3abf-4613-9d8b-718f0754b3f3"
      unitRef="usd">1060000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i21219af6460740dc8a8f2b42aa062bc0_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi0zLTEtMS0xMTk4Njg_e4ad7045-44a4-4d3d-bfba-08f6028e0e1d"
      unitRef="usd">649000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i68ea2486c0a94abfb5ca1108224bba7c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi03LTEtMS0xMTk4Njg_edd08dea-47f4-4e3d-9dd4-fe2b5c06b9da"
      unitRef="usd">13000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i21219af6460740dc8a8f2b42aa062bc0_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfNi05LTEtMS0xMTk4Njg_431b1055-90a6-48a7-888e-eb50583ce849"
      unitRef="usd">60000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2f4b74a32e9248a69778cfd5232923a2_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC0xLTEtMS0xMTk4Njg_e6024ca3-6404-44db-b937-7ab6d525d337"
      unitRef="usd">22000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i83392e630d054b0bb17f041fb38ee1b6_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC0zLTEtMS0xMTk4Njg_066e26aa-41a4-4e68-83fe-d5db08279c89"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iec2bed4f3dfd4f3b860e60ba24d59a28_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC03LTEtMS0xMTk4Njg_860d7fc8-7bf0-405e-84d6-5a5f5abe06c5"
      unitRef="usd">23000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i40052aaebd204ac8bdb5ce6801703b30_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOC05LTEtMS0xMTk4Njg_6661cf8b-383a-478e-906f-3d9b0a149925"
      unitRef="usd">49000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie8c7fb5b46d345b1b31c77de8ad93269_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS0xLTEtMS0xMTk4Njg_76cfa0c5-5823-40f9-9f0b-322e02499d41"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i19424ad839704570b79f42bfb5ddc820_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS0zLTEtMS0xMTk4Njg_15c16b6d-e669-42b5-bb87-3bdbe81ffa9e"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i6bcc9eef7a754a0ea0e93d2b1b2324b5_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS03LTEtMS0xMTk4Njg_24465bf2-1141-402e-ab70-ee65ef1ec95f"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iec60c574487f47fd970e5240db2d6a74_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfOS05LTEtMS0xMTk4Njg_aed1e007-400e-4979-92b7-4e10b6353623"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i09f696edac744dd7a1aa89ee92b1b57f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtMS0xLTEtMTE5ODY4_7198e347-ceca-4c08-ab58-1d3473561c14"
      unitRef="usd">22000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i34fbedc968094ed2a24602471bb9832e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtMy0xLTEtMTE5ODY4_baddaa3f-5a86-477f-828f-5d11376bc193"
      unitRef="usd">46000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i09f696edac744dd7a1aa89ee92b1b57f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtNy0xLTEtMTE5ODY4_c4b0c549-951b-43ef-8823-cd35c8724e84"
      unitRef="usd">37000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i34fbedc968094ed2a24602471bb9832e_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTMtOS0xLTEtMTE5ODY4_a8d6f637-38dc-490d-8277-f69ae340a981"
      unitRef="usd">69000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtMS0xLTEtMTE5ODY4_4e7c7431-1e52-4482-859a-3198b9fc0eb5"
      unitRef="usd">1082000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtMy0xLTEtMTE5ODY4_6937ddfb-4a83-49cd-b2b5-25c1dc21450f"
      unitRef="usd">695000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtNy0xLTEtMTE5ODY4_2f0059f0-d5d4-426d-b194-5a0465dccbc0"
      unitRef="usd">51000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjMyM2MwYzdmZDc4NzRkNjg5OTY0MDgxODlhZWM4MzUyL3RhYmxlcmFuZ2U6MzIzYzBjN2ZkNzg3NGQ2ODk5NjQwODE4OWFlYzgzNTJfMTQtOS0xLTEtMTE5ODY4_c824fb8c-5e52-4df9-bc0e-b9399b2f4806"
      unitRef="usd">129000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUxNw_26f68df4-ac1c-4804-a28c-1e2d300fa178">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information by level for the derivative assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i08b003f2db6844f2a18ece5fe1fec528_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi0xLTEtMS0xMTk4Njg_5ac2ecba-baf0-4cc6-a8b1-e3a5b9e07272"
      unitRef="usd">1082000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i08b003f2db6844f2a18ece5fe1fec528_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi0zLTEtMS0xMTk4Njg_173568ab-69ec-4b33-af69-4c9b9d19d7c1"
      unitRef="usd">36000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="i0f54a6d38f86409f9d004826da691d0a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi03LTEtMS0xMTk4Njg_8660a713-c740-4840-b02a-e6592b9c83fc"
      unitRef="usd">695000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i0f54a6d38f86409f9d004826da691d0a_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMi05LTEtMS0xMTk4Njg_e8e980c9-bc88-4696-8716-6db799533c77"
      unitRef="usd">109000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy0xLTEtMS0xMTk4Njg_a87f99a2-9b8d-4f91-954f-0dd374e23e3f"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i3cb065edd06b42ab95e3ea8629134f5e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy0zLTEtMS0xMTk4Njg_0f2c238f-9640-4031-8bf9-3057f60bfd2a"
      unitRef="usd">14000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy03LTEtMS0xMTk4Njg_ce104910-1df8-48e2-82fa-9a460571f1df"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i273769593a42414b9854eed6b2e7d297_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfMy05LTEtMS0xMTk4Njg_4a427e03-f47c-4ddd-8110-f1ae0e69437b"
      unitRef="usd">20000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC0xLTEtMS0xMTk4Njg_b57a4088-47bf-4f6d-93bd-890e8cf5f01a"
      unitRef="usd">1082000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC0zLTEtMS0xMTk4Njg_5619c69b-78c1-4740-a89c-152309e71c5d"
      unitRef="usd">51000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC03LTEtMS0xMTk4Njg_b1850629-ac8e-4fd8-9504-8bf402297052"
      unitRef="usd">695000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjM5ZmI4NjFiZGNkNTQ3ZGNiNTk1MDYxNWRmY2U5NWJiL3RhYmxlcmFuZ2U6MzlmYjg2MWJkY2Q1NDdkY2I1OTUwNjE1ZGZjZTk1YmJfNC05LTEtMS0xMTk4Njg_fca980ed-7134-4168-8ce6-383790db5dd7"
      unitRef="usd">129000000</us-gaap:DerivativeLiabilities>
    <us-gaap:OffsettingAssetsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODUwNA_9ee6bd0c-b666-4ceb-8543-2112226065f1">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingAssetsTableTextBlock>
    <us-gaap:OffsettingLiabilitiesTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RleHRyZWdpb246ZDMzMWE3YTdhZDQ4NDljNGE0MDlmYTNlZWE0NWFkNDNfODU0MA_b192dacb-a775-4212-905f-38a1e6f0c2c7">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria as stipulated by the terms of the master netting arrangements with each of the counterparties. Derivatives not subject to master netting arrangements are not eligible for net presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount Not Offset on the Balance Sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount of Recognized Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash Collateral (Received) Posted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency exchange rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total return swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OffsettingLiabilitiesTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC0yLTEtMS0xMTk4Njg_df63da44-c1b0-465c-a798-5da0bb0a84e2"
      unitRef="usd">1082000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC00LTEtMS0xMTk4Njg_8cf032e4-a6a8-4320-9feb-a54b1af0c724"
      unitRef="usd">31000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC02LTEtMS0xMTk4Njg_e727dd6d-1fa5-4889-8e19-13c4916e32fc"
      unitRef="usd">704000000</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfNC0xMC0xLTEtMTE5ODY4_fd0f7e6b-83fa-4414-962e-7745aaa2206c"
      unitRef="usd">347000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtMi0xLTEtMTE5ODY4_475a9fbf-e02f-4abb-a8cb-285f544cb695"
      unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtNC0xLTEtMTE5ODY4_6ac83ef3-6c7f-477d-8d6c-77e7ea30d1a9"
      unitRef="usd">31000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtNi0xLTEtMTE5ODY4_4d118849-d46b-4934-be4d-41ba06d51414"
      unitRef="usd">1000000</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="ib5092cafc30846dd94ed5c026e97aa0b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTAtMTAtMS0xLTExOTg2OA_b3e6e068-d618-4439-9b76-86e78339ea0d"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMi0xLTEtMTMzNzA5_d99368b8-df23-4f31-94d5-e58831a799f1"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNC0xLTEtMTMzNzA5_ea266caa-4e5b-4383-bdcf-199433a5ad30"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNi0xLTEtMTMzNzA5_f1530483-9b5b-4b6b-9b79-796a9ce60404"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i47c72990d6894f6999fbd71fa806b6ec_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMTAtMS0xLTEzMzcwOQ_7d774da4-44c8-4837-80ea-e0c6a5d2f740"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMi0xLTEtMTE5ODY4_0d011161-481d-4fb9-890e-bb5d1395314b"
      unitRef="usd">51000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNC0xLTEtMTE5ODY4_cc9f5304-627f-4fe5-beab-1bcc3e64c027"
      unitRef="usd">31000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtNi0xLTEtMTE5ODY4_37c60beb-36ae-4c1b-9ae2-c9230a7c6495"
      unitRef="usd">1000000</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTQtMTAtMS0xLTExOTg2OA_d9df2b17-41c8-459a-a254-85c8107f215e"
      unitRef="usd">18000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtMi0xLTEtMTE5ODY4_e7259b76-5cb8-43a7-80cc-cfede7724578"
      unitRef="usd">1031000000</mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability>
    <mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtNC0xLTEtMTE5ODY4_d265f6ce-ee45-47cf-be37-44040d596baf"
      unitRef="usd">0</mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction>
    <mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtNi0xLTEtMTE5ODY4_d885a231-0aab-4585-9084-a51f71ccb514"
      unitRef="usd">703000000</mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash>
    <us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOmVlODZjYmIyMzYzMTQxNjQ4MjQ3YWMzY2E4ZWMzZGUwL3RhYmxlcmFuZ2U6ZWU4NmNiYjIzNjMxNDE2NDgyNDdhYzNjYThlYzNkZTBfMTUtMTAtMS0xLTExOTg2OA_9258a088-3548-4ae0-bbd7-e259703895a9"
      unitRef="usd">329000000</us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC0yLTEtMS0xMTk4Njg_a5c6eee9-74f8-4888-ba82-d140ade6037e"
      unitRef="usd">695000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC00LTEtMS0xMTk4Njg_e456c610-bca9-41c6-80aa-d3045cc388ba"
      unitRef="usd">109000000</us-gaap:DerivativeAssetNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralObligationToReturnCash
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC02LTEtMS0xMTk4Njg_39ab9365-08b7-4891-a97c-40b620bc10af"
      unitRef="usd">254000000</us-gaap:DerivativeCollateralObligationToReturnCash>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfNC0xMC0xLTEtMTE5ODY4_e9851686-456b-4af6-8ef3-74ad14ad183e"
      unitRef="usd">332000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtMi0xLTEtMTE5ODY4_dae24d2a-3eec-43bc-9bc8-bc17a7be5b19"
      unitRef="usd">109000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtNC0xLTEtMTE5ODY4_0426dbb4-7df4-46e0-a39e-6f336a26cb55"
      unitRef="usd">109000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtNi0xLTEtMTE5ODY4_c439ca94-14d4-4d4b-8079-97bc63fc9b99"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i17154ded948b43b795f47e739a934d01_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTAtMTAtMS0xLTExOTg2OA_abaf7876-0b4d-4823-bec9-882768074791"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtMi0xLTEtMTE5ODY4_fed6387a-4f7e-4e95-a5b2-8fef0e39860a"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtNC0xLTEtMTE5ODY4_b8622bb4-21e4-4b8b-ba0b-fdcfa4a9f3c9"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtNi0xLTEtMTE5ODY4_ff474fab-38ef-4e2b-af01-4f327c6bdcf6"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="i705cf34bc80b41febb1dd15cddb734cb_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTMtMTAtMS0xLTExOTg2OA_85ca109f-7e90-43a5-ba2c-6cd7c28fb1a3"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtMi0xLTEtMTE5ODY4_a1304582-e187-4c86-83b8-52b93659235b"
      unitRef="usd">129000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtNC0xLTEtMTE5ODY4_204af104-ece7-4d0d-9328-18ef7711cc60"
      unitRef="usd">109000000</us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction>
    <us-gaap:DerivativeCollateralRightToReclaimCash
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtNi0xLTEtMTE5ODY4_3c56323b-7657-470c-989b-9638cf232086"
      unitRef="usd">0</us-gaap:DerivativeCollateralRightToReclaimCash>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTQtMTAtMS0xLTExOTg2OA_6fd007a3-29f0-46db-8517-d573b0450e3a"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral>
    <mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtMi0xLTEtMTE5ODY4_948e345d-5eb6-49d2-9355-518e280e5221"
      unitRef="usd">566000000</mdt:DerivativeAssetLiabilityFairValueGrossAssetLiability>
    <mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtNC0xLTEtMTE5ODY4_532cf99f-5c8c-42bf-9000-792d820ee0a4"
      unitRef="usd">0</mdt:DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction>
    <mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtNi0xLTEtMTE5ODY4_36deb9af-364a-48ee-89f9-5e09093a6697"
      unitRef="usd">254000000</mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash>
    <us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV81OC9mcmFnOmQzMzFhN2E3YWQ0ODQ5YzRhNDA5ZmEzZWVhNDVhZDQzL3RhYmxlOjVjMDhjZGVjYzZmMDQ3NzViOGExNjRlOTA1ZjkwZDY1L3RhYmxlcmFuZ2U6NWMwOGNkZWNjNmYwNDc3NWI4YTE2NGU5MDVmOTBkNjVfMTUtMTAtMS0xLTExOTg2OA_9cf80ba6-c22e-435c-8e32-db33a42b3f55"
      unitRef="usd">312000000</us-gaap:DerivativeFairValueAmountOffsetAgainstCollateralNet>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RleHRyZWdpb246NmQ4N2M4NzBmMGVkNGUxNDllY2E2MGExZmM4YWRjNTVfNzM_b820f871-bf9e-4e3f-b5ca-178c7c077bef">Inventories &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory balances, net of reserves, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RleHRyZWdpb246NmQ4N2M4NzBmMGVkNGUxNDllY2E2MGExZmM4YWRjNTVfNzU_7dcc6004-f167-4e02-a5ed-3b7f2b5e38a4">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory balances, net of reserves, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMS0xLTEtMS0xMTk4Njg_2004dc06-f93c-4b5a-b781-f922d4bc31d5"
      unitRef="usd">3317000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMS0zLTEtMS0xMTk4Njg_0c680c49-f264-4f32-89a4-a49a92eddcb7"
      unitRef="usd">3070000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMi0xLTEtMS0xMTk4Njg_2be8d543-5609-47a7-8f8a-d7690731b6c8"
      unitRef="usd">769000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMi0zLTEtMS0xMTk4Njg_6fe8548a-dbdc-4c2b-bb08-805c371ebc3b"
      unitRef="usd">682000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMy0xLTEtMS0xMTk4Njg_748f7df0-c3d0-494e-b4b6-07be9da4b4f6"
      unitRef="usd">969000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfMy0zLTEtMS0xMTk4Njg_2d701674-8483-4e71-989d-58c53606c665"
      unitRef="usd">864000000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfNC0xLTEtMS0xMTk4Njg_3a4bf07b-a4b4-4faa-8527-75648b90835c"
      unitRef="usd">5055000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82NC9mcmFnOjZkODdjODcwZjBlZDRlMTQ5ZWNhNjBhMWZjOGFkYzU1L3RhYmxlOjBkNDZmMmRiNDA0YTRlMzJhZDZlOTNhOTliMTk2ZTI0L3RhYmxlcmFuZ2U6MGQ0NmYyZGI0MDRhNGUzMmFkNmU5M2E5OWIxOTZlMjRfNC0zLTEtMS0xMTk4Njg_c35a4c89-0b8c-4d60-b3e3-10219bd23697"
      unitRef="usd">4616000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI5OQ_4070330f-a33f-4318-b6ab-4fccf29a0866">Goodwill and Other Intangible Assets &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of goodwill by segment: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diabetes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as a result of acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the agreement with DaVita, as disclosed in Note 4 to the consolidated financial statements, the Company allocated $208&#160;million of goodwill to the RCS business that met the criteria to be classified as held for sale during the first quarter of fiscal year 2023. Upon allocation, a goodwill impairment test was performed for the RCS business, and the Company recognized $61 million of goodwill impairment during the six months ended October&#160;28, 2022. The goodwill impairment charges are recognized in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; other operating (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. The Company did not recognize any goodwill impairments during the three months ended October&#160;28, 2022 and the three and six months ended October&#160;29, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any definite-lived intangible asset charges during the three and six months ended October&#160;28, 2022 and the three months ended October&#160;29, 2021. During the six months ended October&#160;29, 2021, the Company recognized $409&#160;million of definite-lived intangible asset charges in connection with MCS within the Cardiovascular Portfolio. Refer to Note 5 to the consolidated financial statements for additional information on what led to the impairment. Intangible asset impairment charges are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any indefinite-lived intangible asset impairments during the three and six months ended October&#160;28, 2022 and October&#160;29, 2021. Due to the nature of IPR&amp;amp;D projects, the Company may experience future delays or failures to obtain regulatory approvals to conduct clinical trials, failures of clinical trials, delays or failures to obtain required market clearances, other failures to achieve a commercially viable product, or the discontinuation of certain projects, and as a result, may recognize impairment losses in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortization Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense for the three months ended October&#160;28, 2022 and October&#160;29, 2021 was $421&#160;million and $431&#160;million, respectively. Intangible asset amortization expense for the six months ended October&#160;28, 2022 and October&#160;29, 2021 was $844 million and $866&#160;million, respectively. Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;28, 2022, excluding any possible future amortization associated with acquired IPR&amp;amp;D which has not yet met technological feasibility, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI4Mw_b4e111f9-692a-477b-9e4a-888b4fc44de6">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of goodwill by segment: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Medical Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diabetes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill as a result of acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i60d4bffbfd284a6a905e87223d86432d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS0xLTEtMS0xMTk4Njg_5ac4a59b-e008-47f9-b807-2c80631f4578"
      unitRef="usd">7160000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iebd53369c48e4ef5b68f6051807d5349_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS0zLTEtMS0xMTk4Njg_3e18b775-9eb2-426f-89df-e095207ad475"
      unitRef="usd">19957000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9ec5f74b25924bd0bc17044be8b8cc7f_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS01LTEtMS0xMTk4Njg_528548a2-f43b-4ff6-805a-7c1d8bbf96f9"
      unitRef="usd">11132000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib08338469c554b8e9fa1ed1bf628cde1_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS03LTEtMS0xMTk4Njg_00a38788-a465-4b64-bd7b-c8818bab3c84"
      unitRef="usd">2254000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMS05LTEtMS0xMTk4Njg_a95ee66e-7c3d-4820-8dc6-de65890c7ad3"
      unitRef="usd">40502000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi0xLTEtMS0xMTk4Njg_468a08ca-03bb-49e4-a911-466d68d220ae"
      unitRef="usd">726000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi0zLTEtMS0xMTk4Njg_79eb1fda-a2c7-4170-a7fc-7cc46abbab3a"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi01LTEtMS0xMTk4Njg_c37076e0-3ead-43d7-a5a1-f62380337c82"
      unitRef="usd">615000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi03LTEtMS0xMTk4Njg_69c27db9-642e-49ec-8802-ce8c50cc1746"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMi05LTEtMS0xMTk4Njg_e039cf24-5b42-44db-97ff-8c6b03ffbaaf"
      unitRef="usd">1340000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy0xLTEtMS0xMTk4Njg_68d36e20-e77c-4d1f-9ec1-120b8baa098a"
      unitRef="usd">-10000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy0zLTEtMS0xMTk4Njg_4a9945c2-27ae-4a8a-9a06-d89078ef306a"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy01LTEtMS0xMTk4Njg_65c2c2d1-aaec-49a1-a457-a95ba0395927"
      unitRef="usd">-3000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy03LTEtMS0xMTk4Njg_b52419af-a0a8-4596-90fd-5832bb62a19f"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfMy05LTEtMS0xMTk4Njg_72558c5c-cf45-474a-8d55-d0b330972b8b"
      unitRef="usd">-13000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTransfers
      contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC0xLTEtMS0xMTk4Njg_ba6bf663-ba04-416d-9b4a-c1be2d093748"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC0zLTEtMS0xMTk4Njg_346ffb91-3da9-4f86-80ae-47ac101d122a"
      unitRef="usd">208000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC01LTEtMS0xMTk4Njg_8f05bdf2-825c-425a-914e-c237e37b4f91"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC03LTEtMS0xMTk4Njg_a71202bf-fdf5-4b02-ad41-e913987ffbf0"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNC05LTEtMS0xMTk4Njg_1b5b6061-c8d7-453f-898a-95fcb7ebc3d0"
      unitRef="usd">208000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i48e4bc70c8f44516acba36d8cff6af5b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS0xLTEtMS0xMTk4Njg_abd08873-8940-4b23-8045-1d49468cd4ed"
      unitRef="usd">-91000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9cdd90550e974e158c0bc945434c3c41_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS0zLTEtMS0xMTk4Njg_9681d89a-165e-4518-8862-b649c588ae90"
      unitRef="usd">-951000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="icc2e7980d7f64d9b82f2079a0d188f34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS01LTEtMS0xMTk4Njg_499e9010-c7ba-40f9-a56d-c2bb33b4ead2"
      unitRef="usd">-163000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1115fddef1a74a1fb2dd0b7ce9a2365b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS03LTEtMS0xMTk4Njg_a8db8ae4-b0ce-4461-8645-4e0b5b27bafe"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNS05LTEtMS0xMTk4Njg_4fbe813b-fa24-4e23-adff-c5804bec93c9"
      unitRef="usd">-1204000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i617c5f38a82c413fa4b606a553f802cf_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi0xLTEtMS0xMTk4Njg_3bfaf686-a4a9-4b71-b3af-f80f4f471d13"
      unitRef="usd">7784000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i50d8dc10f7f74a269ac42c7af38e438d_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi0zLTEtMS0xMTk4Njg_cf8dad91-e7ee-466a-bd3b-f704e0e91cda"
      unitRef="usd">18798000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i50dc8a72d1e845f0bc5eeb780b4167ce_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi01LTEtMS0xMTk4Njg_abcf1697-4aba-4cb9-80d5-5509a2d8c84c"
      unitRef="usd">11581000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3d4bd5b464cf4754bc657a4694f52b1a_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi03LTEtMS0xMTk4Njg_87eb3443-d31c-4067-9f59-2d8f371dff1d"
      unitRef="usd">2254000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOmZhYjYzMDliNzg1YTRjMDY5Nzc3ZDBmYmZhMjAxYWM3L3RhYmxlcmFuZ2U6ZmFiNjMwOWI3ODVhNGMwNjk3NzdkMGZiZmEyMDFhYzdfNi05LTEtMS0xMTk4Njg_086acddf-a4bc-4638-9cdb-1e1cb9ae399e"
      unitRef="usd">40417000000</us-gaap:Goodwill>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i64f3035beec5446b898886392399c009_I20220525"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjQz_26e16e51-7cb2-404b-afde-d363f6a2c5c6"
      unitRef="usd">208000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iaaaa9f5a211e46648d43a13986dd518a_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNDQy_064dbd2f-be9c-4842-80d5-eab68f5d4108"
      unitRef="usd">61000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNjM5_4a8b19c4-96ee-4dcf-9e22-445d42e48bbb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI3Nw_ffa8a8ac-745a-40c1-82bd-23f5e72169cb">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI5Ng_4e0dd992-f373-413f-83f7-f7724545d867">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the gross carrying amount and accumulated amortization of intangible assets: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Definite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-lived:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iae88943d08a644079847bc841e0fe18f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy0xLTEtMS0xMTk4Njg_df9993ed-b52d-43b9-a5f0-307f9ac34c34"
      unitRef="usd">16918000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iae88943d08a644079847bc841e0fe18f_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy0zLTEtMS0xMTk4Njg_fb2d795f-f5e6-4738-9319-b5d0d5c30ede"
      unitRef="usd">7476000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i78ca089b4a214117984874b09ca1d0e6_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy01LTEtMS0xMTk4Njg_7f7ef8f0-f012-4e0e-91b0-70a574d73d17"
      unitRef="usd">16953000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i78ca089b4a214117984874b09ca1d0e6_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfMy03LTEtMS0xMTk4Njg_b18d185e-5e01-4bf5-aba2-785b8f84a7b3"
      unitRef="usd">7005000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic16fb407d39c49d580ac035048e8ce43_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC0xLTEtMS0xMTk4Njg_64c606c5-a34c-4aa9-990f-1d6c47b9c1ea"
      unitRef="usd">11295000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic16fb407d39c49d580ac035048e8ce43_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC0zLTEtMS0xMTk4Njg_c7c6d649-61ea-4cff-90e2-d1a094765f47"
      unitRef="usd">5916000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6bfa7eec43314902906140d18188a9c2_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC01LTEtMS0xMTk4Njg_81d97d49-8bbd-467d-91f9-249353a99c03"
      unitRef="usd">10802000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6bfa7eec43314902906140d18188a9c2_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNC03LTEtMS0xMTk4Njg_a63941a6-bbdc-4c7c-9b66-e49458ae0511"
      unitRef="usd">5667000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i351d6e481f7f40618e1994166ab8abe7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS0xLTEtMS0xMTk4Njg_7e4f5e24-f7b1-434b-b3c3-01a39441ed83"
      unitRef="usd">484000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i351d6e481f7f40618e1994166ab8abe7_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS0zLTEtMS0xMTk4Njg_57dcc334-d57e-4b72-8b0a-16ab5c4f9d9f"
      unitRef="usd">272000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id0837b81f7bc4637bc63f5b62fb85a48_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS01LTEtMS0xMTk4Njg_b78af00f-21b5-4185-8409-eb73df065c98"
      unitRef="usd">473000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id0837b81f7bc4637bc63f5b62fb85a48_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNS03LTEtMS0xMTk4Njg_83a311e8-afea-4ed5-82b0-056708775adc"
      unitRef="usd">266000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi0xLTEtMS0xMTk4Njg_1bd6f74b-11d7-47ba-ad83-35f854cbcc4f"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5a66b1fe567b4c019b2d4f866fa128a6_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi0zLTEtMS0xMTk4Njg_3b4cb3ee-9b69-4e6a-8067-0de57899e3b4"
      unitRef="usd">66000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi01LTEtMS0xMTk4Njg_e5df35e6-2480-4b75-82c9-66b16670bf51"
      unitRef="usd">80000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84f6e5ce0f8c484aa05ca3958ad21271_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNi03LTEtMS0xMTk4Njg_e440d9e4-4d84-49ee-8b46-6d21f869950f"
      unitRef="usd">69000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy0xLTEtMS0xMTk4Njg_63412b2e-62bb-4877-8a42-8179415bff5b"
      unitRef="usd">28802000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy0zLTEtMS0xMTk4Njg_d3b42110-a1bb-4765-a0af-47c22fc8272e"
      unitRef="usd">13730000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy01LTEtMS0xMTk4Njg_d005833f-a368-4e77-aeaa-dfe6df268472"
      unitRef="usd">28308000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfNy03LTEtMS0xMTk4Njg_013fcdcf-5f86-41fd-a943-238283bbd0d3"
      unitRef="usd">13006000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ieb5fa643d9584c9bb178f09a350973e3_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfOS0xLTEtMS0xMTk4Njg_cdcbd711-2e90-47a3-8b01-1130a369b54b"
      unitRef="usd">583000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibf2e63efa08c4ca7914dcaaece2d58c2_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjNkYWE5YmM0ZmY4ZTQzNTM4YWMxMzZlZjJmMzA1MjFkL3RhYmxlcmFuZ2U6M2RhYTliYzRmZjhlNDM1MzhhYzEzNmVmMmYzMDUyMWRfOS01LTEtMS0xMTk4Njg_296cf63e-c08b-4edd-af4b-cb2f9dbf7b2b"
      unitRef="usd">293000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfODU2_7577c196-ed25-4c14-ae21-6e4ef845222f"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTAwNA_deb63398-4b96-473f-92f7-6a8cb567e2d7"
      unitRef="usd">409000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTM2OA_11b68e9d-e9a0-4e36-8bd9-b4d16a847477"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTM2OA_aacb2ed3-ba05-45e9-829e-621674ed0357"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTk3Mw_af008768-540b-47fa-9bad-4a8769111bac"
      unitRef="usd">421000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMTk4MA_c834538d-562c-42b8-8310-3d44f5236c7f"
      unitRef="usd">431000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNTQ5NzU1ODE2MzQ4_3d5ddf6f-41d9-440d-8fe3-0a9a53fe2fa8"
      unitRef="usd">844000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfNTQ5NzU1ODE2MzUy_755630ef-08a4-46c9-8056-e89f79be7ba2"
      unitRef="usd">866000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RleHRyZWdpb246NDJkNjAxMGUwMWY4NDVmMDlmNzIwNDg2M2NjMjZlZjhfMjI4OA_7edd6a32-614c-4247-a976-3b86166af5b1">Estimated aggregate amortization expense by fiscal year based on the carrying value of definite-lived intangible assets at October&#160;28, 2022, excluding any possible future amortization associated with acquired IPR&amp;amp;D which has not yet met technological feasibility, is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMS0xLTEtMS0xMTk4Njg_00c8c06b-6b42-40c9-920b-e22e00ea8b4d"
      unitRef="usd">839000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMi0xLTEtMS0xMTk4Njg_f7ec9911-da6f-4e98-9cf8-1498fcd14be0"
      unitRef="usd">1649000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfMy0xLTEtMS0xMTk4Njg_76bec348-f828-4672-8a54-22e0e9b2bba0"
      unitRef="usd">1627000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNC0xLTEtMS0xMTk4Njg_af414d35-a4a6-48e2-adeb-d2c1a04697e6"
      unitRef="usd">1614000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNS0xLTEtMS0xMTk4Njg_09248f3c-c2d5-4851-932d-4991edeaf5dc"
      unitRef="usd">1590000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV82Ny9mcmFnOjQyZDYwMTBlMDFmODQ1ZjA5ZjcyMDQ4NjNjYzI2ZWY4L3RhYmxlOjMxNDU4ZWY0MDk2NjQ3MGI5Y2Y3NTQ4ZWVkMDkzY2I4L3RhYmxlcmFuZ2U6MzE0NThlZjQwOTY2NDcwYjljZjc1NDhlZWQwOTNjYjhfNi0xLTEtMS0xMTk4Njg_067f9b1d-1fc2-49b7-9f5d-117fc9f84067"
      unitRef="usd">1539000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMzA1OQ_986562bc-2a5f-49a9-bcde-01ad4449a3b1">Income Taxes &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 18, 2022, the U.S. Tax Court (Tax Court) issued its opinion on the previously disclosed litigation regarding the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for fiscal years 2005 and 2006 (Opinion). While the Opinion rejected the IRS&#x2019;s position and the Tax Court determined the methodology advanced by Medtronic was appropriate for purposes of determining the intercompany royalty rate between Puerto Rico and the U.S., it determined that the royalty rate should be higher, thereby increasing income allocated to the U.S. and consequently subject to U.S. tax. This case relates only to fiscal years 2005 and 2006. The Opinion remains subject to finalization by the Tax Court and to appeal by either or both parties. The Company has assumed the Tax Court findings will be applied for all years following fiscal year 2006. As a result, the Company recorded a $764&#160;million net tax charge during the three months ended October&#160;28, 2022 to recognize the estimated tax impact of the Tax Court Opinion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's effective tax rate for the three and six months ended October&#160;28, 2022 was 68.7% and 44.0%, respectively, as compared to 11.8% and 10.3% for the three and six months ended October&#160;29, 2021, respectively. The increase in our effective tax rate for the three and six months ended October&#160;28, 2022, as compared to the corresponding periods in the prior fiscal year, was primarily due to the $764&#160;million net tax charge referenced above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At October&#160;28, 2022 and April&#160;29, 2022, the Company's gross unrecognized tax benefits were $2.6&#160;billion and $1.7&#160;billion, respectively. In addition, the Company had accrued gross interest and penalties of $196&#160;million at October&#160;28, 2022. If all of the Company&#x2019;s unrecognized tax benefits were recognized, approximately $2.4&#160;billion would impact the Company&#x2019;s effective tax rate. At October&#160;28, 2022 and April&#160;29, 2022, the amount of the Company's gross unrecognized tax benefits, net of cash advance, recorded as a noncurrent liability within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accrued income taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the consolidated balance sheets was $1.8&#160;billion and $802&#160;million, respectively. The increase in the Company's gross unrecognized tax benefits, net of cash advance, was primarily due to an increase in unrecognized tax benefits relating to the Tax Court Opinion. The Company recognizes interest and penalties related to income tax matters within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;income tax provision&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income and records the liability within either current or noncurrent &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;accrued income taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 16 to the consolidated financial statements for additional information regarding the status of current tax audits and proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMjc0ODc3OTA4MDI1MA_03335912-58ed-4e0b-9938-ac60a77491bb"
      unitRef="usd">764000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMjc0ODc3OTA4MDI1MA_a102ddd4-b6e6-4951-a2ab-b4a8f220b0fd"
      unitRef="usd">764000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfODA_632870d5-ea00-4168-aecc-8ff139e2cb78"
      unitRef="number">0.687</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE5MTQ3_cf897072-c9f0-40a1-887d-536c47c0e70e"
      unitRef="number">0.440</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfOTk_53e92fff-d363-4514-bf50-84b96d88a995"
      unitRef="number">0.118</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE5MTY5_b264b071-fef9-48d3-9726-fb5cfdd23901"
      unitRef="number">0.103</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTM3NDM4OTUzNTU3NzQ_03335912-58ed-4e0b-9938-ac60a77491bb"
      unitRef="usd">764000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTM3NDM4OTUzNTU3NzQ_a102ddd4-b6e6-4951-a2ab-b4a8f220b0fd"
      unitRef="usd">764000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNTQ5NzU1ODE3NzMz_b6053c4c-3a8e-4e76-b47b-cd99edbf2dd8"
      unitRef="usd">2600000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfNzkz_512b2784-4aa0-4173-9749-316771ce8a42"
      unitRef="usd">1700000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfODY2_64711d4c-ea92-4f50-a015-d82325936cff"
      unitRef="usd">196000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfOTU3_65f4fc1e-f0b6-4fd9-a740-08320d2b4e4a"
      unitRef="usd">2400000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTIwNQ_12605922-a676-47d0-8b4b-33fe211933bd"
      unitRef="usd">1800000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83MC9mcmFnOjllNjRhZjI0YTdmNTQ4MzFhYWY1ODU1ZmQ4ODk2NzgyL3RleHRyZWdpb246OWU2NGFmMjRhN2Y1NDgzMWFhZjU4NTVmZDg4OTY3ODJfMTIxMg_e6b57660-eaa5-4eca-837f-2232a5f9d83b"
      unitRef="usd">802000000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfMTA1MQ_08da7395-69d3-463b-aacc-ab0d55d4c9f7">Earnings Per Share Basic earnings per share is computed based on the weighted average number of ordinary shares outstanding. Diluted earnings per share is computed based on the weighted number of ordinary shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive ordinary shares been issued, and reduced by the number of shares the Company could have repurchased with the proceeds from issuance of the potentially dilutive shares. Potentially dilutive ordinary shares include stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The calculation of weighted average diluted shares outstanding excludes options to purchase approximately 25 million and 20 million ordinary shares for the three and six months ended October&#160;28, 2022, respectively, and 4 million and 2 million ordinary shares for the three and six months ended October&#160;29, 2021, respectively, because their effect would have been anti-dilutive on the Company&#x2019;s earnings per share.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfMTA1NQ_7dbbeaa1-acdb-4992-8a9b-89d06dd3c090">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:16pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to ordinary shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted &#x2013; weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy0xLTEtMS0xMTk4Njg_d2c04f46-7d0a-40f1-a084-38ab61cef2d7"
      unitRef="usd">427000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy0zLTEtMS0xMTk4Njg_c40950b2-8c76-4d36-ab8b-6786d7bb4228"
      unitRef="usd">1311000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy01LTEtMS0xMTk4Njg_0fd8cd4f-6252-4036-85ea-6473ba9f8f83"
      unitRef="usd">1356000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMy03LTEtMS0xMTk4Njg_9fd5444b-356d-422f-b56e-d1e007fbc748"
      unitRef="usd">2074000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS0xLTEtMS0xMTk4Njg_85dd336d-652f-4b69-8125-b7d9eeb2607e"
      unitRef="shares">1329400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS0zLTEtMS0xMTk4Njg_9c9c062b-7c7a-4782-93fb-c9a89f6a8a5d"
      unitRef="shares">1345100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS01LTEtMS0xMTk4Njg_8a44d5c3-6dc2-47a0-bc54-8feeb189b228"
      unitRef="shares">1329400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNS03LTEtMS0xMTk4Njg_4dbfbe97-cadd-491d-a1fb-f7e2f5a261db"
      unitRef="shares">1344800000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy0xLTEtMS0xMTk4Njg_cd655acc-1c77-43eb-9bd5-f0df96f30773"
      unitRef="shares">1600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3affa50db84b49f895fa4532797c87be_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy0zLTEtMS0xMTk4Njg_0c6e99c5-2c30-4940-bff4-0dabd6e49bbf"
      unitRef="shares">8200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy01LTEtMS0xMTk4Njg_dfcb41ca-1bbb-43f7-b58e-8493f18385d2"
      unitRef="shares">2200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfNy03LTEtMS0xMTk4Njg_10e7881b-03ea-422b-9483-5933d40dee70"
      unitRef="shares">8400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC0xLTEtMS0xMTk4Njg_e9fdfcc1-c0d6-420f-b328-aa6db1c831f2"
      unitRef="shares">800000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="ia80b3537de0145e8b97523443127c857_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC0zLTEtMS0xMTk4Njg_8a6f8e28-4ca5-4532-8a91-633fe511b188"
      unitRef="shares">1700000</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC01LTEtMS0xMTk4Njg_ad3205f3-75c0-4e50-b427-3762b8493e89"
      unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
      contextRef="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOC03LTEtMS0xMTk4Njg_59029991-86ed-40bd-b055-d70ff4f41c31"
      unitRef="shares">2000000.0</us-gaap:IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1398815934fb4c929000688ee41577ab_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS0xLTEtMS0xMTk4Njg_b47c69c5-105d-4142-af23-8abdd29a3c24"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS0zLTEtMS0xMTk4Njg_e3d9c12d-9563-4d92-8550-9961ee093f67"
      unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id4b6674cdea049859601401c887d0ed0_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS01LTEtMS0xMTk4Njg_90531219-2df1-42c5-8102-f1df2ec041f6"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfOS03LTEtMS0xMTk4Njg_06663622-5507-4bc2-9c49-b77103fd56c6"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtMS0xLTEtMTE5ODY4_88c3220e-b645-4359-986c-9a395fce9c78"
      unitRef="shares">1332000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtMy0xLTEtMTE5ODY4_8179a366-951d-4f2e-b660-e8343a95e637"
      unitRef="shares">1355300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtNS0xLTEtMTE5ODY4_cb56d6d4-f65c-4f7f-84f9-4b55ae3609dc"
      unitRef="shares">1333300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTAtNy0xLTEtMTE5ODY4_fecdaa6e-c321-400f-9923-91cd16c4e5f2"
      unitRef="shares">1355900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtMS0xLTEtMTE5ODY4_40f5bab9-f183-4fad-bbea-9ea5cd9ddc48"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtMy0xLTEtMTE5ODY4_1a008d80-4e1b-488b-8cbd-daf8e639df51"
      unitRef="usdPerShare">0.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtNS0xLTEtMTE5ODY4_fb53645f-1281-47ce-aac1-3586106ce408"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTEtNy0xLTEtMTE5ODY4_a6a509c1-54e0-4f35-9801-0b0eed15a4df"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItMS0xLTEtMTE5ODY4_03490ece-4bfe-4353-94ff-3f2f09f8c220"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItMy0xLTEtMTE5ODY4_b9cfc900-2836-4188-a804-76bc4d27dc53"
      unitRef="usdPerShare">0.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItNS0xLTEtMTE5ODY4_82ff5b7e-ae7f-411e-b5ad-34a6d68aeb64"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RhYmxlOmU4NGUyN2QxNTI1YzRiMTQ5MjdiMWMwYzFhNDkzNjAzL3RhYmxlcmFuZ2U6ZTg0ZTI3ZDE1MjVjNGIxNDkyN2IxYzBjMWE0OTM2MDNfMTItNy0xLTEtMTE5ODY4_c3610492-8980-4e13-a4ed-b13da18af11b"
      unitRef="usdPerShare">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i74db199c9a774fdb9da00363fa038371_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfODcz_0ab8c88e-41f3-40c1-84fc-bf1f357ff7e6"
      unitRef="shares">25000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0eff972d77b347488f63d31d746a15a0_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfNTQ5NzU1ODE0OTQ5_3491f410-b6c8-4697-b9e2-f6802a1d4356"
      unitRef="shares">20000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8d98793895484125aa0679ce08f1dcd6_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfODgw_16008d67-ca92-46b4-8b79-1b12e85b7985"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3c07e51d429d4cbbad584cb5fe45515d_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83My9mcmFnOjAyMmE1ZTJmMzQ5ZjRkYmFhNWE1YTE5OTU0NDdiNjEwL3RleHRyZWdpb246MDIyYTVlMmYzNDlmNGRiYWE1YTVhMTk5NTQ0N2I2MTBfNTQ5NzU1ODE1MDIx_442550db-07e5-4046-8208-99fe306621c4"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RleHRyZWdpb246ODRiYzUwZTZlMjIyNGZjYWI1ZDI0OGQxZGRlYzc1YzdfMjcy_eed0884d-a6dd-40fd-aeac-cc2f50bf3789">Stock-Based Compensation &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, performance share units, and employee stock purchase plan shares recognized for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RleHRyZWdpb246ODRiYzUwZTZlMjIyNGZjYWI1ZDI0OGQxZGRlYzc1YzdfMjc0_367a6cd0-2194-4bcf-84d7-299005e821ba">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for stock options, restricted stock, performance share units, and employee stock purchase plan shares recognized for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi0xLTEtMS0xMTk4Njg_8d0a0a50-a62b-4b74-a701-d0c405e96bbb"
      unitRef="usd">38000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3affa50db84b49f895fa4532797c87be_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi0zLTEtMS0xMTk4Njg_a5cda662-fa37-4153-b362-c612ddb6bf5f"
      unitRef="usd">35000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia52ced79d82a4ca9b789b4b051662441_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi01LTEtMS0xMTk4Njg_e3564314-0b33-4071-a1cc-7e59c9371332"
      unitRef="usd">50000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3fa4893af5c740d6b45f4af4fb5969a4_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMi03LTEtMS0xMTk4Njg_60a281af-4971-4a0b-bf23-9ff1543e7a1a"
      unitRef="usd">45000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i63da70bba3f64e0191aff3945ba9e9d6_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy0xLTEtMS0xMTk4Njg_8c99c7e0-8f78-4f01-8fb1-c093d7bfc90a"
      unitRef="usd">52000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia80b3537de0145e8b97523443127c857_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy0zLTEtMS0xMTk4Njg_9de0ef61-a3dd-4f27-be30-19286858c51e"
      unitRef="usd">52000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib445586e99c34fe2b630f0200a08260f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy01LTEtMS0xMTk4Njg_e220ed37-6a8a-4e65-8a1e-bed0deae5331"
      unitRef="usd">79000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i90445e3c51ee4d2e94ba0961c1bdc5e3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMy03LTEtMS0xMTk4Njg_e9d5c699-71ac-42c1-9472-d0581a9c52f2"
      unitRef="usd">94000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1398815934fb4c929000688ee41577ab_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC0xLTEtMS0xMTk4Njg_88a3b06c-d974-4b08-a8e7-19205a0ae096"
      unitRef="usd">39000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia901e2bd2ef0439095f774a4f4dd2d84_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC0zLTEtMS0xMTk4Njg_2902b432-e494-49ad-b7d0-2a4f164f14fe"
      unitRef="usd">43000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id4b6674cdea049859601401c887d0ed0_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC01LTEtMS0xMTk4Njg_af92c8a2-770b-41df-8c77-2aac7cde6fe7"
      unitRef="usd">50000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icaacb25f8fb3480696e0df40b059a609_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNC03LTEtMS0xMTk4Njg_8be68b3a-b0c1-4f67-aa0e-3695c11fc889"
      unitRef="usd">50000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4de56b7be4e5417d8cc74ecf01292422_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS0xLTEtMS0xMTk4Njg_30bbc07a-001f-41e4-87c7-44bc7e178ed3"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4dedf22af6864313999d497de5e5d6ee_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS0zLTEtMS0xMTk4Njg_174c3da3-31e4-4bef-a607-7e484fffcfd7"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d7ca207cf164dcc8a0c586bf2859962_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS01LTEtMS0xMTk4Njg_cbc56c67-5c61-450a-87d4-b172c9a995c9"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icce28f9819d44f1cb7eec69a55f52fc9_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNS03LTEtMS0xMTk4Njg_e3bbec72-b841-42cf-b8f2-e82eae3ba867"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi0xLTEtMS0xMTk4Njg_070d7f83-7fe3-4fbe-9b40-e8e1646982b7"
      unitRef="usd">137000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi0zLTEtMS0xMTk4Njg_1da04f70-a7af-49f9-9fa8-a9d198d1fa71"
      unitRef="usd">140000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi01LTEtMS0xMTk4Njg_8ae3e2c1-608c-43ec-b6ed-1b2e13dfe2cb"
      unitRef="usd">199000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfNi03LTEtMS0xMTk4Njg_d6629962-5551-4a7b-ad06-9096829d5427"
      unitRef="usd">209000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i89d75dfd093f41b79b84cc712dd4bdeb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC0xLTEtMS0xMTk4Njg_457380b6-835e-44ed-985f-d9d917756b8c"
      unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b29f486c461430ea0700ecce5ccc168_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC0zLTEtMS0xMTk4Njg_256feb5f-f591-430b-a082-866f842fb1bc"
      unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icd8a11e621df491c8e9bcf6998fa2316_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC01LTEtMS0xMTk4Njg_86ee7ef8-01c0-40c1-81fb-c3cc463b6a17"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c12dca8003843c9b905c9a3220a9dd3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOC03LTEtMS0xMTk4Njg_cb7572d7-5717-46bc-bc87-8dce3ee15009"
      unitRef="usd">21000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida185280d375499c84936e4a6364ca45_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS0xLTEtMS0xMTk4Njg_118b9ea3-ce08-415a-a193-92a3d36da70e"
      unitRef="usd">15000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3b788a6030cc4d249b9f10c42c12d4b3_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS0zLTEtMS0xMTk4Njg_ea2d47f7-8a90-4b64-ae1a-8f9f1835762c"
      unitRef="usd">15000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5fe0629813fc4a7f9ee052e38f52a06d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS01LTEtMS0xMTk4Njg_86beac84-df08-4768-9388-647107d7b099"
      unitRef="usd">22000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia0871f5c80684792904d5a9b080d8746_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfOS03LTEtMS0xMTk4Njg_59f0805f-deae-4d1a-9e21-dd62ae60c6d8"
      unitRef="usd">23000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c9f32e60ed34e03b1eee7e4dd64092d_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtMS0xLTEtMTE5ODY4_a7914fc8-ad30-42b8-a359-cc1f03f968f0"
      unitRef="usd">108000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i93bc1e6379124613960fd7675b514cd8_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtMy0xLTEtMTE5ODY4_8f8bcfdf-04ab-457a-b7ef-be67f7e8a384"
      unitRef="usd">110000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iedf7ecfabdfa4fd796a4fc91dfd1466b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtNS0xLTEtMTE5ODY4_546e89c0-80be-4e04-a7a2-012c86ccda13"
      unitRef="usd">157000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia4b972ff441f4b5f9da1923ccd6b5eba_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTAtNy0xLTEtMTE5ODY4_c0ad589c-37a8-436f-abea-3ff2f3ce6000"
      unitRef="usd">165000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtMS0xLTEtMTE5ODY4_c23f79f2-7c2c-442a-a67e-08c99712e468"
      unitRef="usd">137000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtMy0xLTEtMTE5ODY4_5cf61cf9-c12b-4651-a91b-330a76bf7be3"
      unitRef="usd">140000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtNS0xLTEtMTE5ODY4_cca5dba8-9350-4b32-9b0c-7428de70d629"
      unitRef="usd">199000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTEtNy0xLTEtMTE5ODY4_c1011d48-6998-4179-9e05-7c7b756c7f02"
      unitRef="usd">209000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItMS0xLTEtMTE5ODY4_c9cdd5b7-629e-420a-9b60-b116ac40d821"
      unitRef="usd">26000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItMy0xLTEtMTE5ODY4_c9d55af4-976d-4538-8241-94d32e6fe95a"
      unitRef="usd">26000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItNS0xLTEtMTE5ODY4_9b4ea10d-0f01-44e7-831e-56e598e0d2de"
      unitRef="usd">37000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTItNy0xLTEtMTE5ODY4_897c703d-b0f3-419c-89d3-88e8eb1dcfc1"
      unitRef="usd">37000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtMS0xLTEtMTE5ODY4_c28da299-4637-42ec-a056-d3571b081bf6"
      unitRef="usd">111000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtMy0xLTEtMTE5ODY4_187f5efe-24f0-4168-a8bc-44f439fbfa08"
      unitRef="usd">114000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtNS0xLTEtMTE5ODY4_828d5efb-c107-4d17-816f-90867b364bb0"
      unitRef="usd">162000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83Ni9mcmFnOjg0YmM1MGU2ZTIyMjRmY2FiNWQyNDhkMWRkZWM3NWM3L3RhYmxlOjMwYTMzMDY5Y2YyMjRiNmQ5ODliZmU5NmM5ODZiNzlmL3RhYmxlcmFuZ2U6MzBhMzMwNjljZjIyNGI2ZDk4OWJmZTk2Yzk4NmI3OWZfMTMtNy0xLTEtMTE5ODY4_f55e0ebf-4058-44ff-96c5-31783a232c73"
      unitRef="usd">172000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RleHRyZWdpb246NzJhNmEwZWFiYmRhNGU0YjgyNjY5MmI4Y2E0NDljYTRfNTky_4443fe7b-da08-4a01-81c1-b6fde6d8e110">Retirement Benefit Plans &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various retirement benefit plans, including defined benefit pension plans, post-retirement medical plans, defined contribution savings plans, and termination indemnity plans, covering substantially all U.S. employees and many employees outside the U.S. The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of net periodic benefit cost other than the service component are recognized in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt; in the consolidated statements of income.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RleHRyZWdpb246NzJhNmEwZWFiYmRhNGU0YjgyNjY5MmI4Y2E0NDljYTRfNjA4_acde77ed-608f-46d7-827f-2f5b4cc4525b">The net periodic benefit cost of the defined benefit pension plans included the following components for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC0xLTEtMS0xMTk4Njg_9632fb8d-419a-4635-a445-bc28c975c7d4"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC0zLTEtMS0xMTk4Njg_261f5d9e-ee74-4a76-aaf6-799bdb2e8751"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC01LTEtMS0xMTk4Njg_1aaf45b0-47f2-48e9-a82d-5d79648db554"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNC03LTEtMS0xMTk4Njg_37c2aeff-0031-4ace-ab6b-ec8e98c4e895"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS0xLTEtMS0xMTk4Njg_efcfea5d-aab4-4d24-85f0-7ded1f01bbd9"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS0zLTEtMS0xMTk4Njg_aa9fc209-320c-4442-83d4-09cff7f4c7ea"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS01LTEtMS0xMTk4Njg_80398e81-b57e-4f97-a376-7a5ee5427ad7"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNS03LTEtMS0xMTk4Njg_d54d97d2-c719-48c3-8894-943258da63ab"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi0xLTEtMS0xMTk4Njg_792a88ee-db61-4935-b37a-4da2ca6d1157"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi0zLTEtMS0xMTk4Njg_52cea887-eca1-48b9-9565-012d172e8620"
      unitRef="usd">57000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi01LTEtMS0xMTk4Njg_cdd868a0-d1b6-43d5-aae1-6bb7173b5538"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfNi03LTEtMS0xMTk4Njg_4b295968-9a8e-4372-b038-66e4e14f9530"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC0xLTEtMS0xMTk4Njg_c3df6a4b-f3c4-452e-843b-24c3e6b4c9e8"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC0zLTEtMS0xMTk4Njg_c54006de-968b-4faf-9487-4621539c2766"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC01LTEtMS0xMTk4Njg_70dc1016-ef4f-4754-ada3-3b11195c8e51"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOC03LTEtMS0xMTk4Njg_a9bb41df-d1a0-4405-8344-8f9e73fec486"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS0xLTEtMS0xMTk4Njg_8c26b0c9-e3cf-48dc-b77b-91316862d605"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i356c629eaed743348a53b4bfd8500be7_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS0zLTEtMS0xMTk4Njg_cca50c27-8100-4cb1-9a81-54a49a99c12b"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i8b964c634650403f81e221664044f7b8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS01LTEtMS0xMTk4Njg_054fdab1-f724-42db-be95-1cedb6c29b53"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i88154952c01f4596bcb9022e3ea35840_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfOS03LTEtMS0xMTk4Njg_86b8ea08-bf0a-4736-9c75-c0f82c47d5c4"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtMS0xLTEtMTE5ODY4_14bf5f3d-b8c4-4ada-9ac4-02e360f89d83"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtMy0xLTEtMTE5ODY4_f8c6f3f0-9fd9-4b57-beb5-f64c4860fcee"
      unitRef="usd">50000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtNS0xLTEtMTE5ODY4_54319bf8-660d-43d8-87b5-0cdc192f3dae"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTUtNy0xLTEtMTE5ODY4_18727469-5ef8-4687-acfa-788c8e780196"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtMS0xLTEtMTE5ODY4_47a732bd-2a36-401c-835a-c41d543838fe"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtMy0xLTEtMTE5ODY4_f86656d2-65fc-4667-9718-83e4dcfd275a"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtNS0xLTEtMTE5ODY4_aa56ad00-f852-4b25-94ec-1dab2adb2286"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTYtNy0xLTEtMTE5ODY4_20982729-0abd-460d-8b30-3fde9b48eef7"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctMS0xLTEtMTE5ODY4_c672abc0-482c-4269-aaf3-aa0c1a631904"
      unitRef="usd">112000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctMy0xLTEtMTE5ODY4_5c9af817-f3d5-4b3b-86e4-73aefa87004e"
      unitRef="usd">114000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctNS0xLTEtMTE5ODY4_09136c9e-99d2-4c1b-a680-d51235d3dd89"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTctNy0xLTEtMTE5ODY4_3c82321e-b302-4b55-9f0e-95557c62412b"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktMS0xLTEtMTE5ODY4_8faf03cb-7b5a-4ab7-a545-133e2ead8edf"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktMy0xLTEtMTE5ODY4_d0e2dd5d-0e07-4eef-93ba-81532a4852ad"
      unitRef="usd">-32000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktNS0xLTEtMTE5ODY4_4b3822b2-afa7-4262-88a7-c59da1eba6eb"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMTktNy0xLTEtMTE5ODY4_ae8ebf56-5dc5-4982-86cb-fc8bb23c7851"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i24b0d3bf004b43878087bc40dd58ac63_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtMS0xLTEtMTE5ODY4_6a5afc7d-b3b4-484a-8193-46050919bb6f"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i68bc7daea380420bab51198ec81e539a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtMy0xLTEtMTE5ODY4_3a44c4df-ca08-40c7-8a1e-fa4ef45e6827"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iddeade80625e48a6ac9c35d4ce6c5d9f_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtNS0xLTEtMTE5ODY4_1accffdb-df14-404f-b224-098c117d74d6"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2e65450803fc4b02a050b937fbe7db59_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV83OS9mcmFnOjcyYTZhMGVhYmJkYTRlNGI4MjY2OTJiOGNhNDQ5Y2E0L3RhYmxlOjlhOTMwNTQxZmFhYTRmNmNiM2ZhZjE2Yjg3NmYwYmRhL3RhYmxlcmFuZ2U6OWE5MzA1NDFmYWFhNGY2Y2IzZmFmMTZiODc2ZjBiZGFfMjEtNy0xLTEtMTE5ODY4_ab74ab3b-4674-42fa-b7f5-7b37c95eeddd"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjU3Mg_5eb2998b-526e-49bd-96d9-25c0e788e2d5">Accumulated Other Comprehensive Loss &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in accumulated other comprehensive loss (AOCI), net of tax, and by component:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax on gains and losses on investment securities in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021 was a benefit of $41 million and $6 million, respectively. During the six months ended &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October&#160;28, 2022, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $4&#160;million. During the six months ended October&#160;29, 2021, realized gains and losses on investment securities reclassified from AOCI were reduced by income taxes of $1&#160;million. When realized, gains and losses on investment securities reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to Note&#160;6&#160;to the consolidated financial statements for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended October&#160;28, 2022, the income tax on cumulative translation adjustment was a benefit of $3 million. During the six months ended October&#160;29, 2021, there was no income tax on cumulative translation adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended October&#160;28, 2022 and October&#160;29, 2021, there were no tax impacts on net investment hedges. Refer to Note 8 to the consolidated financial statements for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net change in retirement obligations in other comprehensive income includes amortization of net actuarial losses included in net periodic benefit cost. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, the net change in retirement obligations in other comprehensive income before reclassifications resulted in income tax expense of $1 million and $2&#160;million, respectively. During both the six months ended October&#160;28, 2022 and October&#160;29, 2021, the gains and losses on defined benefit and pension items reclassified from AOCI were reduced by income taxes of&#160;$7 million. When realized, net gains and losses on defined benefit and pension items reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other non-operating income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Refer to Note&#160;14 to the consolidated financial statements&#160;for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax on unrealized gains and losses on cash flow hedges in other comprehensive income before reclassifications during the six months ended October&#160;28, 2022 and October&#160;29, 2021&#160;was&#160;an expense of&#160;$141 million and $42 million, respectively. During the six months ended October&#160;28, 2022 and October&#160;29, 2021, gains and losses on cash flow hedges reclassified from AOCI were reduced by income taxes of&#160;$59 million and $1 million, respectively. When realized, gains and losses on currency exchange rate contracts reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other operating (income) expense, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;cost of products sold,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;and gains and losses on forward starting interest rate derivatives reclassified from AOCI are recognized within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;interest expense.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Refer to Note&#160;8&#160;to the consolidated financial statements for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjU4Nw_471c2bf0-1bd0-4029-bbb5-7d5ffe76889f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in accumulated other comprehensive loss (AOCI), net of tax, and by component:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 29, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investment Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Change in Retirement Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac4974ad9d20428ba8fa1009b1d7e83d_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0xLTEtMS0xMTk4Njg_ae0b935c-0d76-4465-b9c3-f7f6d7b317c6"
      unitRef="usd">-209000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ab310b699e340a0b46bb1aa55af0ce5_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0zLTEtMS0xMTk4Njg_6bab5a4b-296d-4988-9e7f-0e8ef1c067e2"
      unitRef="usd">-2599000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3378e12209024d9d8052dcc6dc3f0a2c_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS01LTEtMS0xMTk4Njg_6bb67ffe-3d35-4629-918b-9ea063223cc5"
      unitRef="usd">841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0b5ac28482240b38b40b82a5691ce06_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS03LTEtMS0xMTk4Njg_7ab8cac9-76dd-4b3e-920a-2ddf2a564f7d"
      unitRef="usd">-773000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i188641c285b14b8895fd2296677da61c_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS05LTEtMS0xMTk4Njg_ad8c9c49-a5a3-419a-825e-ceaedfa65564"
      unitRef="usd">474000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f7d0c01899c445db04cd9b2d85f6968_I20220429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMS0xMS0xLTEtMTE5ODY4_11cbd966-dac6-4cf5-a224-78258ab6f22b"
      unitRef="usd">-2265000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0xLTEtMS0xMTk4Njg_e934cbeb-acb2-466b-8f78-8be1227562b9"
      unitRef="usd">-195000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0zLTEtMS0xMTk4Njg_3117269f-053c-4549-b795-eabcefbe07f6"
      unitRef="usd">-1705000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi01LTEtMS0xMTk4Njg_aef9f004-3ec3-4fd5-a92b-d2009311f4ce"
      unitRef="usd">1409000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi03LTEtMS0xMTk4Njg_5296489a-ef11-49cf-9bd0-59ee20200093"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi05LTEtMS0xMTk4Njg_0a3b132d-01ec-4aca-92d8-2a090378795e"
      unitRef="usd">634000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMi0xMS0xLTEtMTE5ODY4_daca0c25-d65c-4ebd-9f78-c61286ec7a5e"
      unitRef="usd">146000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0xLTEtMS0xMTk4Njg_f789d757-7cdd-460d-8398-651a602ebb0f"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0zLTEtMS0xMTk4Njg_1aae3f20-9c04-4660-849a-ae21307c1392"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy01LTEtMS0xMTk4Njg_dcda3fd3-5f3b-4666-8dbb-c576af1412d2"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy03LTEtMS0xMTk4Njg_42edff25-5651-4364-b3c7-b1144c7446ee"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy05LTEtMS0xMTk4Njg_75e1f7c2-d9c4-4b00-b574-e032484ef5c2"
      unitRef="usd">256000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMy0xMS0xLTEtMTE5ODY4_5e5a3a80-31ad-46d2-98b2-8faaa93e2c45"
      unitRef="usd">243000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0xLTEtMS0xMTk4Njg_6e8283a1-df5b-4312-8b36-adf07f6092a3"
      unitRef="usd">-183000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0zLTEtMS0xMTk4Njg_b9ef89df-97af-42ae-8e3c-4e82e68f750a"
      unitRef="usd">-1705000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC01LTEtMS0xMTk4Njg_d9fb03e9-b523-4db5-955c-d6dcdbb8d3e0"
      unitRef="usd">1409000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC03LTEtMS0xMTk4Njg_1a09f79d-44bd-4100-9b83-67dc947e4434"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC05LTEtMS0xMTk4Njg_68eba18b-88c9-4400-b9e5-c1678b81ad3e"
      unitRef="usd">378000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i28ba042775474bc28935c1b5764479ca_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNC0xMS0xLTEtMTE5ODY4_93afcb20-26d6-4ead-bd58-77ab3ccd2811"
      unitRef="usd">-97000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80f7f42761a242f0ace890eaa6dc8247_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0xLTEtMS0xMTk4Njg_91f7302d-9241-495e-af0d-0e08c24c7009"
      unitRef="usd">-392000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8142fb31d264e0699b5a2404ecd7e2e_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0zLTEtMS0xMTk4Njg_c21e954a-d3e2-47a9-8d9e-bbaad39e3065"
      unitRef="usd">-4304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4d55bb9abcdd40f88c78b3fb670e6a98_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS01LTEtMS0xMTk4Njg_b9e62b0a-5cbe-4ae6-8c52-b9119d4c8b5c"
      unitRef="usd">2250000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69d21fb1bb9c4c179514a671cbf4e411_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS03LTEtMS0xMTk4Njg_25f660a6-86c8-4846-85d5-7b77b1ca25c4"
      unitRef="usd">-769000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e2b7c40e2d14604869e3828bebf8f6c_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS05LTEtMS0xMTk4Njg_2f2a8bad-7b03-4eea-9665-f0983ab2f62f"
      unitRef="usd">852000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12e89df7a7284768b084b028fb30c0b3_I20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfNS0xMS0xLTEtMTE5ODY4_17f7f2af-a2de-45b3-aabe-cef1d1106414"
      unitRef="usd">-2361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i763fe5a14b6f4a0abca07febc595186a_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0xLTEtMS0xMTk4Njg_c91fe69e-1b62-4dc7-8c2d-fd0060bce9e7"
      unitRef="usd">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8dbf04decd1248789e7cf49bc6bfc8f3_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0zLTEtMS0xMTk4Njg_26f8779e-4ddd-4b99-9cfc-eb7e572976cd"
      unitRef="usd">-519000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i51a1f4a27446424fa83923dcf918a2a5_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS01LTEtMS0xMTk4Njg_32311dd4-6550-4797-9548-2a3a82039502"
      unitRef="usd">-1458000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40837b287fac4cbe8238278e9bd46ede_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS03LTEtMS0xMTk4Njg_b209d11a-8a1e-47dd-b677-5400376e9aaa"
      unitRef="usd">-1347000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7edfc27e40204f9580fd94d3ad2410e5_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS05LTEtMS0xMTk4Njg_1ed7e93e-e0be-453c-8ce5-344f12184e78"
      unitRef="usd">-253000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie6fcacd0b8904f8a8c6d6286c1d56f73_I20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfOS0xMS0xLTEtMTE5ODY4_ba368826-a05f-4a75-b92f-16479a68907a"
      unitRef="usd">-3485000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMS0xLTEtMTE5ODY4_32e09357-7b1d-44d4-85d0-034f885ad968"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMy0xLTEtMTE5ODY4_65c01ed4-6013-4546-998c-17ae71a0169c"
      unitRef="usd">-599000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtNS0xLTEtMTE5ODY4_7e5b28ca-b49c-43b0-a99a-6db6e8766975"
      unitRef="usd">780000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtNy0xLTEtMTE5ODY4_40f8fd0c-ea49-4491-9aab-ecb96c11ed3f"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtOS0xLTEtMTE5ODY4_df245265-9f1a-43eb-9856-bec5b1a5b788"
      unitRef="usd">237000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTAtMTEtMS0xLTExOTg2OA_4e9e9beb-3b65-49ca-805c-cd37ab1e5917"
      unitRef="usd">381000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMS0xLTEtMTE5ODY4_cd96eae0-89ea-4802-93bb-a13427361f1d"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMy0xLTEtMTE5ODY4_67effdfe-b689-44a8-8886-db3c6af115ca"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtNS0xLTEtMTE5ODY4_c95f239a-db9b-48ff-b8dd-d51b22e1acff"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtNy0xLTEtMTE5ODY4_ae31fc9b-0e1f-4480-897e-cb3abf06999f"
      unitRef="usd">-33000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtOS0xLTEtMTE5ODY4_57f789d6-a36d-472e-a03d-50bab66a1120"
      unitRef="usd">-32000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTEtMTEtMS0xLTExOTg2OA_9370300e-2810-4685-bfa8-5ff90c5c175c"
      unitRef="usd">-62000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMS0xLTEtMTE5ODY4_68d7176c-3bb7-4a23-949b-9cbaa0f2a9d8"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMy0xLTEtMTE5ODY4_0e0304aa-ce5f-4910-8490-6896603dc7de"
      unitRef="usd">-599000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItNS0xLTEtMTE5ODY4_79296a8a-7f04-46aa-8ba0-7b7b8d2e6b1b"
      unitRef="usd">780000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItNy0xLTEtMTE5ODY4_dc8810b2-bdb5-47a5-af4e-0798032dd92a"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItOS0xLTEtMTE5ODY4_17bb0ca6-b58c-4d28-af34-41b0aac32b31"
      unitRef="usd">269000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ief5f638746f34279aeb6096462d0d3d1_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTItMTEtMS0xLTExOTg2OA_40e6fff2-9722-420b-be17-210c563385df"
      unitRef="usd">443000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic869d6f490e64df1aaefa8121f2d93a3_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMS0xLTEtMTE5ODY4_394b5cb4-5801-4e9b-a184-ca0dd2cd7a76"
      unitRef="usd">48000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6dbdac6c2f7b45c588961b7bd1c42e81_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMy0xLTEtMTE5ODY4_1658ec5c-2ca1-4fe7-98f8-6937d9c8fec7"
      unitRef="usd">-1118000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c544a31d4554d418bd424cc41e57b32_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtNS0xLTEtMTE5ODY4_8b2529e5-cfa8-4731-84db-0f2b34e88022"
      unitRef="usd">-678000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8eee748d81154109a2314b15b0389e0c_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtNy0xLTEtMTE5ODY4_d6ef70a7-49f6-4573-97a6-b679038db448"
      unitRef="usd">-1310000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1f70b5cc5d64bf3933f7dc026250876_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtOS0xLTEtMTE5ODY4_c2f5f4b7-f5f3-452b-8fbe-9369ff5118cf"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b27da620ade4165842447d930ad60a5_I20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RhYmxlOjI5ZWY1Yzc0NTk2MjRiZWQ5Y2NlOWRjODRkNjc4MjRhL3RhYmxlcmFuZ2U6MjllZjVjNzQ1OTYyNGJlZDljY2U5ZGM4NGQ2NzgyNGFfMTQtMTEtMS0xLTExOTg2OA_212f0f2b-458c-454a-81f2-5990c35f54b6"
      unitRef="usd">-3042000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjQ2_f2b51b82-d07d-4735-9832-8ead9d05c305"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjY3_85f37e2a-f8c9-4651-8aed-5816971d61c7"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iee65fab80479488f8db14fdf140bc0ea_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfNDI1_3a1bc277-abdd-4297-9fe2-d99a7ab55110"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i61ba65e855214f5fbfeb2466832d51fd_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTY0OTI2NzQ0NDUyNg_8a46eddb-257f-47ee-9300-2c0ac3905535"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6ef8f476015148708517a60a5d58f505_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfODU0_34162625-4666-4fc0-b4c0-0f5b66f9cc1f"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie832a69f5afb4a64864d311c45c3896a_D20210501-20211029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTAy_08a9efe1-2847-4352-9ddb-e4b4257a95dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2260f92ca62c4b79b0583636fa1d25e9_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTkw_89bc4692-04d8-41a7-8316-adde5c890a90"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="icfb73eb46c89471e881c19b8341d20f7_D20210501-20211029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfOTkw_c700cc54-97c5-454f-a2eb-192980b08f32"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTQyOQ_8459df30-ddfc-4a27-b118-549fdbe1191f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTY0OTI2NzQ0NDYyMg_5b3295fc-4b2f-480a-9f63-1480c7179a10"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8775a870674f4665a7af461c974860c6_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTU3MQ_6b806201-d7e6-4c58-b4b7-e036e5af8ed1"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia66aaef3996a492ab9095a4e4d176fc3_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTU3MQ_9b17eab1-9cc8-4d64-8b03-eae3fe3057f5"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMTk5Ng_11ccf151-58db-4517-ad3c-cdc30cbdc812"
      unitRef="usd">141000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjAwMw_d27cbf8f-669d-446b-ba3d-0519201758c6"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia2e0cbdcd5d14a3782cb8b34a1d659ae_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjEzMQ_80d68f87-e8dd-4703-a85e-91151ddc2c91"
      unitRef="usd">-59000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ieebe202c8604421b9dde3dafd5168629_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84NS9mcmFnOjMxMGFjN2I5ZTA1OTRjMzM4YjVlOTBkNzc4YmY4NGQzL3RleHRyZWdpb246MzEwYWM3YjllMDU5NGMzMzhiNWU5MGQ3NzhiZjg0ZDNfMjE3MA_6f9cc167-31d7-42d8-ab4b-011ca144de03"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:LossContingencyDisclosures
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMTI5Mzk_4f6b4e90-d314-406f-a128-d3775a587785">Commitments and Contingencies &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are involved in a number of legal actions from time to time involving product liability, employment, intellectual property and commercial disputes, shareholder related matters, environmental proceedings, tax disputes, and governmental proceedings and investigations, including those described below. With respect to governmental proceedings and investigations, like other companies in our industry, the Company is subject to extensive regulation by national, state, and local governmental agencies in the United States and in other jurisdictions in which the Company and its affiliates operate. As a result, interaction with governmental agencies is ongoing. The Company&#x2019;s standard practice is to cooperate with regulators and investigators in responding to inquiries. The outcomes of legal actions are not within the Company&#x2019;s complete control and may not be known for prolonged periods of time. In some actions, the enforcement agencies or private claimants seek damages, as well as other civil or criminal remedies (including injunctions barring the sale of products that are the subject of the proceeding), that could require significant expenditures, result in lost revenues, or limit the Company's ability to conduct business in the applicable jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a liability in the consolidated financial statements on an undiscounted basis for loss contingencies related to legal actions when a loss is known or considered probable and the amount may be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. When determining the estimated loss or range of loss, significant judgment is required. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages with incomplete scientific facts or legal discovery, involve unsubstantiated or indeterminate claims for damages, potentially involve penalties, fines or punitive damages, or could result in a change in business practice. The Company classifies certain specified litigation charges and gains related to significant legal matters as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;certain litigation charges, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the consolidated statements of income. The Company recognized no certain litigation charges during the three and six months ended October&#160;28, 2022, respectively, whereas the Company recognized $34 million and $60 million of certain litigation charges during the three and six months ended October&#160;29, 2021, respectively. At October&#160;28, 2022 and April&#160;29, 2022, accrued litigation was approximately $0.3&#160;billion. The ultimate cost to the Company with respect to accrued litigation could be materially different than the amount of the current estimates and accruals and could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows. The Company includes accrued litigation in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;other liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on the consolidated balance sheets. While it is not possible to predict the outcome for most of the legal matters discussed below, the Company believes it is possible that the costs associated with these matters could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intellectual Property Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At any given time, the Company is involved in litigation relating to patents, trademarks, copyrights, trade secrets, and other intellectual property (IP) rights, and licenses, acquisitions or other agreements relating to such rights. This litigation includes, but is not limited to, alleged infringement or misappropriation of IP rights, or breach of obligations related to IP rights, or other claims asserted by competitors, individuals, or, consistent with a growing trend across technology-intensive industries, other entities created specifically to fund IP litigation. While the outcome of these litigation matters is inherently uncertain, it is possible that the results of such litigation could require the Company to pay significant monetary damages and/or royalty payments, and negatively impact the Company's ability to sell current or future products, which could have a material adverse impact on the Company's business, results of operations, financial condition, and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Liability Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pelvic Mesh Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently involved in litigation in various state and federal courts against manufacturers of pelvic mesh products alleging personal injuries resulting from the implantation of those products. Two subsidiaries of Covidien supplied pelvic mesh products to one of the manufacturers, C.R. Bard (Bard), named in the litigation. The litigation includes a federal multi-district litigation in the U.S. District Court for the Northern District of West Virginia and cases in various state courts and jurisdictions outside the U.S. Generally, complaints allege design and manufacturing claims, failure to warn, breach of warranty, fraud, violations of state consumer protection laws and loss of consortium claims. In fiscal year 2016, Bard paid the Company $121&#160;million towards the settlement of 11,000 of these claims.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the agreement with Bard was amended to extend the terms to apply to up to an additional 5,000 claims. That agreement does not resolve the dispute between the Company and Bard with respect to claims that do not settle, if any. As part of the agreement, the Company and Bard agreed to dismiss without prejudice their pending litigation with respect to Bard&#x2019;s obligation to defend and indemnify the Company. The Company estimates law firms representing approximately 16,200 claimants have asserted or may assert claims involving products manufactured by Covidien&#x2019;s subsidiaries. As of November 2, 2022, the Company had reached agreements to settle approximately 15,900 of these claims. The Company's accrued expenses for this matter are included within accrued litigation as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Hernia Mesh Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Starting in fiscal year 2020, plaintiffs began filing lawsuits against certain subsidiaries of the Company in U.S. state and federal courts that allege personal injury from hernia mesh products sold by those subsidiaries. As of November 10, 2022, subsidiaries of the Company have been named as defendants in lawsuits filed on behalf of approximately 6,050 individual plaintiffs, and certain plaintiffs&#x2019; law firms have advised the Company that they may file additional cases in the future. Approximately 5,600 plaintiffs have filed lawsuits in a coordinated proceeding in Massachusetts state court, where they have been consolidated before a single judge. Approximately 350 plaintiffs have filed lawsuits in a coordinated action in Minnesota state court, and there are approximately 90 actions coordinated in a federal Multidistrict Litigation in the U.S. District Court for the District of Massachusetts. The pending lawsuits relate almost entirely to hernia mesh products that have not been subject to recalls, withdrawals, or other adverse regulatory action. The Company has not recorded an expense related to damages in connection with these matters because any potential loss is not currently probable and reasonably estimable. Additionally, the Company is unable to reasonably estimate the range of loss, if any, that may result from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Environmental Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various stages of investigation and cleanup related to environmental remediation matters at a number of sites. These projects relate to a variety of activities, including removal of solvents, metals and other hazardous substances from soil and groundwater. The ultimate cost of site cleanup and timing of future cash flows is difficult to predict given uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a successor to a company which owned and operated a chemical manufacturing facility in Orrington, Maine from 1967 until 1982, and is responsible for the costs of completing an environmental site investigation as required by the Maine Department of Environmental Protection (MDEP). MDEP served a compliance order on Mallinckrodt LLC and U.S. Surgical Corporation, subsidiaries of Covidien, in December 2008, which included a directive to remove a significant volume of soils at the site. After a hearing on the compliance order before the Maine Board of Environmental Protection (Maine Board) to challenge the terms of the compliance order, the Maine Board modified the MDEP order and issued a final order requiring removal of two landfills, capping of the remaining three landfills, installation of a groundwater extraction system and long-term monitoring of the site and the three remaining landfills. The Company has proceeded with remediation in accordance with the MDEP order as modified by the Maine Board order. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the early 2000s, the Company or its predecessors have also been involved in a lawsuit filed in the U.S. District Court for the District of Maine by the Natural Resources Defense Council and the Maine People&#x2019;s Alliance. Plaintiffs sought an injunction requiring the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company's predecessor to conduct extensive studies of mercury contamination of the Penobscot River and Bay and options for remediating such contamination, and to perform appropriate remedial activities, if necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following a trial in March 2002, the court held that conditions in the Penobscot River and Bay may pose an imminent and substantial endangerment and that the Company&#x2019;s predecessor was liable for the cost of performing a study of the River and Bay. Following a second trial in June 2014, the court ordered that further engineering study and engineering design work was needed to determine the nature and extent of remediation in the Penobscot River and Bay. The court also appointed an engineering firm to conduct such studies and issue a report on potential remediation alternatives. In connection with these proceedings, reports have been produced including a variety of cost estimates for a variety of potential remedial options. In March 2021, the parties notified the court that they had agreed on a settlement in principle of all issues in this matter. Following conditional approval of the settlement by the court in August 2022, in September 2022 the parties filed a joint motion for final approval by the court. The conditional court approval did not result in a change to the Company's previous accrual for this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's accrued expenses for environmental proceedings are included within accrued litigation as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2009, the IRS issued its audit report on Medtronic, Inc. for fiscal years 2005 and 2006. Medtronic, Inc. reached agreement with the IRS on some, but not all matters related to these fiscal years. The remaining unresolved issue for fiscal years 2005 and 2006 relates to the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico, which is one of the Company's key manufacturing sites. The U.S. Tax Court (Tax Court) reviewed this dispute, and in June 2016, issued an opinion with respect to the allocation of income between the parties for fiscal years 2005 and 2006 whereby it generally rejected the IRS&#x2019;s position, but also made certain modifications to the Medtronic, Inc. tax returns as filed. In April 2017, the IRS filed a Notice of Appeal to the U.S. Court of Appeals for the Eighth Circuit regarding the Tax Court opinion. Oral argument for the Appeal occurred in March 2018. The U.S. Court of Appeals issued its opinion in August 2018 and remanded the case back to the Tax Court for additional factual findings, which it concluded in June 2021. The Tax Court issued its opinion on August 18, 2022, and it remains subject to appeal by either or both parties. At this time, the Company is evaluating whether to file an appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IRS has issued its audit reports on Medtronic, Inc. for fiscal years 2007 through 2016. Medtronic, Inc. and the IRS have reached agreement on all significant issues except for the allocation of income between Medtronic, Inc. and its wholly-owned subsidiary operating in Puerto Rico for the businesses that are the subject of the U.S. Tax Court matter for fiscal years 2005 and 2006.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medtronic, Inc.&#x2019;s fiscal years 2017, 2018, and 2019 U.S. federal income tax returns are currently being audited by the IRS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Covidien LP (a wholly owned subsidiary of Medtronic plc) has either reached agreement with the IRS or the statute of limitations has lapsed on its U.S. federal income tax returns through fiscal year 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although it is not possible to predict the outcome for most of the income tax matters discussed above, the Company believes it is possible that charges associated with these matters could have a material adverse impact on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 11 for additional discussion of income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company and/or its affiliates periodically enter into agreements that require one or more of the Company and/or its affiliates to indemnify customers or suppliers for specific risks, such as claims for injury or property damage arising as a result of the Company or its affiliates&#x2019; products, the negligence of the Company's personnel, or claims alleging that the Company's products infringe on third-party patents or other intellectual property. The Company also offers warranties on various products. The Company&#x2019;s maximum exposure under these guarantees is unable to be estimated. Historically, the Company has not experienced significant losses on these types of guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes the ultimate resolution of the above guarantees is not expected to have a material effect on the Company&#x2019;s consolidated earnings, financial position, and/or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjU5NA_9cb01b81-15e4-462d-9426-0a4f8d326ece"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjY4OQ_fff144e4-3c26-48af-a60d-ce89d7a4c681"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDM5ODA0NjUyNDIxOA_977f430d-db53-427e-8035-8be3d0e2243b"
      unitRef="usd">60000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia0b6116555c34c9f83363705bad2dc7b_I20221028"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjc5MQ_83aff16d-2087-41ba-9ba8-004e888d388e"
      unitRef="usd">300000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ib6dbf47620f34e0cbc2ca62a86b19498_I20220429"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMjc5MQ_ca4101f7-b2b0-4bd4-a82e-03c9709eae59"
      unitRef="usd">300000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mdt:LossContingencyNumberofSubsidiaries
      contextRef="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMzc0MA_4f072377-5072-4dac-8777-bbc0aaf834dd"
      unitRef="subsidiary">2</mdt:LossContingencyNumberofSubsidiaries>
    <mdt:LossContingencyNumberofManufacturers
      contextRef="ie99b9397534149da83e4718a06bc0e1d_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfMzgwMQ_109607db-bccd-469d-a797-f0bf109f11f7"
      unitRef="manufacturer">1</mdt:LossContingencyNumberofManufacturers>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDI5Mw_674f11d3-0697-426c-88b9-5cfd67f7fc5e"
      unitRef="usd">121000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="ia5e2de4a2c844efe87d8b72767989d12_D20150425-20160429"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDMyMg_281d69a6-48c2-43dc-b39d-59b39c4dc257"
      unitRef="claim">11000</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="id7f39f4a31bc4c9a9b552b6baf0224b9_D20170501-20170531"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDQ0Mw_92b1dfb5-04eb-4313-ab25-0991e6ca6b32"
      unitRef="claim">5000</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3323d48e49714e21a2aa0924d7d7fd8e_I20221028"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNDgxNg_5c051a9a-2ce0-4eea-8e08-b497bba3ec49"
      unitRef="claimant">16200</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="ie8ade720172b41b4909dc7e2c1b1d88e_D20221102-20221102"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTAwNQ_7774b63d-3e93-4e93-ba75-83e222929a42"
      unitRef="claim">15900</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="if898f1e4a80d473cabc86d838cccee2e_D20221110-20221110"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTUwMw_f1244075-0c1e-4497-80a5-26c8d4037ded"
      unitRef="plantiff">6050</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i8380ebe92e864b56ae1b2c2197ab9fa3_D20221110-20221110"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTY1Mw_238170d2-c4e5-453c-b423-46d17b00515d"
      unitRef="plantiff">5600</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i02d1ebdd9f994625a9014f70c6861e5c_D20221110-20221110"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTgxNg_0f47de5a-db4a-4120-be47-12257f6df83f"
      unitRef="plantiff">350</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i30a6362b35d847688440a2d5375ea168_I20221110"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNTkyOA_7340110e-630d-432a-8964-80bc64e26a3f"
      unitRef="claim">90</us-gaap:LossContingencyPendingClaimsNumber>
    <mdt:SiteContingencyNumberofLandfillsRequiringRemoval
      contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzc5NQ_4752ab07-7612-473b-8f84-666f386ac3e2"
      unitRef="landfill">2</mdt:SiteContingencyNumberofLandfillsRequiringRemoval>
    <mdt:SiteContingencyNumberOfLandfillsRequiringCapping
      contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzgzNA_e1c87673-ad58-483c-b926-923e35bebe95"
      unitRef="landfill">3</mdt:SiteContingencyNumberOfLandfillsRequiringCapping>
    <mdt:SiteContingencyNumberOfLandfillsRequiringCapping
      contextRef="ia83c22e2869943c9901ca85607d408ef_D20220430-20221028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV84OC9mcmFnOjgxZDg2N2JhN2UyNzRlMGU4NTlhYmQ5YTVhN2MxYTA5L3RleHRyZWdpb246ODFkODY3YmE3ZTI3NGUwZTg1OWFiZDlhNWE3YzFhMDlfNzk0MQ_497b00a1-bba1-40f8-b4b0-1bfa009a017d"
      unitRef="landfill">3</mdt:SiteContingencyNumberOfLandfillsRequiringCapping>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg1Mg_d21a989d-0876-4f38-876c-f38b908884e4">Segment and Geographic InformationSegment disclosures are on a performance basis consistent with internal management reporting. Net sales of the Company's reportable segments include end-customer revenues from the sale of products the segment develops, manufactures, and distributes. The Company&#x2019;s management evaluates performance of the segments and allocates resources based on net sales and segment operating profit. Segment operating profit represents income before income taxes, excluding interest expense, amortization of intangible assets, centralized distribution costs, non-operating income or expense items, certain corporate charges, and other items not allocated to the segments. &lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended April 29, 2022. Certain depreciable assets may be recorded by one segment, while the depreciation expense is allocated to another segment. The allocation of depreciation expense is based on the proportion of the assets used by each segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes to the reportable segments during the quarter ended October&#160;28, 2022. The Company's four principal operating and reportable segments are as follows: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Operating Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-operating income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized distribution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and associated costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certain litigation charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RCS impairments / costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCS impairments / costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales are attributed to the country based on the location of the customer taking possession of the products or in which the services are rendered. The following table presents net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 for the Company's country of domicile, countries with significant concentrations, and all other countries:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other countries, excluding Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTEzNg_558b603c-21d6-4708-8c68-dc8b6c3abac6"
      unitRef="portfolio">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTEzNg_ea3dea4f-135b-439b-ac8b-35cf451b8cc3"
      unitRef="portfolio">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg3MQ_21e71863-7092-430f-aadf-221e1a4c794c">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Operating Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-operating income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(844)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(866)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centralized distribution costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(622)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and associated costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certain litigation charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RCS impairments / costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MCS impairments / costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i168eaf54a32a4b10ae055d1fd309420b_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi0xLTEtMS0xMTk4Njg_84f8873c-0139-4fb2-b30c-32ae6e646d8e"
      unitRef="usd">1047000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3c68c9b8053c4e069d0d10d554ee743e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi0zLTEtMS0xMTk4Njg_d94c8a7e-e8b8-4eb4-9881-f13374049dbb"
      unitRef="usd">1095000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i69a634b3ac7e4a93bcc654038f139554_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi01LTEtMS0xMTk4Njg_8eb8b64a-b379-41fd-8351-2d83cc38b618"
      unitRef="usd">2003000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia19bc2cc12e847f686364b13145bcfa2_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMi03LTEtMS0xMTk4Njg_0f7e6101-50e5-4717-add4-657c01a51b7b"
      unitRef="usd">2256000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i149726acb078405a812214d92610bf74_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy0xLTEtMS0xMTk4Njg_9136fb5c-0a1e-4b3b-a004-c86dbd9ce1df"
      unitRef="usd">714000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i94ae48a92e344d458bdf1af7ef9dfb83_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy0zLTEtMS0xMTk4Njg_cbae718c-694f-4226-bae9-6c08f14de9a2"
      unitRef="usd">908000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70e9b68daa7e476b86394d75a37314c8_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy01LTEtMS0xMTk4Njg_593217a6-cc82-4c3c-b3b1-ee8ee0ea2ad4"
      unitRef="usd">1356000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4db2d7938ece4d1188f55fb0d90ed8ca_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMy03LTEtMS0xMTk4Njg_d06172bd-8d0f-4136-bdd9-999177aff39c"
      unitRef="usd">1823000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if684219172ea489d828654ce6bda19c7_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC0xLTEtMS0xMTk4Njg_da2195b9-30c1-464a-80bd-8ff288681837"
      unitRef="usd">876000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie88ac8796d2b4f16995fb97c31c6448e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC0zLTEtMS0xMTk4Njg_2945e010-b348-4f94-92be-91f5affd17b4"
      unitRef="usd">887000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1dbc31eff45b4bfa9d8c0fbeda13eb34_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC01LTEtMS0xMTk4Njg_9b764f08-dece-458c-84f9-10489abd13c1"
      unitRef="usd">1691000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3f69ab25f0944c209d12b73a3e7b2556_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNC03LTEtMS0xMTk4Njg_fd2aa4c4-b1fe-4060-8ba9-9be763a4d71c"
      unitRef="usd">1850000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5fb28ceec1a245729e4603a23ff55bf9_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS0xLTEtMS0xMTk4Njg_23218a6c-fab8-4dd1-9ae6-9e5f78918461"
      unitRef="usd">96000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i63ff869d0a4a41f786d7d359f94cb14c_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS0zLTEtMS0xMTk4Njg_05480084-11b1-4935-a3ed-ed38fee54634"
      unitRef="usd">157000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3857837c700c47ee90158dd782777f47_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS01LTEtMS0xMTk4Njg_0fc81a31-7833-43c0-9296-1fd9c763a175"
      unitRef="usd">174000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b5b877f4e5a4a5f80879a1c21a2d977_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNS03LTEtMS0xMTk4Njg_9613da80-3136-4474-bc7b-ef28d187d0bd"
      unitRef="usd">290000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i47ff2bf6f8a94d3e97118363d9a224a2_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi0xLTEtMS0xMTk4Njg_34e308e7-71bf-42ba-8099-7e4f036f83c6"
      unitRef="usd">2733000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3a6af4191c704ad28f09d2139ee771bb_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi0zLTEtMS0xMTk4Njg_6bab31aa-bbab-4121-ab47-8da04d6c57aa"
      unitRef="usd">3047000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i50c477f464714ac1be4ba61e84a7fe9a_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi01LTEtMS0xMTk4Njg_e9f4f209-5867-48ce-b5b6-400a5a41c91f"
      unitRef="usd">5223000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5da000fddfa54c00b738a9d7fa43607b_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNi03LTEtMS0xMTk4Njg_57a3ab13-f4ca-4e79-81c0-884d41542001"
      unitRef="usd">6219000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy0xLTEtMS0xMTk4Njg_3dd523cb-d818-4760-9f11-677232cf0bdf"
      unitRef="usd">-118000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy0zLTEtMS0xMTk4Njg_b6fc18db-00e8-4fe3-a4a1-b82bb3164b3f"
      unitRef="usd">-136000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy01LTEtMS0xMTk4Njg_6c9097ee-0a35-4688-800c-7cd4719afef3"
      unitRef="usd">-282000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfNy03LTEtMS0xMTk4Njg_a966a41f-bc5a-4a2e-bd65-a144b54f504f"
      unitRef="usd">-273000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC0xLTEtMS0xMTk4Njg_586b3ad1-5b0c-4c0d-a730-4d375f292ec2"
      unitRef="usd">109000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC0zLTEtMS0xMTk4Njg_d9e8d2bf-940e-4891-b2b4-ffe41c3e4cbc"
      unitRef="usd">66000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC01LTEtMS0xMTk4Njg_345d69d0-fcd8-454e-a131-abebfea94de8"
      unitRef="usd">192000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOC03LTEtMS0xMTk4Njg_b403a678-cb2e-4855-bf00-71fe1a8c098a"
      unitRef="usd">177000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS0xLTEtMS0xMTk4Njg_3c7371df-4e7a-4a2b-8428-85c6e88884e5"
      unitRef="usd">421000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS0zLTEtMS0xMTk4Njg_0b978fa7-bf0e-4d8d-b52a-530bb2ba80ed"
      unitRef="usd">431000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS01LTEtMS0xMTk4Njg_05816836-68bf-4250-aaee-1191a81e6c0e"
      unitRef="usd">844000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfOS03LTEtMS0xMTk4Njg_0a24bf9b-008a-492a-b35a-ba7ca2fd06d4"
      unitRef="usd">866000000</us-gaap:AmortizationOfIntangibleAssets>
    <mdt:CorporateOverhead
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtMS0xLTEtMTE5ODY4_cd546c46-cda0-4941-8793-9ccc3841153c"
      unitRef="usd">402000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtMy0xLTEtMTE5ODY4_53940a05-958b-4721-865e-7230cbd1e9f1"
      unitRef="usd">415000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtNS0xLTEtMTE5ODY4_4300e103-9aa9-4fd1-86e3-4d4309781383"
      unitRef="usd">816000000</mdt:CorporateOverhead>
    <mdt:CorporateOverhead
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTAtNy0xLTEtMTE5ODY4_c11cfc04-3e9b-43ab-b924-8f9feaec9b99"
      unitRef="usd">864000000</mdt:CorporateOverhead>
    <mdt:CentralizedDistributionCosts
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtMS0xLTEtMTE5ODY4_4f79d9f6-6d0e-4a47-9e90-33e5fb6cc0c5"
      unitRef="usd">311000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtMy0xLTEtMTE5ODY4_0f6542a9-d863-4b1c-8bfd-acaa09b8fb71"
      unitRef="usd">516000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtNS0xLTEtMTE5ODY4_75f090c7-6903-455d-9c85-767304d10ffb"
      unitRef="usd">622000000</mdt:CentralizedDistributionCosts>
    <mdt:CentralizedDistributionCosts
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTEtNy0xLTEtMTE5ODY4_32490803-8722-42c7-a4cb-8ee65812fc99"
      unitRef="usd">981000000</mdt:CentralizedDistributionCosts>
    <us-gaap:RestructuringCharges
      contextRef="if121f0c93f2542b787d18dc65313b4ec_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItMS0xLTEtMTE5ODY4_4d0453c0-14be-4805-aa7e-c391cf584506"
      unitRef="usd">95000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie20fd350e6d74274a06ac9c4f5a4d7f1_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItMy0xLTEtMTE5ODY4_4cc38b25-0ca6-4b88-8e94-500ff1e77ce2"
      unitRef="usd">77000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i03ff4fbd770e476a93fac4538e7a739a_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItNS0xLTEtMTE5ODY4_2774e65f-6aa5-42ca-bfe1-21e61740450c"
      unitRef="usd">171000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ida7e46384f064832b227315992afe5e9_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTItNy0xLTEtMTE5ODY4_4aa146e6-5286-42a9-8add-a99f27c789c3"
      unitRef="usd">159000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtMS0xLTEtMTE5ODY4_72b85c73-3586-4558-a40b-60b65b03974d"
      unitRef="usd">2000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtMy0xLTEtMTE5ODY4_7cfb179f-1f81-4aa8-bb5f-95fd7e82f6c5"
      unitRef="usd">-13000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtNS0xLTEtMTE5ODY4_ca7f0253-46d6-43f0-a75e-e0fe2b061046"
      unitRef="usd">38000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTMtNy0xLTEtMTE5ODY4_9a627c67-b4b5-40eb-b37c-657821477cc5"
      unitRef="usd">6000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtMS0xLTEtMTE5ODY4_7baecc29-5f4e-4a76-a4ac-0d70e4d9b6a9"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtMy0xLTEtMTE5ODY4_75dde7f5-95f9-4302-9384-3b0aac24bff3"
      unitRef="usd">34000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtNS0xLTEtMTE5ODY4_6ad0b124-265f-49c2-8b8b-eed354e04070"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTQtNy0xLTEtMTE5ODY4_bc66ea80-de40-4a29-87b6-7cccda6c0b86"
      unitRef="usd">60000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringCharges
      contextRef="ifec30626328141edab3ec5e1fd7fad30_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtMS0xLTEtMTE5ODY4_cb7ff636-c109-41d5-a4e1-3f6edce9e8c9"
      unitRef="usd">24000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ied00ece93e9e4688918b205b9ade91fc_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtMy0xLTEtMTE5ODY4_14883cd9-099b-4d89-a985-e7c3d21f402e"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i827544a4779342aca7ddd0cc9e3e3373_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtNS0xLTEtMTM1MTc4_57aeb622-75a8-49e5-adb5-b4a6c569fad8"
      unitRef="usd">99000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3b62391f8b8740d7bb9d8216c3714f9e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTUtNy0xLTEtMTM1MTc4_bab4754c-64ca-406c-827a-86fbfaafa2b4"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if4de15689258429f96c8aede9acd4189_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtMS0xLTEtMTE5ODY4_8bc41500-1e71-4170-bd11-24d2aad34838"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia1297ee8d0604a979f5928e67af71318_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtMy0xLTEtMTE5ODY4_cf9a3814-61ea-4b32-ad28-5be0d22a4e9b"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie0d54845eef646a0b6664bce4c66a85d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtNS0xLTEtMTE5ODY4_0d8c45e8-1428-4cd5-94ad-d3fefa548cdb"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0de2e2a292af422b8f366ef645be1066_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTYtNy0xLTEtMTE5ODY4_acf7ff46-1bfe-40df-8633-8365863df1a8"
      unitRef="usd">726000000</us-gaap:RestructuringCharges>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctMS0xLTEtMTE5ODY4_6f4dfdc7-c0d8-498b-98a4-1231d8df55c1"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctMy0xLTEtMTE5ODY4_c7c9e41c-4d02-4114-b553-7fdf5fd5cb36"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctNS0xLTEtMTM1OTgy_c3d2e83f-08ef-461f-8f0d-b362c3297a66"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTctNy0xLTEtMTM1OTgy_79829eb7-f43a-49d6-b0d6-03bf8851df0f"
      unitRef="usd">90000000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <mdt:MedicalDeviceRegulations
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtMS0xLTEtMTE5ODY4_2f5a7c7b-e558-4e46-8651-d92b6fc4dfbe"
      unitRef="usd">37000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtMy0xLTEtMTE5ODY4_ef473a9e-a018-4d75-878c-7e101450f995"
      unitRef="usd">24000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtNS0xLTEtMTE5ODY4_10561799-cfab-47dd-a77c-ab7c4c534cbe"
      unitRef="usd">70000000</mdt:MedicalDeviceRegulations>
    <mdt:MedicalDeviceRegulations
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTgtNy0xLTEtMTE5ODY4_9d31ece6-7089-4c75-8d20-c84d221e62a4"
      unitRef="usd">45000000</mdt:MedicalDeviceRegulations>
    <us-gaap:BusinessExitCosts1
      contextRef="i8330ae7da7a74debb73b7ca141387cc8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMS0xLTEtMTM1MjAx_8913af93-8ef5-4420-8d85-04baafad062e"
      unitRef="usd">37000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i71c3c1cdb5424a44ac88b64ad7ef3f00_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMy0xLTEtMTM1MjAx_ac8b50aa-0a0e-43df-add9-dd277b8e1056"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="idb395127d92d4806adad85a3df96ef16_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNS0xLTEtMTM1MjAx_a354bf38-2741-4067-b163-97c3d1353fd7"
      unitRef="usd">37000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie41bbecdd35543169a02c0249f88437e_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNy0xLTEtMTM1MjAx_25ff1980-2c46-45a3-9f08-d0355924f8d9"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMS0xLTEtMTE5ODY4_4184cc75-a7ca-4744-adf9-875b6309532c"
      unitRef="usd">1395000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktMy0xLTEtMTE5ODY4_037e76a1-d88a-459d-a0ac-dccc5abbe4c3"
      unitRef="usd">1493000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNS0xLTEtMTE5ODY4_657b9804-fd15-4361-9050-a142e487d046"
      unitRef="usd">2438000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOmY3MTUzYTEzYmM1MjQ0Y2I5M2ZkNmZlNjY1MmQ1NGI0L3RhYmxlcmFuZ2U6ZjcxNTNhMTNiYzUyNDRjYjkzZmQ2ZmU2NjUyZDU0YjRfMTktNy0xLTEtMTE5ODY4_76f98ea4-2faa-4553-94fe-33895dd59a43"
      unitRef="usd">2326000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RleHRyZWdpb246ZDA5MDUxY2M5NzA5NGI3ZTkyNmNlNGRlMDFkNjZiODlfMTg1Nw_17b28aa1-b921-46f8-a38c-35daa3ca7372">The following table presents net sales for the three and six months ended October&#160;28, 2022 and October&#160;29, 2021 for the Company's country of domicile, countries with significant concentrations, and all other countries:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 28, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other countries, excluding Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52660540190940b693d1bd02d12d492a_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi0xLTEtMS0xMTk4Njg_41a25ac1-da59-409d-8e55-efb33d13e1e5"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic46769724c574bac915cd348f37fcf2d_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi0zLTEtMS0xMTk4Njg_a7b671f8-e95e-4282-9b1c-60ebf37cba61"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i214e01a959c846e88851e34cc42dc32b_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi01LTEtMS0xMTk4Njg_a30eee93-1e24-4aa9-8f72-e1d04466ed64"
      unitRef="usd">47000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieaeb28a3e4b44b1fa4ad70e8b96300c1_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfMi03LTEtMS0xMTk4Njg_ae132ad0-a550-4f02-b192-369d1616f879"
      unitRef="usd">52000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2874fedb259a4c63a3b1788c6b728f8a_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC0xLTEtMS0xMTk4Njg_029f8403-4e87-4784-853b-3136c05ddd04"
      unitRef="usd">4069000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c41636e30a94f21aff53ded759299fc_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC0zLTEtMS0xMTk4Njg_f47136d1-3acd-4948-8544-1c64568f68af"
      unitRef="usd">3997000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a35a1c554964124abb5ee0031861d95_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC01LTEtMS0xMTk4Njg_d3385d6a-cc40-4056-9786-a2e87470022f"
      unitRef="usd">7835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dd1aa2ff7f54d718d540a25adbd6ff2_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNC03LTEtMS0xMTk4Njg_e3f30091-d527-45a5-b2ec-6e95af0b1eb0"
      unitRef="usd">8098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aa56bae6c344578b698d10d544eafe8_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS0xLTEtMS0xMTk4Njg_0e16affb-895a-475e-b99f-77d3c4053c18"
      unitRef="usd">3491000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5224032c63584bec8b1b1523947f71dd_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS0zLTEtMS0xMTk4Njg_e047702f-a676-4605-8b2f-acc866d95e34"
      unitRef="usd">3823000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8120e40de324a48a75b99dadc77ac4d_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS01LTEtMS0xMTk4Njg_57beb005-77ec-4f68-9b31-75384a6d6a15"
      unitRef="usd">7073000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6eaeba13607d4490a06e297131324140_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNS03LTEtMS0xMTk4Njg_4eace995-847a-4030-adc4-70fb499e93ee"
      unitRef="usd">7685000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib88c0c1ed9ab49caa522738259c03475_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi0xLTEtMS0xMTk4Njg_d4cc4a89-4274-456c-8cb9-cf7f52572e76"
      unitRef="usd">7560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52482a063c8a45dfaeab8842374cd025_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi0zLTEtMS0xMTk4Njg_74367cc8-ae64-4556-9c8b-e606a857abbf"
      unitRef="usd">7820000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia092a03ef5384e598bb50ffc1990cce7_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi01LTEtMS0xMTk4Njg_de995aed-b913-48f6-95fa-239246b5d44a"
      unitRef="usd">14908000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba3d02155da748508b967c01e3e9fc3f_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNi03LTEtMS0xMTk4Njg_6a2b71e7-5a2a-4feb-9f45-17a89a352fc2"
      unitRef="usd">15783000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy0xLTEtMS0xMTk4Njg_bf4a8b75-b885-4a87-b23b-ec35733aaee5"
      unitRef="usd">7585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i236409b4a26046c8895b2b03b157a37e_D20210731-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy0zLTEtMS0xMTk4Njg_ceb94694-89cb-462b-83f5-234b564090b2"
      unitRef="usd">7847000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy01LTEtMS0xMTk4Njg_b2e12a8d-02cc-4a4d-a9e2-0c9f978389e9"
      unitRef="usd">14955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dd8487a2c0445a09993795bf16e3908_D20210501-20211029"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjM5MDBmYWZkYzU3YTRkYTNiZjcxNTcyMjYwZWQzM2I1L3NlYzozOTAwZmFmZGM1N2E0ZGEzYmY3MTU3MjI2MGVkMzNiNV85MS9mcmFnOmQwOTA1MWNjOTcwOTRiN2U5MjZjZTRkZTAxZDY2Yjg5L3RhYmxlOjExOGE5ODdkMTBhZTQxOTM5ZDUzYTJlNmFhYzk3MTZjL3RhYmxlcmFuZ2U6MTE4YTk4N2QxMGFlNDE5MzlkNTNhMmU2YWFjOTcxNmNfNy03LTEtMS0xMTk4Njg_7b207544-a6b7-4fda-8f0f-66cdd831a6ab"
      unitRef="usd">15835000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>104
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M@!_Z2ELVD,B53.3"*%/GXZ4XR=676EC 59JRP3^N!" 7II:/V2Q.V.TB2R%
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M*;&\YAO"]#\K+DJL=%.L?;D1!&>545GX* @2O\24>=-QU?<@IF.^505EY$$
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M0A==W455QZJ\/,Y7RN+E4#93O+Y!NP"<7RMEGSKNAFC^$$1_ 5!+ P04
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M9J4V+BC\>V!+5M?&$^CXZ^ATT'VF&7AZ_>+]BYT\3&9%%5N*^C^\TMN;P6R
M*K:FAUI_%X__9,<)C8V_4M3*_D6/1]ML@,J#TF)W' P*=KQI_].GXT*<#  _
MX0'X. #W!Q21 >0X@-B)MLKLM#Y331?74CPB::S!F[FP:V-'PVQX8\)XKR6\
MRV&<7BQ%HT3-*ZI9A>XU_(,8:87$&BVIVJ(O$&>%+GXT]%!QL+E$0_3C_C.Z
M^.T2_89X@[[QNH9XJ.N1!CG&Z:@\?O2G]J-QY*,GZ)MH]%:AWYN*5>?C1S"-
M;B[X92Z?<-+AGZ7^B/#L \(9Q@$]R[<,G]OA>4(.Z9:66'\DYF_/)-6\V:!;
MLU>YYDQ=A9:I=5.$W9AS?*7VM&0W SBHBLD'-EC\_6_Y)/M':([OY.QLQD4W
MXR+E??$'I!W>E&+'0M-LQT[L6)-='A8YF4RO1P^G\GTCG,TFG=&9K'$G:YP,
MQ&WU7SA([;[6 I)/*9J2UPPUG5YSW[PJS9[?2_' 84NBU3,271!I.HCC]PSB
M.SD[6ZU)MUJ39! _,W!:<MIFV:9"=">DYO^S-T(S;]V-S^)*YKVXAHR*:3BN
MTT[I-*GTSL3)\@1PADK)($.A6BC%@MEHZDDH\IY*WX0488VS3N/LE=5<,PG*
MNGU&G\+J9MY'#^>X)R]@,YV%]<T[??.DOGLMRI]# \(*@4"H#E0TT',_AO-^
MG'T;G,W#$O/,,2I+BOP7Q!1!F"NVTH@]F>-XX&IK3G00.YDG8DQZ.@,V643F
M"4KSI,QORWM$8?=!4MGM*9=&GSU!O'F 2R&?T:,$B XK\1A<X*/_L*BC;M]D
MG(\CRK%3CI/*_]1;)C^8#!B4A?W %[.^L( 1B2VI0VB>9NAR2YL-,W7&22(V
M2ZSLPM:<KGAMD[)5;\H66OX%FX.;3=P:55 G*LWU0492=_ZN 'XO;^<KYA"<
MIQE\6Y;B8$@'29SQ![JJ63RPA9]02#'I1S9@E4_S2&@=E/,DQ19?CX?B)79!
M@>-0QBOZ @-6^3A2-.2.@WD:A-U*[NFS6<86AF4I#^QLYP6%^[P;YI[N@%%1
MQ'0[*N9I+-K#_.IY":KV^3?W1/LVPR*:XATF\S0G_WAK\174[8,1VMAQ7[EO
M1;));!\[@.;S9(HR^UB]I<S/DR3^Y33S3M[..RV'9)Q&\NU)ENU2KPV@S;^R
MW] =^S>?NL-\YC4!(;-Y)%#8X1FG\7Q;54<J0+$/VPPVEW[^@/8U;?0'>SP8
M*-_'J@KLDW<X+?KU3\AJ4D2.!W: QFE WQUDN84BS3;FW.XXV\\$A?HD'I)I
MT:^ 0F9CDL>6V2$;)P&WN*<U:[/-C@)S[7EXBVKBG\Y)YBVO;U5,2*2/P Z:
M. W--F7R[B2[=!-%$_:IF'MJ ^2<QO:" R=.@[-+E0=E^XJ@[J#D "?QE/2;
MH)!97LQ)1+?C*9XD$^47WE#HNU]/E#C)Y5]-E._E[7S6CL8X36-7P98': 2A
M([!=C%C5?$-=^@RN0Z@=]?:8;Q2INK&#,4[#&!KKDK%*H;44.W0A&51 +X\%
M+Y':"JF'FLD=6@D)SB&D"EV<G/:-9!3>1QKFCN89JNBSN@S., !N[-5W :O8
M%!VU<;KO_:K4 78C,YFI%LVFG8\)35"GW]:2@O1[LX!51"=QG"5ISMYU*]^\
M02<)@!.?YO3C,\(0AB-*'5Y)&J^?N:G;FLKB56VI9%M15TP&4Q$)8#*?9?U"
M(&@VB:4BXG!*TC@]C;Z0%20FZ,VMYK#:0&_K/5$(&.%IY.D1.7F&G*;I=[8_
MHO^M6GU"#HNIM[ !JVD14^LX2M["T767Z-,\(CX>"Z],"1@-8ST2<0PE;V3H
M:;MQ<03JY=MGX*,29Y-^_@I8#3'.8[G! 96D&]3?UVM6VL*;/94M9J!=8JB]
MMBFCK<BA%K,7IKY]@/(L4H*10#^*L1>0@-4XECT<)DD:DS8@#I6_)-LG8)Y[
MS7; :AC/) Z5)(W*94PIHAJMV(8WC=E&$"-H-[@(=D4DT)A._0D$K,;1"3@0
MDC0(DQ. =/Z*=!]YQ0SWGPT&K/ \B^S_PK&QR-(/!^T!IKPRS_^#E621A.NO
M5I+OY>U\N@ZP11JP7U_Y!J'P83G#??0'C":QY\>%XVGQ"D\;*$N@!PG*POY7
M>J2_N4-&L_X&&9U\S;UC<F.__5?(/J5KOR7N[G:_,+BUWZOW[G_*KY;M[P2<
MF_9G"]^HA".K4,W6X#+[.(6%DNTO =H76NSME^DKH;78V<LMHU#F& -X?RV$
M?GEA/J#[/<;B_U!+ P04    "  Y@H%5 2FN?H@&   0$   &    'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;*58:V_;-A3]*X0&%"W@^)6^FP1PTG4KAJ)9
MLK8#AGV@)=IB0Y$J2<7Q?OW.O91D)4W2KOL22WR<^SKWD,K!QOF+4"H5Q55E
M;#C,RACKEY-)R$M5R3!VM;*863E?R8A7OYZ$VBM9\*;*3.;3Z=-));7-C@YX
M[-0?';@F&FW5J1>AJ2KIM\?*N,UA-LNZ@3.]+B,-3(X.:KE6YRI^J$\]WB8]
M2J$K98-V5GBU.LP6LY?'CVD]+_BHU28,G@5%LG3N@E[>%H?9E!Q21N61$"1^
M+M6),H: X,:7%C/K3=+&X7.'_H9C1RQ+&=2),Y]T$<O#['DF"K62C8EG;O.K
M:N-Y0GBY,X'_BDV[=IJ)O G15>UF>%!IFW[E59N'[]DP;S?,V>]DB+U\+:,\
M.O!N(SRM!AH]<*B\&\YI2T4YCQZS&OOBT;$,.@BW$J=>!66CI%P=3"*@:<$D
M;V&.$\S\#IBGXIVSL0SB9UNHXOK^"5SJ_9IW?AW/[P5\G\>QF#\?B?ET/K\'
M;[^/<Y_Q]N_"\VMI]3\<WDB<.!N<T85,S+#%M? I'6^TE3;7THAS#"K0, ;Q
MUV(9H@>1_KXM0\F!Q[<[0,WU,M0R5X=93;;\I<J.'OPT>SI]=4]XC_OP'M^'
M_OUE_ $8\4>IT#VYJVIIM]JN16-E4^BH"I'WB<3+JL]9V.4,8.]4$;VS.A>U
MR3G;&A.A609=:.FU"N+AM36CW9:1<%Y$.'"2S#\2I;Q48JF4%<AC+3T,:\O^
M^0+F%1HHEOS>V$C>UE[#J]K S%I9Y:4Q6YI7=4Q["?Z#Y7BXV.STHE)>YU(\
M_# ^'S]*/^*7Q>+TD8 48EO$?#6(6=LDD1VCV V"UA:D:5B$@HA.D)J(V73O
M=UZV\%'G1F& K)ZI=6,2QOG>GV/Q-GGG:FU;8E;20BPIMR.>^G8%$+UI"I30
M&-XAB\_0E31G5:Y"@!IS4%*LI/:[O90<X%-<.FY31'T>QN)$^0C9AS;G1H:@
M5\A7BG)7HTK",H)&$6!@JZ2_W4DL:2WQXPV\)NPJE3?>DV^$-1;O:Q24RPS&
M0HG#M>I@4KLB"+!$6!?[<#48H&W!^/ 4:>UVQU)&.+V%]T)=U3@[**TM!U<Z
MY'";HY! %9O2&37F!DED[/4C+;^U&G>G%%Y\:31<&529TE')"W@3HJZ8G40;
MY*>IZI93Y+-<K> LVX4GSI/?LJ(>8#ICO8IA)(R62VUT1-.-L/!2V8:>*%0;
MZ(G $XAA2A6(V;C0D%<RX1/7[HV1,(K&4U5V_G K<CW&8I''!ENZI*-532$H
M.*^Y.PN-:, 4[RI""(/H4[9/WG]\^WIO]D) $PI5038>9MU8UDE&UDUFI!K$
MRB+%1_5%$>!2P^0DNM(,6N-2>;*6DDFE;'#J-P$Z&3AAR6$$[Q+QD/_1( E
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MDD<8]$*L5:)IY3H^MB)%J:-LP(B6I\*W,=WQVI]4:8V+M2*5.K4DV41N;+&
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M__6"'5'?@=UT>\PN'-?Y+F;H"E5- NVG)F>@XVBPB98Q.I,\IX!AH]1HA8K
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M7_G4%Q>:0PA8!_E5)\BOE"VDKK:#*T5PA7;V:L\V/NVVF!1!D9L"%#5218A
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M3*T'W__^6=+1,(HA0(+99,K2_0>R!F<6.ITGCEEGA FL-'\0TJ,V/E((NYQ
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M965T,34N>&ULG5G;<MLX$OT5E":3M:MD6B)%R<K%578RJ<V4/4G%,[,/6_L
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M*ZN@:E,ZP# ""V-J,.4NZ%CC/FDU;CLB63U6+* QS<,M^5B5A7"^!",BJ0W
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M"[85]D[55]CV,W)\F1+&?Z%N:@=Q -G66%6V8%)0<MF,[+G=ASW )'H#$+>
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M"X)&I^-1 +JQ=A-857D[K90E<_KIAEY#U*Z _A=*V5W@%NC>U_0?4$L#!!0
M   ( #F"@55?)NKX00<  *P3   9    >&PO=V]R:W-H965T<R]S:&5E=#$X
M+GAM;,U82W/;-A#^*QC5D[%F6(NDJ)=C>\:QTS2'M!XG;0^='B 2DM"2! .
M=M1?WV\!BJ(L679[ZD4"0.Q[]]LE+QZ5_LNLA+#L6Y&7YK*WLK8Z'PQ,NA(%
M-V>J$B6>+)0NN,56+P>FTH)GCJC(!W$8C@<%EV7OZL*=W>FK"U7;7);B3C-3
M%P77ZW<B5X^7O:BW.;B7RY6E@\'51<67XK.POU1W&KM!RR63A2B-5"738G'9
MNX[.WR5TWUWX58I'TUDSLF2NU%^T^9A=]D)22.0BM<2!X^]!W(@\)T90XVO#
ML]>*),+N>L/]!V<[;)ES(VY4_IO,[.JR-^VQ3"QXG=M[]?BC:.P9$;]4Y<;]
MLD=_=S3LL;0V5A4-,30H9.G_^;?&#QV":?@,0=P0Q$YO+\AI><LMO[K0ZI%I
MN@UNM'"F.FHH)TL*RF>K\52"SEY]4"I[E'G.>)FQG^U*:/:QM+Q<RGDNV+4Q
MPIJ+@84DNC](&Z[O/-?X&:YC]DF5=F78^S(3V2[] !JV:L8;-=_%1QG^G-HS
M%D\#%H=Q?(3?L#5[Z/@-7V/VGL'L5IHT5Z;6@OU^/3=6(WG^..0&+R4Y+(4*
MZMQ4/!67/52,$?I!]*[>?!>-P[=';$A:&Y)CW/]SZ(YR/:SS:T2Q]M*7E6 +
ME:/>9;EDEM,=QZO$+1"S= 5289@L_99KO::KO%!U:9E:L.6&UWS-C%@"!>PY
M.\7] H>H9M-G-UQG4CUPD]8YU^R3R&3*<_:YUDNW^$G46IE4BC(5""B?"PN1
M7Y3%L^M*RYS%,Y]/[(1- @0%_]$LF(TFM(B":$A/XB >)?A/PF 4QELCN6$<
MJ&10_:0P3[_6TDA"&L,F\9B]^6X:1_%;-HY&[3H*ADG([FH-!Q@!FI3L=99G
M?Z+6"^>ATRCLMR2GP\XZPN:+YJ59( !6L97(,W@:&,OAXO9:'$ZW1+NG-[76
M<,B:66*3<X^,"*IR03V=17W\C.@W&N^(#N(PZ3/4H9KCXJ84G>LF4W)0- TF
MLZEWW6@:[;HNB29(DQV/4>3Y4@M!5@/U[(K=\E^EY0'Y-O,5*#)*DI^4%2PA
MBUVZP,4JEQFW>+J0)2]3B9@:BP/GP<!=NU%%Q<LUXTC$U-T]@0LV";239 WC
M^YO/;%X;%(2A/.66%>B*3J265FC)Z>8<VYP;(Q<2/*'J;A2R6KNLIQJ0VECV
MM>8:Q"1P :.@Z5H@7^&]X1G[I2+_>PVA%4S?:B6AO]3..\A<N BR*J&I$0LO
M\*G2@0MEUW@M4K4LY=]D_3@Z:'Q'3$=W([^QPF.X( S?B_R9*_-#7)#<FJJ;
M ST[\A%'GV08*#1W68^"3E4A^DQ\PY!A1,!*.'R#"MTP;X-+NGLRK\'&TDQF
MK%1V*Y'1Z0']3-=,NT("'C>T]:F_2[OGG>,1)3H[ (\OHN(2<&7VP)#D 2CJ
M BA'GL"QMO)O7[G.%ZT@[@2=[UOP!.YV<?2#$WNS$7OMQ5YW1%YW1?[+Z[<"
M%8KB^3['\)6= X!HI!'Z>RW\;>#%.)A%!!RGDR"9C/O-T6CHC\)PU&\Q$Y$0
MZ:I4N5JNG6LJ,"$' G3BV8B=CL ++*(PF *ML1V/)PXT,PRS&'1]-&E;\@))
MF@"[3N-)W&?)9(C5&,2^P44AV-%V&N)_UF]:QPFYE7B?$!X'DV'8]V?#<-J<
M81[N(P&R)Z9_O+M_PXOJ[2VNC:9DW09=03_K[E_.ZUW>>TG0UN!>JA]/W\,I
M_T*JW[X&-9K;P;/HE(2S+CR]UD"D,H"B;&9\UT4^ 1%IT>#(DSGA#LF),I3J
MC-V+IH^Z_C)Z=7]QV,NSS'5[/)&E?SERJD,)ZAPYI:KGMX6>'5CP=OQ/<5.6
M+P7@**"^/LL.I9/8>*[DED9P:+ZMG4JK/Q'M)TV^X&OG#.W'O47M"#-@S!J6
M:[;@,L>)(<YJ;O&R"H.7!%A* T@J<'W@N7L,_V5UBG!@,G:#I$7CSR&OY0%]
M]AZ^( K#H88+"((H>7-, $@K 4(?VRX13U=2/,")4*4 5%+VY6OV()N6H4B]
M@#7]GP8E14-DW;:$5&@G=NLJUT2VXU?@_+6->"<),7.9[63N_7BV"^GO?=+M
MY_).:VI2LYU37MMIGR:$&WM.DG@[O-"MDV38'@1D527<ZWV^/E!C1_7Z;VGJ
MM9HFR:Y6T_'X.:W>&RL+W\&7F'J76!Y6#&\\W3EQ[KJ>>O*FA&2MQ2MP$C&W
M>Q8%D)7F=>:F#!1/A9@[DJ9L=M0"&X4,),4=NKH7'<KE;4D^KF2Z8FC/#DC6
MHIF;-XW:U<E"<,B0N;3K@$E#V>B'(?/TO>Y@KMT+^L!$"M/<C%8Y'<YHF>"=
M:IRXY8B6\8268UI&"2TG6(YF(2VGM 39H5?O0><+"DINZ;X381BCX<9_3&E/
MVT]1U_X+S/:Z_X[U"2@N\1*8BP5(P[/)J,>T_S;D-U95[GO,7%F,0FZY$AA(
M-%W \X5".VHV)*#]0'?U#U!+ P04    "  Y@H%5@\STFN<%  !C#P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6RM5VMOVS84_2N$FW8MX/D5UW';
M)$"2=E@^= V2=?TP[ ,M75M<*5(EJ3CNK]^YI.1'\VJ' D$LB;R/<^[E(7FX
MM.ZS+XB"N"FU\4>=(H3J=;_OLX)*Z7NV(H.1N76E#'AUB[ZO',D\&I6Z/QH,
M)OU2*M,Y/HS?+MSQH:V#5H8NG/!U64JW.B5MET>=8:?]<*D61> /_>/#2B[H
MBL+'ZL+AK;_VDJN2C%?6"$?SH\[)\/7IF.?'"7\I6OJM9\%(9M9^YI?S_*@S
MX(1(4Q;8@\3/-9V1UNP(:7QI?';6(=EP^[GU_EO$#BPSZ>G,ZD\J#\519]H1
M.<UEK<.E7?Y.#9Z7["^SVL?_8IGF[N]W1%;[8,O&&!F4RJ1?>=/PL&4P'=QC
M,&H,1C'O%"AF^58&>7SH[%(XG@UO_!"A1FLDIPP7Y2HXC"K8A>-SD]F2Q)_R
MAOQA/\ C?^]GC?5ILA[=8ST1[ZT)A1?O3$[YKGT?F:S3&;7IG(X>=/@A"STQ
MFG;%:# :/>!O?PUO/_K;?Q2>>*M\IJVO'8F_3V8^.#3$/W=!3A['=WOD1?+:
M5S*CHPY6@2=W39WC9T^&D\&;!_(=K_,=/^3]T7)\O[7X8,1)O4 'B6'#9U>$
M@L3'WE4O$G)F:Q?$\_7C"Z&\KRD7*GAA*V5XU>"/C0#U6MG:ZY7($X^8IU50
M"QG2\EQ(ERNSB+.EUC9+ W8N5,IJ1F%)9,1[RH.S1F5=@7Q[0IH4<5E8K5>_
MVJ6!:U_/O,H59 *9D(,ON%9&7-3D@A67*K,"BB3F2$9JL2+I/# .7D9WK$CB
M^8<$X45/?"J4IIA9\PWY_@M90"#^>'YY]>S)=#0\>.-%9;U*<F'2X(:IG (Y
M+,'&JJ10V-QJNU@)F5]+DV%@MMK@$TOIA:PJ9RNG9*"8<%4[A$!Y0$SKL*5-
M&;R#JTJ:E7!V)77 +UNVW&W#;Q/D>G;!X&Y^,L3!'2^^L+5&CB0*:!6YV ^.
MD#-*!$7WB>18K::$[,MNVH9C9M9X^E*3"6@&U(F)Y$EQ0I W:*Y">9%!*D&S
MA@^ -9B+.?>7BZVVR\/[B=]V/U=&:O4U=152WJU-),,RVP3_&";%V 08G]E0
MB$JZH,BG*&<-Q077!RU?TK>E1C!N9C2ETIH)@V.M,(U+"&H:!'-TK%TR:UO
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M)0<HO?%)N#%!.CEBX2^R4Z Z>=$FA*E)7!.*%;IB!8_\Y7#C!RZIS@I!P&8
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M AU:F+"PJO5MPT)9:D+\;TU='VI'0.=+1;5ELW "^CYR_B]02P,$%     @
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MW77&!_5Y8W!]N]/M@>^U],QJ91NK.]RL83?;7KOFVN :0DZU_79IO'(KU?!
MFF,QJ)5W6]4ANE7GY+\\AXG5SKNZKSJ%09<8N3M,E-GN&G<@&2>XL4,,(ZA[
MC(=[=\9W(DT%38RO+'ZO;=CU$&FBP@92;5Q30PQO&LA9(WY8'8S;7EOO6AI8
M!JN,J2$#+G7Z6S$*#;]VU\:?N5<LT5Z;T-FU9OU(RJKIZ;+J-BX8 $6HO%UB
M\B4!X53]8KL-! H[:$)&^*[1&_O5*-=MH%/%RT%+!8.[WN-?#=CPL%I7K)8-
MP-WEESB9^=81KEX;2+#N&QY6+0^JY4^Z@=DZ6$KT;EP%D4;RZ>0>F)-F^4MK
MR:Z?.G$#ECC*]Z7W-M0VKCM^WF]LM1G)=L:3:%7Q8:I>XF<R$T!6EMZ+"P$F
M8;\;A,+S[=K!>M/28W__NR>+^>,_!-*MK;6O868:K#+T!*Q2N3BM#!Y-X_SQ
M&M OMN7%<ZVLL<,/?^NMQ_0R)_(?5H8T.79]"I+6=3Q'--^Q@+2FC8$<%6+1
M(R?0_%M]X.>61GUMW;Y5R,CD* UTA>TAN74UST?Q-%7O6A4@09I7W,&T>*HR
M9+'!7CR.O2;%JT;;K28H",9\5;7>XB[R_Z#VB#KZ']W.7MN&GH17(RU!/X]1
M:QKNSN#[MOW2MU'OI?9>XL&HH!M#DL90A_4WNF/+\-7HJ*0*O@[!<'<B-U:N
M;VI,2!;'[7;=VI6M(#8<&VREMAT0'%*+W]!: =0[?+TV;4\7('<#L;O2^O^!
MI1&\$5]H&826?0!>ANSI>K=K,-42\H\\>^1IF*EROB;7S2"6!L# P36V9B!:
MP7(M Q;'FX P<956]5 C0-&6[@/O@(O2@D.1P&XQ0'1"-4@]]K3]QA &\R-X
M7+R&E@P7+?"0O,:[)2M#'L;Z;6E*=K8EH8,.P(-E<U#D^UN:!YXEZY(OFGR1
MEDP/$^71DP@(90VY!5=:EV8K0H&ORZU+0R@]C(VE)\L<Q /%G^%Z=MMOTT#1
M8X9!JLKW4>3!$(56._QD2<)EWW%TG<@^R<%W@SUB8*6O,@L&$"$H_..TM9 +
M$N<76ID:$>Y)@1@4OS+$9.3H7_IZS5',^G @8-RW<8@0@VNP/OL)10/-QMD7
M3AD3RNW9;4C,(\SF5(]UP .P1FV!W14%&[P0G(?"8J)VVG?TJ_:XA;V1URR2
M"1E"&;[*,]:]EU  Y@@& TH2%@8X.]P>TZB5)LR@:&!_YT"!](=)8A^('H (
MX7QGV:*.\V(T> 8Z":D,<CO7T0RZ:0YY(,")AM'H\HJ @%VC1[JCY)F?Y* 2
M3$J(HU6U$3=L!Q!)"6>,%I %7KBB6*Y 9E!)*:(%]$M=+A,&].N87]>X:Q3Z
MI7.(6;*=AV%/!YNHUG1GL:E$I)4LA#E%.4SZ=\.Q?/,<"NN:_*?;>"-H$^PW
MM95BP5"QH$#U'9'%Q/8GB1[!U W6=D_>IL/(#0L1?KC_ '#0-,FA?W@TR]^A
MP+].O*<LWGPL'IA*=Z(!#_02N;5)3T&IB$FE('MHA<3BW3>.7KC?#[/I?;44
MZ<7H%+H,@Q6E,F+-A1GV1V3RS!SBGTL./U %=G**6HY@P=8"_R.05KWGRR;C
M"FG$H^LF1-)-XVXTPD'GL96N$8^@O1;R42:_B><4_@8<:(5Z#UD1\&Q)>@;A
M2XHR'39J!0)]E'"%<IAP3O-,1=,U)@DA*B.74IIF.G0F&):Z@4@ (2JT P&X
M!;!:AE]*&SF/#/#'@T0:R#BSI86+AAU'* %8#XR.Q<&8N>,G"^(2XFS#3,2$
M1-! Y#D$5PG8L3?@2ABP]O]NE=Z5Y=I5*M=208F@(1W7B*&6>>M)U5+6D\6B
M,O)%ZKW3A-O$<+VNS5;[K_A<N=W!4TLF_0Y&6WG3Q6).EOU\+7GGW=5=E9[E
M"@B030Y#P8M4*]IR*HB.M09J"%26<H4>A8Z,0]X*949>*1X[8>H1W8A)*>,Y
MIH)@:]9[1? DG)W<R ;&"L"*C 27>G>5Y<4=2\ D9L;O;MFDHK',%>/;(Z&7
MA @W@@W($P]<AIC.4KU#F;4&Y:\I[NFIB;#(0)87A]-J[=V>50=F$$IXHC&=
MJ38MBI3UX1Y96ZK.6*-R6I7I*?%R]&&-)/U(!JP8J"#S"H28!!],F**PC#,)
M+[AT8>D4 ^Q,F;&@+I&,,+DQL"29<_KCI3Q!TU2!E"[+_G@8I6.D$=-I?TA\
M(86)=P=PBP/=OQ4'9EIL: [**2DN;RQ2 I5D":,QX*JGPB=759-8:_\3P8]Y
M$FF9E':0 EGJR0$ J%@:$& 4_E>QF?,^UT$I]*\,6&6E/AC<_'ZP[.=Q^$?M
M!D9V# 3X=JU1^O9!& M+L#(H;UBPWA,V,ENBJJ;MB3O"2%XHLLBP)1ER+<J!
MQXTHW$7=$"YCO3VET&0PF ^IH<NA*.V>-!CB?D] L$3!936/@7M>.T02V"PN
M4#G)U?L90;#"\)R4,D;"3]3KZ<>I>D5=C#OT%Z5QJ[=B'4XP19A\'GTO<F6V
MTY:TNH<TA)CDSEMI7F[P3#]-J3LJUU^363FGT;6?G:<0;H?KD/@74 ;U5^MA
M2*N35TC#:+Q<:8EPQ[A5A)"F*G68_D^F)6&)"G)1@#5-J\7]-41<K-62H6BA
M!-?@K=HV%!PPZAXY;%*@)+ZCTJ(^X\KK'@7=M75-1$V*_2@G2HJMX<*PBUL*
MC=Z'V"(+?"NG2M0\J$AE7F[#K)#>8>0#<B<XX/S11-9MIVT]@HX?YHMYIJR=
M@UBUL-V 2KB)"6"EYO/);#8;H*Z8Z0.0!S,\EBR:TY( -$_*5',KC#8U D4*
MJHW8YZC%P?#2[_@KK%I+>$.)ASQWFO(SMVWR-+4SDL<0)UP]T;BQB4KE_-Z8
M$<JP[42L(P(;LQ%#<>UX3#$"T'I%E($[@U1?IO#(4DS.S\#766<(A!PJ!2:<
MC/@:JFEJ ^)!ZQ5WD. Y)4$_$H]&S/QH2+(\NEEQ]N..(=@(LL"AE&C,6P=B
M#5^"H] 2>,.;!MSB.2H+X#N+9'[NT@FHIYQ-[  >(-^3#4\:ZZ&$$D[T"8^&
M#FD!6&QI&/EGE-C<S%^D2J:T\T93.D1 F;JD0YRD:-V.%7DX>7K.AS^/4]TQ
M81?(L2'F]-A"8#BK4Q?I3 6@2XJMEU!DJGX"8@&9CM//IXYZ%MRZ/(K;Q6RB
M!'10-2$](DW3+0V["H"@MT6FR77\$?*/R&TKN'9CVI*FJ.#;.!<=)/]L1(=Q
MUD#D\:)*(KIU)>>SM)2WR<D^MJ30E0Q#UF0G9P^T[: ]K$%>V.+NC6Y6W T<
M+?NCR>SAK*"2A4$C=8AV&WZ//EG$A_A\?6UI-4?4*Q*W T<!"5,B5\X_](@P
M)1AD)-[#R2,X9;'(/)5HE964WHYSON9.4ETTR^C:!T0?PJ GMQ_EN-C $ $'
MFX[+3 ,/)Y8&ZK7F%G.]/I'R_L/OES%NFI!\M@6K<YT>RQ;[OS2Y/P[6I[/<
M4B['Y$F2RWX@!I$)Q/OO(A E;QB93_ @XW'23BH91 97U 24WDC&.AL0[!9L
M)=D^8=Z5M\*\H1*#N#+@H_9Z'PN<5-I%EIPW@P[1%F,<W^B4^*CQ3P9O$VJ5
MA5<J "RO>VN*K:QQO;Z$5+ !%\>Y+9D[R3330(Q'/?R3#C4NP(%R&#2G^X*]
M]/#9%B?M[:*?GOO0DH'C7@R%6NQZ)DX\Z#%5;T<[K%=%7_F(Z)?TOF"(:Q/;
MC\4&J"!%8Y#%=J5UQ[NYLA\U+@$)3XL]:13R<;].*#OY1'8OHCXLB4'10DA&
MG3XKK>!AAPNSN&O,1J.1_%S&;5'N-65[::/_#L; *DE;NC)Q#SPX*]M[*)Y1
MX>ZI.CO7\(O29K4Y7FGG;4V78N$W%%ZRWW#:DX^=EES\=E+5K+6O\S;$M\X4
M6REQ;R%-+-[#&[$8<BA[BGVQS(J'O>6([JAV$:!<W69%8*N-JX_;>52<H.:&
MF0*!A&,XB[U.KFG=OC7"LN*>;<T==[.ECL%1"8!/>0ONS[P)V5&I^@'Z&UF%
M^=-'CV&4#FLQ?_ID(=+RS@IM\4I;(*&5M-N8[//.!+.T]LCY>*V.G';8J)'T
M;*($;PSQV,3N3P(F%1MW/KQY>W5WJNB?XC,E=;1*8[DW2<#C*?M^0)C#0[\"
M  '%[U^S-@S GWH49&2@U\[OG%3RI\D_T4'R<TA71=HWFSU)'87,N32\S$L/
M7  $T2#Y:VA_(*Y[:<V0LW,0<E%C>7]_Q3P.R*UYK7+S]4BMF!D'J[URQ.IO
M-]APXUTN*C9$I@C*AGHG-;J/YIN<S+1UM6S(\ 5: Q%,/"7T;(P5[X3+!5GL
M(XSH]@[QT=;(UY1F*H1-#&$)-CI&)X%(^Q#%G<0J(?T0;R5@4,RF<Q'A$#JS
MC55IN[Y':E('BMIXQ53LH&G35V8;9L_SGB:Y2'9,+MD&D!7N#>79C"FIC6P5
M!C..0B N)MT$)[6MU&)Q:Q".-POCK$7;>5U@4#."$8D6-L%)BA^?0XK<(?*D
M[^8D)&,4^&?=\2[E1Y"HWA..OR$R'$@XP&I$\T&U*^. $KFR>MF(FTW5U4#A
M,-)Z0YWPXL!$X3_COERA='E083C2$[J^CI%,QZ&H6J # YIW/G.7BB1KW3)4
MX!(?\9B/I?(A@FH\IT5MRK3&$(7[H*/1(G5T5*'0&5$U-*=->K09)\^5:ED!
M[5$-_]$UC;2-M>JX,<DDVF,>+'RL,IFD B.:.AT B0W'3.AO4H;HR<XQDU)V
M"Z'YY OM[^7]X49Q+;-&H*2+N05\O!=2&I]:*;1O=)0;I*_(MA"M:#T.R>@C
MZ<;:!T-J#4;XSQ[NLYC-'Y0VX!@Q4<)5[V/S? W%##N+S$83E+_&]AB=D&6Y
M6XEA[E?(IKA$7*N92/#CF0<<!?DMYA:\$$DY%.$,SO(1%DZ1@T!4RI7NRXZ5
M/#=C*I_]0J+B]O3 @TN!"DXA/;#SQ'ITMD_&#$45)L4"0T-B=B/RQPL[-&MH
MO4?73V1K4@C%OISX,^T:D_GX8(3TRH:D(F8;BEAJJ<2N%>E9=@&I0H89*[N3
M<U3(#&*P& ^Y0U)Z6 X:BD<*TI23QAW&B',B#49[V:][*"]] GS_9'9=8@2+
MQ4@=05>MOM": ^IY$<A6DA?SI.44R64&V:+[I)MK6Z>>XO'1BO$NN&#C-5<.
M<8OZN&'T#S68;CP4^EO:3>_X_(3ZK+]AEL(C9D_%(]Y]_)1H!/>1X(-=X?L?
M3-U!)EM-:*1I-&IN3P4:Z2''#9W&GY[<?]*:&_(SS>SDK. D'X,BATI%4U%A
M22R5$XM%!^K0M['WFR+X=DGCX"$M)>9U5<Y2<N@D=XZ/E4KG1O<;^/CAGI0$
MF<P>TF:5]&6N>E0\#G!5N<QB0[F_,GC%5^X@E17$4"@*:< R1KYP)W^\2^<+
MK=ES-,MQ+^I[3])QV 3GCR:9+T))T+]S#>9?M<4H[&XW,;>=$')PJ'7:0L%<
M5.Q&Y($+#!DN;^:3+S"(;VGW/'7FA,!5<7LDBGJ\,G1X&M5A[UL^?L2XP$ 8
M#\/D+0IROH0:/SL^BPM=7^YV!LK$P=GB8NU\+>24^Y8VLC?JM073X9 I:]EA
MG:*AIR@ "8G\NN<H2*/$&5W%;96ZY"#S)\7"GXA1Q&Q:RQ(SYT]B)0Q_JA/.
M:\304E=?DX*#E)Q7AI8E.R#]MVW,7-%QF0%%'!I<:S$728?QSDCGLG3S?,Y*
M BE&\>B@N!:[P'N,9:I!QPL<[!U]CX\]L;N?/;QA ."]A""\D >@K7SNS+9Q
M<)&9'('JBQLP,/RC(/B8BAFBTQQJIT"8R+G,QP?@CY&1244S*F%C;C7?*B2_
M[#3_*V"59TO[\>;VT])'^!0W2KXS7V0T.'J&PI:<>A(?G3^5^5(7.-I@%/[>
M%+W*I6%J12L[U(!8B^FP)_[^2MW1T4SJU$RK05:U:ZJ[[#71.7\MRXDAJ>_=
MRUEE/F\3H8S&:?0N"-VBI?HUU9*G'>WO B]>-K2UN-[\AA-BQ7RGQ\285'S'
M,;%\<O3_Z2&QCRBA&1J0 XR:SX^!,&H^CK2.N-14_:G7M'MOA%=Q$4.OZPF/
M#+S,PU&6HZWAR]A(*-X\D?<HXKDC0WU.ZG:ZT:8FF32=_6$&04OGCYG$#1/P
MNR)I8UC>\./3*#Z=!O&2W-(!*.5MH -M7"'16=[AY'+<"Y33ZG)V3788$'4V
M<*0-K\\<2W<B6=II&XX/L3'-NK'TJL$9HB2;DJUIY 1T/$&6CL\<%]',S^.>
M3#K4)NYD?7V/$LHA'>4;]E_.GM ;MZ68HS@ZR1K248YXC#/M(Q2G<<ZX[E9_
MXW<(4 3(JW]]2\TJB8WUX%VCK9*E*=^(^,D&:J]5I_LK:6.(*@Q4BRW5F*.C
MVG(V7Z(*\W6'G;1NAHG'VN8X[\H] B;=?=G=88@X$C\)4D4Z?QSJ!D;\-X7X
MN?<>+XO75A$#:WXYEV&H[>0-UOQK?O_WI;SV.MPN+P^#K*V)NC1FA4=GT\</
M+^2(8_K2N1V_! OR@H#CCQL#7NOI!EQ?.2!/_$(3Y+>B7_P/4$L#!!0    (
M #F"@552R<)T,0<   <2   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM
M;,586W/;-A;^*QBUDU5F&(L74:0<VS..T^YZ.DD]=MH^=/8!(B$)$Y)0 -!R
M^NO['8"DI%AR=O:E+[P Y_*=.\B+K=*?S5H(RY[JJC&7H[6UF_/)Q!1K47-S
MIC:BP<Y2Z9I;O.K5Q&RTX*5CJJM)'(:S2<UE,[JZ<&MW^NI"M;:2C;C3S+1U
MS?77=Z)2V\M1-.H7[N5J;6EA<G6QX2OQ(.QOFSN-M\D@I92U:(Q4#=-B>3FZ
MCL[?38G>$?PNQ=;L/3.R9*'49WJY+2]'(0$2E2@L2>"X/8H;454D"#"^=#)'
M@TIBW'_NI?_L;(<M"V[$C:K^D*5=7X[R$2O%DK>5O5?;_XC.GI3D%:HR[LJV
MGC9)1ZQHC55UQPP$M6S\G3]U?MACR,,3#'''$#O<7I%#^9Y;?G6AU99IHH8T
M>G"F.FZ DPT%Y<%J[$KPV:L'L8*++>--R?XMU$KSS5H6[+;Q\8;C+B86>HAZ
M4G0RWWF9\0F9,_9!-79MV$]-*<I#_@GP#2#C'N2[^$6!OQ;VC,5YP.(PCE^0
MEPQ&)TY>\AVC[\5&:2N;%?OS>F&L1HK\]YBY7MKTN#0JFW.SX86X'*$NC-"/
M8G3UZH=H%KY] >MTP#I]2?K_&: 791Y'_'U%/44I35$ITX*5<2T8%1?;".T(
MFT)0F4C#"H72-98XMM*NF6RLT VOD+X-ZMV)TGT$SMA'="##*\A42V;7@MVH
M>L.;K_\R'15?5((9C\% 6E&UI6"B*=_X.A$:A(^B:2%BJ57MA)!$$KC1JFP+
M\+G%WA"05VIC H+4+A%^LBEP+H"15LM%:X4Y8Y]V<%[]D,=1]M;L6R$>>=5R
M4!YXH3-C0$Q2>56IPE%"D6IU@2=J*B4YL1D\0*0]2/1?S5V2PH:E1"4\G-@A
M/U$X._? (VPA $?T;Y8_D7GBB5Q'?"XDPL"")W1Y(V!Z3?'XR\6;+  %;U:2
M7,^-$1;L!11H7LF_Q)Z7B+Q0AO8;U;S90>M4*]WK8-**VHE!2"5Q:407/F'%
MFNM5[W\%WVE/"XEV\%S)K#KPJX\.+PK5-MX9JI*%W.71L>RAM/7I49-A>%9
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M#(<X\1%[E%Y!X,.+9V/?\U_#'TI%2]0-0V^ 0CWXC% U"&F97 B,B0KV<!Q
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M7'-G0/LH8=OH:,R_<Q$R'/HBU8PHZ AW([/<FD.,;L9 Y$6&8J8@HS_P1YY
M4-^BM(:LB9?ND+F,18@)<9TD5B","P!-I!0R3/*(._YO L;43,KK)@EGTEG]
M(,3LKYB]OREPYQS_S9WSJ5P](F+L(&;<H;V2]&(,*I?U,J[=C0E=_XIN#1%D
M%:].)@-X(TRH<D2JJ=IX7L=_#J^0PO3OC3K><[C5ZCM6"9PX1UE,F"O.-&U<
MJ8=@!C2',C0^!C0CRK&N1+3Y*G-"&T!H*\?;A-R'XP_Z.WB"SH3@##J#Y]#O
M!/\&#.W*EWTO%-5Q6>WA;.6<J'G"Z')6YTN9WX[29$V-#N#UC!)E(\)V4</3
MPDCNLBY93[U8>@1;9]02*.T<DDXJW,0-8%8XO=,0M>-UU(X;(^;(1>LZP=)7
M'(C8SK7K4%0VKW&XI)2F"UG<Z8OK-7J "KG:.NOL''%LC('C/!ANH8PKE(8Y
M3X/*M7.72D3D]%99T%U4=X]$>\%7'75PS39(/ U06?"(A1A6=M6&#+6A2UW)
MPP-"5GB8)+U^L#D4>?W!L0-1*>WU2P$\4VT=A+9-(C:?P #5[1]>]B1/?1(.
M>FY6@U)";W^ACFF*CDQIZ_)>&<MA>2"KN:D88&&H<Y3D3QF7!K6U<;;)N/OT
MD:Q(0QE41UQC.D#P/RDP/&,N&3A74W!LDG&3]Y>,F!4)/+;D6'Q76WF92Y4O
MXD*XTA]AO":*:L/!J.K6OFVD7"_<%QP#+EL5GSG6O>N/1)?%MY&->/&%Z2/3
M>/8PD/ Y3NUU1GA;T,57F^+%JLQ]*9DI:U7JFC%GF')( ,?G2MGJA198?SJ;
M_@-02P,$%     @ .8*!543EM1QE P  9P<  !D   !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&ULC55-;]LX$/TK W51Q$!A28SMN*EMP'9;M(>@09+=/10]
MT-+(8DN1*DG%\?[Z'5*RXBP<8P^6R>',FS><#\YVVORR):*#ITHJ.X]*Y^KK
M.+99B16W0UVCHI-"FXH[VIIM;&N#/ ]&E8Q9DDSBB@L5+69!=FL6,]TX*13>
M&K!-57&S7Z'4NWF41@?!G=B6S@OBQ:SF6[Q']V=]:V@7]RBYJ%!9H148+.;1
M,KU>C;Q^4/A+X,X>K<%'LM'ZE]]\S>=1X@FAQ,QY!$Y_C[A&*3T0T?C=84:]
M2V]XO#Z@?PZQ4RP;;G&MY=\B=^4\FD:08\$;Z>[T[@MV\8P]7J:E#5_8M;HC
M4LX:ZW35&1.#2JCVGS]U]W!D,$U>,6"= 0N\6T>!Y4?N^&)F] Z,UR8TOPBA
M!FLB)Y1/RKTS="K(SBWNT#K39*XQ0FV!JQR^N1(-K+5U%BX>^$:B'<QB1[Z\
M19QUN*L6E[V".X$;K5QIX9/*,7]I'Q/'GB@[$%VQLX#?,C<$-GT'+&'L#-YE
M'_AEP+O\WX'?H>0.<UCZ0A%.H(7ORPUI4>7\.'4#K8/1:0>^FZYMS3.<1]0N
M%LTC1HNW;]))\N$,_5%/?W0._0S]D+E3=,\#/I0(A9;4I![0^;QWG2K^H9N@
MHF@[2+@]-6/KRND@-R^XU$9O#:\L\(U^])@F*%GQ!%5;$NA+ BBA>D.5=LCI
M-5P(124N)76K'<"GJI9ZCP@/:*CP>6CB%2HL!%7FTEJ=B>> X2(==*7[H!V7
ML*R-D,#>M^#P!TQ3^K K^OA%FB:P+KG94FSC!%(V@1&D4Q)R6T+-]S1X/.K5
M9$#0EU/ZCNC'6#*@ LE,0RYX_I,:M%-D=/I^ &_?3%G*/O3_7O;?2,G]:.PY
MC#LRDS30/XHI"S$)E<DFQ^==8PP=<KI;R(6AP>;OGN8/Z.+U3+RC/&:EM[)<
M4CHI8I\4[.Z7Q$U=:^-"W@FD,PM%E5$J"-\?X1,]!!;M,,1ZZ@[:LO!5D:%Q
M]" <^1 YJ8A"$/U0$4<Y+83*O0,=LE=K*[S8TB!T)6%X2FM=U5SMAZ<:)SX:
M?A520OV(M\2\4:Z=@[VT?T66[?!\5F^?H!NJ!T&>)19DF@ROQA&8=JRW&Z?K
M,$HWVM%@#LN27D(T7H'."ZW=8>,=]&_KXE]02P,$%     @ .8*!5>NN\GYT
M"   2QP  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULU5E;;QNW$OXK
MA&KTR( L::_2.K8!V6G: ,FI$3OMP\%YH%:41&275$FN'/77GQER;Y+EC9P^
MM >0]L++<&[?S)![]235%[UFS)"O>2;T=6]MS.9R--+IFN54#^6&">A92I53
M Z]J-=(;Q>C"3LJSD3\>QZ.<<M&[N;)M]^KF2A8FXX+=*Z*+/*=J=\LR^73=
M\WI5PR>^6AML&-U<;>B*/3#S>7.OX&U44UGPG G-I2"*+:][,^_R-L'Q=L!O
MG#WIUC-!2>92?L&7]XOKWA@98AE+#5*@<-NR.Y9E2 C8^*.DV:N7Q(GMYXKZ
M.RL[R#*GFMW)['>^,.OKWK1'%FQ)B\Q\DD^_L%*>".FE,M/V2I[*L>,>20MM
M9%Y.!@YR+MR=?BWU<,H$OYS@6[[=0I;+M]30FRLEGXC"T4 -'ZRH=C8PQP4:
MY<$HZ.4PS]R\XX**E-.,O!?:J +T;33I/])YQO3YU<C &CARE);T;AT]_P5Z
M,?DHA5EK\I-8L,7^_!'P5C/H5PS>^IT$?TW-D/C3 ?''OM]!+Z@%#BR]X 5Z
M[\66:>/$_,]L#C*#8_SWF*".3GB<#H+E4F]HRJY[@ ;-U);U;G[\P8O';SJX
M#&LNPR[J>US.=^2.&K:2:D>H6)!/+(/7!;FE&9B.D0<+WGMD0AB*OGY,FL[U
MCDOSN&9D*3/ +1<K8JQ+E.CE?S)BH/M.YALJ=O_2A+<XYH"V+>49SKB P'&A
M:<8 *W-#-$L+Q0UG5B[-5X(O>4J%:1$@:5M<7$:5(J=2:)GQA7V9E_*[X)5F
M5&M+RZ'=$/ <.6>J=AY+;;91/"-^XIHNGP_ZC6:%([&OW[M]^GV0,>=9!L_Z
M'-2@#?DL("IFH)E%^_$=Y<H29:1MU%]!+$5F6C-X^<"V+"/>)?D\?!B2E=PR
M):PBD&,(C2+=M15W1J(HANN//TQ]SW\#3_T@/,=FX+^Z5IV.-DAZ)]5&*M#<
M,T.$@V :$X_T_4EP#F^>%Y;7BLAI?"5A7,_H1\DYF4XG]E\U?I3*K&#>Q9RF
M7T WK;E1-&WFQAZPD4SLOVK\MQ07I['A-9/Z0,B+\5>UW#%EG!5AI%R"+C92
M<T.\<3VDND-3J]49C*+!CK'?DK(?P*IH(?Q7C8_20(PMC4'B033V4>.A#X:+
M!^-)4E[WS19<DEGATI>U7&O%H*5KL%H0U*_PZ%8[ 8-G9#(8)R'</72C,!ZC
M'\6#.(C<?8R^!!3W<?-_@A+@NQ3,BRP^O&E]?14^P@B<$:B$8\1'X'OE]97X
M:+E3/P0GF<:)_9^"C\1OV3LZMX!I@^:[\%&[^J3=^A)&_.<8@2;_9(S$;6">
M@I$X0*W[_@0Q$H1>>?T;,.(%Z$:(B;X?1@XCTR1P]RAQ&.G(^U&=]Z/.O/^S
MDEJW@?$!WH$'M&2#$6N5V7/.'QJFS1HRX"]TR\@M8\)F9/!P8;@H9/%L!7*/
M!D85OF4LAT8CR9R11Y8C)-1N0&:KE6(KEW=W+8S6I<FQFJ-;UJ/EQ<:5,3;K
MKZPRBH;5K%'&$I6QK971JD6LB2=O]"FFM5I:HY;FM9;21DL'2Y--I:5%6TNF
MT1+=T]+1BN9[ZY(/3%M^!?%\DKL:&^(%.VS;#[FMN'H\VK9:7PZ 9\#"Q.8'
M]/P T!!8),20XT^+.8=Q(X&4W$\ DQTA[W!.F'BN-.@.,X?3HBAT*?FE*'$X
M 83#:.'BP[[HT<#SI_8MBL\/<^+?;"%;]6'! \^#Q,:FOA=\OX7""(JX^%46
MBD!5-CF]TD)^[!+"]UJH)7HT&(]#%Z;#\XZ '-<!.>X,4C,\->!F5^^Z //[
M&Y_]./QP$(?O07L0Y+@\%A]/7%H=7?HU<6Y3<4$XC-=EV-67Y'&M&*L<D^&6
MG3SPK_L-^_[Z+##5#0X'W@DC[I5,&5L 'TKF!#E&#_8&$S^PWNLG-J,.L*H^
M@U(KFGC$9<8:"BO*!90R4!_X9'K86>:)O@?E6M^'OP<PZ'?ZPZ3VATFW46IE
MOZNL_1:5W9A\8/,LGBH4X)T?J2G;CSE YUHO;\J?:;C:"D,F/&WCG;98S!V+
M._0-O99/-@^:Y\EY2'[G9EWVV99!-9>[+)R_'"J:)$N!:%INX#5<BPT@WO <
MUP$:D#%Y[C;[5*_)$OT4(TEA!PA)4HBF*U;Q" LH9D\/# ,=&1<[F-AR)6VX
M&Y+9GIC(3$YW9,&72U"A]< CVK!Z8BDMM#OHX, !4W6MT9(,B5GI[$$%'@(B
M4,%@&^B0\XRO[%Y(DR?0GBQ,V65#\88)FB&5X;=0]K:P(DO!R(Y11:0B&>8;
MA$WH);:?+D$'S1"S5K)8@0KYUK5 03R(P_;85E<UVH")7,LT:0]MVF/8L52A
MU^T4.W UK7$U[<35@SL41OW^]$>!WHAIRN61UH[P&(@Z"9]\LM4<;.F# ,\:
M?J3EIWW4=5H]-R!/:YZN"85JH#JH @^'2"R;3*EKGW[QE LB]C?\Y* F:6^F
MT?\P1BYX!N[/P*@ *2MZ4TR3/NC@"W,:*05O?!T3K(>A.0Z?44;/_@9Q<*GQ
ME$P"OS)QSF#>X@7-3B/\.4?K-,$95)-8 $RG7I<G)K4G)G\QXW<Y:'?"[U[Y
ML8JK$'G -4'(-"L6N.$YL1)HTCP&T@Z=#<G/-G]B9YDL(0AW.[K"8]A4KH1-
ML1B+[!@AQ87<, B[""5@6>:0%P0S1[U9&[@Y@L"B&SW\1U4AS:&JAW6DC_O^
M."XK#%=U0)4"#A=,R&1<ME<%Q^3<'379:K;O0_GQ'BS$E0WVY:"6$G%3T9R(
MV$)E?+1(&;4^\.1,K>QG+ VJ+81QWWKJUOI+V<Q](&J&N\]L'ZE:H1 96\+4
M\7 "FW3E/EVY%R,W]G/17!HC<_NX!EPSA0.@?RFEJ5YP@?K[X<W_ %!+ P04
M    "  Y@H%5F ?R:"P$   ##   &0   'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6R%5FV/HS80_BLC[G3=2-D$,!#82R)E=[OJ25UU=7MM/U3]0,@D00=V
M:CN7S;_O&!(""^$^8-[F>>:9\=B>Z4'([VJ+J.$MS[B:65NM=W?CL4JVF,=J
M)';(Z<]:R#S6]"HW8[63&*\*4)Z-7=L.QGF<<FL^+;Z]R/E4['66<GR1H/9Y
M'LOC/6;B,+,<Z_SA:[K9:O-A/)_NX@V^HOYS]R+I;5RQK-(<N4H%!XGKF;5P
M[NX]8U\8_)7B0=6>P42R%.*[>?FRFEFV$809)MHPQ'3[@0^898:(9/QWXK0J
MEP98?SZS/Q6Q4RS+6.&#R/Y.5WH[LT(+5KB.]YG^*@Z_X2D>W_ E(E/%"(?2
MEKD6)'NE17X"DX(\Y>4]?COEH08([2L ]P1P"]VEHT+E8ZSC^52* TAC36SF
MH0BU0).XE)M)>=62_J:$T_.GE,<\2?D&%E+&?(.4<*W@YEN\S% -IF--3HSI
M.#D1WI>$[A7" )X%UUL%O_(5KIKX,8FK%+IGA?=N+^$?B1Z!&P[!M5VWAX]5
M$;."CUWA>\2EAL=4)9E0>XGPSV*IM*3J^+<KV)++Z^8R*^9.[>($9Q8M"87R
M!UKS3Q^<P/[<H]2KE'I][//?!=_<:I0Y&,U=ZGKQW>J^;1$>1+Z+^?$71?5+
MR1#++-W$9I$H2&A(E<85B#5HLEV+C!8N%<@=W*2<2C#+C.$ GF.]EZD^PO((
M-$=BB;*:)ECL9)J!&YU>'_924EVUW=%?!K?FYL%'\(=A8.YL./%<N(1?P-C(
MMVW8H4P,DT9^>\287-J.#PIY*B1PH;'@].'3A]!UW,_@#,/(!GOD^A>L2M\J
M;-3"!A!%$\+9),4=!<15^=Q*Q#.2HFHCO2BL/-LCNZ9W37M/!;5[G3HCI^:T
MV%9ZY!J4%_DT^E% 26)^=Y(F'<BS5!:$A*S+K:6H(]"H4'L)E$VNZ.V(-&I$
MVDCO ;-+DMJA,J<!K<O]*=2M05DCOYP6S?503\!+J!/_FM=VK(PUO-:S] [:
M]NLW_'KOP5P?KY<_,]40D?1R#$9^7?0VE1>P/8&'+T^OBQ9%"*[/RJNQ=M[Y
M;F>Z/K]!<\DV/7=!'3\LKR;P)SX]N^;3[XG6:4T105W:>LSE].2X/;=>O1B]
MGCB=UMS2UN;8?G%YS2IN ED+R( 1B!7 YL;4 'HM($5G-@JZ>H&M2O),)86D
MY#0VR[\);DV+;U]?Z@UH.[M^/;MEBX*0(75?W:<'"\#WP0_HH%PC'34KVF_/
M?4TBE*Z9$O6-XP0#&NUH4)RLL*)N0.RY'@*G-KAAZI'-C>\.WI]&'^G_<$++
MHWA@$Q>Z#OQQK3'+46Z*]M,<LN2L[-&JKU6'NR@;NXMYV1X_QW*34LP9K@EJ
M-B(+9-EREB]:[(HV;RDT-8W%XY:Z=)3&@/ZO!27W]&(<5'W__']02P,$%
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M:4$O(FI70.NY4G87N WZ-S;^"U!+ P04    "  Y@H%5B*&;""D%  !E#P
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MU6L3.2'=I=Q937\%Z=GU#==2R)V!6]1P5W.-\/Z>%PV:#\O$D@$GEI0#V":
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MRYHZ+FHG0/^W2MG#QAD8>_CZ?U!+ P04    "  Y@H%5+N7GY9,#  "*"
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MDIYL-%Z!]E=:N]W$.^A^ J:_ 5!+ P04    "  Y@H%5"H '@]P#  #)"0
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M3IZ7?VW;R1I^Q?!'SI]8:9.PO6V1;3XWS'#%W/C54O"U0]$GV"RHKN #UNF
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M_RK%-M;]!;A?6-6Z2^=*61P$]W.+_QF$)@$\7RME]PMR,/X+F?\+4$L#!!0
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M2!HP@DP.)!F%)$N R(SD1-OD1#^O 9O0<.>9Q%%$+ UP@&)L:T 7% ;QR)(
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MT^-354MR5/.'2A.H-(E%,T.DS1^_H%J2#ZL7.;=7'""1O0,A %%P^GWL_EH
MJM/OA)I]U.Z)N]W3:RYP+#:X":/'&^J^&"I-8M',6&B/QZ>JC>2H!@^5)E!I
M$HMFANCDZ287U$;R8:TB(;&=$@!1:&]= B)&[?II0'1:96GV4/LC[O9')PEA
MW"*#FSMZ#*+NBZ'2)!;-C)#V=WRJ>DF.:O-0:0*5)K%H9HBTS>,7U$MRH!*2
MV]_+ D7V5@4@XL'@Q@$2G2F(XMHE<;=+.DD3[UE@<--&CSS4;3)4FL2BF8^
MTMXNG*I>,D1U?J@T@4J36#0S1-KYA1?42_9MC0>\V;D!T-A/BQ* )F!V[1,D
MHO;RPOSD.9;M3.\>(%IYRV*_JP^/)3Q^>GQ(Z2_=HSFMSS\$UW<!\+D(KN7A
M$:0:?W@B:I-0FL12>;EZ; [E7T5-$BL/#QD]O*F+I^XIF@]%71?;[N5&I2M5
MMH+F[X]%4;^^:0]P?-3KXO]02P,$%     @ .8*!50"0+?@,!   0Q$  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULM5C;;N,V$/T50ET4NT ;77Q5
M:AM(G%UT@68W2+#M0]$'6AI+Q%*B2E)VTJ_?H23+LBTKE]HOMBC-',XY'(Z&
MFJR%_*YB $T>$YZJJ15KG5W:M@IB2*BZ$!FD^&0I9$(U#F5DJTP"#0NGA-N>
MXPSMA++4FDV*>W=R-A&YYBR%.TE4GB14/ET#%^NIY5J;&_<LBK6Y8<\F&8W@
M ?2W[$[BR*Y10I9 JIA(B83EU+IR+^?NR#@4%G\R6*O&-3%4%D)\-X//X=1R
M3$3 (= &@N+?"N; N4'"./ZM0*UZ3N/8O-Z@?RK((YD%53 7_"\6ZGAJC2T2
MPI+F7-^+]>]0$1H8O$!P5?R2=67K6"3(E19)Y8P1)"PM_^EC)43# 7':';S*
MP=MWZ!]QZ%4.O8)H&5E!ZX9J.IM(L2;26".:N2BT*;R1#4O-,CYHB4\9^NG9
M/:P@S8'\2KY0*:G1E+R_ 4T95Q_P[K>'&_+^W0?RCK"4W#+.47LUL35.;0#L
MH)KFNIS&.S+-D-R*5,>*?$Q#"'?];0RYCMO;Q'WM=0)^#?0%\<:_$,_QO)9X
MYMWN5YE$=[_-?2><7BUCK\#K'<&[88I&D82(%LDIEF0C[-]_H"GYK"%1_[3I
M5N+VVW'-)KY4&0U@:N$N52!78,U^_LD=.K^UD3X1V(X$_5J"?A?Z[ :6("6$
MN+D+YFUD2X1A@6 *S&K6&SL3>]7DT&+C^[7-3FB#.K1!9VB;M9 0B"AE_V&0
M.J::K*DBJ,2*B5SQ)\SP@.>8GB;5PQ>P*2<=-")%*??8= ;VQA49UK2'G;0_
M*LVPT&U)$'C,L'P:^H(L=O1 RLM<YQ)(!I*)4.%#3BO3/%68UVK)<(B/BY='
M&@ 1"\[*C&\M"<.#E1RY_IX^G0S>J,^HUF?4J<]=P92(%4BRCED0(V?SYF-I
M=(PFH;)+1:JZ\J4[&AU+ /($5+:).>]T?J-0XUJH<6=H7W6,$M$@D#F2-/13
M!:U+WHGSVFIV(K =RGY-V3]30?=/*<&)P'8D<)UM;^ \4S<76 *>V^852'.?
MNXZS7P@KJV:U],=N>UUW&]V+^[]?.A5$<V;/[^V'=VC4<P9'PO.VX7G/"!CF
MP2:!</^(/-6F1 3 5G3!V\/MA'QM IT*;5> ;5ODGJLO<D_:&)T*;5>&;6OD
M=O=&+]Q(_8,<'/2&^XG:8M0?'TG4;8/D=G=(987GC"X89YJU%_=NC%<OR3E:
M(W?;&[G#<V7FB7J62H9S=$#NM@5RN[N.%Q70T4&!'X_VT_+0QN_O9:7=.*8F
M(*/B]*Y(417+$VM]M_Y"<%6<B^VM>?EYX9;*B&$[QF&)KL[%")-)EB?V<J!%
M5AQZ%T+C$;JXC(&&((T!/E\*H3<#,T']W63V U!+ P04    "  Y@H%5P8YK
M=RP/  "^WP  &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6RUW5MOVT8>
MA^&O0GB+H@6:6*0DRDX= XEYFIFF#9IV]V*Q%XPTMHCJX))4#L!^^"4EQ?10
M]%CTOKY);%GS#&7-SQIJ_AI>?%[G?Q5SK4OGRW*Q*EZ?S,OR]M7I:3&=ZV5:
MO%S?ZE7UD^MUODS+ZMO\YK2XS74ZVS9:+DZ]P< _7:;9ZN3R8GO;^_SR8KTI
M%]E*O\^=8K-<IOG7MWJQ_OSZQ#WY=L/OV<V\K&\XO;RX36_T!UW^>?L^K[X[
MO5-FV5*OBFR]<G)]_?KDC?M*^6=U@^T]_IGIS\6]KYWZH7Q<K_^JOQ&SUR>#
M^HCT0D_+FDBK_S[I*[U8U%)U''_OT9.[/NN&][_^ID?;!U\]F(]IH:_6BW]E
MLW+^^N3LQ)GIZW2S*']??T[T_@&-:V^Z7A3;?YW/^_L.3ISIIBC7RWWCZ@B6
MV6KW?_IE_XNXU\ =/=# VS?PV@V&#S08[AL,VPW&#S08[1N,CCVD\;[!^-@>
M_'T#_]@>)OL&DV,;G.T;G!W;X'S?X/S8!N[@VS,W.+K)W9.]&W2[4;(=8D%:
MII<7^?JSD]?WK[SZB^TXW;:O1E:VJB/UH<RKGV95N_+RS?3O359D]? NG'0U
M<]X4A2YW7_Z2I1^S1?4S73B)7LR<*L'.AW2AG1?.KVF>IW4:G!\"7:;9HOBQ
MNO7/#X'SPW<_.M\YITXQ3_.J8;9R_EQE9?%3=6/U];MLL:C[NC@MJZ.OC^%T
MNC_28'>DW@-'.G3>K5?EO'#"U4S/.MI']O:^I?UI]5N[^]5YWWYU;STK^&9S
M\](9#GYRO('G=1S/E;WYN_2KXPX?;!W86_\V+5\ZWMF#S<-CFI]OF[M=O\O_
MK_?X_^L]L3>7F\5=\Z[>Q2//VVUN;2Z/Z'W_M'<=O#JB]^[FQB@<W@5XN/6&
M#WAO-T5U2U$X]Y+L_/N7ZC9'E'I9_*?C$-_NR%$W6;^*ORINTZE^?5*]3!<Z
M_Z1/+K__A^L/?NX:YB06D%A(8A&)Q226D)@@,4EB"L*,E(WN4C:RZ9?Q>CW[
M7+UT=87)VK)OF$@LV&'^%JOGUI\N1X.1.[DX_70_)8?W.AN8=XF.@N+'H81\
M>*+KJ,8#S^Q2DETJ"#/&X/AN#(ZM8_"JFKYDJQN]*IUI-8/*9KJ>@55_[1?-
M/*UK?(X/?DW>P#5_25?6GOL..Q(+=]CXWM$/6P<?D?W%C_>7D/T)$I,DIB#,
M&.O^W5CWK6/]_2:?SJLS9><VSZ:Z'N^=0[]KN%OAOG^.22SP#X;601##P_L<
M#/<.9C)J_2E^G$G(AR9(3)*8@C!C%$_N1O'$.HKOYN;3]?)CMMH.V9^<ZS3+
MG4_I8J.=];6STJ63[L^YZQE\WGEN^];:4=]136(!B863@W'K>N/6^"<[C(_H
M,"$[%"0F24Q!F)&4L[NDG#TA*4?DPLKVS06)!206GAT.TW'K;WY$=A@?T6%"
M=BA(3)*8@C C%^=WN3BWYN+^6[!5&C;+[A18D;XI(+& Q,+SPYG/>2L$9'_Q
MX_TE9'^"Q"2)*0@S,N .FC6*@34%?^CI?+5>K&^^OJB7SV9.MBK3U4WV<:'W
MKQ%=H;"C?5.!:@&JA7OM_D =M]_"07N,C^@Q07L4J"9135&:&8][2WCND]X8
MNG^JT1D0*]L[(*06[#7C#';4^N,;[N]DO+7EMU\1CI'B8Z2DXT[N^="\D^CH
MSG5;DNSJ[KPUO5)==YHT(3,'B]<,%L\Z6'XKYSIWUK?;,;*Z<7[(5M6<6__H
MZ"^W>E7HG^HSTL[18G5[CQ92"U M1+4(U6)42U!-H)I$-45I9NJ:15KW&59I
M7729%M4"5 M1+4*U&-425!.H)E%-49J9N&;!UK6OV/ZZ7KV8IL7<J?079?K%
MF<[3_*9[A<Q.]0X:NH:[UXSYQ*@]#R)[C#IZ/'/;\R6RQP35!*I)5%.49H:B
M64%V[4O([[)5MMPL.S- KAU>H5J :B&J1:@6HUJ":@+5)*HI2C-SU:Q6N_XS
M3._0E6I4"U M1+4(U6)42U!-H)I$-45I9N*:E777OK0>%F6V3$L]<S:%OMXL
MG$5VK>LW,YRO.LV+'SL#ARZBHUJ :B&J1:@6/_+$NN/=,]B9+G0E'M4DJBE*
M,]/5K,:[]N7X=^F7!^>)Z(H[J@6H%J):A&HQJB6H)E!-HIJB-#-7S6J^>_X,
M\T1T=1_5 E0+42U"M1C5$E03J"9135&:^1&]IG3 LY<./&6>:"?[!@[5 E0+
M42U"M?B1)];U'YXGH@<B4$VBFJ(T,UU-Y8%GKSP0[W__/EW>_AQTQ@@M+T"U
M -5"5(M0+4:U!-4$JDE44Y1F)JLIT_ \?J;HH24:J!:@6HAJ$:K%J):@FD U
MB6J*TLS$-24:GG5!NJZBN_>9RC)/5\6USA_XV('=ZITTM#0#U4)4BU MWFOW
M*^3.VU6H:(\"U22J*4HS\],47'CV@HM=86$ZG>:;ZFQK7TW866YAAWJ'!RVW
M0+40U2)4BU$M036!:A+5%*69,6M*.+SQ,TP,T>(.5 M0+42U"-5B5$M03:":
M1#5%:6;BFN(.S[X7P5,_7F%G>X<.K>_P#C<(< \^7H%V&1W398QVF:":Z'@
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M3=II0@L=4"U$M0C58E1+4$V@FD0U16EFFII"!]]>Z'#DALY^QYJ^WTX.6K>
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M>U\QO!A6YM?*?*,R[9YB2).QW%83)"R A(60, ($TX3.:J$S^)N-&:1D2%@
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MQ^19]R.@H0<H+7#[L8>+9[.N-=#D XJF6VNR#]<<?EQMU;6-HIMT/2@+-/X
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M0%U8*(U":2&*9FJE<6)=NQ7;L95]JNXPJO=.5TI4M_P9/<V:5^=*A:3Y4%H
MI5$H+4313/4U1K8[!/0TJ#,-I?E06@"E42@M1-%,I33^M&LU),$];=3ZRVSB
M[O8TJ+$,I050&H720A3-U$KC+KMV>_DBSQ9E),E"=Z-LJ7O75G]+1,P+F:5/
MOU-F/WWG@@2UK*&T $JC4%J(HIDB:WQK=_)KW3%SH=8UE.9#:0&41J&T$$4S
M5=<8V*[5_7SRG;,::RQ#& UWVQW4K8;2 BB-0FDABF9JHK&L7;MG_>1V]^R;
M:?;$.I<DJ!$.I050&H720A3-7#C8F.&>\_S?<![4P8;2?"@M@-(HE!:B:*92
M&@?;L_J>V-]P];EV?L,Y@]WU@/:<.FL%ZF%#:11*"U$T4RN-A^W9/>RG-[7G
MWFRS)]:Y5&'7)F,7)V-7)V.7)_\,6]QK;'%O &AJ4 L;2O.AM !*HU!:B**9
M2FDL;,]J?(*;VK"UJ8UV5SG:<^JL%:B)#:51*"U$T4RM-":V9S>QG]S4<+?=
M[!EVKEE0@QQ*"Z T"J6%*)JIP\8@]\: [@9UN:$T'TH+H#0*I84HFJF4QN7V
M[,NSL=UMTMK=AH/=[@;UIJ&T $JC4%J(HJVUTM]ZMED_''_.\EN1%B3F-PKO
M'$U4#<O7SYNO=V2VK!YWOLZDS))J\XXSI1@]0!V_R3+Y;4<_0;UYZG_^/U!+
M P04    "  Y@H%5GZ"K-NL"  "8!P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T."YX;6R-56UOVC 0_BM65DVM!$T([QU$@J*NE5H5E77[,.V#20YBU;%3
MVX'VW^^<A(R5@/J%^.R[YWGN\)U'6ZE>= Q@R%O"A1X[L3'IE>OJ,(:$ZDN9
M@L"3E50)-6BJM:M3!33*@Q+N^I[7<Q/*A!.,\KVY"D8R,YP)F"NBLR2AZGT*
M7&['3LO9;3RQ=6SLAAN,4KJ&!9CG=*[0<BN4B"4@-)."*%B-G4GK:CJT_KG#
M3P9;O;<F-I.EE"_6N(O&CF<% 8?06 2*GPU< ^<6"&6\EIA.16D#]]<[])L\
M=\QE235<2_Z+128>.P.'1+"B&3=/<GL+93Y=BQ=*KO-?LBU]/8>$F38R*8-1
M0<)$\:5O91WV GS_2(!?!OBY[H(H5SFCA@8C);=$66]$LXL\U3P:Q3%A_Y2%
M47C*,,X$D_ U8YK9"FE"140F6H,IEO>,+AG',]#D%GA$\ Z0!>70W'E-/GA=
M<ZHU6S&P.$7,31E#SF=@*./Z@C0_G#3)C.E4:LK)6LDL;9 8SYO(UL0]:! A
M#8F8#J4P3&0(CG=2T4+S&6&"/##.K35R#=;$9N:&9?[3(G__2/Z/H;DD_J!!
M?,_WR?-B1L[/+OZ'<;&D55W]JJY^CML^@CO--.YH+-&_ I/?][A'[@PD^D^=
MU *R4P]IV_-*IS2$L8/]IT%MP F^?FGUO&\G!+<KP>U3Z,&=V( P4KW7"2M"
M>WFH;?--T&JU1NZFAJ]3\75.\LV5_1/->X.DG K3R&\<8*U2;'DT!9@Z)05H
M=U])IUVOI%LIZ9Y4\EW*:(L7J(ZN6T/7K:?K572]DW2/)@:%E]90L69+O/XT
M[Z4Z]MXA>ZM3S]ZOV/N?8#].V3^@;/OUC(.*<7"2\8<TV-BT'"NV&Q1$==2#
M ^KNL5H/*^[A)[CYWH1"'5E2SS\\N.1M[P.]NS=H[9OU0-6:X1#BL,(@[[*/
MZE7Q#A2&D6D^>Y?2X"3/ES$^G:"L YZOI#0[PX[SZC$._@)02P,$%     @
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MRTD :345-+K5S,%SYX:LO^F4,<,Y?(:IV\T6-UX? !ER-TF#W"HHL,6-5P*
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MKMI=:68))"')-(F4"=#NPZBCF>Y65=4'!VX2:PU.;9/L].MK R$),)3,\I*
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M.)$$A$J))5<=E"B2!RR/P^]=D)A0\4&Q?7YVT?MW'] [1&+T0*B"BL74E*I
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M>,/F7'A\=HS6CNXL7:AU!J51*(U!:2&4QJ$T@:*9XM[[.U<^-OE%NB^W4%H
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M72><HN/1O5,5JBU0:#JS2EM4H5.("CJ%@*))%)I.'O%/P$PAJA//6AH/7?F
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MP,))&)S!(!$/#J?IZ6E:C \$65I?K#NU+2@C40O2\A=>QY "C;P<T?RO,JR
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MY@],FR.FM<Y_<N*X.KMC:YH?H#0"2@M :2$4S<Z9TO'"AW*\,*CC!4HCH+0
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MF5MI,W6K786;HYN=N5?Y?M2=X\0[#U;[:TO,:KOO+973;(=,PB8&V3DY-==
MN=I!NWJCQ3S?\?D@M!9I_G+&Z)C)K('Y?"*$7K_)3K#9QSS\#U!+ P04
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M\Y;3:Z>7\"[BY\ 9G0+'<AS%\\P.,1^7YK8JG/=Y#W_8>R<9;C/ W)+/W3O
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M%P!Q?TX(?SLI'#1;TM/_ 5!+ P04    "  Y@H%5?TEDY;T#   6$0  &0
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M2 Q+NL[TK=A^@"J@D>&+1*:*3[*M;!V+1&NE15Z!\0YRQLMO^E@EH@% GFZ
M5P&\?<#P.X!!!1B\U,.P @Q?ZF%4 8K0[3+V(G$!U70^E6)+I+%&-G-19+]
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M[!R54)9#>+G08E5,F?="X\Q:7*9 8Y#& ']?"J%W"^.@_BMD_B]02P,$%
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M9<$$IV3)U(BOOV.:4,/P!9S)^!?6::QC0;"4BH<I6"L(:93\DZ?4B!S K>\
M>"G >RV@E@)J<:*)LCBM2Z)(KR/X&H2)UFQF$'L3HW4V-#+;>*>$ODLU3O4N
M4= 5,59*(-$$!DLA, J>X=M3,"?1#&%$Y2,,2:0W56^?@B^PP<"%E*@2Y TE
M8\JHHIIIB$0N!4Z *+@B5, #84L$LVTPPD"O0:,9](FD$HXO41'*Y(EFOK^[
MA..C$S@"&L&0,J9W6G9LI1,U<NT@3:J?).7M2.IGH,[ :YV"YWA>!7RP'WZQ
M$!K>KH+;VM[,8R_SV(OY:COX-@Z<_M<P;='&(!/U@T=BR['?-WH!N%88RC]5
MYB1JZM5JS'/A7"Y(@%U+%[Y$L4*K]_F3ZSM?JZPZ$%G!N%IF7&T?>^YP HE]
MJ\HVH?!C"O/06O5<IZ6W;97/HASDMQM93$%</1-7?ZVXW$Y6*4QX&KG%&^Z6
MOG*(Z[6K]34R?8V]^FYPA0S<*D%[@6\]( <B*^3H9SGZ'ZJR_$,:=R"R@G'-
MS+CF^RNK63Z4Y<HJ!^VLK%8FKG6@RFJ5%J_Y6_K*(:ZSH[+:F;[V*RJKZL72
MWPM\ZP$Y$%DA1]?9- ;.AZJM5,Z!O#L46]&\7%?EOK^^4H[\V72V3N_>D**V
M33?B[GUGOZ&\4J+"N[6^K; <XVU+M'/]J?DX&!(QHY$$AE,-<LZ:.C^1]-O)
M1/%%W+*.N=(-<#R<ZV\4%"9 WY]RKEXFI@O.OGIZ_P!02P,$%     @ .8*!
M59R868BP!   ,QD  !D   !X;"]W;W)K<VAE971S+W-H965T-C0N>&ULM5EM
M;]LV$/XKA%8,";!$(F7+=F8;2)VU*]"T0;)NGQF)MHE(I$?2=KI?/TI6]&)2
MK!.H7VQ)?N[X'(]W#RE/]UP\R34A"CQG*9,S;ZW4YLKW9;PF&9:7?$.8_F7)
M18:5OA4K7VX$P4EAE*4^"H+(SS!EWGQ:/+L3\RG?JI0R<B> W&89%M_?DY3O
M9Q[T7A[<T]5:Y0_\^72#5^2!J&^;.Z'O_,I+0C/").4,"+*<>=?P:A$&N4&!
M^)N2O6Q<@SR41\Z?\IM/R<P+<D8D);'*76#]M2,+DJ:Y)\WCW]*I5XV9&S:O
M7[Q_*(+7P3QB218\_8<F:CWSQAY(R!)O4W7/]W^2,J!A[B_FJ2P^P;[$!AZ(
MMU+QK#36##+*#M_XN9R(A@$<=!B@T@"=:A"6!F$1Z(%9$=8-5G@^%7P/1([6
MWO*+8FX*:QT-97D:'Y30OU)MI^8W1- =SJ=2 LP2L-@*05C\'?SQ'*\Q6Q%P
M3^43N,5,)U6G3X$+\'6YE$0IRE;@6NJK@^5GBA]I2A75GLYNB,(TE><:_>WA
M!IR].P?O &7@EJ:ISIZ<^DJ3SRGX<4GT_8$HZB#Z-5:7 (U_ RA R&*^<)M?
M;X0VG]C,?3UEU;RA:MY0X2_\X;P!7,S!E2VD@X^!W4=>H5=R@V,R\W0)2B)V
MQ)O_^@N,@M]M ?;DK!5N6(4;NKS//PHN);C.^%:O +X$]R3F*T;_(\G+$CAK
MY/_<-A>' :)B@+RY[.8P&.M4[)HQFJ!H,JPP+>J#BOK@U$RE-45KN@9]IJLG
M9ZV8AU7,PY^=KL, PT8F+H;P*%L6#$03>[JBBGKDI/Z!,LQBBE/PB4DEMGG/
ML;:+R!@\/.9G0F#006]4T1LYZ2VP7 .M&2E61&B29WIJB5Y;R3FXXU*1Q$9U
M9/(X8FHB CO/<<5S[.3Y1>\ #OFW$1I;$C<^HF3!H Y2DXK4Q%F*?W&%4QN?
M29^%UY.S5H0PJ/4T^-FE5X[07K?&XK:@AE%D3Q!L; =@/^57^K$OV9*A"]+F
M5\LN=,K<V^JO]-E:RZ,@/*9K0:'AH(-QK9S0+9WN2BR-6VVLT4)+9A801!W$
M:EV$3@F:5UL]\K+5$WI20<R9$GIW;<]ZKQ+9E[?V!-0B"8<][.&@4VI?'7)/
MWMHAU^(*W>K:1W>RJ:JQD;.@.G=RL!9?Z%;?T[N3*:@79@>U@#HW"+!67NB6
MWK>U*(O<CH+!,6.;*'>VJ%J6H5,3?]2B)F;W&8R.F5E 84>+0K68HJ"OO3MR
MRO*KSUH]>6O'7:LP<JMP#V6*3/&]"*.CK-E G16 &F=CMTB?7*;(E%RC2BV8
M;HJU*B.W*K^I2)&IPP9;$]*QYT&U4".W4+O+LS1NY?"X;U@P7:QJ]43N,V:Q
MF0>"J*U@0.[QQI[A7M6S+V_MD&OU1%%O[<BIPZ^.NR=O[;AKV45NV>VC'=FT
MUEBF%E#7F1/5>HS<>GQZ-S+5]?A(XX2T^=7JB]SJ^[969.JMP=4%:;\%K 4Y
M=)]NW:VH-(Z<2;:!C"3[C3?:^=\)MUBL*),@)4MM%5R.=%3B\(;^<*/XIGC)
M_<B5XEEQN28X(2('Z-^7G*N7F_R]>?4_R?Q_4$L#!!0    ( #F"@56.+&@\
M?0(  +4&   9    >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;*U574_;,!3]
M*U:&)I &2?/A%I9&@E8('M!0.\;#M <WN6TM'#NSW0;^_6PG1(6&;@][27SM
M>X[/L7-OTEK()[4&T.BY9%R-O;76U87OJWP-)5%GH@)N5I9"ED2;4*Y\54D@
MA0.5S ^# /LEH=S+4C=W+[-4;#2C'.XE4INR)/+E"IBHQ][ >YV8T=5:VPD_
M2RNR@CGHA^I>FLCO6 I: E=4<"1A.?8N!Q<3;/-=P@\*M=H9(^MD(<23#6Z+
ML1=80< @UY:!F-<6)L"8)3(R?K><7K>E!>Z.7]FOG7?C94$43 1[I(5>C[V1
MAPI8D@W3,U'?0.LGL7RY8,H]4=WDQMA#^49I4;9@HZ"DO'F3Y_8<=@"#^ -
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MW&2KG()+(:@4X Q<;]4C*D!6 M4&7!/.G[)R RX+5I42L#7HA-[?4$FR7'P
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M%5HW\D940/=%&TNI64;G8B*T;BX:N0+5>N7YC>5=E.'<F_=K56+D#BU:C<J
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M5RP)28%)PAD2L)I:<W<<C?+Y9L)O!/;RZ!KE.UER_C6_^91,+2=?$%"(5<Z
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M_2L6DZ9.V@HAI.LR@M0$IE5:MZC1MH=I#RY<@E5C,]LDW;^?;0@-'8FJ+2^
M[7O._3C8ON&6BWM9 "CT4%(F9TZA5#5U79D64&)YSBM@>B7GHL1*#\7:E94
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M_%T9YOY1PB^I.D?^Y6OD>[X_$,_B.?!W%CX:2N?_O"?_[+U7C''W3XPM7W"
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MZBO?_<K*A$89S^>1S/^B7:&=S'K(WTK%XS)8'T$<)L5_^E1.Q%Z YI@#<!F
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M-&-4O1& ;<%7]=&N,2<L)E$)73$AP8< 2T02\5%QUOH3RK3&XR8 ']Y]!.\
MH>">)(EZ*6:N5#//QW<C/<OE:9:P899]<,^HW L0TAC'%G[0SA^U\%T5L3)L
M\!RV)6P5_!;)'H"3/P'T(+3,9_4:^K2@^S8[OS=Z^.;1*\'HE]]0O] ;-.@]
M]C8]6TY;6?D.>"LR%.&YH[8X@?DS=A;O__!'WB=;0+L4"[H4"SL2JX1^4(9^
M4*CW&T+?N"IM^1ATF8\NQ8(NQ<*.Q"KY&);Y&+8NA8W2(Q$&44,*3NQ1P<YK
M^//"G\[<Y^O UB%P6(4$=4A_4H6$=<C0*R$5:Z/2VJC5VA<JL0J8;/1VH@^O
M9S4RO-4AT( $=<@8&M[JD"&T>QN7WL:MWL*73#4N.%:MCSQP"G0% T@(+*WU
M:ER;P\W0=&O#C V[%HSOFX:MH('=\J2T/&FU?)<R+LE_J&C75'VG:B=17=L!
M<8(2D#!AM3VIA]XP74?X9HHM$,]P7(?T&U(\+?U.6_WF.V5VWBF?]$[9]"E/
M:\,/#)MUA.DAJ$/,15I'P(9%ZGN7?LYK]\GH35-!;J?^:@7H5"WH5"WL2JV:
MA*NFVN^N+&NMKK+2I5K0J5K8E5HU*_"2%?A;Q5G3*XO:V(I7-HRYOUDPT-@_
M0@NF:8?S+WVXW]Z(_[1$:W[;MK6R8,RB98% <P>W#=50LOQ+M^NW-F]OJ--:
ML%H[S4+]&E!@ _7-2OT34-7VI:GTV[O*M]5J+5K)@&F\#C%[30ND9MHR4%,=
MNW2;?GN[^4OU6FN-FK_9E05B+N[ AJDMW#H&FM^U>W4>DV*^*P["A)K]@<K3
MO]7ET_*P[:XX8C*>+_W;E6]Y'N2'<\7YST7^=+)WC_B.4 $2O%5#>;VQR@H_
M'9:=;B3+BM.@)R8E2XO+/48QYCE O=\R)L\W^0#ED>7B?U!+ P04    "  Y
M@H%5XAFSW$X+  !K>@  &0   'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6S-
MG6MSV[@5AO\*1^UTDIDX$L&+Y-3VC","7'=V-YE<V@^=?J EV%:7(EV2LM/^
M^I(2+0CF(4PD;SS>#QM?#AY .$<B\)B7D_N\^*.\D;)ROJW3K#P=W535[;OQ
MN%S<R'52OLUO95;_YBHOUDE5?UM<C\O;0B;+;:-U.F:323A>)ZML=':R_=G'
MXNPDWU3I*I,?"Z?<K-=)\=_W,LWO3T?NZ.$'GU;7-U7S@_'9R6UR+3_+ZNOM
MQZ+^;KRG+%=KF96K/',*>74Z.G??Q>&VP3;B[RMY7QY\[30OY3+/_VB^N5B>
MCB;-B&0J%U6#2.I_[N1<IFE#JL?QGQ8ZVO?9-#S\^H$NMB^^?C&722GG>?J/
MU;*Z.1W-1LY27B6;M/J4W_\BVQ<4-+Q%GI;;_SOW;>QDY"PV996OV\;U"-:K
M;/=O\JV=B(,&;MC3@+4-V- &7MO &]K ;QOX0QL$;8-@:(.P;1 .;3!M&TRW
MR=K-[C8U45(E9R=%?N\4371-:[[8YG?;NL[(*FM*\7-5U+]=U>VJL_/%8K/>
MI$DEE\Z'ZD86SCQ?UT5]TU3;G71^S<O2.7+F-TEV+4MGE3GG'^87SJM(5LDJ
M+5_7O_OZ.7)>_?GUR;BJQ]-0QXNV[_>[OEE/WY[S6YY5-Z7#LZ5<$NV%N7UH
M:#^NYV$_&>QA,MXS(_##HGKKL-D;ATT8(\8S-S?_VR:MFQ_W-H^&]+YK[A+-
M^8#>O4EO<_%CKSW^[L%KJ?#V=>EM>5Y?7395=I$MTLURE5T['_-B^\EU7E7%
MZG)3)9>I=*K<^3W/%G4-%'F:-F$7624+659OG-_K3_'\ROF2?'/^^:G^K5-_
M<-TGQ?)?5)GNAN+30VD.!N_*VV0A3T?U&Z.4Q9T<G?WE3VXX^2M5(TA8A(1Q
M)$P@83$(IE6:OZ\TWT0_>R^O5UG65,]EDB;90E(5LD.$6T1S=+\["]C,]R;;
M_T[&=X<%0,5.&:-B(R+6#4.?BN5D[(3D"HLQQ,.XVMP&^[D-C'.[.Z(LM"/*
MJ[0^I+RNCR3UC\FYWB&#@_$<^8R<DGDWU*,CHVYD/<_D-'<CV91D"F*@[F1"
MSG$WU/<?1VHS'.YG.#3.<'WH>Z)TPT[7 9L$4W(^J=B>,H^H6#<X)N>4B.TK
M<V$QWGC8&+2)G>XG=FJ<V"]YE:3.4\NC5[]NB_FBMYB-G=@>6I"P" GC2)A
MPF(03*NAV;Z&9B]G$3-#5AH2%B%A' D32%@,@FF5=KROM.,?7\0<$\>K8X_\
MQ)X3L8R% 7DD(&(]-J&/!%2L/R.YPF(,\3"N-K?N1.V1)];+F-WZY6$U<RFO
M\D(ZA5RD25FNKE:+I'FKE^2FV-B9[3L52HN@- ZEB9:FK>%\<@T7$Z'>S#46
MPX$P<8W%\&E0CHT,ZQPC:1&4QJ$TT=+T]SR] (V)V-"X:W&9RC'#[UM:YJ.-
M"[GGFA.Q'B-K.2)"W9!<#G,BE$U)JJ &>TPOLHE0OY,2?:*5Y7&-6_L!VY<6
MH%>$%SY^,[?32@3W'>(B*MB;^&3".!G<<Y 3-F..!PY#GV E-URSW?B:%3))
M5_^K]R]QLLH>-BSU*O0BNZL7F6N95<YGN=@4JVHEZ<\R8P_6GV5(6@2E<2A-
M0&DQBJ;7D1(Y;O!RMC*NT2I95QR2%D%I'$H34%J,HND5I\26:S9;@[8T9H9U
MI71]TE'/9WP$[9D3/1_39M=BC/$0JIX=9<=<LQX#;XF@F@Q*BZ T#J6)EO9H
MO4/OD*E8W[PG4I[+-<J-@7LBJ*&"TB(HC4-IHJ5I&P#Z+SE$Y)%YH:[\DFL6
M3-^W(S(RK3..I$50&H?2A$N9NEG/+IB(]1__944_&T)Y+V;V7D_OSEA7M!QY
M])%K;N[,-G]$S_Z,W+I!^Q46KS@>,D8]-<I",=>X'J?^&'71'G^W6[PWN[7V
M^659%<FB(M?9#&JIH+0(2N-0FH#28A1-KR3ENIC9=76.W6^<JJX<^>VV+JNZ
MFBYE)J]6%7E^EQEM74!(6@2E<2A-,$*IT9\@A*8SKMF84F_,K-Z^?P5O4R#0
M4ZN@M A*XU":8(04["S6VQ(A0A\[7[U$E#QD9GDXWYW[T%3&ER+)RC3929_E
MOS<[<TBN\\U0ZYQ#?2&4QJ$T :7%*)I>.LH7LA?D"QG4%T)I$93&H30!I<4H
MFEYQRA<R@"\T,ZPKA7)QP3$M#*%=<ZKKP*7_'&4SS'@86,^1LH;L.:VAN3/K
M9$*M(93&H33!*&LXG=#:D KNUHY>#\H;,H W-#.LTPSUAE :A]($Z]K 3G)-
M(7I.E2ED/\$4FIG6.8::0BB-0VF"4::P]ZU,!#_Q5O:4*_1^U!5ZA#GSO0E]
M9K^Y-^O+:(BN7=>E?2&T:V'SJN.!X]13I)RA]PS.T(,Z0R@M@M(XE":@M!A%
MTRM).4//_OPXN#LRC\&ZTJ!R$4KC4)KP"&=(_^V(B.S[D#FX;M.L%9N-^\&I
M9;_(Y35]6IF98YU>[&67V.LNL1=>8J^\_!F77GK*,'K^R]%$'E1,0FD1E,:A
M- &EQ2B:7G%*3'KF2U(':2(SP[I2NE=_SFB9'T$[YD3'1ZX?D,M>,7R4\4"N
MGB$E\CRSR,-*(G-GUJE$TB(HC4-IPNMZ0-?O.<^0B)VVQ=!7#4H9>F9E.$@1
MF1G628::0"B-0VG"Z\J]3FY-(7I.E?;SS-KONQ21F6F=8Z@&A-(XE"8\XO3!
MWC=R-_:I-[+R@I[9"PX01%T_Q5CPN/LV?U#%1_1\%$Y[]!!4X%F\YGC8*/6;
MH"A_YT]^OASRH9>V0FD1E,:A- &EQ2B:7DE*,_KF"V2?10Z9QV!=:5 -":5Q
M*$WXW8MF._<#,H7H-:&$H6\6ALT^?7</N>86<I]DM2KDU@]]N$Q7U_T+.S/6
M.LU0!PBE<2A-0&DQBJ87CU**_@NZ%YP/U9)06@2E<2A-0&DQBJ97W,$MX<PG
M/@Z[)QQ4)[8T;7$WG=*WWH+VS*F>7<\G;P8@+(89#P3K.5(BS[>_M]SW:R)S
M9];)A)Y""*5Q*$WXQ"WXZ&(@;H%G+ 3E"WVS+QQDB,P,Z_Q"-2"4QJ$TX1,:
MD,YO-] S7GOH*P7HVY\U^*0N,C.M$PY5@E :A]*$W_5]]+DJ1*!G_FA7?M W
M^\&G59%/7.DZ#>E;F9D[L\X=T;/K/=SW\_$M6Z$FS^)%QP.'J2=(N3S_^!ED
M$?2</R@M@M(XE":@M!A%T^\/K+1C8#YM\$>N/C2C;0L(2HN@- ZEB:![EB%]
MYZ\!@7K:E2,,7H C-(_!NCZ@CA!*XU":"+H"D%[S$8'FVX8K7QB8?6'_;<OF
M27GCB+0&]I]:9H9;)QYJ#:$T#J4)*"U&T?024M8P>$'6,(!:0R@M@M(XE":@
MM!A%TRM.6<, 8 W-#.M*V=$.'][@TT\KB* =<Z+C(Q:0ZD<$70_8,\B8""6P
M>GX.'D;QG,;0W)EU(J'&$$KC4)H(NB(P]'JJH1O*S(XA4-8P %A#,\,ZQU!K
M"*5Q*$T$Y!7']+VZB5C/O(I4XC#X">+0S+3..50<0FD<2A,!Y0/)4ZAB(I1U
M/):><^4.@Q]UARW@\- U"^A;EIG[LLY>MV.WYQE$4&\8=%U@SPN.B=#.$/7$
M*&<8/(,S#*#.$$J+H#0.I0DH+4;1]"=>*6<8_CQG:$;;%A"4%D%I'$H3(7%E
M,OVPKY@*-=ZS+%3:,'P!VM \!NL2@6I#*(U#::*E:8>WG@N(B-">!QZ,#QYM
MNY;%]?:IQ65= INLVCU-=/_3_9.1S[?/ W[T\_?N.^X2/Q?NNWCWW&.%WSV&
M^;>DJ/?SI9/*J[JKR=MI7='%[LG&NV^J_';[8-W+O*KR]?;+&YDL9=$$U+^_
MRO/JX9NF@_WSI<_^#U!+ P04    "  Y@H%5??M*CQX(  #^6@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-BYX;6RMG&MOFT@4AO\*\E:K5JIB&,>W;&(I
M"7<E;=2HNQ]6^X' V$;EX@)V6FE__,X !F/C"73??F@,YCQGP.<U9_P"UZ]Q
M\BU=4YI)/\(@2F\&ZRS;7 V'J;NFH9->Q!L:L7>6<1(Z&5M,5L-TDU#'RX/"
M8$AD>3(,'3\:+*[S=4_)XCK>9H$?T:=$2K=AZ"0_[V@0O]X,E,%^Q1=_M<[X
MBN'B>N.LZ#/-OFZ>$K8TK"B>'](H]>-(2NCR9G"K7-EDS@/R+?[TZ6MZ\%KB
MN_(2Q]_X@N7=#&0^(AI0-^,(A_W9T7L:!)S$QO&]A ZJG#SP\/6>KN<[SW;F
MQ4GI?1S\Y7O9^F8P&T@>73K;(/L2OYJTW*$QY[EQD.;_2Z_%MM/Y0'*W:1:'
M93 ;0>A'Q5_G1WD@#@+(N0!2!I#C /E,P*@,&!T%*.<R7)8!ET<!(^5,P+@,
M&!\/B9P)F)0!DZ. R>69@&D9,.V:858&S(X#9F<"YF7 O&L&1=Y_<G)>0<5'
MGM>+ZF3.XCJ)7Z6$;\]X_$5>='D\*Q,_XOIXSA+VKL_BLL5]'(9^Q@H^2R4G
M\J3[.,K\:$4CUZ>I]%ZEF>,'Z8?K8<:2\9"A6X+5 DS.@!7ID:'6J:1%'O5:
MXC5Q_.BM>$,</WDKWGIC_$0 &+*C7!UJLC_4=T1(_!3O+B1%_B@1F1#)#1P_
ME#:!PX[W<MDROOL.-)D<TMH^)#'DT?DIC13.4*9G&9J8\=G-+B0R*P?R]5F5
MWK_[4,#8OK7P]"Z\><Y3]KRVS_]7AL4.M[?T@Z :'SLQO*2^Y[-S ]-5M%VR
M+^QM0I.6A"9FW)88<[M)]AAETCR<+3"[,ZP^"()2'E7?&J.<.SK#?8C3].BK
MXN\'MHUD931,_VD9Z%T!O&P'\B[@*MTX+KT9L--\2I,='2Q^_TV9R'^T20,)
M4Y$P#0G3D3 #"3.1, L)LT&PABPN*UE<BNB+>YJPTV4D!7[FKYR\_W/73K*B
MZ4<I8KWNO]*[-FD(H7VE@82I2)A6P"8YC+?MNX5\/=P=UOOI%J-+.?_7W-!X
M$V6>;C&1VU 6<A=M$*Q1?..J^,;"XKMUW61+O9;B.U=W0E[?ND/"5"1,&Y]6
ME=Q:"SHRK=$YK8E,:R%A=I=]:!3KI"K6B;!8/R<):QVR./HH/3J\<>#S?M]U
M@H,FC&T@L5<^*^B?;>4KS-"W?)$P%0G3D# ="3.0,!,)LY P&P1KZ&1:Z62*
M;K2G2%D@82H2IB%A.A)F(&$F$F8A838(UI#%K)+%3'CZ^+0-7V@BQ<MJ0I]*
M"?V^]?.31D+#>,=.)>]Y*[Y__P/K@O8+;;(1)NPK&R1,1<(T)$Q'PHP"-C[H
M-<A1GX1,9R%A-@C6T,*\TL+\?VC!=38;_K>7%H0)^VH!"5.1, T)TY$P8WZB
MA=&1%I#I+"3,!L$:6E#DVLZ0A6IXHL'.=Z60IFM6Y$])[&W=C,V)G9=\'G$P
M.VXK?#&\;^5#:2J4ID%I.I1F0&DFE&9!:3:*UA3+@?>GH&<7)1&E$"1-A=(T
M*$V'T@PHS832+"C-1M&:"B&U0DC'YJKR"7-?G'53ARMX0U4;B:VZ$>;IK1LD
M3872-"A-A]*,DB::9$ 36E":C:(UQ5";OHK0/#L0PZ%37JBAL8;+X0TS_4Z<
MJ[<@H(XPE*9!:3J49I2T0T$HQX* >KU0FHVB-051V[V*V.^]#>-ME.5G!YIE
M >674;&YMTO]'?7.N6YB9N_"A_J]4)H&I>E0F@&EF5":I9R:UPI1VJQ#&Y6X
M*8#:<E;$GG-]1L@O4$I+'7CY*:%8Q<\%YZY>NA/C>VL!ZD&7M,.OQO')!Z!!
M<^I0F@&EF5":U7)T%:6EOD%)F_5=N]2*V*8^JF^'7R5;E39?JJJ[_5+'.S&_
M=X%#76HH32MIC0]T0DXNL8 F-;HE-:%)+2C-1M&:%5[[RXK0I^OQ>RE[^YE-
M<>GW+>]RZ(Z>J7BH_PREJ5":!J7I4)H!I9E0F@6EV2A:4S^U$:W,X#^A0JUF
M*$V%TC0H38?2#"C-A-(L*,U&T9H*J>UII:L__8MS!*@;K9Q:J\IX?MPQJ-"D
M&I2F0VD&E&9":1:49J-HS9N_:F>:B)UIDR:1[TB/O--Z..RJGFCD\4LT'OJV
M6N*$?94!I:E0F@:EZ5": :694)H%I=DH6E- M5M-X&XU@;K54)H*I6E0F@ZE
M&5":":594)J-HC454KO5I*M;_=;/5:UB.35'YT=]T;UX +TE #6>H30=2C.@
M-!-*LZ T&T5K2J#VJ$E7CWK#ZCR_M[[00+W(12"X[_Z.G'JB$WE\H@2HXPRE
M:5":#J494)H)I5E0FHVB-950F]-$;$[WFV\\.FGJN.LMGYRG7><?4"<;2E.A
M- U*TZ$T THSH30+2K-1M*:@:K.;C.'S#ZB_#:6I4)H&I>E0F@&EF5":!:79
M*%I3(;5=3KK:Y;_>?)TZNN/)\<^S]^)Q]%8"U B'TG0HS8#23"C-@M)L%*VI
MA-I6)V);O6?SY4<13>/,Z=IX03UV*$V%TC0H38?2#"C-A-(L*,U&T9IBJCUV
M O?8"=1CA])4*$V#TG0HS8#23"C-@M)L%*VID-IC)UT]]E]OO%KN.3[]T0MZ
M,S>4ID%I.I1F0&DFE&9!:3:*5@AA>/!@VY FJ_Q!RJGD\MLNBJ=55FNKAS7?
MYH\H/EJO*5>ZTK+>4*[,XE',-;YX,O2CDZS\*)4"NF2IY(LI4T92/&RY6,CB
M3?Y8W9<XR^(P?[FFCD<3O@%[?QG'V7Z!)Z@>>;WX#U!+ P04    "  Y@H%5
M0<#E^TL"  !6!0  &0   'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6R55-]O
MTS 0_E>L(*$A09.F33>5-%*[ =O#1M4*>$ \.,DEL>;8P;ZVX[_'/]I0I*Z#
ME\1GW_?==V??I3NI'G4#@.2IY4+/@@:QFX:A+AIHJ1[(#H0YJ:1J*1I3U:'N
M%-#2@5H>QE$T"5O*1)"E;F^ILE1ND#,!2T7TIFVI^K4 +G>S8!@<-E:L;M!N
MA%G:T1K6@%^ZI3)6V+.4K 6AF11$034+YL/I(K'^SN$K@YT^6A.;22[EHS7N
MRED064' H4#+0,UO"]? N24R,G[N.8,^I 4>KP_L'UWN)I><:KB6_!LKL9D%
M5P$IH:(;CBNYNX5]/DY@(;EV7[+SOLEE0(J-1MGNP49!RX3_TZ=]'8X \?@9
M0+P'Q$ZW#^14WE"D6:KDCBCK;=CLPJ7JT$8<$_92UJC,*3,XS-90FQ(CH:(D
MGT#6BG8-*\B=\/=M"_>./%"EJ*T>N;@!I(SK-VF()KKE"(M]I(6/%#\3:4+N
MI<!&DP^BA/)O?&A4]]+C@_1%?);P<X$#$E^])7$4QZ23"BO)F3S#/.J+,G+,
MHQ>*L@++RD1-OL]SC<H\H1^G$O=LX]-LMJVFNJ,%S +3-QK4%H+L]:OA)'I_
M1NNXUSH^QYX];-H<%)$5,8UJ;\FHU5Z_)A=,],;)*_/<B>.V_;O-QFFX/2$G
MZ>4D_RA'N>+1G,-_Z$E>U!,>O?465.TZ6I-";@3Z9]_O]D-C[GOEC[N?./=4
MU4QHPJ$RT&AP:>(JW\7>0-FYSLDEFCYTR\8,/E#6P9Q74N+!L 'Z49K]!E!+
M P04    "  Y@H%5KC;/L)P(  "*/@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W."YX;6RU6VUOX[@1_BN$6QSV@//:HN2W7!)@(^FN 9KN(NZV'XI^4&3&
M)DX2?12=9 _WXTN]Q#2M$1-OQ_MA8\L/'VEFJ-$\&O+R6<C?R@UCBKSD65%>
M#39*;2]&HS+=L#PI/XHM*_0OCT+FB=)?Y7I4;B5+5O6@/!O1\7@ZRA->#*XO
MZV-?Y/6EV*F,%^R+).4NSQ/Y[89EXOEJX U>#]SS]495!T;7E]MDS99,?=U^
MD?K;:,^RXCDK2BX*(MGCU>"3=Q$'DVI C?@79\_EP6=2F?(@Q&_5E]O5U6!<
M71'+6*HJBD3_>6(AR[**25_'[RWI8'_.:N#AYU?V7VKCM3$/2<E"D?V;K]3F
M:C ?D!5[3':9NA?/?V.M0?4%IB(KZ__)<XL=#TBZ*Y7(V\'Z"G)>-'^3E]81
M!P,T#SR M@/H>P?X[0#_O0."=D#PW@&3=D!M^JBQO79<E*CD^E**9R(KM&:K
M/M3>KT=K?_&BFBA+)?6O7(]3UTNVUF%7)"E6Y%<FUC+9;GA*;HMF#E:Q'.IO
MJ<@9^46*G'S>,ED?+\D-TR#V^NL_DQ=6DH=OY)YMA53)0\;((?L]2T61\HPW
MK$J04).(C*\2Q5;D0\14PK/R1WV^K\N(?/CKCY<CI2VLKG.4MM;<--;0'FM\
M<B<*M2E)7*S8"A@?N<=/'>-'VK-[]])7]]Y0)^'G5'TD=/X3H6-*@>L)WS-\
M40_W('/^O[/'WWUVRQG^?J[Y-9__QEQK)@@OUM8T^\_?-9S<*I:7_X4BWW '
M,'>53R_*;9*RJX%.F"633VQP_<-?O.GX9\CMF&01)EF,1&8%*-@'*'"Q[P,D
MFGM<!V@KQ2-74#@:IFG-5#V-GJZ]8!R,ZW^7HZ=#9P/0R=2'H%$72B=T#D%C
M !I0>@2UW##9NV'B=,-GM6&2%*(8&D?P.LG]1 H&>J,AG!R:.%Z SN@BIU/0
M%0#EXMB\QA, <C9S.6*Z=\34Z8A/>76?_M'<G^)1.T$EQ9I7F3TI2Z9*R!73
MSM4, ^J!OH"@/@B- .@\ *=;#$$[/K;\,=O[8^;TQSTKE=RE:B>K*5$]U+0;
M1,KK!U@J2E4V3[IP.;H+EX3GVX3+^HX:-3]#_G*>\M2\ADD6S;J.]-I[\=CG
M2.>UHC+?1V7NC$K(=+7!"Y)QQ=?-7$TWB5RSLO=VG7<L.YZ:7<30!Z=;]"97
M#'!-C]UH6;[86[YP6MY67@]-'=:D***J.@PR>M%-$_YB MZ8 #18P!F["Z6!
M#V=L .I3YXWIC4T9.W;G['VF;A]BH O<)*?>;*AL$2I;C,5FA^- 57AG+/5:
M<JPP8;)%J&PQ%IL=)FK"1-$*OI;*NGUG/I@40@#KCX/CFJ1U:!<[H13DC0'L
ME'K'A9;M#*-./&=M#:00\B<)$[GBXBDITUV62- OJ,($E2U"98NQV.SX&''B
M!>?,*4[I<W*8,-DB5+88B\T.DQ%/GEL]G913(-T$YXD0Q,+U2P1@M73JR2D
MED[<98D14)Y;08$YY8ZM>)ID9+F3Z^H#Z!DG[\G3%9,M0F6+L=CL"!E)Y\W.
MF550U1LJ6X3*%F.QV6$R&L]SB[R3LDI7<,T\^-44 %V,0?42 5#/[^2)UED
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M7,$(@ %3@J"\#^[=C[S-?<IK_L$__@M02P,$%     @ .8*!59>*NQS
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MG;]3[V'\/);AUO.UAN>OOI/J\7)ON3W^NOPZB3BOKCC7]Q7#\U]02P,$%
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M<',O87!P+GAM;%!+ 0(4 Q0    ( #F"@55Y/'A([0   "L"   1
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M965T,BYX;6Q02P$"% ,4    "  Y@H%5L<Y=%WP$  !L$@  &
M    @($/&P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @
M.8*!57A7_1_M!@  &AX  !@              ("!P1\  'AL+W=O<FMS:&5E
M=',O<VAE970T+GAM;%!+ 0(4 Q0    ( #F"@54<T!EWX0(  !P(   8
M          " @>0F  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M    "  Y@H%5Y?,8X+$-  !\D0  &               @('[*0  >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ .8*!5;Q868"C @  G@<
M !@              ("!XC<  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+
M 0(4 Q0    ( #F"@54$KK;\BP<  )LA   8              " @;LZ  !X
M;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  Y@H%5 2FN?H@&
M   0$   &               @(%\0@  >&PO=V]R:W-H965T<R]S:&5E=#DN
M>&UL4$L! A0#%     @ .8*!5=*0S^FI @  808  !D              ("!
M.DD  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  Y@H%5
MIHL/'4$)  "%%P  &0              @($:3   >&PO=V]R:W-H965T<R]S
M:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #F"@559UW'800X  ( N   9
M      " @9)5  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%
M  @ .8*!5;]J"R$X"   PQL  !D              ("!"F0  'AL+W=O<FMS
M:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  Y@H%5:]<Y[\D)   ,'P
M&0              @(%Y;   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+
M 0(4 Q0    ( #F"@57X9W"D1 H  . <   9              " @7EV  !X
M;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ .8*!50</\ H&
M#@  5#4  !D              ("!](   'AL+W=O<FMS:&5E=',O<VAE970Q
M-BYX;6Q02P$"% ,4    "  Y@H%5FV+D*W@"  !K!0  &0
M@($QCP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( #F"
M@55?)NKX00<  *P3   9              " @>"1  !X;"]W;W)K<VAE971S
M+W-H965T,3@N>&UL4$L! A0#%     @ .8*!58/,])KG!0  8P\  !D
M         ("!6)D  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
M    "  Y@H%5!\F%P1T$  !3"@  &0              @(%VGP  >&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( #F"@55!H0FM@@,  '$(
M   9              " @<JC  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL
M4$L! A0#%     @ .8*!57WG_#O$ P  B D  !D              ("!@Z<
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  Y@H%5ZGOE
M5^L%   4%0  &0              @(%^JP  >&PO=V]R:W-H965T<R]S:&5E
M=#(S+GAM;%!+ 0(4 Q0    ( #F"@54R&U1&'!4  "$]   9
M  " @:"Q  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @
M.8*!55+)PG0Q!P  !Q(  !D              ("!\\8  'AL+W=O<FMS:&5E
M=',O<VAE970R-2YX;6Q02P$"% ,4    "  Y@H%53L1YC@\&  "J#P  &0
M            @(%;S@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4
M Q0    ( #F"@54 )$)!KP4  *@-   9              " @:'4  !X;"]W
M;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ .8*!56-=!O!Q!@
M1A,  !D              ("!A]H  'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6Q02P$"% ,4    "  Y@H%51.6U'&4#  !G!P  &0              @($O
MX0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #F"@57K
MKO)^= @  $L<   9              " @<OD  !X;"]W;W)K<VAE971S+W-H
M965T,S N>&UL4$L! A0#%     @ .8*!59@'\F@L!    PP  !D
M     ("!=NT  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #F"@54NY>?EDP,  (H(   9              "
M@78% 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ .8*!
M588<^7$T P  $ @  !D              ("!0 D! 'AL+W=O<FMS:&5E=',O
M<VAE970S-RYX;6Q02P$"% ,4    "  Y@H%5"H '@]P#  #)"0  &0
M        @(&K# $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0
M   ( #F"@56 F4[X=04  )$,   9              " @;X0 0!X;"]W;W)K
M<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ .8*!571V7RPH!P  GCD
M !D              ("!:A8! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q0
M2P$"% ,4    "  Y@H%5^5Q54-H(  #V50  &0              @(')'0$
M>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #F"@54 D"WX
M# 0  $,1   9              " @=HF 0!X;"]W;W)K<VAE971S+W-H965T
M-#(N>&UL4$L! A0#%     @ .8*!5<&.:W<L#P  OM\  !D
M ("!'2L! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  Y
M@H%5QKIGQ4,&  "O.   &0              @(& .@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( #F"@55H$#"(C 0  *T<   9
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M970T.2YX;6Q02P$"% ,4    "  Y@H%5*F#?#NX#  "[$0  &0
M    @(&\7 $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (
M #F"@55U7.$-^@H  +5D   9              " @>%@ 0!X;"]W;W)K<VAE
M971S+W-H965T-3$N>&UL4$L! A0#%     @ .8*!54A5I]9.!0  NR(  !D
M             ("!$FP! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"
M% ,4    "  Y@H%5[=N?#FH$  !9%0  &0              @(&7<0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( #F"@55D-AX3T (
M )P'   9              " @3AV 0!X;"]W;W)K<VAE971S+W-H965T-30N
M>&UL4$L! A0#%     @ .8*!5<N9*42H P  (@\  !D              ("!
M/WD! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  Y@H%5
M%^+>:.\"  "<"0  &0              @($>?0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4V+GAM;%!+ 0(4 Q0    ( #F"@57*YD@S)0L  "*(   9
M      " @42  0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%
M  @ .8*!5?%,7-59$@  ^ND  !D              ("!H(L! 'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6Q02P$"% ,4    "  Y@H%57%'W 1<'  #3/
M&0              @($PG@$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+
M 0(4 Q0    ( #F"@57#&SQH5 4  )X>   9              " @7ZE 0!X
M;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ .8*!57])9.6]
M P  %A$  !D              ("!":L! 'AL+W=O<FMS:&5E=',O<VAE970V
M,2YX;6Q02P$"% ,4    "  Y@H%5\R*PU;(%  "[*@  &0
M@(']K@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( #F"
M@54*7-[<*P,   $-   9              " @>:T 0!X;"]W;W)K<VAE971S
M+W-H965T-C,N>&UL4$L! A0#%     @ .8*!59R868BP!   ,QD  !D
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M=#8X+GAM;%!+ 0(4 Q0    ( #F"@54O+G>SC0(  *D&   9
M  " @8+- 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @
M.8*!5==TDAW) P  L1   !D              ("!1M ! 'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6Q02P$"% ,4    "  Y@H%5S31)&0 %  #!&P  &0
M            @(%&U $ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4
M Q0    ( #F"@54J!E%$V (  +D)   9              " @7W9 0!X;"]W
M;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ .8*!55JB<]2%!0
M8R@  !D              ("!C-P! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX
M;6Q02P$"% ,4    "  Y@H%56#A?UC,$  "^%   &0              @(%(
MX@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( #F"@57B
M&;/<3@L  &MZ   9              " @;+F 0!X;"]W;W)K<VAE971S+W-H
M965T-S4N>&UL4$L! A0#%     @ .8*!57W[2H\>"   _EH  !D
M     ("!-_(! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
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M  #M%P  #0              @ &("@( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( #F"@567BKL<P    !,"   +              "  30. @!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( #J"@543D4\"L 4  $,T   /              "
M 1T/ @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  Z@H%5NTG2WV("  "T
M+@  &@              @ 'Z% ( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    "  Z@H%5W2=K"Q@"  "%+0  $P              @ &4
L%P( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     5P!7 -@7  #=&0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>671</ContextCount>
  <ElementCount>363</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>163</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited</Role>
      <ShortName>Consolidated Statements of Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Restructuring and Other Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringandOtherCosts</Role>
      <ShortName>Restructuring and Other Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Financing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangements</Role>
      <ShortName>Financing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Derivatives and Currency Exchange Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Retirement Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlans</Role>
      <ShortName>Retirement Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Revenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Restructuring and Other Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringandOtherCostsTables</Role>
      <ShortName>Restructuring and Other Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/RestructuringandOtherCosts</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/FinancialInstruments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Financing Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsTables</Role>
      <ShortName>Financing Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/FinancingArrangements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/Inventories</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/EarningsPerShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Retirement Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlansTables</Role>
      <ShortName>Retirement Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/RetirementBenefitPlans</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails</Role>
      <ShortName>Revenue - Disaggregation of Net Sales by Segment and Division (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails</Role>
      <ShortName>Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails</Role>
      <ShortName>Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Restructuring and Other Costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails</Role>
      <ShortName>Restructuring and Other Costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails</Role>
      <ShortName>Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails</Role>
      <ShortName>Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails</Role>
      <ShortName>Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails</Role>
      <ShortName>Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails</Role>
      <ShortName>Financial Instruments - Summary of Equity and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails</Role>
      <ShortName>Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Financing Arrangements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails</Role>
      <ShortName>Financing Arrangements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Financing Arrangements - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails</Role>
      <ShortName>Financing Arrangements - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails</Role>
      <ShortName>Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/InventoriesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/IncomeTaxes</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Earnings Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>Earnings Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/StockBasedCompensationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Changes in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medtronic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails</Role>
      <ShortName>Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mdt-20221028.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails</Role>
      <ShortName>Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode -  mdt-20221028.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="mdt-20221028.htm">mdt-20221028.htm</File>
    <File>mdt-20221028.xsd</File>
    <File>mdt-20221028_cal.xml</File>
    <File>mdt-20221028_def.xml</File>
    <File>mdt-20221028_lab.xml</File>
    <File>mdt-20221028_pre.xml</File>
    <File>mdt-2023q210qxex311.htm</File>
    <File>mdt-2023q210qxex312.htm</File>
    <File>mdt-2023q210qxex321.htm</File>
    <File>mdt-2023q210qxex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mdt-20221028_g1.jpg</File>
    <File>mdt-20221028_g10.jpg</File>
    <File>mdt-20221028_g11.jpg</File>
    <File>mdt-20221028_g12.jpg</File>
    <File>mdt-20221028_g13.jpg</File>
    <File>mdt-20221028_g2.jpg</File>
    <File>mdt-20221028_g3.jpg</File>
    <File>mdt-20221028_g4.jpg</File>
    <File>mdt-20221028_g5.jpg</File>
    <File>mdt-20221028_g6.jpg</File>
    <File>mdt-20221028_g7.jpg</File>
    <File>mdt-20221028_g8.jpg</File>
    <File>mdt-20221028_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1565">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="87">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>110
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mdt-20221028.htm": {
   "axisCustom": 0,
   "axisStandard": 41,
   "contextCount": 671,
   "dts": {
    "calculationLink": {
     "local": [
      "mdt-20221028_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdt-20221028_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mdt-20221028.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mdt-20221028_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdt-20221028_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mdt-20221028.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 719,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 6
   },
   "keyCustom": 27,
   "keyStandard": 336,
   "memberCustom": 87,
   "memberStandard": 70,
   "nsprefix": "mdt",
   "nsuri": "http://www.medtronic.com/20221028",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.medtronic.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.medtronic.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Revenue",
     "role": "http://www.medtronic.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Restructuring and Other Costs",
     "role": "http://www.medtronic.com/role/RestructuringandOtherCosts",
     "shortName": "Restructuring and Other Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Financial Instruments",
     "role": "http://www.medtronic.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Financing Arrangements",
     "role": "http://www.medtronic.com/role/FinancingArrangements",
     "shortName": "Financing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Derivatives and Currency Exchange Risk Management",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement",
     "shortName": "Derivatives and Currency Exchange Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Inventories",
     "role": "http://www.medtronic.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Income Taxes",
     "role": "http://www.medtronic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Income (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
     "shortName": "Consolidated Statements of Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings Per Share",
     "role": "http://www.medtronic.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Stock-Based Compensation",
     "role": "http://www.medtronic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Retirement Benefit Plans",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlans",
     "shortName": "Retirement Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Commitments and Contingencies",
     "role": "http://www.medtronic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Segment and Geographic Information",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://www.medtronic.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Revenue (Tables)",
     "role": "http://www.medtronic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale (Tables)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Restructuring and Other Costs (Tables)",
     "role": "http://www.medtronic.com/role/RestructuringandOtherCostsTables",
     "shortName": "Restructuring and Other Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Financing Arrangements (Tables)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsTables",
     "shortName": "Financing Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Derivatives and Currency Exchange Risk Management (Tables)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables",
     "shortName": "Derivatives and Currency Exchange Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Inventories (Tables)",
     "role": "http://www.medtronic.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.medtronic.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.medtronic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Retirement Benefit Plans (Tables)",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlansTables",
     "shortName": "Retirement Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Segment and Geographic Information (Tables)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
     "shortName": "Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Revenue - Disaggregation of Net Sales by Segment and Division (Details)",
     "role": "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
     "shortName": "Revenue - Disaggregation of Net Sales by Segment and Division (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia9a3dd382c6945438731d0f15056527b_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)",
     "role": "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
     "shortName": "Revenue - Disaggregation of Net Sales by Market Geography for Each Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i4886727899c748af9b7ca6ecc006d607_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.medtronic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i6d3a8e5da34e4451a2cc414372ccc1f7_I20220830",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Intersect ENT Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i09d5f411538846809c17df42d6baca81_I20220513",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale - Schedule of Fair Value of the Assets Acquired and Liabilities Assumed - Affera Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ief0140ab23f7415d9e84fba89d2ce274_I20220729",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale - Reconciliation of Beginning and Ending Balances of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:BusinessAcquisitionPurchasePriceContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale - Fair Value Measurement, Contingent Consideration, Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "id51339e6172a4fa89793c01ac5372310_I20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i6f5870d0d38b43288e41b0362ecae37f_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details)",
     "role": "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
     "shortName": "Acquisitions and Assets and Liabilities Held for Sale- Assets And Liabilities Classified As Held For Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i6f5870d0d38b43288e41b0362ecae37f_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Restructuring and Other Costs - Narrative (Details)",
     "role": "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
     "shortName": "Restructuring and Other Costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i16be2ec2863d4cd48ac8e0eb7c5810ca_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)",
     "role": "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
     "shortName": "Restructuring and Other Costs - Activity Related to Restructuring Programs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
     "shortName": "Financial Instruments - Investments by Category and Related Balance Sheet Classification (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
     "shortName": "Financial Instruments - Available-For-Sale Securities in Continuous Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails",
     "shortName": "Financial Instruments - Activity Related to the Company's Investment Portfolio and Debt Securities Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i13212ed214a64a10aa002be4cdfbe506_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Financial Instruments - Summary of Equity and Other Investments (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
     "shortName": "Financial Instruments - Summary of Equity and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i13212ed214a64a10aa002be4cdfbe506_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
     "shortName": "Financial Instruments - Activity Related to the Company's Investment Portfolio, Equity and Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mdt:ScheduleofInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Financial Instruments - Narrative (Details)",
     "role": "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i119e631ed11c4cb899625fc2cd92a1e6_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Financing Arrangements - Narrative (Details)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails",
     "shortName": "Financing Arrangements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Financing Arrangements - Long-Term Debt (Details)",
     "role": "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
     "shortName": "Financing Arrangements - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Derivatives and Currency Exchange Risk Management - Narrative (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mdt:UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "iac68bc9471644ffc8005764e8ae89b46_I20210430",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Equity (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
     "shortName": "Consolidated Statements of Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i7a2167e5d29e458f885b0b5ae5d9fa5e_D20210501-20210730",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Derivative (Gains) Losses Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mdt:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Gains and Losses on Derivatives Not Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i68ea2486c0a94abfb5ca1108224bba7c_I20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)",
     "role": "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails",
     "shortName": "Derivatives and Currency Exchange Risk Management - Offsetting Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OffsettingLiabilitiesTableTextBlock",
       "us-gaap:OffsettingAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityNotOffsetPolicyElectionDeduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Inventories (Details)",
     "role": "http://www.medtronic.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i236409b4a26046c8895b2b03b157a37e_D20210731-20211029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i236409b4a26046c8895b2b03b157a37e_D20210731-20211029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets - Carrying Amount and Accumulated Amortization of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)",
     "role": "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets - Estimated Future Aggregate Amortization Expense of Amortizable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Equity (Unaudited) (Parenthetical)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical",
     "shortName": "Consolidated Statements of Equity (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia0b6116555c34c9f83363705bad2dc7b_I20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Income Taxes (Details)",
     "role": "http://www.medtronic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)",
     "role": "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
     "shortName": "Earnings Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ia9dadce75f3a473ab901ae1d134204f0_D20220730-20221028",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i74db199c9a774fdb9da00363fa038371_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Earnings Per Share - Narrative (Details)",
     "role": "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails",
     "shortName": "Earnings Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i74db199c9a774fdb9da00363fa038371_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Stock-Based Compensation (Details)",
     "role": "http://www.medtronic.com/role/StockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "role": "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Retirement Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i82ad7b6f99a64ed38d6a77afc529c0eb_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ief0140ab23f7415d9e84fba89d2ce274_I20220729",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Accumulated Other Comprehensive Loss - Changes in AOCI (Details)",
     "role": "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
     "shortName": "Accumulated Other Comprehensive Loss - Changes in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i28ba042775474bc28935c1b5764479ca_D20220430-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LossContingencyAccrualAtCarryingValue",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "ib6dbf47620f34e0cbc2ca62a86b19498_I20220429",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "portfolio",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Segment and Geographic Information - Narrative (Details)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails",
     "shortName": "Segment and Geographic Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "portfolio",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails",
     "shortName": "Segment and Geographic Information - Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i47ff2bf6f8a94d3e97118363d9a224a2_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i42a5e81244164e1b89cee7c3a3c04385_D20220730-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details)",
     "role": "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails",
     "shortName": "Segment and Geographic Information - Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographic Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i52660540190940b693d1bd02d12d492a_D20220730-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation",
     "role": "http://www.medtronic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdt-20221028.htm",
      "contextRef": "i1a60d7f506ac405ea04abf23120a38f4_D20220430-20221028",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 163,
   "tag": {
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "netLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro-denominated Debt"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japanese Yen-denominated Debt"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r864"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Ordinary Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r873"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mdt_A2007CIFSASeniorNotesDue20386550PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2007 CIFSA Senior Notes Due 2038, 6.550 Percent",
        "label": "2007 CIFSA Senior Notes Due 2038, 6.550 Percent [Member]",
        "terseLabel": "6.550 percent thirty-year 2007 CIFSA senior notes"
       }
      }
     },
     "localname": "A2007CIFSASeniorNotesDue20386550PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_A2015CommercialPaperProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Commercial Paper Program [Member]",
        "label": "2015 Commercial Paper Program [Member]",
        "terseLabel": "Commercial Paper Program"
       }
      }
     },
     "localname": "A2015CommercialPaperProgramMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_A2265PercentThreeYear2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.265 Percent Three-Year 2022 Senior Notes",
        "label": "2.265 Percent Three-Year 2022 Senior Notes [Member]",
        "terseLabel": "2.625 percent three-year 2022 senior notes"
       }
      }
     },
     "localname": "A2265PercentThreeYear2022SeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_A3000PercentSixYear2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.000 Percent Six-Year 2022 Senior Notes",
        "label": "3.000 Percent Six-Year 2022 Senior Notes [Member]",
        "terseLabel": "3.000 percent six-year 2022 senior notes"
       }
      }
     },
     "localname": "A3000PercentSixYear2022SeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_A3125PercentNineYear2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125 Percent Nine-Year 2022 Senior Notes",
        "label": "3.125 Percent Nine-Year 2022 Senior Notes [Member]",
        "terseLabel": "3.125 percent nine-year 2022 senior notes"
       }
      }
     },
     "localname": "A3125PercentNineYear2022SeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_A3375PercentTwelveYear2022SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.375 Percent Twelve-Year 2022 Senior Notes",
        "label": "3.375 Percent Twelve-Year 2022 Senior Notes [Member]",
        "terseLabel": "3.375 percent twelve-year 2022 senior notes"
       }
      }
     },
     "localname": "A3375PercentTwelveYear2022SeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AfferaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affera Inc",
        "label": "Affera Inc [Member]",
        "terseLabel": "Affera Inc"
       }
      }
     },
     "localname": "AfferaIncMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AmendedandRestatedRevolvingCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and Restated Revolving Credit Agreement [Member]",
        "label": "Amended and Restated Revolving Credit Agreement [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "AmendedandRestatedRevolvingCreditAgreementMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_AssetImpairmentChargesAndInventoryWriteDown": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges And Inventory Write-Down",
        "label": "Asset Impairment Charges And Inventory Write-Down",
        "terseLabel": "MCS asset impairment and inventory write-down"
       }
      }
     },
     "localname": "AssetImpairmentChargesAndInventoryWriteDown",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_AssociatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Associated Costs [Member]",
        "label": "Associated Costs [Member]",
        "terseLabel": "Associated Costs"
       }
      }
     },
     "localname": "AssociatedCostsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_BusinessAcquisitionContingentConsiderationAtFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Business Acquisition, Contingent Consideration, at Fair Value [Roll Forward]",
        "terseLabel": "Reconciliation of Beginning and Ending Balances of Contingent Milestone Payments [Roll Forward]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationAtFairValueRollForward",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_BusinessAcquisitionContingentConsiderationMilestonePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent milestone payments in business acquisition transactions.",
        "label": "Business Acquisition, Contingent Consideration, Milestone Payment",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationMilestonePayment",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_BusinessAcquisitionPriceContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Price Contingent Consideration",
        "label": "Business Acquisition, Price Contingent Consideration",
        "terseLabel": "Purchase price contingent consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionPriceContingentConsideration",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_BusinessAcquisitionPurchasePriceContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contingent consideration arrangement resulting from business combinations.",
        "label": "Business Acquisition, Purchase Price Contingent Consideration",
        "terseLabel": "Purchase price allocation adjustments"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceContingentConsideration",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CardiacRhythmandHeartFailureDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiac Rhythm and Heart Failure Division [Member]",
        "label": "Cardiac Rhythm and Heart Failure Division [Member]",
        "terseLabel": "Cardiac Rhythm &amp; Heart Failure"
       }
      }
     },
     "localname": "CardiacRhythmandHeartFailureDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CardiovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiovascular",
        "label": "Cardiovascular [Member]",
        "terseLabel": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CentralizedDistributionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Centralized Distribution Costs",
        "label": "Centralized Distribution Costs",
        "negatedTerseLabel": "Centralized distribution costs"
       }
      }
     },
     "localname": "CentralizedDistributionCosts",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CommercialPaperMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper, Maximum Borrowing Capacity",
        "label": "Commercial Paper, Maximum Borrowing Capacity",
        "terseLabel": "Commercial paper, maximum borrowing amount"
       }
      }
     },
     "localname": "CommercialPaperMaximumBorrowingCapacity",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CoronaryAndPeripheralVascularDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aortic, Peripheral and Venous Division [Member]",
        "label": "Coronary and Peripheral Vascular Division [Member]",
        "terseLabel": "Coronary &amp; Peripheral Vascular"
       }
      }
     },
     "localname": "CoronaryAndPeripheralVascularDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_CorporateOverhead": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate overhead expenses",
        "label": "Corporate Overhead",
        "negatedTerseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateOverhead",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_CranialAndSpinalTechnologiesDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cranial And Spinal Technologies Division",
        "label": "Cranial And Spinal Technologies Division [Member]",
        "terseLabel": "Cranial &amp; Spinal Technologies"
       }
      }
     },
     "localname": "CranialAndSpinalTechnologiesDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_DerivativeAssetLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Asset (Liability) [Abstract]",
        "label": "Derivative Asset (Liability) [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityAbstract",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Asset (Liability), Fair Value, Gross Asset (Liability)",
        "label": "Derivative Asset (Liability), Fair Value, Gross Asset (Liability)",
        "totalLabel": "Gross Amount of Recognized Assets (Liabilities)"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityFairValueGrossAssetLiability",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash",
        "label": "Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash",
        "negatedTotalLabel": "Cash Collateral (Received) Posted"
       }
      }
     },
     "localname": "DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction",
        "label": "Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction",
        "negatedTotalLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeAssetsandLiabilitiesNetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_DiabetesGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes Group [Member]",
        "label": "Diabetes Group [Member]",
        "terseLabel": "Diabetes"
       }
      }
     },
     "localname": "DiabetesGroupMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EarningsPerShareReconciliationDenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Earnings Per Share Reconciliation, Denominator [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationDenominatorAbstract",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_EarningsPerShareReconciliationNumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Earnings Per Share Reconciliation, Numerator [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationNumeratorAbstract",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_EmployeesStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Employees Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeesStockPurchasePlanMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EnterpriseExcellenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enterprise Excellence [Member]",
        "label": "Enterprise Excellence [Member]",
        "terseLabel": "Enterprise Excellence"
       }
      }
     },
     "localname": "EnterpriseExcellenceMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EquityInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investments [Member]",
        "label": "Equity Investments [Member]",
        "terseLabel": "Equity and Other Investments",
        "verboseLabel": "Equity Securities and Other Investments"
       }
      }
     },
     "localname": "EquityInvestmentsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "label": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "totalLabel": "Total equity and other investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]",
        "label": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments [Table Text Block]",
        "terseLabel": "Summary of Equity and Other Investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestmentsTableTextBlock",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdt_GainonInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain on Investments",
        "label": "Gain on Investments",
        "terseLabel": "Gross gains"
       }
      }
     },
     "localname": "GainonInvestments",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_HeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held For Sale",
        "label": "Held For Sale [Member]",
        "terseLabel": "Held For Sale"
       }
      }
     },
     "localname": "HeldForSaleMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_HerniaMeshLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hernia Mesh Litigation",
        "label": "Hernia Mesh Litigation [Member]",
        "terseLabel": "Hernia Mesh Litigation"
       }
      }
     },
     "localname": "HerniaMeshLitigationMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_InProcessResearchDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-Process Research &amp; Development",
        "label": "In-Process Research &amp; Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchDevelopmentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_IncomeTaxesandInterestPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes and Interest Paid [Abstract]",
        "label": "Income Taxes and Interest Paid [Abstract]",
        "terseLabel": "Cash paid for:"
       }
      }
     },
     "localname": "IncomeTaxesandInterestPaidAbstract",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_IntersectENTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intersect ENT",
        "label": "Intersect ENT [Member]",
        "terseLabel": "Intersect ENT"
       }
      }
     },
     "localname": "IntersectENTMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]",
        "label": "Japan, Australia, New Zealand, Korea, Canada, and Western Europe [Member]",
        "terseLabel": "Non-U.S. Developed Markets"
       }
      }
     },
     "localname": "JapanAustraliaNewZealandKoreaCanadaandWesternEuropeMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers (in manufacturers)"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_LossContingencyNumberofSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Subsidiaries",
        "label": "Loss Contingency, Number of Subsidiaries",
        "terseLabel": "Number of subsidiaries (in subsidiaries)"
       }
      }
     },
     "localname": "LossContingencyNumberofSubsidiaries",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_LossonInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss on Investments",
        "label": "Loss on Investments",
        "negatedTerseLabel": "Gross losses"
       }
      }
     },
     "localname": "LossonInvestments",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_MechanicalCirculatorySupportMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mechanical Circulatory Support",
        "label": "Mechanical Circulatory Support [Member]",
        "terseLabel": "Mechanical Circulatory Support"
       }
      }
     },
     "localname": "MechanicalCirculatorySupportMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MechanicalCirculatorySupportOperatingUnitMCSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mechanical Circulatory Support Operating Unit (MCS)",
        "label": "Mechanical Circulatory Support Operating Unit (MCS) [Member]",
        "terseLabel": "Mechanical Circulatory Support Operating Unit (MCS)"
       }
      }
     },
     "localname": "MechanicalCirculatorySupportOperatingUnitMCSMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedicalDeviceRegulations": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Device Regulations",
        "label": "Medical Device Regulations",
        "negatedTerseLabel": "Medical device regulations"
       }
      }
     },
     "localname": "MedicalDeviceRegulations",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_MedicalSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Surgical [Member]",
        "label": "Medical Surgical [Member]",
        "terseLabel": "Medical Surgical"
       }
      }
     },
     "localname": "MedicalSurgicalMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedtronicLuxcoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medtronic Luxco [Member]",
        "label": "Medtronic Luxco [Member]",
        "terseLabel": "Medtronic Luxco"
       }
      }
     },
     "localname": "MedtronicLuxcoMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MedtronicLuxcoSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medtronic Luxco Senior Notes",
        "label": "Medtronic Luxco Senior Notes [Member]",
        "terseLabel": "Medtronic Luxco senior notes"
       }
      }
     },
     "localname": "MedtronicLuxcoSeniorNotesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]",
        "label": "Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea [Member]",
        "terseLabel": "Emerging Markets"
       }
      }
     },
     "localname": "MiddleEastAfricaLatinAmericaEasternEuropeandAsiaExcludingJapanandKoreaMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_NeuromodulationDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neuromodulation Division",
        "label": "Neuromodulation Division [Member]",
        "terseLabel": "Neuromodulation"
       }
      }
     },
     "localname": "NeuromodulationDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_NeuroscienceGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neuroscience Group",
        "label": "Neuroscience Group [Member]",
        "terseLabel": "Neuroscience"
       }
      }
     },
     "localname": "NeuroscienceGroupMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_NonDerivativeInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Derivative Instruments",
        "label": "Non-Derivative Instruments [Member]",
        "terseLabel": "Non-derivative instruments"
       }
      }
     },
     "localname": "NonDerivativeInstrumentsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OffsettingAssetsandLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Offsetting Assets and Liabilities [Table]",
        "label": "Offsetting Assets and Liabilities [Line Items]",
        "terseLabel": "Offsetting Assets and Liabilities [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsandLiabilitiesLineItems",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_OffsettingAssetsandLiabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offsetting Assets and Liabilities [Table]",
        "label": "Offsetting Assets and Liabilities [Table]",
        "terseLabel": "Offsetting Assets and Liabilities [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsandLiabilitiesTable",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_OrringtonMaineChemicalManufacturingFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orrington, Maine Chemical Manufacturing Facility [Member]",
        "label": "Orrington, Maine Chemical Manufacturing Facility [Member]",
        "terseLabel": "Orrington, Maine chemical manufacturing facility"
       }
      }
     },
     "localname": "OrringtonMaineChemicalManufacturingFacilityMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OtherAccruedExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Expenses",
        "label": "Other Accrued Expenses [Member]",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedExpensesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OtherAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Acquisitions",
        "label": "Other Acquisitions [Member]",
        "terseLabel": "Other acquisitions"
       }
      }
     },
     "localname": "OtherAcquisitionsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTotalLabel": "(Gain)\u00a0Loss\u00a0Recognized in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge and Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTotalLabel": "(Gain) Loss Reclassified into Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) On Derivatives Arising During Period, Net Investment Hedge, Net Of Tax",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) On Derivatives Arising During Period, Net Investment Hedge, Net Of Tax",
        "terseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodNetInvestmentHedgeNetOfTax",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_OutsideOfTheUnitedStatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside Of The United States",
        "label": "Outside Of The United States [Member]",
        "terseLabel": "Foreign plan"
       }
      }
     },
     "localname": "OutsideOfTheUnitedStatesMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PelvicMeshLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pelvic Mesh Litigation [Member]",
        "label": "Pelvic Mesh Litigation [Member]",
        "terseLabel": "Pelvic mesh"
       }
      }
     },
     "localname": "PelvicMeshLitigationMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PreTaxExitandDisposalCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre Tax Exit and Disposal Costs [Member]",
        "label": "Pre Tax Exit and Disposal Costs [Member]",
        "terseLabel": "Pre-tax exit and disposal costs and other"
       }
      }
     },
     "localname": "PreTaxExitandDisposalCostsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_ProductDevelopmentMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A milestone in achieving certain product development target.",
        "label": "Product Development Milestone [Member]",
        "terseLabel": "Product development and other milestone-based payments"
       }
      }
     },
     "localname": "ProductDevelopmentMilestoneMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_PurchasedTechnologyAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased technology and patents.",
        "label": "Purchased Technology and Patents [Member]",
        "terseLabel": "Purchased technology and patents"
       }
      }
     },
     "localname": "PurchasedTechnologyAndPatentsMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RenalCareBusinessRCSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renal Care Business (RCS)",
        "label": "Renal Care Business (RCS) [Member]",
        "terseLabel": "Renal Care Business (RCS)"
       }
      }
     },
     "localname": "RenalCareBusinessRCSMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RespiratoryGastrointestinalandRenalDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Respiratory, Gastrointestinal, and Renal Division [Member]",
        "label": "Respiratory, Gastrointestinal, and Renal Division [Member]",
        "terseLabel": "Respiratory, Gastrointestinal, &amp; Renal"
       }
      }
     },
     "localname": "RespiratoryGastrointestinalandRenalDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses, net of reversals, associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges, Net of Restructuring Reversals Including Cost of Product Sold Impact",
        "terseLabel": "Restructuring charges, net"
       }
      }
     },
     "localname": "RestructuringChargesNetOfRestructuringReversalsIncludingCostOfProductSoldImpact",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_RestructuringWriteDownAndImpairmentProvisions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Write Down And Impairment Provisions",
        "label": "Restructuring, Write Down And Impairment Provisions",
        "terseLabel": "Restructuring write down and impairment provisions"
       }
      }
     },
     "localname": "RestructuringWriteDownAndImpairmentProvisions",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_RestructuringsExcludingRCSAndMCSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructurings Excluding RCS and MCS",
        "label": "Restructurings Excluding RCS and MCS [Member]",
        "terseLabel": "Restructurings Excluding RCS and MCS"
       }
      }
     },
     "localname": "RestructuringsExcludingRCSAndMCSMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_RevenueMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A milestone in achieving certain revenue target.",
        "label": "Revenue Milestone [Member]",
        "terseLabel": "Revenue and other performance-based payments"
       }
      }
     },
     "localname": "RevenueMilestoneMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_ScheduleOfDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table]",
        "terseLabel": "Schedule of Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfDebtTable",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdt_ScheduleofInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Investments [Table Text Block]",
        "label": "Schedule of Investments [Table Text Block]",
        "terseLabel": "Activity Related to the Company's Equity and Other Investments Portfolio"
       }
      }
     },
     "localname": "ScheduleofInvestmentsTableTextBlock",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdt_SeniorNotes2009Due20396500PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2009 Due 2039, 6.500 Percent",
        "label": "Senior Notes 2009 Due 2039, 6.500 Percent [Member]",
        "terseLabel": "6.500 percent thirty-year 2009 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2009Due20396500PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2010Due20405550PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2010 Due 2040, 5.550 Percent",
        "label": "Senior Notes 2010 Due 2040, 5.550 Percent [Member]",
        "terseLabel": "5.550 percent thirty-year 2010 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2010Due20405550PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2012Due20424500PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2012 Due 2042, 4.500 Percent",
        "label": "Senior Notes 2012 Due 2042, 4.500 Percent [Member]",
        "terseLabel": "4.500 percent thirty-year 2012 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2012Due20424500PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2013Due20434000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2013 Due 2043, 4.000 Percent",
        "label": "Senior Notes 2013 Due 2043, 4.000 Percent [Member]",
        "terseLabel": "4.000 percent thirty-year 2013 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2013Due20434000PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2014Due20444625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2014 Due 2044, 4.625 Percent",
        "label": "Senior Notes 2014 Due 2044, 4.625 Percent [Member]",
        "terseLabel": "4.625 percent thirty-year 2014 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2014Due20444625PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due20253500PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2025, 3.500 percent",
        "label": "Senior Notes 2015 Due 2025, 3.500 percent [Member]",
        "terseLabel": "3.500 percent ten-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due20253500PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2015Due20454625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2045, 4.625 Percent",
        "label": "Senior Notes 2015 Due 2045, 4.625 Percent [Member]",
        "terseLabel": "4.625 percent thirty-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2015Due20454625PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2017Due20273350PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2017 Due 2027, 3.350 Percent",
        "label": "Senior Notes 2017 Due 2027, 3.350 Percent [Member]",
        "terseLabel": "3.350 percent ten-year 2017 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2017Due20273350PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2022 [Member]",
        "label": "Senior Notes 2019 Due 2022 [Member]",
        "terseLabel": "0.00% Senior Notes due 2022"
       }
      }
     },
     "localname": "SeniorNotes2019Due2022Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20230375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2023, 0.375 Percent",
        "label": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]",
        "verboseLabel": "0.375% Senior Notes due 2023"
       }
      }
     },
     "localname": "SeniorNotes2019Due20230375PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2025 [Member]",
        "label": "Senior Notes 2019 Due 2025 [Member]",
        "terseLabel": "0.25% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2019Due2025Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20260250PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2026, 0.250 Percent",
        "label": "Senior Notes 2019 Due 2026, 0.250 Percent [Member]",
        "terseLabel": "0.250 percent six-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20260250PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20271125PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2027, 1.125 Percent",
        "label": "Senior Notes 2019 Due 2027, 1.125 Percent [Member]",
        "terseLabel": "1.125 percent eight-year 2019 senior notes",
        "verboseLabel": "1.125% Senior Notes due 2027"
       }
      }
     },
     "localname": "SeniorNotes2019Due20271125PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311.00PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "label": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]",
        "terseLabel": "1.00% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311.00PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20311625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent",
        "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "terseLabel": "1.625 percent twelve-year 2019 senior notes",
        "verboseLabel": "1.625% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2019Due20311625PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20321000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2032, 1.000 Percent",
        "label": "Senior Notes 2019 Due 2032, 1.000 Percent [Member]",
        "terseLabel": "1.000 percent twelve-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20321000PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20391.50PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]",
        "verboseLabel": "1.50% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20391.50PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20392250PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "verboseLabel": "2.250 percent twenty-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20392250PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20394500PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]",
        "label": "Senior Notes 2019 Due 2039, 4.500 Percent [Member]",
        "verboseLabel": "2.250% Senior Notes due 2039"
       }
      }
     },
     "localname": "SeniorNotes2019Due20394500PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20401500PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2040, 1.500 Percent",
        "label": "Senior Notes 2019 Due 2040, 1.500 Percent [Member]",
        "terseLabel": "1.500 percent twenty-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20401500PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2049 [Member]",
        "label": "Senior Notes 2019 Due 2049 [Member]",
        "verboseLabel": "1.75% Senior Notes due 2049"
       }
      }
     },
     "localname": "SeniorNotes2019Due2049Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2019Due20501750PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019 Due 2050, 1.750 Percent",
        "label": "Senior Notes 2019 Due 2050, 1.750 Percent [Member]",
        "terseLabel": "1.750 percent thirty-year 2019 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2019Due20501750PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20230000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2023, 0.000 Percent",
        "label": "Senior Notes 2020 Due 2023, 0.000 Percent [Member]",
        "verboseLabel": "0.000% Senior Notes due 2023"
       }
      }
     },
     "localname": "SeniorNotes2020Due20230000PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2025",
        "label": "Senior Notes 2020 Due 2025 [Member]",
        "terseLabel": "0.000% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2020Due2025Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20260000PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2026, 0.000 Percent",
        "label": "Senior Notes 2020 Due 2026, 0.000 Percent [Member]",
        "terseLabel": "0.000 percent five-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20260000PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2028",
        "label": "Senior Notes 2020 Due 2028 [Member]",
        "terseLabel": "0.375% Senior Notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes2020Due2028Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20290375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2029, 0.375 Percent",
        "label": "Senior Notes 2020 Due 2029, 0.375 Percent [Member]",
        "terseLabel": "0.375 percent eight-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20290375PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2032",
        "label": "Senior Notes 2020 Due 2032 [Member]",
        "terseLabel": "0.750% Senior Notes due 2032"
       }
      }
     },
     "localname": "SeniorNotes2020Due2032Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20330750PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2033, 0.750 Percent",
        "label": "Senior Notes 2020 Due 2033, 0.750 Percent [Member]",
        "terseLabel": "0.750 percent twelve-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20330750PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20354375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2015 Due 2035, 4.375 Percent",
        "label": "Senior Notes 2020 Due 2035, 4.375 Percent [Member]",
        "terseLabel": "4.375 percent twenty-year 2015 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20354375PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2040",
        "label": "Senior Notes 2020 Due 2040 [Member]",
        "terseLabel": "1.375% Senior Notes due 2040"
       }
      }
     },
     "localname": "SeniorNotes2020Due2040Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20411375PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2041, 1.375 Percent",
        "label": "Senior Notes 2020 Due 2041, 1.375 Percent [Member]",
        "terseLabel": "1.375 percent twenty-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20411375PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2050",
        "label": "Senior Notes 2020 Due 2050 [Member]",
        "terseLabel": "1.625% Senior Notes due 2050"
       }
      }
     },
     "localname": "SeniorNotes2020Due2050Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2020Due20511625PercentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2020 Due 2051, 1.625 Percent",
        "label": "Senior Notes 2020 Due 2051, 1.625 Percent [Member]",
        "terseLabel": "1.625 percent thirty-year 2020 senior notes"
       }
      }
     },
     "localname": "SeniorNotes2020Due20511625PercentMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2022Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022 Due 2025",
        "label": "Senior Notes 2022 Due 2025 [Member]",
        "terseLabel": "2.625% Senior Notes due 2025"
       }
      }
     },
     "localname": "SeniorNotes2022Due2025Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2022Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022 Due 2028",
        "label": "Senior Notes 2022 Due 2028 [Member]",
        "terseLabel": "3.000% Senior Notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes2022Due2028Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2022Due2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022 Due 2031",
        "label": "Senior Notes 2022 Due 2031 [Member]",
        "terseLabel": "3.125% Senior Notes due 2031"
       }
      }
     },
     "localname": "SeniorNotes2022Due2031Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SeniorNotes2022Due2034Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2022 Due 2034",
        "label": "Senior Notes 2022 Due 2034 [Member]",
        "terseLabel": "3.375% Senior Notes due 2034"
       }
      }
     },
     "localname": "SeniorNotes2022Due2034Member",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SimplificationRestructuringProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simplification Restructuring Program",
        "label": "Simplification Restructuring Program [Member]",
        "terseLabel": "Simplification"
       }
      }
     },
     "localname": "SimplificationRestructuringProgramMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SiteContingencyNumberOfLandfillsRequiringCapping": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site Contingency, Number of Landfills Requiring Capping",
        "label": "Site Contingency, Number of Landfills Requiring Capping",
        "terseLabel": "Number of landfills requiring capping (in landfills)"
       }
      }
     },
     "localname": "SiteContingencyNumberOfLandfillsRequiringCapping",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_SiteContingencyNumberofLandfillsRequiringRemoval": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site Contingency, Number of Landfills Requiring Removal",
        "label": "Site Contingency, Number of Landfills Requiring Removal",
        "terseLabel": "Number of landfills requiring removal (in landfills)"
       }
      }
     },
     "localname": "SiteContingencyNumberofLandfillsRequiringRemoval",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdt_SpecialtyTherapiesDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Therapies Division [Member]",
        "label": "Specialty Therapies Division [Member]",
        "terseLabel": "Specialty Therapies"
       }
      }
     },
     "localname": "SpecialtyTherapiesDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_StructuralHeartAndAorticDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronary and Structural Heart Division [Member]",
        "label": "Structural Heart and Aortic Division [Member]",
        "terseLabel": "Structural Heart &amp; Aortic"
       }
      }
     },
     "localname": "StructuralHeartAndAorticDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_SurgicalInnovationsDivisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Innovations Division [Member]",
        "label": "Surgical Innovations Division [Member]",
        "terseLabel": "Surgical Innovations"
       }
      }
     },
     "localname": "SurgicalInnovationsDivisionMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TechnologyBasedIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-Based Intangible Assets",
        "label": "Technology-Based Intangible Assets",
        "terseLabel": "Technology-based intangible assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssets",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdt_TokyoInterBankOfferedRateTIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tokyo Inter-bank Offered Rate (TIBOR)",
        "label": "Tokyo Inter-bank Offered Rate (TIBOR) [Member]",
        "terseLabel": "TIBOR Rate"
       }
      }
     },
     "localname": "TokyoInterBankOfferedRateTIBORMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TotalOtherCountriesExcludingIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Other Countries, Excluding Ireland [Member]",
        "label": "Total Other Countries, Excluding Ireland [Member]",
        "terseLabel": "Total other countries, excluding Ireland"
       }
      }
     },
     "localname": "TotalOtherCountriesExcludingIrelandMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_TotalOtherCountriesExcludingUnitedStatesandIrelandMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Other Countries, Excluding United States and Ireland [Member]",
        "label": "Total Other Countries, Excluding United States and Ireland [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "TotalOtherCountriesExcludingUnitedStatesandIrelandMember",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdt_UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss), net of tax as of the balance sheet date, related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.",
        "label": "Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesAccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://www.medtronic.com/20221028",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r155",
      "r205",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r225",
      "r229",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r371",
      "r373",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r155",
      "r205",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r225",
      "r229",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r371",
      "r373",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r381",
      "r415",
      "r547",
      "r552",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r781",
      "r835",
      "r837",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r381",
      "r415",
      "r547",
      "r552",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r781",
      "r835",
      "r837",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r325",
      "r351",
      "r353",
      "r354",
      "r355",
      "r381",
      "r415",
      "r488",
      "r547",
      "r552",
      "r581",
      "r582",
      "r583",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r781",
      "r835",
      "r837",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r325",
      "r351",
      "r353",
      "r354",
      "r355",
      "r381",
      "r415",
      "r488",
      "r547",
      "r552",
      "r581",
      "r582",
      "r583",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r781",
      "r835",
      "r837",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r232",
      "r233",
      "r447",
      "r453",
      "r836",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r232",
      "r233",
      "r447",
      "r453",
      "r836",
      "r848",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r756",
      "r758",
      "r761",
      "r859",
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Massachusetts"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINNESOTA",
        "terseLabel": "Minnesota"
       }
      }
     },
     "localname": "MN",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r57",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Reduction of accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowances and credit losses of $203 and $230, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r34",
      "r792",
      "r819"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r37",
      "r792",
      "r819"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r88",
      "r94",
      "r103",
      "r104",
      "r105",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Net Change in Retirement Obligations"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r27",
      "r318"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r94",
      "r103",
      "r104",
      "r105",
      "r106",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r94",
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Investment Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r91",
      "r93",
      "r94",
      "r820",
      "r842",
      "r845"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r90",
      "r94",
      "r103",
      "r104",
      "r105",
      "r157",
      "r158",
      "r159",
      "r659",
      "r744",
      "r838",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive (Loss) Income",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r82",
      "r94",
      "r103",
      "r104",
      "r105",
      "r659",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r41",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r590",
      "r591",
      "r592",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r555",
      "r593",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Total stock-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r47",
      "r239",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowances for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r140",
      "r299",
      "r307"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": {
     "auth_ref": [
      "r94",
      "r103",
      "r104",
      "r105",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent.",
        "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]",
        "terseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiability": {
     "auth_ref": [
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition.",
        "label": "Asset Acquisition, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration liabilities"
       }
      }
     },
     "localname": "AssetAcquisitionContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r253",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r31",
      "r151",
      "r213",
      "r220",
      "r227",
      "r264",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r652",
      "r660",
      "r717",
      "r746",
      "r748",
      "r790",
      "r818"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r56",
      "r151",
      "r264",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r652",
      "r660",
      "r717",
      "r746",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r14",
      "r17",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AuctionRateSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument securities (for example, but not limited to, corporate or municipal bonds) that typically have long-term nominal maturities for which the interest rate is reset through an auction process.",
        "label": "Auction Rate Securities [Member]",
        "terseLabel": "Auction rate securities"
       }
      }
     },
     "localname": "AuctionRateSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r248",
      "r251",
      "r811"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r248",
      "r250",
      "r810"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r248",
      "r252",
      "r812"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r248",
      "r249",
      "r809"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss) [Abstract]",
        "terseLabel": "Activities Related to Debt Securities Portfolio"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r671",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r543",
      "r548",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r543",
      "r548",
      "r622",
      "r623",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]",
        "verboseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Shares price (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedTerseLabel": "Acquisition-related items"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]",
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r626"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net",
        "terseLabel": "Business combination, fair value of net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r633",
      "r634",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration for the transaction, net of cash acquired"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r633",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Previously held investments in Intersect ENT"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r139",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r632",
      "r635",
      "r638"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleReconciliationofBeginningandEndingBalancesofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration, significant unobservable inputs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r629",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Business combination, assets acquired",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r625"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r624",
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Liabilities assumed",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSegmentAllocationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Combination Segment Allocation [Line Items]",
        "terseLabel": "Business Combination Segment Allocation [Line Items]"
       }
      }
     },
     "localname": "BusinessCombinationSegmentAllocationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "negatedTerseLabel": "Exit of business"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r18",
      "r24",
      "r142"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r136",
      "r142",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r136",
      "r723"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Cash flow hedge unrealized gains to be reclassified over the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash flow hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r148",
      "r151",
      "r179",
      "r183",
      "r184",
      "r186",
      "r189",
      "r197",
      "r198",
      "r199",
      "r264",
      "r363",
      "r368",
      "r369",
      "r370",
      "r376",
      "r377",
      "r413",
      "r414",
      "r417",
      "r421",
      "r428",
      "r717",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r66",
      "r798",
      "r825"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends to shareholders (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r40",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Ordinary shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r40",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares\u2014 par value $0.0001, 2.6 billion shares authorized, 1,330,148,578 and 1,330,743,395 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r99",
      "r101",
      "r102",
      "r114",
      "r804",
      "r830"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Medtronic"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r99",
      "r101",
      "r113",
      "r650",
      "r651",
      "r664",
      "r803",
      "r829"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r99",
      "r101",
      "r112",
      "r649",
      "r664",
      "r802",
      "r828"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income including noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r146",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r435",
      "r436",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously included in deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
        "label": "Contract with Customer, Refund Liability, Current",
        "terseLabel": "Rebate obligations"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r489",
      "r537",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r118",
      "r782"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold, excluding amortization of intangible assets"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-related"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DamagesFromProductDefectsMember": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk of loss arises with respect to product defects and recalls, or improperly performed services which actually or allegedly resulted in damages suffered by the injured party, excluding major product liability matters.",
        "label": "Damages from Product Defects [Member]",
        "terseLabel": "Product liability litigation"
       }
      }
     },
     "localname": "DamagesFromProductDefectsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "netLabel": "Amount of current debt obligations outstanding",
        "terseLabel": "Current debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r147",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r395",
      "r402",
      "r403",
      "r405",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Financing Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r32",
      "r34",
      "r36",
      "r150",
      "r155",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r406",
      "r407",
      "r408",
      "r409",
      "r738",
      "r791",
      "r793",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin added to variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r378",
      "r406",
      "r407",
      "r735",
      "r738",
      "r739"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r63",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r64",
      "r150",
      "r155",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r406",
      "r407",
      "r408",
      "r409",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r64",
      "r150",
      "r155",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r429",
      "r430",
      "r431",
      "r432",
      "r734",
      "r735",
      "r738",
      "r739",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r391",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Debt discount, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r256",
      "r277",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "More than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r256",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "More than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r256",
      "r277",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r256",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r275"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Gross realized gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "negatedLabel": "Gross realized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Investments by Category and Related Balance Sheet Presentation"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r255",
      "r276",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Gross Unrealized Losses and Fair Values of Available-for-sale Securities that Have Been in a Continuous Unrealized Loss Position Deemed to be Temporary, Aggregated by Investment Category"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r391",
      "r736"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r466",
      "r504",
      "r531",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r466",
      "r503",
      "r530",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r466",
      "r470",
      "r502",
      "r529",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r500",
      "r527",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r468",
      "r501",
      "r528",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r140",
      "r208"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r72",
      "r73",
      "r78"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "negatedTerseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r71",
      "r77",
      "r80",
      "r716"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Derivative assets:"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeCollateralObligationToReturnCash": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r690"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset",
        "negatedTerseLabel": "Cash Collateral (Received) Posted"
       }
      }
     },
     "localname": "DerivativeCollateralObligationToReturnCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCollateralRightToReclaimCash": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r690"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset",
        "terseLabel": "Cash Collateral (Received) Posted"
       }
      }
     },
     "localname": "DerivativeCollateralRightToReclaimCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r680",
      "r692"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Derivative, excluded component, gain (loss), recognized in earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet": {
     "auth_ref": [
      "r689"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount as of the balance sheet date of the fair value of derivative assets and derivative liabilities that in accordance with the entity's accounting policy were offset against collateral under a master netting arrangement.",
        "label": "Derivative, Fair Value, Amount Offset Against Collateral, Net",
        "totalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueAmountOffsetAgainstCollateralNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r70",
      "r80",
      "r81",
      "r674",
      "r763"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative assets, fair value",
        "verboseLabel": "Gross Amount of Recognized Assets (Liabilities)"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": {
     "auth_ref": [
      "r78",
      "r689"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.",
        "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "totalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r70",
      "r80",
      "r81",
      "r674",
      "r763"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mdt_DerivativeAssetLiabilityFairValueGrossAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "negatedTerseLabel": "Gross Amount of Recognized Assets (Liabilities)",
        "terseLabel": "Derivative liabilities, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": {
     "auth_ref": [
      "r78",
      "r689"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueAmountOffsetAgainstCollateralNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.",
        "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction",
        "negatedTotalLabel": "Net Amount"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r80",
      "r672",
      "r675",
      "r682",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r697",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Currency Exchange Risk Management"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r670",
      "r672",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r670",
      "r672",
      "r682",
      "r687",
      "r688",
      "r691",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "verboseLabel": "Derivative Instruments, (Gain) Loss [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r681",
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "negatedLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r71",
      "r77",
      "r80",
      "r716"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Derivative liabilities:"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": {
     "auth_ref": [
      "r72",
      "r73",
      "r78"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Gross notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r558",
      "r559",
      "r587",
      "r588",
      "r589",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r14",
      "r315",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal group, held-for-sale, not discontinued operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r321"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r543",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r542",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r115",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r177",
      "r179",
      "r186",
      "r188",
      "r189",
      "r193",
      "r194",
      "r701",
      "r702",
      "r805",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per share (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r115",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r179",
      "r186",
      "r188",
      "r189",
      "r193",
      "r194",
      "r701",
      "r702",
      "r805",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted earnings per share (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r723"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.medtronic.com/role/StockBasedCompensationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "negatedLabel": "Income tax benefits"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination Benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteAxis": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Axis]",
        "terseLabel": "Environmental Remediation Site [Axis]"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteDomain": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Domain]",
        "terseLabel": "Environmental Remediation Site [Domain]"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r103",
      "r104",
      "r105",
      "r157",
      "r158",
      "r159",
      "r163",
      "r171",
      "r173",
      "r196",
      "r265",
      "r428",
      "r433",
      "r590",
      "r591",
      "r592",
      "r608",
      "r609",
      "r700",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731",
      "r744",
      "r838",
      "r839",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r25",
      "r214",
      "r262"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r20",
      "r33",
      "r715"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investments with readily determinable fair value (marketable equity securities)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r259"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "mdt_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueandEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Investments without readily determinable fair values"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r707",
      "r708",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Inputs, Liabilities, Quantitative Information [Line Items] (Deprecated 2018-01-31)"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r393",
      "r406",
      "r407",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r537",
      "r708",
      "r753",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r707",
      "r708",
      "r710",
      "r711",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r393",
      "r489",
      "r491",
      "r496",
      "r537",
      "r708",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r393",
      "r406",
      "r407",
      "r489",
      "r491",
      "r496",
      "r537",
      "r708",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r393",
      "r406",
      "r407",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r537",
      "r708",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsQuantitativeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]",
        "terseLabel": "Fair Value Inputs"
       }
      }
     },
     "localname": "FairValueInputsQuantitativeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r393",
      "r406",
      "r407",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r537",
      "r753",
      "r754",
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r712",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r671",
      "r677",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r742"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r259",
      "r260",
      "r261",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r278",
      "r279",
      "r280",
      "r404",
      "r426",
      "r697",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r29",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remaining 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsEstimatedFutureAggregateAmortizationExpenseofAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r300",
      "r303",
      "r306",
      "r310",
      "r783",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r306",
      "r787"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r300",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r80",
      "r489",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Currency exchange rate contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r489",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Non-U.S. government and agency securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r542",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Activity Related to the Company's Available-for-Sale Securities Portfolio"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r140",
      "r410",
      "r411"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r28",
      "r284",
      "r286",
      "r293",
      "r297",
      "r748",
      "r789"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedAfferaAcquisitionDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails",
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r287",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill as a result of acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r140",
      "r285",
      "r290",
      "r296",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r292",
      "r620"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "negatedTerseLabel": "Transfer to held for sale"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r670",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentChargeOnReclassifiedAssets": {
     "auth_ref": [
      "r314",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the asset that is reclassified back to held and used from held-for-sale, the amount of impairment charge that is recognized on the reclassification date.",
        "label": "Impairment Charge on Reclassified Assets",
        "terseLabel": "Non-cash pre-tax charges"
       }
      }
     },
     "localname": "ImpairmentChargeOnReclassifiedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r140",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Definite-lived intangible asset charges"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r140",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "terseLabel": "Impairment of indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "negatedTerseLabel": "Impairment losses recognized"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "IPR&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r109",
      "r213",
      "r219",
      "r223",
      "r226",
      "r229",
      "r788",
      "r799",
      "r807",
      "r832"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r543",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r320",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r152",
      "r602",
      "r606",
      "r607",
      "r613",
      "r615",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.",
        "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority",
        "terseLabel": "Income tax adjustments"
       }
      }
     },
     "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r153",
      "r172",
      "r173",
      "r211",
      "r600",
      "r614",
      "r616",
      "r833"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.",
        "label": "Increase (Decrease) in Accounts and Notes Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r187",
      "r189"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares included in diluted EPS for potentially dilutive effect of nonvested equity-based payment award containing forfeitable rights to dividends or dividend equivalents, whether paid or unpaid.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends",
        "terseLabel": "Employee restricted stock units (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r189",
      "r557"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Share based payments"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r301",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount, Indefinite-lived"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r301",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r298",
      "r304"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r107",
      "r207",
      "r733",
      "r736",
      "r806"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r133",
      "r137",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r48",
      "r282"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r19",
      "r54",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r50",
      "r282"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r49",
      "r282"
     ],
     "calculation": {
      "http://www.medtronic.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Available-For-Sale Debt Securities, Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r60",
      "r151",
      "r221",
      "r264",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r653",
      "r660",
      "r661",
      "r717",
      "r746",
      "r747"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r151",
      "r264",
      "r717",
      "r748",
      "r795",
      "r823"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r62",
      "r151",
      "r264",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r653",
      "r660",
      "r661",
      "r717",
      "r746",
      "r747",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r3",
      "r4",
      "r12",
      "r14",
      "r17",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Gross unrecognized tax benefits, net of cash advance, recorded as noncurrent liability"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r36",
      "r793",
      "r816"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Line of credit, amount outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit, maximum capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount of settlement received"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term loan agreement"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Total debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Excluding Current Maturities [Abstract]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r64",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrued litigation charges"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r348"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "negatedTerseLabel": "Certain litigation charges, net",
        "terseLabel": "Certain litigation charges, net"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Number of claims settled (in claims)"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs (in plaintiffs)"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claimants (in claimants)"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum remaining maturity of foreign currency derivatives"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleFairValueMeasurementContingentConsiderationSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r68",
      "r151",
      "r264",
      "r363",
      "r368",
      "r369",
      "r370",
      "r376",
      "r377",
      "r717",
      "r794",
      "r822"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Changes to noncontrolling ownership interests"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r245",
      "r489",
      "r491",
      "r537",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by mortgage loans.",
        "label": "Collateralized Mortgage-Backed Securities [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r136",
      "r138",
      "r141"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r17",
      "r97",
      "r100",
      "r105",
      "r110",
      "r141",
      "r151",
      "r162",
      "r166",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r185",
      "r213",
      "r219",
      "r223",
      "r226",
      "r229",
      "r264",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r702",
      "r717",
      "r800",
      "r826"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Medtronic",
        "verboseLabel": "Net income attributable to ordinary shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r97",
      "r100",
      "r105",
      "r172",
      "r173",
      "r656",
      "r663"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net investment hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r160",
      "r161",
      "r164",
      "r165",
      "r174",
      "r175",
      "r176",
      "r241",
      "r242",
      "r266",
      "r267",
      "r610",
      "r611",
      "r612",
      "r699",
      "r703",
      "r704",
      "r705",
      "r718",
      "r719",
      "r720",
      "r740",
      "r741",
      "r743",
      "r745",
      "r784",
      "r785",
      "r786",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r433",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "verboseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments (in segments)"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments (in segments)"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsTableTextBlock": {
     "auth_ref": [
      "r75",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.",
        "label": "Offsetting Assets [Table Text Block]",
        "terseLabel": "Offsetting Assets"
       }
      }
     },
     "localname": "OffsettingAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OffsettingLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r75",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.",
        "label": "Offsetting Liabilities [Table Text Block]",
        "terseLabel": "Offsetting Liabilities"
       }
      }
     },
     "localname": "OffsettingLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r213",
      "r219",
      "r223",
      "r226",
      "r229"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment operating profit",
        "totalLabel": "Operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r55",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r671",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "verboseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r83",
      "r91",
      "r721",
      "r722",
      "r724"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r94",
      "r103",
      "r104",
      "r106",
      "r725",
      "r727",
      "r731"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r92",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications, tax expense (benefit)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r84",
      "r91"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gain on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r84",
      "r91",
      "r673",
      "r678",
      "r693"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Recognized in AOCI, Cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r91",
      "r95",
      "r679"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Recognized in income, cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Recognized in AOCI, net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "mdt_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Reclassified into Income, net investment hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r98",
      "r101",
      "r103",
      "r104",
      "r106",
      "r111",
      "r428",
      "r725",
      "r730",
      "r731",
      "r801",
      "r827"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r89",
      "r91"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Net change in retirement obligations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r85",
      "r91"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized loss on investment securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r61",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r671",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other non-operating income, net",
        "terseLabel": "Other non-operating income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other operating (income) expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementDerivativeGainsLossesDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating (income) expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other restructuring costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [
      "r333",
      "r334",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "verboseLabel": "Other Costs"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r123",
      "r126"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r134",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r124",
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r488",
      "r490",
      "r496",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r537",
      "r539",
      "r540",
      "r541",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r37",
      "r464",
      "r465",
      "r487",
      "r537"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Accrued compensation and retirement benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r462",
      "r464",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r515",
      "r518",
      "r522",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r541",
      "r542",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance share units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r129",
      "r132"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.",
        "label": "Proceeds from (Repayments of) Debt",
        "terseLabel": "Proceeds from (repayments of) debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r128",
      "r131",
      "r143"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less",
        "terseLabel": "Change in current debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Proceeds from sales",
        "verboseLabel": "Sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r121",
      "r122",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioandDebtSecuritiesContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "terseLabel": "Proceeds from (repayments of) short-term borrowings (maturities greater than 90 days)",
        "verboseLabel": "Proceeds from short-term debt"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r17",
      "r97",
      "r100",
      "r105",
      "r135",
      "r151",
      "r162",
      "r172",
      "r173",
      "r213",
      "r219",
      "r223",
      "r226",
      "r229",
      "r264",
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r372",
      "r374",
      "r376",
      "r377",
      "r649",
      "r655",
      "r657",
      "r663",
      "r664",
      "r702",
      "r717",
      "r807"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r26",
      "r317"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r319",
      "r748",
      "r813",
      "r824"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r116",
      "r270"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r94",
      "r103",
      "r104",
      "r106",
      "r725",
      "r729",
      "r731"
     ],
     "calculation": {
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Reclassifications"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r92",
      "r96",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassifications, tax expense (benefit)"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r219",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.",
        "label": "Research and Development Asset Acquired Other than Through Business Combination, Written-off",
        "negatedTerseLabel": "IPR&amp;D charges"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r332",
      "r334",
      "r337",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Other Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r333",
      "r336",
      "r343",
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Cost incurred to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r333",
      "r336",
      "r343",
      "r345"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r140",
      "r331",
      "r340",
      "r343"
     ],
     "calculation": {
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedLabel": "Restructuring and associated costs and RCS/MCS impairment / costs",
        "terseLabel": "Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r333",
      "r334",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r334",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r334",
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Accrual adjustments"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r34",
      "r334",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring reserve, current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r69",
      "r334",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring reserve, noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r433",
      "r748",
      "r821",
      "r841",
      "r845"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r157",
      "r158",
      "r159",
      "r163",
      "r171",
      "r173",
      "r265",
      "r590",
      "r591",
      "r592",
      "r608",
      "r609",
      "r700",
      "r838",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r518",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r542",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r518",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r542",
      "r546",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r515",
      "r518",
      "r522",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r515",
      "r518",
      "r522",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r204",
      "r205",
      "r218",
      "r224",
      "r225",
      "r231",
      "r232",
      "r235",
      "r446",
      "r447",
      "r782"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r444",
      "r445",
      "r450",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Period over which remaining performance obligations are expected to be recognized as revenue"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Estimated revenue expected to be recognized in future periods related to unsatisfied performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r94",
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (AOCI) by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Balances of Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r622",
      "r623",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleAssetsAndLiabilitiesClassifiedAsHeldForSaleDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleScheduleofFairValueoftheAssetsAcquiredandLiabilitiesAssumedIntersectENTAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Components and Classification of Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r521",
      "r522",
      "r525",
      "r526",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r672",
      "r682",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Gains and Losses on Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Classification and Fair Value Amounts of Derivative Instruments in Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r13",
      "r15",
      "r16",
      "r17",
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Classified as Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r179",
      "r183",
      "r186",
      "r189",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r17",
      "r151",
      "r263",
      "r264",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsSummaryofEquityandOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r707",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r300",
      "r305",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r300",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain (Loss) on Securities [Line Items]",
        "terseLabel": "Gain (Loss) on Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsIncludingMarketableSecuritiesAndInvestmentsHeldAtCostIncomeStatementReportedAmountsSummaryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGainLossOnInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about realized and unrealized gain (loss) on investment in security.",
        "label": "Schedule of Gain (Loss) on Securities [Table]",
        "terseLabel": "Schedule of Gain (Loss) on Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfGainLossOnInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in the Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r309",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r309",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Gross Carrying Amount of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r23",
      "r51",
      "r52",
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Balances"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Investments [Line Items]",
        "terseLabel": "Schedule of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule of Investments [Table]",
        "terseLabel": "Schedule of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RetirementBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of the Assets Acquired and Liabilities Assumed (Intersect ENT)",
        "verboseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Affera)"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r338",
      "r339",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r117",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Net Sales to External Customers by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r108",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationScheduleofNetSalestoExternalCustomersandPropertyPlantandEquipmentNetbyGeographicRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r213",
      "r216",
      "r222",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r554",
      "r556",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r200",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r235",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r336",
      "r345",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r200",
      "r202",
      "r203",
      "r213",
      "r217",
      "r223",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r234",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general, and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsLongTermDebtDetails",
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails",
      "http://www.medtronic.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r55",
      "r796",
      "r797",
      "r817"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r200",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r235",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r322",
      "r336",
      "r345",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails",
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbyMarketGeographyforEachSegmentDetails",
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails",
      "http://www.medtronic.com/role/SegmentandGeographicInformationIncomeFromOperationsBeforeIncomeTaxesbyReportableSegmentandReconciliationtoConsolidatedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r148",
      "r151",
      "r179",
      "r183",
      "r184",
      "r186",
      "r189",
      "r197",
      "r198",
      "r199",
      "r264",
      "r363",
      "r368",
      "r369",
      "r370",
      "r376",
      "r377",
      "r413",
      "r414",
      "r417",
      "r421",
      "r428",
      "r717",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r67",
      "r103",
      "r104",
      "r105",
      "r157",
      "r158",
      "r159",
      "r163",
      "r171",
      "r173",
      "r196",
      "r265",
      "r428",
      "r433",
      "r590",
      "r591",
      "r592",
      "r608",
      "r609",
      "r700",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r731",
      "r744",
      "r838",
      "r839",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r196",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r39",
      "r40",
      "r428",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of shares under stock purchase and award plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r39",
      "r40",
      "r433",
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of shares under stock purchase and award plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r39",
      "r40",
      "r428",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase of ordinary shares (shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r39",
      "r40",
      "r428",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of ordinary shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r40",
      "r44",
      "r45",
      "r151",
      "r240",
      "r264",
      "r717",
      "r748"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r104",
      "r151",
      "r157",
      "r158",
      "r159",
      "r163",
      "r171",
      "r264",
      "r265",
      "r433",
      "r590",
      "r591",
      "r592",
      "r608",
      "r609",
      "r647",
      "r648",
      "r662",
      "r700",
      "r717",
      "r725",
      "r726",
      "r731",
      "r744",
      "r839",
      "r840"
     ],
     "calculation": {
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLossChangesinAOCIDetails",
      "http://www.medtronic.com/role/ConsolidatedBalanceSheetsUnaudited",
      "http://www.medtronic.com/role/ConsolidatedStatementsofEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r149",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r433",
      "r434",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RevenueDisaggregationofNetSalesbySegmentandDivisionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r732",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r732",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r732",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails",
      "http://www.medtronic.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TotalReturnSwapMember": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts in which one party makes payments at a fixed or variable rate while the counterparty makes payments based on an asset, including the income and capital gains derived therefrom.",
        "label": "Total Return Swap [Member]",
        "verboseLabel": "Total return swaps"
       }
      }
     },
     "localname": "TotalReturnSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementClassificationandFairValueAmountsofDerivativeInstrumentsinBalanceSheetsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementGainsandLossesonDerivativesNotDesignatedasHedgingInstrumentsDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementNarrativeDetails",
      "http://www.medtronic.com/role/DerivativesandCurrencyExchangeRiskManagementOffsettingAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/AcquisitionsandAssetsandLiabilitiesHeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and tradenames"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/GoodwillandOtherIntangibleAssetsCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r259",
      "r260",
      "r261",
      "r404",
      "r426",
      "r697",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsActivityRelatedtotheCompanysInvestmentPortfolioEquityandOtherInvestmentsDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r333",
      "r334",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/RestructuringandOtherCostsActivityRelatedtoRestructuringProgramsDetails",
      "http://www.medtronic.com/role/RestructuringandOtherCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r154",
      "r489",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government and agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsAvailableForSaleSecuritiesinContinuousUnrealizedLossPositionDetails",
      "http://www.medtronic.com/role/FinancialInstrumentsInvestmentsbyCategoryandRelatedBalanceSheetClassificationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Net unrealized gains (losses) on equity and other investments still held"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r597",
      "r604"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued gross interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/FinancingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r178",
      "r189"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted average shares outstanding (shares)",
        "totalLabel": "Diluted - weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r177",
      "r189"
     ],
     "calculation": {
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted average shares outstanding (shares)",
        "verboseLabel": "Basic - weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/ConsolidatedStatementsofIncomeUnaudited",
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medtronic.com/role/EarningsPerShareScheduleofBasicandDilutedEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "68B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5498026-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=29634951&loc=d3e1756-110224"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2459-110228"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13644-110860"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061172-113977"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80784-113994"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)(i)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)(ii)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226038-175313"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r861": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r862": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r863": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r864": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r865": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r866": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r867": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r868": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r869": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r870": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r871": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r872": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r873": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>111
<FILENAME>0001613103-22-000063-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001613103-22-000063-xbrl.zip
M4$L#!!0    ( #J"@54N;3V2-8$# .R=+@ 0    ;61T+3(P,C(Q,#(X+FAT
M;>R]6W<<QY$M_'Y^A3X]'UAYB<R,U+)U%JW;Z(PH>43:/M++K+@EV3((<!H
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MW>%C=0B)!L8>8""A5*T)JT0M=;2\&GSF%G2[@RPR&"?19IS!I@ 5V'4<UFR
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M"$-7 \U,]?$=P50=CV%9C+F[-\3>E(821 PN<%Z5C98/TVW7QW>%3P/)"85
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M3R27OW9SL7VT$3K^ZN3$<9P:A\]FJ&?=-YTNXOIBUABXPT@Y=D\6L2#45KI
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MZ(.GDR9[:/+XY/3X]-'&WK7JML@P'DJ+*924I"!('32M]=: J:.5W!:UG?G
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M.BZ=&XFGZ%?0E)CW%IJKROH]^9^+S=GF9K#YRK_JUB_B_/-O'KYO1,I1S#M
M1'-JS6+5P Q3TI1'A2$B/3M0[7HWGR-R=(#FG?/?GX+S[_/?&R_]+:M8L5@/
MH0P=!9@=2!<)T5@<70ERARSKG3_PB\W)YMR^WCPS];>GDT<;EQ_WSL[L_.R/
M+^[3CZ?;3X_I[.RFXWUH\OCD]/CTT8L_TMD__^%"K+X:#J,<+?8*A0?VH%1I
M.L,E,)D<V+(;MGQZ<79^^L2VW]FQV_52V:(DT:.!E@(-J/3IW#I%;9XWE@1I
M[#];?IVI;TGM&WKRL^IJ"1'JO1 C=M%2L9I%ACB 0L,H05O0D7K1*_& 5T7W
MZ8=]9<B_A>;>&+:EKT[D_2L'?.?*^8V7_I:5DUISS:UE%^50*7GR"F0(TQZ=
M5EJZLNX#=C]C4S^%X[>$9LV$5I0R&$")E$0@0F[^7XFCW1X<<]T!3C2=6B@I
M5&=BB*Y'_+MS LHM>M*X@-+*OR/D547RU3-+*:LTJ9T]7X\U%7 E@#B2Y*DU
M>)J:)TLHX^\2EC6G&;NKQ'6=MB:$E+/KQ,X$D@%'J[$ YB5M_#QP9Y]7_Z5Z
M^EK4_[]TP(#<&I*GLJTD25V7T$NY+[%C?C +],Y!(R(1E.:J-$[S]3W3&!0K
M+&',T]3*\9U;G;V$;GIXWTWYR<63-?9>A $N#3P'3"5#ED3#2BJ>%8X<I-:E
M],.^"1@]7RM@0RHA##-, @&8I.;8M0%6OZEM"1;V:@%YBFG_HI[RI^VIN"?]
MSLZ,MO+X,WMFQZ=/IP]8(ZA:XC3FH,:6" 9A;SV+9T]2/'?TV[[_^OP+VFS_
M0L<7]L<7KW[\#W_'";P77T_HW10ZKU[TU<G3B_.SRU?DG4FOUQ=SW^CL8GO9
MEO?%UO[GPD[DQ;^XDI^\=.IIN-AN-R>/=G5)GSK<_G;^WO[3F=_Q[>7*\!]?
M/'SQU%X3_SN_#R=^*9MC.SL_/5E*)Q((QA!(\O <H25ACR>IM-B+#M!8%L7?
MN2GSJP7(,HWU_5C&.W_\3R"\_':O/_5?O>*SS=EEX]-W[NSWUSXO//N\-,Z3
MB^E:7MG=DY??YI.K]_ ?K]_@^IGKQ],[O-7:C4QJ%TK4%5*(O=)@"EE:+*5>
M]QT>K/U@DSOP?.^DY.^\M=_<*5=R'1Q'%D$(17 JK92I2Y@Q@/:#??XV3O[5
M-H\>GYO>>^9V\6AGD>C@ >Z8G7)K+7#,H4T3@'+FW*?#;GL*RM":+,I.YZ?L
M'CF-7VA%?]J>ZH6<_[3(L; $,!7LT(-B 09FZ1:5H,L(-5(R7!25YV;/(0'<
MK9$<HLZ-K?5#L@UC!E7((:"41&7 - ^#*_'!5 \&=4CD]L)4!T#!F%J+V:.K
M@*M#\4A+DJ,6#@MHV]DC4STD<H?H^OY--A@QB$Q]N U"=_%+HW.$%*EVE>LI
M16T!W2Q?G<CI$WLUU>+?;&;\]NDEJTX>O?R3J[W:[[^_I=UZ?PN-X#D-Q@R#
M 1/V6J&,&H.*!LBVH&:E_8=WAA."1\$6-&A&AIP0#2*'7),)66X+"+CN,I^>
MGM'QY8S(RP9#?\.W(7OCA?]AQSI.M_[0OCE]Z7:GJ'%A>H7]#OLBW^#=3_=+
MWSO1>ZJ7O2!T/%W%\>D4#\[^^.+&U9[Y6[P<C?/V*WT=U:;O]<7I]@$M9J:'
M9*=;Z!AJ1!B)$$/AG#1*PTP9]I^!W[EJV+J4N)A$VY\<W-=P?#YMDWJZW9RY
M#Q$[/IZ.NM@5K6Y\[*>G9Q.9INZA[;,;*L<>TO//GV\<'KWFU/3BI71EQ\KF
MSBAAS0JBX+D 6C!NXHE"6)2\V"U/%JHF(#%P=>E08-3>I^W?9M"LQ#8P+TA-
M[!V:MR\>A@@#<8VF&3@&EIQ2K1:C! @I+L@VWTD;3G[SVS'%UIUI@[UCT>W[
MA%:)8AD!>B&(:3JGUK-)'*.'1$67=(3D@44S'K?-,:)QEI&=28-J*]6#2VN:
M>G^5IR[!%\VD)]^)O _\0_VJOK03SSV.+].7)YN3S330]WSS[#I3OH6=/C-H
M%P]PG4<;X-&-,Q!:CXDDAE!RHR4,[3TP;+]]6!ZDJ&)=(C BASY*31)H.,7L
M^N2BEO=_I\M^1:1XZ2]N>8M+RZP-/;W!$2$/1)<U54OP>SU$^Y*.:MD[-&]_
MPU*TA).C3RU-?02%42J(6BI=ID&-"[+-@TJ=S2>P8).!X ER@QB!"@G&W%A:
M:-*7M)?QP*+9?)$T IT.GZNU0X7:6](*@!@]OM17QT0OP1<=E.A>^JFD$#&-
M5#A5&!0\FVX26QB-J)2Q)#]U8-A>^K"N5=JTN!,\H>88L(7<38IYRC--]U_8
MLM_.U]]VP>\'FR?^U]>KX3=?N)U.;'D/\R+>3X\1!XBFGAM[>)N:[GL>(TB,
M0N2/5K((. =<\Y?5HCL"U99SCP72R-QZ!R6P5$M#&NLHJ^T#MG,,1YH*'A1=
M,P#T&AW8$$824J51%K5X?XOQ?"U\NWU?@JU#$*Y"XNFUUI=;@NO@C'V:Q[D@
M7W+@VP+\&XYIV3I,>9(!M\:=<505:R30 JPC$9\=VUE28*O47);8B-*A\2 I
M4#K'SAE XQ+FQ"T$VQD*:"@C)(NI"D,8 YNG%1X84G>$0[$%V>TA3BS EWB0
MJ*"U#TD(V@)C1!Q<BM/!X%7!=@F^Y,"W!?BW2+&E"#W7;E!JI5P3M9!!W->5
MDO;_4+F?+:Y=O_!SQ_?TA=D#F[8TOI<%G_=RN%QM0A80F+)!@X0MI,J,U'*A
MK+0"B"X/M#@[.Y6-TUAO8]/!S@XS+<$0<G&=@)!"QU2Q\[3DEELO*:\ G!O[
MW6Z\>B$8H?10$*/DBB"%>_< VHM(!"TMZ()R_7UR=O,GU478M7DA+AS![:][
M9LW-I$8,2<:2QN/OAXO< TAKDH;(6FN!S(#4190&P2@=E-<$Z6TZUOF1#99'
MPB)%!X-40>LV*KO,9":'>P7+N',IS9T-W:-2 XDFZPPDQ4T/*3-.0L:J+&!X
M[7ZXT?<"CFKN ERM>W962N=&*BF5%%,6L379SZTKS5UA5+D6HY1[Z ,*9XQA
MF.8T1JPY='JC>C,M9RX"K)N5DOLFC^ED(W3\Z68K%\=T?KI]\>#BZ=/3[?FN
M"C6O9R!<G1OTX.4W^,D @T]IJYO39W0V7<)VGXHS-]8S?T/(S--103V/7"E!
METB%"]24$I6NH[Y9#-QG.NUA#_"!QK=$XVE[;O-<K10&B(4PN_H#'LUJ,_VG
M<Y063^-?/QCH0.L%T3I3P#3\WU JU!AZSAD\30TC2(Z]7J6J,?6C?:\!'FB]
ME[3V/#W^I 3Z[_/T&]72W[0BY.G>:#+$:9T-&9QNJ8-*#,S2%I9GW$D6O9\$
ME*'1M!#-F  ]N=%8JWGRZ?^:VB/VGQA?;$[HQ#/_XZ].)H9,?WW3Q?WYP9>G
MSVQ[<OG,(_/7VMEGQN</ID&KF_/-[G3I+N:@QH40IUFP3BFF.O)T\GO/%4S8
MF3*@U;B ,U=^.HCO[<'QJY-G[G4NS7QG%#FP=0ZV4FQ28BH]]@[NY'KJN;0P
M41AAY"4<U[ _Q/EYPWEY]/.[G.!]8.M;V"HR%$'S2-1!*'&,R0(QF VA; M@
MZP[02K?F<S\]W;I6=('WB^QE7]A2(F:U5KM.OLU<SP_@D4/!5H1L 6R9)Q(?
M*'I[X==T:CRD@E@@&2%7G':%Q5;"Y.+60-$]C7D'BK[CB<XU8AP8XW3T");.
MO?1 .&1@4UO"AO0]4HBW0=Q](4ZMV=.(Y$F$"S3(B6N.JE4"LD4N"ZB@'!+A
MN\/6J1-H3.?C)B>K!B)VFM9N(ZBG%IWVGZU[1)S5BH)]82M&S1Q (=4.;(-#
MY9RUT*!, @LXGN1GV7K_='O^B![9'TG^9GIP;K_I4-9LE*(-"KW!4.RA=2MC
MM-*;AK**-&..4'S@Z XY2BJA%HF2H[LUH38=>S,RN3^3O(I*]/NFRR'LOF^1
MB&UH)1XUN4A,%6/@7#-I&S'Q$LYD^EF.?G&ZM<VCD]=*\9!:_%;6C"Q.&-)J
MG&!::!O2*U%+N9#&<*A#'ZBZ+U1%D6D0>\8$#8P">_ %Q#)ZP0QM%<T+[R,&
M'JAZZU3M,4-M,)TS4H$S(^J@@J7A:)QP"2GPLE8Q;'O^<F"(G7T[/K.GIV?7
M[[?W7(DPW)%UFPX\@E0  ^5N(RGU)LWB_G/EL!*\;H)6):Y%RS #CIDBEY(K
M]U CC;* -N35YIX'@EXNYJ51</1>8E-H)6$PLE \B6$F_\_^$_1GX;FDYJ&2
M]]NYDJ5XPENE:P,/O)4#IEAE##&K1H=H>R#HW)T)K@)K'.)1%])H2#E1J;T-
MA6"\@.60>;FRVEB_+P3-PJ$64PV5(1'W8MD(:YJ2WE$64#&\2VBUVKK5:08>
M*2 *:2#&-F3$4# N8%5@M=GEOE D&W8A"!T!73Z[-%(L1<<DJROR KJ+#C[_
M?:]_NQ#I6MC3*@)KV94)]1Q"*ZURP26(DAV@E6]/35_(Y>ACS\87UY.=+$=)
M-@U9(*@0>^Z22L8<L?LS"^#*8B/.@:#OE&%-8[93P32X0F[8J4E*K?;DOBQ+
MVG^"[A57]G-1<]$$[4G-59B0$Y5+[]8I9+(8$VFV!1!TEQYT7U").<5DZI!0
M!8J!*(3$!J*#K80%3'W<I:7N"RJ>J:!V+#@T0\R# \:2>VOB_Y?;V/^I[WNT
M-6()V_5W=EQ 9990<HZ3DX7 82A 5]-A*=D"SG+8SX6  UO?!ULSY^XB (1;
M!9>I'%KH-96HR;-PPOUGZQX19['EHJ6P%2Q%'%1E] @"&9%3S0,J^L=@78!O
M75CSQBR;^'?&%AEY&CH[<#A7&KT\.80(!I-'X@4<W+/8@M&!HN_8SUM+1K.:
M=12(Y+PD'7$T*?[+?CV)<]D4W=.8=Z#H.Y8GRDB1R(:I@5EV_PDC02L=2LU+
M\*)[I!"7L+:W*^(DI=P;]CHR3UOV$4M,W&LT&F-$V7_B'!+AN\/6$@<4=0KI
M5*X9R*%JTCB88PR1X_ZS=8^(LUI1L"]LM2F%H=!9/12'X"EQZ3GU7A/55-A6
MP-;#F(G=T84B#L96K%(!5H_%0U(6Y0ZYI+" *M]^AN(#1W?'T0$1*N?A#BV"
M3F=&FF3IVJ-6':'O/T=GI\LA[+YOD6B(SM%I RU ;96KE<324VXU]+*&L'O8
MM+][UH3:2DIY<!?0!$S2(X]"R"4$*?O/FOV,O@>J[KYYP4H&)T]00@A G+)Q
MCD"C>H8QPAJH>AB%L@JJ4N302O1<QBE;,%"HZO3M48J[V[@ JBYL%6.&C?P[
MXTKOI4.":8X=6$0*4VM629#[-!MT 6L8AY7@51-48,1JHJTBP'02]# 2"1('
M4%->0/*[VMSS0-"7D^)'35)!6C#H-6*H4 =Y_I)KK+H @AXF3=P65YB81M<^
M'4,%_C_RE*+F5A.&C+4O0)GM9[Y[(.BN6EHP6LPXG7S!@#2PU\)-L2$WPR5$
MV\,HE%43-#5WEYZR3/OAP5,5SW'!3"LG:YKZ MH"[Q):A3S8@777\ 0M5"H9
M6HN71R"'<'WFTSZCM=KL<E\H4DE22>2VW"MHR9[49;9@DJ D;:M8 CCX_-^V
MX91[B24 &#9(*EV'6/'L:J0<J"YA;7&?I@?LY4;^G;5_<7"EZOHU 0)PP  4
M>\+!!;0S[#]7%AMQ#@1]%X+V5#I/=2&=)!%E"JF/A!(&$D;6_2?H7G%E/Q<U
METS0D7K$Q)YB><3E'-E8<JT0@T&L/>T_0?=I%,K."C,IC^!WG3-,/?CBB15P
M@N$9%;+T!>SOW:=1*#O;1QM22Q#$$Y7A8J/V9I$&MMI:CY;7, 9]V:>5Y]XR
MY@X.AT >N3-&(DBU5HL5%G" T?O?N[(O6"6'2=%D8(V@*?C#-#A03SJL4%@!
M5K^RS7EO$/*T*E4WH"@"*)4TXHB=+*=IM6 -UO1K5@?V!9YJ)<>BL2,2B/\W
M4LID1HVM6UC &-"]%-8[.RVTCC#,;UH>!-0;!HH."R8<%-M8P%:C/14+.^N%
M*U%";[VUG*!V#T 9.(JE5MULRA+6EO9>+.RLC$**HRKV-@IP)Q9ESAV+E% P
M+*"38E_%PLX0$HDIC!%U!$^1"KF_(Q2%DF*UL8!*[%Z*A1W.UU&*04=)4Y-X
MXZC%]9TK.?> 'J#6 ,^"JW#1I4'-T31ZXBJ,TP;V,B2)]D31ZG]_=@E/RRY.
MEBKJGNCYQY__SX5?ZWNMQSD&V_//G 17"+6C'%Z]SZOG7MT[??W2&\KO^IE?
M 69+O3;EH-']7LJU=YE&6P4- ZWCN 0S.IAQ C,ZF,LSNCG C)=@QG<!,UZ"
MV7< 9F#7AP&1:U+00<R5<W8?:K%JA'1EF7"PS%]LF7#KEFFIHG9/D<DRC!H9
M"F2,F,.TQ3[*E666<+#,7VJ9Y2C<LF52[N VF5L> *-!;[5'00B#>E'.^U__
M>/#8-?]#VSZ9<K*'+Y[:F^GUDR>VG3#^$_E]V=5RYO1A;R/-O11B>>,S_[0]
M?;2E)PLIN:#G(,##4J$$$FMO)8S,M37+Z#_>,4;L"RR%()=14PY"TV03@NA)
M2#"HZCHI\8+$[=SXS"]NBPNB' J,DA&F70.@L5'K7>.(5!>02,Z-X?N95P 8
M0 N Q090A<*4:F3!T0:UN@#7]^G6='/^!<GFV"_K)B9?;T[LV_'R%>\]#/I#
M-:43_<[5DUN)__?9Z?&SS<FCEQ=P[]'6;/J;A;A?*XE2U9R'5G!-RS76@<4A
M!.BEQP5E, >.[$,6)9$CC. BJTQ#]*8]CIS:=$S3=.2[+B $''CTOO9KU6@5
M4TO1#,(T7\(?-K*@ VKJ9?_#T+^"ZH&=;$ZWWYR>V]F4)WUV8?Y-2BXA_,G5
MPG*B02M1\@20Q. "7-QRJ^3>K58/#(46% WV"*KYG3+V$34 AX8-:A36J2L1
M/1VN:)07<'C>^X+SG2_@Z].31^?_,B_XR64LQ-0-Q(CR5 EAL%[[U+@Z;3SP
M)#RT)2R:'RBQZW7&.K24@F+36?0ADE,$8@'29NXJ%M!T^6Z4Z"\I49T5"XO/
M D@Q]<K9 &3RWSU#HEA;S-,TPM7%YUN!:O[XW%DLLVI(BHYG0[71RG"H4]>1
M[.Y:WN*<\<XZ1".--MP!8YF.$LKNCSM&"#U2"8P+.%GW0(E=[V=N[AJZ2+,6
MP?+H&+I["HYD D/C<KW$O91JN4+_X>.MV?=&V^G++,]N4RYY4$LZ%;NZF(?J
MX3^D:=DQ6LHK"-'SH#5_E&XA)D.'#EN%Z%$Z.M(CU51JC29XI^UO<5YY9P9O
M??1$M;?+$SD4>6A"JBWEE&-?P)BT RO>0ZU[  5AS\Y&AVGD2/>@[2ZC*@[_
MUP*67-])OJ5P+=_"TFK=($I)ZS#K"C%#-^42Z^"0*R:$%03J&:":/THCU%*I
M%0Y0@ TH6^#2J? HM>4%=/Z]+S@7YXQWMJP%V-52G?9/0$W5(W1.=>30 WKV
MM("Y<@=*['I_YZ3>2T@B>3KP8#ITB!33$$ID8PDM4;^HO-)B3&59\=G:<$_.
MP- [A#80.&9+(X-UE/76NM\O5//'YQZG$[UZ97?%0-/J4J[)Q;*%Z<S- '?7
M\A;GC'=6ZU;0;,V&:@5FMV\W>XH 60&++>#@F0,E=GXZ@HF&:?7#'46.@_(T
M]S6K^P[!K*M9BVY7E,AY:6O1H8%D3=RM=,BNIR9H@K56IAUT:7WQ^5:@FC\^
M)TTCF37(M;GDFHX":[5.6BPC1EY-K]@OAW-QSGAW^;.FQ-RF/BJ )"00B]M_
M<2D^6EK M*(#)78]JC^$H:U.$_G0XP!3$LN5DD5Q1<\+F';Y+U<]\NOJR8/-
M\^6N1*NJQV>1;IY#U\@<+0F,6K5!PQA6$*#GP&K^"-U,:A=F*8 P2D&S/'4$
M8HE]FCU[AVUO<?YX5\8^2AJ@<53.#6HUCB-*:>+!;%0<"S@7X\")7<=H**%6
M0&1W"I!RP=9&TU 844QX+37NZV6/'G);6(V;$)4@<S-+$"R@3"V>9EA%*19>
M08B> :KY(S06&(9E&BV2/'<:' 2FD4$1$Q'96G8Z_@HX%^>,=V7J,;AHTR(4
MM4!+T0T?#:&*%,R8%S!0]D")7?>(69,67+@G*V 0<9I1%:*YX.G4RH+[N=^V
M[)%CK$M;@P8!I3 E6=!=03%%4X4FO34H:NNK<=\*5//'9^C)4^8&G&*%5B-:
M[-IQ2"'/GVTU->Y?#N?BG/'.3'UDJ2U7<OL&8L.0H'$52%A3M-74N.\ )7;6
M(Z99F\401KT\_:Q+5FD%%25;&6O)GZ\IX=]D:3W<HSHV#4,AS$#&&-UZ<>HB
M<H@"M[7&Y_<+U?SQV0&4BDT]85; /M6K*$@LV>VP8+O#EK<X9[RS^ R!")BH
M8("!+L53*2UU&L,:A;7DSW>!$CL\]\6@E#C--8*6B$>FWBJ3EM"*I>5ZB7OY
M=8?@-YN3!6^'MJH%8ZO%/+.J%!E2P81:K(J.;"N(T+. -7^,5D^0C$$ZA @F
MT*5::E0Q3T=GA07OL_KM@"[.)>]L0:N;4$W50W4!BT1-820;6 =FQ@5GT7>0
M%#N+TQ!<MHOKMS0=HF<]A\O9)2U[7AW*@N/TVY8^<G;QL; \NL&T.[(,0^Q0
MRR#$PI&KBHW>7ITPM>0H/0-4\\?HAL(M3 >&L4#03!4PCN9RV11<.M]=RUN<
M,]Y9A"ZU0Y+:L#@E4#V?AIA9I%2$9@MN%+MSE-A5? ZY18N1!AE!FHXPPY;3
M$">!1L@+GCYX+[_N0GCX=SM^MN!,.K.A%.S"-B!GZZ.(6&A#"J,;[ IB]$QP
MS1^G!5/5T$@'&( :!?==H YP@>R)U-VVP,4YYIT=6<9Q9'?%8:0*PW+G.JV(
M5-=S,C(L> ;HG:3%SOK&0@\A2:[,!D:-IPVX(;8F(Z* +-=;O%7"N0M<6E]W
M",BCY!X*7AZ!UIE&*6(Q@<?KMMI\^OU"-7^<-NM6.-?:FD=JILZNG!DH<&H1
M>&WY]"^ <W'.>'=C$#P:HX0QS1!44)+$@ TM)$ZYT7)C])VCQ,YFEX2D'8:0
MI0@U*F49G3QY*X4@L"[72]Q+(;1/O_KBP;V?H/*2&%C+TJK>E(U$D(D&0U4W
MW6"1RF!BRX!E!5%Z-L#FC]6D-8=<7875:<)?9VF9K&ASL/VN+#A6[P;4Q;GG
MG76286\60-S2*Z0Z'?Z=H7IZ'=0"85QNQ+ZCQ-A9OW>7! 5K,@U04^M(J2OU
MT4<#L=7,'+MJ,9S.I%A8Q$Y *0SA5EL&26F*X&J=(@S/KLL:1IK, -7\L1H8
M2A<T:=&SZ5BP5TM*S9.I0BN:.?;+X5R<,]Z5J5?IJ2AJG3H,ITV8232#FWQ+
MK6'AY4;I.T>)7<7G%HH[A-RFBBID8BZ8(@XKI#%Q6,M^Z7!-B;J\\Z.U@V6-
MY'R&9AF;$WR8(D4DA=75O6\'JOGC<U(IPFJ4HX T)",>PX:;'Y4P%M#KO2M?
MN$3^O)^U:1N44U07;9Y+<Z1>V-05^:B]587]C\\'2NSZ_&BE5#)T@0# *%VK
M^XRL(W(O2+3_7N*72#8(<7%&VT,?9!BRE @]A1Y3IT#-(W(.(ZUNWMCM0#5_
M?)8\0IC.C&;,T 2HE$96*<K0Z(+Y[EK>XI*E79EZD59[CNZ'0X1&A:.D6(T+
MIR+(*SM38]64V%G^W$N!D"ET-N"J[O==LC5++MFTIKX6+Q&N*%$6MR*=1HA4
MH":/SF#3B.<PH.0:XP@LL(;=TC- -7]\]CB<M'ILCJ%";(6G0V"!6RX]CZ@+
MGI;_6^%<G#/>6=\8=O&\B"%5 O'4J:>158KU1JTL>17ZSE%B5_%9DTR'$(?I
M:!7 T'L4[8.QN81'T;6H^*M60HAQ<7W=K:;:!3S/X@I=!J8>E#O%7JS6M(8]
M6#- -7]\3E8B)<[=ORFH>V"T(GVT6.L@3@NH;[\O.!?GC'=6WRXQNG6;U(0
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M,ZAX N$2Q!!\*D/H064$I;A*==("2PN+^]<6D%#I8 ("*N FE;G9@#$S+IP
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M7W"=,W];<E$H$H*G-!R 8&!-LL$(HXVS+O'Q_DE<,1"*?('K19[@U?C"E;[
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M4@WB8P.B>:_WX[D+4<3(!9+(SY3P2DUA37)0(68O:M#^W(!HWJW5')P1VL?
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M;[2E3*$,881*L8['+M8Q6Y5X<"[RO8*Z6I>U<_\.>W,__\80<K,U20H#-\?
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M>'Y:TU:=C%63,G&RS.BX=NO=%S\.+'I:4S<5Z'WPTT#OIS4]DS/7&2MFMLJ
MR3U4AD?U]^M[/?8O:=<ZF[0:&=VG\>P\?03GB)9L]]HXNCBSB9WOT<+Q/H_\
MI*;NI1EVJ@*]S:ZMM;]TK=M=WX]:]LZ'W5Z'Z.U./O)JLJGU1J=73D_NG$>2
M,YM:*.H-09%$;!3SSNE@(@V,4,VMY28\H.KV WM://:)Y/'SJQ/)L[=?C_9/
MSPX__IT^[SX??7V%CT[>LK=?_Y.^Z]W'X[]>IRMZIT?[?Y)O)Y*O/[X].4!'
M?_WYY9#\Z^/1_JLO1V>OV.'7%^CXY ,]_.IP^N[+XY,#,GTB>?3[T>GAQU?X
MW4D:VU^'Z&C_13[=_'IX\HH?[[NO1U__FY[S@!]^?!</N^BR.HU\@[X<GOS-
MCCY^>"\$U5IB 5A5!?0C J-Y6N1"Q^ L%=:$24^*M4FT;(@$E@O\QR/51<,S
MYG[\]>2[>@A&4V2WC%CG%C8F6!-&1-.,&(GC!F,$1**0&)&H7!-+@X@D6!&$
MYD@UW9>@<&+AQ/8\]QR<R!Q).@,V/@3/!*'6>ZZXX!YKK9"1)?]C;8F13!.C
M]]$&JB1(@C@PG'LS2F^ JD@)\I'3&)NJJ%YXL?#B.O.BC9KJ$*4UVC+DM=4X
MJXN1>6I,)*CPXMKR(IOF11*3&+%+AC.Q"AA2!HRB&+!3(:9=,7*'&R[_7'BQ
M\&)[GGN>(K,R2H\<PDIKQQCW%C&7Z)%XQ:/08OXBLX4A6\>07Z8;Y[YWF#.F
M<W5IKS4P+F-ZA10@; (RBAFOQ>*U9PLY%G)L'3G.P8TZ*1"4<H$40BSA1=N
M0[*XHD$8"6J+TKC&E-B=S@13PAE,+2@2$#!#$>BH,7#N S/"2Z'TNI6X+,18
MB'$9Q.BTB$**Z&WPC!ILHJ1.,\.X-@B1E7L9"_?-Q7U'T^J@XD8B; 4@(2PP
M31380"BH0!P*WE)"8R/U]0KQ%>);9^(KY;4VF!5K&F$@F'(F0%KD@3GN0--
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MW.N@6+1&:4]<(+)X"M>:#M_6=$#$'79( .;4)1TPF<**80^$,XJ"5-1'4>F
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M762^!K] 8F'>*63<\U039CUJ0S!>C5YQ#;\K'K]NJ+T5U,X%KY.)!<D<3)F
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MY-<YE:Q#H=6BCBL-NBL-W4:PS4K-2NL?!VW3X*U,@XN*Y@I$K55FR1O#P(7
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M_^8Z-;Z7(!DN*?9]:HD7G2%VJQW(SZ&_GW9BKK'1M=AHP8)J$5))B,@@6<^
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MS+6U"ND7<F/3KU(IL!;?6$'MT1#\O1 \)S,D!)NB8$7GS,"3XX N C.$:B[
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MR,B\AJ'3@=EHH]1*%2E3E2-FI=ISM8#'JF=W-:3?-=(O*I6HP7@N'.LJJ(,
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M=H:5_NK_?_YDG9=Y,AWWXS2G>N#),'W^BW-G-MZ[%N\M**\6K=5&2<,D%,\
MBF"!9\E""C%YM(YG(-Z3K6'F/<7[[6F;AO<5P/M%G5,XB9PL/?.RVY*+FMPB
M@2PX610'4Z(GG:/OUPZ:%=$Q7PCQ?"K\NE3)<D]]M[L,Z]R(OWZCYQV1?Q?'
M&2?Y69[]3?\>'%4;G&?*&7LVKV]Y;/AB0;$SS(E#D Q+!&)#HYDCQ#"$0!PI
ME$?7;=@1HH6&'@Z]K(9\^MY$T[CD>EQR45EQC$&!(W!8A[,.-L%[P6+4TED
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M<;9.][BW8#K[6G[Q@TDN-I<G%[<\X98G?&=YP@NGN:].6Q>F.3H22)T"#ZC
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M2)X/3064EIO L@^.?+'H&1:2(3Q*EY0MQ<M<D;Q*E>@;DI>,9&^0_K,^I:A
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MYU?CUQ^MQJ^0&J,F\_!OXP ^\^WH4,1$J*,42>%SSJ5(R!FAX(</U$9/<:[
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M0$D(.>7QWC[)ZL51UBD):DZ!WOM$5%YJ5L,J\IG:X[H'F,T0&,<-M3(A*TU
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M3@@P$Y@000MLP(\A3&@$5B @XXQ 4:N8"_P+CPEP@-GB7C4"/ L$6$)DHD:
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MVW1.$/#.Q L,I'%))0[6T3%N=32$6D\P%DQ952/G8R'G>>/CH4@F4@.KKB7
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M E"_?<8N*?;YJ9V^V[4%TNMWVHII7TT2L5(M9Q,E<SXC$RJ3I(M9>XL;6[!
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MC--920=9E8TM>_T0R%MY8C54KST*U#54P C:1YP7&3$E++HE8/1O*]%W\)J
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M&18)3"=1HC/2)ZWZ&+W0\+YF>&\>@/O ^T[G:(< 0A3!G*DN "\UP\@Y,T@
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M*#5>-%G-^-0Y*+QG/BO-9 EH#"\.N=_8@L8"3X %;N)>>&P::.Z%N]! Q[T
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M7#!-HJ$V<Z.R8W[)='1!QR$OJF+JIUD]CW$.<M/G?EH/\8L>A"_RU;P>!_!
MD/8DZ92U&[F#&VG],0OU<D(F:B&3Q(H;D2P1FV(F.LC O PFE(&9EBV*HRY"
MQY[YB*JVL+6%70J(75O8);2P,T"=N^ ]=8IP*%/5I!?$9$@D:<^I51"530C4
MS:*&$C^GA;U%J>OCU6[\%?92/.ZD?J[K+2;J+79W($"6/&OBE6<$RD"M<OY,
MDN<Y)6I00,.]ZRVN[^S\7 47H[1(GSK]D_,RKE("=]3^7HC85*'3N/SBO_Z?
MX4S_<]@X[ ^.,BI%OVKQ_1/NMM(H,R='56:CF7R-?N^&&HY!J;,*_=U>-<FO
MW5O*6@S43M(_3 -W5&I6\ 7VN^EMHY>.EJX\X[(*K6S6:*6_;G]R25?8RRI\
M^.47*QZCG_R+6^SKK7^9SQ#FP[K[5'O8EUGML;DW2*G1Q;_;&S92+Z;X"[^,
MO]H_KG\5+U'HG[SHZRX-?)9;%NY1$7:KA_\U7^*HFHP]D;"]T)>T $E;B)B]
MT-<W3\9^A12J?P_ZN.@X[N]1AG<]2LI47;=3U^U<'@\RFY1@*3(6('ACK>(R
M!QZBY8XE-3X>U+>>,'PNQ.]1ADM+R/,)A:N]^ <2^U2M:+B1KYR&3W:'S.T?
M*9*S-.B_CE/R[L>3YN;Z:6MMG6^58\3]3R?-M8]R8VT/K].D&]^^'N!:Z-;F
M7F=FC.G^ZH_FYD?:W-S&>WWBK;75D^;^ 6Q\^-PM P_QF?"Y/^]M?/@Z-^5=
M2RXB@TR,TH: 48EXJRAQTD'2@9O(9:%.AC/^SQ=1_//<)O!7MX*OUQ!J;I6.
MGD:6,G"AK TF)44CS299D\?CFK6X[;CF>QG"VN#=Q>#-A 6CX-Q';HB+8 G0
M8 EZ-$<,*,-=9@D8'[5"?5Q;]UK,W2]MZUZIH:->(YHSQBL>(6;GO?)"")")
M*00+?&Y N#9TSVKH^ RR2R%KKR+AQ@@"/FIB3$R$9NX<>&D5F#?O^(/3'WX)
M4%=;N==GY1)7)MJ4G$L"LF(>) C#C* IB,#"&,Y)6L.YI;%R, /GI+$R2D]X
M4II 2 CLO#4D6RT-E9+'),H$FQ=AY7Z%OA4?!OWAL+%;<GCJ=A0OXMBNY/B5
MG*M^KS9<]S1<<VH](R2@VAE$9H82R)H1JZ(H P&-4<:[:)"'<K%$->JUBB[K
M@5*MH@M0T9FCHN %: ^!2) ,%=-EXA.3)$>J&)=4HGU]\VYA)3JUBBZABB[L
M**16T06HZ,PA!^=1<@>6N.A+D0<3Q-B82<2OK.$YV^S?O!.Z5M'7JZ(+X_&U
MBBY 16<8NF)2)\8RD8)R B;R,GH0B-,4N;O0"'KDFW>:+I&*_@J91",>/JJ@
MJ;LNW?GU_>VYF/B_<,=J W5? S6O%#\8*;5#F.\9!P(A4N+!*R*]Y?A_+BQ$
M-% S]FDFG;KNM_02M7.A)+S6S@=JYPP)=Y:! 4E)D*Z0\! 0.:C2;XDKIXT&
M*Q*2\-E^2[5ZO@KU7"@!K]7S@>HY0\"-<DIIPPA%(TJ0=REBC0.BK,[,,Z=P
MNU ]9[,,:O5\%>JY4/)=J^<#U7.&?&N6<THVD1R](9"L)][P0$PR7O,0+*/V
MS3L^2[Z?13U_A?CWQ^ZA:P^*=)^WK[AL35$'Q%\&#S]/^+G<RSJIY]Y6:\XH
M+>J"U26?)Z);*7,8/#&NS*9!1J84SVC0])MWLRG:MS=:]7G^\I[G+[S,XEHU
MK6O*%J&^LY0]1"ETL"1J9DKGM40\S8((%GD0T5M16B0OJ*:LUN0E]K@++R2H
M/>Y"5':V6,!FG4-$CRM!$F I$,O $2-E%HX&$YR:F^I2N]Q7H:@+SX6O%74A
MBCI#Z(-42@%/))D8"7!MB=$4M34Y*82))F:&BOH00K_H0/K/^Y*6[XLHMGO'
MKEKHSWL'+DW'R_^96O=(G*TS.G,1DC06E/<V&H-@-N?DA6<QO'FW=CPH_1U+
M4\6CJA]7Z5DYG&I&U1@W.AEAH?-F,6_+IP:I<5+^^8^G);Y#?./XU;2:?^D-
M$N[&68HE<::<WVWTKH78O>,NB?TC,K[R2[<%#V@/^Y&U3G:854ED;DG@T:$J
M<TE<S)X$(5GF00;(9E[<>204XZ9>I0-GZ1%Z?+$1Y\=*1:[N(B0+QVJU;-Q#
M-EIGZ^A/=D];FU^@5:[Y:4=Y4%)+01AWGH %&%6L(S]66J)*TYS1Y-]93JH:
MG+>-01H>EM*T[ZES^G:BE^[PHH_Y-6UUT?IV.HV]U(D-=S3?8JTT[F/NQLV=
M[FWN%G" 4)N[!8KT6A.AT2J*]9<?K;4#MK&ZD[-T5O!(C$!S LP'4JY*(H_6
M0L@^*O?FW75C5A=N^A:.?FLYN9=;Q.=9W3&HMDRB1!A;JJ,D2HE-X,NH+>#>
M<,E%OH];?$QS-[98*[-H]J)Y]V5?[&I3A:4TNQQ#23V+3OBLF=2<*YJB$%[N
M2/GFKLVTGPD?S[3JJ_"Q7FD\TLR!<R5;2_YHK3T,J/3'@Z69-=#ZZUQKM@^V
MUW9/6MTME/8MNKWVB3?7.DCL/O'M#UMTZQN20-Y$B_BU,ZTUVZAM:#'Y]O[7
M@];^YX/6VM;)QK=UV%[#:^XCH=S_=+95@,*WKV76P%GS9$=S%L'J<M(: $&"
MS6A1J2/(Y- 5)BD]F)'50]%,<;78'J5I-#PRK3T#)P1N@+91!J%%LHK9Z=D$
M[]L]UPO%G:\.!JZW.^X!/TOI)B5^+DVZ^<Y75VHL318!J3$"GQ*QJ5&.9A:Y
M1?K"+-QA;H*ICH">0R/^Z'?Q!86VZS3^C6]U<+^.^4M%@C<O)SDTNFA?CZK1
M#.'R00_+@S8.!_W=@>L.$="AZ72=,B%B8@A$F0G1'@Z/4^/+RE\KC5B:^P\:
M_4%C_7C01[?8ZY>Q.67RP'&O,M,ISMZCUS]*PY5&69';W1VD7?Q PU4#M1O]
MXZ/A$5KU(KIE >66^!KP<A$_.9IO<-V2N^ZT7+N1?I3>#M4?%X_Q'5UTN7*^
M$]!PP@*R*Q3S#) U*JRR+!A 5V!E].*:V6Y7QJU<BE$E14WWH]T][O[>'PSZ
M)_B ?[A#%]"AW0YCV%_-6NX?G.R@=91EZA.BS\P15P1#C N24$81@"(I-ZD4
MC:W,YI0V_ A>K#3^F!:8*1F;2X<:)VYX)WDQ(3#P.7'I. 2FK)8T"Z^TQD7B
ME_/EY6/K_3Q?^<?Q8)#*>/F7 #Z?6C!:FY]DZ^P+VUC[>-+:7_VQPZBP3$KT
MI4P%_,<!<=P"H<JZ@-;/,X8(38"=%9+NN9#,D-];GO'-FJ-)Z=ISB$ ;([N,
MEW'?T\#M)K27;?01^(GNN.U,,4X_@V#2@9!9<4&# ^6% \8%T 0J(GWF?NZI
MX*Q8?>P-$1X4*+"9!MTKTH5N)?P6CP?1G?ZZXG3:7&O^V#%26\DU)]0A- ,(
M#EE-DD0'+25GD"WH-^^XF@93#7QW(T8R9\O;I3\W$I3&H#B[R^V>-2VHYBAJ
M"[$N<IX0?!LO;76TLH_CA7W&==W.WA#^:TO(R8Z"9*VG0!#32@))&N)!:J(R
M1T2,6Y4M+UZ)REGNVT ;4;JUKUPO ;/.15*/NBTA2V$@(C\ !.1.6QM91GH&
M\\<@WL6Y+&%.S?/ZE2]G.S;P !D88;C;!!2:!"-=)!)I/P25(P_QS;M6?W:/
M9YQ"01-3L&/U<-#N7#F4X"-,7/ UDK?*2LQ<" 'U<4C#RO6<0V;\,_QQ&]'R
M=]?N5,.X+N'R]/2V]*,]K,:6_3'ZS'N$H!UT06\;N,28,A*'.)H,=\\Y8<_'
MVOZ%/REO8_1DKXRS[>'VN+N=K8.A$"5 8AI !4?+D;H()NOLM+K&9Y 9Y%!>
MZT8>O=1S::FIS-TLR_K9CDJ,*N\"43X@K,@BH], 0;($%ZEUTCOW<RKS4XB8
M)'=<H67*40%CU"NFLI%,,0 K+;OE*=TM(.))?Q"'J?>+[6'S[,N/C4\[CH?@
M0U)$A#*JUN9,7.2:R""=EYX+R=*;=[G]/9'3Y 8S&/'R6&20OO<[WXLE'EOO
M/-:MQM^F3//?WS9.]MIAKYQT?&^749TE$X0<'S;R\<B=X"[=<#:"GPJ#MB^(
MU/>_IY&GF;K/Q"C01O>X<]0FH8(*X;3ASQ6]D5/A+*FZ94B#<HS4*,?T[=S&
MB^-/T8#U&N,/MLLYS^IU%+M Y3E>\.U=D-']C-P<9#1IY6Z$1O07$_[6V2[R
M(D:MB FEGAJ#-)L&8K2AQ$0(4:I2_&OOE#T>F$<V19'2('GWT;ML/==XL1QQ
M+^/M46V]=S?MG6-"BA@M >_#J+.+4TD0QHR+5@<AJ'_SKC<+96>=T0AU#D>Q
M_DE,.X$YK]J5E3F1M1>'Q3Y.$OAJD+&+WPM,K[Z>\]35+.,XGB1?,#7^!.UQ
MNXK*H( .VC_>HB$?XJ_.+S %U3O]WBXIG\?+^.K&^-%A >HEYV%TR;_*VW>#
MV/@OUSW\9^/?_?[@XO.?1Q]H_)4&W]MA'"UM]OOQ\A:C2'=_</%'*Y?KSRF-
M!C(?NM.*5%SWG.7$X^JSCD<1#U%+\5%[/90+-^(L5\Y!QD& <XC;'I8/H@\[
M[+0K G32/MH;^[7OJ>>*U-U:R'Z:K#C>62@#AP_[PW;Y@]^JL=?HN"_G#/_G
MU6#56$KIY4><'_8[QT?7?V1F1-LS26]ING#E[4S\NS>X'/*WFX@?)'= 7,;%
M_N8Z)^YT^.8?5W46U7-\<6E6RBN<?OKGH7_-%(\&_1X"X\-.F+$XS[.F5@EU
ME:#9'Y-3N<?1641I?UW,YUZ2!?_M2\\=HUZE^/>;C'8QT7!!]M_]CQ_\X]TU
M3S'OES^).=\80YZ*.6L39&2.<2<%*,U<8@;Y#\W&:,><GAMS?MZSBL*U&AL>
M+4/UW+/;?^UJ'S=3XZ^PE^)Q!^%46>%FL?N_<+K&:?-DAV7N2JB%!$4E 2<9
M\3$D$D$$3Z4V,L)T^L5SGQ;]]W $&?J7 E8D9=@>%O/3SY4#S?T2W2]U ^?"
M5V7_3\TA#27$?SA,OYU_\<_8'AYVW.EO[5ZUANI#_[P*Y(I3F*HVJ#SAZ->7
M_F*%CGS&N)' ^,XW#T67:L4^R@1W4&KQ$]SY"K_G8/AZL3<O]G:7K<>$WV+T
M\(L:,'P^LJ6PH I>O&\7AM_8JH[=?MG7<H^QU:_U551GB^<#J*^^B-?5-G;^
MXX_CO#-(X%%;R-[B&G>9L_A< G;+NEV4*]$@1;R@GNU=ST![U%XKKH3TF))2
M!@'!9B.$$II*[R*/0?MKPKDS!2^_2G[AN/Y[2[8VX_[6YA;>\VMWZ^S3&:X+
MFMTO8GL3U_6A":W-[7;KP\<?T_7?V_L'N+;67@N?K_5M>[^UUNJVSG9/MS=C
MI[7_.S[K+FMU/]*M_?>Y.:>W2N#!1J,I2H[E!%*0Q'(AB<0]=$[&P+1Z\TZ^
M->K1)]@N4T?&VJC51NW"J'D5?0:M.,T"$@T>E<8I[HSRS((U\T. M5%[*J,V
MTWU&@9!.1R VR#*3.UEB0M7C60)D$[@+YLT[\5;#@V<M/>4<QZG $).5R5IT
M\YKZ&LMSC5^! ?[K2@#YN7E??8U;7..I^^H^0:#QCB!A;OT#5RPIPS5G*0%E
MQE'\5KM$8P;%K;Q3==5ECN-D\4,5BHW_'F7GN]WTXNL=GA0KM/Z@)U-8X7O\
M\!7B__[9V>:=[WZ_3YO=/P^VOVWOM;Y]*K_']7_A&YOO.ZUO?W9;?+N[M=FD
MK>Z7LQ8S=*?JZI <)9*7[EDI)&)R"5P"$EYIJ50Q5>FR=+:!UGF-Q4\39K5D
M012)"HR"BL%SK8*P-BF%1%NZ.F'VQ4O1C]:G'<H5QWT5)*HH"021B>-!$<Z-
M<TQ8YJ-[\^XH]>;GZW+*9 ,WK]T?URU/)3$\,Z1Y,<>DLFZ8_I@\VMC,(@5/
MRY@=Q8*/2FMKP&>%1E2HVQX.%L18[%BQ;*U^+[SN4K&GMFTS1X2\U'XXDXCV
MR1#(Z.X,HY$HZD04(@6NH&Z__ OH;X*0G!.EM-=#LLH&'C7-IE1[4R1WMST'
MNXW^UD=B#U+BF2,QR;5@X W)/NA2)AJ)!44)#2R U99K4\:>O37V5QZ<^D*(
M)E,Y2BE-2.@]#64.%1-8,=,ZH3>E-=%\;@W\ZT:*P#:J%G;;':0&)\VS)FVN
M?42*T-K?WGR_AVO!>S5YZUNKW?R*1--!--X)1V1RE@ H))HV 9%1<P[6,6OR
MFW=TA<M[$LT QC%NE1<)(!1,9@5PQY1F0M!8$\V7+T45T4PL&U"2.)H] <,=
M<<X'$J-123% ;R[>O!NV?UQ+-.VBB.8C'%*^&**IZ@G9CPE4K0])^!@ICP:-
MF#8Q92TSVC=N8^;IH42SQJ)WL6&SA#*@5P$I"**8T@\+$O$1_\&M B.SR9JR
M-^^LO:XG:SWI\Q7H**+6,B(FX8X[@"P0QEJ##L@R)ZDWN2:32Z/ ,V221<\8
M,$&2,0S1J- $B8@E5DLCO40S6U $>TL7EC3V$J>!OA RF31Z2!N"3FB4D\C6
M4(L.TS.7 N3(:C+YW!IX.D$#SJJV7],T .];QOYL,7Q/W4(#MKY]HKBF=KG/
M1GF6?;PNTH0J:DD=,U*E3'C.Z'^U3L1*&TF2PNB8@_?<(TQ=47Q.FY_;D$DN
MI,A.\U@:9-B0D%1F_(*7QH L<5&3R1<O185,QAA=B@KM?F*.0&FJ;UG4!"1+
MS@8O79)OWE6=2J^CDYS7<<OGHI-UW..V[9LHX\F@N3): 4,ZR="Z98[F42F6
M@JGIY%-:,3IEQ79P.U*@-A/D_!3=F8G$*2,(HE NP0!HS]^\ WO=^)<Z-OD*
M=)0GFRUWRFI@$',T/D=NG-)<<,&L722=K',+[JN[?%IWI0ZHL#(1'HQ"W;64
ME,[6Q$:9RYDT:$C+F%M0!R;G9\!F<#1X 3Q;X"9[BZ02'::*)N,_=YLO4'/)
M1]#!]DTAI<-.ZT-K;XN_[VYQ?$_[JW1[?Q?POZ>MS751FL26^VQL_KE?<<GL
MA)9&6(3_)I1A@I[X3 W1#*VNS@QPLTM@DMXW Q9"=#RJG)*-P 38%+UD*GLJ
ME.'FMH.=:BZYO%)4N"1*B_%2 4F9ESI4<,13%8E)@5L(B-Y4_EG+6MQ[6D<F
MZ\CD4OG(.2FPH*1R6GH*$CQ*N4C4R])7.TNEQ74#FVHJ^2A&;"8R::Q75#).
M BTCE+-CQ'H01$>9A(TV ]21R=>NHQJ,C8FK,MP<%%?() 5765!+C6=.UI')
MI5'@F<BD31*0\CNBC9/()[,CR$(RB8A1(5CFJ,YU9/*%L,GJI%52'H+@D".R
MR>"BX3DX[E*^0]O\FDT^04QI?H(B8OXFV^J69J7OV]O=3[19OM_?8AL?UO%Y
M.MW6YJ[<VO_S8/L]LDD5=?".)B(T1_65!HC'G25,IR!-I,@%#:KO"KMO9#+I
MC C,@P=K 6V! <]$XJ6OAS6A3G-]!5)4V"0()2B80$).I1VNY\0HQ'%>0E")
M6<$MNH'*,MTRT76Z<7L=FKP=G]1U:/)1,UV9,\@?E4>D"JY4@ C% 2TH!1\5
MA4665-98=4%QR_.2+&NM &'QA5J&6#5JXC@-1 JG(QJH,N"S8%6PL\ZNCER^
M&A6F$:)(.N48%7B/. 3AB6, (H*12=1T<VE4>(9N&JE]-EX0I<J,U2P%<24E
MUG%)/5-,:%WPZENTT$NDPG7P<B[=]"Z%2$M".KI3P;(35C(ID'+X8$2LJRJ?
M6P,W;M%XI?5ABS?W/XG6V?M]?!^TM18[6_BL6WP=R<+V07-_7;;*NDI5I?"2
MQY12*40)!&@Y+9(<B *N<><9U4F4]CWBOE655$,0D7N;I 5TZZ;($DU:R^1<
MXC7=?/E25.@FSSQ'%B(1F5,"3/'2OB>33 .5067*C/]Y^QY=QRZ?BVO6<9';
MIMA%E/.4- BE =&-@Z25*N=I C&/K]OW+(5MFZ&9N$N@M:,D6*L(6)U*R7<F
M3B#!H-(D;]G"4NSJN.;RZJ^&R+GWNC0Z ^#!!6 2$8J$9+/FMVYC7><>+$)/
M9[BD4#$Z&8$D8!G!*-/$9H<BREFVH"6EV2(850].8Z\#EX_-)!7N5=2*.LL-
M$@"/8# )Y7AB 5STNF:2S]TT?G/UJ/D'_5'IX.9'?.XO?'H*XP;>8_O#E]/M
MM8\G6V=;HE7]=U?B=?=;W]9/FZ6KROZ7T];F7F[N![JQ%@2^)[ZQ^0DV/NW(
M!"(RP8D6 =UNCI88L(Q8<(JB&)36P(5;WCLQ-L:(U#($F\"#8MZSQ -DI2+Z
M>\-HS2U?FUQ].6FN[@B.AB5)0UR4)44M!^*C"H2YR*DUTNMH?]K!IRZY7 37
MM'5<\U&Q:@K*!N]#*>#+$EE*$J4UF9&EJ@!N/4>JQJH+L6FM*S;MX\F.L"*F
M<L05J=#EY-00$PTG)D?FK.3!>+N01-DZ<KF\2IHESQ!95EYH4"IYEEF0.G M
MLC(YU367RZ&\[2GE-9E)X1(G0LM$@&E)O(T.\6G)F?+""<'KHLL7PS9!4J7
M&(^.$;B01NNL(Y7>F)""K]-DGUL)-V[LXWF(GRU(_X WNY]@ZUNS6N_6_BYK
M[O^.[ZK3;:ZU#C8^K/,J;LDXU9+%1%@(R &D!6*IER11K;PS$4#)4G2)^GT_
M;NF,B0Z$UREQH(F:4%JSI614B(Y)7W/+%R]%)6YI;# 9&&(W+1@!))#$6JD)
M&GCTXD8'P>0-:;)UU>7SL<DZ\G';JDL).1FI=1(<I3Q[&H!RQICASKETS6"N
MFDT^CA6;C5!JET$:2YRQGH"*&:%H2L1S+GE4T29.ZZK+5ZZCC 9EHPR.Q5+"
MQTP9.6- A2"-,$+7:;!+H\"SH<N89 #F">/1$@@T$!<B)UDG_)^F1I44@[KJ
M\D7029YTT%0DX$E"0G2H<?<H2X)2ZY!VU'1R"<YT+H-,ZW)C;0NF@TRML]_W
MM[]MB8UOZW*[V^JT/GS=:ZT=G.&SXYH_,?S<:?-L^Z"YMI=;JSO>*(_H*!)#
MI40/S!(J,/IBE91RUN7DE2IUE_?N" L!HJ/E*!\L<.$=2S&"#E9KD#'5B;"O
M0([P/>R$I"W"-46HSP(]01F(ZKDE@5-C+8^92_'FW=%)ZES?R&=Q(T9^X0"E
M8'6 \C'A*EB>A-?@.5.@%3.)V6A-#A*YC$\/3H:M$>D] Y0C.[8C)"!]\))P
M YI ](P@U:<D!!:C$<Q2(>H Y6M7TBR"TD(YA!K@?#*4@_8J #>*L_3@C->:
M4SY&E'*LP26B 8E&(A--!*2SQ(@"*C@JL,X03;(+(I5UC/+16_E$$77"3V8%
MX-'\!A&#EB::()+,=8SR^56P.4$&FJ>HDJ<S9&"M#+/O[&]WF[RUCV1@[0O;
MPL^CNN([^HQ$X>./C0_KIQMKK4(JJ4Z4Y\"(9BZ3,N4;73#/Q)1$573.RE@H
MI/+>&;!9H3AII*S."'#)&Q9+]W=5LA@$];HFE2]?C@JIS+D826&0199\%2,X
M"E+R1 @O!.6:<N6>CE3^PG%*P>LXY6/B5;1<01D=&3,1C"WY.XX&)@7Z3(F8
MIR:53VK'6E-V; =1C 7&$]&A=.PQ1A$?@)$L0_3*^YS U8'*5ZZD -0Y\,Y)
M0R$;[QB74G/K<D[:T3I0N4P:W)[28.6##3R@WB)_+!H,Q%&G2@:[L"JR$&3=
M'_:ED$KK8@(I&7BJ07/GLW"V9$!&2;5,O":52Z""5\OAMN0T&=C&=;:ZG[O-
MM?63YMK[O=;:>WQGZV?-_=VSYH?F*;Z'T]:')M_BK>DR2]E<W?'6:1]])JAN
MK$R03F4*+;ID%I &1D\M3Z7,\OX=8U64AFDED\N@'// I>$FRJ1"S"+5)/.U
MR=67D^;N#I1V[]YSPB&B7$F0Q$<!:/:R+T/*J13^S;M>L6!UG>72,<XZ0G)+
M,!LIA^0A6* ,4@ ;5.*ZC$^4:$!I/8_DN1AG5:HE=B@K82O-21F.A"C5:&*X
M%L33P%1$-R1BJL.8KUQ)G4W!*:Z0=DI(S#D=(?.4C<I&>+/0,&9=9[D LCE6
M7A&BK?*@O*%  +(DQA7N:64VJ->0DZ_K+%\.W00*7@;J'!?@6;*"9FNHU4(!
M4%G3S>=7PH\W)C3B??'92G7<1[SW+F^M?>%X7_SOUEFA![BV'QN;'V%C,Y88
MI@NIC GQ2 ,,JG!6Z'\A*F*%3LYG;AW+I=)2W[=#K(8R:4KF9(P%);,S1GKF
M50PI6YU432]?OAR5&*8%F\&C^ 11NKLYL*2,:R N:L5MYC*K>%,,LZZU7 2C
M%'4,\U$[]YC@=4GV5CX C<(I,"QKBH8N LBZUO)I[=A,8BS35CKT)P1=CB?
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MNN@>0,;J1"$@W%# E3"2"D"V(FA,U!GV4&I9*^G=E'0F1388!5YJPJ6A)>'
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M>CL3_^X-SE=SZ'83\8/D#HC+N-C?7.?$G0[?_..J7T07.+ZX-"OE%4X__?.
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MS1]?6?/M>[J_^XTWC]^?[^^^@?U/?Z9W^?JC>?"ON'<Q7:["HN-* T411XY
M18,,9A1AS)6EA 0(<FM'PC3_0F'\*_!31_BQ07*BA?4DDR:KJ&TN"-&!* &8
M6!C"#X;Y4^L*_"P+?J;*.S(M(PABD%2*(  !2!DJ4" L*..PAICY1M4&,KBO
M7>GT?)(ZK"=WE2TX:)AY3^,*>A?TKAB^.'$)JC%SW($U0A%L G68LB!!,;8D
MXW%\^'E1$'PQ!)_*?S;,$*4415Q2@\ QCQ1HCX11G+J@ I5\:V>:"V3M\;L
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MWT(SZ7U,CG=N)0':>61S"C+ECGA'"7 <LU'^X.ZYFX.3=;E'P>N"U^MC]I9
MRGTQ>RIB2B/&7$><B48  14)LY-J1=Q@$-R[I'+QU@XG!;(+5!:H7#_3MD#E
M?:%R*N;L%(5HE4.\"@3XJ%$"QY!YU;2V-(+"8FN'T <'G3<'*Q]\CRHD_=O
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MC3\PB:S3#DFE95#.<0K[PQ9YP7(6XL)(A9%6@I'NF:NK,-+C,1*II<A/0?O
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M:#WRGL)4N,24-N.]!F :P\O,Y<%P'J/A@DK.L98.-"@7B0K81\$<_#X"M9_
MQ(P&IW%CZT,NMH.J,6]=GI9675^^C/^Y2N>-[W[H-?;!'\9PVIU987EIO>D/
M:HOK<M*JEUU89)/]\N</9Y\R_//L[Z[M[559L)[ORL0'3"HK?8"9((;G%%4Y
MZ#HH1 UL!R+"QN+L[$I;3?-*-I.D/JR.[]GJ41F46B>P$^=%4^VF'M9(OU?]
M-V_FOFN'PT[J^ NK2E7."KD*8?XRPN*/_#E6$L&5XMDO:M6P7ER7L'JLL\2K
M-;@O[# GW3Q@8[EC$'W_2P]Z'NZL+E4_G2N<_%Z7#NXUT^-QGAH*Q\YP,.-=
M>S*,OT\__!$Z0^CAV>^=7C5OU4U_7'UA3D@^8RBL7CB^_,?W3A@=9AOV)A[;
ML2<><9,W3RYO5I=FS)?C:P)O*BFOO8PWR;77?O58@C<%OO[RKQ[[ZVM\E1K+
M&"N-Q?16C[W!G[,1;IOZ5F=)\P\-+OID;M,G#WP<!T_3JYITC<?[2.;:RQQ[
M;0_KLW9M7H\5'8P/,]O-E:%8Q94\OYN_=7I3,\#P'[>8[D4R1C1[@B="0FLJ
M.2RK\]<"8:T'<2)D+8,P;C%.*SI(2UAI2UEF*SI\\];8<X@1^7!9\7JP%#]K
MZJ%T^_ZOKOM2K5!*L,%')1*S7#'K#"8VDD 8IY@GO+A[PMCR-,D)5C,[O1X;
M"1IS('-'<]/8C>EHY_O^WL[YSO:^V*?[^9Y.^_B=V-WN=CX??Q3MXQWX_+G3
M/N\>S[HQ[9S_>0AW?F\?=8\^5R:JM_3S]E>^^^G?QY_WOM+]\Z^\??R6[7[Z
MG'8Z]4)'.F"+K<#(2NH0=XHCJS!! 5?&1B.=<QM;;%G5E%<E0V!AN,)PL\?5
M-B6;CSPU=]PD;42RN3"Q,LIKY6Y,JEP8[E$8KE;N*2?)LE)26$!,(4X$0X[!
M?[TD- 0G71()&*[NAU48[F9!_KG1VYIRFQ74QZ!,T-1R;XU3VCCNL"  ',[)
MXGZ#A=L>@-MJY:XB$Y(SPA%V+/N8*H(L\1ZI*(PW3!'&Z,:6>/!*$878"K$U
MDM@8R&C:@.@FO.(X2,=%XC;QY(21QO+%?0P+L3T L=5J?4ELJ28V(6Z T[C%
M#F6?%V12(H*SJ"RQ&UO\P86VDI#ZEIA\/^.942J&7T=)D@6KL'.6)<DC)@:6
M>6*&"V=--!/7^&(I>UI*.IMC*?/&>!4QTDEIQ!-L&3HY@CPV+"B7\R( )8E2
M$7R-L6LU"-J"J0"XY2)J9Y2@C(,(3I770A4;4".P6[,!&9BPF"1H1RQ4%;,4
M<A$(EABJI1;:"Q(+=M<;NXYS(;2,P.*,ITB=9#AABK'%FDJ<BHVC$=BMVSAR
M/<S %))66\2C%$C;G/(C!ARBC8(QLK&E[EV>IF"WN=@U.1=&9)FF(P\T&NXL
M-I)XXH*'"T6-;P1V:VH\Z#/"2V.0(M8C3CU!ABN* A:@W1LO:*XO99:5'K8D
M@+T=\OZ>'S1QGZK<Z\T_A!FMB3 @.#CN#370,JDUD!$12EE7=/:GYY_VJSDZ
MN[;,8>E1,"K'8^&<KS"J+/=C8;&-L(EL;+%EE;9KT"E(P>Y/SS1,0-H'J2&!
M<&^P$4DI;GGB(="@>='9&X'=FLX.)$L=9Q1%GF,I32Y[IG)H)4P=D? 'E+B-
M+=ZD[%H%NTO&;N!.2L5]R%'/1@LC,>&8>*UA)8#^5W3V1F"WIK/;9*C7EB*E
ML$.<A(2T5PJP:[V"V90IJB7Z)13L-A"['N;:49%T<HQK+(V,."2.'1;&2FR*
MSMX([-9T=NVBU(Y9Y'+*.IZD0M;BB)@TPA.2<GKVAF'W.1RPO_Y%+H-RV'X=
M"?$0A73*11X%)RIH[Q6//F%"#>64%L6] 23TH:ZX,^R<Q\HBC$E.\1TYTLHK
MQ+GS*A*E8V ;6\7FO][0#8E2FZ3./J[,&!.X40#H*(*,)=ZB&="MZ>T$]#46
M+$,LHY:[F!"(>PJIR#6'9>M34 6Z:PU=%I2WL*OZ;*@)'C1![(66+E%0X8VD
M16UO!'1K:KMW7D@/ K_P$D1_@2WLNH$C1Q3UQAI0 ,S<#,0%NVN#75#+J$Y&
M$]AM>2+>J1B]-%:()&CR16UO!G;K1^W,N>@514YSDH_:$WQ*%$5-HX6+5DO5
M,.PNZ:B]>K?:5*+A&OQ>?V2[K9O2'I9<&R42_2;-Z'Y%6PM%/P9%S\FU@55.
MY*L94BDRQ).+R#B.@:(C3*0TFCJ5<VTOJWCBVH>B%XI;5XJ[9T780G&/0W%U
MXT^PF">%D555\&8RR"2KD36!&!U(LHH Q?$'CT@O%%<HKMD4=\]RLX7B'H?B
M:D8R#=ITS)[L$FN/.(L>.1D#(HY&PD*":[GNHUF64VFAN$)Q3>KX(E+<_6K9
M%HI['(JKV1*#E#2?TR A1,Z^H1RR 4MDL)&:FB XK6R)*T-Q$TOCM"'3]2PJ
M EOV$<(MGG&IPPRZ%/JGN:['7;)ZEU:N;2N?0R1:KAZ5BP&=#/KAU(^&&?NU
M"A#W]J-M7+>?:\W[V2JQ)B@14L"&)4Z<,DYS[U7.R\E=B"6LK@'RP>Z<L#HN
M%-/82:29B(CGJO=&BX2""88H):33/EMY&N0B_$A*3J&B)O5M 2H2CIK$M?1<
M$LYPM%AA'*'+PGM/I"X&YT9043U*4,@4'7!/$@94%89!5<&:(BUETIPF1URA
MHD)%3]ZW13RP@K:$1$E)2-P0KZ-Q/DEC=+*4$5D,PXV@HKIA6,:H8M(($X\1
MS]%3FB2'//.PJS G+5F*!U:AHD)%CV7 ]:"+>:LQ9IHS;YS!PAO+@'ZL":'D
M76H&%=4,N-XIH6A02"BB$)?.(^>U0CKXR&(D N/LR$T:1$7/(8;S?1Q&._"'
M5<'H$+_%;O\DEUF_SO>S>*5?)(*P1 NJ<6!*<&.\YH;)R*UDDGO+B\MC$XAH
M3APG(=J9:!GR$>M<?,<B2PQ#AEH6F,R9L".H9_?.XUXB2IJ+7>:4UE9BAD$.
M#I2#%)$(]KP2+KACQ;32".S63"O1PO2H!%*#-:#/.,F1C<0BG6#^-!-*4E^P
MN][8%2EB28TF+'EN53(Q8D$CTTE0BV4HMHA&8'>.+<)%"U(2"BGONTIJ9)C6
M2'(%3!N4PR8K "7A^1ICUV*M2!)>8ZFYRDE+>1#6. QBM%9<%N6]$=BM*>_"
M &9Q/DZ--B(>8,LUD1(4@J0V2NQET(#=>R<^;%XD9Z.5]P^Q"U]^>='Z$GMQ
M8+LO*BW>AN-.KS,<#0 "W^*]%/EGD15.>9,8A54< ^,Q!_3$;#7GL+@Y-C04
M1?[I26EG[V5%2!4Q[;V&9^[S ZL,X<EK9 /,#:<./C%AD/<D89:,U F#-H"7
M52F\0<<;!;T7=1B8\R1*!FN!<DF8D3@%)95P@G ?BI=$4]![-H->G;3S*224
M@XP0%\HBIV)"+DK0\*.V3'- +UG#P\F"WBEZ8X"I]LFZD"P'W!H)_WA#0@J$
M2^F*,M\,]+9G]U[!9=3&8Z2Q XT@8I[C:RG"A'HMO0^6L&R)6U;B@(+>!J+7
M<F<438ESDK@3R<"L&\I@]J43T=FBSC<$O;-[K\<V"( O8LIJQ)E,R+IH$4N)
M)N9!%\)9<I;+*F;<H-/X]4[-M(BI\7[1KRM-7"5=T2H0U^NZRN\I2\HDBI2G
M'G&81V2EB@CG4LB*T,BE7DJ^HD4QLD)'#,\8]R6'SXK@?E9@$3Y)XI-!GE"'
MN!0$64,<8@Q;)5U2+K*E)/$IN%]'W)?$-JN!^YJ9P7LK@K/954!DAQ]&D7'8
M(\6I#E'A((&AEY'9IN!^'7%?LKVL".YK!@J""0E<HQQCACA1!IF(!8C]RBDA
MO4J8+B7=RV/A_CFX([SM^?YQ;(WLCY:+O9CN6;]YW7CKMZ<T4$QK=7V(@V\=
M'^?3UY[]\>=XXMX,^L>%V.Y+;&_G&#",#T$XA4!PB8B#_ D"C<3($5+)ID%3
M L0F:[SVC\9EL'J"XY3G3 E+MUT42G@:2JC).B8(81-'1LF N& ::<H),CQD
MM[04C;"%$@HE/()9HU#"DU!"S>P!-!\MP0'A!*HIYU$AS4A$0D9A=,2!AKBQ
M->>4HU#",Z>$I5L\"B4\#274W"6-\@JS@!Q.#'%B/-(F,*1UU-&1X),G*T()
MQ9-CCB?'BU8O5GE'1_;'':U7XU[.2^;Z;!.=+W^ FKU5--\'IAU'NPGVB[(C
M++0C[,SSA='!4F,0ETPA3J-'%@N) A.*.*R)2S([T-\[I<[20?3$AV>%3@N=
MKHMK4:'3N]+IK(!-M$HBIH@H3Q@$;*F1U2X[&2;.3'+)XNQ:>/^\K85."YT6
M.FVFQU:ATSO2:<V$J4$Z!3IUR,.FEU-&**2)3,A@+96#S=*Y*L1D6?E>"IT6
M.BUTVC!'N$*G=Z736>DT"1%Q= G!9JBS3 I,*KU C"C-+&74J^P K]:'3BLK
M\3]'%EX*_X;.MZUIU]JGQP 8/_Y_7N:=WFFUZK;^!3^;=FT"%9[-PR?]82?_
MX/=![%99<?[XW@FCPRF.+MTUZ3#^>8MUT+?3T?6W7.J6CX"YP>/3 <UMRNF7
M)I,\'JU+?^?F5L #L.-D4_"@E?)@F4L*%%1*J^PWS(D#93:F-QU>5*<[L5\B
M<H-HOR*;H(>_V^YW>S;<^.>5@3CN]*8M$GHSC_OLD#WTP*BY [,3PVC0[W5\
MZZ3KKX[1D[6IW1_!PT;]UJM^K\).YM+6FT[/]GS'=EL?1O!%3L0\;$B#?_O8
MLZ>A ZW\1ZU%%PO #K[ &LB<P"N99OP[-X!U,K\7\RY>]]@)-#4T]]*+],6+
M'GM$LB5@W.ZG0/MFZW'>/K_O_[K"Q$M0W:Y*%W^#\ #<^[(7=D>'<?!W?S@:
MQ%%G4"%B<M(\W.X,?;<_/!W$/7CWGR"/?'UBZ6+WPU2Z\&?[>Y\/X1I( ?^&
M=[SOPH[/X?ET=^_?G=V_VH?M[7<@1;S&("ETXW^_/_O\*9PXRF7[_-^'[>/7
MT(XWG?WC]X?MOS[B_:,O9^VC?;%S_);G>]K;W2-X9FKO?3T[X)RS%)5#P>:\
MFA;G&A^>("=3B#+H"-+<6!J$;3*&ER,8($RL5301XA3C5FBC>91)!1&8DL'
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MPB/J+6!PB@H9G322AJE@O$[1JSR/@)#-36MI$;A%X!:!UTP+]()SRTC@0O#
MB7:!4^X])U$HQ^B](7 +LK<"V94PMG944!,%\CFOEBM&D.;!(9RH8SQJC2G=
M.Y"JA=@68EN(_:X0&V-47 =-B. $&TL9X8X(AYDV$?M6R7T(^+N24"!C4M@J
MQ$V2B O%D%$YU"B5@8,/CG-=AFZ1U42B%H%;!&X1>'-Q6@*<Z(3W(DCN$C.,
M)14\II(*K)5L?;A;#:TK:1N>)I&X4PC^DSN^4X=T<A$9)DU*@A#M$T"K;'VX
M+;BVX/J]U5OFJ I64FQ#Y-FUQRGG*A@&?Y"X&;C=JK<[C<%KDF@HH2D[$P"
M<_*<X!9IDB@2QF#/1!+<R3PW#//5*MX=5'!+AL4_"\D=-.]S/#D'_O+P>^A^
M//AO^*=YD7,[/.WVF_5J8+KZ+WF!>A$7WT]&XVZZ^O&L3C.KGYQ-2WS']E,'
M>/W4=ONCCNV'3B[YA2?!W[K]C\!3Y[$/6QO]9-@==^%"M]\97%\Q?-WDL4Z
M[_=/._!-@(!/G7-8X]FH$_LAADZ=Y%%):JI+I@<MBUF\4N> ="XM+!4>U8^I
M.^X,4N<_;I6V*T6R3F.N#-<Z@55&> J)<.P\CE5M'LT##W,"'P4,T]]O(M!*
MZ[ 'AEF]^#\OK][^'2YRX?/1YU\OW_Q]Q-X #AT]>RV.?X=O?C[K'O_]6AS]
M_A<[AI_?OC_%;Y\=IZ/W?]%W #2".$U1P"JW!V$"&<THTM$&$[#P#(NUP[LZ
MP#.]3 >9AFY#'%LU!:XECFN)XPU[I\$.4)%:E+0WB$M!D+8Q(*&)-(H$27)
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MKW_^XTDG_Z<#>_RQ>N6\B&XI1<O":I@=*4<@&H"C/H#0!/']Q]/R-D5HOYK
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M3[TG-&JNDM2223!J&>'"^61IK=U5<\A;[>[^X8XMPQU.*DH"YR-PGDBGB$)
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MZ_QYWP_.8\=%X(/8Z5:_C>VGU:3]KVV &PQ#'*+J;7YFL 5A,'&]V&E>HO[
M>'#Q<]Z@T:#7#>7BUV%LZ[;M/^YK=QX,N'-J1=2$<DXDC\1I QL%<MTR#UJ7
M%K?V=524G)N:_C8<G%>-32>P;R\NXK#RKOZK$'GUN9-,XK]^&@\M['NW;X=7
MS_.(QN-!/Z]R..C!RYT^A_4.XVB\*"7ZDW,4!F-4+Z85%=_L46EFF!+-??;4
M6I7[L2C.P2I+N5FJ<))A(QC-LX;W06/?4,7EAKCQGJ,S+2*WB+Q!1*9,<FP<
MMU1B+KW61CCJ,'-$*#M3MV_NV6H1>5<0>3F*AN&XE;0$!:T!D84)R&+K4?#>
M"PM&&2]3I?>YN?- R!:16T1N$7D](A,K<5!)8&D]QR):S*U+E!&*+=.)W]I)
MV2+RCB#RZAP0H9S1F*,4B$"<28(,%AA9PFGD6H4RW9/N\S4#/EM$;A&Y1>3-
MZ,@A:. V2SWF7%ALC&$*].1$9&0&ZUN[I%M$WA5$7AFQ)I/1T7)$D\TZLF#(
M\!018V XA2",Y2PC,EO3>F8G$;EXQO\YMO!$^&_H?CQHWNMX<@Z<YP_^&_[8
MO,6Y'9YV^\UB-3!B_9>\.ETP^OORNEKF=9IY_?<X.!W:B[.N[SSO5_P!!S(]
MB?)6MWB+^2U\/QF-N^GJQX-8>;'C" <.'#WJV&'LV/%XV'63<0R=\: S/HL
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M7>LY&ET)> ]$HUO7 _;(]+4]=3E_>0#ME=%=[!) FTFBTP;066\A]\L IRK
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M!D#5!I AH:I#R#BVJ@^C3GV/(#+I@@?T2Y,N2,T$?P@:B:J''!VBSMT[S=S
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MDB:[-\UD]T<)8E7G1[7QX&7&MJ_%68[J(A<'LEM;&<9^@C?ZTF/67_Q*3WF
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MC -K:_KGKZ 3O7[C^F%H^5C(Y?F!B.:6\.ZY2ALX1%=6^S1=6>MFV!IS;\<
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M8']I?*N4/O\K$][K-]A)!0LI2WNH'* BWCY-Y^I9L[NCX0G&K[I)Y9&90'(
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MH4]XM/C3J1K^9/E"P&? ]9&8 :X!1X1@KF(#1.S YN<(NP<138B_>["OFS@
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MPX'0@('JWHZ!X?SN^]_QXMB$,Y#!S/+BZ5"2VY39@7_.;=_SIW"+>"5C[L_
M*B(EVAH!MOD!<IC8!?3B8R:Q(D'$.$AH/ LC%.-^C,";BHBN]*VU^4WFY5FO
MWBV]W;SH;_>V+_I7O&_,N&WUWKV(_%]I"_D+:[?PPE[]? U2@D<" 9@2%XL]
M>Z)T9F#^-@D,H/\P#D"B RZ, S:; &H4,"40X?<P _"1"\O%!&DI #03XS]L
MFOAF!:B;XY(>!\V07H8$.7+IH1JNB L1%8+VIW\?<#$=QD%(1)V1,C6%@L"&
M G]JR9>$FL*GP(@ O1$]]5&!U\!=>F-XTN$NF]-O]9<!'PO46"/BBC/X^)ZY
MH>01&:9BV7,;A6&RBW<&J_>,U9\TPY88[-\#3H)P =L/KBQ(<!IE54&RE*@D
MUV![L'<&I/L%*2H<P)84M!"NL<=1.]5"9V1=?_YV^_Z\>8F:T"B.@%DA5&WN
MQ,A;[GTWGB*+T!HJ,"4@;N%%69:E7\!=T'4"WP.NAHJT[Y'V0.H,!U8'6G1,
M0K!F@?QTHXF-ADP8L1'8)6/-(L+8C8A]*:8$^W+X%+]#S,OPH5";2<!7!3(0
M^-,@W/X1;N8#QT"U5&,9V:SP)EO*-(2:CV"SIIRA= RM(5<0]T-IS4JC*^3:
M#KN+0[!^S__XCKB'9AE(.P%+2VUJPD 0^_@4X';,%TPJJ7D#DC')T5+LES:>
M6DQ)O!!%L_.8*975SU#*V62GA_!^FXM[,B]P"\*#[0"^S_$X/+A'.D*M'4WW
M*<CD /8BL7YU_;]HXN!36FW4!T+UA'G:,@RS;@20P+@7#WU\+CX"L/&LYC\*
MC_XS)$I'ES[#GZJ+E;!C8(2".F]=N:B9CB?T(%PIW*'26F@Q$:8WBW3N""!S
MD! 1PA1VX= 7D?QE!(@I#^-[8Y]XBGYVRO D=@"XPA.%"J\=?SUV_2% 1BI3
M\P7 D]:3,!0O6<?1K [X&^P9=/0YZ6$)BTFO%&Q^EN(M_ 4_ =*Q'W&@*"KI
MM&3I 2"U(+T]X"XI_>\>A!--E&<[^Z#B3HWT$38$(,31\D<69A3OB1^UN_GK
MR/X7MRN<_WHEP+YOC-C(L;M]UG%8>SCJ-[M]X&,-[K3;P^[_-INM5_JI29"Z
M)L?\? B ^W[.1G#$M\Q] *WSU9L\AP=F7KCYXJ7)J_GY/X<!/%JRW8K;I N#
MH%N/S$,N'J@R-G1^OZDPUT[4&5H([#L/R P.4;4@MQD^QFQDBD+J$/H3H/ Y
MF%ZH=_Q;FAU2)YBC[P9,(VG@N,S++.1C< N8.[I$AX%P@3#1.#^[O7[_N@:<
MD3F2WL&^ 8(%#A[.PXA/82FEX\PF\U# C8V!TR@'"FK!^C )0P>LC<C> 9[(
M(N3X5O)&,M; ;D.&0OM6+TF>AKL&U->/S^!'I%"A2\"Z5J>_F\RCR=3Z#S:=
MO;-^ PD561^8<)&Y)<=/MN7P$!! NC>! \=@-X9JD@5(G(BL2"[%= U]GV .
M!'/-^,1L0O9F&"5J'7$T7G9-P)5=7W/-Y3\#V9:B BUL@9D\BM)?3.A(]T6G
M%%@E]L1#  B>P85(@'@ "3IT<S<JI2SP<D^MAW\FYQO.9R#3Y(M14"17HN^M
M;A60%BQ:/XV;7:-X^YC":@"R'B^>WG(-V&']SH;J!T[Z[=GU[Q\'KW6<AJ3O
M"C 5]V#=^UYQ2R"Q-W$GYM4)ZX'#*WYJU2^L8=:OV:UW]0=YER:ZP!RN9#.@
M: OQ!.40/=?1?Q4?6L7+'BYUL\/15_#KHI.VW[?R_N5F-_G W\S_FK\PJ5BF
MZR1W@0N"[)@DAR%O;1(24#&";4<&ZLM]*$O9?YDT3$3E/@(ZY"9#D\#U'RP
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MAPJ>Q(O#7<'?LLT&/"0"H-3,^P)BU@2[]$/9.,P+T1; ?^O6'W11,V+A_@]
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M27SU(YM;K6ZB4(V$IPJIQJ#4$!624_@]^R8B1J%6(S4JE<^4M@Y,,YL^ XK
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M%PX_][C]'1VJJJH!Z&D>3HW]6TD,2[J@8&[B=3(/$KLE"5 T'4 2V30I92W
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MC$P[("H#3SJZ)L7XJNLJ3E4IAL-R_>ITR1JVQI.9N]1#2B:090HP'X2KNE/
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M,Y(I?YUXBJ1QF<A+-,7.X0PNFX7\K?['.Y64\59XM!-Z:!,7#PB<>D,*G2B
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M)>)$8TW!2(M)!F73H5'_QS0KTGIC#U9RZ=*UYW:&KA+RQ;P$S*5_<ET=OE2
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M6'UI3?P(,Q^_A*IFXEH012YX$I/7U0Z=^"$,_E4P\JA?-/L7\"O2:[1Z+IA
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M-Z"@B>@I[2'@I\X,3:0LZDQH@)CUXG[V-9.6&4/K10-:A-(==),P8DM^&'C
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MJ86EU)"?0)&(2:1*AENHC8I=A@I9H%%2FKW=OZ4=#:93S-!?P>(+)=7:>B;
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MQ!F$RA?'V_64.T<^^ ;8R^1%HZGII,%>Y\2DO8Y*Y0QL&_IWP@M#FK6CC,(
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M!OVG!2W"]-5LL>Q7ZRM:%V[\Q<_/PA*/R \.M<CKM#:._R%,:PVF=\>(R[/
M-87];BH- J-)<#^\@AH%]+52R#M,]0YGW6GZ2 ^JVU&G6PFG#:MKL]#%\L6G
M4Z*>]J19WW@BB9X6^O?I=#K_H^*GO]STG%UW2Z>%6XJ8%7#T-'76WI!>60M%
MV.)4R=DVK\DXK$3[3NM7\5Q!F]+J9+6F \T-B\6OLQ[#M,*MS_X!R[ROS7TG
M0J$KDBL0M5*S\J11GQFYZER1GFO2NVY=IJ<)\#%M(XR(^5?7A\.3I&&_\-NT
M>I,B)]D6+,5&6LMJ@5DG,X3,"J3"1%#6V]C>D=X)Z9AV&4;,X /0H!EE=QUM
MM2GRE]%F LLQHX80C <EJG/FD$.T60<57,'FK:J; !]5C901,_KP+#F\"W]:
M2.'SJ4>ZG%/P4=O$A]GG"][K&[)"F4^[.?FNE[7PC,*7/J3E*DQ/ZX+0BVW=
M^T$A#N;Z'TZQ!PD+;IR_.>=))\,@69MKTG&N]9DM<"=Y"8Y\#M'\Z*#!,K[_
MFO$%P9?2B_6WW[KE<3=[/</_BZ$_KRDQD2$HEZ6'&+FL=9@*!"4C.&V2S5D4
MXUIG@.R'^/$X[DVX>=?D/Z"Y!W-K;L*\7C )\OOC?KXZ.G[9?5RC7WR![Q+7
M6 P''J*JK=0*1!\YZ&B*16:<2ZV+@C0#_WC\]0<E;EL2/ R'*^A3_.]Q=@6^
M9(J</N[ *%:;=F<//C'2I"D&+4OH0^N>K\W C^D<<>P<;D:"A^'PUYB]2-8+
MX:!8HVG<"48QB_> 2!HMFK,<AHXK[X=X3*>,8V?K?N8^?(#XKNJ]_SP_[0M%
M<<J%2GSK3[2-]K9_WF"AVXXB[QF'D78FFP=^X<_+?_WRZNIKU>&<KY9O,>1N
M^IF08']"0E3ZG5$J;')\EI]_1OILOEB8,SN%Z'($GA/-A\XXB$DJ2-)JYH-&
MY^^RVD& [MWR]"K C[]T$\^S<3I$,,[79!//P0OM(#-)WHT(JO#6$^MU.,80
M68V/;5_U&-W7@NW:Y]Y?)T]/YJO9<J)M<13J,1"8:6H7WD'(B0,3N3!N4,O@
M!R;<UF#'$#8]/E8.PX7&U/U:!<HR[855P$M-97'*@%,B0!;.!.1%1-.\>_,V
M$_W#1#J/A7;[V?$@OB-YUGU?6T*O\5ULC[2WFWCW5[?T".\I2*--^(O/J?75
MPX=N&:8_U5[>K^.T.UH+M)BX+",3S --&[0,JJ(A>(6@@U;<:<VU:7UA>3MD
M+7()OGCBO\["V?G?.E..IM$W/9YTJY-Z2<^6J%4)2 /(U?'$ _@B!6#FF>GL
M;,8A$HVVA#>J-CD#T.JZX_\A+-<P3653R& SOK$>*-?F/1.72+PJ992R9G7F
M!-Y8 3$XRVUDK#0?2S= &=75VH-09G^+-*/'*8BU@&<7+C]_*1@S*0I9"C8#
MK=L>% 9&D8=,P!WZ(C#QG%M[3'= &H/G=$"VM#10,]9<E/LB%F>MY"2G=;73
M7_(9@B@1<C&*,:&E8ZWO>%Z/9$P[LP?@2 -S#.LE/\>^^TA?0QX\10J;&F[I
M\XM/Z;BZFF^[Q>\_AUG8.)U?/EL3BA8UG:GN*"^ZHUG-* F+?V(^6G=[/-^Y
MW-W'/A"P)A[Z0RBQP>;N>A.YI@#U>(RS!4%Z-2.9L&*JA?Y?3N=_5#1(@X.6
MP2]AWOK%"K]^\BVF2S<%OB2:E5HCA3F$7'O0JH0*8J:!HYA.AFN=U%5'YMJM
MW8%A[COC;@WO;H61$TJ^II? 9&*DINIGR"0A\1(#"L]$:IV2TP[]*.*+L='Z
MZGKP0&1IYE[<AG\77=I<E'"! Q8?0>6:T9$8 K/16,6MB+'U?G1C$481(SUF
MV@]-F[VYWTZY&P&NBD5_4F5R-FE>ZXG94!-#2H@0HBV0DV*%%T1>W,%6R]N0
M'GS!O%5M03G)K1:@<[V0ZF,![PWYZ;'XDA/+D;6NP]!4@+&<O8Z,X7LOG,U(
M\\!KYZUR(+)$< .P==%3\@? J^A %\Z355F(W#JCL+T48SGG?<0CX #T&<\V
MQ.M2%KA<-UV]IE[=878<ML-P\,V%'5338!_A"\+KGEJ[],ZG]<Y1'Z9?]M66
M\[>X7/6S.K(FFDE#=$N@T7N:A4TF(@95:TLC#]J;R,,6OL_>0/8_TCD#<-V3
MWE\464;E0XW7A%$2E(DDLF$)A&;*U2X)TK2.?+9'-Q:GY+#,^OHX:!!K-CQ
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M^.SY[&3"#7QVVJUZ-PTU;^;MI\LX&0VTE8RS(D%K"K&400^A+MJ1?/%L:*)
MT6UC^<[CGCV3AQMO XV==J96FOKQC_0^C"]PL5,F8Z1GDW=MD0D"9!,-*RI
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MY9C7CA*="\HZ="9YK9(2+@9NT3)G74E2Q$''9W?T\Y:W.VZ!^!P[!\Z%9:(
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M@NN,I-.<A@U:Z;SU_S:]QWPUPE_+!CO,OO]TZ[OK2[T^2168UQ!4[?#(+8.
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M GN:;9!F-.XFCPX<'&]*68)T0H=2CWV2IJE.47 (7A-F+M%1X.B"\:W/UI]
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MTY;<%>T3JWV:+7@G/!@M,7GNI>"GG+-S8MGPSTO^W17Q/-+C!9<Z&.O!BF)
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M#6\'6%_]XVTG"8VH[*'\S:84IQN RS!R%X@][;KN .]I]EV;4[M-.HUYZ?.
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M#Z_&:725R9%=3 XUP_2*W-T/R^32FZY%?) 8!=#<*D@Z^9HE+L$E%2!Q&VS
M0O%-Z]N:!P$]B7(LAVEG??[NGZ@>8LT]0/\VG="7\T^_C<)XOFSZMD@_'I@B
MLN+%@@B,EJ7,& 2EZ%O%:4*QPBK=>M>B!>XO4WMM:.S! =UC#*N*HWP@I6(4
MM6M :P0937/PA3O0TEF4@B,/K2?[0W!^F5([C*8>LK;VFIKOML0:"!N-=Z5
M#%Z22V_JM>5<&TUP46CJ]E8_H<+6X7Z90NM$6@]Y6WM 7]2R7W6>LMIX>E'
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M;^;"9PK<>;\G0RL@3Y_+U9CUA^:C@ZS?0V[%/5"KTFX[P.HI96L+I*=)U&I
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MZ.(0=D]>L<7DHJP"'F(!I;.!(&.$I)W1)4LOL'6[H]-7ZH$564Y'J'N0VH-
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M%A3YW!!MSB #ETS&[ (^%.A\ONJ^QPSLK^TA$NVAY5_^\?ZB5J QDS5HF>M
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M>XC!=MC;QC<#FBAFUE6JC9VJ]S@-E^3IX=;??W^-2F<IF%8<$L-J^]@(WI8
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M,)H>AH;'-_^Z_BV&!?Z__\__!5!+ P04    "  Z@H%5!5$_AN^Q  "TW
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M5J81&>28[&"B&2646!Q:N561$.]4V1APK0W%-#F84JL#;70XG5ZW2XGVV06
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M5II1@/$#F5YI<W@=<+_7P_$B57"8W)(0+^"I@@P65>@-T( ( P^2[6:JD:G
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M(B$,J4?HLWL<&B #B@WV@%9*-+9'8I]:K%+Y!# G&ZC)_"@ZV&Y">CE(K9
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M0":-K7MSCJZZ6?']V>5G%W 3C)U'OAE\*+D!57=ORMRX+U-F\8)Y>W:="<Y
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M2:_W5Z8GWC47JAI.UNQO_;X4%\UMD6:6(88>V>?\66J=B0-JKFI>X0]QIQZ
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MX?SCI1[9D0*VGH]JAMQ^\KWE(&I:II&.(GTUP<3I+X923Q5;H\VH@X#TMJG
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MR,[E(.S<>0(O?+UY";R>9>!SRNF)\O*N:[XDRL$3X1P$%_&ROM*:/200P6B
M3K$C] S&E<(CVRB$_29E74ERK27?H^W.\CZ8X8_AK<;%2R6 Y!1*(A)EM;<L
M*K5:%\>[GF86[5O%<^+"J(75Q@*#T&$/2LC!D&),+V?[.@+;YW@"S; P5M7]
M %;?$ X#_2^3.(C,?58-O2P.0A!HSD-"NR$CRMUS'(2TGA%CBOGB*88/+3H_
M)EXCS_#Y 5.7F=OTTUGNGVX;#@S:)1M</&%T]-Q]XT6N O\:*@R!OKA#]704
MM.?1^,+0J[Y;54<SQQ9>W'KDL[NQZ+3^S>6;81\1&\+]R1/HO-"\<.A6^9JI
M><-TFQK!NK&GGH,X%<?4(E)P*[CFL6*M, [BH>HS&W%&T/BW_:<X".3 %_/3
M[<0@S*X[\%=N1FTHLSJC/3S^=KP?/E.O9G-_S5%B)F;=_IV2>\/'=:1F)8>M
M;/A&H>YZ2)%)B_=YUYVAP;'GSGK6SA E'1T^G]);V2Q@IZRC!DF;_G1L_<I^
M@\..-7*%<;];;07[XF)9.9VHB>@?W[8LL*U)#02N>8 ?=]2Y1JS/=M4+$)S7
M$G^T>"\C34Q<RR9([-)6W;HPVZ>5R\:/.)T'\;^C' ;""+0;YN&;FX^;!#YE
M>3CG?L!2 R*U91/P?79O6"E;Q!Z]TTW&_RA2AKH*'LTGF]/LIW'2E ^SW8U9
MN8'$KCQB,U,QNK(9N[)//NMZR3J98H:KQ1GB?O_=#0-U:*H7MS_P!NU4QP]]
MY,V2OB6+[[%>!R\<X>X\?!'$CI)NY=&R(0$'ND0BH2P)OQY,4-RJ,_<=IK]U
M_]()"U77H35T*2L?2P;=PVX4^Y>Q+($0>+:W.O@:="L,SK#?$QO^;Q><_MH.
M9O(V9AL.F>MO4;Q453#J(P=ATP\EJ&7J&_4EOMY 6;-Y"(2,;1C30GR 5@RT
M"QA =V+6A]QM&FW.P/)YF8-X X![.8BBH _ 7-EH=00IR6-L11/3P$&<W/;A
M@I;,0:75DU5WJ&=4>7UMK_9N*'3W7^E>RJSZ_J[CD&C&^>6F/XKQ#*O5))8-
MU*4;MF3+,F60J8=RIC,AA=]3E2_Y>$^749B/+Q"V[7=<)-"XL9W9X"$.8D*"
MQ,-!4-YA#RSG/U(?<][\RL -<T=35Q^^A$4Z3MR68;5F,A80<CKF+%D;,[-!
M_!UXNE;6I$##U))IE5X,O&.&O6(P=4N^Q@ZHV*]UX<Y+70GHUOD1ASQKWA]A
M?9Y[7V9P93#3:IYWVJ@'13-98<C5P$*.!\G^=)\V5-U'H+#%=GVDZAM*\(;\
M/KW3(F[W6I;[&^#IH4#)MYAN^SKR\QI)AAAMRX1&>+[NK,Q;_UWR^]#MVW>.
M'Q"6]-,KE$NT:U.7*91)9O)# BQVHBL)#K)_#AKTN[D>P.P#33VI_'-B:.!H
M46+A3$'=;D'>LW9/T'3R\,>S.H@=SC2T1L=,3)/)&^SR7%G<\C;ISMPL;J5N
M0$;MEGQ?''NRVW7SGDCV5<7=/W?)_^%]P+S6A3T2]"SX_#K"HH2[\UK7V=W-
M*#'$Q.\;UKCW[IF#,H?*:$/GI+R-#NPT:&FIE1 T,S/8430LGQZQZW]LEZ;A
MD2#IWS^N!4H>S?/C(,K(P5^\[P\RCHFUV>NU /XP0WJ=MV7G=GU,$P2!NM;O
MM;T82D;+;A6@N$HN>VA?P^N3L@W?I$*WGK.-B66T;9'VGB4QG"5:#C_CDE.P
MBI_Q7-N,D#^2H+T0H[1EN8X1P%P * .I^^9)- OE*X""C+A]J.JRJ=:MNHKB
MR,=;[&GT\_Z50<602]<W-H@_5AB:><8Q*YN==#;32-69DOWL-/JL3$V)"PH8
M0;:2O$Y'Q?!**M'2,(33[K*#ZAA/BN@=!?.J=\R_K(WW:. !U $2)=5'ZF@(
M4F.E5G<J+:_"J'W2I-WQR#:0*8W:GM978JY3#IS!KT&:[/NX <(NHR5^EGS@
M1=JE<+OW#36HJL(RRZ4SYT=-@RSO1>GWD=[P76U2VB&J)J/V:/ )GP3>!F/"
M4A543^OAOBZX]9RXF@0*!8:]^G;ELJO>>>LKIYE$QEZ3>?1N\$H%0X'^_@=.
MK7ADD[1GX5!RU1UC,6>_N*OH,#N,^-3LF3*UNV[2W/I*ZXI?KX<^+W/,6)OW
M?)R</'**O+#<;UU:W7GL]\>TDX_T^)_&<Z^^?356B7[O1YP<VXQF9&DU(0=Y
M?T(:J6];J*G^K)MU_WB'S_@)XYZI(;P1>]@TFNK2;0+CB%.@H5;3TB9&P*ZG
MF]+LHP^J58>LI;S4VEW#U 27>?[<OB3&6VY^&9? S Y[%_#12E@G_T8%AG9X
M;!UC- '666:_?&X3H\=!!'T1>O[0OH>0I>P"ZM#T5QI67OGSOBSIO))!E30<
MNUS*Y6-W>_)6/-[LE])Z2XNARK4!U/L?*M<L8A8A/(D"!XI=P+@I4'<*)WZG
M120I@'I81^_"8Y,EC: BR^1C1I^?P0SJ6$U1RE)4<@L-&;J(DV*<,>Y\VGQ1
MW#O\D<"++_>#FM,-+J+.YO*.6Z]&91/+\P%5VT)SX5<YKQ+77-F+4'+M@T24
MP)7GN%;396M"NP\HXF,H+@<*>U*_'_L6XW=JZ/4=1N1<8M2?S9%O5LV]6W*@
MA'EFJA:T)YCJ&/6"5'(J2&-21;TDZ)TM!S'H11L!#&CKS*)?>J0*5 N*K+.N
MXZFXP%H%ZTMQ$7]W2T@F;=J#0M(VSU1UPX*)^0GEMFV-4U'/)DC#/_47UG)K
MIN$8[%7JU0-0LD?%GWU:^SR[G?J-65@2Z1V/YB#FMRWOF@FZY.TC?><@!,Q\
MW0(KLGC94XQ9X*(&YG% _ZHKRY(1AQ6#?F,/>(6_<M1T%W9*^E)7[JYQKY5)
MGL#VG?046XFMW2!.8JDOHK[;-XSM&S)#)2G79'D=S-&INYTB#K+J95+O7OP^
MB'F/WFK(P=B?5W)N6S64W/E08KU)+H9'R!L-6BTT3<[D@SO9E6A5J*UF__?.
M*JZ))9\?W\V6)N8/6O_YGFY\\ICAW2GS,[86A+/Z2M\XB+!:7 ]F_;;>(PX"
M@&7+*^)[7<@OLW9=N%ZOF$]'I^/-G2!K\S4C5[TVD2N*^_)DDBX.@N_6LT$T
M]^8[#B*]94*5!1%  Q2-@1RTAR+EHD@KVP!=>,V&]T,&=^<-X"&%-/,+H E#
M!AR$LRTPLTZBR4'VW83_^7PAH)Z"<21LGTC3X"!(<(!LL&KWE0J)0IXSVKS"
M#P4VP?P-.XD:_#/&9*N"?!S$N_6@+5"X?_/-[Q-9Y80)5.0H_W.'3,-4A-?]
M<RA/?98G5MM^INZGWZ3'6)J:NN&NW;5U61M;T]_E'\AWD0I#HEDR).FT&I52
MYP#'BCN5[FM[U./TGV"D'#ZDYMYA5:VW/TV9V5"%8V=W[U0?0$D#=LHEL>_3
M+./Y=%BC]S(="0TJSJN>D& <G7\$-S"ZHSLFL%*5Q\![E^\NYX5&S/81JP55
M\*"[H2LWQ+=&,QD]_XN#H#V?7:5$N:XI'PNT'?) O< 9P6;7E7B@D>7-T)C]
M=(10:QFK9)]W_./G1!1C&_)BX'E_8A:$\D>],8[4 5,V-B+HH^>:=80\<0C?
MB$\G4>+0R,@F%.T:(?3TM0^Q#^@R(I0#" $7\4FI(*HP&]/8(:C>U$=Z9\Z0
M/E1Z"%;?/&@&1F_,8\.G3&)B.G'0 >:G4A[8GKL7) NQ4;X) /&:.1-CB6L:
M_X&UR.T#X=E%&0A9S1C-_MVVA?ON,RY]?!;N+\/M1.^+O,E^'JB<]^*<9X9O
MQYB@$?I&6=*#-T&W85^K,<#%PXZ^L! !PA,9FK*Q6QE#2?U^4:,0Z3=A*OH/
M!^'8F+\PL7J]/6!89;#]L_;*+U^]J_&M>=E@-N7.Z1D]6TGYCRT:<8;#:_TZ
MTQ%0#";5LJD*J%.!Y?4Q$@^P^+B'M.YOM2&-&M4$R__]<49_.+!2 M1Q$.6H
MK[[NT)P5Z,Q!&*/^[HYTK1MS;D.86;=]!B.*H2RH,N51,$U91.4!LVW68#RQ
MC\S0;8-,>.L %N_\V+9&'TEF8?L@3.0FS2YT<1!SER'<!(HI8;F!W3;9\^]6
M%J;G_[]NCN3_'XL,Q]@34)"C,S,:U<-E\/]^F4$Q_AM7G5Z0@OS*MM6L"[@.
MY9$H!$C2G ^JQ_">6A_$M5%2)>\&;Q$6+40PD0\AS87>::#0'7RW]8/ .EB"
M9Q]]6:T!4\8"1D0TS!A!\MSBGC+Q9&PKZ<BGMBW_UT$U;^:-M%%L_VG==\P7
M<+PV]4T9@)I1R/4'1[FOTOU'WD",EQU3?NAW;SVP+^7BTS98/O!95QPU3%FG
M S6J#U\^#1U/YIUYW6W=7#^4:4?:K[05PV7*DA+P29K&[6]RA9&C'1V!>7U]
M*1_FI#'RKUM.?!'>M\-4G8)LH+ZSTM//+7M!Y>>?,E<;N&N$'JGS<;W_A^R6
ML'G=.]*^V>@I<'=,$)1VI2"Y';X+O^5W3/]S[@&"OYQ/R"FRJ<O ]6;0Z8<5
M91&W!N[)G)UO/;<7>22B$-O:[5HV5<$V,I,5>FUA(!3Y]]67V.G3GMVD-\ 0
M4-<5J,\N02O/7C7LNC.'UNA=^G MRSC:W6[WXZ ;"L1Y*@6:#?Y-Q[;Q@D*1
M]_ - .TJ)MK'PU6]/-K+(3;TI6#A2)OH@\7S459S-N):&[EMV8H@N3W0Q'3^
M-];&GBFE=.GQ;G*!KCU1J"3W\4),A>B,*/$/OMEB>P2.NEF,=_D@0,\VU)"P
MN>5HU28FQD'<E.T^1';?J%\G#O1TDX0PE%Y)#6.<9N"]RL.!>:X'?HKIG EM
M\5!"NL4FLXGZ2C0I'6-[367VT/9JQE8-G^OD^LHH=OOZ_U66Q^85"=C:+%'@
M?A#_DQ$*&?KBZ6UK>]@R\.EW:S'E'$3D&@=Q<7N+@[AB_0CGVC^G"HI/<1"P
M9IY LN3Z2=M/>I2DE. V# !:J@3\0=H)1<7XA3Q[@FA7%K):>\<^\)?72B/J
M=]J1TLP9VK.PFX:\FW\K2@XK&>8@Q@2PG>-S6#(*E/#YZVJ]F$6;'F!]%_$[
M;0TR)(('0&J@W"OLZ@DL%1N/1GZ(ZC+ 3>)D<'$P@A5<Y"#J =]Z C.[G[#M
MT:.TE4;:A:'TJS(Q'(0HK)^J.8B>Q'?8J@V&^2O4JE82XQ_<3"UF50%+C:7/
M@"(]D(4JW18:1VW[%1*GARJV^]?_9D^MPTK+%+S%07PS@M)<G)EER[C2S1H)
MH+D(V("]<DX-?;(!RQ2[ %43V8H/+OGC\Y6/SJ-+M_DQ&*,-JW\GU5ZLGEWH
MJPJ ^."9E^<@&/!</V2=A3OG6AVP,_3)A#9Q:MB=U6Y.Q_R"4FLYB,KK',0>
M,):9#3O8!=_D>ZJ;AVG>R2\2O,S%ATK(:7N:'OEZ3["IV?.EC'/-TGIN8C\]
MHSRPW[&TI_DI>-9AWQWC5FI-$]H3WNMVA96*F'WY3*MQAZO5"#'BD"^7[!O#
ML79ININ^ZW0WZ:$R8HELDQHC(,0CZ)T6W1B468;6.$/HQ]21=]33FL:-7NII
MN41*2$EUNSYM[CW+92EZ36W7F0<\3TLOU%N7Z$(O[ &7H24B)6;Z.'G4Z&HM
M=/'F-F3YWLVL+8#P^VG<59,SMV!Y$W_VW^Q-SI6$FL<[04\ "F7$DX6%]F1/
MS&JUUIL6=^=_7;QT=VYS==SH >N'[[+SME8\E]_<*.D=B:'L#<\I'PH4/DQE
MU\9.[7=Z;3U5G+#JDD]MZG1I&L=^\/7@G[Z>Y(#ID)N!I$T&GHKX$5L()[KZ
MHX+C=ETB^\MW<!&'],T;R7T8AJ:I\5J-6N"#FK&2(4?QP,,("C/>I*Z8@W"A
M8TLU&?]*+OWH*'N*@XCQF50PSNRD7(\Y9X$SGZD CF*_"L.A]>?:=(<3\PEL
M$_+LK1!;E[3XE78.(DL]B?_[,76"NS5TZV^^$MR,^2*;Y1UX@Y9>OQEP![GO
M+OF1Z-W=2VX2P[6\[*)W&$4H6P6AOI;BTXC; ]2UDW:9!Y/<E/D;OS8<Z&F2
MDGR1]7JO7[EW06?+1H/AT%BL35+8+9+]V];000_0DI1 5FVX+%?2-G%/^8%J
MW1SS#SB> ;+U9S,<W9ZE>-5V\/JS2XOIMBON2*C7< @2F*6+/!M]R+H.&H6>
MC=#G('0'+XG<1,;4MN_,F ]:H+Q^PM=TO1\ST[^>U^6;!JD*D#/X*TC%*BH9
M57%#.M&?HB4/F1<,B.(TC23Z=W%S[3V9(Q]4H1,T@].2U#O_*6OS6,863Y 7
M[ 5JC),<!#\!VO.(MB'[O.W!>!BAP>JARKAH67CR<31A3@!!SA%>51#C7<%)
M.F_T0 )6# T5\ [=BBI!0[A\<0'/V*N,5=EY?_MVE^5G.?:6B(GP(%BVYMVX
M,]@&C?9LZ N*U+'M3V68+060#(BSN-:?:G^:G&Z?4VJR3;[ZX?1CC8#N2X]+
MP:E.Z!6&BT29'I&8(]"NLL6?[!,PJCLMPNU0I_V]&C^]@:D$\]:^DZ[\+9R\
MMW<(ZB<A2S'R7'[C7*ZDBE6BVQU46.IV,MA G*TY2$!;G.,@?%8[(5_JYR=V
MO?U;)#5B/GSE"_&O721*+FR;DRYO$H,,AZ/_M,1?KH1/QJMA7@3&8B\"=;)>
MA>.P\RM@ZMXUNX_Z)H\.*0Y=6O,4@<C;_1]3Z@FJ1"E:TF3'WO3 M]L'[LFA
MVE$]K <W4CRBJ*0$U:&A6C-:_>8PH^)#B?(.QQK5W@/"#T(>:%T[I<Q![(A^
M#2MFR]QEQ-.):@!-H'GTU_+A#@)UYU4"+82K(C\%7NI6]KJ1Y'9P22U[P"X*
M*-EYM6+KO?["JKL W20-_51V<R([MW^U8CO[U5LKO;U*1HNF6*/L&5N*KF#
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MVW&&NGY#B#8^/']\^ K:\:0XLO&=T81-A\O[VCY3IBSS9%-K\JU!&"_U@%/
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M@=.BJ@C4'S8_D!@77>,,<2M:]$N+->N GS-C(S[6(6+KR.9 /7$<FU&\5E(
M7,?0S,QC'D-=I*_]]2CAIL<J;BKK_,[.,[P05KF_N4)TB34[S-Y-?$IL!!BG
MLS>9I33[\%)LL(UTS;X[OB_'2]WWM)R43%^XSS+X0#:;S3L6LVLRJ=)J20)9
M@;_K37:"W*EZ1;?V_L@Z5.)&7S/?+F2+U+]+\1@(TLUAM=QF:K+O)D;($_=N
MG8]0B'\H)^%Y5A00U@.R Q48CD1&QJW8!]U59[+).?<JM(>$U$NBMQ6(DTD_
MTY0JZ#-1&]%/-K9&%T2*L5>"'B8,&F$B=;:MEF'=$L#R'@R49J?9,K32YU'T
M&^#9@>-Y$NZ)1=T6176O)L5&SB-PJU]JZ5&04/C.]S'&,J&$>A"ZR5(-N^WR
M>=P^,KF\Q-LF8AL<8(R]NOW&^9\'+T))Q=;;E;A+\M)3<CLG4KA##1 /G_D?
MC"G=/OD'7$*586E.8_6.I\@A).&J^\T+AZKSK1W5U47W*A_U$\7_7-L)*P^E
M#8=UXEN $L-!%,=#O[ T<WS8=^&IK^5]7F=02R.7A >I ?4SB_?]1B1<A>RA
MBHG2(#U_JS5@_X2ETLE\&Y6Y-G.#=! _.RI15Z5RVS"JW**_=YZ#.,G\]>^%
MY!+AOXI.DL\XF2G\=Q<=5#,H]Y\E!,1N+$.S#8+CZT_4ICD16)_Z9#7=^Q^2
M#KL*0&I_E5, !Y&MK%%()3&%8$W%U_6#M'KZ(R2]E0;/W\S);1E85B"0)I O
M3+XF2$SCM!S8HS;?<Q ?-($+85F 'D#S&(.AX@8<$ /,.(A.\9J%>C)3G$0S
M70NGI1T%F@N!<-QE!AIN;AC?@/\W75K1Q^T%_DN/2'X+M#187\96D>H/;J&Y
MX$\F'(00'H^AU!!6PX%(U-9N6-FU1P.G1\A]I$P"0S4;3,=2F]@_,.MKMMCV
M<L\-8BEM C* M281A@#C8'K:_U\IZ-+C6(9V\7@L?04\*(W]+1W: ? NZ.)*
MA%1N(=4&BY&797L.+@H 9T*UI<*TX0C+]F([XGI(/%_^_H#$P,I/W,X:^<31
M$UW+)?72\NY',\,39+E[)?+PYS_TKP90"?SS4KOIZ(P,I[ZBVT[)9K\2?1)7
M5?I"'$8RGDH/O,'7ZR]L$ 3HN;XF;^TVHHBKWFP+)N;5'RV)>WHFUB;_>AWS
M\9ST$8FU.28'H:A@%2+H$2*(J2:;_R1=LI]Q]MP&8*)H!@:&;<)6'!($JO7W
M>>@O%40>BOXLR7J_Y&V[6)2XS"\:NO;[DD"0&/;Y&,V-  JIC%&T&E,OC/-&
MN#<2PP+]'I?KZJVBCQ7W[GBA/IG"\^VLD#JDG6$3C?W^M693IWE]YL@:!.A"
M3ZE1N;XP<)RN'CA-9643QPO9R'JQ+^J,W3?,1R-,3(NQT\8&0E9DPME_]S-'
M&I[/)XCN."7FW_2^#PL<!"T.J#- :P[[?<(J_=2-+O"W;4FE-HT7HUX U[10
M\^0'HZ0WR"',/;0"NQ!]PBGM_ALGG'KO<JCMX="Q*P-LYW6BP-' FX[>$2"Y
MO<J8P%(6!?P@H^1NM>:L#.VMF>Q\7 -(;D8.F3,TL></C>U *SFA+:R^][LL
M1<X<K:K\A[&-/T/(QWVQF@9 \8$L6=+BF8F VCN_OM';&V3VO_CAN"DG3?=&
MO<"]M5HK/T1^KU4 ]E/B,!]]320J#'@F.8A#?V+X)&S1&TS81'G/!0IQ$,\K
M-R_2W*/'PX+(H7H7-F\?1LWGN_^C./G?RGO/H";#H&TT@ J(@$B1'A20)KW7
M@$A7D!HI$A4!:0+26T(1D!H5!*6%CH(0I",E(%V4T*NTT*0G- ,I?/']OO<[
M9\[[GIES?IQ?YT=F,I/,\^R]]^Y>U^[LO7?>8GO<-%3Q[*6V8)['QCY>'-$)
MQT,H$0>8Y,AO>.\O;)K5/="W?*VXJ;;GM['FS)+UF6R51LSU8X?>E, C"_!1
M**AC&XU%V Y6F)N KWM;EX,R[_'FG&C&\YX#C@\-8"4"0%D!I^TIBH&F2,*,
M)>$;M*N IXFBI0*TM)N0$0,B3Q_V<;@H1?/NP4'F&:R,^ZD!$O-0G\&8^F*"
M!B0J<4$)N \^;"O9/-PZRZTO^2+M&Q!PL^N*L=QH"U]YT>^T1'(=S!44RT')
MI+2H\=*=-DTR>#/=FE'VR+Z/J]IO,\^^6ACM&2F>-B:H#-V3U) C6+0<P8G7
M\<"B8+]7&SWCW:!:GO"U<P 57XF2SANMNJUG'6]DMR&IP*_ ) 0VX$5B=;@)
M7O%3K,^4FLMGSX>D4<&,F<@SN,+&EL2!"XJ20RQM/Q+]-Z4Y^CHA6\9A^\'%
MN<YKDDG/$)!Y2GY.]$'^X:='*-TW&/P8,>JZQ.O&Y(!I1$B< P8>@+^0.[G[
MB!1:U*C<F8T9^NRVDLMA,.UCG(0/8NY^%L$8HA@ H:[?Q^NU*^'5+>=OPEP]
M,L#J14^K6J0$/3_S1LM"#)+B->F[OL'>'C;9'MB\:E$\14PN4<4QZTYI>BQ[
MXU5H3Z0R3TI(25(:.D6VV2CV<-F/QRT/BQZ-.=B^ISY@W__++MRQEE*##"54
M">_YF(I)O5%0$:U2\])D]HR0.,V6ZK/JQ-Q(*&E]1%EFQ"QP-"3N4IX\HX;F
M_6(*':3=!\$#@-)066*M,3VM8 PDZ'^>K%W*:$1\->BE)WHL:ZI98AM[E>]+
M-J8C1.*KIC/"5&5'Y5X^U51:"_WL@M=@+./3&1B@!2WWP(S69F)Y7_"K9#'A
M,I=7B>B->WW2E3'=)LR/[$QPA[IO=I>HDEF270\H##  .0G""XL0>5F8OZ,9
M-U',6NKH3_-ND^+5;NU2R8H_APTZK%I3]$]9M#LR9'9DJ!S"!T^5#<NOY]-L
M/G0Y5;HN5[0C:_[MSV0*Z)97^@9GSK?&ABYUK0I_DMEVVC*X5YHAW M;TM"R
M#&1QXQ<>E1I7" KUFG7H#A[Z_5GER;PISSC8-%[D\_'V).HM,O8<P!4.P9H\
M(H]C71/#=9?OFW JJ^D72.9\D5.Y)2>GPLLOL8F*1V$=(;/P#ED# #[MUE=J
M)L$)_PJ)M&,YA3MWH%]"LXA]UY<;Q.6\&:V-8*&;9/JBHR_ UW@WO0B7-#-"
M@P>N%E3\0^+T: RUM(::-?[QT^ VA/G%O!]AQM^6/7N[QJ>=I X&84!XE<R3
M@BDO8HLWQW,UD\?1)WG\]9)H4@"8AKT3R.RG?^P#4::@5=ZKUCL_1D?,]B#K
M,#TYOOR($*0PJ0#V O0*45.27(O_BP'&M6H*B7/.# 8*MSW9:AC9^XBZH$A<
M)MI2S#R+/ SAO9$'O!;NB&N;K^R84:PO+9[DJ('KQTT;</%W<V,WJX2:/Q:_
M73#B:N1X:B0RI56_LT142 OJL:G993]#'6@X>"=<GOP^<CI 3B*BIQ%S/&2F
MB(;&U U#O/"RK7-ZG Z&^5JO4PH3'2-C82YZZTI54Y_LV[%J"GOQ@KD!^:%C
M[?]*?/^:6'OLIA+K7=5HZ*7+?@824'4U7^\"#--C'5FLH>;)&-353L'F8^2T
M-UYAYW%X&'],UR(A'6GVN@E&D[GZ/H,[RVQ^8HLL>@PK6,>>P%)_RI>#;+,]
M%D:>MW/Y0SX3KFAKZGODXANQ*\;X-FR?([:JV5/JR)ME^G[I0E>'G*XXFP^S
M2Q<O?Q_[B*4+X0,MU_X"BCLYQR[]41;(*<>J<$78'[U:>Y*&9_X"_0GB(UHN
M,4*5[X._?WO5<$W5HN)E8M_@1[\)H>2BS^1MIM.JFR@?V!(&@K\U@>Z%4??@
M&CN_!>5BS.CM&&!79[\7MY%S7KW/$26@J5SFYPM!1[_TH$!7]Z@<K-J*X#0A
M>>D,@RI2\5,K^_AXQ184XB8\0_'&W^1 #&]6Z:/D]QQM4U\@ >< FL<",JLN
M;9 3&5)-N#.!@?BR&H>.WIM4_Q3_-L)9Z7Y5A>=/ADX9/JLW=!KLC^D$HAS-
MM544=Z8*3.N5C<M;'5/D^PL<2[@3*T7<)"U!9>AI,_+E$&S+R2GV%2O>WC[)
M%*?Q(&Y<0_[3O:];-DPJGF*@=KA*=\+;0U&OE/= _6Y"WQVM>B)T,[1D,C[B
MXGS*KU^Y$T7T-[+F9X2BXO5M+"Z_W5)%EK:S4X1_?@YP0[U2\P_,@O2T04]F
MV>=J'S8V3-CSQ1$^+>C@N8D5<M@%!^(T=R*Z^%OXQ/Y?X"?GO)M]:9E\]QN^
M]2$'9A=#2 K-O6H'86!-G" &'D]FQJO]A>!,FTOP87IC*]*^89]^5[:R) <%
M"K@.,YFYDX/#=2FIZ"FIG*CG\AC(LC0V$L?UA0@J$^0'M0Y?0YG'0.3#74A%
M&B$$?8\52]Q4<K@>9GL<]"W"E+3'0;7)G59/6Q,ID<FPW"YN";&M8$.U!%+H
M9>H7R.OIYUVDK/1L\O$[(H\6CN)% Y0%>@N3JA3F4'$P!I'6:OQ+=*WU!%]X
M!9SEO89^N:E3PTI1^*B/3_YC\HL70B_U[=_N#X R[@/>F-)S561=C]\GFGTB
MI=VO:1F7RE+.'&A,*'[YMDB=E\FG_(O?+N33VD=''LFN<@7V=_/MR)8(]$^_
MVVC6#^" BI;&FD<:F6]-$^\^_E-BND;^BZ3.:%/8JPHI@Q'$B/;P)>"N(O9?
M>3Q>J9T5QYA:\?(3E4N<Q*L0-M=F[:ZMX'54!?P2OO$^;B/.G^1AV-8X[E]I
M-ZL^*/&)5R-(YEN<$7N\M;@.[0+J36IH[&V#4CEU<#/Y%P1K@4A%U"C'H[Z2
M@>'ZD_[WN1Y^.)IQBB8/S23<7G  T]\L?9AQP^K9N[!#G,.C[V._',0?O+-,
MF6Q1/&@A,M<N:XG&6:--Z^Q??3FJ'SN=)I>ZU2Q5,0MD$2THRM2 =5JV@Z"3
MB]@',%J\6=\YX&K5,9KID9T[JY%+UJ.41..16>,M^_XX.1]]?2->5RX ?+;)
ME-S<3X-%]AVV9C78/GI24;<Z&NHXN_CM$7SJI<-6JJL.1O36N\#)J='Y[#TH
M)0OIG' $9!"61;X#V2^^K3R*L#L'F+SMTYYZT',S&K3[JP+GIL/9OTL!WC-'
MBDA3T)]IY'$$UA3-LVD74-T\I:&2@+DO"QA4:&AV8]=>K9W[.$PUWP-3<'"E
MTNX8@K:A;D/KSS;BI_O'!S53CF,\]H,@R-]0L[YI91.YDX91-U"+P5G$LET>
M':ZT"+O2&VKP6B%A=LIZ&/EDW+/4,N8*MNF=$NW7*_ED]DP#6)GB7];$= ?'
MG_@/1KW&)OXP2V"UP2YZ67H.O>22B=EGG._(BDIX.NF?D<Y3R;\/U#!M'AJ+
M-L?%.[#\!C>52>=VXY)=X94P001]NUQPRQ(X:66*R(ZY[_U]]K>QM;="RXRD
MB[/0M>0'*3]\Y"K?JW#Q7C[+[$)A(8NS15U9P?7>KS/.HDNIZQ=BREKSG0#>
M5Z\@_+*(2;+8E:OES4NES3PCQIM(25:0W6#XW8*==-_J\$WW%2_H"7R3:NBZ
M!F[S?O(:7&@EM9XX'KQ(9L@D6.#)HV%A\*3K)U>-91OOC7G>+M:.$$J\^(:_
M-6X?4@G"OOC; V(+?TIZI<CGT;-P<TK#O *5)%VH/%M/;&R\>$&I^]:IT>/\
MVB=^46G;$%".#U1"ZGN$>ROFV/C'/LP*#A/%$)6<$L\JZ8R>S\]_"U4*529R
M[)/-77%^Y%9)T%'[+.KCXNES&#J4_ &UU @[2 (E(8Z7W<X!)2<3Q*%SP* N
M.6QJ'N]]#KAYAE@Y!\P]#5?^_Z2.Q&;NL&$X,!;JE->6*H&E)3,)D>+62'DP
M]S$<4+^&!6^"B6G[O9=XUR:T6K59-S7/FY4ZM/87:00R3,^%%"75G0.>H:Z0
M9U&U52@LH1OG63NQ,N\5PDVC]-$__Q0LNX%_<[QQI20=V]M&YAYRM$U-"0EG
M-@J%=?S&JJ3=LLV@'X%WU\.11#[XFE"R*M>>OOKG/;'.Q",A< %T E1S#DB"
M.:%2N?LB6]V>>A[GBOVEO\KJ%<$ G/]]IV]??XN*K^]&=4?4QGL2J_$7\4ZK
MTKV\ST6G6_5BH]EEYK:5(]XZ4]+ALI6S[FI>\Q-Q!4YJ#O:/[&5M*]?TK[R[
M<>'JCPZ93M[4HC1((Q!K@L*KJ'^GA-<C3?5.!*\B@_=E?,."8F,CCJUH<"P@
MK^-G!]6%OL]"M[T&+K[D0#'U,X[3F/[6$1$1>DQ(/)#_$D/_<?0D.+9\IG**
MR"PX-5"[8V-OF1<SLI>'GB*BMP^[SDB(A+K!L%VM@TGRCSW9V]<Y#A*>?F22
M^?'#\'&$GN.+7%_( +(3/CN("=I9G\&*P%N?+!LF70J+D+;*8@@Q(_A>FE[$
M"BONC, Z/<\![L$WK,X!L:@J&?.H;!X.4,*!'+3Y%]3+OLO3+LW*O0>I,$9D
M-?A3IV'XO0GI96QT:HO\)7_VN"GG3D%"Q_9B666X" 6:_@V!W0Y7),'K) WN
M8@/6XKM!KW_PTWE^J=+X!;J?^<9NZYGZRU?)W^-#!#TX#YN@P' W4DN[/'FX
MP=(N> SCFE+_2VLEP5-D0MA$3*OACPV(&-B:[GOZM,T!V97HDY6G528'<9:0
MS@XE#? [NF&$C=_X='1ED!R1JQF(B*&R%7 OA!4ZC& +@','=X&;IC0,D&8G
M22TS<"GMRP7:RRQ6%ZT!@'*E2!7>1F/97^QGSFJ^91?I)(2_GM8;O\O)6=^;
M!A:(C+9_H2Q#E=Q50_X-:G")+X/8MBY<P195U6)$@@_9WMS]X=0@4B!OR&ZX
M7=T?!AX",9"O>RQRMPML\K-A>S\&?-D^.QZUG9Z9@^>YV4;2:+(;V+C<L-81
MBI0#E2#PPHM$U@T#R@M"H4-*[5SPG=GXQ.-'C>W"$X)PZK,_\*97D>$?HIYI
M^TYD YJ1;U?X!5(AK_PW40MHO=5OJ$S=+;RN0,:3).M;J"!&".)9!-!3?R4J
M.7EE#+L[6:HIQLY.WT&CZ:,VFO<>?X. UOU_55,K;O(CZSV$80T.0-G_IX8-
MX7\-&RA*WDY\0G'/_]VO ?Y_V*_QIS"1[ <JO),HF@\X0F[ R4SJYX#TCUN(
M$VDWU!D-^$@E%'Q(P41:OG/ CWO'9H3K=8LDJHJ]5@W*HRK. 1=0*@AZS'5B
MTG5\YBHZAO(X4C_1\/]&JL.II;[_*M7?/!0])>J=\@P2_[4. T_9D#C#4Q$R
M0T7!  :(%U;N:;KYM)*O >$?C!YD*G.3A[[V./VLL13S-A7:_+_ZA2$GKTGI
M6C>#^=E3JHCFRX1!ACL;ES,9&4)NP^;3!:'LQ(*%N?M.(;=9>R1;AUL,A"RD
MIE+2=\6[OG+V:OI!;)<;;DK3V\"M)8A9)D=:EMV)UQY^L_ZF,K?G12[V%^NZ
MLL)G:BJ[D$CW"YH.?0$S@6'U$+.6>J0"2KZ:M\C4BPABV')D&MEME2^WH[UD
MK_IEY>H-9[X+;PL-963C^MS/.HT$L\CW8*Z+LS$45=:@DH&.>!AFWO5[5LZ/
M:VZWU[N#M'ECLY0NJ5KQ^VSI>VR:P/$J/"<5$;?MX:\S?'\ ('72\?Z+LLU<
M&G/O2;*0-^L+_)BRQ%P'H97!6PN5I4CD7?3D ?*JS'#7G0SQ:^N))B:V<Z9_
MR*DB0T.:'EA=,I,T*;X4ST,PZ\(9&-2)+<,2:CA:G'DLT#9ZU-8:CT/Z.1Z8
M@0_CL8DD"H6-OAT>B O:I5C(!1*V,8GH5_DH.*D[-.6DL/%Z(TOQBV5I83T>
M<VMMP&,O3L!C\%?H%&5)BW$P3\3,WVX@<[CU5?+0U(TYOA^?Y#8/J^Z!63;P
M(\U]^CP46&AW$NNSZC^T*5?_U,AE7WX.B/JFE:;4T:7^8_QSA:JPZ&(1Q6QJ
M0>F N3<^5%LA UL&RZ/)F#;IDR92NL8C @<Q8#+\XHJ$<HS%&##\NFC9SNS[
M%M8UA^]]Y2H75LJK SS9.PZ-2>< 9D?VS[V5RL'U_B-XR5#6(O/13U\F4ZB)
MQ4[B!G?D#_[NCN5O-'[: OVK3&2> ["^0E"NX:-]&B*L:?R%#:^NTXHH1OY'
MOPI#&'?*KT;.P[>VV?C,&SGDNRQ9,C+Z*IH1VT._#NY).9O,/'4*\YS<'CYZ
MF;/-FFE]TN1F1RBK/0952<<BN%K%<*CO)V<;,42CHN!LP^8'%OOWVTP^) BJ
M"--3?9TPI=N[&$!G)#C&3HS' S&0UV0.#XG/>*=N[L6X8T[R[D)FA&3Q]E'P
MM,P?]:G&YS"LC?<L^.[7U-G%%0.X\%U.2!V$5&JAN:#G LJ%>B=@)[_E5A^G
M.;HOOD>/R"P(F5/<['GAV$$0<0?VP"*W8D# I1F>L,BE(8:%=.U7!*.Z9X%Q
M"DUFZ(!R2(\;AX\A3TY46DS4. ;U$<4.Z[1"/=_G<L-,_ETQZ%:(=[/P/':[
M/1^EVOD\\%KP=MY'Y#4<)$41!O1(<[=;K_BTK9:.VI9"5A4WY]9N[1F!<C64
MXP+L223_S'?>AXVKG(AK;L)DM%[C^B@1>8IH C; B;Q%6,)R1'UO&A9V/QO#
MWRH78_G-2%(AS&;C'=-,F<#*VH-R@QOX3H()F7X3U^) *H8Y2<=#U7""<UHM
M&*\;WM*,=5 'X<'J4[ (#=QRS^/4?I;W@.J,X(_<7"'3D= 40%P:V3\'T.W
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MF6X/A,_ZQP <H2.^GR6Q8(P:'+*C>@XHGX*=Y+&2H5WG &H#YI,7TN0(DW,
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ME?C]Y8TD#>'B1\$W]WIY?EF:9LQRB7B0-"=E?@)NVRBK'.EN0FK?XS/Y;,K
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MG8M7B*Z5G:K?'4NSA90$2=L? [^CDA)_5-U*$3VT>I=X&*A8%O_9PJ$.,W<
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MJ:_]#NURZ4_D"G8/E.#Y4**G&_4M-\Z/%JMKQ("4MGZAB?V_4*K_&.$[0L/
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MJN;F=&+_TSL5V/;@SL7N=SKW"QVN6<I?._'\Q:4LT10E_A>70B9>&(GLAY:
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MR-[J_YFZ0()17](=\.AB.C+Y4<D+7-%E:048HK0\M1-J6+H:SD-2H'/!*0;
MQ( 7SBL?UBV:^J+BG0.GPMP?U^Q@O3^";;#> ET2)E4-6=_FAZ>9VZ+."Z[:
MCMWH7FE[S7?/3L/VSS["^*7KF4;!Z'N_TS'#&W1O.G*DN3\AI,#7KNILB9^2
M\1;ZFK)!6#J78F'[E=]=?ZE^1R3H7E<&9&#,'CDMNLV Z(ML$\)901@_R(!D
M%->#<%IEF1ZIO!S22C=.<J.%9O\*7XY9V/*O18$0RIP!,3'"&U&EH R(4C*
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MG2V=.'EZQY.HGJ+P>4N>/F.GA#SY'0YP3?U>;QMIPL%Y0T:2?A581[]\RX#
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MFQU@03S7]E!7LPQ7XA?GI-R6[J/G/.5:LNB;]8/,J9U;C-I-*T/W0&<ER>[
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MX*08D/X/ 3':X)8L'WWY#UPP80JW&W2;^N(5(ABQE%J2$ETA*+F%Z8'R>H<
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ME(/WS;R=K.#OI*C(P(]!X][6LSA_8H&.766V+6HN<5%Z3Q77.;" *P&7QK2
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ME ^2"<L)WWPK;3*?RRJXRF.BMEHQ"B(I369N&U_0F&>6!L@[R!__2" O!"U
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M@V"9Q_!$Q*61(V/TG"R1-$?7RS!8_?FAM+EH!7-56@[NIGD25/0K[G&+_S*
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MG@4J9=Y %OT#8=[TU;&Q_3%3D37OI03O7K/CY4*NQFU67$PGVXZ6O'H ^VL
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M.JL[J; .RJ,?5$/5'?M=HG>,-&H'I&PIYU#4NC43-@0V3\\_.)_GLK$GAFO
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M,)+EL_-=-"\\D7KRF8=[:IOGJ,_WA'?/W/FD0_V%G;RG9(&X#BR4="<M:'Z
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M=JA.)-JQ)"W/\6F1JIV<H\V3&ZP6T6PKO_Z/JOE_M?_.Y#$F_QM02P,$%
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M^;=4W^Z_=^)FDM8KWJ0;OPG!(E^_#E3U*&:EVUR1<19-MUW@/WY/6*OB!+L
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M_'*_82'9T:E7996CT)'2A=&!D5NA?*U&G&X<[11N"LLX3X]IF7TAZXA 1,S
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MZW0A$<_;KE-UQ8"X,Z.J30\\SJO^#BZJ\WM\)B?!Z%1Y_,X3EA)>17B:/4D
M=9[]F&7/W(LFPN18]O1WJ-#K:1&$+K3F;H]+0VH!BC-] ;NJ#QF96R0<4-U9
ML/5^I'>DJ<EX1/J"X$\7,. "6RQ/4)P[Y&/:=9O!XN"7^=C$SJN%2QY^+88-
MHG5KH1Q"KC4@[^;>:*S"1X=*GN=X?Z@2?Y+_2^OLM@_C%1BN2RPE8!:LMW[\
M/R\TQVP(0SLN^6][911_#6# @J*5[#R900T=314YA_(LXU2K-&S/I31_-QZM
MO2 X[WH/C%X"5(X+N;XV[=E-JC1>"0.=X/E(JVBO@!9V!!(QR6CEGC(@SMZN
MZ4X#WF[76>V9,V\\'SBEJ9<6Z:OJ[8ZL*.9"KI  3?@*V+'N6&-GKL*N(>^;
MRP0T'V,NABV_1/IV?6X).[XCCTJ+%U$]?K#HRVL9B0M:%WE;B$D0UF.:#4MQ
MB H'D;ML'.8/!31U63)\/; ==^P#\DQ)HFZ RXFSSK619MTUGH\.YZ>Z.<]]
M^DW.S"<6U%1^10^R7V'(SW)MNK" Y@0X_AV@@M+MV>-SJIJ>5 V0>G+9V8R)
MC^4&U4(WRZ]G_GAD/S!RD&^?Z"/Y]?P4&9]U3M&;>^8GP;#!,.T'?F'(:3C!
M,-+T9@>F]G2K"2VKBJI0-_5Z''4P*SPK>YV Y,O,,TUP>=!S ]=T])>HK9B
M,QMC)<U#JV#)0CD[F\HP[8@BVE!"<PC3/P+;KB)$ZWB>C!3P1RLG1!S^(_NU
M:#M2Q5?/)*6YUO&HO&Y#CCPNI54!%#*9B!K</;1:!*;'HWBU@MKB/6,UL:K[
MRR"'M2](T:M'M$_UY("&NF7\P?-B?'X"^!M@TF)AY/<PFC7H.3A@IR902=LU
M 8]*469 /FWT@MT0+]A&L$O#I=RK!S)*G69Z3WT]7=U=_?;KXU0A%YY9SW3V
M:SPYQ<L<W/\! (KASW7@G!]GO]_ //22!/SN;C8B[YGQT699ACYE7O5=QHI/
M,P)=UP<4+O!):^S@>2$J<(S9 <X=2!%QSV'D5)(@)@@N&L"%U-_ *X0-BG1_
MDZ$% J9M)/$[*1JF=71TH=KOULPB8E>+XH&\GS_BJ@_A/CIV.9_VPL,QU\5Y
M@4E*^,HH[3<%UUEV;<E+E;9VOS9%'S%VKMLR+!KI)^WTZ</Z3('UC<W/0:]:
M@7#R'J?N"9AD'6S'HK'Y_I&5'[4C?V92S(V;:V(=1:NL]'GIVN2;PB>#\X^U
ME>5" %>.B#B8&)<G\.2*T0@_@I<)N];,AHS= 5RU[VJ(,X")69K)127?=(HQ
MP^KE*%M_\S@@_UAN9N QO)L$]GCD_HKIH3:8I!ELKLR),4GWJ@I^LWPW>U/Q
M'&=W78JN3\*UM%?7I21?=V1J"O+4Q"'J[UP0' +[,EU HWCE#QA6>W9N.=Y/
M%\O8O%LB0R0!R,Y<E^'H-X'"I24A$E<N/BW1,PM>;SRJ?,05H3(*SLHW56"<
MZ<@ZPGZ/)[_A0NKXB[MU[,CUSRI1)E_N8"$I?/!4VG$8X^6VX>J,UV6Y) 5S
MZX3=M-?KM)VPT.&34&$PH:Z";B<W3K)DMI&B0% /M#[Q(:@7<:('/M33KB=2
M>OUBUQR"^Y'%:3^=5!_.?+)2E8AE1J8] F8H.);"1>8Q0)!JD\@*>X\F<K0G
M=&HOWQSAS-GB.F2K"E=N#:0;B'9X.YLX%I#)1K>"&)^3_K\(,8^5]/^Q_V/_
MQ_Y?,Q0H$01ET".X>L1?A;#C!QVVJLE41=T8,8.&OO8*J"=FV%%.MXQIV#5-
MK0HU?,CUV=5J]L-LII=T@+AP*VAIC;C)P-)Z5C!,'=9)]MMFG^)/D<41XAWA
MC6,3NULGF_WW^=F%>>]T2>OH%I+G;S>[()CO@'C!,:!GLZ0%X2!1.;MCVIV;
M]S%=E[(1DL$<)4_6^3%SE;Z"*:C0I45[_\;'VY(S(IC:!W9&_B/?+REE91WI
M/E7V UN+OZ9+A+>#W*2[TD+6)6:TN:1[!GB9TNJ*JI"^!O<+:@/R=ZDW54+D
M4C:[.V^=5?[GP'KH*<Q.#!)+#*5JL@X.3?<PBK+)L/L;P1H*?Y"* 5[2]>-A
MV-V!>K6XA;L=BP_NUG^QKC(=X+,]E!$95&G]HUF;(W25Z<'YZB7,+FT]@6DW
M %'NE3FL%L@N8RD.@\V41 2"FI7YQL;7_&/^;$^+ZL>&ASO<VXZ21>LI>C6]
M,M>NB \+:Z^;4G19TL\9#=D,>W8FGES<J@6TO%T2HF\RGL % #SE?GT=I[OJ
M2YB.I6-5;5*?BX3>5P\1+77)')&!M2-/JC,OLOG9%6C=B/7^R^*,*VQ<F&\]
MD$V7AZO@WN]T<: $J^B ^L$K4U[&_-0GY5NJO-6S7SWW*8F6WE.9MG+^<B?S
MRQU3'2%#D:8JWP!EWB4.^9-9N_3A+>7U7R%9/F/I@;,0:0>K_X>Y<S3I?O'-
M$F\&J0C%B&SXB,&R[V#WZ_=>ZLT2XBZ1.R^R[)WW'<]P2&J*5O]@E/;:"I5)
M+^&(O 13JAR0'?4 DAF-7PR?]U;+#K4/PTMSY#$[TX?5'D(W7]JTH-[1/3EB
MD^PGS6:^#< QIG$$%]*YWO,D?=E5-LI9,J_+W8O2MGDT;A7Q^MHW22 35WA(
M]J)[U\H/<3^YQ8,OJC"1?4[0N$*Z/1J3MMUNA19A68(*YB,^8! > 3@P-0"I
MTX+F")::8MFO(M?E[\\O<3+GO(Z 7\D#Y9:7!HF=3"7Q1T1C9CD]M!OPFD5&
MT?,_@^CD>]N'@;+'MN/%UEA@"13#16.?C_E%R*_,;&%>8A>-DCB7#-< $RF.
M\!_JGH[?C*Z6>+A5)2T/&UP;VG;4_=W:Y+'%!>UE++#7AB4]RJ#]0_R*B X<
M49R1.=D,ITR;'7A_J:^ I"8B9:\<Z#"4K9ANH:D\\=5BX]J<EP)EQ07YN(OR
M5>O4177YL_G!5I<+HQQ<_U2^\W,+'/<Y?S2JZ0X7HK_IE<1!@DE80Z*YP8$#
M?BO3H#2Q *IH063,:A 5*@X@"-N#N?[;.G5U^80;9<7$_GZS7K<GEZ?(&9LM
M)A4XEC%8_RJ@N+C>;*AQE5W]2U?ULX>.77NN&@4O5WT(QJM-3S([@*TX97C5
MA&A[PG.I8NI/Y##[B@-BP#460U[& ]JZ\==MPV9]*/./+H8\^X,7V#G.P?MD
M\6U)3+00*$,L%5>F54"U%1<B$LK0H;G4OL*:<B2&)&87XQ-C6F_/^M '_9SB
M]2-N/&V!;DT=HV).UKI^QW;H F90AA0=GAE$QY(%.W$[O]JF_ Z@NR_55^5M
MA1CHI6T\9//'1-*@')$<,,=>L]\\-N((L.O,U(N][.^!=2EOKY&H%<KB6UV4
M;+J[I7!_Q3XR<_WQD'C96<>&PLEOY:YZ?A/.%T_P=1X73-IX:&9!B;D]Y%C9
M:,^8G) [8*!7\;Y1LO1$>TGFO,&H_#^GG/_W&,\6.&."+IC^W>B#7,B4)P&S
MC:JJJ(,%XJ<GVS%U0RN3<[CI9.J>3IK_-U-:R\_DF+  [/%IOT=/[%4B2$HR
M84,*%B^2UK' P7"6U+(;"*@OT ,>V)6,=ZA;</X(STM-M1\F#Q]B'64L+Q*)
M/P[O=_L>_6Q$[;?JJ;;NE1""[K%-N-@"%R(-8E>B=GX$MB?J<#[U:77$I%<R
MX7;[]=]7'F2N<"8&3I*K#RTWO9#N;1/\OKGJ% YFF<;?97$P<7:S?)AJJ*@6
MP)*:HM'3(8DR!(+G@N4\Q]4GFZT$7J443P70%XH&=X-(\2 R.6+I$;*I'^>#
M9/.#^[NA!S@:[%0\^25"$',=KW2O<2V^>9>?0(ODAZN[6$E^'Q\>H<3:'WHH
M?NO59M$BJ?)E,1;OOT>0@6.7<=3$'W(T:)Z]7(CX'?\[%D5 =,=O$X(7<4JA
M.%(WYY;Y:(C9P#WT=\N,EQ4SI@Q_H(=YSC]/:(2SBS.)/@!8PN)9F.+E[<'Y
M^#)9U\F5X,VMQDLS+X]*-]U76SOW=E8Z[A[/-Y8?T$=&W,.+K;6JLTZUYIHJ
M62I?\)B>J=V,BA\K5XW]/"&S5?PQU^5,_B,+O_"+>X)Z85<1TT%=&-%F>[H2
MHPY8+9IIIR/F[C8$OP/>]Q/#<D_PV=?>\UR,4KNM^TEW.I@+F>C''VJ0.K_\
M]( 7AAF":=>'!>")RXS'7UI- 1&.\%4J*7X"+5D3P5*GX,0B#G8L[3D>Z;W^
M2U<T^U"W78YTH]#==ZD'% W:(L\]1U1-LJ0(C(< /[V2Y<LNP),+\!+F)C'8
MTWD]A&W!)(,23Y$]>I%Y,+T-J\"[GV!9*<)-L0X:3_E^YT+F66";MX/&3L)<
MT^5;P,LVAU&Y$#E</(F?%1 ]M\;+THXL*QHQ0.Z^]$G[],2%GAL-X5(BSS^V
M]@6.]I:<^#EVZMS9%\5=^%2,/,9[%MH.DS&[2M%1F6<DLDLXAQ;08E7U$^Z_
M:M=V!(PH>'WKRI)+*0_>6/;1[TVSA1*1-XN?'%>+\QN'2>']5NWFQ'LJ!(#E
M'B^U6*1 A(3GQ1$SM:QYMG'GZ:>QG!^/B(M!0J$[W-KR?(YND1]4&#+O<KJ.
M8U;3*!6\I$4O/<0NX!/%KS-8OYO#,_ES='"V^7AFAO&OPU<DK4<][:7ZI!]6
MJZ+Z^Z<MGHAA&.I@/Q-"SV<D [^9"JC RN&A5#0?$&>3P/2@K;ZHKS\^D5TR
M);)JOG@ERSU/*%9(-0MF9#4K[[O7O&O;I17%3H%Y:Z]-3\X)=NL2$ZG(U%4S
M&[KF'/;A'287(NNUZ!$T/>7NOCB!\QFM9?I_L]V3)1]^,W-&SS2+&"=L'O>*
M]Y_+A?[:.A="S&9\86=S(=Y#.W!0]"A4P0 KXGZ\JJ:AZ5G+[&^Q=\A@^0"_
MFSD[BQ7ZVG[B]\%NB@/'YWM:]T7C^3GM4&$?&KO(7:[[F\']P[J7[I#XT[,2
M#EM;9!;UFG47X:W(..$/<YW"CWZ8N"QZ?2YE]]OAFSD:C6\/V/5^[YRKG+K(
M[ N:><?TI&M2BPFZ<5Y2'^BDKJ&'49KQ&W8.G(R2B#CGI,]$<Z'V=)>+@G'=
MMX-^#S'*00)]C;F"BY7\"F#(YM@*E.O$OOY2XCG,]+8+?=QCB1+><$+1Y)KC
ML5VCL/L8*": 1)1B%-'C(C;!'.VBBLL'/FC(-&]XVUQRL^![P='Y:T*<SL"2
MU4LZ&$]:XK!Q DW8\$.RS*%SVQTO%T<W;G/46IR*%R+D'S-J-_*5(EL06VB_
M!>RJ#@B?1ICV,ZW&MJ%%J,,39C :X4RVMK*Y_,@$=:,[^L0XZ9DEID[R-.82
M2Y_N,X?O)F&/+T?@YL*[2%(131<.N7E%9%S*8U@-^>J;!JL0(&+:3]_@"TRB
M8R-LX@^\_2&OZ(R:XQ]@7U\[@)HQ2_KPPBJ<V6<$BJ(8BWM_,=QU <%2VL6%
M'' <P:S83F V'%WG"]'Q(#!6DM8S=30YG2_]N! K=70X=9[U7'2.T[[$A2P>
M6F[#M([^L?G,A=!N85A%QG.)[,0;L(U)/X2BZS3FOWUO:S6+"^EMQ *J6ZJK
M7A0K:5?_OZO#>];:AH@X1B;[V1_<*A<R/3<WF=PL<^>SB@MM\N'A0Q,^B_NM
M*;XJGW>:9V[S,;5!KR9)- <0>3,\%S$JAU!'Z4%GL"*ZC,'8Q=RL]NG#I>,^
MGX_7/CD+O_1GZ.<NF9Y'GVAN7<RE0*^[DVM? VHQYTG54-8>0Q KIMEOYNMH
MI"XF&TF1;0IY<( Z$V+^;$2E+P;Y 62RAN.GFF.T-YS:5<QHQITD$6($B8)_
MO(';[=] W\HZWOKH;5=XT"W<MU2WG+2>#QKX1 ^0@::3&:/L$IB/KFQ%"LR7
M"\&:J]*"*4]M0\0RT>A/=VTL0FXP7W] ,'RM5<9_FWP3)WQ>)\ S&5$5^##@
M:=$VCI@B [@R=V+:2:Y'Z[+O8\BO<?PN5NK>&!6 ]]"1U=8Y>%IEC#OE2?B,
M$-EU)7%EG.G.&<370PE JQ9Z *]P!Z;@7U%K%U)P.2%]O+<W-<)3<J8O%?7Q
MHB>QU71/ID_U/'/!/=RC L_Z8^!X;N.LUIMF2OS_&U<V2;MVDFC.,."PYDK/
MWR:MZB--YG$:,$>-)G!2R(,':3LJU7ROX5_PZDSND)#?I<U[Y'U9<_2+$X3(
M>9F?3SY5YTJ6>7A::_N.][6HRDPX!APN[:\+=-X[[S -]42Y DVT)K+KO36.
M%NH:G9%)P8D'A$1F$UMKHIY8[%XQ/JK@'7%1X;H:1&BOZQR")>W$$7LQMI;'
MA5! R5'<P87X)OY,@#]":U0)N*ZV]O=;/-BS,YTL:;&WHU@ KP\+)@%:R%4G
M4#'P PFH2*8URRJ7L5/]^G"S\=7&7;JV3BPCQM9>Y5O7O$>.\(76\T>D8.Y&
M!&Q<[=63)^SI'/2N4H1=Q\<)_JP-0P!E8B\JK%'=^L=+7&?S?Y6S,>0]<EV(
M9+QTZS'@VV^J:S?\H4=/DB&3,1M>LIS[(%N_;Z'I1;JT'X^UC V$Y]*JM.L?
M*T6#6QOY9Y\Z^\A<2Z^VO9'NH=:DHAK<5/DF2=OBO[Z<[%\4<=2_*G?T84Q?
MY6?8BDH%)_USLR!S%>:,6@-A29 +Z?=!FV"F[A*X$/N[8?3"F.Q_^38F;QK)
M2G[[=\$ZW7S\%P@N=^_]ESK1U9>FRD@$YIE'6!9U0 GS!,MET@Q*5;)DEL%/
MX2/V9.]]]AVRFJ5_O]%8]+')WJ0Y_W=/?4P^]%T^ HO$DW-QM+NXQ+JU%2XD
M'DISQ MK9-Z]2Y#K!!7YE+Y';Q2RM?JDA^K7OIL*MK"E"[Q!C#C*9"<V$>3_
M9JEBE"W@.G=9M],+.K[:N>U5]X:D/E@WY@>DG^ES4>@ETRP$TQ"$P1@HF)4,
MT/\2SA2(:/8P12X$R1F"[IZMU2ZYK_&1G!(4UIWV;F-'L^G]I',0LX4DVWL"
MU(].Z\>*A2^4OSRGV71X%EJ,_/2ESJ@!5J6H/:<+J&>S9'\S[,#?Q$5$0<4C
M@IP0.U%VL9,#XZU[EL,#_8+S=76>?G"(W/D]_=69>[YS)RU@UR?;J$?&:767
MCP^'I"\,.IW3>I/4^9])]G^QO1X+VP.S&9T?KPM:" X.OAI0?O.FKY#RT;>'
M/@],";_BM36#:&M2$9UX"$J))EM"MZ'BDE<,H.+^=X/#2@*W7[8E*?EGE^A#
M41 !.TG(CB?:6Y/@8/LQ[>%H-?2WJ"XNI TSO<Z\0!MJ7XY\?+M;*&&SBQ\N
M.>OSM*&WWS-&\5S].'9C312E385*U2"OQEUZNG>RKG2RB7\:8T D'MBJSRJ6
M-=YCPW]^?;PE;0/'DOG-$;//I=3!IYLX0H-4*>4K+>5-=(]]OV$7(S8JH\3R
M5_TR^AZ*9SD!^/>!N7D?WWT-\IC(/_'CQ]<UP]G9L4&UFC.=-:8UDNZ/U-+/
MVQY[JU6Q@;^/,@=EZ7K\_?X #\;\\XE"Z\;/B*<7\U4>!:)N:LMYRCGEYF_=
ML0#9:N9%^[]:?T*\QM!N&+,*[6RYD"I-=RYDV!:1E[DMQX4($##]SK4XIF08
MCBV=N45*QJW?T,<R!4NXD(*:"AX.$SX.-04+M)T+67]&2H4R]E1R(:.77Z("
M$+[_^NWY>D\N9/\2C(S]CJV+!G'[\JO_=IW#"N)%FWS4;$,>VCT=T=#.V=LR
M4G?9:/'PG56X?6/$89WKIQ344D_O2QN[9\F[4S6)30'G3!_3/M0(3Q'+8.IA
MVL^R+)#%@?.^Y7'TZU9N94AQX;2E*U>O9+QB.MY7\M/;L:\ V2ZL/31P>^"P
MGTUZ]63^4@NL%V36T/I-V<TL^BSQ?'K70<$DMRF]QK0G%LJ[;:)B,(8PVFD8
M8)),%5PY$5Z('L#5?2Y^&_&<PM>;M>WU?J9XS&QO 5E^NY;A [SZD:_<-=J/
M6>1KRS.E(< B%UC$29COB2@B>'ZI*]%:,WB)L&MT+_M%#A--MUXZX[OWC\P6
M.B#3^W;CUSK#Y.D-S'=6RM,,P[=ODM:[_U5X_B,F,P22305MF8PDI/A1Y[OP
M<M,+YDI?#GFMN8Y7?)^1:;8CC3][<?!][$#GP=@S@G9=7@=ID_>;]=]&C'9[
M_"G*+@@P<IQ=BLID+4O+5EH7?L^R\>9]_U8MHXT7GXL'=/ L6=,N#,T!F22)
MT@'@[[X%X 51ABA,U0VQ!9S7QW,5C)1^6LAD_Z-6ZHLG>YZ)CYMITFJ,Z##S
M[3KM48)339D+29CCMA&:U5Q25!VEFK@GM3BV,+PT[]/VPC5,NS<70J[&2<'(
MA8C=S]N]Q()(XBBU+Q5V$1C"#:;O6,&E^S'1M91"55/5/K>G9-]D4Y2EE0SG
MS2W2KN]?U3,<^]<;S[Y4#.S3F5D^<.+K\_&&$K\NES+'%IMC3?5@;*(3+/ZK
MVHA*7"$P9='CT'J_)/@#S'5DK.):\F'5-,=?2]TSOB]S3I@QWPD3!*(C4S^N
MYK+A[">@=Z.[ K=T4' FDO/E@/=COD\46"+]D3I?^;1NN91WVG#FOI!)R3N&
M-.6KU$1>VB&/07I5/'QK$XK.7_UEO8K(S\S_&7:5YE8*I\T5HW&10+O7*$T<
MA IF&&=,9-=0&W[:J3MW-;--8(_[';^&RAN@8+/#78,";,PY1(TF2]*)(T1A
MJG8A0VC1#"\:>5R'YM1YG-W *,IO#@O+6XX^#2_PE/LBO&U<?)830(47_M#J
M=UY7KJL;"?N!9!6+@*JX,]K@MF"+.YOT$]2ZG#OHW9CV4AC-$0JUDEGK3$&V
MJ?#'5\U[!K;NC9XIV%9_ZMC9B9ET^%.1SU'!M+]648GW^0!4,6]Y?4T7?!Y
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M-?9SC"^&*,YH =*0M.>,$,#U?42))TZ4%D"[+U-Z;6XPSV^_:43['.IQ2;K
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M$O;L4+%GA<ZXO)G\@+J+3-D>1)_!WX4E_UU!P%BIG/RW]8.++Y6L)\QL2H@
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MOJ4$K#LA:#&GDK0JL,?_>SI_@4N>[>%\Q-F38*,FG7Y,&FS48G>:[;8)9%T
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M_RW]@=_'3<YP(9_ZM+8U_F#4WU%"S,/L$DW"Y7*=B2G'/L]^=0I S68/L):
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M8P9V#2I$TT"X(<$T"*#9.&73&M;X)%9G1CR9!&4;=K![\1C^M5:$.&5G54&
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M![-+]&>;W16=G5*\]X_".Y]45EO7C74GV+AR\6]XA%WD9/+8Q.33!74-X&L
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M;%'6"/MZYLPXAX7,+/H[9..<5"8+Q&9.\T8?_XG@^GX=^4C7! .EHQ<2ZD6
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MZ.+LT7B:4B+L^^E?]@[)%&]YW@MH9($\QN^V3YIL;AS_GF 9\%8V'&_AL_Y
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M_7M1\HQU0]%-U4G^S1':&]Z:)YE;-/B+45*%X^=L)AUR1J4MEWD*+1NB &A
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M"",7[?5W3=12XT9CH)#2VK3AM>OC;.SFXN.2UQT2\FG*1+S5R\OK?KQZY[+
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MYO4BM[1.YN*/<M(/;"W K-#U>B[ZQQ@Q2-</KGXAT%M51Y:IY]$VZO1(Z)P
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M].IC+ 5-:71_3H3DHAW 9).E+J88I1*#V8)2;[HR?K]!+R?3/]+O]N-+F.>
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MHMM Q6D 0:17RC[&N)A+*?GYCEQW,OB,C)W%99L>>G(X_ZO'?]^@I[_#UJ/
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M M.HYL!U)^*XHH";=936;<_+&1#D(F!*Y^)G0%@^D>9[OHKBH8FP6RB.KU5
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MGH0SA9=-U92&JK7Q]T3R=?LOL<CE+E7D6,FA(UO!Q>X'S3M9U>8">UB#NL6
ML#$'5G/+;+E=60J2YMK64O,>9[GY2;X/:?Y$FK<4J0.8+EJDH&X. =J!5J3^
MKDK+AGE^ -MK@$ZXW6;A>_MM>)!7.,8S[9$\\QT!$\'9(N1&O]@IC#T@2ASM
M[*<?R9^4WC-K"A^+/E.]KG]Q^$C[+V/5)Z8:E+4FHM*9.[&7V#8]6U]&F"Y
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M8(3WH6<'78%X4FYW"VM_"A5>NB;NFF9&D60?_3&U^B%8OD&/Q+9M\OE]LOK
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MZ4K-([E.Z&[_MSV(Q5K_(S8A$Y2V3H[L*RP)8?DLOK+"!0N\6=A#;?(DB8N
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M2?F@H)P3+);&ZX;Z<Z<QKQ@0;X0TJM/@%]%[_MW61C_E$N"R8/P!LS+3U+A
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MM_2II396#$BMXA4&9-@*_@( \TZA^Q18<^]C#VP,B-"M!IK]'RQ5$LJ G,@
M0/)U?9:7ICL]V9='AO];G]*C?+#;ZJ_I['1+BLM[>S/AF?\UN9,HNL@)>$/6
M1CB)4R,57J_19QO<.?,CZGRSN-G<U.8CR>3EA'KAGLCEP;PK,95#2F^?'W=0
MUW*Q>\U\\/>FE2\8,%,HS@Y%E"]5$7R?%A$VWWE_G9 (37:3:NW(#OO)U!)[
M.^=K2I^'T4"=E;%U*BV!6)86K;(XQ.T*#'VDR[^;"(FY.*VN\]/%NLTF+?"]
MJX]WIN4G%X?31TKBX=TQ,7"P\$R!,P_0I^'$"UD"_:)=&J#W@@"%*+2V*Q"^
M<-330V]9<3DB\J>_)G1[0M4[8:Z.J:D#IH.WONSX-G[/AXKQ79W=WE&S^T"+
M&(8K@QIKPW#OH'4@C67K/+2'%TW&UD;[>@7(DWB[O]X.\3#O?^DOV\<ZWK$
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M/B#BX 5TN!;+XIS7>^'OAOI5>"5<7_JF=15I3Y<%7 NSW"R@B8<9UZA-8)5
M7@^;3B(GT!Y'ARIVV\V8XI:3C8Y6]^?DW]]\3MQ?X3$:N)J1VU^48_ZEK!93
MWOD[0O(^K6<TI@D5/)98^ ,/@HLM/OM_/)_R3^*RID'E0]"Y2 OH*3O/491/
MUDR9>^LXG3M ])R:OL/CAF9IGKS9I[*2#?D^F=X/O=]<R$[?M(*IE]=<O<G+
MF_5R9<+%;LLS\(M_P]"F8_?<\>_1'B^O1%1VM8R_*7T3X)S]TW\F(Z%KD'5,
M "P/&6-Y(3['XP^9L/"[_./2?WPD#-=JD+41O]"N3U:C55&OCE"5)A!&F"-
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M*#I-[KI[<)F._FYM;W]OJ4I0>ZTA-]+*>OZR9+W(,0A(#H+,/#;8)N:)9D.
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MB'9H<I7]TE*4EK'7]/S>EU2L7_J]8,GDUUJ%!Q?%OTJS'=UX0_NTNG( &V9
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MMW%/BN,OKW6-_0_!V!XTT1DMW3"S]9 N-CN8T-SXS+'E FU1-M(>VCU80#_
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MTWF\$#JFVO9",W6:$&)W,[]'S3]NV3:PJ8DO[8L&[)M,X(#G<>FC"KL>N%X
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M@P\A/8&9S[]MYK.=AI^+<7<.$'K<"LH+#Y;)K[^ZBOQRNV;?=(43QR\GW$7
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MVQ'0 ,!)TT)]QXK1;2D1U&I&,M*/R#!KPI=%!*FYR[5HX8.4/OO4UI2(U5K
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M8;/>DU%'/IR9S;\1 %.G0*A>%.75_]'>E44UE6W;""+2&;H @A"03@2,2(]
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M:2:,"7/%J:<_T);^VQ#N @VGH9" )%T<$\8HK!D/A_UC! /N1&-_D!_@'5G
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M;+#AH*3($ =EY]:-/"HDILHQBIX J<D$R".8\!-SGS#E=I X/XW^O)+CT?0
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MOBRM8G%,G;9QR<"R8Z+<BRX,U"$JCH-: (\04^H&>'_E;21 C@&(=*\." 9
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M?'0O6AN8L3R>>3::O7LM=)1$O>X.D'L-FK[/B3RO$\GF-Y\&[AR7 #!!)KY
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MK?YI)0>.:JG)QBS] C6G_Y_]NY6]ZH7,MV5&*)0EH(5L" ;?;NRDA59" M#
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MTQN![O;PFFCL%AHZ-.3(Z+(,;K37#S:H+TA-*6:DG+O4@3'\M?P&<6 YK*R
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M^5HY=P$K5E&L7FUPT9XKS\P<E!3[=+\=__3G[K:1&OE$\5^K0ME;  I5P;<
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MQO-.X,BG23=7 7UX.@[TZNI>3/Q#F^/51'P-*47]>\\):Q.?W\"U6/=6!:>
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M3)E/7>L;LCY)3WW(FAQ(#C-Z/NW3,?57ZN5^\4439:#]%9# ?<1VYVM.,TF
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M@E"%/3A/""X/4<WRHLT*\@WR6,%^#D'KN_?+*+_MOB&?S]<5E BUP80X 0\
MC0FA%VDME#+B>?%/C,!OPD5N4ITG.Z/PH(%2_Z/V?0/R&+MWR41]_?SH[Y#8
M0"1RC]GUM0MI!BU9<R%0LZNH$=Q4!K< >,/SPY&);J2&P%[!]:,./47:@#[K
MU*3%'H8'<=JB(8);%+4/4CQ[U1WYPG3^%F0_1/PXR E68'U6HV.%4CR>,?HI
M-Y4#)8? MPZ]X!]K95.#W3QI])=]RFG9D__=""K=Y]ANU"R^(E)TQW:(0"$
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M4,&6965TO[N$.$CO,WF4@A@M)^4$%.W_/*CY/%Q>4(8+E\SL8,@.9U#IW!8
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M9X>%AACS2?UQC*IMTU)31-+!%ZUUV<,>/?.1^X_T-3Y$*Y^6^I;[R=8:1SY
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MS*6MI9L8UW98, X=G]9]MOUC\_Z4G-NO7KYG:>Z\&G'!563/SHYY2#S^?_B
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M>#/_#*/$K<%=R57&3F /  L;/:*=BC_(_>E,]!'FN4$72)$X.G*E(\?ULFJ
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MT X=)AW[:6O N WO[U0:PP30,]<:O[>]O6?9=IOTX,-BE[Y(-NN-9*N'B*2
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M^&?NG%/7X-0<6AXKR4& =/H? -]/2+938:8\R$\_<YSIE!SYW/M5HG]<SHT
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MX-TNI('(4MC;[LQ4O8D%9V+^-]]/)<!,\>1V97.@BBF5RQ;8 *;H9UD%:$0
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M;MMQO9!*87\61QX:T5&6,>;]"'#5^E!DU]\QU)C1M!&F+B?)2+;=M#,+Q95
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M6\.PP! 7MG-PE:NX?4RENV$5"T(NVLL; S+Y#@&0$^*G:^3$R]1*JN\1ST!
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M)^]&N /=4Y(D5I?31VZP8\E;+&XDD2A5)!%+-<Q^^M2_K.LD6;M>;O&4SW?
MO(%SC_I_=I7G*0J0AF,C/!!:CIE+=O@+["K+6TQ^L)PC(L!$8.S9\401M%CW
M N2SE=**"93.U[4@US)Z@^5?6=/2;=\0[6K+F*9&%Z<>_6M5<]Q%Z;:,'%L2
M+ ;\*=L#$H)P,<QUT(5:IQ":Z:R3YDQW3D2]MLZZ'TLS&WUZC'\S?=-Y$KN'
MI4&'):Q9"M%@B04JI$];;_$S>;H_DU&ZI66]!PK<CR1JS):\GA7DV7<SA&^0
M"_"G=W^FT;@-$[JV7AFBU/)VG<0Z"!,[%=3RW#Q58RRL.%-$5='/6_%NU4$A
M?BD_W'HB\QIGA%2?TQF#8*2S2S'1847HVP[6E0$1FQL_+\(.C<T:V.5;)DA6
M"D,$@PX]^/AV((ZH!@I1:Y]I)P*KG7^L[OOK=A7XGI Y]V!2YVEEQ>.2LX4-
M'N<[%+OO3U_ H( Y*KGW@_ =4@J'9Q1S$HDRS1=H;2NUB5+YZ\K#E<8J@1O2
M!F9=1CR_)P X1XP+-?Z*>GIM!?,2)IS=3%"FZ:5=UA@;/SN*T:(:WJYX1V7K
MET(%[Y=5VN2G?LOWO^3,RRZ+>5%]K#.3[;3K]<S.QU$*=B *6+5EG#(.M2&^
M[!.3T?-N3VDQV+_1F^-SM+CPO;56V,86,R7\_,PSNV>RR1\C7/?FA]U-RF<>
MPP[Y6!4+UI5@1]2XA+HE-ZBEO15XEN<@_L#F<-41ZRI>'OZ_A&O"D)2E;CUI
M]/<!&BZ%N!<,YW+#]@"D6C[M\/R>!=_5TVZ]1RXT*FI .B3W)HG]:Y' Y8SV
M\&EU!FH.2N.2R?@!LI QC&<.G'-,ZX$+$A1I9PJ<@D9Z]!4^K.05SUM\45Z=
M2C*+'%XW"O%63+DBO[H#^;\MWQAGZ8B9'(8-,-"Y\6#!"F18[J?ZB?7")=VZ
M)[?M@<O9V9-RD9YNEYU$LR\NFD;I617=,VH[ES(<='HNQ>:8X-3_.CM(DA@H
M%_0]N*Y#-RR1E=@IF#(I3$\03*--I6PUCS4C1-#GOJS\A<:="[7I*@RM?/R=
M%ATT/2432PK%!Q\6/Z:)>_4_WM)VCN."H#-5=I^O3&QES"QV3K9%-AV9;/-<
MD&YRV)]I'Q@1F++WBO6^1R=E>;B3<+]>\A2N,8>E8@IL,K[0+^DX Z8#B+AM
MA 2J)7_ (]Z)KB(OA9CS'=&./!-^K>7!@9-PRX;V"LU8WU(6? >2U, M#&G?
MN?#7B988B84'D>-TNO_@4_<_-2X&*SG(-UH-#G:#ZP(/%Y;CLJ[&/ "/0M@B
M].1X2QA=K"<**T'?3C2:OVU'ROA '&M)$_X95BNS;SWK((^7(H02/U8(C/3@
MDXEB0 !BCZ4JQ4G9 =@R64?MB2\+O74R4,7IY6BU<!'OBQ>O%<RLFGE^OZ.G
M<<1V'<"+V558?3^6+CC #-M5;G*@P"7/;/\Y\;UP&'.O:G:PT8Z@WOA2?3;0
M"X+?FJ%=N!\FR43,PQO+UU& !6,2#-QUL?[0V[2Z(,F9^7N\>42*G62OV^(9
M?WW(N.WYWJ^)008VA,IX3>FP]XF1;_Z[G9J7;Q':L(LC#XRA]7JL9,?OK*L=
M6#B^E:^L0&T]_9?CZU2(M4*3M/X[_P)NW&1NR(UTKR1C.'C4E"7K]L&9+O%T
MTZ4*8W[,5F+,T.%KR':#2S/?2,Y^89!9;7U<FV1?]0B86EMGPM&&E]KHIO$<
M =#"X7.-0DMM41EX;4R$JG4V*TOS:LZ^S*X?]K7]_T]UA?Y]_GW^??[_/?"=
MF?\ 4$L#!!0    ( #J"@55,%F11.0X#  :T!  3    ;61T+3(P,C(Q,#(X
M7V<R+FIP9^R\=UP3[;8_.B&!T'N+A"95$&D"H8-($Z4I($A30$1Z[X8BH$A'
M1) FJ( T4:K209I*%T1 .J%+)[3D#K[G=[:\>^^SSSGW=]_[SW[\/&'-S#.3
M6?V[UDS$?\-/ -27U#35  @!!&@'_P'X*?+KFBHJ%KKZ.FJ:EU4!" 0 R#4N
MVSDY$U #@*.3AYN^^@6.Z\8F'/ N@  @ 8@ 40"X:>7N<N6JVC4 ')JJ*ASN
MX"+@Q-@9!"#'?_N%-'0Y.(#_V:"Q<G'S  "(+DB+6]NX6X'T?9!V\/9P.=Z_
M!M+TM^R/:0+8,>T&WB!(,Q_3MG_09W^M^8-6.J:M'9VL0?KXGEVL':V/Z1:0
M?N#E:0/2T,L@'>YE9^,-T@,@S>W@Z6@'TMCC<QUM;KH# (S\>+^'C=4=D!8!
M:7*W:_HJ("T' ,3DMK_1MWZC/6Q\/(Z94G%V\76SL[WCP<%O=89#5%H:Q:%A
MX^U@X^$AI'O3ROZFFS6'BK.CRTTG7P#X@^=?@_98MAR@D"5%I24EA<3.B?XF
MJ/_RX']S'.OV#VI3[Y?.((R?_[;O'ZUSS@8 U#8HF[B_[;N5 @"580# _/UO
M^[BS ( *U%M%]V_\,![;RQT/#Q<986%O;^]S=C96YXX%^I_C7R[X;XS?ON_<
M\>7^4SP<%VUNW_1T\. XEIN5LX.SIQN'N\M-*QL.H3\;\?_ZQ']\'V?U;6[;
MN-DX@6<8@E9FYV0+JMO)VL[#SMF)P\[IGRGQ?WG:G\8?=@T.NA<X@-[B'$#=
M30] 5SX#,#HR &J: 1Z!_*?>+I,8 L>>9\2.^</N?PW(WU^5(/;XP]W.]M=Y
M*OK7.*P\W;S^.';LE@ A0 I0 ?0  F #N !^0 @0 Z0 64 )4 4N 3K -< 8
M, >L@#N (^ &> ,!0# 0#CP"XH D(!7(!%X ^4 Q\!:H!&J 1J 5^ 3T %^!
M$6 "F 66@#5@!SB 0"!P" 6$#H* L$-X(((0,0@*H@!1A5R&Z$.,(9806X@3
MQ!,2  F%/((D0%(ASR'YD%)(-:01T@'IA0Q#)B$+D W(/@&4@)R GH"5@)=
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M@J:;'K)49O3%8NV).;J[97QW#P]@7RO^_:4WC0YYDC,WUZ6.<&B<0.P)_H%
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MAF2N8_B. J1PP:Q^A ##1E&@@85 #QR]=A6GR W& "\P!DR7V)?08\&4QIZ
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MY"?.G+E+8VOH<,5)KI2BW>41A,/*6.]C*P1;>9C94.-/[ %Z?V)\_Y21@=K
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M4J>XG3-8<X;@FRR3].RS-Q,':98$/B59<H*33P^E@?*HQ*XYJ\/+2K#I-Q.
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MBN5!,"V+EUARO<NURL*KG28]U&01GY1#[(9)&^@MQ;=-Y>4NOB)2/Y,# +P
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M,3C>^.,%V,%Q'+;2$ <L.O1EP@JK<$#1"@Y(9\D/?D(EGY+4_3J[G\0H'+$
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M)QQG/AMG(VQ)_Y'A]6[:,^(8FGENM.;CZ=<'.. Q#CC(4SLPZ'=7P &>]3B
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M^:LU=89O:D,0AL=50DX*%GC5=OA_FH_^Q^0PVM=39H*?IU(1*J>B*D<1(#2
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MJMHF1-<^M%9YN=RH>?..\]0%C*1QU[$?C33E0A6$5$$BB(&$+7E%'P=<+'.
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M)!L6<1BD5=_J$R?AA*(B)\]L)!;1J3,?>EY1I]1D?^#7 @YGJOT,K=I](3$
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MN2$&6RT[;TI.$Y/-@HFHUNC+Y[4X$S- WR]!ZV1Z_+01 2]B7KBS(+'<>G_
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M^M6E) ..<$89S@LI#5L)=WHHC/MA&UW7*Q$A,,Y9* 9!+]\JF*:>X6*6L=C
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M??"@8QVU.*>Y&@6*5H3<+81?H?C@O[9F[GU_F"HK\OW<'YDMY;V]@LF*RP\
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M7#4]%2@?VPY"+K$D[C\\]D!@Z9A.@:T/BMFW&IU%15D^:^<3/GE\_:<R\MP
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M]U&AF$Z2[+4 0ERR5.>K6TXG%Q4<BZ5XP(V)T#B@(JU"1#>=!( CG !T%A*
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M-G!#8NV\10S\46*R(3Q9!SZ4"83,/==B?.#=O^3Y6B2\)"SV536E5+O$]"%
MT0KQ%,)L<9G@$HJL!9^9>B>=!CRDOU$)80L2]W.\K10X5244RLT^GM65,QGU
MXJII!7N':Z_4*%_="V<RO.#^>'KOKB05=1*U37VJVC4$L=JXWQD^^Q/4*>XL
M' (2S=OCA\#-89.UZ@/U?M2XX0^NK7Z[FU)+G!LD/?D%WFNBC@B"#*-LF-'8
MF&!N=*[)>6A;#FV>D!#@-80^70[9B2-!M_1CQ&6,.#-3KJ7<'QF9F)31@P)K
M#8[8E%7VQ^?NBY^^MDJI]2A9+X8&OJX'][X$!*[>V[\+N3_\S;_^N0@8?V/W
M"79-GCE/.2JG"WZC$=4VMKJ]]<KVZ^B\^VZ .VY(=!@\J"Q\-+4-^@[N'@FD
M^<PAT#$4^1\&RP4<OO.F9'Q$^Y2TCF OOAOZ4?^4[V1V Z/>:+^S$-)^?I]O
M+6K_[7/>7-BYCS;1?-_P75N(O1>-)[ZT#PW?OI[&F4F0Z>.2A='3)\L.E+73
MMCUE!HH @!Z  ( B2 VV&H^\W73BO'>6([[CV(19))^LLRLC#9AG8]G53.W#
M^-5PI7Q#L>[ZJA4&=.AG/+B@]3/.,ZC,N//@6 T9^?YXT@GJ84KY (IW&R]!
M040)D /^*W;8BUZ4]IX:10$ 2 $P %@\!EP/K+=V8QS2[[C<B[;G?7R#EJ;3
M 4O";.*_V*DV50T//G@R.8@.,MKSEC'H]_0O,]0"8\+B\SZ+_L>K7:C]4_ZH
MC56F'[N&!Z?1"$GZ?1/,645?^5S$Z(!TC$]<+Y77ZQ2"@8'>DK>/)1_T+%22
M&+\D9;4\]PV07:^!NC=RN/1!(E+0#/[,.]<&3C FGH?J\D<G,NOPAT,H33.!
MP*$H\M6;:7R.8_/3[*E\_&4TNWJ3R?)@=(T +94:TG)'>KI*XOO#!_=HC62Z
M%>#[O?D%8U03I,P.YW#11A3%2$.XCP?O'"<@P=9\E>\D<HL_*RN"V[/M9<%Y
M0 0-@ %0"\"(O@Q)V#<C8^;]!QT%3V$8QO6.?<L1@CO.M3MZ:'8I$.DEJ0.;
MF!BOV;T.2HF;:KCIA;XCLLSO-972M0!A7^&PY:VJ=Q1[V;'BE1;X_A'1WBDI
M*Y7I3V(1V1%]BUI+:1M60C:^.H[[.LENX!-Y\.WYU9_7,/D__W$-,^["XG+E
M8@F'DW#!L]E[E_.49=$0I'%9*>O7BT9%=;#KUE3&$4F)@5_4>!U^N6%5E*9X
M43$T)'I >:0O+;86YX4%89T^UOWW4W8OE$IH3HOKG<_D?U0L>X;O9'?ZF,(<
MX]R7\8(OF^+>6;([=SAB\ ]?ZXB4];?/6SLC1+RP3B1*OP4$!5HQ^H;%0T5F
M$S1_1*+ZD1*Z[(IKDG%]/]7'4^)T;K1]A7]AWENF4;'L?9:A$(22JQK2GFG9
M9<I91O%"M\U0I&A!'.L&8UNDZ2)()\N%2*[Y*YVV6.74[?9FT5G9Z3/2-O=%
MM&%F>=K0(H%I!!MNS=AQRI4S\]=UA7DP-0)(YAWK;#RK5 C?>W&/KW-!CO%Z
MYVN4/EI'CLFOC;8(!2"@G2%>G[G*'F4\,W05[M9]QOL8NJBM#H4D>K4"PZGG
MVEQ_B/>,$AJF T0;#-0%%, "P+HV*5&&RE,8/'AM[5V)UP^L)E]Z0]- K)D7
MP>K(BFC9A-$#QP(/@39Q1=&]:KTDF_/T:G[TLHU4GNH+&9L)%('^J^?-] O3
MM&[ A2<Z6+VM[MCO=V#+F%2E%,2S1!:F&28Q!]>Q11Q>8W.C\,M7M\::U_C2
M%0B>( 30N?.J5S*D-$P@5GA(BL/E#(8\#HJQ19!XU,MUR7:18K>7;YSB3'$2
M?U.%'D?OJJ :]&XS&IBO^62Y[F1/#[INKT$2Z0I.T5K'M>*O)/9ZCDS(,"%Z
M>)YES#Z9UGY^ZH%I*O)9N\AC)^G9- *'!Z6?$'C5TQ !O%E3U&;R#/..=!1\
MA>"O^MAI7,/J,^Y14V8W797.^/P.S(Q3!"RE0</8+7.<E .K1O+4Z\XWYK6%
MLCUH]PJ2]GX7OJ+3V_D=-.+_#9ZR8(EJ??+H@=*%V*7:N#QG?"*SF8*:&BX(
MPD\DDB@I5G$,K$-MGX1B$:2'/6$5)C0V^0%T&+3_1@1FN^]LN3NO)%-'@4SY
MR9].3!LV8:3\WB*9P 4>W;P#=KF#_--?:C]$[@:\;BC%N'-K.F*P]JD+0I2.
M*JE',+!7U>F@MW.EH3&30W75%[>\/]KY:1Z-+)Z>',ISI7M"?2J)R_#Q!'J4
M5L5N*]H3A"<5RMUIM65JJ/I@NFZ>RF)[:>8<IH@C+OIRT6S8!CUC2_S$3Y_'
M\LL#CYLZ/2DJU"[4=W167<!@)/3V.D@(**(LO264XHEFLG[Q8WW\0J[2LK)W
M'];#W4!&2@&9+(\.:O[3M>R:FUE\U0-K]C',D>.U5ZD$XNG\E*F\#0R%,C8.
M >B^9.W0RFQ#S S-Z5Z(,\-Z;B&!.3YOJ%$#3;MA&*/*&OJVWO"UQZ=U>")?
M[5(1JG$)%96SV[1ZI\Q"[D?#T&?T0,<2S><T(RJO+(7R4X= Y)F@'SNHGYZ:
M)%]0?XC\CMNV>%WDS,&W")C3W3YMAQ^KZOO*AN^^!30)?1EP&;K^5-#6S+P=
M'%Y[+ ;&Z_G,7T !<JJ&;\<H/7LJZJ</Z3G;XAD4DU TOZL>XSG[8GO6$D66
M;/PFG%5&5HWW.A$5)1V8=J*I-O6!4C7+RPEJ56GOUB;'8=Y'"DHU*KRW4CXK
MA@T@V]:B'DN-MJQ_JYJ#*ND))"(4%+I:F:*F;SQ_(7WB=5%Q%8T>'$.D$ND%
M]J7H[+,O9BSNTZVUN,C0=4T@NZDO/Z:NQ0L)'8LQG@!D I',H$_O;27+<\C:
ME>+>7&?]+L+*>Y@G168!GT0BGW$KCN'.?W(_B8R"[A#L.+K/CO/C3HT G@,L
M!!+605L&A).NK4!S]!^<W+&U8[4J;1#4%'L:XZW68LH3X;-AEH5J>]APL*_Z
MAV]K';"I"@[D4J7O3+F?V4DX!,H^]FGQ/>$UM$<.XH:+'4J>1'69/Z^^!K$6
MT3:0C0\L2VC-IEOQU:]9%0R,U6D^">T)P7=+/P07;I5.1:LR1<5H]+$=RP0N
MFV=B:H4@ !&33,W;67$9LF]>9^Z[RQ)/'\=5#DF&J2C7& 5M;I5(AFU?3#+T
M]'HS>9QQ5TUO7\4KH9/<=33@A@6VJ;%!Z3W1D38#2M.>M<+//"$7>6I%/T?8
M%N<NDA?7GC]3&.5LZ>I2@"<;%L*SVOM!;P'O9N:#DV7A+X8H&'J8"C"\"Q\3
MULIG EO<7:<7VG$?1FX%M#QTK&79E6$C;/>9**NIWBG<#=WZ=5[H[)_1[UMM
M_Q=G8NX<)I>,ZY'ZM:"KK'H(@%$/ODG18(<+E4U_NQXGCY>.K@)@9^_YU"QP
M7L&@O3#NM^V/?6TP)!:^L:*[JR*O#N<UG7D;GIGT$'%2;RF0Z&5M^'?$-=?.
MA>6M]08A;DZ$K'[_:KUY9;=B=AM<4"ZYYMRVE\FZHM1E>RII%:_M/24C@[D.
M+-UU_?!?NEJ"CU J9\L!WX=/#EUL-(FO$O-]@K(:T-[/(@A,FBW?XE0O)UR)
M<S]I_[X&+["_IJ/!Q+\65(+B#)219,M]%IE*FJQ(KW @J!,Q:$/-3DJG8<IL
M^C?*4L>K:BAD]BG3=#>2J69R[)D5D"EA835$9CH[KC>+DXZ##R/X4=)KH2O'
M(RD=B]V%RM2.S&VY5'%LW8W(%KB- 73]F9N!?%8C39RN4#@WN*(TCHTX&B"[
MQ+HJ&",*%?+"*SC;,R'# 4C-[>&GM[B09OUR*<(L,FYM:"GIL+!PD"TMN94"
MC?Q"/(AQ17F(]L"\+PBV?BJ:E7A??9\ 4JIM(2B1$M0>M,M7=&Y[T8?:KN]=
M.&/3J7";.6@!W.\I!;#/7UK+. 3TO;=]RA$VW:MLB;H$-7P+,JEFECX,2_LU
MA&9ZO)'%1N*%!?NCQ#P?9KTNMZ\1&ZS>-<C]EMDJ->34](E,]A_CS_!EN53\
MBO>AGR(0_!OOM,C7']GN6E'H'+]28B_1;PPE58%9&[QPBA%6'*K4[LO.&V)S
ME^OCAR6Z3H7GEWT\!-#[M00?-$WGE1E4U*7R\19>-8F<Z#/>YR GM36EVQT]
M\4B2F'^R"T5G[/X91V=':>:.)R?=2BNI)B!=&S]F].V]O3LCL!O=(8Q)$1/\
MUD_-NV['4XN_\?JP0HG='E\1*0X1_O#LRJV!_(>/KAN+W4<FC[9])<8_(]Y=
MH5G@39U6I7D[7=/PJ/9&:X# O.,/8%GI3K(>0'Y1$7\(F 4*(>)6X9!PG[WV
M2&+X.9C$'6?EXGX5H<#0 <+;.=W<>+6NE[E%TH)H?C=<J$TG;). P'<W[FC*
M/PT0[T@^]58L^>68><UD3?XQ-03<'?H9R[ME1#K2A86*SWN7\#6[67KP%L<-
M-WK91$!(29V450-TOZH)K-0SH3)9!7S"_<LZ[/_FX"LRW%Y?JCW$(<^L=>IL
MMFPMZ-7QD.8OS$1P4J>1Z\#FU+%V9R??UQL"Q1"W(L[7*#X-&4;Y!;A#$**,
M[H#=]NESV;OQQ&/7T*D!,0FW4Z&<UBG?8G">,EYJD/ &OB"W@M+9"I%3#4\Z
M/*!7);F9GYIT@><Y><)X:LM\9M+W[SG_D3SEC.@ $D(\4ZD KZM]V! ?+-#4
M/BRVB]N>)0F 4[H$W%4Q!QP37P*\;<^3*5-N@%_?W[UR=8%:Y\H1J W[J\-?
M5XVCU1FU$T5F\&67?\GL;G[WO/TWE1)4)(H-!_:Q8U+AE7_1;MQ$F<>#3^A*
MS JH"BY< NU-&O9\*SC"9K^H;-7I"[:H4+X_XA%, L'9L0VR?-%$^5>L"A,E
MJI%H?E@ +%'',["UE5=UAHEN<D<PI*.&]E53_ZFD]R,2NM?R8(S[V!-@Y'QC
ML>8K5[I MZECN3''DP9%<F#.,"];OQG)^^F?3M:>,]9C+68&3).V^4G <:CR
M]P(Q/=)9D#[QR+0<NZGZ!CY1R'L^A%[!WB2A[#C,=S:K^0S[,KN=X2!I,,\J
M\*J8BQ1P""!3/J1T'76]2T748*QQ7]'WMLKE!^%2['/N"U#^LG:<VE>""WCD
M<\K%EX4!_"+A>D( J N>A386%S=]?X(3QRI'FP<G"K= D9ME 3-\D7-DP;KQ
MMJLRW9SI</IC#B/G5.6 H 7,OK/D@SDNMT1'EML XB;U@A=!*@\*D#@G1EKH
M%D.IULZ&0A.$&)02,@\!F^*L6%5Y9%9+T,*?M'%I,U6(9.U["5)#ZLQ/5P%G
M\0T!8=QEQOPAM+2*W"'0.8O:6FG^#DO]S"LX))!^*6UYSLCJFIE ]J<7S,RR
M76*0G*W.LU,\@=(AALS67].0CT86CI#3LV 88S#&R3DQY$?3\5M&PF]N&G=?
ME"E,T^35NSWMOZ9CY*GRC7(##0EA>>5<DT%TO'7^>/RN/V4HW\F^Z1T_U%_L
M9A%M3="$]D0Z\R[DR@W5C@[ 0(D1 +^$S<YFB_T=5KKS#S:^;V7#L7^" EN3
MC%TEXM/5(2=BX48Z%XO07EBOMX!7,]<1*8+J]QV['Q075&A1G=CLK;6I[Y1^
M%62FMO6=Y$FW:1'H=7K]9"J*E\O<V1D)45D<Z>W^7SVDC=Z=L;^<+&6BX]FP
M7PGZ\+^0G /4%6+8[S1TN[N-)C#3B99*WYZ=WUNAG6T":T^?L8&*:F:.NA^A
M+O*ZXVO]+&X.T<H/<Y^,A+W$R8A.NF8/AT"<2RLR7 Z!P)ZXI=[2EA8$A#*^
M(Z(?G"BM!C.+59'4O.LAV-C@T60B?/&I1J2])E]JC!"/(N./EP[_R"HO'E0Y
M/F).?'B34UX]->9SO'S91X'X>[#9!8'8+PZ1#I>C 1, H + :( 'R&'*7H;M
M"!GQ>DJ(3X;A0")+:O8RVA=>WG8>2?H0O!75X<J]:S1VQGO F;)89 $C8<YH
MA0PF\>A2'51/6]EX4,W+>4O?G[,"(]V-&!60SM %:!&77?L3'NFAP)F>O!-&
MO>_"]03"O=87:+V2T-Y6&<!&=AR*O,OWXT[Y092@[R?$!WYR).8^X=+\^S13
M;HO ]HB>R,5SYZ![-3C=LA[KM<FFNJ)T8=C)[O6KF*TY780RSM-3^9BLQMJ;
MJHCZY:[7O>/U\S<($Z15MJ7@RY",?4GRN[(8NK&)UR=E9.^/67B:</!)& 0*
MO9">0IJ>3&JX7A34+UK4$*UG!,X]_5&R/C>12L=:&G BJ>2CU@8-&Z_-,S]+
M%>JYH;Y.BLOY"H1%H)G@X4QRQ4]WW*<T3/6=J&%SM6(&BMX=6,9V!%3E!1J9
M_2<G:!N;_+?%"''V0V#N%0Z2'-U]CE&*D39R10$N>9ML(_&??FLO7N)C$I.C
MX0HZ>6QB+CK .FN!ML7I&RFEZ\BH^D9,+9;K?0U:%U/2PR^M/-=67#]^8'=A
MCC'IQ)/@VZMTT<G:ID[6*@IC1.8)7N[FGL$CB%)W(_5$6C@GRQ7(=<ZN%JA0
M(0(,G\V:+W(-97\SM.;N:"; Z6[R4A8WQT]*P7EE>64 ZQ9GWS% +QMZ:CJ+
M 6,U,&=I<)]Z)5\([9**N(7X_<QC=4XE1KB<K!IS+#T)1K:A>K VUJ/GE,I<
MF82-2GH VXBH=)!1"FFPYVT8PE7GJ)?FW)\+R+%O<;\^2R&;RK]Y&HTX!,*S
MR0M"/T+.'83Q!!]S7LR@Y#K%Z99^[828]KR[+ECAFJ&:J 8:>0C,!"0\Z[\P
M.A[RJBY*0HU?0A< )^J)^"2A%9VPY4]V;AQT0QF&<@33+NV%%YAJK^BGV9LG
M^\1C?6I8(55?0NDKAR8N^?!^HSW.L]) 82!5 C%R53U@=S]2L4C4.KQYWP:P
M6LN/<R"K/IX5+4^M5K&_\NTUQN')WHL&5-NY]XO?PU*N0(4'J)P%N_$TNX3^
M\7AUGEVEUXFB8Y62=%8N2DV]3Y#OZIMNW/Y*4"&KY#\W&VY@N5G&NJ&-;*/^
M5&LV"] (K+*$Q;6$?<;T0U)#C,GL9;5B1I;)O06:55!MV51K>04^:60 +.M3
M<;YMV8/\MV=WKS!4W@F;?E5 -2&O<BT0(&6)E/VU?-^3^0QJ/GQE*"V"W.31
MI-"8OKJ"%^N6K55;;44& "<:1$G4#1?*UI[%5B32)*E18K$4T%<ZJ(L)EI_*
M?%IX>=RHWO,G@D19^R*R'R?PCM("")( 9DN9!PCDB L]^6[FA$OBPRI\FU=*
M]=-KBBG#[OX8QF?N2K;,Y+3'TZFGSV8^]P0KP8.^)@*H5!^"@K*, 952PHY)
M7< ^^1# )Q\I:U]46^E@\T+"P?GT0^!!#F2G[@3YQ*-YP$=,[U0AGS10\L2S
M=C>:$W#.DOW4< A,.\<][1^RNI,ORLV,]T_CKCLW>>R5]H0_<5/Y;NS 1S<6
M!XR#P.4B&0,*#"BE[\+\FZG[_I;MT,<6</^)=VSV*?&!)].SGJ%ID LIB4R2
M5<:DN\:A4Y-=_#<@ BPZ85U&GA?0LEAW)$N2S53'*I]>3NKKJMWK?HS6:#7K
M1 #"GWQU00#P[5*PK=8\TC3W2M+PS H]WN98W[D8!,]]3YF[E\R&]J$W2VLR
MYI57C@LK30928AW,&9_U0V("_]%$K PTQKW<R>Y=9Q_N'L^6$MX;Q4F]^S%H
MHCIM^GEJH_,0.*5_"+P=*HN<=G6#!(RF.#^N#NA]EUG;^4GHPV8.D_A.')G1
MM=9I</HTXG*EQZ!/HN?$MJT4@,2L?*DT6S.,\9UBG G0RR*YT[DEW$K!+G-O
M#(8;PGW':-@_!Z 8Q20F7R3#&C 6"8_YNQR3/;EY;O']>9! U3FN-TM;TI.H
M:$XO0X!SW6\-/'67E%TUBFX&6P=?=76C^!HG&Y;LE:PWFQR<\JFT_]@ER\X]
M#:CXZ^IW<8,(PKDS4)RV5[;EFCC8[$FKV?5GFK5@ 9RN=;B,RNUS4% 8CQJ1
M./R>_7%9H/N4C8G^0T;FN2 1[>#U9S!>$@+!&XY&[#;)6QX3%'A8Q0BB!BF'
MG21 FICZA^F(/T[_]#]=R7/.N)X^UTU?X58CE,?WD#X%@V5F"-9J;N.FSGQV
M<M0*H>WSQMNGU::T4ST-Z=<U7U<J>^&!OCH]=4'$*XP3D3[E Q:4[&WHH\8K
M1X[0=M7O>\-K-*W.@Q!^"@U>>,'HJ4BJ*%L9G)G#5)0DRPI@W2^5O-5#J$IQ
M\OM]259RWW4M^K!9\.:\%"%V\8X4@9$:KZS>BA"@])<C)$1:>E[[=*45<.Q-
M 4,75IV%D+.D,+0"GLH09Y'FRIE)+3+XE!(63N_-K,ZCGK\O3KY4/9HS&' (
M/ O=F!V;^A2P-S+^+>C+]V%7O^=:?BR5OL8LE^NE(UL6J:0QCAA'3DZ<J*C^
M&GM:ZJF)UA.C; BE602>?\T\_MYV#A/?P$B@J-$AH$O?XTY@;#G'C-=XR?U2
MAA/F')_I&C"3$%^Z59,\,)(.:G]-+."D?^K9PAK4I0SA\?;Z7#<5Z>;7P/WH
M(Q['G7J;GERKBY@E8YVQ-PINHAAO^W9:D!Y(8"ST9>5IX/$TG3W8,SAM4)>[
M"SBI]OWL0"4DWJUUI)C=YUO Q4< BAI'PZ/)AN6E,FOKX[):U!?C0*C-RM1H
M=)#"GY490$Q(8/&^4XT!5P=('QU=;P[[>F P25AF'?Z(#XQ;\:&\YIR1%?>"
M''K"&M<YT?GSD_64H"2L)Z.,,+@KQ*],\H&DV7*W;EO'8U+0A&<0KE_?WKE:
MB >B3J[7OY[&W9I<<E^V$R@44_$PG?!4'56^$WPBCEBO#&T8.66"6F4EM(<C
M)/2@E N<?<$?ZRKUWTA?*%KT2O6$&C!JJY-*@4#W[/S%/HJ>LX,Q5=>3U/9:
MO$'KW<3L^K1%;=T%W@=K??JOJV-6Q&QU+"Y$L9)$\++5D;;:!UY)BS</@;7"
MS1\'SFGC_B3G1WL^V!5"@'/U)YR2<\;2V1\JRHIRU9$:N B ::-+60_YQ^[-
M-^VQ?\_^C^Q 9[XLTBYL-H,L;AJ)][*X)<E&-&EBPIF.12\:WEH4!F>3.V-1
MTUS5YT !2E+G(2LK_-BL'8 7FX5U%C@R!:K,++*_<CWI[JGFJZ.ICT>#(Z],
M$'E]<'H"BPP>:A%6Z@S=JVJMZ(D>/*6SB/KBI6M_UL*TMBP[8=?]R9_3*O 1
ME,(B3[4_BGEKIJ1$],&S#*V'K0H_7[D5[9#)WK_M@(6Q) 9'A'MJ4R^[_L4\
M+(W3:)6C'J,!"9/HP3*S 5 C1J;0(!BO,'AATOT3@^6RU6<O*<W(*VF"^"[)
MC>2KCA_6J$CQ:M\,Z0.#D*H48]H^U8)/@!..'["AFH4 *"6V/&^'JT\GY2OS
M^1-JU)2OJV2'N1\1M_$+4!Z:4C>M6=W,IZ#GU&]!B^;@2EX=RKV$4L#GNTZ'
MTEW+V1&-5[(4NY['.^_UO:N1WC54\^H2&*J+W>B+S*)YHGG372)1#$.1,\'Y
M=6G*-[55R6LJHM]O4Q'X+^X@-WE,/]D3=CIGB4ZS.+="^]2"NU;"(NR:'D'1
MBT#4Y1TOW9$9M/*2Z[TS(7PYH&Z-!M'VDD>OY,CH_;..]6C+DHOJ.'!.+&LR
MG=@-T_E$D+[OL9*Q+DD[51WAQY!.653H,MNV(!(LA8>X:U2I==FB%R"CF_\I
MS-":X8-8[D103<M,7R@N%&GARX= $CF9&0-G9\%=!X([A<A+R,MC<P/2D2?-
M99'WG( @ 30$6%#6%AV\]X!8BCAA,^4<Y\V,Y;@&:G57DQC]W+*H9-R@1*2[
M=.Q>Q4F9 H$[R>_ZJFD9$7B %+^@Q/4BG;>8V\J@/B_$R0E##%>@Y,T).#(5
M_"395*.=+3PF&YX+1:>&F@C!19*I#,%><!+E2@O[8M/1-,L?I:X<=YFS62FB
M$_$F:*Q<XTN^0VXAT@.B 7^"89=NKLVTO1]RF6['M3[<38:Q*T".50RA%2UW
MCR#@+^<=1\MFRQ!D<>N57"_9/8F<TJ2.!2 @]"+D%K#XW_H&5\2AN-58S#F;
M(>?PT5++2$8&(:0L(KES05QU889O[WLVR3 UK%#K^B'0=N5HS:LR'P)3'WZ&
MH)T6KCP$LJ-1JTNH.%@)PP51R0/6!X:[.U$'!_D[[P\!&JW\_7W-0P!EO.\R
M9W_KB@5J[:$EJJ]#]=N6*B[A%_HZHF"CV)Y#X%[NX$'HR4.@N?#@+.K/C2F8
M<STTM=L7/)&]06;Z\<.0G/=K6]TM'W)?'6&G7QCB^Z6M>%.JY^SI?V;HSZUY
MOY03+FG^E:5?F_K=_=_=_]W]W]W_/Z/[M]YFO3[V>92^8)G*,[[$:Q!!27YW
MPMXZ-_;,/RU![[^=!1I-Z=T?'0LD:25MU*8>E^[JZ@&EI'1]*_;];\08_^^4
MJP==4;U[9FE9'M^V)0Z>A&[+#L8W(HI]_U=3R8\ZL5 LY%!FY^1P5^45E$SM
MZ-H?' ('BE/3.OMP*13J$.#Q6"M5CC2<0WE%#4L= GU\C5Q733W^O?)H##E5
MFP^!^.J=*\LB*-&]B"^/4 L)G^)$1,_]4G4T</1\4X= I]6^\#:[:NJ/UJU>
MU8W.5>U4]B>_UAU-H/M,JX< J?3@^!W:[.X#XO=YOEW2M[P+L>]^K4.U:4*^
M'6&QH4. ]@_V/._Z,.V3]]X_U[IQ-,G_O5)U^F3$WA& ^X**Y&W+7V^N4:F-
M.@C\L3B0^QKU[U5\:XFM/PZ!?;_FM@0'XUV["3[K(VR.#-V\><6B^9>Z7^3S
MLG"_?(6IS.$0R%(-/OM7LLL;N7I@]@WR6W2_1?=;=+]%]UMT_W\07=GXA'AW
M#/.<H>9@/L_G"]B9LD$MXPZC@J_0T_L93I57M-0+_@IH3*-8FV=/GOOQ^A!X
M?]/ZK>\A\*?GX.,'[(O\N;$BZ'^6O]__SO+_(+VN&8AL9IS6@U]W\IV<=W9D
M)\@[(@00[P*VY@\!3M3<U,'8(;"<NNA$-L*I*YLVIYS*;R.('K!:E>^N2O[X
M@?H)+?_VNV1,],N/2-4Y.V^I^K/-TX)U1]-X_0B3#O\!@/_T^"XWP<%PUVPB
M?'G@:!JE?3FX<P1I479_(.U_?W*5CU7^@Q[=:_V_;%-X^_@AD'H7+_%.<D?/
MO7FAH?G;UB%PA)E_>7CMDC=B?&#RC?\W7[_Y^LW7;[Y^\_6;K]]\_>;K'_'5
MAUK;?V'E8A,CUH_3$X(GY\&S+?M+IAA0G25\6VV2/P#3U!!!CQG]CYFB]D5C
MZ=\+52<\9F^],_W0_%'O@(02,&:*"4ZRVO'>=#ZF==RL*03Q3SXL^]]6S&Y.
MKV[1' (4AT!_G)??6."='QJHEN9- >N@A+7A\L4^NU.'0&#ZCMU\G(AP;D/>
M9XV_B)C-R-'13*]:M<*[2AAM]NB96\%]I!L.W-PL:?XEBWBP'WMNZ=E23V3G
M+YG#?\GPW:@8J]RP%YD@_>>\X;_F'"\WR$WP4)EV[/W+K.^#!7GC?37F&WR_
M-,SW2\;QS27A[8V5$[]Y^,W#;QY^\_";A_^M/*36$P^!J.:U^(O#O.X_WJ?B
MWC5:&/C4?#=SU&*L''O3(IP;VTM1DQVCPI-ML1Y*>%(5]*3INK7[:$*#SM.R
ML=AQNN@TWJ)";IN S9?/RDH"\_=%BP^!W;E#($G@$)@I.&+&#W4(()O7X:A]
MDSLV[)\/@1)$UON][-VDY:29[+6R\D-@(?W@?,(A$)MWP/[Q$-@_ AKXI$.
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M]#Q9D9.40 <5*\W2ZS01K%D0'>%]S,]K-\/'UC<#89V0]U^X%19YV< 3LJ4
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M&P7.K6/U&7=.;,VQ]1"]"<(F:\*FMX1TPT_/-+L!=K*2#2LJ>S.;6 _X)&_
MQQI]L3NNL<HQ P0_J%S+'@:JR&#GG(Q$O-XNC!S"&F=WFE+K/&70I!=_'='C
M 5VU\YY4F/[C]YCA3W5<?6T)KFR9;0Y(;LI$LXT9EF[ZX\&A$%U@INY'ITL,
M:FNM?H\R=;IT^0^?;8$=LHBLWX!&'8VBYH<+GM\T<1+#L]FI4SHR!0A$#7"M
MH^A#3(\:RRY)"Z'2J[]N^LUYLR\4[9$5 ^L03[^K@N7&83(VY[\-8UX9BR9X
M'HJ!DXGW<G&YDQ\9Q-E YUE]N)/,\'XPT?BHS.EW)5<,2_((559?14T:E+Q
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M\?+?2KRW$G["$R8R<#J[9GQ]]*W@F7%CK2=/'QU4(-J_83$\4Y[C%^B:LIB
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MRW?0D@I! "FI)D#\M)Q1$%NNT"5I7%7VQO^W#;'I=17QZ4 >J!>A+"?4(R5
M2S1J%FJTKDOU)BKQ'4%B%+0@O=CF4.EC.58L[43C+U8#PMKGP^E9T?;/]\,
MZV";>H3-RO?$'0M23Z.T_$#Y0M]Z@:K'4<1[]K:&7!)3:II;Z<1 DD!KQ,56
MX7'4Z$G_JN0'R4.66:Q7>9/'"MR>35W^V/^+0>*UE\EK9+-<+NUMF+X8.@C#
M4.9X^')LH,RSQS*8**^4%ZDP;67Z=X848-9G:\M2K#KPB91WPM^@.J> RREP
M[*0+N;./-W<N_MQ8<2E4\\)EN) >$F)K^ 1K&N&UOMKS30U@=G_SZLGW/D95
M,9=,BLSS!,'"2[*V6!^$/49!N!BP 8U,7B;2?0L^!5Z$=YWT*L*^TZ8B/WQ
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MX HIV(F7A2%L\OD5>+R']++GAD,VK8+N4$5-4+0$C2RR[$?PQSODFOKR-FX
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M,URS];Y78J<Z'ZPO_-^=-JJVM*?CPL*[BISFLSL#:@9(4A=Z6ICBW2Z5#^7
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MU%O^MG=K*>ZFTM<M@6X# V)COU8AP,1VQ4]!2(KD:(^X4^R3+$:-?%Q S(]
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M7// /,5G7B-I8,'_U?A:XO56/0ZD>R93%]>RATMZ$0P*DU,\$2CYQ/SG43B
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M+D"OY 2+$Z-9.X@4_6R^7\(_/;$E=^K1A75-7O4P==+UK6MOXJ]\)ZN*N0&
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M&%_U_+;V<R?62\M=;E.<V=[MRN.A\;@M7+4FT+081-2AC(68/QF:WNN\_B)
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ML+V$QC[P;WVMX[VOMRI>(3X[W.O;M58KEV>6FBXAX;W *Y+1;>%PX(- =GV
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MH@R8R/.(T=E%:OTS%C$Z1QX3_!CI)3]H";%/FU^%_VA;:C<3T*^76!)C]>^
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M?0@.C%5')*:'3)+0Z-0H\AT,HJIZ:MY_X\"]AF$A\^'4@U1NJK[< N#$<;U
M.DVG\CFY\EFSXZ<-.6WP/.%N>V)TF^L8&-Z7//G'C@:\>2-[1^QR>K8CCM.A
M(!3&,XCWT?UN?C;NQ)C0B9I#UQ]Z,M_[G+R,=%W*MU5K)=*EKGW ND<>0"8T
MO\F>\%=X-O5FM.MFH:ZYY)<7%X,O=W*DL@01MSL=S_&$F]R\B%24R&6Z%W^;
M.[,<XL<4\K(A"NA??_.$NY'"7%6MGXI,[UFC8"M'KS9L8Q%#7>IH.'&\Z7EQ
MR8+% '7=RRO!(!M>5V@X)[U2IX20H<Y7'\M\];$>:M%E8>6&Q2\8 S#_,V2Z
MMI3G9&M-33A_C-1EJM4'>#'S<^*8L^(H0--F]PU!JNCLY4GRZ O>=!5B7Z/+
M#]95(+56:=R#5QXJE:4O)2\HH@N3S&[@[I<,"99@T''3HF[AB@;L:H:J9GT:
M_9]5M#3>DEY]A6O$+L#?IXN;?6S;O5SP=LRDP#;LI?>\A, L+ZX%TVR%>("1
MQTMVL2?,ZT?<O=\NEQW!ZD-:%#O5]'TME*U+/A;\S!(F1!NJ2)$/ &( $@!6
M* '\,UAUB)]]S:;-I1L778HIRJ9O:2?B@6OWT!07:LVN%S6]FCG:X.-Z_X,E
M?LHLGW0QZ]S+NI9WM]["H9ZGFY3(LL[.>U]F2?'!&](30E4%E^.4($AN"54J
M7,>-E6_",G*W5!H@%Q."$DB^) UT1L'*SS]Y\1M1 U4KFFV H#:"\J:?6T:[
M!?*:!4:5:D7F3[^#J8=?L4?+JH[TV/)%-E/>9QDFA&YUEV8[4] \TMPV&SJZ
M:C ["VXDVD$_<N<\,1H__?4S?/JE[<^6*8%#$ \(GH$W!1C:\*QJD"^NO$<]
M U?5QN(?68"A_ I3S>CU(WKKQ8[S3V1XW68,,%_JW:X4X*\Y(%.#9W#CZ2'\
MK /\\QT/'PC4@5*S^JU4A<LW!\*0N*3NN;J0;FR/;,/#>]Q%G*9:C3G^-C9$
M<C 6PIWIE4FOJ3VVN)%Z)\ SSVGX#37GU^]\<5[0LK>QVWB;-:'$?2#,]%'@
M$,]>Y*E]@,/D*'^(R&DU25.U\MZ[_'ZUD!"B)-,X+3!3*CBZN\NOGX[M'']B
M1-32[AU@#A/ =&KP%T )8EXBGM5J1B.6$[R;HHPR-D@DD6DXF!KUG>%B3.@P
MJ-B1R8%)JKV?(A\#(1@1M)[W(*QCH+[=7UUO3#3X4R] BL[H>'O97>[*1^T#
M"O;57UT?39?%6^BIWMJ5?<R++"J';G!_=\P[>+7^Y;JK,.7J/>Z[1V<4&ZTO
MDFU2;4@^Z/3<+T4W04-?'W6<?6'JG'E->LV%EQBXXCQ&*^9')&\"UR^WOF3_
MT3OG+NM3Z^Z./O#D%*_>UPV:L@,3* K[2KY*C)GBI/K]9@5TO!K6:3"M95P:
M!R[M5_T&K[V- U^!M ]LW 0]GV"X4QTIG&,DLK']X#8-NRHNHVG18_I.#P:%
MM&$R\3UL5/D/SD6N466V211;LJ9'2;3'R;(T0KZYB2?$T4OJ#EN,YHY5/:*U
ML+N;"P.8+\03BO$:/=<[9^/P'!! \$ODS?LW>S[D5D7SILX)_GC+*AZ=&'E+
M!PM8B\3>PT*N-P18J]PVBNVN4WP;YX874SM'C0KY)"\APV+\[6Q0\2<?A1&(
MD@U T)2UEL?5QS XQ>#BAU. E_];A-S0:I,:=VSA2^%]0!C_/=7GMJPR=>=S
M- 45V6@Q#KC\U?G]4]G:BH@J9G3EF3XD3BP^>2:,\\HRXOW8,%Y1ZA/&P%E9
M5PTHHM,YB$?A$3^SBW.'WY+@A]02U$9RJQ]0J-34H<&I+O130_F#])BA<VI2
MC?-GOV[5[ ./O0,_499@_X;@L#\DU[M#W =FS^X#CB.O3^U0'P0'VY_W@>RP
MFX?ZY<PFZ.**B@+OK>H(RGMN+2WO)&3^=3?T:UN?IRS[0*RLZ[<O/W>-R?#O
M3J;"W^% P-+>+^Q[1[J6),^45L[&;>:7JK82)6T\<V'6\4LUK,=#,AK#K'P@
M%KYLAW *GYL>EH\"%N0D<9!O51FV*NH&PV'B^5?\+S2F6@"J'TI5E69:2F+_
M9_J3:H>EKF0_1#X;FGYZ?:ZQ[(SSH.?:>^)63'(F;!_X%3ML&]C/^:_LY+F&
MR+]#3S)L+J6K/M_<7IT)JG41KW6]:$V\V0'8_5H[&#$A12.'E7J91L?"MZ$A
MTI4S^,,LQ&VFNO&AUC"KS3+JFW"ERB.U)"&D.M!SC$D-H&^F)]S2[S&=Y8^J
MIDRFVG6D#*BP<'*X_QA(7:,%4 2Q Q^T5%$F@$737)!ZU1 >R8:GFHW#.OF6
M]R@L%^2853CN^I2,@?(BQUG&A'-A"W+NAOF9])(M+X6BID'6WGV4'?E,%=TM
M$JR6<&:WYGP$ZO,RYX7ELQT_!&[KI8].S(4&G;*PN]FC@MWA<./4L#!:]YY6
ME9<UG:-_^;UV@-6EV8)#Q3JFK@<:X_ ^MS6JG'H8[5S/>GS5 )+6; TLIJO)
M#4//_LH,?CY^&'4/G/AKM%7X]>&\W!D_^N(VIOX26#^ 61FIH:(Y>XK_S8XA
M8(=XOW!8'E&TA'GUHEYA ]+6C.IR2'R<]\]K_K82;';08UM:OB?Q#P]V#W3)
M$(LF^K?Q1[=[#/JX_[&IY9-S?]^Y48?%J7O?N",J5%R/TN0F;P=!'I^0-R[G
MIY5)_]H#$'"-OR1O3&L. =C>N7.^?N:-8$TGK)& L1P)]V6:^IQ)4Y3XES9&
M[SA-SU?ILE[(#\%< 5VQ6233RPQ#GB]?9=JP,;'MF,OK6IO0[ O70+Z64 +%
ME3=# (:K[C'T9WQ%KCB?X#"(Z Q#.P_F<3B*H]9XX?PHO,]K O;:'Y'2G-LI
M_-^.OMW,V/%B$E?^T=F)BM^QN<5F=0B%2.J2RY&37K/J^6+JL\TLM:50 X5F
MEK$)@MQ[C?H$XUWIT'86!Z'OCY9V+IB6,95*9,57L ;3V5#Q$C,NEVHV;[_9
M69Y GXN^25:K _P3=1@72'36(H/T(#"<OR03-L32.F9B=IS".#,1H-+@HP9
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M%RN((_QT,O?H7%A_(8R)D:(E*!$):]6"UO.//S\55J.]+<"W=<WUXUFOB.W
M [_K^H^F[VM/9PWV@=!]8&%PYL>3@STTS%ZA@.@]/G;,/54@,96B*Y(G$R %
M$'I6%1$R7)5?>T\TG2%U"7&TZW07EI^\SA2N#Y0OR,:,ML6\**W5<KA9A_B8
M9PSSFVIX^"H>KR0HNU *K46[R+4]C"X-\K^*R</%M>K""E_PXW2:78\,OJ;W
MQO*RG0J#-#P/Z^>V5B_]PM2"?M%WS(R7G1=MDYIJ@Q?O!$ Y;[\H",6N3K)H
M4JAK1 EY;FX_NEC)UI?4J>:$QSC1^?Y9EX0-9+!/N9P5_$TJ_!U,^,[I_F3,
M[CLO@K+'PL, VH3&^31)3=.*&O$D$F365LTKPI73<TU4R8KF@]I5/#6 ,*E)
M?U]B>OYZ7'E0!/[X2\P# L12O,N#/V'HHJ]\\0DVZOY!U5MVT_"M5U;Y"X^
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M8Y>V.1%-L;HMD;T.*\09Q4+"M?O*<?4<0=W0B6?#K>?.W8T0\ V<VAQ<#>+
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M9PYC\%#E(XALM4;IFD0L*K8N7]7?"*Z*E37O0/3(J]\_E*6.7X7W8J5D';B
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MA7$^O"_(VEY;^^G3/G%;$J/L&X+:\2GO-:0YIGD-YU   <XZ-9:0NM,O2B&
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M8LQ97[3?C^?QK4MU'3)JGB\/&&0IM(5\,*#6_#]W)L3^)X0K($WY'X2T_GP
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M[M4#JF?A ?I!LA^Z]99D-JHU2#BC5$6ZJR@VPY\YT<(QN<'PD+<3:<!Z[F]
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M*W@IROA"Z(3T3W%0(GJ4XD_X)Z$=&KZ@8HYQK<=U* 8W.$L%!RO*25,(#J
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MC1>-:%]Y:C71"F0M7C.VAHW+HIH!M7Y/-_C&$ZXT2\M(+)VB6I6^<"5 8]=
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M 18K<=G$Q,GQF9F9 25R0#6ONZ5;P:<$WK:IE&]U0_C:G1&^!L<@01J&1HV
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M%VE$NHE$AT=-OQLMS .E1'W/FC78+8PXL3K*RG+S/FM^O(D@^P*<+S!>[X)
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MM?IR>BD)[P53V2!<G)'CFQM17CF53VLI'<6W ^Y_'=(6AS7?ML)[>J6W NV
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M5SL37EA*O]XMJEF=JA&B[HK=B%W0]2PL(T/W,JAD,HQ%+B'.;=ZJ&M=#5+I
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MY@_Q=B3_Q+.QGGU%N1\ ^7D;!19 +C#W?OPQRM?6^P\(M-&,?2\%P]I];<*
M>6QTU6$$LKCUVW')-2MA0W9 FA(M"^P!L4C%3:5@'(^Z[>>,EV=F/Y_<4$FK
MHZT'*KEQ#CN*6D JU%BD)JW0@K$*X\&JU\HDK$(B,CY,36OG/U63V&FD" "U
MN[7?Q[9E9))VN:8\?3=VRAO=+I#PGSJ\JUL=Y1XDI50*K[(X7J]!77K WV],
MEULR9DP.[AI@O)!V]J1_B26+MK^5NI?78AZY5Q,%,]V&/LB7LW+J&3W@XY,\
M^V;#X:[4JK"7[8)!A7@ZXZ60]Y#GGA)!)^[ESJ#[1:;G=-K#7TF=4PV R8BV
M>)/'=2)8_/M>':A[Y:^\F&06Y PN45WWO&<3B];79C'RARR43_YT<\KH,9/+
MP?)51*WZ3@7F=E$M2"NY Y0$C^S;'(^8,I:1*(]RR7P8QR'M"8?XV2N+OJ*&
M18?(#B#1A]$L<L2MM,GXV0:-\=AT)?4/P+>BBP@]X=)Y+)@!V*."4<IX*S/I
MT/<ZR31>R)+IX+4Z%XY:\&K?Q("C.0'@&.!SF%.5^E?<D'\] E/W3:'O;H0S
MUE>8+FT(GD& ZN*"QB-3TF9^ *'HY^E6/M<9^*Z>X?6A0S/4*8L/<O"_T/43
MH/(P2^=/SJJJ\T8@6\^00YE46:CA66RY9DI_:KH&[H2==BH6F>D6'CJ'X4?$
MX^(QJSI.XQ2SR6X^C::W^];<R,Y%0C,331Q'X3>?KAL.H+^?35+D)-O(*)EQ
MW&->^1*D:;87('&:*?[I04D3H 6C?Y(/7D3$@B8,#CW@ 8+%_-T/P*&O )ZB
M."07UBVHY.TJGIZ+Q]K("HOYM[\\^U38H(5IT .I$:SJ&]69>"H YLX@9\MC
M?6B;?YEMZO'_ \C'TO+/6E2O \ZZWL1X254W/3MF;K/06& W[[7WVNQ>CTE<
M7!?*[9%8"Y6#NGM*39K?K+K,[DZO J:JF[YUAR,/(6X"%L)YM8"#^[0XG?4(
M*46]UF[O+8+)M*CQTO.N36(H@.LE"<;@T?_SD2C/N3%_B^^:F3H8%,R\QQ.0
M8D%^2@L1R[!>UTT0V-3-YSN@2Z)O\#^=>(8#8*V0,<"A6L&92C]3/8L7=V^>
MVZL9N29#'G[S30I2=5XU#7E< 2^VH2N_9?9%*<-KKN[[C(=D&>+NH^Q:M[/7
MO'O%+>JOV_IVPL-:@ V!$FW-48=7HC^ BA*+7FC>Y;?&5 $3LE'A%A( TEQV
M(P!+<8?YVGC4[0:7PG4SE]>UUXV9XT[-G.I)73#!D@<E0D-^QMWDK&4;C/%5
M:3-MZ&( W5V;LF7@"UWZ/-%&%=NAI0K&$N-B&:W1</@4?%4 ]-'DS ^ VN+#
MU_'G=1*?>AYJ52A]V$ 3Y%PA^_6#EQN)Z]8Z&B?,-NUK'\[&YK55:MS>W(5%
MMZ<209' V^PZD7_"<A0:<]^YYP8O=[KL+]K^0$+<R2#[0FU_M.%64.>5";X6
M>3FAI*WOC=+W69%3P68E-A=Q9)9:UOJVTL>P=$$9YTM]B%\;0V5XG!^Z1G.0
M7S>GI#IUSG]@VB,A_O8../[I84E4?@ OD:YWYB+E&;M[4ETH9$,XE!,\!N1L
M/Q5\)WN->'T]NSZM5NOKMCNE!QS4 GB#JP'OPP?\=SE^X<G%*.EG/87N0^TQ
MR=;Z")M1YC/\CAQ0BGE;%J\6R@[//Y7<5[06-XN&;G_'%)?P,2,'U+JX6B=Z
M/E]-6FBEPB'1B"V;/X+KY!J.!GH7TRX=W"C Y)AI>X%=XJ2Q1*B].E4P];+>
M-6#FKI@^-'@" L,>G\9A6G:[OZ3<\OJN^!KQJBBG/JBFZ[&8.X,$;T@KN3=_
MM<,/X!\(:/I4AW[U.^V8W6BV3]W4XE3?9B/_C VW$E9,//4'H$_ICBP1%56X
MY"%2Q%)UHJ:/^:W8N7@4K**027J]E3PX,%A-"  .L[+4WT_ ;?\6@EAUF);6
MW5+/W;31]%C"*#Y&F9V;[UII#(+Y6*QS$$8(_A"1AT._,0A@5>"?#BN2PCXY
M;'&E^B$>I:,];2;=C7KB90KIN)Y3HZ@@@Y(@Z8BY\.H(AUJ\F+/)Y (.2"TC
MD6]MI]>M7VQB/[VLQ:5>^C XU'-ACUNEI84@'S?JTCV-N@JL?)!ZFUDH&6Y\
MDR6;UWPI*:%!&D+ZK!JMQR4^]@.XAOF6LRORKN$K3W(M^$- HU>J0R['@&(>
M.#.[OIC'.%U^Y>-:2)W+<=56P]OOTW)T&3<3@N(2@C&M9%%>IDGK-9,^C2XS
M#9APG9<:SRGU %D*KU'H+6HJ;77/[[]%:+)),=)9+&]5OT[KV];F&$QR?^LI
M%WV>8BJV$\H\B-7P! ZWU]\&-P4U[['$D7Y(>R<=/A<@%K P,'(Y@E4C9_^!
M-<3Z]9_ GTP,8Y%/BB[W>W'W!IS3U=KOL[[ 0#P#L_V2NI4N$2P;9=(^LBRN
MN%X\.K"9;Z^=M&-C=S4YB5.%/*@5NMLU@*9R5O>\<GH+4>-NOCIT?/?FDPNA
MAN71^F*>IE9)*( ;L[1 6=.D743//6E>B2?<+5&!E<^"P*DG8+Y?#I.=7'6O
MV#6DXQ?_YTU\"Z8ATB:]?!D;6;0,U(C3'AOHQ<J//P &RS7QXH[UT?+*J#;Y
MFVJ5?O*FQ$HF,257PWG;)4G0FV&+VZ%Y%HY[:IBFA $S^ Q=Q_ER 27'07(6
M0"0>\PE1!E;[>E%O_6RYZ[?QB8/^.IX;_5.I)$44P6,=S47AL/9ETC%6<3XK
M4K/V%""R(V: CY7+N#QX-+:E4&*NN%(*7Q'!(< <C#O=_O7U?'S.SJ ].*C3
M N<3Z+/Z[F4236Q%=AE5"0>9!'ZGW[3D3JNO'EL5"\3R8?%<FUC,M07632.V
MNF5D9W2]PKALUI0R/MNY/4#8L_RF.EUD(4NB%8>=_C%NB;IU8=1Z"O#QT"34
M:M/?*B9=%*Z@=$N[9&^B+(HFH=9PP,J #"=[3;][XT4-_)(L^NXW)1^/F'8%
MGTP&(97-]TKP],7M3<@5H=H(\/'RB[RTN"= =  5; \BK'?#0AGW<4_$^ZTW
MCN^@!<?;3G+5ME=8:%P75 3R;9_7;_'UC8UM/Q)QB4G<R$^*&WQG9,]SYHJ&
M)FRV&=L.<*6QM5V;]'D7ROIN:E!XZ_0(0H:JSSHSML."K@0T"# <$X>Y%+M!
MG->=<Y]_*\0^C(BK"6EOV GC:MU0O@RL.)9<51_F;[8=%5U\:!:]$ 1]ZIC+
MQSPJF&@WV*>+U'A%#?WT4Q7#_G?89+_ISZ*KXDLJ-V0F*3$[6HX8V'R ?UNP
M'L\-QV4:,IP\K=#Q-FZ8W'LR!\OX)TBM1W#G4H,=NH^MG:@!&L3)A9N(LPI6
M0,IB@'64YY/N*<ZNUD=)TTQ6:.QC#14[!#$:+2^B<2SY=&BFCZGAB]2B>F%J
M3C0I6';)O9,\C""D6]]_23^>L-TS(,U[YMQLZW[$-HG"LS^Q2W$GX9T4>Z14
M\J1_52'RA).*7VR^FZB4\@UR-KYPF.TG4E0KCLI W6-/Z5@#/F#H2O]N4/S-
M5R=9M&2YKXAE)G2^G90C0Q=?I?;'K971I/F>QW?S8J-*GFOV28Q004DH1*PC
MV#5RYYNH\R!+O\?U$07C38OS.7.T)>WNS(2BXU&/,3;Q6ECJUGZ_D[<>5419
MT?57V7CC+0?SA0,3]AEPH"#T"8$29\*7JB^"';<@?>):Y"O5&(%Y42*&G$T1
M4(BG(9Y\M25:)GG#R75 XB1+/7EPYUUR!G?3H*E5N2'*-+9N2_^P6\?UHN>N
M]_H)H OT\Y&8+M4\N3P2U'4JFB:;A]+B?+93*?]779"2.0BP&MDS1PNBNDA^
M")(D:.RP= [Q>>,VIFV>2=%?^#X!P+5\>T.)GBT+#'0 F 1&%42D<^ *M1<+
M'.:U;ZI5^=&]$_=JF2=1H0 H<%B6+APH^TF%CJ88;D/0$7:A79R[KA-&7013
M*):8.)_019;TS^?1?4,?Q9\6GGTLG!/MI1"F*C[A#=RBU/-T%\_]_:'04=>?
MT]QQ$_TC&SU!;0>:AUE]O\SW9N5=?^>"/[7:K:7)"3TSB6-+D7@@G!69SJ "
M#VE9618T^XMBDR,X:K0DIVK8V-RS3;TZA(*JCY))G/N11>KN6AQ^V.;9RHG8
MQW/6<3R<.<E-8_:3IO-*6K$A\9F4_)\#:=]G_:6SLNCSKSU9 N"TSX;?;67H
M*WO[YW-["=)VE^8)E-(?E^6\V9S_0 !J,#^B_SW[**%4\*//$;1]->%$-N?/
M(');)C\R:D65 F5EW+O/&3IQS]]DVBM'B,??KO\!.']S<#ZBT;=J_Y=%N/<Y
M*K=XN7;TI++2&/VB>E2X=3Q%>_Y%)#MG-/7Z@2QOZ2YW4.5 G[GO1F?ZUW+\
MM_ZOE=\')-+%4SZL_](A:?8#^%/;*U!*+'3V+T[4UIH4R.%KZTZ;/FBLMR>&
MDF.)>.Y//0>\H]9EM3?,TB[:>+9HO&?;J6;GQ%#)<JR,1WZ,?")ZSTTXP]'Q
M"7*>:X&UV81#OCP53Q>H3R5?-+T2.!IO_O:ZF<C$&0D>OG""QAB?]EE^/$E9
M6LPP)9TEV>I%_-@KA\1AD598?;SDK1^ H) -0+X,DFWMYO-_?_:(5^&Y1VC$
MTFZN;>K(3PC9^X][B8X1N9J6.)3]O1775 N?I;%HN9()/ P[%@KJ(@5/=$,9
MNXS^:Y,<_Z^OG4+GJA&?WF17B(UFK67Q*>K<\'L498R"@8$\:N;<LLGVYNRJ
MM-7?RLFAP0QS/P$QPT=UV>BYR/$;JD8:\^: #$*%VAYR$*,G5B9QPB:,Q,>G
M7PR'-F ERRT$^)^9S8-1@]!Q#_W)7]4A%=K;)T\_6,8V1UDUA!SC[9<XK:OT
M)8W(-.._DJ'Z=..SPX578^^+\79/@V0@!C-SG(29QONQIL$WF,=3@ZF,;F1-
MO:O9SXZ:H"-;+O(8A\"V^G5^;:XX_$5G_F, <W7UZ"D/G/B!UY/N(K->9P8Z
M/"M.5Z+Z=7G&)3S=5OI3!N?8X8]I+%\4MWG;87Q79'.]?:Q&K5)M Z&WW%7
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M5M>UM'[5@,?YPP2@[[L E_ETB56?*TNZD2L/Y]7M\0O'!*QS0V*UB)MR@;1
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M^F&4@'0RK-:S*]9EV%U% BT!X&?]@E9.%AT!<V)4)*K9*D-T-\T*[(35:XZ
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M82 #:-^Q-04U>"O5G2IM<-="@&1"[&[+,E</6D<OZ9[F@],[QJI03O6A4;[
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MI=5[@+8OYP:+.NA"[G]J2"<5DBF*PU[Y[_2IBW4$8^:]'^?T=LZ?P@?UK0_
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M%VG>%!5/H@P.->1@"PHD450@NG,>Q6V?2E Z +U*SP.]PV>TID!$#2TAHFF
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MF\A(4&4WHR0!UR!924&(]I9KI6O3ET+G'9*S*%YT/@V+%A0T+ L?4<SM<<,
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M9(MV5YA%(8A?_$=F(#=])M6J^FQ<CHC1JZ[DUC5J4UI7KQ4(&[6ZSE8:>'?
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MLQ;!.%_ORX!UN'9#YN4A"^H2-FC3B<]_H(82?ZK7@M>@>?0U+LB6?T2H/L>
M,2I.L"<_\(TEK2]RE:5FY@<E<F[KNF]^V4UD.J^7-(8^BES4EH.\EK_R,4W-
M1>>GABFZ08:OUB]A'G*?(;>[:9YTNV-#ZOMG0J_@XZ4[.Y *S@6V-7J"_BK4
M38:-["M]()E<H@N(Q_7"-W$#J02\*1_X4VO=,DQ;LS\*MY4'S6D"Z$1HPIT>
M@ME38T-S4(S7I]NOQD;-1D=RS))DO:85QI$5%$(]4MMM<B$_ON=")%*= QUG
M.)KW^GV#M%+*^;R-+BSU,!;1:@JUBGI9('4_WSS=158Z%#M!ASO/F@E_&/,T
M*L_PU *<P@(E-3I?3^/U5<YA$_+4>FNI+@*A4TTFTD?9E"6-/>1RH57F: !X
M>I90%"PH;K/QZNY-CV@9WB=K[[M;QJL3Q8,O*7_NA7>]V E%Z.ERSMMPN6N1
MI6W#S4']O'(GE8M-#Y_FWK WB,B>E.IF::R-U%-6&8\DY^5B.UXY(N#1?B&M
MNWV8A]86'1:; V348>#.^QI?V*+KG5AJ9V*IU-+S#%N%;7OOW'^\,6.W/B39
M%9,Z^?CKBH5](H/ ["EM=3@>D(3']Y$!]QB:/@U]"XL,&RV<-3&Y9JJZP5?V
MAL2TQ.411>BB HM@TVDSXE 7F$WH9Y6.C+E$8=UJ<PHKUW%G"\I)>6U?-I!%
MY S;D,"!!CS?XEV+$]W>?0\".+JSG:MV6'=-\I"N!KI6>,]FLXGV_$>IJTZB
M 418/DTTUM)]K<['Y3H:X\?]@UC^H/E;10GRC'B+OLE+5Y8A][QT9QL0C$]8
M/) L5:'%H+1\\/,%^8U6#U LM(S$#.$82TVMJED+Q]]2,4:)B_'?/RTV'6HS
MNEDUC/L@*0F"  &=E#6%9)M:X7%=%_DDI*#CYR[2E(QMMD1]K)?>OS/2M]7+
MHO(V?]QN+:W+!;G92F_;:84^*]>,Q#F:LRHL1TOU@565W6^.?"M*[5A&>O.H
M46!4V+%\]:%7-H@]4H/22[%%5?]2D@LA;0O?1-ASS"IHM)83-/!N2N7VD,A0
M%=H> <T+ARE'P(;,N9]:P<W, +?UW:H9M;A;[V&7U)E)D? ](RR[H?CEKWO1
M4G=&R2D;RY$:&5$6HR9*Z+9@ 75 <(X4ED(,' %*_27UD**'9CS2G4$;+<P+
M:8BH9 95A10@8W"F-HVR,7)&='>;WT^LGJZPK$TX+E/C8INOOHWEUW"9$J%H
M OAI*O)=C,8GCM)7>AKY[A)$DBKZ<T8*'*6!(JG)D 9I^>/G=?L66N=98*J>
M_6F.QGQLX<JN.SG-1OH&*4#M39D6\PAU=4+VM&*CLCJK]./'!ST&[7$RFN\I
M"M(HP9-\X[$9HC_PMP_"ZPW<['U>69?!D'WY[*ZNS+[CAJ'GN*(,U\AM&7LO
ME_KFM$])VPL47Y X'4OM&,T7C]4&7_/E<W?-8/>1_$&#N\PBH?=,N<E4%1H,
MFB514B$Y!%V8WI5K5G%5'U4C+-Y5;0XSB0J.I/6!MO(04D)\VAKDN!=8\2A-
M87F)G"*//_%Y?1X8/K.-OU(_:AW%\*Z/9EY%L[_%EZPA# :+WT!3_&O9NEA<
M5'DWU]&)P_#,B*7 O! L,?8,&8BESFN&DR"(@B+(P%\JJ4^DR<<2(P91OS[G
MU2E!@3*G%AH 7(5G,<#Q#Q ^;;'<0GN9+].0_\6]0+-\WK;EKR6DHW1$U'ZI
M),C8<J/E)":Q+K][FWP/$;*Z>)+V6^T&5_"L\F:O[^NT<]J!393_G_:^/![J
MMO_W.V8R2(.LD[%/32'9S61/&)%!B$AD+>O8E]082C&V$:()69*RI)2U&DN,
M?8VRCH9LD:W2QM%SSGF>[ONN^[S.[_Q>Y_F=\_+'^T\OW^OZSO>Z/MO[_?8[
MM9BOWM$Z&UA2)G<Y/P2NDGB[_JZ),2M*K(+=?A+15VZEM!-3>S\Z/IC%\:WG
MRB1T9T297B]KI_I#0Q@/P=_?U/9-,-&\W_@F*E7<38U&HR52".:3]$P!.D<U
MJ.L4,#-3HOEB3"F<[XVJO\5*?5'R(V)@4V^1?8G ;FV4!/0N56T@+4[I8_="
M>P_0IYJCEV]=H2!2<[FNLQM/FW1\1? VM=*061;KD3#=$YT9Q-48%9'J)>^K
MWXKNJ@*2*#'<YZJ+V+SXWF"00)9H/9\\;HE5!4K=V(TG,[\!_?!YLM806&8+
M)NZH(3D&ZLAH2S;<17]K/J(-!2NUKOO9/5^.NNADG#I'4;W:D)J,7+!PE?"J
MSTN.K(E(H@"A.W@[@F,;Y<]UP+(\^ P+O\"W A>]4_H[RU= 5!-0@^.=/GV3
M!+-N1_>&PR-%CH<$&\LN1*8Z.VL&@\8EX/1$$/!NYEZ&Y9V,/(, KE9L=GPZ
M? [&"H<2%>H@%M7_=E.;;?SO@5XJYLUL9W"7?E/JH=IH[CX55+2Z@9G!C-;G
MJTU'F.>*+QQW#X!7&N3*W35K#HVKV5A\EU2>>0.-812?&]3$TW>RCKK([IMJ
M8B+>K^O:GW?@$PV#$-X/]%UPY;OOXWDP$GNWR,YB$[#,0TA.,@+?(7B[/)R\
MI*[EG+^T1!H=L1[CC5=-S\N <[ $A4_)8 $"/Q&*F9Q2&/IKH^?F+R0Q,3CX
M>N?PNUX;'?$.I7I%MR3E%<,)38(RRV@B3,61*8%O9D4W]W%V@YK)44%HPBB/
MC#::O@/5_\4U9M;C%XIP_:!K4-+"WN@%%R?6QP8[^A^FFM4=(QJ_ Z^0R-I@
M=-&E*_P' WC;2_+A[UW.1M]+93E&B:#-=H=+94<W\"4^\">*MFI#CA*(& @G
M6KSD5RIH@-]/[//'-Y=S^,+VBN[F\T=&4':5R(<S8T7,=@1^_$4#$?=G44J"
MU*NY[CGX"M) F:%A<]\1T^1CK!!I-"B=L3'F[D\]=S8 LM9VX(?E4M\[_QO^
MWSYSY86591WD]2,QT&!TRWU_4%.PZ@N\C9:T-]R^\C&3LK7 OB,D"29C 5XP
M4KB6<<YV</!#Y3>= '<'MS:QF F7I.ODF#+V[W06U0I[3A]!MA"U@(J_:@#W
M#_RUTPI.6!Z[HUC3MI/,:JXB6)9\>?_MFP#W93.KY>[ >9OG2S>MWJT^Z^$;
MK2FK]6I2^*3Q\;\/:EAO_#SF;MDX)E">'EO+Q7?68!\2F=R"3&I1!%VF*Z5^
M-+QEJ?LJS5/D.L>NA[*M17K&\BSO6UI$#L#3?E9\GIL3^%5IF8 I_5DYQ>WG
M>E9)JNK1:QD6%AS[5&0!!4\!N+HQU&@MYTV/3.#GF.*R2!DZ3,#?(3,J4-UM
M*SOXZ0\+OAWIFZXB8HJOJZ7VY=497_265@%@!9GI$%)$)VBFY)?:O^Q"FLW*
M)\N*ZH,'?3I?"YDVWY7$02[JWT7:#^A'*X'>[-([K0?S?%-AI9/8$*; "@.9
MQM42#Z^I"\;'>+.?,GHQQA(KATS>O=M@DHR=S.C^2\T(<^D_8Z%,)16E=3FB
M&5-/Q.RS%UPFB?C+D#7F<LFG?U7&+OL_KY,4)#R?ZMJHY]L$OBK](01DOIW?
M?-=C]610BCBM-NF*[8(:%\7U-F,H[H1A@D5<<<'IGF?R\GH^V@@BAXEJ]X[J
ME2[P>H"7:9%3937Q[<B3=3//&)#'%=/(% Q<] -FIA57.*!1-2%X&I^RZ BC
MR<*LMXX$23W].UM);&$V[")NY["V'X3[](B!\K(TOD5FR2C$(^E11-UD4J:6
M^OGW/PWZ\!;<7M<;U'$)<ZM7('&G.L97MG%'S,=7PF<D%W[=',Z&G;&KV;,O
M?]?:*TX<B%"%A-AOV$OC22J K^95RH[I^_U*_V!?N^S<PTZ^U/4_J-?M@P%M
MAD$V@AVW72PE.LZ,"D4A^+S3U*D+$93=55V;0)2-T5+S%W=Q_8I<;/M(P@U/
MF,W;S[[*<6/70?P--@GE^?V5SN/A<D,,=GE.>GQCD/#C0P3-J=6->GZ1KP=%
M8!*!1,,J?N^AQ;WI)RF7+SABP'VB:Z*18]6[- T3<.-3,N/*>DE5*.E7(R$H
M>+-V\V/ [X^?Z\FFY^NK"1O/^#<!+7+-;Z3^?V.M4&:](?;8O>;<!,EY\HKN
M#V\0%C J_C'L\H2[)S3H=;)K>D50>\>MJN8Q5/]:\7G@[3,1=ZE+;HG?7WM>
MUQ5'+)IE[:>)<B4JO/.5QRI59Y!P8A6P.Q;P_0+\X/ACTZ*^FG+6A_\C$OV8
M\<N?QHR@QZY[5#YV88_Z]L*Z HJP)SU!(_TQ#6Q!+W9.A3D6%#*'I5TS!<LL
MVG)BD0[&O0I]:)'C3_WJE:L94B--0HGVB(>4@"9S4H+16DOS":.>6G[77)6;
MD&.EW]]8O_+1W]$B(4IAP-]K<07?//YP$*[X->>.I:4;U0/++(O5+(%I#U.$
M"@0R8G 3YSQ350M256.C]&(8'O$Z2YTB5T 7[:"@>)RM<*EUM^A 6EM5G"TL
M?2):E");!Z=VLG3IO##M^;;+-;?EXU7QG:(0)NMA^'Q<NT^8DQ\I/JH;JKHL
MLJ&I./YE?1-X/5&2VYATRD[2>FQ!W!7$>PWR8)K((OJ1)G'WS!M@:$#1*N#J
MM]@H6#H4*@'Q%R6R:.KT2=Q6.C9>%^AS9.#(WI7T6-ZS':N\PY5\R,AX$(1K
M:.O\X9Q=69<<7[ <-.,]$ME:*27^A 7$?WD_TV1B;:*JH]+HV)R<E<SG6Z8&
M5)DZO5 &,CZXZ+CFQ-25+/$NA.AA1*',0N2KB1ND^!&?$,1 9D6V=G'VE:F@
M;'NJE_,DDT**Z-H^@N*/F&9*XR?UF>KJPGOG\'-EC\OGJU6:]+"=/UH"<]#0
MZ4U@PG)V?+5Y$Q WW 1>=.\X)!3\]+1QL@MD4 64*UD@!FI]@E63G2;JC?!Y
M *"TQHO\[J?WEL\[R]"N4>=>G#Y-@V3B4&ZH[D#>WME0Y!ZS=Q5Q)O;@QUHH
M;Z/,HO 65&FQ73:,^S]*[5=R-UD/<;B+[6MAD9F6UJF>_(2V!*.>(S)Q2O=S
M9Q[,+'_FF^&2-V8V-I@S0)(O%F3_L(!I#S[\]:O&XOOC% ^RX;5]"?BO<YO
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M^+U>:X5MP9\8K?S!#X^SN;N90HAT6DVHG#V/'G@W$[%=93<,*EYXWKUP9B8
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M4<$>=FUW2&[2ACA1!C9J)MP]P[R'3EQ*J_%N;XM[U34JT1U0C':P,A<'>+4
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MV+F\%:SEV>SIS%L^H:3N'8=^LG0H)68M3Z.^7U#9B! *K/ZEQ%G+A5VNR$W
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MY7_YE&T\\TLH7O"Y].4]:U%N(:_6U-3G_ OXI,L/@A^<5'C.(4L$C<!MZ5_
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M2*FN0B1;-.#QL2RO^^<^& 2E26Z6U0!1%!]32I +3*.=AJ+J@#M-J*#,!H2
M:*])X-G O4?ETZ<GX"3P:_O&T##X+=BX189>=CSHP+$36W^>*K3C- 6SQ"$8
MK*5+6>9K/9?S]35LUY**1>(SK9F80':6%-:1Z7ZQI)J4NAJYM^@9D."+'Q"B
M!?+;N@$M$G)_E(L^<DFEK:6]_[7?3N"(N_(UKE+OX$RKQ<4O*?</++/67AE+
MW2GT3FAN^$YA5)UX,"]</&1S!4JX6DH?AYZ@:CPM^I%WI+GU*YT7\+]U2T*
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M'\[5\GZUG4)U^TLMW4T2'+*F6M](^.,!*0(]#9RF"AV"4M8@?\AI!S:Q^D>
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MI6>EQOD;._(5-4 B_%*Q=N52BJ/J9BF#>/]I[OXG=1,F_Z;R@<DD2+4\8;W
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MIJ?XY.0HOME1VI8ZF_^(9";(@- GQ_D_G=S+IB<@<$N\@"J8JI6<7D+O132
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M^I;!&X^H,XX]!/GRBGEV.\OCIS!D_VBQ^T.F'Q:-8(.BU><<13[I\2P\O.A
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MIK!T/AJY<0X@>T0G^"\.R7 D_@7]X#/4!!5' PR.DL7A/-$U-;/)YR:%XP*
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M%?B7YZCB]TC6:OAQ6.:<VW\4 4(?X_:H9ZKG:0 Z[*_Q>07WX-\A2 5O62X
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MV8^H0'=0#HQO8A-)%CPH,P1U ",=!,6V:H=K2<EK[YTKS6F 3WHP56MBXGY
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MKT<XN6=.9?6B1 ]M\9)X6TG&(8KZ>TVFV"0;1>^FMWU_5E.]>#S\)GIE!;O
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M2DH=F9VDN;87XG,S1 7!W0/<5NZ =KLF=V0P M\&G]%Q6=R.^H[2:(+CF+I
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M9]\MF-J\,J><H/:!JO0WZ4"349D@);\?\@D'[T1>>,#P96/T=G$H?!#:T#V
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M-W:@XG1#FHX<^:]ON/7?F,D0J@ZXJ;* 1HSO$M!T%.\Z0K;GA"N7-C[^_5Q
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M<MKO.IX'G#-T9CPY5O3O[7EY,&:BPUCQ)8KE /&:+RE'_@^?]L>&E&F><[N
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M6*!MK'5?IM3M7G%U5KPMDQ2KXUAT:W$,.RYU*.GXK PD(96;LZLGB<+WG%.
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MD4&3Z-Y.98;,VC2#Z<1_L8D  Z8"C(I,I@6V(>V/9BU0W:QJPG\_[,Y"_HZ
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M?AAH)V5U:CU59VBWI.Z2;TJ!V+7]@X_+G83(?+7==WA^'V@'E%$?%!BPC<%
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M"+/^@X97M,=O$*G3]I/JXO9&#=/F-:H&/@A13KWW+PQUC$N0?8V7'XP^EX[
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M_+C[2PVK_2,":]M>1"=S6E%P^2&$S7G^LGOL&OYN@H;*[00,;+B]YTKZ=[.
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MW?C[[O[N'>/L<\[>WV^?\L<<##(R5M::;WF>9\YWOLM?!M6.)"M;D<Z"(Y!
M=5V*.[3/X*0SB.>SFW1S^\-?G876;90)H=++DS^.B.\YM22A,,(, (B>9/WZ
MTEBXLV>O,+RF>=)';K0P.8+IB3R;Z0GC!X4(CK6EFL$9*W]XTQ,F%=JRV/SG
M?M)_8@!5F7YM#G^,XH8WZ3  3X%"@;U[5<DM$)4.$X)FMB> PEU^N-RJ:G9/
M\&X%-WPQ?1,C0 V$(EIJ-M^IWX;C0/S.2N,N_C9K56DQ,</VDE69JA?.N^<E
MV=N?">X/ADQGP)5!!!_XFJ0;18T^-0JJ9'V[<]8-AXHV?6$+V>?%J_E,!11
MU7"P8:ATY_R<7Y\=Q+GY6G"(\Q.IG>2"L6_[18$ZWC;@+DN9+/1-I7\[5P J
MWB2?$UJ'8:JJJ7RW<:@V(XB)JNV9P0H461=FND')N1X2>L:9&:[^YJ,BP0R
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M2;08PFR396#<(8 ^20_@Y]5?FUX7]CM"N7\ DNI -<QTC&< GA?. ^<M=1F
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MO%F6]UC; ^M*L=PYA_10*FZ^G0*<G^ZY9.[$,/9A#/!9MQS$RL&?UBGR?+O
MI>#K27VX1%R#?AI7 CNJ+,O0RRG#3F%W\8AU;#'4W;%*5Z;K$NG&U)1XGM*S
M1-,W2<$.@F3#O3WGO<9)\R]A8A;[_^,-=(,T_ZRPMFC!4ILV^0-C\[;EW3VN
M:59HY!_'4/I53W[AO.,Z"J**&7JA?#^A,K@N:X(7#3%30;-;N\72P@Z/[AP,
M*( Y\6J%"(]']58]][76*.,;#KR,U)RNE:>M>%\@?:P_>?>145<#/Y17^&I!
MQVI<E[8=6SJ:N@U9^[= $D<'""G\9UPG/&WYP'3&HF5*'WG\G>%7E2>Y5_O
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MH#3CGAZ^M++TMTU5I^I6S8B]O=)),U)K'+V*I84>Y H5L?9A3@/X_FV(4'B
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ME<XZPRVGICLL%X0G^G]BY%_3?IU1 N%KC@2'NY2%P&QJ.FD/VP9(*J@+G7F
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M<'KXT'%V0$4FL8%?RWK^MI<UKSKELF&@HQFR?@AH)V<1M9ZJ,[1;4G?)-Z5
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M.)&!D;]8F/@)CZ<?B'D2<!C[=?)C[NDEVU:O?,TLC4?_&?]R9HLQG6?+.G'
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MWX9(K,KK\)6%$P\"0S7TH;LB;P\$%9J$OG& 'U;\[9\HM0M/(^T'O?JQBAU
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ML?$?$Y-3T_CYA=^+2\LKJVO$[9W=/=(^<'#XURX&"!/#ORS_IEV\H%V,?V/
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M-F>?<3V16%W$?5"&)9Q/!W2LKQ*Z*&=^H'%%VZ;XG(WXO.!B8^*0J]:ZI\.
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M[P3+;C\),^+R6LKU.1:79J20^9U/YU23ZS5=?BX#,9Y0^3$OD9)%^5USN?*
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M"*_$=)0^JN;)NKFZFXM^,+'=S.\,2Q^S,49EW?@'O2'__>4.'^0-[Q9@@6R
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MU=OSPYV.^;A\58%7+F"5CD\S_JTZX,KYUK!O2/P,=$*3U-V6]! <)8!_'U-
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MG,Z[WF@O%:VAMY!J>RUATTVA>;P/OLTWTVOP;=E9H&.$Q)3^1*,BS-$A!(R
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M2B02>E689.9O,&W:F1]1F)=I5N:QTSQ;S18OMB;>=C7B];=;YO (FCIKEKA
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MP8?<?L4B30NZ74ZR'.2?!N;/^K2:K%DFTA0T^X^TY*8HJC7CLYX_36T9[7+
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M:6%MW+V!LN S_K/W':3SI3/%)2,O^8F$VADH*W;A>8,)O<]J&6QJ5 TOC"*
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MT>[ (0-Z[@_/)4ZVY6(2R_RW!%]]E8BN#>$UL+_#_>G1;5(1*'26/X&DG&#
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MSKN.+$XX&O9,[??J"JL]I:!%D)76;!5+\B<&8\YSI>FXA%('9>@(1C*[%1]
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M1I<H(Z_I&3UQ[;K[\H=4@</R894:.=+_<!^\_SO^_P_,[MS_ E!+ P04
M"  Z@H%5C[F,W[FG  #BO@  $P   &UD="TR,#(R,3 R.%]G-BYJ<&?LO DX
ME&_\+SSV4,F^FXJRA4(DRR390ZAL,95L22K)-F:*4,2$4(D)":')GB438TF;
M[*',F E9AAG+>#(SS[Q/OW/^9WG?<[W7.?_W__]?[W6N<[ONYYKM>>[[NW\^
M]W,_N-^Y9-@N!QM[&Q@/+P_L//0'XR[#=EI>"K\8  N 08V'.PFS@O'R_&U_
MC[Q_&S_?WZ, /S\?OZ" H. _74AX&]2%! 6WB6X3%OG;H%?;146V_WWS]R+_
MZ51> 3X^ 1$A02&1_^7&?0\3W\;[C?<V'\]>&*\X#Y\X#[<+!H?F*/#/]'A@
M_[GQ\/+Q"P@*0=,0A7[0L N:/A\?-&D!:,;0M_'0]S!^<0&)/8<L!25=+PCM
MO2ZE?R>S:)OJ\9H.:;<!NIK!Q1L)PB(RLG+R"OOVJVMH:AD>-C(^8G+4ZH2U
MC:V=O8/[Z3-G/3R]O/TO!00&!8=<CK@9>2LJ.B8V\6Y2<LJ]^ZE9V8]R<O,>
M/WE:7/*B]&59><6KVKKZAL:FM\TMG<2N[I[>#WT?!X>&1T;'OH]/3%.HOV9F
MYW[/+S!6U]8WF)O GZV_<O' ^'C^I?T/Y1*'Y.+]:P.AOW+Q\$;]_8$XO\">
M0X(2EJY"%ZY+[M6_LTWJ>&9138>PJH$;7?KBC0$1&37#Z7V,OZ+](]G_G& )
M_RK)_HM@_U6N"=AV/A[(>'SB, 2,PRY.U8#];]?;KXUQ8>1J+HSNHB-+,2JC
M8VTYQ60&\K[AJ5[O00OEZ AWQHF66X-6\26LO1._CI].V'9#Y*%EA_0$^C.I
M*64IAN7?5^&%_@*O-TYF>V!*#'0;BKVFY!ITCB1/H <"#CK>$US)T[<IN:9:
MOO>V^=54C>>\J5?6B&&B/WY\KNE5R,VR/2]]>GN6_6^!H[=%-/#FG!>$RX1Q
M%M.2O@LH93F@[!OI><G=G1VZK>437T<?VGV6EO'RM_%L,A#PG8DZ!+O$.*:2
M9'T-4Y=',Z4+,5N $-D>Q#B>4IA'A8OVQQRN\A[%JAKJ&)X0WB4#F[&7I[1^
MA&D4I_ZG_MJ4VD\3HMLR?8$+Y>Q@3A&H&=R^D][XJ)))"_=]Y[G'QC_IF(N>
MJHK,88''].>%VKU<F#\)T":Q)<.9 *-@C(@;-V7BOZ'<*8IVA1[?_ 977-[E
M&K)6K026#K;]+LD-)L(.VL.^"0T:>B@S%IEW 3A+EZU/ +ZPK-CN V;*T_$'
M-=I&&Q9G$J0#I_W=?K0]B/8<EO7O3(C&FP!B7)B  ><>(D0O+0H.:Y=%74]'
M188'ZG)ATZ(,1,J&LM#9PA]EC]63ATXW-3VEZ.,L@)R\H"_/(HZIK%A+G>*Q
MODY2P00C$A"U*\0=ME1;FAC#T9H>E51?BFP*C:4M=(@8*&GQQL3(T6O*#_0F
M\3/\$"P5+JS##_*'?$Q3[X/E=B6PC]2 3J3@=DV<6&U/8.;%QB_5E)&RY/0N
M),U9*]79R/$DV G>ML@L;EY))<F@Y=BB0,PKMC?PB4I3[P3EO]&<>O"O%_/Z
MPD)#5(Y]^O"+)^OXG9$GMV%9 C'A[^& IO'2&983^WC*M%ZG7KJC<:J>8<#(
M.D$L.I$XD7$_YE7(ERR]*T7#U>2XR1L\%C=Y[>@&K4K?A)H'SD7UXB;$R-BE
M5CK1%1B U.DV@%*>#M/TH$U,M<:^.?Z@5^1VH9^-V8'+HH>F+<T\L& O@>Y!
M /:3: RJ*3X%41M%0SX'RKJ,,LWPS]^53N'B#H1L_DH6_7XA9L#VP$ R['P6
MSW.Q%\$O D^[+;^'Z=N;\?CYT*.8/SE97%@P,FU* Q"G:U/G4E!("E9@PNHZ
MI0!!S,-=P3IY^5*MLZ+OI'S^J9BXZ\:"QZSK,96R?PSR[]R1Z7!ZU I;:I)2
MMM1 5^W@PFK"WV.E?8-CF[I#XR8)<J$*J![MQ_5V(B=T5",[+"-4W]YR$\N[
M^AOMY>FQ] Z#0-+C4I9ZJ6G5_N1^6E+)O/LY #W1N=D92QN^GI5K+(AL\ XW
MOUOT^K;%&^K;YV*#<,#8BFE/%ULJX<+XLP$[4(Z^4:_0WZ6WW2?Z4[="\0G^
MB:2>$KGFNQ^^]XE/VO-K'17 #F=A###D)=(. ,?DX\(2$MC"T/$1V+?UJWT'
M8^[^.N>XLOO9@=M8FL=3]XFEW$@EI]G)J7MJ'A_[I'CDQ)^!K9@.*;1Z=!QE
MCBUARXQD()/#50NG)J=5TDH^,P[NN7IS\?2;MWY'I9].6*O62/_1Y,*$.E!6
M QM8>? KAO_F?>N>II  BH[W\L<]+6>29YTLIKXG*16LA-T0JL"FPC@A@"\4
M=Z<Y!<L8<NZ4!#2W(A2:88Z_BU*OC-8=.C,Z+)3W@8"RTDEOV=ZVPGQ.[WDN
M<X7W>I^*9A44.]VDNMY._#V"",J<=1K\3))$2P(^U%O9,F5T4J^*MJ^^CT^:
MO;R,"?YB?6NNSZX3;VJV5[D&VEPKN8[\Y +HI;Q?22?4E+%WE3%5.=EMR/"H
M((%'>6-31D.3>\(B*W2ZA\\.WB+)3N*'%M)3.7?HX4L!D.8WH4EVH8F(.FP/
M<D*(#.*H3L:6],"\RFBG,?>W32Q^?,C5IK-89HA[K+#.J,F%^$\M)/Z 8+YI
M!&!J (KR,%K)R,1+T$5NHA2 4 IBAW?TVDE(L5U.SM\FB94AWRT/)S^->"+>
MUIT1DR$X.*!Q?HFX(3J-9TM9O7^Z^1ZA  YBZL7>A]\G\;#UR$<>3 QS80HW
M%7V/>H5UQ7W^MJ]ZI/]I\]Z#SU-"Y/962A@ 99!)WG-A?6B '[-P:I2P_FJB
M_3,7EMC70(#/(^GVYKK$CM5SNOD5*.0 C7UVMWJH9YKCGX?V6#+KW-D4'%7X
MF,IK OW:9H</8GS1D=-LYLB"HY"#A*#JH*XRZS= Z_60TCZYA\Y,4FBV<^H&
M7N+;%Z7,^ZC:[D>Z7SZ_@C26F&2Q%Q"ERK(5N3 &AH(CPJ4]%Z>4&&+)ALJV
M)T8-Y^\^]/-QK)KO5RHGEFM9;L"]@15F4N/@ 0RY3T=7+M>\FHS?818-7QUO
M0U[JQZ+R^JE^H71C3\8L5$<%G=DGL#TWG)FW8JM&0868/I,W*IJU5S3-3Y\[
M_!%[4GSB]E$LL+N)+6UKRTG D%,QD]_0'W"R%OL] 9?NEM%2:EC0>U#YP7P[
MO#[$M<DE,D(M5/4NAZJVUT577\5=(D=]8PT4YD ^*L)YBB"7<F%U/_&T/:R#
MT86S*[99M*4&)^/33;N0\[+EK_I#(W<%"N_VL!'PRLP9R7FL-#;GP58L""I9
M0-##".GK7-@N:Z5<22+U\4K)(]YJ49\CU\9I]<_&B-#7[=6,W@X"W1$': 1E
M@"J?,#O>Y76>R3Y6R/N^]Y5M::B+VD-_T/N%DZA2!$X;+\7#$J9@ *@VO4_[
MJ4UIZD*.3S(Q0"(C:)KT?KR-D(H01RD8_AJJ^I@PE+:OI375U_%#NK>7][[5
MT8/ROHF:%D4,'U"DE&42S0<*;XJQI?K?J\ 9MEWXI,&0S 7WGX#(5!]>Y\JG
MQR^>VH4O5U__]7&[6U=5@"V_5&<SLK<?,.*;ENU%3K! X?N,,:8=X,3RCD9T
M*.CB*04.Q!XT?+A=IKVA_%TAOL1GG%.M:U-Q9>_.ARX*FO<3&EJ-9G\VH/$
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MK0J(65T "#97?UXLY?E/EV<PWC.+) .7%<DYNZ#;EG]W05][[/F>Z2P'N=#
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M-+\3E6C@,3%5?[K,%_9]=06V6:X!P+IL3V;CK<_^\Q[H7*Q#X"GQQKU4Z3!
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MP=-YC[4L;=!D/Z3\NK'8PBUE8'5+>2.?Q1/*YA%N@*WT. >9R=6K!-G.7N_
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M:N<N*,%0O8JR"XI@Z-S;2N\L?09<=7($@9ZL_+A4=%)EZ7L1]S%)K%"3(M(
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MH:;6B"NSUFKX2$4%UT3M=[D7/*,/Y84YYKP!G6%:)#4J6E^+FD_38'YHVD=
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M@W0#U@^4&/N&U6@(X-04^H";LUJ&VU2IH.3%L](2ER7"E=%5,^6]"DW!8AV
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MV&LHO@OJPY)Q#%4V>DPK+\ )$-HV)6IIG7H"'KG3^UQ+U1A1>J).1[OV;+;
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M75&:P7Z&>:4>UH7>WH^?NZJL7/CV%S23"5*HQ+OB"&*DU64;BM\59I8A"#$
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M]8P(,(MZ#Y:*D[2 @-I(ND9A$_-DGR(Q\?;/^MKHY_7YY@W-J8\F@T1=/V*
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M;2R@@JJ8XR=+]N2]3^S#<&LIAY-[9W<*SVZB7\0MFK8(N=Z0NN:L$C_%NZ&
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M['Q!MQBK#69!"*[TLZ-(]9=NLQ_=OCZ7K<G]>>RW46[27/L%@R/F*:<N<WV
MD_TF'AB)$[& ID[_AA" Z7(.*KGW HB\_O:[]D9UMI.FRKT@J6E':W;/D+1/
M[^Y$-!P@),E#VUB0>@O2#DT&-2<G-VID2U-@?IN3I0PVYQSIK^PN<SW^8TKB
M:[=^>V7.^9JFY@9Y_J;FG+AT^+0@M9-1@/:.^%Z#,J*[CH1I@ CYHPF7J&>3
M/>OOW)YR?"W ^W:VJRM)2FNQ;R9$-RV%SLMX'K2!!A-BE-\#Y4-!IODUNN>.
M4&I?WJSU=?:(BAAQAO_"3>N:>UZ$9/W(?:8&48^/.>!PA:;%'(?)F>B"19K
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M/>FO5MUELQ1/#*^=N *7\=N. 10]<O;[?OZ)K%9*'U5,4]T)>+T:'93ZZD>
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MPPJUN7!G$)5Z?T\;J$FS&BLWSP16RX/I$J_N#AA^Z+\U/T!?1ULU.FP2B(+
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M?N+_<<SCL)$D]T>E=#NO##-E\=S4Z$@2CB:#4*7. L;>Y(E> \9<XFL@IK?
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MOR!]WT N*B9QX>M=] %/?B'HYI843Z=VG?<YU%V'7U(7W:$R9M=*-+!KJ+Y
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M\MI(BQ L@ECH:9;C)P?%15;Z3]?\C"BX57@S:'@HW"A-7"%=3&3]BRGD0';
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MT&Z0I]M]+T']&YY=#KCNJ9*!NA1=U,]ME!MF )MUW,%BT\?,9&EZZ?.2M>%
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MOQ6U =M*$^64V^L*7S% Q4RS/7F\C2QJ\MGH1:S;G=BKT>6AHXQN_OX'K6U
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MGD&B[.Q;_/8KZ@\!#=Y;.<JO/S<Y!@/W,O'*UX'E=#YBP+O&YYF=.!!S8/C
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MN?R?M=;[/.J9:\A^3!_?3J&]!_ZFZ %'60 ,C*#U^5W"//XA.>&)YZ=PAK\
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M>/*9"][&;<0S<->F4MM9RV^% '=*N(=T*]506)U^-R0)R?+!W_!3,B_\S!
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M$LIA>HJR2HY+:HHM?,G+A#N,F;J6+=<.>7,-C4P[B,^N:\J=P7UUV,=ICU1
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MYKK=7^&Y<F';#R<GL1P@ 7Z/IIR%3JMVAQ!#9UR[C..^?^/L[I6P?3.@R(9
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MP8(/%EYXRN[O7E@J\L!S%ZI,2KAMTQZXXPO&F+V*]'$E*6O+"_<J..]!.#M
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M?_9]MO@U^E7%7H_3+U"Y8C_;/OCJ?)\Q']N36/B@M-\>]1P,^@[]G_\S1>I
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M!J-Q3;I]1(ZIFJWQ;>.<7]\EWVF\L/&B^M,J*\JI':_PA$]X]E![Z-TVB6*
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M8-&X8UXV&;*CN'JC3U4^T'6YK^F+A75)R*'4?",A^NN.L_]M(>MO_B[H("W
MC'4,#\C$-/$HME5,N:>&;G^?9Q9:U7_EVDBPV;!%C&,9 O;$/WM%+UX&,L!
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MPJ\9)8===;M9/F87]'"U.[;F'4]DM]7<.^>HG!T,0Y"+)D8Q80A>H@6FT7R
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M81&^V*,>&@KP=)EE']AZH<8=M33'1Y^7M7=</B_8IPPH=A2> :'S4G9!7.'
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MHOFH;P8KAO%#>*+XZ(D&;;_5C>,>KZZURS2>LG$BOHAZ(7;3P7'3)+O?P90
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M-&S9-K)UA/.]";EI>)9?!_UE+XS%"'SOVB$!3JVJ\%.S"=6I?,E-'W  %2<
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M(H#E ":1<VF[18BBY#Q[1U^-N5VQ?LR\0@[C\<5,9?#8BN.Q=ZN#?WPV^[<
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M70.H>A2+E:I2['8J@?^TP*30X9=)"MDIR/KI?,["#)@AU0.8).DLI"=*]S!
M0F8.!KN?4'73R[?$OB!C5/NY3*)>W<A\4'T1$X%'\]7.-%AW^ 1.0'/7=7*Q
M?U9H<V4DEP2H;?41 K<CYS,8;_PTB@ZS>UBEAE9MU-G:U0ZBRT^VN50,$\#"
M:R[N<7N#FTUM[:]+,BU7W1*5RT>L$"B)/D&GI%J;G;BSV1J7P_)#'&8;*X+W
M0IN<K$3/_ _>_#];K?\JU<OD*%HI DK_ A78H&L@OD'%#88Y@\@_V2Z,Z+CK
M&+ ,YZK?S>IS=/WE;#DCA7]7_ES!N&G ZQ@T&HG+0Q+O1\3 ;V CND(!-?$X
M>>)F\>*1> +LZ89D_9_IMT'35H/367.V$05:]&HE2?14*!NPU@D3-E,J RCX
MX>1[LU&6$U4Y"^=^Z$?]W@P.(82DR]1D5I>-"\.Z2Z)/,/WSF\D3&A%3$.*Y
M+8G2$J)&?WH4/BB_0+L9QQ\^%ZQR02;DNEQ8J"X(<2"/WGX7O&J(>C9D?#'U
MQNIU\RFDCLW*]/:NEF,S+<;I[RF>8U!</:I6ARK*UJV[P@"!PX<!:\21:?<_
M+9/=K^\OLJ^[0LP^#G?-G3R,C'QT/.5!HAP./-E O$+<^]#@95)S)_/WT*5S
M3 ?V_*^OT_E/2L5J2_7+@H"Z-9,?!>PE)94.6D,37PL4$D$#-WT^@2(,4 O,
M^K#!Y\9I4X,64D-DH0XUZ?!]8<C Y<-NB3C5 46<R[+*1A#%/[*?G#8!.SD*
MW]#HNK]S<\P>'-]RA*35*:,7P;WO,D/M7S/V>!)V6*4'BVH]JS.7/_5 >WM[
MY0<6M@,6:KOXF7IB\$\%?4?8@-)BM\H M:N0KZ&\YD;.?YO+H'@@.ZT;0L4,
M)IDP8%3G&@#O?T P^.+IE?;$<DZ1 0J*-_^X_T=K]M?=S=Z7:78JBGEG-0XN
M*7VNG8GE^@ 8NX4C QW;4+"!>W:0Y3)Q4ID J2^0-%5U-2!H4+3X""9'\'<'
M>3\K]$)ADL9/B\M,;X/^9]'XK0,HPZBOE<IHCT.ANX(PB\GO,.(YS!\3>T<*
MZQSRMWQ'1#+FUXL^Y&0SPF8NTHM93])J#!!ZEP':+48H(CL[&:#M%_-I$++L
M!P9HS.LU/ #FRP#]6T^_\,5L:Q<Q^2F3<U^0PUN)N/C_6] H]8:7U)B"D ;J
MSI.VNK=$5J64&XN]2G[D5JRXI(>&!1R7J<SX_.3X,7.N$^AY&* @3I59Q&^E
M-)HXKO<RNZ#$CUOZ4%'[VLE3P*M.K74#/[RSQIZ$O=O RK$>[?,29T[J4"E.
M5^_[9./U3#RSG=LA5VCWI8(A,P>U+?'6[+:?CQ"MM)#&\T1+&&#<VCM?>V4N
MBZ)&GYZ3[YCL$*NQ=P0#U=%C\Y'GHB=L5O?%+!_7Y3Z)'OIRR.= G8A.:M-=
M0/.[1@YW(H[63M2G.G\S;=>[/!:2$Q35I'AA0//N4?7?7T[Q<1^2HK;J?2&=
M\ HYF[2R?@ %S$=J,WT/F,UGY/_SYG.=:@.DXQB@)W3^=M)R6L.]VK%*GUG-
MU$%3)(_\GI_/)Z?Q"8QX9&/W&S;BT%:*F4>%E4_I"E&R>K/4^++30>9Y$%NF
M+9OBY)(+LQ8N [GD'%+Y*\E*ZHFRS]U6HR];#K^Y]^BV[_4]GL,C,XT_;R.Y
MO2-1TGZ1(_'].K2/T#EDS,2NXS9*M.W"(-5X8+/*S.LR+1M*ZXB^+$^_BUA=
M70!O.# /.TS.)45,ZV#M93F^6-/[1YS/55J6O50V?F"[^A!TV_@;O#I)XR""
M[7&7;Y/K]0_?G9Y<R83]J-H+==Z'?O-</O$5B->K>'%3U.OLA.RBRA_M1*7"
MLP-:0A^8C>+'@^M6(A=8_E6" 3"^,1VA&F2/WXJ?$^J8V#IL9.7+<D<"VK.Q
M[X3$>G.V1T.)Z71N!\+&9:MRJA^IS>2<P]-H'6O6J)0(YVS,_7C:R!$TV(AP
M+DLAE93]'+:]I<( A51@WLSY3=UNC*=>[PO7>HY7NFA4A^IF7SOA;K3M@%'X
MY;Y*Y25J+*CT?,J,!.-S&LJ[EGG#0Z_1;1;46#@)0;NY^++U (HQ7,-UD<@
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MAF/MPSNA_=J:\"L$#H6I+[NW&:#F^- ['1$[*,-VG\&?3!,HETC$?\9QMO>
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M3+X\, '/^A3TTSXK6GAJXJC^O=^_AZ_49%X=42F(Y)3UEL_UY$[-3\RXA81
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MS?N<D%6C^PMSE2F*)Y+S'HW.5S_;$3S/@MQ<&\&$-,M*MSE,\O4?VAGSP^[
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M7(S>3SA4#9)7ND+7YZ>E]R"FVM<X%XS0*:EW><^67NW0M?NQ:\'D7QI^_ZS
MSWIGKTG4Z--_7^T@O(*M7E];I_DP^](NP3PQD^G=,H)UCZL^>63.BG<FR.#U
MR\[N?4[HLF_/CS>O=(+=^C6R-D;XA]8C\91@ EW8F1QO[$MELZ7(=VC#>60!
M;%N"WWF$YW#NA%'XLX! WV7"$RPEK(D>V.U+3=CB>>((6RC??M*(=$.T<:U)
MLB F8^1RX85K/6KQ7W[G9Q:-S0]>'X(5J()1VCH+K12F>S5K,EZA5;W3*G=
MOKNJT=#SE05I''LOH+-1;S ZZ8!IG<10S!L^,PJN $6^OZ.8J63.0U8EO2'?
MQS;4C>]:/%:+NU/8C%F4^@TK=K%@'AH%4>R:0^FY3_!.W;;#=<J-Q_S5, VT
M_MJES>T*Q4X\!9FYRG=3,(5]K^%<\'GX,4S-NYH&#;=TNEGX6;82>X*^X@XA
M/Y92?+7>!G-F*9660E5G\I_[=B*IO/D0NK7NJ\&A?J(@<JV(8_B,H1=V]USS
M30!\)H<CIO4:4T&I;H9MK)&?LL5QX"K@W.:MEQ=!M Y/;6 4V6]UHGVM74;N
M2>5'-7J5K(3N?#]?^* >!-VIDJT^QML33YF#T!H6)%D/P5[^87F2$%N2-G#H
M_F]G_\/=!&T[X04-:]?"4VTY83?27)T$P)5U^'\69T>#1N7'D)[@]WJ>%QOH
MQ<P2.QN<61!^E/#7];J?69].Q6,.?XY9?%]U2R<DXVZJ6%\BGH>(:3T,(\W
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M53,5P6@Q;[R654N:TD#PHE11_;Y'5JIV_W!ZI[A)?[1GQU0\%5#<"B<3VU/
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M3K+R$)AP'BI/"X/6@T?U^8\-.G3G3USA[JFW0A2B("1-F ()?SF,K:&)2'E
M(YBE$D/$$8%4LA3&L9"A8C0+X]".#AVD3H\GC8K_8S_F1C0Q-\3>T[3%_++3
M/@". [/''G1&YTW,$KD!1N\K@L5L8;5WX@> =R1'WA_,3HZ](V =SKWMDT9S
M\!U-:SOYKK?V<_3-B^"U?L?J]ZM<\.?/<F'>R*_G-'^H/J[J;WY&] ( RQ F
M&0HABM($8A1'4 E&,.$!3Q!Q<=$NBYR<ZU9K98Z.N-&2FJV"G_+%[M//;BZ=
M!>AVKIY?* <F<:,L:&E[ ];Z@D;A&]"H[,^]LX?'D]MG(7!4=] >@$,WT>'.
MWCL,3[G)X7M7E&^*%5NJU?R6\V*EI].,) C35'N+Q 0M()512+#V&PF. KVZ
M3D--2(ZKPK/"ID8V6UV!TN]B7DJ1+\%<#X=MLH$5PM9+22^X#<PL&Y7 %\EE
M_F26CS<FW=,@5[/.VQ^/<F$.JKY(DSE*Y^<)N\\:\B)&_E:5YT6-O<Z\:/2)
ME>?E>]S7HN<.ZFL&H]7]NWGQ_<]2W,G;A3FO?[]XDM72.-/U+_]$\X6Y\C :
MX)74LT^:^)LX)A33",,DB347B2PRQ^Y$LU+"8Z:BB"9L=I3XU;E"&%CE/D%5
M(VRO_F04_[F9D#O=I0#Y8EFL-X?LUVU##_OE9?041G$<?CT?8[7=S#,& V,Q
MJ*VKCW^:/;^-U<T?;H Q?'O;H?4W@-7V=\9HC?Y=L%_[3^@[,=*>P<2^&TX;
M#R.-5L>&Q= :C+;1,1*4[0V2L43V6]^\D4J6V@5M=-+/N]4>_++2BLQXDF1"
M1 )F6:(@2J,0XB#C4,B4ZV?%*(F<,CO.BYK:VD;K!FBMG-M2I@-,NX6,'X@&
M?LUNE-SPIT&KT;,.7?:W9+F,AJ<%2X>@49<KEPT^7*Q8W-&7%]AREU]VF'GV
MET4IZ3S_+RD,-WTNFL22;:K9-W/I-_EC^4I;]_N,!A$),[,OPDUH!DXD)$K&
M, Y(2I*0\H@I-R+QIMO4F.=/I5EV[$RHER&RJGV1769H9?9X]Y-'*VUY*[<4
M+.^I=E>H]G)>2;DP\:YTO:FY*E9'$L &)O!&R@<3(55H+P9\DP^/14E+DX!Z
M=U<V:S# GMLNT6O]N[NB?'9E2G]?+UMJ?9$OS>!<;)%2?&ZPV\G&X!^UC< 8
M"6HK/48_#X"]-^;WI]G(KPKOD!Z_6_R+<'L9"9G/WFK.6C[?"J&GC1&SI//_
M-W]\70@YBS&7!!,)TR@-(4IP!%D<9#!,LTR$B@H2(9OW2K>8J;TB&DW!6M4;
MT"@+M+; J&O'PQ>0[:94?W@-S(Y]H;(F.#LD3G!5)?DO=\73K_H!#4WI'W;L
M=.&QHQ"-G6D;SK"\VGW;_." KSG3*]1O=+%2E"]7I9YQ,Q6&"0F#$"9Q("%B
M.(%,Q!%,2$*Q2%/M9H:VV18V J=&";N#_X>VFO7A_]YO+ , K(&_O/OL&\[1
M#_]WV.[I[!E(^ZU;WX".M/]Z/;!.6Z8N*'7L>UH]9K3-2Q>CVCN03O?U+0A1
M+<N5>986HC_(\DG><EZNZ/Q6_.>J62N&,\(P$J84,:4AA8@S$SH14YBQ,!,L
MP2+.F,M.@)W8J='U6D- MRHZ%VZP0MMN8>P?PX$Y>D]AL-;X!FQ0W2GMLWJ"
M"T;>ZB)8"1VYXH$+$,>U#)SNOJY0U=L?^?*U]D*K<);$$0XC(F" !-8+12D@
MYD0[B8' <9!0E**@1X698TE]0AK&6#)J!<V+EJT5[E>AJ@6H';/TQ&?DNE0U
M.+5Z_NM1'5ONN1152\"+5*$Z-O!< :H35_8_F7B_,$1BV**NE98)'*H@(E#)
M@$ 4*0H9YWJFQYB&.% D21U/*@]%3,V%J/=]=RKVJCQW DC[K?3^\(RQ(VZ/
M3*^][-/&>]R2/A P^L[R:0-/;1"?N;+?U#9M/<1J+C^I]PLA5;[(E_)#_F2.
M-Y=ZC',VE\WYYL$)4!RA5 6Q@DD0"H@()Y!E@80Q21(5I"E.$J?YWU./J9%$
M<YCXFI;EL_&4;Q],#*OQ W96P=HLL+-K?9+OQB1]Q\V.;D88C8$Y:6.!'?:#
M'L5=":8GCNNKQ:A$>"54AVQY[>-ZYJ_0YWJ#X9-ZDS_E0BY$];IX>"B:ZD@S
MF2**4Z&I4B&I5T81AB1,$YA))*102O^/SMK-32[G8G0*[+% &MJ3VFAI8AZJ
M>UK*=<DHQRR6;ISMF,X#=B-5*%HK:@CM4RGR!2V?P5;G&]!HW918\YC"8@6/
MKR26;F'CIK%8&7Z4R&)W5^^\N$=9+I\_Z^_%\G8A3(&U1R.N=CIF:2RXBDW8
M* JT1Y9R"8D4')(T46D2\D2$TC$SKD/<U!ROC;8WX-'H>U.';\F-RL[I<5U
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MRZQE;B;3MY(N*BW3M/Y<B/K3O/;--[5E;LN\TNSVIN:X@[:.*.(BX(Q"@:-
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M(M(^(4HAPG$ :1RG,$DQ2P2A/+ZFT6B7Z,D11:T?R-<J7QUHT0F['6L, ^;
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M\//G38-)O/8M]&I5Y0NI7V_\GZN\JNN):>FM3]O$DZ7^J<JUC'JO?,=#E/$
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M[LP%2],CR_0+T-;^XN>4XWI4.PX^KGCX:&<AUP/0/A[Q\+1^_NI'N6S><"9
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M[W%WOS7PVW^N\N6S.0(N%EK6)EY;ZO5N3!(8H%1[O32F$&>20Q&3*$@T]DG
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M*!!1&+,4LHAF$%$<0L(B"0.*%"6<<N'6RL-6\-3H8J,<X%H[-Z*PQMJ..(9
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MXB (- 63%")S3$KCE$/!PS05F)$(61]/M!\\-5K=Z :,<O9'#WM873YDZ(O
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MJ8FID0Q#S<<\Y8R(('1*RNT6-S5*;I_RMGL9_,-H#&J5>Y^+GX3;SN'S!^+
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MHIDYE!021CG,9**7=1AKU\AIT\:O>E.C\O?;-N* ;JUP#-'Q/(!V[N7+#<O
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MVO@?X$ !3I7B;YAV%--K 3T1.2>9L#$)8=P2I!)0L)Q#33E.,II+*KT;S/<
M^1"\60*^$XG4LV]WFYU&)(NA$=D"__5]Q1Y [9E]C[4+6:U=B.D$5%A'THAL
MP;6C1F0<?)])(_(BSCUH1%X'RE<CLN5.SZ,1>=VUBQJ1'I?>4$#>2'78DK?)
MJ0UG4ZA5@B'!.H%,&V/_6N1)SC$F85ILYX<9&U]7-<;SO9D="KA/L?3;J;L=
MH9[)MP+G("\I>CYJ.P@Q:Z=/!QF^-OJBHV=KGR]_.CQP?GO_,%\^:;VN)!_M
M5^2.K[7+:*V_LXPI1@6C$"%C([B,"LC3%$-#<V0,RCDR7OV'? 8;&PML[05K
M9R]XJ TN$];]XXFK$%\/T&("U_>Z>&MJ)?L*ML9Z)JZ'H^<?AL5$<:#X"T*7
MF:1_M7^"@R&!_CE;;]9EWNCF;K8&>E[V!/D50!@G%O-%JR4(NWJ+P:(O7V>:
M89?W-1%30)=R=I %Y&1=DH)1I5(&D<A32.QW!O+$%8\;)$C*,YV0H);7O@./
MC8W/R+E$T-KQG@:_X*T/<'MF[&.3@7MT@,N;G(#:;%#9'5D_)Q2K/G,9SPW[
M_/F)+6!XY1RV7=\Q >5Z&J,[W/QM5\G!L=!%:B@T*4^<0$X"!:(4YD11DFNA
M4^.U^=?5@+&Q6#/9X+J257B53>>)\N.W/N'OF>=Z0#X\"Z0C?+&2/$*''S:'
MHR,X)RD:7>_3C1+?S1:SC?[-WOM$Y/'EO2LW^-^2D-]6<<I_:[YZ9[_3TRQ'
ME.$DL;-46&(LBA2*Q!"8ZRS/"RJ,EC2$&+N9,39Z]#^!NA%^/[KK']2>2:]R
M )8>G&CK3H S7#I";'HS <X1X#R)QWRW(1F)_SH:,2@+W@;4,1?>>+<.&XJN
M<NIA-5OKMS^EGL^U=;K>J:%"Y[DF B)-!20Z%5!PHV"1)S1'W!1:>)\#7QYF
M;(RVMQ3L30W8_[J,I\>^8124^MXQ/ =0EYW"RT@%[!%&06R@W<&.R(5M UX%
MI&T#\/+%PVW]777@8-/O^J<[:T4>!Z&[$K]&+>K7Y6$EZK80=2J%X3E-%.2:
M&T@X36'!L("YS'!&E1V3B Y"LS>:Y?50#"](^_J<<C<_*OE=');\SFJ7 H]Z
M;YU7OSATB&D:K"+PTIJ[66P]\:W0CBI4&0/C>-*5-UDSM)AE#.C.R%M&N6T'
M^:75RMYHLUS\SF<+_?I.W\\DG__.%X^&R\VC^^4[+MTA_-.V$S9.A5)9 @N,
M4TB8M$R=R@SF'".W XHE\ZJ^Z#3ZV&+>G0.N&M7MH\G:!W#?= *8VHL  :'@
MB;D>)?<*=\]T>H+TUGQP8#_8.M AK@Z'/$"]J4_H!XK"XT]!F(Q35PC;!)V"
M[SF<M%-7=P]$GCK?I&OWB-7LN_T:NK?8>K-ZW"HV_U6K;TYI2MI?E?E<>]7F
M=:7'FVEE#!,,*IUJ&_:KW(G&,TB)9 RELF \J ==9TO&]HK9.P(:GI2*:;4O
M8.],0^/\NHA:Y!GT"_ 'F9>>WT7]34F'3A@WPAFM5T97.P;NIG$C7*?]-FZ]
M84>BG:T?EFL^_\MJ^?CP^B AXN7/V7HJ##.$<@&3@A:0Z,Q&Z505L$APR@G.
MN?#;@O8<;W2D69L+2GO!H<'@#V=R*"]> =R3_>+!V#?'W8)@.(WYX1*+K*Z,
M-BPE^;E^0CR>EW6CE]_YZI^ZW'/8RS[\MLN@$1GG BDGP& 4),:&:85 PL9J
MCEE(CC'B(>32.MK8J&5O;$.)Y8;\I7:H_6@E&H ]D\H-V 53BA<FD0BE?:Q!
MZ<3+[6,R\;NH:_JWC8MF+O>B3"__VV*V67_^\K=Z!P43H;G$$N:%22"A*8;,
MZ7,E1O DL0!0/TT)K]'&1B76L,!#F'8P<U&0+*448I,22/*L@"QA!:1)AC$G
M*$\SXU?T'QW.8<K]]^96E4PQP?5CXFB ]<S$#:2J\J724O#"?25_Z:',T0N7
M:'GO;6,-G.SNX?9IAKO/15T%?1I=@!H1G:"T($A#(@RVRT6F(2\8@ZD@DK),
M(XR\=M_:AQD;_];2-@U3.\1Q5Y!MIXUX>/7,%UVAZB )U(;$#>) 9V\[L$Q0
MFVNG@D&MG^X6C+TU1LO-[I#Y*__YF6]T+>@W6WS[^*!75<W9E&*4V,#!P)P:
M TDA[")/*6*#B41CJ8GK\1H2F?D//3J:V%I>EN%9(SVS&CN [A=D] -EWPRR
M0['.A7&=!IS=KGV]?8!F\UF=E!U-::4[7I$BD8"!!PU+P@$YCE$ZW*$C8RV^
MSU;+17F\/?^L[[6JOB9?9AO]9GG/9XLI3C)6,.6D&NP?=ME#(.-V-6F7CH5*
M$I82'+2&O#[DZ!BJ:3%HF R<S>"/RNK C2D/Y#WI*BJ>O0<ZMT$93D[>Z,0B
MI>L##DM&W@"<D)#_E=W(Y]7CV@9>Z_7KY;V8+<I[[\_QONJ?FU?6D7].#6<*
M*9E"2G3A=/\T%(B[TE^"59*;G- @X0*_8<=&0B_EOQYGE0)T=19^H;?;7_5<
ME7(>3E4ZC)(\Y\./EN*CW#,U;0T&#8L/FMH[HT%I=41^"H,I$D=Y#CHH3X4!
M<<Q5@5??FG[UCL]6?^?S1_VR;.)3-?M[^<U2XGKS>CEW-<,K/O^@-U/*$,OR
MC%O*TM2N\Q2"ELX*:!A/#6&)RCF9;I:68?W(JX,-04RVLZ2_!\UEY[\,:'YT
M"_Q^7-4SJ#T3U][Z"7#V@]*!28UQW0X4U$Z O1=EG40?N5+!($;/DO*WX)GR
MHX(ANIP9%7ZK:-&:VUKXMG -*MXK&R7.S(SORX)=O++2ZB_+I?HQF\]?'C1
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MR!^$TXR>@&L[2OUJL?GBXI9*-/P[G\W=INZ[Y<KU5:VD9!Z7C^N_+5::SYT
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M/K[U4EE+J6I#.ZR80J#W8XS8< Y8D[HW>P(:AH.MY>!%;?LO$_"A!>E@DNF
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M#WC\<+\5[UKD63_P>66:<;1J/G_<E3.*)$Y,=TPH@E"?.3@)M;%API83%)!
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MNWYR0R$_3D.Y4]@WQ3_K*1@ >SO=[1O/@?5X#>0+?E\6]*RJ!)B"5YIOC\V
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MI7/95)9((I91I%(8F\!%HBB&-(P)E&D01Y2EH1#,*2QZ._+4EMV6.;=J'<>
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M.TQ9"'W49<KFG7[*^E.^7&G+^?G#4J]*;0?7]_,?EKR0M)1O9?WG/,"!E"3
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M>-K5F<$L34(L.&0T0Y HED"& @'#.&"((17S*+JR\$4'^:DICU,U#BJ'0"7
MR[9ECD6 >LZ/G;(9#O6!=9!?P'T4A+# ;;B:#EW$;UV6P0(8B\H*-J.X*;YR
M_53,/]W-9:BU%Q?,9/3&D 0R@JF,)40HC*.41BEB5O9.,][45-,G6I:4/VPT
M=K;GERTRW3JDA[P#*X5/=]^_W[WYS]^_O_OQX_OUB_U P(Y8 O-DO7+-3_L5
MNQUAE"5XP.YV31W^<__#PKZA^=U/FB^J_N6KPGA%32O??+E9;<K?EX6D"U,
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MDAP2$B609B2" G$:*J&B@& G#_=EFE-35 W+E8+Z3:[N"_KTD/.VA>OHL[:
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M4H8R*(*$1Q$RH416>=$WX'UJRNK[YO'1>$Y6:IN,9R[N:N>*C>ODYM_"Y:N
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M05I,[?NO,0*L6RO 0V.&]2QU;0@0C25 [DWQ\\K#ILS-81]\(@;^7FSG8&<
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M']\O)C]]P_EB/)O^ZY_XG]F??L)IFN7Q]/.__NFOGWX!]Z?_\6__]$__\G\
M_*^7'W[]Z?4L75[@=/G3JSF&)>:?_A@OO_STMXR+O_]4YK.+G_XVF_]]_"T
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MDI*UZ)DT)X:YVZOU5$/<%0".E6//^O^5_G;R_LMLNDG5R)RDKW5I7D9B(&&
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M'/:+FXNKQ4@FC\9G#<7Y BIF\N"T<<"LDL9'GBUOG?/814>_-_?M 72RK >
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M66N]1<-T\T<_W1\&G>4BA@GQ@Y1XXB@1DL!\.0#<.AV0L2S!D],(RC*$Z%P
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MR8]L8V<.H[R1\=DLNAHS?WN]74$!X]55S\"P1 H*:A]JK,<-)\A@UIS)UB-
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M]@9@@;N W&KP(=775*R T\Z0L\R\0!%34JV[U3U$R\F^TIW/W74L$RVZE!3
M:JR9#Z_ 41P"R% ;%)B<;UWYM0=9/7<);8&->YY28V4,U@KM:(_W?C89'^DC
M/?9IG;7SVTWOH-KZ!45 M(Z!X3J"<K7LMP[,9+2@2^BC"ZWW[3#;^JUT]>/J
MZ\U.TMI%4U(&[SSMU!(4^*+(8?#%>MI8D>765X_[4?:/T #P$.P]V0#P=/T-
MH.7M+5G>Y<4Z*97-"+EX4V]C61UFBR!M5%9[SDMHG8AXC)Y^1Z;WC\!FNAH
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M]&\8ZI5J?C<E6W Y7W<U_7TVG6_^N+J J/]^+87T93K^KTM<W#$"V8BH1-*
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M,7KZ[IC<'BN'# <\2!M#./.O6]RO>_)O?)H7W\>+47#"Y<0\:%V9<4) M,Y
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M+./@33:&MI%C;I\7AT<3T,^1TQXYY]-"WR'J..<)O@F+Y8LR)Z']6IM O;C
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M7<#S$3^O]ARLX@9&<I'9F#H<,X,*OKY<9P71V,@]*W7?06N+]A1!XY8NGRJ
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M7GH]8'KT/D+N"C?^FB5#7#U@R3*ODS(9O$CD:X77$%TRY,BUM)$96Q[>$^^
MFZV?Z\DE-<=-&R&/O2!#"*/7U'\BA>-_89A7=3\.TW1VR@5G@<E"7*DLP7E9
MP& ,(3)AF=C%Y.S^Q9[:-!J@9R!1]V1X!+LY$^RA+15.*U,7BP;%39W$0T$^
M<0>%48C/*>F4#Z=+/V]XMG^NI]Z,UH:GD9![PLV-+;6<"_V )<^P1#H "16Q
M%!#!4]8)R16NK,H^"W>HPWK\N9[:+(9R6$<*N2O<;-_@D+5+F%$!=Y%BMU*7
M5"D5(944C%5$%<M[X^:X-1DG:K)HCILV0AX[T)%WUO+CY*_MOA>#U4:6 +8$
M71L!!/G>&,!1F.>\R58EO4N8L^/W>FJV:!'D#"'FGDS.C??U3-H'5C0ES25J
M#<*Z&K7Y6I2-E:4L0PF.*;]W3K[]<SWU5PP5XAPIY)YPL_:^DG/ST/LJ8YG-
M'LF %O*^O$[IQSIU)$K.G(T4N!V:DV_X7$]=$P.%.,<*N4?<D*X?1OM!VR0Y
M:O V>5"U'224VHXM I=9%&X</Q0WCS_757?$4, Y4LJCQSAWD?V[R?2)"X;$
M3"+B'6#R@H16' 5N5D-&M*DX[B/N%N3L^,&N6B":A#E#2+HGN[-VP5(R^S#J
M9\P@>D]2BK4C7Q!+GO( 2)&+Z) $Z-2!<<Z&SW75SS!0H'.LE$>W.W=AVJ=_
MX^7W)\Y#0%FXM B1<Q(;F@ Q%4G_DPJ+B0=K=G%:>WRRJWZ&)K9G&&GW:'VT
M>I0 ,,,2EY&#+)'\L;<1?*Z#T8K,VEDA'-L[6M[^N:YZ&(:R/D=*>6SK0S_0
MOGKS^N.+>\Q=,^:,?FA6E95"%:& _K;N%] !O$$/1B>E$_+DU4X+WO?Y:%?]
M"TU>LH:2>$\VZ"8G\.+1 R\F%+4X #!4LRJ*():")-_,5-#1YA .?938\+G=
MX'.NM\MMI#QJB_HCIM@-4^9134ED46 6&5(ASI0.E$XR5U>R":Z,4%+[Y[I@
M]OC<;M YG^OE(:3<H<U1C#]F*8B0&))'KBM?52P>8DD%<K%:FRQ%\KND[#M^
M;C?@G.GU<B,I=P4<MF9)/_:_+$<MDP$*Z$JM[*=0SAD+/-GD*)L,ENU?*KCU
M<[L!YUSOE]M(N2?@K', Q?FC'"#GHBD%2%!D'8X66%W%54AD,B4,L=C"#BW9
MV?"YW6H%S_1^N9&4>P(.%]<L"?7(B&;#'<,H25"F+O\L"AP+C'YKN7'96"7V
MK[W8^KG=@',^=\M#2+DKX,AKEJ1Z]-;B\FI.7@:79!TP["E5K"^\@IN((<=2
MV/XQSM;/[0:<,[U9;B3EKH"CKEE2ZM'KKBT^1TXR<KRL"I$T>#H'X*V-Q1!#
MZN'TYAV L_5SNP'G?&Z4AY!R5\"Y;O%0^C%+FG,6.),@L)8A15? FY1!&!M]
M,K*61>X-G*V?VPTX9WJ;W$C*70'G.E'4C#]ZGO,A(1G+#-P%!4IZ3T8T&B@U
M>U39%.7,WL#9^KG=@',^-\A#2+DGX*SC?;VA$$DH$9C-LHXI%Z"$Y% G!8%'
M'1.S@=.A.#"KVO"YW8!SIG?'C:3<7:_PV]L14S'X8A+176H%DI)6$$-UG"%/
MH8BBB:4'I1:C+FH[4<C3NKO\,'EW IN;S5 98T*CZR*$>H] IPD"NKK[F$6%
MAFGCAX#*/ENW3C[B=B]U/K%U:Q_9=@"+^R/*WLVFZ9J+VU%2QE&BE\2J'B35
MQY$ 4:Z*\$O).1C)BVR,E*<IZJE-N UX&FJ@ SSM,7_7H<BKU=<"ZTEA,4 @
M9L$ZXVI;AR(.!G58QX]&'@IG+3%Q^(#D?134'?16B^VL+05#8F"8E"2>X,$%
M8JADJ5460H6AAP3NND)P,)-U,BCM+? .(+-9.!?:"1MB*L!9)*$D%<%;'4&D
MH&,FC;??/+F9DG$CZ0&ATT#P'<#G>N@KOL5 /W 2XFHQW3UV4LJUJ(0#%]D2
M.UJ2 4UUMX'FI1!G@;<>(O@,2>,..Q@04"U5T0&R?EM_=LW6J]EBN7B'RPN?
M*,Q,*\%H))<L&81(SCF6PJ5@W(C4/G/;2,JXXP\&]6K'B[Z?:>T_^^A_3,/7
MV7PY^;^8Z]S@NGOESSE^G5Q]77$H97$6*<HCCHA#K< I(<$0?UKD6 1O/<-R
M#_+&G9MPLC"JG8J.!6'S".O%-+\*WR;+<+DRT^_CY>3S2H&+BR2TJ3W9D$TM
M_ [>UOK=3,R5>FLB3$$W8,2UG;)Q9RZ<* )KI)C#_>:L?OH.;JW7#/R&\\EW
M^C'?<1&(U944TX_?_TI?ZJC^#Y/%?_\1IN%Z:/^[,)^O_NGAJP>.^ER;=03M
M.&ZVHN"&H#M3MR#<_1WSY[HU(=%?39837&R89Z\9VFB* E4C-E54G>- @"\^
M\/HBK-&V]TL'DWN\Q][[TXOK5X[H71$E4/*M<IU;P!!<I#PJ%1N*E3(G;)UN
M'$SLV(\ IT'C8U=_"MUVD;\\9K1:G=7@7B%C4CE:B*YN))5!060R ]?2Y^@Q
M%]5Z<=E3])P=% ^!Q Y /$@_76'MU6RZ.J/WQL\K+:PNQH+VC (CRPU$Q1(8
M8T6(@:*:-)Q-?$Q/?U@[3.M;X72D"CJ T^O9'">?IS>QT@U#-U5&B2MC> $?
M6"T6H?,68REUWH(KC#DA1>N![$\2U N@CM7[P^N\9DKH %&?:GKS 9=7\^G'
M?X=O-_,6@F8LAP2<2XHCE(T0A4:@@Z>ER4&4TMHR;21D[!?U@1!TO-"[6&6]
M#@-^PP4=AVNM5&,MT5N7Z028K.@$)*G "Z-!RB L#RQRUWJ'YV9*>D'/*8.G
M!CKIP"H]YF)]ZAR7SNN80=2&>E6(!><] R:<0Q-44J'UH_DV6L;U;BWT_"QT
M#A!Z!^!Y-YOF-0^8U[;5>.&-E ;H_&1067N(@7[E@K$^.H59M@Z--I#1&V0.
MT>^LK; [P,MOM_2_6*QE=&>Q;UJ&A%&*F )?$GE[EB0$D0+D3-(QP?-H6ONT
M'<@:U\$-@J?6RN@"7QL"@;J!NR[@?OECS>4'O+Q^UO@R^;8RY=%'QCCWD+DW
M=6 GF?)$V:_FCGN=F4G<-(?<(92.75+?RQU58YUV@-P-;-STO2C&A*G[X*,,
MQ$B=+V*L@L+I3QD7+C2_NMI*3"_7#,,A87.@=J1:.L#7J[#X\OIR]N\U0S<S
M^[Q+P6*IHJFC9@.)IG;KDB,IW'-$%5K7]6\DI(MH[5@ESUI+O /8O,/EF^EW
M7"SK6?N9DVQCM"E*X.@E*&T0HJ#04^?(K' Y\I1:Q_E;J>DB/&L,H$:R'Q%%
MB_GRXJ;H8&6*LV;2R1*!TA,*5[E*$"F'AFRT*4XFQQ^.TMR,&?K!]_!"O[O#
MRL-OCKW7ZY0ATU'R'A$G:4WSQ8O+RS7]523KS=&"8?+%@A#<@J*,!*+-&63@
MDLF87<"G[J$6F/[7Y]GW_WWSC6O<W/SN#C=/T3".>SI.F[/&HNT!'K__X\.%
M,\HSDS5H62NX)1$>HI*D2!]C)E.+_"FWLS<<Z)OCJ+^=YAY"85\Q]J#Z_^?/
M_[K@)1DGI0>GZS"9R IX$@18I'#>:)>R?*HZ=&_5TS?'B2N&4_V^8NP@!#W$
MA;Z];<D5*7'&(P>QF@BL@X/H62*.M3!<1LWS*8J,=B9X['62W=SP#*+AKN#\
M;E;5&BY??*W5_1>BE%RT1<A.4F;HM2$_CQ90.Y8P*2%3^R;5S;1T>,TS#!RV
M O$(W72 L3_"7Y.O5U\_8'48-6L,RZOY9/GC?5D7U-R$E??JP_F%<S&5A!(P
M%@1EO*FW_A:T2 :-S8Q\36, 'D3H^=4:M$'G\%H=>1[6/Z9S#)>UY>GF4O?]
M]/YD@OLW:KAXD=+5UZO+^G[U?OD%YZ]F7XGH+SA=K'239E^Q_HAWN'Q?/H6_
M+EC*S(A(V1/3D@01$7PB^3/.0N!.&9%WV< P*)'G][YS'+3[TGH'EOLG9F_D
M\6GV$C]@N@R+Q:1,,/]KLOPRF5XO<OIC-EU^65Q(GZ0FG(+-)5$Z)S2E<X62
M N.+4,4I_G"]2-.+_#U(/;_[N#;6^Q2:[0# =P+^_:]T>94QUQ,ZFY*<;Y@F
MAF>?I_7 OYG^'N;5E2TNO/!>1U;G-.94YWU*BK", Q(I\S9HF>1PT>]>I)Y?
MAM8Z.!Y.L\T /&;KZ-V_K7)95,&0.FZ+;<+C8IO%:9I,CR#L].VHK:380>,J
M4IRA".B0B_-TZ@2%X$X:8*$HRY*B@&0XV]9'X^J351HO?UP';JO)8ZN)>O4C
M])<O?VSZ814GUY=.*&M_>XC 1%TYB+Q6=I"K1)<"&A^9?3A1>82ZK4.Y.[M+
MF(/P?GRUUTG0TU5DM:%KKZB4C$@(43D%)&$)428/AG-B22G.7.N[FS/KI>T
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MF0]YNO@:5FDS"\N;$GB==9:>>;#6DU$IE8:@L@+%DZ-%%.@1_@6CZKEGCPR
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M@.P(FAM%Q^X+P-^5[]_Y ;?#I5\O5NO5%AKQN\OX^SKQ$@W9K!$AL$18S;%
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M\H^'O-]!?HY7=?%=<!]^B^1#$O<3&3573!EP6/ESS@*YDQIR\E)Y7[))K:=
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M-\*?E43W_<ZK"O^KB'W]_]>WI],$;Q4*/!2<_D<V](E>QA,)B)6ZKB]>HZ;
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MI(BUH/!V2'TOZ'29D@TH[H%7)]\%>)HU75.A1&I%7ZQ64OBS"UO%5@K)C:0
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M<NM-OG YL/X-5Q7]I<FS_P)02P,$%     @ .H*!56]\BRIE!   K1(  !<
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MYI0';G?6S^JNR=YZ'?X#4$L! A0#%     @ .H*!52YM/9(U@0, [)TN !
M             ( !     &UD="TR,#(R,3 R."YH=&U02P$"% ,4    "  Z
M@H%5$!WI4J$8  !@&P$ $               @ %C@0, ;61T+3(P,C(Q,#(X
M+GAS9%!+ 0(4 Q0    ( #J"@55 PF2MWBT  #?7 0 4              "
M 3*: P!M9'0M,C R,C$P,CA?8V%L+GAM;%!+ 0(4 Q0    ( #J"@577CO@<
MGYP  -;8!@ 4              "  4+( P!M9'0M,C R,C$P,CA?9&5F+GAM
M;%!+ 0(4 Q0    ( #J"@54%43^&[[$  +3<   3              "  1-E
M! !M9'0M,C R,C$P,CA?9S$N:G!G4$L! A0#%     @ .H*!5=6$SJX+>P
M0Y,  !0              ( !,Q<% &UD="TR,#(R,3 R.%]G,3 N:G!G4$L!
M A0#%     @ .H*!56M92_0]D@   :H  !0              ( !<)(% &UD
M="TR,#(R,3 R.%]G,3$N:G!G4$L! A0#%     @ .H*!5=>!+<3 D0  1JD
M !0              ( !WR0& &UD="TR,#(R,3 R.%]G,3(N:G!G4$L! A0#
M%     @ .H*!59]!Z(?I9@$ B,\! !0              ( !T;8& &UD="TR
M,#(R,3 R.%]G,3,N:G!G4$L! A0#%     @ .H*!54P69%$Y#@, !K0$ !,
M             ( ![!T( &UD="TR,#(R,3 R.%]G,BYJ<&=02P$"% ,4
M"  Z@H%5[H6[2>:V  "RS0  $P              @ %6+ L ;61T+3(P,C(Q
M,#(X7V<S+FIP9U!+ 0(4 Q0    ( #J"@57^(9@$#K<   /.   3
M      "  6WC"P!M9'0M,C R,C$P,CA?9S0N:G!G4$L! A0#%     @ .H*!
M52Z<YLF>IP  N+X  !,              ( !K)H, &UD="TR,#(R,3 R.%]G
M-2YJ<&=02P$"% ,4    "  Z@H%5C[F,W[FG  #BO@  $P
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M              "  1_;$ !M9'0M,C R,C$P,CA?<')E+GAM;%!+ 0(4 Q0
M   ( #J"@56Q"N<%#0@  ',H   7              "  :NM$0!M9'0M,C R
M,W$R,3!Q>&5X,S$Q+FAT;5!+ 0(4 Q0    ( #J"@55DPF=!'P@  (\I   7
M              "  >VU$0!M9'0M,C R,W$R,3!Q>&5X,S$R+FAT;5!+ 0(4
M Q0    ( #J"@55O?(LJ900  *T2   7              "  4&^$0!M9'0M
M,C R,W$R,3!Q>&5X,S(Q+FAT;5!+ 0(4 Q0    ( #J"@55V36^&@ 0  % 3
M   7              "  =O"$0!M9'0M,C R,W$R,3!Q>&5X,S(R+FAT;5!+
4!08     %P 7 .D%  "0QQ$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
